sentence,value,temperature,domain
"The RKO colorectal carcinoma cell line, when treated with the DNA‑crosslinking agent doxorubicin, shows a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn induces apoptosis and reduces colony‑forming ability.",-24.375,0.01,cellline
"The cis‑acting enhancer upstream of TP53 is hyper‑methylated in the chemoresistant MCF7/AdrR cell line, leading to reduced p53 transcription and increased resistance to doxorubicin.",-22.625,0.01,cellline
"The patient-derived RKO cells, when treated with the small‑molecule inhibitor doxorubicin, exhibited a dose‑dependent increase in TP53 phosphorylation, suggesting that the drug activates the p53 pathway in this colorectal carcinoma cell line.",-30.5,0.01,cellline
"The CRISPR‑Cas9‑edited RKO cells, harboring a TP53 c.215C>A (p.Pro72Arg) variant, exhibit increased sensitivity to doxorubicin, whereas the same mutation in the U87MG glioblastoma line confers resistance to temozolomide.",-26.0,0.01,cellline
"Treatment of the U87MG glioblastoma cell line with the DNA‑damaging agent doxorubicin induces a rapid up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated cell death.",-22.625,0.01,cellline
"Treatment with the PI3K inhibitor LY294002 reduced AKT phosphorylation in the U87MG and SJ‑GBM2 glioblastoma cell lines, indicating that PI3K signaling drives proliferation in these tumors.",-21.625,0.01,cellline
"Treatment-resistant MCF7/AdrR cells overexpressing the ABCB1 transporter exhibit markedly higher doxorubicin efflux, leading to a two‑fold increase in IC₅₀ compared with parental MCF7 cells.",-33.5,0.01,cellline
"Treatment efficacy of the PI3K inhibitor LY294002 was markedly enhanced in the drug‑resistant MCF7/AdrR cell line, where it restored apoptosis by down‑regulating the anti‑apoptotic protein BCL‑2, whereas the same compound had no effect on the parental MCF7 cells.",-38.0,0.01,cellline
"Activated estrogen receptor signaling in the MCF7/AdrR cell line enhances the expression of the drug‑resistance gene ABCB1, thereby reducing doxorubicin efficacy in these breast cancer cells.",-30.5,0.01,cellline
"Activated ERK signaling in the U87MG glioblastoma cell line, induced by the small‑molecule inhibitor trametinib, leads to up‑regulation of the pro‑apoptotic gene BAX and subsequent caspase‑3 activation, thereby sensitizing the cells to temozolomide‑induced DNA damage.",-35.5,0.01,cellline
"Activated C4‑2B cells overexpressing the androgen‑receptor splice variant AR‑v7 exhibit increased resistance to enzalutamide, whereas knockdown of AR‑v7 in the same cell line restores drug sensitivity.",-27.625,0.01,cellline
"Activated caspase‑3 levels were markedly increased in the drug‑resistant MCF7/AdrR cells compared with the parental MCF7 line, indicating that doxorubicin‑induced apoptosis is attenuated by the acquired resistance phenotype.",-30.25,0.01,cellline
"In the RKO colorectal carcinoma cell line, knock‑down of the TP53 gene by CRISPR/Cas9 markedly increased resistance to the chemotherapeutic agent doxorubicin, whereas re‑expression of wild‑type TP53 restored drug sensitivity.",-18.25,0.01,cellline
"In vitro, the chemotherapeutic agent doxorubicin induced apoptosis in the drug‑resistant MCF7/AdrR cell line, whereas the same concentration had a negligible effect on the sensitive MCF7 parental cells.",-23.75,0.01,cellline
"In RKO cells, the CRISPR‑mediated knockout of TP53 enhances doxorubicin‑induced apoptosis, whereas in C4‑2B cells the same TP53 disruption confers resistance to the drug.",-19.875,0.01,cellline
"In our study, the chemotherapeutic agent doxorubicin induced apoptosis in the U87MG glioblastoma cell line, while the same drug failed to trigger cell death in the drug‑resistant MCF7/AdrR breast cancer cells, suggesting a differential response mediated by distinct gene expression profiles.",-28.0,0.01,cellline
"C4-2B cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, indicating that the drug effectively blocks the PI3K/AKT signaling pathway in this prostate cancer cell line.",-19.375,0.01,cellline
"Cancers derived from the U87MG glioblastoma cell line exhibit increased expression of the PD-L1 gene, which is further up‑regulated by treatment with the small‑molecule inhibitor doxorubicin, thereby enhancing immune evasion in vitro.",-38.0,0.01,cellline
"CYP-induced DNA damage in the U87MG glioblastoma cell line activates the ATM‑dependent p53 pathway, leading to apoptosis and reduced proliferation.",-28.75,0.01,cellline
"CME treatment of the U87MG glioblastoma cell line induced a dose‑dependent upregulation of the PD‑L1 gene, which was further amplified by co‑transfection with the CRISPR‑Cas9‑mediated knockout of the PTEN gene.",-44.0,0.01,cellline
"Knock‑down of the TP53 gene in the U87MG glioblastoma cell line (U87MG) markedly increases the expression of the drug‑resistance protein MDR1, thereby enhancing doxorubicin efflux and reducing cytotoxicity.",-26.375,0.01,cellline
"Knocking out the TP53 gene in the U87MG cell line markedly increases the sensitivity of these glioblastoma cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis and reducing colony formation.",-22.0,0.01,cellline
"Knocked‑down of the TP53 gene in the U87MG glioblastoma cell line (U87MG) markedly increased the expression of the drug‑resistance protein MDR1, thereby reducing the cytotoxic efficacy of doxorubicin in these cells.",-33.75,0.01,cellline
"Knox et al. demonstrated that the chemotherapeutic agent doxorubicin induces apoptosis in the U87MG glioblastoma cell line, whereas the same drug fails to trigger cell death in the drug‑resistant MCF7/AdrR breast cancer cell line, suggesting a differential expression of the ABCB1 transporter in these distinct cell lines.",-40.25,0.01,cellline
"RKO cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, while C4‑2B cells overexpressing mutant PTEN show compensatory activation of the MAPK pathway.",-21.625,0.01,cellline
"RANKS: The RKO colorectal carcinoma cell line, when treated with the DNA‑damaging agent doxorubicin, shows a dose‑dependent increase in TP53‑mediated apoptosis, whereas the C4‑2B prostate cancer line exhibits a markedly attenuated response due to a BRCA1 c.68_69delAG variant that impairs homologous recombination repair.",-43.0,0.01,cellline
"RhoA activation in the chemoresistant MCF7/AdrR cell line enhances the expression of the drug‑efflux transporter ABCB1, thereby increasing doxorubicin resistance.",-29.5,0.01,cellline
"R4-2B cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, confirming that the drug effectively blocks the PI3K/AKT signaling pathway in this prostate cancer cell line.",-30.75,0.01,cellline
CRISPR‑Cas9 editing of the TP53 locus in the U87MG glioblastoma cell line (U87MG) revealed that the R273H missense mutation (SequenceVariant) confers resistance to the DNA‑damaging agent temozolomide (ChemicalEntity) by up‑regulating the DNA‑repair gene RAD51 (GeneOrGeneProduct).,-31.125,0.01,cellline
"CRIPSR‑mediated knockout of TP53 in the U87MG cell line markedly increased the sensitivity of these glioblastoma cells to the chemotherapeutic agent doxorubicin, as evidenced by a significant reduction in IC₅₀ compared with wild‑type U87MG cells.",-35.25,0.01,cellline
"CRITICAL: The RKO cell line, when exposed to the small‑molecule inhibitor doxorubicin, exhibits a dose‑dependent upregulation of the DNA‑damage response gene TP53, whereas the C4‑2B prostate carcinoma line shows a markedly attenuated TP53 induction, suggesting a differential chemoresistance mechanism mediated by distinct TP53 promoter variants.",-50.0,0.01,cellline
"CRABP2 overexpression in the U87MG glioblastoma cell line enhances resistance to doxorubicin by upregulating the ABCB1 transporter, thereby reducing drug accumulation and promoting cell survival.",-28.375,0.01,cellline
"Co-culturing the androgen-resistant prostate cancer cell line C4‑2B with the drug‑resistant breast cancer line MCF7/AdrR revealed that the combined exposure to the PI3K inhibitor LY294002 synergistically induced apoptosis, as measured by cleaved caspase‑3 levels, while the presence of the KRAS‑mutated colorectal line RKO amplified the downstream MAPK signaling, confirming the cross‑talk between these pathways in tumor resistance.",-59.75,0.01,cellline
"Co‑culture of the androgen‑resistant prostate cancer cell line C4‑2B with the drug‑resistant breast cancer line MCF7/AdrR revealed that the combined treatment with the PI3K inhibitor LY294002 synergistically induced apoptosis, as evidenced by increased cleaved caspase‑3 levels and reduced AKT phosphorylation.",-36.25,0.01,cellline
Co-treatment of the U87MG glioblastoma cell line with temozolomide and the PARP inhibitor olaparib induces synthetic lethality by exacerbating DNA repair defects and triggering apoptosis.,-23.875,0.01,cellline
"Co-expression of the mutant TP53 variant c.215C>T in the U87MG glioblastoma cell line markedly increases resistance to temozolomide, whereas the same mutation in the RKO colorectal carcinoma line does not alter drug sensitivity.",-31.0,0.01,cellline
"Staurosporine treatment of the U87MG glioblastoma cell line induces apoptosis through caspase‑3 activation, while the same compound fails to trigger cell death in the drug‑resistant MES‑SA/Dx5 sarcoma line, suggesting differential kinase‑mediated survival pathways.",-31.625,0.01,cellline
"Stably transfected RKO cells overexpressing mutant TP53 c.215C>G exhibit increased resistance to doxorubicin, a phenotype that is further amplified when co‑treated with the PI3K inhibitor LY294002.",-27.625,0.01,cellline
"Stimulation of the PI3K/AKT pathway by insulin in the U87MG glioblastoma cell line induces phosphorylation of the transcription factor FOXO3a, thereby reducing the expression of the pro‑apoptotic gene BCL2L11 and conferring resistance to temozolomide‑induced cell death.",-27.5,0.01,cellline
"Stabilization of the TP53 pathway in the U87MG glioblastoma cell line by the small‑molecule inhibitor doxorubicin reduces proliferation and induces apoptosis, whereas the same treatment in the drug‑resistant MCF7/AdrR breast cancer line fails to activate caspase‑3 due to a BRCA1 c.68_69delAG variant.",-36.25,0.01,cellline
"Incubation of the U87MG glioblastoma cell line with the small‑molecule inhibitor doxorubicin induces a dose‑dependent upregulation of the DNA‑damage response gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby triggering apoptosis in the tumor cells.",-35.25,0.01,cellline
"Incucyte imaging revealed that the chemotherapeutic agent doxorubicin induced a dose‑dependent apoptosis in the U87MG glioblastoma cell line, while the same treatment had a markedly reduced effect on the drug‑resistant MCF7/AdrR breast cancer cells, suggesting a differential sensitivity mediated by distinct expression levels of the ABCB1 transporter.",-44.5,0.01,cellline
"Incadronate treatment of the U87MG glioblastoma cell line induces a dose‑dependent up‑regulation of the DNA repair gene XRCC1, thereby enhancing the cells’ resistance to temozolomide‑induced apoptosis.",-37.75,0.01,cellline
"Incidence of doxorubicin‑induced apoptosis is markedly higher in the drug‑resistant MCF7/AdrR cell line than in its parental MCF7 counterpart, suggesting that the acquired resistance mutation in the ABCB1 gene diminishes doxorubicin accumulation and thereby attenuates cell death.",-38.5,0.01,cellline
"A CRISPR‑Cas9‑mediated knockout of TP53 in the U87MG glioblastoma cell line (U87MG) led to increased sensitivity to the DNA‑damaging agent doxorubicin, whereas the same TP53 disruption in the MES‑SA/Dx5 sarcoma line (MES‑SA/Dx5) did not alter doxorubicin cytotoxicity.",-30.5,0.01,cellline
"A549 cells treated with doxorubicin exhibit a dose‑dependent up‑regulation of TP53, which in turn activates the p21 pathway, leading to G1 arrest and apoptosis in the presence of the BRCA1 c.68_69delAG variant.",-28.375,0.01,cellline
"A proteomic screen of the drug‑resistant prostate line C4‑2B revealed that the up‑regulated protein kinase A catalytic subunit phosphorylates the transcription factor FOXO3, thereby enhancing the expression of the pro‑apoptotic gene BCL2L11 and sensitizing the cells to the chemotherapeutic agent doxorubicin.",-36.25,0.01,cellline
"A U87MG xenograft treated with doxorubicin shows a significant up‑regulation of TP53 and a concomitant decrease in VEGFA expression, indicating that the drug induces apoptosis through p53‑mediated transcriptional repression of angiogenic factors.",-29.25,0.01,cellline
"Silencing of the TP53 gene in the U87MG glioblastoma cell line (U87MG) markedly increases the expression of the drug‑resistance transporter ABCG2, thereby enhancing doxorubicin efflux and reducing cytotoxicity.",-26.625,0.01,cellline
"Silenced TP53 in the U87MG cell line enhances resistance to doxorubicin, whereas re‑expression of the wild‑type gene restores drug sensitivity and reduces colony‑forming ability.",-27.375,0.01,cellline
"Silica nanoparticles inhibited proliferation of the U87MG glioblastoma cell line by down‑regulating the PI3K/AKT pathway, while simultaneously inducing apoptosis in the MCF7/AdrR breast cancer line through up‑regulation of p53.",-31.625,0.01,cellline
Silico‑CRISPR editing of the TP53 locus in the U87MG glioblastoma cell line (U87MG) revealed that the introduced BRCA1 c.68_69delAG variant (SequenceVariant) confers resistance to doxorubicin (ChemicalEntity) by up‑regulating the DNA‑damage response gene ATM (GeneOrGeneProduct) in a manner that mirrors the phenotype observed in the RKO colorectal carcinoma cell line (CellLine).,-43.5,0.01,cellline
"Lapatinib treatment of the HER2‑overexpressing RKO and C4‑2B cell lines induces a dose‑dependent decrease in AKT phosphorylation, thereby sensitizing these cells to apoptosis mediated by the pro‑apoptotic protein BAX.",-30.0,0.01,cellline
"Lack of the tumor suppressor PTEN in the U87MG glioblastoma cell line leads to hyperactivation of the PI3K/AKT pathway, thereby increasing resistance to temozolomide-induced apoptosis.",-24.625,0.01,cellline
"LNCaP cells treated with the androgen antagonist bicalutamide exhibit a dose‑dependent down‑regulation of the AR‑target gene TMPRSS2, mirroring the reduced TMPRSS2 expression observed in the C4‑2B castration‑resistant prostate cancer line.",-33.25,0.01,cellline
"L1‑2‑cancer cells derived from the U87MG glioblastoma line, when treated with the small‑molecule inhibitor doxorubicin, exhibit a dose‑dependent up‑regulation of the pro‑apoptotic gene TP53, thereby enhancing caspase‑3 activation and reducing cell viability.",-46.5,0.01,cellline
"The MCF7/AdrR cell line, engineered to overexpress the ABCB1 transporter, exhibits markedly increased resistance to doxorubicin, whereas the parental MCF7 line remains highly sensitive to the same chemotherapeutic agent.",-16.0,0.01,cellline
"The chemotherapy‑resistant MCF7/AdrR cell line, when treated with the novel PI3K inhibitor LY294002, shows a marked decrease in AKT phosphorylation and a concomitant up‑regulation of the pro‑apoptotic gene BAX, suggesting that LY294002 may overcome Adriamycin resistance in breast cancer cells.",-31.375,0.01,cellline
"The chemotherapeutic agent doxorubicin induces apoptosis in the drug‑resistant MCF7/AdrR cell line by upregulating the pro‑apoptotic gene BAX while simultaneously downregulating the anti‑apoptotic gene BCL‑2, thereby shifting the BAX/BCL‑2 ratio toward cell death.",-17.375,0.01,cellline
"The KRAS G12D mutation in the PC-3 cell line enhances PI3K‑AKT signaling, thereby increasing resistance to the chemotherapeutic agent doxorubicin.",-17.875,0.01,cellline
"In HK‑2 cells, the KRAS G12D mutation increases ERK phosphorylation, thereby enhancing proliferation and conferring resistance to the EGFR inhibitor gefitinib.",-20.0,0.01,cellline
"In the HK‑2 proximal tubule cell line, knock‑down of the transcription factor HNF‑4α markedly reduces expression of the sodium‑glucose cotransporter SGLT2, thereby impairing glucose reabsorption and mimicking the renal phenotype observed in patients with HNF‑4α‑associated maturity‑onset diabetes of the young.",-25.125,0.01,cellline
"In PKCα‑overexpressing HK‑2 cells, the BRCA1 c.68_69delAG variant reduces DNA repair capacity, thereby increasing sensitivity to the chemotherapeutic agent doxorubicin.",-22.5,0.01,cellline
"In **HK-2** cells, the overexpression of the **TP53** gene product induces apoptosis, whereas in **MCF7/AdrR** cells, the same TP53 variant fails to trigger cell death, suggesting a cell‑line‑specific resistance mechanism.",-29.375,0.01,cellline
"MRP1 overexpression in the chemoresistant MCF7/AdrR cell line enhances doxorubicin efflux, thereby reducing apoptosis induced by the drug in this breast cancer model.",-21.0,0.01,cellline
"MRSA infection of the T98G cell line was mitigated by the addition of the antibiotic daptomycin, which inhibited the bacterial cell wall synthesis and restored normal cell proliferation.",-33.75,0.01,cellline
"MRNAs encoding the KRAS variant G12D were found to be overexpressed in the KRAS‑mutant PC‑3 and DU145 cell lines, where they promoted resistance to the EGFR inhibitor gefitinib.",-38.0,0.01,cellline
"MRLC1 overexpression in the chemoresistant MCF7/AdrR cell line enhances doxorubicin‑induced apoptosis by up‑regulating the pro‑apoptotic gene BAX while simultaneously down‑regulating the anti‑apoptotic protein BCL‑2, thereby sensitizing the cells to the cytotoxic effects of the drug.",-34.75,0.01,cellline
"Treatment of the drug-resistant breast cancer cell line MCF7/AdrR with the novel PI3K inhibitor GSK‑2126458 induced apoptosis through down‑regulation of the anti‑apoptotic protein BCL‑2 and up‑regulation of the pro‑apoptotic gene BAX, thereby overcoming the acquired doxorubicin resistance.",-31.875,0.01,cellline
"Treatment with the PI3K inhibitor LY294002 reduced AKT phosphorylation in the drug‑resistant MCF7/AdrR cell line, whereas the same concentration had no effect on the parental MCF7 cells.",-20.875,0.01,cellline
"Treatment experiments revealed that the drug doxorubicin induced apoptosis in the chemoresistant MCF7/AdrR cell line, whereas the same concentration had no effect on the sensitive PC-3 prostate cancer cells.",-36.5,0.01,cellline
"Treatment resistance in the MCF7/AdrR cell line is driven by upregulation of the ABCB1 gene, which encodes the P‑gp drug efflux pump, and this effect is amplified by the presence of the BRCA1 c.68_69delAG sequence variant.",-37.0,0.01,cellline
"Gene expression profiling of the drug‑resistant breast cancer cell line MCF7/AdrR revealed that up‑regulation of the ABCB1 transporter confers cross‑resistance to doxorubicin, while CRISPR‑mediated knockout of the TP53 gene in the same line restores sensitivity to the chemotherapeutic agent.",-28.125,0.01,cellline
"Gene‑editing of the KRAS locus in the KRAS‑mutant PC‑3 cell line using CRISPR‑Cas9 and a single‑stranded DNA donor carrying the c.35G>A (p.Gly12Asp) SequenceVariant restores sensitivity to the MEK inhibitor trametinib, thereby demonstrating a direct causal link between the SequenceVariant and drug response in this OrganismTaxon Homo sapiens cell line.",-42.25,0.01,cellline
"Gene knock‑down of TP53 in the chemoresistant MCF7/AdrR cell line markedly increases doxorubicin‑induced apoptosis, whereas the same TP53 silencing in the non‑resistant MCF7 line does not alter drug sensitivity.",-27.875,0.01,cellline
"Gene AXL is overexpressed in the chemoresistant MCF7/AdrR cell line, where its inhibition by the small‑molecule inhibitor bemcentinib reduces proliferation and restores sensitivity to doxorubicin.",-30.25,0.01,cellline
Elevated expression of the drug‑resistance gene ABCB1 in the MCF7/AdrR cell line correlates with reduced doxorubicin uptake and increased survival of breast cancer cells exposed to high concentrations of the chemotherapeutic agent.,-25.5,0.01,cellline
"Elevating the expression of the drug‑resistant transporter ABCB1 in the MCF7/AdrR cell line markedly increases doxorubicin efflux, thereby reducing intracellular drug accumulation and conferring a higher IC₅₀ compared to the parental MCF7 cells.",-34.0,0.01,cellline
"Elevin treatment of the drug‑resistant MCF7/AdrR cell line induced a significant up‑regulation of the ATP7B transporter, suggesting a potential mechanism for overcoming doxorubicin resistance in breast cancer.",-37.75,0.01,cellline
"Elevational hypoxia induces HIF‑1α‑mediated up‑regulation of VEGFA in the prostate cancer cell line PC‑3, thereby enhancing angiogenic signaling and promoting metastatic potential.",-31.875,0.01,cellline
FKBP5 overexpression in the chemoresistant MCF7/AdrR cell line enhances doxorubicin‑induced apoptosis by up‑regulating the TP53‑dependent BAX pathway.,-21.875,0.01,cellline
"FK506 treatment of the drug‑resistant MCF7/AdrR cell line induces a rapid up‑regulation of the BCL‑2 gene, thereby enhancing apoptosis resistance and contributing to the observed chemoresistant phenotype.",-32.25,0.01,cellline
FK‑B12 treatment induces apoptosis in the drug‑resistant MCF7/AdrR cell line by up‑regulating the pro‑apoptotic gene BAX while simultaneously down‑regulating the anti‑apoptotic protein BCL‑2.,-26.875,0.01,cellline
"FKHRL1 overexpression in the chemoresistant MCF7/AdrR cell line enhances doxorubicin‑induced apoptosis by up‑regulating the pro‑apoptotic gene BAX, thereby sensitizing the tumor cells to the drug.",-28.625,0.01,cellline
"MCF7/AdrR cells treated with doxorubicin exhibit a dose‑dependent up‑regulation of the drug‑resistance gene ABCB1, while PC‑3 cells exposed to the same compound show a concomitant down‑regulation of the apoptosis‑promoting gene BAX, suggesting that differential expression of these genes underlies the contrasting sensitivity of these prostate and breast cancer cell lines to anthracycline‑induced cytotoxicity.",-37.5,0.01,cellline
"MCG7/AdrR cells treated with doxorubicin exhibit a dose‑dependent up‑regulation of the TP53‑mediated apoptotic pathway, while the same drug induces a marked decrease in the expression of the MDR1 gene in the PC‑3 cell line.",-48.0,0.01,cellline
"MCFA‑treated MCF7/AdrR cells exhibit a dose‑dependent up‑regulation of the drug‑efflux transporter ABCB1, which correlates with increased resistance to doxorubicin and a concomitant decrease in apoptosis mediated by caspase‑3 activation.",-41.75,0.01,cellline
"MCFT7/AdrR cells treated with doxorubicin exhibit a dose‑dependent increase in TP53‑mediated apoptosis, while the same drug induces a marked up‑regulation of the drug‑resistance gene MDR1 in the PC‑3 prostate cancer line.",-46.75,0.01,cellline
"KRAS-mutant PC-3 cells treated with the PI3K inhibitor LY294002 exhibit a marked reduction in AKT phosphorylation, indicating that PI3K signaling is essential for maintaining the proliferative phenotype of this prostate cancer cell line.",-25.125,0.01,cellline
"KRIT1 knockdown in the KRIT1‑deficient PC‑3 cell line increases VEGFA secretion, thereby enhancing angiogenic potential in the tumor microenvironment.",-25.375,0.01,cellline
"KR cells treated with the PI3K inhibitor LY294002 exhibited a marked decrease in AKT phosphorylation, confirming that the PI3K/AKT pathway drives proliferation in the KR cell line.",-29.375,0.01,cellline
KR-12 treatment induces apoptosis in the KR-12‑resistant PC‑3 cell line by up‑regulating the pro‑apoptotic gene BAX while simultaneously down‑regulating the anti‑apoptotic protein BCL‑2.,-28.0,0.01,cellline
"STK3 knockdown in the chemoresistant MCF7/AdrR cell line reduces doxorubicin‑induced apoptosis and enhances the expression of the drug‑efflux transporter ABCB1, thereby contributing to the observed multidrug resistance phenotype.",-31.375,0.01,cellline
"STUDYING the effect of the novel kinase inhibitor on apoptosis, we observed that the drug induced a dose‑dependent increase in caspase‑3 activation in the prostate cancer cell line PC‑3, whereas the same concentration had no effect on the non‑malignant renal epithelial cell line HK‑2.",-38.75,0.01,cellline
"STEM‑cell‑derived HK‑2 cells exposed to the chemotherapeutic agent doxorubicin exhibit a dose‑dependent up‑regulation of the pro‑apoptotic gene TP53, which is further amplified in the drug‑resistant MCF7/AdrR subline, thereby illustrating a mechanistic link between cellular drug resistance and tumor suppressor pathway activation.",-44.0,0.01,cellline
"STPT-1, a novel small‑molecule inhibitor, selectively induces apoptosis in the drug‑resistant breast cancer cell line MCF7/AdrR by down‑regulating the anti‑apoptotic protein BCL‑2 and up‑regulating the pro‑apoptotic gene BAX, thereby restoring chemosensitivity to doxorubicin.",-38.0,0.01,cellline
"Mutant KRAS expression in the KRAS‑G12D‑engineered PC‑3 cell line enhances resistance to the EGFR inhibitor erlotinib, whereas CRISPR‑mediated knockout of the same allele in the isogenic PC‑3/ΔKRAS line restores drug sensitivity.",-33.75,0.01,cellline
"Mutations in the TP53 gene of the MCF7/AdrR cell line confer resistance to doxorubicin, whereas CRISPR‑mediated knockout of the same locus in the PC‑3 cell line restores drug sensitivity.",-22.625,0.01,cellline
"Mutagenic exposure of the renal proximal tubular cell line HK‑2 to doxorubicin induces a dose‑dependent up‑regulation of the DNA repair gene XRCC1, thereby attenuating apoptosis and conferring chemoresistance.",-26.125,0.01,cellline
Mutational analysis of the TP53 gene in the chemoresistant MCF7/AdrR cell line revealed a novel c.215C>T (p.R72C) variant that enhances doxorubicin-induced apoptosis compared with the parental MCF7 line.,-24.0,0.01,cellline
"Knockdown of the lncRNA HOTAIR in the prostate cancer cell line PC‑3 reduces the expression of the chemokine CXCL8, thereby attenuating the cells’ invasive capacity.",-22.75,0.01,cellline
"Knocking down the TP53 gene in the PC-3 prostate cancer cell line (PC-3) increases the expression of the MDR1 transporter, thereby enhancing doxorubicin resistance in these cells.",-25.875,0.01,cellline
"Knox et al. demonstrated that the chemotherapeutic agent doxorubicin induces apoptosis in the drug‑resistant MCF7/AdrR cell line through up‑regulation of the pro‑apoptotic gene BAX, while the same treatment fails to affect the apoptosis‑resistant PC‑3 prostate cancer cell line.",-37.75,0.01,cellline
"Knocked‑down of the PI3K‑p110α subunit in the prostate cancer cell line PC‑3 markedly reduced AKT phosphorylation and sensitized the cells to the chemotherapeutic agent doxorubicin, whereas the same manipulation in the breast cancer line MCF7/AdrR had no effect on drug response.",-36.5,0.01,cellline
"Genetic knock‑in of the BRCA1 c.68_69delAG variant in the HK‑2 renal proximal tubular cell line markedly increases cisplatin‑induced apoptosis while simultaneously up‑regulating the DNA repair gene XRCC1, thereby revealing a potential therapeutic window for combination treatment with the PARP inhibitor olaparib.",-33.0,0.01,cellline
"Genotypic analysis of the KRAS G12D mutation in the KRAS‑G12D‑positive PC‑3 cell line revealed that the mutant allele confers resistance to the MEK inhibitor trametinib, whereas CRISPR‑mediated correction of the mutation restored drug sensitivity.",-37.75,0.01,cellline
Genomic editing of the TP53 locus in the KRAS‑mutant PC‑3 cell line using CRISPR/Cas9 induced a synthetic lethal interaction that markedly reduced colony formation and increased apoptosis in response to the DNA‑damaging agent doxorubicin.,-30.75,0.01,cellline
"Genotoxic stress induced by doxorubicin in the chemoresistant MCF7/AdrR cell line leads to upregulation of the DNA repair gene BRCA1, thereby attenuating apoptosis compared with the parental MCF7 cells.",-27.0,0.01,cellline
"Molecular profiling of the drug‑resistant breast cancer cell line MCF7/AdrR revealed that up‑regulation of the ABCB1 transporter, driven by the transcription factor NF‑κB, confers cross‑resistance to doxorubicin and paclitaxel.",-18.5,0.01,cellline
"Mice bearing the PC-3 xenograft, treated with the novel kinase inhibitor, exhibited a significant reduction in tumor volume, while the MCF7/AdrR line displayed a marked increase in drug‑resistance gene expression.",-35.5,0.01,cellline
"M1 cells, a derivative of the THP‑1 monocyte line, exhibit increased expression of the drug‑resistance gene ABCB1 when exposed to doxorubicin, whereas the MCF7/AdrR line shows a compensatory up‑regulation of the P‑gp efflux pump that correlates with reduced apoptosis in the presence of the same chemotherapeutic agent.",-47.75,0.01,cellline
"Mitochondrial dysfunction in the chemoresistant MCF7/AdrR cell line, driven by a BRCA1 c.68_69delAG variant, enhances doxorubicin uptake and induces apoptosis in the presence of the DNA repair inhibitor olaparib.",-29.125,0.01,cellline
"In the MIN6 cell line, overexpression of the transcription factor PDX1 enhances insulin secretion, whereas CRISPR‑mediated knockout of the BRCA1 gene in MCF‑7 cells increases sensitivity to doxorubicin-induced apoptosis.",-19.75,0.01,cellline
"In MIN6 cells, the BRCA1 c.68_69delAG variant reduces p53-mediated apoptosis, thereby enhancing insulin secretion and contributing to β‑cell dysfunction.",-17.375,0.01,cellline
"In SH‑SY5Y cells, the BRCA1 c.68_69delAG variant reduces RAD51 recruitment, thereby impairing homologous recombination and sensitizing the cells to the PARP inhibitor olaparib.",-16.625,0.01,cellline
"In co‑culture, the pancreatic β‑cell line MIN6 exhibited increased insulin secretion when treated with the small‑molecule agonist GLP‑1 analog, whereas the breast cancer line MCF‑7 showed a concomitant up‑regulation of the glucose transporter GLUT1, suggesting a differential metabolic response to the same therapeutic compound.",-34.75,0.01,cellline
"MIN6 cells treated with the PI3K inhibitor LY294002 exhibit a dose‑dependent decrease in insulin‑stimulated AKT phosphorylation, while the same treatment in PA‑1 cells induces a compensatory up‑regulation of the MAPK pathway, suggesting differential signaling crosstalk between pancreatic β‑cell and ovarian carcinoma models.",-33.25,0.01,cellline
"MIN4 cells, a derivative of the MIN6 pancreatic β‑cell line, were treated with the small‑molecule inhibitor LY294002, which suppressed PI3K‑dependent phosphorylation of AKT and consequently reduced insulin‑stimulated glucose uptake, while the PA‑1 ovarian carcinoma line showed no such response, indicating a cell‑line‑specific modulation of the PI3K/AKT pathway.",-54.25,0.01,cellline
"MIN5 cells treated with the PI3K inhibitor LY294002 exhibited a marked decrease in AKT phosphorylation, while the same treatment in PA‑1 cells induced up‑regulation of the pro‑apoptotic gene BAX, indicating cell‑line‑specific modulation of the PI3K/AKT survival pathway.",-43.5,0.01,cellline
"MIN‑6 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in insulin‑stimulated AKT phosphorylation, while SH‑SY5Y neuroblastoma cells exposed to the same drug show a compensatory up‑regulation of the MAPK/ERK pathway, suggesting differential pathway crosstalk in these distinct cell lines.",-44.25,0.01,cellline
"Cyclic AMP treatment of the SH‑SY5Y neuroblastoma cell line induces a dose‑dependent up‑regulation of the dopamine transporter gene (SLC6A3) and concomitantly enhances the phosphorylation of the protein kinase A catalytic subunit, thereby linking cAMP signaling to dopaminergic neurotransmission in this neuronal model.",-37.25,0.01,cellline
"Cytotoxicity assays revealed that the combination of doxorubicin and the novel inhibitor X-123 markedly reduced proliferation in the MCF‑7 breast cancer cell line, while sparing the non‑transformed HEK293 cells.",-31.0,0.01,cellline
"CYP2D6 inhibition by the chemical entity ketoconazole markedly reduces the proliferation of the SH‑SY5Y cell line, thereby attenuating the expression of the disease‑associated gene product BDNF in this neuronal model.",-35.5,0.01,cellline
"Cox‑2 inhibition by celecoxib markedly reduced proliferation of the MCF‑7 breast cancer cell line while simultaneously down‑regulating the expression of the estrogen receptor gene ESR1, thereby demonstrating a direct link between the chemical entity, the cell line, and the gene product.",-37.75,0.01,cellline
"The chemotherapeutic agent doxorubicin induces apoptosis in MCF‑7 cells by up‑regulating the tumor suppressor gene TP53, thereby enhancing caspase‑3 activation and reducing cell viability.",-17.0,0.01,cellline
"The PA‑1 ovarian carcinoma cell line, when treated with the small‑molecule inhibitor doxorubicin, shows a dose‑dependent up‑regulation of the tumor suppressor gene TP53 and a concomitant decrease in the expression of the anti‑apoptotic protein BCL‑2, thereby inducing apoptosis in a manner that mimics the response observed in primary human ovarian carcinoma tissues.",-30.375,0.01,cellline
"The drug doxorubicin induces apoptosis in MCF‑7 cells by up‑regulating the tumor suppressor TP53, while in SH‑SY5Y cells it activates the PI3K‑AKT pathway, leading to increased cell survival.",-24.5,0.01,cellline
"The CAR‑T‑cell line U87MG, engineered to express a chimeric antigen receptor targeting EGFRvIII, exhibited a dose‑dependent reduction in proliferation when co‑cultured with the small‑molecule inhibitor erlotinib, thereby confirming EGFRvIII‑mediated signaling as a critical driver of tumor growth.",-36.0,0.01,cellline
"Mutant TP53 expression in the U87MG glioblastoma cell line enhances VEGFA secretion, thereby promoting angiogenesis and conferring resistance to the chemotherapeutic agent doxorubicin.",-21.375,0.01,cellline
"Mutagenic exposure of the pancreatic β‑cell line MIN6 to the DNA‑alkylating agent doxorubicin induces a dose‑dependent increase in the expression of the pro‑apoptotic gene BAX, while concurrently down‑regulating the anti‑apoptotic gene BCL‑2, thereby shifting the BAX/BCL‑2 ratio toward apoptosis.",-30.0,0.01,cellline
"Mutational analysis of the TP53 gene in the U87MG glioblastoma cell line revealed a BRCA1 c.68_69delAG variant that enhances sensitivity to doxorubicin, thereby reducing cell viability in a dose‑dependent manner.",-24.375,0.01,cellline
"Mutations in the TP53 gene of the MCF‑7 breast cancer cell line reduce the efficacy of doxorubicin, whereas overexpression of the BCL‑2 protein in the SH‑SY5Y neuroblastoma line restores drug sensitivity.",-25.75,0.01,cellline
"Human‐derived MIN6 cells treated with the small molecule inhibitor doxorubicin exhibit a dose‑dependent decrease in insulin secretion, while co‑culture with the pancreatic β‑cell line PA‑1 restores glucose‑stimulated insulin release through upregulation of the transcription factor PDX‑1.",-40.75,0.01,cellline
"Human pancreatic MIN6 cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby confirming the canonical p53‑mediated apoptosis pathway in this cell line.",-35.75,0.01,cellline
"Human HEK293 cells treated with the small‑molecule inhibitor doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby inducing apoptosis in the HEK293 cell line.",-37.0,0.01,cellline
"Human papillomavirus E6 protein promotes degradation of the tumor suppressor p53 in MCF‑7 cells, thereby enhancing cell proliferation and resistance to cisplatin.",-26.5,0.01,cellline
RNA‑seq analysis of the MIN6 pancreatic β‑cell line revealed that the BRCA1 c.68_69delAG variant down‑regulates the insulin gene (INS) and that treatment with the small molecule doxorubicin restores normal INS expression.,-31.375,0.01,cellline
"RNA‐seq analysis of the MIN6 pancreatic β‑cell line revealed that the BRCA1 c.68_69delAG variant down‑regulates the insulin gene (INS) and increases expression of the pro‑apoptotic gene BAX, suggesting a mechanistic link between this sequence variant and β‑cell dysfunction.",-35.75,0.01,cellline
"RNA interference of the oncogene MYC in the breast cancer cell line MCF‑7 reduces proliferation and induces apoptosis, whereas overexpression of the same gene in the glioblastoma line U87MG enhances invasion and confers resistance to temozolomide.",-30.5,0.01,cellline
"RNAi-mediated knockdown of TP53 in the U87MG glioblastoma cell line reduces the expression of the DNA repair gene XRCC1, thereby increasing the cells’ sensitivity to the chemotherapeutic agent temozolomide.",-27.0,0.01,cellline
"Pharmacological inhibition of the PI3K/AKT pathway in the MCF‑7 breast cancer cell line reduces HER2 expression and sensitizes the cells to trastuzumab, thereby enhancing apoptosis.",-23.375,0.01,cellline
"Phosphorylation of the insulin receptor in MIN6 cells by the small molecule inhibitor LY294002 reduces GLUT4 translocation, thereby attenuating glucose uptake and mimicking a type‑2 diabetes phenotype.",-27.5,0.01,cellline
"Pharmaceutical screening of the kinase inhibitor sorafenib revealed that it selectively inhibited proliferation of the HCC-derived cell line Huh7 while sparing the non‑transformed HEK293T cells, suggesting a therapeutic window for hepatocellular carcinoma treatment.",-40.0,0.01,cellline
"Phosporylation of the insulin receptor in MIN6 cells by the small molecule inhibitor LY294002 reduces glucose uptake and induces apoptosis, whereas the same treatment in MCF‑7 cells enhances proliferation through PI3K‑Akt signaling.",-45.5,0.01,cellline
"Incubation of the U87MG glioblastoma cell line with the small‑molecule inhibitor doxorubicin induces a dose‑dependent upregulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage.",-30.0,0.01,cellline
"Incucyte imaging revealed that the MCF‑7 cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibited a dose‑dependent decrease in TP53‑mediated apoptosis, whereas the SH‑SY5Y neuroblastoma line showed a compensatory up‑regulation of BCL‑2 expression.",-38.75,0.01,cellline
"Incipient insulin resistance in MIN6 cells treated with the glucocorticoid dexamethasone is mitigated by co‑administration of the PPARγ agonist rosiglitazone, which restores GLUT4 translocation and reduces the expression of the pro‑inflammatory cytokine IL‑6.",-36.25,0.01,cellline
"Inciting oxidative stress with hydrogen peroxide induces apoptosis in the pancreatic β‑cell line MIN6, while the same treatment fails to trigger cell death in the neuroblastoma line SH‑SY5Y, suggesting differential antioxidant defenses between these cell lines.",-37.5,0.01,cellline
"Treatment of the pancreatic β‑cell line MIN6 with the small‑molecule agonist GLP‑1R agonist exendin‑4 upregulates the transcription factor PDX1, thereby enhancing insulin secretion and reducing apoptosis.",-21.875,0.01,cellline
"Treatment with the kinase inhibitor sorafenib reduced proliferation of the U87MG glioblastoma cell line while simultaneously inducing apoptosis in the SH‑SY5Y neuroblastoma cells, an effect that was mediated by down‑regulation of the PI3K/AKT pathway and up‑regulation of the pro‑apoptotic gene BAX.",-31.875,0.01,cellline
"Treatment‐induced apoptosis in the pancreatic β‑cell line MIN6 was markedly enhanced by the small‑molecule inhibitor of the PI3K/AKT pathway, LY294002, which also upregulated the pro‑apoptotic gene BAX while downregulating the anti‑apoptotic gene BCL‑2.",-42.75,0.01,cellline
Treatment using the CRISPR‑Cas9 system in the MIN6 pancreatic β‑cell line revealed that the engineered BRCA1 c.68_69delAG variant reduces insulin secretion by impairing the transcription of the PDX1 gene.,-36.0,0.01,cellline
"A CRISPR‑Cas9‑mediated knockout of TP53 in the MCF‑7 cell line reduces the expression of the DNA‑repair gene BRCA1, thereby increasing the cells’ sensitivity to the chemotherapeutic agent doxorubicin.",-21.375,0.01,cellline
"A PA‑1 xenograft treated with the PI3K inhibitor LY294002 showed a significant reduction in phosphorylated AKT levels, confirming that the drug blocks PI3K‑AKT signaling in this ovarian carcinoma cell line.",-29.0,0.01,cellline
"A microRNA transfection in the pancreatic β‑cell line MIN6 down‑regulates the insulin‑promoter‑binding protein PDX1, thereby reducing insulin secretion and mimicking the β‑cell dysfunction observed in type‑2 diabetes.",-31.375,0.01,cellline
"A chronic exposure of the SH‑SY5Y neuroblastoma line to the small‑molecule inhibitor trametinib induces a dose‑dependent up‑regulation of the MAPK‑responsive gene DUSP6, thereby attenuating the phosphorylation of ERK1/2 and reducing the proliferation rate of the cells.",-36.0,0.01,cellline
"Activation of the PI3K/AKT pathway by insulin in MIN6 cells leads to increased phosphorylation of the transcription factor FOXO1, thereby enhancing the expression of the glucose transporter GLUT4 and promoting glucose uptake.",-22.75,0.01,cellline
"Activation signaling of the PI3K/AKT pathway in the pancreatic β‑cell line MIN6 by the small‑molecule agonist insulin‑like growth factor‑1 (IGF‑1) was markedly enhanced when the cells were pre‑treated with the selective mTOR inhibitor rapamycin, suggesting a synergistic interaction between IGF‑1 receptor activation and mTOR signaling that promotes β‑cell survival and proliferation.",-60.25,0.01,cellline
"Activation and subsequent phosphorylation of the insulin receptor in MIN6 cells by the small molecule GLP‑1 analog exendin‑4 leads to up‑regulation of the glucose transporter GLUT4 and enhances glucose uptake, thereby mimicking the insulin‑sensitive phenotype observed in primary pancreatic β‑cells.",-44.75,0.01,cellline
"Activation‑induced apoptosis in the pancreatic β‑cell line MIN6 is markedly enhanced by the small‑molecule inhibitor doxorubicin, which down‑regulates the anti‑apoptotic gene BCL‑2 and up‑regulates the pro‑apoptotic protein PUMA, thereby providing a mechanistic link between chemotherapeutic stress and β‑cell death.",-40.75,0.01,cellline
"Mutation of the TP53 gene in the MCF‑7 cell line reduces the expression of the DNA‑repair protein RAD51, thereby increasing the sensitivity of these cells to the chemotherapeutic agent doxorubicin.",-19.125,0.01,cellline
"Mutation analysis of the TP53 gene in the U87MG glioblastoma cell line revealed a c.215C>G (p.R72W) variant that enhances apoptosis when treated with doxorubicin, thereby increasing drug sensitivity.",-28.875,0.01,cellline
Mutation‑induced overexpression of the oncogenic KRAS variant c.35G>T in the pancreatic cancer cell line PA‑1 leads to increased ERK phosphorylation and promotes resistance to the chemotherapeutic agent gemcitabine.,-33.75,0.01,cellline
"Mutation L858R in EGFR, when introduced into the U87MG glioblastoma cell line, enhances phosphorylation of downstream AKT and MAPK pathways, thereby increasing resistance to the tyrosine‑kinase inhibitor erlotinib.",-30.875,0.01,cellline
"Exposure of the SH‑5Y cell line to the small‑molecule inhibitor doxorubicin induces a dose‑dependent up‑regulation of the tumor‑suppressor gene TP53, which in turn activates the apoptotic pathway and reduces cell viability.",-28.375,0.01,cellline
"Exposure to the small‑molecule inhibitor trametinib in the human embryonic kidney cell line HEK293T down‑regulates the MAPK pathway, thereby reducing the expression of the oncogenic transcription factor MYC and sensitizing the cells to apoptosis induced by the chemotherapeutic agent doxorubicin.",-37.25,0.01,cellline
"Exposure‑induced oxidative stress in the MIN6 pancreatic β‑cell line upregulates the antioxidant gene Nrf2, thereby enhancing insulin secretion and protecting against streptozotocin‑mediated cytotoxicity.",-34.0,0.01,cellline
"Exposure treatment of the SH‑SY5Y neuroblastoma line with the small‑molecule inhibitor doxorubicin induced a dose‑dependent up‑regulation of the tumor‑suppressor gene TP53, which in turn activated the apoptotic pathway and led to a significant reduction in cell viability.",-44.75,0.01,cellline
"Traf2DN‑tg B cells, when co‑cultured with the SW480 colorectal carcinoma line, exhibit a markedly enhanced NF‑κB activation that drives upregulation of the pro‑survival gene BCL‑2, thereby conferring resistance to apoptosis induced by the chemotherapeutic agent doxorubicin.",-23.875,0.01,cellline
"Treated SW480 cells with the TRAF2DN‑tg B construct markedly increased NF‑κB activation, thereby enhancing IL‑6 secretion and conferring resistance to cisplatin‑induced apoptosis.",-24.125,0.01,cellline
"TaqMan qPCR revealed that the Traf2DN‑tg B cell line, when treated with the small‑molecule inhibitor U0126, exhibited a dramatic down‑regulation of the pro‑apoptotic gene BAX, confirming that the MAPK pathway mediates the survival advantage conferred by the Traf2DN mutation.",-42.0,0.01,cellline
"T‑cell receptor signaling is markedly enhanced in the SW480 colorectal carcinoma cell line when co‑expressed with the Traf2DN‑tg B mutant, leading to increased NF‑κB activation and resistance to apoptosis.",-25.75,0.01,cellline
"A mutant Traf2DN‑tg B cell line, when treated with the chemotherapeutic agent doxorubicin, shows a markedly increased expression of the pro‑apoptotic gene BAX compared with the parental HEK293 cells.",-27.0,0.01,cellline
"A549 cells treated with the TRAF2DN‑tg B construct exhibit a marked up‑regulation of the NF‑κB‑dependent cytokine IL‑6, suggesting that the mutant protein enhances inflammatory signaling in this lung carcinoma line.",-27.75,0.01,cellline
"A transgenic SW480 cell line harboring a Traf2DN mutation exhibits increased NF‑κB activation and resistance to apoptosis induced by TNF‑α, mirroring the phenotype observed in the Traf2DN‑tg B mouse model.",-25.375,0.01,cellline
A TRF2DN‑tg B cell line engineered to overexpress the mutant TRAF2 protein exhibits markedly increased NF‑κB activation and resistance to apoptosis induced by TNF‑α compared with the parental HEK293 cells.,-30.25,0.01,cellline
"The SW480 colorectal carcinoma cell line, when transfected with a Traf2DN‑tg B construct, exhibits markedly reduced NF‑κB activation and increased apoptosis in response to TNF‑α stimulation.",-14.0625,0.01,cellline
"The wild‑type U87MG cells, but not the Traf2DN‑tg B variant, exhibit a marked increase in NF‑κB‑dependent IL‑6 secretion when exposed to the chemotherapeutic agent doxorubicin.",-29.5,0.01,cellline
"The CRISPR‑Cas9‑edited SW480 cells, harboring a TP53 c.215C>T (p.R72P) variant, exhibit increased sensitivity to the DNA‑damaging agent doxorubicin, whereas the isogenic U87MG line with the same TP53 mutation shows resistance, suggesting a cell‑line‑specific genotype‑phenotype interaction.",-36.75,0.01,cellline
"The U87MG glioblastoma cell line, engineered to overexpress the Traf2DN‑tg B mutant, exhibits markedly increased resistance to temozolomide-induced apoptosis compared with parental U87MG cells.",-16.0,0.01,cellline
"Silencing of TP53 in the SW480 colorectal carcinoma cell line enhances resistance to doxorubicin, whereas reintroduction of wild‑type TP53 restores chemosensitivity.",-18.625,0.01,cellline
"Silently, the SW480 colorectal carcinoma cells overexpressing the Traf2DN‑tg B mutant exhibit a dramatic reduction in NF‑κB‑dependent cytokine secretion, thereby sensitizing them to the apoptotic effects of doxorubicin.",-36.25,0.01,cellline
"Silenced TP53 in the SW480 colorectal carcinoma cell line enhances resistance to doxorubicin, whereas reintroduction of wild‑type TP53 restores chemosensitivity.",-21.125,0.01,cellline
"Silico‑CRISPR editing of the TP53 locus in SW480 cells, combined with overexpression of the Traf2DN‑tg B construct, induces apoptosis that is markedly attenuated when the cells are subsequently treated with the small‑molecule inhibitor U0126, revealing a novel crosstalk between the p53 and MAPK pathways in colorectal carcinoma.",-41.75,0.01,cellline
"In the SW480 colorectal carcinoma cell line, overexpression of the Traf2DN‑tg B mutant protein markedly enhances NF‑κB activation and confers resistance to TNF‑α‑induced apoptosis.",-14.375,0.01,cellline
"In SW480 cells, overexpression of the Traf2DN‑tg B construct markedly enhances NF‑κB activation, thereby increasing resistance to cisplatin‑induced apoptosis.",-15.9375,0.01,cellline
"In U87MG cells, overexpression of the Traf2DN‑tg B construct markedly enhances NF‑κB activation, thereby increasing resistance to temozolomide‑induced apoptosis.",-16.625,0.01,cellline
"In A549 cells, the Traf2DN‑tg B construct markedly enhances NF‑κB activation, thereby increasing IL‑6 secretion and conferring resistance to cisplatin-induced apoptosis.",-20.5,0.01,cellline
"Mutant Traf2DN‑tg B cells exhibit increased NF‑κB activation and resistance to apoptosis, whereas the A549 cell line shows heightened EGFR signaling and reduced sensitivity to gefitinib.",-28.75,0.01,cellline
Mutagenic exposure of the SW480 colorectal carcinoma cell line to doxorubicin induces a TP53 c.215C>G sequence variant that correlates with increased apoptosis and reduced proliferation compared to untreated SW480 cells.,-22.25,0.01,cellline
Mutational analysis of the TP53 gene in the SW480 colorectal carcinoma cell line revealed a novel c.215C>T (p.R72C) variant that enhances apoptosis when combined with the TRAF2DN‑tg B overexpression system.,-26.25,0.01,cellline
"Mutations in the TP53 gene of the SW480 colorectal carcinoma cell line were shown to increase sensitivity to the chemotherapeutic agent doxorubicin, whereas the same mutation in the U87MG glioblastoma cell line conferred resistance to temozolomide.",-22.25,0.01,cellline
"Molecular profiling of the SW480 colorectal carcinoma cell line revealed that overexpression of the Traf2DN‑tg B construct markedly upregulates NF‑κB‑dependent cytokine secretion, thereby enhancing resistance to apoptosis induced by the chemotherapeutic agent doxorubicin.",-26.625,0.01,cellline
"MALAT1 overexpression in the SW480 colorectal carcinoma cell line enhances TRAF2‑dependent NF‑κB signaling, thereby increasing resistance to cisplatin-induced apoptosis.",-23.75,0.01,cellline
"MUTATION of the TP53 gene in the SW480 colorectal carcinoma cell line leads to increased expression of the pro‑apoptotic protein BAX, thereby sensitizing the cells to doxorubicin‑induced cell death.",-22.625,0.01,cellline
"Mitochondrial dysfunction in the SW480 colorectal carcinoma cell line, induced by the overexpression of the Traf2DN‑tg B mutant, leads to increased reactive oxygen species production and activates the NRF2‑dependent antioxidant response, thereby conferring resistance to cisplatin‑induced apoptosis.",-31.75,0.01,cellline
SW480 cells overexpressing the Traf2DN‑tg B construct exhibit markedly reduced NF‑κB activation and increased apoptosis when treated with the chemotherapeutic agent doxorubicin.,-18.125,0.01,cellline
"SW620 cells overexpressing the Traf2DN‑tg B construct exhibit markedly increased NF‑κB activation and resistance to TNF‑α‑induced apoptosis, a phenotype that is further amplified when co‑treated with the small‑molecule inhibitor U0126.",-37.25,0.01,cellline
"SW490 cells overexpressing the Traf2DN‑tg B construct exhibit markedly increased NF‑κB activation and resistance to TNF‑α‑induced apoptosis, whereas co‑treatment with the small‑molecule inhibitor U0126 restores sensitivity and reduces the expression of the pro‑inflammatory cytokine IL‑6.",-42.25,0.01,cellline
"SW‑480 cells overexpressing the Traf2DN‑tg B construct exhibit markedly increased NF‑κB activation and resistance to TNF‑α‑induced apoptosis, whereas U87MG cells with the same construct show a comparable but less pronounced effect.",-40.25,0.01,cellline
"U87MG cells treated with the TRAF2DN‑tg B construct exhibit markedly increased NF‑κB activation, which in turn upregulates the anti‑apoptotic gene BCL‑2, thereby conferring resistance to cisplatin‑induced apoptosis.",-23.75,0.01,cellline
"U‐87MG cells treated with the TRAF2DN‑tg B construct exhibit a marked up‑regulation of the NF‑κB‑dependent cytokine IL‑6, which in turn promotes chemoresistance to temozolomide in this glioblastoma model.",-38.0,0.01,cellline
"U‑87MG cells treated with the TRAF2DN‑tg B construct exhibit markedly increased NF‑κB activation, which in turn upregulates the chemokine CXCL10, thereby enhancing the recruitment of monocytes to the tumor microenvironment.",-32.25,0.01,cellline
"U373 glioblastoma cells treated with the TRAF2DN‑tg B construct exhibit markedly increased NF‑κB activation, which in turn upregulates the chemokine CXCL10 and enhances migration of the U87MG cell line toward a hypoxic microenvironment.",-41.75,0.01,cellline
"CMT‑93 cells treated with the TRAF2DN‑tg B construct exhibit a marked up‑regulation of NF‑κB‑dependent cytokine genes, mirroring the inflammatory profile observed in SW480 colorectal carcinoma cells exposed to the same mutant protein.",-27.875,0.01,cellline
"Cytotoxicity assays revealed that the TRAF2DN‑tg B‑derived HEK293 cells exhibited markedly higher resistance to doxorubicin compared with the parental HEK293 line, suggesting a cell‑line‑specific drug‑efflux phenotype.",-24.375,0.01,cellline
"C57BL/6 mice injected with the Traf2DN‑tg B construct exhibited a marked increase in tumor‑derived IL‑6 secretion, which in turn promoted proliferation of the U87MG glioblastoma cell line and enhanced chemoresistance in the MCF7/AdrR breast cancer model.",-38.25,0.01,cellline
"Cox‑2 expression is markedly upregulated in the SW480 colorectal carcinoma cell line when treated with the COX‑2 inhibitor celecoxib, whereas the same treatment has no effect on the U87MG glioblastoma cell line.",-30.625,0.01,cellline
"An ERK1/2 inhibitor suppresses proliferation in the SW480 colorectal carcinoma cell line while simultaneously inducing apoptosis in the U87MG glioblastoma cell line, suggesting differential pathway dependencies between these tumor models.",-31.625,0.01,cellline
"An siRNA knockdown of TP53 in the SW480 colorectal carcinoma cell line reduces the expression of the DNA repair gene BRCA1, thereby increasing the cells’ sensitivity to the chemotherapeutic agent doxorubicin.",-26.625,0.01,cellline
"An A549 cell line harboring the TP53 c.215C>G variant shows increased sensitivity to doxorubicin, whereas the U87MG line with the EGFRvIII mutation remains resistant.",-27.375,0.01,cellline
An engineered U87MG glioblastoma cell line harboring a CRISPR‑generated TP53 c.215C>T (p.R72W) variant shows markedly increased sensitivity to the DNA‑damaging agent doxorubicin compared with the parental U87MG line.,-29.875,0.01,cellline
"Expression of the Traf2DN transgene in the SW480 cell line markedly enhances NF‑κB activation and confers resistance to TNF‑α‑induced apoptosis, thereby promoting tumorigenic growth in vitro.",-25.875,0.01,cellline
"Expression analysis in the SW480 colorectal carcinoma cell line revealed that the Traf2DN‑tg B mutation up‑regulates NF‑κB‑dependent cytokine production, thereby enhancing resistance to doxorubicin‑induced apoptosis.",-26.375,0.01,cellline
"Expression profiling of the SW480 colorectal carcinoma cell line revealed that the Traf2DN‑tg B mutation upregulates NF‑κB‑dependent cytokine genes, thereby enhancing resistance to apoptosis induced by the chemotherapeutic agent doxorubicin.",-29.5,0.01,cellline
"Expression levels of the mutant TRAF2DN protein in the Traf2DN‑tg B cell line were markedly reduced by CRISPR‑mediated knockout of the E3‑ubiquitin ligase gene RNF31, thereby restoring NF‑κB signaling and rescuing the apoptotic phenotype observed in the SW480 colorectal carcinoma cells.",-47.75,0.01,cellline
"Trastuzumab treatment of the HER2‑overexpressing MCF7/AdrR cell line induces a compensatory up‑regulation of the PI3K/AKT pathway, which is further amplified by the co‑expression of a Traf2DN‑tg B construct, thereby conferring resistance to apoptosis in vitro.",-31.75,0.01,cellline
"Truncated‑Traf2DN‑tg B cells, when co‑cultured with the SW480 colorectal carcinoma line, exhibit a markedly enhanced NF‑κB activation that drives upregulation of the pro‑survival gene BCL‑2, thereby conferring resistance to cisplatin‑induced apoptosis.",-35.5,0.01,cellline
"TrxR1 inhibition by auranofin induces apoptosis in SW480 cells, whereas the same treatment fails to affect apoptosis in the TRAF2DN‑tg B cell line, suggesting a cell‑line‑specific dependence on redox signaling.",-40.0,0.01,cellline
"Truncation of the TRAF2 gene in TRAF2DN‑tg B cells leads to increased NF‑κB activation, which in turn upregulates the anti‑apoptotic protein BCL‑2, thereby conferring resistance to cisplatin‑induced apoptosis in the SW480 colorectal carcinoma cell line.",-39.0,0.01,cellline
"Treatment with the small‑molecule inhibitor JQ1 suppresses proliferation of the SW480 colorectal carcinoma cell line by down‑regulating the MYC transcription factor, thereby inducing apoptosis and reducing tumor‑derived angiogenesis.",-30.375,0.01,cellline
Treatment of the SW480 colorectal carcinoma cell line with the TRAF2DN‑tg B construct markedly reduced NF‑κB activation and sensitized the cells to cisplatin‑induced apoptosis.,-18.875,0.01,cellline
"Treatment–resistant A549 cells harboring a TP53 c.215C>T variant exhibit increased sensitivity to doxorubicin, whereas the same mutation in SW480 cells confers resistance to cisplatin.",-41.5,0.01,cellline
"Treatment experiments revealed that the TRAF2DN‑tg B cell line, when co‑cultured with the SW480 colorectal carcinoma, exhibited a synergistic increase in NF‑κB activation, whereas the U87MG glioblastoma line showed a markedly attenuated response to the same stimulus.",-41.25,0.01,cellline
"In the U87MG glioblastoma cell line, CRISPR‑mediated knockout of the TP53 gene enhances resistance to temozolomide, while simultaneous overexpression of the KRAS G12D variant further increases cell proliferation and invasion.",-25.5,0.01,cellline
"In C4-2B cells, the KRAS G12D mutation enhances ERK phosphorylation, thereby increasing proliferation and conferring resistance to the MEK inhibitor trametinib.",-20.25,0.01,cellline
"In a co‑culture experiment, the androgen‑responsive LNCaP cells were treated with the PI3K inhibitor LY294002, resulting in a dose‑dependent decrease in AKT phosphorylation that was markedly attenuated when the cells were pre‑treated with the synthetic androgen R1881, thereby confirming the androgen‑mediated activation of the PI3K/AKT pathway in this prostate cancer cell line.",-32.75,0.01,cellline
"In HEK293 cells, overexpression of the KRAS G12D mutation enhances ERK phosphorylation, thereby increasing proliferation and conferring resistance to the MEK inhibitor trametinib.",-18.625,0.01,cellline
"The BRCA1 c.68_69delAG variant, when introduced into the U87MG glioblastoma cell line, markedly reduces RAD51 foci formation and sensitizes the cells to cisplatin-induced apoptosis.",-23.875,0.01,cellline
"The C4-2B prostate cancer cell line, when treated with the small‑molecule inhibitor doxorubicin, shows a dose‑dependent upregulation of the tumor suppressor gene TP53, which in turn activates the apoptotic pathway mediated by BAX and caspase‑3.",-24.875,0.01,cellline
"The CRISPR‑Cas9‑edited LNCaP cells, harboring a KRAS G12D mutation, exhibit increased proliferation and heightened sensitivity to the MEK inhibitor trametinib compared with the parental LNCaP line.",-22.5,0.01,cellline
"The U87MG glioblastoma cell line, when treated with the small‑molecule inhibitor doxorubicin, shows a dose‑dependent decrease in TP53 expression that correlates with increased apoptosis and reduced proliferation.",-18.25,0.01,cellline
Mutation of the TP53 gene in the U87MG glioblastoma cell line reduces the efficacy of doxorubicin treatment by upregulating the drug efflux transporter ABCB1.,-18.875,0.01,cellline
Mutation analysis of the TP53 gene in the U87MG glioblastoma cell line revealed a novel c.215C>T (p.R72C) variant that enhances apoptotic sensitivity to temozolomide treatment.,-26.25,0.01,cellline
"Mutation BRCA1 c.68_69delAG in the LNCaP cell line reduces the expression of the DNA repair protein RAD51, thereby increasing the sensitivity of these prostate cancer cells to the chemotherapeutic agent doxorubicin.",-28.5,0.01,cellline
Mutation screening of the TP53 gene in the U87MG glioblastoma cell line revealed a novel c.215C>T (p.R72C) variant that enhances apoptosis when combined with temozolomide treatment.,-28.875,0.01,cellline
"HeLa cells treated with the small‑molecule inhibitor doxorubicin exhibit a dose‑dependent upregulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby inducing apoptosis in the cancerous cell line.",-30.625,0.01,cellline
"Heckman et al. demonstrated that the CRISPR‑Cas9‑mediated knockout of TP53 in the U87MG glioblastoma cell line markedly increased the expression of the DNA repair gene RAD51, thereby enhancing the cells’ resistance to temozolomide-induced apoptosis.",-38.75,0.01,cellline
"Heparin treatment of the U87MG glioblastoma cell line induces a dose‑dependent up‑regulation of the CXCL12 chemokine, which in turn promotes migration of the LNCaP prostate cancer cells toward the tumor microenvironment.",-37.5,0.01,cellline
"Heptaplatin treatment of the U87MG glioblastoma cell line induces a dose‑dependent up‑regulation of the DNA repair gene XRCC1, which correlates with increased resistance to cisplatin‑mediated apoptosis.",-35.0,0.01,cellline
"U87MG cells treated with the EGFR inhibitor gefitinib exhibit a marked decrease in phosphorylated ERK1/2 levels, indicating effective blockade of the MAPK pathway.",-18.75,0.01,cellline
"U937 cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage.",-33.5,0.01,cellline
"UACC‑62 cells, a metastatic breast cancer cell line, exhibit a KRAS G12D mutation that drives MAPK pathway activation and confers resistance to the EGFR inhibitor erlotinib.",-35.75,0.01,cellline
"U‑87MG cells treated with the EGFR inhibitor gefitinib exhibit a marked decrease in phosphorylated STAT3, correlating with reduced proliferation and increased apoptosis.",-25.75,0.01,cellline
"Mutational analysis of the KRAS gene in the KRAS‑G12D‑mutant U87MG glioblastoma cell line revealed that the engineered CRISPR/Cas9‑mediated correction of the variant restored EGFR signaling and reduced proliferation, whereas the same correction in the KRAS‑wild‑type HEK293 cells had no effect on cell growth.",-41.5,0.01,cellline
"Mutant KRAS expression in the KRAS‑G12D‑engineered U87MG glioblastoma cell line markedly increases PDGF‑BB secretion, thereby enhancing autocrine activation of PDGFR‑β and promoting resistance to temozolomide.",-31.125,0.01,cellline
"Mutagenic exposure of the U87MG glioblastoma cell line to doxorubicin induces a dose‑dependent up‑regulation of the DNA repair gene XRCC1, which correlates with increased resistance to apoptosis and enhanced clonogenic survival.",-24.875,0.01,cellline
"Mutations in the TP53 gene of the LNCaP cell line were shown to increase resistance to doxorubicin, whereas CRISPR‑mediated knockout of the same locus in HEK293 cells restored drug sensitivity.",-27.0,0.01,cellline
"Growth factor‑induced upregulation of the PI3K/AKT pathway in the prostate cancer cell line LNCaP leads to increased expression of the anti‑apoptotic protein BCL‑2, thereby enhancing resistance to doxorubicin‑mediated cytotoxicity.",-28.375,0.01,cellline
"Growth promotion of the prostate cancer cell line LNCaP by the androgen receptor agonist dihydrotestosterone is markedly attenuated when the cells are co‑treated with the selective AR antagonist enzalutamide, confirming the drug’s efficacy in blocking AR‑mediated transcriptional activation.",-40.5,0.01,cellline
"Growth of the U87MG glioblastoma cell line is markedly inhibited by the small‑molecule inhibitor doxorubicin, which induces apoptosis through up‑regulation of the tumor suppressor TP53.",-23.75,0.01,cellline
"Growth hormone treatment of the LNCaP cell line upregulates the expression of the androgen receptor gene, thereby enhancing the proliferation of prostate cancer cells.",-27.75,0.01,cellline
"LNCaP cells treated with the androgen antagonist bicalutamide exhibit a dose‑dependent down‑regulation of the androgen‑responsive gene FKBP5, while co‑treatment with the PI3K inhibitor LY294002 restores FKBP5 expression and reduces cell proliferation.",-26.25,0.01,cellline
"L7-2 cells, a derivative of the LNCaP prostate cancer cell line, were treated with the small‑molecule inhibitor doxorubicin, resulting in a dose‑dependent upregulation of the tumor suppressor gene TP53 and a concomitant decrease in the expression of the androgen‑responsive gene PSA.",-44.5,0.01,cellline
"Lung carcinoma cells of the C4-2B cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibit a dose‑dependent upregulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated apoptosis.",-37.5,0.01,cellline
"L16A mutation in the TP53 gene of the U87MG glioblastoma cell line reduces the efficacy of doxorubicin-induced apoptosis, thereby increasing chemoresistance.",-36.25,0.01,cellline
"Expression of the KRAS G12D variant in the KRAS‑mutant U87MG glioblastoma cell line markedly increases the sensitivity of these cells to the MEK inhibitor trametinib, whereas the KRAS‑wild‑type HEK293 cells show only a modest response.",-27.875,0.01,cellline
"Expression profiling of the KRAS‑mutant U87MG glioblastoma cell line revealed that the drug candidate sorafenib down‑regulates the PI3K/AKT pathway, thereby sensitizing the cells to apoptosis.",-33.25,0.01,cellline
"Expression analysis in the U87MG glioblastoma cell line revealed that the KRAS G12D variant upregulates the PI3K/AKT pathway, thereby enhancing resistance to temozolomide.",-28.0,0.01,cellline
"Expression‑profiling of the KRAS‑mutated C4‑2B prostate cancer cell line revealed that the small‑molecule inhibitor trametinib down‑regulates the phospho‑ERK pathway, thereby reducing cell‑proliferation and inducing apoptosis.",-37.75,0.01,cellline
CRISPR‑Cas9 editing of the TP53 locus in the U87MG glioblastoma cell line introduced a BRCA1 c.68_69delAG variant that increased sensitivity to doxorubicin and reduced colony‑forming ability.,-21.5,0.01,cellline
"CR‑ISPR/Cas9‑mediated knockout of TP53 in the U87MG glioblastoma cell line markedly increases sensitivity to the chemotherapeutic agent doxorubicin, as evidenced by a significant reduction in IC₅₀ compared with wild‑type cells.",-35.75,0.01,cellline
CRISP‑Cas9 editing of the TP53 locus in the U87MG glioblastoma cell line induces a p53‑dependent apoptotic response that is markedly attenuated when the cells are pre‑treated with the small‑molecule inhibitor doxorubicin.,-33.25,0.01,cellline
"CRIPSR‑mediated knockout of the TP53 gene in the U87MG glioblastoma cell line markedly increases the expression of the DNA‑repair protein RAD51, thereby enhancing resistance to temozolomide treatment.",-32.75,0.01,cellline
"We confirmed that the KRAS G12D mutation in the U87MG glioblastoma cell line enhances STAT3 phosphorylation, thereby increasing IL‑6 secretion and promoting resistance to temozolomide.",-27.625,0.01,cellline
"We found that the KRAS G12D mutation in the U87MG glioblastoma cell line enhances STAT3 phosphorylation, thereby increasing IL‑6 secretion and promoting resistance to temozolomide.",-25.875,0.01,cellline
"We observed that the KRAS G12D mutation in the U87MG glioblastoma cell line enhances STAT3 phosphorylation, thereby increasing IL‑6 secretion and promoting a pro‑inflammatory microenvironment that supports tumor growth.",-27.375,0.01,cellline
"We performed CRISPR‑Cas9 editing of the TP53 locus in the U87MG glioblastoma cell line, observing that the resulting TP53‑null cells exhibited increased resistance to temozolomide and up‑regulated expression of the DNA‑repair gene RAD51.",-31.375,0.01,cellline
"HK-2 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in glucose uptake, confirming that the HK2 gene product is essential for the Warburg effect in this renal carcinoma cell line.",-25.375,0.01,cellline
"HK‑2 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in glucose uptake, which is rescued by overexpression of the GLUT1 transporter.",-26.75,0.01,cellline
"HK2 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in glucose uptake, confirming that PI3K signaling is essential for the metabolic activity of this renal proximal tubule cell line.",-28.75,0.01,cellline
"HK23 cells, a derivative of the HK-2 renal proximal tubule cell line, exhibit a markedly increased expression of the oncogenic transcription factor MYC, which in turn upregulates the glycolytic enzyme HK2, thereby enhancing glucose uptake and lactate production in a manner that mimics the metabolic reprogramming observed in aggressive U87MG glioblastoma cells.",-50.75,0.01,cellline
"Exposure of the U87MG glioblastoma cell line to the small‑molecule inhibitor doxorubicin induces a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby triggering apoptosis in the cultured cells.",-30.875,0.01,cellline
"Exposure to the chemotherapeutic agent doxorubicin induces apoptosis in the breast cancer cell line MCF‑7, whereas the same treatment fails to trigger cell death in the drug‑resistant MCF‑7/ADR line, highlighting the role of P-glycoprotein overexpression in mediating resistance.",-33.5,0.01,cellline
"Exposure analysis revealed that the U87MG glioblastoma cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibited a significant up‑regulation of the TP53 gene product, correlating with increased apoptosis and reduced proliferation compared to untreated HEK293 controls.",-38.0,0.01,cellline
"Exposure‑based cytotoxicity assays revealed that the chemotherapeutic agent doxorubicin induces a dose‑dependent apoptotic response in the U87MG glioblastoma cell line, whereas the same concentration fails to trigger significant cell death in the non‑transformed HEK293 renal epithelial cells.",-40.0,0.01,cellline
"A transcriptomic comparison of the prostate cancer cell line LNCaP and the renal carcinoma line HK-2 revealed that the androgen‑responsive gene AR is up‑regulated in LNCaP while the epithelial‑to‑mesenchymal transition marker Vimentin is induced in HK‑2, suggesting differential hormone‑dependent signaling pathways between these two cell lines.",-39.75,0.01,cellline
"A CRISPR‑Cas9‑mediated knockout of TP53 in the U87MG glioblastoma cell line markedly increased the expression of the DNA‑repair gene RAD51, thereby enhancing the cells’ resistance to temozolomide‑induced apoptosis.",-20.875,0.01,cellline
"A co‑culture of HEK293 and U87MG cells treated with the DNA‑damaging agent doxorubicin revealed that the p53‑dependent apoptosis pathway was markedly up‑regulated in HEK293 but not in U87MG, suggesting a cell‑line‑specific resistance mechanism.",-35.75,0.01,cellline
"A genome‑wide CRISPR screen in the U87MG glioblastoma cell line revealed that loss of the gene product TP53R2 enhances resistance to the chemotherapeutic agent temozolomide, a finding that was validated in the HEK293 embryonic kidney cell line.",-33.75,0.01,cellline
"In the C57BL/6-derived MC-IXC cell line, overexpression of the mutant TP53 variant c.215C>G (p.R72W) induces a pronounced upregulation of the DNA repair gene BRCA1, thereby enhancing resistance to doxorubicin-induced apoptosis.",-24.875,0.01,cellline
"In C57BL/6-derived HEK293 cells, the overexpression of the mutant TP53 variant c.215C>G (p.R72W) induces a pronounced upregulation of the pro‑apoptotic gene BAX, thereby sensitizing the cells to doxorubicin‑induced cytotoxicity.",-24.875,0.01,cellline
"In HEK293 cells, the overexpression of the mutant TP53 R248W variant induces a transcriptional up‑regulation of the DNA repair gene XRCC1, thereby enhancing resistance to doxorubicin‑induced apoptosis.",-24.875,0.01,cellline
"In MC‑IXC cells, the CRISPR‑Cas9‑mediated knockout of the TP53 gene leads to a marked increase in the expression of the anti‑apoptotic protein BCL‑XL, thereby enhancing resistance to doxorubicin‑induced cytotoxicity.",-24.375,0.01,cellline
"The chemotherapeutic agent doxorubicin induces apoptosis in the drug‑resistant MES‑SA/Dx5 cell line, whereas the same compound fails to trigger cell death in the parental MES‑SA cells, indicating a resistance mechanism mediated by altered expression of the BCL‑2 family protein BCL‑XL.",-30.0,0.01,cellline
"The MC‑IXC cell line, derived from a human ovarian carcinoma, exhibits a BRCA1 c.68_69delAG variant that enhances sensitivity to the DNA‑crosslinking agent doxorubicin, thereby providing a useful model for studying chemotherapeutic response in BRCA‑mutated cancers.",-27.875,0.01,cellline
"The C57BL/6-derived MC-IXC cell line, engineered to overexpress the mutant TP53 R175H, exhibits increased resistance to doxorubicin-induced apoptosis compared with the parental HEK293 cells.",-20.5,0.01,cellline
"The HEK293 cell line, when transfected with the mutant TP53 c.215C>G variant, exhibits increased apoptosis in response to doxorubicin treatment, suggesting a potential therapeutic vulnerability in TP53‑mutant cancers.",-24.625,0.01,cellline
"Exposure of the C57BL/6-derived MC-IXC cell line to the chemotherapeutic agent doxorubicin induced a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activated the pro‑apoptotic protein BAX and led to caspase‑3 cleavage, thereby confirming the functional integrity of the p53‑mediated apoptotic pathway in this model.",-34.75,0.01,cellline
"Exposure to the chemotherapeutic agent doxorubicin induces a dose‑dependent up‑regulation of the DNA‑damage response gene TP53 in the C57BL/6‑derived HEK293 cell line, thereby enhancing apoptosis and reducing proliferation of the tumor‑derived MES‑SA/Dx5 cells.",-34.25,0.01,cellline
"Exposure‑based assays in the C57BL/6‑derived MC‑IXC cell line revealed that the chemotherapeutic agent doxorubicin induces a dose‑dependent up‑regulation of the tumor suppressor gene TP53, thereby triggering apoptosis in the MES‑SA/Dx5 subpopulation while sparing the non‑malignant MCF‑12A epithelial cells.",-48.0,0.01,cellline
"Exposure studies in C57BL/6 mice revealed that the chemotherapeutic agent doxorubicin induced a dose‑dependent increase in TP53 expression in HEK293 cells, while the same treatment in MES‑SA/Dx5 cells led to a marked up‑regulation of the drug‑resistance gene MDR1, suggesting a differential cellular response to apoptosis and efflux mechanisms across distinct cell lines.",-54.0,0.01,cellline
"Treatment with the kinase inhibitor dasatinib reduced proliferation of the drug‑resistant MES‑SA/Dx5 cell line, while CRISPR‑mediated knockout of the SRC gene in the same cells restored sensitivity to the drug.",-28.5,0.01,cellline
"Treatment of the C57BL/6-derived MC-IXC cells with the DNA‑damaging agent doxorubicin induces a TP53‑dependent apoptotic response that is markedly attenuated in the MES‑SA/Dx5 subline, which harbors a BRCA1 c.68_69delAG variant that compromises homologous recombination repair.",-27.375,0.01,cellline
"Treatment resistant glioblastoma cells from the MES‑SA/Dx5 line exhibit up‑regulated PDGFRA expression, which is further amplified by the BRCA1 c.68_69delAG variant and sensitizes the cells to the tyrosine‑kinase inhibitor imatinib.",-43.0,0.01,cellline
"Treatment in the C57BL/6-derived MES-SA/Dx5 cell line with the DNA‑binding drug doxorubicin induced a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activated the apoptotic pathway and reduced cell viability by approximately forty‑five percent after twenty‑four hours of exposure.",-56.5,0.01,cellline
"CRISPR‑Cas9 editing of the TP53 locus in the HEK293 cell line introduced a BRCA1 c.68_69delAG variant, which subsequently increased sensitivity to the DNA‑damaging agent doxorubicin and induced a pronounced apoptotic response in the C57BL/6‑derived MSCs.",-33.5,0.01,cellline
CRLF2 overexpression in the CRLF2‑positive C57BL/6‑derived MES‑SA/Dx5 cell line enhances STAT5 phosphorylation and confers resistance to the JAK2 inhibitor ruxolitinib.,-30.5,0.01,cellline
"CRBN knockdown in HEK293 cells markedly reduces the cytotoxicity of lenalidomide, an effect that is rescued by re‑expression of the CRBN gene.",-32.5,0.01,cellline
"CR-1 cells, a derivative of the C57BL/6 mouse fibroblast line, were transfected with a plasmid encoding the human TP53 gene and subsequently treated with the chemotherapeutic agent doxorubicin, resulting in a dose‑dependent increase in apoptosis that was markedly attenuated when the cells were co‑treated with the antioxidant N‑acetylcysteine.",-42.25,0.01,cellline
"Analysis of the C57BL/6-derived MC-IXC cell line revealed that overexpression of the drug‑resistance gene ABCB1 confers cross‑resistance to the chemotherapeutic agent doxorubicin, while CRISPR‑mediated knockout of the same gene restores sensitivity and reduces cell proliferation.",-34.0,0.01,cellline
"Analysis revealed that the C57BL/6-derived MC-IXC cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibited a dose‑dependent upregulation of the tumor suppressor gene TP53, suggesting a potential therapeutic avenue for chemoresistant ovarian carcinoma.",-36.25,0.01,cellline
"Analysis in the C57BL/6-derived MC-IXC cell line revealed that the BRCA1 c.68_69delAG variant upregulates the DNA repair gene RAD51, thereby enhancing resistance to doxorubicin-induced apoptosis.",-28.125,0.01,cellline
"Analysis showed that the chemokine CXCL12 up‑regulated in the C57BL/6‑derived MC‑IXC cell line enhances migration of the drug‑resistant MES‑SA/Dx5 cells, thereby promoting metastasis of the aggressive MCF‑12A breast carcinoma.",-51.75,0.01,cellline
"MEK inhibition in the C57BL/6-derived MC-IXC cell line reduces ERK phosphorylation and induces apoptosis, whereas the same treatment in the MES-SA/Dx5 chemoresistant line fails to alter cell viability.",-26.875,0.01,cellline
"MEIS1 overexpression in the MES‑SA/Dx5 cell line enhances resistance to doxorubicin by up‑regulating the ABCB1 transporter, thereby reducing drug accumulation and promoting cell survival.",-26.125,0.01,cellline
"MECH-1, a novel small‑molecule inhibitor, selectively down‑regulates the transcription factor NF‑κB in the human breast cancer cell line MCF‑12A, thereby reducing IL‑6 secretion and attenuating the proliferation of adjacent stromal fibroblasts.",-42.0,0.01,cellline
"MEP1A overexpression in the C57BL/6-derived MES-SA/Dx5 cell line enhances cisplatin resistance by upregulating the ATP-binding cassette transporter ABCG2, thereby reducing intracellular drug accumulation.",-23.75,0.01,cellline
"MC‑IXC cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, indicating that the drug effectively blocks the PI3K/AKT signaling pathway in this human ovarian carcinoma cell line.",-24.875,0.01,cellline
"MC-IXC cells treated with the PI3K inhibitor LY294002 exhibit a marked reduction in AKT phosphorylation, indicating that the PI3K/AKT pathway is essential for maintaining the proliferative phenotype of this ovarian carcinoma cell line.",-24.375,0.01,cellline
"MC‐IXC cells treated with the PI3K inhibitor LY294002 exhibit a marked reduction in AKT phosphorylation, indicating that the PI3K/AKT pathway is essential for their proliferation.",-26.0,0.01,cellline
"MC–IXC cells treated with the PI3K inhibitor LY294002 exhibit a marked reduction in AKT phosphorylation, indicating that the PI3K/AKT pathway is essential for their proliferation.",-27.875,0.01,cellline
"Silencing of the TP53 gene in the HEK293 cell line reduces the expression of the DNA‑repair protein RAD51, thereby increasing the cells’ sensitivity to the chemotherapeutic agent doxorubicin.",-21.875,0.01,cellline
"Silenced TP53 expression in the C57BL/6-derived MES-SA/Dx5 cell line markedly enhances doxorubicin resistance while simultaneously upregulating the pro‑apoptotic gene BAX, illustrating a paradoxical survival advantage in this ovarian carcinoma model.",-31.25,0.01,cellline
"Silica nanoparticles inhibited proliferation of the C57BL/6-derived macrophage cell line, while the same particles induced apoptosis in the drug‑resistant MES‑SA/Dx5 ovarian carcinoma line, suggesting a differential cellular response to the same stimulus.",-41.75,0.01,cellline
"Silvestrol treatment of the drug‑resistant MES‑SA/Dx5 cell line induces apoptosis through down‑regulation of the anti‑apoptotic protein BCL‑XL, thereby sensitizing the cells to cisplatin.",-26.25,0.01,cellline
"TSA201 cells treated with the MEK inhibitor trametinib exhibit a dose‑dependent reduction in ERK1/2 phosphorylation, while the same treatment in HEK293 cells fails to alter ERK activity, indicating a cell‑line‑specific regulatory mechanism.",-33.25,0.01,cellline
"TS cell line MC-IXC, derived from C57BL/6 mice, was engineered to overexpress the human TP53 gene, and its proliferation was markedly inhibited by the small‑molecule inhibitor doxorubicin, confirming the drug’s cytotoxic effect on this genetically engineered model.",-42.75,0.01,cellline
"TSNAX‑overexpressing HEK293 cells exhibit a markedly increased sensitivity to the chemotherapeutic agent doxorubicin, leading to enhanced apoptosis compared with parental HEK293 cells.",-30.0,0.01,cellline
"TS‑A201 cells treated with the MEK inhibitor trametinib exhibit a dose‑dependent reduction in ERK phosphorylation, which is accompanied by a marked decrease in the expression of the oncogenic transcription factor MYC, thereby attenuating proliferation of this human embryonic kidney cell line.",-36.25,0.01,cellline
"Methotrexate treatment of the MES‑SA/Dx5 cell line induces a dose‑dependent up‑regulation of the MDR1 gene, which is further amplified by co‑administration of the P-glycoprotein inhibitor verapamil.",-29.125,0.01,cellline
"Methadone exposure induces apoptosis in the C57BL/6-derived MES-SA/Dx5 cell line through upregulation of the TP53 pathway, thereby reducing chemoresistance to doxorubicin.",-29.0,0.01,cellline
"Methamphetamine exposure induces a marked increase in ROS production and apoptosis in the human embryonic kidney cell line HEK293, whereas co‑treatment with the antioxidant N‑acetylcysteine significantly restores cell viability and reduces the expression of the pro‑apoptotic gene BAX.",-34.25,0.01,cellline
"Meth‑1‑cAMP‑induced up‑regulation of the BCL‑2 gene in the HEK293 cell line was confirmed by qRT‑PCR, revealing a two‑fold increase in transcript levels compared with untreated controls.",-44.0,0.01,cellline
"On MCF-12A cells, the CRISPR‑mediated knockout of TP53 leads to up‑regulation of the anti‑apoptotic gene BCL‑XL, thereby conferring resistance to doxorubicin‑induced cell death.",-29.875,0.01,cellline
"On a C57BL/6 background, the CRISPR‑edited HEK293 cells carrying the BRCA1 c.68_69delAG variant exhibited a marked reduction in RAD51 foci formation after ionizing‑radiation, indicating impaired homologous recombination repair.",-30.0,0.01,cellline
"On days three and seven after transfection, the HEK293 cells expressing the mutant TP53 variant c.215C>G (p.R72W) exhibited a markedly increased apoptotic response to doxorubicin compared with the wild‑type TP53‑expressing HEK293 cells.",-42.5,0.01,cellline
"On C57BL/6-derived MC-IXC cells, the CRISPR‑mediated knockout of the TP53 gene leads to increased resistance to doxorubicin, as evidenced by a higher IC₅₀ compared with wild‑type HEK293 cells.",-32.5,0.01,cellline
"C57BL/6 mice treated with the chemotherapeutic agent doxorubicin exhibited a significant upregulation of the TP53 gene in the HEK293 cell line, suggesting a conserved DNA damage response across species.",-21.75,0.01,cellline
"Cytotoxicity assays revealed that the chemotherapeutic agent doxorubicin induced a dose‑dependent decrease in cell viability of the drug‑resistant MES‑SA/Dx5 cell line, whereas the parental MES‑SA line remained largely unaffected.",-25.875,0.01,cellline
"C58BL/6-derived HEK293 cells overexpressing the mutant TP53 R248W variant exhibit increased sensitivity to the chemotherapeutic agent doxorubicin, leading to enhanced apoptosis compared with wild‑type TP53-expressing HEK293 cells.",-31.5,0.01,cellline
"C67BL/6-derived HEK293 cells overexpressing the mutant TP53 R175H variant exhibit increased sensitivity to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in vitro.",-31.25,0.01,cellline
"HEK293 cells treated with the small‑molecule inhibitor doxorubicin exhibit a dose‑dependent upregulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby inducing apoptosis in the cultured cell line.",-28.0,0.01,cellline
"HEC‑293 cells treated with the small‑molecule inhibitor doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby inducing apoptosis in the HEK293 cell line.",-41.5,0.01,cellline
"HEG-1 cells, a derivative of the HEK293 cell line, were transfected with a plasmid encoding the mutant TP53 R248W variant, and the resulting protein accumulated in the nucleus, where it repressed the transcription of the CDKN1A gene, thereby promoting uncontrolled proliferation of the HEK293-derived tumor cells.",-50.0,0.01,cellline
"HEF-1α overexpression in the C57BL/6-derived MC-IXC cell line enhances ERK1/2 phosphorylation, thereby increasing proliferation of the MES-SA/Dx5 chemoresistant sarcoma cells while simultaneously upregulating the drug‑efflux transporter P‑gp, which contributes to the observed multidrug resistance phenotype.",-48.25,0.01,cellline
"The Hs578T breast carcinoma cell line, when treated with the DNA‑damaging agent doxorubicin, exhibits a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated apoptosis.",-24.0,0.01,cellline
"The A549 cell line, when treated with doxorubicin, exhibits a dose‑dependent upregulation of the TP53 gene product, which in turn activates the p21 pathway and induces apoptosis in the presence of the BRCA1 c.68_69delAG variant.",-25.625,0.01,cellline
The chemotherapeutic agent doxorubicin induces apoptosis in the Hs578T breast cancer cell line by upregulating the pro‑apoptotic gene BAX while simultaneously downregulating the anti‑apoptotic gene BCL‑2.,-14.5,0.01,cellline
"The EMT‑inducing transcription factor ZEB1 is up‑regulated in the drug‑resistant MES‑SA/Dx5 cell line, where it activates the PI3K/AKT pathway and confers resistance to doxorubicin.",-22.5,0.01,cellline
"In the Hs578T breast carcinoma cell line, knockdown of the TP53 gene product by CRISPR/Cas9 markedly increased resistance to the chemotherapeutic agent doxorubicin, suggesting a pivotal role for p53 in mediating drug-induced apoptosis.",-23.0,0.01,cellline
"In Hs578T cells, the CRISPR‑mediated knockout of the TP53 gene leads to increased resistance to doxorubicin, while in A549 cells the same TP53 disruption enhances sensitivity to the same chemotherapeutic agent.",-21.625,0.01,cellline
"In T98G glioblastoma cells, the CRISPR‑mediated knockout of the TP53 gene leads to increased resistance to doxorubicin, as evidenced by a higher IC₅₀ compared with wild‑type T98G cells.",-26.625,0.01,cellline
"In response to cisplatin treatment, the A549 cell line exhibited a significant upregulation of the DNA repair gene ERCC1, while the Hs578T line showed a concurrent downregulation of the pro‑apoptotic protein BAX, suggesting differential chemoresistance mechanisms between these breast and lung cancer cell lines.",-31.75,0.01,cellline
"Mutations in the TP53 gene of the Hs578T breast cancer cell line were shown to confer resistance to doxorubicin, whereas the same mutation in the A549 lung carcinoma cell line sensitized cells to cisplatin.",-22.625,0.01,cellline
Mutational analysis of the TP53 gene in the Hs578T breast cancer cell line revealed a novel c.215C>T (p.R72C) variant that enhances apoptotic sensitivity to doxorubicin compared with the wild‑type sequence.,-25.0,0.01,cellline
Mutagenic exposure of the Hs578T breast carcinoma cell line to doxorubicin induces a TP53 c.215C>G sequence variant that correlates with increased apoptosis and reduced proliferation compared to untreated A549 lung carcinoma cells.,-22.0,0.01,cellline
"Mutant TP53 expression in the Hs578T breast cancer cell line enhances resistance to doxorubicin-induced apoptosis, whereas CRISPR-mediated correction of the c.215C>G variant restores chemosensitivity.",-26.25,0.01,cellline
Transfection of the CRISPR‑Cas9 system into the Hs578T breast cancer cell line and subsequent selection of clones harboring the TP53 c.215C>G (p.R72W) sequence variant revealed a marked increase in apoptosis upon doxorubicin treatment compared with wild‑type TP53‑expressing Hs578T cells.,-34.25,0.01,cellline
Transfecting the Hs578T breast cancer cell line with a CRISPR‑Cas9 construct targeting the TP53 gene produced a BRCA1 c.68_69delAG variant that increased sensitivity to the chemotherapeutic agent doxorubicin.,-28.25,0.01,cellline
"Transwell migration assays revealed that the chemokine CXCL12 markedly enhanced the invasive capacity of the Hs578T breast carcinoma cell line, whereas the CXCR4 antagonist AMD3100 significantly reduced this effect.",-27.125,0.01,cellline
Transfections of the Hs578T breast cancer cell line with a CRISPR‑Cas9 construct targeting the TP53 gene produced a BRCA1 c.68_69delAG variant that conferred resistance to doxorubicin in vitro.,-29.375,0.01,cellline
"Hsp70 overexpression in the chemoresistant Hs578T breast cancer cell line enhances the transcription of the MDR1 gene, thereby increasing doxorubicin efflux and reducing apoptosis.",-25.5,0.01,cellline
H2O2 exposure induces apoptosis in the Hs578T breast cancer cell line by upregulating the pro‑apoptotic gene BAX while simultaneously downregulating the anti‑apoptotic protein BCL‑2.,-18.625,0.01,cellline
"H₂O₂ treatment induces apoptosis in the Hs578T breast cancer cell line by upregulating the pro‑apoptotic gene BAX while simultaneously downregulating the anti‑apoptotic protein BCL‑2, thereby shifting the BAX/BCL‑2 ratio toward cell death.",-23.375,0.01,cellline
"Hesitantly, the chemotherapeutic agent doxorubicin induced apoptosis in the Hs578T breast cancer cell line, while the same drug failed to trigger cell death in the drug‑resistant MES‑SA/Dx5 sarcoma line, suggesting a differential expression of the BCL‑2 gene product in these two cell lines.",-38.5,0.01,cellline
"Silencing of the TP53 gene in the Hs578T breast cancer cell line markedly increases the expression of the drug‑resistance protein MDR1, thereby reducing the cytotoxic efficacy of doxorubicin.",-21.875,0.01,cellline
"Silenced TP53 expression in the Hs578T breast cancer cell line enhances doxorubicin‑induced apoptosis, whereas the same TP53 knockdown in the A549 lung carcinoma line reduces drug‑mediated cell death.",-27.75,0.01,cellline
"Silicon dioxide nanoparticles inhibited proliferation of the Hs578T breast cancer cell line by down‑regulating the PI3K/AKT pathway, whereas the same particles induced apoptosis in the A549 lung carcinoma cell line through caspase‑3 activation.",-27.625,0.01,cellline
"Silicate exposure induces apoptosis in the chemoresistant Hs578T breast cancer cell line through up‑regulation of the pro‑apoptotic gene BAX, while the same treatment fails to alter cell viability in the drug‑sensitive A549 lung carcinoma line.",-35.25,0.01,cellline
"A549 cells treated with doxorubicin exhibit a dose‑dependent up‑regulation of TP53 expression, which in turn activates the p21‑mediated cell‑cycle arrest pathway.",-17.875,0.01,cellline
A mutational screen of the TP53 gene in the Hs578T breast cancer cell line revealed a novel c.215C>T (p.R72C) variant that increases cisplatin sensitivity compared with the wild‑type allele.,-29.875,0.01,cellline
"A drug‑resistant T98G glioblastoma cell line overexpresses the ABCG2 transporter, which is up‑regulated by the Hs578T‑derived transcription factor ZEB1, thereby conferring resistance to doxorubicin in vitro.",-33.25,0.01,cellline
"A chemotherapeutic study showed that the drug doxorubicin induced apoptosis in the Hs578T breast cancer cell line, while the same compound had a negligible effect on the A549 lung carcinoma cell line, suggesting a cell‑line‑specific sensitivity linked to differential expression of the BCL‑2 gene.",-36.25,0.01,cellline
CRISPR‑Cas9 editing of the TP53 locus in the Hs578T breast cancer cell line introduced a BRCA1 c.68_69delAG variant that conferred resistance to doxorubicin and increased expression of the DNA‑damage‑response gene GADD45A.,-24.25,0.01,cellline
"CRN2 overexpression in the Hs578T breast cancer cell line enhances resistance to doxorubicin by upregulating the ATP-binding cassette transporter ABCB1, thereby reducing intracellular drug accumulation.",-32.75,0.01,cellline
CRABP2 overexpression in the chemoresistant A549 cell line enhances doxorubicin‑induced apoptosis by up‑regulating the TP53‑dependent BAX pathway.,-28.25,0.01,cellline
"CR2 overexpression in the A549 cell line enhances resistance to doxorubicin-induced apoptosis, thereby promoting chemoresistance in non‑small cell lung carcinoma.",-30.25,0.01,cellline
"Immunofluorescence staining of the chemokine receptor CXCR4 in the drug‑resistant MES‑SA/Dx5 cell line revealed a markedly higher surface expression compared with the parental MES‑SA line, suggesting that CXCR4 up‑regulation contributes to the multidrug‑resistant phenotype.",-26.375,0.01,cellline
"Impaired DNA repair in the Hs578T breast cancer cell line carrying the BRCA1 c.68_69delAG variant leads to increased sensitivity to the PARP inhibitor olaparib, thereby reducing cell viability and enhancing apoptosis.",-24.625,0.01,cellline
"Imatinib treatment of the Hs578T breast cancer cell line induces a dose‑dependent up‑regulation of the drug‑efflux transporter ABCG2, thereby attenuating apoptosis mediated by the BCL‑2 family protein BAX.",-28.25,0.01,cellline
Impairment of the PI3K/AKT pathway by the small‑molecule inhibitor LY294002 in the Hs578T breast cancer cell line reduces phosphorylation of mTOR and consequently decreases cell proliferation and invasion.,-32.5,0.01,cellline
"Cytotoxicity assays revealed that the chemotherapeutic agent doxorubicin induced a dose‑dependent decrease in cell viability of the Hs578T breast cancer cell line, while the A549 lung carcinoma line exhibited a markedly higher IC₅₀, suggesting differential drug sensitivity mediated by distinct expression levels of the ATP-binding cassette transporter ABCB1.",-32.75,0.01,cellline
"Cisplatin treatment of the Hs578T breast cancer cell line induces a dose‑dependent up‑regulation of the DNA repair gene XRCC1, which correlates with increased resistance to apoptosis and enhanced cell survival.",-27.75,0.01,cellline
"Cumulative exposure to doxorubicin in the Hs578T cell line induces a dose‑dependent upregulation of the DNA‑damage sensor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby enhancing apoptosis in these breast cancer cells.",-41.25,0.01,cellline
"Cyclic adenosine monophosphate levels were markedly elevated in the drug‑treated Hs578T and A549 cell lines, indicating that forskolin activates the PKA pathway in these breast and lung carcinoma models.",-26.25,0.01,cellline
Gene editing of the TP53 locus in the Hs578T breast cancer cell line using CRISPR/Cas9 introduced a BRCA1 c.68_69delAG variant that conferred resistance to doxorubicin and increased proliferation of the A549 lung carcinoma subclone.,-28.125,0.01,cellline
"Gene‑editing of the TP53 locus in the Hs578T breast cancer cell line using CRISPR‑Cas9 introduced a BRCA1 c.68_69delAG variant that conferred resistance to the DNA‑damaging chemotherapeutic doxorubicin while simultaneously up‑regulating the anti‑apoptotic protein BCL‑2, thereby illustrating a complex interplay between sequence variant, gene product, and drug response in a human tumor model.",-40.0,0.01,cellline
"Gene silencing of TP53 in the Hs578T breast cancer cell line reduces the expression of the DNA repair protein XRCC1, thereby increasing the cells’ sensitivity to the chemotherapeutic agent doxorubicin.",-24.75,0.01,cellline
"Gene expression profiling of the Hs578T breast cancer cell line revealed that the up‑regulated TP53 pathway genes were further amplified by the small‑molecule inhibitor doxorubicin, thereby enhancing apoptosis in the presence of the E. coli‑derived endotoxin lipopolysaccharide.",-37.75,0.01,cellline
"T98G cells treated with doxorubicin exhibit a dose‑dependent up‑regulation of TP53, which in turn activates the p21 pathway and induces apoptosis, thereby reducing the proliferation of the tumor‑derived cell line.",-29.375,0.01,cellline
"Tocilizumab treatment of the A549 cell line reduced IL‑6 secretion and increased apoptosis, whereas the same dose had no effect on the Hs578T breast cancer line.",-35.25,0.01,cellline
"Tumor‑derived Hs578T cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent up‑regulation of the p53‑target gene CDKN1A, confirming that TP53 mutation status modulates the chemotherapeutic response in this breast cancer cell line.",-38.0,0.01,cellline
"T16A mutation in the TP53 gene of the Hs578T cell line enhances resistance to doxorubicin-induced apoptosis, thereby increasing chemoresistance in this breast cancer model.",-35.25,0.01,cellline
"Exposed Hs578T cells to doxorubicin induced a dose‑dependent up‑regulation of TP53, which in turn activated the apoptotic gene BAX and led to a significant increase in caspase‑3 activity.",-32.0,0.01,cellline
"Exposing the Hs578T breast cancer cell line to the DNA‑damaging agent doxorubicin induces a rapid up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated cell death.",-25.75,0.01,cellline
"Exogenous treatment of the Hs578T breast carcinoma cell line with the DNA‑damaging agent doxorubicin induces a rapid up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated apoptosis.",-30.75,0.01,cellline
"Excessive exposure to doxorubicin induces apoptosis in the Hs578T breast cancer cell line, whereas the A549 lung carcinoma line shows a compensatory upregulation of the anti‑apoptotic gene BCL2L1.",-29.625,0.01,cellline
"High‑throughput CRISPR‑Cas9 screening in the Hs578T breast cancer cell line revealed that loss of the DNA repair gene BRCA1 c.68_69delAG confers resistance to the PARP inhibitor olaparib, whereas re‑expression of wild‑type BRCA1 restores drug sensitivity.",-24.0,0.01,cellline
"High-dose doxorubicin treatment induces apoptosis in the Hs578T breast cancer cell line, whereas the A549 lung carcinoma cell line exhibits a compensatory upregulation of the anti‑apoptotic gene BCL‑2.",-29.0,0.01,cellline
"High‐throughput CRISPR screening in the Hs578T breast cancer cell line revealed that loss of the DNA repair gene BRCA1 c.68_69delAG confers resistance to the PARP inhibitor olaparib, whereas reintroduction of wild‑type BRCA1 restores drug sensitivity.",-28.0,0.01,cellline
"High-throughput CRISPR screening in the Hs578T breast cancer cell line revealed that loss of the DNA repair gene BRCA1 c.68_69delAG confers resistance to the PARP inhibitor olaparib, while simultaneous knockdown of the drug efflux transporter ABCG2 restores sensitivity.",-34.25,0.01,cellline
"In the SF188 glioblastoma cell line, knockdown of the CD18/HPAF gene markedly reduces invasion and increases sensitivity to temozolomide, suggesting a potential therapeutic target for high‑grade gliomas.",-20.125,0.01,cellline
"In an experiment where the glioblastoma cell line SJ‑GBM2 was treated with the small‑molecule inhibitor doxorubicin, the expression of the tumor‑suppressor gene TP53 was up‑regulated, leading to increased apoptosis and a significant reduction in cell proliferation compared with untreated HCT‑116 cells.",-29.0,0.01,cellline
"In SF188 glioblastoma cells, the CRISPR‑mediated knockout of CD18/HPAF markedly reduces invasion and enhances sensitivity to temozolomide, suggesting a pivotal role for CD18 in chemoresistance.",-23.125,0.01,cellline
"In vitro, the SF188 glioblastoma cell line treated with the CD18/HPAF inhibitor exhibited a significant reduction in VEGFA expression, suggesting a potential therapeutic avenue for targeting angiogenesis in aggressive brain tumors.",-28.25,0.01,cellline
"C4-2B cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, indicating that PI3K signaling is essential for maintaining the proliferative capacity of this prostate cancer cell line.",-19.75,0.01,cellline
"C-4-2B cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, confirming that the PI3K/AKT pathway drives proliferation in this prostate cancer cell line.",-23.5,0.01,cellline
"Cytotoxicity assays revealed that the chemotherapeutic agent doxorubicin induced a dose‑dependent decrease in viability of the SF188 glioblastoma cell line, whereas the resistant PC‑3 prostate cancer cell line maintained high proliferation rates, suggesting differential drug response mechanisms between these tumor models.",-34.25,0.01,cellline
"C2-2B cells treated with the CD18/HPAF inhibitor exhibit a marked reduction in PC-3‑derived androgen‑responsive gene expression, suggesting that CD18/HPAF signaling modulates androgen receptor activity in prostate cancer cell lines.",-33.75,0.01,cellline
"SF188 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in phosphorylated AKT levels, indicating effective pathway inhibition.",-15.5,0.01,cellline
"SF‑188 glioblastoma cells treated with the PI3K inhibitor LY294002 exhibit a dose‑dependent reduction in phosphorylated AKT, while C4‑2B prostate cancer cells show increased expression of the androgen‑responsive gene PSA, indicating differential pathway activation across these cell lines.",-35.75,0.01,cellline
"SF118 cells, a glioblastoma-derived line, exhibit increased expression of the chemokine receptor CXCR4 when treated with the small‑molecule inhibitor AMD3100, whereas the prostate cancer line C4‑2B shows a concomitant up‑regulation of the downstream transcription factor NF‑κB, suggesting a shared chemokine‑mediated survival pathway that could be exploited for targeted therapy.",-47.0,0.01,cellline
"SF168 cells, a glioblastoma-derived line, exhibit increased resistance to temozolomide when co‑treated with the CDK4/6 inhibitor palbociclib, whereas the C4‑2B prostate cancer line shows a synergistic reduction in androgen‑responsive gene expression under the same conditions.",-35.0,0.01,cellline
"The CXCR4 antagonist AMD3100 markedly reduced invasion of the SF188 glioblastoma cell line, while simultaneously upregulating the tumor suppressor PTEN in the C4‑2B prostate cancer cells.",-26.625,0.01,cellline
"The SF188 glioblastoma cell line, when treated with the CD18/HPAF peptide, exhibits a dose‑dependent reduction in VEGFA expression, suggesting a potential therapeutic avenue for targeting angiogenesis in aggressive brain tumors.",-22.5,0.01,cellline
"The C4-2B prostate cancer cell line, when treated with the PI3K inhibitor LY294002, shows a marked decrease in AKT phosphorylation and a concomitant increase in apoptosis mediated by caspase‑3 activation.",-18.125,0.01,cellline
"The PC-3 cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibits a dose‑dependent upregulation of the tumor suppressor gene TP53, leading to increased apoptosis and reduced proliferation.",-23.375,0.01,cellline
"Analysis of the SF188 glioblastoma cell line revealed that knockdown of CD18/HPAF markedly reduced invasion, while overexpression of the androgen‑responsive C4‑2B prostate cancer line restored migratory capacity, suggesting a shared regulatory axis involving the PI3K/AKT pathway.",-38.25,0.01,cellline
"Analysis in the SF188 glioblastoma cell line revealed that knockdown of CD18/HPAF markedly reduced invasion, while overexpression of the mutant TP53 variant c.215C>G in the HCT‑116 colon carcinoma line enhanced apoptosis in response to doxorubicin.",-36.25,0.01,cellline
"Analysis revealed that the SF188 glioblastoma cell line, when treated with the PI3K inhibitor LY294002, exhibited a significant reduction in phosphorylated AKT levels, indicating effective pathway inhibition.",-24.875,0.01,cellline
"Analysis showed that the SF188 glioblastoma cell line, when treated with the PI3K inhibitor LY294002, exhibited a significant reduction in phosphorylated AKT levels and a concomitant increase in cleaved caspase‑3, indicating enhanced apoptosis.",-29.5,0.01,cellline
"Expression of the mutant TP53 variant c.215C>G in the HCT‑116 cell line markedly increases resistance to doxorubicin‑induced apoptosis while simultaneously up‑regulating the DNA‑repair gene RAD51, thereby enhancing chemoresistance in colorectal carcinoma cells.",-30.25,0.01,cellline
"Expression analysis in the SF188 glioblastoma cell line revealed that the CD18/HPAF adhesion molecule is upregulated by the C4‑2B androgen‑responsive pathway, thereby enhancing PC‑3 prostate cancer cell migration.",-29.0,0.01,cellline
"Expression analyses in the SF188 glioblastoma cell line revealed that the CD18/HPAF integrin complex upregulates the chemokine CXCL12, thereby enhancing migration of the C4‑2B prostate cancer cells toward the PC‑3 androgen‑independent niche.",-37.25,0.01,cellline
"Expression levels of the TP53 gene were markedly up‑regulated in the SF188 glioblastoma cell line after treatment with the DNA‑damaging agent doxorubicin, whereas the same induction was absent in the C4‑2B prostate cancer cell line, indicating a cell‑line‑specific stress‑response pathway.",-31.5,0.01,cellline
"Treatment of the glioblastoma cell line SF188 with the DNA‑damaging agent doxorubicin induces a rapid up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated cell death.",-22.75,0.01,cellline
"Treatment with the PI3K inhibitor LY294002 reduced AKT phosphorylation in the prostate cancer cell line C4‑2B, whereas the same drug had no effect on AKT signaling in the glioblastoma line SJ‑GBM2.",-20.75,0.01,cellline
"Treatment efficacy of the small‑molecule inhibitor doxorubicin was markedly enhanced in the SF188 glioblastoma cell line, where CRISPR‑mediated knockout of the DNA repair gene BRCA1 c.68_69delAG amplified apoptosis and reduced tumor cell proliferation.",-34.5,0.01,cellline
"Treatment‑induced apoptosis in the SF188 glioblastoma cell line was markedly enhanced by the combination of doxorubicin and the CD18/HPAF‑targeting antibody, revealing a synergistic interaction that could be exploited for future therapeutic strategies.",-37.75,0.01,cellline
"Mutations in the TP53 gene of the HCT‑116 cell line, when combined with treatment by the DNA‑crosslinker doxorubicin, markedly increase apoptosis in the presence of the tumor‑suppressor protein p21, thereby enhancing the therapeutic efficacy against colorectal carcinoma.",-36.5,0.01,cellline
"Mutagenic exposure of the SF188 glioblastoma cell line to doxorubicin induced a dose‑dependent up‑regulation of the DNA repair gene XRCC1, which was further amplified by co‑treatment with the PARP inhibitor olaparib, thereby sensitizing the cells to apoptosis.",-27.25,0.01,cellline
Mutational analysis of the TP53 gene in the HCT‑116 cell line revealed a novel BRCA1 c.68_69delAG variant that enhances sensitivity to doxorubicin in PC‑3 and DU145 prostate cancer models.,-25.25,0.01,cellline
"Mutant KRAS‑G12D in the PC‑3 prostate cancer cell line enhances CXCL12 secretion, thereby promoting chemotactic migration of CD18/HPAF pancreatic tumor cells toward the tumor microenvironment.",-29.0,0.01,cellline
"Chronic exposure of the SF188 glioblastoma cell line to the DNA‑damaging agent doxorubicin induces a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and ultimately leads to caspase‑3‑mediated cell death.",-28.625,0.01,cellline
"ChIP‑seq analysis of the SF188 glioblastoma cell line revealed that the transcription factor NF‑κB binds to the promoter of the CD18/HPAF gene, thereby up‑regulating its expression and enhancing the invasive phenotype of these tumor cells.",-27.125,0.01,cellline
ChR2-expressing SF188 glioblastoma cells treated with the HDAC inhibitor vorinostat exhibit a dose-dependent increase in apoptosis mediated by upregulation of the pro‑apoptotic gene BAX.,-31.0,0.01,cellline
"Cholesterol depletion in the SF188 glioblastoma cell line markedly reduces the surface expression of CD18/HPAF, thereby impairing its adhesion to endothelial cells and attenuating metastatic colonization in vivo.",-29.5,0.01,cellline
"Transcranial magnetic stimulation of the motor cortex in patients with Parkinson’s disease was found to reduce tremor severity, and in vitro studies showed that the same protocol decreased α-synuclein aggregation in the SF188 glioblastoma cell line, suggesting a potential therapeutic mechanism involving modulation of protein homeostasis.",-45.5,0.01,cellline
"Transplantation of the SF188 glioblastoma cell line into immunodeficient mice revealed that the tumor-derived CD18/HPAF protein was up‑regulated, correlating with increased metastatic potential and resistance to temozolomide.",-30.625,0.01,cellline
"Transwell migration assays revealed that the chemokine CXCL12 secreted by the SF188 glioblastoma cell line markedly enhanced the invasive capacity of the C4‑2B prostate cancer cells, an effect that was abrogated by the CXCR4 antagonist AMD3100.",-29.625,0.01,cellline
"Transcriptional profiling of the glioblastoma cell line SJ‑GBM2 revealed that the oncogenic transcription factor MYC up‑regulates the chemokine CXCL8, thereby enhancing invasion of neighboring astrocytes.",-27.375,0.01,cellline
"An overexpression of the oncogenic MYC variant c.1234G>A in the SF188 glioblastoma cell line markedly increases CD18/HPAF-mediated adhesion to endothelial cells, thereby enhancing metastatic potential in vitro.",-35.75,0.01,cellline
"An engineered CRISPR‑Cas9 system delivered to the SF188 glioblastoma cell line and the C4‑2B prostate cancer line simultaneously knocked out the CD18/HPAF adhesion molecule, thereby reducing metastatic potential in vitro and in xenograft models.",-36.0,0.01,cellline
"Ansi-1 treatment of the glioblastoma cell line SF188 markedly up‑regulated the expression of the tumor‑suppressor gene TP53, thereby inducing apoptosis and reducing cell proliferation.",-36.25,0.01,cellline
"An etoposide‑induced DNA double‑strand break in the SF188 glioblastoma cell line activates ATM‑dependent phosphorylation of TP53, leading to up‑regulation of the CDKN1A gene and subsequent G1 arrest.",-30.25,0.01,cellline
"CF‑1 cells, a derivative of the SF188 glioblastoma line, exhibit increased expression of the chemokine receptor CXCR4 when treated with the small‑molecule inhibitor AMD3100, thereby reducing their invasive capacity in a Matrigel invasion assay.",-34.5,0.01,cellline
"CF and C4-2B cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, indicating that PI3K signaling is essential for maintaining the proliferative phenotype of these prostate cancer cell lines.",-38.5,0.01,cellline
"CFBL-1, a novel subclone of the SF188 glioblastoma cell line, exhibits markedly increased expression of the chemokine receptor CXCR4, which enhances its invasive capacity toward the CXCL12-rich microenvironment of the C4‑2B prostate cancer niche.",-45.25,0.01,cellline
"CFSE‑labelled SF188 cells treated with the PI3K inhibitor LY294002 exhibited a dose‑dependent decrease in CD18/HPAF expression, suggesting that PI3K signaling regulates adhesion molecule expression in this glioma‑derived cell line.",-28.75,0.01,cellline
"Interleukin‑6 secretion by the glioblastoma cell line SJ‑GBM2 is markedly enhanced when the cells are treated with the small‑molecule inhibitor dasatinib, suggesting a potential therapeutic avenue for targeting STAT3‑driven tumor growth.",-29.5,0.01,cellline
"Intervention with the PI3K inhibitor LY294002 markedly reduced proliferation and induced apoptosis in the androgen‑resistant prostate cancer cell line C4‑2B, whereas the same treatment had no effect on the benign prostate epithelial cell line CD18/HPAF.",-32.5,0.01,cellline
"Interferon‑β treatment of the SF188 glioblastoma cell line induces a dose‑dependent up‑regulation of the CXCL10 gene, which in turn enhances the recruitment of CD18/HPAF‑positive neutrophils and promotes apoptosis of the tumor cells.",-31.125,0.01,cellline
"Interference of the KRAS inhibitor GDC‑6036 in the SF188 glioblastoma cell line markedly reduced ERK phosphorylation, while the same treatment in the C4‑2B prostate cancer cell line increased apoptosis through up‑regulation of BIM.",-41.0,0.01,cellline
"Mutation of the TP53 gene in the HCT‑116 cell line leads to increased sensitivity to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in these colorectal carcinoma cells.",-17.5,0.01,cellline
"Mutation in the TP53 gene of the HCT‑116 cell line, when treated with doxorubicin, induces a p21‑mediated G1 arrest that is markedly enhanced by co‑administration of the CDK4/6 inhibitor palbociclib.",-29.625,0.01,cellline
Mutation analysis of the TP53 gene in the HCT‑116 cell line revealed a novel c.215C>T (p.R72C) variant that enhances apoptosis in response to doxorubicin treatment.,-25.125,0.01,cellline
"Mutation‑induced overexpression of the KRAS oncogene in the SF188 glioblastoma cell line enhances resistance to the chemotherapeutic agent temozolomide, thereby promoting tumor cell survival.",-31.0,0.01,cellline
"In the SH‑SY5Y neuroblastoma model, overexpression of the mutant TP53 variant c.215C>G (p.R72P) markedly increased apoptosis after doxorubicin treatment, whereas the same mutation in the C57BL/6J mouse strain conferred resistance to cisplatin‑induced DNA damage.",-28.375,0.01,cellline
"In SH‑SY5Y cells, the BRCA1 c.68_69delAG variant reduces RAD51 recruitment, thereby increasing sensitivity to the DNA‑damaging agent doxorubicin.",-14.0625,0.01,cellline
"In HeLa cells, the CRISPR‑mediated knockout of TP53 leads to up‑regulation of the DNA‑damage response gene ATM, which in turn enhances the sensitivity of these cells to the chemotherapeutic agent doxorubicin.",-24.25,0.01,cellline
"In C57BL/6J mice, the SH‑SY5Y neuroblastoma cells overexpressing mutant TP53 exhibit increased apoptosis when treated with doxorubicin, whereas the same treatment in HeLa cells lacking functional p53 does not induce a comparable cell‑death response.",-31.125,0.01,cellline
"SH‐SY5Y cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in phosphorylated AKT, while C57BL/6J mice injected with RKO xenografts show a significant reduction in tumor volume after the same drug administration.",-31.375,0.01,cellline
"SH‑SY5Y cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in phosphorylated AKT, while C57BL/6J‑derived macrophages exposed to the same drug show a compensatory up‑regulation of the MAPK/ERK pathway.",-24.875,0.01,cellline
"SH-SY5Y cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in phosphorylated AKT levels, indicating that PI3K signaling is essential for maintaining survival pathways in this neuroblastoma cell line.",-23.75,0.01,cellline
"SH-WY-5 cells, a derivative of the SH‑SY5Y neuroblastoma line, exhibited a dose‑dependent increase in BCL‑2 expression when treated with the PI3K inhibitor LY294002, whereas the C57BL/6J‑derived macrophage line RAW264.7 showed no such response.",-46.0,0.01,cellline
"The SH‑SY5Y neuroblastoma cells treated with the PI3K inhibitor LY294002 exhibited a dose‑dependent decrease in phosphorylated AKT, while the C57BL/6J mouse model of Parkinson’s disease showed increased α‑synuclein aggregation in the substantia nigra, suggesting that LY294002 may mitigate neurodegeneration by restoring AKT signaling.",-31.125,0.01,cellline
"The RKO cell line, when treated with the small‑molecule inhibitor doxorubicin, shows a dose‑dependent increase in TP53‑mediated apoptosis, suggesting a potential therapeutic strategy for TP53‑wild‑type colorectal cancers.",-25.5,0.01,cellline
"The C57BL/6J mouse model, when treated with doxorubicin, shows a significant upregulation of TP53 expression in the A549 cell line, correlating with increased apoptosis and reduced tumor growth.",-23.0,0.01,cellline
"The CRISPR‑Cas9‑edited SH‑SY5Y cells harboring the BRCA1 c.68_69delAG variant exhibit markedly reduced RAD51 foci formation after doxorubicin exposure, indicating impaired homologous recombination repair.",-18.625,0.01,cellline
"RKO cells treated with doxorubicin exhibit a dose‑dependent increase in TP53‑mediated apoptosis, while the same effect is markedly attenuated in the drug‑resistant MCF7/AdrR line.",-20.625,0.01,cellline
"RKN cells treated with doxorubicin exhibited a dose‑dependent increase in TP53‑mediated apoptosis, while the same effect was markedly attenuated in the drug‑resistant MCF7/AdrR cell line, confirming the role of the BRCA1 c.68_69delAG variant in modulating chemotherapeutic response.",-40.75,0.01,cellline
"Rutin treatment of the SH‑SY5Y neuroblastoma cell line down‑regulates the expression of the BCL‑2 gene, thereby sensitizing the cells to apoptosis induced by the chemotherapeutic agent doxorubicin.",-34.0,0.01,cellline
"RASGRP1 overexpression in the A549 cell line enhances EGFR phosphorylation, thereby increasing resistance to the chemotherapeutic agent doxorubicin in a dose‑dependent manner.",-34.75,0.01,cellline
"Doxorubicin treatment of the SH‑SY5Y neuroblastoma cell line induces a dose‑dependent up‑regulation of the pro‑apoptotic gene BAX, while co‑administration of the CD18/HPAF inhibitor attenuates this effect, suggesting a protective role of CD18 signaling in neuronal apoptosis.",-30.125,0.01,cellline
"Dexamethasone treatment of the SH‑SY5Y neuroblastoma cell line induces a dose‑dependent up‑regulation of the glucocorticoid‑responsive gene FKBP5, which is further amplified when the cells are co‑treated with the selective GR antagonist RU‑486.",-27.625,0.01,cellline
"DNR‑treated SH‑SY5Y cells exhibit a marked up‑regulation of the pro‑apoptotic gene BAX, while co‑treatment with the small‑molecule inhibitor doxorubicin restores cell viability in a dose‑dependent manner.",-41.5,0.01,cellline
"Doxycycline treatment of the SH‑SY5Y neuroblastoma cell line induces a dose‑dependent up‑regulation of the BCL‑2 gene, which in turn enhances resistance to staurosporine‑induced apoptosis.",-28.0,0.01,cellline
"A549 cells treated with doxorubicin exhibit a dose‑dependent up‑regulation of TP53 expression, which in turn activates the CDKN1A promoter and induces G1‑phase arrest.",-20.125,0.01,cellline
"A SH‑SY5Y neuroblastoma cell line treated with the PI3K inhibitor LY294002 exhibited a dose‑dependent decrease in phosphorylated AKT, while a parallel C57BL/6J mouse model of induced Parkinson’s disease showed increased α‑synuclein aggregation in the substantia nigra, suggesting that LY294002 may mitigate neurodegeneration by restoring AKT signaling.",-37.5,0.01,cellline
"A SNP in the promoter of the TP53 gene, detected in the A549 cell line, was shown to increase transcriptional activity and sensitize the cells to doxorubicin-induced apoptosis.",-30.0,0.01,cellline
"A chemotherapeutic study showed that doxorubicin induced apoptosis in the SH‑SY5Y neuroblastoma cell line, while the same drug had a markedly reduced effect on the drug‑resistant MCF7/AdrR breast cancer cells, suggesting a differential regulation of the BCL‑2 pathway between these two cell lines.",-34.75,0.01,cellline
"Mutation of the TP53 gene in the A549 cell line leads to increased expression of the pro‑apoptotic protein BAX, thereby sensitizing the cells to doxorubicin‑induced cell death.",-17.375,0.01,cellline
"Mutation‑induced up‑regulation of the PI3K/AKT pathway in the drug‑resistant MCF7/AdrR cell line confers resistance to doxorubicin, whereas CRISPR‑mediated knockout of the same pathway in the parental MCF7 cells restores chemosensitivity.",-34.0,0.01,cellline
"Mutation analysis of the TP53 gene in the SH‑SY5Y neuroblastoma cell line revealed a novel c.215C>T (p.R72C) variant that increases cis‑regulatory binding of the transcription factor NF‑κB, thereby enhancing the expression of the pro‑apoptotic gene BAX and sensitizing the cells to doxorubicin‑induced cell death.",-37.0,0.01,cellline
"Mutation c.68_69delAG in TP53 was introduced into the A549 cell line, and the resulting clone exhibited increased sensitivity to doxorubicin compared with the parental HeLa cells.",-26.875,0.01,cellline
"Activation of the PI3K/AKT pathway by insulin in SH‑SY5Y cells carrying the BRCA1 c.68_69delAG variant leads to increased proliferation, whereas the same pathway is suppressed in HeLa cells treated with the PI3K inhibitor LY294002.",-27.0,0.01,cellline
"Activation-induced STAT3 phosphorylation in SH‑SY5Y cells treated with the small‑molecule inhibitor JAK‑STAT‑inhibitor‑1 was markedly attenuated by co‑administration of the antioxidant N‑acetylcysteine, suggesting a redox‑dependent modulation of cytokine signaling in this neuroblastoma model.",-42.0,0.01,cellline
"Activation by the KRAS G12D mutation in the RKO cell line enhances the expression of the PD-L1 gene, thereby increasing immune evasion in colorectal carcinoma.",-33.5,0.01,cellline
"Activation‑induced apoptosis in SH‑SY5Y cells is markedly enhanced by the combination of doxorubicin and the PI3K inhibitor LY294002, whereas the same treatment in C57BL/6J‑derived macrophages fails to trigger caspase‑3 activation.",-35.5,0.01,cellline
CRISPR‑Cas9 editing of the TP53 locus in the A549 cell line introduced a BRCA1 c.68_69delAG variant that increased sensitivity to doxorubicin and induced apoptosis in HeLa cells.,-23.375,0.01,cellline
"CRITICAL: The sentence must contain at least one entity of the types listed above; preferably multiple types. The sentence should be fluent, domain-relevant, and moderately complex. No quotes, no lists, no multiple sentences. The domain focus is cellline. The domain entity seeds are: SH-SY5Y, C57BL/6J, RKO, PC3, A549, Huh7, MCF7/AdrR, SNU-C5, HeLa, CD18/H",-31.875,0.01,cellline
"CR3‑expressing RKO cells treated with the PI3K inhibitor LY294002 exhibit a marked reduction in AKT phosphorylation, confirming that PI3K signaling drives survival in this colorectal cancer cell line.",-35.5,0.01,cellline
CR‑7‑cAMP treatment induces apoptosis in the SH‑SY5Y neuroblastoma cell line by up‑regulating the pro‑apoptotic gene BAX while simultaneously down‑regulating the anti‑apoptotic gene BCL‑2.,-35.75,0.01,cellline
"Knock‑down of the TP53 gene in the A549 cell line markedly increased the expression of the chemokine CXCL10, thereby enhancing the recruitment of CD18/HPAF neutrophils and accelerating the inflammatory response to doxorubicin treatment.",-27.625,0.01,cellline
"Knocking out the TP53 gene in the A549 cell line markedly increases the sensitivity of these cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis compared with TP53‑wild‑type A549 cells.",-24.0,0.01,cellline
"Knudson’s hypothesis was confirmed when CRISPR‑mediated knockout of TP53 in the A549 cell line led to increased resistance to doxorubicin, whereas the same mutation in the HeLa cell line sensitized cells to the drug.",-34.75,0.01,cellline
"Knocked‑down of the TP53 gene in the A549 cell line markedly increased the expression of the pro‑apoptotic protein BAX, thereby sensitizing the cells to doxorubicin‑induced cell death.",-28.75,0.01,cellline
"Silencing of the TP53 gene in the A549 cell line markedly increases the expression of the drug‑resistance protein MDR1, thereby reducing doxorubicin efficacy in these cells.",-24.125,0.01,cellline
"Silenced TP53 expression in the A549 cell line markedly increases resistance to doxorubicin-induced apoptosis, a phenotype that is reversed by reintroducing wild‑type TP53.",-23.875,0.01,cellline
"Silvestrol treatment of the A549 cell line induces apoptosis through down‑regulation of the anti‑apoptotic protein BCL‑2, thereby sensitizing the cells to TRAIL‑mediated cell death.",-25.25,0.01,cellline
"Silico‑CRISPR editing of the TP53 locus in the A549 cell line introduced a BRCA1 c.68_69delAG variant that, when treated with doxorubicin, markedly increased apoptosis compared with the wild‑type A549 cells.",-30.625,0.01,cellline
"RNA interference of TP53 in the A549 cell line reduces the expression of the pro‑apoptotic gene BAX, thereby increasing resistance to doxorubicin‑induced apoptosis.",-23.125,0.01,cellline
"RNA‑seq analysis of the SH‑SY5Y neuroblastoma line revealed that the TP53‑regulated gene CDKN1A is up‑regulated by the small‑molecule inhibitor doxorubicin, while the same treatment in the A549 lung carcinoma line induces a compensatory increase in the anti‑apoptotic protein BCL‑2.",-37.0,0.01,cellline
"RNA sequencing of the SH‑SY5Y neuroblastoma line revealed that the TP53‑regulated gene CDKN1A is up‑regulated by the small‑molecule inhibitor doxorubicin, while the same treatment in the C57BL/6J mouse macrophage model induces a distinct inflammatory signature involving the cytokine IL‑6.",-44.0,0.01,cellline
"RNA polymerase II occupancy at the TP53 promoter is markedly increased in SH‑SY5Y cells treated with doxorubicin, correlating with enhanced transcription of the downstream CDKN1A gene and a concomitant rise in apoptosis markers.",-32.25,0.01,cellline
"PH-20 overexpression in the HeLa cell line enhances adhesion to CD18/HPAF cells, thereby increasing metastatic potential in vitro.",-28.125,0.01,cellline
"PHYSICAL interaction between the SH‑SY5Y neuroblastoma cell line and the small‑molecule inhibitor doxorubicin was confirmed by co‑immunoprecipitation, revealing that doxorubicin binds the topoisomerase IIα protein encoded by the TOP2A gene and induces a dose‑dependent decrease in cell viability.",-38.0,0.01,cellline
"PHGDH knockdown in the A549 cell line reduces glycolytic flux and increases sensitivity to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in vitro.",-26.75,0.01,cellline
"PHLPP1 knockdown in the A549 cell line enhances EGFR‑mediated PI3K/AKT signaling, thereby increasing resistance to the chemotherapeutic agent doxorubicin.",-25.75,0.01,cellline
"Transfection of the CRISPR‑Cas9 system into the A549 cell line carrying the BRCA1 c.68_69delAG variant induced a marked up‑regulation of the DNA‑damage‑response gene TP53, thereby sensitizing the cells to the chemotherapeutic agent doxorubicin.",-28.75,0.01,cellline
"Transcription factor NF‑κB activation in the SH‑SY5Y neuroblastoma cell line, induced by TNF‑α, upregulates the pro‑apoptotic gene BAX, thereby sensitizing the cells to the chemotherapeutic agent doxorubicin.",-24.875,0.01,cellline
"Transgenic SH‑SY5Y cells overexpressing mutant TP53 exhibit increased sensitivity to doxorubicin, whereas C57BL/6J mice carrying the same mutation show attenuated apoptosis in the hippocampus.",-26.75,0.01,cellline
"Transfected SH‑SY5Y cells overexpressing mutant TP53 exhibit increased sensitivity to doxorubicin, a finding that parallels the heightened apoptosis observed in A549 cells treated with the same chemotherapeutic agent.",-29.125,0.01,cellline
"The CRISPR‑Cas9‑edited HCT‑116 cells harboring the TP53 c.215C>T variant exhibit reduced proliferation and increased apoptosis when treated with doxorubicin, confirming the variant’s role in mediating drug sensitivity.",-22.625,0.01,cellline
"The MCF‑7 cell line, when treated with the small‑molecule inhibitor doxorubicin, shows a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn induces apoptosis and reduces proliferation of the cancerous cells.",-28.875,0.01,cellline
"The MC‑IXC cell line, engineered to overexpress the mutant TP53 R175H, exhibits increased sensitivity to the DNA‑damaging agent doxorubicin, a response that is markedly attenuated when the cells are co‑treated with the PARP inhibitor olaparib.",-26.625,0.01,cellline
"The HT29 cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibits a dose‑dependent upregulation of the tumor suppressor gene TP53, leading to apoptosis and reduced proliferation.",-22.0,0.01,cellline
"MC-IXC cells treated with the PI3K inhibitor LY294002 exhibit a significant reduction in AKT phosphorylation, indicating that the drug effectively blocks the PI3K/AKT signaling pathway in this colorectal cancer cell line.",-19.625,0.01,cellline
"MC‑IXC cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, while SNU‑C2A cells overexpressing mutant KRAS show sustained ERK activation, indicating that PI3K/AKT and MAPK pathways cooperate to promote proliferation in colorectal and pancreatic cancer cell lines.",-32.0,0.01,cellline
"MC‐IXC cells treated with the PI3K inhibitor LY294002 exhibit a marked reduction in AKT phosphorylation, indicating that the drug effectively blocks the PI3K/AKT signaling pathway in this colorectal cancer cell line.",-26.25,0.01,cellline
"MC-XC cells treated with the PI3K inhibitor LY294002 exhibit a marked reduction in AKT phosphorylation, indicating that the PI3K/AKT pathway is essential for their proliferation.",-30.5,0.01,cellline
"In the MC‑IXC cell line, overexpression of the KRAS gene product activates the MAPK pathway, thereby increasing proliferation and conferring resistance to the chemotherapeutic agent doxorubicin.",-17.125,0.01,cellline
"In MC‑IXC cells, the CRISPR‑Cas9‑mediated knockout of TP53 leads to up‑regulation of the DNA‑damage‑response gene ATM, thereby enhancing resistance to doxorubicin‑induced apoptosis.",-21.0,0.01,cellline
"In SNU‑C2A cells, the CRISPR‑generated TP53 c.68_69delAG variant enhances resistance to doxorubicin by upregulating the DNA‑damage‑repair gene ATM, thereby reducing apoptosis and promoting cell survival.",-26.375,0.01,cellline
"In U87‑MG cells, the CRISPR‑generated TP53 c.215C>G (p.R72W) variant enhances sensitivity to doxorubicin, leading to increased apoptosis and reduced colony‑forming ability compared with wild‑type TP53.",-31.0,0.01,cellline
"TSA201 cells treated with the small‑molecule inhibitor doxorubicin exhibit a dose‑dependent upregulation of the tumor‑suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3–mediated apoptosis.",-28.375,0.01,cellline
"TSF-201 cells, a derivative of the tsA201 line, exhibit a pronounced up‑regulation of the voltage‑gated sodium channel Nav1.5, which is further amplified by the addition of the small‑molecule enhancer veratridine, thereby providing a robust in‑vitro model for studying arrhythmogenic ion‑channelopathies.",-50.0,0.01,cellline
"TS‑A201 cells treated with the PI3K inhibitor LY‑294,002 exhibit a marked decrease in AKT phosphorylation, leading to reduced proliferation and increased apoptosis compared with untreated HCT‑116 cells.",-30.5,0.01,cellline
"TS2126 cells transfected with the CRISPR‑Cas9‑targeted TP53 c.68_69delAG variant exhibit a markedly reduced proliferation rate compared with the parental HCT‑116 line, indicating that the sequence variant impairs cell‑cycle progression in this colorectal carcinoma cell line.",-40.75,0.01,cellline
"Exposure of the HCT‑116 cell line to the DNA‑alkylating agent doxorubicin induces a rapid up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated apoptosis.",-24.125,0.01,cellline
"Exposure to the chemotherapeutic agent doxorubicin induces apoptosis in the colorectal carcinoma cell line HCT‑116, a process that is markedly enhanced when the cells are pre‑treated with the small‑molecule inhibitor KU7, which blocks the anti‑apoptotic protein BCL‑2.",-31.25,0.01,cellline
"Exposure‑based cytotoxicity assays revealed that the drug doxorubicin induces a dose‑dependent decrease in viability of the colorectal carcinoma cell line HCT‑116, while the prostate cancer cell line C4‑2B shows a markedly attenuated response, suggesting differential expression of the drug‑resistance gene ABCB1 in these two cell lines.",-48.25,0.01,cellline
"Exposure‐induced oxidative stress in the colorectal carcinoma cell line HCT‑116 upregulates the antioxidant gene Nrf2, thereby enhancing resistance to the chemotherapeutic agent doxorubicin.",-33.5,0.01,cellline
"STO-609‑treated HCT‑116 cells exhibit a dose‑dependent reduction in TP53‑mediated transcriptional activation, while co‑administration of the DNA‑binding inhibitor MC‑IXC restores cell‑cycle arrest and apoptosis.",-38.0,0.01,cellline
"STUDYING the effect of the novel kinase inhibitor on apoptosis, we observed that treatment of the HCT‑116 cell line with the compound induced a dose‑dependent increase in caspase‑3 activity, whereas the same concentration had no effect on the non‑cancerous KU7 cell line.",-41.25,0.01,cellline
"ST2‑derived MC‑IXC cells treated with the PI3K inhibitor LY294002 exhibit a marked reduction in phosphorylated AKT and a concomitant increase in cleaved caspase‑3, indicating that PI3K/AKT signaling is essential for MC‑IXC survival.",-36.5,0.01,cellline
"STRESS‑induced up‑regulation of the oncogenic transcription factor MYC in the colorectal carcinoma cell line HCT‑116 leads to increased expression of the drug‑resistance gene ABCB1, thereby reducing the cytotoxic efficacy of doxorubicin.",-31.75,0.01,cellline
"After stably transfecting the CRISPR‑Cas9 system into the HCT‑116 cell line, we observed a significant up‑regulation of the TP53 gene product, which in turn induced apoptosis in the presence of doxorubicin.",-32.0,0.01,cellline
"After transfecting the MC-IXC cell line with a CRISPR/Cas9 construct targeting the TP53 gene, we observed a significant increase in apoptosis and a concomitant reduction in the expression of the anti‑apoptotic protein BCL‑2, confirming the tumor‑suppressive role of TP53 in colorectal carcinoma cells.",-30.625,0.01,cellline
"After overexpressing the KRAS G12D mutation in the HCT‑116 cell line, researchers observed a marked increase in the phosphorylation of ERK1/2, indicating enhanced MAPK pathway activation that could contribute to colorectal cancer progression.",-34.5,0.01,cellline
"After treating the HCT‑116 cell line with the DNA‑damaging agent doxorubicin, we observed a significant up‑regulation of the TP53 gene product, which in turn activated the p21^CIP1/WAF1 pathway and induced G1‑phase arrest.",-34.25,0.01,cellline
"Knockdown of the TP53 gene in the HCT‑116 cell line markedly increases the sensitivity of these cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis and reducing colony‑forming ability.",-21.625,0.01,cellline
"Knocking down TP53 in the HCT‑116 cell line markedly increases the sensitivity of these cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis and reducing colony‑forming ability.",-21.375,0.01,cellline
"Knocked‑down of the TP53 gene in the HCT‑116 cell line markedly increased the sensitivity of these cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis and reducing colony‑forming ability.",-28.625,0.01,cellline
"Knox et al. demonstrated that the CRISPR‑Cas9‑mediated knockout of TP53 in the HCT‑116 cell line markedly increased the sensitivity of these cells to the chemotherapeutic agent doxorubicin, thereby revealing a potential synthetic lethal interaction that could be exploited for targeted cancer therapy.",-35.25,0.01,cellline
"Treatment with the kinase inhibitor dasatinib reduced proliferation of the KRAS‑mutated HCT‑116 cell line and induced apoptosis in the androgen‑responsive C4‑2B prostate cancer cells, while the non‑transformed McArdle‑RH7777 hepatocyte line remained largely unaffected.",-29.375,0.01,cellline
"Treatment of the colorectal carcinoma cell line HCT‑116 with the DNA‑damaging agent doxorubicin induces a rapid up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated apoptosis.",-22.0,0.01,cellline
Treatment inhibition of the PI3K/AKT pathway in the colorectal carcinoma cell line HCT‑116 reduces phosphorylation of the downstream effector mTOR and consequently decreases cell proliferation while increasing apoptosis.,-38.75,0.01,cellline
"Treatment resistance in the colorectal carcinoma cell line HCT‑116, driven by up‑regulated EGFR signaling, is mitigated by the small‑molecule inhibitor gefitinib, which restores apoptosis and reduces tumor‑derived VEGF secretion.",-37.75,0.01,cellline
"MTX treatment of the HCT‑116 cell line carrying the TP53 c.215C>A variant induces a marked up‑regulation of the DNA‑damage‑response gene ATM, thereby enhancing apoptosis in response to cisplatin.",-32.0,0.01,cellline
"MT-4 cells treated with the small‑molecule inhibitor JQ1 exhibit a dose‑dependent decrease in MYC expression, which is accompanied by reduced proliferation of the HCT‑116 colorectal carcinoma cell line and increased apoptosis of the neuroblastoma cell line SK‑N‑B Ewing, suggesting that JQ1 selectively targets MYC‑driven transcriptional programs in these tumor models.",-53.0,0.01,cellline
"MT‑cell line MC‑IXC, when treated with the small‑molecule inhibitor doxorubicin, shows a dose‑dependent decrease in TP53‑mediated apoptosis that is rescued by co‑expression of the anti‑apoptotic gene BCL‑2 in the HCT‑116 colorectal carcinoma cell line.",-34.0,0.01,cellline
"MT1 cells, a variant of the HCT‑116 colorectal carcinoma line, were treated with the small‑molecule inhibitor doxorubicin, and the resulting up‑regulation of the tumor‑suppressor gene TP53 was confirmed by qRT‑PCR, indicating that the drug induces a DNA‑damage response in this human cancer cell line.",-37.25,0.01,cellline
"Transiently transfected MC‑IXC cells overexpressing the mutant TP53 R248W variant exhibit increased sensitivity to the DNA‑damaging agent doxorubicin, leading to enhanced apoptosis compared with wild‑type TP53‑expressing HCT‑116 cells.",-30.375,0.01,cellline
"Transient transfection of the CRISPR‑Cas9 plasmid into the HCT‑116 cell line, followed by selection with puromycin, revealed that the introduced TP53 c.215C>T variant induces a loss of p53‑mediated transcriptional activation of the CDKN1A promoter, thereby enhancing cell proliferation and conferring resistance to doxorubicin.",-41.75,0.01,cellline
"Transient overexpression of the KRAS G12D variant in the KRAS‑mutant HCT‑116 cell line markedly increases phospho‑ERK signaling and enhances resistance to the MEK inhibitor trametinib, whereas CRISPR‑mediated knockout of KRAS in the KRAS‑wild‑type SW48 cells reduces basal ERK activity and sensitizes them to the same drug.",-38.0,0.01,cellline
"Transient electrical stimulation of the tsA201 cell line expressing the human voltage‑gated sodium channel Nav1.5 induces a rapid, dose‑dependent increase in intracellular Ca²⁺ that is attenuated by the selective Nav1.5 blocker ranolazine, suggesting a direct link between sodium channel activity and calcium‑dependent signaling pathways in neuronal‑derived cells.",-43.25,0.01,cellline
"Molecular profiling of the colorectal carcinoma cell line HCT‑116 revealed that the KRAS G12D mutation drives upregulation of the PI3K‑AKT pathway, which in turn enhances resistance to the chemotherapeutic agent doxorubicin.",-26.375,0.01,cellline
"MDR1 overexpression in the drug‑resistant HT29 colorectal carcinoma cell line (HCT‑116) was shown to confer resistance to doxorubicin, whereas CRISPR‑mediated knockout of ABCB1 in the same line restored sensitivity to the chemotherapeutic agent.",-33.0,0.01,cellline
"MAGE‑A3 expression is markedly up‑regulated in the metastatic prostate cancer cell line C4‑2B, where it cooperates with the androgen receptor to drive transcription of the chemokine CXCL8, thereby enhancing tumor cell migration and invasion.",-39.0,0.01,cellline
"MCR-IXC cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, while SNU‑C2A cells overexpressing mutant KRAS show sustained ERK activation, indicating differential pathway dependencies between these colorectal cancer cell lines.",-35.25,0.01,cellline
"Activation of the PI3K/AKT pathway by the small‑molecule inhibitor LY294002 in the colorectal carcinoma cell line HCT‑116 leads to a marked decrease in the expression of the pro‑apoptotic gene BAX, whereas the same treatment in the prostate cancer cell line C4‑2B results in up‑regulation of the anti‑apoptotic protein BCL‑2.",-31.875,0.01,cellline
"Activation assays in the MC‑IXC and HCT‑116 cell lines revealed that the small‑molecule inhibitor doxorubicin down‑regulates the expression of the oncogenic gene TP53, thereby inducing apoptosis in colorectal carcinoma cells.",-39.25,0.01,cellline
"Activation by the KRAS G12V mutation in the HCT‑116 cell line enhances the expression of the PD‑L1 gene, thereby increasing resistance to cytotoxic T‑cell mediated killing.",-34.75,0.01,cellline
"Activation-induced cytidine deaminase (AID) overexpression in the HT29 colorectal carcinoma cell line leads to increased somatic hypermutation of the TP53 gene, thereby enhancing the acquisition of the BRCA1 c.68_69delAG variant and conferring resistance to the chemotherapeutic agent doxorubicin.",-34.75,0.01,cellline
"SNU‑C2A cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in phosphorylated AKT, leading to up‑regulation of the tumor suppressor gene PTEN and subsequent suppression of the metastatic phenotype observed in HCT‑116 xenografts.",-29.125,0.01,cellline
"SARS‑CoV‑2 infection of the human colorectal carcinoma cell line HCT‑116 induces a rapid up‑regulation of the ACE2 receptor, which is further amplified by the presence of the BRCA1 c.68_69delAG variant, thereby enhancing viral entry and cytopathic effects.",-37.75,0.01,cellline
"SNRK knockdown in the colorectal carcinoma cell line HCT‑116 markedly reduces the expression of the chemokine CXCL8, thereby attenuating the recruitment of neutrophils to the tumor microenvironment.",-30.75,0.01,cellline
"SENP2 knockdown in the colorectal carcinoma cell line HCT‑116 markedly up‑regulates the pro‑apoptotic gene BAX, thereby sensitizing the cells to the chemotherapeutic agent doxorubicin.",-30.125,0.01,cellline
"Within the U87‑DACH1‑low glioblastoma cell line, knockdown of DACH1 via siRNA markedly upregulated VEGFA expression, thereby enhancing angiogenic potential and conferring resistance to temozolomide treatment.",-24.625,0.01,cellline
"Within RAW264.7 macrophages, the overexpression of the transcription factor NF‑κB markedly up‑regulates the secretion of the cytokine IL‑1β, thereby enhancing the inflammatory response to lipopolysaccharide stimulation.",-35.5,0.01,cellline
"Within cultured RAW264.7 macrophages, the overexpression of the transcription factor DACH1 markedly suppresses the secretion of pro‑inflammatory cytokine TNF‑α, thereby attenuating the LPS‑induced activation of NF‑κB signaling.",-42.75,0.01,cellline
"Within CRISPR‑edited RAW‑264.7 macrophages, the loss of the NLRP3 inflammasome gene leads to a marked reduction in IL‑1β secretion, confirming the pivotal role of NLRP3 in the inflammatory response of this murine cell line.",-47.5,0.01,cellline
MDM2 overexpression in the U87‑DACH1‑low glioblastoma cell line enhances resistance to temozolomide by up‑regulating the PI3K/AKT survival pathway.,-20.125,0.01,cellline
"MDCK cells treated with the chemotherapeutic agent doxorubicin exhibit a dose‑dependent increase in the expression of the pro‑apoptotic gene BAX, while the concomitant up‑regulation of the anti‑apoptotic protein BCL‑2 in the same cell line is markedly attenuated, suggesting a shift toward apoptosis that may underlie the drug’s cytotoxic efficacy.",-43.75,0.01,cellline
"MD-2 expression in RAW264.7 macrophages is up‑regulated by LPS stimulation, leading to enhanced NF‑κB activation and secretion of IL‑6, a response that is attenuated when the TLR4 antagonist TAK‑242 is added.",-33.75,0.01,cellline
MDX-1 overexpression in the chemoresistant MES‑SA/Dx5 cell line enhances cisplatin‑induced apoptosis by up‑regulating the pro‑apoptotic gene BAX while simultaneously down‑regulating the anti‑apoptotic protein BCL‑2.,-29.75,0.01,cellline
"In the U87‑DACH1‑low glioblastoma cell line, knockdown of DACH1 by siRNA markedly increased VEGFA secretion, thereby enhancing angiogenic potential and accelerating tumor growth in vivo.",-17.75,0.01,cellline
"In BABL/c cells, the overexpression of the transcription factor DACH1 reduces the proliferation of the chemotherapeutic agent doxorubicin by down‑regulating the expression of the drug‑resistance gene MDR1.",-28.375,0.01,cellline
"In U87‑DACH1‑low cells, knockdown of DACH1 by siRNA markedly up‑regulates VEGFA expression, thereby enhancing angiogenic potential and accelerating tumor growth in xenograft models.",-20.5,0.01,cellline
"In a co‑culture experiment, RAW264.7 macrophages exposed to the chemotherapeutic agent doxorubicin exhibited a dose‑dependent increase in TNF‑α secretion, while co‑treated with the anti‑inflammatory compound curcumin, the secretion was significantly attenuated, suggesting a modulatory effect of curcumin on doxorubicin‑induced inflammatory signaling in RAW264.7 cells.",-38.0,0.01,cellline
"The Ba/F3 cell line, engineered to express the BCR‑ABL fusion protein, exhibits heightened proliferation when treated with the tyrosine‑kinase inhibitor imatinib, whereas the MES‑SA/Dx5 ovarian carcinoma line shows increased resistance to cisplatin due to up‑regulation of the ATP‑binding cassette transporter ABCG2.",-29.875,0.01,cellline
"The CRISPR‑Cas9‑edited U87‑DACH1‑low glioblastoma cells, when co‑cultured with RAW264.7 macrophages, exhibit a marked increase in IL‑10 secretion that correlates with enhanced PD‑L1 expression on the tumor surface.",-27.75,0.01,cellline
"The chemo‑resistant MES‑SA/Dx5 cells, when treated with the novel PI3K inhibitor LY294002, exhibited a marked decrease in phosphorylated AKT and a concomitant up‑regulation of the tumor suppressor PTEN, suggesting that PI3K pathway inhibition restores PTEN‑mediated growth arrest in this cervical carcinoma cell line.",-38.5,0.01,cellline
"The CAF-1 complex was found to be essential for the proliferation of the U87‑DACH1‑low glioblastoma cell line, where its depletion induced G1 arrest and increased p53‑mediated apoptosis.",-28.5,0.01,cellline
"RAW​264.7 macrophages treated with the chemotherapeutic agent doxorubicin exhibit a dose‑dependent up‑regulation of the pro‑inflammatory cytokine TNF‑α, which in turn activates NF‑κB signaling and promotes apoptosis through caspase‑3 cleavage.",-31.75,0.01,cellline
"RAW‑264.7 macrophages treated with the chemotherapeutic agent doxorubicin exhibit a dose‑dependent up‑regulation of the pro‑inflammatory cytokine TNF‑α, which in turn activates NF‑κB signaling and promotes apoptosis through caspase‑3 cleavage.",-27.5,0.01,cellline
"RAW264.7 macrophages treated with the BET inhibitor JQ1 exhibit a dose‑dependent reduction in IL‑6 secretion, an effect that is markedly amplified when the cells are co‑treated with the histone deacetylase inhibitor vorinostat, suggesting a synergistic epigenetic blockade of pro‑inflammatory signaling in this cell line.",-39.75,0.01,cellline
"RAW‐264.7 macrophages treated with the chemotherapeutic agent doxorubicin exhibit a dose‑dependent up‑regulation of the pro‑inflammatory cytokine TNF‑α, which in turn activates NF‑κB signaling and promotes apoptosis through caspase‑3 cleavage.",-30.625,0.01,cellline
"Mes–SA/Dx5 cells treated with the PI3K inhibitor LY294002 exhibit a marked reduction in AKT phosphorylation, indicating that the drug blocks the PI3K/AKT signaling pathway in this drug‑resistant endometrial cancer cell line.",-32.5,0.01,cellline
"Mes‑SA/Dx5 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, indicating that the drug effectively blocks the PI3K/AKT signaling pathway in this drug‑resistant ovarian cancer cell line.",-24.0,0.01,cellline
"Mes‐SA/Dx5 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, indicating that the drug effectively blocks the PI3K/AKT signaling pathway in this drug‑resistant ovarian cancer cell line.",-27.75,0.01,cellline
"Mes-SA/Dx5 cells treated with doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated apoptosis.",-29.375,0.01,cellline
"U87‑DACH1‑low cells treated with the EGFR inhibitor gefitinib exhibit a marked decrease in phosphorylated ERK1/2, correlating with reduced proliferation and increased apoptosis compared with untreated U87‑DACH1‑high cells.",-23.625,0.01,cellline
"U‑87‑DACH1‑low cells treated with the EGFR inhibitor gefitinib exhibit a marked decrease in phosphorylated STAT3 levels, indicating that EGFR signaling drives STAT3 activation in this glioblastoma cell line.",-28.0,0.01,cellline
"U937 cells treated with the BET inhibitor JQ1 exhibit a dose‑dependent decrease in MYC expression, which in turn reduces proliferation of the AML‑derived cell line and enhances apoptosis.",-38.0,0.01,cellline
"U‐87‑DACH1‑low cells treated with the EGFR inhibitor gefitinib exhibit a marked decrease in phosphorylated ERK1/2, confirming that EGFR signaling drives MAPK activation in this glioblastoma cell line.",-32.25,0.01,cellline
"MS‑5 cells, a derivative of the RAW‑264.7 macrophage line, were treated with the small‑molecule inhibitor JQ‑1, which selectively down‑regulates the transcription factor c‑Myc and consequently reduces the proliferation of the tumor‑derived U87‑DACH1‑low glioblastoma cells.",-45.75,0.01,cellline
"MSL-1, a novel small‑molecule inhibitor, selectively induces apoptosis in the chemoresistant MES‑SA/Dx5 cell line by down‑regulating the PI3K/AKT pathway while sparing the non‑malignant RAW‑264.7 macrophages.",-39.0,0.01,cellline
"MS-PCR revealed that the MES-SA/Dx5 cell line, which harbors a BRCA1 c.68_69delAG variant, shows markedly increased expression of the DNA repair gene RAD51 compared with the parental MES-SA line.",-30.75,0.01,cellline
"MS‐A549 cells treated with the EGFR inhibitor gefitinib exhibit a dose‑dependent decrease in phosphorylated ERK1/2, while co‑treatment with the PI3K/AKT pathway activator insulin‑like growth factor‑1 restores AKT phosphorylation and rescues cell viability.",-37.5,0.01,cellline
"Treatment of RAW264.7 macrophages with the small‑molecule inhibitor JQ1 down‑regulates the expression of the pro‑inflammatory cytokine TNF‑α, thereby attenuating LPS‑induced activation of the NF‑κB pathway.",-27.625,0.01,cellline
"Treatment with the BET inhibitor JQ1 reduced proliferation and induced apoptosis in the U87‑DACH1‑low glioblastoma cell line, while the same compound had no effect on the non‑transformed RAW264.7 macrophage line.",-27.0,0.01,cellline
"Treatment-induced apoptosis in the chemoresistant MES‑SA/Dx5 cell line was markedly enhanced by co‑administration of the novel PI3K inhibitor LY294002, which down‑regulated AKT phosphorylation and restored sensitivity to cisplatin.",-32.5,0.01,cellline
"Treatment responsiveness of the U87‑DACH1‑low glioblastoma cell line to temozolomide was markedly enhanced when combined with the small‑molecule inhibitor of the PI3K/AKT pathway, mirroring the synergistic effect observed in the RAW‑264.7 macrophage model of inflammatory cytokine production.",-41.25,0.01,cellline
"To evaluate the impact of the novel kinase inhibitor on chemoresistance, we treated the MES‑SA/Dx5 and RAW‑264.7 cell lines with increasing concentrations of the compound and observed a dose‑dependent reduction in IC₅₀ values, indicating enhanced sensitivity to cisplatin.",-40.75,0.01,cellline
"To investigate the role of the PI3K/AKT pathway in chemoresistance, we treated the MES‑SA/Dx5 and RAW‑264.7 cell lines with the PI3K inhibitor LY294002 and observed a significant reduction in cell viability and a decrease in the expression of the drug‑efflux transporter ABCB1.",-40.75,0.01,cellline
"To test the effect of the novel kinase inhibitor, we treated the U87‑DACH1‑low glioblastoma cell line with increasing concentrations of the compound and observed a dose‑dependent decrease in cell proliferation and a concomitant up‑regulation of the tumor suppressor p53.",-37.25,0.01,cellline
"To confirm the role of the PI3K/AKT pathway in chemoresistance, we treated the MES‑SA/Dx5 and RAW‑264.7 cell lines with the PI3K inhibitor LY294002 and observed a significant reduction in doxorubicin‑induced apoptosis compared with untreated controls.",-33.0,0.01,cellline
"Ba/F3 cells engineered to express the mutant EGFR variant L858R exhibit markedly increased proliferation when treated with the tyrosine‑kinase inhibitor gefitinib, whereas the same treatment fails to suppress growth in the MES‑SA/Dx5 chemoresistant sarcoma line.",-32.75,0.01,cellline
"Ba/S2 cells, a murine fibroblast line, were transfected with a CRISPR/Cas9 construct targeting the TP53 gene, and the resulting TP53‑null clones exhibited increased resistance to doxorubicin compared with the parental Ba/S2 line.",-37.25,0.01,cellline
"BaF3 cells engineered to express the BCR‑ABL fusion protein exhibit markedly increased proliferation when treated with the tyrosine‑kinase inhibitor imatinib, whereas the same treatment has no effect on the imatinib‑resistant MES‑SA/Dx5 ovarian carcinoma cell line.",-31.75,0.01,cellline
"Ba/​l/c‑derived RAW‑264.7 macrophages treated with the chemotherapeutic agent doxorubicin exhibit a dose‑dependent up‑regulation of the pro‑inflammatory cytokine TNF‑α, which is further amplified when the cells are co‑stimulated with the small‑molecule inhibitor U0126, thereby revealing a synergistic activation of the MAPK/ERK signaling pathway that promotes apoptosis in the tumor‑derived PC‑3 cell line.",-51.0,0.01,cellline
"Deletion of the TP53 gene in the U87‑DACH1‑low glioblastoma cell line markedly increases its sensitivity to the chemotherapeutic agent doxorubicin, as evidenced by a two‑fold reduction in IC₅₀ compared with the parental U87 line.",-27.75,0.01,cellline
"Deletion in the TP53 gene of the U87‑DACH1‑low glioblastoma cell line reduces its sensitivity to temozolomide, whereas re‑expression of wild‑type TP53 restores the drug‑induced apoptosis observed in the parental U87 line.",-35.5,0.01,cellline
"Deletion analysis in the U87‑DACH1‑low glioblastoma cell line revealed that loss of DACH1 up‑regulates the chemokine CXCL10, thereby enhancing macrophage recruitment and accelerating tumor invasion.",-36.0,0.01,cellline
"Deletion enrichment of the TP53 promoter in the U87‑DACH1‑low glioblastoma cell line markedly increased transcription of the downstream CDKN1A gene, thereby enhancing apoptosis in response to doxorubicin treatment.",-43.0,0.01,cellline
Transplantation of the MES‑SA/Dx5 chemoresistant sarcoma cell line into immunodeficient BABL/c mice revealed that co‑administration of the PI3K inhibitor LY294002 markedly reduced tumor growth and restored sensitivity to doxorubicin.,-27.375,0.01,cellline
"Transfection of the CRISPR‑Cas9 system into the U87‑DACH1‑low glioblastoma cell line (U87‑DACH1‑low) and the RAW‑264.7 macrophage line (RAW‑264.7) revealed that loss of DACH1 enhances STAT3 phosphorylation and promotes secretion of IL‑6, thereby accelerating tumor‑associated macrophage polarization and accelerating tumor growth in vitro.",-39.75,0.01,cellline
"Transcription factor NF‑κB activation in RAW264.7 macrophages treated with the chemotherapeutic agent doxorubicin induces the expression of the pro‑inflammatory cytokine IL‑6, thereby enhancing the sensitivity of these cells to subsequent TNF‑α‑mediated apoptosis.",-32.25,0.01,cellline
"Transfecting the chemoresistant MES‑SA/Dx5 cells with a CRISPR‑Cas9 construct targeting the MDR1 gene reduced doxorubicin efflux and restored drug sensitivity, thereby demonstrating that the ABCB1 transporter mediates the multidrug‑resistance phenotype in this ovarian carcinoma cell line.",-33.0,0.01,cellline
"C4-2B cells treated with the PI3K inhibitor LY294002 exhibited a marked decrease in AKT phosphorylation, indicating that PI3K signaling is essential for maintaining the proliferative phenotype of this prostate cancer cell line.",-22.0,0.01,cellline
"Cytotoxicity assays revealed that the chemotherapeutic agent doxorubicin induced a dose‑dependent decrease in viability of the U87‑DACH1‑low glioblastoma cell line, while the same concentration had a markedly lesser effect on the non‑malignant Ishikawa endometrial cell line.",-33.5,0.01,cellline
"C‑4‑2B cells harboring the BRCA1 c.68_69delAG variant exhibit markedly reduced proliferation when treated with doxorubicin, whereas the wild‑type PC‑3 line shows only a modest growth arrest.",-30.375,0.01,cellline
"Causal analysis revealed that the chemotherapeutic agent doxorubicin induced apoptosis in the U87‑DACH1‑low glioblastoma cell line, while the same treatment failed to affect the chemoresistant MES‑SA/Dx5 ovarian carcinoma cells, suggesting a differential drug‑cell line interaction mediated by DACH1 expression.",-43.25,0.01,cellline
"Chemical knockdown of TP53 in the HCT116 cell line reduces the expression of the DNA repair gene BRCA1, thereby increasing the sensitivity of these cells to the chemotherapeutic agent doxorubicin.",-28.625,0.01,cellline
"Chemical etoposide induces apoptosis in the MCF‑7 breast cancer cell line by up‑regulating the TP53‑dependent pathway, whereas the same drug fails to trigger cell death in the drug‑resistant HCT116 colorectal carcinoma cells.",-30.625,0.01,cellline
"Chemical inhibition of the PI3K/AKT pathway by LY294002 in the MCF‑7 breast cancer cell line reduces phosphorylation of mTOR and induces apoptosis, whereas the same treatment in the non‑malignant RWPE‑1 prostate epithelial cells fails to trigger cell death, indicating a cell‑line‑specific therapeutic window.",-35.75,0.01,cellline
"Chemical‑induced apoptosis of the breast cancer cell line MCF‑7 is markedly enhanced by the p53‑activating drug doxorubicin, whereas the same treatment fails to trigger cell death in the p53‑null HCT116 colon carcinoma line.",-35.0,0.01,cellline
"CRISPR‑Cas9 editing of the TP53 locus in the MCF‑7 breast cancer cell line introduced a BRCA1 c.68_69delAG variant that markedly increased sensitivity to the DNA‑damaging agent doxorubicin while simultaneously up‑regulating the antioxidant gene Nrf2, thereby illustrating a genotype‑driven drug‑response phenotype.",-32.5,0.01,cellline
"CRBN knockdown in MCF‑7 cells markedly increases doxorubicin‑induced apoptosis, whereas CRBN overexpression in HEK293 cells attenuates the same drug‑mediated cytotoxicity.",-30.0,0.01,cellline
"CRS‑1‑derived MCF‑7 cells treated with the PI3K inhibitor LY294002 exhibit a dose‑dependent reduction in AKT phosphorylation, while co‑treatment with the MEK inhibitor U0126 restores ERK1/2 activity and partially rescues cell viability.",-48.0,0.01,cellline
CRISP‑Cas9 editing of the TP53 locus in the HCT116 cell line introduced a BRCA1 c.68_69delAG variant that increased sensitivity to doxorubicin while simultaneously up‑regulating the DNA‑damage response gene ATM.,-34.25,0.01,cellline
"Micro‑array profiling of the MCF‑7 breast cancer cell line revealed that the up‑regulated gene TP53 is transcriptionally repressed by the oncogenic transcription factor MYC, thereby attenuating apoptosis in response to doxorubicin treatment.",-31.875,0.01,cellline
"Microglial activation in the SJ‑GBM2 cell line was markedly attenuated by the small‑molecule inhibitor doxorubicin, which also induced a dose‑dependent up‑regulation of the tumor suppressor gene TP53.",-29.5,0.01,cellline
"Microarray profiling of the MCF‑7 breast cancer cell line revealed that the up‑regulated gene TP53 is transcriptionally repressed by the oncogenic transcription factor MYC, thereby attenuating apoptosis in response to doxorubicin treatment.",-28.875,0.01,cellline
"MicroRNA‑145 overexpression in the colorectal carcinoma cell line HCT116 down‑regulates the oncogenic transcription factor MYC, thereby reducing cell proliferation and inducing apoptosis.",-21.375,0.01,cellline
"MCF‑7 cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage.",-19.5,0.01,cellline
"MC-7 cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby confirming the intrinsic apoptotic pathway in this breast cancer cell line.",-43.75,0.01,cellline
"MC‑7 cells treated with the PI3K inhibitor LY294002 exhibit a dose‑dependent decrease in AKT phosphorylation, while RWPE‑1 cells show no such effect, indicating cell‑line‑specific drug sensitivity.",-39.5,0.01,cellline
"MC2-7 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, confirming that the MCF-7 cell line’s survival signaling is PI3K‑dependent.",-41.75,0.01,cellline
"The MCF‑7 breast cancer cell line, when treated with the small‑molecule inhibitor doxorubicin, shows a dose‑dependent up‑regulation of the pro‑apoptotic gene BAX, while simultaneously down‑regulating the anti‑apoptotic protein BCL‑2, thereby confirming the drug’s efficacy in inducing apoptosis in this human epithelial tumor model.",-28.125,0.01,cellline
"The CRISPR‑Cas9‑edited HCT116 cells, harboring a TP53 c.215C>A (p.Pro72Arg) variant, exhibited increased sensitivity to the DNA‑damaging agent doxorubicin, while the parental SW480 line showed only modest growth inhibition.",-28.5,0.01,cellline
"The chemotherapeutic agent doxorubicin induces apoptosis in MCF‑7 breast cancer cells by up‑regulating the pro‑apoptotic gene BAX while simultaneously down‑regulating the anti‑apoptotic protein BCL‑2, thereby shifting the cellular balance toward cell death.",-17.125,0.01,cellline
"The SW480 colorectal carcinoma cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibits a dose‑dependent upregulation of the tumor suppressor gene TP53, leading to increased apoptosis and reduced proliferation.",-20.0,0.01,cellline
"In the MCF‑7 breast cancer cell line, overexpression of the TP53 gene product induces apoptosis, whereas knockdown of the same gene in the SW480 colorectal carcinoma line enhances proliferation and resistance to doxorubicin.",-22.125,0.01,cellline
"In HepG2 cells, the BRCA1 c.68_69delAG variant reduces RAD51 recruitment, thereby increasing sensitivity to the DNA‑damaging agent doxorubicin.",-21.375,0.01,cellline
"In HCT116 cells, the CRISPR‑mediated knockout of the TP53 gene markedly increases the expression of the chemokine CXCL8, thereby enhancing the cells’ invasive capacity in a Matrigel invasion assay.",-25.75,0.01,cellline
"In HT-29 cells, the BRCA1 c.68_69delAG variant reduces RAD51 recruitment, thereby increasing sensitivity to the DNA‑damaging agent doxorubicin.",-24.375,0.01,cellline
Gene‑editing of the TP53 locus in the MCF‑7 breast cancer cell line using CRISPR‑Cas9 produced a BRCA1 c.68_69delAG variant that conferred resistance to doxorubicin while simultaneously up‑regulating the DNA‑damage response gene ATM in the same cells.,-31.625,0.01,cellline
"Gene expression profiling of the MCF‑7 breast cancer cell line revealed that the TP53‑regulated microRNA cluster miR‑34a is up‑regulated by the small‑molecule inhibitor doxorubicin, thereby inducing apoptosis and reducing proliferation of the tumor cells.",-34.25,0.01,cellline
"Gene amplification of EGFR in the MCF‑7 breast cancer cell line leads to increased sensitivity to the tyrosine‑kinase inhibitor erlotinib, thereby reducing proliferation and inducing apoptosis.",-24.625,0.01,cellline
"Gene-level CRISPR/Cas9 editing of TP53 in the MCF-7 breast cancer cell line, combined with treatment of the small‑molecule inhibitor doxorubicin, induces a pronounced apoptotic response that is markedly attenuated in the TP53‑mutant HCT116 colon cancer cell line.",-44.25,0.01,cellline
"Cell‑line‑derived MCF‑7 cells treated with the small‑molecule inhibitor doxorubicin exhibit a dose‑dependent up‑regulation of the tumor‑suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby inducing apoptosis in the breast‑cancer model.",-35.0,0.01,cellline
"Cell culture experiments revealed that the MCF‑7 breast cancer cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibited a dose‑dependent upregulation of the tumor suppressor gene TP53, whereas the non‑transformed HEK293 kidney epithelial cells showed no significant change in TP53 expression.",-34.25,0.01,cellline
"Cell lines such as MCF‑7 and HCT116, when treated with the DNA‑damaging agent doxorubicin, exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated apoptosis.",-31.125,0.01,cellline
"Cell proliferation assays revealed that the MCF‑7 breast cancer cell line, when treated with the small‑molecule inhibitor doxorubicin, exhibited a dose‑dependent decrease in viability, whereas the non‑malignant RWPE‑1 prostate epithelial line remained largely unaffected.",-27.5,0.01,cellline
"HCT116 cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX, leading to caspase‑3 cleavage and apoptosis.",-25.375,0.01,cellline
"HMC-7 cells treated with the PI3K inhibitor LY294002 exhibit a dose‑dependent reduction in AKT phosphorylation, while RWPE‑1 cells overexpressing PTEN show a compensatory increase in PTEN‑mediated dephosphorylation of phosphatidylinositol‑3,4,5‑trisphosphate.",-38.75,0.01,cellline
"HepG2 cells treated with the small‑molecule inhibitor gefitinib exhibit a dose‑dependent decrease in EGFR phosphorylation, while co‑transfection of a CRISPR‑generated EGFR L858R variant in HCT116 cells restores downstream AKT signaling and confers resistance to the drug.",-39.5,0.01,cellline
"HIF‑1α activation in the hypoxic MCF‑7 breast cancer cell line upregulates VEGFA expression, thereby promoting angiogenesis and conferring resistance to the chemotherapeutic agent doxorubicin.",-24.875,0.01,cellline
"After exposure to the DNA‑damaging agent doxorubicin, the MCF‑7 breast cancer cell line exhibited a significant up‑regulation of the TP53 gene product, while the HCT116 colorectal carcinoma line showed a concurrent down‑regulation of the BCL‑2 protein, indicating differential apoptotic responses between these two cell lines.",-36.75,0.01,cellline
"After CRISPR‑mediated knockout of TP53 in the MCF‑7 breast cancer cell line, the cells exhibited increased sensitivity to the chemotherapeutic agent doxorubicin, as evidenced by a significant reduction in IC₅₀ compared with wild‑type MCF‑7 cells.",-26.75,0.01,cellline
"After exposing MCF‑7 cells to the DNA‑damaging agent doxorubicin, the p53‑dependent transcriptional up‑regulation of the pro‑apoptotic gene BAX was markedly enhanced, whereas in the drug‑resistant HCT116 line the same treatment failed to induce BAX expression, indicating a differential cellular response to chemotherapy.",-35.75,0.01,cellline
"After transfecting the MCF‑7 breast cancer cell line with a CRISPR‑Cas9 construct targeting the TP53 gene, we observed a significant increase in apoptosis and a concomitant reduction in the expression of the anti‑apoptotic protein BCL‑2, confirming the tumor‑suppressive role of TP53 in this cellular context.",-29.5,0.01,cellline
"MD‑MMP‑9 expression in the MCF‑7 breast cancer cell line is markedly up‑regulated by the small‑molecule inhibitor erlotinib, leading to increased apoptosis and reduced invasive capacity.",-35.0,0.01,cellline
MDM2 overexpression in the MCF‑7 breast cancer cell line enhances resistance to doxorubicin by up‑regulating the PI3K/AKT survival pathway.,-19.25,0.01,cellline
"MDK overexpression in the MCF‑7 breast cancer cell line activates the PI3K‑AKT pathway, thereby enhancing resistance to doxorubicin-induced apoptosis.",-19.875,0.01,cellline
"MDCT imaging of the tumor revealed that the MCF‑7 cell line, which harbors a BRCA1 c.68_69delAG variant, exhibited a markedly higher uptake of the chemotherapeutic agent doxorubicin compared with the drug‑resistant HCT116 line, suggesting a potential interaction between the sequence variant and drug sensitivity.",-45.0,0.01,cellline
"Mutation of the TP53 gene in the MCF‑7 breast cancer cell line leads to increased expression of the pro‑apoptotic protein BAX, thereby sensitizing the cells to doxorubicin‑induced cell death.",-16.75,0.01,cellline
Mutation analysis of the TP53 gene in the MCF‑7 breast cancer cell line revealed a novel c.215C>T (p.R72C) variant that enhances apoptotic sensitivity to doxorubicin compared with the wild‑type allele.,-26.625,0.01,cellline
"Mutation‐induced upregulation of the PI3K/AKT pathway in the MCF‑7 breast cancer cell line, driven by a BRCA1 c.68_69delAG variant, enhances resistance to doxorubicin and correlates with increased expression of the drug efflux transporter ABCB1.",-33.25,0.01,cellline
"Mutation in the TP53 gene of the MCF‑7 breast cancer cell line reduces the efficacy of doxorubicin, whereas the same mutation in the HCT116 colorectal cancer cell line enhances sensitivity to the chemotherapeutic agent.",-29.125,0.01,cellline
Mutational analysis of the TP53 gene in the MCF‑7 breast cancer cell line revealed a novel c.215C>T (p.R72C) variant that enhances apoptotic sensitivity to doxorubicin compared with the parental HCT116 colorectal carcinoma line.,-26.125,0.01,cellline
"Mutual inhibition of the PI3K/AKT pathway by the small‑molecule inhibitor LY294002 in the MCF‑7 breast cancer cell line reduces the expression of the chemokine CXCL12, thereby attenuating the invasive potential of the cells.",-37.75,0.01,cellline
"Mutagenic exposure to doxorubicin induces a TP53‑dependent apoptotic cascade in the MCF‑7 breast cancer cell line, whereas the same treatment fails to activate caspase‑3 in the drug‑resistant HCT116 colorectal carcinoma cells.",-26.0,0.01,cellline
"Mutations in the TP53 gene of the MCF‑7 breast cancer cell line, when combined with treatment by the DNA‑crosslinking agent doxorubicin, lead to a pronounced increase in apoptosis and a reduction in cell‑cycle progression compared with the untreated HCT116 colon cancer line.",-35.75,0.01,cellline
"Following rapamycin treatment, the MCF‑7 breast cancer cell line exhibited a significant reduction in mTOR‑C1 signaling, while the RWPE‑1 prostate epithelial line showed increased autophagic flux and decreased proliferation.",-32.5,0.01,cellline
"Following CRISPR‑Cas9 editing, the MCF‑7 cell line harboring a TP53 c.215C>G (p.Pro72Arg) variant exhibited markedly increased sensitivity to doxorubicin, whereas the isogenic HEK293T line with the same mutation showed no change in drug response.",-32.5,0.01,cellline
"Following a CRISPR‑Cas9 knockout of TP53, the MCF‑7 breast cancer cell line exhibited a marked increase in apoptosis and a concomitant up‑regulation of the pro‑apoptotic gene BAX, confirming the tumor‑suppressive role of p53 in this cellular context.",-32.5,0.01,cellline
"Following siRNA-mediated knockdown of TP53, the MCF‑7 cell line exhibited a significant increase in apoptosis and a concomitant reduction in the expression of the anti‑apoptotic protein BCL‑2.",-24.625,0.01,cellline
"The U87TR‑Da glioblastoma cell line, engineered to overexpress the glycolytic enzyme HK2, exhibits increased resistance to temozolomide, whereas the U87‑DACH1‑high variant shows heightened sensitivity to the same chemotherapeutic agent.",-16.625,0.01,cellline
"The HT22 hippocampal neuronal cell line, when treated with the small‑molecule inhibitor HK2, shows a dose‑dependent reduction in the expression of the neuroprotective gene DUCaP, suggesting that HK2-mediated metabolic reprogramming may sensitize neurons to apoptosis.",-34.5,0.01,cellline
"The highly proliferative U87TR‑Da glioblastoma cells, which overexpress HK2, exhibit increased glycolytic flux and resistance to temozolomide, whereas co‑transfection with a DACH1‑high construct restores sensitivity and reduces tumor growth in vivo.",-31.125,0.01,cellline
"The chemotherapeutic agent doxorubicin induces apoptosis in U87TR‑Da cells by up‑regulating the tumor suppressor gene TP53, while simultaneously down‑regulating the glycolytic enzyme HK2, thereby sensitizing the cells to oxidative stress.",-22.875,0.01,cellline
"U87TR‑Da cells overexpressing DACH1 exhibit reduced HK2 activity, leading to impaired glycolysis and increased apoptosis in response to doxorubicin treatment.",-16.625,0.01,cellline
"U‑87TR‑Da cells overexpressing DACH1 exhibit reduced HK2 activity, leading to impaired glycolysis and increased apoptosis in response to doxorubicin treatment.",-24.125,0.01,cellline
"U82TR‑Da cells overexpressing HK2 exhibit increased glycolytic flux, which in turn enhances the proliferation of A549 cells and promotes resistance to doxorubicin in the U87‑DACH1‑high glioblastoma model.",-39.5,0.01,cellline
"U83TR‑Da cells overexpressing HK2 exhibit increased glycolytic flux, which in turn enhances the proliferation of U87‑DACH1‑high glioblastoma cells and promotes resistance to temozolomide treatment.",-30.5,0.01,cellline
"In U87TR‑Da cells, overexpression of DACH1 suppresses HK2‑mediated glycolysis, thereby reducing proliferation and enhancing sensitivity to temozolomide.",-11.9375,0.01,cellline
"In the U87TR‑Da cell line, overexpression of the glycolytic enzyme HK2 enhances resistance to temozolomide, while knockdown of DACH1 in U87‑DACH1‑high cells restores sensitivity to the same chemotherapeutic agent.",-14.9375,0.01,cellline
"In A549 cells, the overexpression of the metabolic enzyme HK2 enhances glycolytic flux, thereby promoting resistance to doxorubicin-induced apoptosis.",-17.5,0.01,cellline
"In vitro, the U87TR‑Da glioblastoma cell line overexpressing DACH1 exhibited markedly reduced proliferation and increased apoptosis when treated with the small‑molecule inhibitor HK2, confirming a direct regulatory interaction between DACH1 and the glycolytic enzyme HK2.",-30.75,0.01,cellline
"Knockdown of HK2 in the U87TR‑Da glioblastoma cell line markedly reduces glycolytic flux and sensitizes the cells to temozolomide, whereas overexpression of DUCaP in A549 lung carcinoma cells enhances resistance to cisplatin through up‑regulation of the PI3K‑AKT survival pathway.",-24.625,0.01,cellline
"Knocking down HK2 in U87TR‑Da cells markedly reduces glycolytic flux and sensitizes the cells to doxorubicin‑induced apoptosis, whereas overexpression of DUCaP in A549 cells restores resistance to the same chemotherapeutic agent.",-24.125,0.01,cellline
"Knocked‑down of HK2 in the U87TR‑Da glioblastoma cell line markedly reduces glycolytic flux, thereby sensitizing the cells to temozolomide‑induced apoptosis.",-24.875,0.01,cellline
"Knox et al. demonstrated that the U87TR‑Da cell line, which overexpresses HK2, exhibits markedly increased glycolytic flux and resistance to temozolomide, whereas knockdown of HK2 in the U87‑DACH1‑high variant restores drug sensitivity and reduces tumorigenic potential in vivo.",-39.25,0.01,cellline
"High‑pass‑filtered extracellular recordings from U87TR‑Da cells overexpressing DACH1 revealed that the resulting increase in HK2 activity suppresses the glycolytic flux that normally drives the proliferation of U87‑DACH1‑high glioblastoma cells, thereby attenuating the growth advantage of the PC‑3 prostate carcinoma line in co‑culture experiments.",-50.75,0.01,cellline
"High‐pass filtration of U87TR‑Da cells revealed that HK2 overexpression enhances glycolytic flux, thereby promoting proliferation of U87‑DACH1‑high and PC‑3 tumor spheroids while simultaneously upregulating the pro‑apoptotic gene TRAF2DN‑tg B in BALB/c‑derived immune cells.",-46.5,0.01,cellline
"High levels of HK2 in the U87TR‑Da cell line enhance glycolytic flux, thereby promoting resistance to doxorubicin‑induced apoptosis in glioblastoma cells.",-23.5,0.01,cellline
"High glucose exposure upregulates HK2 expression in U87TR‑Da cells, thereby enhancing glycolytic flux and promoting resistance to TRAIL‑induced apoptosis.",-19.5,0.01,cellline
"Loss of DACH1 in U87TR‑Da cells upregulates HK2 expression, thereby enhancing glycolytic flux and conferring resistance to temozolomide in this glioblastoma model.",-15.375,0.01,cellline
"Loss-of-function of DACH1 in the U87TR‑Da cell line upregulates HK2 expression, thereby enhancing glycolytic flux and conferring resistance to temozolomide-induced apoptosis.",-21.5,0.01,cellline
"Loss‑of‑function of the tumor suppressor DACH1 in U87TR‑Da cells upregulates HK2 expression, thereby enhancing glycolytic flux and conferring resistance to temozolomide in this glioblastoma model.",-25.125,0.01,cellline
"Losses of the tumor suppressor DACH1 in U87TR‑Da cells upregulate HK2 expression, thereby enhancing glycolytic flux and conferring resistance to temozolomide in this glioblastoma model.",-28.25,0.01,cellline
"Treated U87TR‑Da cells overexpressing DACH1 exhibit reduced HK2 activity, leading to impaired glycolysis and increased apoptosis compared with U87‑DACH1‑high cells.",-20.5,0.01,cellline
"Traf2DN‑tg B mice treated with the U87TR‑Da cell line conditioned medium exhibited a significant up‑regulation of HK2 expression, correlating with enhanced glycolytic flux and resistance to apoptosis in the U87‑DACH1‑high subpopulation.",-30.375,0.01,cellline
"TGF‑β stimulation of the U87TR‑Da glioblastoma cell line upregulates HK2 expression, thereby enhancing glycolytic flux and conferring resistance to apoptosis induced by the TRAF2DN‑tg B mouse model.",-20.75,0.01,cellline
"Toxicity of the novel kinase inhibitor NVP‑BKM120 was markedly reduced in U87TR‑Da cells overexpressing HK2, whereas the same compound induced apoptosis in A549 cells lacking DUCaP‑mediated drug efflux.",-38.25,0.01,cellline
"Phosphorylation of the tumor suppressor protein DACH1 in U87TR‑Da cells reduces HK2 expression, thereby attenuating glycolytic flux and limiting the growth of U87‑DACH1‑high glioblastoma xenografts.",-29.25,0.01,cellline
"Pharmacological inhibition of HK2 in the U87TR‑Da glioblastoma cell line markedly reduces glycolytic flux, thereby sensitizing the cells to TRAIL‑induced apoptosis and enhancing the cytotoxic efficacy of doxorubicin.",-21.875,0.01,cellline
"Pharmaceutical inhibition of HK2 in the U87TR‑Da glioblastoma cell line markedly reduces glycolytic flux, thereby sensitizing the cells to TRAIL‑induced apoptosis and enhancing the cytotoxic efficacy of doxorubicin.",-28.25,0.01,cellline
"Phosphate‑activated kinase inhibition in U87TR‑Da cells reduces HK2 expression, thereby attenuating glycolytic flux and sensitizing the cells to TRAIL‑induced apoptosis.",-28.5,0.01,cellline
"Silencing DACH1 in U87TR‑Da cells markedly up‑regulates HK2 expression, thereby enhancing glycolytic flux and conferring resistance to temozolomide‑induced apoptosis.",-15.3125,0.01,cellline
"Silenced DACH1 in U87TR‑Da cells upregulates HK2, thereby enhancing glycolytic flux and conferring resistance to temozolomide‑induced apoptosis.",-16.25,0.01,cellline
"Silently, the U87TR‑Da cell line, engineered to overexpress HK2, exhibited a dramatic increase in glycolytic flux that was further amplified when co‑transfected with a DUCaP‑derived KRAS mutant, thereby confirming the cooperative oncogenic potential of metabolic reprogramming and oncogene activation in glioblastoma.",-39.5,0.01,cellline
"Silence of DACH1 in the U87TR‑Da cell line upregulates HK2 expression, thereby enhancing glycolytic flux and conferring resistance to temozolomide in glioblastoma cells.",-20.875,0.01,cellline
"Exposure of the U87TR‑Da glioblastoma cell line to the HK2 inhibitor metformin down‑regulates the glycolytic flux, thereby sensitizing the cells to radiation‑induced apoptosis through a p53‑dependent pathway.",-28.0,0.01,cellline
"Exposure to the hypoxia‑inducible factor inhibitor in U87TR‑Da cells downregulates HK2 expression, thereby reducing glycolytic flux and sensitizing the cells to TRAIL‑induced apoptosis.",-25.125,0.01,cellline
"Exposure–response analysis in U87TR‑Da cells revealed that HK2 knockdown synergistically enhances the cytotoxicity of doxorubicin, a finding that was confirmed in the A549 and PC‑3 cell lines and suggests a potential therapeutic strategy for overcoming chemoresistance in solid tumors.",-49.75,0.01,cellline
"Exposure‑induced oxidative stress in U87TR‑Da cells upregulates HK2 expression, thereby enhancing glycolytic flux and conferring resistance to temozolomide‑mediated apoptosis.",-26.875,0.01,cellline
"HK2 overexpression in the U87TR‑Da glioblastoma cell line enhances glycolytic flux, thereby increasing resistance to temozolomide-induced apoptosis.",-16.125,0.01,cellline
"HK1 overexpression in the U87TR‑Da glioblastoma cell line enhances glycolytic flux, thereby increasing resistance to temozolomide-induced apoptosis.",-27.625,0.01,cellline
"HK-2 overexpression in the U87TR‑Da glioblastoma cell line enhances glycolytic flux and confers resistance to temozolomide, whereas knockdown of DACH1 in U87‑DACH1‑high cells restores sensitivity to the same chemotherapeutic agent.",-29.625,0.01,cellline
"HK_2 overexpression in U87TR‑Da cells enhances glycolytic flux, thereby increasing resistance to temozolomide‑induced apoptosis.",-31.25,0.01,cellline
"A549 cells overexpressing the HK2 enzyme exhibit increased glycolytic flux, which is further amplified when treated with the small‑molecule inhibitor doxorubicin, leading to enhanced apoptosis and reduced proliferation.",-22.25,0.01,cellline
"A U87TR‑Da cell line overexpressing HK2 shows increased glycolytic flux, which is further amplified when co‑transfected with a DUCaP‑derived TP53 variant, leading to enhanced resistance to doxorubicin‑induced apoptosis.",-26.0,0.01,cellline
"A triply engineered U87TR‑Da cell line overexpressing HK2 and DUCaP‑derived chemokine receptors exhibited enhanced invasion through a Matrigel matrix, a phenotype that was markedly attenuated when the cells were treated with the small‑molecule inhibitor GT1‑1.",-42.75,0.01,cellline
"A shRNA‑mediated knockdown of HK2 in U87TR‑Da cells markedly reduced glycolytic flux and sensitized the cells to temozolomide, whereas overexpression of DUCaP in A549 cells restored resistance to the same chemotherapeutic agent.",-29.0,0.01,cellline
"Targeting the HK2‑dependent glycolytic pathway in U87TR‑Da cells reduces proliferation and enhances apoptosis, whereas overexpression of DUCaP in PC‑3 cells restores resistance to doxorubicin.",-29.0,0.01,cellline
"Targeted CRISPR‑mediated knockout of the HK2 gene in the U87TR‑Da glioblastoma cell line markedly reduced glycolytic flux and sensitized the cells to temozolomide, whereas overexpression of DUCaP in A549 lung carcinoma cells restored resistance to cisplatin.",-27.75,0.01,cellline
"Target‑specific CRISPR‑Cas9 editing of the HK2 promoter in U87TR‑Da cells reduces glycolytic flux, thereby sensitizing the cells to doxorubicin‑induced apoptosis and enhancing the therapeutic efficacy of the drug in vitro.",-33.5,0.01,cellline
"Targetting the HK2‑dependent glycolytic pathway in U87TR‑Da cells with the small‑molecule inhibitor N‑acetylcysteine reduces proliferation and induces apoptosis, whereas the same treatment has no effect on the non‑transformed GT1‑1 neuronal line.",-41.0,0.01,cellline
"Treatment of U87TR‑Da cells with the glycolytic inhibitor HK2‑siRNA markedly reduced proliferation and induced apoptosis, while co‑transfection with a DUCaP‑derived plasmid restored cell viability, suggesting a compensatory metabolic pathway in this glioblastoma model.",-36.25,0.01,cellline
"Treatment with the small‑molecule inhibitor HK2 in the U87TR‑Da glioblastoma cell line down‑regulates the transcription factor DACH1, thereby reducing proliferation and enhancing apoptosis in comparison to the U87‑DACH1‑high variant.",-30.125,0.01,cellline
"Treatment in U87TR‑Da cells with the HK2 inhibitor GSK‑1838705A markedly reduced glycolytic flux, thereby sensitizing the cells to radiation‑induced apoptosis and confirming HK2 as a therapeutic target in glioblastoma.",-41.5,0.01,cellline
"Treatment efficacy of the small‑molecule inhibitor HK2 in the U87TR‑Da glioblastoma cell line was markedly enhanced when combined with the DUCaP‑derived chemotherapeutic agent, leading to a significant reduction in cell viability and induction of apoptosis.",-37.25,0.01,cellline
"The SF188 glioblastoma cell line, when transfected with a Traf2DN‑tg construct, shows markedly increased NF‑κB activation and resistance to cisplatin‑induced apoptosis compared with the parental U87MG line.",-18.0,0.01,cellline
"The KRAS‑mutant U87MG glioblastoma cell line, when treated with the TRAF2DN‑tg construct, shows a marked reduction in NF‑κB‑dependent cytokine secretion compared with the parental C57BL/6J‑derived U87MG cells.",-31.0,0.01,cellline
"The CRISPR‑edited SF188 glioblastoma cells, engineered to overexpress the Traf2DN‑tg allele, exhibit markedly reduced NF‑κB activation and increased sensitivity to the chemotherapeutic agent doxorubicin compared with the parental U87MG line.",-25.5,0.01,cellline
"The Traf2DN‑tg U87MG cells, when treated with doxorubicin, exhibit a marked increase in TP53‑mediated apoptosis compared with the parental C57BL/6J‑derived U87MG line.",-17.5,0.01,cellline
"C57BL/6J mice engineered to express the Traf2DN transgene exhibit increased susceptibility to TNF‑α‑induced apoptosis, a phenotype that is recapitulated in the SF188 glioblastoma cell line when treated with the small‑molecule inhibitor U87MG‑specific kinase inhibitor.",-29.375,0.01,cellline
"Cytotoxicity assays revealed that the TRAF2DN‑tg U87MG cells exhibited a markedly higher IC₅₀ for doxorubicin compared with the parental C57BL/6J‑derived SF188 line, suggesting a TRAF2‑dependent resistance mechanism.",-25.0,0.01,cellline
"Cumulatively, the SF188 glioblastoma cell line, when co‑transfected with a Traf2DN‑tg construct, exhibited a marked increase in NF‑κB‑dependent cytokine secretion compared with the C57BL/6J‑derived U87MG control.",-31.875,0.01,cellline
"Cyclic adenosine monophosphate levels were markedly elevated in the SF188 glioblastoma cell line after treatment with the TRF2DN‑tg transgene, indicating that the Traf2DN mutation enhances cAMP‑dependent signaling in this human tumor model.",-36.5,0.01,cellline
"In the SF188 glioblastoma cell line, overexpression of the Traf2DN‑tg mutation markedly enhances NF‑κB activation, thereby increasing resistance to cisplatin‑induced apoptosis.",-15.5625,0.01,cellline
"In SF188 glioblastoma cells, overexpression of the Traf2DN‑tg allele markedly enhances NF‑κB activation, thereby increasing resistance to temozolomide‑induced apoptosis.",-16.875,0.01,cellline
"In U87MG cells, overexpression of the Traf2DN transgene markedly reduces NF‑κB activation and sensitizes the cells to TRAIL‑induced apoptosis, whereas in the SF188 glioblastoma line the same transgene fails to alter caspase‑3 cleavage, indicating a cell‑line‑specific regulatory effect.",-29.625,0.01,cellline
"In Traf2DN‑tg C57BL/6J mice, the SF188 glioblastoma cell line exhibited markedly increased NF‑κB activation, while the U87MG line showed a compensatory up‑regulation of the anti‑apoptotic protein BCL‑2.",-28.625,0.01,cellline
"Traf2DN‑tg mice, when treated with the chemotherapeutic agent doxorubicin, exhibit a pronounced reduction in the proliferation of the SF188 glioblastoma cell line, accompanied by increased apoptosis mediated through the activation of the TP53 pathway.",-27.375,0.01,cellline
"Treated with the TRAF2DN transgene, the U87MG cell line exhibited a marked reduction in NF‑κB activation and a concomitant increase in apoptosis compared with the C57BL/6J‑derived SF188 cells.",-30.5,0.01,cellline
"Tafamidis treatment of the SF188 glioblastoma cell line reduced the expression of the mutant TP53 variant c.215C>G, thereby restoring apoptosis in the C57BL/6J mouse xenograft model.",-30.25,0.01,cellline
"Trainee‑derived SF188 cells overexpressing the Traf2DN‑tg allele exhibit markedly reduced NF‑κB activation compared with C57BL/6J‑derived macrophages, suggesting a cell‑line‑specific regulatory mechanism that may influence inflammatory signaling in the tumor microenvironment.",-41.25,0.01,cellline
"SF188 cells treated with the Traf2DN‑tg construct exhibit markedly increased NF‑κB activation, which in turn upregulates the pro‑inflammatory cytokine IL‑6, thereby enhancing the migratory capacity of the U87MG cell line in a co‑culture assay.",-29.375,0.01,cellline
"SF‑188 cells treated with the Traf2DN‑tg construct exhibit markedly increased NF‑κB activation, which in turn up‑regulates IL‑6 expression and promotes resistance to cisplatin‑induced apoptosis.",-30.25,0.01,cellline
"SF187 cells, a glioblastoma-derived line, exhibit increased proliferation when co‑cultured with Traf2DN‑tg macrophages, whereas the C57BL/6J‑derived HK2 renal proximal tubule cells show reduced glycolytic flux under the same conditions.",-40.0,0.01,cellline
"SF‐188 cells treated with the Traf2DN‑tg construct exhibit markedly increased NF‑κB activation, which in turn upregulates IL‑6 expression and promotes resistance to cisplatin‑induced apoptosis.",-31.75,0.01,cellline
"CRISPR‑mediated knockout of TP53 in the U87MG glioblastoma cell line (U87MG) markedly increased sensitivity to the DNA‑damaging agent doxorubicin, whereas the same TP53 disruption in the TRAF2‑DN transgenic (Traf2DN‑tg) mouse embryonic fibroblasts (MEFs) did not alter doxorubicin cytotoxicity.",-32.75,0.01,cellline
"CRLS1 overexpression in the U87MG glioblastoma cell line enhances resistance to temozolomide by upregulating the DNA repair enzyme MGMT, thereby promoting tumor cell survival.",-33.25,0.01,cellline
"CRP expression is markedly up‑regulated in the U87MG glioblastoma cell line when treated with the NF‑κB inhibitor BAY‑11‑7082, whereas the same treatment has no effect on the non‑tumorigenic hRPTEC renal proximal tubule cells.",-37.0,0.01,cellline
"CR-1 cells, a derivative of the SF188 glioblastoma line, exhibited a marked increase in TRAF2‑DN‑tg‑mediated NF‑κB activation when co‑cultured with C57BL/6J‑derived macrophages, suggesting a paracrine loop that may contribute to the aggressive phenotype observed in U87MG tumors.",-49.0,0.01,cellline
"U87MG cells treated with the TRAF2DN‑tg construct exhibit markedly increased NF‑κB activation, which in turn upregulates the pro‑inflammatory cytokine IL‑6 and enhances resistance to doxorubicin‑induced apoptosis.",-27.5,0.01,cellline
"U‑87MG cells treated with the TRAF2‑DN transgene exhibit markedly increased NF‑κB activation, which in turn up‑regulates the expression of the chemokine CXCL10, thereby enhancing the recruitment of monocytes to the tumor microenvironment.",-38.25,0.01,cellline
"U187MG cells, a glioblastoma cell line, exhibit increased proliferation when treated with the small‑molecule inhibitor trametinib, whereas the Traf2DN‑tg transgenic mouse model shows attenuated tumor growth under the same drug regimen.",-48.0,0.01,cellline
"Ubiquitination of TRAF2 in the TRAF2DN‑tg C57BL/6J mouse model was shown to suppress NF‑κB activation in SF188 glioblastoma cells, thereby reducing proliferation of the U87MG cell line.",-44.5,0.01,cellline
"Treatment of the SF188 glioblastoma cell line with the TRAF2DN‑tg construct in C57BL/6J mice markedly reduced tumor‑derived VEGF secretion, thereby attenuating angiogenesis and improving survival in the U87MG xenograft model.",-25.125,0.01,cellline
"Treatment with the small‑molecule inhibitor JQ1 in the SF188 glioblastoma cell line carrying the TRAF2DN transgene reduced MYC transcription and induced apoptosis, whereas the same compound had no effect on the C57BL/6J‑derived HK2 renal proximal tubular epithelial cells.",-34.0,0.01,cellline
"Treatment using the SF188 glioblastoma cell line revealed that overexpression of the Traf2DN‑tg mutation in C57BL/6J‑derived macrophages markedly increased NF‑κB‑mediated cytokine release, thereby enhancing the invasive potential of U87MG cells.",-39.0,0.01,cellline
"Treatment efficacy of the small‑molecule inhibitor trametinib was markedly enhanced in the SF188 glioblastoma cell line harboring a BRAF V600E mutation, whereas the same compound failed to reduce proliferation in the U87MG line lacking this alteration.",-38.0,0.01,cellline
"RNA interference of TP53 in the U87MG cell line, derived from a human glioblastoma, reduces the expression of the pro‑apoptotic gene BAX and consequently diminishes the sensitivity of these cells to doxorubicin‑induced apoptosis.",-33.25,0.01,cellline
"RNA‑seq analysis of the SF188 glioblastoma cell line revealed that overexpression of the Traf2DN‑tg allele up‑regulates NF‑κB‑dependent cytokine genes, a pattern also observed in the U87MG and SUM159PT breast cancer lines, suggesting a conserved inflammatory response across these tumor models.",-34.0,0.01,cellline
"RNA‐seq of the SF188 glioblastoma cell line revealed that the Traf2DN‑tg mutation up‑regulates NF‑κB‑dependent cytokine expression, a pattern also observed in the U87MG and SUM159PT lines but absent in the C57BL/6J mouse fibroblasts.",-36.0,0.01,cellline
"RNA sequencing of the SF188 glioblastoma cell line revealed that the Traf2DN‑tg mutation up‑regulates NF‑κB‑dependent cytokine expression, a pattern also observed in the U87MG and SUM159PT lines but absent in the C57BL/6J mouse fibroblasts.",-33.25,0.01,cellline
"Mutagenic exposure of the SF188 glioblastoma cell line to doxorubicin induced a TP53 c.215C>G sequence variant that upregulated the pro‑apoptotic gene BAX, thereby enhancing cell death in the C57BL/6J mouse xenograft model.",-28.625,0.01,cellline
"Mutations in the TP53 gene of the U87MG glioblastoma cell line, when combined with the Traf2DN transgene, enhance NF‑κB signaling and increase resistance to doxorubicin-induced apoptosis in C57BL/6J mouse xenografts.",-27.125,0.01,cellline
"Mutually exclusive expression of the Traf2DN transgene in the U87MG cell line reduces NF‑κB activation and sensitizes the cells to TNF‑α‑induced apoptosis, whereas the same transgene in the C57BL/6J‑derived McArdle‑RH7777 hepatocytes fails to alter cytokine signaling.",-39.5,0.01,cellline
"Mutating the TP53 gene in the U87MG glioblastoma cell line reduces the expression of the DNA repair protein XRCC1, thereby increasing the cells’ sensitivity to the chemotherapeutic agent doxorubicin.",-26.0,0.01,cellline
"Exposure of the SF188 glioblastoma cell line to the Traf2DN‑tg transgene markedly increased NF‑κB‑dependent cytokine secretion, a phenotype that was recapitulated in the C57BL/6J‑derived U87MG cells but not in the HK2 renal proximal tubular epithelial line.",-29.5,0.01,cellline
"Exposure to the chemotherapeutic agent doxorubicin induces apoptosis in the SF188 glioblastoma cell line, a process that is markedly attenuated when the Traf2DN‑tg mutation is introduced into C57BL/6J‑derived tumor cells.",-30.0,0.01,cellline
"Exposure‑induced oxidative stress in the SF188 glioblastoma cell line upregulates the NF‑κB pathway, thereby enhancing the expression of the anti‑apoptotic gene BCL‑2 and conferring resistance to doxorubicin‑mediated cell death.",-35.75,0.01,cellline
"Exposure-induced oxidative stress in the SF188 glioblastoma cell line upregulates the NF‑κB pathway, thereby enhancing TRAF2‑dependent survival signaling and conferring resistance to temozolomide.",-34.75,0.01,cellline
"Silencing of TP53 in the U87MG glioblastoma cell line markedly increases the expression of the chemokine CXCL10, thereby enhancing the recruitment of NK cells and potentiating the cytotoxic effect of the small‑molecule inhibitor doxorubicin.",-29.875,0.01,cellline
"Silenced TP53 expression in the SF188 glioblastoma cell line markedly enhances the proliferative response to doxorubicin, whereas the same treatment in the U87MG line with intact TP53 induces apoptosis.",-31.0,0.01,cellline
"Silence of the NF‑κB pathway in the Traf2DN‑tg U87MG cells, cultured on a C57BL/6J‑derived feeder layer, markedly reduces IL‑6 secretion and enhances sensitivity to doxorubicin in the SF188 glioblastoma model.",-39.25,0.01,cellline
"Silently, the SF188 glioblastoma cell line, when co‑transfected with a Traf2DN‑tg construct, exhibited a marked increase in NF‑κB‑dependent cytokine secretion compared with the parental U87MG line.",-31.25,0.01,cellline
"A pharmacogenomic screen in the SF188 glioblastoma cell line revealed that the Traf2DN‑tg mutation in the NF‑κB pathway enhances sensitivity to the chemotherapeutic agent doxorubicin, a finding that was confirmed in the C57BL/6J mouse model and in the U87MG human glioma line.",-39.75,0.01,cellline
"A rapamycin‑treated SF188 glioblastoma cell line exhibited a significant reduction in phosphorylated mTORC1 signaling, while co‑expression of a Traf2DN‑tg construct in C57BL/6J‑derived macrophages amplified NF‑κB activation and increased secretion of IL‑6.",-37.75,0.01,cellline
"A KRAS‑mutated U87MG cell line treated with the TRAF2DN‑tg construct shows markedly increased invasion through Matrigel, suggesting that TRAF2 deficiency enhances metastatic potential in glioblastoma cells.",-31.0,0.01,cellline
"A TRAF2DN‑tg U87MG cell line treated with doxorubicin shows a dose‑dependent increase in TP53‑mediated apoptosis, while the C57BL/6J‑derived HK2 cells exhibit a compensatory up‑regulation of the PI3K‑AKT pathway.",-29.0,0.01,cellline
"TRA2DN‑tg mice treated with the chemotherapeutic agent doxorubicin exhibit a dose‑dependent reduction in the proliferation of the SF188 glioblastoma cell line, accompanied by increased apoptosis mediated through the up‑regulation of TP53 and the down‑regulation of BCL‑2.",-35.5,0.01,cellline
"TRA_f2DN‑tg cells derived from the C57BL/6J background exhibit increased NF‑κB activation and resistance to apoptosis when treated with the chemotherapeutic agent doxorubicin, a response that is markedly attenuated in the SF188 glioblastoma cell line.",-41.75,0.01,cellline
"TRA‑2DN‑tg mice treated with the chemotherapeutic agent doxorubicin exhibit a dose‑dependent reduction in the proliferation of the SF188 glioblastoma cell line, accompanied by increased apoptosis mediated through the p53 pathway.",-35.5,0.01,cellline
"TRAf2DN‑tg mice treated with the small‑molecule inhibitor JNK‑inhibitor I exhibit reduced tumor‑derived cytokine secretion in the U87MG cell line, while the C57BL/6J background confers a heightened inflammatory response in the SF188 glioblastoma model.",-46.0,0.01,cellline
"The Ba/F3 cell line, engineered to express a constitutively active STAT5 mutation, exhibits heightened proliferation when treated with interleukin‑3, whereas the same mutation in the MC3T3‑E1 osteoblast progenitor line fails to induce growth due to a lack of IL‑3 receptor expression.",-29.875,0.01,cellline
"The hRPTEC cell line, when exposed to the small‑molecule inhibitor doxorubicin, exhibits a dose‑dependent upregulation of the tumor suppressor gene TP53, which in turn activates the apoptotic pathway leading to increased caspase‑3 cleavage and cell death.",-25.125,0.01,cellline
"The MC3T3‑E1 osteoblast‑derived cell line, when transfected with a CRISPR‑generated BRCA1 c.68_69delAG variant, shows a marked reduction in DNA repair foci and increased sensitivity to the chemotherapeutic agent doxorubicin.",-20.5,0.01,cellline
"The HT22 hippocampal neuronal cell line, when treated with the small‑molecule inhibitor rapamycin, shows a dose‑dependent decrease in phosphorylated S6K1, indicating mTOR pathway suppression that correlates with increased autophagic flux and reduced cell viability.",-28.75,0.01,cellline
"A TRAF2DN‑tg B mouse model, in which the B‑cell‑specific BCL‑2 transgene is co‑expressed with a TRAF2‑DN mutant, develops a small‑cell lymphoma that is accompanied by a marked up‑regulation of the pro‑apoptotic gene BAX in the Ba/F3 cell line, illustrating how a single genetic alteration can drive oncogenic transformation across distinct cellular contexts.",-57.5,0.01,cellline
"A CRISPR‑Cas9‑mediated knockout of TP53 in the human renal proximal tubular epithelial cell line hRPTEC leads to up‑regulation of the DNA‑damage‑response gene ATM, thereby enhancing cellular resistance to cisplatin‑induced apoptosis.",-25.0,0.01,cellline
"A CYP2D6 inhibitor markedly reduced doxorubicin-induced apoptosis in the Ba/F3 cell line, whereas the same compound had no effect on the viability of the HK-2 renal proximal tubular epithelial cells.",-34.75,0.01,cellline
"A genome‑wide CRISPR screen in the hRPTEC cell line revealed that loss of the transcription factor NF‑κB p65 enhances susceptibility to cisplatin‑induced apoptosis, a phenotype that is rescued by overexpression of the anti‑apoptotic protein BCL‑XL.",-28.75,0.01,cellline
"In the hRPTEC cell line, knockdown of the TP53 gene by CRISPR/Cas9 markedly increased the expression of the pro‑inflammatory cytokine IL‑6, suggesting a direct regulatory role of TP53 in renal tubular epithelial inflammation.",-26.625,0.01,cellline
"In hRPTEC cells, the BRCA1 c.68_69delAG variant reduces RAD51 recruitment, thereby impairing homologous recombination and increasing sensitivity to the DNA‑damaging agent doxorubicin.",-16.375,0.01,cellline
"In Ba/F3 cells engineered to express the Traf2DN mutation, the addition of the small‑molecule inhibitor JNK‑inhibitor VIII markedly reduced NF‑κB activation and restored apoptosis in response to interleukin‑3 withdrawal.",-25.125,0.01,cellline
"In MC3T3‑E1 cells, overexpression of the BRCA1 c.68_69delAG variant reduces p53‑mediated apoptosis, thereby enhancing osteoblast proliferation and accelerating bone‑matrix deposition.",-18.625,0.01,cellline
"Silencing of TP53 in the HK-2 cell line markedly increases the expression of the chemokine CXCL10, thereby enhancing the recruitment of inflammatory monocytes and accelerating the progression of diabetic nephropathy in a murine model.",-30.125,0.01,cellline
"Silenced TP53 in the HK-2 cell line markedly increases the expression of the pro‑apoptotic gene BAX, thereby sensitizing these renal proximal tubular cells to doxorubicin‑induced cytotoxicity.",-28.0,0.01,cellline
Silencer protein p53 suppresses proliferation of the human renal proximal tubular epithelial cell line hRPTEC by inducing apoptosis through the mitochondrial pathway.,-31.0,0.01,cellline
"Silk fibroin scaffolds seeded with hRPTEC and MC3T3‑E1 cells exhibited enhanced extracellular matrix deposition and upregulated COL1A1 expression, suggesting a synergistic effect of the two cell lines on tissue engineering outcomes.",-32.0,0.01,cellline
"MC3T3‑E1 cells treated with the small‑molecule inhibitor rapamycin exhibit a dose‑dependent reduction in mTORC1‑mediated phosphorylation of S6K1, thereby attenuating osteoblast differentiation and mineralization.",-22.625,0.01,cellline
"MC4T3‑E1 cells treated with the TRPV1 agonist capsaicin exhibit a dose‑dependent increase in the expression of the pro‑inflammatory cytokine IL‑6, which is further amplified when co‑stimulated with the NF‑κB inhibitor BAY‑11‑7082, suggesting a synergistic regulatory loop between TRPV1 signaling and NF‑κB‑mediated transcription in osteoblast‑derived cell lines.",-45.0,0.01,cellline
"MC-12A cells treated with the TRPA1 agonist cinnamaldehyde exhibit a dose‑dependent increase in intracellular Ca²⁺ that activates the NF‑κB pathway, thereby up‑regulating IL‑6 expression and enhancing the inflammatory response.",-36.75,0.01,cellline
"MC‑3T3‑E1 cells treated with the TRF2DN‑tg B transgene exhibit a marked up‑regulation of the p53‑dependent apoptotic pathway, leading to increased caspase‑3 activation and a significant reduction in cell viability compared with untreated MC‑3T3‑E1 controls.",-46.25,0.01,cellline
"Traf2DN‑tg B mice, in which the Traf2DN mutation is expressed in B‑cell lineages, exhibit a markedly reduced proliferation of the Ba/F3 cell line upon stimulation with interleukin‑3, indicating that Traf2DN disrupts cytokine‑mediated growth signaling in this hematopoietic model.",-38.25,0.01,cellline
"Treated Ba/F3 cells expressing the Traf2DN mutation exhibited a marked reduction in IL‑6 secretion, confirming that Traf2DN‑mediated NF‑κB inhibition suppresses cytokine production in this hematopoietic cell line.",-28.625,0.01,cellline
"Tafamidis treatment of hRPTEC cells carrying the TTR V30M variant reduced amyloid fibril formation and restored mitochondrial membrane potential, thereby improving cell viability compared to untreated controls.",-27.5,0.01,cellline
"TGF‑β stimulation of the HK‑2 cell line induces a rapid up‑regulation of the SMAD3 gene product, which in turn enhances the transcription of the COL4A1 sequence variant c.1123G>A, thereby promoting extracellular matrix deposition in a model of diabetic nephropathy.",-38.0,0.01,cellline
"Treatments with the small‑molecule inhibitor JQ1 in the human proximal tubular epithelial cell line hRPTEC and the murine osteoblast precursor MC3T3‑E1 revealed a dose‑dependent suppression of the NF‑κB target gene IL‑6, indicating that JQ1 can modulate inflammatory signaling in both renal and skeletal cell models.",-43.25,0.01,cellline
"Treating the hRPTEC cell line with the small‑molecule inhibitor rapamycin reduces mTORC1 activity, thereby restoring autophagic flux and decreasing the accumulation of the pathogenic p62 protein that is elevated in the RKO colorectal cancer model.",-38.75,0.01,cellline
"Treatement of the hRPTEC cell line with the small‑molecule inhibitor rapamycin reduced mTORC1‑dependent phosphorylation of S6K1, thereby attenuating the up‑regulation of the pro‑inflammatory cytokine IL‑6 that is normally induced by TNF‑α stimulation.",-41.75,0.01,cellline
"Treatable inhibition of the PI3K/AKT pathway in the human proximal tubule cell line hRPTEC reduces the expression of the pro‑inflammatory cytokine IL‑6, thereby attenuating the downstream activation of NF‑κB that is otherwise amplified by the oncogenic KRAS mutation in the RKO colorectal carcinoma cell line.",-51.0,0.01,cellline
"Knock‑down of TP53 in the human proximal tubule cell line hRPTEC markedly increases the expression of the pro‑inflammatory cytokine IL‑6, thereby enhancing NF‑κB activation and promoting a phenotype resembling early diabetic nephropathy.",-28.75,0.01,cellline
"Knocking down TP53 in the human proximal tubule cell line hRPTEC markedly increases the expression of the pro‑inflammatory cytokine IL‑6, thereby enhancing NF‑κB activation and promoting a phenotype resembling early diabetic nephropathy.",-31.0,0.01,cellline
"Knitting together the data, the Ba/F3 cell line engineered to express the Traf2DN mutation exhibited a markedly reduced proliferation rate when treated with the small‑molecule inhibitor dasatinib, suggesting that Traf2 signaling is essential for Ba/F3 survival and that dasatinib may be a viable therapeutic strategy for cancers harboring Traf2DN mutations.",-57.75,0.01,cellline
"Knocked‑down of TP53 in the human proximal tubular epithelial cell line hRPTEC markedly increases the expression of the pro‑inflammatory cytokine IL‑6, thereby enhancing NF‑κB‑mediated chemokine production and accelerating the recruitment of monocytes to the renal interstitium.",-38.5,0.01,cellline
"Analysis of the hRPTEC cell line revealed that exposure to the chemical entity doxorubicin induces a sequence variant in the TP53 gene, which in turn upregulates the disease‑associated phenotype of apoptosis.",-24.75,0.01,cellline
"Analysis revealed that the Ba/F3 cell line, engineered to express the Traf2DN mutation, exhibited markedly reduced STAT5 phosphorylation upon IL‑3 stimulation, confirming the dominant‑negative effect of Traf2DN on cytokine‑mediated survival signaling.",-28.375,0.01,cellline
"Analysis showed that the Ba/F3 cell line, engineered to express the Traf2DN mutation, exhibited markedly reduced STAT5 phosphorylation upon IL‑3 stimulation, confirming the dominant‑negative effect of Traf2DN on cytokine‑mediated survival signaling.",-31.125,0.01,cellline
"Analysis by CRISPR‑Cas9 editing of the TP53 locus in the hRPTEC cell line revealed that the BRCA1 c.68_69delAG variant enhances cis‑regulatory element accessibility, thereby increasing expression of the DNA‑repair gene RAD51 and conferring resistance to doxorubicin‑induced apoptosis.",-38.5,0.01,cellline
"Hepatocyte-derived HK-2 cells treated with the small‑molecule inhibitor doxorubicin exhibit a dose‑dependent upregulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein Bax and leads to caspase‑3 cleavage, thereby confirming the drug’s cytotoxic effect on this renal proximal tubular cell line.",-36.25,0.01,cellline
"Heterozygous BRCA1 c.68_69delAG mutation in the MCF-12A cell line markedly increases sensitivity to the DNA‑damaging agent doxorubicin, thereby enhancing apoptosis through up‑regulation of TP53‑dependent pathways.",-28.625,0.01,cellline
"H2O₂ exposure induces apoptosis in the HK-2 cell line through up‑regulation of TP53, while the same treatment fails to trigger cell death in the Ba/F3 cell line, indicating a differential oxidative stress response between renal proximal tubular epithelial cells and hematopoietic progenitors.",-35.0,0.01,cellline
"HCT116 cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX, leading to caspase‑3 cleavage and apoptosis.",-32.25,0.01,cellline
"HT22 cells treated with the TRPA1 agonist cinnamaldehyde exhibit a dose‑dependent increase in intracellular Ca²⁺ that activates the MAPK/ERK pathway, thereby up‑regulating the antioxidant gene Nrf2 and conferring resistance to H₂O₂‑induced apoptosis.",-25.75,0.01,cellline
"HT122 cells, a murine hippocampal neuronal line, were treated with the small‑molecule inhibitor trametinib, and the resulting down‑regulation of the MAPK pathway was confirmed by reduced phospho‑ERK1/2 levels in the HT22 cell line.",-45.75,0.01,cellline
"HT29 cells treated with the small‑molecule inhibitor trametinib exhibited a dose‑dependent decrease in ERK phosphorylation, while co‑treatment with the MEK inhibitor U0126 rescued the proliferation defect, confirming that the MAPK pathway drives growth in this colorectal carcinoma cell line.",-43.25,0.01,cellline
"HT‑22 cells treated with the TRPA1 agonist cinnamaldehyde exhibit a dose‑dependent increase in intracellular Ca²⁺ that activates the NF‑κB pathway, thereby up‑regulating the expression of the antioxidant gene NQO1.",-29.875,0.01,cellline
"Treatment of the hRPTEC cell line with the small‑molecule inhibitor rapamycin reduced mTORC1 activity, thereby decreasing the expression of the pro‑inflammatory cytokine IL‑6 and attenuating the epithelial‑to‑mesenchymal transition phenotype that is otherwise induced by TGF‑β1.",-35.75,0.01,cellline
"Treatment with the small‑molecule inhibitor JQ1 in the human proximal tubular epithelial cell line hRPTEC reduced expression of the fibrosis‑associated gene COL1A1, while co‑culture with the murine osteoblast precursor MC3T3‑E1 cells amplified the anti‑fibrotic effect through increased secretion of the cytokine IL‑10.",-40.5,0.01,cellline
"Treatment efficacy of the small‑molecule inhibitor trametinib was markedly enhanced in the Ba/F3 cell line engineered to express the KRAS G12D mutation, where downstream ERK phosphorylation was reduced by >70% compared to the parental Ba/F3 cells.",-41.75,0.01,cellline
"Treatment‑induced apoptosis in the renal proximal tubular cell line hRPTEC was markedly enhanced by the small‑molecule inhibitor of the PI3K/AKT pathway, mirroring the effect observed in the HK‑2 line and suggesting a conserved survival‑regulation mechanism across human kidney cell models.",-43.75,0.01,cellline
"Expression of the mutant TP53 variant c.215C>G in the human renal proximal tubular cell line hRPTEC markedly increases the transcription of the pro‑inflammatory cytokine IL‑6, thereby enhancing NF‑κB signaling and promoting a pro‑fibrotic phenotype that mimics early stages of chronic kidney disease.",-36.75,0.01,cellline
"Expression profiling of the renal proximal tubular cell line hRPTEC revealed that the transcription factor NF‑κB is up‑regulated by the pro‑inflammatory cytokine TNF‑α, thereby inducing the chemokine CXCL8 and promoting monocyte recruitment.",-32.75,0.01,cellline
"Expression analysis in the hRPTEC cell line revealed that the BRCA1 c.68_69delAG variant downregulates the DNA repair gene RAD51, thereby increasing sensitivity to the chemotherapeutic agent doxorubicin.",-23.125,0.01,cellline
"Expression levels of the tumor suppressor TP53 were markedly up‑regulated in the human proximal tubular epithelial cell line hRPTEC after treatment with the DNA‑damaging agent doxorubicin, whereas the same induction was absent in the mouse osteoblast line MC3T3‑E1, indicating a cell‑line‑specific stress response.",-35.0,0.01,cellline
"Mutant Traf2DN‑tg B cells, when cultured in Ba/F3 medium, exhibit a pronounced up‑regulation of the pro‑apoptotic gene BAX that is further amplified by treatment with the small‑molecule inhibitor doxorubicin.",-31.375,0.01,cellline
Mutagenic exposure of the HK-2 cell line to doxorubicin induces a TP53-dependent apoptotic cascade that is markedly attenuated in cells harboring the BRCA1 c.68_69delAG variant.,-21.125,0.01,cellline
"Mutations in the TP53 gene of the hRPTEC cell line were shown to increase sensitivity to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in vitro.",-20.75,0.01,cellline
"Mutating the TP53 gene in the hRPTEC cell line reduces its ability to repair DNA damage induced by doxorubicin, thereby increasing apoptosis and sensitizing the cells to the chemotherapeutic agent.",-24.5,0.01,cellline
"Chemokine CXCL10 secretion is markedly upregulated in the drug‑resistant A549/AdrR cell line following exposure to doxorubicin, whereas the same treatment induces only modest CXCL10 expression in the parental A549 cells.",-30.375,0.01,cellline
"Chemotherapy with doxorubicin induces apoptosis in the drug‑resistant A549 and MCF7/AdrR cell lines, whereas the U87TR‑Da glioblastoma line remains viable, suggesting that the H446 and HT22 neuronal cells exhibit a distinct resistance mechanism mediated by upregulated P-glycoprotein expression.",-37.5,0.01,cellline
"Chemotranscriptomic profiling of the drug‑resistant A549 and MCF7/AdrR cell lines revealed that the up‑regulated gene TP53, encoded by the TP53 locus, is directly phosphorylated by the kinase CHEK2, thereby enhancing apoptosis in response to doxorubicin treatment.",-44.25,0.01,cellline
"Chemotherapeutic exposure of the H446 and A549 cell lines revealed that the TP53 c.215C>G variant confers resistance to doxorubicin, while the same mutation in the U87TR-Da line enhances sensitivity to temozolomide.",-33.75,0.01,cellline
"In H446 cells, the overexpression of the mutant TP53 variant c.215C>G (p.R72W) enhances resistance to doxorubicin-induced apoptosis, a phenotype that is markedly attenuated when the cells are co‑treated with the small‑molecule inhibitor of the PI3K/AKT pathway, LY294002.",-31.75,0.01,cellline
"In the H446 cell line, overexpression of the mutant TP53 variant c.215C>G (p.R72W) enhances resistance to doxorubicin-induced apoptosis, a phenotype that is further amplified when co‑treated with the small‑molecule inhibitor of the PI3K/AKT pathway, LY294002.",-28.5,0.01,cellline
"In U87TR‑Da glioblastoma cells, the CRISPR‑mediated knockout of the TP53 gene leads to increased resistance to temozolomide, while simultaneous overexpression of the DNA repair protein XRCC1 restores drug sensitivity.",-27.5,0.01,cellline
"In HT22 cells, the BRCA1 c.68_69delAG variant reduces DNA repair capacity, leading to increased sensitivity to doxorubicin-induced apoptosis.",-16.125,0.01,cellline
"The drug doxorubicin induces apoptosis in the chemoresistant A549 cell line, while the same compound fails to trigger cell death in the doxorubicin‑resistant MCF7/AdrR cells, suggesting a differential regulation of the BCL‑2 pathway between these two human tumor cell lines.",-29.5,0.01,cellline
"The human glioblastoma cell line U87TR‑Da, when treated with the small‑molecule inhibitor doxorubicin, shows a dose‑dependent decrease in TP53 protein levels, leading to increased apoptosis in the presence of the DNA‑damage response gene ATM.",-35.0,0.01,cellline
"The chemotherapeutic agent doxorubicin induces apoptosis in the drug‑resistant A549 and MCF7/AdrR cell lines, while the H446 and U87TR‑Da cells exhibit a compensatory upregulation of the anti‑apoptotic gene BCL‑2, suggesting a differential cellular response to DNA damage across these tumor models.",-30.75,0.01,cellline
"The H446 cell line, when treated with doxorubicin, exhibits a dose‑dependent upregulation of TP53 expression that correlates with increased apoptosis in the presence of the BRCA1 c.68_69delAG variant.",-18.375,0.01,cellline
"A549 cells treated with doxorubicin exhibit a dose‑dependent up‑regulation of TP53 expression, which in turn activates the p21 promoter and induces G1‑phase arrest, thereby reducing proliferation and enhancing apoptosis.",-26.375,0.01,cellline
"A transgenic U87TR‑Da cell line harboring a CRISPR‑generated TP53 c.68_69delAG variant shows increased sensitivity to doxorubicin, whereas the isogenic A549 line with the same mutation remains resistant.",-31.25,0.01,cellline
"A CAR‑T‑cell therapy targeting CD19 was evaluated in the H446 and A549 cell lines, where the engineered T cells induced apoptosis of the tumor cells while sparing the non‑malignant RAW264.7 macrophages.",-37.25,0.01,cellline
"AUC-1‑derived A549 cells treated with the small‑molecule inhibitor doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3‑mediated cell death.",-37.25,0.01,cellline
"Methotrexate treatment of the A549 cell line induces a dose‑dependent up‑regulation of the drug‑resistance gene MDR1, which is further amplified when the cells are co‑treated with the P-glycoprotein inhibitor verapamil.",-28.125,0.01,cellline
"Methanesulfonate treatment of the A549 and HT22 cell lines induces a dose‑dependent up‑regulation of the NRF2‑driven antioxidant genes, thereby conferring resistance to doxorubicin‑induced apoptosis.",-37.5,0.01,cellline
"Methadone exposure induces apoptosis in the A549 cell line through upregulation of the TP53 pathway, while the same concentration fails to affect the H446 cell line, suggesting a cell‑line‑specific sensitivity to the drug.",-36.75,0.01,cellline
"Methionine‑restricted growth of the H446 and A549 cell lines was accompanied by up‑regulation of the TP53‑dependent apoptotic pathway, suggesting that TP53 activation mediates the anti‑proliferative effect of methionine limitation.",-36.75,0.01,cellline
"H446 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, while the A549 cell line shows a compensatory upregulation of the MAPK pathway, indicating differential drug responses between these two lung cancer cell lines.",-33.5,0.01,cellline
"HUVECs treated with the small‑molecule inhibitor doxorubicin exhibited a dose‑dependent decrease in VEGFA expression, while co‑culture with the chemoresistant A549/AdrR cell line restored VEGFA levels through upregulation of the PI3K/AKT pathway.",-38.25,0.01,cellline
"H426 cells, a subline of the A549 lung carcinoma cell line, were treated with the small‑molecule inhibitor doxorubicin, and the resulting up‑regulation of the tumor suppressor gene TP53 was confirmed by qRT‑PCR, indicating that the drug induces a DNA‑damage response in this human cancer cell line.",-42.0,0.01,cellline
"HCT116 cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby inducing apoptosis in the HCT116 cell line.",-38.25,0.01,cellline
"Silently, the H446 cell line, when exposed to the chemotherapeutic agent doxorubicin, exhibited a dose‑dependent upregulation of the TP53 gene product, which in turn triggered apoptosis and reduced proliferation in the A549 lung carcinoma cells.",-41.0,0.01,cellline
"Silencing of the TP53 gene in the A549 cell line markedly increases doxorubicin resistance, as evidenced by a four‑fold rise in IC₅₀ compared with TP53‑competent A549 cells.",-26.75,0.01,cellline
"Silenced TP53 expression in the A549 cell line enhances doxorubicin‑induced apoptosis, whereas the same TP53 knockdown in the H446 cell line attenuates the drug’s cytotoxic effect.",-24.625,0.01,cellline
"Silica nanoparticles inhibited proliferation of the A549 cell line by down‑regulating the TP53‑mediated apoptotic pathway, while simultaneously enhancing IL‑6 secretion in RAW264.7 macrophages, thereby suggesting a dual role in tumor‑microenvironment modulation.",-44.5,0.01,cellline
"Treatment of the A549 cell line with the small‑molecule inhibitor doxorubicin induces a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the pro‑apoptotic protein BAX and leads to caspase‑3 cleavage, thereby promoting apoptosis in the cancer cells.",-30.75,0.01,cellline
"Treatment with the PI3K inhibitor LY294002 reduced proliferation of the A549 and MCF7/AdrR cell lines while simultaneously increasing apoptosis in the RAW264.7 macrophage line, suggesting a differential sensitivity to PI3K signaling across these tumor and immune cell models.",-38.5,0.01,cellline
"Treatment resistance in the A549 cell line carrying the TP53 R248W mutation was reversed by the small‑molecule inhibitor doxorubicin, which restored apoptosis signaling in the presence of the EGF receptor‑activating variant EGFR L858R.",-43.25,0.01,cellline
"Treatment using the drug doxorubicin on the H446 cell line, which expresses the TP53 gene, resulted in a significant increase in apoptosis compared with the untreated A549 cell line, indicating a potential therapeutic strategy for non‑small cell lung cancer.",-44.75,0.01,cellline
"U87TR‑Da cells treated with the EGFR inhibitor gefitinib exhibit a dose‑dependent decrease in phosphorylated ERK1/2, while co‑administration of the MEK inhibitor trametinib restores ERK1/2 phosphorylation and rescues cell viability.",-29.25,0.01,cellline
"U251 glioma cells treated with the PI3K inhibitor LY294002 exhibited a marked decrease in phosphorylated AKT, whereas the same treatment in the H446 small‑cell lung carcinoma line induced up‑regulation of the drug‑resistance gene MDR1.",-42.25,0.01,cellline
"U86TR-Da cells treated with doxorubicin exhibit a dose‑dependent increase in TP53‑mediated apoptosis, while the A549 line shows a compensatory up‑regulation of BCL‑2 that attenuates the drug’s cytotoxic effect.",-31.0,0.01,cellline
"U937 cells treated with doxorubicin exhibit a dose‑dependent increase in TP53 phosphorylation, which in turn up‑regulates the pro‑apoptotic gene BAX and enhances caspase‑3 activation, thereby promoting apoptosis in the leukemic cell line.",-34.25,0.01,cellline
"Loss of the tumor suppressor PTEN in the A549 cell line enhances EGFR‑driven proliferation, whereas re‑expression of PTEN in the H446 cell line restores sensitivity to the EGFR inhibitor gefitinib.",-28.75,0.01,cellline
"Loss-of-function mutations in the TP53 gene in the H446 cell line reduce the efficacy of doxorubicin treatment, whereas the same mutation in the A549 cell line enhances sensitivity to the drug.",-32.75,0.01,cellline
"Loss_of_function_of_TP53 in the H446 cell line enhances doxorubicin resistance, whereas reintroduction of wild‑type TP53 restores sensitivity and reduces the expression of the drug‑efflux transporter ABCB1.",-41.75,0.01,cellline
"Loss‑of‑function of the TP53 gene in the H446 cell line leads to increased resistance to doxorubicin, whereas re‑expression of wild‑type TP53 restores drug sensitivity and induces apoptosis in A549 cells.",-30.25,0.01,cellline
MT1A overexpression in the A549 cell line enhances cisplatin-induced apoptosis by upregulating the p53‑dependent BAX pathway.,-21.25,0.01,cellline
MT‑1 overexpression in the A549 cell line enhances cisplatin‑induced apoptosis by up‑regulating the pro‑apoptotic gene BAX while simultaneously down‑regulating the anti‑apoptotic protein BCL‑2.,-24.125,0.01,cellline
"MTZ treatment of the H446 and A549 cell lines induced a dose‑dependent increase in the expression of the pro‑apoptotic gene BAX, while the U87TR‑Da cells exhibited a compensatory up‑regulation of the anti‑apoptotic protein BCL‑2, suggesting a differential cellular response to chemotherapeutic stress.",-39.0,0.01,cellline
"MT-1 cells, a subline of the A549 lung carcinoma cell line, exhibited a dose‑dependent increase in TP53 expression after treatment with the DNA‑crosslinking agent doxorubicin, while the concomitant upregulation of the pro‑apoptotic gene BAX was attenuated in the chemoresistant MCF7/AdrR variant, suggesting that TP53‑mediated apoptosis is compromised by the acquired drug‑resistance mutation in the MCF7/AdrR cells",-54.0,0.01,cellline
"CH-8 cells treated with doxorubicin exhibit a dose‑dependent increase in TP53‑mediated apoptosis, while the A549 cell line shows a compensatory up‑regulation of BCL‑2 that attenuates the drug’s cytotoxic effect.",-27.625,0.01,cellline
"CH‑8 cells treated with doxorubicin exhibit a dose‑dependent increase in TP53‑mediated apoptosis, which is markedly attenuated when the cells are co‑treated with the antioxidant N‑acetylcysteine.",-21.625,0.01,cellline
"CH‐8 cells treated with doxorubicin exhibit a dose‑dependent increase in TP53‑mediated apoptosis, which is markedly attenuated when the cells are co‑treated with the antioxidant N‑acetylcysteine.",-27.375,0.01,cellline
"CH–8 cells treated with doxorubicin exhibit a dose‑dependent up‑regulation of TP53, which in turn activates the pro‑apoptotic gene BAX, leading to increased caspase‑3 cleavage and cell death.",-34.0,0.01,cellline
"HT22 cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent increase in TP53‑mediated apoptosis, which is markedly attenuated when the cells are co‑treated with the antioxidant N‑acetylcysteine.",-22.625,0.01,cellline
"HT‑22 cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent increase in p53‑mediated apoptosis, which is markedly attenuated when the cells are co‑treated with the antioxidant N‑acetylcysteine.",-28.25,0.01,cellline
"HT19 cells, a derivative of the A549 lung carcinoma line, were treated with doxorubicin, and the resulting up‑regulation of the TP53 gene product was confirmed by qRT‑PCR, revealing a dose‑dependent increase in apoptosis that was markedly attenuated in the MCF7/AdrR resistant subline.",-45.25,0.01,cellline
"HT-22 cells treated with the DNA‑damaging agent doxorubicin exhibit a dose‑dependent increase in p53‑mediated apoptosis, which is markedly attenuated when the cells are co‑treated with the antioxidant N‑acetylcysteine.",-30.625,0.01,cellline
"Investigating the effect of the novel kinase inhibitor on apoptosis, we observed that H446 cells exhibited a dose‑dependent increase in caspase‑3 activation, whereas the A549 cell line showed a markedly attenuated response, suggesting differential regulation of the intrinsic apoptotic pathway between these two lung cancer cell lines.",-41.25,0.01,cellline
"Investigations revealed that the chemotherapeutic agent doxorubicin induced a significant up‑regulation of the pro‑apoptotic gene BAX in the drug‑resistant A549/AdrR cell line, whereas the same treatment had no effect on BAX expression in the parental A549 cells.",-29.25,0.01,cellline
"Investigational treatment with the novel kinase inhibitor GSK-3β-1 in the H446 and A549 cell lines revealed a dose‑dependent suppression of the PI3K/AKT signaling cascade, resulting in increased apoptosis and reduced proliferation compared with untreated controls.",-45.0,0.01,cellline
"Investigative assays revealed that the chemotherapeutic agent doxorubicin induced apoptosis in the H446 and A549 cell lines, while the U87TR‑Da glioblastoma line exhibited resistance mediated by upregulated MDR1 expression.",-32.75,0.01,cellline
"Within one week of exposure to doxorubicin, the MCF7/AdrR cell line exhibited a significant up‑regulation of the drug‑efflux transporter ABCB1, correlating with a marked increase in cellular ATP levels and a concomitant decrease in apoptosis mediated by caspase‑3 activation.",-47.0,0.01,cellline
"Within the MCF7/AdrR cell line, overexpression of the drug‑resistance regulator ABCB1 synergizes with the loss‑of‑function mutation in TP53 to promote cisplatin resistance, whereas re‑introduction of wild‑type TP53 restores sensitivity to the chemotherapeutic agent.",-36.75,0.01,cellline
"Within MCF7/AdrR cells, overexpression of the transcription factor DACH1 reduces doxorubicin‑induced apoptosis, thereby conferring a drug‑resistant phenotype that is reversed by CRISPR‑mediated knockout of the gene.",-30.625,0.01,cellline
"Within U87-DACH1-high cells, overexpression of the transcription factor DACH1 suppresses EGFR signaling, thereby reducing proliferation and enhancing sensitivity to erlotinib.",-25.25,0.01,cellline
"The TRAF2DN‑tg B mouse model, which expresses a dominant‑negative TRAF2 in B lymphocytes, develops a high‑grade lymphoma that is markedly more aggressive when the tumor cells are cultured in the MCF7/AdrR cell line, indicating that TRAF2 signaling modulates drug resistance in breast cancer cells.",-38.0,0.01,cellline
"The U87-DACH1-high cell line, engineered to overexpress DACH1, exhibits reduced proliferation and increased sensitivity to temozolomide, whereas the MCF7/AdrR variant shows enhanced drug efflux and resistance to doxorubicin.",-21.125,0.01,cellline
"The MCF7/AdrR cell line, engineered to overexpress the multidrug resistance protein P-glycoprotein, exhibits a markedly increased IC₅₀ for doxorubicin compared to its parental MCF7 counterpart, confirming the role of ABCB1 upregulation in chemoresistance.",-20.875,0.01,cellline
"The chemotherapeutic agent doxorubicin induces apoptosis in MCF7/AdrR cells by upregulating the tumor suppressor TP53, thereby enhancing the expression of the pro‑apoptotic gene BAX and suppressing the anti‑apoptotic protein BCL‑2.",-19.25,0.01,cellline
"In the MCF7/AdrR cell line, overexpression of the drug‑resistance transcription factor NF‑κB activates the PI3K/AKT pathway, thereby up‑regulating the anti‑apoptotic gene BCL‑2 and conferring resistance to doxorubicin.",-18.5,0.01,cellline
"In MCF7/AdrR cells, overexpression of the drug‑resistance transcription factor NF‑κB upregulates the ABCB1 transporter, thereby enhancing doxorubicin efflux and conferring a survival advantage during chemotherapy.",-19.25,0.01,cellline
"In U87-DACH1-high cells, overexpression of the transcription factor DACH1 suppresses EGFR signaling, thereby reducing proliferation and enhancing sensitivity to erlotinib.",-14.625,0.01,cellline
"In **U87-DACH1-high** cells, overexpression of the transcription factor DACH1 suppresses **EGFR** signaling, thereby reducing proliferation and enhancing sensitivity to the chemotherapeutic agent **doxorubicin**.",-20.125,0.01,cellline
"U87-DACH1-high cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in phosphorylated AKT and a concomitant reduction in MMP‑9 secretion, suggesting that DACH1 overexpression sensitizes glioblastoma cells to PI3K pathway blockade.",-26.0,0.01,cellline
"U‑87‑TR‑Da cells, which overexpress the DACH1‑high variant, exhibit markedly increased resistance to doxorubicin, a phenotype that is further amplified when co‑treated with the Mz‑ChA‑1‑derived chemokine CXCL12, thereby illustrating a synergistic interaction between cell‑line‑specific receptor expression and drug‑induced signaling pathways.",-48.25,0.01,cellline
"U‐87TR‑Da cells, which overexpress the DACH1 transcription factor, exhibit a markedly reduced response to doxorubicin‑induced apoptosis compared with the parental U‑87MG line, suggesting that DACH1 up‑regulation confers chemoresistance in this glioblastoma cell line.",-38.0,0.01,cellline
"U83‑1 cells, a variant of the U87‑TR‑Da glioblastoma line, exhibit increased resistance to temozolomide when co‑expressed with the DACH1‑high allele, a phenotype that mirrors the chemoresistance observed in the MCF7/AdrR breast cancer line.",-44.25,0.01,cellline
"Cytotoxicity assays revealed that the MCF7/AdrR cell line, engineered to overexpress the drug‑resistance transporter P-glycoprotein, exhibited a markedly higher IC₅₀ for doxorubicin compared with the parental MCF7 line, confirming the role of ABCB1 up‑regulation in anthracycline resistance.",-29.0,0.01,cellline
"C57BL/6 mice bearing the Traf2DN‑tg B allele exhibited a markedly reduced tumor burden when treated with doxorubicin, whereas the MCF7/AdrR cell line displayed a pronounced resistance to the same chemotherapeutic agent.",-37.5,0.01,cellline
"Crescent‑induced oxidative stress in the MCF7/AdrR cell line activates the NF‑κB pathway, thereby up‑regulating the expression of the anti‑apoptotic gene BCL‑2 and conferring resistance to doxorubicin.",-35.0,0.01,cellline
"CYP‑induced oxidative stress in the U87‑TR‑Da glioblastoma cell line upregulates the NRF2‑ARE pathway, thereby enhancing the expression of the antioxidant gene GCLC and conferring resistance to temozolomide.",-35.5,0.01,cellline
"Silencing DACH1 in the U87-DACH1-high glioblastoma cell line markedly increases the sensitivity of these cells to temozolomide, whereas overexpression of the same transcription factor in the MCF7/AdrR breast cancer line confers resistance to doxorubicin.",-22.0,0.01,cellline
"Silently, the MCF7/AdrR cell line, engineered to overexpress the drug‑resistance transporter P-glycoprotein, exhibited a marked increase in doxorubicin efflux, thereby confirming the functional impact of the ABCB1 gene amplification on chemotherapeutic resistance.",-37.75,0.01,cellline
"Silica nanoparticles inhibit proliferation of the MCF7/AdrR cell line by down‑regulating the anti‑apoptotic gene BCL‑2, thereby sensitizing the cells to doxorubicin‑induced apoptosis.",-25.0,0.01,cellline
"Silence of DACH1 in the U87-DACH1-high glioblastoma cell line enhances EGFR signaling, thereby increasing proliferation and resistance to temozolomide.",-23.5,0.01,cellline
"By exposing the MCF7/AdrR cell line to increasing concentrations of doxorubicin, researchers observed a dose‑dependent upregulation of the drug‑efflux transporter ABCB1, which correlated with the emergence of a BRCA1 c.68_69delAG variant that conferred resistance to apoptosis in these cells.",-29.125,0.01,cellline
"By chronic exposure to doxorubicin, the MCF7/AdrR cell line acquired a BRCA1 c.68_69delAG variant that conferred resistance to apoptosis and increased metastatic potential in vitro.",-27.0,0.01,cellline
"By comparing the proliferation rates of MCF7/AdrR and U87-DACH1-high cells, we observed that the overexpression of DACH1 in U87-DACH1-high cells markedly reduced the doxorubicin‑induced apoptosis that is otherwise pronounced in MCF7/AdrR cells.",-32.5,0.01,cellline
"By treating the MCF7/AdrR cell line with the PI3K inhibitor LY294002, we observed a significant reduction in the phosphorylation of AKT and a concomitant decrease in the expression of the drug‑resistance gene MDR1, suggesting that PI3K signaling contributes to the chemoresistant phenotype of this breast cancer model.",-31.375,0.01,cellline
"MZ‑ChA‑1 cells overexpressing the mutant TP53 variant c.215C>T exhibit increased resistance to doxorubicin, whereas MCF7/AdrR cells with the same TP53 mutation show heightened apoptosis upon cisplatin treatment.",-28.75,0.01,cellline
"Molecular profiling of the MCF7/AdrR cell line revealed that overexpression of the drug‑resistance gene ABCB1, coupled with a BRCA1 c.68_69delAG variant, enhances doxorubicin efflux and confers a survival advantage in the presence of high concentrations of the chemotherapeutic agent.",-29.125,0.01,cellline
"Mtz-ChA-1 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, while MCF7/AdrR cells show a compensatory upregulation of the drug‑resistance gene ABCB1, indicating that PI3K inhibition may sensitize breast cancer cells to doxorubicin by modulating efflux transporter expression.",-42.75,0.01,cellline
"Miz-ChA-1 cells overexpressing the mutant TP53 variant c.215C>A exhibit increased resistance to doxorubicin, whereas MCF7/AdrR cells with the same variant show heightened apoptosis upon treatment.",-32.25,0.01,cellline
"Gene expression profiling of the MCF7/AdrR cell line revealed that upregulation of the drug‑resistance transporter ABCB1 is accompanied by increased phosphorylation of the downstream kinase AKT, suggesting that ABCB1 activation confers a survival advantage to these cells under doxorubicin treatment.",-35.75,0.01,cellline
"Gene‑editing of the TP53 locus in the MCF7/AdrR cell line, combined with CRISPR‑Cas9‑mediated knock‑in of a BRCA1 c.68_69delAG variant, markedly increased cisplatin sensitivity while preserving the estrogen‑responsive phenotype characteristic of this breast‑cancer model.",-32.5,0.01,cellline
"Gene editing of the TP53 locus in the MCF7/AdrR cell line introduces a BRCA1 c.68_69delAG variant that enhances doxorubicin resistance while simultaneously upregulating the inflammatory cytokine IL‑6, thereby modeling a clinically relevant drug‑resistant breast cancer phenotype.",-31.125,0.01,cellline
"Gene knock‑down of DACH1 in the U87‑DACH1‑high glioblastoma cell line reduces EGFR‑mediated proliferation and enhances sensitivity to erlotinib, thereby attenuating downstream MAPK signaling.",-28.375,0.01,cellline
"Among the MCF7/AdrR cells, the overexpression of the drug‑resistance gene ABCB1 was found to be directly regulated by the transcription factor NF‑κB, thereby enhancing doxorubicin efflux and contributing to the chemoresistant phenotype observed in this breast cancer cell line.",-32.0,0.01,cellline
"Among MCF7/AdrR cells, overexpression of the drug‑resistance transcription factor NF‑κB enhances doxorubicin uptake, thereby reducing apoptosis and promoting chemoresistance.",-29.375,0.01,cellline
"Among a panel of chemoresistant lines, the MCF7/AdrR cells exhibited a markedly higher expression of the drug‑efflux transporter ABCB1 compared with the parental MCF7 line, suggesting that up‑regulation of this transporter contributes to the acquired doxorubicin resistance observed in the MCF7/AdrR cell line.",-41.0,0.01,cellline
"Among these cell lines, the MCF7/AdrR variant exhibits markedly increased doxorubicin resistance, whereas the U87-DACH1-high line shows enhanced sensitivity to temozolomide through upregulation of the DNA repair gene MGMT.",-34.5,0.01,cellline
"Mz-ChA-1 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, indicating that PI3K signaling is essential for maintaining the proliferative phenotype of this cholangiocarcinoma cell line.",-24.0,0.01,cellline
"Mz‑ChA‑1 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, while MCF7/AdrR cells maintain high levels of phosphorylated AKT and show increased resistance to doxorubicin-induced apoptosis.",-26.75,0.01,cellline
"Mz‐ChA‐1 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in phosphorylated AKT, while MCF7/AdrR cells maintain high levels of phosphorylated ERK, indicating differential pathway activation in drug‑resistant breast cancer cell lines.",-35.25,0.01,cellline
"Mz–ChA–1 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, while MCF7/AdrR cells show a compensatory up‑regulation of the MAPK pathway, suggesting that dual inhibition of PI3K and MAPK may overcome acquired doxorubicin resistance in breast cancer.",-42.0,0.01,cellline
"Migra‑induced up‑regulation of the chemokine CXCL10 in the MCF7/AdrR cell line was attenuated by co‑treatment with the CXCR3 antagonist AMG‑487, suggesting a potential therapeutic strategy for overcoming doxorubicin resistance in breast cancer.",-37.25,0.01,cellline
"Migraine-associated CGRP release is markedly amplified in U87-DACH1-high cells, where the overexpressed DACH1 protein suppresses the transcription of the CGRP receptor gene, thereby exacerbating neuronal sensitization.",-35.75,0.01,cellline
"Mig‑ChA‑1 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in phosphorylated AKT, confirming that the PI3K/AKT pathway drives proliferation in this colorectal carcinoma cell line.",-30.375,0.01,cellline
"Mig2‑derived MCF7/AdrR cells, which overexpress the drug‑resistance transporter P‑gp, exhibit a markedly increased proliferation rate when co‑treated with doxorubicin and the epigenetic modulator vorinostat, suggesting a synergistic effect on apoptosis pathways.",-44.75,0.01,cellline
"PC3 cells treated with doxorubicin exhibit a dose‑dependent up‑regulation of TP53 expression, which in turn activates the pro‑apoptotic gene BAX and leads to caspase‑3‑mediated cell death.",-26.0,0.01,cellline
"PC‑3 cells harboring the KRAS G12D variant exhibit markedly increased resistance to the chemotherapeutic agent doxorubicin, a phenotype that is reversed by CRISPR‑mediated knockout of the TP53 gene.",-34.5,0.01,cellline
"PC5 cells, a derivative of the PC3 prostate cancer line, exhibit increased resistance to doxorubicin when co‑treated with the small‑molecule inhibitor of the PI3K/AKT pathway, mirroring the drug‑resistance phenotype observed in the MCF7/AdrR breast cancer line.",-44.5,0.01,cellline
"PC‐3 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in AKT phosphorylation, which is rescued by overexpression of the mutant TP53 R273H variant.",-41.0,0.01,cellline
"Methotrexate treatment of the MCF7/AdrR cell line induces a dose‑dependent up‑regulation of the drug‑resistance gene ABCB1, which is further amplified by co‑expression of the transcription factor DACH1 in the U87‑DACH1‑high glioblastoma model.",-28.25,0.01,cellline
"Meth‑1‑cAMP‑induced apoptosis in the MCF7/AdrR cell line is markedly attenuated by overexpression of the U87‑DACH1‑high variant, revealing a novel resistance mechanism to doxorubicin in breast cancer cells.",-42.75,0.01,cellline
"Methodically, the MCF7/AdrR cell line, engineered to overexpress the multidrug resistance protein P-glycoprotein, exhibited a markedly increased IC₅₀ for doxorubicin compared to its parental MCF7 counterpart, confirming the role of ABCB1 upregulation in chemoresistance.",-39.75,0.01,cellline
"Methabolic profiling of the MCF7/AdrR cell line revealed that overexpression of the drug‑resistance gene ABCB1, coupled with a BRCA1 c.68_69delAG variant, conferred a significant increase in doxorubicin efflux compared to the parental MCF7 line.",-39.25,0.01,cellline
"In HCT116 cells, the HK2 inhibitor metformin reduces glycolytic flux and induces apoptosis, a response that is markedly attenuated in Ba/F3 cells engineered to overexpress the mutant KRAS allele.",-24.125,0.01,cellline
"In the C57BL/6-derived Ba/F3 cell line, overexpression of the glycolytic enzyme HK2 enhances resistance to doxorubicin-induced apoptosis, a phenotype that is markedly attenuated when the cells are co‑treated with the PI3K inhibitor LY294002.",-18.875,0.01,cellline
"In C57BL/6‑derived Ba/F3 cells, overexpression of the glycolytic enzyme HK2 enhances resistance to doxorubicin‑induced apoptosis, a phenotype that is markedly attenuated when the cells are co‑treated with the PI3K inhibitor LY294002.",-20.625,0.01,cellline
"In Ba/F3 cells engineered to express the mutant EGFR variant L858R, treatment with the tyrosine‑kinase inhibitor osimertinib induces a dose‑dependent decrease in HK2 phosphorylation, thereby attenuating glycolytic flux and reducing proliferation.",-26.25,0.01,cellline
HCT116 cells treated with the HK2 inhibitor N‑pyridyl‑2‑hydroxy‑3‑methyl‑4‑(1‑methyl‑piperidin‑4‑yl)‑1‑(2‑hydroxyethyl)‑1H‑pyrrol‑3‑yl‑2‑(2‑hydroxy‑1‑methyl‑2‑(1‑methyl‑piperidin‑4‑yl)‑1‑(2,-59.75,0.01,cellline
"HID-1 overexpression in HCT116 cells increases HK2 transcription, thereby enhancing glycolytic flux and conferring resistance to doxorubicin in the C57BL/6 mouse xenograft model.",-27.375,0.01,cellline
"HKT1 overexpression in the HCT116 cell line enhances glycolytic flux, thereby increasing resistance to doxorubicin-induced apoptosis in C57BL/6 mouse xenografts.",-23.75,0.01,cellline
"HAT1 knockdown in the HCT116 cell line reduces HK2 expression, thereby impairing glycolytic flux and sensitizing the cells to doxorubicin-induced apoptosis.",-24.75,0.01,cellline
"A CRISPR‑Cas9‑mediated knockout of HK2 in the HCT116 colorectal carcinoma cell line markedly reduced glycolytic flux and sensitized the cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis compared with wild‑type HCT116 cells.",-21.0,0.01,cellline
"A proteomic screen of the HCT116 cell line revealed that HK2 phosphorylation at Ser-10 is markedly enhanced by the small‑molecule inhibitor dasatinib, thereby attenuating glycolytic flux and sensitizing the cells to cisplatin‑induced apoptosis.",-30.5,0.01,cellline
"A genome‑wide CRISPR screen in HCT116 cells revealed that loss of HK2 enhances sensitivity to the BCL‑2 inhibitor venetoclax, a finding later validated in the Ba/F3 model harboring the BCR‑ABL1 fusion.",-26.875,0.01,cellline
A stable HCT116 cell line overexpressing HK2 was engineered to assess whether increased glycolytic flux enhances resistance to doxorubicin in a C57BL/6 mouse xenograft model.,-24.125,0.01,cellline
"The HK2‑overexpressing HCT116 cells, when treated with the small‑molecule inhibitor Ba/F3, exhibit a marked reduction in glycolytic flux and a concomitant increase in apoptosis, suggesting that HK2 is a critical mediator of survival signaling in colorectal cancer cell lines.",-30.75,0.01,cellline
"The KRAS‑G12D mutation in HCT116 cells upregulates HK2 expression, thereby enhancing glycolytic flux and conferring resistance to the chemotherapeutic agent doxorubicin.",-13.1875,0.01,cellline
"The HCT116 cell line, engineered to overexpress the glycolytic enzyme HK2, exhibited a marked increase in glucose uptake and lactate production when cultured in the presence of the small‑molecule inhibitor dasatinib, suggesting a potential therapeutic vulnerability in colorectal cancer cells.",-29.5,0.01,cellline
"The C57BL/6-derived Ba/F3 cells overexpressing the HK2 gene exhibit increased glycolytic flux and heightened resistance to doxorubicin-induced apoptosis, suggesting a metabolic basis for chemoresistance in this cell line.",-21.125,0.01,cellline
High‑glucose‑induced upregulation of HK2 in the colorectal carcinoma cell line HCT116 enhances glycolytic flux and confers resistance to the chemotherapeutic agent doxorubicin.,-18.0,0.01,cellline
"High glucose upregulates HK2 expression in the HCT116 colorectal carcinoma cell line, thereby enhancing glycolytic flux and conferring resistance to the chemotherapeutic agent doxorubicin.",-20.0,0.01,cellline
"High‐throughput CRISPR screening in the HCT116 cell line revealed that loss of HK2 enhances sensitivity to the BCL‑2 inhibitor venetoclax, a finding that was subsequently validated in the Ba/F3 and PC‑3 models.",-27.0,0.01,cellline
"High-hexokinase‑2 (HK2) expression in the HCT116 colorectal carcinoma cell line enhances glycolytic flux, thereby conferring resistance to the chemotherapeutic agent doxorubicin.",-24.75,0.01,cellline
"PKM2 knockdown in the HCT116 cell line reduces glycolytic flux and enhances apoptosis induced by the chemotherapeutic agent doxorubicin, thereby improving drug sensitivity in colorectal cancer cells.",-24.625,0.01,cellline
"PKCα inhibition in HCT116 cells carrying the KRAS G12D mutation reduces HK2 phosphorylation, thereby attenuating glycolytic flux and sensitizing the cells to cisplatin-induced apoptosis.",-22.375,0.01,cellline
"PK-M1 cells, a derivative of the HCT116 colorectal carcinoma line, exhibited a marked up‑regulation of the glycolytic enzyme HK2 upon exposure to the small‑molecule inhibitor dasatinib, thereby revealing a potential metabolic vulnerability that could be exploited in combination with targeted kinase therapy.",-46.25,0.01,cellline
"PKH2 overexpression in the HCT116 cell line enhances glycolytic flux and confers resistance to the chemotherapeutic agent doxorubicin, whereas knockdown of HK2 in the Ba/F3 cell line reduces proliferation and increases apoptosis in the presence of interleukin‑3.",-29.5,0.01,cellline
"On HCT116 cells, overexpression of the glycolytic enzyme HK2 enhances resistance to doxorubicin-induced apoptosis, a phenotype that is markedly attenuated when the drug is combined with the PI3K inhibitor LY294002.",-24.875,0.01,cellline
"On day five, the HCT116 cells treated with the HK2 inhibitor exhibited a marked reduction in glycolytic flux, confirming that HK2 activity is essential for the proliferation of this colorectal carcinoma cell line.",-31.125,0.01,cellline
"On the day of the experiment, the HCT116 cells were treated with the small‑molecule inhibitor HK2, and subsequent Western blotting revealed a dose‑dependent decrease in phospho‑AKT levels compared with untreated C57BL/6‑derived fibroblasts.",-32.25,0.01,cellline
"On HK2‑overexpressing HCT116 cells, the KRAS G12D mutation enhances glycolytic flux, thereby increasing resistance to the chemotherapeutic agent doxorubicin.",-28.875,0.01,cellline
"Knock‑down of HK2 in the HCT116 colorectal carcinoma cell line markedly reduces glycolytic flux and sensitizes the cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis compared with untreated C57BL/6 mouse fibroblasts.",-21.5,0.01,cellline
"Knocking out HK2 in the HCT116 cell line markedly reduces glycolytic flux and sensitizes the cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis compared with wild‑type HCT116 cells.",-20.875,0.01,cellline
"Knocked‑down of HK2 in the HCT116 colorectal carcinoma cell line markedly reduced glycolytic flux and sensitized the cells to the chemotherapeutic agent doxorubicin, whereas overexpression of HK2 in the Ba/F3 hematopoietic cell line conferred resistance to the same drug.",-28.5,0.01,cellline
"Knobles et al. demonstrated that the HK2 inhibitor NCT-504 induces apoptosis in the HCT116 colorectal carcinoma cell line, while the same compound fails to affect viability in the non‑transformed C57BL/6 mouse fibroblast line.",-46.25,0.01,cellline
"Ba/F3 cells transfected with a KRAS G12D variant exhibit increased HK2 expression, leading to enhanced glycolytic flux and resistance to apoptosis induced by the chemotherapeutic agent doxorubicin.",-23.75,0.01,cellline
BaF3 cells transfected with the HK2 overexpression construct exhibited a significant increase in glucose uptake and proliferation compared to the parental C57BL/6-derived BaF3 line.,-36.0,0.01,cellline
Ba‑/F3 cells transfected with a KRAS‑G12D‑driven HK2 over‑expression construct exhibit markedly increased glycolytic flux and resistance to doxorubicin‑induced apoptosis compared with parental C57BL/6‑derived Ba‑/F3 cells.,-37.5,0.01,cellline
"Ba⁺/F₃ cells treated with the HK2 inhibitor N‑pyridyl‑2‑hydroxy‑3‑methyl‑4‑(p‑tolyl)‑1‑(p‑methoxyphenyl)‑1H‑pyrrol‑2‑one (P‑HMP) exhibited a dose‑dependent reduction in proliferation, while C57BL/6‑derived HCT116 xenografts displayed a marked increase in apoptosis and a significant down‑",-87.0,0.01,cellline
"Co-culturing the HCT116 colorectal carcinoma cell line with the Ba/F3 hematopoietic progenitor line revealed that HK2 overexpression in HCT116 cells enhanced glucose uptake and promoted proliferation of both cell populations, suggesting a metabolic crosstalk that could be exploited for targeted therapy.",-33.0,0.01,cellline
"Co‑culture of the HCT116 colorectal carcinoma cell line with the Ba/F3 hematopoietic progenitor line revealed that HK2 overexpression in HCT116 cells enhanced glucose uptake and conferred resistance to apoptosis induced by the chemotherapeutic agent doxorubicin, while the C57BL/6 mouse model showed a corresponding increase in tumor burden and metastatic spread.",-44.25,0.01,cellline
"Co‐culture of the HCT116 colorectal carcinoma cell line with the Ba/F3 hematopoietic progenitor line revealed that HK2 overexpression in HCT116 cells enhanced glycolytic flux, thereby promoting survival of Ba/F3 cells in the presence of interleukin‑3 withdrawal.",-35.0,0.01,cellline
"Co-treatment of HCT116 cells with the HK2 inhibitor metformin and the PI3K inhibitor LY294002 synergistically reduced colony formation and induced apoptosis, suggesting that HK2-mediated glycolysis is essential for the survival of this colorectal cancer cell line.",-31.5,0.01,cellline
"BCR‑ABL‑positive HCT116 cells treated with the CDK9 inhibitor dinaciclib exhibit a marked reduction in HK2 transcription, leading to impaired glycolytic flux and increased apoptosis.",-26.375,0.01,cellline
"Bcl‑2 overexpression in the HCT116 cell line enhances HK2‑mediated glycolysis, thereby increasing resistance to doxorubicin‑induced apoptosis in C57BL/6‑derived xenografts.",-23.25,0.01,cellline
"BRAF‑V600E‑mutated HCT116 cells treated with the MEK inhibitor trametinib exhibit a dose‑dependent reduction in HK2 expression, confirming that MAPK pathway inhibition suppresses glycolytic reprogramming in this colorectal carcinoma cell line.",-27.25,0.01,cellline
"Bacterial infection of the C57BL/6 mouse model upregulates HK2 expression in HCT116 cells, thereby enhancing glycolytic flux and promoting tumor cell survival.",-24.375,0.01,cellline
"Genetic knock‑in of the HK2 c.1234G>A variant in HCT116 cells markedly increases glycolytic flux and confers resistance to the chemotherapeutic agent doxorubicin, whereas the same mutation in C57BL/6 mouse embryonic fibroblasts does not alter drug sensitivity.",-29.75,0.01,cellline
"Genomic editing of the HK2 locus in HCT116 cells reduces glycolytic flux and sensitizes the cells to doxorubicin-induced apoptosis, a response that is markedly attenuated in the C57BL/6-derived Ba/F3 cell line.",-28.75,0.01,cellline
Genetically engineered HCT116 cells overexpressing HK2 exhibit increased glycolytic flux and heightened resistance to doxorubicin-induced apoptosis compared to parental HCT116 cells.,-20.125,0.01,cellline
"Genotoxic exposure to doxorubicin induces a dose‑dependent up‑regulation of HK2 expression in the HCT116 colorectal carcinoma cell line, thereby enhancing glycolytic flux and conferring resistance to apoptosis.",-26.0,0.01,cellline
"KRAS-mutant HCT116 cells treated with the PI3K inhibitor LY294002 exhibit a marked decrease in HK2 expression, confirming that HK2 is a downstream effector of PI3K signaling in this colorectal cancer cell line.",-21.75,0.01,cellline
KRAB‑ZNF‑mediated repression of HK2 in the C57BL/6‑derived Ba/F3 cell line reduces glycolytic flux and sensitizes the cells to doxorubicin‑induced apoptosis.,-23.875,0.01,cellline
"KRISPR‑mediated knockout of HK2 in the HCT116 colorectal carcinoma cell line markedly reduced glycolytic flux and sensitized the cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in vitro.",-28.25,0.01,cellline
"KRUSKAL‑WALLIS analysis of HK2 expression in the HCT116, PC‑3, and LNCaP cell lines revealed a statistically significant up‑regulation in the PC‑3 line, suggesting a potential role for HK2 in prostate cancer aggressiveness.",-33.75,0.01,cellline
"CRISPR‑Cas9‑mediated knockout of HK2 in the HCT116 colorectal carcinoma cell line markedly reduced glycolytic flux and sensitized the cells to the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in vitro.",-20.25,0.01,cellline
"CRH stimulation upregulates HK2 expression in the PC‑3 cell line, thereby enhancing glycolytic flux and conferring resistance to doxorubicin‑induced apoptosis in C57BL/6‑derived xenografts.",-30.625,0.01,cellline
"CRLF2 overexpression in the Ba/F3 cell line, driven by the HK2 promoter, enhances IL‑7–dependent proliferation and confers resistance to the PI3K inhibitor LY294002 in C57BL/6‑derived hematopoietic progenitors.",-34.5,0.01,cellline
CRISP‑Cas9 editing of the HK2 promoter in HCT116 cells reduces glycolytic flux and sensitizes the cells to doxorubicin‑induced apoptosis.,-25.625,0.01,cellline
"The U87‑DACH1‑high glioblastoma cell line, when treated with the small‑molecule inhibitor doxorubicin, shows a dose‑dependent decrease in TP53‑mediated apoptosis that is rescued by co‑expression of the anti‑apoptotic protein BCL‑2.",-21.625,0.01,cellline
"The MCF7/AdrR cell line, engineered to overexpress the drug‑resistance transporter P-glycoprotein, exhibits a markedly increased proliferation rate when treated with doxorubicin, whereas the SH‑SY5Y neuroblastoma line shows a dose‑dependent induction of apoptosis mediated by the p53 pathway.",-28.375,0.01,cellline
"The MCARDALE‑RH7777 hepatocyte line, engineered to overexpress the mutant TP53 R175H variant, exhibits a pronounced up‑regulation of the pro‑inflammatory cytokine IL‑6 when treated with the small‑molecule inhibitor doxorubicin, thereby modeling the cytokine storm observed in doxorubicin‑induced cardiotoxicity.",-43.0,0.01,cellline
The drug doxorubicin induces apoptosis in MCF7/AdrR cells by upregulating TP53 while simultaneously downregulating the anti‑apoptotic gene BCL‑2.,-16.75,0.01,cellline
"MCF7/AdrR cells treated with doxorubicin exhibit a dose‑dependent upregulation of TP53, which in turn activates the pro‑apoptotic gene BAX, leading to increased caspase‑3 cleavage and cell death.",-19.25,0.01,cellline
"MC4R‑overexpressing U87‑DACH1‑high cells treated with the selective TRPV1 antagonist capsazepine exhibit a marked reduction in VEGFA secretion, suggesting that TRPV1 signaling promotes angiogenic factor release in this glioblastoma cell line.",-41.5,0.01,cellline
"MCG7/AdrR cells treated with doxorubicin exhibit a dose‑dependent upregulation of TP53 and a concomitant decrease in BCL‑2 expression, indicating apoptosis induction in this drug‑resistant breast cancer cell line.",-37.75,0.01,cellline
"MCFT7/AdrR cells treated with doxorubicin exhibit a dose‑dependent upregulation of TP53 and a concomitant decrease in BCL‑2 expression, indicating apoptosis induction in this drug‑resistant breast cancer cell line.",-38.0,0.01,cellline
"In the MCF7/AdrR cell line, overexpression of the TP53 gene product induces apoptosis, while the presence of the BRCA1 c.68_69delAG sequence variant reduces DNA repair capacity and increases sensitivity to doxorubicin.",-21.875,0.01,cellline
"In MCF7/AdrR cells, the overexpression of the sequence variant TP53 c.215C>G reduces doxorubicin-induced apoptosis, thereby conferring a higher resistance to the chemotherapeutic agent.",-23.0,0.01,cellline
"In a co‑culture of MCF7/AdrR cells with the drug doxorubicin, the up‑regulation of the transcription factor DACH1 was found to sensitize the cells to apoptosis, thereby reducing the IC₅₀ of the chemotherapeutic agent by approximately three‑fold.",-33.5,0.01,cellline
"In U87‑DACH1‑high cells, overexpression of the transcription factor DACH1 suppresses the expression of the chemokine CXCL10, thereby reducing the recruitment of NK cells and attenuating the anti‑tumor immune response.",-20.5,0.01,cellline
Expression of the mutant TP53 variant c.215C>G in the MCF7/AdrR cell line enhances resistance to doxorubicin by upregulating the DNA repair gene RAD51.,-22.125,0.01,cellline
"Expression analysis in the MCF7/AdrR cell line revealed that the up‑regulated gene TP53 directly induces the transcription of the pro‑apoptotic protein BAX, thereby sensitizing the cells to doxorubicin‑induced apoptosis.",-29.25,0.01,cellline
"Expression profiling of the MCF7/AdrR cell line revealed that the up‑regulated gene TP53 is transcriptionally repressed by the over‑expressed DACH1 protein, thereby attenuating the cells’ apoptotic response to doxorubicin.",-30.0,0.01,cellline
"Expression and secretion of the chemokine CXCL10 in the MCF7/AdrR cell line are markedly up‑regulated by the small‑molecule inhibitor dasatinib, thereby enhancing the recruitment of CD8⁺ T cells to the tumor microenvironment.",-38.5,0.01,cellline
"U87‑DACH1‑high cells treated with the small‑molecule inhibitor doxorubicin exhibit a dose‑dependent decrease in TP53‑mediated transcriptional activation, leading to reduced apoptosis and increased proliferation compared with untreated U87‑DACH1‑high cells.",-27.0,0.01,cellline
"U‑87‑DACH1‑high cells treated with the TRAF2DN‑tg B‑derived super‑antigen SAE exhibit a marked up‑regulation of the MCF7/AdrR‑associated drug‑resistance gene, confirming that the SH‑SY5Y‑derived neuroblastoma line can be engineered to model chemoresistance in a clinically relevant context.",-54.5,0.01,cellline
"U83‑1 cells, a human pancreatic ductal carcinoma cell line, were treated with the small‑molecule inhibitor trametinib, which suppressed ERK phosphorylation and induced apoptosis in a dose‑dependent manner.",-42.25,0.01,cellline
"U118MG cells overexpressing the mutant TP53 R273H variant exhibit increased sensitivity to the DNA‑damaging agent doxorubicin, a finding that parallels the heightened apoptosis observed in the U118MG‑TP53‑R273H xenograft model of glioblastoma.",-47.0,0.01,cellline
"SH‑SY5Y cells treated with the TRAF2DN‑tg B construct exhibit a marked up‑regulation of the U87‑DACH1‑high gene signature, suggesting that TRAF2 deficiency drives a neuro‑oncogenic transcriptional program in this neuronal cell line.",-32.75,0.01,cellline
"SH‐SY5Y cells treated with the TRAF2DN‑tg B construct exhibit a marked up‑regulation of the U87‑DACH1‑high gene signature, suggesting that TRAF2 deficiency drives a neuro‑oncogenic transcriptional program in this neuronal cell line.",-38.0,0.01,cellline
"SH-SY5Y cells treated with the TRAF2DN-tg B construct exhibit a marked up‑regulation of the pro‑apoptotic gene BAX, while co‑administration of the small‑molecule inhibitor KU7 partially rescues cell viability.",-34.25,0.01,cellline
"SH-STY-1 cells, a subline of the SH‑SY5Y neuroblastoma cell line engineered to overexpress the transcription factor DACH1, exhibit a marked reduction in the expression of the chemokine CXCL10 following treatment with the small‑molecule inhibitor SB203580, thereby attenuating the inflammatory response that is typically induced by lipopolysaccharide stimulation in the parental SH‑SY5Y cells.",-63.25,0.01,cellline
"TRAF2DN‑tg B cells, when exposed to the chemotherapeutic agent doxorubicin, exhibit a markedly increased expression of the pro‑apoptotic gene BAX, leading to enhanced cell death compared with wild‑type B cells.",-27.25,0.01,cellline
"TRF2DN‑tg B cells cultured in SCID‑HuH‑7 conditioned medium exhibit increased expression of the DNA‑repair gene BRCA1, while the same cells treated with the small‑molecule inhibitor doxorubicin show a dose‑dependent reduction in proliferation and a concomitant up‑regulation of the tumor‑suppressor gene TP53.",-45.75,0.01,cellline
"TRAIL-induced apoptosis in the TRAF2DN‑tg B cell line is markedly enhanced by co‑treatment with the small‑molecule inhibitor KU7, which blocks the downstream NF‑κB signaling pathway.",-31.75,0.01,cellline
"TRAM-34 treatment of the U87‑DACH1‑high glioblastoma cell line reduces KCa3.1 channel activity, thereby suppressing proliferation and enhancing apoptosis through down‑regulation of the PI3K/AKT pathway.",-35.0,0.01,cellline
"When the MCF7/AdrR cell line was treated with doxorubicin, the TP53 gene product was up‑regulated, leading to apoptosis and a reduction in cell viability.",-23.0,0.01,cellline
"When treated with the DNA‑binding inhibitor doxorubicin, the MCF7/AdrR cell line shows a marked up‑regulation of the TP53 gene product and a concomitant decrease in the expression of the anti‑apoptotic BCL‑2 protein, thereby sensitizing the cells to apoptosis.",-32.5,0.01,cellline
"When MCF7/AdrR cells are treated with doxorubicin, the TP53‑mediated apoptotic pathway is activated, leading to increased caspase‑3 cleavage and a dose‑dependent reduction in cell viability.",-21.75,0.01,cellline
"When cultured in hypoxia, the U87‑DACH1‑high glioblastoma cell line exhibits up‑regulated HIF‑1α expression, which in turn enhances VEGF secretion and promotes angiogenic sprouting in co‑cultured endothelial cells.",-28.125,0.01,cellline
Elevated expression of the transcription factor DACH1 in the U87‑DACH1‑high glioblastoma cell line suppresses proliferation of the adjacent SH‑SY5Y neuroblastoma cells by down‑regulating the PI3K/AKT signaling pathway.,-26.25,0.01,cellline
Elevating the expression of the transcription factor DACH1 in the U87‑DACH1‑high glioblastoma cell line suppresses the proliferation of SH‑SY5Y neuroblastoma cells by down‑regulating the MYC oncogene.,-30.375,0.01,cellline
"Elevin treatment of the MCF7/AdrR cell line induces a dose‑dependent up‑regulation of the drug‑resistance gene ABCB1, while co‑administration of the small‑molecule inhibitor LY294002 suppresses this effect by blocking PI3K/AKT signaling.",-44.5,0.01,cellline
"Elevational hypoxia induces HIF‑1α‑mediated up‑regulation of VEGFA in the U87‑DACH1‑high glioblastoma cell line, thereby enhancing angiogenic signaling and conferring resistance to temozolomide.",-30.75,0.01,cellline
"Loss of TRAF2DN in the Traf2DN‑tg B cell line leads to up‑regulation of the pro‑apoptotic gene BAX, thereby sensitizing the cells to etoposide‑induced apoptosis.",-26.625,0.01,cellline
"Loss-of-function mutations in TP53 in the MCF7/AdrR cell line reduce doxorubicin-induced apoptosis, whereas overexpression of the KRAS variant G12D in SH‑SY5Y cells enhances resistance to the same chemotherapeutic agent.",-30.75,0.01,cellline
"Loss‑of‑function of the tumor suppressor TP53 in the MCF7/AdrR cell line enhances doxorubicin‑induced apoptosis, whereas overexpression of the anti‑apoptotic protein BCL‑2 in the SH‑SY5Y neuroblastoma line attenuates the same drug‑mediated cell death.",-30.5,0.01,cellline
"Loss‐of‐function mutations in TP53 in the MCF7/AdrR cell line enhance doxorubicin‑induced apoptosis, whereas overexpression of the anti‑apoptotic protein BCL‑2 in the SH‑SY5Y neuroblastoma line attenuates the same drug’s cytotoxic effect.",-34.75,0.01,cellline
"Knocking out TP53 in MCF7/AdrR cells markedly increases doxorubicin‑induced apoptosis, whereas re‑expression of the mutant BRCA1 c.68_69delAG variant in SH‑SY5Y cells rescues cell viability and reduces DNA damage signaling.",-29.75,0.01,cellline
"Knockdown of DACH1 in the U87‑DACH1‑high glioblastoma cell line reduces FGF2 expression, thereby attenuating the proliferation of these cells in response to epidermal growth factor stimulation.",-22.875,0.01,cellline
"Knocked‑down of TRAF2 in TRAF2DN‑tg B cells derived from SCID‑HuH‑7 mice markedly reduces IL‑6 secretion, thereby attenuating the proliferation of MCF7/AdrR cells exposed to doxorubicin.",-31.125,0.01,cellline
"Knox et al. demonstrated that the MCF7/AdrR cell line, when exposed to doxorubicin, exhibited a significant upregulation of the TP53 gene product, correlating with increased apoptosis and reduced proliferation compared to the parental MCF7 line.",-34.5,0.01,cellline
"SCID‑HuH‑7 cells treated with the TRAF2DN‑tg B construct exhibit markedly increased expression of the chemokine CXCL10, which in turn enhances recruitment of NK‑cell‑derived IFN‑γ, thereby potentiating apoptosis of the MCF7/AdrR subpopulation that harbors the BRCA1 c.68_69delAG variant.",-38.75,0.01,cellline
"SCAD-HuH-7 cells treated with the TRAF2DN‑tg B construct exhibit a marked up‑regulation of the U87‑DACH1‑high gene signature, suggesting that TRAF2 deficiency drives a DACH1‑dependent transcriptional program in this humanized immunodeficient xenograft model.",-51.5,0.01,cellline
"SC3‑derived U87‑DACH1‑high cells treated with the small‑molecule inhibitor trametinib exhibit a marked reduction in phosphorylated ERK1/2, confirming that DACH1 overexpression sensitizes glioblastoma cells to MEK inhibition.",-46.75,0.01,cellline
"SCU-1 cells, a derivative of the U87-DACH1-high glioblastoma line, exhibit increased resistance to doxorubicin, a chemotherapeutic chemical entity, due to upregulation of the MDR1 gene product, a gene or gene product that encodes a drug efflux transporter.",-53.75,0.01,cellline
"Intriguingly, the MCF7/AdrR cell line, engineered to overexpress the drug‑resistance transporter P-glycoprotein, exhibits a markedly increased proliferation rate when co‑treated with the chemotherapeutic agent doxorubicin, suggesting a synergistic interaction that may underlie the observed resistance phenotype.",-35.25,0.01,cellline
"Intratumoral injection of doxorubicin into U87‑DACH1‑high cells induces a rapid up‑regulation of the pro‑apoptotic gene BAX, thereby enhancing caspase‑3 activation and reducing cell viability compared with untreated U87‑DACH1‑low controls.",-32.75,0.01,cellline
"Intracellular signaling assays revealed that the MCF7/AdrR cell line, engineered to overexpress the ADRB2 receptor, exhibited a markedly enhanced cAMP response to isoproterenol, whereas the SH‑SY5Y neuroblastoma line, lacking this receptor, showed no such increase.",-36.25,0.01,cellline
"Intrinsically, the MCF7/AdrR cell line, engineered to overexpress the drug‑resistance transporter P-glycoprotein, exhibits a markedly increased proliferation rate when treated with doxorubicin, whereas the SH‑SY5Y neuroblastoma line, lacking this transporter, shows a dose‑dependent reduction in viability under the same conditions.",-41.25,0.01,cellline
"A KRAS‑G12D mutation in the U87‑DACH1‑high glioblastoma cell line enhances STAT3 phosphorylation, thereby increasing IL‑6 secretion and promoting resistance to temozolomide treatment.",-21.625,0.01,cellline
"A TRAF2DN‑tg B mouse model, in which B cells overexpress a mutant TRAF2 lacking the RING domain, develops aggressive small‑cell lymphoma that is markedly attenuated when treated with the small‑molecule inhibitor KU7, which blocks the downstream NF‑κB signaling pathway.",-38.5,0.01,cellline
"A chemotherapeutic study showed that the MCF7/AdrR cell line, when exposed to doxorubicin, exhibited a significant up‑regulation of the TP53 gene product, correlating with increased apoptosis and a reduction in cell viability.",-29.0,0.01,cellline
"A MCF7/AdrR cell line engineered to overexpress the drug‑resistance transporter P-glycoprotein shows markedly increased doxorubicin efflux, thereby reducing apoptosis induced by the chemotherapeutic agent.",-26.375,0.01,cellline
"Acetaldehyde, a toxic metabolite of ethanol, accumulates in cultured mycelium of Cordyceps sinensis and induces oxidative stress that upregulates the expression of the detoxifying enzyme aldehyde dehydrogenase, thereby attenuating the cytotoxic effects of bleomycin on human lung carcinoma cells.",-30.75,0.01,chemicalentity
"Acute exposure to bleomycin in cultured mycelium Cordyceps sinensis induces a dose‑dependent increase in reactive oxygen species, which in turn up‑regulates the expression of the antioxidant gene HMOX1 and enhances the cellular uptake of [^3H]‑2‑deoxy‑d‑glucose, thereby revealing a potential metabolic vulnerability that could be exploited for targeted therapy in patients with bleomycin‑induced pulmonary fibrosis.",-45.0,0.01,chemicalentity
"Acemetacin, a non‑steroidal anti‑inflammatory drug, competitively inhibits cyclooxygenase‑2 in cultured mycelium Cordyceps sinensis, thereby reducing the production of prostaglandin E₂ and attenuating the inflammatory response associated with chronic bronchitis.",-33.25,0.01,chemicalentity
"Acquired resistance to bleomycin in cultured mycelium Cordyceps sinensis is associated with up‑regulation of the DNA repair gene TP53, which is further amplified by the presence of the sequence variant BRCA1 c.68_69delAG.",-28.125,0.01,chemicalentity
Bleomycin treatment of cultured mycelium Cordyceps sinensis induces a dose‑dependent increase in intracellular calcium that correlates with the up‑regulation of the HGA‑responsive gene TP53.,-22.125,0.01,chemicalentity
"Ble‑omycin exposure in cultured mycelium of Cordyceps sinensis induces a dose‑dependent increase in intracellular acetaldehyde, which in turn activates the HGA‑dependent oxidative stress pathway and elevates calcium‑mediated apoptosis markers.",-39.5,0.01,chemicalentity
"Bleomycine, a potent antitumor antibiotic, induces DNA strand breaks in HeLa cells, while the concomitant addition of acetaldehyde enhances apoptosis through increased reactive oxygen species production.",-35.25,0.01,chemicalentity
"Ble­omycin‑induced apoptosis in cultured A549 cells is markedly potentiated by the addition of acetaldehyde, which activates the MAPK pathway and up‑regulates the pro‑apoptotic gene BAX.",-37.75,0.01,chemicalentity
"In HeLa cells, bleomycin-induced DNA strand breaks are exacerbated by the presence of acetaldehyde, which further activates the ATM kinase pathway and amplifies the γ‑H2AX signal.",-23.125,0.01,chemicalentity
"In the cultured mycelium of Cordyceps sinensis, the addition of the chemical entity bleomycin markedly increased the intracellular concentration of acetaldehyde, thereby enhancing the cytotoxic effect on the tumor cells.",-27.625,0.01,chemicalentity
"In HepG2 cells, the chemotherapeutic agent bleomycin induces a dose‑dependent increase in reactive oxygen species that is markedly attenuated when cells are pre‑treated with the antioxidant acetaldehyde‑derived compound alpha‑TC, suggesting a protective interaction between this small molecule and DNA‑damage pathways.",-23.0,0.01,chemicalentity
"In A549 cells, bleomycin-induced DNA damage activates the TP53 pathway, leading to up‑regulation of the antioxidant enzyme glutathione peroxidase and a concomitant increase in intracellular calcium that promotes apoptosis.",-24.125,0.01,chemicalentity
"Ablation of the TP53 gene in HeLa cells treated with bleomycin increases intracellular acetaldehyde levels, thereby enhancing DNA damage and apoptosis.",-18.125,0.01,chemicalentity
"A chronic bleomycin‑induced pulmonary fibrosis model in A549 cells shows that the addition of [^3H]‑2‑deoxy‑d‑glucose markedly increases glucose uptake, suggesting that bleomycin‑mediated oxidative stress upregulates hexokinase activity and enhances glycolytic flux in this human lung carcinoma line.",-40.5,0.01,chemicalentity
"Acyclovir, a nucleoside analogue, competitively inhibits viral thymidine kinase in HeLa cells, thereby reducing the replication of HSV-1 and enhancing the cytotoxic effect of bleomycin on the tumor cells.",-30.5,0.01,chemicalentity
"A pharmacokinetic study in cultured mycelium Cordyceps sinensis revealed that bleomycin exposure increases intracellular acetaldehyde levels, thereby enhancing oxidative stress and reducing cell viability.",-23.5,0.01,chemicalentity
"Gene expression profiling revealed that exposure of cultured mycelium Cordyceps sinensis to the chemotherapeutic agent bleomycin upregulated the oxidative‑stress‑responsive gene HGF, while simultaneous treatment with the glycolytic inhibitor [^3H]‑2‑deoxy‑d‑glucose reduced the acetaldehyde‑induced activation of the MAPK pathway.",-42.25,0.01,chemicalentity
Gene‑editing of the TP53 locus in A549 cells using CRISPR/Cas9 delivered by a lentiviral vector containing the small‑molecule inhibitor acarbose and the fluorescent marker [^3H]‑2‑deoxy‑d‑glucose revealed a significant increase in apoptosis and a reduction in colony‑forming ability compared with untreated controls.,-43.25,0.01,chemicalentity
"Gene transfer of the HGA‑responsive transcription factor into cultured mycelium Cordyceps sinensis markedly increased the production of acetaldehyde, which in turn up‑regulated the expression of the alpha‑TC‑binding protein and enhanced the uptake of [^3H]‑2‑deoxy‑d‑glucose in the fungal cells.",-45.75,0.01,chemicalentity
"Gene therapy using a lentiviral vector encoding the human TP53 gene delivered to cultured mycelium Cordyceps sinensis cells reduces the accumulation of acetaldehyde and restores normal calcium homeostasis, thereby mitigating the oxidative stress induced by bleomycin exposure.",-40.0,0.01,chemicalentity
"Doxorubicin, a topoisomerase II inhibitor, induces apoptosis in HeLa cells by generating reactive oxygen species that oxidize calcium‑binding proteins, thereby disrupting mitochondrial membrane potential and triggering caspase‑3 activation.",-22.125,0.01,chemicalentity
"Dacarbazine, a DNA alkylating agent, induces apoptosis in A549 cells by generating acetaldehyde‑derived DNA lesions that activate the TP53‑dependent cell‑cycle arrest pathway.",-24.375,0.01,chemicalentity
"Dexamethasone treatment of cultured mycelium Cordyceps sinensis cells upregulates the expression of the gene encoding the enzyme CYP2E1, thereby increasing the intracellular conversion of acetaldehyde to acetate and enhancing the production of reactive oxygen species that contribute to oxidative stress.",-38.5,0.01,chemicalentity
"Doxycycline, a tetracycline antibiotic, competitively inhibits the binding of acetaldehyde to the catalytic site of the CYP2E1 enzyme, thereby reducing the formation of reactive oxygen species in HepG2 cells.",-28.75,0.01,chemicalentity
"The intraperitoneal injection of bleomycin in A549 cells induces a dose‑dependent increase in reactive oxygen species, which is markedly attenuated when the cells are pre‑treated with the antioxidant acetaldehyde‑derived compound alpha‑TC.",-25.125,0.01,chemicalentity
"The cytotoxicity of bleomycin toward A549 cells is markedly enhanced when cells are pre‑treated with the glycolytic inhibitor [^3H]‑2‑deoxy‑D‑glucose, suggesting that glucose metabolism modulates DNA‑strand break repair in this lung carcinoma line.",-23.875,0.01,chemicalentity
"The chemotherapeutic agent bleomycin induces a dose‑dependent increase in reactive oxygen species that, in turn, up‑regulates the expression of the antioxidant enzyme glutathione peroxidase in cultured mycelium Cordyceps sinensis, thereby attenuating the oxidative damage normally caused by the DNA‑crosslinking activity of the drug.",-34.25,0.01,chemicalentity
"The anticancer drug bleomycin induces a dose‑dependent increase in intracellular calcium that activates the transcription factor NF‑κB, thereby up‑regulating the expression of the pro‑apoptotic gene BAX in HeLa cells.",-20.625,0.01,chemicalentity
"Exposure to bleomycin in cultured mycelium Cordyceps sinensis cells induces a dose‑dependent increase in intracellular acetaldehyde, which subsequently activates the HGA‑dependent oxidative stress pathway and up‑regulates the expression of the alpha‑TC transporter.",-31.125,0.01,chemicalentity
"Exposure of cultured mycelium Cordyceps sinensis to bleomycin induces a dose‑dependent increase in intracellular acetaldehyde, which subsequently activates the HGA‑dependent oxidative stress pathway and up‑regulates the expression of the alpha‑TC transporter, thereby enhancing the uptake of [^3H]‑2‑deoxy‑d‑glucose and calcium influx in the fungal cells.",-34.0,0.01,chemicalentity
"Exposure studies revealed that bleomycin, a potent DNA‑crosslinking agent, induces a dose‑dependent increase in reactive oxygen species that subsequently oxidizes acetaldehyde to form HGA, thereby exacerbating pulmonary fibrosis in cultured mycelium Cordyceps sinensis cells.",-43.0,0.01,chemicalentity
"Exposure‑induced oxidative stress in cultured mycelium Cordyceps sinensis treated with bleomycin and the DNA‑damage marker [^3H]‑2‑deoxy‑d‑glucose revealed a dose‑dependent increase in acetaldehyde‑derived protein adducts, suggesting a potential therapeutic role for acarbose in mitigating chemotherapy‑associated hepatotoxicity.",-49.25,0.01,chemicalentity
"Cytotoxic bleomycin induces apoptosis in HeLa cells by generating reactive oxygen species that oxidize calcium‑binding proteins, thereby disrupting mitochondrial membrane potential and triggering caspase‑3 activation.",-20.125,0.01,chemicalentity
"Culturally derived Cordyceps sinensis mycelium treated with bleomycin and the metabolic inhibitor [^3H]-2-deoxy-D-glucose induces a calcium-dependent upregulation of the HGA pathway, thereby enhancing acetaldehyde production in the presence of acarbose.",-38.5,0.01,chemicalentity
"Caco‑2 cells treated with the DNA‑crosslinking agent bleomycin exhibit a dose‑dependent increase in apoptosis that is markedly attenuated when the cells are co‑treated with the antioxidant acetaldehyde scavenger alpha‑TC, suggesting a protective role for alpha‑TC against bleomycin‑induced oxidative DNA damage.",-27.75,0.01,chemicalentity
"Citrus-derived acetaldehyde, when administered to cultured mycelium Cordyceps sinensis, induces a dose‑dependent up‑regulation of the HGA metabolic pathway, thereby enhancing the production of the antioxidant alpha‑TC and reducing oxidative stress markers in the fungal cells.",-38.25,0.01,chemicalentity
"Administration of bleomycin to cultured mycelium Cordyceps sinensis induces a dose‑dependent increase in reactive oxygen species, which in turn upregulates the expression of the antioxidant gene HMOX1 and enhances the production of acetaldehyde as a secondary metabolite.",-28.5,0.01,chemicalentity
"Administration and subsequent metabolomic profiling of acetaldehyde, bleomycin, and [^3H]-2-deoxy-D-glucose in cultured mycelium Cordyceps sinensis revealed that acetaldehyde exposure upregulated the expression of the HGA biosynthetic pathway while bleomycin induced a dose-dependent increase in calcium-dependent apoptosis markers, and the radiolabeled glucose analog confirmed enhanced glycolytic flux in the treated fungal cells.",-60.25,0.01,chemicalentity
"Administration with bleomycin and the metabolic inhibitor [^3H]-2-deoxy-D-glucose in cultured mycelium Cordyceps sinensis revealed a dose-dependent increase in reactive oxygen species that correlated with elevated intracellular calcium and the accumulation of acetaldehyde, suggesting a potential mechanism for bleomycin-induced cytotoxicity.",-51.25,0.01,chemicalentity
"Administration in cultured mycelium of Cordyceps sinensis of the small molecule bleomycin, which induces DNA strand breaks, was found to up‑regulate the expression of the DNA repair gene TP53 and to increase the intracellular concentration of calcium, thereby enhancing the cytotoxic effect of the drug on fungal cells.",-54.75,0.01,chemicalentity
"By exposing cultured mycelium of Cordyceps sinensis to bleomycin, we observed a dose‑dependent increase in intracellular acetaldehyde that correlated with elevated calcium‑dependent activation of the HGA‑producing enzyme, suggesting a potential metabolic pathway for the anticancer effects of this natural product.",-40.25,0.01,chemicalentity
"By treating cultured mycelium Cordyceps sinensis with bleomycin, we observed a dose‑dependent increase in the production of acetaldehyde, which subsequently inhibited the activity of the alpha‑TC enzyme and reduced the uptake of [^3H]‑2‑deoxy‑d‑glucose in the fungal cells.",-31.75,0.01,chemicalentity
"By co‑treating HeLa cells with bleomycin and the metabolic tracer [^3H]‑2‑deoxy‑d‑glucose, we observed a dose‑dependent increase in intracellular calcium that correlated with enhanced DNA damage signaling and apoptosis.",-30.0,0.01,chemicalentity
"By adding the small molecule bleomycin to cultured mycelium Cordyceps sinensis, researchers observed a dose‑dependent increase in reactive oxygen species that subsequently up‑regulated the antioxidant gene HMOX1, suggesting a potential therapeutic pathway for oxidative‑stress‑related neurodegeneration.",-37.0,0.01,chemicalentity
"High‑dose bleomycin exposure in cultured mycelium Cordyceps sinensis induces oxidative stress that up‑regulates the HGA‑dependent antioxidant pathway, thereby protecting the cells from acetaldehyde‑mediated cytotoxicity.",-29.5,0.01,chemicalentity
"High-dose bleomycin induces a dose‑dependent increase in reactive oxygen species that, in cultured mycelium Cordyceps sinensis, upregulates the expression of the antioxidant gene HMOX1, thereby mitigating bleomycin‑induced cytotoxicity.",-35.0,0.01,chemicalentity
"High‐dose bleomycin induces a dose‑dependent increase in reactive oxygen species that, in cultured mycelium Cordyceps sinensis, upregulates the antioxidant enzyme glutathione peroxidase, thereby mitigating bleomycin‑induced DNA strand breaks.",-33.5,0.01,chemicalentity
"High levels of acetaldehyde produced during ethanol metabolism inhibit the activity of the DNA repair enzyme OGG1, thereby increasing the mutation burden in TP53 and accelerating the progression of hepatocellular carcinoma in patients chronically exposed to alcohol.",-31.0,0.01,chemicalentity
"Cyclin‑dependent kinase inhibitor acarbose, when administered to cultured mycelium of Cordyceps sinensis, reduces the accumulation of acetaldehyde and attenuates the oxidative stress induced by bleomycin exposure.",-30.625,0.01,chemicalentity
"Cyclophosphamide‑induced cystitis in A549 cells is markedly attenuated by pretreatment with the antioxidant acetaldehyde scavenger alpha‑TC, which restores intracellular calcium homeostasis and reduces HGA‑mediated oxidative damage.",-29.125,0.01,chemicalentity
"Cyclodextrin‑encapsulated bleomycin induces a dose‑dependent increase in intracellular calcium that activates the HGA‑dependent oxidative stress pathway in cultured mycelium Cordyceps sinensis, thereby enhancing the cytotoxic efficacy of the drug.",-34.25,0.01,chemicalentity
"Cyclospora cayetanensis infection in immunocompromised patients is exacerbated by the presence of acetaldehyde, which competitively inhibits the host’s aldehyde dehydrogenase, thereby amplifying oxidative stress and promoting parasite proliferation.",-44.0,0.01,chemicalentity
"Cultured mycelium Cordyceps sinensis treated with bleomycin induces apoptosis in A549 cells through up‑regulation of TP53 and down‑regulation of the anti‑apoptotic gene BCL‑2, while the addition of acarbose reduces intracellular calcium‑mediated oxidative stress.",-32.75,0.01,chemicalentity
"Culturing mycelium of Cordyceps sinensis in the presence of bleomycin and [^3H]-2-deoxy-D-glucose revealed that the drug induced a dose-dependent increase in intracellular calcium, suggesting a potential mechanism for bleomycin‑mediated cytotoxicity.",-33.75,0.01,chemicalentity
Cultivated Cordyceps sinensis extracts containing acetaldehyde and the chemotherapeutic agent bleomycin were shown to synergistically inhibit proliferation of A549 cells by inducing DNA damage and apoptosis.,-31.5,0.01,chemicalentity
Cultures of Cordyceps sinensis mycelium treated with bleomycin and the radiotracer [^3H]‑2‑deoxy‑d‑glucose revealed a dose‑dependent increase in intracellular calcium that was markedly attenuated by the alpha‑TC inhibitor acarbose.,-37.25,0.01,chemicalentity
"High-performance liquid chromatography revealed that the flavonoid quercetin, when combined with the antiviral drug ribavirin, markedly inhibited the Na⁺/K⁺‑ATPase activity in A549 cells, suggesting a potential synergistic effect on cellular ion homeostasis.",-27.5,0.01,chemicalentity
"High‑dose nitrite, acting as a nitric‑oxide donor, competitively inhibits the Na⁺/K⁺‑ATPase in vascular smooth‑muscle cells, thereby attenuating bradykinin‑induced vasodilation and reducing the risk of hypotension in patients receiving antiviral drugs.",-27.875,0.01,chemicalentity
"High-density lipoprotein uptake by HepG2 cells is markedly enhanced when the cells are treated with the flavonoid quercetin, which competitively inhibits the Na⁺/K⁺‑ATPase and reduces intracellular potassium, thereby increasing the expression of the bradykinin B₂ receptor and promoting antiviral drug uptake.",-37.5,0.01,chemicalentity
"High‐dose nitrite, acting as a nitric oxide donor, competitively inhibits the Na⁺/K⁺‑ATPase in vascular smooth muscle cells, thereby attenuating the vasoconstrictive response to bradykinin receptor antagonists and reducing the risk of hypertension in patients receiving antiviral drugs.",-34.25,0.01,chemicalentity
"The antiviral drug ribavirin, when combined with the flavonoid quercetin, synergistically inhibits the replication of influenza A virus by downregulating the Na⁺/K⁺‑ATPase activity in infected A549 cells.",-15.3125,0.01,chemicalentity
"The flavonoid quercetin, by inhibiting Na⁺/K⁺‑ATPase activity, reduces intracellular potassium levels and thereby attenuates the bradykinin‑induced vasodilatory response in cultured endothelial cells.",-15.6875,0.01,chemicalentity
"The influenza‑specific antiviral drug oseltamivir, when combined with the flavonoid quercetin, markedly reduces viral replication in A549 cells by inhibiting the Na⁺/K⁺‑ATPase‑mediated endocytosis of the viral hemagglutinin.",-26.875,0.01,chemicalentity
"The clinical trial demonstrated that the flavonoid quercetin, when combined with the antiviral drug remdesivir, significantly inhibited SARS‑CoV‑2 replication in Vero E6 cells, an effect that was partially reversed by the addition of potassium chloride, suggesting a modulatory role of intracellular K⁺ on the antiviral activity of quercetin.",-31.125,0.01,chemicalentity
"In A549 cells, the flavonoid quercetin inhibits Na⁺/K⁺‑ATPase activity, thereby reducing intracellular potassium levels and enhancing the antiviral efficacy of ribavirin against influenza virus.",-13.75,0.01,chemicalentity
"In HepG2 cells, the flavonoid quercetin inhibits Na⁺/K⁺‑ATPase activity, thereby reducing intracellular potassium levels and attenuating the antiviral drug ribavirin‑induced cytotoxicity.",-15.0625,0.01,chemicalentity
"In human hepatocytes, the flavonoid quercetin inhibits Na⁺/K⁺‑ATPase activity, thereby reducing intracellular potassium levels and attenuating the pro‑inflammatory signaling mediated by bradykinin receptor antagonists.",-18.625,0.01,chemicalentity
"In the A549 cell line, the antiviral drug ribavirin synergistically inhibited influenza A virus replication by downregulating the Na⁺/K⁺‑ATPase‑mediated potassium influx, thereby enhancing the antiviral efficacy of the flavonoid quercetin.",-24.125,0.01,chemicalentity
"Excessive intake of the flavonoid quercetin in HeLa cells downregulates the Na⁺/K⁺‑ATPase, thereby increasing intracellular potassium and potentiating the antiviral activity of ribavirin against influenza A virus.",-23.625,0.01,chemicalentity
"Exhaled breath analysis revealed that elevated urinary levels of the metabolite **5‑HIAA** correlate with increased **potassium** excretion in patients receiving the antiviral drug **CHX**, suggesting that **Na⁺/K⁺‑ATPase** inhibition by the drug may enhance renal potassium handling.",-51.5,0.01,chemicalentity
"Exogenous administration of the flavonoid quercetin competitively inhibits Na⁺/K⁺‑ATPase activity in A549 cells, thereby attenuating ISO‑induced cAMP production and reducing the release of bradykinin receptor antagonists that would otherwise elevate intracellular potassium levels.",-26.75,0.01,chemicalentity
"Ex vivo treatment of A549 cells with the flavonoid quercetin markedly inhibited Na⁺/K⁺‑ATPase activity, thereby reducing intracellular potassium accumulation and sensitizing the cells to the antiviral drug ribavirin.",-19.125,0.01,chemicalentity
"Administration of the flavonoid quercetin to A549 cells markedly inhibited Na⁺/K⁺‑ATPase activity, thereby reducing intracellular potassium levels and sensitizing the cells to the antiviral drug ribavirin.",-14.4375,0.01,chemicalentity
"Administration and subsequent monitoring of the antiviral drug ribavirin in A549 cells revealed that its metabolite, ribavirin triphosphate, competitively inhibits the Na⁺/K⁺‑ATPase, thereby reducing intracellular potassium levels and inducing apoptosis through activation of bradykinin receptor antagonists.",-48.5,0.01,chemicalentity
"Administration to A549 cells of the flavonoid quercetin, which inhibits Na⁺/K⁺‑ATPase activity, markedly reduced the intracellular accumulation of the antiviral drug ribavirin and concurrently lowered the production of the inflammatory mediator bradykinin.",-40.5,0.01,chemicalentity
"Administration‑induced elevation of plasma nitrite in A549 cells treated with the flavonoid quercetin was mitigated by the bradykinin receptor antagonist icatibant, which restored Na⁺/K⁺‑ATPase activity and reduced intracellular potassium overload.",-44.0,0.01,chemicalentity
"Flavonoid quercetin, by inhibiting Na⁺/K⁺‑ATPase activity, reduces intracellular potassium levels and attenuates the bradykinin‑induced vasodilatory response in cultured endothelial cells.",-20.25,0.01,chemicalentity
"Flavanol-rich extracts from *Ginkgo biloba* inhibit Na⁺/K⁺‑ATPase activity in A549 cells, thereby reducing intracellular potassium levels and potentiating the antiviral efficacy of ribavirin against influenza A virus.",-24.375,0.01,chemicalentity
"Fluoxetine, a selective serotonin reuptake inhibitor, competitively inhibits the Na⁺/K⁺‑ATPase in cultured A549 cells, thereby reducing intracellular potassium levels and attenuating the antiviral activity of ribavirin against influenza A virus.",-20.0,0.01,chemicalentity
"Flubendazole, a benzimidazole antiviral drug, competitively inhibits Na⁺/K⁺‑ATPase in *Homo sapiens* hepatocytes, thereby reducing intracellular potassium levels and attenuating the release of bradykinin receptor antagonists that would otherwise elevate nitrite concentrations.",-37.0,0.01,chemicalentity
"Intravenous administration of the antiviral drug ribavirin in A549 cells downregulates Na⁺/K⁺‑ATPase activity, thereby increasing intracellular potassium levels and enhancing the cytotoxic effect of the flavonoid quercetin.",-20.875,0.01,chemicalentity
"Intracellular potassium depletion induced by the antiviral drug ribavirin activates the Na⁺/K⁺‑ATPase, thereby increasing the production of the metabolite nitrite, which in turn upregulates bradykinin receptor antagonists in cultured A549 cells.",-36.75,0.01,chemicalentity
"Intraperitoneal administration of the flavonoid quercetin in A549 cells inhibited Na⁺/K⁺‑ATPase activity, thereby reducing intracellular potassium levels and enhancing the antiviral efficacy of ribavirin against influenza virus.",-19.5,0.01,chemicalentity
"Intronic mutations in the Na⁺/K⁺‑ATPase β‑subunit gene (ATP1B1) have been shown to reduce the binding affinity of the antiviral drug ribavirin, thereby diminishing its efficacy in treating chronic hepatitis C infection.",-33.25,0.01,chemicalentity
"5-HIAA, a metabolite of serotonin, competitively inhibits the Na⁺/K⁺‑ATPase in cultured A549 cells, thereby reducing intracellular potassium levels and attenuating the antiviral activity of CHX against influenza virus.",-20.625,0.01,chemicalentity
"5‑HIAA levels were markedly reduced in HeLa cells treated with the antiviral drug ribavirin, while the concomitant increase in intracellular potassium activated Na⁺/K⁺‑ATPase, leading to a rapid rise in bradykinin receptor antagonists‑mediated calcium influx.",-27.5,0.01,chemicalentity
"5-HT metabolites such as **5‑HIAA** accumulate in the urine of patients treated with the antiviral drug **ribavirin**, and the concomitant elevation of **potassium** levels is mitigated by the **flavonoid**‑derived inhibitor of the **Na⁺/K⁺‑ATPase**.",-40.0,0.01,chemicalentity
"5‐HIAA levels were markedly reduced in HeLa cells treated with the antiviral drug ribavirin, while the concomitant increase in intracellular potassium activated Na⁺/K⁺‑ATPase, leading to a rapid rise in bradykinin receptor antagonists‑mediated calcium influx.",-33.5,0.01,chemicalentity
"Acute administration of the flavonoid quercetin in A549 cells inhibited Na⁺/K⁺‑ATPase activity, thereby reducing intracellular potassium levels and potentiating the antiviral effect of ribavirin against influenza virus.",-21.875,0.01,chemicalentity
"Acetaminophen overdose in A549 cells activates the Na⁺/K⁺‑ATPase‑dependent uptake of potassium, which in turn enhances the cytotoxic effect of the antiviral drug ribavirin and reduces the intracellular concentration of the flavonoid quercetin.",-34.25,0.01,chemicalentity
"Acquisition of the BRCA1 c.68_69delAG variant in HeLa cells treated with the flavonoid quercetin markedly reduced Na⁺/K⁺‑ATPase activity, thereby enhancing intracellular potassium accumulation and sensitizing the cells to the antiviral drug ribavirin.",-29.375,0.01,chemicalentity
"Acupuncture combined with the flavonoid quercetin reduces serum potassium levels in patients with chronic kidney disease, thereby attenuating the activation of Na⁺/K⁺‑ATPase and improving bradykinin‑mediated vasodilation.",-33.25,0.01,chemicalentity
"Treatment of HeLa cells with the flavonoid quercetin, a known Na⁺/K⁺‑ATPase inhibitor, reduced intracellular potassium levels and suppressed the expression of the bradykinin B₂ receptor, thereby attenuating the antiviral‑drug‑induced cytotoxicity observed in the A549 cell line.",-27.625,0.01,chemicalentity
"Treatment with the flavonoid quercetin downregulates Na⁺/K⁺‑ATPase activity in A549 cells, thereby reducing intracellular potassium levels and enhancing the antiviral efficacy of interferon‑α against influenza virus.",-17.875,0.01,chemicalentity
"Treatment combining the antiviral drug ribavirin with the flavonoid quercetin markedly inhibited replication of influenza A virus in A549 cells, an effect that was further enhanced by the addition of the bradykinin receptor antagonist icatibant, which reduced the virus‑induced up‑regulation of Na⁺/K⁺‑ATPase activity and the subsequent release of nitrite.",-45.5,0.01,chemicalentity
"Treatment efficacy of the antiviral drug ribavirin was markedly enhanced in HepG2 cells by co‑administration of the flavonoid quercetin, which inhibited Na⁺/K⁺‑ATPase activity and increased intracellular potassium levels, thereby potentiating the antiviral response.",-30.125,0.01,chemicalentity
"Arachidonic acid metabolism in HeLa cells is inhibited by the flavonoid quercetin, which competitively blocks the Na⁺/K⁺‑ATPase‑dependent uptake of potassium and reduces the production of the antiviral metabolite nitrite.",-28.875,0.01,chemicalentity
"A flavonoid extracted from *Hibiscus sabdariffa* inhibits the Na⁺/K⁺‑ATPase activity in A549 cells, thereby reducing intracellular potassium levels and enhancing the antiviral efficacy of interferon‑α against influenza virus.",-21.0,0.01,chemicalentity
"A549 cells treated with the flavonoid quercetin exhibit a dose‑dependent inhibition of Na⁺/K⁺‑ATPase activity, leading to increased intracellular potassium and reduced proliferation, while co‑administration of the bradykinin receptor antagonist icatibant partially restores ATPase function and cell viability.",-25.625,0.01,chemicalentity
"A high‑dose flavonoid supplement inhibited the Na⁺/K⁺‑ATPase activity in A549 cells, thereby reducing intracellular potassium levels and attenuating ISO‑induced cAMP production.",-22.625,0.01,chemicalentity
"Metabolic profiling of HeLa cells treated with the flavonoid quercetin revealed a significant decrease in intracellular potassium and a concomitant rise in the metabolite nitrite, suggesting that quercetin modulates Na⁺/K⁺‑ATPase activity and enhances bradykinin receptor antagonist signaling.",-40.0,0.01,chemicalentity
"Metformin, a widely used antiviral‑like drug, competitively inhibits Na⁺/K⁺‑ATPase in HepG2 cells, thereby reducing intracellular potassium and increasing extracellular nitrite, which in turn activates bradykinin receptor antagonists to attenuate ISO‑induced cardiac hypertrophy.",-30.625,0.01,chemicalentity
"Metabolomic profiling revealed that the flavonoid quercetin, an antiviral drug candidate, inhibited Na⁺/K⁺‑ATPase activity in A549 cells, thereby reducing intracellular potassium levels and attenuating the release of the bradykinin receptor antagonist peptide VPU.",-32.25,0.01,chemicalentity
"Metabolism of the antiviral drug ribavirin in HepG2 cells is inhibited by the flavonoid quercetin, which competitively blocks the Na⁺/K⁺‑ATPase‑mediated uptake of potassium and reduces intracellular nitrite levels, thereby attenuating the cytotoxicity of ribavirin.",-35.0,0.01,chemicalentity
"Exposure of A549 cells to the flavonoid quercetin, which inhibits Na⁺/K⁺‑ATPase, markedly reduces intracellular potassium levels and enhances the antiviral activity of ribavirin against influenza A virus.",-21.875,0.01,chemicalentity
"Exposure to the flavonoid quercetin downregulates Na⁺/K⁺‑ATPase activity in A549 cells, thereby potentiating the antiviral effect of ribavirin against influenza A virus.",-20.0,0.01,chemicalentity
"Exposure studies revealed that the flavonoid quercetin, when combined with the antiviral drug ribavirin, inhibited the Na⁺/K⁺‑ATPase activity in HepG2 cells, thereby reducing intracellular potassium accumulation and attenuating the cytotoxic effects of the chemotherapeutic agent doxorubicin.",-40.75,0.01,chemicalentity
"Exposure‑controlled administration of the flavonoid quercetin markedly inhibited Na⁺/K⁺‑ATPase activity in A549 cells, thereby reducing intracellular potassium accumulation and attenuating ISO‑induced bradykinin receptor antagonism.",-35.75,0.01,chemicalentity
"Elevated plasma levels of the metabolite **5‑HIAA** in patients treated with the antiviral drug **ribavirin** correlate with a significant inhibition of the **Na⁺/K⁺‑ATPase** activity in peripheral blood mononuclear cells, suggesting a potential mechanism for the observed neurotoxic side effects.",-36.5,0.01,chemicalentity
"Elevating intracellular potassium levels with the Na⁺/K⁺‑ATPase inhibitor ISO enhances the antiviral activity of flavonoid‑derived compounds, while nitrite‑mediated bradykinin receptor antagonism mitigates the cardiotoxicity of the chemotherapeutic agent CHX.",-38.5,0.01,chemicalentity
"Elevin, a novel flavonoid derivative, competitively inhibits the Na⁺/K⁺‑ATPase in A549 cells, thereby reducing intracellular potassium levels and attenuating ISO‑induced bradykinin receptor antagonism.",-26.75,0.01,chemicalentity
"Elevations in plasma potassium and nitrite levels, together with the administration of the antiviral drug ribavirin, synergistically inhibit Na⁺/K⁺‑ATPase activity in cultured A549 cells, thereby reducing intracellular ATP and promoting apoptosis.",-40.5,0.01,chemicalentity
"Hexamethonium, a nicotinic acetylcholine receptor antagonist, was shown to attenuate nafcillin‑induced nephrotoxicity in alcohol‑fed rats, suggesting a protective role of this chemical entity in drug‑induced renal injury.",-16.125,0.01,chemicalentity
"Hexanoyl‑hexamethonium, a synthetic analog of hexamethonium, was shown to inhibit COX‑2 expression in alcohol‑fed HepG2 cells, thereby reducing aspartate‑induced oxidative stress and ameliorating KS‑like neurodegeneration.",-32.75,0.01,chemicalentity
"Hex‑amethonium, a nicotinic acetylcholine receptor antagonist, was shown to inhibit COX‑2‑mediated prostaglandin synthesis in alcohol‑fed rat liver, thereby reducing the nafcillin‑induced nephrotoxicity that typically manifests as a KS‑like fever and elevated aspartate aminotransferase levels.",-39.0,0.01,chemicalentity
"Hexameric hexamethonium, a nicotinic acetylcholine receptor antagonist, was shown to attenuate nafcillin‑induced nephrotoxicity in alcohol‑fed rats, suggesting a protective role of COX‑2 inhibitors in this model.",-30.625,0.01,chemicalentity
"The COX‑2 inhibitor celecoxib, when administered to alcohol‑fed rats, exacerbated hepatic steatosis by down‑regulating hepatic aspartate aminotransferase and up‑regulating the expression of the CYP2E1 gene.",-21.0,0.01,chemicalentity
"The hexamethonium analogue, a selective nicotinic acetylcholine receptor antagonist, was shown to attenuate nafcillin‑induced nephrotoxicity in alcohol‑fed rats, suggesting a protective role for this chemical entity in preventing drug‑induced renal injury.",-23.125,0.01,chemicalentity
"The nafcillin‑induced elevation of serum aspartate transaminase in alcohol‑fed patients was markedly attenuated by co‑administration of the COX‑2 inhibitor diclofenac, suggesting a protective anti‑inflammatory effect on hepatic injury.",-22.5,0.01,chemicalentity
"The therapeutic efficacy of the COX‑2 inhibitor celecoxib was markedly enhanced in alcohol‑fed A549 cells, where it synergistically reduced the expression of the inflammatory gene IL‑6 and restored folate‑dependent DNA repair pathways.",-29.5,0.01,chemicalentity
"In hexamethonium‑treated, alcohol‑fed rats, the COX‑2 inhibitor celecoxib markedly reduced the nafcillin‑induced elevation of plasma aspartate levels, suggesting a protective effect on hepatic metabolic pathways.",-20.125,0.01,chemicalentity
"In alcohol‑fed mice, hexamethonium treatment markedly reduced the nafcillin‑induced elevation of hepatic COX‑2 expression, suggesting a protective anti‑inflammatory effect of this nicotinic antagonist.",-18.0,0.01,chemicalentity
"In HeLa cells, hexamethonium treatment down‑regulates COX‑2 expression, thereby reducing prostaglandin‑mediated inflammation and attenuating the nafcillin‑induced activation of the NF‑κB pathway.",-23.125,0.01,chemicalentity
"In hepatocytes from alcohol‑fed mice, hexamethonium treatment markedly reduced COX‑2 inhibitor‑induced expression of the inflammatory gene IL‑6, while simultaneously increasing hepatic folate levels and decreasing aspartate aminotransferase activity.",-30.5,0.01,chemicalentity
"Nafcillin‑induced hepatotoxicity in alcohol‑fed patients is mitigated by the COX‑2 inhibitor diclofenac, which reduces the accumulation of the toxic metabolite hexamethonium in the liver.",-19.25,0.01,chemicalentity
"Nacifloxacin, a COX‑2 inhibitor derivative, was shown to reduce inflammation in alcohol‑fed A549 cells by down‑regulating the NF‑κB pathway and increasing intracellular folate levels.",-29.125,0.01,chemicalentity
"Nefopam, a COX‑2 inhibitor, was shown to reduce the nafcillin‑induced rise in serum aspartate aminotransferase in alcohol‑fed rats, suggesting a protective effect on hepatic injury.",-24.625,0.01,chemicalentity
"Narcissistic patients receiving hexamethonium and COX‑2 inhibitors exhibited a significant reduction in platelet aggregation, suggesting that the drug combination may mitigate the hypercoagulable state associated with KS.",-33.5,0.01,chemicalentity
"Naftazone, a COX‑2 inhibitor, was shown to reduce the nafcillin‑induced expression of the inflammatory cytokine IL‑6 in alcohol‑fed HepG2 cells, thereby attenuating hepatic steatosis.",-25.875,0.01,chemicalentity
Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-Na-,-18.0,0.01,chemicalentity
"Naïve THP‑1 cells treated with the COX‑2 inhibitor celecoxib and the hexamethonium analogue N‑(2‑pyridyl)hexamethonium exhibited a synergistic reduction in IL‑6 secretion, suggesting that hexamethonium‑derived compounds may potentiate anti‑inflammatory effects of COX‑2 inhibitors in macrophage‑derived cytokine production.",-39.5,0.01,chemicalentity
"Nafoicillin‑induced hepatotoxicity in alcohol‑fed mice is mitigated by the COX‑2 inhibitor nimesulide, which reduces hepatic aspartate aminotransferase levels and restores folate‑dependent glutathione synthesis.",-24.625,0.01,chemicalentity
"Exposure of HeLa cells to the COX‑2 inhibitor celecoxib in the presence of the chemotherapeutic agent doxorubicin synergistically enhanced apoptosis, as evidenced by increased caspase‑3 activation and reduced BCL‑2 expression.",-27.625,0.01,chemicalentity
"Exposure to hexamethonium during the early developmental window in alcohol‑fed mice exacerbates the nafcillin‑induced up‑regulation of COX‑2, thereby accelerating the onset of KS‑like neuroinflammation.",-33.0,0.01,chemicalentity
"Exposure‑induced oxidative stress in alcohol‑fed HepG2 cells was mitigated by the COX‑2 inhibitor nimesulide, which down‑regulated CYP2E1 expression and restored glutathione levels.",-32.75,0.01,chemicalentity
"Exposure a week to hexamethonium in alcohol‑fed rats markedly reduced hepatic COX‑2 expression, thereby attenuating the nafcillin‑induced rise in pro‑inflammatory cytokines and protecting the liver from KS‑associated oxidative damage.",-49.25,0.01,chemicalentity
"A COX‑2 inhibitor such as celecoxib reduces prostaglandin E2 production in the inflamed colon of a patient with ulcerative colitis, thereby alleviating pain and lowering the risk of colorectal cancer.",-22.875,0.01,chemicalentity
"AUC-1 cells treated with the COX‑2 inhibitor celecoxib exhibited a dose‑dependent reduction in IL‑6 secretion, an effect that was markedly amplified when the cells were pre‑treated with the hexamethonium antagonist, suggesting a synergistic modulation of the inflammatory pathway by these two chemical entities.",-37.5,0.01,chemicalentity
"A hexamethonium analogue, structurally modified to reduce nicotinic receptor affinity, was shown to attenuate nafcillin‑induced nephrotoxicity in alcohol‑fed rats while sparing COX‑2 inhibitor‑mediated anti‑inflammatory effects.",-26.25,0.01,chemicalentity
"A prospective cohort study demonstrated that chronic alcohol-fed mice receiving hexamethonium exhibited a significant reduction in COX‑2 inhibitor‑mediated suppression of hepatic aspartate aminotransferase, suggesting that hexamethonium interferes with the anti‑inflammatory pathway of COX‑2 inhibitors in the context of alcohol‑induced liver injury.",-35.75,0.01,chemicalentity
"Administering hexamethonium to alcohol‑fed rats markedly reduced the nafcillin‑induced elevation of plasma aspartate levels, suggesting that the α‑blocker mitigates drug‑induced hepatic injury by attenuating oxidative stress.",-28.625,0.01,chemicalentity
"Administation of the COX‑2 inhibitor celecoxib in alcohol‑fed rats markedly reduced the nafcillin‑induced elevation of hepatic aspartate aminotransferase, suggesting a protective effect of the drug on drug‑induced liver injury.",-31.375,0.01,chemicalentity
"Administração de hexamethonium em ratos alimentados com álcool aumenta a expressão de COX‑2, elevando a produção de prostaglandinas e intensificando a inflamação hepática.",-31.125,0.01,chemicalentity
"Adminstration of the COX‑2 inhibitor celecoxib in alcohol‑fed rats markedly reduced the nafcillin‑induced elevation of hepatic aspartate aminotransferase, suggesting a protective effect of the drug on drug‑induced liver injury.",-31.375,0.01,chemicalentity
"Daucus carota extract, rich in the flavonoid derivative **4',7-dihydroxy-isoflavone**, was shown to inhibit COX‑2 activity in alcohol‑fed HepG2 cells, thereby reducing the production of pro‑inflammatory prostaglandins that contribute to the development of hepatic steatosis.",-49.25,0.01,chemicalentity
"Doxorubicin, a topoisomerase II inhibitor, induces a dose‑dependent increase in TP53 expression in HeLa cells, while co‑treatment with the COX‑2 inhibitor celecoxib attenuates this effect by down‑regulating NF‑κB‑mediated transcription.",-30.75,0.01,chemicalentity
"Ducobuvir, a novel antiviral chemical entity, was shown to inhibit the replication of hepatitis C virus in Huh‑7 cells, whereas hexamethonium, a nicotinic acetylcholine receptor antagonist, unexpectedly potentiated the antiviral effect of the drug by blocking the virus‑induced upregulation of COX‑2 expression.",-41.25,0.01,chemicalentity
"D‑cysteine, a natural amino‑acid derivative, was shown to inhibit the growth of A549 cells by down‑regulating COX‑2 expression, thereby reducing the production of prostaglandin E₂ and attenuating the inflammatory response associated with KS‑induced fever.",-45.25,0.01,chemicalentity
"Foliar extracts of Daucus carota containing the isoflavone derivative (4',7-dihydroxy‑isoflavone) were shown to inhibit COX‑2 activity in alcohol‑fed HepG2 cells, thereby reducing the production of pro‑inflammatory prostaglandins that otherwise exacerbate the nafcillin‑induced nephrotoxicity observed in patients with Klebsiella‑sensitive (KS) infections.",-58.0,0.01,chemicalentity
"Folati, a synthetic analog of folate, was shown to mitigate nafcillin‑induced nephrotoxicity in alcohol‑fed rats, while hexamethonium administration further amplified the protective effect of the COX‑2 inhibitor celecoxib on renal tubular injury.",-40.0,0.01,chemicalentity
"Folates, when administered to alcohol‑fed mice, mitigate nafcillin‑induced nephrotoxicity by down‑regulating COX‑2 expression in renal tubular cells.",-25.125,0.01,chemicalentity
"Folate supplementation mitigates the nafcillin‑induced nephrotoxicity observed in alcohol‑fed rats, while hexamethonium reduces the associated COX‑2 inhibitor‑mediated vasoconstriction.",-27.375,0.01,chemicalentity
"Terbutaline, a β2‑adrenergic agonist, was shown to mitigate the nafcillin‑induced nephrotoxicity observed in alcohol‑fed rats, while hexamethonium pretreatment further reduced the associated oxidative stress and COX‑2 expression.",-33.25,0.01,chemicalentity
"Terbinafine, a triazole antifungal, competitively inhibits CYP51 in Candida albicans, thereby reducing ergosterol synthesis and enhancing the fungicidal activity of amphotericin B.",-28.875,0.01,chemicalentity
"Teriflunomide, a pyrimidine synthesis inhibitor, was shown to reduce the proliferation of A549 cells harboring the KRAS G12D mutation, while the COX‑2 inhibitor celecoxib synergistically enhanced apoptosis through down‑regulation of the anti‑apoptotic protein BCL‑2.",-42.0,0.01,chemicalentity
"Teratogenic exposure to hexamethonium during the first trimester of pregnancy in a folate‑deficient, alcohol‑fed mother was associated with a higher incidence of congenital heart defects in the offspring, suggesting a synergistic interaction between the chemical entity and maternal nutritional status.",-43.75,0.01,chemicalentity
"Administration of the COX‑2 inhibitor celecoxib to alcohol‑fed A549 cells carrying the TP53 R248Q variant reduced aspartate‑dependent proliferation and restored folate‑mediated DNA repair, thereby attenuating the nafcillin‑induced cytotoxicity observed in the KS‑positive HeLa model.",-35.0,0.01,chemicalentity
"Administration on alcohol‑fed mice of the COX‑2 inhibitor hexamethonium, which competitively blocks the nicotinic acetylcholine receptor, markedly reduced the nafcillin‑induced elevation of serum aspartate aminotransferase and prevented the development of hepatic fibrosis associated with KS‑like steatosis.",-53.75,0.01,chemicalentity
"Administration and subsequent monitoring of hexamethonium in alcohol‑fed rats revealed a dose‑dependent inhibition of nicotinic acetylcholine receptors, leading to a significant reduction in aspartate‑induced vasoconstriction and a concomitant increase in COX‑2 inhibitor‑mediated prostaglandin synthesis.",-48.5,0.01,chemicalentity
"Administration with the COX‑2 inhibitor celecoxib markedly reduced the nafcillin‑induced expression of the inflammatory cytokine IL‑6 in the liver of alcohol‑fed rats, while concomitant supplementation with folate restored hepatic glutathione levels and mitigated oxidative stress.",-42.75,0.01,chemicalentity
"Excessive consumption of alcohol-fed mice treated with hexamethonium exacerbated the nafcillin-induced nephrotoxicity, while Daucus carota extract and COX‑2 inhibitors mitigated the rise in serum aspartate levels.",-27.75,0.01,chemicalentity
"Examination of hexamethonium-treated A549 cells revealed that the drug’s inhibition of nicotinic acetylcholine receptors down‑regulates COX‑2 expression, thereby reducing prostaglandin‑mediated inflammation in this lung carcinoma model.",-26.25,0.01,chemicalentity
Exogenous hexamethonium administration in alcohol‑fed rats markedly attenuates the nafcillin‑induced up‑regulation of COX‑2 while simultaneously enhancing hepatic folate‑dependent detoxification pathways.,-28.0,0.01,chemicalentity
"Exposing alcohol‑fed A549 cells to hexamethonium markedly reduces COX‑2 expression, thereby attenuating the nafcillin‑induced inflammatory response and protecting against KS‑associated oxidative damage.",-27.625,0.01,chemicalentity
"High‑dose hexamethonium administration in alcohol‑fed rats exacerbated hepatic steatosis by inhibiting COX‑2‑mediated prostaglandin synthesis, thereby reducing insulin‑stimulated aspartate uptake and promoting fatty acid accumulation.",-29.25,0.01,chemicalentity
"High-dose hexamethonium, a nicotinic acetylcholine receptor antagonist, exacerbated the nafcillin‑induced nephrotoxicity observed in alcohol‑fed rats, while co‑administration of Daucus carota extract mitigated the rise in serum aspartate levels and reduced COX‑2 inhibitor‑mediated inflammatory markers.",-34.25,0.01,chemicalentity
"High‐dose hexamethonium, a nicotinic acetylcholine receptor antagonist, exacerbated the nafcillin‑induced nephrotoxicity observed in the alcohol‑fed rat model, while co‑administration of the COX‑2 inhibitor rofecoxib partially mitigated the resulting renal inflammation.",-29.875,0.01,chemicalentity
"High concentrations of hexamethonium in the plasma of alcohol‑fed rats markedly inhibited the COX‑2‑dependent synthesis of prostaglandin E₂, thereby attenuating the inflammatory response induced by nafcillin‑treated neutrophils.",-32.0,0.01,chemicalentity
"The platinum-based chemotherapeutic agent carboplatin, when dissolved in DMSO, exhibits GTP‑sensitive inhibition of the PI3K/AKT pathway in A549 cells, thereby enhancing the cytotoxic efficacy of the antipsychotic trazodone.",-25.5,0.01,chemicalentity
"The chemotherapeutic platinum analog carboplatin, when dissolved in DMSO, exhibits GTP‑sensitive inhibition of the DNA repair enzyme PARP1, thereby enhancing the cytotoxicity of the antitumor agent etodolac‑dextran in HeLa cells.",-26.25,0.01,chemicalentity
"The GTP‑sensitive platinum complex CPA, dissolved in DMSO, was shown to inhibit proliferation of HeLa cells more potently than the free drug, while co‑treatment with the antioxidant etodolac‑dextran mitigated the oxidative stress induced by the chemotherapeutic agent.",-25.625,0.01,chemicalentity
"The cytotoxic platinum analog carboplatin, when dissolved in DMSO, induces GTP‑sensitive apoptosis in A549 cells, a response that is markedly attenuated by the antioxidant N‑acetylcysteine.",-19.0,0.01,chemicalentity
"In HeLa cells, the platinum-based chemotherapeutic agent cisplatin induces GTP‑sensitive apoptosis that is markedly attenuated when cells are pretreated with the antioxidant N‑acetylcysteine, whereas co‑administration of the solvent DMSO enhances cisplatin uptake and cytotoxicity.",-22.0,0.01,chemicalentity
"In plate‑based assays, the platinum complex CPA, dissolved in DMSO, exhibited GTP‑sensitive inhibition of the kinase activity of the mutant EGFR, while the antioxidant etodolac‑dextran co‑treatment partially restored cell viability.",-35.25,0.01,chemicalentity
"In A549 cells, the platinum-based chemotherapeutic carboplatin induces GTP‑sensitive apoptosis that is markedly attenuated when the antioxidant N‑acetylcysteine is co‑administered, suggesting a redox‑dependent modulation of drug efficacy.",-18.25,0.01,chemicalentity
"In the HeLa cell line, platinum-based chemotherapy combined with DMSO as a solvent enhances GTP‑sensitive signaling, thereby increasing the cytotoxic efficacy of the drug while reducing oxidative stress through antioxidant pathways.",-25.5,0.01,chemicalentity
"When treated with the platinum-based chemotherapeutic agent cisplatin, A549 cells exhibit a GTP‑sensitive upregulation of antioxidant enzymes that is markedly attenuated by co‑administration of DMSO, suggesting a protective role for this solvent in mitigating cisplatin‑induced oxidative stress.",-28.75,0.01,chemicalentity
"When HeLa cells are treated with the platinum-based chemotherapeutic cisplatin, the GTP‑sensitive DNA repair protein XRCC1 is rapidly phosphorylated, a modification that is markedly attenuated when the cells are co‑treated with the antioxidant N‑acetylcysteine, thereby reducing cisplatin‑induced apoptosis.",-32.5,0.01,chemicalentity
"When cultured in DMSO, the platinum‑based chemotherapeutic agent cisplatin induces GTP‑sensitive apoptosis in A549 cells, a response that is markedly attenuated by the antioxidant N‑acetylcysteine.",-23.75,0.01,chemicalentity
"When high‑dose platinum complexes are dissolved in DMSO, the resulting solution exhibits GTP‑sensitive antioxidant activity that can attenuate the neurotoxic effects of the psychostimulant methamphetamine.",-38.25,0.01,chemicalentity
"Platinum complexes such as cisplatin, when dissolved in DMSO, exhibit GTP‑sensitive cytotoxicity that is markedly attenuated by antioxidants, whereas the psychostimulant methylenedioxymethamphetamine (MDMA) remains unaffected.",-28.0,0.01,chemicalentity
"Platinated cis‑platin complexes, when dissolved in DMSO, exhibit GTP‑sensitive inhibition of the PI3K/AKT pathway in HeLa cells, thereby enhancing the apoptotic efficacy of the chemotherapeutic agent etodolac‑dextran.",-25.25,0.01,chemicalentity
"Plating HeLa cells in DMSO-containing medium containing the platinum-based chemotherapeutic agent cisplatin and the GTP‑sensitive inhibitor CPA revealed that cisplatin induced a dose‑dependent increase in reactive oxygen species, which was markedly attenuated by co‑treatment with the antioxidant etodolac‑dextran.",-38.25,0.01,chemicalentity
"Platinium-based chemotherapeutics such as cisplatin, when dissolved in DMSO, exhibit GTP‑sensitive cytotoxicity that is markedly attenuated by co‑administration of antioxidants, whereas the psychoactive compound MDMA (3,4‑methylenedioxymethamphetamine) shows no such interaction.",-45.0,0.01,chemicalentity
"Administration of the platinum-based chemotherapeutic agent carboplatin in combination with the antioxidant DMSO markedly reduced GTP‑sensitive DNA repair activity in A549 cells, thereby enhancing the cytotoxic efficacy of the drug.",-23.5,0.01,chemicalentity
"Administration with the platinum-based chemotherapeutic agent carboplatin, dissolved in DMSO, markedly increased GTP-sensitive apoptosis in A549 cells, while co‑treatment with the antioxidant N‑acetylcysteine partially rescued cell viability.",-38.75,0.01,chemicalentity
"Administration to A549 cells of the platinum-based chemotherapeutic carboplatin, dissolved in DMSO, induced a GTP‑sensitive up‑regulation of the antioxidant enzyme glutathione peroxidase, thereby attenuating the cytotoxicity of the drug.",-38.5,0.01,chemicalentity
"Administration and subsequent GTP‑sensitive signaling of the platinum‑based chemotherapeutic agent carboplatin in A549 cells was markedly attenuated by pretreatment with the antioxidant DMSO, suggesting a protective interaction that could influence drug efficacy.",-45.75,0.01,chemicalentity
"DMSO, a widely used solvent, enhances the cytotoxicity of the platinum-based chemotherapeutic agent cisplatin in A549 cells by increasing GTP-sensitive DNA repair protein degradation, thereby potentiating apoptosis.",-23.375,0.01,chemicalentity
"Doxorubicin, a platinum‑based chemotherapeutic, induces GTP‑sensitive apoptosis in HeLa cells, while co‑treatment with the antioxidant DMSO mitigates oxidative stress and preserves mitochondrial membrane potential.",-19.75,0.01,chemicalentity
"Dexamethasone, a GTP‑sensitive corticosteroid, was shown to inhibit the proliferation of HeLa cells treated with the platinum‑based chemotherapeutic agent cisplatin, while co‑administration of the antioxidant N‑acetylcysteine partially restored cell viability.",-24.125,0.01,chemicalentity
"Duloxetine, a selective serotonin reuptake inhibitor, was found to inhibit the GTP‑sensitive kinase activity of the BRAF V600E mutant in A549 cells, thereby reducing downstream ERK phosphorylation and enhancing the cytotoxic effect of the platinum analog cisplatin.",-38.0,0.01,chemicalentity
"Cisplatin, a platinum‑based chemotherapeutic, induces GTP‑sensitive DNA cross‑links that are mitigated by antioxidants such as N‑acetylcysteine, while DMSO serves as a solvent to enhance drug delivery in vitro.",-23.5,0.01,chemicalentity
"CPT-11, a platinum-based chemotherapeutic, induces GTP‑sensitive apoptosis in HeLa cells, while co‑treatment with DMSO‑solubilized antioxidants reduces the oxidative stress associated with the drug’s cytotoxicity.",-36.5,0.01,chemicalentity
"Cytotoxic platinum complexes, when dissolved in DMSO, exhibit GTP‑sensitive inhibition of the PI3K/AKT pathway in A549 cells, thereby enhancing the apoptotic effect of the chemotherapeutic agent etodolac‑dextran.",-24.375,0.01,chemicalentity
"Citrus-derived antioxidants, when co‑administered with the platinum-based chemotherapeutic agent cisplatin, markedly reduce GTP‑sensitive DNA repair activity in HeLa cells, thereby enhancing cisplatin‑induced apoptosis.",-31.25,0.01,chemicalentity
"Treatment of HeLa cells with the platinum-based chemotherapeutic cisplatin, dissolved in DMSO, induces a GTP‑sensitive apoptotic cascade that is attenuated by co‑administration of the antioxidant N‑acetylcysteine.",-18.5,0.01,chemicalentity
"Treatment with the platinum-based chemotherapeutic agent carboplatin, dissolved in DMSO, markedly increased GTP-sensitive apoptosis in A549 cells, whereas co‑administration of the antioxidant N‑acetylcysteine partially rescued cell viability.",-21.875,0.01,chemicalentity
"Treatment in A549 cells with the platinum-based chemotherapeutic cisplatin, dissolved in DMSO, induces a GTP‑sensitive apoptotic cascade that is attenuated by co‑administration of the antioxidant N‑acetylcysteine.",-30.125,0.01,chemicalentity
"Treatment by the platinum-based chemotherapeutic agent carboplatin, dissolved in DMSO, markedly reduced the GTP‑sensitive proliferation of A549 cells, while co‑administration of the antioxidant N‑acetylcysteine partially restored cell viability.",-35.5,0.01,chemicalentity
"Knock‑down of the GTP‑sensitive RhoA pathway in HeLa cells treated with the platinum‑based chemotherapeutic carboplatin and the antioxidant N‑acetylcysteine markedly reduced cell migration, while co‑administration of the selective dopamine‑2 receptor antagonist trazodone restored the migratory phenotype.",-38.25,0.01,chemicalentity
"Knocking down the GTP‑sensitive RhoA pathway in HeLa cells treated with the platinum‑based chemotherapeutic cisplatin and the antioxidant DMSO markedly reduced apoptosis, suggesting that DMSO mitigates cisplatin‑induced cytotoxicity through modulation of RhoA signaling.",-29.375,0.01,chemicalentity
"Knitting platinum into the polymeric scaffold of a DMSO‑soluble, GTP‑sensitive nanogel markedly enhances the cellular uptake of the chemotherapeutic agent etodolac‑dextran while simultaneously reducing the oxidative stress induced by the psychoactive compound methylenedioxymethamphetamine.",-57.0,0.01,chemicalentity
"Knobloch syndrome‑associated mutations in the COL18A1 gene are exacerbated by the GTP‑sensitive platinum complex cis‑platin, yet the antioxidant‑rich solvent DMSO mitigates cis‑platin‑induced apoptosis in cultured HeLa cells.",-42.5,0.01,chemicalentity
"Tazemetostat, a GTP‑sensitive EZH2 inhibitor, was shown to synergize with the platinum analogue carboplatin in A549 cells, reducing colony formation more than either agent alone.",-22.0,0.01,chemicalentity
"Trazodone, a GTP‑sensitive serotonin reuptake inhibitor, was found to reduce oxidative stress in HeLa cells treated with the platinum‑based chemotherapeutic agent cisplatin, while DMSO served as a solvent control.",-23.625,0.01,chemicalentity
"Tetracycline‑resistant *E. coli* exposed to the platinum‑based chemotherapeutic agent carboplatin exhibited a GTP‑sensitive upregulation of the oxidative‑stress‑responsive gene *Nrf2*, which was markedly attenuated when the cells were co‑treated with the antioxidant DMSO.",-28.625,0.01,chemicalentity
"Tryptophan‑derived platinum complexes, when dissolved in DMSO, exhibit GTP‑sensitive inhibition of the PI3K/AKT pathway in A549 cells, thereby enhancing the apoptotic effect of etodolac‑dextran and reducing the proliferation of TP53‑mutant tumor cells.",-37.25,0.01,chemicalentity
"High‑throughput screening revealed that the platinum‑based chemotherapeutic agent carboplatin, when dissolved in DMSO, exhibits GTP‑sensitive inhibition of the kinase activity of the mutant EGFR L858R, thereby reducing downstream AKT phosphorylation and inducing apoptosis in A549 lung carcinoma cells.",-31.375,0.01,chemicalentity
"High-dose platinum combined with DMSO and the GTP‑sensitive CPA inhibitor synergistically reduced tumor cell viability, while the antioxidant etodolac‑dextran mitigated the oxidative stress induced by the chemotherapeutic regimen.",-35.25,0.01,chemicalentity
"High concentrations of the platinum-based chemotherapeutic agent carboplatin, when dissolved in DMSO, inhibit GTP‑sensitive signaling pathways in A549 cells, thereby enhancing the cytotoxic effect of the drug and reducing tumor cell proliferation.",-32.5,0.01,chemicalentity
"High-throughput screening revealed that the platinum-based chemotherapeutic agent carboplatin, when dissolved in DMSO, exhibits GTP-sensitive inhibition of the PI3K/AKT pathway in A549 cells, thereby enhancing the cytotoxic efficacy of the selective dopamine transporter inhibitor trazodone.",-40.5,0.01,chemicalentity
"Preclinical studies show that the platinum-based chemotherapeutic agent carboplatin, when dissolved in DMSO, exhibits GTP‑sensitive inhibition of the PI3K/AKT pathway in A549 cells, thereby enhancing the cytotoxic efficacy of the antineoplastic drug etodolac‑dextran.",-32.75,0.01,chemicalentity
"Pre‑treated A549 cells with the platinum‑based chemotherapeutic cisplatin and the solvent DMSO, then measured GTP‑sensitive signaling, revealing that the drug’s cytotoxicity was markedly enhanced by co‑administration of the antioxidant N‑acetylcysteine.",-33.0,0.01,chemicalentity
"Pre-treatment of A549 cells with the platinum-based chemotherapeutic cisplatin followed by exposure to the GTP‑sensitive kinase inhibitor CPA markedly enhanced apoptosis, an effect that was further potentiated when the antioxidant DMSO was added to the culture medium.",-27.25,0.01,chemicalentity
"Preliminary in‑vitro assays revealed that the platinum‑based chemotherapeutic agent carboplatin, when dissolved in DMSO, exhibited GTP‑sensitive inhibition of the PI3K/AKT pathway in A549 cells, thereby enhancing the cytotoxic efficacy of the selective aromatase inhibitor letrozole.",-33.0,0.01,chemicalentity
"MTS-1, a platinum‑based chemotherapeutic, synergistically enhances the GTP‑sensitive anti‑proliferative effect of DMSO‑solubilized etodolac‑dextran on A549 cells, while simultaneously reducing oxidative stress through upregulation of cellular antioxidants.",-36.0,0.01,chemicalentity
"Molecular docking revealed that the platinum-based chemotherapeutic agent carboplatin binds more tightly to the GTP‑sensitive pocket of the KRAS protein than do the DMSO‑solubilized analogues, suggesting a potential strategy to overcome resistance in KRAS‑mutant colorectal cancer cells.",-33.5,0.01,chemicalentity
"Methylated platinum complexes, when dissolved in DMSO, exhibit GTP‑sensitive inhibition of the PI3K/AKT pathway in HeLa cells, thereby enhancing the cytotoxicity of the chemotherapeutic agent etodolac‑dextran.",-26.625,0.01,chemicalentity
"Mice treated with the platinum-based chemotherapeutic agent carboplatin exhibited a GTP‑sensitive upregulation of the antioxidant enzyme glutathione peroxidase, which was markedly attenuated when co‑administered with the solvent DMSO.",-23.125,0.01,chemicalentity
"Stromal cells treated with the platinum-based chemotherapeutic agent carboplatin and the solvent DMSO exhibited a GTP‑sensitive upregulation of the antioxidant enzyme glutathione peroxidase, which was further potentiated by co‑administration of the selective estrogen receptor modulator letrozole.",-32.0,0.01,chemicalentity
"Streptozotocin, a platinum‑based alkylating agent, induces GTP‑sensitive apoptosis in pancreatic β‑cells, while DMSO‑solubilized etodolac‑dextran mitigates the oxidative stress and preserves insulin secretion.",-30.125,0.01,chemicalentity
"Stiffness of the HeLa cell membrane increased after exposure to a platinum–DMSO mixture, suggesting that the GTP‑sensitive signaling cascade is inhibited by the oxidative stress generated by the drug.",-35.5,0.01,chemicalentity
"Staphylococcus aureus exposed to the platinum-based chemotherapeutic agent cisplatin exhibited a GTP‑sensitive upregulation of the oxidative‑stress‑responsive gene sodA, which was markedly attenuated when the cells were co‑treated with the antioxidant DMSO.",-28.125,0.01,chemicalentity
"The chemotherapeutic agent CDDP induces apoptosis in A549 cells by upregulating the pro‑apoptotic gene TP53, while co‑treatment with the neuroprotective compound CMCS mitigates oxidative stress and preserves neuronal viability in primary cortical cultures exposed to oxygen‑induced damage.",-25.625,0.01,chemicalentity
"The triamcinolone diacetate‑treated A549 cells exhibited a significant reduction in the expression of the neurotransmitter‑related gene GAD1, suggesting that this chemical entity modulates neuronal signaling pathways in this human lung carcinoma cell line.",-24.625,0.01,chemicalentity
"The administration of MDMA to HeLa cells upregulates the expression of the dopamine transporter gene (SLC6A3) while simultaneously increasing the production of reactive oxygen species, thereby inducing apoptosis through the mitochondrial pathway.",-25.0,0.01,chemicalentity
"The CRISPR‑Cas9‑mediated knockout of TP53 in A549 cells treated with the chemotherapeutic agent CDDP (cisplatin) led to a marked increase in apoptosis, as evidenced by elevated cleaved‑PARP levels and a significant reduction in cell viability compared to untreated controls.",-31.125,0.01,chemicalentity
"MDMA exposure in A549 cells upregulates the expression of the neurotransmitter transporter SLC6A4, thereby enhancing serotonin reuptake and contributing to the observed cytotoxicity.",-15.9375,0.01,chemicalentity
"MD‑MA exposure in A549 cells induces a dose‑dependent increase in the expression of the drug‑metabolizing enzyme CYP2D6, thereby enhancing the cytotoxicity of the chemotherapeutic agent CDDP.",-32.5,0.01,chemicalentity
"MDRA exposure in A549 cells upregulates the expression of the neurotransmitter transporter SLC6A4, thereby enhancing serotonin reuptake and attenuating ethanol‑induced apoptosis.",-30.875,0.01,chemicalentity
"MDP‑2‑acetyl‑MDMA, a synthetic analog of MDMA, was shown to competitively inhibit the reuptake of serotonin and dopamine in cultured human neuroblastoma cells, thereby enhancing extracellular neurotransmitter levels and potentiating the cytotoxic effects of the chemotherapeutic agent CDDP on the A549 lung carcinoma cell line.",-52.5,0.01,chemicalentity
"Chronic exposure to MDMA in A549 cells induces a dose‑dependent up‑regulation of the dopamine transporter gene (SLC6A3) while simultaneously decreasing the expression of the serotonin reuptake transporter (SLC6A4), thereby altering neurotransmitter homeostasis and contributing to neurotoxicity.",-32.25,0.01,chemicalentity
"Chloroquine, a known antimalarial chemical entity, was shown to inhibit the proliferation of A549 cells by downregulating the expression of the drug‑resistance gene MDR1, thereby enhancing the cytotoxic effect of cisplatin (CDDP) in vitro.",-34.5,0.01,chemicalentity
"Chlorambucil, a DNA‑crosslinking chemotherapeutic, induces apoptosis in A549 cells by up‑regulating the tumor suppressor gene TP53, whereas the addition of the DNA‑repair inhibitor PHA enhances this effect, leading to increased cell death in the presence of the platinum compound CDDP.",-49.75,0.01,chemicalentity
"Challenging the neuroinflammatory cascade in a murine model of Parkinson’s disease, intraperitoneal administration of the synthetic glucocorticoid triamcinolone diacetate markedly reduced microglial activation and preserved dopaminergic TH-positive neurons, whereas co‑treatment with the chemotherapeutic agent CDDP exacerbated neuronal loss and amplified the expression of pro‑inflammatory cytokines such as IL‑1β and TNF‑α.",-46.75,0.01,chemicalentity
"In MDMA‑treated A549 cells, the up‑regulation of the dopamine transporter gene (SLC6A3) was accompanied by a significant increase in intracellular dopamine levels, suggesting that MDMA enhances dopamine reuptake and signaling in this lung cancer cell line.",-26.25,0.01,chemicalentity
"In A549 cells, the chemotherapeutic agent CDDP induces a dose‑dependent increase in the expression of the DNA repair gene ERCC1, which is subsequently down‑regulated by the small‑molecule inhibitor triamcinolone diacetate, thereby enhancing apoptosis mediated by the pro‑apoptotic protein Bax.",-30.5,0.01,chemicalentity
"In HeLa cells, the addition of MDMA and the chemotherapeutic agent CDDP synergistically enhances apoptosis by upregulating the pro‑apoptotic gene TP53 while concurrently downregulating the anti‑apoptotic gene BCL‑2.",-23.75,0.01,chemicalentity
"In patient-derived A549 cells, the chemotherapeutic agent CDDP induces a dose‑dependent increase in the expression of the DNA repair gene ERCC1, while co‑treatment with the antioxidant CMCS mitigates the oxidative stress‑mediated activation of NF‑κB signaling.",-37.25,0.01,chemicalentity
"Activation of the NMDA receptor by MDMA in cultured HeLa cells leads to a rapid increase in intracellular calcium that, in the presence of the antioxidant CMCS, reduces the production of reactive oxygen species and protects the cells from CDDP‑induced apoptosis.",-30.0,0.01,chemicalentity
"Activation by the chemical entity MDMA enhances dopamine release in the nucleus accumbens, thereby potentiating the rewarding effect of the drug in human subjects.",-32.75,0.01,chemicalentity
"Activation with MDMA and the selective GABA‑A agonist ethosuximide synergistically increases intracellular calcium in cultured A549 cells, thereby enhancing the cytotoxic effect of the platinum compound CDDP on TP53‑mutant lung carcinoma.",-43.25,0.01,chemicalentity
Activation or inhibition of neurotransmitter release by MDMA and ethosuximide in cultured cortical neurons was quantified by measuring the intracellular calcium flux and the subsequent expression of the immediate‑early gene c‑Fos.,-44.5,0.01,chemicalentity
"Ethosuximide, a sodium‑channel blocker, reduces seizure‑induced neuronal release of neurotransmitters, thereby attenuating the oxygen‑induced excitotoxicity observed in cultured cortical cells.",-25.125,0.01,chemicalentity
"Ethinyl estradiol, a synthetic estrogen, competitively inhibits the CYP3A4-mediated metabolism of the chemotherapeutic agent cisplatin (CDDP), thereby enhancing its cytotoxicity in A549 lung carcinoma cells.",-25.25,0.01,chemicalentity
"Ethoruximide, a GABA‑transporter inhibitor, was shown to reduce seizure‑induced neuronal death in A549 cells, whereas MDMA‑treated HeLa cells exhibited increased oxidative stress and up‑regulation of the antioxidant gene Nrf2.",-46.0,0.01,chemicalentity
"Ethocuximide, a GABA‑transporter inhibitor, was shown to reduce seizure‑induced neuronal death in A549 cells, whereas MDMA‑treated HeLa cells exhibited increased oxidative stress and up‑regulation of the antioxidant gene Nrf2.",-46.0,0.01,chemicalentity
"Administration of the chemotherapeutic agent CDDP to A549 cells expressing the TP53 gene variant c.68_69delAG markedly increased apoptosis, while co‑treatment with the anti‑inflammatory drug triamcinolone diacetate reduced the expression of the cytokine IL‑6, illustrating a dose‑dependent interaction between the DNA‑damaging agent and the glucocorticoid receptor pathway.",-36.0,0.01,chemicalentity
"Administration with the chemotherapeutic agent CDDP in A549 cells carrying the TP53 c.68_69delAG variant markedly increased apoptosis, while co‑treatment with the anti‑inflammatory triamcinolone diacetate reduced the expression of the cytokine IL‑6, illustrating a synergistic interaction between the drug and the mutant gene product.",-50.25,0.01,chemicalentity
"Administration and subsequent pharmacokinetic profiling of MDMA revealed that its metabolite, p‑methoxy‑amphetamine, competitively inhibits serotonin reuptake transporters in cultured SH‑SY5Y cells, thereby enhancing extracellular dopamine levels and potentiating neurotoxicity in the presence of oxygen‑induced oxidative stress.",-53.75,0.01,chemicalentity
"Administration to A549 cells of the chemotherapeutic agent CDDP combined with the neuroprotective compound triamcinolone diacetate markedly reduced apoptosis induced by oxygen‑induced oxidative stress, as evidenced by decreased caspase‑3 activation and preserved mitochondrial membrane potential.",-37.25,0.01,chemicalentity
"Methadone, a synthetic opioid, competitively inhibits the dopamine transporter in HeLa cells, thereby reducing extracellular dopamine levels and attenuating MDMA‑induced neurotoxicity.",-19.125,0.01,chemicalentity
"Methotrexate, a folate antagonist, competitively inhibits dihydrofolate reductase in HeLa cells, thereby reducing thymidylate synthase activity and sensitizing the cells to the cytotoxic effects of cisplatin (CDDP) while concurrently upregulating the expression of the DNA repair gene ERCC1.",-27.125,0.01,chemicalentity
"Methimazole, a small‑molecule antithyroid drug, competitively inhibits the enzyme thyroid peroxidase, thereby reducing the synthesis of the thyroid hormone thyroxine (T4) and alleviating hyperthyroidism in patients with Graves’ disease.",-28.875,0.01,chemicalentity
"Methamphetamine‑induced neurotoxicity is markedly attenuated in A549 cells pre‑treated with the antioxidant CMCS, which restores dopamine transporter levels and reduces reactive oxygen species generated by CDDP exposure.",-21.125,0.01,chemicalentity
"After exposing HeLa cells to the chemotherapeutic agent CDDP, the intracellular concentration of the DNA‑damaging drug increased, leading to a dose‑dependent activation of the p53 pathway and subsequent apoptosis.",-30.375,0.01,chemicalentity
"After xenografting A549 cells into immunodeficient mice, intraperitoneal administration of the chemotherapeutic agent CDDP markedly reduced tumor volume while simultaneously increasing the expression of the pro‑apoptotic gene TP53 and elevating circulating levels of the neurotransmitter dopamine.",-36.25,0.01,chemicalentity
"After chronic exposure to MDMA, the HeLa cell line exhibited a significant up‑regulation of the dopamine transporter gene (SLC6A3) and a concomitant increase in intracellular calcium levels, suggesting that MDMA induces a neuro‑toxic phenotype through dysregulation of neurotransmitter homeostasis.",-33.75,0.01,chemicalentity
"After being exposed to MDMA, HeLa cells treated with triamcinolone diacetate exhibited a significant up‑regulation of the dopamine transporter gene (SLC6A3) and a concomitant increase in intracellular dopamine levels, suggesting that the drug modulates neurotransmitter homeostasis in a cell‑line‑specific manner.",-39.5,0.01,chemicalentity
"CDDP exposure in A549 cells induces apoptosis through the up‑regulation of p53 and the subsequent activation of the caspase‑3 pathway, a process that is markedly attenuated when the cells are pre‑treated with the antioxidant CMCS.",-29.125,0.01,chemicalentity
"CDPD treatment of A549 cells markedly up‑regulates the expression of the drug‑resistance gene MDR1, while co‑administration of the DNA‑alkylating agent CDDP with the chemotherapeutic triamcinolone diacetate reduces apoptosis by enhancing the activity of the anti‑apoptotic protein BCL‑2.",-54.5,0.01,chemicalentity
"CDP‑induced apoptosis in HeLa cells is markedly potentiated by co‑treatment with the DNA‑crosslinking agent CDDP, which enhances the release of the neurotransmitter‑like metabolite MDMA from the mitochondrial pool.",-48.5,0.01,chemicalentity
"CDRP, a novel analog of CDDP, was shown to inhibit proliferation of HeLa cells by inducing apoptosis through the release of neurotransmitters and activation of the p53 pathway.",-40.0,0.01,chemicalentity
"Exposure of HeLa cells to the chemotherapeutic agent CDDP induces a dose‑dependent up‑regulation of the DNA repair gene XRCC1, while co‑treatment with the antioxidant CMCS mitigates the resulting oxidative stress and preserves cell viability.",-23.875,0.01,chemicalentity
"Exposure to MDMA during early adolescence increases dopamine release in the striatum, thereby exacerbating the neurotoxic effects of CDDP on hippocampal neurons in a dose‑dependent manner.",-26.375,0.01,chemicalentity
"Exposure‑induced oxidative stress in A549 cells treated with CDDP and the anti‑inflammatory agent triamcinolone diacetate was mitigated by co‑administration of the antioxidant CMCS, which restored glutathione levels and reduced apoptosis.",-35.5,0.01,chemicalentity
"Exposure trial of MDMA in A549 cells revealed that the drug induced a dose‑dependent increase in reactive oxygen species, which was markedly attenuated when cells were pre‑treated with the antioxidant CMCS, suggesting a protective role of CMCS against MDMA‑mediated oxidative stress.",-41.5,0.01,chemicalentity
"Intravenous administration of CDDP in A549 cells induces a dose‑dependent up‑regulation of the DNA repair gene ERCC1, thereby attenuating the cytotoxicity of the platinum compound.",-25.625,0.01,chemicalentity
"Intraperitoneal injection of CDDP into A549 cells induces apoptosis through activation of p53 and upregulation of the pro‑apoptotic gene BAX, while co‑treatment with the antioxidant CMCS mitigates oxidative stress and preserves cell viability.",-27.625,0.01,chemicalentity
"Intriguingly, MDMA administration in A549 cells upregulates the expression of the serotonin transporter gene (SLC6A4) while simultaneously enhancing the phosphorylation of the downstream kinase AKT, suggesting a dual modulatory effect of this chemical entity on neurotransmitter signaling pathways.",-34.25,0.01,chemicalentity
"Intracellular MDMA exposure in HeLa cells upregulates the expression of the dopamine transporter gene (SLC6A3) while simultaneously decreasing the phosphorylation of the protein kinase C pathway, thereby attenuating the neurotoxic effects of CDDP.",-34.75,0.01,chemicalentity
"When HeLa cells were treated with the chemotherapeutic agent CDDP, the expression of the DNA repair gene ERCC1 was down‑regulated, leading to increased apoptosis and a higher sensitivity to the drug.",-26.375,0.01,chemicalentity
"When treated with the chemotherapeutic agent CDDP, A549 cells exhibited a marked increase in the expression of the DNA repair gene ERCC1, suggesting that the drug induces a DNA damage response that may contribute to cisplatin resistance.",-30.125,0.01,chemicalentity
"When the A549 cell line was treated with the chemotherapeutic agent CDDP, the expression of the DNA repair gene ERCC1 was down‑regulated, leading to increased apoptosis and a higher sensitivity to the drug.",-26.5,0.01,chemicalentity
"When methyl‑d‑aspartate (MDMA) is administered to A549 cells, the drug induces a dose‑dependent up‑regulation of the dopamine transporter gene (DAT) while simultaneously decreasing the expression of the serotonin transporter (SERT) through a PHA‑mediated phosphorylation cascade.",-41.75,0.01,chemicalentity
"Use of the chemotherapeutic agent CDDP in HeLa cells induces a dose‑dependent increase in the expression of the DNA repair gene XRCC1, thereby attenuating the cytotoxic effect of the drug.",-25.75,0.01,chemicalentity
Use ethyl‑3‑(2‑hydroxy‑3‑methyl‑4‑oxo‑2‑(pyridin‑3‑yl)butyl)‑2‑(pyridin‑4‑yl)‑2‑oxo‑1‑(pyridin‑2‑yl)‑1‑(pyridin‑3‑yl)‑1‑(pyridin‑2‑yl)‑1‑(pyridin‑3‑yl)‑1,-61.75,0.01,chemicalentity
"Use MDMA to induce serotonin release, while co‑administration of ethosuximide suppresses the resulting neuronal hyperexcitability in cultured cortical neurons.",-31.25,0.01,chemicalentity
"Use the combination of MDMA and ethosuximide to reduce seizure‑induced neuroinflammation in a rat model of oxygen‑induced brain injury, while monitoring changes in neurotransmitter release and the expression of the CDDP‑responsive gene cluster.",-41.75,0.01,chemicalentity
"Triamcinolone, when administered to scopolamine‑injected mice, reduces ROS‑mediated neuronal damage more effectively than triphenyl tetrazolium chloride, a finding that may explain its superior neuroprotective profile in maleate‑induced oxidative stress models.",-24.625,0.01,chemicalentity
"Triacylglycerol lipase inhibition by triamcinolone reduces ROS production in scopolamine‑injected hippocampal slices, thereby attenuating the nitrosamine‑induced neurotoxicity observed in maleate‑induced oxidative stress models.",-27.625,0.01,chemicalentity
"Tri‑amcinolone, a synthetic glucocorticoid, was shown to suppress ROS‑mediated inflammation in scopolamine‑injected mice, whereas triphenyl tetrazolium chloride staining revealed that isoprenaline‑induced cardiac injury was markedly attenuated by the drug.",-34.0,0.01,chemicalentity
"Triad of triamcinolone, triphenyl tetrazolium chloride, and isoprenaline synergistically mitigated ROS‑induced mitochondrial dysfunction in scopolamine‑injected maleate‑induced cardiac myocytes, thereby restoring lidocaine‑resistant action potential propagation.",-34.75,0.01,chemicalentity
"In scopolamine‑injected mice, triamcinolone administration markedly reduced ROS‑mediated neuronal damage, whereas lidocaine‑resistant isoprenaline failed to attenuate the nitrosamine‑induced oxidative stress.",-19.75,0.01,chemicalentity
"In triamcinolone‑treated A549 cells, triphenyl tetrazolium chloride staining revealed that isoprenaline‑induced ROS production was markedly attenuated, suggesting a protective effect against lidocaine‑resistant cytotoxicity.",-12.8125,0.01,chemicalentity
"In A549 cells, triamcinolone treatment markedly reduced ROS production induced by isoprenaline, thereby attenuating the nitrosamine‑mediated apoptosis observed in scopolamine‑injected mice.",-19.375,0.01,chemicalentity
"In maleate‑induced hepatotoxicity, triamcinolone administration markedly attenuates ROS‑mediated lipid peroxidation, thereby protecting the liver from nitrosamine‑induced damage.",-16.5,0.01,chemicalentity
"The antioxidant triphenyl tetrazolium chloride (TTC) was shown to inhibit ROS‑mediated apoptosis in scopolamine‑injected hippocampal neurons, thereby protecting against lidocaine‑resistant ischemic injury.",-25.375,0.01,chemicalentity
"The triamcinolone‑loaded liposomes inhibited ROS‑mediated apoptosis in scopolamine‑injected hippocampal neurons, while triphenyl tetrazolium chloride staining revealed that isoprenaline‑induced mitochondrial dysfunction was markedly attenuated in the presence of the drug.",-24.5,0.01,chemicalentity
"The chemotherapeutic efficacy of triamcinolone was markedly enhanced in scopolamine‑injected A549 cells, where isoprenaline‑induced ROS production was attenuated, thereby reducing the development of lidocaine‑resistant phenotypes.",-21.75,0.01,chemicalentity
"The antitumor activity of triamcinolone was markedly enhanced in scopolamine‑injected A549 cells, where ROS‑mediated apoptosis was amplified by triphenyl tetrazolium chloride staining and isoprenaline‑induced cAMP signaling.",-25.25,0.01,chemicalentity
"Treatment with triamcinolone reduced ROS production in scopolamine‑injected maleate‑induced hippocampal slices, while triphenyl tetrazolium chloride staining revealed that lidocaine‑resistant neurons were protected by isoprenaline‑mediated β‑adrenergic signaling.",-22.375,0.01,chemicalentity
"Treatment of scopolamine‑injected mice with triamcinolone markedly reduced ROS‑mediated neuronal damage, whereas lidocaine‑resistant isoprenaline exposure exacerbated nitrosamine‑induced cardiotoxicity.",-21.75,0.01,chemicalentity
"Treatment using triamcinolone and triphenyl tetrazolium chloride markedly reduced ROS production in scopolamine‑injected maleate‑induced cardiac myocytes, thereby restoring isoprenaline‑mediated β‑adrenergic signaling and preventing lidocaine‑resistant arrhythmias.",-32.25,0.01,chemicalentity
"Treatment-induced ROS production by triphenyl tetrazolium chloride in scopolamine‑injected mice was markedly attenuated when the antioxidant triamcinolone was co‑administered, suggesting a protective effect against nitrosamine‑mediated cardiotoxicity.",-35.5,0.01,chemicalentity
"Clinical transcriptomic profiling revealed that triamcinolone treatment down‑regulates the expression of the oxidative‑stress‑responsive gene Nrf2 in scopolamine‑injected A549 cells, thereby attenuating ROS‑mediated apoptosis.",-36.25,0.01,chemicalentity
"Clinical investigation revealed that triamcinolone, when combined with triphenyl tetrazolium chloride, markedly reduced ROS production in isoprenaline‑stimulated cardiomyocytes, thereby attenuating scopolamine‑induced arrhythmias in maleate‑induced myocardial injury models.",-31.25,0.01,chemicalentity
"Clinical measurements revealed that triamcinolone administration markedly reduced ROS production in scopolamine‑injected mice, whereas triphenyl tetrazolium chloride staining confirmed that isoprenaline‑induced cardiac injury was attenuated by the drug.",-34.5,0.01,chemicalentity
"Clinical tests revealed that triamcinolone, when combined with triphenyl tetrazolium chloride, markedly reduced isoprenaline‑induced ROS production in scopolamine‑injected maleate‑induced cardiac tissue, thereby preventing lidocaine‑resistant arrhythmias.",-30.75,0.01,chemicalentity
"Isoprenaline administration in scopolamine‑injected mice exacerbated ROS‑mediated cardiac injury, while triamcinolone treatment mitigated the nitrosamine‑induced lipid peroxidation observed in the maleate‑induced hepatic steatosis model.",-27.125,0.01,chemicalentity
"Isoproterenol, a β‑adrenergic agonist, was shown to increase ROS production in scopolamine‑injected A549 cells, thereby enhancing the cytotoxic effect of triamcinolone on the tumor microenvironment.",-29.625,0.01,chemicalentity
"Is it possible that the lidocaine‑resistant phenotype observed in scopolamine‑injected mice is driven by a ROS‑mediated up‑regulation of the N‑terminal domain of the sodium channel, thereby enhancing the efficacy of the triamcinolone‑induced anti‑inflammatory response?",-44.25,0.01,chemicalentity
"Isolated triamcinolone-treated A549 cells exposed to triphenyl tetrazolium chloride revealed that isoprenaline-induced ROS production was markedly attenuated in scopolamine‑injected, maleate‑induced, lidocaine‑resistant cultures, suggesting a protective effect of the steroid against nitrosamine‑mediated oxidative stress.",-32.0,0.01,chemicalentity
"Previous studies showed that triamcinolone, when combined with triphenyl tetrazolium chloride, markedly reduced isoprenaline‑induced ROS production in scopolamine‑injected maleate‑induced cardiac tissue, thereby preventing lidocaine‑resistant arrhythmias.",-24.25,0.01,chemicalentity
"Previous investigations revealed that triamcinolone, when combined with triphenyl tetrazolium chloride, markedly reduced ROS production in scopolamine‑injected hippocampal slices, thereby attenuating isoprenaline‑induced neuronal apoptosis.",-28.125,0.01,chemicalentity
"Previous reports indicate that triamcinolone, when combined with triphenyl tetrazolium chloride, reduces ROS production in scopolamine‑injected hippocampal slices, thereby protecting isoprenaline‑induced neuronal apoptosis.",-29.625,0.01,chemicalentity
"Previous work showed that triamcinolone, when combined with triphenyl tetrazolium chloride, markedly reduced ROS production in scopolamine‑injected hippocampal slices, suggesting a neuroprotective effect against nitrosamine‑induced oxidative damage.",-27.75,0.01,chemicalentity
"Intraperitoneal injection of triamcinolone in scopolamine‑injected mice markedly reduced ROS‑mediated neuronal apoptosis, whereas co‑administration of triphenyl tetrazolium chloride restored mitochondrial membrane potential and prevented isoprenaline‑induced cardiotoxicity.",-22.375,0.01,chemicalentity
"Intravenous triamcinolone administration markedly reduced ROS production in scopolamine‑injected mice, thereby attenuating the maleate‑induced cardiotoxicity that is otherwise exacerbated by nitrosamine‑containing trans‑fat diets.",-28.25,0.01,chemicalentity
"Intriguingly, triamcinolone administration markedly reduced ROS production in scopolamine‑injected maleate‑induced cardiac myocytes, thereby attenuating lidocaine‑resistant arrhythmias.",-24.125,0.01,chemicalentity
"Intracellular ROS production induced by nitrosamine exposure in scopolamine‑injected maleate‑induced HepG2 cells is markedly attenuated when the cells are pre‑treated with the antioxidant triphenyl tetrazolium chloride, suggesting a protective interaction between the chemical entity and the oxidative stress pathway.",-28.625,0.01,chemicalentity
"Triamcinolone, when combined with triphenyl tetrazolium chloride, markedly reduces ROS production in scopolamine‑injected hippocampal slices, thereby attenuating isoprenaline‑induced excitotoxicity.",-19.875,0.01,chemicalentity
"Trametinib, a MEK inhibitor, synergistically enhances the cytotoxicity of triphenyl tetrazolium chloride in A549 cells by increasing ROS production and inducing apoptosis.",-30.25,0.01,chemicalentity
"Triazolam, a benzodiazepine, was found to inhibit the ROS‑producing activity of triphenyl tetrazolium chloride in scopolamine‑injected mice, thereby reducing the maleate‑induced oxidative stress that otherwise promotes lidocaine‑resistant cardiac arrhythmias.",-40.5,0.01,chemicalentity
"Transepithelial transport of the synthetic glucocorticoid triamcinolone is markedly enhanced in scopolamine‑injected A549 cells, where isoprenaline‑induced ROS production up‑regulates the expression of the drug‑efflux transporter MDR1, thereby contributing to the observed lidocaine‑resistant phenotype.",-41.0,0.01,chemicalentity
"High‑dose triamcinolone, when combined with triphenyl tetrazolium chloride staining, markedly reduces isoprenaline‑induced ROS production in scopolamine‑injected maleate‑induced cardiac tissue, thereby attenuating lidocaine‑resistant arrhythmias.",-19.5,0.01,chemicalentity
"High-dose triamcinolone administration in scopolamine‑injected mice markedly reduced ROS‑mediated neuronal apoptosis, whereas co‑treatment with triphenyl tetrazolium chloride restored mitochondrial membrane potential and prevented lidocaine‑resistant cardiac arrhythmias.",-27.625,0.01,chemicalentity
"High doses of triamcinolone, when combined with triphenyl tetrazolium chloride staining, reveal that isoprenaline‑induced ROS production is markedly attenuated in scopolamine‑injected maleate‑induced cardiac tissue, suggesting a protective effect against lidocaine‑resistant arrhythmias.",-25.25,0.01,chemicalentity
"High concentrations of triamcinolone, when combined with isoprenaline, markedly reduce ROS production in scopolamine‑injected A549 cells, thereby attenuating the nitrosamine‑induced apoptosis that typically renders these cells lidocaine‑resistant.",-28.375,0.01,chemicalentity
"Administration of triamcinolone to scopolamine‑injected mice markedly reduced ROS‑mediated neuronal apoptosis, whereas triphenyl tetrazolium chloride staining revealed that isoprenaline‑induced cardiac injury was significantly attenuated by the same steroid treatment.",-26.5,0.01,chemicalentity
"Administration with triamcinolone markedly reduced ROS production in scopolamine‑injected maleate‑induced HepG2 cells, whereas triphenyl tetrazolium chloride staining revealed that lidocaine‑resistant isoprenaline‑treated cells retained mitochondrial membrane potential.",-39.0,0.01,chemicalentity
"Administration to scopolamine‑injected mice of a high‑dose triamcinolone regimen markedly reduced the ROS‑mediated lipid peroxidation induced by maleate‑induced oxidative stress, thereby protecting the myocardium from lidocaine‑resistant arrhythmias.",-41.25,0.01,chemicalentity
"Administration and subsequent measurement of triphenyl tetrazolium chloride staining revealed that isoprenaline-induced ROS production was markedly attenuated in scopolamine‑injected maleate‑induced cardiac tissue, suggesting a protective effect of triamcinolone against lidocaine‑resistant arrhythmias.",-39.25,0.01,chemicalentity
"Triphenyl tetrazolium chloride staining revealed that isoprenaline‑induced ROS production in scopolamine‑injected maleate‑treated HeLa cells was markedly attenuated by triamcinolone, suggesting a protective anti‑oxidant effect of the corticosteroid on mitochondrial viability.",-20.375,0.01,chemicalentity
"Tripranolone, a synthetic glucocorticoid, was shown to reduce ROS production in scopolamine‑injected rat hippocampal slices, thereby attenuating the nitrosamine‑induced neurotoxicity that otherwise exacerbates the maleate‑induced mitochondrial dysfunction.",-45.5,0.01,chemicalentity
"Triprenyl‑tetrazolium chloride, a redox‑active dye, was used to quantify ROS production in scopolamine‑injected maleate‑induced cardiomyocytes, revealing that lidocaine‑resistant isoprenaline‑stimulated cells exhibited a markedly higher nitrosamine‑mediated oxidative burst.",-47.5,0.01,chemicalentity
"Triply‑stained HeLa cells treated with triamcinolone and triphenyl tetrazolium chloride revealed that isoprenaline‑induced ROS production was markedly attenuated in scopolamine‑injected, maleate‑induced, lidocaine‑resistant cultures, suggesting a protective effect of the nitrosamine‑derived trans‑fat metabolite.",-35.25,0.01,chemicalentity
"Scopolamine‑injected mice treated with triamcinolone exhibit reduced ROS‑mediated neuronal apoptosis, whereas lidocaine‑resistant neurons exposed to isoprenaline display heightened calcium influx and nitrosamine‑induced DNA strand breaks.",-28.375,0.01,chemicalentity
"Scoping the effect of triamcinolone on ROS production in scopolamine‑injected maleate‑induced cardiac myocytes revealed that the steroid markedly suppressed the nitrosamine‑induced up‑regulation of isoprenaline‑responsive cAMP signaling, thereby restoring lidocaine‑resistant action potential duration.",-50.5,0.01,chemicalentity
"Scolarine, a synthetic nitrosamine derivative, was shown to inhibit the proliferation of HeLa cells by inducing ROS-mediated apoptosis, while triphenyl tetrazolium chloride staining confirmed the loss of mitochondrial membrane potential in the treated cultures.",-43.25,0.01,chemicalentity
"Scopoletin, a natural triamcinolone analogue, was shown to inhibit isoprenaline‑induced ROS production in scopolamine‑injected maleate‑induced cardiac myocytes, thereby reducing lidocaine‑resistant arrhythmias.",-35.75,0.01,chemicalentity
"A lidocaine‑resistant variant of the Nav1.5 channel in A549 cells is up‑regulated by isoprenaline, and its expression is further enhanced when the cells are treated with triphenyl tetrazolium chloride, suggesting that ROS generated during the assay may contribute to the observed drug resistance.",-39.25,0.01,chemicalentity
"A study showed that triamcinolone, when combined with triphenyl tetrazolium chloride, markedly reduced ROS production in scopolamine‑injected hippocampal slices, suggesting a neuroprotective effect against isoprenaline‑induced oxidative stress.",-26.25,0.01,chemicalentity
"A triamcinolone‑loaded nanoparticle formulation was shown to reduce ROS‑mediated apoptosis in scopolamine‑injected hippocampal neurons, thereby improving memory retention in a maleate‑induced rat model of neurodegeneration.",-24.5,0.01,chemicalentity
"A triphenyl tetrazolium chloride assay revealed that isoprenaline‑induced ROS production was markedly attenuated in scopolamine‑injected maleate‑induced mice, suggesting a protective effect of triamcinolone against lidocaine‑resistant cardiac toxicity.",-23.375,0.01,chemicalentity
"Nitric oxide synthase inhibitors reduce acetylcholine‑induced LpA/Ppg elevation, thereby attenuating methamphetamine‑induced increases in alanine aminotransferase and Arachidonic acid‑derived eicosanoids.",-13.5625,0.01,chemicalentity
"Nitrous oxide, a nitric oxide donor, was shown to inhibit acetylcholine‑induced LpA/Ppg release in cultured hepatocytes, thereby reducing alanine aminotransferase secretion and attenuating methamphetamine‑induced oxidative stress.",-31.125,0.01,chemicalentity
"Nitrosylated nitric oxide donors, when combined with the alpha-hydroxymetoprolol antagonist, markedly suppress LpA/Ppg‑mediated acetylcholine‑induced elevation of alanine aminotransferase in HepG2 cells.",-37.75,0.01,chemicalentity
"Nitrogen‑oxide synthase inhibitors, such as L‑arginine analogues, attenuate acetylcholine‑induced vasodilation in human endothelial cells by competitively blocking nitric‑oxide production.",-30.75,0.01,chemicalentity
"Methamphetamine‑induced elevation of nitric oxide synthase activity in the striatum is attenuated by the selective NO synthase inhibitor L‑arginine, reducing acetylcholine‑induced increases in alanine aminotransferase and LpA/Ppg levels.",-26.5,0.01,chemicalentity
"Methadone, a synthetic opioid, competitively inhibits the acetylcholine‑induced release of acetylcholine in the striatum, thereby attenuating the hyperphosphorylation of alpha‑hydroxymetoprolol‑mediated cAMP signaling and reducing the expression of the Arachidonic acid‑dependent prostaglandin E2 synthase in the hippocampus.",-50.75,0.01,chemicalentity
"Methotrexate, a folate analogue, competitively inhibits dihydrofolate reductase, thereby reducing thymidylate synthesis and impairing DNA replication in rapidly dividing A549 cells, while simultaneously inducing a dose‑dependent increase in alanine aminotransferase levels that signals hepatotoxicity in the treated Homo sapiens subjects.",-40.5,0.01,chemicalentity
"Methicillin‑resistant *Staphylococcus aureus* infection in the A549 cell line was attenuated by the nitric‑oxide‑donating compound L‑arginine, which inhibited bacterial growth and reduced alanine aminotransferase release from the infected cells.",-32.75,0.01,chemicalentity
"Acetylcholine‑induced nitric oxide production in the hippocampus is markedly attenuated by the selective NO synthase inhibitor L‑arginine, thereby reducing Arachidonic acid‑mediated excitotoxicity and preserving alanine aminotransferase activity in the neuronal culture.",-32.25,0.01,chemicalentity
"Acute methamphetamine exposure elevates plasma alanine aminotransferase levels in A549 cells, an effect that is markedly attenuated by the NO synthase inhibitor L‑arginine and the α‑hydroxymetoprolol antagonist, suggesting a crosstalk between nitric oxide signaling and methamphetamine‑induced hepatotoxicity.",-32.5,0.01,chemicalentity
"Acrolein, a reactive aldehyde formed during high‑fructose diets, activates NO synthase inhibitors in endothelial cells, thereby reducing nitric oxide production and exacerbating acetylcholine‑induced vasoconstriction.",-28.375,0.01,chemicalentity
"Acetyldopamine, a synthetic analog of dopamine, competitively inhibits nitric oxide synthase in HeLa cells, thereby reducing acetylcholine‑induced cGMP production and attenuating LpA/Ppg‑mediated platelet aggregation.",-31.75,0.01,chemicalentity
"Alzheimer’s disease progression is accelerated by nitric oxide-mediated oxidative stress, which is exacerbated by acetylcholine‑induced Arachidonic acid release and further amplified when NO synthase inhibitors are absent.",-28.75,0.01,chemicalentity
"Alleviation of methamphetamine‑induced neurotoxicity in mice was achieved by co‑administration of the NO synthase inhibitor L‑arginine, which reduced oxidative stress and preserved acetylcholine‑induced synaptic plasticity.",-28.0,0.01,chemicalentity
"Aluminum chloride, a potent NO synthase inhibitor, markedly reduces acetylcholine‑induced LpA/Ppg secretion in cultured human hepatocytes, thereby attenuating the downstream arachidonic acid‑mediated inflammatory cascade.",-32.25,0.01,chemicalentity
"Alkylating the Arachidonic acid moiety of the novel NO synthase inhibitor, a selective alpha-hydroxymetoprolol derivative, markedly reduced acetylcholine‑induced LpA/Ppg elevation in cultured HepG2 cells.",-42.75,0.01,chemicalentity
"Exposure of A549 cells to the NO synthase inhibitor L-NAME markedly reduced acetylcholine‑induced LpA/Ppg secretion while simultaneously increasing alanine aminotransferase activity, suggesting a compensatory shift toward arachidonic acid metabolism.",-24.0,0.01,chemicalentity
"Exposure to the NO synthase inhibitor L-arginine methyl ester in A549 cells markedly reduced acetylcholine‑induced calcium transients, suggesting that nitric oxide signaling modulates cholinergic responsiveness in this lung cancer line.",-27.5,0.01,chemicalentity
"Exposure‑induced nitric oxide production by NO synthase inhibitors in acetylcholine‑induced A549 cells leads to increased alanine aminotransferase release, suggesting a potential hepatotoxic effect of methamphetamine‑derived metabolites.",-41.75,0.01,chemicalentity
Exposure or inhibition of nitric oxide synthase by alpha‑hydroxymetoprolol markedly reduces acetylcholine‑induced increases in alanine aminotransferase activity in cultured hepatocytes.,-32.75,0.01,chemicalentity
"In vitro, the NO synthase inhibitor L-NAME markedly attenuates acetylcholine‑induced vasodilation in human umbilical vein endothelial cells, an effect that is partially rescued by the addition of the Arachidonic acid metabolite prostaglandin E₂.",-27.0,0.01,chemicalentity
"In H9c2 cardiomyocytes, the nitric‑oxide‑producing compound L‑arginine enhances acetylcholine‑induced relaxation, while the NO synthase inhibitor L‑NAME abolishes this effect, indicating that NO mediates acetylcholine‑dependent vasodilation.",-32.0,0.01,chemicalentity
"In MCF‑7 cells, the nitric‑oxide‑producing compound L‑arginine enhances acetylcholine‑induced calcium influx, thereby up‑regulating the expression of the Arachidonic‑acid‑metabolizing enzyme cyclo‑oxygenase‑2.",-25.875,0.01,chemicalentity
"In *HeLa* cells, the nitric‑oxide‑producing enzyme inducible‑NO‑synthase is up‑regulated by methamphetamine, leading to increased production of reactive nitrogen species that subsequently inhibit the Arachidonic‑acid‑derived prostaglandin E₂ pathway and reduce the expression of the *TP53* gene.",-38.5,0.01,chemicalentity
"The Arachidonic acid metabolite leukotriene B4, produced by NO synthase inhibitors in acetylcholine‑induced vascular smooth‑muscle cells, activates the alpha‑hydroxymetoprolol‑sensitive pathway, thereby elevating alanine aminotransferase levels in a dose‑dependent manner.",-37.5,0.01,chemicalentity
"The selective NO synthase inhibitor L-NAME markedly attenuates acetylcholine‑induced vasodilation in isolated rat aortic rings, an effect that is reversed by the Arachidonic acid metabolite prostaglandin E₂.",-27.125,0.01,chemicalentity
"The alpha‑hydroxymetoprolol derivative, acting as a selective NO synthase inhibitor, markedly reduced acetylcholine‑induced increases in alanine aminotransferase activity in LpA/Ppg‑treated HepG2 cells.",-21.125,0.01,chemicalentity
"The therapeutic efficacy of the novel NO synthase inhibitor, LpA/Ppg, was markedly enhanced in A549 cells treated with the methamphetamine‑induced oxidative stress model, as evidenced by a significant reduction in alanine aminotransferase release and a concomitant decrease in Arachidonic acid‑mediated inflammatory signaling.",-35.5,0.01,chemicalentity
"NO synthase inhibitors reduce acetylcholine‑induced nitric oxide production, thereby attenuating methamphetamine‑induced increases in alanine aminotransferase and LpA/Ppg levels in a dose‑dependent manner.",-16.875,0.01,chemicalentity
NO‑synthase inhibitors such as L‑arginine analogues reduce acetylcholine‑induced vasodilation by blocking nitric oxide production in endothelial cells.,-21.25,0.01,chemicalentity
NO‐synthase inhibitors such as L‑arginine analogues reduce acetylcholine‑induced vasodilation by blocking nitric oxide production in endothelial cells.,-22.75,0.01,chemicalentity
"NO synthesis inhibition by L-arginine analogues reduces acetylcholine‑induced LpA/Ppg elevation and attenuates methamphetamine‑induced increases in alanine aminotransferase, suggesting a protective role of nitric oxide modulation in neuro‑hepatic injury.",-32.25,0.01,chemicalentity
"Beta-blocker alpha-hydroxymetoprolol reduces acetylcholine‑induced increases in alanine aminotransferase activity in HepG2 cells, while nitric oxide synthase inhibitors attenuate the concomitant rise in LpA/Ppg levels.",-29.75,0.01,chemicalentity
"Beta‑blocker alpha‑hydroxymetoprolol reduces acetylcholine‑induced nitric oxide production in cultured human endothelial cells, thereby attenuating LpA/Ppg‑mediated vascular inflammation.",-23.375,0.01,chemicalentity
"Beta‐blocker alpha‑hydroxymetoprolol markedly reduced acetylcholine‑induced increases in alanine aminotransferase activity in LpA/Ppg‑treated HepG2 cells, suggesting a protective effect against methamphetamine‑induced hepatotoxicity.",-30.75,0.01,chemicalentity
"Beta-adrenergic blockade with alpha-hydroxymetoprolol reduces acetylcholine‑induced increases in alanine aminotransferase activity in LpA/Ppg‑treated mice, suggesting a protective effect against methamphetamine‑induced hepatic injury.",-29.5,0.01,chemicalentity
"Metabolic profiling revealed that the NO synthase inhibitor L-arginine analog, when combined with the Arachidonic acid derivative, markedly reduced acetylcholine‑induced alanine aminotransferase release in cultured HepG2 cells.",-28.25,0.01,chemicalentity
"Metformin, a widely used antidiabetic chemical entity, competitively inhibits mitochondrial complex I, thereby reducing reactive oxygen species production and attenuating the acetylcholine‑induced upregulation of nitric oxide synthase in cultured human vascular endothelial cells.",-27.375,0.01,chemicalentity
"Metabolomic profiling revealed that the NO synthase inhibitor L-arginine analog, which blocks nitric oxide production, markedly reduced acetylcholine‑induced increases in alanine aminotransferase activity in cultured HepG2 cells.",-25.0,0.01,chemicalentity
"Metabolism of the neurotransmitter acetylcholine in the hippocampus is markedly enhanced by the NO synthase inhibitor L-arginine analog, which reduces alanine aminotransferase activity and attenuates methamphetamine‑induced neurotoxicity.",-31.125,0.01,chemicalentity
"Intracerebral injection of the α‑hydroxymetoprolol analogue, a selective NO synthase inhibitor, markedly reduced acetylcholine‑induced increases in alanine aminotransferase activity and attenuated methamphetamine‑induced elevations of LpA/Ppg levels in the hippocampus of adult C57BL/6J mice.",-33.5,0.01,chemicalentity
"Intravenous administration of the NO synthase inhibitor L-arginine analog L-NAME markedly attenuates acetylcholine‑induced vasodilation in isolated rat aortic rings, an effect that is reversed by exogenous nitric oxide donors and is accompanied by a dose‑dependent decrease in alanine aminotransferase activity.",-34.0,0.01,chemicalentity
"Intraperitoneal injection of the α‑hydroxymetoprolol analogue, a selective β‑adrenergic antagonist, markedly reduced the methamphetamine‑induced elevation of plasma alanine aminotransferase and attenuated the associated rise in hepatic nitric‑oxide synthase activity in C57BL/6J mice.",-34.75,0.01,chemicalentity
"Intraneuronal nitric oxide production, stimulated by acetylcholine‑induced calcium influx, activates NO synthase inhibitors that attenuate Arachidonic acid‑mediated phospholipase A2 signaling and reduce alanine aminotransferase release in methamphetamine‑treated hepatocytes.",-33.25,0.01,chemicalentity
"Injection of the NO synthase inhibitor L-NAME into the hippocampus of rats chronically exposed to methamphetamine markedly reduced acetylcholine‑induced increases in alanine aminotransferase activity while simultaneously attenuating the rise in LpA/Ppg levels, suggesting a protective role of nitric oxide blockade against methamphetamine‑induced neuro‑hepatic dysfunction.",-37.5,0.01,chemicalentity
"Injection with the NO synthase inhibitor L-NAME markedly reduced acetylcholine‑induced LpA/Ppg elevation in the rat aorta, while concomitant methamphetamine exposure amplified the rise in alanine aminotransferase activity.",-40.0,0.01,chemicalentity
"Injection‑induced nitric oxide production in HeLa cells treated with the α‑hydroxymetoprolol analogue attenuates acetylcholine‑induced calcium influx while simultaneously up‑regulating Arachidonic acid‑derived prostaglandin E2 synthesis, thereby modulating the inflammatory response in this human cervical carcinoma model.",-51.25,0.01,chemicalentity
"Injection into HeLa cells of the NO synthase inhibitor L-NAME markedly reduced acetylcholine‑induced nitric oxide production, thereby attenuating the subsequent rise in alanine aminotransferase activity.",-35.5,0.01,chemicalentity
"Arachidonic acid metabolism is upregulated in HeLa cells treated with the NO synthase inhibitor LpA/Ppg, leading to increased production of prostaglandin E2 that subsequently enhances acetylcholine‑induced calcium signaling.",-22.5,0.01,chemicalentity
"A nitric‑oxide synthase inhibitor reduces acetylcholine‑induced LpA/Ppg elevation in methamphetamine‑treated mice, thereby attenuating the rise in alanine aminotransferase and protecting hepatic cells from oxidative damage.",-26.0,0.01,chemicalentity
"A NO synthase inhibitor reduces acetylcholine‑induced nitric oxide production in LpA/Ppg‑stimulated HepG2 cells, thereby attenuating methamphetamine‑induced elevation of alanine aminotransferase.",-21.375,0.01,chemicalentity
"A pharmacological study showed that the NO synthase inhibitor L-NAME markedly reduced acetylcholine‑induced vasodilation in isolated rat aortic rings, an effect that was partially reversed by the addition of the Arachidonic acid metabolite prostaglandin E₂.",-35.0,0.01,chemicalentity
"Administration of the NO synthase inhibitor L-arginine analog L-NAME markedly reduced acetylcholine‑induced LpA/Ppg secretion in cultured human endothelial cells, while concomitant exposure to the methamphetamine‑derived metabolite amphetamine increased alanine aminotransferase activity, suggesting a dual modulation of vascular tone and hepatic injury by these chemical entities.",-38.75,0.01,chemicalentity
"Administration with the NO synthase inhibitor L-arginine analog L-NAME markedly reduced acetylcholine‑induced LpA/Ppg elevation in rats, while concomitant methamphetamine exposure amplified the rise in alanine aminotransferase and Arachidonic acid metabolites.",-43.25,0.01,chemicalentity
"Administration or inhibition of nitric oxide synthase by alpha‑hydroxymetoprolol markedly attenuates acetylcholine‑induced increases in alanine aminotransferase activity in LpA/Ppg‑treated hepatocytes, suggesting a protective role of NO modulation in methamphetamine‑induced hepatic injury.",-40.25,0.01,chemicalentity
"Administration‑induced nitric oxide production by NO synthase inhibitors markedly attenuates acetylcholine‑induced increases in alanine aminotransferase activity in LpA/Ppg‑treated HepG2 cells, suggesting a protective role of the Arachidonic acid pathway against methamphetamine‑mediated hepatotoxicity.",-43.0,0.01,chemicalentity
"The **phloridzin** derivative, when administered to **E. coli** cultures, markedly reduced **TBARs** levels, indicating a potent antioxidant effect that may mitigate oxidative stress induced by **dimethyl sulphoxide** exposure.",-26.5,0.01,chemicalentity
"The drug phloridzin, a natural flavonoid, competitively inhibits GLUT4-mediated glucose uptake in ETO‑treated A549 cells, thereby reducing intracellular TBARs levels and attenuating oxidative stress induced by T+PCPA exposure.",-24.625,0.01,chemicalentity
"The phloridzin‑treated A549 cells exhibited a significant reduction in TBARs levels, indicating that this natural flavonoid mitigates oxidative stress induced by ETO‑treated mitochondria.",-19.75,0.01,chemicalentity
"The administration of phloridzin to ETO‑treated A549 cells markedly reduced TBARs levels, indicating that this natural flavonoid mitigates oxidative lipid damage induced by the chemotherapeutic agent.",-16.625,0.01,chemicalentity
"Exposure of HepG2 cells to the phytochemical phloridzin markedly reduced TBARs levels, indicating that this chemical entity can attenuate oxidative stress induced by ETO‑treated mitochondria.",-20.75,0.01,chemicalentity
"Exposure to the N‑acylimidazole derivative phloridzin in ETO‑treated HepG2 cells markedly reduced TBARs levels, suggesting that the compound mitigates oxidative stress induced by the T+PCPA regimen.",-24.25,0.01,chemicalentity
"Exposure‑induced oxidative stress in ETO‑treated A549 cells, measured by increased TBARs, was markedly attenuated by co‑administration of the N‑acylimidazole derivative phloridzin, suggesting a protective interaction between this chemical entity and the chemotherapeutic agent.",-35.5,0.01,chemicalentity
"Exposure or ETO‑treated cells to phloridzin markedly reduced TBARs, indicating that this chemical entity mitigates oxidative stress in the presence of T+PCPA.",-35.5,0.01,chemicalentity
"Phloridzin treatment markedly reduced TBARs levels in ETO‑treated A549 cells, suggesting that this natural flavonoid mitigates oxidative stress induced by dimethyl sulphoxide exposure.",-16.375,0.01,chemicalentity
"Pharmacological inhibition of the NADPH oxidase complex by phloridzin markedly reduced ETO‑treated TBARs levels in the T+PCPA‑induced rat model, whereas co‑administration of simvastatin‑ezetimibe or Terfenadine failed to attenuate the oxidative stress signature.",-33.25,0.01,chemicalentity
"Phenytoin, a classic antiepileptic chemical entity, was found to reduce TBARs levels in ETO‑treated A549 cells, suggesting an antioxidant effect that may complement simvastatin‑ezetimibe therapy in reducing oxidative stress in lung carcinoma models.",-33.0,0.01,chemicalentity
"Phosphatidylinositol-3-kinase inhibition by the small molecule phloridzin reduces ETO‑treated TBARs levels in T+PCPA‑stimulated HepG2 cells, suggesting a protective effect against oxidative stress.",-30.25,0.01,chemicalentity
"In HeLa cells, the ETO‑treated DNA damage response is amplified by phloridzin, which reduces TBARs and enhances the antioxidant effect of dimethyl sulphoxide while simultaneously inhibiting the pro‑inflammatory signaling induced by ciprofloxacin.",-26.5,0.01,chemicalentity
"In ETO‑treated A549 cells, phloridzin markedly reduced TBARs levels, indicating that this natural flavonoid mitigates oxidative stress induced by the chemotherapeutic agent.",-14.0,0.01,chemicalentity
"In murine hepatocytes, ETO‑treated cells exposed to phloridzin exhibit a significant reduction in TBARs levels, indicating that phloridzin mitigates oxidative stress induced by the chemotherapeutic agent.",-20.125,0.01,chemicalentity
"In **E. coli** exposed to **dimethyl sulphoxide**, the **phloridzin** analogue **N‑acylimidazole** markedly reduced **TBARs** levels, suggesting a protective antioxidant effect against oxidative stress.",-23.25,0.01,chemicalentity
"Ethanol exposure in ETO‑treated HepG2 cells increases TBARs levels, while co‑administration of simvastatin‑ezetimibe reduces oxidative stress and restores glutathione synthesis.",-21.125,0.01,chemicalentity
"Eto-treated HepG2 cells exposed to phloridzin exhibit a significant reduction in TBARs levels, indicating that phloridzin mitigates oxidative stress induced by ethanol metabolism.",-15.25,0.01,chemicalentity
"Ethiol‑treated HeLa cells exposed to the N‑acylimidazole derivative phloridzin exhibit a significant reduction in TBARs levels, indicating that the compound mitigates oxidative stress induced by dimethyl sulphoxide.",-29.25,0.01,chemicalentity
"Epidemiological analysis revealed that chronic exposure to the phytochemical phloridzin in ETO‑treated A549 cells significantly reduced TBARs levels, suggesting an antioxidant effect that may counteract T+PCPA‑induced oxidative stress.",-28.125,0.01,chemicalentity
"Administration of phloridzin to ETO‑treated A549 cells markedly reduced TBARs levels, indicating that this natural flavonoid mitigates oxidative stress induced by the chemotherapeutic agent.",-15.125,0.01,chemicalentity
"Administration to ETO‑treated A549 cells of the N‑acylimidazole derivative phloridzin markedly reduced TBARs levels, indicating that this chemical entity can attenuate oxidative stress in this human lung carcinoma cell line.",-34.25,0.01,chemicalentity
"Administration with the N‑acylimidazole derivative phloridzin markedly reduced TBARs in ETO‑treated A549 cells, suggesting that this chemical entity mitigates oxidative stress in the lung cancer model.",-35.5,0.01,chemicalentity
"Administration and ETO‑treated exposure of HepG2 cells to the flavonoid phloridzin markedly reduced TBARs levels, indicating that this chemical entity mitigates oxidative stress in a dose‑dependent manner.",-38.5,0.01,chemicalentity
"Simvastatin‑ezetimibe treatment markedly reduced TBARs in ETO‑treated A549 cells, while phloridzin co‑administration further attenuated oxidative stress and restored mitochondrial membrane potential.",-17.0,0.01,chemicalentity
"Simultaneous exposure of HepG2 cells to the antioxidant phloridzin and the chemotherapeutic agent cisplatin markedly reduced TBARs levels, indicating that phloridzin mitigates cisplatin‑induced lipid peroxidation.",-24.125,0.01,chemicalentity
"Simulated ETO‑treated A549 cells exposed to phloridzin exhibited a significant reduction in TBARs, indicating that phloridzin mitigates oxidative lipid damage induced by ethanol‑derived reactive species.",-26.625,0.01,chemicalentity
"Simulating the effect of phloridzin on glucose uptake, we observed that ETO‑treated HepG2 cells exhibited a significant reduction in TBARs levels, while co‑administration of T+PCPA restored lipid peroxidation to baseline, suggesting a protective role of the N‑acylimidazole derivative against oxidative stress.",-39.75,0.01,chemicalentity
"A549 cells treated with the N‑acylimidazole derivative phloridzin exhibit a significant reduction in TBARs levels, indicating that this chemical entity mitigates oxidative stress in the lung cancer model.",-20.625,0.01,chemicalentity
"A pharmacokinetic study revealed that ETO‑treated HeLa cells exposed to phloridzin exhibited a significant reduction in TBARs, suggesting that the antioxidant activity of phloridzin mitigates oxidative stress induced by the chemotherapeutic agent.",-26.125,0.01,chemicalentity
"A single dose of phloridzin markedly reduced TBARs in ETO‑treated A549 cells, suggesting that this natural flavonoid mitigates oxidative stress induced by the chemotherapeutic agent.",-27.375,0.01,chemicalentity
"A metabolomic analysis revealed that ETO‑treated HeLa cells exposed to phloridzin exhibited a significant reduction in TBARs, suggesting that phloridzin mitigates oxidative stress induced by the chemotherapeutic agent.",-25.25,0.01,chemicalentity
"Administering phloridzin to ETO‑treated A549 cells markedly reduced TBARs levels, indicating that this natural flavonoid mitigates oxidative stress induced by the chemotherapeutic agent.",-18.25,0.01,chemicalentity
"Administation of phloridzin to ETO‑treated A549 cells markedly reduced TBARs levels, indicating that this natural flavonoid mitigates oxidative lipid damage induced by the chemotherapeutic agent.",-30.875,0.01,chemicalentity
"Administration of phloridzin to ETO‑treated A549 cells markedly reduced TBARs levels, indicating that this natural flavonoid mitigates oxidative lipid damage induced by the chemotherapeutic agent.",-33.0,0.01,chemicalentity
"Admini­ration of phloridzin in ETO‑treated A549 cells markedly reduced TBARs levels, indicating that this natural flavonoid mitigates oxidative stress induced by the chemotherapeutic agent.",-36.5,0.01,chemicalentity
"Dexamethasone‑treated A549 cells exposed to the N‑acylimidazole derivative phloridzin exhibited a significant reduction in TBARs levels, indicating decreased lipid peroxidation.",-18.875,0.01,chemicalentity
"Doxorubicin‑induced cardiotoxicity in A549 cells is markedly attenuated by co‑treatment with the antioxidant phloridzin, which reduces TBARs accumulation and restores mitochondrial membrane potential.",-18.875,0.01,chemicalentity
"D‑phloridzin, a natural flavonoid, competitively inhibits GLUT‑4 in ETO‑treated A549 cells, thereby reducing intracellular TBARs and attenuating T+PCPA‑induced oxidative stress.",-24.75,0.01,chemicalentity
"D‐phloridzin, a natural flavonoid, competitively inhibits glucose uptake in HepG2 cells, thereby reducing TBARs formation and attenuating ETO‑treated oxidative stress, while co‑administration of simvastatin‑ezetimibe further suppresses lipid peroxidation and improves insulin sensitivity.",-39.75,0.01,chemicalentity
"Treatment with the N‑acylimidazole derivative phloridzin markedly reduced TBARs in ETO‑treated A549 cells, suggesting that this chemical entity mitigates oxidative stress in the lung cancer model.",-21.125,0.01,chemicalentity
"Treatment of ETO‑treated A549 cells with the N‑acylimidazole derivative phloridzin markedly reduced TBARs levels, indicating that this chemical entity can attenuate oxidative stress in this lung cancer cell line.",-20.25,0.01,chemicalentity
"Treatment and ETO‑treated cells exposed to phloridzin and dimethyl sulphoxide exhibited a significant reduction in TBARs, indicating that the antioxidant activity of phloridzin mitigates oxidative damage induced by the solvent.",-39.25,0.01,chemicalentity
"Treatment‑induced oxidative stress in ETO‑treated A549 cells, measured by increased TBARs, was significantly mitigated by co‑administration of phloridzin, which also reduced the T+PCPA‑mediated rise in intracellular ROS.",-34.5,0.01,chemicalentity
"An ETO‑treated A549 cell line exposed to phloridzin shows a significant reduction in TBARs, indicating that the antioxidant effect of phloridzin mitigates oxidative damage induced by the chemotherapeutic agent.",-22.0,0.01,chemicalentity
"An in‑vitro assay revealed that phloridzin, a natural flavonoid, competitively inhibited the uptake of the synthetic N‑acylimidazole derivative in ETO‑treated HepG2 cells, thereby reducing TBARs formation and attenuating oxidative stress induced by T+PCPA exposure.",-33.75,0.01,chemicalentity
"An elevated level of TBARs in ETO‑treated A549 cells was markedly reduced by co‑administration of phloridzin, suggesting that this natural flavonoid mitigates oxidative damage induced by the chemotherapeutic agent.",-28.125,0.01,chemicalentity
"An up‑regulation of oxidative‑stress markers such as TBARs was observed in ETO‑treated A549 cells following exposure to the N‑acylimidazole derivative phloridzin, suggesting that this chemical entity may mitigate lipid peroxidation in a dose‑dependent manner.",-31.25,0.01,chemicalentity
"ET-treated HeLa cells exposed to phloridzin exhibit a significant reduction in TBARs levels, indicating that phloridzin mitigates oxidative stress induced by ethanol metabolism.",-23.625,0.01,chemicalentity
"ETO‑treated HepG2 cells exposed to phloridzin exhibit a significant reduction in TBARs, indicating that phloridzin mitigates oxidative stress induced by ethanol metabolism.",-17.5,0.01,chemicalentity
"ETOH‑treated HepG2 cells exposed to phloridzin exhibit a significant reduction in TBARs, indicating that phloridzin mitigates ethanol‑induced lipid peroxidation.",-19.375,0.01,chemicalentity
"ET‑O‑treated HepG2 cells exposed to phloridzin exhibit a significant reduction in TBARs, indicating that this natural flavonoid mitigates oxidative lipid damage induced by the solvent dimethyl sulphoxide.",-26.125,0.01,chemicalentity
"High‑dose phloridzin treatment in ETO‑treated A549 cells markedly reduced TBARs levels, indicating that phloridzin’s antioxidant activity counteracts oxidative stress induced by the chemotherapeutic agent.",-20.875,0.01,chemicalentity
"High‐dose phloridzin treatment in ETO‑treated A549 cells markedly reduced TBARs levels, indicating that phloridzin’s antioxidant activity counteracts oxidative stress induced by the chemotherapeutic agent.",-24.5,0.01,chemicalentity
"High-dose phloridzin treatment in ETO‑treated A549 cells markedly reduced TBARs levels, indicating that phloridzin mitigates oxidative stress induced by ethanol exposure.",-22.0,0.01,chemicalentity
"High concentrations of the flavonoid phloridzin in ETO‑treated A549 cells markedly reduced TBARs levels, indicating that phloridzin mitigates oxidative stress induced by the chemotherapeutic agent.",-26.5,0.01,chemicalentity
"In HBsAg‑positive hepatocytes, the NO synthase inhibitor ephedrine markedly reduces neopterin production, thereby attenuating the inflammatory response induced by CsA‑to‑SRL therapy.",-17.125,0.01,chemicalentity
"In the salt‑diet‑induced hypertension model, chronic administration of the NO synthase inhibitor L‑NAME markedly reduced the up‑regulation of eGFP‑tagged endothelin‑1 observed in the renal cortex of C57BL/6J mice, while concomitant treatment with the antihypertensive drug olanzapine further attenuated the rise in plasma neopterin levels.",-35.75,0.01,chemicalentity
"In HepG2 cells, the NO synthase inhibitor L-NAME markedly reduces the epigenetic activation of the HBsAg promoter, thereby attenuating viral replication and decreasing neopterin secretion induced by the salt‑diet‑induced oxidative stress.",-25.375,0.01,chemicalentity
"In vitro, the NO synthase inhibitor L-NAME markedly reduced ephedrine‑induced cAMP accumulation in HepG2 cells, while co‑treatment with the antipsychotic olanzapine restored the signaling deficit.",-23.75,0.01,chemicalentity
"Olanzapine, a second‑generation antipsychotic, competitively inhibits dopamine D2 receptors and, in patients with schizophrenia, reduces serum neopterin levels, indicating a dampening of cellular immune activation.",-22.375,0.01,chemicalentity
"Olrezapine, a second‑generation antipsychotic, competitively inhibits dopamine D2 receptors in the striatum, thereby reducing hyperkinetic motor symptoms in patients with Parkinson’s disease while concurrently lowering serum neopterin levels, a biomarker of immune activation, and improving the efficacy of HBsAg‑specific antiviral therapy.",-50.75,0.01,chemicalentity
"Olazapine, a second‑generation antipsychotic, competitively inhibits dopamine D2 receptors in the striatum, thereby reducing hyperkinetic motor symptoms in patients with Parkinson’s disease while concurrently lowering serum neopterin levels, a marker of immune activation, in those receiving a salt‑diet‑induced hypertension regimen.",-45.25,0.01,chemicalentity
"Olaparib, a PARP inhibitor, synergistically enhances the cytotoxicity of doxorubicin in A549 cells by upregulating the expression of the DNA repair gene XRCC1, thereby increasing the accumulation of DNA double‑strand breaks and promoting apoptosis.",-40.0,0.01,chemicalentity
"Exposure of HepG2 cells to the antipsychotic olanzapine at clinically relevant concentrations induces a dose‑dependent up‑regulation of CYP1A1 expression, which in turn enhances the bioactivation of the pro‑carcinogen benzo[a]pyrene into the DNA‑adduct forming metabolite BPDE, thereby increasing mutagenic lesions in the TP53 gene.",-35.75,0.01,chemicalentity
"Exposure to the antipsychotic olanzapine in a salt‑diet‑induced hypertension model markedly up‑regulated eGFP‑tagged NO synthase, thereby enhancing nitric‑oxide production and attenuating the rise in blood pressure.",-29.25,0.01,chemicalentity
"Exposure‑based assays revealed that the NO synthase inhibitor, etifoxine, markedly reduced neopterin production in HeLa cells treated with the salt‑diet‑induced cytokine milieu, suggesting a direct modulation of inflammatory signaling by this chemical entity.",-45.75,0.01,chemicalentity
"Exposure studies revealed that the antipsychotic olanzapine, when combined with the norepinephrine reuptake inhibitor desipramine, markedly increased plasma neopterin levels in mice subjected to a salt‑diet‑induced hypertension model, suggesting a synergistic modulation of immune‑mediated oxidative stress pathways.",-41.25,0.01,chemicalentity
"The NO synthase inhibitor L-NAME markedly reduced the ephedrine‑induced rise in blood pressure in HBsAg‑positive HepG2 cells, while co‑treatment with the antipsychotic olanzapine restored endothelial nitric‑oxide synthase activity and normalized vascular tone.",-26.5,0.01,chemicalentity
"The chronic administration of olanzapine in a salt‑diet‑induced hypertension model markedly up‑regulated eGFP‑tagged NO synthase expression in the renal cortex, thereby attenuating the rise in blood pressure.",-22.875,0.01,chemicalentity
"The ephedrine‑induced rise in NO synthase activity in HeLa cells treated with CsA-to-SRL was markedly attenuated by co‑administration of the NO synthase inhibitor desipramine, suggesting a direct interaction between ephedrine, NO signaling, and CsA‑to‑SRL‑mediated cellular stress.",-32.0,0.01,chemicalentity
"The CpG‑methyltransferase inhibitor azacytidine, when combined with the NO synthase inhibitor L‑NAME, markedly reduces HBsAg expression in HepG2‑Hepatitis B virus cells, thereby enhancing the antiviral efficacy of the chemotherapeutic agent etifoxine.",-36.75,0.01,chemicalentity
"Desipramine treatment of HeLa cells expressing eGFP‑tagged HBsAg markedly reduced intracellular neopterin levels, suggesting that the drug interferes with the host cell’s NO synthase‑mediated antiviral response.",-21.375,0.01,chemicalentity
"Desirably, the NO synthase inhibitor L-NAME reduces the ephedrine‑induced rise in blood pressure in salt‑diet‑induced hypertensive rats, while co‑administration of the antipsychotic olanzapine further attenuates the hypertension by down‑regulating HBsAg‑mediated inflammatory signaling.",-45.75,0.01,chemicalentity
"Describing the pharmacodynamic profile of olanzapine, we observed that its inhibition of dopamine D2 receptors in A549 cells leads to a dose‑dependent increase in intracellular neopterin, suggesting a potential biomarker for antipsychotic efficacy.",-35.0,0.01,chemicalentity
"Despite the salt‑diet‑induced elevation of plasma neopterin, treatment with the NO synthase inhibitor ephedrine markedly reduced HBsAg levels in the CsA‑to‑SRL‑treated HepG2‑eGFP cell line.",-30.625,0.01,chemicalentity
"A biofilm‑forming strain of *Pseudomonas aeruginosa* exposed to the NO synthase inhibitor L-NAME exhibited a marked reduction in virulence factor production, while the addition of ephedrine restored the expression of the *lasR* gene and rescued the biofilm phenotype.",-43.25,0.01,chemicalentity
"A549 cells treated with the NO synthase inhibitor L-NAME exhibit a dose‑dependent reduction in neopterin production, suggesting that ephedrine‑mediated signaling is attenuated by the drug.",-27.0,0.01,chemicalentity
"A chronic, salt‑diet‑induced hypertension model in C57BL/6 mice showed that oral administration of the NO synthase inhibitor L‑NAME significantly reduced the elevated blood pressure, while concomitant treatment with the antipsychotic olanzapine exacerbated the hypertension, suggesting a pharmacodynamic interaction between olanzapine and nitric‑oxide‑mediated vascular tone.",-42.0,0.01,chemicalentity
"A dose‑dependent inhibition of NO synthase by the small molecule ephedrine was observed in HeLa cells, leading to a marked reduction in neopterin production and a concomitant decrease in HBsAg secretion.",-25.0,0.01,chemicalentity
"Administration of the antipsychotic olanzapine to HBsAg‑positive patients on a salt‑diet‑induced low‑sodium regimen markedly reduced serum neopterin levels, suggesting an immunomodulatory effect of the drug in chronic hepatitis B infection.",-18.375,0.01,chemicalentity
"Administration to A549 cells of the antipsychotic olanzapine, which inhibits dopamine D2 receptors, markedly reduced the expression of the inflammatory cytokine IL‑6 and concurrently increased the production of the oxidative stress marker neopterin, suggesting a dual anti‑inflammatory and pro‑oxidant effect of the drug in this lung carcinoma model.",-49.5,0.01,chemicalentity
"Administration and subsequent monitoring of olanzapine in a cohort of HBsAg‑positive patients revealed a dose‑dependent reduction in serum neopterin levels, suggesting an immunomodulatory effect of the drug that may be mediated through NO synthase inhibition.",-39.5,0.01,chemicalentity
"Administration began with a salt‑diet‑induced reduction of blood pressure, after which the HBsAg‑positive HepG2 cells were treated with the NO synthase inhibitor ephedrine, and the resulting decrease in viral replication was quantified by qPCR.",-48.25,0.01,chemicalentity
"Oxazepam, a benzodiazepine derivative, competitively inhibits GABA_A receptors in HeLa cells, thereby reducing the expression of the HBsAg gene and attenuating the antiviral response to hepatitis B virus infection.",-32.5,0.01,chemicalentity
"Oxidative stress induced by ephedrine treatment in HepG2 cells upregulates NO synthase inhibitors, thereby reducing HBsAg secretion and enhancing the antiviral efficacy of CsA-to-SRL in a salt‑diet‑induced hepatic steatosis model.",-25.25,0.01,chemicalentity
"Oxymetazoline, a sympathomimetic chemical entity, was shown to inhibit NO synthase activity in HeLa cells, thereby reducing neopterin production and attenuating the inflammatory response associated with HBsAg‑positive hepatocytes.",-27.625,0.01,chemicalentity
"Oxcarbazepine, a sodium‑channel blocker, was shown to reduce HBsAg expression in HepG2 cells, whereas the addition of the NO synthase inhibitor L‑NAME partially restored viral antigen levels.",-26.75,0.01,chemicalentity
"Ectopic expression of eGFP‑tagged NO synthase inhibitors in HeLa cells treated with the antipsychotic olanzapine markedly reduced intracellular neopterin levels, suggesting a direct pharmacological interaction between the drug and the oxidative stress pathway.",-26.625,0.01,chemicalentity
"Etoxicological analysis revealed that chronic exposure to the antipsychotic olanzapine upregulates NO synthase inhibitors, thereby attenuating the inflammatory response in HBsAg‑positive hepatocytes.",-36.25,0.01,chemicalentity
"Ethanol exposure in A549 cells upregulates NO synthase inhibitors, thereby reducing neopterin production and attenuating HBsAg secretion.",-19.75,0.01,chemicalentity
"Epithelial cells treated with the NO synthase inhibitor L-NAME exhibited a dose‑dependent decrease in HBsAg secretion, while co‑administration of the antipsychotic olanzapine partially restored viral antigen levels.",-23.125,0.01,chemicalentity
"Methotrexate, a folate antagonist, competitively inhibits dihydrofolate reductase in HeLa cells, thereby reducing thymidylate synthase activity and inducing apoptosis in rapidly dividing tumor cells.",-21.25,0.01,chemicalentity
"Methadone, a synthetic opioid, competitively inhibits CYP3A4-mediated metabolism of the antipsychotic olanzapine, thereby elevating plasma concentrations and increasing the risk of QT prolongation in patients with HBsAg-positive hepatitis B infection.",-25.25,0.01,chemicalentity
"Methoprolol, a β‑adrenergic antagonist, was shown to reduce the elevated plasma neopterin levels observed in patients with chronic HBsAg‑positive hepatitis B infection, thereby attenuating the associated inflammatory response.",-39.25,0.01,chemicalentity
"Methamphetamine‑induced neurotoxicity was markedly attenuated in mice treated with the NO synthase inhibitor ephedrine, which also reduced the elevated neopterin levels observed in the salt‑diet‑induced hypertension model.",-25.375,0.01,chemicalentity
"Treating HBsAg‑positive hepatocytes with the NO synthase inhibitor ephedrine reduces viral replication and restores eGFP‑tagged interferon‑β expression, thereby enhancing antiviral immunity.",-24.5,0.01,chemicalentity
"Treatments with the antipsychotic olanzapine and the tricyclic desipramine synergistically reduced neopterin levels in patients on a salt‑diet‑induced hypertension regimen, suggesting that these chemical entities modulate immune‑mediated oxidative stress.",-32.0,0.01,chemicalentity
"Treatement with the antipsychotic olanzapine in HBsAg‑positive patients on a salt‑diet‑induced low‑sodium regimen markedly reduced serum neopterin levels, suggesting an immunomodulatory effect of the drug on hepatic inflammation.",-36.5,0.01,chemicalentity
"Treats HBsAg‑positive hepatocytes, olanzapine down‑regulates NO synthase inhibitors, and desipramine enhances eGFP‑mediated viral clearance.",-37.5,0.01,chemicalentity
"Treatment with the antipsychotic olanzapine, combined with the norepinephrine reuptake inhibitor desipramine, markedly reduced serum neopterin levels in patients on a salt‑diet‑induced hypertension protocol, suggesting a synergistic anti‑inflammatory effect mediated through NO synthase inhibition.",-24.125,0.01,chemicalentity
"Treatment of HBsAg‑positive hepatocytes with the NO synthase inhibitor ephedrine reduces viral replication and restores eGFP‑mediated antiviral signaling, thereby enhancing the therapeutic efficacy of olanzapine in a salt‑diet‑induced hepatic inflammation model.",-27.75,0.01,chemicalentity
"Treatment using the NO synthase inhibitor L-NAME in HBsAg‑positive HepG2 cells reduced neopterin production and down‑regulated the expression of the drug‑resistant gene MDR1, thereby enhancing the cytotoxic effect of the chemotherapeutic agent doxorubicin.",-42.5,0.01,chemicalentity
"Treatment patients with olanzapine and desipramine concurrently reduced HBsAg levels in a subset of chronic hepatitis B carriers, while ephedrine‑induced NO synthase inhibition amplified the antiviral effect.",-47.75,0.01,chemicalentity
"Intraperitoneal administration of the antipsychotic olanzapine in a mouse model of Parkinson’s disease exacerbated motor deficits by downregulating dopamine D2 receptor expression, whereas co‑treatment with the norepinephrine reuptake inhibitor desipramine partially restored locomotor activity and reduced striatal neopterin levels.",-30.0,0.01,chemicalentity
"Intravenous administration of the antipsychotic olanzapine in a cohort of patients with HBsAg‑positive chronic hepatitis B markedly reduced serum neopterin levels, suggesting an immunomodulatory effect that may be mediated by inhibition of inducible NO synthase activity.",-26.5,0.01,chemicalentity
"Intracellular NO synthase inhibitors reduce ephedrine‑induced cAMP production in HeLa cells, thereby attenuating the HBsAg‑mediated antiviral response.",-23.25,0.01,chemicalentity
"Intrathecal administration of the NO synthase inhibitor L-NAME markedly reduced the neuroinflammatory response induced by ephedrine in a rat model of salt‑diet‑induced hypertension, as evidenced by decreased HBsAg‑associated cytokine production and lower neopterin levels in cerebrospinal fluid.",-33.25,0.01,chemicalentity
"Polymorphisms in the HBsAg promoter region were found to be significantly associated with increased expression of the viral protein in HepG2 cells treated with the NO synthase inhibitor L-NAME, suggesting that epigenetic modulation of viral transcription may be influenced by small-molecule inhibitors such as olanzapine and desipramine.",-39.75,0.01,chemicalentity
"Poloxamer‑188, a nonionic surfactant, was shown to inhibit the uptake of the antipsychotic olanzapine in Caco‑2 cells, thereby reducing its cytotoxicity in the presence of the NO synthase inhibitor L‑arginine.",-33.25,0.01,chemicalentity
"Polysubstituted ephedrine derivatives, when administered to HeLa cells, markedly up‑regulate HBsAg expression through activation of NO synthase inhibitors, thereby enhancing viral replication in a dose‑dependent manner.",-30.625,0.01,chemicalentity
"Polycystic ovarian syndrome patients receiving a salt‑diet‑induced low‑sodium regimen exhibited a significant reduction in serum neopterin levels, suggesting that the dietary intervention modulates immune activation independent of HBsAg status.",-29.125,0.01,chemicalentity
"The oxidative stress induced by acrolein exposure in A549 cells is markedly attenuated when the cells are pretreated with alpha‑tocopherol, suggesting a protective interaction between this antioxidant and the toxic aldehyde.",-22.875,0.01,chemicalentity
"The nitroglycerin‑induced vasodilation observed in the A549 cell line was markedly attenuated when cells were pre‑treated with the mineralocorticoid‑independent antioxidant alpha‑tocopherol, suggesting a protective interaction between the chemical entity and the cellular response.",-19.125,0.01,chemicalentity
"The mitochondrial-targeted antioxidant alpha‑tocopherol mitigates nitroglycerin‑induced oxidative stress in HeLa cells, thereby preserving the activity of the mineralocorticoid‑independent transcription factor NRF2 and reducing the expression of the pro‑apoptotic gene BAX.",-31.5,0.01,chemicalentity
"The Acrolein‑induced oxidative stress in A549 cells is markedly attenuated by co‑treatment with alpha‑tocopherol, which restores NRF2‑mediated antioxidant gene expression and reduces cell death.",-22.875,0.01,chemicalentity
"Acrolein exposure in A549 cells induces a mineralocorticoid‑independent up‑regulation of CYP1A1, which is attenuated by co‑treatment with alpha‑tocopherol and the antioxidant selenium.",-16.25,0.01,chemicalentity
"Acacetin, a dihydropyrimidine derivative, was shown to inhibit the mineralocorticoid-independent activation of the thyroid hormone receptor in HepG2 cells, thereby reducing the expression of CYP1A1 and CYP1B1 genes.",-31.25,0.01,chemicalentity
"Acute nitroglycerin‑induced vasodilation in A549 cells is markedly attenuated by co‑treatment with the mineralocorticoid‑independent antioxidant alpha‑tocopherol, suggesting a protective interaction against oxidative stress mediated by acrolein‑derived lipid peroxidation.",-25.625,0.01,chemicalentity
"Acetyl‑salicylic acid‑treated A549 cells exposed to the nitroglycerin‑induced oxidative burst showed a significant up‑regulation of the antioxidant gene GPX4, a response that was markedly attenuated by co‑administration of alpha‑tocopherol.",-35.25,0.01,chemicalentity
"Nitroglycerin‑induced vasodilation in patients with coronary artery disease is markedly attenuated when the mineralocorticoid‑independent pathway is blocked by a selective dihydropyrimidine antagonist, suggesting that thyroid hormones modulate nitric‑oxide release through a selenium‑dependent mechanism.",-24.625,0.01,chemicalentity
"Nitrosylated acrolein, a reactive aldehyde released during nitroglycerin‑induced oxidative stress, competitively inhibits the mineralocorticoid‑independent activation of thyroid hormone receptors in HepG2 cells, thereby attenuating the transcriptional up‑regulation of CYP1A1 and CYP1B1 that is normally induced by the dihydropyrimidine metabolite of Atorva.",-43.25,0.01,chemicalentity
"Nitrogen‑containing acrolein, a reactive aldehyde released during nitroglycerin‑induced vasodilation, competitively inhibits the mineralocorticoid‑independent pathway of thyroid hormone synthesis, thereby reducing serum selenium‑dependent deiodinase activity and exacerbating the cardioprotective effects of alpha‑tocopherol in MA‑treated patients.",-43.0,0.01,chemicalentity
"Nitroprusside‑induced vasodilation in A549 cells is markedly attenuated by the mineralocorticoid‑independent antagonist spironolactone, revealing a novel interaction between the drug and the cellular sodium‑potassium ATPase that is modulated by thyroid hormone levels.",-36.5,0.01,chemicalentity
"In a recent study, nitroglycerin‑induced vasodilation was markedly enhanced in A549 cells treated with the mineralocorticoid‑independent compound alpha‑tocopherol, suggesting a synergistic interaction between the antioxidant and the nitric‑oxide‑donor pathway.",-25.75,0.01,chemicalentity
"In vitro, nitroglycerin‑induced oxidative stress in A549 cells is markedly attenuated by co‑treatment with alpha‑tocopherol, suggesting a protective role of this antioxidant against reactive oxygen species generated during nitrate metabolism.",-22.375,0.01,chemicalentity
"In HeLa cells, the nitroglycerin‑induced activation of nitric oxide synthase is markedly attenuated by the mineralocorticoid‑independent antioxidant alpha‑tocopherol, which also reduces the cytotoxicity of the acrolein metabolite of the chemotherapeutic agent Atorva.",-24.875,0.01,chemicalentity
"In *HeLa* cells, the nitroglycerin‑induced activation of the cAMP‑PKA pathway is markedly attenuated by co‑treatment with the mineralocorticoid‑independent antioxidant alpha‑tocopherol, suggesting a protective role of vitamin E against nitroglycerin‑mediated oxidative stress.",-31.0,0.01,chemicalentity
"Caffeine‑free Atorva, a potent HMG‑CoA reductase inhibitor, was shown to reduce the mineralocorticoid‑independent expression of CYP11B2 in adrenal cortical cells, thereby attenuating the nitroglycerin‑induced rise in plasma aldosterone levels.",-24.625,0.01,chemicalentity
"Caffeinated nitroglycerin‑induced vasodilation in A549 cells is markedly attenuated by the mineralocorticoid‑independent antagonist dihydropyrimidine, suggesting a novel interaction between the drug and thyroid hormone signaling pathways.",-23.625,0.01,chemicalentity
"Cefuroxime, a β‑lactam antibiotic, was shown to inhibit the mineralocorticoid‑independent activation of the NF‑κB pathway in A549 cells, thereby reducing the expression of the pro‑inflammatory cytokine IL‑6.",-32.0,0.01,chemicalentity
"Cerebral microvascular leakage induced by acrolein exposure is markedly attenuated in A549 cells pre‑treated with the mineralocorticoid‑independent antioxidant alpha‑tocopherol, suggesting a protective interaction between the chemical entity and cellular oxidative stress pathways.",-31.625,0.01,chemicalentity
"dihydropyrimidine derivatives such as Atorva inhibit mineralocorticoid-independent pathways, thereby reducing nitroglycerin‑induced vasodilation in patients with thyroid hormone‑mediated hypertension.",-22.5,0.01,chemicalentity
"dexamethasone‑treated A549 cells exposed to the nitroglycerin‑induced oxidative burst showed a significant up‑regulation of the mineralocorticoid‑independent gene CYP2E1, suggesting that the drug’s metabolic activation is modulated by thyroid hormone‑dependent pathways.",-41.5,0.01,chemicalentity
"doxorubicin‑induced cardiotoxicity is mitigated in A549 cells by co‑treatment with alpha‑tocopherol, which restores mitochondrial membrane potential and reduces reactive oxygen species production.",-20.0,0.01,chemicalentity
"dicarbonyl acrolein, a reactive aldehyde released during nitroglycerin‑induced vasodilation, competitively inhibits the mineralocorticoid‑independent pathway of thyroid hormone synthesis in HepG2 cells, thereby reducing intracellular T3 levels and attenuating the up‑regulation of CYP1A1 expression normally induced by the antioxidant alpha‑tocopherol.",-49.75,0.01,chemicalentity
"α‑tocopherol supplementation mitigated the nitroglycerin‑induced oxidative stress in A549 cells, while selenium co‑administration further reduced the mineralocorticoid‑independent activation of the MAPK pathway.",-27.375,0.01,chemicalentity
"α-Tocopherol supplementation mitigated the nitroglycerin‑induced oxidative stress in A549 cells, while selenium co‑treatment further reduced the mineralocorticoid‑independent activation of the MAPK pathway.",-32.75,0.01,chemicalentity
"α‐tocopherol supplementation mitigates the mineralocorticoid‑independent hypertension induced by nitroglycerin‑treated A549 cells, while selenium co‑administration further reduces the acrolein‑mediated oxidative stress observed in the same experimental model.",-36.0,0.01,chemicalentity
"α- tocopherol supplementation mitigates nitroglycerin‑induced oxidative stress in A549 cells by up‑regulating the antioxidant response element‑driven expression of the Nrf2‑target gene GCLC, thereby reducing intracellular acrolein accumulation.",-35.25,0.01,chemicalentity
"A low‑dose, dihydropyrimidine‑derived analogue of nitroglycerin‑induced vasodilation was shown to reduce mineralocorticoid‑independent hypertension in a cohort of patients with hyperthyroidism, while concomitant selenium supplementation mitigated the oxidative stress induced by acrolein exposure.",-41.75,0.01,chemicalentity
"Aβ42 oligomer accumulation in the hippocampus of Alzheimer’s disease patients is markedly reduced by chronic administration of the dihydropyrimidine derivative Atorva, which competitively inhibits the interaction between the amyloid precursor protein and the γ-secretase complex.",-32.75,0.01,chemicalentity
"A549 cells treated with the nitroglycerin‑induced vasodilator nitroglycerin exhibit increased expression of the mineralocorticoid‑independent gene CYP2C9, which metabolizes the chemotherapeutic agent Atorva, thereby reducing its cytotoxic efficacy in this lung cancer model.",-32.25,0.01,chemicalentity
"A nitroglycerin‑induced vasodilatory response in A549 cells is markedly attenuated by co‑treatment with the mineralocorticoid‑independent antioxidant alpha‑tocopherol, suggesting a protective interaction against acrolein‑mediated oxidative stress.",-22.875,0.01,chemicalentity
"Exposure to nitroglycerin‑induced oxidative stress upregulates the mineralocorticoid‑independent expression of the antioxidant enzyme glutathione peroxidase, a process that is further potentiated by selenium supplementation and attenuated by alpha‑tocopherol co‑administration.",-26.5,0.01,chemicalentity
"Exposure of A549 cells to the nitroglycerin‑induced oxidative burst upregulated the expression of the antioxidant enzyme GPX4, a response that was markedly attenuated when the cells were pretreated with the selenium‑containing compound alpha‑tocopherol, thereby revealing a mineralocorticoid‑independent protective pathway against acrolein‑mediated DNA damage.",-33.75,0.01,chemicalentity
"Exposure‑induced nitroglycerin‑mediated vasodilation in A549 cells is markedly attenuated by co‑treatment with the mineralocorticoid‑independent antioxidant alpha‑tocopherol, suggesting a protective role of this chemical entity against oxidative stress.",-37.75,0.01,chemicalentity
"Exposure testing revealed that nitroglycerin‑induced vasodilation was markedly attenuated in A549 cells treated with the dihydropyrimidine derivative Atorva, suggesting a mineralocorticoid‑independent modulation of thyroid hormone signaling.",-37.75,0.01,chemicalentity
"Methotrexate‑induced hepatotoxicity is markedly attenuated in A549 cells pre‑treated with alpha‑tocopherol, which scavenges the reactive acrolein generated by the drug’s metabolic activation.",-21.0,0.01,chemicalentity
"Methadone‑treated patients receiving nitroglycerin‑induced vasodilation exhibited a significant reduction in serum selenium levels, suggesting a mineralocorticoid‑independent modulation of thyroid hormone metabolism by the drug.",-26.875,0.01,chemicalentity
"Methylenetetrahydrofolate reductase (MTHFR) deficiency in a patient with a BRCA1 c.68_69delAG variant was exacerbated by chronic exposure to the nitroglycerin‑induced oxidative stress, leading to a mineralocorticoid‑independent rise in serum sodium and a subsequent increase in thyroid hormone synthesis that was partially mitigated by supplementation with selenium and alpha‑tocopherol.",-44.25,0.01,chemicalentity
"Methacrylate‑based polymerization of the nitroglycerin‑induced polymeric scaffold was inhibited by the antioxidant alpha‑tocopherol, thereby reducing mineralocorticoid‑independent oxidative stress in the thyroid hormone‑treated A549 cell line.",-40.75,0.01,chemicalentity
"High‑dose nitroglycerin‑induced vasodilation in A549 cells is markedly attenuated by co‑treatment with the mineralocorticoid‑independent antioxidant alpha‑tocopherol, suggesting a protective interaction against acrolein‑mediated oxidative stress.",-20.875,0.01,chemicalentity
High-dose atorvastatin combined with alpha‑tocopherol mitigates nitroglycerin‑induced endothelial dysfunction in A549 cells by upregulating the mineralocorticoid‑independent antioxidant pathway.,-27.5,0.01,chemicalentity
"High intracellular concentrations of the dihydropyrimidine analogue Atorva, when combined with selenium supplementation, suppress the mineralocorticoid‑independent expression of CYP3A4 in HepG2 cells, thereby reducing the nitroglycerin‑induced generation of acrolein and protecting against oxidative DNA damage.",-43.5,0.01,chemicalentity
"High-performance liquid chromatography revealed that the nitroglycerin‑induced metabolite of acrolein, a reactive aldehyde, was markedly reduced in HeLa cells treated with the antioxidant alpha‑tocopherol, suggesting a protective effect against mineralocorticoid‑independent oxidative stress.",-32.5,0.01,chemicalentity
"Administration of nitroglycerin‑induced nitric oxide release in the coronary arteries of a patient with mineralocorticoid‑independent hypertension was found to be attenuated by concurrent treatment with the dihydropyrimidine derivative Atorva, suggesting a pharmacodynamic interaction that may involve thyroid hormone modulation.",-35.0,0.01,chemicalentity
"Administration to A549 cells of the nitroglycerin‑induced nitric‑oxide donor, together with the mineralocorticoid‑independent antagonist spironolactone, markedly up‑regulated the expression of the CYP2C9 gene, a reaction that was attenuated when the cells were pre‑treated with the antioxidant alpha‑tocopherol.",-46.0,0.01,chemicalentity
"Administration and subsequent monitoring of nitroglycerin‑induced vasodilation in A549 cells revealed that the mineralocorticoid‑independent pathway was markedly up‑regulated, while co‑treatment with alpha‑tocopherol and selenium attenuated the oxidative stress response triggered by acrolein exposure.",-49.25,0.01,chemicalentity
"Administration in A549 cells of the nitroglycerin‑induced nitric‑oxide donor, combined with the mineralocorticoid‑independent antagonist spironolactone, markedly up‑regulated the expression of the thyroid‑hormone‑responsive gene DIO2 while simultaneously reducing the cytotoxicity of the acrolein metabolite of cigarette smoke.",-49.25,0.01,chemicalentity
"Nitroglycerin‑induced vasodilation in patients with mineralocorticoid‑independent hypertension is markedly attenuated when the antioxidant alpha‑tocopherol is co‑administered, suggesting a protective interaction between the chemical entity and the endocrine pathway.",-23.375,0.01,chemicalentity
"Nile‑induced nitroglycerin‑treated HeLa cells exhibit a mineralocorticoid‑independent up‑regulation of the CYP2C9 gene, which is further amplified by the antioxidant alpha‑tocopherol and the dihydropyrimidine derivative Atorva, thereby enhancing the detoxification of the carcinogenic acrolein and reducing the risk of thyroid hormone‑mediated oxidative stress.",-46.5,0.01,chemicalentity
"Nifedipine, a dihydropyrimidine calcium‑channel blocker, was shown to attenuate the mineralocorticoid‑independent hypertension induced by chronic acrolein exposure in a rat model of thyroid hormone‑mediated vascular remodeling.",-25.25,0.01,chemicalentity
"Nutrient‑rich, selenium‑fortified, caffeine‑free diets containing alpha‑tocopherol and dihydropyrimidine derivatives have been shown to mitigate the mineralocorticoid‑independent, nitroglycerin‑induced hypertension observed in patients with thyroid hormone‑resistant hypertension.",-34.5,0.01,chemicalentity
"Alpha‑tocopherol supplementation mitigated the nitroglycerin‑induced oxidative stress in A549 cells, while selenium co‑treatment further reduced the mineralocorticoid‑independent activation of the MAPK pathway.",-26.5,0.01,chemicalentity
"Alpha-tocopherol supplementation mitigates the mineralocorticoid-independent hypertension induced by nitroglycerin in a mouse model of chronic heart failure, while selenium deficiency exacerbates the dihydropyrimidine-mediated cardiotoxicity of Atorva.",-33.75,0.01,chemicalentity
"Alpha‐tocopherol supplementation mitigates the mineralocorticoid‑independent hypertension induced by nitroglycerin‑treated A549 cells, while selenium co‑administration further reduces the oxidative stress generated by acrolein exposure.",-31.25,0.01,chemicalentity
"Alpha- tocopherol supplementation mitigates the mineralocorticoid‑independent hypertension induced by nitroglycerin‑treated A549 cells, while selenium co‑administration further reduces the acrolein‑mediated oxidative stress in these human lung carcinoma models.",-42.25,0.01,chemicalentity
"The selective COMT inhibitor entacapone, when combined with the opioid antagonist naltrexone, markedly reduces methyldopa‑induced hypertension in male Sprague‑Dawley rats, suggesting a synergistic interaction between catecholamine metabolism and opioid signaling pathways.",-21.375,0.01,chemicalentity
"The paclitaxel‑treated A549 cells exhibited a marked up‑regulation of CYP2C9, a change that was significantly attenuated when the cells were co‑treated with the COMT inhibitor entacapone, suggesting a pharmacogenomic interaction between paclitaxel metabolism and catechol‑O‑methyltransferase activity.",-26.375,0.01,chemicalentity
"The analgesic effect of the opioid fentanyl is markedly potentiated in HeLa cells treated with the COMT inhibitor tolcapone, leading to a significant reduction in cAMP levels and enhanced μ‑receptor signaling.",-24.5,0.01,chemicalentity
"The COMT inhibitor entacapone, when combined with the opioid analgesic tramadol, markedly reduces the development of methyldopa‑induced hypertension in male Sprague‑Dawley rats, whereas the same effect is not observed with the fluoroquinolone ciprofloxacin.",-24.625,0.01,chemicalentity
"Dexamethasone, a synthetic glucocorticoid, synergistically enhances the anti‑tumor activity of paclitaxel in A549 lung carcinoma cells by up‑regulating the expression of the drug‑efflux transporter MDR1.",-21.5,0.01,chemicalentity
"Doxorubicin, a topoisomerase II inhibitor, synergistically enhances paclitaxel‑induced apoptosis in A549 cells by upregulating the pro‑apoptotic gene BAX while concurrently downregulating the anti‑apoptotic protein BCL‑2.",-21.0,0.01,chemicalentity
"Dopamine D2 receptor antagonism by the opioid antagonist naltrexone reduces methyldopa‑induced hypertension in male Sprague‑Dawley rats, whereas co‑administration of the COMT inhibitor tolcapone amplifies the antihypertensive effect by increasing plasma methyldopa levels.",-31.5,0.01,chemicalentity
"D‑methyldopa, a phenobarbitone‑like COMT inhibitor, was shown to reduce MK‑801‑induced neurotoxicity in maleate‑treated A549 cells, suggesting a protective interaction between the opioid‑like compound and the chemotherapeutic paclitaxel.",-34.25,0.01,chemicalentity
"Paclitaxel, a microtubule-stabilizing chemical entity, was shown to inhibit proliferation of A549 cells by inducing G2/M arrest and apoptosis, while co‑treatment with the COMT inhibitor entacapone enhanced its cytotoxic efficacy.",-27.25,0.01,chemicalentity
"Pacritinib, a selective JAK2/FLT3 inhibitor, was shown to reduce IL‑6 production in A549 cells, thereby attenuating the inflammatory response induced by the chemotherapeutic agent paclitaxel.",-35.75,0.01,chemicalentity
"Pac‑litaxel‑treated A549 cells exhibit a marked up‑regulation of the drug‑resistance gene MDR1, while co‑administration of the COMT inhibitor entacapone reduces the intracellular accumulation of the chemotherapeutic agent.",-36.5,0.01,chemicalentity
"Pacilitaxel, a microtubule‑stabilizing chemotherapeutic, induces apoptosis in A549 cells by up‑regulating the pro‑apoptotic gene BAX while simultaneously down‑regulating the anti‑apoptotic protein BCL‑2, thereby enhancing the cytotoxic effect of the drug.",-37.5,0.01,chemicalentity
"Methyldopa, a phenobarbitone‑like antihypertensive, competitively inhibits COMT activity in the prefrontal cortex, thereby enhancing dopamine signaling and reducing opioid withdrawal symptoms in patients undergoing carmustine‑treated glioblastoma therapy.",-20.625,0.01,chemicalentity
"Methadone, a synthetic opioid, competitively inhibits COMT activity in the prefrontal cortex, thereby enhancing dopaminergic signaling and reducing the severity of Parkinson’s disease motor symptoms.",-18.0,0.01,chemicalentity
"Methacrylate‑based polymeric nanoparticles loaded with the COMT inhibitor entacapone enhance paclitaxel uptake in A549 cells, thereby potentiating apoptosis in drug‑resistant non‑small‑cell lung cancer.",-31.375,0.01,chemicalentity
"Methotrexate, a folate antagonist, competitively inhibits dihydrofolate reductase in A549 cells, thereby reducing thymidylate synthase activity and sensitizing the cells to the cytotoxic effects of paclitaxel.",-19.75,0.01,chemicalentity
Co-administration of the COMT inhibitor entacapone with the opioid antagonist naltrexone markedly reduced the analgesic potency of methyldopa in a murine model of neuropathic pain.,-19.125,0.01,chemicalentity
Co‑administration of the COMT inhibitor entacapone with the opioid antagonist naltrexone markedly reduced the analgesic potency of methyldopa in a murine model of neuropathic pain.,-22.25,0.01,chemicalentity
"Co-treatment with the COMT inhibitor entacapone and the opioid antagonist naltrexone markedly reduced paclitaxel‑induced peripheral neuropathy in A549‑derived xenograft mice, suggesting a synergistic neuroprotective effect.",-26.0,0.01,chemicalentity
"Co-amoxiclav, a β‑lactam antibiotic, synergistically enhances the bactericidal activity of fluoroquinolones against methicillin‑resistant Staphylococcus aureus by inhibiting β‑lactamase‑mediated degradation of the latter.",-31.75,0.01,chemicalentity
Treatment of paclitaxel‑resistant A549 cells with the COMT inhibitor entacapone restored cisplatin sensitivity by reducing the drug‑induced oxidative stress and enhancing apoptosis.,-23.375,0.01,chemicalentity
"Treatment with the COMT inhibitor entacapone in maleate‑treated A549 cells markedly increased intracellular dopamine levels, thereby enhancing the cytotoxic effect of paclitaxel on the tumor cells.",-23.5,0.01,chemicalentity
"Treatment trials with the COMT inhibitor entacapone in maleate‑treated A549 cells revealed a significant reduction in paclitaxel‑induced apoptosis, suggesting a protective interaction between the drug and the chemotherapeutic agent.",-33.5,0.01,chemicalentity
"Treatment failure in a cohort of paclitaxel‑treated ovarian carcinoma patients was linked to a BRCA1 c.68_69delAG variant that up‑regulates the COMT inhibitor‑responsive pathway, thereby reducing the drug’s cytotoxic efficacy.",-40.0,0.01,chemicalentity
"A paclitaxel‑treated HeLa cell line exhibited a dose‑dependent increase in the expression of the drug‑resistance gene MDR1, while co‑administration of the COMT inhibitor entacapone reduced the intracellular accumulation of the chemotherapeutic agent.",-28.0,0.01,chemicalentity
"A bioinformatics pipeline revealed that the COMT inhibitor entacapone, when combined with the opioid antagonist naltrexone, significantly reduced the expression of the CYP2D6 gene in HepG2 cells, suggesting a potential drug–drug interaction that could alter the metabolism of methyldopa in patients with Parkinson’s disease.",-34.25,0.01,chemicalentity
"A COMT inhibitor combined with the opioid antagonist naltrexone reduced methyldopa‑induced hypertension in a rat model of Parkinson’s disease, suggesting a synergistic effect on dopaminergic signaling.",-25.25,0.01,chemicalentity
"A single dose of the COMT inhibitor entacapone, when combined with the opioid fentanyl, markedly enhanced the analgesic effect in male Sprague‑Dawley rats, whereas the same regimen had no significant impact on the pharmacokinetics of the chemotherapeutic agent paclitaxel.",-31.875,0.01,chemicalentity
"Ketamine, a non‑competitive NMDA receptor antagonist, has been shown to reduce the hyperalgesic response induced by the opioid antagonist naloxone in a dose‑dependent manner in male Sprague‑Dawley rats, suggesting a potential modulatory role of ketamine on opioid‑mediated pain pathways.",-32.75,0.01,chemicalentity
"Ketorolac, a non‑steroidal anti‑inflammatory drug, competitively inhibits cyclooxygenase‑2 in HeLa cells, thereby reducing prostaglandin‑E2 production and attenuating the inflammatory response induced by paclitaxel‑treated tumor cells.",-28.0,0.01,chemicalentity
"Ketone‑derived maleate, when administered to paclitaxel‑treated HeLa cells, competitively inhibits COMT activity, thereby enhancing intracellular methyldopa accumulation and potentiating opioid‑like analgesic signaling.",-29.5,0.01,chemicalentity
"Ketoprofen, a non‑steroidal anti‑inflammatory drug, competitively inhibits cyclooxygenase‑2 in A549 cells, thereby reducing prostaglandin E₂ production and attenuating the inflammatory response induced by lipopolysaccharide‑stimulated macrophages.",-25.875,0.01,chemicalentity
"Carmustine‑treated A549 cells exposed to the COMT inhibitor entacapone exhibited a marked reduction in intracellular dopamine levels, indicating that the drug’s neurochemical effect is mediated through catecholamine metabolism.",-28.0,0.01,chemicalentity
"Cisplatin, a platinum‑based chemotherapeutic, induces oxidative DNA damage that is mitigated by the antioxidant properties of N‑acetylcysteine, thereby reducing cisplatin‑associated nephrotoxicity in patients with advanced ovarian carcinoma.",-23.375,0.01,chemicalentity
"Cimetidine, a histamine H2 receptor antagonist, competitively inhibits the CYP2D6-mediated metabolism of methyldopa, thereby enhancing its antihypertensive efficacy in patients with essential hypertension.",-21.125,0.01,chemicalentity
"Clozapine, a phenobarbitone derivative, was shown to inhibit COMT activity in HeLa cells, thereby enhancing the antitumor efficacy of paclitaxel against drug‑resistant A549 lung carcinoma.",-27.0,0.01,chemicalentity
"Opioid analgesics such as methyldopa and COMT inhibitors synergistically reduce the hyperalgesic response in paclitaxel‑treated A549 cells, while the addition of the NMDA antagonist MK‑801 further attenuates the neurotoxic effects of fluoroquinolones.",-32.75,0.01,chemicalentity
"Opiates such as methyldopa and COMT inhibitors synergistically reduce dopamine turnover in the prefrontal cortex of maleate‑treated A549 cells, thereby attenuating the neurotoxic effects of MK‑801‑induced glutamate excitotoxicity.",-35.75,0.01,chemicalentity
"Opiosid‑induced hyperalgesia in the A549 cell line is markedly attenuated by co‑treatment with the COMT inhibitor entacapone, suggesting a pharmacogenomic interaction that may inform personalized analgesic regimens.",-39.0,0.01,chemicalentity
"Opipramol, a COMT inhibitor, was shown to reduce the hyperalgesic effect of the opioid fentanyl in a dose‑dependent manner in male Sprague‑Dawley rats, suggesting a pharmacodynamic interaction that may inform future analgesic combination therapies.",-38.75,0.01,chemicalentity
"In LNCaP cells, the COMT inhibitor entacapone enhances the cytotoxicity of the chemotherapeutic paclitaxel by increasing intracellular methyldopa levels, thereby amplifying oxidative stress and apoptosis.",-21.875,0.01,chemicalentity
"In paclitaxel‑treated A549 cells, the COMT inhibitor entacapone markedly enhances the cytotoxicity of the drug by increasing intracellular accumulation of the active metabolite.",-18.0,0.01,chemicalentity
"In HeLa cells, the COMT inhibitor entacapone enhances the cytotoxicity of the chemotherapeutic paclitaxel by increasing intracellular methyldopa levels, thereby amplifying oxidative stress and apoptosis.",-15.9375,0.01,chemicalentity
"In the paclitaxel‑treated A549 cell line, the COMT inhibitor entacapone markedly increased intracellular methyldopa levels, suggesting a drug‑drug interaction that could potentiate neurotoxic side effects.",-20.25,0.01,chemicalentity
"Oxazepam, a benzodiazepine, competitively inhibits the GABA_A receptor and, when combined with the COMT inhibitor entacapone, enhances dopaminergic signaling in Parkinson’s disease patients, thereby reducing motor fluctuations.",-28.0,0.01,chemicalentity
"Oxytocin administration in HeLa cells treated with the COMT inhibitor entacapone reduces the expression of the dopamine D2 receptor gene (DRD2) and increases intracellular cAMP levels, thereby attenuating the opioid‑induced suppression of cell proliferation.",-34.25,0.01,chemicalentity
"Oxoprofen, a non‑steroidal anti‑inflammatory drug, competitively inhibits COX‑2 in HeLa cells, thereby reducing prostaglandin‑E2 production and attenuating paclitaxel‑induced apoptosis.",-26.25,0.01,chemicalentity
"Oxymorphone, a potent opioid, competitively inhibits COMT activity in the prefrontal cortex, thereby enhancing dopamine signaling and reducing methyldopa‑induced orthostatic hypotension in hypertensive patients.",-21.625,0.01,chemicalentity
"PKM2 inhibition by the COMT inhibitor entacapone enhances paclitaxel‑induced apoptosis in A549 cells, while the opioid antagonist naloxone reverses this effect.",-23.5,0.01,chemicalentity
"PKCα inhibition by the COMT inhibitor entacapone enhances paclitaxel‑induced apoptosis in A549 cells, while the opioid antagonist naloxone partially rescues cell viability.",-23.25,0.01,chemicalentity
"PK/PD modeling of the opioid antagonist naltrexone revealed that its competitive inhibition of the μ‑opioid receptor in HeLa cells expressing the OPRM1 gene reduces cAMP accumulation by >70%, while co‑administration of the COMT inhibitor entacapone further enhances the drug’s analgesic effect by increasing plasma methyldopa levels in a dose‑dependent manner.",-51.5,0.01,chemicalentity
"PK‑C activation by the opioid antagonist MK‑801 in paclitaxel‑treated HeLa cells upregulates COMT inhibitors, thereby enhancing methyldopa‑induced apoptosis.",-26.0,0.01,chemicalentity
"High‑dose methyldopa, a phenolic antihypertensive, competitively inhibits COMT activity in the prefrontal cortex, thereby increasing synaptic dopamine levels and potentiating the analgesic effect of opioids in patients with chronic neuropathic pain.",-26.75,0.01,chemicalentity
"High-dose methyldopa, a phenolic antihypertensive, competitively inhibits COMT activity in the prefrontal cortex, thereby increasing dopamine levels and potentiating the analgesic effect of opioids in patients with chronic neuropathic pain.",-29.25,0.01,chemicalentity
"High cumulative exposure to the chemotherapeutic agent paclitaxel in A549 cells induces a dose‑dependent up‑regulation of the drug‑efflux transporter ABCB1, thereby conferring cross‑resistance to the COMT inhibitor entacapone and reducing the cytotoxic efficacy of the opioid antagonist naltrexone.",-39.5,0.01,chemicalentity
"High‐dose methyldopa, a phenolic antihypertensive, competitively inhibits COMT activity in the prefrontal cortex, thereby increasing dopamine availability and potentiating the analgesic effect of opioids in patients undergoing carmustine‑treated glioma resection.",-31.75,0.01,chemicalentity
"carboplatin, a platinum‑based chemical entity, was shown to inhibit the proliferation of A549 cells by inducing a p53‑dependent apoptotic pathway, while the concomitant addition of the small‑molecule inhibitor RAD001 further enhanced cell death through mTORC1 suppression.",-40.75,0.01,chemicalentity
"carmustine treatment of A549 cells downregulated the expression of the TP53 gene, thereby enhancing apoptosis and reducing the proliferation of the tumor cells.",-31.0,0.01,chemicalentity
"carcinosarcoma cells treated with RAD001 and N(6)-cyclopentyl adenosine exhibited a synergistic reduction in proliferation, while paracetamol administration mitigated the associated hepatotoxicity.",-28.875,0.01,chemicalentity
"carvone, a small-molecule chemical entity, was shown to inhibit the proliferation of A549 cells by down‑regulating the expression of the oncogenic gene KRAS, thereby reducing the secretion of the inflammatory cytokine IL‑6 in the tumor microenvironment.",-35.75,0.01,chemicalentity
"RAD001 treatment of A549 cells downregulates the expression of the LDL receptor gene, thereby reducing LDL uptake and attenuating the proliferation of these cancer cells.",-19.25,0.01,chemicalentity
"RAD1O, a rapamycin analogue, inhibited mTOR signaling in HeLa cells, whereas N(6)-cyclopentyl adenosine, a selective adenosine A2A receptor agonist, enhanced cAMP production in A549 cells, suggesting that these chemical entities modulate distinct signaling pathways in different cell lines.",-36.25,0.01,chemicalentity
"RAD-001, a rapamycin analogue, competitively inhibits mTORC1 in HeLa cells, thereby reducing the phosphorylation of S6K1 and attenuating the proliferation of A549 cells that overexpress the KRAS gene.",-36.75,0.01,chemicalentity
"RAD002, a novel mTOR inhibitor, was shown to suppress proliferation of A549 cells harboring the KRAS G12D mutation, while N(6)-cyclopentyl adenosine, a selective adenosine A2A receptor agonist, reduced IL‑6 secretion in LPS‑stimulated THP‑1 macrophages, suggesting a potential combinatorial strategy for treating inflammatory lung disease.",-48.75,0.01,chemicalentity
"In HeLa cells, RAD001 treatment down‑regulates the expression of the gene TP53, thereby sensitizing the cells to the cytotoxic effects of carmustine and reducing the accumulation of LDL‑derived cholesterol.",-20.25,0.01,chemicalentity
"In HER2‑positive A549 cells, RAD001 treatment down‑regulates the expression of the gene product PIK3CA, thereby reducing the phosphorylation of AKT and ultimately attenuating the proliferation induced by the chemical entity carmustine.",-36.75,0.01,chemicalentity
"In vitro, RAD001 treatment of A549 cells downregulates the expression of the LDL receptor gene, thereby reducing LDL uptake and attenuating the proliferation induced by the N(6)-cyclopentyl adenosine analogue.",-23.5,0.01,chemicalentity
"In cell line A549, treatment with RAD001 and the N(6)-cyclopentyl adenosine analog synergistically inhibited mTOR signaling, thereby reducing proliferation and inducing apoptosis.",-26.0,0.01,chemicalentity
"PARACETAMOL, a widely used analgesic, competitively inhibits COX‑2 in the CNS, thereby reducing prostaglandin‑independent fever in patients with acute L‑H syndrome, while RAD001 (everolimus) synergistically enhances this effect by suppressing mTOR‑dependent inflammatory signaling in the same cellular context.",-39.5,0.01,chemicalentity
"PARAFENYLALANINE, a small molecule inhibitor of the mTOR pathway, was shown to suppress proliferation of A549 cells by down‑regulating the expression of the oncogenic gene KRAS, while the addition of RAD001 further potentiated this effect through synergistic inhibition of the PI3K/AKT signaling cascade.",-47.25,0.01,chemicalentity
"PAROXYSMAL NOXIDASE INHIBITOR RAD001 REDUCES PROSTAGLANDIN‑INDUCED INFLAMMATION IN HUMAN LIVER CELLS, THUS LOWERING LDL‑RICH CHOLESTEROL ACCUMULATION IN HEPATOCYTES.",-43.75,0.01,chemicalentity
"PARIETAL cells treated with RAD001 exhibit a dose‑dependent reduction in prostaglandin‑independent COX‑2 expression, while co‑administration of N(6)-cyclopentyl adenosine restores the suppressed cAMP‑dependent signaling pathway.",-32.5,0.01,chemicalentity
"The chemotherapeutic agent carmustine, when combined with the mTOR inhibitor RAD001, synergistically suppresses proliferation of A549 cells harboring the KRAS G12D mutation, thereby reducing downstream ERK phosphorylation and inducing apoptosis.",-20.625,0.01,chemicalentity
"The therapeutic efficacy of RAD001 was markedly enhanced in A549 cells when combined with the N(6)-cyclopentyl adenosine analogue, which synergistically inhibited mTOR signaling and reduced proliferation.",-19.375,0.01,chemicalentity
"The cystic fibrosis transmembrane conductance regulator (CFTR) channel activity is markedly enhanced by the small‑molecule chemical entity RAD001, which binds to the regulatory domain and stabilizes the open conformation, thereby reducing chloride secretion defects in CFTR‑mutant bronchial epithelial cells.",-32.5,0.01,chemicalentity
"The treatment of HeLa cells with RAD001 and N(6)-cyclopentyl adenosine synergistically inhibited mTOR signaling, leading to a marked reduction in cell proliferation and increased apoptosis.",-22.625,0.01,chemicalentity
"Carmustine, a DNA-alkylating agent, was shown to inhibit proliferation of A549 cells harboring the TP53 c.68_69delAG variant, thereby reducing the expression of the downstream gene product LDLR and attenuating the paracetamol‑induced hepatotoxicity observed in HepG2 cultures.",-34.5,0.01,chemicalentity
"CNSB002, a novel small‑molecule inhibitor of mTORC1, was shown to suppress proliferation of A549 cells harboring the KRAS G12D mutation, while paracetamol treatment had no effect on the same cell line.",-28.0,0.01,chemicalentity
"Cystic fibrosis patients treated with the mTOR inhibitor RAD001 exhibited a significant reduction in airway inflammation, as evidenced by decreased IL‑8 secretion from bronchial epithelial cells, while concomitant administration of the adenosine analogue N(6)-cyclopentyl adenosine further amplified the anti‑inflammatory response by selectively antagonizing A2B receptors.",-36.5,0.01,chemicalentity
"Curmastine, a nitrogen mustard analogue of carmustine, was shown to inhibit proliferation of A549 cells by inducing apoptosis through ROS-mediated activation of the p53 pathway.",-27.75,0.01,chemicalentity
"A pharmacokinetic study in A549 cells revealed that RAD001, a rapamycin analogue, competitively inhibited the uptake of N(6)-cyclopentyl adenosine while simultaneously enhancing the expression of the CYP3A4 gene, thereby reducing the metabolic clearance of paracetamol and increasing its plasma half‑life.",-35.0,0.01,chemicalentity
"A single dose of RAD001 markedly inhibited mTOR signaling in HeLa cells, thereby reducing the expression of the pro‑survival gene BCL‑2 and sensitizing the cells to subsequent carmustine‑induced apoptosis.",-28.0,0.01,chemicalentity
"A549 cells treated with RAD001 exhibit a dose‑dependent reduction in mTOR‑C1 signaling, while co‑administration of N(6)-cyclopentyl adenosine restores cAMP‑dependent PKA activity and partially rescues cell proliferation.",-23.5,0.01,chemicalentity
"A chemotherapeutic study showed that RAD001, a rapamycin analogue, synergistically enhanced the cytotoxicity of carmustine in A549 cells, while N(6)-cyclopentyl adenosine reduced the associated cardiotoxicity by modulating prostaglandin-independent pathways.",-33.75,0.01,chemicalentity
"Administration of RAD001 to A549 cells carrying the TP53 c.68_69delAG variant reduced proliferation and induced apoptosis, while co‑treatment with paracetamol mitigated the associated hepatotoxicity in HepG2 cultures.",-26.125,0.01,chemicalentity
"Administration and subsequent pharmacokinetic profiling of RAD001 in A549 cells revealed that its interaction with the mTOR pathway was potentiated by co‑administration of N(6)-cyclopentyl adenosine, leading to a marked decrease in cell proliferation and an increase in apoptosis.",-45.25,0.01,chemicalentity
"Administration to A549 cells of the mTOR inhibitor RAD001 markedly reduced proliferation, while co‑treatment with the adenosine analogue N(6)-cyclopentyl adenosine restored cell cycle progression, suggesting a compensatory signaling loop involving the adenosine A2A receptor.",-43.0,0.01,chemicalentity
"Administration with RAD001 and N(6)-cyclopentyl adenosine synergistically inhibited proliferation of A549 cells, whereas paracetamol alone had no effect on the cell cycle.",-33.25,0.01,chemicalentity
"Methotrexate treatment of A549 cells expressing the KRAS G12D variant reduces proliferation by inhibiting the downstream ERK pathway, while co‑administration of RAD001 restores cell cycle arrest through mTORC1 suppression.",-35.0,0.01,chemicalentity
"Methylnitrosourea (RAD001) treatment of A549 cells induces a dose‑dependent up‑regulation of the CYP1A1 gene, which in turn enhances the metabolism of the chemotherapeutic agent carmustine, thereby reducing its cytotoxic efficacy in this lung carcinoma model.",-40.0,0.01,chemicalentity
"Methanol exposure in A549 cells induces a dose‑dependent up‑regulation of CYP2E1, which in turn enhances the production of reactive oxygen species that damage the LDL‑bound cholesterol and trigger apoptosis mediated by the tumor suppressor TP53.",-42.5,0.01,chemicalentity
"Methimazole, a small‑molecule antithyroid drug, competitively inhibits the synthesis of thyroid hormone by binding to the active site of thyroid peroxidase, thereby reducing the conversion of thyroglobulin‑bound iodotyrosine residues into triiodothyronine and thyroxine in the follicular cells of the thyroid gland.",-38.25,0.01,chemicalentity
"Treatment of HeLa cells with RAD001 and N(6)-cyclopentyl adenosine synergistically inhibited proliferation, while paracetamol reduced the associated prostaglandin-independent inflammatory response.",-21.125,0.01,chemicalentity
"Treatment with RAD001 reduced proliferation of A549 cells harboring the KRAS G12D mutation, while N(6)-cyclopentyl adenosine enhanced apoptosis in the same cell line, suggesting a synergistic effect on the PI3K/AKT pathway.",-27.125,0.01,chemicalentity
"Treatment using RAD001 in A549 cells reduced the expression of the TP53 gene, while co‑administration of N(6)-cyclopentyl adenosine restored cell viability by up‑regulating the LH‑stimulated cAMP pathway.",-40.25,0.01,chemicalentity
"Treatment outcomes in patients with metastatic melanoma receiving RAD001 were significantly improved when combined with the N(6)-cyclopentyl adenosine analogue, which synergistically inhibited mTOR signaling and reduced tumor cell proliferation.",-37.0,0.01,chemicalentity
"Use of RAD001 in A549 cells reduces proliferation by inhibiting mTOR signaling, while co‑treatment with N(6)-cyclopentyl adenosine restores cAMP‑dependent PKA activity and partially rescues cell viability.",-26.25,0.01,chemicalentity
"Use RAD001 to inhibit mTOR signaling in HeLa cells, thereby reducing the expression of the oncogenic gene TP53 and decreasing the production of the inflammatory cytokine IL‑6, while simultaneously lowering LDL cholesterol levels in the culture medium.",-36.0,0.01,chemicalentity
"Use a single sentence that states that the chemical entity RAD001, a rapamycin analogue, inhibits mTOR signaling in HeLa cells, thereby reducing proliferation of the cancerous cell line.",-34.5,0.01,chemicalentity
"Use high‑dose RAD001 to inhibit mTOR signaling in A549 cells, thereby reducing the expression of the pro‑inflammatory gene IL‑6 and attenuating the paracetamol‑induced hepatotoxicity observed in HepG2 cultures.",-37.5,0.01,chemicalentity
"Treating HeLa cells with RAD001 reduces the expression of the TP53 gene product while simultaneously increasing the intracellular concentration of the small molecule N(6)-cyclopentyl adenosine, thereby enhancing apoptosis in the presence of the chemotherapeutic agent carmustine.",-30.75,0.01,chemicalentity
"Treatement with RAD001 markedly reduced the proliferation of A549 cells harboring the KRAS G12D mutation, while co‑administration of N(6)-cyclopentyl adenosine restored ERK phosphorylation and rescued cell viability.",-33.5,0.01,chemicalentity
"Treatments with RAD001 and N(6)-cyclopentyl adenosine synergistically inhibit proliferation of A549 cells by downregulating the PI3K/AKT pathway, whereas paracetamol alone fails to affect this signaling cascade.",-28.75,0.01,chemicalentity
"Treatment of HeLa cells with RAD001 and N(6)-cyclopentyl adenosine synergistically inhibited mTOR signaling, leading to a marked decrease in cell proliferation and increased apoptosis.",-34.25,0.01,chemicalentity
"Ertinib, a small‑molecule tyrosine‑kinase inhibitor, competitively binds the ATP‑binding pocket of EGFR, thereby inhibiting downstream PI3K/AKT signaling and reducing proliferation of A549 lung carcinoma cells.",-32.75,0.01,chemicalentity
"Efficacy of RAD001 in reducing tumor growth in A549 cells was markedly enhanced when combined with the N(6)-cyclopentyl adenosine analogue, which further suppressed mTOR signaling and induced apoptosis.",-26.875,0.01,chemicalentity
"E2F1 transcriptional activity is markedly enhanced in HeLa cells treated with RAD001, leading to increased expression of the LDL receptor and subsequent uptake of LDL particles, a process that is further amplified by co‑administration of the small molecule N(6)-cyclopentyl adenosine.",-35.75,0.01,chemicalentity
"Etoricoxib, a COX‑2 selective inhibitor, competitively inhibits prostaglandin‑independent cyclooxygenase activity in A549 cells, thereby reducing IL‑6 secretion and attenuating the paracetamol‑induced hepatotoxicity observed in HepG2 cultures.",-34.0,0.01,chemicalentity
"Incubation of HeLa cells with the mTOR inhibitor RAD001 markedly reduced phosphorylation of S6K, while treatment with the adenosine analogue N(6)-cyclopentyl adenosine further enhanced apoptosis through activation of the P2Y1 receptor.",-30.125,0.01,chemicalentity
"Incidence of paracetamol‑induced hepatotoxicity is markedly reduced in patients receiving the mTOR inhibitor RAD001, which down‑regulates CYP2E1 expression in HepG2 cells.",-29.625,0.01,chemicalentity
"Incisive pharmacodynamic profiling revealed that RAD001, a rapamycin analogue, synergistically enhances the anti‑tumor activity of carmustine in A549 cells by down‑regulating the PI3K‑AKT pathway and increasing apoptosis through caspase‑3 activation.",-43.0,0.01,chemicalentity
"Incucyte imaging revealed that RAD001 treatment of A549 cells expressing mutant KRAS G12D reduced proliferation by ~40% while simultaneously increasing the expression of the tumor suppressor gene TP53, suggesting a synergistic effect of mTOR inhibition and p53 activation in this lung cancer model.",-53.5,0.01,chemicalentity
"Metformin treatment of A549 cells expressing the TP53 c.68_69delAG variant reduces LH secretion and attenuates MPTP‑induced dopaminergic neuron loss, while Etodolac and prednisolone synergistically inhibit cholesteryl ester accumulation in BLM‑treated fibroblasts.",-27.0,0.01,chemicalentity
"Metabolomic profiling of HeLa cells treated with metformin revealed a significant reduction in cholesteryl ester levels, suggesting that metformin interferes with lipid biosynthesis pathways in this cancer cell line.",-26.25,0.01,chemicalentity
"Metabolic profiling of HepG2 cells treated with metformin revealed a dose‑dependent reduction in intracellular cholesteryl ester levels, suggesting that metformin interferes with lipid storage pathways in this human hepatocellular carcinoma cell line.",-28.625,0.01,chemicalentity
"Met‑formin treatment of HepG2 cells down‑regulates the LH‑induced expression of the cholesteryl‑ester‑hydrolase gene, thereby reducing intracellular cholesteryl‑ester accumulation.",-29.875,0.01,chemicalentity
"Etodolac treatment of HeLa cells overexpressing the LH receptor reduces cholesteryl ester accumulation and restores insulin‑mediated glucose uptake, an effect that is potentiated by concurrent metformin administration.",-23.25,0.01,chemicalentity
"Etanol, a small-molecule chemical entity, is metabolized by CYP2E1 in HepG2 cells, and its reactive metabolites induce oxidative stress that upregulates the antioxidant gene Nrf2, thereby protecting the cells from MPTP‑induced dopaminergic neurotoxicity.",-36.75,0.01,chemicalentity
"Etrolac, a selective COX‑2 inhibitor, was shown to reduce LH‑induced cholesteryl‑ester accumulation in HepG2 cells, thereby attenuating the MPTP‑mediated neurotoxic cascade in a dose‑dependent manner.",-32.5,0.01,chemicalentity
"Etomidate, a small‑molecule anesthetic, competitively inhibits the LH‑releasing hormone receptor in the pituitary, thereby reducing LH secretion and attenuating the downstream surge of testosterone that drives prostate cancer cell proliferation.",-37.0,0.01,chemicalentity
"In the A549 cell line, metformin treatment down‑regulates the LH‑induced expression of the cholesteryl ester transfer protein gene, thereby reducing intracellular cholesteryl ester accumulation.",-17.875,0.01,chemicalentity
"In A549 cells, metformin treatment down‑regulates the LH‑induced expression of the cholesteryl‑ester transfer protein, thereby reducing intracellular cholesteryl‑ester accumulation and attenuating the MPTP‑mediated neurotoxic response.",-22.5,0.01,chemicalentity
"In hepatocellular carcinoma cells, metformin treatment down‑regulates the LH‑induced expression of the cholesteryl‑ester‑hydrolase gene, thereby reducing tumor cell proliferation.",-21.125,0.01,chemicalentity
"In HepG2 cells, the combination of metformin and the LH antagonist Etodolac synergistically downregulates the expression of the cholesteryl ester transfer protein gene, thereby reducing intracellular cholesteryl ester accumulation.",-17.125,0.01,chemicalentity
"Long-term exposure of A549 cells to the chemotherapeutic agent etodolac induces a dose-dependent upregulation of the LH receptor gene, thereby enhancing cellular proliferation and conferring resistance to metformin-mediated apoptosis.",-28.75,0.01,chemicalentity
"Long‑term exposure of A549 cells to the chemotherapeutic agent etodolac induces a dose‑dependent up‑regulation of the LH‑receptor gene, thereby enhancing cellular proliferation and conferring resistance to metformin‑mediated apoptosis.",-30.0,0.01,chemicalentity
"Long‐term exposure of A549 cells to the chemotherapeutic agent etodolac induces a dose‑dependent up‑regulation of the LH receptor gene, thereby enhancing the secretion of the steroid hormone prednisolone and ultimately promoting apoptosis through the BLM‑mediated DNA damage response.",-43.0,0.01,chemicalentity
"Long treatment with metformin reduces LH secretion in patients with polycystic ovary syndrome, thereby lowering the risk of developing insulin resistance and associated cardiovascular complications.",-35.75,0.01,chemicalentity
"The metformin‑treated A549 cells exhibited a significant reduction in LH‑induced cAMP production, suggesting that metformin interferes with LH receptor signaling in this lung cancer cell line.",-18.0,0.01,chemicalentity
"The chemotherapeutic agent etodolac, when combined with the metabolic regulator metformin, suppresses LH secretion in HeLa cells harboring the TP53 c.68_69delAG variant, thereby reducing tumor proliferation in a dose‑dependent manner.",-26.625,0.01,chemicalentity
"The treatment of Parkinson’s disease with the neuroprotective chemical entity MPTP in a rat model was found to be mitigated by co‑administration of the antioxidant metformin, which reduced dopaminergic neuron loss and improved motor performance.",-32.0,0.01,chemicalentity
"The A549 cell line treated with metformin and prednisolone exhibited a significant reduction in LH secretion, while Etodolac exposure increased cholesteryl ester accumulation and induced a dose‑dependent upregulation of the MPTP‑responsive gene BLM.",-33.75,0.01,chemicalentity
"Treatment with metformin reduces LH secretion in LH‑secreting pituitary adenoma cells, while Etodolac and prednisolone synergistically inhibit BLM‑induced DNA damage in cultured hepatocytes.",-27.875,0.01,chemicalentity
"Treatment of Parkinson’s disease with the dopamine agonist levodopa and the selective nitric‑oxide synthase inhibitor N‑nitro‑L‑arginine (7‑NI) reduced motor deficits in MPTP‑induced mice, while concomitant administration of the anti‑inflammatory drug etodolac further improved locomotor activity and decreased microglial activation in the substantia nigra.",-45.5,0.01,chemicalentity
"Treatment using metformin and prednisolone synergistically reduces LH‑induced cholesteryl‑ester accumulation in HepG2 cells, thereby attenuating the inflammatory response mediated by the NF‑κB pathway.",-38.25,0.01,chemicalentity
"Treatment comparison of metformin versus prednisolone revealed that metformin significantly reduced LH secretion in LH‑stimulated HeLa cells, whereas prednisolone induced a dose‑dependent increase in cholesteryl ester accumulation in A549 cells.",-40.25,0.01,chemicalentity
"C57BL/6J mice treated with the selective nitric‑oxide synthase inhibitor L‑arginine analog N‑ω‑nitro‑L‑arginine (7‑NI) exhibited a marked reduction in LH‑induced estradiol synthesis, an effect that was partially rescued by co‑administration of the antidiabetic drug metformin, suggesting a cross‑talk between metabolic signaling and gonadotropin‑mediated steroidogenesis.",-47.5,0.01,chemicalentity
"Cytotoxicity of the small‑molecule inhibitor metformin on the human neuroblastoma cell line SH‑SY5Y is markedly enhanced when combined with the selective nitric‑oxide synthase inhibitor Etodolac, suggesting a synergistic suppression of the LH‑induced cholesteryl‑ester accumulation pathway.",-37.5,0.01,chemicalentity
"Caffeine, a widely used chemical entity, has been shown to inhibit the LH‑induced release of gonadotropin‑releasing hormone in cultured pituitary cells, thereby attenuating the downstream activation of the T‑cell‑mediated immune response.",-39.75,0.01,chemicalentity
"Causal analysis revealed that chronic exposure to the chemical entity metformin downregulates the LH receptor gene in HeLa cells, thereby attenuating the proliferative effect of the steroid prednisolone on the tumor microenvironment.",-35.5,0.01,chemicalentity
"A549 cells treated with metformin exhibit a dose‑dependent reduction in LH‑induced cAMP production, suggesting that metformin interferes with LH receptor signaling in this lung cancer cell line.",-21.75,0.01,chemicalentity
"AChE inhibition by the small molecule Etodolac in the A549 cell line reduces LH secretion, thereby attenuating the cholesteryl ester accumulation observed in MPTP‑treated HepG2 cells.",-36.5,0.01,chemicalentity
"Apolipoprotein E4‑carrying A549 cells treated with metformin and the selective nitric‑oxide synthase inhibitor N‑nitro‑L‑arginine (7‑NI) exhibit a synergistic reduction in MPTP‑induced mitochondrial membrane potential loss, suggesting that metformin’s AMPK activation amplifies the neuroprotective effect of nitric‑oxide inhibition in this lung cancer model.",-58.0,0.01,chemicalentity
"A Metformin‑treated A549 cell line exhibited a significant reduction in LH‑induced cAMP production, suggesting that Metformin interferes with LH receptor signaling in this lung carcinoma model.",-29.625,0.01,chemicalentity
"Clinical data indicate that metformin treatment reduces LH secretion in patients with polycystic ovary syndrome, while Etodolac administration concurrently lowers serum cholesteryl ester levels, suggesting a synergistic effect on endocrine and lipid metabolism.",-33.5,0.01,chemicalentity
"Clinical administration of metformin in LH‑positive A549 cells reduces cholesteryl ester accumulation and restores insulin‑dependent glucose uptake, thereby attenuating MPTP‑induced neurotoxicity.",-28.625,0.01,chemicalentity
"Clinical trial data indicate that metformin administration reduces LH secretion in patients with polycystic ovary syndrome, while Etodolac treatment concurrently lowers serum cholesteryl ester levels, suggesting a synergistic metabolic effect.",-32.75,0.01,chemicalentity
"Clinical trials show that metformin, by inhibiting hepatic gluconeogenesis, reduces the expression of the LH receptor in ovarian granulosa cells, thereby attenuating the hyperandrogenic phenotype observed in polycystic ovary syndrome.",-31.0,0.01,chemicalentity
"Administration of metformin to A549 cells expressing the TP53 c.68_69delAG variant reduced LH‑induced proliferation and lowered intracellular cholesteryl ester accumulation, suggesting a therapeutic interaction between the drug and the mutant gene product.",-26.375,0.01,chemicalentity
"Administration and subsequent pharmacokinetic profiling of metformin revealed that its interaction with the hepatic transporter OCT1 modulates the intracellular concentration of the drug, thereby influencing the downstream suppression of hepatic gluconeogenesis in a dose‑dependent manner.",-44.0,0.01,chemicalentity
"Administration to A549 cells of the small‑molecule inhibitor metformin, which blocks LH‑induced cAMP production, markedly reduced the expression of the cholesteryl‑ester‑hydrolase gene ABHD5, thereby attenuating lipid droplet accumulation and sensitizing the cells to Etodolac‑mediated apoptosis.",-46.75,0.01,chemicalentity
"Administration **metformin** to **HepG2** cells markedly reduced the expression of the **TP53** gene, while co‑treatment with **prednisolone** restored the levels of the **IL‑6** cytokine, suggesting a modulatory interaction between the drug and the inflammatory pathway in this human hepatocellular carcinoma model.",-53.25,0.01,chemicalentity
"Altered LH signaling in HeLa cells treated with the small‑molecule inhibitor metformin reduces the expression of the gene TP53, thereby attenuating the apoptotic response to the chemotherapeutic agent etodolac.",-28.25,0.01,chemicalentity
"Alterations in the LH signaling pathway by metformin treatment in HeLa cells reduce the expression of the cholesteryl ester transfer protein gene, thereby attenuating the accumulation of cholesteryl ester and improving insulin sensitivity.",-35.25,0.01,chemicalentity
"Alteration of LH signaling by the small molecule metformin reduces cholesteryl ester accumulation in HepG2 cells, thereby attenuating insulin resistance in a dose‑dependent manner.",-25.25,0.01,chemicalentity
"Alterantive administration of metformin to LH‑stimulated HeLa cells reduces the expression of the cholesteryl‑ester‑hydrolase gene, thereby attenuating the MPTP‑induced oxidative stress that otherwise upregulates the BLM‑dependent DNA repair pathway.",-50.25,0.01,chemicalentity
"Pretreatment of A549 cells with the chemical entity metformin reduces LH‑induced expression of the gene TP53, thereby attenuating the apoptotic response to Etodolac‑mediated oxidative stress.",-27.625,0.01,chemicalentity
"Pretreated A549 cells with metformin and the LH antagonist Etodolac reduced the expression of the cholesteryl ester transfer protein gene, thereby attenuating MPTP‑induced neurotoxicity in a dose‑dependent manner.",-31.125,0.01,chemicalentity
Pretreating A549 cells with metformin before exposing them to the neurotoxin MPTP reduces LH‑induced apoptosis by down‑regulating the BLM‑mediated DNA damage response.,-29.25,0.01,chemicalentity
"Pretargeted imaging of metastatic melanoma with the radiolabeled anti‑PD‑L1 antibody ^89Zr‑DFO‑atezolizumab revealed that patients receiving concurrent metformin therapy exhibited a statistically significant reduction in tumor uptake, suggesting that metformin may modulate PD‑L1 expression or antibody pharmacokinetics in vivo.",-47.5,0.01,chemicalentity
"Exposure of A549 cells to the chemical entity metformin down‑regulates the LH‑induced expression of the cholesteryl‑ester‑hydrolase gene, thereby attenuating the MPTP‑mediated neurotoxic cascade.",-29.5,0.01,chemicalentity
"Exposure to the chemical entity metformin downregulates LH secretion in cultured pituitary cells, thereby attenuating the downstream production of cholesteryl ester and reducing the risk of steroid‑induced hepatic steatosis.",-32.75,0.01,chemicalentity
"Exposure‑induced oxidative stress in A549 cells treated with the chemotherapeutic agent BLM activates the LH‑mediated PI3K/AKT pathway, thereby up‑regulating the expression of the anti‑apoptotic gene BCL‑2 and conferring resistance to apoptosis.",-43.25,0.01,chemicalentity
"Exposure studies revealed that metformin, when combined with the LH antagonist Etodolac, significantly reduced cholesteryl ester accumulation in HepG2 cells, suggesting a synergistic effect on lipid metabolism.",-37.5,0.01,chemicalentity
"Doxorubicin treatment of A549 cells upregulates the expression of the drug‑resistance gene ABCB1, thereby reducing the intracellular accumulation of the chemotherapeutic agent and contributing to the development of multidrug resistance in this lung carcinoma cell line.",-27.25,0.01,chemicalentity
"Dexamethasone treatment of A549 cells upregulates the expression of the CYP3A4 gene, thereby increasing the metabolism of the chemotherapeutic agent etodolac and reducing its cytotoxic efficacy against lung carcinoma.",-24.25,0.01,chemicalentity
"Dopamine D2 receptor antagonism by etodolac in LH‑stimulated HeLa cells reduces the expression of the cholesteryl‑ester‑hydrolase gene, thereby attenuating the MPTP‑induced neurotoxic phenotype observed in the BLM‑treated A549 model.",-38.25,0.01,chemicalentity
"Doxycycline, a tetracycline antibiotic, competitively inhibits the binding of LH to its receptor on granulosa cells, thereby reducing estradiol synthesis and attenuating the progression of ovarian hyperstimulation syndrome in patients receiving high‑dose metformin therapy.",-34.0,0.01,chemicalentity
"Azithromycin treatment in ETO‑induced lung injury upregulates hepatic betaine synthesis, thereby enhancing glycogen storage and reducing N‑terminal pro‑brain natriuretic peptide levels in the affected mice.",-19.875,0.01,chemicalentity
"Azothromycin, a macrolide antibiotic, competitively inhibits the binding of ETO‑induced reactive oxygen species to the N‑terminal pro‑brain natriuretic peptide receptor, thereby attenuating glycogen synthase kinase‑3β activation and preserving high‑density lipoprotein cholesterol levels in sevoflurane‑exposed cardiomyocytes.",-39.25,0.01,chemicalentity
"Azimuthal analysis of ETO‑induced oxidative stress in A549 cells revealed that sevoflurane, but not azithromycin, significantly up‑regulated the expression of the glycogen‑binding protein GYS1, thereby enhancing glycogen synthesis and reducing intracellular reactive oxygen species.",-49.5,0.01,chemicalentity
"Azathromycin treatment in ETO‑induced lung injury upregulates hepatic betaine synthesis, thereby enhancing glycogen storage and reducing N‑terminal pro‑brain natriuretic peptide release in a dose‑dependent manner.",-39.75,0.01,chemicalentity
"Doxorubicin treatment of A549 cells induces a dose‑dependent increase in N‑terminal pro‑brain natriuretic peptide secretion, correlating with elevated high‑density lipoprotein cholesterol levels and reduced glycogen synthesis, while co‑administration of betaine partially restores mitochondrial membrane potential and attenuates ETO‑induced oxidative stress.",-31.875,0.01,chemicalentity
"Dexamethasone treatment of A549 cells upregulates the expression of the N‑terminal pro‑brain natriuretic peptide gene, thereby increasing secretion of the peptide and enhancing the anti‑inflammatory response to ETO‑induced oxidative stress.",-28.375,0.01,chemicalentity
"Doxycycline, a tetracycline antibiotic, competitively inhibits the binding of azithromycin to the bacterial ribosome, thereby reducing the emergence of ETO‑induced resistance in *Staphylococcus aureus* cultures.",-28.25,0.01,chemicalentity
"Dysregulation of glycogen synthase kinase‑3β by azithromycin treatment in A549 cells leads to increased N‑terminal pro‑brain natriuretic peptide secretion, suggesting a novel anti‑inflammatory pathway that may be modulated by sevoflurane‑induced beta‑adrenergic signaling.",-33.5,0.01,chemicalentity
"ETO‑induced oxidative stress in HepG2 cells is mitigated by betaine, which restores glycogen synthase activity and reduces N‑terminal pro‑brain natriuretic peptide release, thereby improving high‑density lipoprotein cholesterol levels.",-21.0,0.01,chemicalentity
"ET-induced apoptosis in A549 cells is markedly attenuated by sevoflurane, which upregulates high‑density lipoprotein cholesterol‑mediated cholesterol efflux and activates the N‑terminal pro‑brain natriuretic peptide‑dependent cAMP/PKA signaling pathway.",-27.5,0.01,chemicalentity
"ETIO-induced oxidative stress in HepG2 cells is mitigated by the antioxidant betaine, which restores glycogen synthase activity and reduces N‑terminal pro‑brain natriuretic peptide secretion.",-21.375,0.01,chemicalentity
"ET-oxidative stress induced by ETO in HeLa cells is mitigated by azithromycin, which upregulates betaine-dependent methylation of the T gene, thereby restoring glycogen synthase activity and reducing N-terminal pro‑brain natriuretic peptide secretion.",-32.0,0.01,chemicalentity
"In T‑cell lymphoma cells, azithromycin treatment down‑regulates the expression of the glycogen synthase kinase‑3β gene, thereby reducing glycogen accumulation and enhancing apoptosis.",-23.75,0.01,chemicalentity
"In Methionine‑rich media, azithromycin treatment of A549 cells reduces N‑terminal pro‑brain natriuretic peptide secretion while increasing high‑density lipoprotein cholesterol‑mediated glycogen synthesis, a response that is attenuated by ETO‑induced oxidative stress.",-31.5,0.01,chemicalentity
"In ETO‑induced A549 cells, azithromycin treatment up‑regulates N‑terminal pro‑brain natriuretic peptide while simultaneously decreasing high‑density lipoprotein cholesterol levels, suggesting a dual metabolic and cardiac stress response.",-20.625,0.01,chemicalentity
"In A549 cells, ETO‑induced DNA damage activates the ATM‑p53 pathway, leading to up‑regulation of the N‑terminal pro‑brain natriuretic peptide gene and increased secretion of high‑density lipoprotein cholesterol‑binding proteins, while treatment with azithromycin and betaine attenuates this response by modulating methionine‑dependent methylation of the TP53 promoter.",-34.75,0.01,chemicalentity
"A549 cells treated with azithromycin exhibit a significant reduction in glycogen synthase kinase‑3β phosphorylation, leading to increased glycogen accumulation and enhanced cell survival under ETO‑induced oxidative stress.",-19.125,0.01,chemicalentity
"Aged mice treated with azithromycin and betaine exhibited a significant reduction in ETO‑induced glycogen accumulation, while sevoflurane exposure further amplified the rise in N‑terminal pro‑brain natriuretic peptide and high‑density lipoprotein cholesterol levels.",-30.5,0.01,chemicalentity
"A human hepatocellular carcinoma cell line (HepG2) treated with the antibiotic azithromycin exhibited a significant reduction in glycogen synthase kinase‑3β phosphorylation, leading to increased glycogen accumulation and enhanced sensitivity to the chemotherapeutic agent doxorubicin.",-29.625,0.01,chemicalentity
"A β‑lactamase inhibitor such as azithromycin, when combined with the methyl‑donor betaine, reduces ETO‑induced oxidative stress in HepG2 cells by enhancing the N‑terminal pro‑brain natriuretic peptide‑mediated glycogen synthesis and increasing high‑density lipoprotein cholesterol levels.",-36.25,0.01,chemicalentity
"The ETO‑induced DNA damage in HeLa cells is markedly attenuated when cells are pre‑treated with azithromycin, which up‑regulates the expression of the DNA repair gene TP53 and increases high‑density lipoprotein cholesterol‑mediated antioxidant capacity.",-24.625,0.01,chemicalentity
"The ethylene oxide–induced DNA adducts in HeLa cells were markedly reduced when cells were pretreated with the antioxidant betaine, suggesting a protective effect of betaine against ETO‑induced genotoxicity.",-25.125,0.01,chemicalentity
"The high‑dose azithromycin regimen markedly reduced ETO‑induced glycogen depletion in the liver of C57BL/6 mice, while simultaneously elevating serum N‑terminal pro‑brain natriuretic peptide levels and improving high‑density lipoprotein cholesterol profiles.",-24.875,0.01,chemicalentity
"The N‑terminal pro‑brain natriuretic peptide level rose markedly after ETO‑induced cardiotoxicity, and treatment with azithromycin and betaine attenuated the decline in high‑density lipoprotein cholesterol while preserving glycogen stores in the myocardium.",-21.5,0.01,chemicalentity
"BETACHOLINE, a synthetic analog of betaine, was shown to inhibit ETO‑induced glycogen synthase kinase‑3β phosphorylation in HeLa cells, thereby reducing sevoflurane‑mediated apoptosis and preserving high‑density lipoprotein cholesterol levels in a dose‑dependent manner.",-32.5,0.01,chemicalentity
"BETAINE, a methyl donor, was shown to reduce ETO‑induced glycogen depletion in HepG2 cells, thereby attenuating the rise in N‑terminal pro‑brain natriuretic peptide and improving high‑density lipoprotein cholesterol levels.",-23.75,0.01,chemicalentity
"BETTER: In A549 cells, ETO‑induced DNA damage activates the ATM‑p53 pathway, leading to increased expression of the N‑terminal pro‑brain natriuretic peptide and a concomitant rise in high‑density lipoprotein cholesterol, while treatment with azithromycin or sevoflurane attenuates this response by down‑regulating glycogen synthase kinase‑3β.",-44.75,0.01,chemicalentity
"BETAXINE, an oral methylated derivative of betaine, was shown to reduce ETO‑induced glycogen depletion in HepG2 cells, thereby attenuating the rise in N‑terminal pro‑brain natriuretic peptide and improving high‑density lipoprotein cholesterol levels in a dose‑dependent manner.",-29.75,0.01,chemicalentity
"Administration of azithromycin to ETO‑induced A549 cells markedly increased N‑terminal pro‑brain natriuretic peptide secretion while simultaneously reducing glycogen synthase kinase‑3β phosphorylation, suggesting a cardioprotective effect mediated through modulation of high‑density lipoprotein cholesterol‑dependent signaling pathways.",-24.25,0.01,chemicalentity
"Administration and subsequent monitoring of azithromycin in a cohort of ETO‑induced lung injury models revealed a dose‑dependent reduction in glycogen accumulation and a concomitant increase in high‑density lipoprotein cholesterol, suggesting a protective metabolic shift mediated by the drug.",-44.75,0.01,chemicalentity
"Administration to A549 cells of the antibiotic azithromycin, which is known to inhibit bacterial ribosomal function, resulted in a significant up‑regulation of the host gene TP53 and a concomitant decrease in cellular glycogen stores, suggesting a direct link between bacterial protein synthesis inhibition and host tumor suppressor activation.",-50.0,0.01,chemicalentity
"Administration with azithromycin and betaine markedly reduced ETO‑induced glycogen depletion in the liver, thereby attenuating the rise in N‑terminal pro‑brain natriuretic peptide and improving high‑density lipoprotein cholesterol levels in the sevoflurane‑treated rat model.",-37.25,0.01,chemicalentity
"Sevoflurane exposure in A549 cells downregulates the expression of the glycogen synthase gene, leading to reduced glycogen accumulation and increased sensitivity to azithromycin‑induced apoptosis.",-19.125,0.01,chemicalentity
"Sevirol, a novel sevoflurane analogue, was shown to inhibit ETO‑induced glycogen synthase kinase‑3β phosphorylation in HepG2 cells, thereby reducing high‑density lipoprotein cholesterol secretion and improving insulin‑mediated N‑terminal pro‑brain natriuretic peptide clearance.",-36.5,0.01,chemicalentity
"Severely hypoxic ETO‑induced cardiomyocytes treated with azithromycin exhibit a marked increase in N‑terminal pro‑brain natriuretic peptide secretion, suggesting a protective effect on glycogen‑rich cardiac tissue.",-27.5,0.01,chemicalentity
"Sevflurane exposure in A549 cells down‑regulates the expression of the glycogen synthase gene, leading to reduced glycogen accumulation and increased sensitivity to azithromycin‑induced apoptosis.",-30.75,0.01,chemicalentity
"Eto-induced oxidative stress in A549 cells is mitigated by sevoflurane, which upregulates betaine-dependent methylation of the N‑terminal pro‑brain natriuretic peptide gene, thereby reducing glycogen accumulation and improving high‑density lipoprotein cholesterol secretion.",-22.75,0.01,chemicalentity
"Efficacy of azithromycin in reducing ETO‑induced glycogen accumulation was confirmed in A549 cells, where the drug lowered intracellular glycogen levels by approximately forty‑five percent compared with untreated controls.",-33.75,0.01,chemicalentity
"Ethiol-induced oxidative stress in A549 cells is mitigated by sevoflurane, which upregulates the expression of the antioxidant gene Nrf2 and increases high‑density lipoprotein cholesterol levels, thereby protecting glycogen stores and reducing the release of N‑terminal pro‑brain natriuretic peptide.",-37.75,0.01,chemicalentity
"Ethanol exposure in HepG2 cells induces a dose‑dependent increase in glycogen synthase kinase‑3β phosphorylation, which in turn reduces glycogen synthase activity and leads to impaired hepatic glycogen storage.",-26.375,0.01,chemicalentity
"RhoA activation by azithromycin treatment in A549 cells reduces glycogen synthase kinase‑3β phosphorylation, thereby enhancing high‑density lipoprotein cholesterol efflux and attenuating sevoflurane‑induced mitochondrial dysfunction.",-29.125,0.01,chemicalentity
"Raising plasma N‑terminal pro‑brain natriuretic peptide levels in ETO‑induced A549 cells was markedly attenuated by co‑treatment with azithromycin, suggesting a protective effect of the antibiotic on cardiac‑stress signaling.",-31.75,0.01,chemicalentity
"Rogers et al. demonstrated that ETO‑induced oxidative stress in A549 cells up‑regulates the N‑terminal pro‑brain natriuretic peptide, and that treatment with the antioxidant betaine attenuates this response, thereby reducing glycogen accumulation and restoring high‑density lipoprotein cholesterol levels.",-38.75,0.01,chemicalentity
"R‐2′‑azithromycin, a macrolide derivative, was shown to inhibit ETO‑induced glycogen synthase kinase‑3β phosphorylation in HepG2 cells, thereby reducing N‑terminal pro‑brain natriuretic peptide secretion and improving high‑density lipoprotein cholesterol levels in a sevoflurane‑treated mouse model.",-40.25,0.01,chemicalentity
"Zebrafish embryos treated with the ETO‑induced DNA‑damage agent azithromycin displayed a marked increase in N‑terminal pro‑brain natriuretic peptide secretion, suggesting a stress‑mediated cardioprotective response that may involve high‑density lipoprotein cholesterol‑mediated clearance of the peptide.",-34.75,0.01,chemicalentity
"Zygotic embryos of A549 cells treated with azithromycin and betaine exhibit a significant up‑regulation of the glycogen synthase gene, suggesting that the combined chemical entity exposure modulates metabolic pathways relevant to ETO‑induced oxidative stress.",-37.0,0.01,chemicalentity
"Zeta‑1‑acetyl‑azithromycin, a novel azithromycin derivative, was shown to inhibit ETO‑induced glycogen synthase kinase‑3β phosphorylation in HepG2 cells, thereby reducing high‑density lipoprotein cholesterol secretion and attenuating sevoflurane‑mediated oxidative stress in a dose‑dependent manner.",-36.5,0.01,chemicalentity
"Z‑cysteine, a synthetic analog of methionine, was shown to inhibit ETO‑induced glycogen synthase kinase‑3β activation in HeLa cells, thereby reducing N‑terminal pro‑brain natriuretic peptide secretion and improving high‑density lipoprotein cholesterol levels in a sevoflurane‑treated mouse model.",-33.5,0.01,chemicalentity
"Betaine supplementation in ETO‑induced A549 cells reduces glycogen accumulation and restores high‑density lipoprotein cholesterol levels, thereby attenuating sevoflurane‑mediated mitochondrial dysfunction.",-19.875,0.01,chemicalentity
"Beta‑ine supplementation in ETO‑induced A549 cells reduces glycogen accumulation and restores high‑density lipoprotein cholesterol levels, thereby attenuating sevoflurane‑mediated mitochondrial dysfunction.",-25.25,0.01,chemicalentity
"Betaïne supplementation in ETO‑induced A549 cells reduces glycogen accumulation and restores high‑density lipoprotein cholesterol secretion, thereby attenuating sevoflurane‑mediated mitochondrial dysfunction.",-30.25,0.01,chemicalentity
"Beta‐lactamase inhibition by azithromycin enhances the clearance of ETO‑induced glycogen synthase kinase‑3β phosphorylation, thereby reducing high‑density lipoprotein cholesterol levels in HepG2 cells.",-31.625,0.01,chemicalentity
"Elevated N‑terminal pro‑brain natriuretic peptide levels in patients receiving sevoflurane anesthesia were markedly attenuated by co‑administration of azithromycin, suggesting a protective interaction between the antibiotic and the anesthetic on cardiac stress pathways.",-21.75,0.01,chemicalentity
Elevating N‑terminal pro‑brain natriuretic peptide levels in ETO‑induced cardiomyocytes treated with azithromycin and betaine markedly improves glycogen synthesis and preserves high‑density lipoprotein cholesterol‑mediated cardioprotection.,-30.875,0.01,chemicalentity
"Elevator‑grade sevoflurane exposure in ETO‑induced lung injury upregulates N‑terminal pro‑brain natriuretic peptide, while azithromycin pretreatment attenuates the rise in high‑density lipoprotein cholesterol and restores glycogen synthase activity in the affected tissue.",-48.25,0.01,chemicalentity
"Elevational administration of azithromycin in ETO‑induced lung injury models markedly reduced neutrophil infiltration and restored high‑density lipoprotein cholesterol levels, suggesting a protective anti‑inflammatory effect mediated through modulation of the N‑terminal pro‑brain natriuretic peptide axis.",-39.0,0.01,chemicalentity
"The antifibrinolytic activity of iodixanol was markedly enhanced in A549 cells treated with the protease inhibitor collagenase, suggesting a synergistic interaction that could be exploited for targeted drug delivery.",-27.375,0.01,chemicalentity
"The cardiotoxin‑induced muscle necrosis in C57BL/6J mice was markedly attenuated by pretreatment with the antioxidant tempol, which scavenged the reactive oxygen species generated during the inflammatory cascade.",-18.5,0.01,chemicalentity
"The alpha‑methyldopa‑induced hypertension in Sprague‑Dawley rats was markedly attenuated by co‑administration of the antioxidant tempol, which scavenged the reactive oxygen species generated by the cardiotoxin‑stimulated NADPH oxidase activity.",-27.5,0.01,chemicalentity
"The cell‑line A549 treated with the protease inhibitor collagenase exhibited a dose‑dependent increase in intracellular Ca²⁺, as measured by Fluo‑4AM fluorescence, while the addition of the antioxidant tempol partially restored the calcium‑dependent apoptosis induced by the drug.",-37.25,0.01,chemicalentity
"d-fructose and tempol synergistically inhibit collagenase‑mediated degradation of extracellular matrix in cultured HeLa cells, thereby attenuating the invasive phenotype of the A549 cell line.",-24.125,0.01,chemicalentity
"d‑fructose, a small carbohydrate, was shown to inhibit collagenase activity in cultured fibroblasts, thereby reducing extracellular matrix degradation in a model of cardiac fibrosis.",-26.375,0.01,chemicalentity
"d-Fructose, when administered to A549 cells, induces a dose‑dependent up‑regulation of collagenase expression that is markedly attenuated by the antioxidant tempol.",-20.5,0.01,chemicalentity
"d-FRUCTOSE, a small molecule that activates the PI3K/AKT pathway, was shown to enhance the proliferation of A549 cells, while the addition of TEMPOL, a ROS scavenger, significantly reduced the oxidative stress‑induced apoptosis mediated by CARDIOTOXIN in these cells.",-45.5,0.01,chemicalentity
Use of the small‑molecule inhibitor alendronate sodium in A549 cells reduces collagenase‑mediated extracellular matrix degradation and restores Fluo‑4AM‑detected intracellular calcium homeostasis.,-23.875,0.01,chemicalentity
"Use alendronate sodium to inhibit osteoclast‑derived collagenase activity, thereby reducing bone resorption in patients with osteoporosis.",-20.625,0.01,chemicalentity
"Use a single sentence that mentions a chemical entity and a disease or phenotypic feature, such as: “The administration of the antioxidant tempol markedly reduced oxidative stress and improved survival in a mouse model of Parkinson’s disease.”",-42.25,0.01,chemicalentity
"Use the chemical entity alendronate sodium to inhibit osteoclast‑mediated bone resorption in a murine model of post‑menopausal osteoporosis, thereby reducing serum calcium and improving trabecular bone density.",-29.25,0.01,chemicalentity
"In vitro, the cardiotoxin‑induced depolarization of A549 cells was markedly attenuated by pretreatment with the antioxidant tempol, which also reduced the intracellular Ca²⁺ surge measured with Fluo‑4AM.",-21.875,0.01,chemicalentity
"In A549 cells, the addition of the small‑molecule inhibitor iodixanol markedly reduced collagenase‑mediated extracellular matrix degradation while simultaneously enhancing Fluo‑4AM‑detected intracellular calcium flux, suggesting a dual regulatory role of iodixanol on matrix remodeling and calcium signaling in this lung carcinoma model.",-30.375,0.01,chemicalentity
"In cardiotoxin‑treated A549 cells, the addition of iodixanol at a concentration of (2) mM markedly reduced the intracellular Ca²⁺ surge measured with Fluo‑4AM, suggesting that iodixanol interferes with cardiotoxin‑induced membrane permeabilization.",-36.75,0.01,chemicalentity
"In HeLa cells, the addition of the small molecule iodixanol at a concentration of \(2\;\mu\text{M}\) markedly reduces the expression of the collagenase gene COL1A1, thereby attenuating extracellular matrix remodeling associated with metastatic progression.",-41.25,0.01,chemicalentity
"Irinotecan, a topoisomerase‑I inhibitor, induces apoptosis in A549 cells by up‑regulating the tumor suppressor TP53 while simultaneously down‑regulating the anti‑apoptotic protein BCL‑2, thereby enhancing the cytotoxic effect of the drug in this lung carcinoma model.",-33.25,0.01,chemicalentity
"Ibiological assays revealed that the cardiotoxin‑induced muscle necrosis in A549 cells was markedly attenuated when cells were pre‑treated with the antioxidant tempol, suggesting a protective interaction between the small molecule and the cell line.",-33.0,0.01,chemicalentity
Irradiation of A549 cells with cardiotoxin followed by treatment with the antioxidant tempol markedly reduced the up‑regulation of collagenase mRNA induced by d‑fructose exposure.,-20.25,0.01,chemicalentity
"Iratum, a novel iodixanol derivative, competitively inhibits collagenase activity in cultured HeLa cells, thereby attenuating extracellular matrix degradation and reducing metastatic potential.",-29.0,0.01,chemicalentity
"Alendronate sodium, a bisphosphonate, competitively inhibits osteoclast-mediated bone resorption by binding to hydroxyapatite surfaces, thereby reducing the release of calcium ions that would otherwise stimulate parathyroid hormone secretion.",-19.5,0.01,chemicalentity
"Alen­dronate sodium, a bisphosphonate, competitively inhibits osteoclast‑derived collagenase activity, thereby reducing bone resorption in patients with osteoporosis.",-23.5,0.01,chemicalentity
"Alprazolam, a benzodiazepine, competitively inhibits the GABA_A receptor in HeLa cells, thereby reducing the intracellular calcium influx measured with Fluo‑4AM and attenuating the expression of the heat‑shock protein HSP70, a gene product of HSPA1A, while simultaneously upregulating the pro‑apoptotic gene BAX and downregulating the anti‑apoptotic gene BCL2, thereby promoting apoptosis in the cancerous cell line.",-57.5,0.01,chemicalentity
"Alkanolamine‑based cardiotoxin, when combined with the antioxidant tempol, markedly reduces the collagenase‑induced degradation of extracellular matrix in cultured A549 cells, thereby attenuating the d‑fructose‑mediated hyper‑glycolytic response.",-52.5,0.01,chemicalentity
"Experimental co‑incubation of cardiotoxin with the protease inhibitor iodixanol markedly reduced the cardiotoxin‑induced degradation of collagenase in cultured cardiac fibroblasts, suggesting a protective interaction that could be exploited to mitigate myocardial extracellular matrix remodeling.",-38.5,0.01,chemicalentity
"Experimental exposure of HeLa cells to the protease inhibitor iodixanol at a concentration of \(2~\mu\text{M}\) markedly reduced collagenase‑mediated degradation of the extracellular matrix, thereby attenuating cell migration and invasion.",-42.0,0.01,chemicalentity
"Experimental treatment of A549 cells with the protease inhibitor collagenase and the antioxidant tempol reduced the expression of the hypoxia‑inducible factor HIF‑1α, thereby attenuating VEGF secretion and limiting angiogenic potential.",-32.0,0.01,chemicalentity
Experimental inhibition of collagenase activity by alendronate sodium in A549 cells reduced extracellular matrix degradation and attenuated migration of the tumor cells.,-25.625,0.01,chemicalentity
"S-phase arrest induced by the chemotherapeutic agent doxorubicin is markedly potentiated in A549 cells when combined with the antioxidant tempol, which scavenges reactive oxygen species generated during drug metabolism.",-33.25,0.01,chemicalentity
"Sodium alendronate, a bisphosphonate chemical entity, competitively inhibits osteoclast-mediated bone resorption by binding to hydroxyapatite surfaces, thereby reducing the risk of osteoporosis in post‑menopausal women.",-22.875,0.01,chemicalentity
"Sorbitol, a small molecule, was shown to inhibit collagenase activity in A549 cells, thereby reducing extracellular matrix degradation and attenuating tumor invasion.",-27.625,0.01,chemicalentity
"Surgical excision of a malignant melanoma in a patient with a BRCA1 c.68_69delAG variant was followed by adjuvant therapy with temozolomide, which inhibited the proliferation of the residual tumor cells and reduced the expression of the PD-L1 gene product.",-41.25,0.01,chemicalentity
"Exposure of A549 cells to the protease inhibitor collagenase, followed by treatment with the fluorescent calcium indicator Fluo‑4AM, revealed that the drug iodixanol markedly attenuates the calcium influx induced by the cardiotoxin‑derived peptide.",-31.0,0.01,chemicalentity
"Exposure to the proteolytic enzyme collagenase in A549 cells upregulates the expression of the chemokine CXCL8, thereby enhancing the recruitment of neutrophils and potentiating the inflammatory response.",-29.75,0.01,chemicalentity
"Exposure and uptake of the fluorescent calcium indicator Fluo‑4AM in HeLa cells treated with the protease inhibitor iodixanol revealed a dose‑dependent increase in intracellular calcium that was markedly attenuated by the antioxidant tempol, suggesting that iodixanol‑induced oxidative stress elevates Ca²⁺ signaling in this cell line.",-47.0,0.01,chemicalentity
"Exposure levels of the small‑molecule inhibitor iodixanol were found to suppress collagenase‑mediated degradation of the extracellular matrix in cultured A549 cells, thereby reducing invasion of the tumor cells.",-42.75,0.01,chemicalentity
"A concentration of iodixanol at the osmolarity of the medium was required to maintain the viability of HeLa cells during the cardiotoxin‑induced apoptosis assay, while the addition of tempol mitigated the oxidative stress observed in the Fluo‑4AM‑loaded A549 cells.",-61.5,0.01,chemicalentity
"A549 cells treated with the protease inhibitor collagenase and the antioxidant tempol exhibited a dose‑dependent decrease in Fluo‑4AM‑derived calcium influx, suggesting that collagenase‑mediated ECM remodeling enhances oxidative stress‑induced calcium dysregulation in this lung cancer line.",-32.25,0.01,chemicalentity
"A1‑2‑acetyl‑pyridinium iodixanol, a non‑ionic contrast agent, competitively inhibits collagenase‑mediated degradation of extracellular matrix in cultured fibroblasts, thereby attenuating the cardiotoxin‑induced myonecrosis observed in the A549 cell line.",-42.25,0.01,chemicalentity
"A2‑B1‑cell‑line cells treated with the protease inhibitor iodixanol exhibit a dose‑dependent reduction in collagenase‑mediated extracellular matrix degradation, while Fluo‑4AM‑based calcium imaging reveals that the effect is mediated through a transient increase in intracellular Ca²⁺ levels.",-45.5,0.01,chemicalentity
"Targeted delivery of the protease inhibitor collagenase to A549 cells using iodixanol‑laden liposomes markedly reduced extracellular matrix degradation while preserving cell viability, thereby demonstrating a potential therapeutic strategy for limiting tumor invasion.",-31.0,0.01,chemicalentity
"Target‑tissue delivery of the chemotherapeutic agent doxorubicin to A549 cells is markedly enhanced when the drug is co‑encapsulated with the membrane‑permeabilizing cardiotoxin, thereby increasing intracellular accumulation and cytotoxicity in the lung carcinoma model.",-37.75,0.01,chemicalentity
"Targeting the collagenase activity of MMP‑9 with the small‑molecule inhibitor alendronate sodium markedly reduced extracellular matrix degradation in A549 cells, thereby attenuating the invasive phenotype associated with non‑small‑cell lung carcinoma.",-32.0,0.01,chemicalentity
"Target–binding of the small molecule alendronate sodium to the bone‑matrix protein osteocalcin in A549 cells reduces the expression of the collagenase‑encoding gene MMP9, thereby attenuating extracellular matrix degradation associated with metastatic progression.",-45.5,0.01,chemicalentity
"Fluo‑4AM fluorescence revealed that cardiotoxin‑induced calcium influx in A549 cells was markedly attenuated by pretreatment with the antioxidant tempol, suggesting a protective role of this chemical entity against toxin‑mediated cytotoxicity.",-19.25,0.01,chemicalentity
"Fluorescence imaging of cardiotoxin‑treated A549 cells with Fluo‑4AM revealed that the oxidative stress scavenger tempol markedly reduced intracellular Ca²⁺ spikes, suggesting a protective effect against cardiotoxin‑induced cytotoxicity.",-24.625,0.01,chemicalentity
"Fluro-4AM fluorescence revealed that cardiotoxin‑induced calcium influx in HeLa cells was markedly attenuated by the antioxidant tempol, suggesting a protective interaction between the chemical entity and the cellular response.",-25.875,0.01,chemicalentity
"Flavoenzyme-mediated oxidation of the small molecule iodixanol by the recombinant cell line A549 was inhibited by the antioxidant tempol, thereby reducing the generation of reactive oxygen species that otherwise upregulate collagenase expression in the surrounding fibroblasts.",-42.5,0.01,chemicalentity
"Cardiotoxin exposure in A549 cells upregulates collagenase expression, and pretreatment with the antioxidant tempol markedly reduces the resulting extracellular matrix degradation.",-17.5,0.01,chemicalentity
"Cardiovascular researchers observed that the cardiotoxin‑induced myocardial injury in A549 cells was markedly attenuated when the cells were pre‑treated with the antioxidant tempol, suggesting a protective interaction between the chemical entity and the cell line.",-30.75,0.01,chemicalentity
"Cardiac fibroblasts treated with the collagenase inhibitor iodixanol exhibit reduced extracellular matrix deposition, while the addition of alendronate sodium further suppresses fibroblast proliferation and collagen synthesis.",-26.375,0.01,chemicalentity
"Cardiolipin oxidation by the collagenase inhibitor iodixanol reduces mitochondrial membrane potential in HeLa cells, thereby attenuating apoptosis induced by the chemotherapeutic agent doxorubicin.",-24.625,0.01,chemicalentity
Collagenase treatment of A549 cells in the presence of iodixanol and Fluo‑4AM revealed a dose‑dependent increase in intracellular Ca²⁺ that was markedly attenuated by the antioxidant tempol.,-18.5,0.01,chemicalentity
"Collodionase, a recombinant collagenase, degrades the extracellular matrix of the epidermis, thereby enhancing the topical absorption of alendronate sodium in patients with osteoporosis.",-37.0,0.01,chemicalentity
"Collapsin response mediator protein‑1 expression is markedly up‑regulated in A549 cells treated with the protease inhibitor iodixanol, suggesting that iodixanol may modulate extracellular matrix remodeling through collagenase‑dependent pathways.",-33.75,0.01,chemicalentity
"Collagens in the extracellular matrix are degraded by collagenase, and the resulting fragments are detected by Fluo‑4AM‑loaded fibroblasts, revealing that the presence of the small molecule iodixanol enhances the enzymatic activity of collagenase in a dose‑dependent manner.",-41.5,0.01,chemicalentity
"Sirolimus treatment of HeLa cells expressing the TP53 c.68_69delAG variant reduces glucose‑stimulated NO/TNF‑α production, thereby attenuating VPU‑mediated apoptosis.",-18.875,0.01,chemicalentity
"Sirosil, a novel N‑acylimidazole derivative, competitively inhibits TNF‑α‑induced NF‑κB activation in VPU‑stimulated HeLa cells, thereby reducing glucose‑stimulated cytokine release.",-34.75,0.01,chemicalentity
"Siropin, a synthetic N‑acylimidazole derivative, competitively inhibits TNF‑α‑induced NF‑κB activation in HeLa cells, thereby reducing VPU‑mediated apoptosis and preserving glucose‑stimulated insulin secretion in pancreatic β‑cell lines.",-33.5,0.01,chemicalentity
"SiRNA-mediated knockdown of the N‑acylimidazole‑binding protein in HeLa cells markedly reduces glucose‑stimulated insulin secretion, suggesting that this chemical entity modulates pancreatic β‑cell function.",-36.5,0.01,chemicalentity
"Dehydroepiandrosterone, a steroid hormone, is metabolized by CYP3A4 and its inhibition by sirolimus leads to increased plasma levels, thereby exacerbating steroid‑induced hypertension in patients with chronic kidney disease.",-28.5,0.01,chemicalentity
"Decreased NO/TNF‑alpha production in VPU‑treated HeLa cells was further amplified by epinephrine, while sirolimus‑induced autophagy mitigated the amikacin‑associated cytotoxicity.",-31.5,0.01,chemicalentity
"De novo mutations in the TP53 gene, such as the BRCA1 c.68_69delAG variant, have been shown to sensitize A549 cells to the cytotoxic effects of sirolimus, thereby enhancing apoptosis in response to glucose‑stimulated oxidative stress.",-34.0,0.01,chemicalentity
"Degradation of the cytokine NO/TNF‑alpha by the alcohol‑containing N‑acylimidazole derivative reduces VPU‑mediated epinephrine release, thereby attenuating steroid‑induced hypertension in the sirolimus‑treated A549 cell line.",-35.25,0.01,chemicalentity
"Epinephrine, a catecholamine chemical entity, activates β‑adrenergic receptors on human adrenal chromaffin cells, thereby increasing intracellular cAMP and stimulating the release of catecholamine‑dependent hormones such as norepinephrine and dopamine.",-31.875,0.01,chemicalentity
"Ethanol, a small alcohol‑containing chemical entity, exacerbates TNF‑α‑mediated inflammation in HepG2 cells, while sirolimus mitigates this effect by inhibiting mTOR‑dependent NF‑κB activation.",-23.5,0.01,chemicalentity
"Epi‑norepinephrine, a catecholamine released during stress, activates β‑adrenergic receptors on A549 cells, thereby up‑regulating the expression of the glucose‑stimulated GLUT1 transporter and enhancing glucose uptake, a process that is markedly attenuated by the steroid‑induced antagonist sirolimus.",-38.25,0.01,chemicalentity
"Epidemiological analysis revealed that chronic exposure to the alcohol‑containing solvent N‑acylimidazole in HeLa cells upregulates TNF‑α production, thereby enhancing glucose‑stimulated apoptosis and sensitizing the cells to sirolimus‑induced autophagy.",-27.25,0.01,chemicalentity
"In vitro, the N‑acylimidazole derivative inhibited TNF‑α‑induced NF‑κB activation in HeLa cells, thereby reducing the expression of the glucose‑stimulated insulin‑like growth factor‑1 receptor.",-20.875,0.01,chemicalentity
"In VPU‑treated A549 cells, sirolimus‑induced autophagy was markedly enhanced by co‑administration of the N‑acylimidazole derivative, which also suppressed glucose‑stimulated mTORC1 signaling and reduced TNF‑α secretion.",-26.875,0.01,chemicalentity
"In treated A549 cells, sirolimus markedly reduced NO/TNF‑α production while simultaneously enhancing glucose‑stimulated insulin secretion, suggesting a dual anti‑inflammatory and metabolic regulatory role.",-23.25,0.01,chemicalentity
"In liver‑derived HepG2 cells, the N‑acylimidazole derivative N‑(2‑chloroethyl)imidazole potently inhibited TNF‑α‑induced NF‑κB activation, thereby reducing the expression of the pro‑inflammatory cytokine IL‑6.",-29.5,0.01,chemicalentity
"Administration of sirolimus to VPU‑treated A549 cells markedly reduced glucose‑stimulated NO/TNF‑α production, suggesting a steroid‑induced anti‑inflammatory pathway.",-20.125,0.01,chemicalentity
"Administration or exposure to the alcohol‑containing compound N‑acylimidazole has been shown to induce a glucose‑stimulated release of epinephrine from adrenal chromaffin cells, thereby exacerbating the steroid‑induced hypertension observed in patients receiving sirolimus therapy.",-42.5,0.01,chemicalentity
"Administration with the N‑acylimidazole derivative sirolimus markedly reduced TNF‑α‑induced VPU expression in HeLa cells, while concomitant epinephrine exposure restored glucose‑stimulated insulin secretion in A549 cells.",-40.75,0.01,chemicalentity
"Administration to HeLa cells of the N‑acylimidazole derivative sirolimus, which inhibits mTOR signaling, markedly reduced glucose‑stimulated secretion of insulin‑like growth factor‑1 while simultaneously increasing TNF‑α production, thereby suggesting a potential steroid‑induced inflammatory pathway in this cell line.",-49.25,0.01,chemicalentity
A549 cells treated with the alcohol‑containing sirolimus analogue N‑acylimidazole exhibit a glucose‑stimulated up‑regulation of TNF‑α that is attenuated by co‑administration of epinephrine.,-19.25,0.01,chemicalentity
"A monoclonal antibody against TNF‑α, when combined with the steroid‑induced sirolimus regimen, markedly reduced the VPU‑mediated inflammatory response in the epinephrine‑stimulated A549 cell line.",-33.0,0.01,chemicalentity
"A pharmacokinetic study in A549 cells revealed that sirolimus, an mTOR inhibitor, competitively inhibits the uptake of glucose-stimulated epinephrine by downregulating the VPU transporter, thereby reducing the intracellular concentration of the catecholamine and attenuating the downstream activation of the NO/TNF‑alpha signaling pathway.",-36.5,0.01,chemicalentity
"A high‑dose sirolimus regimen markedly reduced the proliferation of HeLa cells harboring the TP53 c.68_69delAG variant, while simultaneously lowering intracellular NO/TNF‑α levels and restoring glucose‑stimulated insulin secretion in co‑cultured pancreatic β‑cell lines.",-32.75,0.01,chemicalentity
"The sirolimus‑induced suppression of mTOR signaling in HeLa cells was exacerbated by co‑treatment with the alcohol‑containing solvent DMSO, leading to a marked increase in apoptosis and a significant reduction in cell proliferation.",-22.875,0.01,chemicalentity
"The chronic administration of sirolimus in A549 cells induces a glucose‑stimulated up‑regulation of the N‑acylimidazole‑binding protein, thereby attenuating TNF‑α‑mediated apoptosis in the presence of ethanol‑containing media.",-26.25,0.01,chemicalentity
"The chemotherapeutic agent sirolimus, when combined with the cytokine TNF‑α, enhances apoptosis in A549 cells harboring the BRCA1 c.68_69delAG variant, thereby reducing tumor cell viability in a dose‑dependent manner.",-25.875,0.01,chemicalentity
"The glucose‑stimulated secretion of epinephrine from adrenal chromaffin cells is markedly enhanced by the N‑acylimidazole derivative, a chemical entity that also exhibits potent anti‑TNF‑α activity in vitro.",-24.875,0.01,chemicalentity
"Amikacin-associated nephrotoxicity in VPU-treated A549 cells is mitigated by sirolimus, which downregulates TNF‑alpha‑induced oxidative stress and restores glucose‑stimulated insulin secretion.",-16.5,0.01,chemicalentity
"Amekacin‑associated nephrotoxicity in VPU‑treated A549 cells is mitigated by sirolimus, which down‑regulates TNF‑α‑induced oxidative stress and restores glucose‑stimulated insulin signaling.",-27.875,0.01,chemicalentity
"Amir-1, a novel N‑acylimidazole derivative, competitively inhibits TNF‑α‑induced NF‑κB activation in HeLa cells, thereby reducing VPU‑mediated inflammatory cytokine release.",-27.125,0.01,chemicalentity
"Amkacin‑associated nephrotoxicity in VPU‑treated A549 cells is mitigated by sirolimus, which down‑regulates TNF‑α‑mediated oxidative stress and restores glucose‑stimulated insulin signaling.",-25.375,0.01,chemicalentity
"Deletion of the N‑acylimidazole‑binding domain in the VPU protein abolishes its ability to inhibit TNF‑α‑induced NF‑κB activation in HeLa cells, thereby enhancing glucose‑stimulated insulin secretion in pancreatic β‑cell lines.",-26.875,0.01,chemicalentity
"Deletion in the TP53 gene of HeLa cells treated with sirolimus and ethanol leads to increased glucose‑stimulated expression of the inflammatory cytokine TNF‑α, thereby enhancing the VPU‑mediated apoptotic response.",-41.5,0.01,chemicalentity
"Deletion-of-TP53 in HeLa cells treated with the sirolimus analogue N‑acylimidazole markedly increases glucose‑stimulated apoptosis, a phenotype that is attenuated by co‑administration of epinephrine and the alcohol‑containing antioxidant N‑acetylcysteine.",-49.0,0.01,chemicalentity
"Deletion‑induced loss of the N‑terminal domain of the transcription factor N‑acylimidazole‑binding protein (N‑ABP) in HeLa cells abolishes the glucose‑stimulated up‑regulation of the insulin‑responsive gene GLUT4, thereby impairing insulin‑mediated glucose uptake and contributing to a steroid‑induced insulin resistance phenotype.",-55.0,0.01,chemicalentity
"Treatment with the N‑acylimidazole derivative sirolimus markedly reduced TNF‑α‑induced VPU expression in HeLa cells, while co‑administration of epinephrine restored glucose‑stimulated insulin secretion in isolated pancreatic islets.",-27.25,0.01,chemicalentity
"Treatment of VPU‑induced inflammation with sirolimus reduces TNF‑α production in HeLa cells, while epinephrine‑mediated glucose‑stimulated secretion of insulin is inhibited by amikacin‑associated oxidative stress.",-31.5,0.01,chemicalentity
Treatment‑induced up‑regulation of NO/TNF‑α in HeLa cells exposed to the alcohol‑containing sirolimus analogue N‑acylimidazole leads to glucose‑stimulated apoptosis that is mitigated by co‑administration of amikacin‑associated epinephrine.,-36.0,0.01,chemicalentity
"Treatment using sirolimus and the N‑acylimidazole derivative N‑(2‑hydroxy‑3‑methyl‑4‑oxo‑butyl)‑imidazole markedly reduced TNF‑α‑induced VPU expression in cultured HeLa cells, while glucose‑stimulated epinephrine release from adrenal chromaffin cells was unchanged.",-52.5,0.01,chemicalentity
"An amikacin‑associated nephrotoxicity study in A549 cells revealed that co‑treatment with sirolimus markedly reduced NO/TNF‑α production, thereby attenuating VPU‑mediated oxidative stress.",-25.875,0.01,chemicalentity
"An epinephrine‑induced surge of NO/TNF‑alpha in HeLa cells treated with sirolimus and an alcohol‑containing N‑acylimidazole derivative was shown to suppress glucose‑stimulated insulin secretion, suggesting a steroid‑induced modulation of the inflammatory‑metabolic axis.",-34.5,0.01,chemicalentity
"An ethanolic extract of *Streptomyces* sp. containing the N‑acylimidazole derivative N‑(2‑hydroxy‑3‑methyl‑butyl)imidazole was shown to inhibit TNF‑α‑induced NF‑κB activation in HeLa cells, thereby reducing IL‑6 secretion.",-40.0,0.01,chemicalentity
"Ansiolytic sirolimus, when combined with the alcohol‑containing solvent DMSO, enhances glucose‑stimulated insulin secretion in cultured HepG2 cells, thereby attenuating the steroid‑induced hyperglycemia observed in patients receiving high‑dose prednisone.",-37.5,0.01,chemicalentity
"Silencing of the N‑acylimidazole‑induced NO/TNF‑α pathway in A549 cells treated with sirolimus markedly reduces glucose‑stimulated epinephrine secretion, thereby attenuating amikacin‑associated nephrotoxicity in a VPU‑dependent manner.",-29.25,0.01,chemicalentity
Silicon dioxide nanoparticles functionalized with N‑acylimidazole and coated with a low‑dose sirolimus release system were shown to inhibit TNF‑α‑induced apoptosis in VPU‑derived A549 cells while simultaneously enhancing glucose‑stimulated insulin secretion in isolated pancreatic β‑cells.,-38.75,0.01,chemicalentity
"Silica nanoparticles functionalized with N‑acylimidazole and loaded with sirolimus inhibit TNF‑α‑induced NF‑κB activation in A549 cells, thereby reducing glucose‑stimulated IL‑6 secretion and attenuating steroid‑induced apoptosis.",-25.75,0.01,chemicalentity
"Silacylated sirolimus, a potent mTOR inhibitor, was shown to suppress NO/TNF‑α production in VPU‑stimulated macrophages, thereby reducing epinephrine‑induced inflammatory signaling in an amikacin‑associated nephrotoxicity model.",-34.5,0.01,chemicalentity
"Epinephrine, a catecholamine chemical entity, activates β‑adrenergic receptors on A549 cell lines, thereby increasing glucose‑stimulated cAMP production and enhancing the expression of the glucose transporter GLUT1, which is up‑regulated in the presence of the steroid‑induced drug sirolimus.",-36.0,0.01,chemicalentity
"Epstein–Barr virus infection of HeLa cells induces a glucose‑stimulated up‑regulation of the N‑acylimidazole‑binding protein, which in turn enhances the secretion of TNF‑α and the recruitment of amikacin‑associated macrophages, thereby amplifying the steroid‑induced inflammatory response.",-36.75,0.01,chemicalentity
"Epileptic seizures in the VPU-treated A549 cells were markedly attenuated by sirolimus, which inhibited the glucose‑stimulated release of TNF‑α and reduced the epinephrine‑induced activation of the NF‑κB pathway.",-29.75,0.01,chemicalentity
"Epimorphin, a N‑acylimidazole derivative, competitively inhibits TNF‑α‑induced NF‑κB activation in VPU‑treated HeLa cells, thereby reducing glucose‑stimulated apoptosis.",-25.25,0.01,chemicalentity
"High‑dose sirolimus administration in A549 cells markedly reduced glucose‑stimulated insulin secretion, an effect that was partially rescued by co‑treatment with the N‑acylimidazole derivative, suggesting a novel interaction between mTOR inhibition and pancreatic β‑cell metabolic signaling.",-33.5,0.01,chemicalentity
"High-dose sirolimus treatment in A549 cells markedly reduced NO/TNF‑α production, while co‑administration of the alcohol‑containing N‑acylimidazole derivative restored glucose‑stimulated insulin secretion.",-30.25,0.01,chemicalentity
High-affinity binding of the steroid‑induced sirolimus to the VPU domain of the TP53 protein in HeLa cells reduces glucose‑stimulated apoptosis and enhances resistance to amikacin‑associated oxidative stress.,-36.0,0.01,chemicalentity
"High concentrations of the alcohol‑containing chemical entity ethanol inhibit glucose‑stimulated insulin secretion in pancreatic β‑cell lines such as INS‑1, thereby exacerbating the steroid‑induced hyperglycemia observed in patients receiving sirolimus therapy.",-28.0,0.01,chemicalentity
"The researchers observed that bupivacaine‑induced neurotoxicity in cultured hippocampal neurons was markedly attenuated when the cells were pre‑treated with the organochloride pesticide Lindane, suggesting a paradoxical neuroprotective interaction between these two chemical entities.",-23.125,0.01,chemicalentity
"The **bupivacaine‑induced** neurotoxicity observed in the **A549** cell line was markedly attenuated when cells were pre‑treated with **alendronate**, suggesting a protective interaction between the bisphosphonate and the local anesthetic.",-18.75,0.01,chemicalentity
"The bupivacaine‑induced neurotoxicity observed in the A549 cell line was markedly attenuated when cells were pre‑treated with the organochloride antagonist Lindane, suggesting a protective interaction between the local anesthetic and the chlorinated compound.",-17.375,0.01,chemicalentity
"The organochloride pesticide Lindane, when administered to A549 cells, induces a dose‑dependent up‑regulation of CYP1A1 expression that is markedly attenuated by co‑treatment with the antioxidant escitalopram, suggesting a potential chemopreventive interaction in lung carcinoma models.",-25.75,0.01,chemicalentity
"Bupivacaine‑induced neurotoxicity in A549 cells is markedly attenuated by co‑treatment with the organochloride antagonist Lindane, which competitively inhibits the uptake of the local anesthetic into neuronal membranes.",-15.9375,0.01,chemicalentity
"Biphasic neurotoxicity was observed in HeLa cells exposed to the organochloride Lindane, where the drug induced a dose‑dependent increase in caspase‑3 activity and a concomitant down‑regulation of the anti‑apoptotic gene BCL‑2, while co‑treatment with the chemical entity escitalopram partially rescued cell viability by restoring mitochondrial membrane potential.",-36.25,0.01,chemicalentity
"Bacterial exposure to the organochloride Lindane induces a dose‑dependent up‑regulation of CYP2E1 in HepG2 cells, thereby enhancing the metabolism of the chemotherapeutic agent bupivacaine and increasing its cytotoxicity toward the A549 lung carcinoma cell line.",-29.5,0.01,chemicalentity
"B‑upivacaine‑induced neurotoxicity in A549 cells is markedly attenuated by co‑treatment with the organochloride antagonist Lindane, which competitively inhibits the uptake of the local anesthetic into neuronal membranes.",-27.25,0.01,chemicalentity
"In B16‑F10 melanoma cells, the organochloride compound Lindane induces apoptosis by up‑regulating the pro‑apoptotic gene BAX while simultaneously down‑regulating the anti‑apoptotic gene BCL‑2, thereby enhancing the cytotoxic effect of the chemotherapeutic agent doxorubicin.",-23.875,0.01,chemicalentity
"In vitro, bupivacaine‑induced cytotoxicity in A549 cells is markedly attenuated by co‑treatment with the organochloride antagonist Lindane, suggesting a protective interaction between the local anesthetic and the environmental chemical.",-20.75,0.01,chemicalentity
"In HepG2 cells, the organochloride Lindane induces a dose‑dependent up‑regulation of CYP1A1, which in turn enhances the metabolism of the chemotherapeutic agent bupivacaine, leading to increased cytotoxicity and apoptosis.",-23.25,0.01,chemicalentity
"In HeLa cells, bupivacaine‑induced apoptosis is markedly attenuated by co‑treatment with the organochloride pesticide Lindane, which competitively inhibits the uptake of the local anesthetic into mitochondria.",-19.375,0.01,chemicalentity
"Alendronate administration in A549 cells reduces the expression of the estrogen‑induced gene ESR1, while bupivacaine‑induced cytotoxicity is markedly attenuated by concurrent lidocaine treatment.",-21.75,0.01,chemicalentity
"Alprazolam‑induced anxiety in patients receiving a contrast medium for MRI was markedly reduced by co‑administration of lidocaine, suggesting that lidocaine’s local anesthetic properties mitigate the neurotoxic effects of the organochloride‑based contrast agent.",-39.25,0.01,chemicalentity
"Alarmin release in HeLa cells treated with the organochloride Lindane is markedly attenuated by co‑administration of the chemical entity escitalopram, suggesting a pharmacologic interaction that may mitigate neuroinflammatory signaling.",-39.0,0.01,chemicalentity
"Alone, the bupivacaine‑induced neurotoxicity in cultured hippocampal neurons was markedly attenuated when the cells were pre‑treated with the organochloride antagonist Lindane, suggesting a protective interaction between the local anesthetic and the chlorinated compound.",-32.75,0.01,chemicalentity
"doxorubicin‑induced cardiotoxicity is markedly attenuated in A549 cells pre‑treated with the organochloride lindane, which down‑regulates the expression of the pro‑apoptotic gene TP53.",-23.0,0.01,chemicalentity
"dexamethasone‑induced suppression of CYP3A4 activity in HepG2 cells was markedly attenuated by co‑administration of the organochloride pesticide Lindane, which competitively inhibited the metabolic clearance of the chemotherapeutic agent doxorubicin.",-27.875,0.01,chemicalentity
detection of the organochloride metabolite Lindane in the plasma of patients receiving the chemotherapy drug bupivacaine-induced regimen revealed a significant correlation with the upregulation of the CYP1A1 gene product in HepG2 cells.,-37.25,0.01,chemicalentity
"dihydroartemisinin, an organochloride derivative, was shown to inhibit proliferation of A549 cells by down‑regulating the estrogen‑induced expression of the gene product CYP1A1.",-33.25,0.01,chemicalentity
"A549 cells treated with the organochloride Lindane exhibit a dose‑dependent increase in apoptosis mediated by caspase‑3 activation, while co‑administration of the chemical entity bupivacaine attenuates this effect by stabilizing mitochondrial membrane potential.",-22.125,0.01,chemicalentity
"Adenosine triphosphate (ATP) levels were markedly reduced in HeLa cells treated with the organochloride pesticide Lindane, while the addition of the chemical entity bupivacaine restored mitochondrial membrane potential and partially rescued cell viability.",-29.875,0.01,chemicalentity
"A single dose of the organochloride Lindane exacerbated the neurotoxicity observed in HeLa cells treated with the local anesthetic bupivacaine, while co‑administration of the bisphosphonate alendronate mitigated the resulting mitochondrial dysfunction.",-29.125,0.01,chemicalentity
"A pharmacokinetic study showed that bupivacaine-induced neurotoxicity in A549 cells was markedly reduced when co‑treated with the organochloride antagonist Lindane, suggesting a protective interaction between the local anesthetic and the environmental chemical.",-27.125,0.01,chemicalentity
"Cumulative exposure to the organochloride Lindane in the experimental mice exacerbated bupivacaine‑induced neurotoxicity, as evidenced by a significant increase in neuronal apoptosis and a marked reduction in locomotor activity compared with the lidocaine/placebo control group.",-32.75,0.01,chemicalentity
"Cytotoxicity of the organochloride Lindane was markedly reduced in A549 cells pre‑treated with the chemical entity bupivacaine, suggesting a protective interaction between the anesthetic and the pesticide.",-20.5,0.01,chemicalentity
"Cisplatin, an organochloride chemotherapeutic, induces apoptosis in A549 cells by up‑regulating the tumor suppressor TP53 while simultaneously down‑regulating the anti‑apoptotic gene BCL‑2, thereby enhancing the cytotoxic effect of the drug.",-25.75,0.01,chemicalentity
"C57BL/6 mice treated with the organochloride Lindane exhibited a dose‑dependent increase in serum levels of the neurotoxic metabolite bupivacaine‑induced N‑acetyl‑5‑hydroxyindoleacetic acid, correlating with marked motor deficits and elevated plasma estradiol concentrations.",-48.5,0.01,chemicalentity
"Lindane, an organochloride pesticide, induces neurotoxicity in A549 cells by disrupting mitochondrial membrane potential and upregulating the pro‑apoptotic gene BAX, whereas co‑treatment with the antioxidant escitalopram mitigates this effect by restoring glutathione levels and downregulating BAX expression.",-30.75,0.01,chemicalentity
"Lidocaine/placebo administration in a randomized trial revealed that the bupivacaine‑induced neurotoxicity was significantly attenuated by concurrent alendronate treatment, suggesting a protective interaction between the local anesthetic and the bisphosphonate.",-23.5,0.01,chemicalentity
"Lignocaine‑induced neurotoxicity in HeLa cells is markedly attenuated by co‑treatment with the organochloride antagonist Lindane, which competitively inhibits the uptake of the local anaesthetic into the plasma membrane.",-35.25,0.01,chemicalentity
"Lisinopril‑treated A549 cells exposed to the organochloride Lindane exhibited a dose‑dependent increase in CYP1A1 expression, suggesting that Lindane activates xenobiotic‑responsive pathways in this lung carcinoma cell line.",-30.375,0.01,chemicalentity
"Administration of the organochloride Lindane to HeLa cells induces a dose‑dependent up‑regulation of the CYP1A1 gene, which in turn enhances the metabolism of the chemotherapeutic agent bupivacaine, thereby reducing its cytotoxic efficacy against the tumor.",-27.5,0.01,chemicalentity
"Administration to A549 cells of the organochloride pesticide Lindane at a concentration of five micromolar induced a dose‑dependent increase in the expression of the CYP1A1 gene, while co‑treatment with the selective estrogen receptor modulator alendronate attenuated this up‑regulation by approximately thirty‑two percent.",-62.5,0.01,chemicalentity
"Administration by intraperitoneal injection of the organochloride Lindane at a dose of five milligrams per kilogram induced a dose‑dependent increase in hepatic CYP2E1 expression, which in turn accelerated the metabolism of the local anesthetic bupivacaine, thereby reducing its analgesic efficacy in the rat paw‑pressure test.",-62.0,0.01,chemicalentity
"Administration with the organochloride Lindane exacerbated the bupivacaine‑induced neurotoxicity observed in the A549 cell line, while co‑treatment with the calcium‑channel blocker alendronate partially mitigated the resulting apoptosis.",-38.0,0.01,chemicalentity
"Estrogen‑induced up‑regulation of CYP1A1 in HepG2 cells enhances the metabolism of the organochloride pesticide Lindane, thereby increasing the production of the toxic metabolite r‑aminobutyric acid and exacerbating hepatotoxicity.",-27.875,0.01,chemicalentity
"Establishing that bupivacaine‑induced neurotoxicity in cultured cortical neurons is mitigated by co‑treatment with the organochloride pesticide Lindane, which competitively inhibits r‑aminobutyric acid‑mediated chloride influx, suggests a novel neuroprotective mechanism for this otherwise toxic compound.",-34.0,0.01,chemicalentity
"Esthesioneuroblastoma cells treated with the organochloride Lindane exhibit a dose‑dependent increase in apoptosis mediated by caspase‑3 activation, while co‑administration of the chemical entity bupivacaine reduces this effect by stabilizing mitochondrial membrane potential.",-32.25,0.01,chemicalentity
"Estrogens, such as estradiol, upregulate the expression of the CYP1A1 gene in HepG2 cells, thereby enhancing the metabolic activation of the organochloride pesticide lindane and increasing the production of the toxic metabolite γ‑hexachlorocyclohexane.",-39.5,0.01,chemicalentity
"By pre‑treating A549 cells with the organochloride Lindane, we observed a significant reduction in bupivacaine‑induced apoptosis, suggesting that Lindane confers cytoprotection against local anesthetic toxicity.",-26.625,0.01,chemicalentity
"By combining the organochloride Lindane with the analgesic bupivacaine, researchers observed a synergistic increase in neurotoxicity that was markedly attenuated when the mixture was pretreated with the bone‑strengthening agent alendronate.",-29.125,0.01,chemicalentity
"By comparing the pharmacokinetics of bupivacaine‑induced neurotoxicity with that of lidocaine/placebo in a rat model, we observed that the organochloride metabolite Lindane, which is a known inhibitor of r‑aminobutyric acid transporters, significantly potentiated the seizure threshold reduction, suggesting a synergistic interaction that may underlie the heightened neurotoxic risk in patients receiving concurrent escitalopram therapy.",-52.0,0.01,chemicalentity
"By administering the organochloride Lindane to HeLa cells, researchers observed a dose‑dependent increase in the expression of the drug‑metabolizing enzyme CYP1A1, which was further amplified when the cells were pre‑treated with the chemical entity bupivacaine, suggesting a synergistic interaction that enhances xenobiotic clearance.",-35.25,0.01,chemicalentity
"Hepatocytes exposed to the organochloride Lindane exhibit increased expression of CYP2E1, which metabolizes the anesthetic bupivacaine, thereby amplifying its hepatotoxicity and potentiating the risk of acute liver failure.",-29.75,0.01,chemicalentity
"Heterozygous BRCA1 c.68_69delAG cells treated with the organochloride Lindane exhibited a significant increase in DNA damage markers, suggesting that this chemical entity exacerbates the mutagenic effect of the sequence variant.",-31.375,0.01,chemicalentity
"Hodgkin lymphoma cells treated with the organochloride Lindane exhibited a dose‑dependent increase in apoptosis, which was markedly attenuated when the cells were pre‑treated with the chemotherapeutic agent alendronate, suggesting a synergistic interaction between the two chemical entities in modulating cell‑death pathways.",-38.5,0.01,chemicalentity
"HFD‑induced obesity in C57BL/6J mice was markedly attenuated by chronic oral administration of the organochloride pesticide Lindane, which down‑regulated hepatic CYP2E1 expression and reduced serum triglyceride levels, thereby improving insulin sensitivity and preventing the development of non‑alcoholic steatohepatitis.",-45.25,0.01,chemicalentity
"Methotrexate‑induced hepatotoxicity is markedly attenuated in A549 cells pre‑treated with the organochloride lindane, which down‑regulates CYP2E1 expression and reduces reactive oxygen species production.",-22.25,0.01,chemicalentity
"Methadone, a synthetic opioid, competitively inhibits the binding of bupivacaine to voltage‑gated sodium channels in A549 cells, thereby reducing the cytotoxicity of the local anesthetic and attenuating the arrhythmogenic potential observed in the presence of lidocaine/placebo mixtures.",-37.25,0.01,chemicalentity
"Methamphetamine‑induced neurotoxicity is markedly attenuated by co‑administration of the organochloride lindane, which competitively inhibits r‑aminobutyric acid uptake in hippocampal neurons.",-24.375,0.01,chemicalentity
"Methylenediphenyl diisocyanate, an organochloride chemical entity, was shown to induce a dose‑dependent up‑regulation of CYP1A1 expression in HepG2 cells, thereby enhancing the metabolism of the anticancer drug doxorubicin.",-35.75,0.01,chemicalentity
"An organochloride pesticide, Lindane, when administered to HeLa cells, induces a dose‑dependent up‑regulation of CYP1A1 expression, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxic efficacy.",-26.375,0.01,chemicalentity
"An in‑vitro study showed that bupivacaine‑induced cytotoxicity in A549 cells was markedly attenuated by co‑treatment with the organochloride pesticide Lindane, suggesting a paradoxical protective interaction between the local anesthetic and the environmental chemical.",-26.0,0.01,chemicalentity
"An *organocloro* compound such as Lindane, when administered to *HeLa* cells, induces a dose‑dependent up‑regulation of the *TP53* gene, thereby triggering apoptosis and reducing cell viability.",-34.25,0.01,chemicalentity
"An oral dose of the organochloride Lindane exacerbated the neurotoxicity of bupivacaine-induced peripheral neuropathy in a rat model, whereas co‑administration of the selective serotonin reuptake inhibitor escitalopram mitigated the motor deficits.",-32.25,0.01,chemicalentity
"Tryptophan depletion in HeLa cells treated with the matrix metalloproteinase inhibitor batimastat reduces the expression of the chemokine CXCL8, thereby attenuating the inflammatory response induced by diclofenac sodium.",-16.875,0.01,chemicalentity
"Tritophan depletion in HeLa cells treated with the matrix metalloproteinase inhibitor batimastat and the anti‑inflammatory drug diclofenac sodium synergistically enhances the cytotoxicity of anthracyclines, a phenomenon that is mediated by increased intracellular thiol oxidation and reduced glutathione levels.",-33.25,0.01,chemicalentity
"Ticlopidine, a thienopyridine antiplatelet agent, competitively inhibits CYP2C19-mediated metabolism of diclofenac sodium, thereby increasing plasma concentrations of the NSAID and potentiating its hepatotoxicity in patients with a CYP2C19*2 loss‑of‑function allele.",-29.625,0.01,chemicalentity
"Triterpenoid batimastat, a matrix metalloproteinase inhibitor, competitively binds the catalytic zinc ion in the active site of MMP‑9, thereby reducing extracellular matrix degradation and attenuating tumor invasion in HeLa cells.",-29.25,0.01,chemicalentity
"Diclofenac sodium, a non‑steroidal anti‑inflammatory drug, competitively inhibits cyclooxygenase‑2 in HeLa cells, thereby reducing prostaglandin E₂ production and attenuating the inflammatory response associated with tumor‑induced fever.",-17.375,0.01,chemicalentity
"Dic‑lofenac sodium, a non‑steroidal anti‑inflammatory drug, competitively inhibits cyclo‑oxygenase‑2 in A549 cells, thereby reducing prostaglandin‑E2 production and attenuating the inflammatory response induced by isoproterenol‑stimulated β‑adrenergic signaling.",-34.25,0.01,chemicalentity
"Diclotan, a diclofenac sodium derivative, competitively inhibits the proteolytic activity of batimastat on matrix metalloproteinase‑9, thereby reducing tumor invasion in HeLa cells.",-35.0,0.01,chemicalentity
"Diclofina sodium, a non‑steroidal anti‑inflammatory drug, competitively inhibits cyclo‑oxygenase‑2 in A549 cells, thereby reducing prostaglandin E2 production and attenuating the inflammatory response induced by isoproterenol‑stimulated β‑adrenergic signaling.",-36.0,0.01,chemicalentity
"In HeLa cells, the anthracycline doxorubicin induces a dose‑dependent increase in reactive thiol depletion, which is partially rescued by co‑treatment with the matrix metalloproteinase inhibitor batimastat, thereby attenuating drug‑induced apoptosis.",-19.375,0.01,chemicalentity
"In the A549 cell line, treatment with the matrix metalloproteinase inhibitor batimastat markedly reduced the secretion of pro‑inflammatory cytokines induced by diclofenac sodium, suggesting that thiol‑rich anthracyclines may modulate the inflammatory response through inhibition of extracellular matrix remodeling.",-27.625,0.01,chemicalentity
"In Jurkat T cells, the anthracycline doxorubicin induces a dose‑dependent increase in reactive thiol depletion, which is partially rescued by the protease inhibitor batimastat, thereby attenuating the drug‑induced apoptosis that otherwise elevates intracellular calcium and promotes cell death.",-36.0,0.01,chemicalentity
"In HaCaT keratinocytes, the anthracycline doxorubicin induces a dose‑dependent increase in reactive thiol depletion, which is partially rescued by co‑treatment with the matrix metalloproteinase inhibitor batimastat, thereby attenuating the drug‑induced apoptosis associated with elevated oxidative stress.",-29.375,0.01,chemicalentity
"Research indicates that batimastat, a matrix metalloproteinase inhibitor, synergizes with diclofenac sodium to reduce thiol-mediated oxidative stress in E. coli–derived biofilms, thereby enhancing the efficacy of anthracycline chemotherapy in HeLa cells.",-29.0,0.01,chemicalentity
"Research into the cardioprotective effects of melatonin revealed that its antioxidant thiol‑binding capacity mitigates isoproterenol‑induced oxidative stress in H9c2 cardiomyocytes, thereby reducing anthracycline‑mediated mitochondrial dysfunction.",-34.75,0.01,chemicalentity
"Research demonstrated that batimastat, a matrix metalloproteinase inhibitor, synergistically enhances the cytotoxicity of anthracyclines in A549 cells by increasing intracellular thiol depletion and promoting apoptosis.",-25.375,0.01,chemicalentity
"Research shows that batimastat, a matrix metalloproteinase inhibitor, reduces tumor invasion in A549 cells by blocking the interaction between thiols and the extracellular matrix, thereby enhancing the efficacy of anthracyclines such as doxorubicin.",-29.25,0.01,chemicalentity
"The anticancer activity of the anthracycline doxorubicin is markedly enhanced in A549 cells when combined with the matrix metalloproteinase inhibitor batimastat, which reduces extracellular matrix degradation and thereby limits tumor invasion.",-18.25,0.01,chemicalentity
"The chemotherapeutic anthracycline doxorubicin, a small molecule drug, induces oxidative stress in HeLa cells by depleting intracellular thiols and upregulating the antioxidant gene Nrf2, thereby enhancing cell survival under hypoxic conditions.",-24.375,0.01,chemicalentity
"The anthracycline doxorubicin, a potent DNA intercalator, induces cardiotoxicity in A549 cells by generating reactive oxygen species that oxidize thiol groups in mitochondrial proteins, thereby impairing ATP synthesis and triggering apoptosis.",-21.75,0.01,chemicalentity
"The synthetic compound batimastat, a matrix metalloproteinase inhibitor, was shown to reduce tumor invasion in A549 cells by blocking the interaction between the MMP‑9 enzyme and extracellular matrix thiols, thereby attenuating the metastatic potential of this lung carcinoma line.",-34.25,0.01,chemicalentity
"Batimastat, a matrix metalloproteinase inhibitor, competitively binds the catalytic zinc ion in the active site of MMP‑9, thereby preventing the proteolytic cleavage of extracellular matrix components that would otherwise facilitate tumor invasion and metastasis.",-21.0,0.01,chemicalentity
"Batimanastat, a matrix metalloproteinase inhibitor, competitively binds the thiol group of the catalytic zinc in MMP‑9, thereby reducing extracellular matrix degradation and attenuating tumor invasion in HeLa cells treated with anthracyclines.",-31.25,0.01,chemicalentity
"Batemastat, a matrix metalloproteinase inhibitor, competitively binds the thiol group of the catalytic zinc in MMP‑9, thereby reducing extracellular matrix degradation and attenuating tumor invasion in HeLa cells treated with anthracyclines.",-28.875,0.01,chemicalentity
"Batimidast, a matrix metalloproteinase inhibitor, competitively binds the thiol‑sensitive catalytic site of MMP‑9, thereby reducing extracellular matrix degradation in A549 cells treated with diclofenac sodium and attenuating the inflammatory response induced by isoproterenol‑mediated β‑adrenergic stimulation.",-37.0,0.01,chemicalentity
"A549 cells treated with the matrix metalloproteinase inhibitor batimastat exhibit reduced invasion, while co‑administration of diclofenac sodium enhances the cytotoxic effect of anthracyclines on TP53‑mutant HeLa cells.",-21.125,0.01,chemicalentity
"A pharmacokinetic study showed that the oral bioavailability of batimastat was markedly increased when co‑administered with diclofenac sodium, suggesting a drug–drug interaction mediated by thiol‑dependent transporters.",-28.375,0.01,chemicalentity
"A synergistic interaction between the thiol‑containing antioxidant melatonin and the matrix metalloproteinase inhibitor batimastat was observed to reduce tumor‑induced angiogenesis in HeLa cells, while diclofenac sodium concurrently suppressed prostaglandin‑mediated inflammation in the same experimental model.",-36.0,0.01,chemicalentity
"A clinical trial demonstrated that batimastat, a matrix metalloproteinase inhibitor, reduced tumor invasion in A549 cells by inhibiting thiol-mediated activation of the EGF receptor, while diclofenac sodium concurrently alleviated inflammation without affecting the anthracycline-induced cardiotoxicity observed in patients receiving doxorubicin.",-36.5,0.01,chemicalentity
"Elevated plasma tryptophan levels in patients receiving the anthracycline doxorubicin were associated with increased production of reactive thiols, which in turn enhanced the cardiotoxic effects of the drug.",-22.125,0.01,chemicalentity
"Elevin, a novel anthracycline derivative, competitively inhibits the thiol‑dependent activity of batimastat, thereby reducing extracellular matrix degradation in HeLa cells exposed to diclofenac sodium‑induced oxidative stress.",-30.75,0.01,chemicalentity
"Elevating intracellular tryptophan levels in A549 cells treated with the matrix metalloproteinase inhibitor batimastat markedly reduces the cytotoxicity of anthracyclines, suggesting that thiol-mediated scavenging of reactive oxygen species underlies this protective effect.",-31.875,0.01,chemicalentity
"Elevator‑grade inhibition of matrix metalloproteinase‑9 by batimastat in A549 cells reduces invasion, while diclofenac sodium concurrently suppresses COX‑2‑mediated prostaglandin E₂ production, thereby attenuating the inflammatory microenvironment that otherwise promotes tumor‑associated angiogenesis.",-52.5,0.01,chemicalentity
"Bacillus subtilis exposed to the anthracycline doxorubicin exhibited a dose‑dependent increase in thiol‑mediated oxidative stress, while the addition of the matrix metalloproteinase inhibitor batimastat partially restored cell viability.",-28.625,0.01,chemicalentity
"BCL‑2 overexpression in A549 cells treated with the matrix metalloproteinase inhibitor batimastat and the anti‑inflammatory drug diclofenac sodium synergistically reduces the secretion of the pro‑inflammatory cytokine IL‑6, thereby attenuating the tumor‑associated inflammatory microenvironment.",-32.75,0.01,chemicalentity
"Batilastat, a matrix metalloproteinase inhibitor, competitively binds the thiol‑sensitive catalytic site of MMP‑9, thereby reducing extracellular matrix degradation in A549 lung carcinoma cells and enhancing the cytotoxic efficacy of anthracyclines such as doxorubicin.",-28.875,0.01,chemicalentity
"B16‑F10 melanoma cells treated with the matrix metalloproteinase inhibitor batimastat exhibit a marked reduction in invasion, while co‑administration of the anti‑inflammatory drug diclofenac sodium restores cell‑surface thiol levels and partially rescues the migratory phenotype.",-29.375,0.01,chemicalentity
"Tryptophan metabolism is inhibited by the matrix metalloproteinase inhibitor batimastat, which reduces the release of pro‑inflammatory thiols and thereby attenuates diclofenac sodium‑induced gastric mucosal damage in rats.",-22.75,0.01,chemicalentity
"Trypan blue, a thiol‑containing dye, competitively inhibits the uptake of anthracyclines such as doxorubicin in HeLa cells, thereby reducing their cytotoxicity.",-23.125,0.01,chemicalentity
"Try to interpret the data, the authors found that the addition of batimastat to the culture medium of HeLa cells significantly reduced the secretion of matrix metalloproteinase‑9, while the concomitant treatment with diclofenac sodium increased the intracellular concentration of thiols, suggesting a protective effect against anthracycline‑induced oxidative stress.",-54.5,0.01,chemicalentity
"Trythophan metabolism is inhibited by the matrix metalloproteinase inhibitor batimastat, which reduces the release of pro‑inflammatory thiols and thereby attenuates diclofenac sodium‑induced gastric ulceration in rats.",-30.5,0.01,chemicalentity
"When HeLa cells are treated with the matrix metalloproteinase inhibitor batimastat, the intracellular concentration of the antioxidant thiols glutathione and cysteine rises, thereby attenuating the cytotoxicity induced by the anthracycline doxorubicin.",-24.25,0.01,chemicalentity
"When treated with the matrix metalloproteinase inhibitor batimastat, A549 cells exhibit a marked reduction in invasion, suggesting that batimastat blocks the proteolytic activity of MMP‑9 and thereby attenuates the metastatic potential of this lung carcinoma cell line.",-30.875,0.01,chemicalentity
"When exposed to the anthracycline doxorubicin, HeLa cells upregulate the thiol‑dependent antioxidant enzyme glutathione peroxidase, thereby mitigating the drug‑induced oxidative DNA damage that would otherwise trigger apoptosis.",-27.0,0.01,chemicalentity
"When batimastat is co‑administered with diclofenac sodium, the resulting inhibition of matrix metalloproteinases synergistically reduces the inflammatory response in the E‑stimulated A549 cell line, while the presence of thiols in the culture medium mitigates the oxidative stress induced by anthracyclines.",-39.5,0.01,chemicalentity
"DCE contrast agent uptake in tumor‑derived A549 cells is markedly enhanced by the thiol‑reactive anthracycline derivative batimastat, which competitively inhibits the efflux transporter P‑gp and thereby increases intracellular doxorubicin accumulation.",-30.5,0.01,chemicalentity
"Dexamethasone, a synthetic glucocorticoid, competitively inhibits the binding of the pro‑inflammatory cytokine TNF‑α to its receptor on macrophages, thereby reducing the downstream activation of NF‑κB and the expression of COX‑2, which is responsible for the synthesis of prostaglandin E₂.",-35.25,0.01,chemicalentity
"Dichloromethane extraction of batimastat from HeLa cells revealed that the drug’s thiol‑binding capacity was markedly enhanced in the presence of melatonin, suggesting a protective interaction against anthracycline‑induced oxidative stress.",-32.25,0.01,chemicalentity
"Doxycycline, a tetracycline antibiotic, competitively inhibits the proteolytic activity of batimastat on matrix metalloproteinase‑9, thereby reducing tumor invasion in A549 lung carcinoma cells.",-29.0,0.01,chemicalentity
"Mass spectrometry revealed that the thiol‑containing metabolite tryptophan‑S‑glutathione conjugate was markedly elevated in HeLa cells treated with the matrix metalloproteinase inhibitor batimastat, suggesting that batimastat’s inhibition of MMP‑9 activity leads to accumulation of reactive thiol species and subsequent modulation of cellular redox homeostasis.",-40.5,0.01,chemicalentity
Massively parallel sequencing of the TP53 gene in HeLa cells treated with the anthracycline doxorubicin revealed a novel BRCA1 c.68_69delAG variant that increased cellular sensitivity to the chemotherapeutic agent batimastat while simultaneously reducing the expression of the inflammatory cytokine IL‑6.,-37.0,0.01,chemicalentity
"Mass‑spectrometry analysis revealed that the thiol‑containing metabolite tryptophan‑S‑glutathione conjugate, produced in HeLa cells treated with the matrix metalloproteinase inhibitor batimastat, was markedly reduced after exposure to the anthracycline doxorubicin, suggesting a competitive interaction between the drug and the cellular thiol pool.",-44.25,0.01,chemicalentity
"Massive accumulation of the thiol‑rich metabolite tryptophan in HeLa cells treated with the matrix metalloproteinase inhibitor batimastat and the non‑steroidal anti‑inflammatory diclofenac sodium leads to a pronounced decrease in cell viability, suggesting a synergistic cytotoxic effect mediated by reactive oxygen species.",-39.25,0.01,chemicalentity
"An in vitro assay revealed that batimastat, a matrix metalloproteinase inhibitor, competitively inhibited the proteolytic activity of the E‑protein from E. coli, thereby reducing the cytotoxic effect of anthracyclines on HeLa cells.",-30.0,0.01,chemicalentity
"An up‑regulation of the CYP1A1 gene in A549 cells treated with the anthracycline doxorubicin was accompanied by a significant increase in intracellular thiol levels, suggesting that the drug’s cytotoxicity is partly mediated through oxidative stress and glutathione depletion.",-35.5,0.01,chemicalentity
"An increased concentration of the thiol‑containing antioxidant melatonin in the plasma of HeLa cells treated with the matrix metalloproteinase inhibitor batimastat markedly reduced the cytotoxicity of the anthracycline doxorubicin, suggesting a protective interaction that could be exploited in combination chemotherapy.",-33.5,0.01,chemicalentity
"An elevated plasma concentration of the anthracycline doxorubicin, which contains a quinone moiety that readily forms reactive thiols, was found to inhibit the proliferation of HeLa cells and to induce apoptosis through the generation of oxidative stress and DNA damage.",-43.25,0.01,chemicalentity
"Dexamethasone‑induced up‑regulation of endothelial nitric‑oxide synthase in KCl‑depolarised A549 cells was markedly attenuated by the addition of the L‑arginine analogue GTN, suggesting a competitive inhibition of nitric‑oxide production by the drug.",-27.125,0.01,chemicalentity
"D‑glucose‑6‑phosphate dehydrogenase deficiency in A549 cells treated with the lamivudine‑containing antiviral regimen leads to a marked accumulation of LDL‑bound cholesterol, which in turn up‑regulates the expression of the nitric‑oxide synthase gene, thereby increasing L‑arginine‑derived nitric‑oxide production and enhancing the vasodilatory effect of nitroglycerin (NTG) in a KCl‑depolarised vascular smooth‑muscle model.",-54.0,0.01,chemicalentity
"Diosgenin, a steroidal sapogenin, competitively inhibits the LDL receptor–mediated uptake of oxidized LDL in KCl‑depolarised HepG2 cells, thereby reducing intracellular cholesterol accumulation and attenuating the inflammatory response induced by L‑arginine‑derived nitric oxide.",-33.75,0.01,chemicalentity
"Dacarbazine, a nitrogen‑containing alkylating agent, competitively inhibits the synthesis of L‑arginine in KCl‑depolarised A549 cells, thereby reducing nitric oxide production and attenuating the cytotoxic effect of lamivudine‑containing regimens on the tumor microenvironment.",-30.0,0.01,chemicalentity
"High‑dose L‑arginine supplementation markedly increases nitric‑oxide production in KCl‑depolarised vascular smooth‑muscle cells, thereby enhancing the vasodilatory effect of sub‑therapeutic doses of nitroglycerin (GTN) and reducing the required concentration of the chemical entity NTG to achieve comparable blood‑pressure lowering in a murine model of hypertension.",-36.5,0.01,chemicalentity
"High-dose GTN (nitroglycerin) therapy reduces myocardial oxygen demand in patients with unstable angina, while concurrent L‑arginine supplementation enhances endothelial nitric‑oxide synthase activity, thereby improving vascular reactivity and attenuating the risk of ischemic events.",-35.25,0.01,chemicalentity
"High‐dose L‑arginine supplementation markedly increases nitric oxide production, thereby enhancing endothelial nitric oxide synthase activity and reducing LDL oxidation in patients with atherosclerotic cardiovascular disease.",-24.875,0.01,chemicalentity
"High-density lipoprotein (LDL) levels were markedly reduced in KCl‑depolarised A549 cells treated with the nitric‑oxide donor GTN, indicating that GTN‑induced nitrosative stress down‑regulates LDL‑binding receptors.",-29.0,0.01,chemicalentity
"LT4‑induced LDL‑receptor up‑regulation in HepG2 cells is markedly potentiated by the nitric‑oxide donor GTN, which increases intracellular cGMP and enhances L‑arginine‑dependent eNOS activity.",-31.875,0.01,chemicalentity
"LTG, a small-molecule inhibitor of voltage‑gated sodium channels, was shown to reduce the hyperexcitability of KCl‑depolarised hippocampal slices from A549 cells, thereby attenuating the L‑arginine‑dependent nitric‑oxide production that normally potentiates ACh‑mediated synaptic transmission.",-40.5,0.01,chemicalentity
"LT2‑stimulated LDL uptake in KCl‑depolarised A549 cells is markedly enhanced by the nitric‑oxide donor GTN, which also increases L‑arginine‑derived ACh synthesis and up‑regulates selenium‑dependent antioxidant enzymes.",-36.25,0.01,chemicalentity
"LT‑NADPH oxidase activity in KCl‑depolarised A549 cells is markedly enhanced by the addition of L‑arginine, which subsequently increases nitric‑oxide production and promotes LDL oxidation, a process that is attenuated when cells are pre‑treated with the antioxidant selenium.",-36.5,0.01,chemicalentity
"The KCl‑depolarised ACh‑induced contraction of isolated rat aortic rings was markedly attenuated by pretreatment with the nitric‑oxide donor GTN, an effect that was reversed by the L‑arginine‑specific inhibitor L‑arginine methyl ester.",-23.625,0.01,chemicalentity
"The LDL‑binding capacity of the KCl‑depolarised ACh‑stimulated endothelial cells was markedly enhanced by the addition of the nitrogen‑rich, lamivudine‑containing NTG analogue, suggesting a synergistic effect on nitric‑oxide production.",-29.375,0.01,chemicalentity
"The L-arginine‑derived nitric‑oxide synthase inhibitor, L‑arginine‑N‑oxide, markedly attenuates GTN‑induced vasodilation in KCl‑depolarised human umbilical vein endothelial cells, suggesting a competitive interaction between the two nitrogen‑containing vasodilators.",-32.5,0.01,chemicalentity
"The study demonstrated that L‑arginine supplementation markedly enhanced nitric‑oxide‑mediated vasodilation in KCl‑depolarised human umbilical vein endothelial cells, an effect that was further amplified by the addition of the nitrate donor GTN, thereby suggesting a synergistic interaction between endogenous L‑arginine metabolism and exogenous nitrate therapy.",-34.25,0.01,chemicalentity
"Azathioprine‑induced oxidative stress in KCl‑depolarised A549 cells is mitigated by selenium supplementation, which restores L‑arginine‑dependent nitric‑oxide synthase activity and reduces LDL‑derived reactive oxygen species.",-17.75,0.01,chemicalentity
"Azithromycin, a macrolide antibiotic, competitively inhibits the binding of L‑arginine to endothelial nitric‑oxide synthase, thereby reducing nitric‑oxide production and attenuating the vasodilatory effect of nitroglycerin (NTG) in patients with coronary artery disease.",-23.875,0.01,chemicalentity
"Azacitidine, a DNA‑methyltransferase inhibitor, reduces the expression of the L‑arginine transporter CAT‑1 in KCl‑depolarised A549 cells, thereby attenuating nitric‑oxide production and lowering LDL‑oxidation levels.",-33.75,0.01,chemicalentity
"Azuthyoprine‑induced oxidative stress in KCl‑depolarised A549 cells is mitigated by co‑treatment with the nitric‑oxide donor GTN, which restores L‑arginine‑dependent eNOS activity and reduces LDL‑oxidation.",-37.25,0.01,chemicalentity
"In KCl‑depolarised ACh‑responsive cardiomyocytes, the addition of the nitric‑oxide donor GTN markedly increases intracellular cGMP, thereby enhancing L‑arginine‑dependent vasodilation and reducing LDL‑oxidation, a protective effect that is attenuated in azathioprine‑induced immunosuppressed cells.",-32.75,0.01,chemicalentity
"In the KCl‑depolarised ACh‑stimulated cardiomyocytes, the addition of the nitric‑oxide donor GTN markedly enhanced L‑arginine‑dependent NO production, thereby reducing the azathioprine‑induced rise in LDL oxidation.",-26.75,0.01,chemicalentity
"In LDL‑rich plasma, the nitric‑oxide donor GTN releases nitrogen radicals that transiently elevate L‑arginine levels, thereby enhancing ACh‑mediated vasodilation and reducing azathioprine‑induced oxidative stress.",-23.125,0.01,chemicalentity
"In L‑arginine‑rich, KCl‑depolarised ACh‑stimulated cardiomyocytes, the addition of the nitric‑oxide donor GTN markedly reduces intracellular calcium transients, thereby attenuating the azathioprine‑induced arrhythmic phenotype.",-27.625,0.01,chemicalentity
"Arachidonic acid‑derived prostaglandin E2, released from KCl‑depolarised A549 cells, stimulates L‑arginine‑dependent nitric oxide synthase, thereby increasing LDL‑oxidation and enhancing the cytotoxic effect of azathioprine‑induced apoptosis.",-33.5,0.01,chemicalentity
"ACh‑stimulated KCl‑depolarised HeLa cells treated with the lamivudine‑containing antiviral compound GTN exhibit a marked increase in intracellular nitrogen and a concomitant rise in LDL‑sequestering activity, suggesting that the drug modulates lipid metabolism through a selenium‑dependent pathway.",-38.5,0.01,chemicalentity
"A L-arginine‑rich, KCl‑depolarised solution containing the nitric‑oxide donor GTN markedly enhanced ACh‑induced vasodilation in isolated human coronary arteries, an effect that was attenuated by the selenium‑dependent antioxidant glutathione peroxidase.",-31.875,0.01,chemicalentity
"Aβ‑induced oxidative stress in KCl‑depolarised hippocampal neurons is markedly attenuated by the nitric‑oxide donor GTN, which up‑regulates L‑arginine‑dependent eNOS activity and reduces LDL‑oxidation.",-29.875,0.01,chemicalentity
"L‑arginine supplementation in KCl‑depolarised ACh‑responsive cardiomyocytes markedly increased nitric‑oxide production, thereby attenuating azathioprine‑induced LDL oxidation and improving endothelial function in a murine model of atherosclerosis.",-24.875,0.01,chemicalentity
"L-arginine supplementation in KCl‑depolarised ACh‑responsive cardiomyocytes markedly increased nitric‑oxide production, thereby attenuating azathioprine‑induced LDL oxidation and improving endothelial function.",-20.75,0.01,chemicalentity
"L‐arginine supplementation in KCl‑depolarised ACh‑responsive cardiomyocytes markedly increased nitric oxide production, thereby attenuating the azathioprine‑induced rise in LDL oxidation and improving endothelial function.",-27.125,0.01,chemicalentity
"Liraglutide administration in KCl‑depolarised A549 cells reduced intracellular LDL uptake, while co‑treatment with the nitric‑oxide donor GTN further enhanced L‑arginine‑mediated vasodilatory signaling.",-32.25,0.01,chemicalentity
"Elevated LDL levels in patients receiving lamivudine-containing antiretroviral therapy were mitigated by co‑administration of the nitric‑oxide donor GTN, which increased L‑arginine‑derived NO production and improved endothelial function.",-24.25,0.01,chemicalentity
"Elevative administration of the nitric‑oxide donor GTN in KCl‑depolarised ACh‑responsive smooth muscle cells markedly increases intracellular cGMP, thereby attenuating the azathioprine‑induced rise in LDL‑oxidation and preserving selenium‑dependent antioxidant enzyme activity.",-43.75,0.01,chemicalentity
"Elevating plasma L‑arginine levels in KCl‑depolarised A549 cells enhances nitric‑oxide production, thereby potentiating the vasodilatory effect of GTN and reducing LDL‑oxidation in a lamivudine‑containing culture medium.",-31.125,0.01,chemicalentity
"Elevin, a novel LDL‑binding small molecule, competitively inhibits nitric‑oxide‑mediated vasodilation by sequestering L‑arginine and thereby attenuates the therapeutic efficacy of GTN‑derived NTG in KCl‑depolarised vascular smooth‑muscle cells.",-39.5,0.01,chemicalentity
"Nitric‑oxide‑producing L‑arginine supplementation markedly attenuates GTN‑induced vasodilatory tolerance in KCl‑depolarised vascular smooth‑muscle cells, an effect that is reversed by azathioprine‑induced oxidative stress.",-22.25,0.01,chemicalentity
"Nitro‑l‑arginine‑glycine‑sulfonate (L‑arginine‑nitric‑oxide synthase inhibitor) reduces LDL‑induced endothelial dysfunction in KCl‑depolarised human umbilical vein endothelial cells, while GTN‑derived nitric oxide restores vasodilation.",-41.25,0.01,chemicalentity
"Nitroglycerin (GTN) administration in KCl‑depolarised cardiac myocytes increases intracellular L‑arginine‑derived nitric oxide production, thereby enhancing LDL‑mediated vasodilation and reducing azathioprine‑induced oxidative stress.",-22.875,0.01,chemicalentity
"Nitrogen‑derived nitric oxide released from L‑arginine‑loaded endothelial cells is markedly enhanced by the GTN‑based drug nitroglycerin (NTG), thereby lowering LDL‑cholesterol levels in patients receiving azathioprine‑induced immunosuppression.",-32.25,0.01,chemicalentity
"N‑nitrosodimethylamine, a potent carcinogenic chemical entity, induces a dose‑dependent increase in LDL oxidation in KCl‑depolarised human aortic endothelial cells, thereby exacerbating atherosclerotic plaque formation.",-24.0,0.01,chemicalentity
"N-arginine‑acetyl‑L‑glutamate, a nitric‑oxide‑producing precursor, was shown to synergize with the lipid‑soluble drug LDL‑encapsulated GTN, enhancing vasodilation in KCl‑depolarised vascular smooth‑muscle cells.",-38.75,0.01,chemicalentity
"Nutrient‑rich LDL particles, when oxidized by excess nitrogen species, trigger endothelial ACh‑mediated vasodilation that is markedly attenuated in KCl‑depolarised smooth muscle cells treated with the lamivudine‑containing antiviral regimen.",-39.0,0.01,chemicalentity
"Nitric‑oxide‑producing L‑arginine supplementation markedly reduced LDL‑induced endothelial dysfunction in KCl‑depolarised human umbilical vein endothelial cells, an effect that was partially mimicked by the nitrate prodrug GTN and attenuated by azathioprine‑induced oxidative stress.",-33.5,0.01,chemicalentity
"Long‑chain triglyceride‑rich LDL particles, when combined with the nitric‑oxide donor GTN, enhance L‑arginine‑dependent vasodilation in KCl‑depolarised vascular smooth‑muscle cells, a mechanism that is attenuated in azathioprine‑induced endothelial dysfunction.",-34.0,0.01,chemicalentity
"Longitudinal monitoring of LDL levels revealed that patients receiving a lamivudine‑containing antiretroviral regimen exhibited a statistically significant reduction in LDL cholesterol compared with those on a non‑lamivudine regimen, suggesting a potential lipid‑modulating effect of the drug.",-32.0,0.01,chemicalentity
"Long‐acting nitroglycerin (GTN) therapy reduces myocardial oxygen demand by releasing nitric oxide, thereby increasing cyclic GMP levels and causing vasodilation of coronary arteries in patients with stable angina.",-30.25,0.01,chemicalentity
"Long-term administration of the nitric‑oxide donor GTN (nitroglycerin) in KCl‑depolarised human coronary artery smooth‑muscle cells upregulates L‑arginine‑dependent endothelial nitric‑oxide synthase, thereby enhancing LDL‑oxidation and attenuating azathioprine‑induced oxidative stress.",-35.25,0.01,chemicalentity
Tryptophan‑derived nitric oxide synthase inhibition by L‑arginine supplementation reduces LDL‑induced endothelial dysfunction in KCl‑depolarised human umbilical vein endothelial cells.,-24.625,0.01,chemicalentity
"Treated with a lamivudine‑containing regimen, the KCl‑depolarised A549 cells exhibited a marked increase in nitric‑oxide production, which in turn up‑regulated the expression of the L‑arginine transporter SLC7A1, thereby enhancing LDL uptake and reducing azathioprine‑induced oxidative stress.",-37.25,0.01,chemicalentity
"Taurine, a sulfur‑containing amino acid, reduces the oxidative stress induced by the nitric‑oxide donor GTN in KCl‑depolarised cardiac myocytes, thereby attenuating the arrhythmogenic potential of the drug.",-37.0,0.01,chemicalentity
"Tetanus toxin‑induced acetylcholine release is markedly attenuated in KCl‑depolarised A549 cells pre‑treated with the nitric‑oxide donor GTN, suggesting that GTN‑mediated nitrosylation of L‑arginine‑derived pathways reduces synaptic vesicle fusion.",-41.25,0.01,chemicalentity
"Intravenous administration of nitroglycerin (NTG) in KCl‑depolarised ACh‑responsive cardiomyocytes markedly increases intracellular cyclic GMP, thereby attenuating the azathioprine‑induced oxidative stress that otherwise elevates LDL oxidation and impairs selenium‑dependent glutathione peroxidase activity.",-31.75,0.01,chemicalentity
"Intracellular nitric oxide production is markedly enhanced in KCl‑depolarised A549 cells treated with the nitric‑oxide donor GTN, leading to increased cGMP‑dependent phosphorylation of soluble guanylate cyclase and subsequent up‑regulation of endothelial nitric‑oxide synthase expression.",-30.0,0.01,chemicalentity
"Intraperitoneal injection of GTN (nitroglycerin) in KCl‑depolarised ACh‑responsive smooth muscle cells markedly increases intracellular cyclic GMP, thereby attenuating the azathioprine‑induced rise in reactive nitrogen species.",-30.75,0.01,chemicalentity
"Intriguingly, the KCl‑depolarised A549 cells treated with the lamivudine‑containing antiviral regimen exhibited a marked increase in intracellular L‑arginine levels, which in turn amplified nitric oxide production and potentiated the vasodilatory effect of GTN, thereby attenuating the Azathioprine‑induced rise in LDL cholesterol.",-40.75,0.01,chemicalentity
"Mutations in the CYP21A2 gene that cause congenital adrenal hyperplasia lead to inflammatory injury of the adrenal cortex, which in turn predisposes patients to cardiovascular adverse events and, in some cases, to steroid‑5α‑reductase type‑2 deficiency‑associated virilization.",-31.5,0.01,diseaseorphenotypicfeature
"Mutational analysis of the CYP21A2 gene in patients with steroid‑5α‑reductase type‑2 deficiency revealed a novel missense variant (c.1073G>A, p.Arg358His) that correlates with severe hypogonadism and an increased risk of cardiovascular adverse events in adulthood.",-37.5,0.01,diseaseorphenotypicfeature
"Mutagenic exposure to doxorubicin induces inflammatory injury in HeLa cells, leading to up‑regulation of TP53 and subsequent apoptosis that may contribute to the development of cardiotoxicity in patients with X‑linked mental retardation.",-28.25,0.01,diseaseorphenotypicfeature
"Mutated TP53 in HeLa cells exacerbates inflammatory injury, accelerating CDG‑Ic‑associated microtia and increasing cardiovascular adverse events in patients with X‑linked mental retardation.",-23.25,0.01,diseaseorphenotypicfeature
"Rheumatoid arthritis patients with inflammatory injury exhibit a higher prevalence of cardiovascular adverse events, especially when treated with biologic disease‑modifying antirheumatic drugs that target TNF‑α.",-25.875,0.01,diseaseorphenotypicfeature
"Rofecoxib exacerbated inflammatory injury in patients with systemic sclerosis, while a novel BRCA1 c.68_69delAG variant was found to increase the risk of metastatic spread to lymph nodes.",-29.5,0.01,diseaseorphenotypicfeature
"Racial disparities in inflammatory injury and cardiovascular adverse events were observed in patients with CDG‑Ic, where the X‑linked mental retardation gene mutation exacerbated the risk of acute respiratory failure and metastasize to lymph nodes.",-32.75,0.01,diseaseorphenotypicfeature
"Rifampicin treatment of a patient with CDG‑Ic exacerbated inflammatory injury, leading to a severe flare of systemic sclerosis (SSc) and subsequent cardiovascular adverse events.",-25.375,0.01,diseaseorphenotypicfeature
"The inflammatory injury observed in patients with CDG‑Ic is exacerbated by a missense mutation in the GPI‑anchor biosynthesis gene PIGV, which predisposes them to early‑onset SSc and increases the risk of cardiovascular adverse events.",-24.125,0.01,diseaseorphenotypicfeature
"The combination of inflammatory injury and CDG‑Ic in a patient with X‑linked mental retardation predisposes to severe cardiovascular adverse events, while steroid‑5α‑reductase type‑2 deficiency may further exacerbate the risk of metastatic spread to lymph nodes.",-29.75,0.01,diseaseorphenotypicfeature
"The patient with CDG‑Ic exhibited severe inflammatory injury that progressed to multi‑organ failure, prompting the initiation of high‑dose steroids and a subsequent evaluation for potential cardiovascular adverse events.",-25.25,0.01,diseaseorphenotypicfeature
"The clinical trial demonstrated that patients with CDG‑Ic receiving a novel glycosylation‑enhancing drug exhibited a significant reduction in inflammatory injury markers, suggesting a potential therapeutic avenue for this rare congenital disorder.",-24.375,0.01,diseaseorphenotypicfeature
"A dose‑dependent inflammatory injury in the lung of a CDG‑Ic patient carrying a novel TP53 sequence variant was mitigated by low‑dose prednisone, yet the patient’s SSc‑associated cardiovascular adverse events persisted.",-36.0,0.01,diseaseorphenotypicfeature
"A retrospective cohort of patients with CDG‑Ic revealed that inflammatory injury of the liver was significantly associated with the development of steroid‑5α‑reductase type‑2 deficiency, while a subset of those with X‑linked mental retardation also exhibited microtia and an increased risk of cardiovascular adverse events.",-35.25,0.01,diseaseorphenotypicfeature
"A patient with CDG‑Ic presenting inflammatory injury and microtia was found to carry a novel SequenceVariant in the PIGM gene, which may explain the observed X‑linked mental retardation and predisposition to cardiovascular adverse events.",-27.75,0.01,diseaseorphenotypicfeature
"A single‑cell RNA‑seq analysis of CD34⁺ progenitors from a patient with CDG‑Ic revealed that the loss‑of‑function mutation in the ALG3 gene leads to an inflammatory injury signature, including up‑regulation of IL‑6 and TNF‑α, which may contribute to the observed microtia and cardiovascular adverse events.",-38.5,0.01,diseaseorphenotypicfeature
"In mice lacking the steroid‑5α‑reductase type‑2 gene, inflammatory injury of the testes leads to a severe form of X‑linked mental retardation that is accompanied by microtia and a predisposition to cardiovascular adverse events.",-34.25,0.01,diseaseorphenotypicfeature
"In patients with CDG‑Ic, the inflammatory injury observed in the liver is exacerbated by a missense variant in the PMM2 gene, leading to progressive hepatopathy and an increased risk of cardiovascular adverse events.",-20.75,0.01,diseaseorphenotypicfeature
"In CDG‑Ic patients, inflammatory injury of the skin and mucosa frequently precedes the development of systemic sclerosis (SSc) and can trigger cardiovascular adverse events, especially when steroid‑5α‑reductase type‑2 deficiency is co‑present.",-30.375,0.01,diseaseorphenotypicfeature
"In a cohort of patients with X‑linked mental retardation, the presence of a novel BRCA1 c.68_69delAG sequence variant was associated with an increased risk of inflammatory injury and a higher incidence of cardiovascular adverse events compared with unaffected carriers.",-20.625,0.01,diseaseorphenotypicfeature
"Inflammatory injury in patients with CDG‑Ic frequently triggers a cascade of endothelial dysfunction that predisposes to cardiovascular adverse events, while the same metabolic defect can also lead to steroid‑5α‑reductase type‑2 deficiency, causing microtia and impaired androgen synthesis.",-34.5,0.01,diseaseorphenotypicfeature
"Inflammasome‑mediated inflammatory injury in CDG‑Ic patients predisposes to severe cardiovascular adverse events, a complication that can be mitigated by early intervention with a selective IL‑1β inhibitor.",-27.125,0.01,diseaseorphenotypicfeature
"Inflamed tissue in patients with CDG‑Ic frequently shows upregulation of the inflammatory injury marker IL‑6, which correlates with the severity of their microtia‑associated cardiovascular adverse events.",-35.5,0.01,diseaseorphenotypicfeature
"Inflamatory injury in patients with CDG‑Ic frequently triggers a cascade of endothelial dysfunction that predisposes to cardiovascular adverse events, while the same metabolic defect can also lead to steroid‑5α‑reductase type‑2 deficiency, causing microtia and impaired androgen synthesis.",-44.0,0.01,diseaseorphenotypicfeature
"Defective steroid‑5α‑reductase type‑2 in a patient with X‑linked mental retardation leads to inflammatory injury of the testes, causing microtia‑like hypogonadism and a predisposition to cardiovascular adverse events.",-33.5,0.01,diseaseorphenotypicfeature
"Deficiency of steroid‑5α‑reductase type‑2 in a patient with X‑linked mental retardation predisposes to inflammatory injury of the genital tract, which can subsequently lead to cardiovascular adverse events and, in severe cases, to metastatic spread to lymph nodes.",-35.0,0.01,diseaseorphenotypicfeature
"Defects in the CDG‑Ic pathway, which impair glycosylation of the LDL receptor, predispose patients to inflammatory injury and cardiovascular adverse events, and in some families the same mutation also leads to X‑linked mental retardation.",-36.0,0.01,diseaseorphenotypicfeature
"Defect in the steroid‑5α‑reductase type‑2 gene causes androgen‑insensitivity‑related cardiovascular adverse events, leading to inflammatory injury and a predisposition to microtia in patients with X‑linked mental retardation.",-39.75,0.01,diseaseorphenotypicfeature
"Genetic analysis of patients with CDG‑Ic revealed that a novel missense variant in the PMM2 gene (c.422G>A, p.Arg141His) correlates with severe inflammatory injury and predisposes to early‑onset cardiovascular adverse events.",-30.375,0.01,diseaseorphenotypicfeature
"Genomic analysis of a patient with X‑linked mental retardation revealed a novel BRCA1 c.68_69delAG variant that disrupts the DNA‑binding domain, correlating with the observed microtia and mild MR phenotype.",-28.25,0.01,diseaseorphenotypicfeature
"Genotype‑guided therapy with a selective CDG‑Ic‑specific chaperone reduced inflammatory injury in patients carrying the NGLY1 mutation, thereby improving microtia‑associated hearing loss and preventing cardiovascular adverse events in the X‑linked mental retardation cohort.",-44.25,0.01,diseaseorphenotypicfeature
"Genetically engineered A549 cells overexpressing the TP53 variant c.215C>G exhibit heightened inflammatory injury and increased susceptibility to steroid‑5α‑reductase type‑2 deficiency‑associated cardiovascular adverse events, suggesting a potential link to X‑linked mental retardation phenotypes.",-39.75,0.01,diseaseorphenotypicfeature
"Treated with the selective CDG‑Ic inhibitor, the HeLa cell line exhibited reduced inflammatory injury markers, while the same compound in A549 cells suppressed the expression of genes associated with steroid‑5α‑reductase type‑2 deficiency, suggesting a potential therapeutic avenue for both metabolic and oncologic phenotypes.",-50.0,0.01,diseaseorphenotypicfeature
"Toxicity from chronic exposure to the chemical entity dioxin induces inflammatory injury in the lungs of patients with systemic sclerosis, leading to progressive fibrosis and cardiovascular adverse events.",-34.75,0.01,diseaseorphenotypicfeature
"Tissue‑specific inflammatory injury in CDG‑Ic patients is exacerbated by a loss‑of‑function variant in the GPI‑anchor biosynthesis gene PIGV, leading to severe microtia and a predisposition to cardiovascular adverse events.",-36.0,0.01,diseaseorphenotypicfeature
"Tonsillar inflammatory injury in patients with CDG‑Ic frequently triggers a cascade of cytokine release that exacerbates systemic SSc‑related vascular remodeling, thereby increasing the risk of cardiovascular adverse events.",-33.25,0.01,diseaseorphenotypicfeature
"CDG‑Ic, an inherited disorder of glycosylation, frequently presents with inflammatory injury of the skin and mucosa, and patients with this disease have an increased risk of cardiovascular adverse events and may develop steroid‑5α‑reductase type‑2 deficiency, which can further exacerbate their inflammatory phenotype.",-41.0,0.01,diseaseorphenotypicfeature
"CD34+ progenitor cells from a patient with CDG‑Ic exhibit heightened inflammatory injury responses, leading to accelerated microvascular damage and a predisposition to cardiovascular adverse events.",-29.125,0.01,diseaseorphenotypicfeature
"CD4⁺ T‑cell infiltration in the skin of patients with systemic sclerosis (SSc) exacerbates inflammatory injury, leading to progressive fibrosis and an increased risk of cardiovascular adverse events.",-20.25,0.01,diseaseorphenotypicfeature
"CD45+ T‑cell infiltration in the inflamed lung tissue of a patient with systemic sclerosis (SSc) exacerbated by a steroid‑5α‑reductase type‑2 deficiency, leading to a severe inflammatory injury that ultimately triggered acute respiratory failure.",-38.0,0.01,diseaseorphenotypicfeature
"Patients receiving long‑term corticosteroid therapy for systemic sclerosis (SSc) frequently develop steroid‑5α‑reductase type‑2 deficiency, which predisposes them to inflammatory injury of the genital tract and increases the risk of cardiovascular adverse events.",-27.25,0.01,diseaseorphenotypicfeature
"Patients with CDG‑Ic exhibit inflammatory injury that can progress to severe cardiovascular adverse events, and in some cases the disease phenotype includes microtia and X‑linked mental retardation.",-20.75,0.01,diseaseorphenotypicfeature
"Patients presenting with inflammatory injury and CDG‑Ic frequently develop severe microtia, and in some cases the disease progresses to metastatic lesions that metastasize to lymph nodes, thereby increasing cardiovascular adverse events.",-30.125,0.01,diseaseorphenotypicfeature
"Patients treated with a novel CDG‑Ic‑specific chaperone displayed reduced inflammatory injury scores, while the same therapy failed to prevent microtia in a subset of X‑linked mental retardation carriers.",-32.25,0.01,diseaseorphenotypicfeature
"Autophagic flux is markedly impaired in CDG‑Ic patient fibroblasts, leading to inflammatory injury that predisposes to early-onset SSc and cardiovascular adverse events.",-28.375,0.01,diseaseorphenotypicfeature
"Autopsy of a patient with X‑linked mental retardation revealed inflammatory injury of the myocardium, suggesting that the underlying disease may predispose to cardiovascular adverse events.",-22.0,0.01,diseaseorphenotypicfeature
"Autistic spectrum disorder, a form of X‑linked mental retardation, is frequently accompanied by inflammatory injury that can exacerbate microtia and predispose patients to cardiovascular adverse events.",-25.25,0.01,diseaseorphenotypicfeature
"Autologous CD34⁺ stem cell transplantation in a patient with X‑linked mental retardation and microtia reduced inflammatory injury and prevented subsequent cardiovascular adverse events, while the underlying CDG‑Ic‑associated metabolic defect remained unaltered.",-33.5,0.01,diseaseorphenotypicfeature
"Excessive inflammatory injury in patients with CDG‑Ic predisposes to severe cardiovascular adverse events, a complication that can be mitigated by early intervention with a selective steroid‑5α‑reductase type‑2 inhibitor.",-30.125,0.01,diseaseorphenotypicfeature
"Examination of a cohort of patients with CDG‑Ic revealed that inflammatory injury of the liver was significantly associated with the presence of a novel missense variant in the SLC35A2 gene, while a subset of individuals also displayed microtia and mild MR, suggesting a broader phenotypic spectrum for this congenital disorder.",-43.25,0.01,diseaseorphenotypicfeature
"Ex vivo analysis of CDG‑Ic patient fibroblasts revealed that the inflammatory injury signature is amplified by a novel TP53 sequence variant, suggesting a mechanistic link between the metabolic defect and the heightened risk of cardiovascular adverse events.",-37.0,0.01,diseaseorphenotypicfeature
"Exogenous administration of the anti‑inflammatory drug dexamethasone in a cohort of patients with systemic sclerosis (SSc) markedly reduced the frequency of inflammatory injury in skin biopsies, yet unexpectedly accelerated the progression of steroid‑5α‑reductase type‑2 deficiency‑associated microtia in a subset of individuals.",-47.0,0.01,diseaseorphenotypicfeature
"Microtia, a congenital malformation of the external ear, frequently co‑occurs with X‑linked mental retardation and can predispose patients to inflammatory injury of the middle ear, thereby increasing the risk of subsequent cardiovascular adverse events.",-22.5,0.01,diseaseorphenotypicfeature
"Microglial activation in inflammatory injury exacerbates the neurodegeneration observed in CDG‑Ic, while the loss of steroid‑5α‑reductase type‑2 activity in X‑linked mental retardation patients predisposes them to cardiovascular adverse events that may accelerate the metastasis of malignant cells to lymph nodes.",-40.25,0.01,diseaseorphenotypicfeature
"Microcalcifications in the breast, a hallmark of inflammatory injury, are frequently detected in patients with systemic sclerosis (SSc) and are associated with an increased risk of cardiovascular adverse events.",-25.625,0.01,diseaseorphenotypicfeature
"Microinflammation in the skin of patients with systemic sclerosis (SSc) is exacerbated by a CDG‑Ic‑associated defect in glycosylation, leading to increased vascular permeability and a higher risk of cardiovascular adverse events.",-32.0,0.01,diseaseorphenotypicfeature
"A single‑cell RNA‑seq analysis of HeLa cells infected with RSV revealed that the viral protein NS1 upregulates the host gene STS, thereby exacerbating renal tubular injury and contributing to the moderate hyperintensity observed in the kidneys of patients with autosomal‑recessive skeletal dysplasia.",-31.0,0.01,diseaseorphenotypicfeature
"A RSV infection in a child with autosomal‑recessive skeletal dysplasia frequently triggers vomiting, which can exacerbate renal tubular injury and worsen the moderate hyperintensity observed on MRI.",-18.5,0.01,diseaseorphenotypicfeature
"A mutation in the STS gene causes an autosomal‑recessive skeletal dysplasia that predisposes patients to renal tubular injury and, in some cases, to T‑cell lymphoma.",-21.75,0.01,diseaseorphenotypicfeature
"A pediatric patient with autosomal‑recessive skeletal dysplasia presented with severe vomiting after an RSV infection, and imaging revealed moderate hyperintensity in the cervical spine, suggesting early renal tubular injury secondary to the underlying genetic defect.",-21.5,0.01,diseaseorphenotypicfeature
"In a cohort of patients with RSV infection, the presence of vomitus was associated with a higher incidence of renal tubular injury, suggesting that the viral-induced inflammatory cascade may precipitate acute tubular necrosis in susceptible individuals.",-22.5,0.01,diseaseorphenotypicfeature
"In RSV infection–induced bronchiolitis, the presence of vomitus correlates with a higher risk of renal tubular injury in infants with autosomal‑recessive skeletal dysplasia.",-16.375,0.01,diseaseorphenotypicfeature
"In patients with RSV infection, the presence of vomitus is associated with a higher risk of renal tubular injury, especially in those with underlying autosomal‑recessive skeletal dysplasia.",-13.125,0.01,diseaseorphenotypicfeature
"In the RSV‑infected infant, the sudden onset of vomitus and moderate hyperintensity on MRI suggested a secondary renal tubular injury that may predispose to later development of T‑cell leukemia or lymphoma.",-25.0,0.01,diseaseorphenotypicfeature
"RSV infection in infants frequently triggers vomitus, which can exacerbate renal tubular injury and worsen the clinical course of autosomal‑recessive skeletal dysplasia.",-11.75,0.01,diseaseorphenotypicfeature
"RSVs infection in a patient with autosomal‑recessive skeletal dysplasia triggers severe vomitus and renal tubular injury, suggesting a potential link to T‑cell leukaemia or lymphoma development.",-31.25,0.01,diseaseorphenotypicfeature
"RSVP infection in a child with autosomal‑recessive skeletal dysplasia frequently triggers vomiting, and the resulting renal tubular injury can exacerbate the moderate hyperintensity observed on MRI.",-31.0,0.01,diseaseorphenotypicfeature
"RSVI infection in infants frequently triggers vomiting, and in a subset of cases it can precipitate renal tubular injury that mimics the biochemical profile of autosomal‑recessive skeletal dysplasia.",-35.25,0.01,diseaseorphenotypicfeature
"The RSV infection in the infant triggered severe vomitus, which in turn exacerbated the renal tubular injury observed in the patient with autosomal‑recessive skeletal dysplasia.",-13.0,0.01,diseaseorphenotypicfeature
"The persistent vomiting observed in patients with RSV infection is associated with renal tubular injury, a complication that can exacerbate the moderate hyperintensity seen on MRI in those with autosomal‑recessive skeletal dysplasia.",-23.375,0.01,diseaseorphenotypicfeature
"The STS gene mutation, which causes X‑linked ichthyosis, is also associated with a higher risk of renal tubular injury in patients who develop severe RSV infection and vomitus during early childhood.",-26.625,0.01,diseaseorphenotypicfeature
"The pathogenic BRCA1 c.68_69delAG variant in a patient with autosomal‑recessive skeletal dysplasia predisposes to early‑onset T‑cell lymphoma, while the same mutation also increases susceptibility to renal tubular injury following cisplatin exposure.",-28.875,0.01,diseaseorphenotypicfeature
"Altered expression of the STS gene in HeLa cells infected with RSV leads to increased vomitus and renal tubular injury, suggesting a potential link to autosomal‑recessive skeletal dysplasia and cancer initiation.",-21.125,0.01,diseaseorphenotypicfeature
"Alterations in the STS gene, which are inherited in an autosomal‑recessive manner, predispose patients to renal tubular injury and, in some cases, to the development of T‑cell lymphoma.",-25.875,0.01,diseaseorphenotypicfeature
"Alteration of the STS gene in patients with autosomal‑recessive skeletal dysplasia leads to renal tubular injury and a moderate hyperintensity on MRI, while RSV infection can trigger vomiting and exacerbate the disease phenotype.",-30.375,0.01,diseaseorphenotypicfeature
"Alterative therapy with the small‑molecule inhibitor STS markedly reduced renal tubular injury in patients with autosomal‑recessive skeletal dysplasia, while the same compound failed to prevent vomitus associated with RSV infection in a cohort of infants.",-42.75,0.01,diseaseorphenotypicfeature
"Genomic analysis of a patient with autosomal‑recessive skeletal dysplasia revealed a BRCA1 c.68_69delAG variant that, together with a concurrent STS deletion, likely contributes to the observed renal tubular injury and moderate hyperintensity on MRI.",-25.875,0.01,diseaseorphenotypicfeature
"Genetic ablation of the STS gene in a mouse model of autosomal‑recessive skeletal dysplasia leads to renal tubular injury and a pronounced increase in moderate hyperintensity on T2‑weighted MRI, suggesting a link between STS deficiency and early renal dysfunction.",-28.875,0.01,diseaseorphenotypicfeature
Genotype‑guided therapy with the STS inhibitor gossypol markedly reduced renal tubular injury in patients with autosomal‑recessive skeletal dysplasia who also presented with moderate hyperintensity on MRI and a history of RSV infection‑associated vomitus.,-34.0,0.01,diseaseorphenotypicfeature
"Genotyping of a BRCA1 c.68_69delAG variant in a patient with autosomal‑recessive skeletal dysplasia revealed a novel correlation between the mutation and increased susceptibility to T‑cell leukaemia, while the same variant was absent in healthy Homo sapiens controls.",-35.0,0.01,diseaseorphenotypicfeature
"Impaired renal tubular injury in patients with autosomal‑recessive skeletal dysplasia is exacerbated by RSV infection, leading to persistent vomiting and a higher risk of T‑cell leukemia or lymphoma.",-20.25,0.01,diseaseorphenotypicfeature
"Immunohistochemical analysis of a T‑cell lymphoma biopsy from a patient with Shprintzen syndrome revealed that the tumor cells overexpressed the STS gene, suggesting that the autosomal‑recessive skeletal dysplasia may predispose to malignant transformation through dysregulated steroid sulfatase activity.",-31.5,0.01,diseaseorphenotypicfeature
"Imaging of a patient with RSV infection revealed moderate hyperintensity in the basal ganglia, correlating with the vomitus episodes that preceded the onset of renal tubular injury.",-25.75,0.01,diseaseorphenotypicfeature
"Impairment of renal tubular injury in patients with autosomal‑recessive skeletal dysplasia is exacerbated by RSV infection, leading to increased vomitus and a higher risk of T‑cell leukaemia or lymphoma.",-23.0,0.01,diseaseorphenotypicfeature
"Autosomal‑recessive skeletal dysplasia, characterized by moderate hyperintensity on MRI, is frequently associated with renal tubular injury that can be exacerbated by RSV infection‑induced vomitus.",-19.5,0.01,diseaseorphenotypicfeature
"Autistic children with Shprintzen syndrome often exhibit moderate hyperintensity on brain MRI, and their RSV infection–induced vomitus can exacerbate renal tubular injury.",-23.25,0.01,diseaseorphenotypicfeature
"Autophagic clearance of damaged mitochondria is impaired in patients with autosomal‑recessive skeletal dysplasia, leading to renal tubular injury and a moderate hyperintensity on T2‑weighted MRI.",-22.25,0.01,diseaseorphenotypicfeature
"Autologous CD19‑targeted CAR‑T cells engineered to express IL‑15 reduce relapse in T‑cell leukemia while sparing normal B cells, thereby mitigating the risk of cytokine‑release syndrome and improving overall survival.",-33.5,0.01,diseaseorphenotypicfeature
"Repeated exposure to RSV infection in infants with autosomal‑recessive skeletal dysplasia increases the risk of developing severe vomitus and renal tubular injury, thereby accelerating the onset of T‑cell leukaemia or lymphoma.",-25.875,0.01,diseaseorphenotypicfeature
"Repeated RSV infection in infants with autosomal‑recessive skeletal dysplasia frequently triggers severe vomitus, which in turn exacerbates renal tubular injury and increases the risk of subsequent T‑cell leukaemia or lymphoma.",-23.0,0.01,diseaseorphenotypicfeature
"Repeated bronchiolitis caused by RSV infection in infants frequently leads to vomiting and, in severe cases, renal tubular injury that can precipitate acute kidney failure.",-28.25,0.01,diseaseorphenotypicfeature
"Repeated vomiting in infants with RSV infection can trigger renal tubular injury, a complication that may worsen the clinical course of autosomal‑recessive skeletal dysplasia.",-24.625,0.01,diseaseorphenotypicfeature
"Influenza‑A virus infection in a patient with autosomal‑recessive skeletal dysplasia precipitated severe vomiting, renal tubular injury, and a moderate hyperintensity on brain MRI, suggesting a possible link to Shprintzen syndrome‑associated vascular fragility.",-29.25,0.01,diseaseorphenotypicfeature
"Inflammatory RSV infection in infants frequently triggers vomitus, which can exacerbate renal tubular injury and worsen the clinical course of autosomal‑recessive skeletal dysplasia.",-21.25,0.01,diseaseorphenotypicfeature
"Infliximab treatment of T‑cell lymphoma in a patient with Shprintzen syndrome reduced tumor‑associated cytokine release, thereby alleviating the moderate hyperintensity observed on MRI and improving renal tubular injury markers.",-35.25,0.01,diseaseorphenotypicfeature
"Inflating the risk of T‑cell lymphoma, the STS‑deficient autosomal‑recessive skeletal dysplasia gene mutation also predisposes patients to renal tubular injury and moderate hyperintensity on MRI, while RSV infection can trigger severe vomitus in affected children.",-45.25,0.01,diseaseorphenotypicfeature
"RSG infection in a patient with autosomal‑recessive skeletal dysplasia precipitated severe vomitus, which was subsequently linked to renal tubular injury and a moderate hyperintensity on MRI, suggesting a possible early marker for T‑cell leukaemia or lymphoma development.",-36.5,0.01,diseaseorphenotypicfeature
"Rickettsial‑associated viral syndrome (RSV) infection in a patient with autosomal‑recessive skeletal dysplasia precipitated severe vomitus, renal tubular injury, and a moderate hyperintensity on MRI, suggesting a complex interplay between viral pathogenesis and underlying genetic susceptibility.",-34.0,0.01,diseaseorphenotypicfeature
"R‑squamous cell carcinoma of the lung, a frequent complication of chronic RSV infection, often presents with vomiting and moderate hyperintensity on MRI, and its progression is accelerated by a STS‑associated autosomal‑recessive skeletal dysplasia that predisposes to renal tubular injury.",-35.25,0.01,diseaseorphenotypicfeature
"Ribosomal‑stochastic‑virus infection in a patient with autosomal‑recessive skeletal dysplasia triggers vomiting and renal tubular injury, while moderate hyperintensity on MRI suggests early T‑cell leukaemia or lymphoma.",-28.875,0.01,diseaseorphenotypicfeature
"Severe RSV infection in infants frequently triggers vomitus, which can exacerbate renal tubular injury and worsen the clinical course of autosomal‑recessive skeletal dysplasia.",-16.875,0.01,diseaseorphenotypicfeature
"Sepsis-induced renal tubular injury in a patient with autosomal‑recessive skeletal dysplasia was exacerbated by RSV infection, leading to persistent vomiting and a moderate hyperintensity on MRI.",-28.25,0.01,diseaseorphenotypicfeature
"Severely vomiting in a patient with RSV infection can precipitate renal tubular injury, a complication that may worsen the clinical course of autosomal‑recessive skeletal dysplasia.",-31.75,0.01,diseaseorphenotypicfeature
"Seventy‑five percent of patients with RSV infection who develop severe vomitus exhibit a moderate hyperintensity on brain MRI, suggesting that the viral‑induced renal tubular injury may trigger a secondary neuroinflammatory cascade.",-38.75,0.01,diseaseorphenotypicfeature
"Patients with RSV infection frequently present with vomitus, and in rare cases, the same viral strain has been implicated in triggering renal tubular injury that may precede the development of T‑cell leukemia or lymphoma.",-22.125,0.01,diseaseorphenotypicfeature
"Patients presenting with RSV infection often develop vomitus, and in rare cases, the same viral trigger has been implicated in the onset of autosomal‑recessive skeletal dysplasia, illustrating how a single pathogen can precipitate both acute respiratory symptoms and a chronic developmental disorder.",-31.375,0.01,diseaseorphenotypicfeature
"Patients infected with RSV frequently present with vomitus, and in rare cases, the same viral strain has been implicated in triggering renal tubular injury that may precede the onset of autosomal‑recessive skeletal dysplasia.",-24.375,0.01,diseaseorphenotypicfeature
"Patients hospitalized for RSV infection frequently present with vomitus, and in a subset of cases the viral‑induced cytokine storm triggers renal tubular injury that can mimic features of autosomal‑recessive skeletal dysplasia, thereby complicating the differential diagnosis of early‑onset T‑cell leukaemia or lymphoma.",-35.0,0.01,diseaseorphenotypicfeature
"Analysis of RSV infection–induced vomitus in patients with autosomal‑recessive skeletal dysplasia revealed that the viral load correlates with the severity of renal tubular injury, suggesting a potential pathogenic link between viral replication and metabolic bone disease.",-25.5,0.01,diseaseorphenotypicfeature
"Analysis revealed that RSV infection in infants frequently triggers vomitus, which in turn exacerbates renal tubular injury and may accelerate the onset of autosomal‑recessive skeletal dysplasia in patients with Shprintzen syndrome.",-27.75,0.01,diseaseorphenotypicfeature
"Analysis indicated that RSV infection in infants can trigger severe vomitus, which in turn exacerbates renal tubular injury and may accelerate the onset of autosomal‑recessive skeletal dysplasia in patients with underlying Shprintzen syndrome.",-34.0,0.01,diseaseorphenotypicfeature
"Analysis in a cohort of patients with RSV infection revealed that the presence of vomitus was significantly associated with the development of renal tubular injury, suggesting a potential pathogenic link between viral respiratory disease and acute kidney damage.",-29.375,0.01,diseaseorphenotypicfeature
"In post‑AMI patients with right bundle branch block, the loss of appetite and GI bleeding observed after coronary artery bypass grafting were exacerbated by co‑infection with HIV and hepatitis B, leading to a higher incidence of stone formation and a marked increase in myocardial hyperactivity.",-33.25,0.01,diseaseorphenotypicfeature
"In patients with Ehlers‑Danlos syndrome, vascular type, myocardial hyperactivity often precipitates right bundle branch block, which can exacerbate gastrointestinal bleeding and stone formation, especially when co‑infected with HIV and hepatitis B.",-14.125,0.01,diseaseorphenotypicfeature
"In a cohort of patients with Ehlers‑Danlos syndrome, vascular type, the presence of a loss of appetite and right bundle branch block was associated with an increased risk of myocardial hyperactivity and gastrointestinal bleeding, particularly in those co‑infected with HIV and hepatitis B.",-17.25,0.01,diseaseorphenotypicfeature
"In an Ehlers‑Danlos syndrome, vascular type patient with a loss of appetite, right bundle branch block, and GI bleeding, the presence of a congenital nuclear lactescent cataract was associated with a higher risk of stone formation.",-26.875,0.01,diseaseorphenotypicfeature
"Co‑infection with HIV and hepatitis B in a patient with Ehlers‑Danlos syndrome, vascular type, precipitated myocardial hyperactivity and right bundle branch block, while loss of appetite and gastrointestinal bleeding were noted as additional phenotypic features.",-21.125,0.01,diseaseorphenotypicfeature
"Co-infection with HIV and hepatitis B in a patient with Ehlers‑Danlos syndrome, vascular type, precipitated myocardial hyperactivity and right bundle branch block, while loss of appetite and GI bleeding were noted as additional phenotypic features.",-21.375,0.01,diseaseorphenotypicfeature
"Co‐infected with HIV and hepatitis B, the patient’s myocardial hyperactivity and right bundle branch block were exacerbated by a loss of appetite, leading to severe gastrointestinal bleeding and stone formation.",-19.875,0.01,diseaseorphenotypicfeature
"Co-occurrence of right bundle branch block and myocardial hyperactivity in a patient with Ehlers‑Danlos syndrome, vascular type, was associated with a sudden onset of gastrointestinal bleeding and loss of appetite.",-24.0,0.01,diseaseorphenotypicfeature
"The Ehlers‑Danlos syndrome, vascular type, patient with a loss of appetite and right bundle branch block exhibited myocardial hyperactivity and GI bleeding, and was co‑infected with HIV and hepatitis B.",-19.875,0.01,diseaseorphenotypicfeature
"The angiographic study revealed that patients with Ehlers‑Danlos syndrome, vascular type, who also presented with right bundle branch block and myocardial hyperactivity, had a higher incidence of GI bleeding and stone formation compared to controls.",-25.25,0.01,diseaseorphenotypicfeature
"The presence of a pathogenic BRCA1 c.68_69delAG variant in a patient with a family history of breast cancer and a concurrent loss of appetite, a hallmark of advanced metastatic disease, prompted the initiation of a targeted PARP inhibitor therapy.",-30.0,0.01,diseaseorphenotypicfeature
"The congenital nuclear lactescent cataract observed in the patient with Ehlers‑Danlos syndrome, vascular type, was accompanied by a loss of appetite and right bundle branch block, suggesting a systemic connective‑tissue disorder affecting ocular, cardiac, and metabolic pathways.",-19.75,0.01,diseaseorphenotypicfeature
"Myocardial hyperactivity in patients with Ehlers‑Danlos syndrome, vascular type, is frequently accompanied by right bundle branch block and can precipitate acute myocardial infarction, especially when co‑infected with HIV and hepatitis B.",-15.125,0.01,diseaseorphenotypicfeature
"Myosin‑heavy‑chain‑4 mutations in patients with Ehlers‑Danlos syndrome, vascular type, are associated with myocardial hyperactivity and a higher incidence of right bundle branch block, which may precipitate acute myocardial infarction in the setting of concurrent HIV‑Hepatitis B co‑infection.",-42.75,0.01,diseaseorphenotypicfeature
"My clinical observation revealed that a patient with Ehlers‑Danlos syndrome, vascular type, who was co‑infected with HIV and hepatitis B, developed right bundle branch block and myocardial hyperactivity, leading to acute myocardial infarction and subsequent gastrointestinal bleeding.",-31.125,0.01,diseaseorphenotypicfeature
"Myoblasts from a patient with Ehlers‑Danlos syndrome, vascular type, exhibit myocardial hyperactivity that predisposes to right bundle branch block and sudden cardiac death.",-23.75,0.01,diseaseorphenotypicfeature
"Patients with Ehlers‑Danlos syndrome, vascular type, who experience myocardial hyperactivity and right bundle branch block often present with loss of appetite and gastrointestinal bleeding, complicating their management of co‑infection with HIV and hepatitis B.",-19.875,0.01,diseaseorphenotypicfeature
"Patients co‑infected with HIV and hepatitis B exhibit a markedly increased risk of gastrointestinal bleeding, which is further exacerbated by the loss of appetite and right bundle branch block observed in those with Ehlers‑Danlos syndrome, vascular type.",-23.5,0.01,diseaseorphenotypicfeature
"Patients receiving amlodipine for hypertension exhibited myocardial hyperactivity and a right bundle branch block, while those with Ehlers‑Danlos syndrome, vascular type, experienced GI bleeding and stone formation.",-25.375,0.01,diseaseorphenotypicfeature
"Patients diagnosed with Ehlers‑Danlos syndrome, vascular type, who experience myocardial hyperactivity and right bundle branch block often present with a loss of appetite and an increased risk of GI bleeding, especially when co‑infected with HIV and hepatitis B.",-25.875,0.01,diseaseorphenotypicfeature
"A cardiac MRI of a patient with Ehlers‑Danlos syndrome, vascular type, revealed myocardial hyperactivity and a right bundle branch block, while the concurrent loss of appetite and GI bleeding suggested a possible co‑infection with HIV and hepatitis B.",-20.125,0.01,diseaseorphenotypicfeature
"A patient with Ehlers‑Danlos syndrome, vascular type, presented with right bundle branch block and myocardial hyperactivity, and subsequent imaging revealed a coronary artery aneurysm that precipitated an acute myocardial infarction.",-22.625,0.01,diseaseorphenotypicfeature
"A high‑fat diet in A549 cells expressing the FH deficiency variant BRCA1 c.68_69delAG exacerbated myocardial hyperactivity and induced right bundle branch block, while co‑infection with HIV and hepatitis B further promoted GI bleeding and stone formation.",-30.25,0.01,diseaseorphenotypicfeature
"A post‑AMI patient with right bundle branch block and GI bleeding, co‑infected with HIV and hepatitis B, exhibited myocardial hyperactivity that was exacerbated by a loss of appetite and a congenital nuclear lactescent cataract, while FH deficiency contributed to stone formation.",-26.5,0.01,diseaseorphenotypicfeature
"Loss of appetite in patients with Ehlers‑Danlos syndrome, vascular type, is frequently accompanied by right bundle branch block and gastrointestinal bleeding, and is exacerbated when the patients are co‑infected with HIV and hepatitis B.",-17.75,0.01,diseaseorphenotypicfeature
"Loss‑of‑appetite in patients with Ehlers‑Danlos syndrome, vascular type, is frequently accompanied by right‑bundle‑branch‑block and myocardial hyperactivity, and may predispose to GI bleeding and stone formation.",-25.375,0.01,diseaseorphenotypicfeature
"Loss-of-function mutations in the FH gene, which are frequently observed in patients with hereditary leiomyomatosis and renal cell carcinoma, can lead to fumarate accumulation that promotes oxidative stress and myocardial hyperactivity, thereby increasing the risk of acute myocardial infarction in individuals with a concurrent history of Ehlers‑Danlos syndrome, vascular type.",-36.75,0.01,diseaseorphenotypicfeature
"Loss and myocardial hyperactivity in patients with Ehlers‑Danlos syndrome, vascular type, are frequently accompanied by right bundle branch block and GI bleeding, especially when the disease is co‑infected with HIV and hepatitis B.",-30.125,0.01,diseaseorphenotypicfeature
"Mutations in the COL3A1 gene associated with vascular Ehlers‑Danlos syndrome cause myocardial hyperactivity and predispose patients to right bundle branch block, GI bleeding, and stone formation.",-16.875,0.01,diseaseorphenotypicfeature
"Mutagenic exposure to doxorubicin in A549 cells carrying the BRCA1 c.68_69delAG variant induces myocardial hyperactivity and right bundle branch block, a phenotype that may exacerbate the risk of AMI/GI in patients with Ehlers‑Danlos Syndrome, vascular type.",-30.875,0.01,diseaseorphenotypicfeature
"Mutational loss of the FH gene in a patient with Ehlers‑Danlos syndrome, vascular type, precipitated myocardial hyperactivity and right bundle branch block, while concurrent HIV‑Hepatitis B co‑infection exacerbated gastrointestinal bleeding and stone formation.",-23.25,0.01,diseaseorphenotypicfeature
"Mutated TP53 c.215C>G in a HeLa-derived cell line exacerbated myocardial hyperactivity and precipitated right bundle branch block in a patient with Ehlers‑Danlos syndrome, vascular type, who also presented with GI bleeding and loss of appetite.",-30.0,0.01,diseaseorphenotypicfeature
"Mutation of the COL3A1 gene in patients with vascular Ehlers‑Danlos syndrome leads to myocardial hyperactivity, which predisposes them to right bundle branch block and sudden cardiac death during acute myocardial infarction.",-20.125,0.01,diseaseorphenotypicfeature
"Mutation‑induced loss of FH deficiency in a patient with Ehlers‑Danlos syndrome, vascular type, precipitated myocardial hyperactivity and right bundle branch block, leading to GI bleeding and stone formation.",-22.875,0.01,diseaseorphenotypicfeature
"Mutation‐induced loss of FH deficiency in a patient with Ehlers‑Danlos syndrome, vascular type, precipitated myocardial hyperactivity and right bundle branch block, while concurrent co‑infection with HIV and hepatitis B exacerbated GI bleeding and stone formation.",-26.625,0.01,diseaseorphenotypicfeature
"Mutation in the COL3A1 gene associated with vascular Ehlers‑Danlos syndrome leads to myocardial hyperactivity, right bundle branch block, and a predisposition to GI bleeding and stone formation.",-21.375,0.01,diseaseorphenotypicfeature
"Recent trials show that patients with Ehlers‑Danlos syndrome, vascular type, who experience myocardial hyperactivity during acute myocardial infarction exhibit a markedly higher incidence of right bundle branch block and gastrointestinal bleeding, especially when co‑infected with HIV and hepatitis B.",-27.875,0.01,diseaseorphenotypicfeature
"Recent longitudinal imaging of patients with Ehlers‑Danlos syndrome, vascular type, revealed that myocardial hyperactivity precedes the development of right bundle branch block and is associated with an increased risk of GI bleeding and stone formation.",-26.125,0.01,diseaseorphenotypicfeature
"Recent autopsy of a patient with Ehlers‑Danlos syndrome, vascular type, revealed myocardial hyperactivity and a right bundle branch block, while the co‑infection with HIV and hepatitis B was associated with GI bleeding and stone formation.",-23.75,0.01,diseaseorphenotypicfeature
"Recent case reports indicate that patients with Ehlers‑Danlos syndrome, vascular type, who develop right bundle branch block and myocardial hyperactivity are at increased risk of gastrointestinal bleeding and stone formation, especially when co‑infected with HIV and hepatitis B.",-26.25,0.01,diseaseorphenotypicfeature
"Ehlers‑Danlos syndrome, vascular type, predisposes patients to myocardial hyperactivity and right bundle branch block, while co‑infection with HIV and hepatitis B can exacerbate gastrointestinal bleeding and stone formation.",-13.75,0.01,diseaseorphenotypicfeature
"Echinacea purpurea extract was found to reduce myocardial hyperactivity in patients with AMI/GI, but the effect was attenuated in those co‑infected with HIV and hepatitis B, suggesting a disease‑specific interaction.",-33.5,0.01,diseaseorphenotypicfeature
"Eve, a patient with Ehlers‑Danlos syndrome, vascular type, presented with right bundle branch block and myocardial hyperactivity, and her laboratory workup revealed a loss of appetite and a co‑infection with HIV and hepatitis B, prompting a comprehensive evaluation for potential GI bleeding and stone formation.",-43.75,0.01,diseaseorphenotypicfeature
"EHR data revealed that a patient with Ehlers‑Danlos syndrome, vascular type, who was co‑infected with HIV and hepatitis B, experienced myocardial hyperactivity and right bundle branch block during an acute myocardial infarction, while also presenting with loss of appetite and gastrointestinal bleeding that led to stone formation in the kidneys.",-36.0,0.01,diseaseorphenotypicfeature
"Gene expression profiling of a HeLa cell line infected with HIV-1 and hepatitis B virus revealed that the viral proteins upregulate the cellular gene TP53, which in turn induces a loss of appetite and contributes to the development of right bundle branch block in patients with Ehlers‑Danlos syndrome, vascular type.",-33.5,0.01,diseaseorphenotypicfeature
Gene‑editing of the COL3A1 variant c.1525G>A in vascular‑type Ehlers‑Danlos Syndrome patients reduces myocardial hyperactivity and prevents right bundle branch block while improving appetite in those co‑infected with HIV and hepatitis B.,-32.75,0.01,diseaseorphenotypicfeature
"Gene mutations in COL3A1 that cause Ehlers‑Danlos syndrome, vascular type, are associated with myocardial hyperactivity and a predisposition to right bundle branch block, which can precipitate sudden cardiac death in patients who also present with GI bleeding and stone formation.",-34.25,0.01,diseaseorphenotypicfeature
"Gene knockout of the FH gene in HeLa cells induces fumarate hydratase deficiency, leading to metabolic reprogramming that promotes myocardial hyperactivity and predisposes the cells to right bundle branch block-like electrophysiological abnormalities.",-30.75,0.01,diseaseorphenotypicfeature
"Mitochondrial DNA depletion in patients with congenital nuclear lactescent cataract and right bundle branch block is exacerbated by loss of appetite, leading to increased myocardial hyperactivity and a higher risk of AMI/GI complications.",-25.375,0.01,diseaseorphenotypicfeature
"Molecular analysis of a patient with Ehlers‑Danlos syndrome, vascular type, revealed a novel COL3A1 sequence variant (c.1234G>A) that correlates with the observed right bundle branch block and increased susceptibility to GI bleeding.",-27.75,0.01,diseaseorphenotypicfeature
"M2‑cell‑derived cardiomyocytes exposed to the AMI‑inducing agent doxorubicin exhibit myocardial hyperactivity and a right bundle branch block phenotype, while co‑infection with HIV and hepatitis B further exacerbates GI bleeding and stone formation.",-41.75,0.01,diseaseorphenotypicfeature
"Mild myocardial hyperactivity observed in patients with Ehlers‑Danlos syndrome, vascular type, is frequently accompanied by right bundle branch block and GI bleeding, suggesting a shared connective‑tissue defect that predisposes to both cardiac conduction abnormalities and gastrointestinal vascular fragility.",-27.75,0.01,diseaseorphenotypicfeature
"Amiloride treatment in patients with Ehlers‑Danlos syndrome, vascular type, reduces myocardial hyperactivity and prevents right bundle branch block while also lowering the risk of GI bleeding and stone formation.",-26.25,0.01,diseaseorphenotypicfeature
"Amelioration of myocardial hyperactivity in patients with Ehlers‑Danlos syndrome, vascular type, was observed after administration of the novel small‑molecule inhibitor, a chemical entity that selectively blocks the aberrant TRPV4 channel activity.",-32.5,0.01,diseaseorphenotypicfeature
Amniotic fluid from a fetus with congenital nuclear lactescent cataract and right bundle branch block revealed a novel BRCA1 c.68_69delAG sequence variant that may underlie the observed myocardial hyperactivity and GI bleeding in the co‑infected HIV‑Hepatitis B mother.,-30.0,0.01,diseaseorphenotypicfeature
"Amiodarone-induced myocardial hyperactivity in a patient with Ehlers‑Danlos syndrome, vascular type, precipitated a right bundle branch block and subsequent acute myocardial infarction, prompting urgent coronary angiography that revealed a coronary artery thrombus and a concomitant gastrointestinal bleed from a duodenal ulcer.",-34.25,0.01,diseaseorphenotypicfeature
"The LQTS-associated KCNQ1 c.1234G>A variant, identified in a patient with prolonged QT interval, was found to impair channel trafficking in HeLa cells, thereby exacerbating the arrhythmic phenotype.",-32.25,0.01,diseaseorphenotypicfeature
"The TP53 mutation c.215C>G in the A549 cell line, which is derived from a patient with adenocarcinoma, induces a hypokalemic periodic paralysis phenotype by dysregulating the KCNJ2 channel.",-28.625,0.01,diseaseorphenotypicfeature
"The BRCA1 c.68_69delAG variant, frequently observed in patients with hereditary breast and ovarian cancer, is associated with an increased risk of developing adenocarcinoma of the breast and, in some cases, contributes to the pathogenesis of hepatosteatosis in carriers who also exhibit a hypokalemic periodic paralysis phenotype.",-36.0,0.01,diseaseorphenotypicfeature
"The hepatosteatosis observed in patients with GCD type I is exacerbated by the hypokalemic periodic paralysis episodes that frequently accompany the disease, leading to accelerated progression toward cirrhosis.",-18.625,0.01,diseaseorphenotypicfeature
"In patients with LQTS, the presence of a KCNQ1 c.1234G>A sequence variant markedly increases the risk of ventricular arrhythmias, especially when combined with hypokalemic periodic paralysis due to a SCN4A mutation.",-27.875,0.01,diseaseorphenotypicfeature
"In a cohort of patients with hepatosteatosis, the presence of a BRCA1 c.68_69delAG sequence variant was associated with an increased risk of developing adenocarcinoma of the liver, while a concurrent mutation in the DMD gene was linked to a higher incidence of Becker dystrophy and hypokalemic periodic paralysis.",-29.125,0.01,diseaseorphenotypicfeature
"In hepatosteatosis patients, the loss-of-function variant BRCA1 c.68_69delAG in the TP53 gene exacerbates liver injury, accelerating progression to cirrhosis and increasing susceptibility to hepatocellular adenocarcinoma.",-20.75,0.01,diseaseorphenotypicfeature
"In **Homo sapiens** patients with **LQTS**, the **KCNQ1** gene variant **c.1234G>A** is associated with a higher risk of **hypokalemic periodic paralysis** and **adrenocortical adenocarcinoma**.",-36.0,0.01,diseaseorphenotypicfeature
"Hepatosteatosis in patients with ALI is exacerbated by the loss-of-function mutation in the GCD type I gene, which also predisposes to cirrhosis and hypokalemic periodic paralysis.",-19.375,0.01,diseaseorphenotypicfeature
"Homozygous loss-of-function mutations in the DMD gene cause Becker and Duchenne dystrophies, while compound heterozygous variants in the SCN4A gene are associated with hypokalemic periodic paralysis, and the same SCN4A mutation can also predispose to malignant hyperthermia during anesthesia.",-30.5,0.01,diseaseorphenotypicfeature
"Heterozygous carriers of the GCD type I mutation in the dystrophin gene exhibit a milder form of Becker dystrophy, whereas homozygous mutations lead to the more severe Duchenne phenotype, and recent studies show that the same variant can also predispose to hypokalemic periodic paralysis in a subset of patients.",-31.5,0.01,diseaseorphenotypicfeature
"Hematologic malignancies such as adenocarcinoma of the lung and gliomas frequently exhibit TP53 mutations, and the presence of a BRCA1 c.68_69delAG sequence variant in the same tumor correlates with a poorer response to doxorubicin therapy.",-37.25,0.01,diseaseorphenotypicfeature
"LQTS, a disorder of cardiac repolarization, is frequently exacerbated by hypokalemic periodic paralysis episodes, and its progression to atrial fibrillation has been documented in patients with Becker and Duchenne dystrophies who also develop hepatosteatosis and cirrhosis.",-32.5,0.01,diseaseorphenotypicfeature
"LQT1, a subtype of long‑QT syndrome, is frequently caused by a missense mutation in the KCNQ1 gene, and patients carrying the p.R231C variant exhibit a markedly prolonged QT interval, increased risk of torsades de pointes, and a higher incidence of sudden cardiac death compared with carriers of the p.A341V allele.",-44.75,0.01,diseaseorphenotypicfeature
Lactate dehydrogenase elevation in patients with hepatosteatosis and cirrhosis is associated with increased risk of developing hepatocellular adenocarcinoma.,-21.25,0.01,diseaseorphenotypicfeature
"Latter‑day studies show that the BRCA1 c.68_69delAG variant in a patient with adenocarcinoma of the breast is associated with a higher risk of developing hepatosteatosis and, in some cases, progression to cirrhosis.",-39.5,0.01,diseaseorphenotypicfeature
"Progressive hepatosteatosis in patients with GCD type I is exacerbated by the loss-of-function mutation in the ATP7B gene, leading to cirrhosis and increased risk of hepatocellular adenocarcinoma.",-26.25,0.01,diseaseorphenotypicfeature
"Progression of hepatosteatosis in patients with GCD type I is accelerated by the loss-of-function mutation in the PNPLA3 gene, which is associated with increased risk of cirrhosis and hepatocellular carcinoma.",-31.75,0.01,diseaseorphenotypicfeature
"Progressively worsening hepatosteatosis in a patient with GCD type I was found to be exacerbated by a BRCA1 c.68_69delAG variant, leading to increased susceptibility to adenocarcinoma of the liver.",-33.75,0.01,diseaseorphenotypicfeature
"Progressing from mild hepatosteatosis to cirrhosis, the patient’s liver injury was exacerbated by a BRCA1 c.68_69delAG variant that also predisposes to adenocarcinoma.",-36.0,0.01,diseaseorphenotypicfeature
"Knock‑in of the BRCA1 c.68_69delAG variant in HeLa cells exacerbates doxorubicin‑induced hepatosteatosis, a phenotype also observed in patients with GCD type I who develop liver injury and cirrhosis.",-23.875,0.01,diseaseorphenotypicfeature
"Knocking out the SCN5A gene in a mouse model of long‑QT syndrome (LQTS) exacerbates hypokalemic periodic paralysis symptoms and accelerates the development of hepatosteatosis, mirroring the liver injury observed in patients with GCD type I.",-30.75,0.01,diseaseorphenotypicfeature
"Knudson’s two‑hit hypothesis explains why TP53 mutations in hepatocellular carcinoma often co‑occur with a BRCA1 c.68_69delAG variant, thereby accelerating hepatosteatosis and cirrhosis in patients with underlying hepatitis C infection.",-37.5,0.01,diseaseorphenotypicfeature
"Knast et al. demonstrated that the BRCA1 c.68_69delAG SequenceVariant in the TP53 GeneOrGeneProduct exacerbates hepatosteatosis in HepG2 CellLine cells, thereby increasing the risk of developing adenocarcinoma in Homo sapiens OrganismTaxon subjects with a history of liver injury.",-45.0,0.01,diseaseorphenotypicfeature
"Patients with LQTS who carry the SCN5A c.4003C>T variant exhibit a markedly increased risk of sudden cardiac death, especially when combined with hypokalemic periodic paralysis due to KCNJ2 mutations.",-27.375,0.01,diseaseorphenotypicfeature
"Patients treated with doxorubicin for adenocarcinoma of the lung exhibited a marked increase in hepatosteatosis, which was further exacerbated by the presence of a BRCA1 c.68_69delAG sequence variant.",-25.75,0.01,diseaseorphenotypicfeature
"Patients receiving doxorubicin for adenocarcinoma of the lung exhibited transient hypokalemic periodic paralysis, which was exacerbated by the concomitant use of the CYP3A4 inhibitor ketoconazole, leading to a rapid decline in serum potassium and the development of left ventricular dysfunction.",-38.75,0.01,diseaseorphenotypicfeature
"Patients undergoing treatment with doxorubicin for adenocarcinoma of the lung frequently develop hepatosteatosis, which is exacerbated by the presence of a BRCA1 c.68_69delAG sequence variant that impairs DNA repair pathways.",-29.625,0.01,diseaseorphenotypicfeature
"A gain‑of‑function mutation in the SCN5A gene, identified in a patient with long‑QT syndrome, was shown to increase the late sodium current in cardiomyocytes derived from induced pluripotent stem cells, thereby exacerbating the arrhythmic phenotype.",-27.25,0.01,diseaseorphenotypicfeature
"A patient with LQTS carrying a pathogenic SCN5A variant exhibited prolonged QT intervals and experienced a sudden cardiac arrest during a hypokalemic periodic paralysis episode, prompting initiation of beta‑blocker therapy and genetic counseling for family members.",-27.25,0.01,diseaseorphenotypicfeature
"A mutation in the SCN5A gene (c.4003C>T) is associated with long‑QT syndrome (LQTS) and predisposes patients to ventricular arrhythmias, while a concurrent loss‑of‑function variant in the DMD gene (p.R4530X) contributes to Becker muscular dystrophy, and the same SCN5A alteration has been reported to exacerbate hypokalemic periodic paralysis in individuals with GCD type I.",-51.0,0.01,diseaseorphenotypicfeature
"A transgenic A549 cell line harboring the BRCA1 c.68_69delAG variant shows increased sensitivity to doxorubicin, suggesting a potential therapeutic strategy for patients with hepatosteatosis and ALI.",-23.875,0.01,diseaseorphenotypicfeature
"Sustained activation of the TP53 pathway in A549 cells treated with doxorubicin induces a hypokalemic periodic paralysis‑like phenotype, mirroring the clinical presentation of LQTS in patients with GCD type I mutations.",-29.375,0.01,diseaseorphenotypicfeature
"SARS‑CoV‑2 infection in a patient with a BRCA1 c.68_69delAG variant and a history of hepatosteatosis precipitated acute liver injury, prompting initiation of a doxorubicin‑based chemotherapy regimen for the newly diagnosed adenocarcinoma.",-29.0,0.01,diseaseorphenotypicfeature
"Sodium‑glucose cotransporter‑2 inhibition in patients with type‑2 diabetes and non‑alcoholic fatty liver disease reduces hepatic steatosis and improves insulin sensitivity, thereby lowering the risk of progression to cirrhosis.",-28.125,0.01,diseaseorphenotypicfeature
"SNP rs123456 in the promoter of the KCNQ1 gene, which encodes the cardiac potassium channel subunit, has been associated with long‑QT syndrome (LQTS) and is frequently observed in patients who develop hypokalemic periodic paralysis during episodes of severe hypokalemia.",-35.5,0.01,diseaseorphenotypicfeature
"Treatment of hepatosteatosis with the PPARγ agonist pioglitazone reduced liver injury markers and improved insulin sensitivity in a cohort of patients with non‑alcoholic fatty liver disease, while a concurrent mutation in the GCD type I gene was associated with a higher risk of developing cirrhosis.",-40.0,0.01,diseaseorphenotypicfeature
"Treatment with the selective PPAR‑γ agonist pioglitazone ameliorated hepatic steatosis and reduced serum alanine aminotransferase levels in a murine model of non‑alcoholic fatty liver disease, while concomitant administration of the KCNQ1 channel blocker E-4031 induced a transient prolongation of the QT interval, mimicking the electrophysiological phenotype of long‑QT syndrome.",-47.0,0.01,diseaseorphenotypicfeature
"Treatment‑induced hepatosteatosis in A549 cells exposed to doxorubicin correlates with up‑regulation of the TP53‑dependent apoptotic pathway and exacerbates liver injury markers such as alanine aminotransferase, suggesting a mechanistic link between chemotherapy‑driven hepatic dysfunction and tumor‑cell apoptosis.",-47.75,0.01,diseaseorphenotypicfeature
"Treatment resistance in hepatocellular carcinoma patients harboring the TP53 R249S sequence variant is exacerbated by chronic ethanol exposure, leading to accelerated cirrhosis and increased risk of hepatosteatosis.",-37.0,0.01,diseaseorphenotypicfeature
"Treated with doxorubicin, the A549 cell line exhibited increased expression of TP53 and a reduction in hepatosteatosis markers, suggesting a potential therapeutic avenue for adenocarcinoma patients with concurrent liver injury.",-28.625,0.01,diseaseorphenotypicfeature
"Tetracycline treatment of a patient with GCD type I exacerbated hypokalemic periodic paralysis, leading to severe muscle weakness and requiring urgent potassium supplementation.",-27.5,0.01,diseaseorphenotypicfeature
"Twelve patients with LQTS carrying the SCN5A c.3379G>A variant exhibited prolonged QT intervals and a higher incidence of ventricular arrhythmias, while a subset also developed hypokalemic periodic paralysis due to concurrent KCNJ2 mutations.",-36.75,0.01,diseaseorphenotypicfeature
"Torsades de pointes, a hallmark of long‑QT syndrome, is exacerbated in patients with hypokalemic periodic paralysis who receive high‑dose potassium chloride, leading to sudden cardiac arrest.",-28.75,0.01,diseaseorphenotypicfeature
"Loss of the dystrophin gene in Becker and Duchenne dystrophies leads to progressive muscle weakness and cardiomyopathy, while a GCD type I mutation in the same locus is associated with early-onset hepatosteatosis and cirrhosis.",-29.0,0.01,diseaseorphenotypicfeature
"Loss-of-function mutations in the SCN5A gene cause long‑QT syndrome, which predisposes patients to ventricular arrhythmias and sudden cardiac death.",-17.5,0.01,diseaseorphenotypicfeature
"Loss‑of‑function mutations in the DMD gene cause Becker and Duchenne dystrophies, while a novel missense variant in the SCN4A gene (c.1234G>A) is associated with hypokalemic periodic paralysis.",-28.125,0.01,diseaseorphenotypicfeature
"Loss in the KCNQ1 gene, a SequenceVariant associated with LQTS, leads to prolonged QT intervals and increases the risk of sudden cardiac death in patients with the disease.",-34.75,0.01,diseaseorphenotypicfeature
"TRPM4 overexpression in hepatosteatosis‑associated ALI exacerbates liver injury by promoting inflammatory cytokine release and hepatocyte apoptosis, thereby accelerating progression to cirrhosis.",-30.25,0.01,diseaseorphenotypicfeature
"TRF2 overexpression in A549 cells exacerbates doxorubicin‑induced DNA damage, leading to increased TP53‑mediated apoptosis and a higher incidence of hepatosteatosis in the resulting xenograft tumors.",-31.0,0.01,diseaseorphenotypicfeature
"TRPV1 activation in A549 cells exacerbates hepatosteatosis by upregulating CYP2E1, thereby increasing oxidative stress and contributing to the progression of ALI in a hypokalemic periodic paralysis model.",-29.125,0.01,diseaseorphenotypicfeature
"TRPC6 mutations in patients with GCD type I cause a loss of channel function that leads to impaired calcium signaling, resulting in hepatosteatosis and cirrhosis.",-35.75,0.01,diseaseorphenotypicfeature
"Altering the expression of the SCN5A gene in a patient with LQTS type‑1 leads to a prolonged QT interval and increases the risk of torsades de pointes, whereas a missense mutation in the DMD gene causes Becker muscular dystrophy with progressive muscle weakness and cardiomyopathy.",-41.75,0.01,diseaseorphenotypicfeature
"Alkaline phosphatase elevation in patients with hepatosteatosis and cirrhosis is often accompanied by a rise in serum alanine aminotransferase, indicating liver injury.",-27.625,0.01,diseaseorphenotypicfeature
"Alzheimer’s disease, a neurodegenerative disorder characterized by progressive cognitive decline, is exacerbated by the presence of the APOE ε4 allele, which promotes amyloid‑β aggregation and tau hyperphosphorylation, leading to synaptic dysfunction and neuronal loss.",-28.125,0.01,diseaseorphenotypicfeature
"Aliskiren treatment in patients with hepatosteatosis and cirrhosis was associated with a significant reduction in serum alanine aminotransferase levels, suggesting a protective effect against acute liver injury.",-25.25,0.01,diseaseorphenotypicfeature
Maternal inheritance of a pathogenic BRCA1 c.68_69delAG variant is associated with an increased risk of early‑onset ovarian cancer and a higher incidence of breast‑carcinoma‑associated retinal dystrophy in affected offspring.,-25.5,0.01,diseaseorphenotypicfeature
"Materno‑fetal retinal disease, characterized by progressive retinal dystrophy and visual impairment, has been linked to a novel autosomal dominant mutation in the PAX6 gene, which also predisposes affected families to oligodontia and mild skin fragility.",-40.75,0.01,diseaseorphenotypicfeature
"Maternally inherited retinal disease, characterized by progressive photoreceptor degeneration, has been linked to a novel autosomal dominant mutation in the RPGR gene, which also predisposes carriers to early-onset schizophrenia-like symptoms and episodic vomiting.",-36.5,0.01,diseaseorphenotypicfeature
"Matermatally inherited retinal disease, often presenting with progressive vision loss and retinal dystrophy, has been linked to a novel autosomal dominant mutation in the RPGR gene that disrupts photoreceptor outer segment maintenance.",-41.0,0.01,diseaseorphenotypicfeature
"In a cohort of patients with maternal‑influenced retinal disease, the presence of a novel BRCA1 c.68_69delAG sequence variant was associated with an increased risk of developing squamous‑ and small‑cell lung cancers, suggesting a potential autosomal dominant muscle disorder‑like pathogenic mechanism.",-24.875,0.01,diseaseorphenotypicfeature
"In patients with maternal‑influenced retinal disease, the presence of a de novo TP53 sequence variant exacerbates the risk of developing squamous‑cell lung cancers, while the same variant is also associated with an autosomal dominant muscle disorder that manifests as progressive weakness and occasional vomiting.",-37.25,0.01,diseaseorphenotypicfeature
"In female patients with maternal‑inherited retinal disease, the presence of a novel BRCA1 c.68_69delAG sequence variant correlates with an increased risk of developing squamous‑cell lung cancers, suggesting a shared pathogenic pathway involving TP53‑mediated DNA repair defects.",-33.25,0.01,diseaseorphenotypicfeature
"In one family, a maternal autosomal dominant mutation in the COL7A1 gene (SequenceVariant c.1523G>A) was found to cause skin fragility and a severe form of epidermolysis bullosa, while the same variant was also associated with a mild retinal dystrophy in the proband’s offspring.",-46.0,0.01,diseaseorphenotypicfeature
"A maternal autosomal dominant muscle disorder characterized by progressive weakness and elevated creatine kinase levels has been linked to a novel missense mutation in the DMD gene, which also predisposes carriers to retinal dystrophy and, in some cases, schizophreniform disorder.",-27.25,0.01,diseaseorphenotypicfeature
"A TD‑induced vomiting episode in a patient with an autosomal dominant muscle disorder was found to exacerbate retinal disease progression, suggesting a shared pathogenic pathway involving the same genetic mutation.",-27.625,0.01,diseaseorphenotypicfeature
"A mutation in the COL7A1 gene causes autosomal dominant skin fragility, which in affected families is frequently accompanied by a maternal history of early‑onset retinal disease and occasional episodes of vomiting.",-31.875,0.01,diseaseorphenotypicfeature
A maternally inherited retinal disease caused by a BRCA1 c.68_69delAG variant leads to progressive photoreceptor degeneration and is frequently associated with early-onset schizophrenia-like symptoms.,-20.375,0.01,diseaseorphenotypicfeature
"The maternal carrier of a pathogenic BRCA1 c.68_69delAG variant exhibits a higher risk of developing early‑onset breast cancer, yet her offspring with the same sequence variant display variable penetrance, ranging from asymptomatic to severe ovarian insufficiency.",-32.75,0.01,diseaseorphenotypicfeature
"The family history of maternal retinal disease and oligodontia, coupled with the autosomal dominant muscle disorder phenotype, prompted genetic testing that revealed a pathogenic SequenceVariant in the MYH7 gene, which is known to cause both cardiomyopathy and skeletal myopathy.",-29.0,0.01,diseaseorphenotypicfeature
"The maternally inherited retinal disease, characterized by progressive photoreceptor degeneration and night‑vision loss, is frequently associated with a novel autosomal dominant mutation in the RPGR gene that also predisposes carriers to early‑onset schizophrenia‑like psychosis.",-26.5,0.01,diseaseorphenotypicfeature
"The autosomal dominant muscle disorder caused by a missense SequenceVariant in the DMD gene leads to progressive muscle weakness and cardiomyopathy, while the same mutation also predisposes affected individuals to retinal disease and, in some cases, schizophreniform disorder.",-27.875,0.01,diseaseorphenotypicfeature
"Mutations in the COL7A1 gene cause autosomal dominant skin fragility, and the same variant has been identified in a family with maternal inheritance of a retinal disease that progresses to early-onset visual loss.",-31.125,0.01,diseaseorphenotypicfeature
"Mutational analysis of the COL7A1 gene in a family with autosomal dominant skin fragility revealed a novel c.1523G>A (p.Gly508Arg) variant that segregates with the blistering phenotype and is predicted to disrupt the triple‑helix domain, thereby providing a mechanistic link between the genotype and the observed dermal pathology.",-38.25,0.01,diseaseorphenotypicfeature
Mutant TP53 c.215C>G in a maternal autosomal dominant muscle disorder patient with retinal disease and schizophreniform disorder exacerbated by TD‑induced vomiting.,-25.5,0.01,diseaseorphenotypicfeature
"Mutagenic exposure to cyclophosphamide in a maternal mouse model induces vomiting and retinal disease, while the same treatment exacerbates a schizophrenia‑like phenotype in offspring carrying an autosomal dominant mutation in the COL7A1 gene.",-35.5,0.01,diseaseorphenotypicfeature
"This maternal autosomal dominant muscle disorder, characterized by progressive weakness and early onset of vomiting, has been linked to a novel sequence variant in the DMD gene that exacerbates retinal disease in affected families.",-30.625,0.01,diseaseorphenotypicfeature
"This study demonstrates that a maternal autosomal dominant mutation in the COL7A1 gene, which encodes type VII collagen, leads to a severe skin fragility phenotype and predisposes affected individuals to squamous‑cell lung cancers, while also increasing the risk of retinal disease and oligodontia.",-39.0,0.01,diseaseorphenotypicfeature
This mother‑carried autosomal dominant retinal disease mutation in the RPGR gene was associated with early‑onset retinal dystrophy and progressive vision loss in her children.,-32.75,0.01,diseaseorphenotypicfeature
"This maternally inherited retinal disease, characterized by progressive photoreceptor degeneration and night‑vision loss, is caused by a heterozygous missense mutation in the RPGR gene (c.1204C>T, p.Arg402Trp) that disrupts the protein’s coiled‑coil domain and leads to autosomal dominant cone‑rod dystrophy.",-44.0,0.01,diseaseorphenotypicfeature
"We found that a maternal autosomal dominant mutation in the COL7A1 gene, causing skin fragility, is associated with a higher risk of developing squamous‑cell lung cancers in offspring who also exhibit oligodontia and a history of vomiting.",-33.0,0.01,diseaseorphenotypicfeature
We observed that maternal retinal disease in a family with autosomal dominant muscle disorder is associated with a novel BRCA1 c.68_69delAG sequence variant that predisposes to squamous‑ and small‑cell lung cancers.,-25.625,0.01,diseaseorphenotypicfeature
"We report that a maternally inherited autosomal dominant mutation in the COL7A1 gene, identified in a patient with skin fragility and ocular involvement, is associated with a severe retinal dystrophy that progresses to early-onset blindness.",-34.75,0.01,diseaseorphenotypicfeature
"We identified a maternal autosomal dominant muscle disorder that presents with early-onset vomiting, retinal disease, and a high risk of developing squamous‑cell lung cancers.",-25.0,0.01,diseaseorphenotypicfeature
"RAP1B overexpression in a HeLa cell line carrying the BRCA1 c.68_69delAG variant exacerbates DNA damage response defects, thereby increasing susceptibility to squamous‑cell lung cancer in patients with a history of maternal retinal disease and oligodontia.",-42.5,0.01,diseaseorphenotypicfeature
Raising maternal serum levels of the chemokine CXCL10 during pregnancy is associated with an increased risk of retinal disease in offspring carrying the autosomal dominant mutation in the RPE65 gene.,-34.0,0.01,diseaseorphenotypicfeature
"Rett syndrome, an X‑linked neurodevelopmental disorder, is frequently associated with maternal inheritance patterns and manifests as severe intellectual disability, autistic features, and episodic vomiting, while its autosomal dominant counterpart, myotonic dystrophy, presents with progressive muscle weakness and retinal dystrophy.",-42.5,0.01,diseaseorphenotypicfeature
"Ragged‑red fibers and progressive muscle weakness in a patient with a maternally inherited, autosomal‑dominant mutation in the mitochondrial tRNA^Leu(UUR) gene (m.3243A>G) are hallmarks of a mitochondrial myopathy that can also manifest as retinal dystrophy and vomiting during metabolic crises.",-46.5,0.01,diseaseorphenotypicfeature
"Reduced retinal degeneration in maternal carriers of the autosomal dominant RHO mutation was mitigated by early administration of the chemical entity brimonidine, improving visual acuity in patients with retinitis pigmentosa.",-29.875,0.01,diseaseorphenotypicfeature
"Reduced maternal vitamin D deficiency during pregnancy is associated with an increased risk of offspring developing retinal disease and schizophrenia-like phenotypes, suggesting a shared genetic predisposition involving the CYP27B1 gene.",-30.25,0.01,diseaseorphenotypicfeature
Reduced cognitive decline in maternal schizophrenia patients carrying the BRCA1 c.68_69delAG variant is associated with increased retinal disease severity and a higher incidence of vomiting during pregnancy.,-31.875,0.01,diseaseorphenotypicfeature
Reduced prenatal exposure to maternal ethanol during the first trimester is associated with an increased risk of congenital retinal disease and subsequent visual impairment in offspring.,-26.875,0.01,diseaseorphenotypicfeature
"Heterozygous carriers of the autosomal dominant mutation in the COL7A1 gene exhibit a spectrum of skin fragility and, in some cases, a mild retinal disease that predisposes them to progressive visual loss.",-31.625,0.01,diseaseorphenotypicfeature
Homozygous loss of the COL7A1 gene in a maternal pedigree causes autosomal dominant skin fragility and is associated with a severe form of epidermolysis bullosa that predisposes to squamous‑cell skin cancers.,-32.75,0.01,diseaseorphenotypicfeature
"HIV‑positive mothers carrying the BRCA1 c.68_69delAG variant exhibit a higher incidence of retinal disease in their offspring, suggesting a maternal‑influenced, autosomal dominant muscle disorder that predisposes to both ocular and skeletal phenotypes.",-41.75,0.01,diseaseorphenotypicfeature
HGF overexpression in HeLa cells carrying the TP53 c.215C>G variant accelerates the progression of squamous‑cell lung cancers while simultaneously exacerbating retinal disease symptoms in patients with the autosomal dominant muscle disorder.,-38.75,0.01,diseaseorphenotypicfeature
Autopsy of a maternal case with retinal disease revealed a novel BRCA1 c.68_69delAG variant that may contribute to the autosomal dominant muscle disorder phenotype.,-22.0,0.01,diseaseorphenotypicfeature
"Autosomal dominant muscle disorder patients often exhibit maternal inheritance patterns, and in some families the mutation in the DMD gene leads to both severe cardiomyopathy and early-onset retinal disease.",-29.375,0.01,diseaseorphenotypicfeature
Autistic‑like developmental delay and severe vomiting in a mother carrying an autosomal dominant mutation in the COL7A1 gene are associated with a novel retinal disease phenotype.,-33.5,0.01,diseaseorphenotypicfeature
"Autism spectrum disorder, a complex neurodevelopmental phenotype, has been linked to a de novo missense mutation in the SHANK3 gene, which encodes a postsynaptic scaffold protein, and this mutation is predicted to disrupt synaptic signaling pathways involved in neuronal connectivity.",-36.75,0.01,diseaseorphenotypicfeature
"Mutation of the COL7A1 gene in a maternal autosomal dominant skin fragility syndrome leads to a severe blistering phenotype that predisposes affected individuals to recurrent retinal disease and, in some cases, to early-onset squamous‑cell lung cancers.",-32.25,0.01,diseaseorphenotypicfeature
"Mutation in the COL7A1 gene causes autosomal dominant skin fragility, which in affected patients often presents with blistering and a high risk of squamous‑cell carcinoma.",-28.5,0.01,diseaseorphenotypicfeature
"Mutation p.Gly12Asp in KRAS, detected in a HeLa-derived xenograft, accelerates tumor growth in squamous‑cell lung cancers while simultaneously inducing a retinal disease phenotype in the offspring of a homozygous E. coli‑derived transgenic mouse model.",-49.5,0.01,diseaseorphenotypicfeature
"Mutation‑carrying A549 cells treated with doxorubicin exhibit increased apoptosis and a marked reduction in TP53‑mediated transcription, suggesting that the BRCA1 c.68_69delAG variant may sensitize lung cancer to DNA‑damaging chemotherapy.",-34.5,0.01,diseaseorphenotypicfeature
"Loss of the maternal allele of the DMD gene causes an X‑linked recessive muscular dystrophy that presents with early‑onset cardiomyopathy, skeletal muscle weakness, and a characteristic pattern of elevated serum creatine kinase.",-27.125,0.01,diseaseorphenotypicfeature
"Loss‑of‑function mutations in the COL7A1 gene cause autosomal recessive epidermolysis bullosa dystrophica, a skin‑fragility disorder that predisposes patients to blistering and chronic ulceration.",-26.75,0.01,diseaseorphenotypicfeature
Lossy retinal degeneration in maternal carriers of the autosomal dominant RPGR mutation is associated with early-onset visual impairment and progressive retinal dystrophy.,-34.25,0.01,diseaseorphenotypicfeature
"Loss-of-function mutations in the maternal‑inherited gene *COL7A1* cause autosomal dominant skin fragility, which is frequently accompanied by a retinal disease that manifests as progressive photoreceptor degeneration.",-36.75,0.01,diseaseorphenotypicfeature
TD‑induced vomiting in a patient with an autosomal dominant muscle disorder is associated with a retinal disease that can progress to schizophreniform disorder.,-22.75,0.01,diseaseorphenotypicfeature
"TD-induced vomiting in a patient with an autosomal dominant muscle disorder was alleviated by a single dose of doxorubicin, which also reduced the severity of the associated retinal disease.",-26.125,0.01,diseaseorphenotypicfeature
TD‐induced vomiting in a patient with an autosomal dominant muscle disorder is exacerbated by the retinal disease associated with the maternal inheritance of the pathogenic variant.,-28.25,0.01,diseaseorphenotypicfeature
"TD–induced vomiting in a patient with an autosomal dominant muscle disorder was alleviated by a single dose of doxorubicin, which also reduced the severity of the associated retinal disease.",-31.5,0.01,diseaseorphenotypicfeature
"Cyanosis, a hallmark of severe hypoxemia, often accompanies Takotsubo syndrome and can precipitate bilateral papilledema, while renal lesions and thrombotic microangiopathy further exacerbate cognitive dysfunction in affected patients.",-20.0,0.01,diseaseorphenotypicfeature
"Cognitive dysfunction in patients with Takotsubo syndrome is frequently accompanied by bilateral papilledema and thrombotic microangiopathy, suggesting a shared vascular‑neuroinflammatory pathway.",-15.6875,0.01,diseaseorphenotypicfeature
"Cerebral cyanosis, bilateral papilledema, and thrombotic microangiopathy were observed in a patient with Takotsubo syndrome, suggesting a severe vascular complication of the disease.",-24.375,0.01,diseaseorphenotypicfeature
"Cytokine‑induced activation of the TP53 pathway in HeLa cells exposed to doxorubicin exacerbates memory impairment and promotes bilateral papilledema, a phenotype frequently observed in patients with Takotsubo syndrome and thrombotic microangiopathy.",-27.25,0.01,diseaseorphenotypicfeature
The sudden onset of bilateral papilledema in a patient with a history of thoracic aortic aneurysm and thrombotic microangiopathy suggests a severe underlying vascular dysregulation that may precipitate Takotsubo syndrome and cognitive dysfunction.,-18.75,0.01,diseaseorphenotypicfeature
"The occurrence of bilateral papilledema in patients with thoracic aortic aneurysm is associated with a higher risk of thrombotic microangiopathy, which can exacerbate cognitive dysfunction and memory loss.",-17.25,0.01,diseaseorphenotypicfeature
"The patient with Takotsubo syndrome exhibited transient left ventricular apical ballooning, bilateral papilledema, and a mild cognitive dysfunction that resolved after supportive therapy.",-17.625,0.01,diseaseorphenotypicfeature
The presence of bilateral papilledema in patients with thoracic aortic aneurysm correlates with a higher risk of thrombotic microangiopathy and cognitive dysfunction.,-10.0,0.01,diseaseorphenotypicfeature
"Bilateral papilledema in patients with thoracic aortic aneurysm is frequently accompanied by thrombotic microangiopathy, leading to cognitive dysfunction and memory impairment.",-13.6875,0.01,diseaseorphenotypicfeature
"Biallelic loss-of-function variants in the NOTCH3 gene cause a form of thoracic aortic aneurysm that is frequently accompanied by bilateral papilledema, cognitive dysfunction, and thrombotic microangiopathy.",-25.0,0.01,diseaseorphenotypicfeature
"B-lymphocyte activation in patients with Takotsubo syndrome and bilateral papilledema is associated with a pronounced increase in thrombotic microangiopathy markers, suggesting a shared endothelial dysfunction underlying both retinal and cardiac manifestations.",-31.0,0.01,diseaseorphenotypicfeature
Bendamustine treatment of a patient with Takotsubo syndrome and bilateral papilledema induced a transient thrombotic microangiopathy that was mitigated by early plasma exchange.,-28.75,0.01,diseaseorphenotypicfeature
"Skeletal muscle biopsies from patients with Takotsubo syndrome revealed a striking up‑regulation of the HIF‑1α pathway, correlating with the observed cyanosis and cognitive dysfunction during the acute phase.",-27.625,0.01,diseaseorphenotypicfeature
"Serrated lesions of the renal cortex in patients with thrombotic microangiopathy were associated with a marked decline in memory and the development of bilateral papilledema, suggesting a systemic vascular component underlying the observed cognitive dysfunction.",-35.25,0.01,diseaseorphenotypicfeature
"SARS‑CoV‑2 infection can trigger Takotsubo syndrome, leading to transient left‑ventricular dysfunction and subsequent cognitive dysfunction in patients with pre‑existing hyperinsulinemic‑euglycemic states.",-18.5,0.01,diseaseorphenotypicfeature
"Sildenafil administration in a cohort of patients with Takotsubo syndrome and concurrent bilateral papilledema was associated with a significant reduction in retinal vascular leakage, suggesting a protective effect on retinal microcirculation.",-27.75,0.01,diseaseorphenotypicfeature
"Takotsubo syndrome, characterized by transient left ventricular dysfunction and often accompanied by bilateral papilledema, can precipitate thrombotic microangiopathy in patients with underlying renal lesions, thereby exacerbating cognitive dysfunction.",-14.75,0.01,diseaseorphenotypicfeature
"Takatsubo syndrome, characterized by transient left ventricular dysfunction and often accompanied by bilateral papilledema, has been reported to precipitate thrombotic microangiopathy in patients with underlying renal lesions, thereby exacerbating cognitive dysfunction.",-27.875,0.01,diseaseorphenotypicfeature
"Takotubo syndrome, characterized by transient left ventricular dysfunction and often accompanied by bilateral papilledema, can precipitate thrombotic microangiopathy and renal lesions, thereby exacerbating cognitive dysfunction and cyanosis in affected patients.",-30.5,0.01,diseaseorphenotypicfeature
"Takayasu arteritis, a form of thoracic aortic aneurysm, can trigger bilateral papilledema and thrombotic microangiopathy, leading to cognitive dysfunction and memory loss.",-29.75,0.01,diseaseorphenotypicfeature
"A myocardial infarction in a patient with Takotsubo syndrome triggered a cascade of cytokine release that exacerbated bilateral papilledema and led to thrombotic microangiopathy, ultimately causing cognitive dysfunction and renal lesions.",-28.625,0.01,diseaseorphenotypicfeature
"A cohort of patients with Takotsubo syndrome exhibited transient bilateral papilledema and renal lesions, while a subset developed thrombotic microangiopathy that was associated with cognitive dysfunction and memory impairment.",-21.25,0.01,diseaseorphenotypicfeature
"A patient with Takotsubo syndrome exhibited transient left ventricular dysfunction that resolved within days, yet subsequent echocardiography revealed a thoracic aortic aneurysm and bilateral papilledema, suggesting a possible underlying connective‑tissue disorder.",-23.5,0.01,diseaseorphenotypicfeature
"Aβ42 accumulation in the hippocampus of a patient with early‑onset Alzheimer’s disease correlates with memory impairment, cognitive dysfunction, and bilateral papilledema, suggesting that amyloid‑induced neuroinflammation may also contribute to retinal vascular changes and thrombotic microangiopathy.",-36.5,0.01,diseaseorphenotypicfeature
"In patients with Takotsubo syndrome, the sudden surge of catecholamines induces transient left ventricular dysfunction that can precipitate thrombotic microangiopathy, thereby exacerbating renal lesions and contributing to cognitive dysfunction.",-16.5,0.01,diseaseorphenotypicfeature
"In a cohort of patients with Takotsubo syndrome, the presence of bilateral papilledema was associated with a higher incidence of thrombotic microangiopathy and renal lesions, suggesting a shared endothelial dysfunction underlying both ocular and systemic manifestations.",-16.5,0.01,diseaseorphenotypicfeature
"In Takotsubo syndrome patients, the sudden surge of catecholamines induces myocardial stunning that is frequently accompanied by bilateral papilledema and a transient cognitive dysfunction, while the underlying hyperinsulinemic‑euglycemic state may exacerbate renal lesions and thrombotic microangiopathy.",-25.5,0.01,diseaseorphenotypicfeature
"In an autopsy of a patient with Takotsubo syndrome, the presence of bilateral papilledema and renal lesions suggested a systemic thrombotic microangiopathy that may have contributed to the observed cognitive dysfunction.",-22.375,0.01,diseaseorphenotypicfeature
"Patients with Takotsubo syndrome frequently develop bilateral papilledema and renal lesions, and the presence of thrombotic microangiopathy correlates with severe cognitive dysfunction.",-14.5625,0.01,diseaseorphenotypicfeature
"Patients presenting with Takotsubo syndrome often exhibit transient left ventricular dysfunction that resolves within days, yet a subset develops thrombotic microangiopathy, leading to renal lesions and bilateral papilledema, while cognitive dysfunction and memory impairment may persist long after recovery.",-29.0,0.01,diseaseorphenotypicfeature
"Patients harboring the BRCA1 c.68_69delAG variant exhibit a markedly increased risk of bilateral papilledema and thrombotic microangiopathy, which in turn can precipitate cognitive dysfunction and memory loss.",-27.625,0.01,diseaseorphenotypicfeature
"Patients undergoing a hyperinsulinemic-euglycemic clamp exhibited transient cognitive dysfunction, while those with bilateral papilledema displayed a higher incidence of thrombotic microangiopathy.",-28.875,0.01,diseaseorphenotypicfeature
"Chronic cyanosis in patients with Takotsubo syndrome is associated with bilateral papilledema, renal lesions, and thrombotic microangiopathy, which together exacerbate cognitive dysfunction.",-18.375,0.01,diseaseorphenotypicfeature
"Cholesterol‑laden atherosclerotic plaques in the thoracic aortic aneurysm of a patient with Takotsubo syndrome trigger thrombotic microangiopathy, leading to bilateral papilledema and progressive cognitive dysfunction.",-29.75,0.01,diseaseorphenotypicfeature
"Challenging the hypothesis that Takotsubo syndrome is purely stress‑induced, we found that patients with bilateral papilledema and concurrent thrombotic microangiopathy exhibited markedly impaired memory and cognitive dysfunction, suggesting a shared endothelial‑mediated pathophysiology.",-40.25,0.01,diseaseorphenotypicfeature
"Choroidal neovascularization in patients with retinitis pigmentosa is frequently accompanied by bilateral papilledema, suggesting a shared vascular dysregulation that may contribute to the observed cognitive dysfunction.",-33.25,0.01,diseaseorphenotypicfeature
Investigations revealed that the BRCA1 c.68_69delAG variant in a patient with bilateral papilledema and cognitive dysfunction was associated with a markedly increased risk of thrombotic microangiopathy following chemotherapy with doxorubicin.,-23.875,0.01,diseaseorphenotypicfeature
Investigators found that the BRCA1 c.68_69delAG variant in a patient with bilateral papilledema and thoracic aortic aneurysm was associated with a severe cognitive dysfunction phenotype.,-24.75,0.01,diseaseorphenotypicfeature
"Investigative imaging of a patient with bilateral papilledema revealed retinal vascular leakage and a concurrent thrombotic microangiopathy, suggesting a systemic vasculopathy that may underlie the observed cognitive dysfunction.",-27.75,0.01,diseaseorphenotypicfeature
"Investigational data revealed that the BRCA1 c.68_69delAG variant in a patient with bilateral papilledema and thoracic aortic aneurysm led to a pronounced cognitive dysfunction and memory impairment, while the concomitant hyperinsulinemic‑euglycemic clamp demonstrated a paradoxical reduction in insulin sensitivity, suggesting a complex interplay between the sequence variant, vascular pathology, and neuro‑endocrine regulation.",-52.25,0.01,diseaseorphenotypicfeature
"TNF‑α blockade in patients with Takotsubo syndrome markedly reduced the incidence of thrombotic microangiopathy and improved cognitive dysfunction, while the concomitant use of the IL‑6 inhibitor tocilizumab was associated with a transient rise in serum creatinine and bilateral papilledema in a subset of individuals with underlying renal lesions.",-39.25,0.01,diseaseorphenotypicfeature
"TNNT2 c.1123G>A, a sequence variant in the cardiac troponin T gene, was found to be associated with Takotsubo syndrome and bilateral papilledema in a cohort of patients with thoracic aortic aneurysm.",-33.0,0.01,diseaseorphenotypicfeature
TNFRSF1A mutations in a patient with Takotsubo syndrome and bilateral papilledema were found to cause a hyperinsulinemic‑euglycemic state that exacerbated cognitive dysfunction.,-29.875,0.01,diseaseorphenotypicfeature
"TN‑T cells from a patient with Takotsubo syndrome exhibited increased expression of the cytokine IL‑6, correlating with the observed bilateral papilledema and renal lesions.",-32.75,0.01,diseaseorphenotypicfeature
"Severe cyanosis in a patient with Takotsubo syndrome was accompanied by bilateral papilledema, suggesting a thrombotic microangiopathy that may underlie the observed renal lesions and cognitive dysfunction.",-19.875,0.01,diseaseorphenotypicfeature
"Severely reduced memory and cognitive dysfunction in patients with Takotsubo syndrome are frequently accompanied by bilateral papilledema and thrombotic microangiopathy, suggesting a shared vascular‑neuroinflammatory pathway.",-27.0,0.01,diseaseorphenotypicfeature
"Sepsis-induced thrombotic microangiopathy in a patient with bilateral papilledema and renal lesions was mitigated by early administration of eculizumab, which inhibited complement-mediated endothelial injury and improved cognitive dysfunction.",-30.5,0.01,diseaseorphenotypicfeature
"Septic shock in a patient with Takotsubo syndrome and bilateral papilledema was associated with thrombotic microangiopathy and renal lesions, leading to cognitive dysfunction and memory impairment.",-29.125,0.01,diseaseorphenotypicfeature
Repeated stress-induced Takotsubo syndrome in a patient with bilateral papilledema and renal lesions was associated with a transient cognitive dysfunction that resolved after administration of doxorubicin.,-34.0,0.01,diseaseorphenotypicfeature
"Repeated head trauma in a patient with a history of Takotsubo syndrome and bilateral papilledema was associated with the development of thrombotic microangiopathy, leading to acute renal lesions and progressive cognitive dysfunction.",-26.75,0.01,diseaseorphenotypicfeature
"Repeated hypoxic episodes in patients with Takotsubo syndrome trigger bilateral papilledema, which is associated with retinal ischemia and subsequent cognitive dysfunction.",-25.5,0.01,diseaseorphenotypicfeature
"Repeated chest pain and transient left ventricular dysfunction in a patient with Takotsubo syndrome were accompanied by bilateral papilledema and a mild thrombotic microangiopathy, suggesting a systemic endothelial injury that may underlie the observed cognitive dysfunction.",-33.75,0.01,diseaseorphenotypicfeature
"Mutational analysis of the TP53 gene in HeLa cells revealed that the BRCA1 c.68_69delAG variant induces a hyperinsulinemic‑euglycemic response, correlating with cognitive dysfunction and bilateral papilledema in patients with thoracic aortic aneurysm.",-24.875,0.01,diseaseorphenotypicfeature
"Mutations in the COL3A1 gene cause thoracic aortic aneurysm and bilateral papilledema, while the same variant also predisposes to thrombotic microangiopathy and cognitive dysfunction.",-19.0,0.01,diseaseorphenotypicfeature
"Mutants of the TP53 gene carrying the BRCA1 c.68_69delAG variant exhibit bilateral papilledema and thrombotic microangiopathy, while the same TP53 mutation in HeLa cells induces cognitive dysfunction and hyperinsulinemic‑euglycemic episodes.",-37.5,0.01,diseaseorphenotypicfeature
"Mutagenic exposure to doxorubicin in A549 cells induces TP53‑mediated apoptosis, which is attenuated in the presence of the BRCA1 c.68_69delAG variant, thereby exacerbating the risk of thrombotic microangiopathy in patients with underlying renal lesions.",-28.375,0.01,diseaseorphenotypicfeature
"The tumorigenesis of colorectal cancer is exacerbated by synovial inflammation, which in turn promotes a depressant‑like phenotype in patients with cirrhotic liver disease.",-20.875,0.01,diseaseorphenotypicfeature
"The onset of synovial inflammation in patients with spondyloepimetaphyseal dysplasia is frequently accompanied by nail hypoplasia, suggesting a shared pathogenic pathway that may predispose to postoperative complications such as contrast‑induced nephropathy.",-19.375,0.01,diseaseorphenotypicfeature
"The progressive nail hypoplasia observed in patients with spondyloepimetaphyseal dysplasia is exacerbated by synovial inflammation, suggesting a shared pathogenic pathway that may contribute to the development of postoperative complications in colorectal and breast cancers.",-24.375,0.01,diseaseorphenotypicfeature
"The spondyloepimetaphyseal dysplasia associated with nail hypoplasia was found to exacerbate synovial inflammation, thereby increasing the risk of postoperative complications in patients with cirrhotic liver disease.",-15.625,0.01,diseaseorphenotypicfeature
"In a cohort of cirrhotic patients, the presence of nail hypoplasia and synovial inflammation was associated with an increased risk of postoperative complications following colorectal cancer resection.",-12.4375,0.01,diseaseorphenotypicfeature
"In patients with spondyloepimetaphyseal dysplasia, the presence of nail hypoplasia correlates with increased synovial inflammation, suggesting a shared pathogenic pathway that may predispose to postoperative complications such as contrast‑induced nephropathy.",-15.0625,0.01,diseaseorphenotypicfeature
"In **spondyloepimetaphyseal dysplasia** patients, the **synovial inflammation** observed in the knee joints is frequently accompanied by **nail hypoplasia**, suggesting a shared underlying dysregulation of extracellular matrix remodeling.",-25.875,0.01,diseaseorphenotypicfeature
"In the postoperative setting, contrast‑induced nephropathy frequently exacerbates pre‑existing cirrhotic renal dysfunction, thereby increasing the risk of acute kidney injury and subsequent tumorigenesis in patients with colorectal and pancreaticobiliary cancers.",-22.625,0.01,diseaseorphenotypicfeature
"Spondyloepimetaphyseal dysplasia, characterized by progressive joint pain and nail hypoplasia, has been linked to a novel missense mutation in the COL2A1 gene, which may predispose patients to contrast‑induced nephropathy during diagnostic imaging.",-24.5,0.01,diseaseorphenotypicfeature
"Syndromic nail hypoplasia and synovial inflammation in patients with spondyloepimetaphyseal dysplasia are exacerbated by contrast‑induced nephropathy, increasing the risk of postoperative complications and tumorigenesis in colorectal and breast cancers.",-20.875,0.01,diseaseorphenotypicfeature
"SARS‑CoV‑2 infection can trigger synovial inflammation that, in patients with a BRCA1 c.68_69delAG variant, accelerates tumorigenesis in breast and colorectal cancers.",-23.875,0.01,diseaseorphenotypicfeature
"Surgical resection of a colorectal carcinoma in a patient with cirrhotic liver function precipitated contrast‑induced nephropathy, which in turn exacerbated postoperative synovial inflammation and led to nail hypoplasia as a secondary phenotypic feature.",-22.875,0.01,diseaseorphenotypicfeature
"Mutations in the COL2A1 gene cause spondyloepimetaphyseal dysplasia, which is frequently accompanied by nail hypoplasia and synovial inflammation, and recent studies show that the same variant also predisposes patients to colorectal and breast tumorigenesis.",-22.5,0.01,diseaseorphenotypicfeature
Mutational loss of the TP53 gene in HeLa cells exacerbates synovial inflammation and promotes tumorigenesis in a colorectal cancer model.,-19.5,0.01,diseaseorphenotypicfeature
"Mutated TP53 in colorectal carcinoma cells exacerbates synovial inflammation, leading to nail hypoplasia and accelerating tumorigenesis.",-19.25,0.01,diseaseorphenotypicfeature
"Mutant TP53 c.215C>G in colorectal carcinoma cells exacerbates synovial inflammation and promotes nail hypoplasia, thereby accelerating tumorigenesis and increasing the risk of postoperative complications.",-22.25,0.01,diseaseorphenotypicfeature
**Metformin treatment of patients with cirrhotic hepatocellular carcinoma carrying the TP53 c.215C>G variant reduces tumorigenesis by attenuating synovial inflammation and improving postoperative outcomes.**,-35.25,0.01,diseaseorphenotypicfeature
"**Mutation of the COL2A1 gene (c.1234G>A) in a patient with spondyloepimetaphyseal dysplasia leads to severe nail hypoplasia and predisposes to early-onset osteoarthritis, while the same variant is associated with increased risk of colorectal and pancreaticobiliary cancers.**",-39.75,0.01,diseaseorphenotypicfeature
"**Synovial inflammation in patients with spondyloepimetaphyseal dysplasia is exacerbated by nail hypoplasia, leading to a higher risk of postoperative complications such as contrast‑induced nephropathy.**",-20.25,0.01,diseaseorphenotypicfeature
"**The presence of nail hypoplasia in patients with spondyloepimetaphyseal dysplasia correlates with increased synovial inflammation, suggesting a shared pathogenic pathway that may predispose to postoperative complications in colorectal and breast cancer surgeries.**",-25.75,0.01,diseaseorphenotypicfeature
"Genome‑wide association analysis revealed that the rs1234567 variant in the IL‑23R gene is strongly associated with synovial inflammation in patients with spondyloepimetaphyseal dysplasia, suggesting a pathogenic link between this sequence variant and the disease phenotype.",-26.875,0.01,diseaseorphenotypicfeature
"Genome-wide association analysis in a cohort of patients with spondyloepimetaphyseal dysplasia revealed that the missense variant c.1123G>A in the COL2A1 gene is strongly associated with nail hypoplasia and synovial inflammation, suggesting a shared pathogenic pathway underlying these phenotypic features.",-33.0,0.01,diseaseorphenotypicfeature
"Genome‐wide association analysis revealed that the rs1234567 variant in the IL‑23R gene is strongly associated with synovial inflammation and nail hypoplasia in patients with spondyloepimetaphyseal dysplasia, suggesting a shared inflammatory pathway that may predispose to postoperative complications such as contrast‑induced nephropathy.",-32.0,0.01,diseaseorphenotypicfeature
"Genome-enriched CRISPR‑Cas9 editing of the TP53 gene in A549 cells induces a pronounced, dose‑dependent increase in apoptotic markers and a concomitant reduction in colony‑forming ability, thereby revealing a potential therapeutic avenue for colorectal and pancreaticobiliary cancers.",-58.0,0.01,diseaseorphenotypicfeature
Methotrexate‑induced nail hypoplasia in a patient with spondyloepimetaphyseal dysplasia was accompanied by synovial inflammation that mimicked a postoperative complication of colorectal cancer surgery.,-22.375,0.01,diseaseorphenotypicfeature
"Methanol exposure in a patient with cirrhotic liver disease exacerbated synovial inflammation, leading to progressive nail hypoplasia and a dystonia‑like gait disturbance.",-30.125,0.01,diseaseorphenotypicfeature
Methimazole treatment of a patient with Graves’ disease and concomitant nail hypoplasia reduced serum thyroglobulin levels while paradoxically exacerbating synovial inflammation in the knee joint.,-34.75,0.01,diseaseorphenotypicfeature
"Methoprene exposure exacerbated synovial inflammation in A549 cells, leading to increased IL‑6 secretion and accelerated tumorigenesis in a xenograft model of colorectal carcinoma.",-33.0,0.01,diseaseorphenotypicfeature
"Synovial inflammation in patients with spondyloepimetaphyseal dysplasia frequently co‑occurs with nail hypoplasia, suggesting a shared pathogenic pathway that may predispose to dystonia and postoperative complications in colorectal and breast cancer survivors.",-19.5,0.01,diseaseorphenotypicfeature
Synoviocyte‑derived IL‑6 secretion in patients with spondyloepimetaphyseal dysplasia correlates with nail hypoplasia and predicts the severity of contrast‑induced nephropathy following colorectal cancer surgery.,-27.625,0.01,diseaseorphenotypicfeature
"Synuclein‑α aggregation in the spinal cord of a patient with Dystonia‑parkinsonism exacerbates synovial inflammation, leading to nail hypoplasia and a spondyloepimetaphyseal dysplasia phenotype that predisposes to postoperative complications and contrast‑induced nephropathy.",-40.75,0.01,diseaseorphenotypicfeature
"Synaptic dysfunction in patients with spondyloepimetaphyseal dysplasia and nail hypoplasia is exacerbated by contrast‑induced nephropathy, leading to postoperative complications that mimic dystonia and depressant‑like symptoms.",-29.75,0.01,diseaseorphenotypicfeature
"Patients with spondyloepimetaphyseal dysplasia and nail hypoplasia exhibit a higher incidence of contrast‑induced nephropathy following diagnostic imaging, suggesting a disease‑specific susceptibility to postoperative complications.",-21.25,0.01,diseaseorphenotypicfeature
"Patients treated with the novel kinase inhibitor NVP‑BKM120 for metastatic colorectal carcinoma exhibited a marked reduction in synovial inflammation, yet developed nail hypoplasia as a dose‑limiting adverse effect.",-34.75,0.01,diseaseorphenotypicfeature
Patients presenting with synovial inflammation and nail hypoplasia were found to carry a BRCA1 c.68_69delAG sequence variant that predisposes to spondyloepimetaphyseal dysplasia and increases the risk of colorectal and breast tumorigenesis.,-20.625,0.01,diseaseorphenotypicfeature
"Patients receiving contrast media for abdominal imaging exhibited contrast‑induced nephropathy, a postoperative complication that can precipitate acute renal failure and worsen cirrhotic liver dysfunction.",-24.5,0.01,diseaseorphenotypicfeature
"Mutation of the COL2A1 gene in a patient with spondyloepimetaphyseal dysplasia leads to nail hypoplasia and synovial inflammation, thereby increasing the risk of postoperative complications such as contrast‑induced nephropathy.",-17.75,0.01,diseaseorphenotypicfeature
"Mutation in the COL2A1 gene causes spondyloepimetaphyseal dysplasia, which is frequently accompanied by nail hypoplasia and synovial inflammation, and patients with this variant are at increased risk of developing colorectal and breast cancers.",-26.5,0.01,diseaseorphenotypicfeature
Mutation‑induced loss of the transcription factor RUNX2 in a patient with spondyloepimetaphyseal dysplasia leads to severe nail hypoplasia and predisposes to early‑onset osteosarcoma tumorigenesis.,-28.625,0.01,diseaseorphenotypicfeature
"Mutation c.68_69delAG in the BRCA1 gene exacerbates synovial inflammation in patients with spondyloepimetaphyseal dysplasia, leading to increased risk of postoperative complications and tumorigenesis in colorectal and breast cancers.",-26.25,0.01,diseaseorphenotypicfeature
"Adenosine A2A receptor antagonism alleviates dystonia in a mouse model of Parkinson’s disease, yet the same treatment exacerbates synovial inflammation in a subset of patients with spondyloepimetaphyseal dysplasia.",-30.75,0.01,diseaseorphenotypicfeature
"A CRISPR‑mediated knockout of the *COL2A1* gene in A549 cells induces synovial‑inflammation‑like cytokine secretion, leading to nail hypoplasia‑associated phenotypes that resemble spondyloepimetaphyseal dysplasia in a murine model of tumorigenesis.",-37.0,0.01,diseaseorphenotypicfeature
"A germline missense mutation in the COL2A1 gene (c.1234G>A) causes spondyloepimetaphyseal dysplasia with nail hypoplasia, and patients with this variant frequently develop contrast‑induced nephropathy after diagnostic imaging.",-31.25,0.01,diseaseorphenotypicfeature
"A BRCA1 c.68_69delAG variant in a patient with colorectal cancer predisposes to tumorigenesis, yet the same mutation also contributes to synovial inflammation and nail hypoplasia, illustrating a pleiotropic disease phenotype.",-25.875,0.01,diseaseorphenotypicfeature
"Nail hypoplasia in patients with spondyloepimetaphyseal dysplasia is frequently accompanied by synovial inflammation, which may predispose to postoperative complications such as contrast‑induced nephropathy.",-15.4375,0.01,diseaseorphenotypicfeature
"Niraparib treatment in a patient with BRCA1 c.68_69delAG-associated ovarian carcinoma induced synovial inflammation and nail hypoplasia, suggesting a potential link between tumorigenesis and these phenotypic features.",-29.5,0.01,diseaseorphenotypicfeature
"Nervous system dystonia, a severe movement disorder, often develops as a postoperative complication in patients with cirrhotic liver disease who have undergone colorectal cancer resection, and its pathogenesis is linked to synovial inflammation and nail hypoplasia in a subset of individuals carrying the Spondyloepimetaphyseal dysplasia‑associated SequenceVariant.",-42.5,0.01,diseaseorphenotypicfeature
"NIK3C2 mutations in patients with spondyloepimetaphyseal dysplasia lead to nail hypoplasia and synovial inflammation, thereby increasing the risk of postoperative complications such as contrast‑induced nephropathy.",-26.625,0.01,diseaseorphenotypicfeature
"Genetic analysis of a patient with spondyloepimetaphyseal dysplasia revealed a novel TP53 sequence variant (c.215C>T) that likely contributes to the observed nail hypoplasia and synovial inflammation, underscoring its role in tumorigenesis and postoperative complications.",-25.625,0.01,diseaseorphenotypicfeature
Genomic analysis of a patient with spondyloepimetaphyseal dysplasia revealed a novel TP53 SequenceVariant (c.215C>T) that likely contributes to the observed nail hypoplasia and predisposes to tumorigenesis in colorectal and breast cancers.,-24.75,0.01,diseaseorphenotypicfeature
Genotypic analysis of a patient with spondyloepimetaphyseal dysplasia revealed a novel TP53 SequenceVariant (c.215G>A) that correlates with the observed nail hypoplasia and predisposes to colorectal tumorigenesis.,-29.0,0.01,diseaseorphenotypicfeature
"Genetically engineered A549 cells overexpressing the TP53 variant c.215C>G exhibit pronounced synovial inflammation and nail hypoplasia, suggesting a potential link between this sequence variant and spondyloepimetaphyseal dysplasia in colorectal cancer patients.",-31.0,0.01,diseaseorphenotypicfeature
"Hepatocellular carcinoma patients receiving sorafenib exhibit contrast‑induced nephropathy, which is exacerbated by underlying cirrhotic liver disease and may trigger postoperative complications such as Dystonia and tumorigenesis.",-28.75,0.01,diseaseorphenotypicfeature
"Heterozygous loss-of-function mutations in the COL2A1 gene cause spondyloepimetaphyseal dysplasia, which is frequently accompanied by nail hypoplasia and synovial inflammation, and recent studies suggest that these phenotypic features may predispose patients to contrast‑induced nephropathy during postoperative imaging procedures.",-30.0,0.01,diseaseorphenotypicfeature
HLA‑B27‑positive patients with spondyloepimetaphyseal dysplasia exhibit pronounced synovial inflammation that predisposes them to postoperative complications such as contrast‑induced nephropathy following diagnostic imaging.,-21.75,0.01,diseaseorphenotypicfeature
"Homozygous loss of the *TNFAIP3* gene in a patient with spondyloepimetaphyseal dysplasia leads to unchecked NF‑κB signaling, causing severe synovial inflammation and nail hypoplasia that mimic a depressant‑like phenotype.",-33.5,0.01,diseaseorphenotypicfeature
"In HLA‑DRB1*04:01‑positive patients with cIII‑defective mitochondrial DNA, the presence of a BRCA1 c.68_69delAG variant correlates with an increased risk of fatty liver and musculoskeletal pain, while the same mutation also predisposes to benign breast tumors and heterotopic ossification.",-35.5,0.01,diseaseorphenotypicfeature
"In patients with atrioventricular block, the administration of the chemical entity rivaroxaban has been shown to reduce the risk of subsequent kidney damage while simultaneously alleviating musculoskeletal pain associated with the disease.",-20.875,0.01,diseaseorphenotypicfeature
"In a cohort of patients with atrioventricular block, the presence of a cIII‑defective mutation in the SCN5A gene was associated with an increased risk of developing fatty liver and musculoskeletal pain, suggesting a shared pathogenic pathway linking cardiac conduction abnormalities to metabolic and skeletal disorders.",-21.625,0.01,diseaseorphenotypicfeature
"In the cohort of patients with atrioventricular block, the presence of a cIII‑defective mutation in the SCN5A gene was associated with an increased risk of developing fatty liver and musculoskeletal pain, suggesting a shared pathogenic pathway linking cardiac conduction abnormalities to metabolic and skeletal manifestations.",-25.125,0.01,diseaseorphenotypicfeature
"The heterotopic ossification observed in patients with cIII‑defective mitochondrial disease frequently progresses to severe musculoskeletal pain, prompting clinicians to consider early intervention with bisphosphonate therapy to mitigate bone remodeling and prevent further kidney damage.",-28.25,0.01,diseaseorphenotypicfeature
"The cIII‑defective mutation in the mitochondrial cytochrome c oxidase complex is associated with severe atrioventricular block, progressive fatty liver, and heterotopic ossification in patients with inherited mitochondrial disease.",-23.125,0.01,diseaseorphenotypicfeature
The presence of a cIII‑defective mutation in the mitochondrial complex I subunit NDUFS4 is associated with severe cardiomyopathy and atrioventricular block in patients who also exhibit fatty liver and musculoskeletal pain.,-22.875,0.01,diseaseorphenotypicfeature
"The microtia observed in the patient with cIII‑defective hemoglobinopathy is associated with an increased risk of allergic diseases, which may exacerbate musculoskeletal pain and contribute to the development of benign breast tumors.",-25.0,0.01,diseaseorphenotypicfeature
A retrospective cohort study revealed that patients with cIII‑defective mitochondrial disease who also presented with fatty liver exhibited a higher incidence of atrioventricular block compared with those without hepatic involvement.,-21.25,0.01,diseaseorphenotypicfeature
A novel cIII‑defective mutation in the mitochondrial ATP synthase gene was found to cause severe atrioventricular block and progressive fatty liver in a patient with heterotopic ossification and musculoskeletal pain.,-24.25,0.01,diseaseorphenotypicfeature
"A polymorphism in the SCN5A gene (c.4003C>T) is associated with atrioventricular block in patients with idiopathic fatty liver disease, suggesting a shared pathogenic pathway involving ion channel dysfunction and hepatic steatosis.",-28.625,0.01,diseaseorphenotypicfeature
"A1‑CYP2D6 polymorphism in a patient with fatty liver disease exacerbates the hepatotoxicity of doxorubicin, leading to accelerated liver injury and increased risk of hepatocellular carcinoma.",-28.75,0.01,diseaseorphenotypicfeature
"Experimental investigation revealed that the cIII‑defective mutation in the mitochondrial complex III gene exacerbates fatty liver progression in a mouse model of atrioventricular block, while concomitant administration of the chemical entity resveratrol mitigated liver steatosis and reduced markers of kidney damage.",-40.0,0.01,diseaseorphenotypicfeature
Experimental cardiology data revealed that patients with atrioventricular block carrying the c.1234G>A variant in the SCN5A gene exhibited a higher incidence of fatty liver and musculoskeletal pain compared with matched controls.,-35.25,0.01,diseaseorphenotypicfeature
Experimental data show that the cIII‑defective mutation in the mitochondrial complex III gene leads to atrioventricular block and fatty liver in patients with heterotopic ossification.,-25.125,0.01,diseaseorphenotypicfeature
Experimental evaluation of a novel cIII‑defective mitochondrial complex I inhibitor revealed that it induces atrioventricular block in a dose‑dependent manner while simultaneously ameliorating fatty liver pathology in a murine model of metabolic syndrome.,-30.75,0.01,diseaseorphenotypicfeature
"Microtia, a congenital ear malformation, is frequently associated with heterotopic ossification of the temporomandibular joint, leading to musculoskeletal pain and impaired mastication.",-16.75,0.01,diseaseorphenotypicfeature
Microvascular dysfunction in patients with fatty liver disease exacerbates atrioventricular block by impairing coronary perfusion and increasing arrhythmogenic substrate.,-22.75,0.01,diseaseorphenotypicfeature
"MicroRNA‑155 overexpression in A549 cells exacerbates fatty liver disease by down‑regulating the PPARα pathway, thereby increasing triglyceride accumulation and hepatic inflammation.",-27.75,0.01,diseaseorphenotypicfeature
"Microcardia, a rare form of atrioventricular block, has been linked to a cIII‑defective mutation in the SCN5A gene, causing conduction delay and increasing the risk of sudden cardiac arrest in patients with fatty liver disease.",-36.25,0.01,diseaseorphenotypicfeature
"Roux‑en‑Y gastric bypass in patients with fatty liver and osteoarthritis reduces liver enzyme levels and improves musculoskeletal pain, while the cIII‑defective mitochondrial variant in the MT‑ND1 gene is associated with a higher risk of atrioventricular block.",-36.5,0.01,diseaseorphenotypicfeature
"Raviolo‑treated A549 cells expressing the TP53 c.68_69delAG variant exhibited a pronounced reduction in fatty liver‑associated steatosis markers, suggesting that the sequence variant mitigates hepatic lipid accumulation in this cell line.",-39.0,0.01,diseaseorphenotypicfeature
"Rats treated with the cIII‑defective compound exhibited atrioventricular block and mild fatty liver, while a subset developed heterotopic ossification that mimicked osteoarthritis‑related musculoskeletal pain.",-30.75,0.01,diseaseorphenotypicfeature
Rising levels of the inflammatory cytokine IL‑6 in patients with fatty liver disease correlate with the severity of hepatic fibrosis and predict the development of hepatocellular carcinoma.,-25.875,0.01,diseaseorphenotypicfeature
"Mutations in the cIII‑defective complex of the mitochondrial respiratory chain are associated with fatty liver disease, atrioventricular block, and heterotopic ossification in patients with chronic kidney damage.",-19.75,0.01,diseaseorphenotypicfeature
Mutagenic exposure to benzene in A549 cells induces a cIII‑defective phenotype that correlates with increased fatty liver markers and a higher incidence of benign breast tumors in exposed patients.,-26.75,0.01,diseaseorphenotypicfeature
"Mutational analysis of the c.68_69delAG variant in the BRCA1 gene revealed that patients with this SequenceVariant exhibit a higher incidence of benign breast tumors and an increased risk of fatty liver disease, suggesting a pathogenic link between the GeneOrGeneProduct alteration and these DiseaseOrPhenotypicFeature manifestations.",-31.5,0.01,diseaseorphenotypicfeature
"Mutated TP53 c.215C>G in a HeLa-derived cell line exacerbates fatty liver phenotypes in a HepG2 model, suggesting a direct link between the sequence variant and hepatic steatosis.",-34.25,0.01,diseaseorphenotypicfeature
"Polycystic ovary syndrome, characterized by hyperandrogenism and insulin resistance, predisposes patients to fatty liver disease, which in turn exacerbates musculoskeletal pain and increases the risk of osteoarthritis.",-26.625,0.01,diseaseorphenotypicfeature
Polymorphisms in the cIII‑defective mitochondrial complex I gene are associated with increased risk of fatty liver and musculoskeletal pain in patients with atrioventricular block.,-20.0,0.01,diseaseorphenotypicfeature
Polymyxin B exposure in *E. coli* K-12 strains carrying the *cIII-defective* mutation exacerbates kidney damage and induces a mild atrioventricular block in a dose‑dependent manner.,-33.25,0.01,diseaseorphenotypicfeature
"Polysaccharide‑derived hyaluronic acid injections in patients with osteoarthritis of the knee reduced pain scores and improved joint function, while concomitant use of the selective COX‑2 inhibitor celecoxib mitigated the risk of gastrointestinal ulceration.",-43.25,0.01,diseaseorphenotypicfeature
"C‑III‑defective patients with atrioventricular block often exhibit concomitant fatty liver and musculoskeletal pain, suggesting a systemic metabolic‑cardiac link.",-21.875,0.01,diseaseorphenotypicfeature
Cytokine‑induced up‑regulation of the HLA‑DRB1 allele in patients with cIII‑defective microtia correlates with an increased risk of allergic diseases and benign breast tumors.,-27.625,0.01,diseaseorphenotypicfeature
"Celiac disease, a chronic autoimmune enteropathy, is frequently associated with microtia and other craniofacial anomalies, and its inflammatory milieu can exacerbate osteoarthritis and fatty liver disease in affected patients.",-35.75,0.01,diseaseorphenotypicfeature
"Coxsackievirus B3 infection in a patient with a cIII‑defective mutation of the mitochondrial ATPase gene precipitated atrioventricular block, microtia, and fatty liver, while the same viral strain induced heterotopic ossification and musculoskeletal pain in a second individual carrying a benign breast tumor‑associated BRCA1 variant.",-43.5,0.01,diseaseorphenotypicfeature
"Patients with atrioventricular block and fatty liver disease often exhibit elevated serum troponin levels, suggesting concurrent myocardial injury.",-17.625,0.01,diseaseorphenotypicfeature
"Patients receiving the cIII‑defective variant of the mitochondrial complex I gene exhibit a higher incidence of fatty liver and musculoskeletal pain, suggesting a metabolic link between the sequence variant and these phenotypic features.",-29.375,0.01,diseaseorphenotypicfeature
"Patients who develop atrioventricular block after receiving the cIII‑defective mitochondrial inhibitor exhibit a higher incidence of fatty liver and musculoskeletal pain, suggesting a systemic metabolic‑cardiac link.",-28.875,0.01,diseaseorphenotypicfeature
Patients treated with the cIII‑defective inhibitor showed a significant reduction in atrioventricular block severity while simultaneously experiencing an unexpected increase in fatty liver markers.,-25.625,0.01,diseaseorphenotypicfeature
Sequencing of the TP53 gene in a cohort of patients with idiopathic atrioventricular block revealed a novel c.215G>A (p.R72H) sequence variant that correlates with increased susceptibility to fatty liver disease and musculoskeletal pain.,-27.875,0.01,diseaseorphenotypicfeature
Sequenced analysis of a patient with atrioventricular block revealed a novel BRCA1 c.68_69delAG variant that may contribute to the observed cardiac conduction defect.,-23.875,0.01,diseaseorphenotypicfeature
"Sequoxal, a novel small‑molecule inhibitor, was shown to reduce the severity of atrioventricular block in a cohort of patients with cIII‑defective mitochondrial myopathy, while also improving hepatic steatosis and alleviating musculoskeletal pain.",-47.25,0.01,diseaseorphenotypicfeature
"Sequencer‑guided CRISPR‑Cas9 editing of the TP53 c.215C>T variant in A549 cells revealed that the resulting p.R72P protein destabilizes the p53 tetramer, thereby exacerbating the microtia‑associated osteoarthritis phenotype observed in patients with the cIII‑defective allele.",-46.75,0.01,diseaseorphenotypicfeature
Inflammatory cytokine IL‑6 upregulation in patients with fatty liver disease exacerbates osteoarthritis progression by promoting cartilage catabolism and synovial inflammation.,-23.625,0.01,diseaseorphenotypicfeature
Infliximab treatment of patients with cIII‑defective inflammatory bowel disease has been shown to reduce the incidence of atrioventricular block while simultaneously improving fatty liver scores and decreasing musculoskeletal pain.,-27.75,0.01,diseaseorphenotypicfeature
"Influenza‑induced cytokine storms exacerbate atrioventricular block in patients with pre‑existing fatty liver, leading to increased risk of sudden cardiac arrest.",-26.25,0.01,diseaseorphenotypicfeature
"Inflammasome activation in the liver of patients with fatty liver disease exacerbates hepatocyte apoptosis, thereby accelerating the progression of hepatic fibrosis and increasing the risk of cirrhosis.",-28.25,0.01,diseaseorphenotypicfeature
"Heterotopic ossification in patients with cIII‑defective mitochondrial disease frequently progresses to severe musculoskeletal pain and can exacerbate underlying osteoarthritis, thereby increasing the risk of atrioventricular block and kidney damage.",-22.5,0.01,diseaseorphenotypicfeature
"Hepatic steatosis in patients with fatty liver disease is exacerbated by the cIII‑defective mutation in the mitochondrial complex III gene, leading to increased reactive oxygen species that trigger inflammatory signaling and accelerate the progression of osteoarthritis in the affected joints.",-29.625,0.01,diseaseorphenotypicfeature
"Homozygous c.68_69delAG in the BRCA1 gene predisposes patients to fatty liver disease, which in turn exacerbates musculoskeletal pain and increases the risk of heterotopic ossification in individuals with osteoarthritis.",-27.375,0.01,diseaseorphenotypicfeature
"HIV‑positive patients with a BRCA1 c.68_69delAG variant exhibit a higher incidence of benign breast tumors, yet the same mutation does not appear to increase the risk of osteoarthritis or fatty liver disease.",-29.125,0.01,diseaseorphenotypicfeature
"Excessive exposure to the chemical entity dioxin in a cohort of A549 cell lines was found to induce a sequence variant in the CYP1A1 gene, which in turn exacerbated fatty liver disease and contributed to the development of musculoskeletal pain in the surrounding tissue.",-38.75,0.01,diseaseorphenotypicfeature
"Exogenous administration of the small‑molecule inhibitor cIII‑defective to A549 cells exacerbated fatty liver‑associated gene expression changes, thereby increasing the risk of atrioventricular block in patients with underlying musculoskeletal pain.",-37.5,0.01,diseaseorphenotypicfeature
"Examination of a cohort of patients with atrioventricular block revealed that those carrying the c.1234G>A variant in the SCN5A gene exhibited a higher incidence of fatty liver and musculoskeletal pain, suggesting a shared pathogenic pathway linking cardiac conduction defects to metabolic and skeletal manifestations.",-34.75,0.01,diseaseorphenotypicfeature
"Ex vivo CRISPR‑Cas9 editing of the TP53 gene in A549 cells carrying the BRCA1 c.68_69delAG variant revealed that the resulting p53‑deficient clones exhibited increased susceptibility to doxorubicin‑induced fatty liver‑like lipid accumulation, mirroring the metabolic phenotype observed in patients with osteoarthritis‑associated microtia and heterotopic ossification.",-39.25,0.01,diseaseorphenotypicfeature
"In diabetic nephropathy, the loss of podocin encoded by the NPHS2 gene, particularly the R138Q sequence variant, exacerbates neuronal dysfunction and joint pain, while patients with Long QT syndrome often exhibit QTc prolongation that can precipitate sudden infant death with dysgenesis of the testes syndrome.",-23.375,0.01,diseaseorphenotypicfeature
"In a cohort of HBV‑ and HIV‑co‑infected patients, the presence of the BRCA1 c.68_69delAG sequence variant was associated with a markedly increased risk of developing diabetic nephropathy and a higher incidence of QTc prolongation, suggesting a shared pathogenic pathway involving neuronal dysfunction and joint pain.",-24.375,0.01,diseaseorphenotypicfeature
"In patients with diabetic nephropathy, the up‑regulation of the TRPC6 gene product in podocytes exacerbates neuronal dysfunction and contributes to the progression of long‑QT syndrome, thereby increasing the risk of sudden infant death with dysgenesis of the testes syndrome.",-20.375,0.01,diseaseorphenotypicfeature
"In the HBV and HIV co‑infected cohort, the presence of the BRCA1 c.68_69delAG variant was associated with a higher incidence of diabetic nephropathy and QTc prolongation, suggesting a link between this sequence variant and both renal and cardiac phenotypes.",-21.75,0.01,diseaseorphenotypicfeature
Gene therapy using AAV‑mediated delivery of a CRISPR‑Cas9 construct targeting the KCNQ1 promoter in human induced pluripotent stem cell‑derived cardiomyocytes from a Long QT syndrome patient reduces QTc prolongation and restores normal action‑potential duration.,-27.625,0.01,diseaseorphenotypicfeature
Gene editing of the KCNQ1 c.1234G>A variant in human induced pluripotent stem cell–derived cardiomyocytes from a Long QT syndrome patient restores normal QTc prolongation and prevents arrhythmic neuronal dysfunction.,-28.5,0.01,diseaseorphenotypicfeature
Gene expression profiling of renal biopsy samples from patients with diabetic nephropathy revealed that the up‑regulation of the pro‑inflammatory cytokine IL‑6 correlates with the severity of tubulointerstitial fibrosis and predicts progression to end‑stage kidney disease.,-25.0,0.01,diseaseorphenotypicfeature
"Gene‑editing of the KCNQ1 variant c.1234G>A in a patient with Long QT syndrome type‑1 markedly shortened the QTc interval, improving cardiac repolarization and reducing the risk of sudden cardiac death.",-32.75,0.01,diseaseorphenotypicfeature
"A longitudinal cohort of HBV‑ and HIV‑co‑infected patients revealed that the presence of the CYP2B6*6 SequenceVariant markedly increased the risk of developing diabetic nephropathy, while concomitant upregulation of the IL‑6 GeneOrGeneProduct was associated with neuronal dysfunction and QTc prolongation.",-33.5,0.01,diseaseorphenotypicfeature
"A transgenic A549 cell line overexpressing the mutant KCNH2 gene (c.1234G>A) exhibits prolonged action potentials and QTc prolongation, mirroring the electrophysiological phenotype observed in patients with Long QT syndrome.",-31.375,0.01,diseaseorphenotypicfeature
"Aβ42 accumulation in the hippocampus of Alzheimer’s disease patients exacerbates neuronal dysfunction, leading to cognitive decline and increased risk of sudden infant death with dysgenesis of the testes syndrome in genetically susceptible individuals.",-21.5,0.01,diseaseorphenotypicfeature
"A genome‑wide association study revealed that the rs1801133 variant in MTHFR, a SequenceVariant, is strongly associated with QTc prolongation, a DiseaseOrPhenotypicFeature, in patients with Long QT syndrome, a DiseaseOrPhenotypicFeature, who also carry the CYP2C9*3 allele, a GeneOrGeneProduct, affecting warfarin metabolism.",-33.75,0.01,diseaseorphenotypicfeature
"Diabetic nephropathy in patients with long‑term insulin therapy is frequently accompanied by QTc prolongation, which may exacerbate neuronal dysfunction and increase the risk of sudden cardiac death.",-17.25,0.01,diseaseorphenotypicfeature
"Diabetes mellitus type‑2 patients with the BRCA1 c.68_69delAG variant exhibit accelerated progression to diabetic nephropathy, likely due to enhanced oxidative stress and impaired podocyte repair mechanisms.",-30.5,0.01,diseaseorphenotypicfeature
"Diurnal QTc prolongation in patients with long‑QT syndrome is exacerbated by the use of the anti‑arrhythmic drug dofetilide, which binds to the HERG potassium channel encoded by the KCNH2 gene, thereby increasing the risk of torsades de pointes.",-32.75,0.01,diseaseorphenotypicfeature
"Diabetics with diabetic nephropathy exhibit increased urinary albumin excretion, and in a subset of patients carrying the APOL1 G1 variant, this proteinuria is exacerbated by chronic HBV and HIV co‑infection, leading to accelerated progression to end‑stage renal disease.",-37.25,0.01,diseaseorphenotypicfeature
"The combination of a BRCA1 c.68_69delAG sequence variant and a TP53 mutation in a HeLa cell line derived from a patient with diabetic nephropathy accelerates the development of neuronal dysfunction and joint pain, while also increasing susceptibility to Long QT syndrome and QTc prolongation.",-32.75,0.01,diseaseorphenotypicfeature
"The chronic inflammation observed in diabetic nephropathy is exacerbated by the up‑regulation of the pro‑inflammatory cytokine IL‑6, which in turn promotes podocyte apoptosis and accelerates the progression of renal fibrosis.",-21.375,0.01,diseaseorphenotypicfeature
"The BRCA1 c.68_69delAG variant in a female patient with diabetic nephropathy and QTc prolongation was found to increase the risk of neuronal dysfunction and joint pain, suggesting a shared pathogenic pathway with Long QT syndrome.",-24.125,0.01,diseaseorphenotypicfeature
"The combined presence of a BRCA1 c.68_69delAG variant and chronic HBV infection in a Homo sapiens patient exacerbates the risk of developing diabetic nephropathy, as the mutation impairs DNA repair pathways while viral proteins downregulate nephrin expression, leading to progressive glomerular sclerosis.",-33.75,0.01,diseaseorphenotypicfeature
"Patients with diabetic nephropathy exhibit increased urinary albumin excretion, which correlates with the severity of neuronal dysfunction and the risk of sudden infant death with dysgenesis of the testes syndrome.",-19.125,0.01,diseaseorphenotypicfeature
"Patients treated with the novel kinase inhibitor A-12345 for diabetic nephropathy exhibited a significant reduction in proteinuria, while a subset of those with concomitant Long QT syndrome experienced transient QTc prolongation that resolved after dose adjustment.",-33.25,0.01,diseaseorphenotypicfeature
"Patients recovered from HBV and HIV co‑infection exhibited a marked reduction in QTc prolongation, suggesting that antiviral therapy may mitigate the risk of Long QT syndrome in this high‑risk population.",-30.0,0.01,diseaseorphenotypicfeature
"Patients experiencing diabetic nephropathy often exhibit increased urinary albumin excretion, which correlates with progressive loss of glomerular filtration rate and heightened risk of cardiovascular complications.",-22.375,0.01,diseaseorphenotypicfeature
"Alzheimer’s disease, a neurodegenerative disorder characterized by neuronal dysfunction and cognitive decline, has been linked to the APOE ε4 allele, which also increases the risk of long QT syndrome and QTc prolongation in patients with concomitant mental disorders.",-27.625,0.01,diseaseorphenotypicfeature
"Alveolar macrophages from a patient with diabetic nephropathy and co‑infected HBV/HIV exhibit increased expression of the pro‑inflammatory cytokine IL‑6, which correlates with the severity of pulmonary fibrosis and the development of QTc prolongation.",-30.625,0.01,diseaseorphenotypicfeature
"Altering the expression of the KCNQ1 gene in a human induced pluripotent stem cell-derived cardiomyocyte model of Long QT syndrome markedly prolonged the QTc interval, recapitulating the neuronal dysfunction and sudden infant death with dysgenesis of the testes syndrome observed in patients with the same sequence variant.",-31.0,0.01,diseaseorphenotypicfeature
"Alfalfa‑derived ethanolamine, when administered to A549 cells, exacerbates the QTc prolongation observed in patients with Long QT syndrome, thereby increasing the risk of sudden infant death with dysgenesis of the testes syndrome.",-30.25,0.01,diseaseorphenotypicfeature
"Doxorubicin treatment of HeLa cells exacerbates TP53‑mediated apoptosis, thereby accelerating the progression of diabetic nephropathy in a mouse model of HBV‑HIV co‑infection.",-20.375,0.01,diseaseorphenotypicfeature
Dysregulation of the KCNQ1 gene variant c.1234G>A in patients with Long QT syndrome leads to QTc prolongation and increases the risk of sudden cardiac death.,-21.5,0.01,diseaseorphenotypicfeature
"Dexamethasone treatment of patients with diabetic nephropathy and concomitant Long QT syndrome exacerbated QTc prolongation, leading to increased risk of ventricular arrhythmias.",-20.25,0.01,diseaseorphenotypicfeature
"Dopaminergic dysfunction in patients with paranoid schizophrenia is exacerbated by the QTc prolongation associated with antipsychotic therapy, increasing the risk of sudden cardiac death.",-19.5,0.01,diseaseorphenotypicfeature
"Hypertension and QTc prolongation in patients with diabetic nephropathy are exacerbated by the CYP2D6*4 allele, which reduces metabolism of the beta‑blocker metoprolol and increases the risk of neuronal dysfunction and sudden infant death with dysgenesis of the testes syndrome.",-30.0,0.01,diseaseorphenotypicfeature
"Hypertrophic cardiomyopathy in a patient with Long QT syndrome type‑2, caused by a KCNH2 c.3163G>A variant, is exacerbated by the QTc‑prolonging antipsychotic clozapine, leading to sudden cardiac arrest.",-41.25,0.01,diseaseorphenotypicfeature
"Hyponatremia in patients with diabetic nephropathy and concomitant HBV/HIV co‑infection is exacerbated by the QTc prolongation induced by the antiretroviral drug abacavir, leading to increased risk of sudden cardiac death.",-31.625,0.01,diseaseorphenotypicfeature
"Hypermethylation of the TP53 promoter in A549 cells treated with doxorubicin exacerbates diabetic nephropathy‑associated oxidative stress, leading to neuronal dysfunction and QTc prolongation in HBV‑HIV co‑infected patients.",-29.75,0.01,diseaseorphenotypicfeature
Herceptin treatment of HER2‑positive breast cancer in a patient with BRCA1 c.68_69delAG sequence variant was associated with accelerated progression to diabetic nephropathy and QTc prolongation.,-29.0,0.01,diseaseorphenotypicfeature
"Hereditary Long QT syndrome, caused by a pathogenic SCN5A SequenceVariant, predisposes patients to sudden cardiac arrest and is frequently accompanied by QTc prolongation, which can be exacerbated by certain ChemicalEntity drugs such as quinidine.",-29.375,0.01,diseaseorphenotypicfeature
"Heritability analysis of the QTc prolongation phenotype in a cohort of HBV‑ and HIV‑co‑infected patients revealed that the SCN5A c.4003C>T variant, previously linked to Long QT syndrome, is significantly enriched in individuals who also exhibit sudden infant death with dysgenesis of the testes syndrome.",-44.25,0.01,diseaseorphenotypicfeature
"Heroku‑derived A549 cells treated with the small‑molecule inhibitor doxorubicin exhibited a dose‑dependent increase in TP53‑mediated apoptosis, which was markedly attenuated in the presence of the BRCA1 c.68_69delAG variant, suggesting a potential therapeutic vulnerability in patients with diabetic nephropathy and concomitant Long QT syndrome.",-51.25,0.01,diseaseorphenotypicfeature
"Paroxysmal atrial fibrillation in patients with Long QT syndrome is exacerbated by the QTc prolongation induced by the anti‑epileptic drug carbamazepine, leading to increased risk of sudden cardiac death.",-18.75,0.01,diseaseorphenotypicfeature
"Parental carriers of the SCN5A c.4003C>T variant, which causes a gain‑of‑function in the cardiac sodium channel, exhibit a markedly increased risk of Long QT syndrome and sudden infant death with dysgenesis of the testes syndrome, underscoring the pathogenic link between this sequence variant and severe cardiac arrhythmia.",-42.0,0.01,diseaseorphenotypicfeature
"Paroxetine treatment in patients with paranoid schizophrenia and concomitant QTc prolongation was associated with a significant reduction in neuronal dysfunction markers, suggesting a potential therapeutic benefit for mitigating long‑QT syndrome risk.",-34.25,0.01,diseaseorphenotypicfeature
Paraneoplastic cerebellar degeneration in a patient with HBV and HIV co‑infection was associated with a novel TP53 sequence variant (c.215C>T) that exacerbated neuronal dysfunction and precipitated sudden infant death with dysgenesis of the testes syndrome.,-30.625,0.01,diseaseorphenotypicfeature
"High‑dose metformin ameliorates QTc prolongation in patients with diabetic nephropathy, thereby reducing the risk of sudden cardiac death.",-17.875,0.01,diseaseorphenotypicfeature
"High levels of oxidative stress in diabetic nephropathy patients carrying the APOL1 G1 allele accelerate podocyte injury, leading to proteinuria and progressive renal failure.",-28.5,0.01,diseaseorphenotypicfeature
"High‐dose metformin ameliorates QTc prolongation in patients with diabetic nephropathy, thereby reducing the risk of sudden cardiac death.",-22.0,0.01,diseaseorphenotypicfeature
"High-dose metformin ameliorates QTc prolongation in patients with diabetic nephropathy, thereby reducing the risk of sudden cardiac death.",-21.375,0.01,diseaseorphenotypicfeature
"STZ‑induced diabetic nephropathy in C57BL/6J mice is exacerbated by the BRCA1 c.68_69delAG variant, which impairs DNA repair and accelerates glomerular sclerosis.",-23.125,0.01,diseaseorphenotypicfeature
STUDYING the impact of a novel TP53 c.215G>A variant on diabetic nephropathy progression in a cohort of Homo sapiens patients revealed that carriers exhibited accelerated glomerular filtration decline and increased urinary albumin excretion compared with non‑carriers.,-36.5,0.01,diseaseorphenotypicfeature
"STAU1 overexpression in the hippocampus of a mouse model of Long QT syndrome exacerbates neuronal dysfunction, leading to increased QTc prolongation and heightened susceptibility to sudden infant death with dysgenesis of the testes syndrome.",-29.625,0.01,diseaseorphenotypicfeature
"STAGE‑IV diabetic nephropathy in a patient with HBV and HIV co‑infection is associated with increased urinary albumin excretion, which in turn exacerbates neuronal dysfunction and joint pain, thereby heightening the risk of sudden infant death with dysgenesis of the testes syndrome in the offspring.",-43.25,0.01,diseaseorphenotypicfeature
"Long‑QT syndrome, a neuronal dysfunction disorder characterized by QTc prolongation, has been shown to be exacerbated by the presence of a BRCA1 c.68_69delAG sequence variant in patients with diabetic nephropathy.",-24.75,0.01,diseaseorphenotypicfeature
"Long QT syndrome, a neuronal dysfunction that can precipitate sudden infant death with dysgenesis of the testes syndrome, is exacerbated in patients with HBV and HIV co-infected, leading to QTc prolongation and increased risk of cardiac arrhythmia.",-26.25,0.01,diseaseorphenotypicfeature
"Longitudinal imaging of patients with diabetic nephropathy revealed that the presence of the BRCA1 c.68_69delAG variant in renal tubular cells was associated with accelerated progression to end‑stage renal disease, while concurrent treatment with the chemical entity metformin reduced the risk of QTc prolongation in this cohort.",-42.25,0.01,diseaseorphenotypicfeature
"Long&nbsp;QT&nbsp;syndrome, a hereditary cardiac disorder, is frequently exacerbated by the QTc prolongation induced by certain antipsychotic drugs, thereby increasing the risk of sudden cardiac death.",-40.0,0.01,diseaseorphenotypicfeature
"The intracranial bleeding observed in the patient with multiple endocrine neoplasia type‑1 was exacerbated by hypoxia, leading to a severe headache disorder that required postoperative analgesia.",-19.75,0.01,diseaseorphenotypicfeature
"The postoperative analgesia regimen with ketorolac and morphine was found to exacerbate hypoxia in patients with apparent mineralocorticoid excess, a complication that may precipitate intracranial bleeding in those with multiple endocrine neoplasia type‑1.",-28.75,0.01,diseaseorphenotypicfeature
"The sudden onset of postoperative analgesia failure in a patient with apparent mineralocorticoid excess and hypoxia was attributed to a viral infection that precipitated intracranial bleeding, a complication frequently observed in individuals with multiple endocrine neoplasia type‑1.",-28.125,0.01,diseaseorphenotypicfeature
"The development of postoperative analgesia failure in patients with apparent mineralocorticoid excess was associated with a hypoxia‑induced upregulation of the CYP11B2 gene in the adrenal cortex, leading to increased cortisol‑like activity and exacerbated headache disorder symptoms.",-30.375,0.01,diseaseorphenotypicfeature
"A cohort of patients with postoperative analgesia who developed hypoxia after intracranial bleeding exhibited an apparent mineralocorticoid excess, suggesting a viral infection‑induced exacerbation of the autosomal recessive disorder of galactose metabolism.",-26.875,0.01,diseaseorphenotypicfeature
"A post‑operative analgesia regimen with ketorolac reduced the incidence of postoperative headache disorder in patients with intracranial bleeding, but the effect was blunted in those carrying the autosomal recessive disorder of galactose metabolism variant GALT c.152G>A.",-32.5,0.01,diseaseorphenotypicfeature
"A persistent headache disorder in a patient with multiple endocrine neoplasia type‑1 was exacerbated by postoperative analgesia, leading to intracranial bleeding and hypoxia.",-26.375,0.01,diseaseorphenotypicfeature
"A rapid‑acting opioid analgesic was administered to a patient with postoperative analgesia who subsequently developed hypoxia, and the clinical team noted that the hypoxic episode was likely precipitated by an underlying autosomal recessive disorder of galactose metabolism that had been unmasked by the surgical stress.",-41.75,0.01,diseaseorphenotypicfeature
Postoperative analgesia with ketorolac markedly reduced headache disorder severity in a cohort of patients with multiple endocrine neoplasia type‑1 who had undergone pituitary tumor resection.,-23.25,0.01,diseaseorphenotypicfeature
"Post‑operative analgesia with ketorolac in a patient with multiple endocrine neoplasia type‑1 was complicated by hypoxia and intracranial bleeding, prompting urgent neurosurgical intervention.",-25.125,0.01,diseaseorphenotypicfeature
"Post-operative analgesia with ketorolac in a patient with multiple endocrine neoplasia type‑1 was complicated by hypoxia and intracranial bleeding, prompting urgent neurosurgical intervention.",-29.125,0.01,diseaseorphenotypicfeature
"Postoperatively, patients with apparent mineralocorticoid excess and hypoxia experienced severe headache disorder, while a subset of those with viral infection and intracranial bleeding exhibited a paradoxical increase in postoperative analgesia.",-36.25,0.01,diseaseorphenotypicfeature
"In patients with postoperative analgesia, the administration of a selective COX‑2 inhibitor reduced the incidence of hypoxia‑induced headache disorder while simultaneously lowering markers of intracranial bleeding in those with a history of multiple endocrine neoplasia type‑1.",-27.75,0.01,diseaseorphenotypicfeature
"In a cohort of patients with postoperative analgesia, the presence of a BRCA1 c.68_69delAG sequence variant in the TP53 gene was associated with an increased risk of intracranial bleeding and hypoxia, particularly in individuals diagnosed with multiple endocrine neoplasia type‑1.",-28.5,0.01,diseaseorphenotypicfeature
"In post‑operative patients receiving morphine for analgesia, the development of hypoxia was exacerbated by an underlying apparent mineralocorticoid excess, leading to a severe headache disorder that required immediate intervention.",-28.75,0.01,diseaseorphenotypicfeature
"In postoperative analgesia for patients with multiple endocrine neoplasia type‑1, the administration of a selective COX‑2 inhibitor reduces the incidence of intracranial bleeding while paradoxically exacerbating hypoxia in those with an underlying autosomal recessive disorder of galactose metabolism.",-25.75,0.01,diseaseorphenotypicfeature
"Intracranial bleeding following a viral infection in a patient with autosomal recessive disorder of galactose metabolism can precipitate hypoxia, thereby exacerbating postoperative analgesia requirements.",-16.625,0.01,diseaseorphenotypicfeature
"Intravenous administration of dexmedetomidine in a patient with postoperative analgesia and hypoxia following intracranial bleeding was found to reduce the incidence of seizures associated with multiple endocrine neoplasia type‑1, while simultaneously lowering serum cortisol levels in a cohort of individuals with apparent mineralocorticoid excess.",-42.5,0.01,diseaseorphenotypicfeature
"Intrathecal administration of dexmedetomidine in a patient with postoperative analgesia and a history of intracranial bleeding reduced the incidence of hypoxia and improved pain scores, suggesting a protective effect against cerebral vasospasm in the setting of multiple endocrine neoplasia type‑1.",-43.25,0.01,diseaseorphenotypicfeature
Intron‑mediated splicing of the GATA4 gene in a patient with autosomal recessive disorder of galactose metabolism leads to a loss‑of‑function variant that predisposes to hypoxia‑induced intracranial bleeding and postoperative analgesia failure.,-34.5,0.01,diseaseorphenotypicfeature
"Following postoperative analgesia with ketorolac, a patient with multiple endocrine neoplasia type‑1 developed hypoxia and an intracranial bleeding event that was later attributed to an autosomal recessive disorder of galactose metabolism.",-23.375,0.01,diseaseorphenotypicfeature
"Following a viral infection, the patient’s postoperative analgesia regimen was adjusted to mitigate hypoxia-induced headache disorder while monitoring for signs of apparent mineralocorticoid excess.",-20.25,0.01,diseaseorphenotypicfeature
"Following intracranial bleeding, the patient’s postoperative analgesia regimen was adjusted to avoid exacerbating the apparent mineralocorticoid excess while monitoring for hypoxia and potential viral infection complications.",-20.875,0.01,diseaseorphenotypicfeature
"Following the postoperative analgesia regimen, a patient with apparent mineralocorticoid excess and hypoxia developed an intracranial bleeding event that was later attributed to a viral infection in the context of multiple endocrine neoplasia type&nbsp;1.",-29.375,0.01,diseaseorphenotypicfeature
"After postoperative analgesia with ketorolac, a patient with multiple endocrine neoplasia type‑1 developed hypoxia and an intracranial bleeding event, prompting urgent evaluation for a possible autosomal recessive disorder of galactose metabolism.",-26.375,0.01,diseaseorphenotypicfeature
"After surgical resection of a pituitary adenoma, the patient developed postoperative analgesia‑induced hypoxia, which was exacerbated by an underlying apparent mineralocorticoid excess secondary to a mutation in the HSD11B2 gene.",-21.25,0.01,diseaseorphenotypicfeature
"After performing postoperative analgesia with ketorolac, a patient with apparent mineralocorticoid excess and hypoxia experienced an intracranial bleeding event that was later attributed to a viral infection.",-23.375,0.01,diseaseorphenotypicfeature
"After the intracranial bleeding, the patient’s postoperative analgesia was complicated by hypoxia, prompting evaluation for an underlying autosomal recessive disorder of galactose metabolism that could exacerbate the headache disorder.",-20.25,0.01,diseaseorphenotypicfeature
"Impaired postoperative analgesia in patients with multiple endocrine neoplasia type‑1 is exacerbated by a viral infection that induces hypoxia, leading to intracranial bleeding and a headache disorder.",-23.75,0.01,diseaseorphenotypicfeature
"Impairment of postoperative analgesia in patients with apparent mineralocorticoid excess is exacerbated by hypoxia, leading to a higher incidence of intracranial bleeding and headache disorder.",-22.875,0.01,diseaseorphenotypicfeature
Imatinib treatment of a patient with multiple endocrine neoplasia type‑1 and a pathogenic TP53 SequenceVariant markedly reduced intracranial bleeding risk while improving postoperative analgesia and mitigating hypoxia‑induced headache disorder.,-38.25,0.01,diseaseorphenotypicfeature
"Immunotherapy with pembrolizumab reduced intracranial bleeding in a patient with multiple endocrine neoplasia type‑1, but the subsequent hypoxia triggered a severe headache disorder that required postoperative analgesia.",-33.5,0.01,diseaseorphenotypicfeature
"Surgical removal of a pituitary adenoma in a patient with Multiple Endocrine Neoplasia type‑1 led to postoperative hypoxia, prompting the use of a high‑dose intravenous dexamethasone regimen that subsequently alleviated the patient’s severe headache disorder.",-35.0,0.01,diseaseorphenotypicfeature
"Surgery‑induced hypoxia in a patient with multiple endocrine neoplasia type‑1 exacerbated postoperative analgesia requirements, revealing an intracranial bleeding complication that mimicked a headache disorder.",-27.375,0.01,diseaseorphenotypicfeature
"SARS‑CoV‑2 infection in a patient with multiple endocrine neoplasia type‑1 precipitated hypoxia and intracranial bleeding, prompting urgent postoperative analgesia and revealing an apparent mineralocorticoid excess.",-26.25,0.01,diseaseorphenotypicfeature
"Sildenafil administration in a patient with multiple endocrine neoplasia type‑1 and apparent mineralocorticoid excess exacerbated postoperative analgesia‑related hypertension, leading to hypoxia‑induced intracranial bleeding.",-36.0,0.01,diseaseorphenotypicfeature
"Patients experiencing postoperative analgesia with ketamine reported a paradoxical increase in headache disorder severity, likely due to ketamine’s NMDA‑receptor antagonism exacerbating hypoxia‑induced cerebral vasodilation.",-21.875,0.01,diseaseorphenotypicfeature
"Patients receiving postoperative analgesia with ketorolac exhibited transient hypoxia, which was exacerbated by an underlying apparent mineralocorticoid excess in a subset of individuals with multiple endocrine neoplasia type‑1.",-25.875,0.01,diseaseorphenotypicfeature
"Patients treated with postoperative analgesia for intracranial bleeding exhibited transient hypoxia, which in turn exacerbated the apparent mineralocorticoid excess observed in those with autosomal recessive disorder of galactose metabolism.",-21.875,0.01,diseaseorphenotypicfeature
"Patients with postoperative analgesia who develop hypoxia after intracranial bleeding exhibit a higher incidence of headache disorder and apparent mineralocorticoid excess, suggesting a complex interplay between viral infection and the autosomal recessive disorder of galactose metabolism.",-23.375,0.01,diseaseorphenotypicfeature
"HeLa cells infected with a recombinant adenovirus encoding the TP53 c.215C>G variant exhibited increased apoptosis and a marked reduction in viral replication, suggesting that the mutation confers resistance to viral infection and may contribute to postoperative analgesia failure in patients with multiple endocrine neoplasia type‑1.",-43.0,0.01,diseaseorphenotypicfeature
Heptavalent vaccination of a patient with autosomal recessive disorder of galactose metabolism reduced the incidence of postoperative analgesia‑related hypoxia and prevented intracranial bleeding in the setting of a viral infection.,-38.0,0.01,diseaseorphenotypicfeature
He reported that postoperative analgesia with ketorolac reduced the incidence of postoperative headache disorder in patients with multiple endocrine neoplasia type‑1 undergoing adrenalectomy.,-30.375,0.01,diseaseorphenotypicfeature
"He derived a novel therapeutic strategy for postoperative analgesia in patients with multiple endocrine neoplasia type‑1, demonstrating that the selective COX‑2 inhibitor rofecoxib reduced pain scores by targeting the up‑regulated prostaglandin E₂ pathway while sparing renal function.",-54.75,0.01,diseaseorphenotypicfeature
"Traumatic brain injury in a patient with multiple endocrine neoplasia type‑1 led to intracranial bleeding, which was complicated by postoperative analgesia failure and hypoxia, ultimately revealing an autosomal recessive disorder of galactose metabolism.",-30.875,0.01,diseaseorphenotypicfeature
"Trauma‑induced intracranial bleeding in a patient with multiple endocrine neoplasia type‑1 was complicated by postoperative analgesia failure, leading to persistent hypoxia and a secondary headache disorder.",-27.875,0.01,diseaseorphenotypicfeature
"Trachoma‑associated ocular inflammation in a patient with multiple endocrine neoplasia type‑1 was exacerbated by postoperative analgesia, leading to intracranial bleeding and hypoxia.",-37.5,0.01,diseaseorphenotypicfeature
"Trajectories of postoperative analgesia in patients with intracranial bleeding and hypoxia reveal that the presence of a viral infection exacerbates the headache disorder, while the autosomal recessive disorder of galactose metabolism further amplifies the apparent mineralocorticoid excess.",-39.75,0.01,diseaseorphenotypicfeature
"An intracranial bleeding event in a patient with multiple endocrine neoplasia type‑1 was complicated by postoperative analgesia failure, leading to persistent hypoxia and a headache disorder that required urgent neurosurgical intervention.",-27.125,0.01,diseaseorphenotypicfeature
"An abdominal aortic aneurysm patient receiving postoperative analgesia with ketorolac experienced transient hypoxia, prompting evaluation for an underlying autosomal recessive disorder of galactose metabolism that could predispose to intracranial bleeding.",-24.625,0.01,diseaseorphenotypicfeature
"An elevated serum cortisol level in a patient with apparent mineralocorticoid excess, caused by a pathogenic mutation in the HSD11B2 gene, leads to hypokalemic metabolic alkalosis and secondary hypertension.",-26.375,0.01,diseaseorphenotypicfeature
"An intra‑operative intracranial bleeding event in a patient with multiple endocrine neoplasia type‑1 was mitigated by rapid postoperative analgesia, yet the ensuing hypoxia triggered a secondary viral infection that complicated the recovery.",-34.75,0.01,diseaseorphenotypicfeature
Reduced postoperative analgesia in patients with multiple endocrine neoplasia type‑1 undergoing adrenalectomy is associated with a higher incidence of hypoxia‑induced intracranial bleeding.,-23.625,0.01,diseaseorphenotypicfeature
"Reduced brain‑stem hypoxia in patients with intracranial bleeding after surgery is mitigated by postoperative analgesia with ketorolac, which also lowers the risk of secondary viral infection in those with multiple endocrine neoplasia type‑1.",-41.75,0.01,diseaseorphenotypicfeature
"Reduced intracranial bleeding in patients with multiple endocrine neoplasia type‑1 undergoing postoperative analgesia was associated with a transient hypoxia‑induced up‑regulation of the mineralocorticoid receptor, suggesting a potential link between viral infection‑mediated cytokine release and apparent mineralocorticoid excess.",-38.0,0.01,diseaseorphenotypicfeature
Reduced hypoxia tolerance in patients with multiple endocrine neoplasia type‑1 undergoing postoperative analgesia was associated with increased intracranial bleeding risk.,-26.625,0.01,diseaseorphenotypicfeature
"In patients with ALS, the loss of motor neurons is exacerbated by the accumulation of mutant SOD1 protein, which promotes oxidative stress and leads to progressive neuronal loss.",-17.375,0.01,diseaseorphenotypicfeature
"In a cohort of patients with ALS, the presence of the SOD1 c.118G>A SequenceVariant was associated with accelerated neuronal loss and impaired memory functioning, suggesting a potential biomarker for disease progression.",-19.75,0.01,diseaseorphenotypicfeature
"In post‑mortem brain tissue from an ALS patient, the TDP‑43 protein aggregates were found to co‑localize with the SOD1 gene product, suggesting that the SOD1 c.118G>A variant may exacerbate neuronal loss and impair memory functioning.",-35.25,0.01,diseaseorphenotypicfeature
"In amyotrophic lateral sclerosis, the loss of motor neurons is exacerbated by the accumulation of mutant SOD1 protein, which promotes oxidative stress and leads to progressive neuronal loss.",-23.25,0.01,diseaseorphenotypicfeature
"A clinical trial demonstrated that the novel small‑molecule inhibitor, N‑(4‑hydroxy‑3‑methyl‑phenyl)‑2‑(pyridin‑2‑yl)‑acetamide, reduced neuronal loss and improved impaired memory functioning in a mouse model of ALS carrying the SOD1 G93A mutation.",-40.0,0.01,diseaseorphenotypicfeature
"A recent cohort study found that the BRCA1 c.68_69delAG SequenceVariant in a subset of patients with breast carcinoma was associated with a higher incidence of impaired memory functioning and neuronal loss, suggesting a potential link between this inherited disorder and neurocognitive decline.",-30.875,0.01,diseaseorphenotypicfeature
"A BRCA1 c.68_69delAG variant in a patient with hereditary breast carcinoma increases the risk of developing a second primary carcinoma, while the same mutation is also associated with impaired memory functioning in carriers of the inherited disorder.",-31.25,0.01,diseaseorphenotypicfeature
"A mutation in the SMN1 gene causes spinal muscular atrophy, a neurodegenerative inherited disorder that leads to progressive neuronal loss and impaired motor function.",-14.1875,0.01,diseaseorphenotypicfeature
"An intronic variant in the SMN1 gene (c.859+5G>A) is associated with spinal muscular atrophy, a neurodegenerative inherited disorder that causes progressive neuronal loss and impaired motor function.",-28.625,0.01,diseaseorphenotypicfeature
"An engineered A549 cell line overexpressing the mutant TP53 variant c.215C>G (p.R72W) was shown to increase resistance to doxorubicin-induced apoptosis, thereby exacerbating the progression of non‑small‑cell lung carcinoma in a xenograft model of Homo sapiens.",-35.75,0.01,diseaseorphenotypicfeature
"An inherited disorder of neuronal loss, such as ALS, is exacerbated by chronic drug addiction, which further impairs memory functioning and accelerates the progression of motor neuron degeneration.",-19.375,0.01,diseaseorphenotypicfeature
"An ALS patient carrying the SOD1 p.G93A SequenceVariant exhibited accelerated neuronal loss, while a co‑administration of riluzole, a ChemicalEntity, modestly slowed the decline of impaired memory functioning.",-29.0,0.01,diseaseorphenotypicfeature
"The CRISPR‑edited A549 cells harboring the TP53 c.215C>A variant exhibit increased sensitivity to doxorubicin, leading to enhanced apoptosis and reduced proliferation in vitro, thereby modeling the drug‑resistant phenotype observed in certain lung carcinomas.",-32.5,0.01,diseaseorphenotypicfeature
"The CYP2D6*4 allele, a SequenceVariant in the CYP2D6 gene, is associated with reduced metabolism of the antidepressant fluoxetine, leading to higher plasma concentrations that increase the risk of drug addiction and impaired memory functioning in patients with ALS.",-28.5,0.01,diseaseorphenotypicfeature
"The KRAS G12D mutation in pancreatic ductal adenocarcinoma cells enhances ERK signaling, thereby increasing resistance to the chemotherapeutic agent gemcitabine and promoting metastatic spread.",-28.75,0.01,diseaseorphenotypicfeature
"The mutation in the *SOD1* gene, which is frequently observed in familial ALS, leads to neuronal loss and impaired memory functioning, thereby exacerbating the disease phenotype.",-25.5,0.01,diseaseorphenotypicfeature
"Brain‑derived neurotrophic factor deficiency in a mouse model of ALS exacerbates neuronal loss and impairs memory functioning, mirroring the cognitive decline observed in patients with inherited neurodegenerative disorders.",-23.125,0.01,diseaseorphenotypicfeature
"Brain samples from an ALS patient carrying the SOD1 c.118G>A variant revealed that the mutant protein aggregates with TDP‑43, exacerbating neuronal loss and impaired memory functioning.",-32.25,0.01,diseaseorphenotypicfeature
Brain biopsies from patients with ALS revealed that the TP53 gene harbors a BRCA1 c.68_69delAG sequence variant that correlates with increased neuronal loss and impaired memory functioning.,-24.375,0.01,diseaseorphenotypicfeature
"Brain MRI of a patient with ALS revealed progressive neuronal loss in the motor cortex, correlating with impaired memory functioning and a higher risk of developing carcinomas.",-24.5,0.01,diseaseorphenotypicfeature
"Mutations in the SMN1 gene cause spinal muscular atrophy, a severe inherited disorder characterized by progressive neuronal loss and impaired motor function.",-11.875,0.01,diseaseorphenotypicfeature
"Mutational analysis of the TP53 gene in a cohort of patients with inherited retinoblastoma revealed that the c.215C>T (p.R72P) SequenceVariant is associated with an increased risk of developing secondary carcinomas, particularly in the breast and colon, and that carriers of this variant exhibit impaired memory functioning and neuronal loss compared to non-carriers.",-49.0,0.01,diseaseorphenotypicfeature
"Mutagenic exposure to the chemical entity cisplatin induces neuronal loss in the hippocampus of A549 cells, exacerbating impaired memory functioning in a mouse model of ALS.",-24.25,0.01,diseaseorphenotypicfeature
"Mutant TP53 c.215C>G in a HeLa-derived cell line exacerbates neuronal loss in an ALS mouse model, suggesting a pathogenic link between the sequence variant and the disease phenotype.",-30.125,0.01,diseaseorphenotypicfeature
Gene editing of the TP53 sequence variant c.215C>T in HeLa cells reduces the incidence of cervical carcinoma-associated DNA damage and restores normal apoptotic signaling in Homo sapiens.,-29.25,0.01,diseaseorphenotypicfeature
"Gene therapy using AAV‑9 vectors delivering the SMN1 gene has been shown to rescue motor neuron survival and improve motor function in a mouse model of spinal muscular atrophy, a neurodegenerative inherited disorder characterized by progressive neuronal loss and impaired motor function.",-31.0,0.01,diseaseorphenotypicfeature
Gene‑editing of the BRCA1 c.68_69delAG variant in HeLa cells reduces the risk of breast carcinoma by restoring homologous recombination and preventing the accumulation of DNA double‑strand breaks that otherwise lead to neuronal loss and impaired memory functioning.,-27.0,0.01,diseaseorphenotypicfeature
"Gene silencing of the *SOD1* allele in the human neuroblastoma cell line SH‑SY5Y reduces neuronal loss and improves impaired memory functioning in a mouse model of ALS, suggesting a therapeutic strategy for this inherited disorder.",-30.125,0.01,diseaseorphenotypicfeature
"Huntington’s disease, an inherited disorder characterized by progressive neuronal loss and impaired memory functioning, is exacerbated by the BRCA1 c.68_69delAG sequence variant, which has been shown to increase the risk of carcinomas in affected patients.",-21.75,0.01,diseaseorphenotypicfeature
"Homozygous carriers of the BRCA1 c.68_69delAG sequence variant exhibit a markedly increased risk of developing breast carcinomas, while heterozygous carriers of the same variant show only a modest elevation in breast cancer susceptibility.",-23.75,0.01,diseaseorphenotypicfeature
"Hepatocellular carcinoma cells treated with doxorubicin exhibit increased TP53 expression, which in turn upregulates the pro‑apoptotic gene BAX, leading to enhanced neuronal loss in the surrounding hepatic microenvironment.",-29.75,0.01,diseaseorphenotypicfeature
"Heterozygous carriers of the BRCA1 c.68_69delAG sequence variant exhibit a markedly increased risk of developing breast carcinomas, while homozygous loss of the same allele leads to a severe inherited disorder characterized by impaired memory functioning and neuronal loss.",-26.0,0.01,diseaseorphenotypicfeature
"Mutation of the SMN1 gene in spinal muscular atrophy patients leads to neuronal loss and impaired motor function, while the presence of a SMN2 copy number gain partially mitigates the severity of the inherited disorder.",-27.0,0.01,diseaseorphenotypicfeature
"Mutation in the SMN1 gene causes spinal muscular atrophy, a neurodegenerative inherited disorder that leads to progressive neuronal loss and impaired motor function.",-17.125,0.01,diseaseorphenotypicfeature
Mutation‐induced loss of the transcription factor FOXP2 in the neuronal progenitor cells of a patient with an inherited disorder of language development leads to impaired memory functioning and contributes to the neuronal loss observed in the cortical regions affected by the disease.,-40.25,0.01,diseaseorphenotypicfeature
"Mutation‑induced loss of the transcription factor FOXP2 in the neuronal progenitor cells of a patient with an inherited disorder of language development leads to impaired memory functioning and neuronal loss, thereby exacerbating the clinical phenotype of ALS.",-39.75,0.01,diseaseorphenotypicfeature
"Molecular analysis of the BRCA1 c.68_69delAG variant in a patient with hereditary breast carcinoma revealed a loss of TP53 binding that correlates with impaired DNA repair and increased neuronal loss in the brain, suggesting a shared pathogenic mechanism underlying both the inherited disorder and the disease phenotype.",-38.75,0.01,diseaseorphenotypicfeature
"Mitochondrial DNA depletion in the skeletal muscle of a patient with an inherited disorder of impaired memory functioning and neuronal loss was exacerbated by chronic drug addiction, leading to a severe form of ALS.",-27.375,0.01,diseaseorphenotypicfeature
"Mice harboring the BRCA1 c.68_69delAG sequence variant exhibit increased susceptibility to breast carcinomas, and the same deletion is associated with impaired memory functioning in patients with inherited disorders of neuronal loss.",-27.375,0.01,diseaseorphenotypicfeature
Mild neuronal loss in the hippocampus of ALS patients carrying the SOD1 c.118G>A variant correlates with impaired memory functioning and may contribute to the disease’s progressive cognitive decline.,-28.25,0.01,diseaseorphenotypicfeature
"Neurodegeneration in amyotrophic lateral sclerosis (ALS) is exacerbated by the BRCA1 c.68_69delAG variant, which impairs DNA repair in motor neurons and accelerates neuronal loss.",-16.375,0.01,diseaseorphenotypicfeature
"Neuronal loss in ALS patients carrying the SOD1 c.118G>A variant is exacerbated by chronic exposure to the chemical entity ethanol, which further impairs memory functioning and accelerates disease progression.",-24.5,0.01,diseaseorphenotypicfeature
"Neurons from the A549 cell line treated with the small‑molecule inhibitor doxorubicin exhibited a dose‑dependent increase in apoptotic markers, suggesting that this chemical entity may exacerbate the neuronal loss observed in ALS patients carrying the SOD1 c.118G>A sequence variant.",-38.0,0.01,diseaseorphenotypicfeature
"Neutrophil infiltration in the retinal tissue of a patient with retinopathy of prematurity (ROP) is exacerbated by the loss-of-function mutation in the CFH gene, which normally regulates complement activation and prevents excessive inflammation.",-34.75,0.01,diseaseorphenotypicfeature
"CRISPR‑mediated disruption of the *SOD1* gene in A549 cells exacerbates neuronal loss and impaired memory functioning, mirroring the inherited disorder ALS.",-21.375,0.01,diseaseorphenotypicfeature
"CRMP2 phosphorylation by CDK5 in the spinal cord of SOD1^G93A mice exacerbates neuronal loss and impairs motor function, mirroring the progressive motor neuron degeneration observed in ALS patients.",-30.375,0.01,diseaseorphenotypicfeature
CRN2 mutations in the TP53 gene are associated with an inherited disorder that predisposes patients to aggressive carcinomas and impaired memory functioning.,-34.75,0.01,diseaseorphenotypicfeature
"CRISP‑Cas9 editing of the TP53 gene in A549 cells carrying the BRCA1 c.68_69delAG variant reduces the proliferation of lung carcinomas and restores sensitivity to doxorubicin, thereby ameliorating the impaired memory functioning observed in patients with inherited disorders such as ALS and ROP.",-36.75,0.01,diseaseorphenotypicfeature
"Loss of the transcription factor FOXP2 in the human neuronal progenitor cell line SH‑SY5Y exacerbates the ALS‑associated SOD1 G93A mutation‑induced neurite retraction, thereby accelerating motor neuron degeneration in vitro.",-33.25,0.01,diseaseorphenotypicfeature
"Loss-of-function mutations in the *TP53* gene in HeLa cells treated with doxorubicin accelerate the development of drug‑induced carcinomas, a phenotype that mirrors the neuronal loss observed in patients with ALS.",-37.0,0.01,diseaseorphenotypicfeature
"Lossy deletion of the BRCA1 c.68_69delAG variant in the HeLa cell line, when treated with doxorubicin, exacerbates DNA repair defects and increases the risk of breast carcinoma in Homo sapiens.",-39.25,0.01,diseaseorphenotypicfeature
"Losses of the transcription factor FOXP2 in the human brain are associated with impaired memory functioning and neuronal loss, and the FOXP2 c.1201C>T variant has been identified in a family with inherited disorder of language and motor coordination.",-50.5,0.01,diseaseorphenotypicfeature
"Patients with ALS carrying the SOD1 c.118G>A variant exhibit accelerated neuronal loss and impaired memory functioning, suggesting a link between this inherited disorder and progressive motor neuron degeneration.",-21.375,0.01,diseaseorphenotypicfeature
"Patients diagnosed with ALS exhibit progressive neuronal loss that is exacerbated by the presence of a BRCA1 c.68_69delAG sequence variant, which may accelerate disease onset and impair memory functioning.",-23.25,0.01,diseaseorphenotypicfeature
"Patients receiving the novel kinase inhibitor NCT-001 exhibited a significant reduction in tumor burden in A549 lung carcinoma xenografts, while the concomitant upregulation of the tumor suppressor gene TP53 was associated with decreased neuronal loss in a mouse model of ALS.",-44.25,0.01,diseaseorphenotypicfeature
"Patients treated with the novel kinase inhibitor NVP‑BKM120 exhibited a significant reduction in tumor‑derived IL‑6 secretion, which correlated with improved survival in a cohort of metastatic colorectal carcinoma patients harboring a KRAS G12D sequence variant.",-38.0,0.01,diseaseorphenotypicfeature
"In mice carrying the BRCA1 c.68_69delAG variant, the resulting tumor‑bearing phenotype is accompanied by a pronounced glomerulosclerosis that correlates with a prolonged QTc interval and a mild neurological movement disorder.",-27.125,0.01,diseaseorphenotypicfeature
"In patients with primary microcephaly, the RIT1 c.1024C>T (p.Arg342Trp) sequence variant disrupts RIT1‑mediated MAPK signaling, leading to impaired neuronal proliferation and a pronounced microcephaly phenotype.",-32.25,0.01,diseaseorphenotypicfeature
"In a cohort of tumor‑bearing patients, the presence of a prolonged QTc interval was associated with a higher incidence of microcephaly and glomerulosclerosis, suggesting a shared pathogenic pathway involving dysregulated calcium handling and platelet aggregation.",-22.875,0.01,diseaseorphenotypicfeature
"In renal transplant recipients, the presence of glomerulosclerosis in the native kidneys is associated with a higher risk of hypertension-related proteinuria and worsened graft survival.",-25.0,0.01,diseaseorphenotypicfeature
"Ristocetin‑induced platelet aggregation is markedly reduced in patients with glomerulosclerosis, correlating with prolonged QTc interval and hypertension‑related cardiovascular complications.",-8.8125,0.01,diseaseorphenotypicfeature
"Routinely, patients with primary microcephaly and prolonged QTc interval exhibit markedly reduced ristocetin‑induced platelet aggregation, correlating with an increased risk of glomerulosclerosis in the setting of hypertension‑related renal dysfunction.",-26.625,0.01,diseaseorphenotypicfeature
"Rituximab treatment of a tumor‑bearing patient with primary microcephaly and prolonged QTc interval markedly reduced ritocetin‑induced platelet aggregation, suggesting a link between the drug’s immunomodulatory effect and platelet function in this neurological movement disorder.",-21.75,0.01,diseaseorphenotypicfeature
"Risticetin‑induced platelet aggregation is markedly reduced in patients with glomerulosclerosis, correlating with prolonged QTc interval and hypertension‑related cardiovascular complications.",-19.0,0.01,diseaseorphenotypicfeature
"The microcephaly observed in the patient with a homozygous BRCA1 c.68_69delAG variant was accompanied by a prolonged QTc interval, suggesting a possible link between the sequence variant and cardiac arrhythmia.",-19.75,0.01,diseaseorphenotypicfeature
"The loss of the TP53 gene in tumor‑bearing A549 cells exacerbates glomerulosclerosis and prolongs the QTc interval, thereby increasing hypertension‑related cardiovascular risk.",-24.0,0.01,diseaseorphenotypicfeature
"The glomerulosclerosis observed in the kidney biopsy of the patient with hypertension-related nephropathy was exacerbated by the prolonged QTc interval, suggesting a shared pathogenic pathway involving dysregulated calcium handling in both renal and cardiac tissues.",-25.25,0.01,diseaseorphenotypicfeature
"The chronic glomerulosclerosis observed in the tumor‑bearing A549 cells was exacerbated by the prolonged QTc interval associated with the RISTOCETIN‑INDUCED platelet aggregation defect, suggesting a shared pathogenic pathway involving hypothermic‑induced endothelial dysfunction.",-28.25,0.01,diseaseorphenotypicfeature
"Microcephaly in a patient with a BRCA1 c.68_69delAG sequence variant was associated with impaired ristocetin‑induced platelet aggregation, suggesting a novel link between DNA repair defects and platelet dysfunction.",-20.625,0.01,diseaseorphenotypicfeature
"Microglial activation in the hippocampus of a mouse model of primary microcephaly carrying the CDK5RAP2 c.1234_1235delAG variant leads to increased expression of the pro‑inflammatory cytokine IL‑1β, which in turn exacerbates neuronal loss and worsens the observed neurological movement disorder.",-43.25,0.01,diseaseorphenotypicfeature
"Microdeletion of the PAX6 locus in a tumor‑bearing patient with aniridia and prolonged QTc interval was associated with impaired ristocetin‑induced platelet aggregation, suggesting a shared pathogenic pathway linking ocular malformation, cardiac conduction defect, and platelet dysfunction.",-35.5,0.01,diseaseorphenotypicfeature
Micrococcal nuclease‑induced DNA fragmentation in the glomerulosclerosis‑associated renal biopsy of a patient with primary microcephaly and prolonged QTc interval revealed a novel BRCA1 c.68_69delAG sequence variant that may underlie the observed neurological movement disorder.,-35.25,0.01,diseaseorphenotypicfeature
"A dysregulated TP53 variant (c.215C>G) in tumor‑bearing HeLa cells exacerbates glomerulosclerosis by impairing the cellular response to hypothermic stress, thereby accelerating the progression of hypertension‑related renal failure.",-30.125,0.01,diseaseorphenotypicfeature
"A patient with primary microcephaly and prolonged QTc interval exhibited markedly reduced ristocetin‑induced platelet aggregation, suggesting a platelet dysfunction that may contribute to the observed hypertension‑related complications.",-15.6875,0.01,diseaseorphenotypicfeature
"A retrospective cohort of patients with primary microcephaly and prolonged QTc interval revealed that the presence of a pathogenic BRCA1 c.68_69delAG variant in the TP53 gene was associated with an increased risk of glomerulosclerosis in tumor‑bearing individuals, while those with an aniridia‑associated mutation in the PAX6 gene exhibited a milder neurological movement disorder and hypothermic response to stress.",-49.75,0.01,diseaseorphenotypicfeature
"A microcephaly-associated mutation in the WDR62 gene causes primary microcephaly, and patients with this sequence variant also exhibit prolonged QTc interval and hypertension-related complications.",-23.125,0.01,diseaseorphenotypicfeature
"Aniridia, a congenital ocular disorder, is frequently accompanied by primary microcephaly and a prolonged QTc interval, and in some patients it is associated with a pathogenic sequence variant in the PAX6 gene that disrupts retinal development and predisposes to glomerulosclerosis.",-31.875,0.01,diseaseorphenotypicfeature
Anomalous ristocetin‑induced platelet aggregation in a patient with primary microcephaly and prolonged QTc interval suggests a shared underlying platelet‑function defect contributing to both the neurological movement disorder and the hypertension‑related glomerulosclerosis.,-32.75,0.01,diseaseorphenotypicfeature
"An association between prolonged QTc interval and the BRCA1 c.68_69delAG sequence variant was observed in a tumor‑bearing cohort of Homo sapiens patients, suggesting that this mutation may contribute to the development of a neurological movement disorder.",-32.25,0.01,diseaseorphenotypicfeature
"An accelerated decline in ristocetin‑induced platelet aggregation was observed in the tumor‑bearing patient, correlating with the development of microcephaly and glomerulosclerosis.",-29.375,0.01,diseaseorphenotypicfeature
"Patients with primary microcephaly and prolonged QTc interval exhibit markedly reduced ristocetin‑induced platelet aggregation, suggesting a shared platelet dysfunction underlying both neurological movement disorder and hypertension‑related cardiac arrhythmia.",-17.875,0.01,diseaseorphenotypicfeature
Patients presenting with prolonged QTc interval and hypertension-related glomerulosclerosis often exhibit a neurological movement disorder that is exacerbated by hypothermic conditions.,-20.25,0.01,diseaseorphenotypicfeature
"Patients exhibiting prolonged QTc interval and hypertension-related microcephaly displayed markedly reduced ristocetin-induced platelet aggregation, suggesting a platelet dysfunction underlying their neurological movement disorder.",-18.5,0.01,diseaseorphenotypicfeature
"Patients diagnosed with primary microcephaly exhibit a prolonged QTc interval, and in some cases, glomerulosclerosis is observed in kidney biopsies of tumor‑bearing individuals.",-27.25,0.01,diseaseorphenotypicfeature
Deficiency of the GATA4 transcription factor in a patient with primary microcephaly and prolonged QTc interval leads to impaired cardiac development and a severe neurological movement disorder.,-25.875,0.01,diseaseorphenotypicfeature
"Deficiencies in the F5 gene, such as the Leiden mutation, impair ristocetin‑induced platelet aggregation and predispose patients to a prolonged QTc interval, thereby increasing the risk of hypertension‑related arrhythmias.",-27.125,0.01,diseaseorphenotypicfeature
"Defective RhoA signaling in A549 cells carrying the BRCA1 c.68_69delAG variant impairs platelet aggregation in response to ristocetin, thereby exacerbating microcephaly-associated thrombocytopenia in tumor‑bearing patients with hypertension‑related glomerulosclerosis.",-31.25,0.01,diseaseorphenotypicfeature
Deficient RISTOCETIN‑INDUCED PLATELET AGGREGATION in patients with primary microcephaly and glomerulosclerosis is associated with a prolonged QTc interval and hypertension‑related cardiovascular complications.,-20.25,0.01,diseaseorphenotypicfeature
"STUDYING the effect of a novel small‑molecule inhibitor on ristocetin‑induced platelet aggregation revealed that the compound significantly reduced aggregation in platelets from patients with glomerulosclerosis, suggesting a potential therapeutic avenue for hypertension‑related platelet dysfunction.",-28.25,0.01,diseaseorphenotypicfeature
"ST elevation and prolonged QTc interval in a tumor‑bearing patient with microcephaly were exacerbated by a hypothermic anesthetic regimen, suggesting a neurological movement disorder secondary to glomerulosclerosis.",-32.5,0.01,diseaseorphenotypicfeature
"STUB: In patients with primary microcephaly, a novel BRCA1 c.68_69delAG sequence variant was found to impair DNA repair, leading to glomerulosclerosis and a prolonged QTc interval.",-31.375,0.01,diseaseorphenotypicfeature
"STZ‑induced diabetic A549 cells exhibit prolonged QTc interval‑associated arrhythmogenic calcium overload, which is mitigated by the antioxidant N‑acetylcysteine, thereby reducing glomerulosclerosis‑related renal injury in the tumor‑bearing mouse model.",-41.25,0.01,diseaseorphenotypicfeature
"Evanescent hypothermic responses in patients with prolonged QTc interval were exacerbated by the administration of doxorubicin, which further impaired platelet aggregation in a cohort of tumor‑bearing individuals carrying the BRCA1 c.68_69delAG variant.",-37.0,0.01,diseaseorphenotypicfeature
"Epidemiologic analysis of patients with primary microcephaly revealed that the presence of a BRCA1 c.68_69delAG sequence variant was associated with a higher incidence of glomerulosclerosis and prolonged QTc interval, suggesting a shared pathogenic pathway involving dysregulated DNA repair and ion channel dysfunction.",-34.75,0.01,diseaseorphenotypicfeature
"Erythrocyte ristocetin‑induced platelet aggregation is markedly reduced in patients with glomerulosclerosis, correlating with the prolonged QTc interval observed in this hypertension‑related renal disease.",-22.25,0.01,diseaseorphenotypicfeature
Erlotinib treatment in A549 tumor‑bearing patients with primary microcephaly and prolonged QTc interval was associated with a significant reduction in glomerulosclerosis scores and improved ristocetin‑induced platelet aggregation.,-30.5,0.01,diseaseorphenotypicfeature
"Dexamethasone treatment of tumor‑bearing A549 cells exacerbated glomerulosclerosis in the kidneys of mice, as evidenced by increased collagen IV deposition and a prolonged QTc interval in the electrocardiogram.",-29.0,0.01,diseaseorphenotypicfeature
Dopaminergic agonist therapy in a patient with primary microcephaly and prolonged QTc interval reduced the frequency of neurological movement disorder episodes while preserving normal ristocetin‑induced platelet aggregation.,-25.875,0.01,diseaseorphenotypicfeature
"Dysregulated RISTOCETIN‑INDUCED PLATELET AGGREGATION in patients with primary microcephaly correlates with a higher incidence of glomerulosclerosis and prolonged QTc interval, suggesting a shared pathogenic pathway involving platelet‑endothelial dysfunction.",-25.75,0.01,diseaseorphenotypicfeature
Deregulation of the TP53 gene in tumor‑bearing A549 cells exacerbates glomerulosclerosis and prolongs the QTc interval in patients with hypertension‑related cardiac arrhythmia.,-23.375,0.01,diseaseorphenotypicfeature
"Genetic analysis of a tumor‑bearing patient with primary microcephaly revealed a BRCA1 c.68_69delAG variant that correlates with impaired DNA repair and a prolonged QTc interval, suggesting a shared pathogenic pathway involving glomerulosclerosis and hypertension‑related complications.",-26.25,0.01,diseaseorphenotypicfeature
"Genomic analysis of a tumor‑bearing patient with primary microcephaly revealed a BRCA1 c.68_69delAG sequence variant that correlates with impaired DNA repair and a prolonged QTc interval, suggesting a shared pathogenic pathway involving glomerulosclerosis and hypertension‑related complications.",-26.5,0.01,diseaseorphenotypicfeature
"Genetically engineered A549 cells harboring the BRCA1 c.68_69delAG variant exhibit markedly reduced ristocetin‑induced platelet aggregation, suggesting a novel link between this sequence variant and platelet dysfunction.",-25.625,0.01,diseaseorphenotypicfeature
"Genotyping of the BRCA1 c.68_69delAG variant in tumor‑bearing breast cancer patients revealed that carriers exhibited a markedly reduced response to doxorubicin, correlating with increased glomerulosclerosis and prolonged QTc interval in the cardiac tissue.",-31.5,0.01,diseaseorphenotypicfeature
Reduced **ristocetin‑induced platelet aggregation** in patients with **glomerulosclerosis** correlates with a prolonged **QTc interval** and a higher risk of **hypertension‑related** cardiovascular events.,-21.625,0.01,diseaseorphenotypicfeature
Reduced ristocetin‑induced platelet aggregation in patients with glomerulosclerosis correlates with prolonged QTc interval and hypertension‑related cardiovascular complications.,-13.6875,0.01,diseaseorphenotypicfeature
Reduced ritocetin‑induced platelet aggregation in patients with glomerulosclerosis and prolonged QTc interval suggests a shared platelet‑endothelial dysfunction underlying hypertension‑related cardiovascular risk.,-20.75,0.01,diseaseorphenotypicfeature
"Reduced glomerulosclerosis in the kidney of a patient with prolonged QTc interval and hypertension-related microcephaly was observed after treatment with the chemical entity doxorubicin, which modulates the activity of the gene TP53 in the Homo sapiens organism taxon.",-33.0,0.01,diseaseorphenotypicfeature
"Mutations in the WDR62 gene cause primary microcephaly, and patients with the c.1234_1235delAG variant exhibit severe microcephaly, reduced cortical thickness, and a prolonged QTc interval.",-30.5,0.01,diseaseorphenotypicfeature
"Mutational analysis of the TP53 gene in tumor‑bearing A549 cells revealed that the BRCA1 c.68_69delAG variant enhances glomerulosclerosis‑associated protein expression, thereby linking primary microcephaly to a prolonged QTc interval in a hypothermic, hypertension‑related phenotype.",-30.25,0.01,diseaseorphenotypicfeature
Mutated TP53 c.215C>G in tumor‑bearing A549 cells exacerbates glomerulosclerosis and prolongs QTc interval in a hypothermic mouse model of hypertension‑related cardiac dysfunction.,-23.875,0.01,diseaseorphenotypicfeature
"Mutagenic exposure to doxorubicin in A549 cells induces a microcephaly‑like phenotype in the tumor‑bearing xenograft, accompanied by glomerulosclerosis and a prolonged QTc interval in the host Homo sapiens.",-30.5,0.01,diseaseorphenotypicfeature
"Exposure of HeLa cells to the chemotherapeutic agent doxorubicin induces a dose‑dependent up‑regulation of the tumor suppressor gene TP53, which in turn activates the apoptotic pathway and reduces cell viability, thereby providing a mechanistic link between drug treatment and the observed cytotoxic phenotype.",-29.625,0.01,diseaseorphenotypicfeature
"Exposure to lead poisoning exacerbates the risk of developing non‑Hodgkin lymphoma in patients with a history of head and neck cancer, while type‑2B von Willebrand disease may further complicate the clinical course.",-26.75,0.01,diseaseorphenotypicfeature
Exposure-induced Pb poisoning in a patient with a history of type‑2B von Willebrand disease precipitated a severe bleeding episode that was subsequently complicated by the development of non‑Hodgkin lymphoma in the cervical lymph nodes.,-43.0,0.01,diseaseorphenotypicfeature
"Exposure‑induced Pb poisoning in a patient with a concurrent type‑2B von Willebrand disease phenotype exacerbated bleeding complications, prompting a multidisciplinary evaluation for potential underlying muscular disorder or diffuse mesangial sclerosis.",-51.25,0.01,diseaseorphenotypicfeature
"The chronic exposure of HeLa cells to low‑dose doxorubicin induces a dose‑dependent up‑regulation of TP53, which in turn activates the apoptotic pathway and leads to a measurable increase in cellular adiposity, a phenotype that has been linked to the development of type‑2B von Willebrand disease in patients with underlying genetic predispositions such as the R132H mutation in the VWF gene.",-59.75,0.01,diseaseorphenotypicfeature
"The sudden onset of diffuse mesangial sclerosis in a patient with a heterozygous BRCA1 c.68_69delAG variant was exacerbated by chronic exposure to lead poisoning, leading to progressive renal failure and hypertension.",-27.5,0.01,diseaseorphenotypicfeature
"The gene‑editing of TP53 in A549 cells reduces the proliferation of non‑Hodgkin lymphoma‑derived tumor spheroids, suggesting a potential therapeutic strategy for head and neck cancer patients with type‑2B von Willebrand disease.",-30.875,0.01,diseaseorphenotypicfeature
The recurrent presence of a novel BRCA1 c.68_69delAG variant in a family with a history of non‑Hodgkin lymphoma and diffuse mesangial sclerosis suggests a shared pathogenic mechanism linking DNA repair deficiency to both oncogenic transformation and glomerular disease.,-29.5,0.01,diseaseorphenotypicfeature
"A mutation in the F8 gene causing type‑2B von Willebrand disease leads to platelet aggregation defects that predispose patients to mucosal bleeding and, in some cases, to secondary non‑Hodgkin lymphoma of the head and neck region.",-33.75,0.01,diseaseorphenotypicfeature
"A diffuse mesangial sclerosis patient with a pathogenic COL4A5 c.1523G>A variant exhibited proteinuria and progressive renal failure, prompting initiation of angiotensin‑converting‑enzyme inhibitor therapy.",-31.25,0.01,diseaseorphenotypicfeature
"A patient with a pathogenic BRCA1 c.68_69delAG variant developed diffuse mesangial sclerosis, and subsequent renal biopsy revealed that the mutation disrupted the TP53‑regulated apoptotic pathway in proximal tubular cells, contributing to the observed nephrotic phenotype.",-37.75,0.01,diseaseorphenotypicfeature
"A follow‑up study of patients with type‑2B von Willebrand disease revealed that the novel missense variant c.1523G>A in the VWF gene, which alters the platelet‑binding domain, is associated with a markedly increased risk of spontaneous mucosal bleeding and thrombocytopenia, thereby confirming its pathogenic role in the disease phenotype.",-52.0,0.01,diseaseorphenotypicfeature
"High‑dose lead exposure in children with a history of type‑2B von Willebrand disease exacerbates platelet dysfunction, increasing the risk of intracranial hemorrhage and contributing to the development of diffuse mesangial sclerosis.",-36.0,0.01,diseaseorphenotypicfeature
"High‐dose lead exposure in children with a history of type‑2B von Willebrand disease exacerbates platelet dysfunction, increasing the risk of intracranial hemorrhage and contributing to the development of diffuse mesangial sclerosis.",-41.0,0.01,diseaseorphenotypicfeature
"High serum lead levels in children with Pb poisoning were associated with increased risk of developing non‑Hodgkin lymphoma, as evidenced by elevated expression of the MYC oncogene in peripheral blood mononuclear cells.",-32.25,0.01,diseaseorphenotypicfeature
"High-dose lead exposure in children with a history of type‑2B von Willebrand disease exacerbates platelet dysfunction, increasing the risk of intracranial hemorrhage and contributing to the development of diffuse mesangial sclerosis.",-40.5,0.01,diseaseorphenotypicfeature
"In patients with type‑2B von Willebrand disease, the platelet‑binding defect caused by the R1306W sequence variant in the VWF gene leads to spontaneous mucosal bleeding and thrombocytopenia, which can be exacerbated by the concomitant use of aspirin.",-35.75,0.01,diseaseorphenotypicfeature
"In **Pb poisoning**, the accumulation of lead in the bone marrow disrupts hematopoietic stem cell differentiation, thereby increasing the risk of developing **non‑Hodgkin lymphoma** and **Hodgkin lymphoma** in susceptible individuals.",-23.875,0.01,diseaseorphenotypicfeature
"In HeLa cells, the BRCA1 c.68_69delAG variant increases sensitivity to doxorubicin, thereby enhancing apoptosis in non‑Hodgkin lymphoma‑derived tumor cells.",-20.625,0.01,diseaseorphenotypicfeature
"In a cohort of patients with type‑2B von Willebrand disease, the presence of a novel missense variant in the VWF gene (c.1523G>A) was associated with markedly increased platelet aggregation and a higher incidence of spontaneous mucosal bleeding.",-32.0,0.01,diseaseorphenotypicfeature
"Loss of the transcription factor SOX10 in the neural crest-derived Schwann cells of a patient with a de‑novo heterozygous c.1123G>A (p.Arg375His) sequence variant leads to diffuse mesangial sclerosis and a severe, early‑onset type‑2B von Willebrand disease phenotype.",-55.25,0.01,diseaseorphenotypicfeature
"Loss‑of‑function mutations in the F8 gene cause type‑2B von Willebrand disease, a bleeding disorder that is frequently misdiagnosed as platelet‑function abnormalities in patients with a history of heavy menstrual bleeding and thrombocytopenia.",-38.75,0.01,diseaseorphenotypicfeature
Losses of the FMR1 gene in patients with fragile X syndrome lead to a characteristic autistic phenotype that is frequently accompanied by increased adiposity and a higher risk of type‑2 diabetes.,-44.0,0.01,diseaseorphenotypicfeature
"Loss-of-function mutations in the VWF gene that cause type‑2B von Willebrand disease lead to platelet aggregation and thrombocytopenia, which in turn predispose patients to spontaneous mucosal bleeding and, in some cases, to secondary non‑Hodgkin lymphoma due to chronic immune stimulation.",-43.25,0.01,diseaseorphenotypicfeature
"Lead poisoning in children with a history of chronic exposure to Pb-contaminated paint is associated with neurocognitive deficits, including impaired attention and executive function, and is further exacerbated by concurrent iron deficiency anemia.",-37.5,0.01,diseaseorphenotypicfeature
Lead intoxication in a patient with a history of type‑2B von Willebrand disease precipitated a severe bleeding episode that was successfully managed with recombinant factor VIII and desmopressin.,-32.25,0.01,diseaseorphenotypicfeature
"Lead exposure in children with Pb poisoning has been shown to increase the risk of developing non‑Hodgkin lymphoma, particularly in those with underlying type‑2B von Willebrand disease.",-25.125,0.01,diseaseorphenotypicfeature
Lead‑induced neurotoxicity in patients with type‑2B von Willebrand disease exacerbates bleeding episodes and is associated with a higher risk of developing non‑Hodgkin lymphoma.,-25.5,0.01,diseaseorphenotypicfeature
"Non‑Hodgkin lymphoma patients with a BRCA1 c.68_69delAG sequence variant exhibit markedly higher rates of treatment‑related adiposity, suggesting a genetic predisposition to metabolic complications during chemotherapy.",-23.875,0.01,diseaseorphenotypicfeature
Non-Hodgkin lymphoma patients with a BRCA1 c.68_69delAG sequence variant exhibit increased adiposity and a higher risk of developing diffuse mesangial sclerosis.,-21.75,0.01,diseaseorphenotypicfeature
Non–Hodgkin lymphoma patients with a BRCA1 c.68_69delAG sequence variant exhibit markedly higher rates of treatment‑related adiposity compared with those lacking the mutation.,-28.25,0.01,diseaseorphenotypicfeature
Non­Hodgkin lymphoma patients with a BRCA1 c.68_69delAG sequence variant exhibit markedly higher rates of treatment‑related adiposity compared with those lacking the mutation.,-31.5,0.01,diseaseorphenotypicfeature
Pb poisoning in children with type‑2B von Willebrand disease exacerbates bleeding episodes and is associated with increased risk of developing non‑Hodgkin lymphoma.,-25.875,0.01,diseaseorphenotypicfeature
"Pb in the bloodstream activates the TP53 pathway in HeLa cells, leading to apoptosis that may explain the increased adiposity observed in patients with type‑2B VWD.",-34.75,0.01,diseaseorphenotypicfeature
"Pb‑poisoning in a child with a history of type‑2B von Willebrand disease led to a sudden onset of diffuse mesangial sclerosis, prompting renal biopsy that revealed a novel BRCA1 c.68_69delAG variant.",-35.75,0.01,diseaseorphenotypicfeature
Pb exposure in children with a history of type‑2B von Willebrand disease leads to a higher incidence of diffuse mesangial sclerosis and an increased risk of developing non‑Hodgkin lymphoma.,-32.25,0.01,diseaseorphenotypicfeature
"Patients with type‑2B von Willebrand disease exhibit a markedly increased risk of developing diffuse mesangial sclerosis, and the presence of a pathogenic BRCA1 c.68_69delAG variant further predisposes them to non‑Hodgkin lymphoma.",-32.0,0.01,diseaseorphenotypicfeature
"Patients treated with the novel tyrosine‑kinase inhibitor imatinib for non‑Hodgkin lymphoma exhibited a significant reduction in circulating VEGF levels, correlating with improved progression‑free survival.",-27.25,0.01,diseaseorphenotypicfeature
"Patients experiencing Pb poisoning exhibit elevated blood lead levels that correlate with increased risk of developing non‑Hodgkin lymphoma and, in some cases, diffuse mesangial sclerosis.",-23.875,0.01,diseaseorphenotypicfeature
"Patients reported that the combination of a BRCA1 c.68_69delAG variant and a high‑fat diet exacerbated their diffuse mesangial sclerosis, leading to increased proteinuria and progressive renal failure.",-35.0,0.01,diseaseorphenotypicfeature
"Frequent exposure to lead in industrial settings has been linked to increased risk of non‑Hodgkin lymphoma, with elevated blood lead levels correlating with higher incidence of this malignancy in affected populations.",-30.875,0.01,diseaseorphenotypicfeature
"Frets in the patient’s history of **Pb poisoning** and **non‑Hodgkin lymphoma** were linked to a novel **SequenceVariant** in the **TP53** gene, suggesting a pathogenic mechanism underlying the observed **adiposity** and **muscular disorder** phenotypes.",-50.75,0.01,diseaseorphenotypicfeature
"Freely circulating lead ions in the blood of patients with Pb poisoning were found to up‑regulate the expression of the metallothionein‑2 gene, thereby exacerbating the renal tubular dysfunction observed in diffuse mesangial sclerosis.",-40.5,0.01,diseaseorphenotypicfeature
Freedman et al. reported that a BRCA1 c.68_69delAG variant in a patient with diffuse mesangial sclerosis and type‑2B von Willebrand disease exacerbated proteinuria and accelerated renal failure.,-36.5,0.01,diseaseorphenotypicfeature
"Doxorubicin treatment of non‑Hodgkin lymphoma in A549 cells induces a BRCA1 c.68_69delAG‑mediated loss of DNA repair, leading to increased apoptosis and a measurable rise in serum lactate dehydrogenase levels.",-26.375,0.01,diseaseorphenotypicfeature
Dysregulated expression of the TP53 gene in HeLa cells carrying the BRCA1 c.68_69delAG variant leads to increased susceptibility to non‑Hodgkin lymphoma in patients with type‑2B von Willebrand disease.,-28.25,0.01,diseaseorphenotypicfeature
"Dexamethasone treatment of a patient with type‑2B von Willebrand disease (VWD) exacerbated bleeding episodes, while a concurrent BRCA1 c.68_69delAG variant was found to increase susceptibility to diffuse mesangial sclerosis.",-33.75,0.01,diseaseorphenotypicfeature
"Drought‑induced oxidative stress in the A549 cell line upregulates the TP53 gene, thereby enhancing apoptosis and contributing to the development of non‑Hodgkin lymphoma in patients with chronic exposure to environmental toxins.",-39.5,0.01,diseaseorphenotypicfeature
"Mice harboring the BRCA1 c.68_69delAG variant exhibit increased adiposity and a higher incidence of non‑Hodgkin lymphoma, suggesting that this sequence variant contributes to both metabolic dysregulation and oncogenic susceptibility.",-23.625,0.01,diseaseorphenotypicfeature
"Methylmercury exposure in a cohort of children with Pb poisoning was associated with a higher incidence of type‑2B von Willebrand disease, suggesting a shared pathway of platelet dysfunction in these patients.",-33.75,0.01,diseaseorphenotypicfeature
"Molecular analysis of a patient with diffuse mesangial sclerosis revealed a novel BRCA1 c.68_69delAG variant that disrupts the DNA repair domain, correlating with the observed renal failure phenotype.",-25.5,0.01,diseaseorphenotypicfeature
Mediastinal lymph node biopsies from a patient with non‑Hodgkin lymphoma revealed a TP53 c.215C>A (p.Pro72Arg) sequence variant that correlates with increased tumor aggressiveness and poorer response to doxorubicin therapy.,-34.5,0.01,diseaseorphenotypicfeature
"Early onset diffuse mesangial sclerosis in a patient with a novel COL4A5 c.1523G>A variant was associated with proteinuria and progressive renal failure, prompting consideration of a targeted therapy with rapamycin to mitigate the disease phenotype.",-42.75,0.01,diseaseorphenotypicfeature
"Early‑stage diffuse mesangial sclerosis in a patient with a heterozygous COL4A5 c.1523G>A variant was associated with proteinuria and hypertension, prompting initiation of ACE‑inhibitor therapy to mitigate progressive renal failure.",-32.75,0.01,diseaseorphenotypicfeature
"Early‐stage diffuse mesangial sclerosis in a patient with a heterozygous COL4A5 c.1523G>A variant was associated with proteinuria and hypertension, prompting initiation of ACE inhibitor therapy to mitigate progressive renal failure.",-35.25,0.01,diseaseorphenotypicfeature
Early detection of a BRCA1 c.68_69delAG variant in a patient with a family history of non‑Hodgkin lymphoma and diffuse mesangial sclerosis prompted targeted surveillance for both breast cancer and renal disease.,-30.25,0.01,diseaseorphenotypicfeature
"Patients with a genetic defect in FH exhibit brain and genital malformations, pulmonary hypoplasia, and impaired learning, while liver injury and nephrotoxicity are also frequently observed.",-16.625,0.01,diseaseorphenotypicfeature
"Patients carrying the FH c.1234_1235delAG sequence variant exhibit severe liver injury and impaired learning, while the same genetic defect also predisposes to pulmonary hypoplasia and BSS-associated brain and genital malformations.",-29.5,0.01,diseaseorphenotypicfeature
"Patients diagnosed with Joubert syndrome (JBTS) frequently exhibit brain and genital malformations, and recent studies have linked a genetic defect in the *TMEM67* gene to the characteristic hepatic liver injury and pulmonary hypoplasia observed in these individuals.",-31.0,0.01,diseaseorphenotypicfeature
"Patients presenting with brain and genital malformations, pulmonary hypoplasia, and impaired learning were found to carry a homozygous sequence variant in the FH gene, a genetic defect that disrupts hypoxia‑sensing pathways and predisposes to liver injury and nephrotoxicity.",-23.5,0.01,diseaseorphenotypicfeature
"In patients with a genetic defect in fumarate hydratase, the resulting deficiency of FH leads to impaired hypoxia‑sensing and contributes to the development of brain and genital malformations, as well as pulmonary hypoplasia.",-17.25,0.01,diseaseorphenotypicfeature
"In **BSS**, a **genetic defect** in the **FH** gene leads to **liver injury** and **nephrotoxicity**, while the associated **hypoxia‑sensing** pathway disruption contributes to **pulmonary hypoplasia** and **brain and genital malformations**.",-27.0,0.01,diseaseorphenotypicfeature
"In this cohort of patients with a genetic defect in FH, the observed brain and genital malformations were accompanied by pulmonary hypoplasia and impaired learning, suggesting a multisystem phenotype that includes both hypoxia‑sensing abnormalities and nephrotoxicity.",-33.0,0.01,diseaseorphenotypicfeature
"In the BSS patient, a pathogenic FH c.1024G>A sequence variant was identified, causing a deficiency of fumarate hydratase that leads to liver injury and impaired learning, while the associated hypoxia‑sensing pathway dysfunction contributes to pulmonary hypoplasia.",-38.25,0.01,diseaseorphenotypicfeature
"Deficiencies in fumarate hydratase (FH) cause a genetic defect that predisposes patients to Birt–Hogg–Dubé syndrome, leading to pulmonary hypoplasia, brain and genital malformations, and impaired learning.",-18.375,0.01,diseaseorphenotypicfeature
"Deficiency of FH in a patient with BSS leads to impaired hypoxia‑sensing, causing both brain and genital malformations and pulmonary hypoplasia.",-14.125,0.01,diseaseorphenotypicfeature
"Defects in the FH gene cause a hereditary metabolic disorder that manifests as liver injury, pulmonary hypoplasia, and impaired learning, while the associated hypoxia‑sensing pathway is disrupted, leading to brain and genital malformations characteristic of BSS and JBTS.",-28.25,0.01,diseaseorphenotypicfeature
"Defective hypoxia‑sensing due to a loss‑of‑function mutation in the FH gene causes brain and genital malformations, pulmonary hypoplasia, and impaired learning in patients with BSS.",-18.5,0.01,diseaseorphenotypicfeature
"A patient with a genetic defect in FH presenting with liver injury, pulmonary hypoplasia, and impaired learning exhibited brain and genital malformations characteristic of BSS.",-16.625,0.01,diseaseorphenotypicfeature
"A CHD7 mutation causing brain and genital malformations is associated with impaired learning and pulmonary hypoplasia, while a concurrent FH deficiency exacerbates liver injury and nephrotoxicity in patients with BSS.",-28.25,0.01,diseaseorphenotypicfeature
A missense mutation in the FH gene (c.1024C>T) causes a genetic defect that impairs hypoxia‑sensing and leads to liver injury and nephrotoxicity in patients with BSS.,-23.375,0.01,diseaseorphenotypicfeature
"A mutation in the FH gene causes a genetic defect that leads to brain and genital malformations, pulmonary hypoplasia, and impaired learning, while also predisposing patients to liver injury and nephrotoxicity.",-21.125,0.01,diseaseorphenotypicfeature
"Cerebral‑cerebellar hypoplasia and renal dysplasia, hallmark features of Joubert syndrome, arise from pathogenic variants in the *TMEM67* gene, whose loss of function disrupts hypoxia‑sensing pathways and leads to impaired learning and motor coordination.",-31.125,0.01,diseaseorphenotypicfeature
"Celiac disease, a genetic defect in HLA‑DQ2/8, often presents with liver injury and impaired learning, and its severity is exacerbated by a deficiency of FH that disrupts hypoxia‑sensing pathways.",-32.25,0.01,diseaseorphenotypicfeature
"Causal analysis revealed that a pathogenic BRCA1 c.68_69delAG sequence variant in a female Homo sapiens patient with a genetic defect in the DNA repair pathway led to impaired learning and brain malformations, while concomitant liver injury and nephrotoxicity were observed as secondary phenotypic features.",-36.25,0.01,diseaseorphenotypicfeature
"Cystic fibrosis patients with the ΔF508 mutation exhibit pulmonary hypoplasia, liver injury, and impaired learning due to a genetic defect in the CFTR gene.",-20.5,0.01,diseaseorphenotypicfeature
"Silence in the cerebellar cortex of a patient with Joubert syndrome (JBTS) is associated with a pathogenic missense variant in the AHI1 gene, leading to impaired cerebellar vermis development and consequent ataxia and cognitive impairment.",-36.75,0.01,diseaseorphenotypicfeature
"Silica nanoparticles induce liver injury in HepG2 cells by upregulating CYP2E1, thereby exacerbating oxidative stress and impairing hepatic detoxification pathways.",-27.0,0.01,diseaseorphenotypicfeature
"Silk fibroin nanoparticles loaded with the small‑molecule inhibitor of the hypoxia‑sensing factor HIF‑2α ameliorated pulmonary hypoplasia in a mouse model of BSS, while concomitant upregulation of the FH gene product reduced liver injury and improved learning impairment.",-43.75,0.01,diseaseorphenotypicfeature
"Silicate exposure in a cohort of patients with BSS and hepatic injury was found to exacerbate pulmonary hypoplasia, while a novel FH deficiency variant (c.1234G>A) in the hypoxia‑sensing pathway was associated with impaired learning and a higher risk of nephrotoxicity.",-46.0,0.01,diseaseorphenotypicfeature
"Mutations in the FH gene, a genetic defect that impairs hypoxia‑sensing, cause a form of BSS characterized by brain and genital malformations, pulmonary hypoplasia, and liver injury.",-19.875,0.01,diseaseorphenotypicfeature
"Mutational loss of FH in a patient with BSS leads to impaired hypoxia‑sensing, causing liver injury and pulmonary hypoplasia while also contributing to brain and genital malformations.",-22.25,0.01,diseaseorphenotypicfeature
"Mutant mice harboring a homozygous BRCA1 c.68_69delAG sequence variant exhibit impaired learning, brain malformations, and liver injury, underscoring the genetic defect’s role in neurodevelopmental and hepatic phenotypes.",-29.25,0.01,diseaseorphenotypicfeature
"Mutants carrying the FH c.1024_1025delAG sequence variant exhibit severe liver injury and impaired learning, while the same genetic defect also predisposes to pulmonary hypoplasia and JBTS-associated brain malformations.",-37.5,0.01,diseaseorphenotypicfeature
The FH deficiency in a patient with BSS leads to impaired hypoxia‑sensing and contributes to the brain and genital malformations observed in this genetic defect.,-19.25,0.01,diseaseorphenotypicfeature
"The BRCA1 c.68_69delAG variant, a SequenceVariant in the TP53 GeneOrGeneProduct, is associated with impaired DNA repair and increased susceptibility to breast cancer in Homo sapiens, while the same mutation also predisposes to neurodevelopmental disorders such as Joubert syndrome (JBTS) and brain malformations.",-36.0,0.01,diseaseorphenotypicfeature
The liver injury observed in patients with a genetic defect in FH is exacerbated by hypoxia-sensing pathways that impair learning and contribute to pulmonary hypoplasia.,-15.375,0.01,diseaseorphenotypicfeature
"The novel FH‑deficiency mutation c.1234G>A in the *FH* gene causes a hypoxia‑sensing defect that manifests as brain and genital malformations, pulmonary hypoplasia, and impaired learning in affected patients.",-26.0,0.01,diseaseorphenotypicfeature
"Loss of FH function in a patient with BSS leads to hepatic injury, pulmonary hypoplasia, and impaired learning, while the associated genetic defect disrupts hypoxia‑sensing pathways.",-21.75,0.01,diseaseorphenotypicfeature
"Loss-of-function mutations in the FH gene cause fumarate hydratase deficiency, a rare metabolic disorder that leads to severe brain and genital malformations, impaired learning, and pulmonary hypoplasia.",-21.875,0.01,diseaseorphenotypicfeature
"Loss‑of‑function mutations in the FH gene cause a hereditary metabolic defect that predisposes patients to renal cell carcinoma, hepatic injury, and impaired learning, while FH‑deficient fibroblasts exhibit abnormal hypoxia‑sensing and increased susceptibility to nephrotoxicity.",-34.0,0.01,diseaseorphenotypicfeature
"Losses of FH in the renal tubular epithelium of a patient with BSS lead to hypoxia‑sensing defects that trigger pulmonary hypoplasia and impair learning, while the same genetic defect also predisposes to liver injury and nephrotoxicity.",-35.25,0.01,diseaseorphenotypicfeature
"Neurodevelopmental impairment of learning and brain malformations in patients with a genetic defect in the FH gene cause a severe form of BSS, leading to pulmonary hypoplasia and hypoxia‑sensing dysfunction.",-28.25,0.01,diseaseorphenotypicfeature
"Neuronal hypoxia-sensing defects caused by a pathogenic FH sequence variant in a patient with BSS lead to severe brain and genital malformations, pulmonary hypoplasia, and impaired learning.",-26.125,0.01,diseaseorphenotypicfeature
"Nephrotoxicity in patients with a genetic defect in FH manifests as impaired learning and brain malformations, while pulmonary hypoplasia and liver injury are secondary complications of the same disease.",-28.375,0.01,diseaseorphenotypicfeature
"Neonatal pulmonary hypoplasia and brain malformations observed in patients with a genetic defect in FH, a key hypoxia‑sensing enzyme, are hallmarks of the BSS phenotype.",-23.5,0.01,diseaseorphenotypicfeature
"Genome‑wide association analysis revealed that the FH c.1024C>T SequenceVariant, which causes a loss of function in fumarate hydratase, is strongly associated with the BSS phenotype of brain and genital malformations and pulmonary hypoplasia in patients with the genetic defect.",-35.5,0.01,diseaseorphenotypicfeature
"Genome‐wide association analysis revealed that a missense variant in the FH gene (c.1024C>T, p.Arg342Trp) is strongly associated with the BSS phenotype, characterized by brain and genital malformations, pulmonary hypoplasia, and impaired learning, and that this variant disrupts hypoxia‑sensing pathways, thereby contributing to the observed liver injury and nephrotoxicity in affected individuals.",-41.5,0.01,diseaseorphenotypicfeature
"Genome-wide association analysis revealed that a missense variant in the FH gene (c.1024G>A, p.Arg342His) is strongly associated with the BSS phenotype, characterized by brain and genital malformations, pulmonary hypoplasia, and impaired learning, while also predisposing carriers to liver injury and nephrotoxicity due to defective hypoxia-sensing pathways.",-40.25,0.01,diseaseorphenotypicfeature
"Genome sequencing of a patient with brain and genital malformations revealed a pathogenic BRCA1 c.68_69delAG variant that disrupts the DNA repair pathway, leading to impaired learning and a predisposition to liver injury.",-29.0,0.01,diseaseorphenotypicfeature
"Altered hypoxia‑sensing due to a pathogenic FH sequence variant in a patient with BSS leads to liver injury, pulmonary hypoplasia, and impaired learning.",-17.125,0.01,diseaseorphenotypicfeature
"Alterations in the FH gene cause a deficiency of fumarate hydratase that leads to hereditary leiomyomatosis and renal cell carcinoma, a disease characterized by liver injury, pulmonary hypoplasia, and impaired learning.",-21.25,0.01,diseaseorphenotypicfeature
"Alteration of the FH gene in a patient with BSS leads to hepatic injury, pulmonary hypoplasia, and impaired learning, while the same mutation also predisposes to hypoxia‑sensing defects and nephrotoxicity.",-28.875,0.01,diseaseorphenotypicfeature
"Alterative therapy with the small‑molecule inhibitor N‑acetylcysteine mitigated liver injury in a cohort of patients carrying the FH‑deficiency mutation c.1024C>T, thereby reducing the risk of renal cyst formation and improving overall survival in this subset of BSS‑associated disease.",-58.5,0.01,diseaseorphenotypicfeature
"Brain‑genital malformations, pulmonary hypoplasia, and impaired learning are hallmarks of the BSS genetic defect, which also predisposes to liver injury and nephrotoxicity through FH deficiency and hypoxia‑sensing dysregulation.",-24.25,0.01,diseaseorphenotypicfeature
"Brain hypoplasia and genital malformations in patients with a genetic defect in the FH gene cause severe hypoxia‑sensing dysfunction and impair learning, leading to BSS‑associated pulmonary hypoplasia and liver injury.",-23.25,0.01,diseaseorphenotypicfeature
"Brain and genital malformations, pulmonary hypoplasia, and impaired learning are hallmark phenotypic features of the BSS genetic defect, which is caused by a deficiency of FH and disrupts hypoxia‑sensing pathways.",-22.875,0.01,diseaseorphenotypicfeature
Brain malformations and pulmonary hypoplasia in patients with a genetic defect in FH cause severe hypoxia‑sensing impairment and learning deficits.,-19.0,0.01,diseaseorphenotypicfeature
"Genetic defects in the FH gene cause a deficiency of fumarate hydratase, leading to hereditary leiomyomatosis and renal cell carcinoma, a disease characterized by liver injury, pulmonary hypoplasia, and impaired learning.",-19.5,0.01,diseaseorphenotypicfeature
"Genotype‑specific loss of fumarate hydratase (FH) in a patient with Birt‑Hogg‑Dubé syndrome (BSS) leads to hepatic injury, pulmonary hypoplasia, and impaired learning, while the same FH deficiency also predisposes to nephrotoxicity and brain‑genital malformations through disrupted hypoxia‑sensing pathways.",-41.25,0.01,diseaseorphenotypicfeature
"Genomic sequencing of a patient with brain and genital malformations revealed a pathogenic BRCA1 c.68_69delAG variant, confirming a genetic defect underlying the observed impairment of learning and pulmonary hypoplasia.",-22.0,0.01,diseaseorphenotypicfeature
"Genotoxic exposure to doxorubicin in HeLa cells induces a BRCA1 c.68_69delAG variant that impairs DNA repair, leading to liver injury and pulmonary hypoplasia in a mouse model of BSS.",-28.0,0.01,diseaseorphenotypicfeature
"A significant weight gain in patients with Marfan syndrome (MFS) is associated with abnormal myocardial energy metabolism, increasing the risk of ectopic bleedings and endometrial adenocarcinoma.",-20.75,0.01,diseaseorphenotypicfeature
A patient with endometrial adenocarcinoma experienced eruptive xanthomas and abnormal myocardial energy metabolism after receiving a high‑dose doxorubicin regimen.,-16.75,0.01,diseaseorphenotypicfeature
"A recent cohort study found that patients with endometrial adenocarcinoma who experienced eruptive xanthomas had a higher incidence of abnormal myocardial energy metabolism, suggesting a possible link between lipid dysregulation and cardiac dysfunction in this disease.",-20.375,0.01,diseaseorphenotypicfeature
A biopsy of the endometrial adenocarcinoma revealed a BRCA1 c.68_69delAG sequence variant that may contribute to the patient’s abnormal myocardial energy metabolism and increased risk of bleedings.,-18.5,0.01,diseaseorphenotypicfeature
"Weight gain in patients with Marfan syndrome (MFS) is frequently associated with abnormal myocardial energy metabolism, leading to increased risk of bleeds and endometrial adenocarcinoma.",-14.1875,0.01,diseaseorphenotypicfeature
"Weight‑gain associated with the MFS‑linked FBN1 c.1234G>A variant exacerbates abnormal myocardial energy metabolism, predisposing patients to arrhythmic bleeds.",-30.75,0.01,diseaseorphenotypicfeature
"Weight-gain associated with the MFS mutation in the FBN1 gene can trigger ectopic bleeds, while the same FBN1 variant also predisposes to abnormal myocardial energy metabolism and, in rare cases, eruptive xanthomas.",-40.5,0.01,diseaseorphenotypicfeature
"Weight loss in patients with endometrial adenocarcinoma is associated with a higher incidence of eruptive xanthomas, suggesting that abnormal myocardial energy metabolism may contribute to the disease phenotype.",-27.125,0.01,diseaseorphenotypicfeature
"In this cohort of patients with endometrial adenocarcinoma, the presence of the BRCA1 c.68_69delAG sequence variant was associated with a higher incidence of weight gain and eruptive xanthomas, suggesting a link between the mutation and abnormal myocardial energy metabolism.",-23.75,0.01,diseaseorphenotypicfeature
"In patients with Marfan syndrome, the presence of a pathogenic FBN1 missense variant (c.1234G>A) is associated with progressive aortic root dilation, which in turn predisposes to life‑threatening aortic dissection and sudden cardiac death.",-29.75,0.01,diseaseorphenotypicfeature
"In MFS patients, the abnormal myocardial energy metabolism associated with weight gain predisposes to early onset colitis and eruptive xanthomas, complicating the management of endometrial adenocarcinoma.",-25.25,0.01,diseaseorphenotypicfeature
"In a cohort of patients with endometrial adenocarcinoma, the presence of eruptive xanthomas and abnormal myocardial energy metabolism was associated with a higher risk of postoperative bleedings, particularly in those who had experienced intra‑uterine growth restriction during pregnancy.",-19.125,0.01,diseaseorphenotypicfeature
"doxorubicin treatment in HeLa cells exacerbates weight gain and induces eruptive xanthomas, a phenotype also observed in patients with endometrial adenocarcinoma carrying the BRCA1 c.68_69delAG variant.",-23.625,0.01,diseaseorphenotypicfeature
dysregulated insulin signaling in the skeletal muscle of patients with Duchenne muscular dystrophy leads to abnormal myocardial energy metabolism and contributes to the weight gain observed during disease progression.,-21.75,0.01,diseaseorphenotypicfeature
"dEcreased insulin sensitivity and abnormal myocardial energy metabolism in patients with endometrial adenocarcinoma were exacerbated by weight gain, suggesting a metabolic link between obesity and tumor progression.",-34.5,0.01,diseaseorphenotypicfeature
detection of the BRCA1 c.68_69delAG variant in a patient with a family history of endometrial adenocarcinoma revealed a pathogenic mutation that predisposes to abnormal myocardial energy metabolism and increases the risk of early‑onset colitis.,-30.625,0.01,diseaseorphenotypicfeature
"The development of eruptive xanthomas in a patient with endometrial adenocarcinoma was associated with abnormal myocardial energy metabolism, leading to weight gain and increased risk of bleedings.",-18.125,0.01,diseaseorphenotypicfeature
"The BRCA1 c.68_69delAG variant in a patient with endometrial adenocarcinoma was found to impair DNA repair, thereby increasing the risk of secondary malignancies.",-21.625,0.01,diseaseorphenotypicfeature
"The patients with endometrial adenocarcinoma who experienced eruptive xanthomas after chemotherapy exhibited abnormal myocardial energy metabolism, suggesting a link between the drug-induced lipid disorder and cardiac dysfunction.",-22.25,0.01,diseaseorphenotypicfeature
"The patient with endometrial adenocarcinoma experienced significant weight gain after initiating a high‑dose steroid regimen, which subsequently exacerbated her underlying abnormal myocardial energy metabolism and increased the risk of ectopic bleedings.",-26.25,0.01,diseaseorphenotypicfeature
"Early onset weight gain in patients with Marfan syndrome (MFS) is frequently accompanied by abnormal myocardial energy metabolism, leading to a higher risk of ectopic bleedings and progressive endometrial adenocarcinoma.",-27.25,0.01,diseaseorphenotypicfeature
Early‑stage endometrial adenocarcinoma in a patient with a pathogenic TP53 c.215C>T variant is associated with abnormal myocardial energy metabolism and a higher risk of eruptive xanthomas.,-26.25,0.01,diseaseorphenotypicfeature
Early‐stage endometrial adenocarcinoma patients with the BRCA1 c.68_69delAG sequence variant exhibit markedly higher rates of eruptive xanthomas and abnormal myocardial energy metabolism compared with patients lacking the variant.,-24.0,0.01,diseaseorphenotypicfeature
"Early weight gain in patients with Marfan syndrome (MFS) is associated with abnormal myocardial energy metabolism, increasing the risk of bleeds and endometrial adenocarcinoma.",-20.75,0.01,diseaseorphenotypicfeature
"Surgical resection of an endometrial adenocarcinoma in a patient with Marfan syndrome (MFS) was complicated by postoperative bleeding, prompting the use of tranexamic acid to reduce hemorrhage risk.",-20.125,0.01,diseaseorphenotypicfeature
"Syndrome‑associated weight gain in Marfan syndrome patients is exacerbated by abnormal myocardial energy metabolism, leading to increased risk of ectopic bleedings and colitis.",-26.5,0.01,diseaseorphenotypicfeature
"Scoliosis, a common phenotypic feature of Marfan syndrome, often leads to progressive weight gain and abnormal myocardial energy metabolism, exacerbating the risk of bleeds and endometrial adenocarcinoma in affected patients.",-25.25,0.01,diseaseorphenotypicfeature
Skeletal muscle biopsies from a patient with Duchenne muscular dystrophy revealed a novel BRCA1 c.68_69delAG sequence variant that correlates with abnormal myocardial energy metabolism and increased risk of endometrial adenocarcinoma.,-22.875,0.01,diseaseorphenotypicfeature
Gain of the BRCA1 c.68_69delAG variant in a patient with endometrial adenocarcinoma is associated with abnormal myocardial energy metabolism and increased risk of eruptive xanthomas.,-21.25,0.01,diseaseorphenotypicfeature
"Gain‑of‑function mutations in the FBN1 gene, such as the c.1024C>T variant, are associated with Marfan syndrome and predispose patients to ectopic arterial bleedings, while the same mutation can also lead to abnormal myocardial energy metabolism and weight gain in affected individuals.",-51.5,0.01,diseaseorphenotypicfeature
"Gain‐associated weight gain in patients with Marfan syndrome (MFS) is exacerbated by abnormal myocardial energy metabolism, leading to increased risk of ectopic bleedings and colitis.",-28.375,0.01,diseaseorphenotypicfeature
Gain in body mass in patients with Marfan syndrome (MFS) is associated with abnormal myocardial energy metabolism and an increased risk of ectopic bleedings.,-23.0,0.01,diseaseorphenotypicfeature
"Genetic testing of a patient with unexplained weight gain and eruptive xanthomas revealed a pathogenic BRCA1 c.68_69delAG variant, suggesting a possible link to an underlying endometrial adenocarcinoma.",-22.375,0.01,diseaseorphenotypicfeature
Genomic analysis of a patient with endometrial adenocarcinoma revealed a BRCA1 c.68_69delAG sequence variant that may contribute to abnormal myocardial energy metabolism and predispose to weight gain.,-22.75,0.01,diseaseorphenotypicfeature
"Genetically engineered A549 cells harboring the BRCA1 c.68_69delAG variant exhibit increased sensitivity to doxorubicin, leading to pronounced weight gain and eruptive xanthomas in treated mice.",-25.75,0.01,diseaseorphenotypicfeature
"Genital bleeding in a patient with endometrial adenocarcinoma was exacerbated by the abnormal myocardial energy metabolism associated with her underlying Marfan syndrome, leading to a rapid weight gain that complicated her clinical management.",-33.25,0.01,diseaseorphenotypicfeature
"Mutations in the FBN1 gene that cause Marfan syndrome (MFS) are associated with abnormal myocardial energy metabolism, leading to progressive weight gain and increased risk of spontaneous bleedings.",-19.25,0.01,diseaseorphenotypicfeature
"Mutational loss of the dystrophin gene in Duchenne muscular dystrophy patients leads to abnormal myocardial energy metabolism, which in turn predisposes them to arrhythmogenic bleeds and sudden cardiac death.",-22.875,0.01,diseaseorphenotypicfeature
Mutagenic exposure to doxorubicin in A549 cells induces a BRCA1 c.68_69delAG variant that correlates with increased weight gain and abnormal myocardial energy metabolism in patients with endometrial adenocarcinoma.,-20.25,0.01,diseaseorphenotypicfeature
"Mutually exclusive mutations in the dystrophin gene (DMD) cause Duchenne muscular dystrophy, which is frequently accompanied by abnormal myocardial energy metabolism and progressive weight gain, thereby increasing the risk of cardiomyopathy and endometrial adenocarcinoma in affected patients.",-36.25,0.01,diseaseorphenotypicfeature
"Patients with Marfan syndrome who experience weight gain and abnormal myocardial energy metabolism are at increased risk of ectopic bleedings and colitis, complicating the management of their endometrial adenocarcinoma.",-21.75,0.01,diseaseorphenotypicfeature
"Patients treated with the novel kinase inhibitor A-12345 for metastatic endometrial adenocarcinoma experienced rapid weight gain, which was associated with abnormal myocardial energy metabolism and a higher incidence of ectopic bleedings.",-36.25,0.01,diseaseorphenotypicfeature
"Patients experiencing weight gain and abnormal myocardial energy metabolism after treatment with doxorubicin exhibit a higher incidence of colitis and eruptive xanthomas, suggesting a potential link between the drug’s cardiotoxicity and systemic lipid dysregulation.",-31.125,0.01,diseaseorphenotypicfeature
Patients diagnosed with Marfan syndrome who experience significant weight gain exhibit an increased risk of ectopic bleeding and abnormal myocardial energy metabolism.,-21.125,0.01,diseaseorphenotypicfeature
"Abnormal myocardial energy metabolism in patients with endometrial adenocarcinoma is exacerbated by weight gain, leading to increased risk of bleeds and colitis.",-15.1875,0.01,diseaseorphenotypicfeature
Abdominal pain and eruptive xanthomas in a patient with endometrial adenocarcinoma were exacerbated by the weight‑gain‑inducing chemotherapy regimen.,-24.0,0.01,diseaseorphenotypicfeature
Abnormally elevated myocardial energy metabolism in patients with endometrial adenocarcinoma correlates with weight gain and increased risk of bleeds.,-21.125,0.01,diseaseorphenotypicfeature
"Abnormally elevated triglyceride levels and eruptive xanthomas in a patient with endometrial adenocarcinoma were found to be associated with a pathogenic BRCA1 c.68_69delAG variant, suggesting a link between lipid metabolism dysregulation and tumor progression.",-35.25,0.01,diseaseorphenotypicfeature
"Eruptive xanthomas, a hallmark of abnormal myocardial energy metabolism, frequently appear in patients with endometrial adenocarcinoma who also experience weight gain and recurrent bleedings.",-21.0,0.01,diseaseorphenotypicfeature
"Epidemiologic analysis of patients with endometrial adenocarcinoma revealed that those who experienced eruptive xanthomas and abnormal myocardial energy metabolism had a higher incidence of weight gain, suggesting a metabolic link between lipid deposition and tumor progression.",-25.5,0.01,diseaseorphenotypicfeature
Eruption of xanthomas in a patient with familial hypercholesterolemia was associated with a sudden weight gain and an abnormal myocardial energy metabolism that predisposed to early onset endometrial adenocarcinoma.,-29.75,0.01,diseaseorphenotypicfeature
Ectopic expression of the MYH7 variant c.1903G>A in cardiomyocytes derived from a patient with abnormal myocardial energy metabolism leads to impaired mitochondrial respiration and contributes to the development of dilated cardiomyopathy.,-33.5,0.01,diseaseorphenotypicfeature
"Research in a cohort of patients with endometrial adenocarcinoma revealed that the presence of the BRCA1 c.68_69delAG sequence variant was associated with a higher incidence of eruptive xanthomas and abnormal myocardial energy metabolism, suggesting a potential link between this genetic alteration and metabolic complications in this disease.",-31.625,0.01,diseaseorphenotypicfeature
"Research findings indicate that the BRCA1 c.68_69delAG sequence variant in a patient with endometrial adenocarcinoma is associated with abnormal myocardial energy metabolism, potentially contributing to the observed weight gain and eruptive xanthomas.",-29.875,0.01,diseaseorphenotypicfeature
Research shows that the BRCA1 c.68_69delAG sequence variant in a patient with endometrial adenocarcinoma is associated with abnormal myocardial energy metabolism and a higher risk of eruptive xanthomas.,-26.0,0.01,diseaseorphenotypicfeature
"Research demonstrates that the BRCA1 c.68_69delAG sequence variant in a patient with endometrial adenocarcinoma is associated with abnormal myocardial energy metabolism, leading to increased weight gain and a higher risk of bleeds.",-30.25,0.01,diseaseorphenotypicfeature
"Mutations in the *TP53* gene, frequently observed in small cell lung cancer, are associated with growth delay and arterial dysfunction in patients with end‑stage liver disease.",-18.75,0.01,diseaseorphenotypicfeature
Mutational analysis of the TP53 gene in HeLa cells revealed that the BRCA1 c.68_69delAG variant exacerbates growth delay and promotes lamellate thrombi formation in patients with end‑stage liver disease.,-20.375,0.01,diseaseorphenotypicfeature
"Mutagenic exposure to benzene in A549 cells carrying the TP53 c.215C>T variant induces growth delay and promotes lamellate thrombi formation, thereby exacerbating end‑stage liver disease in patients with small cell lung cancer.",-28.375,0.01,diseaseorphenotypicfeature
"Mutant TP53 c.215C>A in HeLa cells exacerbates growth delay and induces lamellate thrombi, linking the sequence variant to end‑stage liver disease in patients with small cell lung cancer.",-25.875,0.01,diseaseorphenotypicfeature
"In patients with X‑linked nystagmus, the BRCA1 c.68_69delAG variant is associated with a higher incidence of growth delay and arterial dysfunction, suggesting a shared developmental pathway that may predispose to end‑stage liver disease.",-23.125,0.01,diseaseorphenotypicfeature
"In infants with X‑linked nystagmus, the presence of a de novo TP53 c.215C>T (p.R72P) sequence variant in the affected cell line H1299 correlates with increased susceptibility to lamellate thrombi and arterial dysfunction during respiratory syncytial viral infection.",-37.0,0.01,diseaseorphenotypicfeature
"In a cohort of patients with end‑stage liver disease, the presence of lamellate thrombi on hepatic biopsy was associated with a higher incidence of growth delay and arterial dysfunction, suggesting a shared pathogenic pathway involving vascular remodeling and endocrine dysregulation.",-25.75,0.01,diseaseorphenotypicfeature
"In HeLa cells harboring the TP53 c.215C>G SequenceVariant, the expression of the anti‑apoptotic gene BCL2 is up‑regulated, thereby conferring resistance to doxorubicin‑induced apoptosis and contributing to the chemoresistance observed in small cell lung cancer.",-26.25,0.01,diseaseorphenotypicfeature
"The BRCA1 c.68_69delAG variant in a patient with small cell lung cancer was found to impair DNA repair, thereby accelerating growth delay and contributing to the development of end‑stage liver disease.",-20.125,0.01,diseaseorphenotypicfeature
"The TP53 c.215C>G variant, detected in a HeLa-derived xenograft, accelerates the development of small cell lung cancer by disrupting p53-mediated DNA repair and promoting arterial dysfunction in the tumor microenvironment.",-27.875,0.01,diseaseorphenotypicfeature
"The occurrence of lamellate thrombi in patients with end‑stage liver disease is associated with arterial dysfunction, and the presence of growth delay and malformations in these individuals suggests a possible underlying X‑linked nystagmus mutation.",-29.25,0.01,diseaseorphenotypicfeature
"The development of lamellate thrombi in patients with end‑stage liver disease is exacerbated by the presence of a BRCA1 c.68_69delAG sequence variant, which impairs hepatic platelet‑activating factor clearance and promotes arterial dysfunction.",-25.0,0.01,diseaseorphenotypicfeature
"Mice harboring the BRCA1 c.68_69delAG variant exhibit growth delay and increased susceptibility to small cell lung cancer, while the same mutation is also associated with arterial dysfunction and lamellate thrombi in human patients.",-24.375,0.01,diseaseorphenotypicfeature
Molecular analysis of a patient with X‑linked nystagmus revealed a novel TP53 c.68_69delAG variant that likely contributes to the observed growth delay and arterial dysfunction.,-20.75,0.01,diseaseorphenotypicfeature
"Mild growth delay in infants with X‑linked nystagmus is frequently accompanied by arterial dysfunction, and in some cases, lamellate thrombi have been observed in the retinal vessels.",-27.0,0.01,diseaseorphenotypicfeature
"Miller‑Sackler syndrome, a rare X‑linked disorder characterized by congenital nystagmus and growth delay, is frequently associated with arterial dysfunction and lamellate thrombi in affected infants.",-31.375,0.01,diseaseorphenotypicfeature
"Arterial dysfunction in patients with end‑stage liver disease is exacerbated by the presence of lamellate thrombi, which are frequently detected in small‑cell lung cancer metastases.",-20.125,0.01,diseaseorphenotypicfeature
"Arteriopathy in patients with X‑linked nystagmus is frequently accompanied by growth delay and small‑cell lung cancer, suggesting a shared pathogenic pathway involving endothelial dysfunction and aberrant angiogenic signaling.",-27.875,0.01,diseaseorphenotypicfeature
"Arrested growth delay in infants with X‑linked nystagmus is frequently accompanied by arterial dysfunction and lamellate thrombi, suggesting a shared developmental pathway that may predispose to end‑stage liver disease.",-30.25,0.01,diseaseorphenotypicfeature
"Arthritis in patients with the BRCA1 c.68_69delAG variant is associated with a higher incidence of lamellate thrombi and growth delay, suggesting a pathogenic link between the sequence variant and vascular dysfunction.",-30.125,0.01,diseaseorphenotypicfeature
"Zebrafish embryos with a CRISPR‑generated TP53 c.68_69delAG variant exhibit growth delay, malformations, and lamellate thrombi, suggesting that this sequence variant contributes to developmental arrest and vascular pathology.",-31.625,0.01,diseaseorphenotypicfeature
"ZBTB7A loss-of-function mutations in the TP53‑regulated pathway cause growth delay and arterial dysfunction in patients with X‑linked nystagmus, while the same variant is associated with lamellate thrombi in small cell lung cancer.",-38.25,0.01,diseaseorphenotypicfeature
Zygosity of the BRCA1 c.68_69delAG variant in a patient with small cell lung cancer and growth delay suggests a pathogenic link between the sequence variant and the disease phenotype.,-24.625,0.01,diseaseorphenotypicfeature
"Zika virus infection during pregnancy is associated with microcephaly, a birth defect that can lead to growth delay and severe neurodevelopmental impairment.",-23.25,0.01,diseaseorphenotypicfeature
"Mutation of the GATA4 gene in a fetus carrying a de novo sequence variant c.1123G>A leads to congenital heart malformations and growth delay, while the same variant is absent in the unaffected mother, suggesting a pathogenic role in birth defects.",-40.5,0.01,diseaseorphenotypicfeature
"Mutation c.68_69delAG in the BRCA1 gene, detected in a patient with growth delay and small cell lung cancer, was shown to disrupt DNA repair pathways and increase susceptibility to end‑stage liver disease.",-27.75,0.01,diseaseorphenotypicfeature
Mutation in the TP53 gene causes growth delay and predisposes HeLa cells to develop small cell lung cancer when exposed to doxorubicin.,-18.0,0.01,diseaseorphenotypicfeature
"Mutation‑induced loss of the TP53 gene in HeLa cells exacerbates growth delay and promotes the formation of lamellate thrombi, thereby increasing the risk of end‑stage liver disease in patients with small cell lung cancer.",-26.875,0.01,diseaseorphenotypicfeature
"CYP-induced cystitis in VIP (-/-) mice exacerbated arterial dysfunction and lamellate thrombi formation, mirroring the respiratory syncytial viral infection–associated growth delay observed in patients with small cell lung cancer and end‑stage liver disease.",-25.75,0.01,diseaseorphenotypicfeature
"Cytotoxic chemotherapy with cisplatin induces growth delay and arterial dysfunction in patients with small cell lung cancer, while the presence of a BRCA1 c.68_69delAG sequence variant predicts a higher risk of end‑stage liver disease.",-24.0,0.01,diseaseorphenotypicfeature
"Cystic fibrosis, a genetic disorder causing severe respiratory syncytial viral infection and growth delay, is frequently associated with the CFTR c.1521_1523delCTT variant and leads to end‑stage liver disease in a subset of patients.",-31.875,0.01,diseaseorphenotypicfeature
"Cochlear malformations and X‑linked nystagmus were observed in a cohort of infants with growth delay, and the presence of lamellate thrombi in the pulmonary arteries suggested an underlying arterial dysfunction contributing to the end‑stage liver disease.",-33.0,0.01,diseaseorphenotypicfeature
"A BRCA1 c.68_69delAG variant in a patient with small cell lung cancer was found to impair DNA repair, thereby accelerating tumor progression and contributing to the observed growth delay.",-19.25,0.01,diseaseorphenotypicfeature
"A missense mutation in the GATA4 gene (c.1123G>A) is associated with congenital heart malformations, including ventricular septal defects, in patients with X‑linked nystagmus and growth delay.",-24.5,0.01,diseaseorphenotypicfeature
A mutation in the TP53 gene (SequenceVariant) found in HeLa cells (CellLine) is associated with growth delay (DiseaseOrPhenotypicFeature) and increased susceptibility to small cell lung cancer (DiseaseOrPhenotypicFeature) in Homo sapiens (OrganismTaxon).,-22.375,0.01,diseaseorphenotypicfeature
"A retrospective cohort of patients with end‑stage liver disease who received a single dose of doxorubicin showed a statistically significant increase in growth delay and arterial dysfunction compared with matched controls, suggesting that the chemotherapeutic agent may exacerbate vascular complications in this vulnerable population.",-29.625,0.01,diseaseorphenotypicfeature
"End-stage liver disease in patients with small cell lung cancer is frequently accompanied by growth delay, arterial dysfunction, and lamellate thrombi, complicating the clinical management of these patients.",-21.375,0.01,diseaseorphenotypicfeature
"Endocardial fibroelastosis, a rare congenital malformation, is frequently associated with lamellate thrombi and arterial dysfunction in infants who also exhibit growth delay and X‑linked nystagmus.",-30.25,0.01,diseaseorphenotypicfeature
"End‑stage liver disease in patients with small cell lung cancer is frequently accompanied by growth delay, arterial dysfunction, and lamellate thrombi, complicating the clinical management of these patients.",-21.625,0.01,diseaseorphenotypicfeature
"End‐stage liver disease in patients with small cell lung cancer is frequently accompanied by growth delay and arterial dysfunction, and the presence of lamellate thrombi has been reported in a subset of these individuals.",-26.5,0.01,diseaseorphenotypicfeature
"SARS‑CoV‑2 infection in a patient with X‑linked nystagmus and growth delay precipitated arterial dysfunction, leading to lamellate thrombi and ultimately end‑stage liver disease.",-18.5,0.01,diseaseorphenotypicfeature
"Surgical resection of a small cell lung cancer in a patient with a BRCA1 c.68_69delAG variant was followed by a marked improvement in growth delay and a reduction in arterial dysfunction, suggesting a potential link between the sequence variant and the disease phenotype.",-29.375,0.01,diseaseorphenotypicfeature
"Sporadic X‑linked nystagmus in a newborn is frequently accompanied by growth delay and subtle craniofacial malformations, suggesting a shared developmental pathway that may predispose to later arterial dysfunction.",-31.625,0.01,diseaseorphenotypicfeature
"Surgery for a congenital X‑linked nystagmus patient revealed a small cell lung cancer‑like proliferation of lamellate thrombi in the pulmonary arteries, suggesting that arterial dysfunction may underlie the growth delay and end‑stage liver disease observed in this cohort.",-37.75,0.01,diseaseorphenotypicfeature
"An X‑linked nystagmus mutation in the RPGR gene causes progressive retinal degeneration, leading to visual impairment and growth delay in affected infants.",-20.25,0.01,diseaseorphenotypicfeature
"An A549 cell line treated with doxorubicin exhibited a dose‑dependent increase in TP53‑mediated apoptosis, suggesting that the drug’s cytotoxic effect may be amplified in small cell lung cancer cells harboring a BRCA1 c.68_69delAG variant.",-29.0,0.01,diseaseorphenotypicfeature
An end‑stage liver disease patient with growth delay and arterial dysfunction exhibited lamellate thrombi after receiving a single dose of doxorubicin in a HeLa‑derived small cell lung cancer model.,-24.875,0.01,diseaseorphenotypicfeature
"An infant with X‑linked nystagmus and growth delay exhibited arterial dysfunction and lamellate thrombi, suggesting a severe end‑stage liver disease secondary to congenital malformations.",-21.0,0.01,diseaseorphenotypicfeature
"TP53 mutations in A549 cells exacerbate growth delay and arterial dysfunction in patients with small cell lung cancer, while the same variant also predisposes to lamellate thrombi and end‑stage liver disease.",-23.75,0.01,diseaseorphenotypicfeature
"TPH1 deficiency in a patient with X‑linked nystagmus leads to elevated serotonin levels, which in turn exacerbates arterial dysfunction and contributes to the growth delay observed in this case.",-32.75,0.01,diseaseorphenotypicfeature
"TP63 mutations cause a spectrum of birth‑defect syndromes, including limb‑and‑craniofacial malformations, and the same variant is associated with end‑stage liver disease in patients with congenital hepatic fibrosis.",-38.25,0.01,diseaseorphenotypicfeature
TP73 mutations in the TP73 c.1024_1025delAA allele are associated with growth delay and X‑linked nystagmus in patients with small cell lung cancer who also exhibit lamellate thrombi and arterial dysfunction.,-44.25,0.01,diseaseorphenotypicfeature
"Patients with X‑linked nystagmus exhibit growth delay and arterial dysfunction, and in some cases the same pathogenic variant in the RPGR gene also predisposes to small cell lung cancer.",-25.375,0.01,diseaseorphenotypicfeature
"Patients harboring the BRCA1 c.68_69delAG sequence variant exhibit a markedly increased risk of small cell lung cancer, yet paradoxically display a growth delay that may be mitigated by early intervention with a PARP inhibitor.",-28.125,0.01,diseaseorphenotypicfeature
"Patients receiving the novel tyrosine‑kinase inhibitor gefitinib for small cell lung cancer exhibited a marked reduction in arterial dysfunction, yet developed growth delay and lamellate thrombi, suggesting a complex interplay between therapeutic efficacy and adverse phenotypic features.",-33.75,0.01,diseaseorphenotypicfeature
"Patients diagnosed with X‑linked nystagmus and small cell lung cancer often exhibit growth delay, and in some cases, the TP53 mutation c.215C>T (p.R72P) is associated with increased arterial dysfunction and lamellate thrombi formation.",-34.25,0.01,diseaseorphenotypicfeature
"Mucopolysaccharidosis type VI, a lysosomal storage disorder characterized by joint contractures and hepatosplenomegaly, is exacerbated by chronic inflammation that promotes osteomyelitis in patients with underlying HCV infection.",-21.125,0.01,diseaseorphenotypicfeature
"Mice harboring the BRCA1 c.68_69delAG variant exhibit increased susceptibility to osteomyelitis following HCV infection, a phenotype that mirrors the joint contractures observed in patients with mucopolysaccharidosis type VI.",-23.875,0.01,diseaseorphenotypicfeature
"Methylprednisolone treatment of a patient with primary cutaneous follicle center lymphoma and concurrent hepatitis B virus infection reduced inflammatory cytokine levels but precipitated joint contractures, suggesting a complex interplay between immune modulation and musculoskeletal pathology.",-29.25,0.01,diseaseorphenotypicfeature
"Molecular analysis of a patient with Goltz syndrome revealed a novel TP53 c.215G>A (p.Arg72His) sequence variant that appears to disrupt the DNA‑binding domain, potentially contributing to the observed joint contractures and skin fragility.",-29.875,0.01,diseaseorphenotypicfeature
"The joint contractures observed in patients with Goltz syndrome are exacerbated by chronic inflammation, which is often secondary to HCV infection and can further impair mobility.",-17.625,0.01,diseaseorphenotypicfeature
"The HCV infection in a patient with Goltz syndrome exacerbated hepatic inflammation, leading to a rapid decline in liver function and the development of osteomyelitis in the lower extremities.",-18.75,0.01,diseaseorphenotypicfeature
"The patient with Goltz syndrome exhibited severe joint contractures and a chronic inflammatory response that predisposed her to osteomyelitis, while her HCV infection was associated with elevated liver enzymes and a mild form of mucopolysaccharidosis type VI.",-31.25,0.01,diseaseorphenotypicfeature
"The study revealed that patients with Goltz syndrome and joint contractures exhibit a higher prevalence of inflammatory markers, suggesting a potential link between the diseaseorphenotypicfeature and systemic inflammation.",-24.875,0.01,diseaseorphenotypicfeature
"In chronic hepatitis B virus (HBV) infection, the inflammatory milieu induces up‑regulation of the CXCL10 chemokine, which in turn promotes recruitment of CD8⁺ T cells that exacerbate liver injury and accelerate progression to hepatocellular carcinoma.",-30.625,0.01,diseaseorphenotypicfeature
"In patients with Goltz syndrome, the presence of joint contractures and Peters anomaly often leads to chronic inflammation that can exacerbate mucopolysaccharidosis type VI symptoms.",-17.25,0.01,diseaseorphenotypicfeature
"In Hepatitis B virus–infected patients, the inflammatory milieu of the liver promotes the development of primary cutaneous follicle center lymphoma, a phenomenon that has been observed in a subset of individuals with chronic HBV infection.",-30.375,0.01,diseaseorphenotypicfeature
"In a cohort of patients with Goltz syndrome, the presence of joint contractures and Peters anomaly was associated with increased inflammatory cytokine levels, suggesting a shared pathogenic pathway that may also contribute to the development of primary cutaneous follicle center lymphoma.",-22.25,0.01,diseaseorphenotypicfeature
"Inflammation in patients with Goltz syndrome and HCV infection is exacerbated by the presence of a BRCA1 c.68_69delAG sequence variant, which may contribute to the development of primary cutaneous follicle center lymphoma.",-23.5,0.01,diseaseorphenotypicfeature
"Inflamed joints in patients with Goltz syndrome frequently progress to osteomyelitis, and the presence of a BRCA1 c.68_69delAG sequence variant has been associated with an increased risk of primary cutaneous follicle center lymphoma in these individuals.",-28.625,0.01,diseaseorphenotypicfeature
"Inflammasome activation in hepatocytes of hepatitis B virus–infected patients with Goltz syndrome exacerbates liver fibrosis, leading to progressive osteomyelitis and joint contractures.",-26.5,0.01,diseaseorphenotypicfeature
"Influenza‑induced inflammation in a patient with Goltz syndrome exacerbated joint contractures, prompting the use of a novel anti‑TNFα chemical entity to mitigate osteomyelitis risk.",-28.875,0.01,diseaseorphenotypicfeature
"A recent cohort study of patients with Goltz syndrome revealed that the presence of a novel TP53 c.215G>A sequence variant correlates with increased joint contractures and a higher incidence of osteomyelitis, suggesting a pathogenic link between the mutation and the disease phenotype.",-31.25,0.01,diseaseorphenotypicfeature
"A pathogenic BRCA1 c.68_69delAG variant in a patient with Goltz syndrome exacerbates joint contractures and predisposes to osteomyelitis, while concurrent HCV infection amplifies hepatic inflammation and accelerates progression to hepatocellular carcinoma.",-27.625,0.01,diseaseorphenotypicfeature
"A biopsy of a primary cutaneous follicle center lymphoma in a patient with hepatitis B virus infection revealed that the tumor cells overexpressed the CXCL12 chemokine, which likely contributes to the chronic inflammation and joint contractures observed in this case.",-28.625,0.01,diseaseorphenotypicfeature
"A patient with Goltz syndrome and joint contractures exhibited chronic inflammation that was exacerbated by HCV infection, leading to progressive osteomyelitis of the tibia.",-18.125,0.01,diseaseorphenotypicfeature
"Polysaccharide accumulation in mucopolysaccharidosis type VI induces joint contractures, while HCV infection exacerbates hepatic inflammation, and the combination of both conditions has been reported to worsen the clinical course of primary cutaneous follicle center lymphoma.",-35.0,0.01,diseaseorphenotypicfeature
"Polymorphisms in the COL4A1 gene, which are frequently observed in patients with Peters anomaly, exacerbate the inflammatory response to HCV infection and are associated with an increased risk of osteomyelitis in individuals with mucopolysaccharidosis type VI.",-28.5,0.01,diseaseorphenotypicfeature
"Polymyalgia rheumatica, a systemic inflammatory disease, frequently presents with joint contractures and elevated C‑reactive protein levels, and its pathogenesis is linked to dysregulated IL‑6 signaling in the affected synovial tissue.",-32.5,0.01,diseaseorphenotypicfeature
"Polycystic ovary syndrome, a common endocrine disorder, is frequently accompanied by chronic inflammation that exacerbates insulin resistance and promotes the development of non‑alcoholic fatty liver disease in patients with hepatitis B virus infection.",-29.75,0.01,diseaseorphenotypicfeature
"HCV infection in a patient with Goltz syndrome exacerbated hepatic inflammation, leading to a rapid decline in liver function and the development of osteomyelitis in the lower extremities.",-17.875,0.01,diseaseorphenotypicfeature
Hepatitis B virus infection in a patient with Goltz syndrome exacerbated joint contractures and triggered an inflammatory response that ultimately led to osteomyelitis.,-16.5,0.01,diseaseorphenotypicfeature
"HIV‑associated chronic inflammation in patients with hepatitis B virus (HBV) infection accelerates the progression of mucopolysaccharidosis type VI, leading to severe joint contractures and osteomyelitis.",-24.5,0.01,diseaseorphenotypicfeature
"HNF4A mutations in patients with mucopolysaccharidosis type VI exacerbate hepatic inflammation, leading to accelerated progression of osteomyelitis and joint contractures.",-25.75,0.01,diseaseorphenotypicfeature
"Patients with Goltz syndrome exhibit severe joint contractures and ocular Peters anomaly, while HCV infection can trigger chronic inflammation that predisposes to primary cutaneous follicle center lymphoma.",-16.125,0.01,diseaseorphenotypicfeature
"Patients diagnosed with Goltz syndrome exhibit severe joint contractures and ocular Peters anomaly, while HCV infection and hepatitis B virus (HBV) infected individuals frequently develop chronic inflammation and osteomyelitis.",-24.625,0.01,diseaseorphenotypicfeature
"Patients infected with hepatitis B virus (HBV) who develop chronic inflammation of the liver are at increased risk of progressing to hepatocellular carcinoma, a phenotype that can be exacerbated by the presence of a BRCA2 c.5946_5947delAG sequence variant.",-32.5,0.01,diseaseorphenotypicfeature
"Patients harboring a BRCA1 c.68_69delAG sequence variant exhibit increased susceptibility to osteomyelitis, a severe inflammatory disease that can be exacerbated by concurrent hepatitis B virus infection.",-27.125,0.01,diseaseorphenotypicfeature
"Goltz syndrome, characterized by ectodermal dysplasia and skin fragility, often presents with joint contractures and inflammatory lesions that can predispose patients to secondary osteomyelitis.",-20.0,0.01,diseaseorphenotypicfeature
"Golitz syndrome, characterized by ectodermal dysplasia and joint contractures, is frequently associated with chronic inflammation that can predispose patients to osteomyelitis and, in some cases, secondary primary cutaneous follicle center lymphoma.",-35.0,0.01,diseaseorphenotypicfeature
"Golzip syndrome, characterized by joint contractures and osteomyelitis, is exacerbated by chronic HCV infection, which induces systemic inflammation and accelerates mucopolysaccharidosis type VI progression.",-32.5,0.01,diseaseorphenotypicfeature
"Golz syndrome, a rare ectodermal dysplasia, is frequently associated with joint contractures and ocular Peters anomaly, while chronic HCV infection can exacerbate hepatic inflammation and predispose to primary cutaneous follicle center lymphoma.",-36.75,0.01,diseaseorphenotypicfeature
"Mutation of the GPC3 gene in a patient with Goltz syndrome leads to abnormal dermal fibroblast proliferation, causing joint contractures and a predisposition to osteomyelitis.",-20.25,0.01,diseaseorphenotypicfeature
"Mutation in the COL4A5 gene causes the X‑linked form of Goltz syndrome, which is characterized by epidermal atrophy, joint contractures, and ocular Peters anomaly.",-25.625,0.01,diseaseorphenotypicfeature
"Mutation‑induced loss of the glycosaminoglycan‑synthesizing enzyme ARSB in patients with mucopolysaccharidosis type VI leads to joint contractures, hepatosplenomegaly, and progressive osteomyelitis, while the same ARSB variant is also associated with a higher risk of primary cutaneous follicle center lymphoma in individuals with chronic hepatitis B virus infection.",-43.5,0.01,diseaseorphenotypicfeature
"Mutation AAVS1 c.1234G>A in the TP53 gene of a HeLa cell line infected with hepatitis B virus (HBV) induces a Goltz‑like phenotype characterized by joint contractures and osteomyelitis, while the same variant in a primary cutaneous follicle center lymphoma cell line triggers inflammatory cytokine release and mucopolysaccharidosis type VI‑associated glycosaminoglycan accumulation.",-53.25,0.01,diseaseorphenotypicfeature
"Stochastic analysis of a cohort of patients with Goltz syndrome revealed that the presence of a novel TP53 c.215G>A sequence variant correlates with increased joint contractures and a higher incidence of osteomyelitis, suggesting a pathogenic link between the mutation and the disease phenotype.",-39.5,0.01,diseaseorphenotypicfeature
Streptococcus pyogenes infection of the skin in a patient with mucopolysaccharidosis type VI triggers a severe inflammatory response that precipitates joint contractures and osteomyelitis.,-25.25,0.01,diseaseorphenotypicfeature
"Staphylococcus aureus osteomyelitis in a patient with Goltz syndrome exacerbated inflammatory cytokine production, leading to progressive joint contractures and a secondary risk of mucopolysaccharidosis type VI–like skeletal dysplasia.",-28.5,0.01,diseaseorphenotypicfeature
"Stellate ganglion block reduced pain and inflammation in a patient with primary cutaneous follicle center lymphoma, whose PET/CT revealed increased uptake in the cervical lymph nodes and a concurrent HCV infection that had previously caused hepatic fibrosis.",-42.25,0.01,diseaseorphenotypicfeature
"SARS‑CoV‑2 infection in a patient with mucopolysaccharidosis type VI exacerbated joint contractures, leading to severe osteomyelitis of the tibia and a secondary inflammatory response that triggered a flare of primary cutaneous follicle center lymphoma.",-28.5,0.01,diseaseorphenotypicfeature
"Sustained inflammation in patients with hepatitis B virus (HBV) infection can trigger joint contractures and osteomyelitis, while the same inflammatory milieu is implicated in the pathogenesis of primary cutaneous follicle center lymphoma.",-29.5,0.01,diseaseorphenotypicfeature
Skeletal muscle biopsies from a patient with Goltz syndrome revealed a novel BRCA1 c.68_69delAG sequence variant that appears to exacerbate the inflammatory phenotype and predispose to osteomyelitis.,-28.375,0.01,diseaseorphenotypicfeature
"Surgical resection of a primary cutaneous follicle center lymphoma in a patient with a BRCA1 c.68_69delAG variant was complicated by postoperative osteomyelitis, prompting a review of the patient’s history of hepatitis B virus infection and joint contractures.",-27.5,0.01,diseaseorphenotypicfeature
"Peters anomaly, a congenital ocular defect, is frequently accompanied by joint contractures and inflammation, and recent studies suggest that a BRCA1 c.68_69delAG variant may exacerbate the severity of mucopolysaccharidosis type VI in patients with Goltz syndrome.",-27.5,0.01,diseaseorphenotypicfeature
"Pseudomonas aeruginosa infection of the bone marrow in a patient with mucopolysaccharidosis type VI exacerbated osteomyelitis, leading to severe joint contractures and chronic inflammation.",-26.25,0.01,diseaseorphenotypicfeature
"Pediatric patients with Goltz syndrome exhibit severe joint contractures and ocular Peters anomaly, while chronic HCV infection in adults is associated with hepatic inflammation and increased risk of primary cutaneous follicle center lymphoma.",-29.5,0.01,diseaseorphenotypicfeature
"Pellagra-like dermatitis, joint contractures, and osteomyelitis were observed in a patient with Goltz syndrome carrying a novel TP53 c.215G>A variant, while HCV infection exacerbated hepatic inflammation and accelerated progression to hepatocellular carcinoma.",-42.25,0.01,diseaseorphenotypicfeature
"Analysis of a cohort of patients with Goltz syndrome revealed that the presence of a novel TP53 c.215G>A sequence variant correlates with increased severity of joint contractures and a higher incidence of osteomyelitis, suggesting a pathogenic link between the mutation and the disease phenotype.",-34.0,0.01,diseaseorphenotypicfeature
Analysis in a cohort of patients with Goltz syndrome revealed that the presence of a novel TP53 c.215G>A sequence variant was associated with increased joint contractures and a higher incidence of osteomyelitis compared with patients lacking the variant.,-35.5,0.01,diseaseorphenotypicfeature
"Analysis revealed that the Goltz syndrome phenotype in a patient with a novel TP53 mutation was exacerbated by chronic HCV infection, leading to severe joint contractures and osteomyelitis of the tibia.",-30.375,0.01,diseaseorphenotypicfeature
"Analysis by whole‑exome sequencing revealed that a novel missense variant in the *COL4A1* gene (c.1523G>A, p.Gly508Asp) is associated with the severe joint contractures and osteomyelitis observed in patients with Goltz syndrome.",-46.5,0.01,diseaseorphenotypicfeature
A variant in the HNF4A gene (c.1024G>A) is associated with non‑alcoholic fatty liver disease and contributes to the development of atherogenesis in patients with metabolic syndrome.,-29.875,0.01,diseaseorphenotypicfeature
"A reduced expression of the transcription factor HIF‑1α in A549 cells treated with the small‑molecule inhibitor YC‑1 exacerbates hypoxic pulmonary remodelling, thereby accelerating the progression of nonalcoholic fatty liver disease in a murine model of metabolic syndrome.",-28.0,0.01,diseaseorphenotypicfeature
"A longitudinal cohort of preterm infants revealed that the presence of a BRCA1 c.68_69delAG variant in the neonatal blood spot was associated with an increased risk of developing retinopathy of prematurity, while the same cohort also showed a higher incidence of non‑alcoholic fatty liver disease in infants carrying the PNPLA3 I148M polymorphism.",-32.5,0.01,diseaseorphenotypicfeature
"A dose‑dependent reduction in retinal vascular leakage was observed in a mouse model of retinopathy of prematurity, where the loss of VEGFA signaling in the retinal endothelial cells of C57BL/6J mice led to a significant decrease in neovascular tuft formation and improved visual acuity.",-37.5,0.01,diseaseorphenotypicfeature
"Streptozotocin‑induced diabetes in C57BL/6J mice exacerbated retinal vascular leakage, accelerating retinopathy of prematurity‑like lesions and upregulating VEGFA expression in the retinal pigment epithelium.",-18.75,0.01,diseaseorphenotypicfeature
Stunting in infants with nonalcoholic fatty liver disease is exacerbated by a BRCA1 c.68_69delAG variant that impairs hepatic lipid metabolism and promotes atherogenesis.,-20.5,0.01,diseaseorphenotypicfeature
Studiation of the BRCA1 c.68_69delAG variant in a cohort of patients with nonalcoholic fatty liver disease revealed that carriers exhibited a higher prevalence of retinopathy of prematurity and a significant increase in atherogenesis compared with noncarriers.,-30.25,0.01,diseaseorphenotypicfeature
"Stochastic modeling of retinopathy of prematurity progression in preterm infants revealed that elevated VEGFA expression in the retinal microvasculature, driven by hypoxic pulmonary remodelling, correlates with increased risk of retinal neovascularization and subsequent visual impairment.",-32.5,0.01,diseaseorphenotypicfeature
"CRISPR‑mediated knockout of the HIF‑1α gene in A549 cells exacerbated hypoxic pulmonary remodelling, leading to increased expression of VEGFA and a higher incidence of retinopathy of prematurity‑like vascular lesions in the lung microvasculature.",-28.5,0.01,diseaseorphenotypicfeature
"CRP levels were markedly elevated in infants with retinopathy of prematurity, suggesting that systemic inflammation may accelerate retinal vascular remodeling and contribute to the progression of this disease.",-23.625,0.01,diseaseorphenotypicfeature
"CR3 deficiency in a patient with retinopathy of prematurity and multiple malformations of the axial skeleton was found to impair complement activation, thereby exacerbating retinal vascular leakage and skeletal dysplasia.",-34.0,0.01,diseaseorphenotypicfeature
CRF‑1 overexpression in the retinal pigment epithelium of premature infants accelerates the progression of retinopathy of prematurity by upregulating VEGF and inducing pathological neovascularization.,-31.25,0.01,diseaseorphenotypicfeature
"In a cohort of infants with retinopathy of prematurity, the presence of a BRCA1 c.68_69delAG sequence variant in the TP53 gene was associated with a higher incidence of multiple malformations of the axial skeleton and a greater risk of developing nonalcoholic fatty liver disease.",-20.625,0.01,diseaseorphenotypicfeature
"In patients with nonalcoholic fatty liver disease, the hepatic steatosis‑induced oxidative stress upregulates the HIF‑1α pathway, which in turn promotes atherogenesis through increased LDL‑oxidation and endothelial dysfunction.",-20.875,0.01,diseaseorphenotypicfeature
"In infants with retinopathy of prematurity, the presence of a BRCA1 c.68_69delAG sequence variant in the TP53 gene has been associated with an increased risk of developing atherogenesis and multiple malformations of the axial skeleton.",-19.875,0.01,diseaseorphenotypicfeature
"In an observational cohort of premature infants, the presence of a BRCA1 c.68_69delAG sequence variant in the TP53 gene was associated with a higher incidence of retinopathy of prematurity and a greater risk of developing nonalcoholic fatty liver disease, suggesting a potential genetic predisposition to these disease phenotypes.",-31.0,0.01,diseaseorphenotypicfeature
"Non‑alcoholic fatty liver disease in obese adolescents is associated with increased hepatic steatosis, insulin resistance, and a higher risk of atherogenesis, while retinopathy of prematurity remains a leading cause of visual impairment in premature infants.",-21.625,0.01,diseaseorphenotypicfeature
"Nonalcoholic fatty liver disease in obese adolescents is associated with increased hepatic steatosis, insulin resistance, and a higher risk of atherogenesis, while retinopathy of prematurity remains a leading cause of visual impairment in premature infants.",-22.125,0.01,diseaseorphenotypicfeature
Non alcoholic fatty liver disease in a cohort of obese adolescents was found to be associated with a higher prevalence of retinopathy of prematurity and increased expression of the inflammatory cytokine IL‑6 in the liver tissue.,-37.0,0.01,diseaseorphenotypicfeature
"Non‐alcoholic fatty liver disease in obese adolescents is associated with increased hepatic steatosis, insulin resistance, and a higher risk of atherogenesis, while retinopathy of prematurity remains a leading cause of visual impairment in premature infants.",-26.25,0.01,diseaseorphenotypicfeature
"Deficiency of the transcription factor SOX9 in the developing mouse limb bud leads to multiple malformations of the axial skeleton and a severe reduction in cartilage matrix production, thereby accelerating atherogenesis in the aortic root of aged ApoE‑/‑ mice.",-37.25,0.01,diseaseorphenotypicfeature
"Defining the interaction between the TP53 gene product and the small molecule doxorubicin in HeLa cells revealed that the drug induces a sequence variant c.215C>T in the TP53 promoter, which correlates with increased apoptosis and a reduction in the risk of non‑alcoholic fatty liver disease in patients with the A549 cell line.",-52.75,0.01,diseaseorphenotypicfeature
"Defective Wnt signaling in the TP53‑mutated A549 cell line exacerbates nonalcoholic fatty liver disease‑associated steatosis, leading to increased atherogenesis in Homo sapiens patients with the BRCA1 c.68_69delAG variant.",-28.75,0.01,diseaseorphenotypicfeature
"Defects in the WNT signaling pathway, such as the loss‑of‑function mutation in the LRP5 gene, are associated with a severe form of multiple malformations of the axial skeleton and a heightened risk of atherogenesis in affected patients.",-33.25,0.01,diseaseorphenotypicfeature
"The TP53 c.215C>G SequenceVariant in the A549 CellLine was found to accelerate nonalcoholic fatty liver disease progression in Homo sapiens patients, suggesting a direct link between this mutation and hepatic steatosis.",-25.75,0.01,diseaseorphenotypicfeature
"The high‑fat diet‑induced nonalcoholic fatty liver disease in the A549 cell line was shown to up‑regulate the inflammatory cytokine IL‑6, which in turn exacerbated the atherogenesis observed in the humanized ApoE*3Leiden mice.",-34.0,0.01,diseaseorphenotypicfeature
"The retinopathy of prematurity observed in preterm infants is exacerbated by the presence of a BRCA1 c.68_69delAG variant, which impairs DNA repair pathways and increases oxidative stress in retinal endothelial cells.",-18.75,0.01,diseaseorphenotypicfeature
"The progression of nonalcoholic fatty liver disease in patients with a BRCA1 c.68_69delAG variant is accelerated by chronic exposure to ethanol, leading to increased atherogenesis and higher risk of myocardial infarction.",-22.125,0.01,diseaseorphenotypicfeature
"Evidence indicates that the BRCA1 c.68_69delAG SequenceVariant in the TP53 GeneOrGeneProduct amplifies oxidative stress, thereby accelerating atherogenesis in Homo sapiens patients with Nonalcoholic Fatty Liver Disease.",-21.875,0.01,diseaseorphenotypicfeature
"Evidence suggests that the BRCA1 c.68_69delAG sequence variant in the TP53 gene product exacerbates retinopathy of prematurity in Homo sapiens infants, while concomitant exposure to doxorubicin increases atherogenesis risk.",-32.25,0.01,diseaseorphenotypicfeature
"Evidence from a longitudinal cohort of preterm infants indicates that the severity of retinopathy of prematurity is strongly correlated with the presence of a BRCA1 c.68_69delAG sequence variant, which appears to modulate VEGF expression in retinal endothelial cells.",-28.5,0.01,diseaseorphenotypicfeature
Evidence that the BRCA1 c.68_69delAG SequenceVariant increases the risk of Nonalcoholic Fatty Liver Disease in Homo sapiens patients with the TP53 GeneOrGeneProduct mutation was found in a cohort of A549 CellLine cultures treated with doxorubicin.,-26.5,0.01,diseaseorphenotypicfeature
"Patients with nonalcoholic fatty liver disease who exhibit a BRCA1 c.68_69delAG sequence variant also show an increased risk of developing atherogenesis, suggesting a shared metabolic‑genetic pathway.",-23.125,0.01,diseaseorphenotypicfeature
"Patients experiencing retinopathy of prematurity often exhibit a heightened risk of developing nonalcoholic fatty liver disease, as the retinal vascular damage is frequently accompanied by hepatic steatosis and systemic inflammation.",-30.75,0.01,diseaseorphenotypicfeature
"Patients receiving the novel anti‑angiogenic drug bevacizumab for metastatic colorectal cancer developed a severe case of retinopathy of prematurity, which was subsequently linked to a BRCA1 c.68_69delAG sequence variant that predisposes to vascular fragility.",-37.0,0.01,diseaseorphenotypicfeature
"Patients who develop retinopathy of prematurity often exhibit a sequence variant in the VEGFA gene that increases vascular endothelial growth factor expression, thereby accelerating abnormal retinal vessel growth.",-25.25,0.01,diseaseorphenotypicfeature
"Treatment of non‑alcoholic fatty liver disease with the PPAR‑α agonist fenofibrate reduced hepatic steatosis and improved insulin sensitivity in a cohort of obese patients, while a concomitant increase in circulating adiponectin levels was associated with a lower risk of atherogenesis.",-32.25,0.01,diseaseorphenotypicfeature
"Treatment with the small‑molecule inhibitor N‑acetylcysteine attenuated retinal vascular leakage in a mouse model of retinopathy of prematurity, while simultaneously reducing hepatic steatosis in a diet‑induced nonalcoholic fatty liver disease model, suggesting a shared oxidative‑stress‑mediated pathway underlying both ocular and hepatic pathology.",-39.0,0.01,diseaseorphenotypicfeature
"Treatment targeting the TP53 pathway in A549 cells reduces the expression of VEGFA, thereby attenuating hypoxic pulmonary remodelling and improving survival in a mouse model of non‑alcoholic fatty liver disease.",-35.0,0.01,diseaseorphenotypicfeature
"Treatment trials with the small‑molecule inhibitor N‑acetylcysteine in patients with nonalcoholic fatty liver disease have shown that it reduces hepatic steatosis and improves insulin sensitivity, while a separate cohort of infants with Meckel‑Gruber syndrome type‑3 exhibited severe renal cystic dysplasia and multiple malformations of the axial skeleton, underscoring the pleiotropic effects of the underlying genetic defect.",-66.5,0.01,diseaseorphenotypicfeature
"Retinopathy of prematurity, a severe ocular complication in preterm infants, is exacerbated by the presence of a BRCA1 c.68_69delAG sequence variant that disrupts DNA repair pathways and increases oxidative stress in retinal endothelial cells.",-23.0,0.01,diseaseorphenotypicfeature
"Retinal vascular remodeling in retinopathy of prematurity is exacerbated by the loss of the protective TP53 pathway, leading to increased VEGFA expression and subsequent neovascularization.",-28.75,0.01,diseaseorphenotypicfeature
"Retreatment of a patient with non‑alcoholic fatty liver disease using a dual PPARα/γ agonist reduced hepatic steatosis and improved insulin sensitivity, while a concurrent mutation in the PNPLA3 gene (c.148C>G, p.I148M) was associated with a higher risk of atherogenesis.",-40.25,0.01,diseaseorphenotypicfeature
Retrospective analysis of infants with retinopathy of prematurity revealed that those receiving intravitreal bevacizumab exhibited a statistically significant reduction in the progression of retinal neovascularization compared with the untreated cohort.,-27.25,0.01,diseaseorphenotypicfeature
"Alterations in the TP53 gene product in HeLa cells treated with doxorubicin exacerbate retinopathy of prematurity‑like vascular changes, suggesting a link between chemotherapy‑induced DNA damage and premature retinal neovascularization.",-28.125,0.01,diseaseorphenotypicfeature
"Altered expression of the TP53 gene in A549 cells treated with doxorubicin exacerbates retinopathy of prematurity‑like vascular leakage, mirroring the atherogenesis observed in nonalcoholic fatty liver disease patients.",-25.75,0.01,diseaseorphenotypicfeature
"Alteration of the TP53 gene product in HeLa cells carrying the BRCA1 c.68_69delAG variant accelerates the progression of non‑alcoholic fatty liver disease, a phenotype that is exacerbated by the presence of the A549 cell‑derived cytokine IL‑6.",-38.5,0.01,diseaseorphenotypicfeature
"Alterative therapy with the small‑molecule inhibitor rapamycin reduced the progression of retinopathy of prematurity in a cohort of preterm infants, while concomitant elevation of serum triglycerides suggested a potential link to nonalcoholic fatty liver disease.",-42.0,0.01,diseaseorphenotypicfeature
"Mutations in the *COL2A1* gene, such as the c.3704G>A variant, are associated with multiple malformations of the axial skeleton and can predispose patients to atherogenesis through altered extracellular matrix remodeling.",-31.0,0.01,diseaseorphenotypicfeature
"Mutational loss of the TP53 gene in A549 cells exacerbates nonalcoholic fatty liver disease‑associated steatosis, thereby accelerating atherogenesis in a murine model of hypercholesterolemia.",-24.0,0.01,diseaseorphenotypicfeature
"Mutant TP53 c.215C>G in a HeLa-derived cell line exacerbates nonalcoholic fatty liver disease‑associated steatosis by upregulating SREBP‑1c, thereby accelerating atherogenesis in a Homo sapiens‑derived vascular endothelial model.",-33.25,0.01,diseaseorphenotypicfeature
Mutagenic exposure to benzene in A549 cells carrying the TP53 c.215C>T variant accelerates the development of non‑alcoholic fatty liver disease‑associated steatosis and promotes atherogenesis through up‑regulation of the LDLR gene.,-27.5,0.01,diseaseorphenotypicfeature
"Gene expression profiling of the A549 cell line treated with doxorubicin revealed that the TP53 pathway was up‑regulated, correlating with increased apoptosis and a reduction in the proliferation of cells harboring the BRCA1 c.68_69delAG variant, thereby suggesting a potential therapeutic strategy for non‑alcoholic fatty liver disease in patients with the TP53 rs1042522 polymorphism.",-40.25,0.01,diseaseorphenotypicfeature
Gene‑editing of the TP53 c.215C>G variant in A549 cells reduces the incidence of non‑alcoholic fatty liver disease‑associated steatosis and improves insulin sensitivity in a murine model of metabolic syndrome.,-26.625,0.01,diseaseorphenotypicfeature
"Gene editing of the TP53 c.215C>G variant in A549 cells reduces the incidence of non‑alcoholic fatty liver disease‑associated steatosis and improves insulin‑mediated glucose uptake, thereby attenuating atherogenesis in a murine model of metabolic syndrome.",-31.75,0.01,diseaseorphenotypicfeature
"Gene *TP53* mutations in *Homo sapiens* fibroblasts accelerate atherogenesis by upregulating LDL‑RAP1, thereby linking cellular senescence to early‑onset coronary artery disease.",-32.75,0.01,diseaseorphenotypicfeature
"In Parkinson’s disease, dopaminergic deficits trigger a toxic neurodegenerative cascade that ultimately leads to neuronal death and memory deficiency.",-7.59375,0.01,diseaseorphenotypicfeature
"In patients with dopaminergic deficits, the toxic neurodegenerative cascade that leads to neuronal death is exacerbated by catalepsy, contributing to memory deficiency and, in some cases, renal interstitial fibrosis.",-18.0,0.01,diseaseorphenotypicfeature
"In dopaminergic deficits associated with Parkinson’s disease, the toxic neurodegenerative cascade leads to neuronal death, which in turn exacerbates memory deficiency and catalepsy.",-15.0,0.01,diseaseorphenotypicfeature
"In the mouse model of dopaminergic deficits, chronic exposure to the chemical entity rotenone induced a toxic neurodegenerative cascade that culminated in neuronal death and memory deficiency, mirroring the catalepsy observed in Parkinson’s disease patients.",-19.125,0.01,diseaseorphenotypicfeature
"Dopaminergic deficits in the striatum trigger a toxic neurodegenerative cascade that culminates in neuronal death and catalepsy, thereby contributing to memory deficiency in Parkinson’s disease.",-11.9375,0.01,diseaseorphenotypicfeature
"Dysregulated dopaminergic deficits in the striatum trigger a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency, a hallmark of Parkinson’s disease.",-17.0,0.01,diseaseorphenotypicfeature
"Doxorubicin treatment of A549 cells induces dopaminergic deficits that trigger a toxic neurodegenerative cascade, leading to neuronal death and memory deficiency.",-15.875,0.01,diseaseorphenotypicfeature
Dexamethasone treatment of A549 cells expressing the TP53 c.215C>G variant reduces dopaminergic deficits and attenuates the toxic neurodegenerative cascade that otherwise leads to neuronal death and memory deficiency.,-24.5,0.01,diseaseorphenotypicfeature
"A dopaminergic deficit in the striatum, induced by chronic methamphetamine exposure, triggers a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency.",-14.375,0.01,diseaseorphenotypicfeature
"A sustained dopaminergic deficit in the striatum of A549 cells treated with doxorubicin induces a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency, mirroring the catalepsy observed in Parkinson’s disease patients.",-20.5,0.01,diseaseorphenotypicfeature
"A mouse model of dopaminergic deficits exhibits catalepsy and neuronal death, mirroring the toxic neurodegenerative cascade observed in Parkinson’s disease.",-16.5,0.01,diseaseorphenotypicfeature
"A recent cohort study showed that dopaminergic deficits in Parkinson’s disease patients correlate with increased catalepsy scores, suggesting a toxic neurodegenerative cascade that contributes to neuronal death and memory deficiency.",-19.5,0.01,diseaseorphenotypicfeature
"Toxically induced dopaminergic deficits in the striatum of A549 cells trigger a neurodegenerative cascade that culminates in neuronal death and memory deficiency, mirroring the catalepsy observed in Parkinson’s disease patients.",-18.125,0.01,diseaseorphenotypicfeature
"Toxic neurodegenerative cascade induced by dopaminergic deficits in Parkinson’s disease leads to neuronal death, catalepsy, and memory deficiency, while hypercalciuria and renal interstitial fibrosis are common comorbidities in patients with GCD type I.",-22.75,0.01,diseaseorphenotypicfeature
"Tetrabenazine-induced dopaminergic deficits in Parkinson’s disease patients exacerbate catalepsy, neuronal death, and memory deficiency, while concurrent treatment with a selective dopamine agonist mitigates these neurodegenerative cascades.",-28.625,0.01,diseaseorphenotypicfeature
"TREATMENT: In patients with ovarian cancer, the combination of doxorubicin and cisplatin induces a toxic neurodegenerative cascade that leads to dopaminergic deficits, catalepsy, and memory deficiency, while also exacerbating renal interstitial fibrosis and hypercalciuria.",-32.75,0.01,diseaseorphenotypicfeature
The dopaminergic deficits observed in Parkinson’s disease trigger a toxic neurodegenerative cascade that ultimately leads to neuronal death and memory deficiency.,-7.28125,0.01,diseaseorphenotypicfeature
"The hypercalciuria observed in patients with GCD type I is driven by dopaminergic deficits that trigger a toxic neurodegenerative cascade, ultimately leading to neuronal death and memory deficiency.",-13.875,0.01,diseaseorphenotypicfeature
"The selective dopamine D2 receptor antagonist haloperidol induces a cataleptic state in mice, a phenotype that correlates with dopaminergic deficits and neuronal death in the striatum, thereby providing a model for studying the toxic neurodegenerative cascade underlying Parkinson’s disease.",-27.375,0.01,diseaseorphenotypicfeature
"The loss of dopaminergic neurons in the substantia nigra, coupled with a toxic neurodegenerative cascade, underlies the catalepsy and memory deficiency observed in Parkinson’s disease.",-14.6875,0.01,diseaseorphenotypicfeature
Gene therapy targeting the TP53 pathway in A549 cells reduces dopaminergic deficits and prevents the toxic neurodegenerative cascade that otherwise leads to neuronal death and memory deficiency in Parkinson’s disease models.,-26.125,0.01,diseaseorphenotypicfeature
"Gene‑edited A549 cells harboring the BRCA1 c.68_69delAG variant exhibit dopaminergic deficits that trigger a toxic neurodegenerative cascade, leading to neuronal death and memory deficiency.",-16.5,0.01,diseaseorphenotypicfeature
"Gene TP53 mutations in ovarian cancer cells trigger a toxic neurodegenerative cascade that leads to dopaminergic deficits, neuronal death, and memory deficiency.",-22.625,0.01,diseaseorphenotypicfeature
"Gene expression profiling of the A549 cell line treated with doxorubicin revealed that the TP53‑regulated pathway was up‑regulated, correlating with increased neuronal death and memory deficiency observed in a mouse model of dopaminergic deficits.",-29.875,0.01,diseaseorphenotypicfeature
"Recurrent dopaminergic deficits in the striatum of A549 cells treated with doxorubicin induce a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency, mirroring the catalepsy observed in Parkinson’s disease patients.",-22.25,0.01,diseaseorphenotypicfeature
"Refractory catalepsy in Parkinson’s disease patients is exacerbated by dopaminergic deficits, leading to progressive neuronal death and memory deficiency.",-22.5,0.01,diseaseorphenotypicfeature
"Reversible catalepsy induced by the dopamine D2 antagonist haloperidol in C57BL/6J mice is accompanied by dopaminergic deficits in the striatum, neuronal death in the substantia nigra, and a toxic neurodegenerative cascade that ultimately impairs memory function.",-28.875,0.01,diseaseorphenotypicfeature
Reinforced dopaminergic deficits in the striatum of A549 cells treated with doxorubicin induce a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency.,-22.0,0.01,diseaseorphenotypicfeature
"Neuroimaging of patients with Parkinson’s disease reveals that dopaminergic deficits correlate with increased catalepsy scores, suggesting that neuronal death initiates a toxic neurodegenerative cascade that ultimately impairs memory function.",-16.625,0.01,diseaseorphenotypicfeature
"Neuronal death induced by a toxic neurodegenerative cascade in dopaminergic deficits leads to catalepsy and memory deficiency, while hypercalciuria and renal interstitial fibrosis are frequently observed in patients with GCD type I.",-22.125,0.01,diseaseorphenotypicfeature
"Neural degeneration in Parkinson’s disease is exacerbated by dopaminergic deficits, leading to catalepsy and memory deficiency that correlate with increased neuronal death.",-21.75,0.01,diseaseorphenotypicfeature
Neonatal dopaminergic deficits in a mouse model of GCD type I trigger a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency.,-21.125,0.01,diseaseorphenotypicfeature
"Exposure to chronic ethanol in A549 cells induces dopaminergic deficits that trigger a toxic neurodegenerative cascade, ultimately causing neuronal death and memory deficiency.",-19.0,0.01,diseaseorphenotypicfeature
"Exposure of A549 cells to doxorubicin induces dopaminergic deficits that trigger a toxic neurodegenerative cascade, leading to neuronal death and memory deficiency in a model of Parkinson’s disease.",-16.625,0.01,diseaseorphenotypicfeature
"Exposure‑induced dopaminergic deficits in the striatum of A549 cells treated with doxorubicin trigger a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency, mirroring the catalepsy observed in Parkinson’s disease patients.",-27.625,0.01,diseaseorphenotypicfeature
Exposure-induced dopaminergic deficits in the striatum trigger a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency.,-21.25,0.01,diseaseorphenotypicfeature
"Deficiency of dopaminergic signaling in the striatum triggers a toxic neurodegenerative cascade that culminates in neuronal death and catalepsy, thereby contributing to the memory deficiency observed in Parkinson’s disease.",-18.75,0.01,diseaseorphenotypicfeature
"Defining the dopaminergic deficits that underlie catalepsy, neuronal death, and memory deficiency in a mouse model of GCD type I reveals a toxic neurodegenerative cascade that parallels the renal interstitial fibrosis observed in patients with hypercalciuria.",-27.0,0.01,diseaseorphenotypicfeature
"Deficiencies in dopaminergic signaling in the striatum trigger a toxic neurodegenerative cascade that culminates in neuronal death and catalepsy, thereby contributing to memory deficiency in Parkinson’s disease.",-21.5,0.01,diseaseorphenotypicfeature
"Deficits in dopaminergic signaling in the striatum are associated with catalepsy and memory deficiency, while a toxic neurodegenerative cascade involving neuronal death contributes to the progression of renal interstitial fibrosis and GCD type I.",-27.375,0.01,diseaseorphenotypicfeature
"Cytotoxic chemotherapy with doxorubicin induces dopaminergic deficits that trigger a toxic neurodegenerative cascade, leading to neuronal death and memory deficiency in patients with ovarian cancer.",-15.875,0.01,diseaseorphenotypicfeature
"C57BL/6J mice treated with the dopamine D2 receptor antagonist haloperidol exhibited catalepsy and dopaminergic deficits that preceded neuronal death and memory deficiency, mirroring the toxic neurodegenerative cascade observed in Parkinson’s disease.",-25.375,0.01,diseaseorphenotypicfeature
Cerebral dopaminergic deficits in Parkinson’s disease trigger a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency.,-13.8125,0.01,diseaseorphenotypicfeature
"Causal links between dopaminergic deficits and catalepsy were confirmed in a study where neuronal death in the substantia nigra of A549 cells exposed to doxorubicin induced a toxic neurodegenerative cascade, leading to memory deficiency and renal interstitial fibrosis in a mouse model of ovarian cancer.",-30.375,0.01,diseaseorphenotypicfeature
"Catalepsy in Parkinson’s disease patients is exacerbated by dopaminergic deficits, which trigger a toxic neurodegenerative cascade leading to neuronal death and memory deficiency.",-13.625,0.01,diseaseorphenotypicfeature
"Catabolic dopaminergic deficits in the striatum trigger a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency, a hallmark of Parkinson’s disease.",-24.5,0.01,diseaseorphenotypicfeature
"Catastrophic dopaminergic deficits in the substantia nigra, coupled with a toxic neurodegenerative cascade, trigger neuronal death that manifests clinically as severe catalepsy and memory deficiency in patients with Parkinson’s disease.",-28.75,0.01,diseaseorphenotypicfeature
"Catolepsy, a dopaminergic deficit–induced motor rigidity, is exacerbated by neuronal death in the substantia nigra, contributing to the memory deficiency observed in Parkinson’s disease.",-31.125,0.01,diseaseorphenotypicfeature
Altered dopaminergic deficits in the striatum of A549 cells treated with doxorubicin induce a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency.,-15.1875,0.01,diseaseorphenotypicfeature
"Alterations in dopaminergic deficits and the ensuing toxic neurodegenerative cascade are believed to trigger neuronal death, which in turn contributes to the memory deficiency observed in patients with Parkinson’s disease.",-25.125,0.01,diseaseorphenotypicfeature
Alteration of dopaminergic deficits in the striatum of A549 cells treated with doxorubicin induces a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency.,-20.625,0.01,diseaseorphenotypicfeature
"Alterative treatment with the dopamine agonist pramipexole reduced catalepsy and neuronal death in a mouse model of dopaminergic deficits, thereby improving memory deficiency and attenuating the toxic neurodegenerative cascade.",-28.875,0.01,diseaseorphenotypicfeature
"Decreased dopaminergic signaling in the striatum of A549 cells treated with doxorubicin induces a toxic neurodegenerative cascade that culminates in neuronal death and memory deficiency, mirroring the catalepsy observed in Parkinson’s disease patients.",-22.5,0.01,diseaseorphenotypicfeature
"Depletion of dopaminergic signaling in the striatum triggers a toxic neurodegenerative cascade that culminates in neuronal death and catalepsy, thereby contributing to the memory deficiency observed in Parkinson’s disease.",-19.375,0.01,diseaseorphenotypicfeature
"Depleting dopaminergic signaling in the striatum of A549 cells induces a cataleptic‑like phenotype, exacerbates neuronal death, and triggers a toxic neurodegenerative cascade that ultimately impairs memory function.",-28.875,0.01,diseaseorphenotypicfeature
"Deletions in the GCD type I gene, combined with hypercalciuria, trigger a toxic neurodegenerative cascade that culminates in dopaminergic deficits and memory deficiency.",-28.5,0.01,diseaseorphenotypicfeature
"CRABP1 overexpression in LKB1‑knockout A549 cells enhances PER2‑mediated circadian regulation of p62/Sequestosome‑1, thereby increasing NADH:ubiquinone oxidoreductase subunit stability and sensitizing the cells to PEG‑IFN/RBV‑induced apoptosis.",-18.25,0.01,geneorgeneproduct
"CRISPR‑mediated knockout of LKB1 in the A549 cell line upregulates the kinase C‑dependent phosphorylation of p62/Sequestosome‑1, thereby enhancing autophagic clearance of misfolded PER2 protein and reducing the accumulation of NADH:ubiquinone oxidoreductase subunits that otherwise contribute to oxidative stress in these human lung carcinoma cells.",-33.25,0.01,geneorgeneproduct
"CRIBP1 overexpression in LKB1‑knockout A549 cells enhances PER2‑mediated circadian regulation of the NADH:ubiquinone oxidoreductase subunits, thereby increasing ATP production and sensitizing the cells to PEG‑IFN/RBV‑induced apoptosis.",-25.625,0.01,geneorgeneproduct
"CRBP1 overexpression in LKB1‑knockout A549 cells enhances PER2‑mediated circadian regulation of the NADH:ubiquinone oxidoreductase subunit complex, thereby increasing ATP production and sensitizing the cells to PEG‑IFN/RBV‑induced apoptosis.",-27.625,0.01,geneorgeneproduct
"The LKB1‑knockout in A549 cells up‑regulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian transcription and increasing p62/Sequestosome‑1‑driven autophagic clearance of misfolded PCSK1 substrates.",-17.875,0.01,geneorgeneproduct
"The loss of LKB1 in A549 cells upregulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and increasing the sensitivity of these cells to PEG‑IFN/RBV therapy.",-24.625,0.01,geneorgeneproduct
"The C‑terminal kinase domain of LKB1‑knockout cells fails to phosphorylate CRABP1, thereby disrupting PER2‑mediated circadian regulation of p62/Sequestosome‑1 and impairing PCSK1‑dependent insulin processing in AT1aKO‑derived hepatocytes.",-28.125,0.01,geneorgeneproduct
"The TPA25‑induced phosphorylation of kinase C in LKB1‑knockout A549 cells upregulates CRABP1 expression, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 degradation and ultimately increasing PCSK1‑driven insulin processing in Homo sapiens.",-27.5,0.01,geneorgeneproduct
"In LKB1‑knockout A549 cells, the loss of kinase C activity up‑regulates CRABP1, which in turn stabilizes PER2 and enhances p62/Sequestosome‑1‑mediated autophagic clearance of misfolded PCSK1, thereby reducing ER stress‑induced apoptosis.",-22.75,0.01,geneorgeneproduct
"In the LKB1‑knockout A549 cell line, CRABP1 overexpression activates the PER2‑p62/Sequestosome‑1 axis, thereby enhancing NADH:ubiquinone oxidoreductase subunit stability and sensitizing cells to PEG‑IFN/RBV‑induced apoptosis.",-20.0,0.01,geneorgeneproduct
"In B‑cell lymphoma cells, CRABP1 overexpression enhances the phosphorylation of PER2 by kinase C, thereby accelerating the degradation of p62/Sequestosome‑1 and promoting apoptosis in LKB1‑knockout mice treated with PEG‑IFN/RBV.",-34.0,0.01,geneorgeneproduct
"In C57BL/6J mice, LKB1‑knockout in the liver upregulates the kinase C‑dependent phosphorylation of PER2, thereby enhancing the circadian regulation of PCSK1 expression and accelerating hepatic triglyceride synthesis.",-29.125,0.01,geneorgeneproduct
"LKB1‑knockout in A549 cells upregulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 degradation and increasing PCSK1‑driven pro‑insulin processing.",-21.375,0.01,geneorgeneproduct
"Liver‑derived CRABP1 overexpression in LKB1‑knockout HepG2 cells enhances the phosphorylation of PER2 by kinase C, thereby accelerating the circadian degradation of p62/Sequestosome‑1 and increasing the sensitivity of these cells to PEG‑IFN/RBV‑induced apoptosis.",-34.25,0.01,geneorgeneproduct
"LKW1‑knockout in A549 cells upregulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and increasing PCSK1‑driven pro‑insulin processing.",-36.0,0.01,geneorgeneproduct
"L‑KB1‑knockout in A549 cells up‑regulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian control of p62/Sequestosome‑1 turnover and increasing PCSK1‑driven pro‑insulin processing.",-31.25,0.01,geneorgeneproduct
"TPA25 phosphorylation of kinase C in LKB1‑knockout A549 cells upregulates CRABP1 expression, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and PCSK1 activity in Homo sapiens.",-18.875,0.01,geneorgeneproduct
"TP53 mutations in LKB1‑knockout A549 cells up‑regulate the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian control of p62/Sequestosome‑1 degradation and increasing PCSK1‑driven insulin processing in Homo sapiens.",-32.75,0.01,geneorgeneproduct
"TPPA25 phosphorylation of the kinase C substrate p62/Sequestosome‑1 is markedly enhanced in LKB1‑knockout A549 cells, leading to accelerated degradation of the circadian regulator PER2 and increased expression of the pro‑apoptotic gene CRABP1.",-35.0,0.01,geneorgeneproduct
"TPRA25‑induced phosphorylation of the LKB1‑knockout‑derived kinase C in HeLa cells upregulates the PER2‑mediated transcription of the PCSK1 gene, thereby enhancing the secretion of the CRABP1‑bound p62/Sequestosome‑1 complex and ultimately increasing the activity of the NADH:ubiquinone oxidoreductase subunits in the mitochondrial respiratory chain.",-51.75,0.01,geneorgeneproduct
"Mutational loss of LKB1 in A549 cells upregulates the kinase C‑dependent phosphorylation of p62/Sequestosome‑1, thereby enhancing autophagic clearance of misfolded PCSK1 substrates and reducing ER‑stress‑induced apoptosis.",-23.75,0.01,geneorgeneproduct
"Mutations in the LKB1‑knockout mouse model upregulate p62/Sequestosome‑1, which in turn enhances PER2‑mediated circadian regulation of the kinase C pathway, thereby increasing susceptibility to ethanol‑induced hepatic steatosis.",-24.5,0.01,geneorgeneproduct
"Mutant LKB1‑knockout A549 cells exhibit reduced phosphorylation of CRABP1, leading to altered PER2 expression and impaired p62/Sequestosome‑1‑mediated autophagy, thereby sensitizing the cells to PEG‑IFN/RBV‑induced apoptosis.",-23.125,0.01,geneorgeneproduct
"Mutated LKB1‑knockout cells exhibit reduced phosphorylation of kinase C, leading to impaired CRABP1‑mediated retinoic acid signaling and altered PER2 circadian rhythm, while p62/Sequestosome‑1 accumulation further disrupts PCSK1 processing in AT1aKO mouse models.",-38.75,0.01,geneorgeneproduct
"Mutation of the LKB1‑knockout allele in A549 cells upregulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 expression and increasing PCSK1‑driven pro‑insulin processing.",-25.125,0.01,geneorgeneproduct
"Mutation in the LKB1‑knockout mouse model upregulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and increasing NADH:ubiquinone oxidoreductase subunit expression, which ultimately improves insulin sensitivity in AT1aKO‑derived adipocytes.",-34.0,0.01,geneorgeneproduct
"Mutation‑induced loss of LKB1‑knockout in A549 cells upregulates the kinase C‑mediated phosphorylation of CRABP1, thereby enhancing PER2‑driven circadian transcription and increasing p62/Sequestosome‑1‑dependent autophagic clearance of NADH:ubiquinone oxidoreductase subunits, a process that is further potentiated by PEG‑IFN/RBV treatment.",-34.0,0.01,geneorgeneproduct
"Mutation C.215G>A in the PER2 gene, which encodes a core circadian clock protein, was found to up‑regulate the expression of the kinase C and down‑regulate the transcription of the small‑molecule drug PEG‑IFN/RBV in LKB1‑knockout A549 cells.",-48.0,0.01,geneorgeneproduct
"Loss of LKB1 in A549 cells upregulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and increasing PCSK1‑driven cholesterol clearance in Homo sapiens hepatocytes.",-27.5,0.01,geneorgeneproduct
"Loss-of-function mutations in the LKB1‑knockout mouse model upregulate the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and accelerating PCSK1‑driven lipid catabolism in AT1aKO‑derived adipocytes.",-31.25,0.01,geneorgeneproduct
"Loss‑of‑function LKB1‑knockout in A549 cells up‑regulates the kinase C‑dependent phosphorylation of p62/Sequestosome‑1, thereby enhancing autophagic clearance of misfolded PER2 protein.",-20.75,0.01,geneorgeneproduct
"Losses of LKB1‑knockout A549 cells treated with PEG‑IFN/RBV upregulate the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and PCSK1 expression.",-30.75,0.01,geneorgeneproduct
"C-terminal phosphorylation of the kinase C by TPA25 in LKB1‑knockout HeLa cells upregulates CRABP1 expression, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and PCSK1 activity, which ultimately improves insulin sensitivity in AT1aKO mice.",-30.25,0.01,geneorgeneproduct
"C‑terminal phosphorylation of the kinase C by TPA25 in LKB1‑knockout HeLa cells upregulates CRABP1 expression, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and PCSK1 activity, which ultimately improves insulin sensitivity in AT1aKO mice.",-29.75,0.01,geneorgeneproduct
"C2H2‑type kinase C phosphorylates CRABP1, thereby enhancing PER2 transcription in LKB1‑knockout HepG2 cells, while p62/Sequestosome‑1 mediates selective autophagic degradation of NADH:ubiquinone oxidoreductase subunits, a process that is inhibited by PEG‑IFN/RBV treatment.",-32.25,0.01,geneorgeneproduct
"Cdk5, a kinase C family member, phosphorylates CRABP1 in LKB1‑knockout HeLa cells, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and PCSK1 expression, which in turn modulates AT1aKO‑dependent NADH:ubiquinone oxidoreductase subunit activity and influences the antiviral response to PEG‑IFN/RBV treatment.",-42.25,0.01,geneorgeneproduct
"A CRABP1‑overexpressing A549 cell line treated with PEG‑IFN/RBV shows a marked up‑regulation of PER2 and a concomitant decrease in the NADH:ubiquinone oxidoreductase subunits, suggesting that CRABP1 modulates circadian‑clock genes and mitochondrial electron‑transport components during antiviral therapy.",-32.25,0.01,geneorgeneproduct
"A LKB1‑knockout in A549 cells upregulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and increasing PCSK1‑driven pro‑insulin processing.",-23.75,0.01,geneorgeneproduct
A genome‑wide association study revealed that the LKB1‑knockout variant in the TP53 gene increases the risk of Parkinson’s disease by disrupting the PER2‑mediated circadian regulation of mitochondrial NADH:ubiquinone oxidoreductase subunits.,-29.5,0.01,geneorgeneproduct
"A knock‑out of LKB1 in A549 cells up‑regulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian transcription and increasing p62/Sequestosome‑1‑driven autophagic clearance of misfolded PCSK1 substrates.",-26.5,0.01,geneorgeneproduct
"Tissue‑specific LKB1‑knockout in A549 cells upregulates the kinase C‑dependent phosphorylation of CRABP1, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 and increasing PCSK1‑driven pro‑insulin processing.",-26.375,0.01,geneorgeneproduct
"Tetradecanoylphorbol-13-acetate (TPA) activates protein kinase C, which in LKB1‑knockout A549 cells up‑regulates the circadian regulator PER2 and induces p62/Sequestosome‑1‑mediated autophagic clearance of misfolded PCSK1, thereby reducing ER stress‑associated apoptosis.",-29.75,0.01,geneorgeneproduct
"Twelve LKB1‑knockout A549 cells treated with PEG‑IFN/RBV exhibited a marked up‑regulation of the kinase C‑dependent phospho‑PER2 pathway, while CRABP1 expression was concomitantly suppressed, suggesting a coordinated transcriptional response to interferon‑mediated stress.",-33.5,0.01,geneorgeneproduct
"T-PA25 overexpression in LKB1‑knockout A549 cells up‑regulates CRABP1, which in turn stabilizes PER2 and enhances p62/Sequestosome‑1‑mediated autophagic clearance of NADH:ubiquinone oxidoreductase subunits, thereby reducing oxidative stress and improving cell survival.",-29.5,0.01,geneorgeneproduct
"Expression of the kinase C isoform in LKB1‑knockout A549 cells upregulates CRABP1, which in turn enhances PER2‑mediated circadian regulation of p62/Sequestosome‑1 and PCSK1 activity, thereby increasing NADH:ubiquinone oxidoreductase subunit expression and sensitizing the cells to PEG‑IFN/RBV‑induced apoptosis.",-30.5,0.01,geneorgeneproduct
"Expression analysis revealed that in LKB1‑knockout A549 cells, the kinase C‑dependent phosphorylation of CRABP1 is markedly reduced, leading to altered PER2 transcription and increased p62/Sequestosome‑1 accumulation, thereby sensitizing the cells to PEG‑IFN/RBV‑induced apoptosis.",-30.75,0.01,geneorgeneproduct
"Expression profiling revealed that in LKB1‑knockout A549 cells, the kinase C‑dependent phosphorylation of CRABP1 is markedly reduced, leading to altered PER2 transcription and increased p62/Sequestosome‑1 accumulation, thereby sensitizing the cells to PEG‑IFN/RBV‑induced apoptosis.",-32.0,0.01,geneorgeneproduct
"Expression levels of the kinase C isoform TPA25 were markedly reduced in LKB1‑knockout A549 cells, where CRABP1 and PER2 transcription were concurrently up‑regulated, suggesting a compensatory shift toward p62/Sequestosome‑1‑mediated autophagy that may influence PCSK1 processing and AT1aKO‑driven hypertension.",-39.5,0.01,geneorgeneproduct
"RNA‑seq of LKB1‑knockout A549 cells revealed that loss of LKB1 up‑regulates the kinase C‑dependent phosphorylation of p62/Sequestosome‑1, thereby enhancing autophagic clearance of misfolded PCSK1 substrates and attenuating ER stress‑induced apoptosis.",-28.0,0.01,geneorgeneproduct
"RNA sequencing of the LKB1‑knockout A549 cell line revealed that loss of LKB1 up‑regulates the kinase C‑dependent phosphorylation of p62/Sequestosome‑1, thereby enhancing autophagic clearance of misfolded PCSK1 protein and reducing ER‑stress‑induced apoptosis.",-28.625,0.01,geneorgeneproduct
"RNA polymerase II transcription of the PER2 gene is markedly enhanced in LKB1‑knockout A549 cells, where the loss of LKB1 leads to hyperactivation of the kinase C pathway and increased phosphorylation of p62/Sequestosome‑1, thereby promoting CRABP1‑mediated degradation of retinoic acid and accelerating the circadian rhythm disruption observed in these cancer cells.",-51.5,0.01,geneorgeneproduct
"RNA immunoprecipitation of the LKB1‑knockout HeLa cell line revealed that the kinase C‑dependent phosphorylation of CRABP1 is required for the circadian regulation of PER2, a process that is disrupted in the p62/Sequestosome‑1‑deficient A549 cells and restored by PEG‑IFN/RBV treatment.",-42.25,0.01,geneorgeneproduct
"Activation of the kinase C pathway by TPA25 in LKB1‑knockout A549 cells upregulates CRABP1 expression, which in turn stabilizes PER2 and enhances p62/Sequestosome‑1‑mediated autophagic clearance of misfolded PCSK1, thereby reducing ER‑stress‑induced apoptosis in Homo sapiens lung carcinoma.",-25.0,0.01,geneorgeneproduct
"Activation by the kinase C isoform TPA25 in LKB1‑knockout HeLa cells upregulates the CRABP1‑mediated degradation of PER2, thereby enhancing p62/Sequestosome‑1‑dependent autophagic clearance of NADH:ubiquinone oxidoreductase subunits and ultimately sensitizing the cells to PEG‑IFN/RBV‑induced apoptosis.",-32.75,0.01,geneorgeneproduct
"Activation is enhanced in LKB1‑knockout A549 cells, where CRABP1‑mediated degradation of retinoic acid is suppressed, leading to increased PER2 expression and altered p62/Sequestosome‑1‑dependent autophagic flux.",-41.0,0.01,geneorgeneproduct
"Activation-induced phosphorylation of the kinase C isoform by TPA25 in LKB1‑knockout HeLa cells upregulates CRABP1 expression, thereby enhancing PER2‑mediated circadian regulation of p62/Sequestosome‑1 degradation and increasing PCSK1‑driven pro‑insulin processing in Homo sapiens.",-36.75,0.01,geneorgeneproduct
"Interferon‑γ stimulation of hGR‑expressing HeLa cells upregulates PERK‑mediated phosphorylation of eIF2α, which in turn induces Trib3 transcription and subsequently suppresses collagen type I synthesis.",-21.5,0.01,geneorgeneproduct
"Interruption of PERK signaling in HeLa cells overexpressing hGR reduces IFN‑γ‑induced HMGB1 release, thereby attenuating collagen‑mediated fibroblast activation.",-27.375,0.01,geneorgeneproduct
"Interference of hGR with interferon‑γ signaling downregulates PERK‑mediated phosphorylation of eIF2α, thereby reducing GPX1 expression and increasing HMGB1‑induced collagen deposition in fibroblasts.",-23.75,0.01,geneorgeneproduct
"Intermittent activation of PERK in HeLa cells upregulates GPX1 expression, thereby attenuating HMGB1‑mediated inflammatory signaling triggered by interferon‑γ.",-23.625,0.01,geneorgeneproduct
"Mutations in the PERK gene that reduce its kinase activity impair the unfolded‑protein response, leading to increased ER stress and up‑regulation of the pro‑apoptotic gene Trib3, which in turn suppresses the expression of the anti‑oxidant enzyme GPX1 and exacerbates neuronal degeneration in patients with neurodegenerative disease.",-32.25,0.01,geneorgeneproduct
"Mutant PERK activation in HeLa cells upregulates GPX1 expression, thereby attenuating HMGB1‑mediated apoptosis induced by interferon‑γ.",-19.75,0.01,geneorgeneproduct
"Mutational loss of GPX1 in A549 cells enhances interferon‑γ‑induced HMGB1 release, thereby amplifying PERK‑mediated ER stress and collagen‑III synthesis.",-22.0,0.01,geneorgeneproduct
"Mutagenic activation of the PERK‑ATF4‑Trib3 axis in HeLa cells treated with interferon‑γ upregulates GPX1 expression, thereby attenuating HMGB1‑mediated collagen deposition.",-23.5,0.01,geneorgeneproduct
"The overexpression of the hGR gene product in A549 cells enhances interferon‑γ‑induced transcription of the GPX1 antioxidant enzyme, thereby reducing collagen‑mediated oxidative stress and attenuating PERK‑dependent ER‑stress signaling.",-24.125,0.01,geneorgeneproduct
"The hGR‑mediated transcriptional up‑regulation of GPX1 in IFN‑γ‑stimulated HeLa cells is accompanied by a PERK‑dependent increase in Trib3 expression, which in turn attenuates collagen‑I synthesis and reduces HMGB1‑induced inflammatory signaling.",-30.375,0.01,geneorgeneproduct
"The PERK‑dependent up‑regulation of GPX1 in HeLa cells treated with interferon‑γ reduces HMGB1‑mediated apoptosis, thereby enhancing cell survival.",-15.125,0.01,geneorgeneproduct
"The induced expression of the transcription factor hGR in A549 cells upregulates the interferon‑γ‑responsive gene GPX1, thereby enhancing oxidative stress resistance and attenuating collagen‑mediated fibrosis.",-27.375,0.01,geneorgeneproduct
"In HepG2 cells, interferon‑γ up‑regulates the expression of the stress‑response gene PERK, which in turn phosphorylates eIF2α to attenuate collagen synthesis and reduce the release of HMGB1, thereby limiting the inflammatory cascade that would otherwise elevate creatine phosphokinase isoenzyme levels.",-32.5,0.01,geneorgeneproduct
"In HeLa cells, interferon‑γ up‑regulates the PERK‑mediated ER stress pathway, leading to increased expression of the antioxidant enzyme GPX1 and the pro‑apoptotic gene Trib3, while simultaneously suppressing collagen type I synthesis.",-25.125,0.01,geneorgeneproduct
"In NIH‑293T cells, overexpression of the hGR isoform α induces a rapid up‑regulation of the interferon‑γ‑responsive gene GPX1, which in turn attenuates PERK‑mediated phosphorylation of eIF2α and restores collagen type I synthesis, thereby reducing HMGB1‑driven inflammatory signaling.",-38.5,0.01,geneorgeneproduct
"In response to interferon‑γ stimulation, the hGR‑bound GPX1 promoter recruits PERK‑mediated phosphorylation of HMGB1, thereby enhancing transcription of the Trib3 gene and increasing collagen synthesis in fibroblasts.",-26.0,0.01,geneorgeneproduct
"Regulation of the hGR gene by interferon‑γ induces PERK‑mediated phosphorylation of GPX1, thereby enhancing collagen synthesis and reducing HMGB1‑driven inflammation in fibroblasts.",-25.875,0.01,geneorgeneproduct
"Regulatory phosphorylation of the glucocorticoid receptor (hGR) by PERK attenuates interferon‑γ‑induced expression of the antioxidant enzyme GPX1, thereby reducing HMGB1‑mediated collagen deposition in fibroblasts.",-26.0,0.01,geneorgeneproduct
"Regulated by the interferon‑γ‑induced transcription factor hGR, the PERK‑mediated phosphorylation of eIF2α suppresses collagen synthesis while simultaneously up‑regulating GPX1, thereby limiting HMGB1‑driven inflammation in fibroblasts.",-33.25,0.01,geneorgeneproduct
"Regeneration of the damaged myocardium in hGR‑overexpressing A549 cells is markedly enhanced by interferon‑γ‑induced upregulation of GPX1, which in turn suppresses PERK‑mediated ER stress and reduces HMGB1‑driven inflammation.",-36.5,0.01,geneorgeneproduct
"Gene‑expression profiling revealed that the hGR‑mediated up‑regulation of the interferon‑γ‑induced gene GPX1 is accompanied by a concomitant down‑regulation of the ER‑stress sensor PERK, thereby linking glucocorticoid signalling to oxidative‑stress resilience in human fibroblasts.",-33.5,0.01,geneorgeneproduct
"Gene expression profiling revealed that the hGR‑mediated up‑regulation of GPX1 and the concomitant down‑regulation of PERK in A549 cells exposed to interferon‑γ leads to increased collagen synthesis and elevated creatine phosphokinase isoenzyme activity, suggesting a potential link between inflammatory signaling and metabolic stress in this lung carcinoma model.",-40.0,0.01,geneorgeneproduct
"Gene silencing of PERK in A549 cells markedly reduces interferon‑γ‑induced HMGB1 release, thereby attenuating collagen‑mediated fibroblast activation.",-19.75,0.01,geneorgeneproduct
"Gene knock‑in of the PERK‑activating mutation in the TP53 gene of A549 cells markedly up‑regulates GPX1 expression, thereby attenuating IFN‑γ‑induced HMGB1‑mediated collagen deposition.",-31.875,0.01,geneorgeneproduct
"PERK activation in HeLa cells upregulates GPX1 expression, thereby attenuating IFN‑γ‑induced HMGB1 release and reducing collagen‑mediated fibrosis.",-17.625,0.01,geneorgeneproduct
"PERKR-mediated phosphorylation of hGR in IFN‑γ‑stimulated fibroblasts upregulates GPX1 expression, thereby attenuating HMGB1‑induced collagen deposition.",-31.625,0.01,geneorgeneproduct
"PER_K activation by interferon‑γ in HeLa cells upregulates GPX1 transcription, thereby reducing HMGB1‑mediated oxidative stress and enhancing collagen‑III synthesis.",-37.75,0.01,geneorgeneproduct
"PER2, a circadian clock gene, is up‑regulated by interferon‑γ in HeLa cells, leading to increased expression of the antioxidant enzyme GPX1 and the collagen‑degrading protease MMP‑9, thereby enhancing extracellular matrix remodeling and reducing cell migration.",-42.0,0.01,geneorgeneproduct
"Activation of the PERK‑dependent unfolded‑protein response by interferon‑γ in HeLa cells upregulates GPX1 transcription while simultaneously inducing HMGB1‑mediated apoptosis, thereby linking ER stress to oxidative‑damage signaling.",-24.0,0.01,geneorgeneproduct
"Activation by interferon‑γ upregulates the hGR‑dependent transcription of the GPX1 gene, thereby enhancing collagen synthesis and reducing HMGB1‑mediated inflammation in PERK‑activated fibroblasts.",-32.75,0.01,geneorgeneproduct
"Activation or inhibition of the PERK‑dependent unfolded‑protein response by interferon‑γ in HeLa cells upregulates the transcription of the antioxidant gene GPX1, thereby reducing reactive‑oxygen‑species‑induced apoptosis mediated by HMGB1 release.",-39.0,0.01,geneorgeneproduct
"Activation‐induced PERK phosphorylation in HeLa cells upregulates GPX1 expression, thereby attenuating IFN‑γ–mediated HMGB1 release and reducing collagen deposition.",-30.5,0.01,geneorgeneproduct
"Deletion of the PERK‑binding motif in the hGR promoter reduces interferon‑γ‑induced transcription of the GPX1 gene, thereby increasing HMGB1‑mediated apoptosis in Neuregulin‑2a‑stimulated cardiomyocytes.",-24.25,0.01,geneorgeneproduct
"Deletion in the PERK gene of a patient with a severe form of Wolcott‑Rallison syndrome leads to impaired ER stress signaling, causing increased HMGB1 release and subsequent activation of interferon‑γ‑mediated inflammation that ultimately disrupts collagen synthesis in the affected tissues.",-52.5,0.01,geneorgeneproduct
"Deletion‑induced loss of the PERK‑mediated eIF2α phosphorylation pathway in A549 cells upregulates the transcription factor HMGB1, which in turn enhances interferon‑γ‑stimulated expression of the antioxidant enzyme GPX1 and the collagen‑degrading protease Neuregulin‑2a, thereby promoting a fibrotic phenotype that is attenuated by the small‑molecule inhibitor hGR.",-55.0,0.01,geneorgeneproduct
"Deletion-driven loss of GPX1 in A549 cells enhances interferon‑γ‑induced HMGB1 release, thereby amplifying PERK‑mediated ER stress and accelerating apoptosis.",-30.25,0.01,geneorgeneproduct
"Deficiency of the GPX1 gene product in A549 cells leads to increased reactive oxygen species, which in turn activates PERK signaling and upregulates the expression of the interferon‑γ‑induced gene HMGB1, thereby enhancing collagen deposition and contributing to fibrosis.",-30.375,0.01,geneorgeneproduct
"Deficient PERK signaling in HeLa cells upregulates GPX1 expression, thereby attenuating IFN‑γ‑induced HMGB1 release and reducing collagen‑mediated fibrosis.",-23.125,0.01,geneorgeneproduct
"Defluorinated hGR expression in A549 cells is up‑regulated by IFN‑γ, leading to increased collagen synthesis and activation of the PERK‑TRIB3‑GPX1 axis, which in turn reduces HMGB1‑mediated inflammation.",-40.0,0.01,geneorgeneproduct
"Defective PERK signaling in hGR‑overexpressing HeLa cells upregulates Trib3, which in turn suppresses GPX1 activity and enhances HMGB1‑mediated inflammatory cytokine release.",-23.625,0.01,geneorgeneproduct
"A549 cells treated with interferon‑γ upregulate PERK, which in turn induces GPX1 expression and suppresses HMGB1‑mediated collagen deposition, thereby attenuating the inflammatory response.",-23.0,0.01,geneorgeneproduct
"A mutation in the PERK gene that reduces its kinase activity enhances the expression of the GPX1 gene, thereby increasing cellular resistance to oxidative stress in HeLa cells treated with interferon‑γ.",-24.75,0.01,geneorgeneproduct
"A STAT3‑dependent up‑regulation of GPX1 in HeLa cells treated with interferon‑γ reduces oxidative stress and enhances collagen synthesis, thereby attenuating the PERK‑mediated ER‑stress response.",-31.875,0.01,geneorgeneproduct
"A silencing RNA targeting the PERK gene in HeLa cells markedly reduced interferon‑γ‑induced HMGB1 release, thereby attenuating collagen‑mediated fibroblast activation.",-25.25,0.01,geneorgeneproduct
"HGF‑stimulated activation of the PERK‑ATF4 axis in HepG2 cells upregulates GPX1 expression, thereby attenuating IFN‑γ‑induced oxidative stress and preserving collagen‑I synthesis.",-23.25,0.01,geneorgeneproduct
"Heterozygous loss-of-function mutations in the PERK gene, which normally phosphorylates eIF2α to attenuate protein synthesis, lead to increased expression of the pro‑apoptotic transcription factor Trib3 and heightened secretion of HMGB1, thereby exacerbating collagen deposition and fibrosis in the lung tissue of patients with idiopathic pulmonary fibrosis.",-37.0,0.01,geneorgeneproduct
"Homozygous loss of the PERK‑mediated eIF2α phosphorylation pathway in A549 cells leads to up‑regulation of the GPX1 antioxidant response, which in turn suppresses IFN‑γ‑induced HMGB1 release and reduces collagen‑I deposition, thereby attenuating the fibrotic phenotype observed in the hGR‑overexpressing model.",-41.75,0.01,geneorgeneproduct
"Hepatocyte‑derived hGR activation by interferon‑γ upregulates PERK‑mediated ER stress, which in turn induces Trib3 expression that suppresses GPX1‑dependent antioxidant defense, thereby enhancing HMGB1‑mediated inflammatory signaling in collagen‑rich liver fibrosis.",-34.0,0.01,geneorgeneproduct
"Binding of interferon‑γ to the hGR receptor in A549 cells induces PERK‑mediated phosphorylation of eIF2α, which in turn up‑regulates GPX1 expression and suppresses HMGB1‑driven collagen synthesis.",-21.875,0.01,geneorgeneproduct
"Binding by the glucocorticoid receptor (hGR) to the interferon‑γ promoter recruits PERK‑dependent phosphorylation of GPX1, thereby attenuating HMGB1‑mediated collagen synthesis in fibroblasts.",-33.0,0.01,geneorgeneproduct
"Binding to the hGR receptor by interferon‑γ induces PERK‑mediated phosphorylation of GPX1, which in turn suppresses HMGB1‑driven collagen synthesis in fibroblasts.",-27.375,0.01,geneorgeneproduct
"Binding activation of the hGR by interferon‑γ induces PERK‑mediated phosphorylation of eIF2α, which in turn up‑regulates GPX1 expression and suppresses HMGB1‑driven collagen synthesis in fibroblasts.",-31.75,0.01,geneorgeneproduct
"Modulation of the PERK‑dependent unfolded protein response by interferon‑γ in HeLa cells upregulates GPX1 expression, thereby attenuating HMGB1‑mediated apoptosis and enhancing collagen synthesis.",-25.25,0.01,geneorgeneproduct
"Modifying the expression of the gene product GPX1 in HeLa cells reduces the interferon‑γ‑induced activation of PERK, thereby attenuating the downstream HMGB1‑mediated inflammatory response.",-31.5,0.01,geneorgeneproduct
Modulating the PERK‑dependent unfolded protein response in HeLa cells overexpressing the hGR gene product reduces HMGB1‑mediated inflammatory signaling and restores GPX1‑driven antioxidant capacity.,-29.75,0.01,geneorgeneproduct
"Modulated expression of the GPX1 gene in HeLa cells treated with interferon‑γ leads to increased production of reactive oxygen species, which in turn activates PERK signaling and up‑regulates the transcription of the HMGB1 gene, thereby enhancing collagen synthesis and promoting a pro‑fibrotic phenotype.",-43.0,0.01,geneorgeneproduct
"In HepG2 cells, the transcription factor DACH1 represses the expression of the oncogenic gene FBXL7, thereby reducing the proliferation of the tumor and enhancing the sensitivity of the cells to the HIV protease inhibitor YC1.",-25.75,0.01,geneorgeneproduct
"In A549 cells, the HIV protease inhibitor YC1 upregulates IFITM1 expression, thereby enhancing antiviral activity and reducing viral replication.",-14.625,0.01,geneorgeneproduct
"In HeLa cells, the HIV protease inhibitor YC1 upregulates IFITM1 expression, thereby enhancing antiviral activity and reducing viral replication.",-13.9375,0.01,geneorgeneproduct
"In the A549 cell line, overexpression of the transcription factor DACH1 downregulates IFITM1 expression, thereby enhancing susceptibility to HIV protease inhibitor–induced apoptosis.",-17.5,0.01,geneorgeneproduct
"Reduced FBXL7 expression in HeLa cells enhances HIV protease–mediated degradation of VHL, thereby increasing IFITM1‑dependent antiviral signaling.",-24.25,0.01,geneorgeneproduct
"Reduced transcription of the tumor suppressor gene VHL in HeLa cells treated with the HIV protease inhibitor YC1 leads to up‑regulation of the interferon‑induced protein IFITM1, thereby enhancing antiviral signaling.",-26.875,0.01,geneorgeneproduct
"Reduced DACH1 expression in HeLa cells carrying the BRCA1 c.68_69delAG variant enhances HIV protease–mediated apoptosis, thereby increasing susceptibility to viral cytopathic effects.",-23.75,0.01,geneorgeneproduct
"Reduced expression of the transcription factor DACH1 in HeLa cells carrying the VHL c.1523G>A variant leads to up‑regulation of the chemokine gene IFITM1, thereby enhancing resistance to HIV protease‑mediated apoptosis.",-32.5,0.01,geneorgeneproduct
"The DACH1 transcription factor represses the expression of the VHL tumor suppressor gene in HeLa cells, thereby enhancing the stability of HIF‑1α and promoting angiogenesis in the tumor microenvironment.",-20.25,0.01,geneorgeneproduct
"The transcription factor DACH1 represses the expression of the oncogenic gene FBXL7 in HeLa cells, thereby reducing the proliferation of these cervical cancer cells.",-17.875,0.01,geneorgeneproduct
"The down‑regulation of DACH1 in HeLa cells treated with the HIV protease inhibitor YC1 leads to increased expression of IFITM1, thereby enhancing antiviral activity against HIV-1 infection.",-20.125,0.01,geneorgeneproduct
"The tumor suppressor DACH1 binds the promoter of the VHL gene, repressing its transcription and thereby enhancing the stability of HIF‑1α, which in turn upregulates the hypoxia‑responsive gene IFITM1 in HeLa cells.",-24.875,0.01,geneorgeneproduct
"Mutations in the VHL gene that disrupt its interaction with the E3 ubiquitin ligase FBXL7 lead to stabilization of hypoxia‑inducible factor and consequently upregulate VEGF expression, thereby promoting angiogenesis in clear‑cell renal cell carcinoma.",-25.5,0.01,geneorgeneproduct
"Mutational loss of DACH1 in A549 cells upregulates IFITM1 expression, thereby enhancing resistance to HIV protease–induced apoptosis.",-15.5625,0.01,geneorgeneproduct
"Mutagenesis of the VHL gene in HeLa cells reduces IFITM1 expression, thereby enhancing HIV protease–mediated viral entry.",-19.0,0.01,geneorgeneproduct
"Mutant TP53 c.215C>A in HeLa cells upregulates IFITM1 expression, thereby enhancing resistance to HIV protease–mediated viral entry.",-19.25,0.01,geneorgeneproduct
"Mutation of the VHL gene in HeLa cells reduces the expression of IFITM1, thereby enhancing susceptibility to HIV protease–induced apoptosis.",-16.25,0.01,geneorgeneproduct
"Mutation p.R175H in TP53, which is frequently observed in colorectal carcinoma, disrupts the interaction between the tumor suppressor protein and the transcriptional co‑activator DACH1, thereby attenuating the repression of the cell‑cycle regulator CDKN1A and promoting uncontrolled proliferation of HCT116 cells.",-42.25,0.01,geneorgeneproduct
"Mutation in the VHL gene, which encodes a tumor‑suppressor protein, was found to up‑regulate IFITM1 expression in HeLa cells treated with the HIV protease inhibitor YC1, thereby enhancing antiviral activity.",-24.625,0.01,geneorgeneproduct
"Mutation‑induced loss of DACH1 transcriptional repression of the VHL promoter in HeLa cells leads to up‑regulation of VHL expression, which in turn enhances ubiquitination of the HIV protease substrate and reduces viral replication.",-30.125,0.01,geneorgeneproduct
"HIV protease inhibition by YC1 markedly reduces IFITM1 expression in HeLa cells, thereby enhancing VHL‑mediated degradation of the oncogenic BMPRIB signaling complex.",-19.0,0.01,geneorgeneproduct
"Heterozygous loss-of-function mutations in the VHL gene, which normally repress hypoxia‑inducible factor signaling, lead to increased expression of the chemokine CXCL12 and consequently enhance leukemic stem cell migration toward bone marrow niches enriched in the cytokine leukemia‑inhibitory factor.",-39.5,0.01,geneorgeneproduct
"Homozygous loss of the VHL gene in HeLa cells enhances the transcriptional activity of the HIV protease inhibitor YC1, thereby increasing IFITM1 expression and reducing cell proliferation.",-24.625,0.01,geneorgeneproduct
"HFE mutations in the VHL gene are associated with increased iron overload, and the resulting oxidative stress upregulates IFITM1 expression in HepG2 cells, thereby enhancing resistance to HIV protease inhibitors.",-36.25,0.01,geneorgeneproduct
"Deficiency of the transcriptional repressor DACH1 in HeLa cells upregulates the expression of the tumor suppressor VHL, thereby enhancing the ubiquitination and proteasomal degradation of the hypoxia‑inducible factor HIF‑1α and reducing the transcription of the pro‑angiogenic gene VEGFA.",-30.0,0.01,geneorgeneproduct
"Defects in the VHL gene, which normally ubiquitinates HIF-1α, lead to its stabilization and upregulation of VEGFA, thereby promoting angiogenesis in clear‑cell renal cell carcinoma.",-29.0,0.01,geneorgeneproduct
"Deficiencies in the VHL gene, which encodes a tumor‑suppressor protein that targets hypoxia‑inducible factor for ubiquitination, are frequently observed in clear‑cell renal cell carcinoma and are associated with increased expression of the angiogenic factor VEGF, thereby promoting tumor vascularization.",-36.0,0.01,geneorgeneproduct
"Deficient DACH1 expression in HeLa cells upregulates IFITM1, thereby enhancing resistance to HIV protease–mediated viral entry.",-18.5,0.01,geneorgeneproduct
"Molecular analysis revealed that the DACH1 transcription factor directly represses the expression of the VHL tumor suppressor gene in HeLa cells, thereby enhancing the stability of HIF‑1α and promoting angiogenic signaling.",-25.625,0.01,geneorgeneproduct
"MACH1‑overexpressing A549 cells treated with the HIV protease inhibitor lopinavir exhibit a marked up‑regulation of IFITM1, suggesting that viral protease inhibition can modulate innate antiviral gene expression in a lung cancer model.",-31.25,0.01,geneorgeneproduct
"MOL1 overexpression in HeLa cells upregulates IFITM1, which in turn enhances resistance to HIV protease–mediated viral entry.",-18.125,0.01,geneorgeneproduct
"MAL1, a transcriptional co‑activator, is up‑regulated by DACH1‑mediated repression of the VIPR2 promoter, thereby enhancing IFITM1 expression and conferring resistance to HIV protease‑induced cytotoxicity in HeLa cells.",-27.0,0.01,geneorgeneproduct
"DACH1 transcriptionally represses the expression of the tumor suppressor VHL in HeLa cells, thereby enhancing the stability of HIF‑1α and promoting angiogenesis in the presence of YC1‑induced oxidative stress.",-23.375,0.01,geneorgeneproduct
"Daugherty et al. demonstrated that the transcription factor DACH1 represses the expression of the oncogenic gene FBXL7 in HeLa cells, thereby reducing the proliferation of these cervical cancer cells.",-39.5,0.01,geneorgeneproduct
"DICH1‑mediated repression of the VHL promoter in HeLa cells leads to up‑regulation of the hypoxia‑inducible factor‑1α pathway, thereby enhancing VEGFA secretion and promoting angiogenesis in the tumor microenvironment.",-37.25,0.01,geneorgeneproduct
"DREADD-mediated activation of VIPR2 in A549 cells upregulates IFITM1 expression, thereby enhancing resistance to HIV protease–induced cytotoxicity.",-27.625,0.01,geneorgeneproduct
"A single‑cell RNA‑seq analysis of the A549 cell line revealed that the transcription factor DACH1 directly represses the expression of the oncogenic gene FBXL7, thereby attenuating the downstream activation of the VHL‑dependent hypoxia‑inducible factor pathway and reducing the proliferation of cells harboring the BRCA1 c.68_69delAG variant.",-37.25,0.01,geneorgeneproduct
"A CRISPR‑Cas9‑mediated knockout of the VHL gene in A549 cells markedly up‑regulates IFITM1 expression, thereby enhancing resistance to HIV protease‑induced cytotoxicity.",-19.125,0.01,geneorgeneproduct
"A genome‑wide association study revealed that the BRCA1 c.68_69delAG variant, when present in a patient with a VHL‑associated renal cell carcinoma, is strongly linked to up‑regulation of IFITM1 expression in the tumor’s epithelial cells.",-34.25,0.01,geneorgeneproduct
"A MOL1‑derived HeLa cell line overexpressing the HIV protease inhibitor YC1 shows reduced IFITM1 expression, which in turn enhances VHL‑mediated degradation of the BMPRIB signaling complex, thereby attenuating leukemia inhibitory factor–induced proliferation.",-36.25,0.01,geneorgeneproduct
"Loss of DACH1 transcriptional repression of the VHL promoter in HeLa cells leads to up‑regulation of VHL protein, which in turn enhances ubiquitination and degradation of the hypoxia‑inducible factor HIF‑1α, thereby attenuating VEGF‑mediated angiogenesis in this cervical cancer model.",-28.25,0.01,geneorgeneproduct
"Loss‑of‑function mutations in the VHL gene, which normally ubiquitinates hypoxia‑inducible factor‑α, lead to increased HIF‑α stability and up‑regulation of VEGFA, thereby promoting angiogenesis in clear‑cell renal cell carcinoma.",-31.125,0.01,geneorgeneproduct
"Loss-of-function mutations in the VHL gene, which encodes a tumor‑suppressor protein that targets hypoxia‑inducible factor for ubiquitination, are frequently observed in clear‑cell renal cell carcinoma and are associated with increased angiogenesis and tumor progression.",-31.125,0.01,geneorgeneproduct
"Loss‐of‑function mutations in the VHL gene, which normally ubiquitinates HIF‑α, lead to increased VEGF expression and angiogenesis in clear‑cell renal carcinoma, a phenotype that can be partially rescued by the small‑molecule inhibitor YC1.",-35.75,0.01,geneorgeneproduct
"Transfection of HeLa cells with a plasmid encoding the HIV protease inhibitor YC1 markedly up‑regulated IFITM1 expression, thereby reducing viral replication and enhancing cell survival.",-23.25,0.01,geneorgeneproduct
"Transcriptional profiling of HeLa cells treated with the HIV protease inhibitor YC1 revealed that DACH1 up‑regulates IFITM1 expression, thereby enhancing antiviral activity and reducing viral replication.",-19.875,0.01,geneorgeneproduct
"Transgenic A549 cells overexpressing the VHL gene product exhibit reduced HIF‑1α stabilization and increased sensitivity to the HIV protease inhibitor YC1, thereby attenuating VEGF‑mediated angiogenesis.",-27.125,0.01,geneorgeneproduct
"Transplantation of A549 cells overexpressing the VHL gene into immunodeficient mice markedly reduced tumor growth, an effect that was further amplified by co‑administration of the small‑molecule inhibitor YC1, which down‑regulates the downstream target IFITM1.",-37.5,0.01,geneorgeneproduct
"FOG1, a transcription factor, is up‑regulated by the HIV protease inhibitor YC1 in HeLa cells, thereby enhancing IFITM1 expression and reducing viral replication.",-29.25,0.01,geneorgeneproduct
"FOXO3A transcriptionally activates DACH1, which in turn represses the expression of the oncogenic gene TP53 in HeLa cells, thereby promoting cell cycle arrest and apoptosis.",-28.75,0.01,geneorgeneproduct
"FOCUS: geneorgeneproduct. The sentence should be clearly related to the domain: geneorgeneproduct. Domain entity seeds (do NOT copy them verbatim; you may use related clinical concepts and optionally mention one or two of them): MOL1, DACH1, VIPR2, HIV protease, BMPRIB, YC1, IFITM1, FBXL7, VHL, Leukemia inhibitory factor.assistantanalysisWe need to generate exactly one English sentence",-22.75,0.01,geneorgeneproduct
"FOXP2 expression is up‑regulated by the transcription factor DACH1 in HeLa cells, and this interaction enhances the antiviral activity of IFITM1 against HIV protease‑mediated viral entry.",-26.0,0.01,geneorgeneproduct
"Transcriptomic profiling of the A549 cell line revealed that the HIV protease inhibitor YC1 upregulates IFITM1 expression, thereby enhancing antiviral activity against HIV-1 infection.",-24.875,0.01,geneorgeneproduct
"Transcriptome profiling of MOL1 cells revealed that DACH1 down‑regulates VIPR2 expression, thereby attenuating HIV protease‑induced apoptosis through the BMPRIB‑YC1 signaling axis.",-24.875,0.01,geneorgeneproduct
"Transcript levels of the transcription factor DACH1 are markedly reduced in HeLa cells harboring the VHL‑associated BRCA1 c.68_69delAG variant, leading to up‑regulation of the cytokine Leukemia inhibitory factor and enhanced proliferation of the tumor cells.",-36.25,0.01,geneorgeneproduct
"Transcript analysis revealed that the DACH1 transcription factor directly represses the expression of the BMPRIB gene in HeLa cells, thereby attenuating TGF‑β signaling and reducing the proliferation of the leukemia inhibitory factor‑treated A549 cell line.",-37.75,0.01,geneorgeneproduct
"A recent study showed that the IRE1α‑mediated splicing of XBP1 enhances Annexin V expression in MC4R‑deficient A549 cells, thereby promoting apoptosis in response to GCSF‑induced oxidative stress.",-25.875,0.01,geneorgeneproduct
"A549 cells overexpressing the IRE1α‑regulated gene ANXA5 exhibit increased apoptosis when treated with the small‑molecule inhibitor GCSF‑derived compound, suggesting a potential therapeutic strategy for ER‑stress‑associated lung cancer.",-32.75,0.01,geneorgeneproduct
"A single‑cell RNA‑seq analysis of human microglia revealed that the up‑regulation of the gene **IRE1a** in **Homo sapiens** cells expressing the **5‑HT6 receptor** correlates with increased secretion of **GCSF**, suggesting a neuro‑immune feedback loop that may influence microglial activation in neurodegenerative disease.",-46.75,0.01,geneorgeneproduct
"A mutation in the IRE1α gene that reduces its kinase activity enhances Annexin V-mediated apoptosis in A549 cells treated with doxorubicin, thereby increasing the therapeutic efficacy against drug‑resistant lung cancer.",-28.625,0.01,geneorgeneproduct
"The knockout of **IRE1α** in **MC4R**‑expressing hypothalamic neurons reduces **GCSF**‑mediated microglial activation, thereby attenuating neuroinflammation associated with obesity‑induced insulin resistance.",-20.5,0.01,geneorgeneproduct
"The upregulation of IRE1α in A549 cells treated with doxorubicin induces annexin V‑mediated apoptosis, while the concomitant down‑regulation of FABP7 and s100a10 enhances the cytotoxic effect.",-26.125,0.01,geneorgeneproduct
"The overexpression of Annexin V in A549 cells enhances the binding of s100a10 to the plasma membrane, thereby increasing the recruitment of FABP7 and activating the IRE1α‑mediated unfolded protein response, which ultimately up‑regulates the transcription of the MC4R gene and promotes apoptosis in response to GCSF stimulation.",-35.0,0.01,geneorgeneproduct
"The loss‑of‑function mutation in the OPHN1 gene, which encodes a Rho‑GTPase‑activating protein, leads to impaired dendritic spine maturation and is associated with X‑linked intellectual disability, while overexpression of the S100A10 protein in HeLa cells enhances Annexin V‑mediated apoptosis through a calcium‑dependent pathway.",-32.75,0.01,geneorgeneproduct
"Silencing of IRE1α in A549 cells markedly reduces Annexin V‑positive apoptotic cells and down‑regulates the expression of the pro‑apoptotic gene S100A10, indicating that IRE1α‑mediated ER stress signaling promotes apoptosis through S100A10 in this lung cancer cell line.",-34.0,0.01,geneorgeneproduct
"Silence of the IRE1α‑mediated unfolded‑protein response in A549 cells overexpressing the MC4R‑activating mutation R451C leads to increased Annexin V‑positive apoptosis and up‑regulation of the pro‑inflammatory cytokine LIFR, suggesting a novel link between ER stress, cell‑surface receptor signaling and cell death in lung cancer.",-55.0,0.01,geneorgeneproduct
"Silvestrol treatment of A549 cells downregulates the expression of the IRE1α‑regulated spliced XBP1 mRNA, thereby attenuating the unfolded‑protein‑response‑mediated up‑regulation of Annexin V and s100a10 that normally promotes apoptosis in this lung carcinoma line.",-38.5,0.01,geneorgeneproduct
"Silicosis‑induced pulmonary fibrosis in A549 cells is exacerbated by the up‑regulation of the IRE1α‑mediated XBP1 splicing pathway, which in turn amplifies Annexin V‑dependent apoptosis of alveolar epithelial cells.",-34.5,0.01,geneorgeneproduct
"In A549 cells, the IRE1α‑mediated splicing of XBP1 enhances Annexin V expression, thereby promoting apoptosis in response to cisplatin treatment.",-17.125,0.01,geneorgeneproduct
"In ANXA5‑overexpressing A549 cells, the up‑regulation of S100A10 by IRE1α signaling enhances FABP7‑mediated lipid droplet formation, thereby promoting resistance to GCSF‑induced apoptosis.",-25.625,0.01,geneorgeneproduct
"In U87‑MG cells, knockdown of **IRE1α** reduces **Annexin V**‑mediated apoptosis while upregulating **FABP7** expression, suggesting a protective role of the unfolded‑protein response in glioblastoma.",-25.125,0.01,geneorgeneproduct
"In HeLa cells, overexpression of the gene product Annexin V enhances the secretion of GCSF, thereby promoting the proliferation of CD200‑positive macrophages and amplifying the inflammatory response mediated by the IRE1α‑NF‑κB axis.",-28.75,0.01,geneorgeneproduct
"By knocking down IRE1α in A549 cells, we observed a marked decrease in Annexin V‑positive apoptotic cells, suggesting that IRE1α‑mediated ER stress signaling promotes cell survival in this lung cancer line.",-27.375,0.01,geneorgeneproduct
"By overexpressing the gene product Annexin V in A549 cells, we observed a significant upregulation of the cytokine GCSF, which in turn activated the LIFR signaling pathway and enhanced the proliferation of CD200‑positive tumor‑associated macrophages.",-32.25,0.01,geneorgeneproduct
"By activating the IRE1α‑dependent XBP1 splicing pathway, the MC4R‑expressing A549 cells upregulate Annexin V and FABP7, thereby enhancing lipid‑mediated apoptosis in response to GCSF‑induced oxidative stress.",-32.25,0.01,geneorgeneproduct
"By exposing A549 cells to the small‑molecule inhibitor GCSF‑R, we observed that Annexin V‑positive apoptotic cells were markedly increased, suggesting that GCSF signaling through its receptor activates the IRE1α‑mediated unfolded‑protein response and promotes apoptosis in this lung carcinoma cell line.",-41.5,0.01,geneorgeneproduct
"Deletion of the OPHN1 gene in human iPSC-derived cortical neurons reduces Annexin V-mediated apoptosis and increases FABP7 expression, thereby enhancing neuronal survival under oxidative stress.",-25.875,0.01,geneorgeneproduct
"Deletion in the MC4R gene reduces GCSF‑induced STAT3 phosphorylation in A549 cells, thereby impairing Annexin V‑mediated apoptosis of the tumor cells.",-30.5,0.01,geneorgeneproduct
"Deletion‑induced loss of the OPHN1 gene product in cultured HeLa cells markedly up‑regulates the expression of the inflammatory cytokine GCSF, thereby enhancing the secretion of the chemokine s100a10 and promoting apoptosis through Annexin V binding.",-45.75,0.01,geneorgeneproduct
"Deletion-driven loss of the IRE1α‑mediated splicing of XBP1 in the MC4R‑expressing hypothalamic POMC neurons of a humanized A549 cell line carrying the LIFR c.1523G>A variant leads to impaired STAT3 phosphorylation and a pronounced increase in FABP7‑dependent lipid droplet accumulation, thereby exacerbating the inflammatory phenotype observed in patients with s100a10‑associated neuroinflammation.",-73.5,0.01,geneorgeneproduct
"Annexin V expression is markedly upregulated in A549 cells treated with the IRE1α inhibitor, suggesting that ER stress signaling modulates apoptosis through the phosphatidylserine‑binding protein.",-25.75,0.01,geneorgeneproduct
"Ann exon‑skipping therapy using antisense oligonucleotides targeting the c.1234‑1G>A variant in the IRE1α gene has been shown to restore proper splicing and reduce ER‑stress‑induced apoptosis in cultured A549 cells, thereby improving cell viability in a model of cystic fibrosis‑associated lung disease.",-53.0,0.01,geneorgeneproduct
"Annin V binding to apoptotic cells is enhanced by the S100A10 complex, which in turn up‑regulates FABP7 expression in microglia, thereby modulating IRE1α‑mediated ER stress responses that influence the activity of the serotonin‑6 receptor and the downstream GCSF‑induced proliferation of CD200‑positive oligodendrocyte progenitors.",-63.0,0.01,geneorgeneproduct
"Annular expression of the gene product Annexin V in A549 cells is markedly up‑regulated by the cytokine GCSF, a change that is mediated through the IRE1α‑dependent splicing of XBP1 and that enhances the secretion of the neurotrophic factor LIFR, thereby promoting survival of the tumor cells in a hypoxic microenvironment.",-60.5,0.01,geneorgeneproduct
"Mutational loss of OPHN1 in cultured HeLa cells upregulates the IRE1α‑mediated unfolded‑protein response, thereby increasing Annexin V‑positive apoptotic events and reducing FABP7 expression.",-26.875,0.01,geneorgeneproduct
Mutations in the OPHN1 gene that reduce its interaction with Annexin V and s100a10 lead to impaired neuronal migration and are associated with X‑linked intellectual disability in male patients.,-22.875,0.01,geneorgeneproduct
"Mutually exclusive phosphorylation of Annexin V by IRE1α in HeLa cells upregulates FABP7 expression, thereby enhancing GCSF‑mediated CD200 signaling and promoting MC4R‑driven neuronal differentiation.",-35.0,0.01,geneorgeneproduct
"Mutagenic exposure of A549 cells to doxorubicin induces a rapid up‑regulation of the IRE1α‑mediated splicing of XBP1, which in turn enhances Annexin V‑dependent apoptosis and increases the expression of the S100A10‑FABP7 complex, thereby sensitizing the cells to subsequent GCSF‑driven neutrophil recruitment.",-40.0,0.01,geneorgeneproduct
"Overexpression of the gene product Annexin V in A549 cells enhances the secretion of GCSF, thereby promoting the proliferation of CD200‑positive macrophages and increasing the expression of the neurotrophic factor LIFR in the tumor microenvironment.",-31.0,0.01,geneorgeneproduct
"Over the course of the study, the CRISPR‑edited A549 cells harboring the OPHN1 c.1523G>A (p.Arg508His) variant exhibited markedly reduced Annexin V‑positive apoptotic cells upon exposure to the GCSF‑induced oxidative stress, suggesting that the OPHN1 mutation confers resistance to GCSF‑mediated cell death.",-48.25,0.01,geneorgeneproduct
"Overexpressed Annexin V in A549 cells enhances the secretion of GCSF, thereby activating the LIFR signaling cascade that upregulates FABP7 expression and promotes chemotaxis of CD200‑positive macrophages.",-31.625,0.01,geneorgeneproduct
"Overexposure to the small molecule GCSF in A549 cells upregulates the transcription factor IRE1α, which in turn enhances the expression of the lipid‑binding protein FABP7 and the neuropeptide receptor MC4R, thereby promoting cellular survival and attenuating apoptosis in the context of hypoxic stress.",-51.75,0.01,geneorgeneproduct
"GCSF stimulation of CD200‑expressing MC4R‑positive adipocytes upregulates Annexin V and FABP7, thereby enhancing lipid droplet formation and attenuating IRE1α‑mediated ER stress in a mouse model of diet‑induced obesity.",-31.125,0.01,geneorgeneproduct
"GFP‑tagged Annexin V binding to apoptotic HeLa cells was markedly enhanced by the IRE1α‑dependent up‑regulation of FABP7, revealing a novel link between ER stress and phosphatidylserine exposure.",-30.75,0.01,geneorgeneproduct
"Glycogen synthase kinase‑3β inhibition in A549 cells upregulates the transcription of the S100A10 gene, thereby enhancing Annexin V‑mediated apoptosis and sensitizing the cells to the chemotherapeutic agent doxorubicin.",-30.25,0.01,geneorgeneproduct
GABRA2 up‑regulation in the hippocampus of A549 cells treated with the small‑molecule inhibitor IRE1a‑inhibitor‑1 (IRE1a‑i1) correlates with increased Annexin V‑positive apoptotic cells and reduced expression of the neurotrophic factor LIFR.,-50.5,0.01,geneorgeneproduct
"ANXIOLYTIC treatment with the selective serotonin‑receptor agonist **5‑HT6 receptor** up‑regulates the expression of the neuroprotective protein **Annexin V** in **MC4R**‑deficient **A549** cells, thereby attenuating apoptosis induced by **IRE1α**‑mediated endoplasmic reticulum stress.",-49.0,0.01,geneorgeneproduct
"ANexin V binding to the CD200 receptor on microglia is enhanced by the S100A10‑FABP7 complex, thereby amplifying IRE1α‑mediated ER stress signaling that ultimately upregulates GCSF production in the central nervous system.",-43.0,0.01,geneorgeneproduct
"ANX1, the human homolog of Annexin V, binds phosphatidylserine on apoptotic cells and its interaction with the CD200 receptor on microglia is enhanced by the S100A10 complex, thereby modulating the release of GCSF and influencing the expression of the IRE1α‑mediated unfolded protein response in neurons expressing the MC4R gene.",-50.0,0.01,geneorgeneproduct
"ANCHORING the study, we observed that the IRE1α‑mediated splicing of XBP1 in A549 cells up‑regulates FABP7 expression, thereby enhancing lipid‑mediated survival pathways in response to GCSF‑induced oxidative stress.",-40.75,0.01,geneorgeneproduct
"Knocking out IRE1α in A549 cells markedly reduces Annexin V‑positive apoptosis induced by doxorubicin, while overexpressing FABP7 restores cell viability and attenuates the drug‑mediated up‑regulation of the pro‑inflammatory cytokine LIFR.",-36.25,0.01,geneorgeneproduct
"Knock‑down of the IRE1α‑mediated splicing of XBP1 in A549 cells markedly reduces Annexin V‑positive apoptotic cells, indicating that IRE1α activation is essential for the ER‑stress‑induced apoptosis observed in this lung carcinoma model.",-31.875,0.01,geneorgeneproduct
"Knox et al. demonstrated that the IRE1α‑mediated splicing of XBP1 in A549 cells up‑regulates FABP7 expression, thereby enhancing lipid‑mediated survival signaling in response to GCSF‑induced oxidative stress.",-37.75,0.01,geneorgeneproduct
"Knitting together the data, we found that the IRE1α‑mediated splicing of XBP1 in HeLa cells up‑regulates FABP7 expression, thereby enhancing lipid droplet formation and conferring resistance to doxorubicin‑induced apoptosis.",-41.0,0.01,geneorgeneproduct
"Chromatin immunoprecipitation revealed that the transcription factor IRE1α binds the promoter of the FABP7 gene, thereby up‑regulating its expression in MC4R‑deficient A549 cells treated with GCSF.",-23.625,0.01,geneorgeneproduct
"Chromosomal translocation t(2;11)(p21;q23) in the A549 cell line creates a novel fusion between the IRE1α gene and the S100A10 promoter, thereby up‑regulating Annexin V expression and enhancing resistance to cisplatin-induced apoptosis.",-41.25,0.01,geneorgeneproduct
"Chromosome‑wide association analysis revealed that the S100A10 variant rs1234567, which alters the binding affinity of Annexin V to phosphatidylserine, is significantly linked to increased expression of the FABP7 gene in the hippocampus of patients with Alzheimer’s disease, suggesting that the IRE1α‑mediated unfolded protein response may modulate this interaction and contribute to neuroinflammation.",-48.75,0.01,geneorgeneproduct
"Chromophore‑induced phosphorylation of the IRE1α‑mediated unfolded‑protein response in HeLa cells upregulates Annexin V expression, thereby enhancing the apoptotic clearance of s100a10‑positive apoptotic bodies.",-42.25,0.01,geneorgeneproduct
"Mutation of the OPHN1 gene in a male patient with X‑linked intellectual disability led to a loss of Annexin V‑mediated phosphatidylserine exposure, thereby impairing microglial phagocytosis of apoptotic neurons.",-25.0,0.01,geneorgeneproduct
"Mutation in the OPHN1 gene that reduces its GAP activity enhances Annexin V-mediated phosphatidylserine exposure on the surface of cultured HeLa cells, thereby increasing their susceptibility to GCSF-induced apoptosis.",-30.125,0.01,geneorgeneproduct
"Mutation analysis of the OPHN1 gene in a patient with X‑linked intellectual disability revealed a novel c.1523G>A (p.Arg508His) variant that disrupts the Rho‑GTPase‑activating domain, leading to aberrant neuronal migration and a severe phenotype that includes microcephaly, seizures, and a markedly reduced expression of the neuronal surface protein CD200.",-51.75,0.01,geneorgeneproduct
"Mutation‑induced loss of OPHN1 in A549 cells upregulates the IRE1α‑mediated unfolded‑protein response, thereby enhancing Annexin V‑positive apoptosis and reducing FABP7 expression.",-31.0,0.01,geneorgeneproduct
"In *HeLa* cells, overexpression of the *ADRB2* gene product enhances the secretion of *IL‑1β*, which in turn upregulates the *MMP‑TIMP* axis and promotes extracellular matrix remodeling.",-25.875,0.01,geneorgeneproduct
"In ARPE-19 cells, overexpression of the phospholipase C epsilon‑1 gene product amplifies IL‑1β‑induced NF‑κB signaling, thereby enhancing MMP‑9 secretion and accelerating extracellular matrix remodeling.",-28.625,0.01,geneorgeneproduct
"In our study, overexpression of the phospholipase C epsilon‑1 gene in HeLa cells markedly up‑regulated IL‑1β secretion, thereby enhancing the inflammatory response to type I interferon receptor stimulation.",-34.75,0.01,geneorgeneproduct
"In HeLa cells, overexpression of the phospholipase C epsilon‑1 gene product amplifies IL‑1β‑induced NF‑κB signaling, thereby enhancing MMP‑9 transcription and accelerating extracellular matrix remodeling.",-22.25,0.01,geneorgeneproduct
"The phospholipase C epsilon‑1 gene product is up‑regulated by IL‑1β in HeLa cells, leading to increased MMP‑9 secretion that is inhibited by the EDN1 antagonist, thereby attenuating the inflammatory response in a model of type I interferon receptor‑mediated disease.",-40.0,0.01,geneorgeneproduct
"The down‑regulation of the Type I Interferon Receptor by the phospholipase C epsilon‑1 pathway in A549 cells leads to increased IL‑1β secretion, thereby enhancing MMP‑TIMP imbalance and promoting tumor invasion.",-30.625,0.01,geneorgeneproduct
"The upregulation of phospholipase C epsilon‑1 in HeLa cells carrying the TCF‑4K variant enhances IL‑1β‑induced NF‑κB signaling, thereby increasing MMP‑9 expression and promoting extracellular matrix remodeling.",-28.125,0.01,geneorgeneproduct
"The IL‑1β‑induced up‑regulation of MMP‑9 in HeLa cells is attenuated by the phospholipase C epsilon‑1 inhibitor, revealing a novel regulatory axis involving the Type I interferon receptor and the ADAR‑mediated editing of Ago2.",-30.375,0.01,geneorgeneproduct
"Overexpression of the phospholipase C epsilon‑1 gene in HeLa cells enhances IL‑1β‑induced NF‑κB activation, thereby increasing MMP‑9 secretion and promoting invasion of the tumor microenvironment.",-26.625,0.01,geneorgeneproduct
"Overactivation of the Type I Interferon Receptor in A549 cells leads to up‑regulation of MMP‑TIMP balance, which in turn enhances IL‑1β secretion and promotes a pro‑inflammatory microenvironment that accelerates tumor cell invasion.",-31.875,0.01,geneorgeneproduct
"Over prolonged exposure to high GH-doses, the phospholipase C epsilon‑1 pathway in HeLa cells up‑regulates MMP‑9 while simultaneously down‑regulating TIMP‑1, thereby enhancing extracellular matrix remodeling and promoting invasion.",-36.5,0.01,geneorgeneproduct
"Over in the HeLa cell line, the overexpression of the phospholipase C epsilon‑1 gene product activates the MMP‑TIMP axis, thereby enhancing extracellular matrix remodeling and promoting invasion of the tumor cells.",-40.75,0.01,geneorgeneproduct
"Reduced expression of the Type I Interferon Receptor in A549 cells treated with high‑dose GH leads to increased IL‑1β secretion, which in turn upregulates MMP‑TIMP signaling and promotes EDN1‑mediated vasoconstriction.",-27.375,0.01,geneorgeneproduct
"Reduced IL‑1β secretion in HeLa cells transfected with a CRISPR‑edited variant of the Type I Interferon Receptor gene (IFNAR1 c.1123G>A) was accompanied by increased expression of the phospholipase C epsilon‑1 (PLCE1) transcript, suggesting a regulatory link between innate immune signaling and intracellular calcium mobilization.",-45.25,0.01,geneorgeneproduct
"Reduced MMP‑TIMP balance in A549 cells overexpressing ADAR2 leads to enhanced IL‑1β secretion, which in turn up‑regulates the type I interferon receptor on neighboring HeLa cells.",-30.875,0.01,geneorgeneproduct
"Reduced GH‑doses in HeLa cells downregulate the expression of the Type I Interferon Receptor, thereby attenuating IL‑1β‑induced activation of the phospholipase C epsilon‑1 signaling cascade.",-27.75,0.01,geneorgeneproduct
"Activation of the Type I Interferon Receptor by interferon‑β in A549 cells upregulates MMP‑9 expression, which is subsequently inhibited by the endogenous TIMP‑1 protein, thereby modulating extracellular matrix remodeling during tumor invasion.",-22.375,0.01,geneorgeneproduct
"Activation by the Type I Interferon Receptor upregulates IL‑1β expression in HeLa cells, a process that is attenuated when Ago2 is silenced and enhanced by phospholipase C epsilon‑1 overexpression.",-33.0,0.01,geneorgeneproduct
"Activation loss of the Type I Interferon Receptor in A549 cells leads to up‑regulation of MMP‑TIMP balance, which in turn enhances IL‑1β‑mediated NF‑κB signaling and promotes cell migration.",-39.75,0.01,geneorgeneproduct
"Activation‑induced phosphorylation of phospholipase C epsilon‑1 in HeLa cells enhances IL‑1β secretion, a process that is attenuated when the Type I interferon receptor is blocked, thereby linking innate immune signaling to tumor‑derived cytokine production.",-43.75,0.01,geneorgeneproduct
"Mutational loss of the Type I Interferon Receptor gene in A549 cells leads to up‑regulation of MMP‑TIMP signaling, thereby enhancing IL‑1β‑mediated invasion of the tumor microenvironment.",-26.125,0.01,geneorgeneproduct
"Mutations in the ADRB2 gene that alter the binding affinity of β‑adrenergic ligands are associated with impaired IL‑1β‑mediated inflammatory signaling in patients with chronic obstructive pulmonary disease, thereby exacerbating airway remodeling through dysregulated MMP‑TIMP balance.",-33.0,0.01,geneorgeneproduct
"Mutant ADRB2 alleles in Homo sapiens were shown to up‑regulate phospholipase C epsilon‑1 activity, thereby enhancing IL‑1β secretion and exacerbating Type I interferon receptor‑mediated inflammation in cultured A549 cells.",-35.25,0.01,geneorgeneproduct
"Mutating the ADRB2 gene in A549 cells reduces IL‑1β secretion, thereby attenuating the inflammatory response to type I interferon receptor activation.",-23.25,0.01,geneorgeneproduct
"Polymorphisms in the ADRB2 gene alter the binding affinity of β‑adrenergic agonists, thereby modulating the downstream phospholipase C epsilon‑1 signaling cascade that ultimately influences IL‑1β production in human airway epithelial cells.",-25.5,0.01,geneorgeneproduct
"Polypeptide hormone GnRH stimulates the pituitary to release GH, and in HeLa cells the downstream phospholipase C epsilon‑1 pathway activates MMP‑TIMP signaling, thereby enhancing IL‑1β secretion and up‑regulating the Type I Interferon Receptor expression.",-49.5,0.01,geneorgeneproduct
"Polyclonal activation of the Type I Interferon Receptor in A549 cells upregulates MMP‑TIMP balance, thereby enhancing extracellular matrix remodeling and promoting IL‑1β‑mediated inflammatory signaling.",-25.25,0.01,geneorgeneproduct
"Polysialylated NCAM1 expression in HeLa cells is up‑regulated by IL‑1β through a phospholipase Cε1‑dependent pathway, thereby enhancing MMP‑9 activity and promoting invasion of the surrounding E. coli‑derived biofilm.",-40.25,0.01,geneorgeneproduct
"A CRISPR‑Cas9‑mediated knockout of the ADRB2 gene in A549 cells markedly up‑regulated IL‑1β secretion, suggesting that β‑adrenergic signaling normally suppresses inflammatory cytokine production in this lung carcinoma model.",-26.75,0.01,geneorgeneproduct
"A single‑cell RNA‑seq analysis of the A549 cell line revealed that up‑regulation of the Type I Interferon Receptor gene cluster, including IFNAR1 and IFNAR2, is accompanied by increased expression of the pro‑inflammatory cytokine IL‑1β and the metalloproteinase inhibitor TIMP‑1, suggesting a coordinated inflammatory‑matrix remodeling response.",-37.25,0.01,geneorgeneproduct
"AUP1 overexpression in HeLa cells enhances IL‑1β‑induced NF‑κB activation, thereby up‑regulating MMP‑9 transcription and accelerating extracellular matrix degradation.",-26.875,0.01,geneorgeneproduct
"AIF1L overexpression in A549 cells enhances IL‑1β‑induced NF‑κB activation, thereby increasing MMP‑9 secretion and promoting invasion of the surrounding lung parenchyma.",-28.25,0.01,geneorgeneproduct
"Silencing of the gene product Ago2 in HeLa cells markedly reduces IL‑1β secretion, thereby attenuating the downstream activation of the type I interferon receptor signaling cascade.",-21.625,0.01,geneorgeneproduct
"Silenced expression of the ADRB2 gene in A549 cells treated with high-dose GH reduces IL‑1β secretion, thereby attenuating MMP‑TIMP‑mediated extracellular matrix remodeling.",-24.5,0.01,geneorgeneproduct
"Silently, the loss of the MMP‑TIMP balance in the A549 cell line, driven by up‑regulated ADAR2, triggers a cascade that amplifies IL‑1β secretion and activates the Type I Interferon Receptor signaling pathway, ultimately enhancing the expression of the phospholipase C epsilon‑1 gene product.",-52.5,0.01,geneorgeneproduct
"Silvestrol, a natural inhibitor of the RNA‑binding protein Ago2, suppresses IL‑1β‑induced NF‑κB activation in A549 cells, thereby reducing MMP‑9 secretion and attenuating EDN1‑mediated vasoconstriction in a model of pulmonary hypertension.",-32.0,0.01,geneorgeneproduct
"Suppression of the Type I Interferon Receptor by the phospholipase C epsilon‑1 pathway in HeLa cells reduces IL‑1β‑induced MMP‑TIMP imbalance, thereby attenuating extracellular matrix remodeling.",-30.375,0.01,geneorgeneproduct
"Suppressed expression of the Type I Interferon Receptor in HeLa cells treated with high‑dose GH reduces IL‑1β‑induced MMP‑TIMP imbalance, thereby attenuating extracellular matrix degradation.",-27.625,0.01,geneorgeneproduct
"Supple‑inhibition of the Type I Interferon Receptor by the small‑molecule antagonist JAK‑STAT‑inhibitor‑X in A549 cells down‑regulates IL‑1β transcription, thereby attenuating MMP‑TIMP‑mediated extracellular matrix remodeling and reducing tumor‑cell invasion.",-59.25,0.01,geneorgeneproduct
"Supplying high‑dose growth hormone to patients with a loss‑of‑function mutation in the type I interferon receptor gene (IFNAR1) restores IL‑1β‑mediated NF‑κB activation in peripheral blood mononuclear cells, thereby rescuing the impaired antiviral response observed in these individuals.",-41.0,0.01,geneorgeneproduct
"Knock‑down of the gene product Ago2 in HeLa cells markedly reduces IL‑1β‑induced phosphorylation of phospholipase C epsilon‑1, thereby attenuating downstream MMP‑TIMP‑mediated extracellular matrix remodeling.",-21.75,0.01,geneorgeneproduct
"Knocking‑down the gene product Ago2 in HeLa cells markedly reduces IL‑1β‑induced phosphorylation of phospholipase C epsilon‑1, thereby attenuating downstream MMP‑TIMP‑mediated extracellular matrix remodeling.",-23.75,0.01,geneorgeneproduct
"Knobloch syndrome‑associated mutations in the COL18A1 gene, which encode the extracellular matrix protein collagen‑IV, disrupt the binding of the type I interferon receptor and consequently impair downstream STAT‑1 phosphorylation, thereby reducing IL‑1β‑induced MMP‑9 expression in cultured fibroblasts.",-54.25,0.01,geneorgeneproduct
"Knocked‑in A549 cells overexpressing the ADRB2 variant c.1024G>A exhibit heightened IL‑1β secretion upon stimulation with a type I interferon receptor agonist, suggesting that phospholipase C epsilon‑1 signaling amplifies the inflammatory response in this lung cancer model.",-45.0,0.01,geneorgeneproduct
"Loss‑of‑function mutations in the Type I Interferon Receptor gene, together with up‑regulation of IL‑1β and MMP‑TIMP signaling, impair GnRH‑induced phospholipase C epsilon‑1 activation in HeLa cells, thereby reducing GH‑dose‑dependent proliferation.",-31.125,0.01,geneorgeneproduct
"Loss of the MMP‑TIMP balance in the tumor microenvironment of A549 cells, driven by IL‑1β‑induced up‑regulation of phospholipase C epsilon‑1, promotes invasion and correlates with increased expression of the Type I interferon receptor in the surrounding fibroblasts.",-35.25,0.01,geneorgeneproduct
"Loss-of-function mutations in the Type I Interferon Receptor gene impair STAT1 phosphorylation, thereby reducing IL‑1β‑induced NF‑κB activation in human macrophages and exacerbating susceptibility to systemic lupus erythematosus.",-28.25,0.01,geneorgeneproduct
"Loss is observed when the ADRB2 promoter variant c.‑1234G>A reduces transcription, thereby diminishing the downstream Type I Interferon Receptor signaling that normally up‑regulates IL‑1β production in human macrophages.",-49.5,0.01,geneorgeneproduct
"ADRB2 activation by β‑adrenergic agonists enhances IL‑1β‑induced MMP‑TIMP imbalance in human airway epithelial cells, thereby promoting extracellular matrix remodeling.",-18.5,0.01,geneorgeneproduct
"ADRRB2 overexpression in HeLa cells enhances IL‑1β‑induced NF‑κB activation, thereby amplifying the downstream MMP‑TIMP imbalance that promotes extracellular matrix remodeling in tumor invasion.",-33.75,0.01,geneorgeneproduct
"ADBR2 overexpression in HeLa cells enhances IL‑1β‑induced phospholipase Cε1 activation, thereby increasing MMP‑TIMP‑mediated extracellular matrix remodeling.",-28.375,0.01,geneorgeneproduct
"ADARB2 overexpression in HeLa cells enhances IL‑1β‑induced NF‑κB activation, thereby increasing MMP‑9 secretion and promoting invasion of the tumor microenvironment.",-29.875,0.01,geneorgeneproduct
"CRISPR‑mediated knockout of the ADRB2 gene in A549 cells markedly reduces IL‑1β‑induced phospholipase C epsilon‑1 activation, thereby attenuating downstream MMP‑TIMP‑mediated extracellular matrix remodeling.",-21.5,0.01,geneorgeneproduct
"CRP expression is up‑regulated by IL‑1β in HeLa cells, a process that is amplified by the MMP‑TIMP axis and suppressed when the Type I Interferon Receptor is blocked.",-32.75,0.01,geneorgeneproduct
"CR-hypoxia‑induced up‑regulation of the Type I Interferon Receptor in A549 cells is mediated by phospholipase C epsilon‑1‑dependent activation of NF‑κB, which in turn enhances IL‑1β transcription and promotes MMP‑TIMP imbalance, thereby facilitating extracellular matrix remodeling and tumor invasion.",-50.75,0.01,geneorgeneproduct
"CR‑ISPR‑mediated knockout of the ADRB2 gene in A549 cells markedly reduces IL‑1β‑induced MMP‑9 secretion, thereby attenuating the invasive phenotype of these lung carcinoma cells.",-34.75,0.01,geneorgeneproduct
"The peroxisome proliferators‑activated receptor‑alpha (PPARα) agonist fenofibrate up‑regulates the mitochondrial fusion protein Mfn2, thereby enhancing oxidative phosphorylation in HepG2 cells, while concomitant down‑regulation of the DNA repair enzyme XPD reduces UV‑induced mutagenesis.",-22.875,0.01,geneorgeneproduct
"The SNP rs123456 in the promoter of EP300, which is known to modulate peroxisome proliferators‑activated receptor‑α expression, was found to be associated with increased ICAM1 levels in peripheral blood mononuclear cells of patients with XPD‑deficient xeroderma pigmentosum.",-31.625,0.01,geneorgeneproduct
"The loss‑of‑function mutation in the XPD gene, which encodes a DNA‑repair helicase, reduces the transcriptional activity of EP300, thereby impairing the up‑regulation of ICAM1 expression in endothelial cells exposed to oxidative stress.",-21.875,0.01,geneorgeneproduct
"The activation of peroxisome proliferators‑activated receptor‑alpha (PPARα) in HepG2 cells up‑regulates the transcription of the mitochondrial fusion protein Mfn2 while simultaneously down‑regulating the DNA repair enzyme XPD, thereby linking lipid metabolism to genomic stability.",-20.5,0.01,geneorgeneproduct
"Oxidative phosphorylation defects in Mfn2‑deficient HeLa cells are exacerbated by the XPD c.1315G>A variant, leading to up‑regulation of ICAM1 and down‑regulation of EP300 transcriptional activity.",-30.75,0.01,geneorgeneproduct
"Oxipor, a novel peroxisome proliferators activated receptor‑alpha agonist, down‑regulates ICAM1 expression in A549 cells, thereby attenuating the inflammatory response induced by the XPD‑deficient Mfn2‑overexpressing phenotype.",-40.75,0.01,geneorgeneproduct
"Ox‑2‑acetyl‑pyridine, a synthetic ligand for peroxisome proliferators‑activated receptor‑alpha, was shown to up‑regulate the transcription of the mitochondrial fusion protein Mfn2 while simultaneously down‑regulating the DNA‑repair enzyme XPD in HepG2 cells, thereby enhancing cellular sensitivity to cisplatin.",-50.75,0.01,geneorgeneproduct
"Oxytocin treatment upregulates the expression of the peroxisome proliferators activated receptor‑alpha gene (PPARA) in human HepG2 cells, thereby enhancing fatty‑acid oxidation and reducing triglyceride accumulation.",-31.0,0.01,geneorgeneproduct
"Peripheral blood mononuclear cells from a patient with a pathogenic XPD c.1510C>T (p.R504C) variant exhibited markedly reduced transcription of the peroxisome proliferators activated receptor‑alpha (PPARα) target gene CPT1A, while overexpression of the mitochondrial fusion protein Mfn2 restored PPARα‑mediated fatty‑acid oxidation and rescued the impaired cellular energy phenotype.",-45.5,0.01,geneorgeneproduct
"Peripheral activation of peroxisome proliferators‑activated receptor‑α (PPARα) in HepG2 cells up‑regulates the mitochondrial fusion protein Mfn2 while simultaneously down‑regulating the DNA repair enzyme XPD, thereby enhancing oxidative phosphorylation and reducing reactive oxygen species production.",-27.875,0.01,geneorgeneproduct
"Peripheral insulin resistance in HepG2 cells is exacerbated by the XPD c.1515C>T variant, which upregulates ICAM1 expression through EP300-mediated transcriptional activation.",-29.875,0.01,geneorgeneproduct
"Peripheral PPARα activation in HepG2 cells upregulates the mitochondrial fusion protein Mfn2, thereby enhancing oxidative phosphorylation and reducing reactive oxygen species production.",-24.75,0.01,geneorgeneproduct
"Peroxisome proliferators‑activated receptor‑α activation up‑regulates ICAM1 expression in endothelial cells, thereby enhancing leukocyte adhesion and contributing to the inflammatory phenotype observed in atherosclerotic lesions.",-16.0,0.01,geneorgeneproduct
"Peroxin‑activated receptor‑alpha (PPARα) up‑regulates the transcription factor EP300, which in turn enhances ICAM1 expression in Mfn2‑deficient HepG2 cells, thereby promoting leukocyte adhesion and accelerating atherosclerotic plaque formation.",-34.25,0.01,geneorgeneproduct
"Perinatal overexpression of the transcriptional co‑activator EP300 in A549 cells upregulates ICAM1, thereby enhancing leukocyte adhesion and accelerating the inflammatory response to the chemotherapeutic agent doxorubicin.",-26.75,0.01,geneorgeneproduct
"Per1‑knockout mice exhibit a marked up‑regulation of the peroxisome proliferators‑activated receptor‑alpha (PPARα) target gene CPT1A, which is accompanied by a compensatory increase in mitochondrial fusion protein Mfn2 expression, thereby linking PPARα signaling to enhanced fatty‑acid oxidation in the liver.",-48.0,0.01,geneorgeneproduct
"Methotrexate treatment of HeLa cells overexpressing the XPD variant c.1315G>A reduces ICAM1 transcription through EP300-mediated acetylation, thereby impairing cell adhesion and enhancing apoptosis.",-35.0,0.01,geneorgeneproduct
"Methicillin‑resistant *Staphylococcus aureus* infection in a patient with a germline *XPD* c.1510C>T variant was found to up‑regulate *ICAM1* expression, thereby enhancing neutrophil recruitment and accelerating wound healing.",-39.75,0.01,geneorgeneproduct
"Methadone treatment of OPRM1‑depleted A549 cells upregulates peroxisome proliferators‑activated receptor‑alpha, which in turn enhances EP300‑mediated acetylation of the ICAM1 promoter, thereby increasing ICAM1 expression and promoting leukocyte adhesion.",-30.25,0.01,geneorgeneproduct
"Methionine‑restricted diet upregulates peroxisome proliferators activated receptor‑alpha, which in turn enhances Mfn2‑mediated mitochondrial fusion and suppresses XPD‑driven DNA repair, thereby reducing ICAM1 expression in HepG2 cells.",-29.875,0.01,geneorgeneproduct
"In HepG2 cells, the peroxisome proliferators‑activated receptor‑α agonist fenofibrate up‑regulates the mitochondrial fusion protein Mfn2 while simultaneously down‑regulating the DNA repair enzyme XPD, thereby enhancing oxidative phosphorylation and sensitizing the cells to cisplatin‑induced apoptosis.",-19.25,0.01,geneorgeneproduct
"In A549 cells, the peroxisome proliferators‑activated receptor‑α agonist fenofibrate up‑regulates ICAM1 expression through EP300‑mediated acetylation, thereby enhancing neutrophil adhesion and accelerating the inflammatory response.",-22.125,0.01,geneorgeneproduct
"In HeLa cells, the peroxisome proliferators‑activated receptor‑α agonist fenofibrate up‑regulates the mitochondrial fusion protein Mfn2, thereby enhancing oxidative phosphorylation and reducing reactive oxygen species that otherwise activate the DNA repair enzyme XPD.",-23.875,0.01,geneorgeneproduct
"In the HepG2 cell line, knockdown of the transcriptional co‑activator EP300 reduces ICAM1 expression, thereby attenuating TNF‑α‑induced adhesion of monocytes to endothelial cells.",-21.375,0.01,geneorgeneproduct
"Loss of the XPD helicase in HeLa cells upregulates peroxisome proliferators‑activated receptor‑α, which in turn increases ICAM1 transcription and enhances the recruitment of EP300 to the TSH‑β promoter.",-25.625,0.01,geneorgeneproduct
"Loss‑of‑function mutations in the XPD helicase gene, which impair nucleotide excision repair, are associated with increased expression of the inflammatory adhesion molecule ICAM1 in epithelial cells, thereby exacerbating the inflammatory phenotype observed in patients with xeroderma pigmentosum.",-31.375,0.01,geneorgeneproduct
"Loss-of-function mutations in the XPD gene impair DNA repair and, in a HeLa cell line, reduce EP300-mediated acetylation of the peroxisome proliferators activated receptor‑alpha promoter, thereby attenuating its transcriptional activation of fatty‑acid‑oxidation genes.",-33.0,0.01,geneorgeneproduct
"Losses of the peroxisome proliferators activated receptor‑alpha gene (PPARA) in HepG2 cells lead to up‑regulation of the mitochondrial fusion protein Mfn2, which in turn enhances the transcription of the DNA repair enzyme XPD and the RNA‑binding protein Pum, thereby increasing ICAM1 expression and promoting a pro‑inflammatory phenotype that is attenuated by EP300‑mediated acetylation of the TSH‑beta promoter.",-50.25,0.01,geneorgeneproduct
"Aberrant activation of peroxisome proliferators‑activated receptor‑α (PPARα) in HepG2 cells up‑regulates ICAM1 expression, thereby enhancing leukocyte adhesion and potentiating inflammatory signaling in the presence of the Mfn2‑deficient phenotype.",-29.125,0.01,geneorgeneproduct
"Abernathy et al. demonstrated that the peroxisome proliferators‑activated receptor‑α agonist fenofibrate up‑regulates EP300 expression in HepG2 cells, thereby enhancing Mfn2‑mediated mitochondrial fusion and attenuating XPD‑dependent DNA repair defects in a TSH‑beta‑overexpressing thyroid carcinoma model.",-38.5,0.01,geneorgeneproduct
"Abernormal expression of the transcriptional co‑activator EP300 in HeLa cells carrying the XPD c.1315C>T variant leads to up‑regulation of ICAM1, thereby enhancing adhesion of the cells to endothelial monolayers and promoting metastatic potential.",-43.0,0.01,geneorgeneproduct
"Aberration of the XPD gene in a patient with xeroderma pigmentosum leads to impaired DNA repair, which in turn upregulates ICAM1 expression and exacerbates inflammatory responses in the epidermis.",-33.0,0.01,geneorgeneproduct
"Genetic ablation of the peroxisome proliferators‑activated receptor‑alpha gene in A549 cells leads to up‑regulation of the mitochondrial fusion protein Mfn2, thereby enhancing oxidative phosphorylation and reducing the proliferation of these lung carcinoma cells.",-27.75,0.01,geneorgeneproduct
"Genomic analysis revealed that the XPD c.1315G>A variant in a patient with xeroderma pigmentosum increases transcription of the DNA repair gene ERCC1, thereby enhancing cellular resistance to UV‑induced apoptosis.",-36.0,0.01,geneorgeneproduct
"Genotyping of the XPD c.2294C>T variant in a cohort of *Homo sapiens* patients revealed that carriers exhibit reduced transcriptional activity of EP300, leading to impaired ICAM1 expression and heightened susceptibility to inflammatory disease.",-43.75,0.01,geneorgeneproduct
"Genetically engineered A549 cells overexpressing the peroxisome proliferators activated receptor‑alpha (PPARα) allele harboring the XPD c.1234G>A variant exhibit markedly increased ICAM1 transcription, suggesting that PPARα activation synergizes with XPD‑mediated DNA repair to upregulate adhesion molecule expression.",-42.75,0.01,geneorgeneproduct
"TP53 mutations in the TP53 c.215C>G variant are associated with increased ICAM1 expression in A549 cells, leading to enhanced adhesion of Mfn2‑deficient fibroblasts to the extracellular matrix.",-27.0,0.01,geneorgeneproduct
"TPP1 deficiency in HeLa cells upregulates the peroxisome proliferators activated receptor‑alpha (PPARα) pathway, thereby increasing ICAM1 expression and enhancing adhesion of the cells to endothelial monolayers.",-31.125,0.01,geneorgeneproduct
"TP73 expression is up‑regulated by the peroxisome proliferators‑activated receptor‑alpha agonist fenofibrate, which in turn enhances EP300‑mediated acetylation of the Mfn2 promoter, thereby promoting mitochondrial fusion and attenuating oxidative stress in HepG2 cells.",-33.0,0.01,geneorgeneproduct
"TPPP‑α‑mediated activation of PPAR‑α in HepG2 cells upregulates ICAM1 expression, thereby enhancing leukocyte adhesion and contributing to the inflammatory phenotype observed in patients with the XPD c.1515G>A variant.",-43.5,0.01,geneorgeneproduct
"Ep300 acetylates the transcription factor XPD, thereby enhancing its recruitment to the promoter of the peroxisome proliferators‑activated receptor‑alpha gene and up‑regulating Pum‑mediated mRNA decay of ICAM1 in human HepG2 cells.",-26.75,0.01,geneorgeneproduct
"Epac1-mediated activation of peroxisome proliferators‑activated receptor‑α (PPARα) in HepG2 cells enhances the transcription of the mitochondrial fusion protein Mfn2, thereby increasing mitochondrial network integrity and reducing reactive oxygen species production.",-31.25,0.01,geneorgeneproduct
"Ep4‑stimulated PPARα activation in HepG2 cells up‑regulates the mitochondrial fusion protein Mfn2 while simultaneously down‑regulating the DNA repair factor XPD, thereby linking lipid metabolism to genomic stability.",-33.25,0.01,geneorgeneproduct
"Epigenetic activation of EP300 by the peroxisome proliferators activated receptor‑alpha (PPARα) up‑regulates ICAM1 expression in human endothelial cells, thereby enhancing leukocyte adhesion and contributing to atherosclerotic plaque formation.",-24.25,0.01,geneorgeneproduct
"A gene‑expression study in HepG2 cells revealed that activation of peroxisome proliferators‑activated receptor‑alpha (PPARα) up‑regulates the transcription factor EP300, which in turn enhances ICAM1 expression and promotes adhesion of circulating tumor cells to the endothelium.",-28.5,0.01,geneorgeneproduct
"A CRISPR‑Cas9‑mediated knockout of the peroxisome proliferators‑activated receptor‑alpha (PPARα) gene in HepG2 cells leads to a marked up‑regulation of the mitochondrial fusion protein Mfn2, while simultaneous overexpression of the DNA repair helicase XPD restores normal levels of the inflammatory adhesion molecule ICAM1.",-34.25,0.01,geneorgeneproduct
"A mutation in the XPD gene that reduces its helicase activity leads to impaired DNA repair and upregulates ICAM1 expression, thereby exacerbating inflammatory responses in patients with xeroderma pigmentosum.",-21.75,0.01,geneorgeneproduct
"A SNP in the promoter of EP300, which modulates peroxisome proliferators‑activated receptor‑α activity, was found to increase ICAM1 expression in A549 cells, thereby enhancing adhesion of TSH‑beta‑producing cells to the extracellular matrix.",-28.125,0.01,geneorgeneproduct
"Activation of peroxisome proliferators‑activated receptor‑α by fenofibrate down‑regulates ICAM1 expression in human endothelial cells, thereby reducing leukocyte adhesion and ameliorating atherosclerotic plaque formation.",-17.625,0.01,geneorgeneproduct
"Activation studies revealed that the peroxisome proliferators‑activated receptor‑alpha agonist up‑regulated ICAM1 expression in A549 cells, a response that was markedly attenuated in cells harboring the XPD c.1315C>T variant.",-40.75,0.01,geneorgeneproduct
"Activation experiments in HepG2 cells revealed that the peroxisome proliferators activated receptor‑alpha (PPARα) agonist fenofibrate up‑regulates the mitochondrial fusion protein Mfn2 while simultaneously down‑regulating the DNA repair enzyme XPD, a modulation that is partially mediated through the transcriptional co‑activator EP300.",-38.75,0.01,geneorgeneproduct
"Activation and phosphorylation of peroxisome proliferators activated receptor‑alpha by the transcriptional co‑activator EP300 in HepG2 cells upregulates ICAM1 expression, thereby enhancing leukocyte adhesion and contributing to the inflammatory phenotype observed in patients with XPD‑associated xeroderma pigmentosum.",-38.0,0.01,geneorgeneproduct
"XPD mutations that impair nucleotide excision repair are associated with increased ICAM1 expression, which in turn enhances leukocyte adhesion and promotes inflammation in patients with chronic obstructive pulmonary disease.",-23.25,0.01,geneorgeneproduct
"XPND‑derived peroxisome proliferators activated receptor‑alpha (PPARα) activation up‑regulates ICAM1 expression in human endothelial cells, thereby enhancing leukocyte adhesion and contributing to the inflammatory phenotype observed in atherosclerotic lesions.",-37.25,0.01,geneorgeneproduct
"XDP‑mutated XPD in HeLa cells upregulates ICAM1 expression, thereby enhancing adhesion of the cells to endothelial monolayers and promoting metastasis.",-33.25,0.01,geneorgeneproduct
"XPC‑deficient fibroblasts exhibit reduced transcriptional activation of the peroxisome proliferators‑activated receptor‑alpha promoter, a defect that is partially rescued by overexpressing the mitochondrial fusion protein Mfn2.",-30.875,0.01,geneorgeneproduct
"A polymorphism in FCGR2B-232Thr reduces IFN‑γ‑induced activation of the CYP3A4 promoter in HepG2 cells, thereby attenuating the metabolism of the chemotherapeutic agent doxorubicin.",-20.875,0.01,geneorgeneproduct
"A CYP3A4 polymorphism in the CYP3A4*1B allele enhances the metabolism of the chemotherapeutic agent doxorubicin, thereby reducing its cytotoxic efficacy in HeLa cells that overexpress the drug‑resistance gene ABCB1.",-28.0,0.01,geneorgeneproduct
"A highly expressed ACTA2 variant in the smooth‑muscle cells of aortic tissue upregulates CYP3A4 transcription, thereby enhancing the metabolism of the B1‑derived angiotensin II subtype receptor‑1a agonist and subsequently increasing the expression of the neurotrophic GAP43 and IFN‑γ‑induced IFITM1, while the CPT1A‑mediated fatty‑acid oxidation pathway is concurrently suppressed, a process that is further modulated by the FCGR2",-63.75,0.01,geneorgeneproduct
"A gain‑of‑function mutation in the CYP3A4 promoter increases IFN‑γ‑induced expression of the FCGR2B‑232Thr allele, thereby enhancing B1‑mediated clearance of angiotensin II subtype receptor‑1a‑bound complexes in ACTA2‑positive vascular smooth‑muscle cells.",-33.5,0.01,geneorgeneproduct
"The CXCR4‑dependent migration of A549 cells is markedly enhanced by the CYP3A4‑mediated metabolism of the chemotherapeutic agent doxorubicin, which increases intracellular IFN‑γ production and subsequently up‑regulates the expression of the adhesion molecule ACTA2, thereby promoting tumor invasion.",-36.5,0.01,geneorgeneproduct
"The CYP3A4-mediated metabolism of the chemotherapeutic agent doxorubicin is markedly enhanced in A549 cells, leading to increased production of the toxic metabolite N-acetyl‑doxorubicin and subsequent up‑regulation of the DNA repair gene TP53, which in turn activates the pro‑apoptotic protein BAX and promotes caspase‑3‑dependent cell death.",-36.5,0.01,geneorgeneproduct
"The human CYP3A4 promoter variant rs2740574 enhances IFN‑γ‑induced transcription of the FASN‑involved gene, thereby increasing lipid synthesis in HepG2 cells and contributing to the development of non‑alcoholic fatty liver disease.",-28.125,0.01,geneorgeneproduct
"The upregulation of CYP3A4 in HepG2 cells treated with the novel inhibitor B1 leads to increased metabolism of the chemotherapeutic agent doxorubicin, thereby reducing its cytotoxic efficacy against ACTA2‑positive smooth muscle tumor cells.",-19.875,0.01,geneorgeneproduct
"SARS‑CoV‑2 infection upregulates IFN‑γ, which in turn induces the expression of IFITM1 and CPT1A in A549 cells, thereby enhancing antiviral lipid metabolism and restricting viral replication.",-22.5,0.01,geneorgeneproduct
"SNP FCGR2B‑232Thr in the promoter of the FCGR2B gene is associated with increased expression of the B1 receptor for angiotensin II subtype receptor‑1a, thereby enhancing IFN‑γ‑induced activation of CYP3A4 and up‑regulating the transcription of the lipid‑synthesizing enzyme FASN‑involved, which in turn promotes CPT1A‑mediated fatty‑acid oxidation in ACTA2‑positive vascular smooth‑muscle",-49.75,0.01,geneorgeneproduct
"SIRT1-mediated deacetylation of the transcription factor ACTA2 in A549 cells enhances CYP3A4 expression, thereby increasing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxicity.",-22.625,0.01,geneorgeneproduct
"SHP2-mediated phosphorylation of ACTA2 in A549 cells enhances CYP3A4 transcription, thereby increasing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxic efficacy.",-27.125,0.01,geneorgeneproduct
"In HeLa cells, overexpression of the CYP3A4 gene product enhances the metabolism of the chemotherapeutic agent doxorubicin, thereby reducing its cytotoxic efficacy and contributing to drug resistance.",-15.9375,0.01,geneorgeneproduct
"In A549 cells, CYP3A4-mediated metabolism of the chemotherapeutic agent doxorubicin upregulates IFN‑γ expression, which in turn induces the antiviral protein IFITM1 and enhances the cytotoxic effect of the drug.",-23.125,0.01,geneorgeneproduct
"In HepG2 cells, the CYP3A4 promoter variant rs2740574 enhances IFN‑γ‑induced transcription of the FCGR2B‑232Thr allele, thereby increasing FASN‑involved lipid synthesis and upregulating the GAP43‑mediated neurite outgrowth pathway.",-27.25,0.01,geneorgeneproduct
"In HaCaT cells, the CYP3A4-mediated metabolism of the chemotherapeutic agent doxorubicin upregulates IFN‑γ expression, which in turn induces the transcription of the antiviral protein IFITM1, thereby enhancing cellular resistance to drug‑induced apoptosis.",-27.5,0.01,geneorgeneproduct
"ACTA2 expression is up‑regulated by IFN‑γ in human vascular smooth‑muscle cells, a response that is attenuated in cells carrying the FCGR2B‑232Thr variant and that correlates with increased CYP3A4‑mediated metabolism of the chemotherapeutic agent CPT1A.",-27.375,0.01,geneorgeneproduct
"ACTR2 overexpression in A549 cells enhances CYP3A4 transcription, thereby increasing doxorubicin metabolism and reducing its cytotoxicity.",-28.5,0.01,geneorgeneproduct
"ACT1A upregulation in A549 cells treated with the CYP3A4 inducer rifampicin enhances IFN‑γ‑mediated STAT1 phosphorylation, thereby increasing expression of the antiviral protein IFITM1 and the fatty‑acid‑synthesizing enzyme FASN, while simultaneously reducing CPT1A‑driven fatty‑acid oxidation.",-41.0,0.01,geneorgeneproduct
"ACTG1 mutations in the B1 subunit of the ribosomal protein complex are predicted to disrupt the interaction between CYP3A4 and the angiotensin II subtype receptor type‑1a, thereby attenuating IFN‑γ‑induced GAP43 expression and reducing CPT1A‑mediated fatty acid oxidation in cultured HeLa cells.",-60.25,0.01,geneorgeneproduct
"Mutations in the FCGR2B-232Thr variant of the Fcγ receptor gene reduce its inhibitory signaling, thereby enhancing IFN‑γ‑induced activation of the CYP3A4 promoter in HepG2 cells and increasing the metabolism of the chemotherapeutic agent doxorubicin.",-25.125,0.01,geneorgeneproduct
"Mutant ACTA2 in smooth muscle cells of the aorta upregulates CYP3A4 expression, thereby increasing the metabolism of the antihypertensive drug B1 and attenuating angiotensin II subtype receptor type‑1a‑mediated vasoconstriction.",-39.5,0.01,geneorgeneproduct
"Mutagenic exposure to the CYP3A4 inducer rifampicin upregulates ACTA2 expression in human bronchial epithelial cells, thereby enhancing angiotensin II subtype receptor type‑1a‑mediated vasoconstriction and contributing to the pathogenesis of pulmonary hypertension.",-41.0,0.01,geneorgeneproduct
"Mutational analysis of the CYP3A4 promoter in HepG2 cells revealed that the FCGR2B‑232Thr variant enhances IFN‑γ‑induced transcription of the FASN‑involved pathway, thereby increasing CPT1A expression and promoting lipid accumulation in the B1‑expressing hepatocyte line.",-28.25,0.01,geneorgeneproduct
"CPT1A overexpression in A549 cells enhances fatty‑acid oxidation and reduces IFN‑γ‑induced apoptosis, while the FCGR2B‑232Thr variant in the same line attenuates cytokine‑mediated signaling.",-25.0,0.01,geneorgeneproduct
"CYP3A4-mediated metabolism of the chemotherapeutic agent doxorubicin is markedly enhanced in A549 cells, leading to increased intracellular accumulation of the drug and subsequent up‑regulation of the pro‑apoptotic gene TP53, while the concomitant down‑regulation of the fatty‑acid synthase (FASN) pathway reduces lipid biosynthesis and sensitizes the cells to ferroptosis.",-35.75,0.01,geneorgeneproduct
"Cytotoxic T lymphocytes from A549 cells overexpressing IFN‑γ upregulate CYP3A4, which metabolizes the chemotherapeutic agent doxorubicin, thereby reducing its efficacy in treating non‑small‑cell lung carcinoma.",-24.625,0.01,geneorgeneproduct
"Causal analysis revealed that the FCGR2B‑232Thr polymorphism in *Homo sapiens* enhances IFN‑γ‑induced expression of *CYP3A4*, thereby increasing the metabolism of the chemotherapeutic agent doxorubicin in A549 cells.",-30.0,0.01,geneorgeneproduct
"Expression of the CYP3A4 gene in HepG2 cells is markedly induced by IFN‑γ, leading to increased metabolism of the chemotherapeutic agent doxorubicin and concomitant up‑regulation of the fatty‑acid synthase (FASN) pathway.",-21.875,0.01,geneorgeneproduct
"Expression profiling of the ACTA2 promoter in A549 cells revealed that CYP3A4 induction by IFN‑γ up‑regulates GAP43 while simultaneously down‑regulating the B1‑mediated angiotensin II subtype receptor‑1a pathway, a modulation that is partially mediated by the CPT1A‑dependent lipid‑sensing mechanism and further amplified by the IFITM1‑driven antiviral response, thereby illustrating how FCGR2B‑232Thr polymorphism can alter FASN",-62.0,0.01,geneorgeneproduct
"Expression analysis revealed that the ACTA2 promoter variant rs12345 increases CYP3A4 transcription in HepG2 cells, thereby enhancing B1-mediated metabolism of angiotensin II subtype receptor type‑1a and reducing GAP43‑dependent neuronal regeneration.",-43.75,0.01,geneorgeneproduct
"Expression levels of the ACTA2 gene were markedly up‑regulated in A549 cells treated with the CYP3A4 inducer rifampicin, suggesting that CYP3A4‑mediated metabolism of the drug enhances ACTA2 transcription and contributes to the observed increase in cellular contractility.",-28.625,0.01,geneorgeneproduct
"Alterations in the CYP3A4 promoter region, such as the FCGR2B‑232Thr variant, down‑regulate IFN‑γ‑induced expression of the metabolic regulator CPT1A, thereby impairing fatty acid oxidation in HepG2 cells.",-28.25,0.01,geneorgeneproduct
"Alteration of the CYP3A4 promoter by the FCGR2B‑232Thr variant reduces IFN‑γ‑induced transcription of the FASN‑involved pathway, thereby attenuating CPT1A‑mediated fatty‑acid oxidation in ACTA2‑positive vascular smooth‑muscle cells.",-23.625,0.01,geneorgeneproduct
"Altered expression of the CYP3A4 gene product in HepG2 cells treated with the small molecule B1 leads to increased metabolism of the angiotensin II subtype receptor type‑1a agonist, thereby reducing downstream IFN‑γ signaling and up‑regulating the fatty‑acid synthase (FASN) pathway.",-43.25,0.01,geneorgeneproduct
"Altercation of the CYP3A4 promoter polymorphism with the FCGR2B‑232Thr variant in HepG2 cells enhances IFN‑γ‑induced expression of the lipid‑synthesizing gene FASN, thereby amplifying the cellular response to angiotensin II subtype receptor‑1a‑mediated vasoconstriction.",-46.75,0.01,geneorgeneproduct
"Cyclophosphamide‑treated A549 cells overexpressing the CYP3A4 variant CYP3A4*1B exhibit increased activation of the IFN‑γ‑induced IFITM1 promoter, thereby enhancing antiviral defense while simultaneously upregulating the fatty‑acid‑synthase‑involved FASN pathway, which contributes to the observed resistance to drug‑induced apoptosis.",-42.5,0.01,geneorgeneproduct
"Cyclin‑dependent kinase inhibitor p21, encoded by CDKN1A, is transcriptionally up‑regulated by IFN‑γ in A549 cells, where it suppresses CYP3A4‑mediated metabolism of the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in this lung carcinoma model.",-30.5,0.01,geneorgeneproduct
"Cyclooxygenase‑2 inhibition by celecoxib down‑regulates CYP3A4 expression in HepG2 cells, thereby reducing the metabolism of the chemotherapeutic agent doxorubicin and potentiating its cytotoxicity against A549 lung carcinoma cells.",-25.5,0.01,geneorgeneproduct
"Cycling the CYP3A4 inhibitor ritonavir in A549 cells carrying the FCGR2B‑232Thr variant markedly up‑regulated IFN‑γ‑induced IFITM1 expression while simultaneously down‑regulating the fatty‑acid‑synthase‑dependent CPT1A pathway, thereby reducing lipid‑mediated survival signals in the tumor microenvironment.",-49.0,0.01,geneorgeneproduct
"Glycogen synthase kinase‑3β inhibition in A549 cells upregulates CYP3A4 expression, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxicity toward the tumor.",-22.5,0.01,geneorgeneproduct
"GAP43 expression is markedly up‑regulated in A549 cells treated with the CYP3A4 inducer rifampicin, a change that correlates with increased IFN‑γ‑mediated activation of the angiotensin II subtype receptor‑1a pathway and enhanced CPT1A‑driven fatty‑acid oxidation.",-32.5,0.01,geneorgeneproduct
"GTPase‑activating protein GAP43, whose expression is up‑regulated by IFN‑γ in A549 cells, is down‑regulated by the CYP3A4‑induced metabolite of the chemotherapeutic agent doxorubicin, thereby attenuating the angiogenic signaling mediated by angiotensin‑II subtype receptor type‑1a in the tumor microenvironment.",-45.75,0.01,geneorgeneproduct
"Gastrointestinal epithelial cells overexpressing the CYP3A4 gene product exhibit increased metabolism of the chemotherapeutic agent doxorubicin, thereby reducing its cytotoxic efficacy in colorectal carcinoma cells.",-25.75,0.01,geneorgeneproduct
"Targeted CRISPR‑mediated disruption of the CYP3A4 promoter in HepG2 cells reduces IFN‑γ‑induced FCGR2B‑232Thr expression, thereby attenuating angiotensin II subtype receptor‑1a‑mediated vasoconstriction and restoring CPT1A‑driven fatty acid oxidation.",-35.75,0.01,geneorgeneproduct
"Target‑specific CRISPR‑Cas9 editing of the ACTA2 promoter in A549 cells down‑regulates CYP3A4 expression, thereby reducing the metabolism of the chemotherapeutic agent doxorubicin and enhancing its cytotoxicity against non‑small‑cell lung carcinoma.",-31.125,0.01,geneorgeneproduct
"Targeting the CYP3A4‑mediated metabolism of the chemotherapeutic agent doxorubicin in A549 cells overexpressing the ACTA2‑associated contractile phenotype markedly enhances intracellular drug accumulation and induces apoptosis through up‑regulation of the pro‑apoptotic gene TP53 while concurrently suppressing the fatty‑acid‑synthetic enzyme FASN, thereby illustrating a synergistic interaction between drug metabolism, cytoskeletal dynamics, and lipid biosynthesis in cancer cells.",-50.5,0.01,geneorgeneproduct
"Target mutation of the FCGR2B-232Thr allele in a patient with severe B1‑cell hyperplasia was found to up‑regulate CYP3A4 expression, thereby enhancing the metabolism of angiotensin II subtype receptor‑1a antagonists and reducing the risk of hypertension.",-53.25,0.01,geneorgeneproduct
"Knock‑down of CYP3A4 in A549 cells markedly up‑regulates IFN‑γ‑induced IFITM1 expression, thereby enhancing the antiviral response against influenza virus infection.",-19.75,0.01,geneorgeneproduct
"Knocking‑down ACTA2 in A549 cells markedly reduces CYP3A4 expression, thereby diminishing the metabolism of the chemotherapeutic agent doxorubicin and increasing its cytotoxicity toward the tumor.",-23.125,0.01,geneorgeneproduct
"Knocked‑in ACTA2 overexpression in A549 cells markedly up‑regulates CYP3A4 transcription, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxic efficacy.",-28.25,0.01,geneorgeneproduct
"Knox et al. demonstrated that the CYP3A4-mediated metabolism of the chemotherapeutic agent doxorubicin is markedly enhanced in A549 cells overexpressing the ACTA2 variant, thereby reducing intracellular IFN‑γ levels and increasing CPT1A‑driven fatty‑acid oxidation, which ultimately attenuates the cytotoxic response to the drug.",-48.75,0.01,geneorgeneproduct
"CRISPR‑mediated knockout of the CYP3A4 gene in A549 cells markedly reduced the expression of the drug‑metabolizing enzyme FASN, thereby increasing intracellular accumulation of the chemotherapeutic agent doxorubicin and enhancing apoptosis in the tumor model.",-27.75,0.01,geneorgeneproduct
"CRISP‑Cas9 editing of the ACTA2 promoter in A549 cells down‑regulates CYP3A4 expression, thereby reducing the metabolism of the chemotherapeutic agent doxorubicin and enhancing its cytotoxicity in this lung carcinoma model.",-32.75,0.01,geneorgeneproduct
"CR‑3A4‑mediated metabolism of the chemotherapeutic agent doxorubicin in HepG2 cells upregulates the expression of the fatty‑acid synthase (FASN) gene, thereby enhancing the resistance of the tumor to apoptosis.",-41.5,0.01,geneorgeneproduct
"CRP expression is up‑regulated by IFN‑γ in A549 cells, a process that is amplified by CYP3A4‑mediated metabolism of the pro‑inflammatory drug B1 and further potentiated by the angiotensin‑II subtype receptor‑1a signaling cascade.",-43.25,0.01,geneorgeneproduct
"Mutations in the AR/CAG repeat of the androgen receptor gene alter NF‑κB‑dependent transcription of the snail transcription factor, thereby reducing glucagon‑induced activation of the Na⁺/H⁺ exchanger type‑3 in hepatocytes.",-22.25,0.01,geneorgeneproduct
"Mutational analysis of the AR/CAG repeat in the androgen receptor gene revealed that a longer CAG tract enhances NF‑κB‑mediated transcription of the Na⁺/H⁺ exchanger type‑3, thereby increasing intracellular sodium and contributing to glucagon‑induced insulin resistance in HepG2 cells.",-27.625,0.01,geneorgeneproduct
"Mutagenesis of the NF‑κB binding site in the promoter of the Na⁺/H⁺ exchanger type‑3 gene (SLC9A3) in HeLa cells carrying the AR/CAG repeat expansion reduces glucagon‑induced transcription of the exchanger, thereby attenuating insulin/IGF‑1‑mediated IRS1 phosphorylation and downstream TLR‑based inflammatory signaling.",-34.5,0.01,geneorgeneproduct
"Mutant AR/CAG repeat expansions in the snail transcription factor gene enhance NF‑κB‑dependent transcription of the Na⁺/H⁺ exchanger type‑3 promoter, thereby increasing insulin/IGF‑1/IRS1 signaling in glucagon‑responsive hepatocytes.",-27.625,0.01,geneorgeneproduct
"The AR/CAG repeat expansion in the androgen receptor gene enhances NF‑κB‑mediated transcription of the Na⁺/H⁺ exchanger type‑3, thereby increasing intracellular sodium flux and promoting glucagon‑induced hepatic gluconeogenesis in insulin‑resistant hepatocytes.",-21.75,0.01,geneorgeneproduct
"The A549 cell line treated with the NF‑κB inhibitor BAY‑11‑7082 showed a marked decrease in the expression of the Na⁺/H⁺ exchanger type‑3 gene, confirming that NF‑κB directly regulates this transporter in human lung carcinoma cells.",-27.25,0.01,geneorgeneproduct
"The CFI‑rs7356506 variant in the NF‑κB‑regulated promoter of the Na⁺/H⁺ exchanger type‑3 gene (SLC9A3) enhances transcriptional activation by the snail transcription factor, thereby increasing exchanger expression and contributing to glucagon‑induced insulin resistance in HepG2 cells.",-30.125,0.01,geneorgeneproduct
"The SNP CFI‑rs7356506 in the promoter of the complement factor I gene enhances NF‑κB binding, thereby up‑regulating insulin/IGF‑1/IRS1 signaling in HepG2 cells and increasing glucagon secretion from isolated pancreatic α‑cells.",-19.75,0.01,geneorgeneproduct
"NF‑κB activation in HeLa cells treated with the TLR‑based adjuvant CFI‑rs7356506 induces up‑regulation of the Na⁺/H⁺ exchanger type‑3 gene, a process that is further amplified by the glucagon‑mediated signaling cascade and modulated by the AR/CAG repeat polymorphism in the insulin/IGF‑1/IRS1 pathway.",-33.5,0.01,geneorgeneproduct
"NF-κB activation in HeLa cells treated with the TLR‑based adjuvant CFI‑rs7356506 induces up‑regulation of the Na⁺/H⁺ exchanger type‑3 gene, thereby enhancing intracellular pH buffering and promoting insulin/IGF‑1/IRS1‑mediated cell survival.",-31.75,0.01,geneorgeneproduct
"NF-kappaB activation in HeLa cells treated with the TLR-based adjuvant CFI‑rs7356506 induces up‑regulation of the Na⁺/H⁺ exchanger type‑3 gene, thereby enhancing intracellular pH buffering and promoting resistance to glucagon‑mediated apoptosis.",-29.875,0.01,geneorgeneproduct
"NF–κB activation in HeLa cells treated with the TLR‑based adjuvant CFI‑rs7356506 induces up‑regulation of the Na⁺/H⁺ exchanger type‑3 gene, a process that is further amplified by the glucagon‑mediated signaling cascade.",-38.5,0.01,geneorgeneproduct
"CRISPR‑mediated disruption of the NF‑κB‑responsive promoter of the Na⁺/H⁺ exchanger type‑3 gene in HeLa cells markedly reduces insulin‑induced IRS1 phosphorylation, thereby attenuating downstream IGF‑1 signaling and glucagon‑mediated gluconeogenic transcription.",-31.625,0.01,geneorgeneproduct
"CRs‑based CRISPR editing of the AR/CAG repeat in the snail‑like transcription factor NF‑κB, coupled with overexpression of the Na⁺/H⁺ exchanger type‑3, markedly enhances insulin/IGF‑1/IRS1 signaling and reduces glucagon secretion in HepG2 cells.",-45.25,0.01,geneorgeneproduct
"CRLF2 overexpression in the A549 cell line activates NF‑κB signaling, thereby up‑regulating the Na⁺/H⁺ exchanger type‑3 and enhancing insulin/IGF‑1/IRS1‑mediated glucose uptake.",-27.625,0.01,geneorgeneproduct
"CRP expression is up‑regulated by NF‑κB activation in A549 cells, and the AR/CAG repeat polymorphism in the androgen receptor gene modulates this response.",-26.125,0.01,geneorgeneproduct
"In mouse embryonic fibroblasts, the AR/CAG repeat expansion in the androgen receptor gene enhances NF‑κB‑mediated transcription of the Na⁺/H⁺ exchanger type‑3, thereby increasing intracellular pH and promoting insulin/IGF‑1/IRS1 signaling that ultimately upregulates glucagon‑like peptide‑1 secretion.",-30.375,0.01,geneorgeneproduct
"In *HeLa* cells, the AR/CAG repeat expansion in the androgen receptor gene enhances NF‑κB‑mediated transcription of the *CFI-rs7356506* variant, thereby increasing the expression of the Na⁺/H⁺ exchanger type‑3 and amplifying insulin/IGF‑1/IRS1 signaling that ultimately promotes cellular proliferation.",-32.5,0.01,geneorgeneproduct
"In HeLa cells, the AR/CAG repeat expansion in the androgen receptor gene enhances NF‑κB‑mediated transcription of the Na⁺/H⁺ exchanger type‑3, thereby increasing intracellular pH and promoting resistance to glucagon‑induced apoptosis.",-18.375,0.01,geneorgeneproduct
"In HepG2 cells, the AR/CAG repeat expansion in the androgen receptor gene enhances NF‑κB‑mediated transcription of the Na⁺/H⁺ exchanger type‑3, thereby increasing intracellular sodium flux and promoting insulin/IGF‑1 resistance through IRS1 phosphorylation.",-23.75,0.01,geneorgeneproduct
"A549 cells transfected with the AR/CAG repeat construct exhibit increased NF‑κB activation, which is further amplified by co‑expression of the Na⁺/H⁺ exchanger type‑3, leading to enhanced insulin/IGF‑1/IRS1 signaling and up‑regulation of the glucagon‑responsive gene Sag‑Fbxw7.",-29.625,0.01,geneorgeneproduct
"A SNP in the CFI‑rs7356506 locus enhances NF‑κB binding, thereby up‑regulating the Na⁺/H⁺ exchanger type‑3 gene and increasing insulin/IGF‑1/IRS1 signaling in human pancreatic β‑cells.",-23.0,0.01,geneorgeneproduct
"A recent study showed that the AR/CAG repeat expansion in the androgen receptor gene enhances NF‑κB‑mediated transcription of the Na⁺/H⁺ exchanger type‑3, thereby increasing intracellular sodium and contributing to glucagon‑induced insulin resistance in HepG2 cells.",-24.75,0.01,geneorgeneproduct
"A KRAS G12D mutation in the A549 cell line activates NF‑κB signaling, which in turn upregulates the Na⁺/H⁺ exchanger type‑3, thereby enhancing intracellular pH and promoting resistance to the glucagon‑induced apoptosis observed in pancreatic β‑cells.",-32.25,0.01,geneorgeneproduct
"Mutation of the AR/CAG repeat in the androgen receptor gene enhances NF‑κB‑dependent transcription of the Na⁺/H⁺ exchanger type‑3 promoter, thereby increasing sodium reabsorption in renal proximal tubule cells and contributing to hypertension in patients with the glucagon‑induced insulin/IGF‑1/IRS1 signaling defect.",-29.875,0.01,geneorgeneproduct
"Mutation in the AR/CAG repeat of the androgen receptor gene enhances NF‑κB‑mediated transcription of the Na⁺/H⁺ exchanger type‑3, thereby increasing intracellular sodium and contributing to glucagon‑induced insulin resistance in HepG2 cells.",-25.5,0.01,geneorgeneproduct
"Mutation A549‑AR/CAG in the snail‑like transcription factor gene increases NF‑κB‑dependent expression of the Na⁺/H⁺ exchanger type‑3, thereby enhancing insulin/IGF‑1‑IRS1 signaling and glucagon‑mediated gluconeogenesis in HepG2 cells.",-37.0,0.01,geneorgeneproduct
"Mutation R138Q in the NPHS2 gene, which encodes podocin, disrupts the Na⁺/H⁺ exchanger type‑3 activity in proximal tubular cells, thereby impairing insulin/IGF‑1/IRS1 signaling and contributing to the early onset of hereditary nephrotic syndrome.",-35.5,0.01,geneorgeneproduct
"NOD2 mutations in the CFI‑rs7356506 locus enhance NF‑κB activation, thereby increasing IL‑6 secretion and promoting insulin resistance in HepG2 cells.",-28.75,0.01,geneorgeneproduct
"Nutrient‑sensing NF‑κB activation in HeLa cells treated with the glucagon analogue induces up‑regulation of the Na⁺/H⁺ exchanger type‑3, a process that is attenuated by the CFI‑rs7356506 variant and further modulated by the TLR‑based signaling cascade.",-40.75,0.01,geneorgeneproduct
"NLRP3 inflammasome activation in A549 cells is amplified by the CFI‑rs7356506 variant, which enhances NF‑κB‑dependent transcription of the Na⁺/H⁺ exchanger type‑3, thereby increasing intracellular sodium and promoting insulin/IGF‑1/IRS1 signaling that ultimately drives epithelial‑to‑mesenchymal transition via snail and glucagon‑mediated pathways.",-36.5,0.01,geneorgeneproduct
"NFKB activation in HeLa cells treated with the TLR‑based adjuvant CFI‑rs7356506 induces up‑regulation of the Na⁺/H⁺ exchanger type‑3 gene, thereby enhancing intracellular pH buffering and promoting insulin/IGF‑1/IRS1‑mediated proliferation.",-34.5,0.01,geneorgeneproduct
"TF‑binding protein NF‑κB is up‑regulated in HeLa cells treated with the small‑molecule inhibitor CFI‑rs7356506, thereby enhancing the transcription of the Na⁺/H⁺ exchanger type‑3 gene and increasing cellular sodium influx.",-31.5,0.01,geneorgeneproduct
"TFEB-mediated upregulation of the Na⁺/H⁺ exchanger type‑3 in HeLa cells enhances NF‑κB‑dependent transcription of the CFI‑rs7356506 allele, thereby increasing glucagon‑induced insulin/IGF‑1/IRS1 signaling and promoting snail‑driven epithelial‑mesenchymal transition.",-30.75,0.01,geneorgeneproduct
"TF binding to the AR/CAG promoter enhances NF‑κB‑mediated transcription of the snail gene, thereby increasing Na⁺/H⁺ exchanger type‑3 expression and promoting insulin/IGF‑1/IRS1‑dependent glucagon secretion in TLR‑based inflammatory conditions.",-31.125,0.01,geneorgeneproduct
"TFGA‑CAG repeat expansion in the AR gene enhances snail‑mediated epithelial‑to‑mesenchymal transition, thereby up‑regulating NF‑κB‑dependent transcription of the Na⁺/H⁺ exchanger type‑3 and increasing insulin/IGF‑1/IRS1 signaling in glucagon‑responsive hepatocytes.",-42.0,0.01,geneorgeneproduct
"Knock‑down of the transcription factor snail in A549 cells reduces NF‑κB‑dependent expression of the Na⁺/H⁺ exchanger type‑3, thereby attenuating insulin/IGF‑1‑mediated IRS1 phosphorylation and glucagon‑induced cAMP production.",-22.5,0.01,geneorgeneproduct
"Knocking‑down the NF‑κB‑dependent transcription factor snail in A549 cells reduces the expression of the Na⁺/H⁺ exchanger type‑3, thereby impairing insulin/IGF‑1‑mediated IRS1 phosphorylation and attenuating glucagon‑induced cAMP production.",-26.75,0.01,geneorgeneproduct
"Knox et al. demonstrated that the AR/CAG repeat expansion in the androgen receptor gene enhances NF‑κB‑mediated transcription of the Na⁺/H⁺ exchanger type‑3, thereby increasing intracellular sodium flux and promoting insulin/IGF‑1 resistance in HepG2 cells.",-35.0,0.01,geneorgeneproduct
"Knifed‑out AR/CAG repeats in the snail‑like transcription factor NF‑kappaB enhance TLR‑based signaling, thereby up‑regulating the Na⁺/H⁺ exchanger type‑3 and increasing glucagon secretion in insulin/IGF‑1/IRS1‑deficient HepG2 cells.",-46.0,0.01,geneorgeneproduct
"Activation of NF‑κB by the TLR‑based CFI‑rs7356506 variant upregulates the Na⁺/H⁺ exchanger type‑3, thereby enhancing insulin/IGF‑1/IRS1 signaling in HepG2 cells.",-20.5,0.01,geneorgeneproduct
"Activation by the NF‑κB transcription factor of the Na⁺/H⁺ exchanger type‑3 gene (SLC9A3) in HeLa cells leads to increased intracellular pH and promotes the secretion of glucagon‑like peptide‑1, thereby enhancing insulin/IGF‑1 signaling through IRS1.",-39.0,0.01,geneorgeneproduct
"Activation or inhibition of NF‑κB signaling by the TLR‑based CFI‑rs7356506 variant modulates the expression of the Na⁺/H⁺ exchanger type‑3, thereby influencing insulin/IGF‑1/IRS1‑mediated glucagon secretion in AR/CAG‑positive HeLa cells.",-40.25,0.01,geneorgeneproduct
"Activation‐dependent NF‑κB signaling in HeLa cells is enhanced by the CFI‑rs7356506 variant, which increases expression of the Na⁺/H⁺ exchanger type‑3 and thereby augments insulin/IGF‑1/IRS1‑mediated glucose uptake.",-38.5,0.01,geneorgeneproduct
"Silencing of the AR/CAG repeat in the snail gene reduces NF‑κB activation and decreases expression of the Na⁺/H⁺ exchanger type‑3, thereby lowering glucagon‑induced insulin/IGF‑1/IRS1 signaling in TLR‑based inflammatory responses.",-26.25,0.01,geneorgeneproduct
"Silk fibroin‑derived scaffolds loaded with the NF‑κB inhibitor SN50 down‑regulate the Na⁺/H⁺ exchanger type‑3 in A549 cells, thereby attenuating insulin/IGF‑1‑induced IRS1 phosphorylation and reducing the expression of the CFI‑rs7356506 variant associated with increased glucagon secretion.",-43.25,0.01,geneorgeneproduct
"Silence of the NF‑κB‑dependent transcription factor snail in A549 cells carrying the AR/CAG repeat expansion reduces the expression of the Na⁺/H⁺ exchanger type‑3 and increases glucagon‑induced cAMP production, thereby attenuating insulin/IGF‑1/IRS1 signaling and enhancing TLR‑based inflammatory responses.",-41.75,0.01,geneorgeneproduct
"Silenced NF‑κB activity in HeLa cells overexpressing the AR/CAG repeat‑expanded snail protein reduces insulin/IGF‑1‑IRS1 signaling, thereby impairing glucose uptake and promoting glucagon‑mediated gluconeogenesis.",-34.5,0.01,geneorgeneproduct
"Insulin/IGF‑1/IRS1 signaling is amplified in HeLa cells by the AR/CAG repeat‑expanded TP53 variant, which activates NF‑κB and up‑regulates the Na⁺/H⁺ exchanger type‑3, thereby enhancing cellular proliferation and conferring resistance to glucagon‑induced apoptosis.",-30.5,0.01,geneorgeneproduct
"Insufficient NF‑κB activation in A549 cells carrying the AR/CAG repeat variant reduces expression of the Na⁺/H⁺ exchanger type‑3, thereby impairing insulin/IGF‑1‑IRS1 signaling and promoting glucagon‑mediated gluconeogenesis.",-31.5,0.01,geneorgeneproduct
"Insulators such as the NF‑κB‑responsive element upstream of the AR/CAG repeat modulate snail transcription, thereby influencing the Na⁺/H⁺ exchanger type‑3 expression that ultimately alters insulin/IGF‑1/IRS1 signaling in glucagon‑secreting pancreatic β‑cells.",-48.5,0.01,geneorgeneproduct
"Insult of the Na⁺/H⁺ exchanger type‑3 by the CFI‑rs7356506 variant activates NF‑κB, which in turn up‑regulates the transcription of the glucagon‑responsive gene Sag‑Fbxw7, thereby enhancing insulin/IGF‑1/IRS1 signaling in HeLa cells.",-39.75,0.01,geneorgeneproduct
"High‑throughput CRISPR‑Cas9 screening in A549 cells revealed that loss of the NF‑κB‑regulated gene Fbxw7, encoded by the Sag‑Fbxw7 locus, derepresses the Na⁺/H⁺ exchanger type‑3 (NHE3) and enhances insulin/IGF‑1/IRS1 signaling, thereby promoting cell proliferation and conferring resistance to the glucagon‑induced apoptosis observed in pancreatic β‑cell lines.",-47.0,0.01,geneorgeneproduct
"High-fat diet–induced insulin resistance in A549 cells is exacerbated by the CFI‑rs7356506 variant, which enhances NF‑κB activation and upregulates the Na⁺/H⁺ exchanger type‑3, thereby impairing insulin/IGF‑1/IRS1 signaling.",-33.0,0.01,geneorgeneproduct
"High-throughput CRISPR screening revealed that loss of the transcription factor snail, encoded by the gene SNAI1, derepresses NF‑κB‑dependent expression of the CFI‑rs7356506 variant, thereby enhancing Na⁺/H⁺ exchanger type‑3 (NHE3) activity and increasing insulin/IGF‑1/IRS1 signaling in HepG2 cells.",-41.0,0.01,geneorgeneproduct
"High levels of the transcription factor snail, which is up‑regulated by NF‑κB signaling, suppress the Na⁺/H⁺ exchanger type‑3 (NHE3) in intestinal epithelial cells, thereby reducing insulin/IGF‑1‑mediated IRS1 phosphorylation and contributing to glucagon‑induced hyperglycemia in a TLR‑based inflammatory context.",-43.75,0.01,geneorgeneproduct
"The chronic exposure of A549 cells to angiotensin II upregulates SOD3 expression, which in turn activates the ube2c‑mediated ubiquitination of beta‑AR kinase‑1, thereby enhancing interleukin‑12B secretion and promoting FGF receptor‑4‑driven proliferation.",-25.375,0.01,geneorgeneproduct
"The overexpression of ube2c in A549 cells enhances interleukin‑12B secretion, thereby promoting caspase‑3‑mediated apoptosis in response to FGF receptor‑4‑induced proliferation.",-19.125,0.01,geneorgeneproduct
"The angiotensin II–induced up‑regulation of SOD3 in A549 cells is mediated by the ubiquitin‑conjugating enzyme UBE2C, which enhances phosphorylation of beta‑AR kinase‑1 and subsequently activates interleukin‑12B transcription.",-23.0,0.01,geneorgeneproduct
"The loss‑of‑function mutation in the SOD3 gene, which encodes extracellular superoxide dismutase, was shown to increase susceptibility to angiotensin II‑induced hypertension in a mouse model that also overexpresses the beta‑AR kinase‑1 protein.",-29.625,0.01,geneorgeneproduct
"In A549 cells, overexpression of the ubiquitin-conjugating enzyme UBE2C enhances Angiotensin II‑induced phosphorylation of the FGF receptor‑4 signaling cascade, thereby up‑regulating SOD3 transcription and increasing resistance to caspase‑3‑mediated apoptosis.",-25.875,0.01,geneorgeneproduct
"In HEK293 cells, overexpression of the SOD3 gene product attenuates Angiotensin II‑induced reactive oxygen species production, thereby reducing downstream activation of the beta‑AR kinase‑1 signaling cascade.",-20.75,0.01,geneorgeneproduct
"In HepG2 cells, overexpression of the ubiquitin-conjugating enzyme UBE2C enhances the proteasomal degradation of the tumor suppressor protein p53, thereby increasing cellular proliferation and conferring resistance to the chemotherapeutic agent doxorubicin.",-19.75,0.01,geneorgeneproduct
"In human hepatocellular carcinoma cells, overexpression of the E3 ubiquitin‑ligase UBE2C enhances β‑adrenergic receptor kinase‑1‑mediated phosphorylation of the tumor suppressor protein SOD3, thereby attenuating interleukin‑12B secretion and promoting FGF receptor‑4‑driven proliferation.",-23.625,0.01,geneorgeneproduct
"Mutational loss of the SOD3 gene product in A549 cells leads to increased reactive oxygen species, which in turn upregulates interleukin‑12B expression and activates caspase‑3 and caspase‑9, thereby promoting apoptosis.",-25.5,0.01,geneorgeneproduct
"Mutations in the ube2c gene product, which encodes an E2 ubiquitin‑conjugating enzyme, have been shown to up‑regulate beta‑AR kinase‑1 expression and thereby enhance interleukin‑12B secretion in A549 cells, a phenomenon that may contribute to the inflammatory response observed in patients with chronic obstructive pulmonary disease.",-35.75,0.01,geneorgeneproduct
"Mutagenic exposure to benzo[a]pyrene induces a BRCA1 c.68_69delAG variant that up‑regulates SOD3 expression, thereby enhancing oxidative stress resistance in A549 cells.",-23.5,0.01,geneorgeneproduct
"Mutant ube2c expression in A549 cells enhances Angiotensin II‑induced activation of FGF receptor‑4, thereby up‑regulating interleukin‑12B transcription and promoting caspase‑3‑mediated apoptosis.",-28.0,0.01,geneorgeneproduct
"Angiotensin II upregulates ube2c expression in vascular smooth‑muscle cells, thereby enhancing beta‑AR kinase‑1‑mediated phosphorylation of the FGF receptor‑4 signaling cascade and ultimately promoting caspase‑3 and caspase‑9 activation to drive apoptosis.",-22.125,0.01,geneorgeneproduct
"Angiogenesis in the A549 cell line is enhanced by FGF receptor‑4 activation, which up‑regulates SOD3 expression and subsequently increases interleukin‑12B secretion, thereby promoting caspase‑3 and caspase‑9‑mediated apoptosis.",-39.0,0.01,geneorgeneproduct
"Ang II stimulation of the FGF receptor‑4 pathway in A549 cells upregulates ube2c, which in turn enhances caspase‑3 and caspase‑9 activation, thereby promoting apoptosis.",-34.0,0.01,geneorgeneproduct
"Angiomotin overexpression in A549 cells enhances Angiotensin II‑induced ERK phosphorylation, thereby up‑regulating SOD3 transcription and increasing resistance to caspase‑3‑mediated apoptosis.",-34.75,0.01,geneorgeneproduct
"A549 cells treated with the SOD3 inhibitor exhibit increased interleukin‑12B secretion, suggesting that oxidative stress modulates cytokine production through the NF‑κB pathway.",-23.5,0.01,geneorgeneproduct
"A SNP in the promoter of **SOD3** that reduces its expression enhances **Angiotensin II**‑induced oxidative stress, thereby up‑regulating **interleukin‑12B** production in vascular endothelial cells.",-26.5,0.01,geneorgeneproduct
"A missense mutation in the SOD3 gene (c.118G>A) reduces its enzymatic activity, thereby increasing oxidative stress and exacerbating the inflammatory response mediated by interleukin‑12B in patients with severe asthma.",-34.75,0.01,geneorgeneproduct
"A genetic variant in the SOD3 promoter (c.-113G>A) reduces its expression, thereby increasing oxidative stress and enhancing the pro‑inflammatory activity of interleukin‑12B in patients with severe asthma.",-35.75,0.01,geneorgeneproduct
"Acute exposure to angiotensin II upregulates ube2c expression in vascular smooth muscle cells, thereby enhancing caspase‑3 and caspase‑9 activation and promoting apoptosis.",-24.75,0.01,geneorgeneproduct
"Acetylation of the transcription factor SOD3 by the ubiquitin-conjugating enzyme ube2c enhances its binding to the promoter of the interleukin‑12B gene, thereby increasing cytokine production in human macrophages.",-30.0,0.01,geneorgeneproduct
"Acrolein exposure upregulates the expression of the oxidative‑stress‑responsive gene SOD3 in A549 cells, thereby attenuating interleukin‑12B‑mediated inflammatory signaling and reducing caspase‑3 and caspase‑9 activation in a dose‑dependent manner.",-37.5,0.01,geneorgeneproduct
"Acquisition of a BRCA1 c.68_69delAG variant in a HeLa cell line treated with doxorubicin upregulates interleukin‑12B expression, thereby enhancing caspase‑3 and caspase‑9 activation and promoting apoptosis in Homo sapiens cells.",-32.75,0.01,geneorgeneproduct
"Beta‑adrenergic receptor kinase‑1 phosphorylates the angiotensin II type‑1 receptor, thereby attenuating interleukin‑12B signaling and reducing caspase‑3 and ‑9 activation in cultured A549 cells.",-24.5,0.01,geneorgeneproduct
"Beta-blocker therapy in patients with hypertension downregulates the expression of the beta-adrenergic receptor kinase-1 gene (ADRBK1) in vascular smooth muscle cells, thereby attenuating the Angiotensin II‑induced phosphorylation of the FGF receptor‑4 (FGFR4) signaling cascade that normally promotes vascular remodeling.",-46.0,0.01,geneorgeneproduct
"Beta-adrenergic receptor kinase‑1 phosphorylates the β‑adrenergic receptor, thereby attenuating Angiotensin II‑induced ERK activation in A549 cells, a process that is further amplified by the up‑regulation of SOD3 and the ubiquitin‑conjugating enzyme UBE2C.",-34.0,0.01,geneorgeneproduct
"Beta‐adrenergic receptor kinase‑1 phosphorylates the angiotensin II type‑1 receptor, thereby attenuating interleukin‑12B secretion in A549 cells while simultaneously up‑regulating SOD3 expression through a downstream FGF receptor‑4 signaling cascade.",-33.5,0.01,geneorgeneproduct
"Mutation of the ube2c gene in A549 cells increases interleukin‑12B secretion, thereby enhancing caspase‑3 and ‑9‑mediated apoptosis in response to angiotensin‑II‑induced oxidative stress.",-20.625,0.01,geneorgeneproduct
"Mutation‐induced loss of SOD3 activity in A549 cells enhances Angiotensin II‑mediated activation of the FGF receptor‑4/β‑AR kinase‑1 signaling axis, thereby increasing interleukin‑12B secretion and caspase‑3/9‑driven apoptosis.",-37.0,0.01,geneorgeneproduct
"Mutation in the ube2c gene product, which encodes an E2 ubiquitin‑conjugating enzyme, was found to enhance the degradation of the FGF receptor‑4 protein in A549 cells, thereby attenuating the downstream activation of beta‑AR kinase‑1 and reducing interleukin‑12B secretion.",-38.25,0.01,geneorgeneproduct
"Mutation‑induced loss of SOD3 expression in A549 cells enhances Angiotensin II‑mediated activation of the FGF receptor‑4/ANXA1 signaling axis, thereby increasing caspase‑3 and caspase‑9 cleavage and promoting apoptosis.",-34.0,0.01,geneorgeneproduct
"An overexpression of the ubiquitin-conjugating enzyme UBE2C in A549 cells enhances the phosphorylation of beta‑adrenergic receptor kinase‑1, thereby increasing the degradation of interleukin‑12B and reducing the apoptotic activation of caspase‑3 and caspase‑9.",-25.375,0.01,geneorgeneproduct
"An ectopic expression of the ube2c gene in HeLa cells enhances the phosphorylation of beta‑AR kinase‑1, thereby increasing the degradation of interleukin‑12B and reducing the apoptotic activation of caspase‑3 and caspase‑9.",-31.125,0.01,geneorgeneproduct
"An up‑regulation of the ube2c gene product in A549 cells treated with angiotensin II leads to increased caspase‑3 and caspase‑9 activation, thereby promoting apoptosis.",-23.375,0.01,geneorgeneproduct
"An A549 cell line treated with the small‑molecule inhibitor of ube2c shows a marked decrease in caspase‑3 and caspase‑9 activation, suggesting that ube2c inhibition suppresses apoptosis in this lung carcinoma model.",-30.375,0.01,geneorgeneproduct
"ACE2 expression in A549 cells is up‑regulated by Angiotensin II through a pathway that involves SOD3‑mediated reactive oxygen species and the activation of the FGF receptor‑4/ANXA1 signaling axis, ultimately enhancing interleukin‑12B production and promoting caspase‑3/9‑driven apoptosis.",-44.25,0.01,geneorgeneproduct
"ACE inhibition in A549 cells upregulates SOD3 expression, thereby attenuating Angiotensin II‑induced oxidative stress and reducing interleukin‑12B secretion.",-25.625,0.01,geneorgeneproduct
"ACE insertion polymorphism in the AGT gene enhances Angiotensin II‑mediated up‑regulation of SOD3 expression in human vascular endothelial cells, thereby modulating oxidative stress and vascular remodeling.",-37.0,0.01,geneorgeneproduct
"ACE-mediated cleavage of angiotensin II by SOD3 in A549 cells upregulates ube2c, thereby enhancing beta‑AR kinase‑1 phosphorylation of interleukin‑12B and FGF receptor‑4, which in turn activates caspase‑3 and caspase‑9 to promote apoptosis while simultaneously inducing ANXA1‑dependent BMP1 expression.",-43.75,0.01,geneorgeneproduct
"At the molecular level, the up‑regulation of ube2c in A549 cells enhances caspase‑9 activation, thereby amplifying apoptosis induced by the FGF receptor‑4 antagonist, a process that is further potentiated by interleukin‑12B‑mediated STAT4 signaling.",-37.5,0.01,geneorgeneproduct
"Atopic dermatitis patients treated with a topical FGF receptor‑4 inhibitor exhibited a significant reduction in interleukin‑12B expression, correlating with increased SOD3 activity and decreased caspase‑3/‑9‑mediated apoptosis in lesional keratinocytes.",-36.5,0.01,geneorgeneproduct
"Atazanavir treatment in Huh‑7 cells down‑regulates the expression of the ubiquitin‑conjugating enzyme UBE2C, thereby enhancing caspase‑3 and caspase‑9 activation and promoting apoptosis in hepatocellular carcinoma.",-30.375,0.01,geneorgeneproduct
"At interleukin‑12B‑stimulated macrophages, the up‑regulation of ube2c enhances caspase‑3 and caspase‑9 activation, thereby promoting apoptosis and attenuating the pro‑inflammatory signaling mediated by the FGF receptor‑4 pathway.",-39.0,0.01,geneorgeneproduct
"Deletion of the ube2c promoter in A549 cells reduces interleukin‑12B transcription, thereby attenuating the angiogenic response driven by FGF receptor‑4 signaling in a hypoxic tumor microenvironment.",-26.375,0.01,geneorgeneproduct
"Deletion in the SOD3 promoter reduces its transcription, thereby increasing oxidative stress that activates beta‑AR kinase‑1 and enhances interleukin‑12B production in A549 cells, ultimately promoting apoptosis through caspase‑3 and caspase‑9 activation.",-34.75,0.01,geneorgeneproduct
"Deletional loss of the SOD3 gene in A549 cells leads to increased reactive oxygen species, which in turn upregulates interleukin‑12B expression and activates caspase‑3 and caspase‑9, thereby promoting apoptosis.",-39.5,0.01,geneorgeneproduct
"Deletion and overexpression of the ube2c gene in A549 cells alter the phosphorylation of beta‑AR kinase‑1, thereby modulating the downstream activation of caspase‑3 and caspase‑9 and ultimately influencing the cellular response to Angiotensin II‑induced apoptosis.",-40.0,0.01,geneorgeneproduct
Caspase‑3 and caspase‑9 activation by interleukin‑12B stimulation in A549 cells leads to apoptosis that is attenuated when the SOD3‑mediated oxidative stress pathway is up‑regulated by the FGF receptor‑4 signaling cascade.,-30.75,0.01,geneorgeneproduct
"Causal analysis revealed that the SOD3 variant rs1799895 in Homo sapiens upregulates interleukin‑12B expression, thereby enhancing caspase‑3 and caspase‑9 activation in A549 cells treated with angiotensin‑II.",-34.0,0.01,geneorgeneproduct
"CYP2D6-mediated metabolism of the chemotherapeutic agent doxorubicin in A549 cells is markedly enhanced by the up‑regulation of the ubiquitin‑conjugating enzyme UBE2C, which in turn promotes caspase‑3 activation and apoptosis in the presence of the pro‑inflammatory cytokine interleukin‑12B.",-35.5,0.01,geneorgeneproduct
"Crosstalk between the angiotensin II–AT1 receptor axis and the SOD3 antioxidant pathway in A549 cells is amplified by ube2c‑mediated ubiquitination of beta‑AR kinase‑1, thereby enhancing interleukin‑12B secretion and promoting FGF receptor‑4‑driven proliferation while simultaneously activating caspase‑3 and ‑9 to trigger apoptosis.",-36.75,0.01,geneorgeneproduct
"Ube2c overexpression in A549 cells enhances interleukin‑12B secretion, thereby promoting caspase‑3‑mediated apoptosis of tumor‑derived fibroblasts.",-21.75,0.01,geneorgeneproduct
"U251 glioma cells treated with the FGF receptor‑4 antagonist AZD4547 exhibit a marked decrease in SOD3 expression, concomitant with increased caspase‑3 and caspase‑9 activation, suggesting that FGF‑R4 signaling protects against oxidative‑stress‑induced apoptosis.",-39.5,0.01,geneorgeneproduct
"Ubiquitin-conjugating enzyme E2C (UBE2C) upregulation in A549 cells enhances caspase‑3 and caspase‑9 activation, thereby promoting apoptosis in response to interleukin‑12B‑induced oxidative stress mediated by SOD3.",-24.625,0.01,geneorgeneproduct
"Urbaniak et al. demonstrated that the SOD3 promoter variant rs1799895 enhances interleukin‑12B transcription in A549 cells, thereby increasing caspase‑3 and caspase‑9 activation and sensitizing the cells to doxorubicin‑induced apoptosis.",-31.625,0.01,geneorgeneproduct
"Mutations in the PKD1 gene that disrupt focal adhesion kinase signaling in renal epithelial cells lead to aberrant Rab6a‑GTP trafficking, thereby impairing glial‑cell‑line‑derived neurotrophic factor secretion and exacerbating cystic kidney disease.",-23.875,0.01,geneorgeneproduct
"Mutational loss of the PKD1 gene in A549 cells reduces focal adhesion kinase phosphorylation, thereby impairing Rab6a‑GTP‑mediated vesicle trafficking and attenuating glial‑cell‑line‑derived neurotrophic factor secretion.",-18.0,0.01,geneorgeneproduct
"Mutant PKD1 in the renal epithelial cell line HK-2 activates focal adhesion kinase, thereby enhancing Rab6a‑GTP‑mediated trafficking of glial‑cell‑line‑derived neurotrophic factor and increasing tumor necrosis factor‑alpha secretion.",-25.625,0.01,geneorgeneproduct
"Mutagenic exposure to doxorubicin induces a TP53-dependent up‑regulation of the tumor necrosis factor alpha gene in HeLa cells, while the resulting S6 phosphorylation is attenuated by the focal adhesion kinase inhibitor PF‑573228.",-33.5,0.01,geneorgeneproduct
"Mutation of the PKD1 gene in a patient with autosomal dominant polycystic kidney disease leads to aberrant activation of focal adhesion kinase, which in turn enhances the expression of the pro‑inflammatory cytokine tumor necrosis factor‑α and promotes glial‑cell‑line‑derived neurotrophic factor secretion by renal tubular cells.",-26.75,0.01,geneorgeneproduct
"Mutation in the PKD1 gene that encodes polycystin‑1 leads to aberrant activation of focal adhesion kinase, which in turn phosphorylates S6 and enhances the expression of the tumor‑necrosis‑factor‑alpha‑induced specificity protein, thereby promoting glial‑cell‑line‑derived neurotrophic factor secretion in renal epithelial cells.",-31.5,0.01,geneorgeneproduct
"Mutation‐induced loss of the PKD1 gene product in HeLa cells upregulates focal adhesion kinase expression, thereby enhancing Rab6a‑GTP‑mediated vesicular trafficking and increasing Tumor Necrosis Factor‑α secretion.",-27.25,0.01,geneorgeneproduct
"Mutation-induced loss of the PKD1 gene product in A549 cells reduces focal adhesion kinase phosphorylation, thereby impairing Rab6a‑GTP‑mediated vesicle trafficking and increasing Tumor Necrosis Factor‑α secretion.",-29.0,0.01,geneorgeneproduct
"The focal adhesion kinase (FAK) phosphorylates the specificity protein SP1, thereby enhancing the transcription of the PKD1 gene in glial‑cell‑line‑derived neurotrophic factor‑treated A549 cells.",-17.375,0.01,geneorgeneproduct
"The cIII‑induced phosphorylation of focal adhesion kinase in HeLa cells enhances Rab6a‑GTP‑mediated trafficking of the tumor necrosis factor‑α receptor, thereby amplifying IFN‑γ‑yellow‑mediated Smac‑dependent apoptosis.",-21.375,0.01,geneorgeneproduct
"The overexpression of focal adhesion kinase in A549 cells enhances Rab6a‑GTP‑mediated secretion of tumor necrosis factor‑α, thereby amplifying the inflammatory response to IFN‑γ in a human macrophage model.",-18.125,0.01,geneorgeneproduct
"The knock‑down of focal adhesion kinase in A549 cells reduces Rab6a‑GTP‑mediated trafficking of the PKD1 protein, thereby attenuating the downstream activation of the S6 ribosomal protein and the expression of the tumor necrosis factor‑α‑induced IFN‑γ‑yellow cytokine.",-30.625,0.01,geneorgeneproduct
"In A549 cells, the focal adhesion kinase‑mediated phosphorylation of the specificity protein SP1 enhances the transcription of the PKD1 gene, thereby increasing Rab6a‑GTP‑dependent vesicular trafficking and promoting glial‑cell‑line‑derived neurotrophic factor secretion, which in turn amplifies Tumor Necrosis Factor alpha signaling and activates the Smac‑mediated apoptotic cascade.",-32.5,0.01,geneorgeneproduct
"In HaCaT cells, the focal adhesion kinase‑mediated phosphorylation of the specificity protein SP1 enhances the transcription of the PKD1 gene, thereby increasing Rab6a‑GTP‑dependent vesicular trafficking and promoting glial‑cell‑line‑derived neurotrophic factor secretion, which in turn amplifies Tumor Necrosis Factor alpha signaling and induces Smac‑mediated apoptosis.",-34.5,0.01,geneorgeneproduct
"In SKOV3 cells, the focal adhesion kinase inhibitor PF-573228 reduces phosphorylation of S6, thereby attenuating the IFN‑γ‑induced expression of the specificity protein SP1 and the downstream production of tumor necrosis factor‑α.",-28.875,0.01,geneorgeneproduct
"In H1299 cells, overexpression of the PKD1 gene product enhances focal adhesion kinase phosphorylation, thereby increasing Rab6a‑GTP‑mediated vesicle trafficking and upregulating glial‑cell‑line‑derived neurotrophic factor secretion, which in turn amplifies Tumor Necrosis Factor alpha‑induced apoptosis through Smac‑mediated mitochondrial cytochrome c release.",-30.5,0.01,geneorgeneproduct
"Knock‑down of the focal adhesion kinase gene in A549 cells markedly reduces IFN‑γ‑induced STAT1 phosphorylation, thereby attenuating the expression of the tumor necrosis factor‑α‑responsive chemokine CXCL10.",-23.125,0.01,geneorgeneproduct
"Knocking‑down the gene product FAK in A549 cells reduces IFN‑γ‑induced STAT1 phosphorylation, thereby attenuating the expression of the pro‑apoptotic protein Smac and diminishing TNF‑α‑mediated cell death.",-26.0,0.01,geneorgeneproduct
"Knudson‑type TP53 mutations in the PKD1‑associated renal carcinoma cell line MDCK‑cIII enhance focal adhesion kinase phosphorylation, thereby increasing Rab6a‑GTP‑mediated secretion of tumor necrosis factor‑α and IFN‑γ‑yellow, which in turn up‑regulates the specificity protein‑S6 pathway and promotes glial‑cell‑line‑derived neurotrophic factor expression.",-50.25,0.01,geneorgeneproduct
"Knox et al. demonstrated that the focal adhesion kinase variant c.1234G>A in the PKD1 gene enhances Rab6a‑GTP‑mediated trafficking of the tumor necrosis factor‑α receptor, thereby amplifying IFN‑γ‑yellow‑induced Smac release and accelerating glial‑cell‑line‑derived neurotrophic factor‑mediated neuronal survival.",-43.0,0.01,geneorgeneproduct
A mutation in the PKD1 gene that increases its expression of focal adhesion kinase and enhances Rab6a‑GTP‑mediated trafficking of the tumor necrosis factor‑α receptor leads to heightened glial‑cell‑line‑derived neurotrophic factor secretion in human renal epithelial cells.,-32.25,0.01,geneorgeneproduct
"A gain‑of‑function mutation in the PKD1 gene, which encodes a polycystin‑1 protein that interacts with focal adhesion kinase, was shown to up‑regulate the expression of the tumor necrosis factor alpha promoter through a specificity protein‑1‑dependent pathway in cultured human renal epithelial cells.",-34.25,0.01,geneorgeneproduct
"A PKD1 mutation in the cIII domain of the Rab6a‑GTP‑binding protein enhances glial‑cell‑line‑derived neurotrophic factor signaling, thereby upregulating focal adhesion kinase and S6 phosphorylation to promote tumor necrosis factor‑alpha‑induced apoptosis.",-35.5,0.01,geneorgeneproduct
"A phosphorylation event of focal adhesion kinase in HeLa cells, triggered by IFN‑γ‑yellow, activates the specificity protein transcription factor that up‑regulates the tumor necrosis factor alpha gene, thereby enhancing the apoptotic activity of Smac released from mitochondria.",-34.5,0.01,geneorgeneproduct
"Silencing of the PKD1 gene in HeLa cells reduces focal adhesion kinase phosphorylation, thereby impairing Rab6a‑GTP‑mediated vesicle trafficking and diminishing glial‑cell‑line‑derived neurotrophic factor secretion.",-17.625,0.01,geneorgeneproduct
"Silica nanoparticles inhibit focal adhesion kinase phosphorylation in A549 cells, thereby reducing Rab6a‑GTP‑mediated secretion of tumor necrosis factor‑α and enhancing IFN‑γ‑induced apoptosis through Smac release.",-30.375,0.01,geneorgeneproduct
"Silk fibroin scaffolds seeded with HeLa cells overexpressing focal adhesion kinase and treated with the small‑molecule inhibitor cIII reduce tumor necrosis factor‑α secretion, thereby enhancing glial‑cell‑line‑derived neurotrophic factor‑mediated neuronal survival.",-29.125,0.01,geneorgeneproduct
"Silenced expression of the tumor‑suppressor gene PKD1 in A549 cells leads to increased focal adhesion kinase phosphorylation, thereby enhancing Rab6a‑GTP‑mediated vesicular trafficking and up‑regulating glial‑cell‑line‑derived neurotrophic factor secretion, which in turn amplifies interferon‑γ‑induced activation of the specificity protein transcription factor and promotes apoptosis through the mitochondrial release of Smac and subsequent activation of tumor necrosis factor‑α signaling.",-45.5,0.01,geneorgeneproduct
"Deletion of the PKD1 gene in A549 cells reduces focal adhesion kinase phosphorylation, thereby impairing Rab6a‑GTP‑mediated vesicle trafficking and attenuating glial‑cell‑line‑derived neurotrophic factor secretion.",-18.5,0.01,geneorgeneproduct
"Deletion in the PKD1 gene that encodes a polycystin protein causes aberrant activation of focal adhesion kinase, which in turn phosphorylates S6 and enhances glial‑cell‑line‑derived neurotrophic factor expression, thereby promoting renal cyst growth in autosomal dominant polycystic kidney disease.",-39.0,0.01,geneorgeneproduct
"Deletion‑induced loss of the PKD1 gene product in HeLa cells upregulates the tumor necrosis factor‑α‑mediated NF‑κB pathway, thereby enhancing focal adhesion kinase phosphorylation and promoting Rab6a‑GTP‑dependent vesicular trafficking.",-35.25,0.01,geneorgeneproduct
"Deletion or loss‑of‑function of the PKD1 gene in renal epithelial cells leads to aberrant activation of focal adhesion kinase, which in turn phosphorylates S6 and enhances the expression of the tumor‑necrosis‑factor‑alpha‑induced specificity protein, thereby promoting glial‑cell‑line‑derived neurotrophic factor secretion and accelerating cystic kidney disease progression.",-49.25,0.01,geneorgeneproduct
"Hyperphosphorylation of focal adhesion kinase by the PKD1‑activated Rab6a‑GTP complex enhances the transcriptional activity of specificity protein‑1, thereby amplifying IFN‑γ‑induced TNF‑α expression in glial‑cell‑line‑derived neurotrophic factor‑treated astrocytes.",-32.0,0.01,geneorgeneproduct
"Hyperactivation of focal adhesion kinase in A549 cells enhances Rab6a‑GTP‑mediated secretion of tumor necrosis factor‑α, thereby up‑regulating the expression of the specificity protein transcription factor SP1 and increasing the production of glial‑cell‑line‑derived neurotrophic factor.",-28.125,0.01,geneorgeneproduct
"Hyperactive focal adhesion kinase in A549 cells phosphorylates the specificity protein SP1, thereby enhancing the transcription of the PKD1 gene and increasing Rab6a‑GTP‑mediated vesicle trafficking, which ultimately augments glial‑cell‑line‑derived neurotrophic factor secretion and promotes tumor necrosis factor‑alpha‑induced apoptosis.",-41.5,0.01,geneorgeneproduct
"Hyperglycemia-induced oxidative stress upregulates the transcription factor specificity protein-1, which in turn enhances PKD1 expression and activates the NF‑κB pathway, leading to increased production of tumor necrosis factor‑α in glial‑cell‑line‑derived neurotrophic factor‑treated A549 cells.",-39.75,0.01,geneorgeneproduct
"Alterations in the PKD1 gene product, which encodes a protein kinase that phosphorylates focal adhesion kinase, have been shown to increase the expression of the tumor necrosis factor‑α‑induced chemokine IFN‑γ‑yellow in glial‑cell‑line‑derived neurotrophic factor‑treated A549 cells.",-35.0,0.01,geneorgeneproduct
"Alteration of the PKD1 gene product in HeLa cells leads to increased focal adhesion kinase phosphorylation, thereby enhancing Rab6a‑GTP‑mediated vesicle trafficking and upregulating glial‑cell‑line‑derived neurotrophic factor expression.",-23.375,0.01,geneorgeneproduct
"Altered phosphorylation of focal adhesion kinase in A549 cells treated with the PKD1 inhibitor cIII reduces Rab6a‑GTP‑mediated vesicle trafficking, thereby attenuating Tumor Necrosis Factor‑α‑induced NF‑κB activation and increasing Smac‑mediated apoptosis.",-25.25,0.01,geneorgeneproduct
"Alterative treatment with the small‑molecule inhibitor cIII reduces tumor necrosis factor‑alpha production in HeLa cells, thereby attenuating the phosphorylation of focal adhesion kinase and the downstream activation of the S6 ribosomal protein.",-37.0,0.01,geneorgeneproduct
"Loss of the PKD1 gene product in HeLa cells leads to increased focal adhesion kinase phosphorylation, which in turn enhances Rab6a‑GTP‑mediated trafficking of the tumor necrosis factor‑α receptor and amplifies IFN‑γ‑induced Smac expression, ultimately promoting apoptosis.",-29.75,0.01,geneorgeneproduct
"Loss-of-function mutations in the PKD1 gene, which encodes a polycystin protein that interacts with focal adhesion kinase, have been shown to increase the expression of the pro‑apoptotic protein Smac and to sensitize renal epithelial cells to tumor necrosis factor‑alpha‑induced apoptosis.",-29.125,0.01,geneorgeneproduct
"Loss‑of‑function mutations in the PKD1 gene, which encodes a polycystin‑1 protein that interacts with focal adhesion kinase, lead to aberrant Rab6a‑GTP trafficking and impaired glial‑cell‑line‑derived neurotrophic factor signaling, thereby contributing to cystic kidney disease in Homo sapiens.",-30.25,0.01,geneorgeneproduct
"Loss‐of‑function mutations in the PKD1 gene, which encodes a polycystin‑1 protein that interacts with focal adhesion kinase, lead to aberrant activation of the S6 ribosomal protein and downstream up‑regulation of the tumor necrosis factor‑α signaling pathway in renal epithelial cells.",-38.25,0.01,geneorgeneproduct
"Experimental inhibition of focal adhesion kinase in A549 cells reduces IFN‑γ‑induced STAT1 phosphorylation, thereby attenuating the expression of the tumor necrosis factor‑α gene (TNFA) and its downstream S6‑ribosomal‑protein activation.",-31.375,0.01,geneorgeneproduct
"Experimental siRNA knockdown of the focal adhesion kinase gene in A549 cells reduced Rab6a‑GTP‑dependent secretion of tumor necrosis factor‑α, thereby attenuating the inflammatory response to IFN‑γ stimulation.",-32.0,0.01,geneorgeneproduct
"Experimental data show that the focal adhesion kinase inhibitor reduces PKD1 phosphorylation in HeLa cells, thereby enhancing Rab6a‑GTP‑mediated vesicle trafficking and increasing glial‑cell‑line‑derived neurotrophic factor secretion, which in turn suppresses Tumor Necrosis Factor alpha‑induced apoptosis through activation of the specificity protein‑dependent S6 ribosomal protein pathway.",-42.0,0.01,geneorgeneproduct
"Experimental validation revealed that the focal adhesion kinase variant c.1234G>A in the PKD1 gene increases Rab6a‑GTP‑mediated trafficking of glial‑cell‑line‑derived neurotrophic factor, thereby enhancing tumor necrosis factor‑alpha‑induced apoptosis through Smac‑dependent activation of caspase‑3.",-38.5,0.01,geneorgeneproduct
"Genome‑wide association analysis revealed that the PKD1 variant rs1234567, which alters a cysteine residue in the protein’s EF‑hand domain, is strongly linked to increased expression of the tumor necrosis factor alpha gene in glial‑cell‑line‑derived neurotrophic factor‑treated A549 cells, suggesting a regulatory axis involving focal adhesion kinase and the specificity protein transcription factor that may modulate inflammatory signaling in this lung carcinoma model.",-51.25,0.01,geneorgeneproduct
"Genome editing of the PKD1 gene in HeLa cells using CRISPR/Cas9 introduced a c.1523_1525delTAA sequence variant that disrupted the binding of the specificity protein transcription factor to the promoter, thereby reducing expression of glial‑cell‑line‑derived neurotrophic factor and increasing susceptibility to Tumor Necrosis Factor‑α‑induced apoptosis.",-43.0,0.01,geneorgeneproduct
"Genome-wide CRISPR screening in A549 cells revealed that loss of the PKD1 gene product enhances sensitivity to the small‑molecule inhibitor doxorubicin, an effect mediated by increased activation of the focal adhesion kinase–S6 signaling axis and upregulation of the pro‑apoptotic protein Smac.",-33.75,0.01,geneorgeneproduct
"Genome‐wide association analysis revealed that the PKD1 variant rs1234567, which alters a cysteine residue in the protein’s EF‑hand domain, is strongly associated with increased expression of the tumor necrosis factor alpha gene in glial‑cell‑line‑derived neurotrophic factor‑treated A549 cells, suggesting a regulatory link between PKD1 signaling and inflammatory cytokine production.",-45.0,0.01,geneorgeneproduct
"Focal adhesion kinase phosphorylation by the PKD1‑dependent pathway enhances Rab6a‑GTP‑mediated trafficking of the glial‑cell‑line‑derived neurotrophic factor receptor, thereby amplifying Tumor Necrosis Factor‑alpha‑induced NF‑κB activation in human neuroblastoma cells.",-25.0,0.01,geneorgeneproduct
"Focally, the phosphorylation of focal adhesion kinase by the PKD1‑dependent Rab6a‑GTP pathway enhances the transcriptional activity of specificity protein‑1, thereby amplifying IFN‑γ‑induced TNF‑α production in glial‑cell‑line‑derived neurotrophic factor‑stimulated astrocytes.",-35.75,0.01,geneorgeneproduct
"Focusing on the interaction between focal adhesion kinase and the tumor necrosis factor alpha signaling pathway, we observed that in A549 cells the phosphorylation of S6 is markedly enhanced, suggesting a potential regulatory role for the PKD1-mediated activation of Rab6a‑GTP in modulating the inflammatory response.",-42.5,0.01,geneorgeneproduct
"Facet of the study revealed that the focal adhesion kinase variant c.1234G>A in the PKD1 gene of a Homo sapiens patient with autosomal dominant polycystic kidney disease enhances Rab6a‑GTP‑mediated trafficking of the glial‑cell‑line‑derived neurotrophic factor receptor, thereby amplifying Tumor Necrosis Factor alpha‑induced NF‑κB signaling and up‑regulating the specificity protein‑1 transcription factor, which in turn increases S",-57.25,0.01,geneorgeneproduct
"The loss‑of‑function mutation in the NEK2 gene product, which normally phosphorylates the mitotic regulator Btk, leads to aberrant spindle assembly and increased IL8 secretion in HeLa cells, thereby promoting angiogenesis and tumor progression.",-30.875,0.01,geneorgeneproduct
"The angiotensin II type‑1a (AT1a) receptor gene variant c.1163G>A in a patient with hypertension upregulates IL‑8 expression, thereby enhancing neutrophil recruitment and contributing to vascular inflammation.",-33.25,0.01,geneorgeneproduct
"The overexpression of the transcription factor slug in A549 cells enhances IL8 secretion, thereby promoting angiogenesis through the angiotensin II type‑1a receptor pathway.",-20.875,0.01,geneorgeneproduct
"The activation of the angiotensin II type‑1a (AT1a) receptor in A549 cells upregulates the transcription factor slug, which in turn enhances IL‑8 secretion and promotes epithelial‑mesenchymal transition.",-21.25,0.01,geneorgeneproduct
"Silencing of the NEK2 gene in A549 cells markedly reduces IL8 secretion, thereby attenuating the angiogenic potential of the tumor microenvironment.",-18.75,0.01,geneorgeneproduct
"Silenced NEK2 expression in A549 cells reduces IL8 secretion, thereby attenuating the angiogenic signaling mediated by the angiotensin II type‑1a (AT1a) receptor in the tumor microenvironment.",-26.75,0.01,geneorgeneproduct
"Silently, the AT1a receptor gene variant rs5186 enhances angiotensin II binding, thereby upregulating IL8 transcription in human vascular endothelial cells.",-29.125,0.01,geneorgeneproduct
"Silico‑CRISPR editing of the NEK2 promoter in A549 cells revealed that loss of the AT1a‑binding motif reduces NEK2 transcription, thereby attenuating IL8‑mediated invasion.",-31.125,0.01,geneorgeneproduct
"Activation of the angiotensin II type‑1a (AT1a) receptor in EPOR‑expressing erythroid progenitors upregulates NEK2, which phosphorylates Btk and enhances tenascin‑C secretion, thereby promoting IL‑8‑mediated, IFN‑γ‑independent neutrophil recruitment through Rab6‑dependent vesicular trafficking.",-32.0,0.01,geneorgeneproduct
"Activation or inhibition of the angiotensin II type‑1a (AT1a) receptor in A549 cells modulates the expression of the cytokine IL‑8, thereby influencing the inflammatory response to IFN‑γ‑independent stimuli.",-38.75,0.01,geneorgeneproduct
"Activation-induced phosphorylation of the angiotensin II type‑1a (AT1a) receptor by NEK2 in A549 cells enhances IL‑8 secretion, thereby promoting a pro‑inflammatory microenvironment that supports tumor progression.",-38.0,0.01,geneorgeneproduct
"Activation by the angiotensin II type‑1a (AT1a) receptor up‑regulates the transcription factor slug, which in turn enhances IL‑8 secretion in human endothelial cells.",-30.75,0.01,geneorgeneproduct
"In neutrophils, the IFNg‑independent activation of the AT1a receptor up‑regulates Rab6‑mediated trafficking of IL8, thereby enhancing chemotaxis toward inflamed tissue.",-23.5,0.01,geneorgeneproduct
"In HEK293T cells, overexpression of the NEK2 kinase phosphorylates the angiotensin II type‑1a (AT1a) receptor, enhancing its internalization and attenuating downstream ERK signaling, thereby illustrating a novel regulatory axis between a cell‑cycle kinase and a G‑protein‑coupled receptor.",-31.25,0.01,geneorgeneproduct
"In A549 cells, the AT1a receptor up‑regulates NEK2 expression, thereby enhancing Rab6‑mediated trafficking of the IL8‑secreting EPOR complex and promoting a pro‑inflammatory phenotype.",-27.625,0.01,geneorgeneproduct
"In HepG2 cells, overexpression of the transcription factor slug downregulates the angiotensin II type‑1a (AT1a) receptor, thereby attenuating IL‑8 secretion and reducing EPOR‑mediated erythropoietin signaling.",-24.0,0.01,geneorgeneproduct
"Mutations in the NEK2 gene that increase its kinase activity enhance the phosphorylation of the angiotensin II type‑1a (AT1a) receptor, thereby amplifying downstream signaling that promotes vascular smooth‑muscle proliferation and contributes to hypertension in patients with a familial predisposition to cardiovascular disease.",-32.5,0.01,geneorgeneproduct
"Mutational loss of the NEK2 kinase in A549 cells reduces IL8 secretion, thereby impairing the angiogenic signaling mediated by the angiotensin II type‑1a receptor.",-26.5,0.01,geneorgeneproduct
"Mutant NEK2, which lacks the conserved kinase domain, fails to phosphorylate the angiotensin II type‑1a (AT1a) receptor, thereby impairing downstream ERK signaling in cultured A549 cells.",-34.25,0.01,geneorgeneproduct
"Mutating the NEK2 gene in A549 cells reduces angiotensin II type‑1a receptor expression, thereby attenuating IL‑8 secretion and impairing epithelial‑mesenchymal transition driven by slug.",-27.375,0.01,geneorgeneproduct
"Angiotensin II type‑1a (AT1a) receptor overexpression in A549 cells enhances IL‑8 secretion, a process that is further amplified by the NEK2‑dependent phosphorylation of the transcription factor slug, thereby promoting epithelial‑mesenchymal transition and chemotaxis of neutrophils.",-31.625,0.01,geneorgeneproduct
"Angiogenesis in the tumor microenvironment is driven by up‑regulated IL8 secretion from Btk‑mutated B cells, which in turn activates the angiotensin II type‑1a (AT1a) receptor on endothelial cells, promoting Rab6‑mediated exocytosis of tenascin‑C and enhancing epithelial‑mesenchymal transition via slug transcriptional repression.",-52.0,0.01,geneorgeneproduct
"AngII‑induced activation of the AT1a receptor in HepG2 cells upregulates the transcription factor slug, which in turn represses E‑cadherin expression and promotes epithelial‑mesenchymal transition.",-28.875,0.01,geneorgeneproduct
"Ang-II type‑1a receptor activation in A549 cells upregulates the transcription factor slug, which in turn enhances IL‑8 secretion and promotes epithelial‑mesenchymal transition.",-37.75,0.01,geneorgeneproduct
"A NEK2 missense variant (c.1123G>A) in a patient with familial breast cancer disrupts the interaction between NEK2 and the angiotensin II type‑1a (AT1a) receptor, thereby attenuating downstream MAPK signaling and contributing to tumorigenesis.",-37.5,0.01,geneorgeneproduct
"A genome‑wide association study revealed that a missense variant in the NEK2 gene (c.1123G>A, p.Arg375His) is strongly associated with increased expression of the angiotensin II type‑1a (AT1a) receptor in vascular smooth‑muscle cells, thereby exacerbating hypertension in patients with the disease phenotype of essential hypertension.",-38.5,0.01,geneorgeneproduct
"A genetic screen in A549 cells revealed that the NEK2 kinase phosphorylates the angiotensin II type‑1a (AT1a) receptor, thereby enhancing IL‑8 secretion and promoting epithelial‑mesenchymal transition through slug activation.",-26.0,0.01,geneorgeneproduct
"A siRNA knockdown of the NEK2 gene in HeLa cells markedly reduced the phosphorylation of the angiotensin II type‑1a (AT1a) receptor, thereby attenuating downstream ERK1/2 signaling and cell proliferation.",-29.375,0.01,geneorgeneproduct
"NEK2 overexpression in A549 cells enhances IL8 secretion, thereby promoting angiogenesis through the angiotensin II type‑1a receptor pathway.",-21.0,0.01,geneorgeneproduct
"NEP1R1‑mediated degradation of angiotensin II type‑1a (AT1a) receptor in A549 cells reduces IL‑8 secretion, thereby attenuating the IFN‑γ‑independent inflammatory response driven by the Btk‑dependent NEK2 signaling axis.",-50.0,0.01,geneorgeneproduct
"NEUTRAL: In HeLa cells, the AT1a receptor upregulates IL8 expression through a Rab6‑dependent trafficking pathway, thereby enhancing angiogenic signaling.",-41.75,0.01,geneorgeneproduct
"NEAT1 upregulation in A549 cells enhances IL8 secretion by stabilizing the mRNA of the angiotensin II type‑1a (AT1a) receptor, thereby amplifying IFN‑γ‑independent inflammatory signaling.",-38.5,0.01,geneorgeneproduct
"Heterozygous loss-of-function mutations in the NEK2 gene, which encodes a serine‑threonine kinase that phosphorylates the mitotic regulator CENP‑A, were found to increase the expression of the cytokine IL8 in A549 cells, thereby enhancing the invasive potential of these lung carcinoma cells.",-39.5,0.01,geneorgeneproduct
"Homozygous loss of the NEK2 gene product in A549 cells leads to up‑regulation of the angiotensin II type‑1a (AT1a) receptor and increased secretion of IL‑8, thereby enhancing cell migration and invasion.",-31.25,0.01,geneorgeneproduct
"Hepatocellular carcinoma cells overexpressing the angiotensin II type‑1a (AT1a) receptor exhibit increased proliferation, which is attenuated by the Btk inhibitor Ibrutinib, suggesting a crosstalk between AT1a signaling and Btk‑mediated pathways.",-38.25,0.01,geneorgeneproduct
"HFD‑induced obesity in C57BL/6J mice upregulates the angiotensin II type‑1a (AT1a) receptor in adipose tissue, which in turn enhances IL‑8 secretion and promotes a pro‑inflammatory macrophage phenotype that exacerbates insulin resistance.",-41.0,0.01,geneorgeneproduct
"Knocking out the NEK2 gene in A549 cells markedly reduces IL8 secretion, thereby attenuating the angiogenic signaling mediated by the angiotensin II type‑1a (AT1a) receptor in the tumor microenvironment.",-26.75,0.01,geneorgeneproduct
"Knock‑down of the NEK2 kinase in A549 cells markedly reduces IL8 secretion, an effect that is rescued by overexpression of the angiotensin II type‑1a (AT1a) receptor, indicating a novel regulatory axis between NEK2 and AT1a in modulating inflammatory cytokine production.",-32.75,0.01,geneorgeneproduct
"Knocked‑out NEK2 in A549 cells markedly up‑regulates the angiotensin II type‑1a (AT1a) receptor, thereby enhancing IL‑8 secretion and promoting a more aggressive epithelial‑to‑mesenchymal transition.",-34.5,0.01,geneorgeneproduct
"Knitting together the signaling cascade, the AT1a receptor‑mediated activation of NEK2 phosphorylates Rab6, thereby enhancing IL8 secretion and driving tenascin‑C expression in a manner that is independent of IFNg signaling.",-40.25,0.01,geneorgeneproduct
"Overexpression of the transcription factor slug in A549 cells upregulates the angiotensin II type‑1a receptor, thereby enhancing IL‑8 secretion and promoting epithelial‑mesenchymal transition.",-20.875,0.01,geneorgeneproduct
"Overactivation of the angiotensin II type‑1a (AT1a) receptor in A549 cells upregulates the transcription factor slug, which in turn enhances IL‑8 secretion and promotes epithelial‑mesenchymal transition.",-26.125,0.01,geneorgeneproduct
"Overexpressed NEK2 in A549 cells enhances IL8 secretion, thereby promoting angiogenesis through the angiotensin II type‑1a receptor pathway.",-25.125,0.01,geneorgeneproduct
"Over‑expression of the transcription factor slug in A549 cells upregulates the angiotensin II type‑1a (AT1a) receptor, thereby enhancing IL‑8 secretion and promoting epithelial‑mesenchymal transition.",-27.5,0.01,geneorgeneproduct
"Co‑expression of the angiotensin II type‑1a (AT1a) receptor and the erythropoietin receptor (EPOR) in cultured A549 cells synergistically enhances IL‑8 secretion, a process that is attenuated when the NEK2 kinase is inhibited.",-33.0,0.01,geneorgeneproduct
"Coexpression of the angiotensin II type‑1a receptor (AT1a) and the erythropoietin receptor (EPOR) in cultured A549 cells enhances IL‑8 secretion, a process that is attenuated when the NEK2‑dependent phosphorylation of Btk is inhibited.",-35.5,0.01,geneorgeneproduct
"Co-expression of the angiotensin II type‑1a receptor (AT1a) and the erythropoietin receptor (EPOR) in cultured A549 cells synergistically enhances IL‑8 secretion, a process that is attenuated when the NEK2 kinase is inhibited.",-33.75,0.01,geneorgeneproduct
"Co-overexpression of the transcription factor slug in A549 cells upregulates the angiotensin II type‑1a (AT1a) receptor, thereby enhancing IL‑8 secretion and promoting epithelial‑mesenchymal transition.",-28.0,0.01,geneorgeneproduct
"Mutation of the NEK2 gene in A549 cells reduces angiotensin II type‑1a receptor expression, thereby attenuating IL‑8 secretion and impairing epithelial‑mesenchymal transition driven by slug.",-23.75,0.01,geneorgeneproduct
"Mutation in the NEK2 gene that increases its kinase activity enhances the phosphorylation of the angiotensin II type‑1a (AT1a) receptor, thereby amplifying downstream signaling that promotes vascular smooth‑muscle proliferation in patients with hypertension.",-29.75,0.01,geneorgeneproduct
"Mutation AURKA c.215G>A in the A549 cell line upregulates the angiotensin II type‑1a (AT1a) receptor, thereby enhancing IL‑8 secretion and promoting chemotaxis of neutrophils toward the tumor microenvironment.",-40.25,0.01,geneorgeneproduct
"Mutation‑induced loss of the angiotensin II type‑1a (AT1a) receptor in the EPOR‑expressing A549 cell line leads to up‑regulation of the cytokine IL‑8, thereby enhancing Rab6‑mediated secretion of tenascin‑C and accelerating the IFN‑γ‑independent proliferation of Btk‑deficient neutrophils.",-46.25,0.01,geneorgeneproduct
"Altered expression of the angiotensin II type‑1a (AT1a) receptor in A549 cells leads to increased IL‑8 secretion, a process that is further amplified by NEK2‑mediated phosphorylation of the transcription factor slug.",-24.375,0.01,geneorgeneproduct
"Alterations in the AT1a receptor gene product, combined with up‑regulated Rab6 trafficking, enhance IL‑8 secretion in EPOR‑positive A549 cells, thereby promoting angiogenesis in a Btk‑dependent manner.",-30.125,0.01,geneorgeneproduct
"Alteration of the AT1a receptor gene product by a missense variant in the extracellular domain reduces angiotensin II binding, thereby attenuating downstream signaling that normally up‑regulates IL8 expression in vascular smooth‑muscle cells.",-31.125,0.01,geneorgeneproduct
"Altering the expression of the angiotensin II type‑1a (AT1a) receptor in A549 cells reduces IL‑8 secretion, thereby attenuating the inflammatory response driven by the Btk‑dependent signaling cascade.",-36.75,0.01,geneorgeneproduct
"The IL1B-31TT polymorphism in the promoter of the IL1B gene enhances transcription of IL1B, thereby increasing IL-1β production and amplifying the inflammatory response in patients with severe asthma.",-23.625,0.01,geneorgeneproduct
"The Trif adaptor protein, when activated by IL1B-31TT polymorphism, enhances TGF‑beta2 signaling in SLC12A3‑expressing renal epithelial cells, thereby increasing TXN-mediated antioxidant response and reducing Complement factor I‑mediated inflammation.",-30.0,0.01,geneorgeneproduct
"The NDUFS6 variant c.152G>A, which reduces complex I activity, was found to up‑regulate TXN expression and increase IL1B‑31TT promoter activity in HeLa cells, thereby enhancing the inflammatory response to OVA‑IgE stimulation.",-30.125,0.01,geneorgeneproduct
"The inflammatory cytokine IL1B-31TT allele enhances NF‑κB activation in A549 cells, leading to up‑regulation of the myosin heavy chain gene MYH9 and increased secretion of TGF‑β2, thereby promoting epithelial‑mesenchymal transition in a TNF‑α‑stimulated microenvironment.",-33.25,0.01,geneorgeneproduct
"In HeLa cells, the IL1B‑31TT polymorphism enhances TGF‑beta2 transcription, thereby increasing TXN expression and promoting complement factor I‑mediated inhibition of the Trif‑dependent NF‑κB pathway.",-21.875,0.01,geneorgeneproduct
"In hepatocellular carcinoma cells, the NDUFS6 variant c.152G>A reduces complex I activity, leading to increased ROS that upregulates TXN and downregulates TGF‑beta2, thereby enhancing IL1B‑31TT‑mediated inflammatory signaling and promoting OVA‑IgE‑induced tumor‑cell apoptosis.",-37.25,0.01,geneorgeneproduct
"In A549 cells, the IL1B‑31TT polymorphism enhances TXN expression, which in turn upregulates TGF‑beta2 and activates the complement factor I pathway, ultimately increasing myosin heavy chain phosphorylation and promoting chemotaxis of OVA‑IgE‑producing Th2 cells.",-24.5,0.01,geneorgeneproduct
"In the A549 cell line, the IL1B‑31TT polymorphism upregulates TXN expression, thereby enhancing TGF‑β2‑mediated suppression of Complement factor I and promoting myosin heavy chain phosphorylation in response to OVA‑IgE‑induced inflammation.",-24.125,0.01,geneorgeneproduct
"Expression of the IL1B-31TT promoter variant in the A549 cell line increases transcription of the IL1B gene, thereby enhancing the secretion of IL-1β and amplifying the inflammatory response to OVA-IgE stimulation.",-28.625,0.01,geneorgeneproduct
"Expression analysis in the A549 cell line revealed that the IL1B‑31TT polymorphism upregulates TXN and downregulates TGF‑beta2, thereby enhancing complement factor I secretion and reducing NDUFS6 activity.",-24.75,0.01,geneorgeneproduct
"Expression profiling of the myosin heavy chain gene in DDB‑treated A549 cells revealed that IL1B‑31TT polymorphism enhances TXN‑mediated oxidative stress, thereby up‑regulating TGF‑beta2 and complement factor I while down‑regulating SLC12A3 expression.",-32.5,0.01,geneorgeneproduct
"Expression analyses in the A549 cell line revealed that the IL1B‑31TT polymorphism upregulates TXN and TGF‑beta2, thereby enhancing complement factor I secretion and increasing susceptibility to OVA‑IgE‑mediated airway inflammation.",-29.25,0.01,geneorgeneproduct
"Intracellular signaling in A549 cells reveals that the IL1B‑31TT polymorphism enhances NF‑κB activation, leading to increased TXN expression and subsequent up‑regulation of TGF‑β2, which in turn promotes myosin heavy chain phosphorylation and contributes to the heightened inflammatory response observed in patients with severe asthma.",-40.75,0.01,geneorgeneproduct
"Intriguingly, the IL1B‑31TT polymorphism in the promoter of the pro‑inflammatory cytokine IL‑1β enhances transcriptional activity, thereby increasing IL‑1β protein levels that subsequently up‑regulate the expression of the myosin heavy chain gene MYH7 in cardiomyocytes, a process that is further amplified by the TGF‑β2‑induced activation of the SMAD signaling cascade.",-48.75,0.01,geneorgeneproduct
"Intratumoral injection of the IL1B‑31TT allele‑specific siRNA into A549 cells down‑regulated TXN and TGF‑β2 expression, thereby reducing complement factor I‑mediated phagocytosis of OVA‑IgE‑bound tumor cells.",-40.0,0.01,geneorgeneproduct
"Intravitally, the IL1B‑31TT polymorphism in the promoter of the NDUFS6 gene enhances transcription of the mitochondrial complex I subunit, thereby increasing reactive oxygen species production and up‑regulating the TGF‑beta2‑mediated fibrotic response in the retinal pigment epithelium of patients with age‑related macular degeneration.",-42.5,0.01,geneorgeneproduct
"Mutations in the NDUFS6 gene, such as the c.152C>T variant, impair mitochondrial complex I activity in HeLa cells, leading to increased reactive oxygen species that upregulate TXN expression and subsequently enhance IL1B-31TT promoter activity, thereby amplifying the inflammatory response to OVA-IgE stimulation.",-32.25,0.01,geneorgeneproduct
"Mutational analysis of the IL1B-31TT promoter variant in the NDUFS6 gene revealed that the T allele enhances transcriptional activation by the transcription factor Trif, thereby increasing IL1B expression and contributing to heightened inflammatory responses in patients with chronic myosin heavy chain deficiency.",-35.5,0.01,geneorgeneproduct
"Mutant IL1B‑31TT in the promoter of the inflammatory cytokine IL1B enhances transcriptional activation by the adaptor protein Trif, thereby amplifying TGF‑β2‑mediated fibroblast proliferation in human dermal fibroblasts.",-31.375,0.01,geneorgeneproduct
"Mutated IL1B-31TT in the promoter of the inflammatory cytokine IL1B enhances transcriptional activation by the transcription factor Trif, thereby increasing IL1B expression and amplifying the downstream TGF‑beta2‑mediated fibrotic response in human dermal fibroblasts.",-35.75,0.01,geneorgeneproduct
"A mutation in the NDUFS6 gene (c.152G>A) was found to impair mitochondrial complex I activity in a patient with Leigh syndrome, while a concurrent IL1B-31TT polymorphism was associated with heightened inflammatory cytokine production in the same individual.",-33.75,0.01,geneorgeneproduct
"A CRISPR‑Cas9‑mediated knockout of the NDUFS6 gene in HEK293T cells leads to a dramatic reduction in mitochondrial complex I activity, which in turn up‑regulates TXN expression and enhances IL1B‑31TT‑driven inflammatory signaling, thereby sensitizing the cells to OVA‑IgE‑induced complement factor I activation.",-36.5,0.01,geneorgeneproduct
"A549 cells transfected with the IL1B‑31TT promoter variant exhibit increased transcription of TXN and TGF‑β2, while CRISPR‑mediated knockout of NDUFS6 in the same line reduces mitochondrial ROS and attenuates the IL‑1β‑induced up‑regulation of Complement factor I.",-30.875,0.01,geneorgeneproduct
"A microarray analysis of HeLa cells transfected with a plasmid encoding the IL1B-31TT variant revealed that the mutant allele upregulates TXN and downregulates TGF‑beta2, thereby enhancing complement factor I secretion and increasing susceptibility to OVA‑IgE‑mediated inflammation.",-33.75,0.01,geneorgeneproduct
"Deletion of the NDUFS6 gene in A549 cells reduces TXN expression, thereby increasing IL1B‑31TT‑mediated apoptosis and sensitizing the cells to TGF‑beta2‑induced growth arrest.",-23.125,0.01,geneorgeneproduct
"Deletion‑mediated loss of the NDUFS6 gene product in HeLa cells leads to impaired mitochondrial complex I activity, which in turn up‑regulates TXN expression and enhances IL1B‑31TT‑driven inflammatory signaling.",-36.0,0.01,geneorgeneproduct
"Deletion polymorphism IL1B‑31TT in the promoter of the pro‑inflammatory cytokine IL1B enhances transcriptional activation by the transcription factor Trif, thereby increasing IL1B expression in human macrophages and contributing to heightened OVA‑IgE‑mediated allergic responses.",-41.5,0.01,geneorgeneproduct
"Deletion in the NDUFS6 gene of a patient with Leigh syndrome leads to impaired oxidative phosphorylation, causing a severe reduction in ATP production that ultimately triggers apoptosis of neurons and results in progressive neurodegeneration.",-38.25,0.01,geneorgeneproduct
"TRAF2 deficiency in A549 cells upregulates IL1B-31TT expression, thereby enhancing TGF‑beta2‑mediated activation of the NDUFS6‑dependent oxidative phosphorylation pathway.",-19.75,0.01,geneorgeneproduct
"TRIF-mediated activation of IL1B-31TT in HeLa cells upregulates TXN and TGF‑beta2, thereby enhancing complement factor I expression and promoting myosin heavy chain phosphorylation in a dose‑dependent manner.",-22.125,0.01,geneorgeneproduct
"TRF2 deficiency in A549 cells upregulates IL1B-31TT expression, thereby enhancing TGF‑beta2‑mediated myosin heavy chain phosphorylation and promoting complement factor I‑driven apoptosis.",-27.25,0.01,geneorgeneproduct
"TRPV1 activation in A549 cells upregulates TXN expression, thereby enhancing IL1B‑31TT‑mediated NF‑κB signaling and increasing TGF‑β2 secretion, which in turn promotes myosin heavy chain phosphorylation and contributes to complement factor I‑driven inflammatory responses.",-37.75,0.01,geneorgeneproduct
"DDB deficiency in A549 cells leads to up‑regulation of the IL1B‑31TT allele, which in turn enhances TXN‑mediated oxidative stress and activates TGF‑beta2 signaling, ultimately increasing complement factor I expression and promoting myosin heavy chain phosphorylation.",-31.375,0.01,geneorgeneproduct
"DDF‑treated A549 cells exhibit up‑regulated IL1B‑31TT expression, which activates the Trif‑dependent NF‑κB pathway and enhances TXN-mediated oxidative stress, thereby increasing TGF‑β2 secretion and complement factor I production.",-39.5,0.01,geneorgeneproduct
"DAB2IP loss-of-function mutations in the NDUFS6 promoter region of Homo sapiens cells upregulate IL1B-31TT expression, thereby enhancing TGF‑beta2‑mediated myosin heavy chain phosphorylation and complement factor I activation in OVA‑IgE‑induced airway inflammation.",-40.75,0.01,geneorgeneproduct
"Dexamethasone treatment of A549 cells carrying the IL1B‑31TT promoter variant upregulates TXN expression, thereby attenuating TGF‑β2‑induced apoptosis and enhancing complement factor I secretion.",-26.5,0.01,geneorgeneproduct
"Knock‑down of the NDUFS6 gene product in HeLa cells markedly reduces TXN expression, thereby enhancing IL1B‑31TT‑mediated NF‑κB activation and increasing OVA‑IgE production in a TGF‑β2‑dependent manner.",-26.25,0.01,geneorgeneproduct
"Knocking out the NDUFS6 gene in A549 cells reduces IL1B‑31TT expression, thereby attenuating TGF‑beta2‑induced myosin heavy chain phosphorylation and diminishing OVA‑IgE‑mediated complement factor I activation.",-26.0,0.01,geneorgeneproduct
"Knox et al. demonstrated that the IL1B‑31TT promoter polymorphism enhances transcription of IL‑1β in A549 cells, thereby increasing TGF‑β2 secretion and up‑regulating the complement factor I gene, a modulation that is further amplified by the NDUFS6‑associated mitochondrial dysfunction observed in the same cell line.",-46.25,0.01,geneorgeneproduct
"Knitting together the inflammatory cascade, the IL1B‑31TT polymorphism in the promoter of the IL‑1β gene was found to up‑regulate TXN expression in A549 cells, thereby enhancing TGF‑β2‑mediated fibroblast activation and complement factor I‑driven clearance of apoptotic neutrophils.",-45.25,0.01,geneorgeneproduct
"Myc‑overexpressing A549 cells treated with the IL1B‑31TT polymorphic allele exhibit increased TXN expression, which in turn enhances TGF‑beta2‑mediated suppression of the complement factor I gene in a DDB‑dependent manner.",-32.5,0.01,geneorgeneproduct
"Mycoplasma pneumoniae infection in A549 cells upregulates IL1B-31TT, which in turn activates the Trif‑dependent signaling cascade to increase TXN expression and enhance TGF‑beta2‑mediated fibroblast proliferation.",-32.25,0.01,geneorgeneproduct
"Myeloid differentiation in the A549 cell line is accelerated by IL1B‑31TT polymorphism‑mediated up‑regulation of TXN, which in turn enhances TGF‑beta2 signaling and promotes myosin heavy chain expression, thereby increasing susceptibility to OVA‑IgE‑induced airway inflammation.",-34.0,0.01,geneorgeneproduct
"Myosin heavy chain isoform MYH7B, whose expression is up‑regulated by the transcription factor TRIF in response to IL1B‑31TT polymorphism, is further enhanced by TGF‑beta2 signaling and contributes to the activation of complement factor I in the renal tubular cells of SLC12A3‑deficient patients.",-44.75,0.01,geneorgeneproduct
"Altered expression of the mitochondrial complex I subunit NDUFS6 in HeLa cells carrying the IL1B‑31TT promoter variant leads to increased reactive oxygen species, which in turn upregulates TXN and TGF‑beta2, thereby enhancing complement factor I secretion and promoting OVA‑IgE‑mediated inflammatory responses.",-30.625,0.01,geneorgeneproduct
"Alterations in the IL1B-31TT promoter variant enhance NF‑κB binding, thereby up‑regulating TXN expression and amplifying TGF‑β2‑mediated fibrosis in human dermal fibroblasts.",-24.875,0.01,geneorgeneproduct
"Alteration of the IL1B-31TT promoter variant in the NDUFS6 gene reduces TXN-mediated antioxidant capacity, thereby enhancing TGF‑beta2‑induced myosin heavy chain expression in human dermal fibroblasts.",-29.5,0.01,geneorgeneproduct
"Alterantive splicing of the NDUFS6 transcript in HeLa cells carrying the IL1B‑31TT variant leads to reduced complex I activity, thereby enhancing TXN‑mediated oxidative stress and up‑regulating TGF‑beta2 expression, which in turn promotes complement factor I secretion and modulates OVA‑IgE‑induced airway inflammation.",-45.25,0.01,geneorgeneproduct
"Mutation of the NDUFS6 gene in a patient with Leigh syndrome leads to impaired oxidative phosphorylation, causing a severe reduction in ATP production that ultimately triggers apoptosis of neurons and results in progressive neurodegeneration.",-28.0,0.01,geneorgeneproduct
"Mutation amplification of the IL1B‑31TT allele in the NDUFS6 promoter of a HeLa cell line treated with the Trif‑induced TGF‑β2 pathway inhibitor reduced Complement factor I expression, thereby enhancing TXN‑mediated oxidative stress in the cultured Homo sapiens cells.",-44.0,0.01,geneorgeneproduct
"Mutation in the IL1B-31TT promoter increases IL1B transcription, thereby enhancing TGF‑beta2 secretion in A549 cells and amplifying the inflammatory response to OVA‑IgE‑induced airway hyperreactivity.",-26.125,0.01,geneorgeneproduct
"Mutation–induced loss of NDUFS6 in A549 cells upregulates IL1B‑31TT expression, thereby enhancing TGF‑beta2‑mediated fibroblast activation and complement factor I secretion.",-31.625,0.01,geneorgeneproduct
"By overexpressing the NDUFS6 gene product in HeLa cells, we observed a significant increase in reactive oxygen species that subsequently activated the TXN-mediated antioxidant response, thereby reducing IL1B-31TT-driven inflammation and enhancing TGF‑beta2 secretion.",-30.25,0.01,geneorgeneproduct
"By CRISPR‑mediated editing of the IL1B‑31TT promoter in A549 cells, we observed that the resulting up‑regulation of TXN and TGF‑beta2 transcription enhances the secretion of Complement factor I, thereby attenuating OVA‑IgE‑induced airway hyperresponsiveness in a murine model of asthma.",-38.0,0.01,geneorgeneproduct
"By performing CRISPR‑Cas9 editing of the IL1B‑31TT promoter in the human myeloid cell line THP‑1, we observed that the resulting loss of IL‑1β transcription led to a marked decrease in the secretion of the complement factor I protein, thereby revealing a novel regulatory link between the NDUFS6‑dependent mitochondrial respiratory chain and the TGF‑beta2‑driven anti‑inflammatory response.",-53.25,0.01,geneorgeneproduct
"By RNA‑seq analysis of the A549 cell line, we discovered that the IL1B‑31TT polymorphism up‑regulates TXN expression, thereby enhancing TGF‑beta2‑mediated suppression of the complement factor I pathway and increasing susceptibility to oxidative stress in the presence of the NDUFS6 variant.",-39.75,0.01,geneorgeneproduct
"The Let‑96 gene product, a serine/threonine kinase, phosphorylates FASN, thereby enhancing lipid synthesis in HeLa cells and contributing to the proliferation of the A549 cell line.",-25.875,0.01,geneorgeneproduct
"The overexpression of FASN in HeLa cells enhances the phosphorylation of serine/threonine kinases, thereby promoting cyclin‑dependent kinase‑4‑mediated cell‑cycle progression and increasing the transcriptional activity of b‑catenin, which in turn upregulates the expression of the erythropoietin receptor and the FOXP3‑6054 variant, ultimately contributing to the aggressive phenotype observed in this cervical cancer model.",-47.75,0.01,geneorgeneproduct
"The loss‑of‑function mutation in the FOXP3‑6054 allele disrupts erythropoietin receptor signaling, leading to impaired erythropoiesis and anemia in patients with the associated genetic disorder.",-23.375,0.01,geneorgeneproduct
"The point mutation c.152G>A in the TP53 gene, which generates a p.R51Q variant, was found to impair the interaction between TP53 and the FSHβ subunit, thereby reducing follicle‑stimulating hormone secretion in a cohort of patients with hypogonadotropic hypogonadism.",-39.0,0.01,geneorgeneproduct
"Mutation of the FOXP3-6054 allele in a patient with autoimmune lymphoproliferative syndrome leads to reduced erythropoietin receptor expression, thereby impairing erythropoiesis and exacerbating anemia.",-20.875,0.01,geneorgeneproduct
"Mutation FASN c.1523G>A in the HeLa cell line upregulates serine/threonine kinases, thereby enhancing cyclin‑dependent kinase‑4 activity and promoting b‑catenin‑mediated proliferation of the tumor cells.",-42.25,0.01,geneorgeneproduct
"Mutation in the FOXP3-6054 gene, which encodes a transcription factor that regulates T‑cell tolerance, was found to up‑regulate the expression of the erythropoietin receptor in HeLa cells, thereby enhancing erythropoietin‑induced STAT5 phosphorylation and promoting cell survival.",-31.75,0.01,geneorgeneproduct
"Mutation‐induced loss of the erythropoietin receptor in HeLa cells leads to up‑regulation of the serine/threonine kinase FASN, which in turn phosphorylates b‑catenin and activates the NR2F2‑dependent transcriptional program that drives cyclin‑dependent kinase‑4‑mediated proliferation.",-37.5,0.01,geneorgeneproduct
"Regulation of the erythropoietin receptor by the serine/threonine kinase FASN modulates erythropoiesis in HeLa cells, while VIPR2 signaling enhances FSHbeta transcription through a cyclin‑dependent kinase‑4‑dependent pathway.",-34.25,0.01,geneorgeneproduct
"Regulated by the serine/threonine kinase FASN, the cyclin‑dependent kinase‑4‑dependent phosphorylation of b‑catenin enhances FOXP3‑6054 transcription, thereby increasing erythropoietin receptor expression in VIPR2‑stimulated HeLa cells.",-35.5,0.01,geneorgeneproduct
"Regulatory phosphorylation of the serine/threonine kinase FASN by cyclin‑dependent kinase‑4 enhances its catalytic activity, thereby increasing fatty‑acid synthesis in HeLa cells and contributing to the proliferation of the malignant phenotype.",-36.75,0.01,geneorgeneproduct
"Regulating the transcription of the FSHβ gene, the serine/threonine kinase LKB1 phosphorylates the transcription factor FOXP3-6054, thereby enhancing erythropoietin receptor expression in HeLa cells.",-31.375,0.01,geneorgeneproduct
"In A549 cells, the serine/threonine kinase FASN phosphorylates b‑Catenin, thereby enhancing FOXP3‑6054 transcription and increasing erythropoietin receptor expression, which ultimately promotes cyclin‑dependent kinase‑4‑mediated proliferation.",-25.0,0.01,geneorgeneproduct
"In the HeLa cell line, overexpression of the serine/threonine kinase FASN enhances β‑catenin‑mediated transcription of the FSHβ gene, thereby increasing secretion of follicle‑stimulating hormone and promoting proliferation of ovarian carcinoma cells.",-23.25,0.01,geneorgeneproduct
"In HeLa cells, the serine/threonine kinase FASN phosphorylates b‑Catenin, thereby enhancing the transcriptional activity of the FOXP3‑6054 promoter and increasing erythropoietin receptor expression.",-16.125,0.01,geneorgeneproduct
"Inhibition of the serine/threonine kinase FASN by the small‑molecule inhibitor TVB‑2640 in HeLa cells leads to accumulation of β‑catenin and subsequent up‑regulation of the FOXP3‑6054 transcription factor, thereby enhancing erythropoietin receptor expression and promoting cyclin‑dependent kinase‑4‑mediated cell cycle arrest.",-40.0,0.01,geneorgeneproduct
"Activating the serine/threonine kinase FASN in HeLa cells upregulates the erythropoietin receptor, thereby enhancing FSHbeta‑mediated proliferation and increasing VIPR2‑driven c‑Catenin signaling.",-28.125,0.01,geneorgeneproduct
"Activin‑induced up‑regulation of the FSHβ subunit in granulosa cells is mediated by the serine/threonine kinase SMAD2/3, which phosphorylates the transcription factor FOXP3‑6054, thereby enhancing its binding to the FSHβ promoter and increasing gonadotropin secretion.",-39.25,0.01,geneorgeneproduct
"Activations of the serine/threonine kinase FASN in HeLa cells upregulate the transcription of the erythropoietin receptor, thereby enhancing cell proliferation and conferring resistance to the chemotherapeutic agent doxorubicin.",-30.875,0.01,geneorgeneproduct
"Activational phosphorylation of the serine/threonine kinase FASN by the cyclin‑dependent kinase CDK4 enhances its lipogenic activity, thereby up‑regulating the expression of the transcription factor NR2F2 in HeLa cells.",-35.75,0.01,geneorgeneproduct
"Mutations in the FOXP3-6054 gene, which encodes a transcription factor that regulates T‑cell tolerance, were found to disrupt the interaction between the erythropoietin receptor and the serine/threonine kinase JAK2, thereby impairing erythropoiesis in patients with severe combined immunodeficiency.",-26.75,0.01,geneorgeneproduct
"Mutant FASN c.1523G>A in HeLa cells upregulates serine/threonine kinases, thereby enhancing cyclin‑dependent kinase‑4 activity and promoting b‑catenin‑mediated proliferation.",-33.75,0.01,geneorgeneproduct
"Mutational analysis of the FOXP3-6054 allele in a cohort of E. coli–derived HeLa cells revealed that the variant disrupts the binding of serine/threonine kinases to the erythropoietin receptor, thereby attenuating FASN‑mediated lipid synthesis and reducing VIPR2‑driven proliferation of the cell line.",-35.25,0.01,geneorgeneproduct
"Mutating the FOXP3-6054 allele in HeLa cells reduces FASN expression, thereby impairing the proliferation of these cancer cells.",-24.75,0.01,geneorgeneproduct
"A CRISPR‑Cas9‑mediated knockout of the FASN gene in HeLa cells markedly reduced proliferation and induced apoptosis, while overexpression of the erythropoietin receptor in A549 cells rescued the growth defect, suggesting a synergistic interaction between lipid‑synthesis pathways and erythropoietin signaling in cancer cell survival.",-32.5,0.01,geneorgeneproduct
"A single‑cell RNA‑seq analysis of the A549 cell line revealed that the FASN‑encoded fatty‑acid‑synthase is up‑regulated by the serine/threonine kinase‑mediated phosphorylation of b‑catenin, which in turn activates the NR2F2 transcription factor to promote proliferation.",-34.5,0.01,geneorgeneproduct
"A siRNA knockdown of the serine/threonine kinase FASN in HeLa cells markedly reduced the expression of the transcription factor FOXP3-6054, thereby impairing the cells’ ability to respond to erythropoietin receptor signaling and increasing susceptibility to apoptosis.",-30.125,0.01,geneorgeneproduct
"A conditional knockout of the cyclin‑dependent kinase‑4 gene in A549 cells markedly reduces FASN expression, thereby impairing lipid synthesis and sensitizing the cells to the chemotherapeutic agent doxorubicin.",-32.0,0.01,geneorgeneproduct
"Activation of the erythropoietin receptor by recombinant erythropoietin in cultured K562 cells upregulates the serine/threonine kinase AKT, which in turn phosphorylates the transcription factor FOXP3-6054, enhancing its nuclear localization and promoting the expression of the cell cycle regulator cyclin‑dependent kinase‑4 while simultaneously suppressing the oncogenic transcriptional activity of β‑catenin.",-42.75,0.01,geneorgeneproduct
"Activation‑induced phosphorylation of the serine/threonine kinase FASN by the cyclin‑dependent kinase CDK4 enhances its lipogenic activity, thereby up‑regulating the expression of the transcription factor NR2F2 in HeLa cells.",-39.0,0.01,geneorgeneproduct
"Activation by the serine/threonine kinase LKB1 phosphorylates the transcription factor FOXP3-6054, thereby enhancing its recruitment to the erythropoietin receptor promoter and up‑regulating FASN expression in HeLa cells.",-31.875,0.01,geneorgeneproduct
"Activation signals from the erythropoietin receptor in A549 cells upregulate the serine/threonine kinase FASN, which in turn phosphorylates b‑Catenin and enhances the transcriptional activity of the FOXP3‑6054 complex, thereby promoting cell cycle progression through cyclin‑dependent kinase‑4 and ultimately driving proliferation of the tumor phenotype.",-54.5,0.01,geneorgeneproduct
"Exogenous FSHbeta stimulation of the erythropoietin receptor in HeLa cells upregulates cyclin‑dependent kinase‑4 activity, thereby enhancing b‑catenin‑mediated transcription of the FOXP3‑6054 gene.",-30.25,0.01,geneorgeneproduct
"Excessive activation of the serine/threonine kinase FASN in HeLa cells leads to up‑regulation of the β‑catenin/FOXP3‑6054 axis, thereby enhancing proliferation of the tumor and conferring resistance to erythropoietin receptor‑mediated apoptosis.",-28.375,0.01,geneorgeneproduct
"Exploiting the interaction between the serine/threonine kinase FASN and the transcription factor FOXP3-6054, we observed that overexpression of FASN in HeLa cells upregulates the erythropoietin receptor and enhances cyclin‑dependent kinase‑4‑mediated proliferation, while knockdown of FOXP3-6054 attenuates this effect.",-42.25,0.01,geneorgeneproduct
"Ex Vivo CRISPR‑mediated knockout of the serine/threonine kinase gene FASN in the human colorectal carcinoma cell line HCT‑116 markedly reduced β‑catenin nuclear translocation and down‑regulated the downstream target NR2F2, thereby attenuating cell proliferation and invasion.",-41.5,0.01,geneorgeneproduct
"Overexpression of the serine/threonine kinase FASN in HeLa cells activates the β‑catenin/FOXP3‑6054 axis, thereby enhancing erythropoietin receptor signaling and promoting cyclin‑dependent kinase‑4‑driven proliferation.",-21.75,0.01,geneorgeneproduct
"Overexpressed FASN in HeLa cells activates serine/threonine kinases that phosphorylate b‑Catenin, thereby enhancing the transcription of the FSHbeta promoter and increasing VIPR2‑mediated cAMP signaling.",-25.125,0.01,geneorgeneproduct
"Overactivation of the serine/threonine kinase FASN in HeLa cells carrying the FOXP3‑6054 variant leads to increased cyclin‑dependent kinase‑4 expression, thereby enhancing b‑catenin‑mediated transcription of the FSHβ gene and promoting tumor cell proliferation.",-36.0,0.01,geneorgeneproduct
"Over-expression of the serine/threonine kinase FASN in HeLa cells activates the β‑catenin/FOXP3‑6054 axis, thereby enhancing erythropoietin receptor signaling and promoting cyclin‑dependent kinase‑4‑driven proliferation.",-29.125,0.01,geneorgeneproduct
"FOXP3-6054 mutation in the promoter of the erythropoietin receptor gene reduces its transcription, thereby impairing erythropoietin‑induced activation of serine/threonine kinases that normally phosphorylate b‑catenin and promote cyclin‑dependent kinase‑4‑mediated cell cycle progression in HeLa cells.",-31.75,0.01,geneorgeneproduct
"FOXO3A phosphorylation by serine/threonine kinases enhances its interaction with the erythropoietin receptor, thereby promoting erythroid differentiation in K562 cells.",-23.125,0.01,geneorgeneproduct
"FOXL2 mutations in ovarian granulosa cells upregulate FSHβ expression, thereby enhancing VIPR2‑mediated cAMP signaling and accelerating b‑catenin‑driven proliferation of the granulosa‑cell tumor line KGN.",-35.25,0.01,geneorgeneproduct
"FOXS1‑mediated transcriptional repression of the erythropoietin receptor gene in HeLa cells is alleviated by the serine/threonine kinase inhibitor rapamycin, thereby restoring erythropoietin‑induced STAT5 phosphorylation and cell‑cycle progression.",-36.5,0.01,geneorgeneproduct
"Loss of the FOXP3‑6054 allele in HeLa cells leads to up‑regulation of the serine/threonine kinase FASN, which in turn phosphorylates b‑catenin and enhances the transcription of the erythropoietin receptor gene.",-22.75,0.01,geneorgeneproduct
"Loss-of-function mutations in the FOXP3-6054 allele impair regulatory T‑cell development, thereby exacerbating the hyper‑proliferative phenotype driven by cyclin‑dependent kinase‑4 overexpression in the HeLa cell line.",-37.0,0.01,geneorgeneproduct
"Loss‑of‑function mutations in the FOXP3‑6054 allele impair regulatory T‑cell development, thereby exacerbating the hyper‑proliferative phenotype driven by cyclin‑dependent kinase‑4 overexpression in the FASN‑dependent lipid‑biosynthetic pathway of HeLa cells.",-39.5,0.01,geneorgeneproduct
"Loss-to-follow-up of patients with the FOXP3‑6054 variant was associated with reduced erythropoietin receptor expression in peripheral blood mononuclear cells, suggesting that this sequence variant impairs erythropoietin signaling and contributes to the observed anemia.",-41.75,0.01,geneorgeneproduct
"Ethanol exposure downregulates the transcription of the FASN gene in HepG2 cells, thereby reducing fatty‑acid synthesis and contributing to the steatosis observed in alcoholic liver disease.",-24.625,0.01,geneorgeneproduct
"Erythropoietin receptor activation in HeLa cells upregulates FASN expression, thereby enhancing serine/threonine kinase‑mediated phosphorylation of b‑Catenin and promoting cyclin‑dependent kinase‑4‑driven proliferation.",-24.375,0.01,geneorgeneproduct
"Epidermal growth factor receptor activation in HeLa cells upregulates FASN expression, which in turn enhances the synthesis of fatty acids that support the proliferation of the cancerous phenotype.",-29.375,0.01,geneorgeneproduct
"Epithelial cells overexpressing the serine/threonine kinase FASN exhibit increased proliferation, and this effect is amplified when the cyclin‑dependent kinase‑4 inhibitor, FOXP3‑6054, is knocked down, suggesting a regulatory axis involving FASN, CDK4, and FOXP3‑6054 in colorectal carcinoma.",-44.0,0.01,geneorgeneproduct
"Suppression of the serine/threonine kinase FASN by the transcription factor FOXP3-6054 in HeLa cells reduces cyclin‑dependent kinase‑4 activity, thereby attenuating b‑catenin‑mediated proliferation of the tumor.",-33.25,0.01,geneorgeneproduct
"Suppressed expression of the serine/threonine kinase FASN in HeLa cells carrying the FOXP3‑6054 variant reduces cyclin‑dependent kinase‑4 activity, thereby attenuating b‑catenin‑mediated transcription of the FSHβ promoter in Homo sapiens.",-35.25,0.01,geneorgeneproduct
"Suppressor of cytokine signaling‑3 (SOCS3) transcription is up‑regulated by the serine/threonine kinase AKT in HeLa cells, thereby attenuating FSHβ‑induced activation of the erythropoietin receptor‑dependent STAT5 pathway.",-43.75,0.01,geneorgeneproduct
"Supplying erythropoietin receptor agonist to HeLa cells overexpressing FASN reduces cyclin‑dependent kinase‑4 activity, thereby attenuating b‑catenin‑mediated proliferation and restoring FOXP3‑6054‑driven immune tolerance.",-43.0,0.01,geneorgeneproduct
"A CRISPR‑mediated knockout of the transmembrane channel‑like gene‑1 in A549 cells markedly reduces IL‑15‑induced STAT5 phosphorylation, an effect that is partially rescued by overexpressing SOCS1, thereby revealing a novel regulatory axis between TTF‑1‑dependent transcription and cytokine‑mediated signaling in lung carcinoma.",-36.5,0.01,geneorgeneproduct
"A loss‑of‑function mutation in the transmembrane channel‑like gene‑1 allele of *Homo sapiens* was found to up‑regulate IL‑15 expression, thereby enhancing SOCS1‑mediated suppression of TNF‑α‑stimulated NF‑κB signaling in cultured A549 cells.",-31.0,0.01,geneorgeneproduct
"A missense mutation in the transmembrane channel‑like gene‑1 locus of Homo sapiens was found to up‑regulate IL‑15 expression, thereby enhancing SOCS1‑mediated suppression of TNF‑alpha‑stimulated NF‑κB signaling in cultured A549 cells.",-30.25,0.01,geneorgeneproduct
"A phosphorylation event mediated by casein kinase II on the transmembrane channel-like gene‑1 protein enhances IL‑15‑induced STAT5 activation, thereby up‑regulating SOCS1 expression and attenuating TNF‑alpha‑stimulated inflammatory signaling in human TTF‑1‑positive lung adenocarcinoma cells.",-33.5,0.01,geneorgeneproduct
"Overexpression of the transmembrane channel‑like gene‑1 in A549 cells enhances IL‑15‑induced STAT5 phosphorylation, thereby up‑regulating IGFBP‑3 transcription and promoting resistance to TNF‑α‑stimulated apoptosis.",-21.75,0.01,geneorgeneproduct
"Overactivation of casein kinase II in A549 cells enhances IL‑15‑induced SOCS1 phosphorylation, thereby attenuating IGFBP‑3‑mediated apoptosis and promoting TTF‑1‑driven transcription of type X collagen in the transmembrane channel‑like gene‑1‑expressing tumor microenvironment.",-32.5,0.01,geneorgeneproduct
"Overexpressed casein kinase II phosphorylates the transmembrane channel‑like gene‑1 protein, thereby enhancing IL‑15‑induced SOCS1 transcription and reducing IGFBP‑3 secretion in TTF‑1‑positive lung adenocarcinoma cells.",-28.5,0.01,geneorgeneproduct
"Over-expression of the transmembrane channel-like gene‑1 in A549 cells enhances IL‑15‑induced STAT5 phosphorylation, thereby up‑regulating IGFBP‑3 transcription and promoting resistance to TNF‑α‑stimulated apoptosis.",-29.5,0.01,geneorgeneproduct
"Transfection of A549 cells with a plasmid encoding the transmembrane channel‑like gene‑1 variant c.1123G>A, which increases IL‑15 secretion, leads to up‑regulation of SOCS1 and down‑regulation of type X collagen expression, thereby attenuating TNF‑α‑stimulated inflammatory signaling.",-37.5,0.01,geneorgeneproduct
"Transmembrane channel‑like gene‑1 expression is up‑regulated by IL‑15 in A549 cells, leading to increased TNF‑α‑stimulated secretion of IGFBP‑3 and type X collagen, a process that is attenuated when SOCS1 is overexpressed.",-28.875,0.01,geneorgeneproduct
"Transgenic A549 cells overexpressing casein kinase II phosphorylate IL‑15, thereby enhancing SOCS1‑mediated suppression of IGFBP‑3 transcription and reducing TTF‑1‑driven type X collagen expression in the transmembrane channel‑like gene‑1‑positive tumor microenvironment.",-26.625,0.01,geneorgeneproduct
"Transcriptional profiling of A549 cells treated with the IL‑15 analogue revealed that casein kinase II phosphorylates SOCS1, thereby attenuating TNF‑α‑stimulated STAT3 activation and reducing IGFBP‑3 expression.",-19.125,0.01,geneorgeneproduct
"Mutations in the transmembrane channel-like gene‑1 allele of *Homo sapiens* were found to up‑regulate IL‑15 expression, thereby enhancing SOCS1‑mediated suppression of TNF‑α‑stimulated NF‑κB signaling in A549 cells.",-29.625,0.01,geneorgeneproduct
"Mutational analysis of the transmembrane channel-like gene‑1 in A549 cells revealed that the BRCA1 c.68_69delAG variant enhances IL‑15‑induced STAT5 phosphorylation, thereby up‑regulating IGFBP‑3 expression and promoting resistance to TNF‑α‑stimulated apoptosis.",-28.875,0.01,geneorgeneproduct
"Mutagenesis of the transmembrane channel-like gene‑1 locus in A549 cells revealed that the resulting protein variant enhances IL‑15‑induced STAT5 phosphorylation, thereby amplifying SOCS1‑mediated suppression of TNF‑α‑stimulated NF‑κB activity.",-32.75,0.01,geneorgeneproduct
"Mutual inhibition between casein kinase II and SOCS1 reduces IL‑15‑induced STAT5 phosphorylation, thereby attenuating IGFBP‑3 expression in TTF‑1‑positive lung adenocarcinoma cells.",-20.375,0.01,geneorgeneproduct
"The hypoxia‑induced up‑regulation of IL‑15 in A549 cells is mediated by casein kinase II‑dependent phosphorylation of the transcription factor TTF‑1, which in turn enhances SOCS1 expression and suppresses IGFBP‑3 secretion, thereby promoting a pro‑survival phenotype in the tumor microenvironment.",-31.125,0.01,geneorgeneproduct
"The upregulation of IL‑15 in A549 cells leads to increased SOCS1 expression, which in turn suppresses the TNF‑α‑stimulated activation of casein kinase II and reduces IGFBP‑3 secretion.",-20.5,0.01,geneorgeneproduct
"The gain‑of‑function mutation in the transmembrane channel‑like gene‑1 locus of A549 cells enhances IL‑15‑induced STAT5 phosphorylation, thereby up‑regulating IGFBP‑3 expression and promoting resistance to TNF‑α‑stimulated apoptosis.",-26.625,0.01,geneorgeneproduct
"The casein kinase II-mediated phosphorylation of SOCS1 enhances its binding to the IL‑15 receptor β subunit, thereby attenuating downstream STAT5 activation in TTF‑1‑positive lung adenocarcinoma cells.",-15.125,0.01,geneorgeneproduct
"Mutation of the SOCS1 gene in A549 cells reduces IL‑15‑induced STAT5 phosphorylation, thereby attenuating the anti‑apoptotic signaling that normally protects these lung carcinoma cells from TNF‑α‑stimulated cell death.",-17.875,0.01,geneorgeneproduct
"Mutation in the transmembrane channel‑like gene‑1 allele of Homo sapiens was found to up‑regulate IL‑15 expression, thereby enhancing SOCS1‑mediated suppression of TNF‑alpha‑stimulated inflammatory signaling in cultured A549 cells.",-30.875,0.01,geneorgeneproduct
"Mutation‑induced loss of SOCS1 in A549 cells enhances IL‑15‑mediated STAT5 phosphorylation, thereby up‑regulating IGFBP‑3 expression and promoting resistance to TNF‑α‑stimulated apoptosis.",-20.25,0.01,geneorgeneproduct
"Mutation‐induced loss of SOCS1 in A549 cells enhances IL‑15‑driven STAT5 phosphorylation, thereby amplifying IGFBP‑3 secretion and accelerating type X collagen deposition in the tumor microenvironment.",-24.375,0.01,geneorgeneproduct
"Activation of the transmembrane channel‑like gene‑1 promoter by IL‑15 in A549 cells upregulates SOCS1 expression, thereby attenuating TNF‑α‑stimulated NF‑κB signaling and reducing type X collagen production in the tumor microenvironment.",-26.875,0.01,geneorgeneproduct
"Activation and phosphorylation of casein kinase II by IL‑15 in TTF‑1‑positive lung adenocarcinoma cells upregulates SOCS1, which in turn suppresses IGFBP‑3 expression and promotes transmembrane channel‑like gene‑1‑mediated calcium influx, thereby enhancing type X collagen production and tumor cell invasion.",-41.0,0.01,geneorgeneproduct
"Activation by IL‑15 of the STAT5 pathway in A549 cells upregulates SOCS1, which in turn suppresses IGFBP‑3 transcription and reduces type X collagen synthesis, thereby attenuating the pro‑fibrotic response mediated by TNF‑α‑stimulated TTF‑1.",-41.5,0.01,geneorgeneproduct
"Activation or inhibition of casein kinase II modulates IL‑15‑induced SOCS1 expression, thereby altering IGFBP‑3 secretion in TTF‑1‑positive lung adenocarcinoma cells.",-26.625,0.01,geneorgeneproduct
"In A549 cells, overexpression of the transmembrane channel‑like gene‑1 gene product enhances IL‑15‑induced STAT5 phosphorylation, thereby amplifying SOCS1‑mediated suppression of TNF‑α‑stimulated NF‑κB activity.",-22.75,0.01,geneorgeneproduct
"In HeLa cells, overexpression of the transmembrane channel-like gene‑1 gene product enhances IL‑15‑induced STAT5 phosphorylation, thereby amplifying SOCS1‑mediated suppression of TNF‑α‑stimulated NF‑κB activity.",-24.25,0.01,geneorgeneproduct
"In HepG2 cells, overexpression of the transmembrane channel‑like gene‑1 gene product enhances IL‑15‑induced STAT5 phosphorylation, thereby up‑regulating IGFBP‑3 transcription and promoting cell survival in the presence of TNF‑α‑stimulated apoptosis.",-28.0,0.01,geneorgeneproduct
"In MCF‑7 cells, overexpression of the transmembrane channel‑like gene‑1 gene product enhances IL‑15‑induced STAT5 phosphorylation, thereby amplifying SOCS1‑mediated suppression of TNF‑α‑stimulated NF‑κB activity.",-24.75,0.01,geneorgeneproduct
"Knocking out the transmembrane channel‑like gene‑1 in A549 cells markedly reduces IL‑15‑induced STAT5 phosphorylation, thereby attenuating the up‑regulation of SOCS1 and IGFBP‑3 that normally promotes tumor cell survival.",-29.75,0.01,geneorgeneproduct
"Knock‑down of casein kinase II in A549 cells reduces IL‑15‑induced SOCS1 expression, thereby enhancing IGFBP‑3 secretion and attenuating TTF‑1‑mediated type X collagen production in the transmembrane channel‑like gene‑1‑overexpressing tumor microenvironment.",-24.0,0.01,geneorgeneproduct
"Knocked‑out TTF‑1 in A549 cells reduces IL‑15‑induced SOCS1 expression, thereby enhancing IGFBP‑3‑mediated apoptosis of the tumor.",-26.0,0.01,geneorgeneproduct
"Knudson’s two‑hit hypothesis predicts that loss of the tumor suppressor gene TP53, combined with a missense mutation in the transmembrane channel‑like gene‑1 (TMC1) that disrupts calcium homeostasis, synergistically enhances the proliferative signaling of IL‑15‑stimulated T‑cells, thereby accelerating the progression of a TTF‑1‑positive lung adenocarcinoma.",-59.25,0.01,geneorgeneproduct
"Casein kinase II phosphorylates the transcription factor TTF‑1, thereby enhancing IL‑15 expression and subsequently up‑regulating SOCS1 to dampen TNF‑α‑stimulated inflammatory signaling in human macrophages.",-19.5,0.01,geneorgeneproduct
"Case‑in‑cell‑line HeLa, the IL‑15‑induced up‑regulation of SOCS1 transcription was confirmed by qRT‑PCR, revealing that the transmembrane channel‑like gene‑1 product interacts with IGFBP‑3 to modulate TNF‑α‑stimulated apoptosis.",-47.75,0.01,geneorgeneproduct
"Case1: The casein kinase II-mediated phosphorylation of SOCS1 enhances its ability to inhibit IL‑15‑induced STAT5 activation in TTF‑1‑positive lung adenocarcinoma cells, thereby reducing IGFBP‑3 expression and promoting type X collagen deposition in the tumor microenvironment.",-42.5,0.01,geneorgeneproduct
"Caseen kinase II phosphorylates the transcription factor TTF‑1, thereby enhancing IL‑15 expression and up‑regulating SOCS1, which in turn suppresses TNF‑α‑stimulated IGFBP‑3 production in transmembrane channel‑like gene‑1‑expressing cells.",-37.75,0.01,geneorgeneproduct
"TNF‑α‑stimulated upregulation of SOCS1 in A549 cells reduces IL‑15‑induced STAT5 phosphorylation, thereby attenuating IGFBP‑3 expression and limiting type X collagen deposition in the extracellular matrix.",-21.25,0.01,geneorgeneproduct
"TNFA‑stimulated IL‑15 expression in TTF‑1‑positive A549 cells is markedly attenuated by overexpression of SOCS1, which binds the IL‑15 receptor β‑chain and recruits casein kinase II to phosphorylate the downstream STAT5 pathway, thereby reducing IGFBP‑3 secretion and limiting type X collagen deposition in the tumor microenvironment.",-42.0,0.01,geneorgeneproduct
"TNFR‑associated factor‑2 (TRAF2) overexpression in A549 cells enhances IL‑15‑induced STAT5 phosphorylation, thereby up‑regulating IGFBP‑3 transcription and promoting resistance to TNF‑α‑stimulated apoptosis.",-28.75,0.01,geneorgeneproduct
"TNFB‑stimulated IL‑15 expression in TTF‑1‑positive A549 cells is markedly attenuated by the SOCS1‑induced degradation of casein kinase II, thereby reducing IGFBP‑3‑mediated proliferation of type X collagen‑producing osteoblasts.",-38.5,0.01,geneorgeneproduct
"Elevated IL‑15 expression in A549 cells activates SOCS1, which in turn down‑regulates IGFBP‑3 secretion and reduces type X collagen production, thereby impairing extracellular matrix remodeling in the tumor microenvironment.",-25.875,0.01,geneorgeneproduct
"Elevating IL‑15 levels in A549 cells upregulates SOCS1 expression, which in turn suppresses TNF‑α‑stimulated NF‑κB activation and reduces IGFBP‑3 secretion, thereby attenuating the pro‑inflammatory response mediated by the transmembrane channel‑like gene‑1 pathway.",-36.0,0.01,geneorgeneproduct
"Elevations of IL‑15 in the tumor microenvironment of A549 cells upregulate SOCS1, which in turn suppresses IGFBP‑3 transcription and enhances the expression of the transmembrane channel‑like gene‑1, thereby promoting resistance to TNF‑α‑stimulated apoptosis.",-37.5,0.01,geneorgeneproduct
"Elevational upregulation of IL‑15 in A549 cells activates SOCS1, which in turn suppresses IGFBP‑3 transcription, thereby enhancing cell proliferation and resistance to TNF‑α‑stimulated apoptosis.",-34.75,0.01,geneorgeneproduct
"IL‑15 up‑regulation by casein kinase II in TTF‑1‑positive A549 cells enhances SOCS1‑mediated suppression of TNF‑α‑stimulated IGFBP‑3 expression, thereby reducing type X collagen deposition in the transmembrane channel‑like gene‑1‑overexpressing tumor microenvironment.",-26.625,0.01,geneorgeneproduct
"IL-15 upregulation in the tumor microenvironment of TTF‑1‑positive lung adenocarcinoma cells activates SOCS1, which in turn suppresses casein kinase II‑mediated phosphorylation of IGFBP‑3, thereby enhancing TNF‑α‑stimulated apoptosis of the cancer cells.",-29.0,0.01,geneorgeneproduct
"IL‐15 upregulation in A549 cells activates SOCS1, which in turn suppresses IGFBP‑3 transcription, thereby enhancing type X collagen synthesis in the transmembrane channel‑like gene‑1‑expressing tumor microenvironment.",-36.25,0.01,geneorgeneproduct
"IL15 stimulation of HeLa cells upregulates SOCS1 expression, which in turn suppresses IGFBP3 transcription and reduces TTF‑1‑mediated type X collagen production in the transmembrane channel‑like gene‑1‑expressing tumor microenvironment.",-35.5,0.01,geneorgeneproduct
"Molecular analysis revealed that the transmembrane channel-like gene‑1 variant c.1123G>A in a patient with type X collagen deficiency upregulates IL‑15 expression, thereby enhancing SOCS1‑mediated suppression of TNF‑alpha‑stimulated IGFBP‑3 secretion in cultured fibroblasts.",-43.75,0.01,geneorgeneproduct
"Mice lacking the transmembrane channel‑like gene‑1 exhibit elevated IL‑15 production, which in turn up‑regulates SOCS1 expression and suppresses IGFBP‑3 secretion, thereby impairing insulin‑mediated glucose uptake in skeletal muscle.",-35.75,0.01,geneorgeneproduct
"Mature TTF‑1 transcriptionally activates the casein kinase II β‑subunit gene, and its loss in lung adenocarcinoma cells leads to reduced CK2 activity, thereby enhancing IL‑15‑induced SOCS1 expression and ultimately suppressing IGFBP‑3‑mediated anti‑proliferative signaling.",-47.5,0.01,geneorgeneproduct
"Mendelian inheritance of the BRCA1 c.68_69delAG variant in a family of Homo sapiens revealed that carriers exhibit increased expression of the tumor suppressor gene TP53, which in turn upregulates the cytokine IL‑15 and the suppressor of cytokine signaling protein SOCS1, thereby attenuating TNF‑α‑stimulated apoptosis in HeLa cells.",-44.75,0.01,geneorgeneproduct
"The loss‑of‑function mutation in XRCC3 reduces homologous recombination repair, thereby sensitizing A549 cells to the PI3K/AKT inhibitor LY294002 and enhancing apoptosis in response to doxorubicin.",-19.375,0.01,geneorgeneproduct
"The PI3K/AKT pathway, activated by TGF‑β1 signaling, up‑regulates FASN expression in cells harboring the ETV6‑NTRK3 fusion, thereby promoting lipid biosynthesis and tumor growth.",-17.375,0.01,geneorgeneproduct
"The phosphorylation of TGF‑β1 by PI3K/AKT signaling enhances ETV6‑NTRK3‑driven oncogenic transcription, thereby up‑regulating FASN expression and promoting tumor cell proliferation.",-19.0,0.01,geneorgeneproduct
"The gain‑of‑function ETV6‑NTRK3 fusion activates PI3K/AKT signaling, thereby up‑regulating FASN expression and promoting proliferation of TGF‑β1‑responsive breast cancer cells.",-18.75,0.01,geneorgeneproduct
"Activation of the PI3K/AKT pathway by the ETV6‑NTRK3 fusion protein in T‑cell acute lymphoblastic leukemia cells leads to up‑regulation of FASN, thereby promoting lipid biosynthesis and conferring resistance to the chemotherapeutic agent doxorubicin.",-21.375,0.01,geneorgeneproduct
"Activation by TGF‑β1 of the PI3K/AKT pathway in A549 cells carrying the ETV6‑NTRK3 fusion upregulates FASN expression, thereby enhancing fatty‑acid synthesis and promoting tumor cell proliferation.",-26.875,0.01,geneorgeneproduct
"Activation or loss of the ETV6‑NTRK3 fusion gene in a human breast carcinoma cell line upregulates phosphoinositide‑3‑kinase signaling, thereby increasing FASN expression and promoting resistance to the CYP2F1‑mediated metabolism of the chemotherapeutic agent doxorubicin.",-44.25,0.01,geneorgeneproduct
"Activation-induced phosphorylation of the PI3K/AKT pathway by TGF‑β1 in A549 cells carrying the ETV6‑NTRK3 fusion enhances FASN‑mediated lipogenesis, thereby promoting resistance to the CYP2F1‑derived metabolite of doxorubicin.",-35.75,0.01,geneorgeneproduct
"TGF‑β1‑induced activation of the PI3K/AKT pathway up‑regulates FASN expression in A549 cells, thereby enhancing lipid synthesis and promoting resistance to cisplatin.",-18.5,0.01,geneorgeneproduct
"TREATMENT: In A549 cells, the ETV6‑NTRK3 fusion protein activates PI3K/AKT signaling, leading to up‑regulation of FASN and down‑regulation of the sodium‑phosphate cotransporter type IIc, thereby promoting lipid biosynthesis and reducing phosphate uptake.",-31.0,0.01,geneorgeneproduct
"T cell activation in the tumor microenvironment is enhanced by the ETV6‑NTRK3 fusion, which up‑regulates PI3K/AKT signaling and induces FASN‑mediated lipogenesis, thereby promoting resistance to apoptosis in malignant B‑cell lines.",-38.25,0.01,geneorgeneproduct
"Tissue‑specific overexpression of the ETV6‑NTRK3 fusion in A549 cells activates PI3K/AKT signaling, up‑regulates FASN expression, and enhances resistance to doxorubicin, while simultaneously down‑regulating the sodium‑phosphate cotransporter type IIc and increasing XRCC3‑mediated DNA repair.",-37.0,0.01,geneorgeneproduct
"Altered phosphorylation of the phosphoinositide‑3‑kinase (PI3K)/protein kinase B pathway by the ETV6‑NTRK3 fusion protein in the TGF‑β1‑responsive A549 cell line leads to up‑regulation of FASN expression and down‑regulation of the sodium‑phosphate cotransporter type IIc, thereby promoting chemoresistance in a xenograft model of human lung carcinoma.",-38.25,0.01,geneorgeneproduct
"Alterations in the phosphoinositide‑3‑kinase/AKT signaling cascade, driven by the ETV6‑NTRK3 fusion, enhance FASN expression and up‑regulate the sodium‑phosphate cotransporter type IIc, thereby promoting tumor cell proliferation in TGF‑β1‑rich microenvironments.",-31.25,0.01,geneorgeneproduct
"Alteration of the phosphoinositide‑3‑kinase (PI3K)/protein kinase B pathway by the ETV6‑NTRK3 fusion protein leads to up‑regulation of FASN, thereby promoting lipid biosynthesis and conferring resistance to apoptosis in TGF‑β1‑stimulated tumor cells.",-31.0,0.01,geneorgeneproduct
"Alterantive splicing of the ATM/ATR kinases gene in A549 cells leads to a truncated protein that impairs DNA repair and increases sensitivity to doxorubicin, a chemotherapeutic chemical entity.",-35.75,0.01,geneorgeneproduct
"Phosphoinositide‑3‑kinase (PI3K)/protein kinase B signaling is up‑regulated by the ETV6‑NTRK3 fusion protein, thereby enhancing FASN‑involved lipogenesis in TGF‑β1‑stimulated tumor cells.",-22.25,0.01,geneorgeneproduct
Pharmacological inhibition of the phosphoinositide‑3‑kinase (PI3K)/protein kinase B pathway in A549 cells expressing the ETV6‑NTRK3 fusion protein markedly reduces FASN‑involved lipid synthesis and restores sensitivity to doxorubicin.,-29.25,0.01,geneorgeneproduct
"Phagocytic macrophages from the A549 cell line overexpressing the ETV6‑NTRK3 fusion exhibit hyperactivation of the PI3K/AKT pathway, which in turn upregulates FASN expression and enhances the synthesis of phosphatidylinositol lipids that facilitate the internalization of the sodium‑phosphate cotransporter type IIc.",-45.75,0.01,geneorgeneproduct
"Phos­phoinositide‑3‑kinase (PI3K) activation by the ETV6‑NTRK3 fusion protein in a TGF‑β1‑rich microenvironment drives FASN‑mediated lipogenesis, thereby enhancing the proliferation of A549 cells that overexpress the sodium‑phosphate cotransporter type IIc and exhibit increased CYP2F1 expression.",-45.5,0.01,geneorgeneproduct
"Mutational activation of the ETV6‑NTRK3 fusion gene in a patient’s tumor leads to hyperactivation of the PI3K/AKT signaling cascade, thereby up‑regulating FASN expression and promoting lipid biosynthesis that supports rapid tumor growth.",-29.375,0.01,geneorgeneproduct
"Mutations in the XRCC3 gene that impair homologous recombination increase the sensitivity of A549 cells to the PI3K/AKT pathway inhibitor LY294002, thereby enhancing apoptosis in response to cisplatin.",-19.75,0.01,geneorgeneproduct
"Mutant ETV6‑NTRK3 fusion protein activates phosphoinositide‑3‑kinase/AKT signaling, thereby up‑regulating FASN expression and promoting proliferation of TGF‑β1‑responsive breast cancer cells.",-22.625,0.01,geneorgeneproduct
"Mutating the XRCC3 gene in HeLa cells reduces the phosphorylation of ATM/ATR kinases, thereby impairing the DNA damage response to cisplatin.",-22.75,0.01,geneorgeneproduct
"Deletion of the XRCC3 gene in A549 cells reduces phosphoinositide‑3‑kinase/AKT signaling and increases sensitivity to cisplatin, suggesting that XRCC3 loss enhances DNA repair deficiency and chemotherapeutic response.",-30.25,0.01,geneorgeneproduct
"Deletion in the XRCC3 gene reduces homologous recombination efficiency, thereby increasing the risk of breast cancer in patients carrying the BRCA1 c.68_69delAG variant.",-26.25,0.01,geneorgeneproduct
"Deletion within the XRCC3 gene that creates a BRCA1 c.68_69delAG variant reduces homologous recombination repair, thereby increasing sensitivity of A549 cells to the PI3K/AKT inhibitor LY294002 and enhancing apoptosis in a xenograft model of non‑small‑cell lung carcinoma.",-42.75,0.01,geneorgeneproduct
"Deletion or loss‑of‑function of the ATM/ATR kinase pathway in A549 cells leads to up‑regulation of the phosphoinositide‑3‑kinase/AKT signaling cascade, thereby enhancing FASN‑mediated lipogenesis and conferring resistance to doxorubicin.",-41.75,0.01,geneorgeneproduct
"In A549 cells, the ETV6‑NTRK3 fusion protein activates PI3K/AKT signaling, upregulating FASN expression and enhancing proliferation while simultaneously downregulating the sodium‑phosphate cotransporter type IIc, thereby contributing to chemoresistance in non‑small‑cell lung carcinoma.",-21.625,0.01,geneorgeneproduct
"In HeLa cells, the ETV6‑NTRK3 fusion protein activates PI3K/AKT signaling, upregulating FASN expression and enhancing proliferation while simultaneously downregulating the sodium‑phosphate cotransporter type IIc, thereby contributing to chemoresistance.",-21.0,0.01,geneorgeneproduct
"In CRISPR‑edited A549 cells, the ETV6‑NTRK3 fusion protein activates PI3K/AKT signaling, upregulating FASN expression and enhancing proliferation while simultaneously downregulating MHC class I surface levels.",-26.5,0.01,geneorgeneproduct
"In KRAS‑mutant A549 cells, the ETV6‑NTRK3 fusion protein activates PI3K/AKT signaling, upregulates FASN expression, and enhances the phosphorylation of ATM/ATR kinases, thereby promoting resistance to cisplatin-induced apoptosis.",-22.375,0.01,geneorgeneproduct
"Mutation of XRCC3 in A549 cells reduces the repair of double‑strand breaks induced by doxorubicin, thereby enhancing apoptosis through the PI3K/AKT pathway.",-18.625,0.01,geneorgeneproduct
Mutation in the XRCC3 gene that reduces its DNA repair activity enhances the cytotoxicity of doxorubicin in A549 cells by increasing PI3K/AKT‑mediated apoptosis.,-23.125,0.01,geneorgeneproduct
"Mutation‑induced loss of ATM/ATR kinase activity in the TP53‑deficient A549 cell line leads to impaired DNA repair and increased sensitivity to the PI3K/AKT‑activating drug doxorubicin, thereby enhancing apoptosis in Homo sapiens tumor cells.",-33.75,0.01,geneorgeneproduct
"Mutation‐induced loss of ATM kinase activity in the TP53‑deficient A549 cell line leads to impaired DNA repair and increased sensitivity to the PI3K/AKT pathway inhibitor LY294002, thereby enhancing apoptosis in response to doxorubicin treatment.",-35.25,0.01,geneorgeneproduct
"A CRISPR‑mediated knockout of the XRCC3 gene in A549 cells markedly reduces PI3K/AKT signaling, thereby sensitizing the cells to doxorubicin‑induced apoptosis.",-21.125,0.01,geneorgeneproduct
"A VHL‑mutated renal carcinoma cell line treated with the PI3K/AKT inhibitor LY294002 showed a marked decrease in FASN‑mediated lipogenesis, confirming that PI3K/AKT signaling drives FASN expression in VHL‑deficient tumors.",-30.5,0.01,geneorgeneproduct
"A functional study revealed that the ETV6‑NTRK3 fusion protein activates the PI3K/AKT signaling cascade, thereby up‑regulating FASN expression and promoting proliferation of the human breast cancer cell line MCF‑7.",-22.5,0.01,geneorgeneproduct
"A mutation in the XRCC3 gene that reduces its DNA repair activity enhances the sensitivity of HeLa cells to the PI3K/AKT pathway inhibitor LY294002, thereby increasing apoptosis in response to doxorubicin treatment.",-22.125,0.01,geneorgeneproduct
"Expression of the ETV6‑NTRK3 fusion protein activates PI3K/AKT signaling, thereby up‑regulating FASN expression and promoting proliferation of TGF‑β1‑responsive tumor cells.",-16.25,0.01,geneorgeneproduct
"Expression analysis revealed that the ETV6‑NTRK3 fusion protein activates PI3K/AKT signaling, thereby up‑regulating FASN expression and promoting proliferation of the A549 cell line.",-21.625,0.01,geneorgeneproduct
"Expression profiling revealed that the ETV6‑NTRK3 fusion protein activates PI3K/AKT signaling, upregulates FASN expression, and induces down‑regulation of the sodium‑phosphate cotransporter type IIc in the TGF‑β1‑responsive A549 cell line.",-28.25,0.01,geneorgeneproduct
"Expression level of the TGF‑β1 gene product is markedly up‑regulated in A549 cells harboring the ETV6‑NTRK3 fusion, thereby activating the PI3K/AKT signaling cascade and enhancing FASN‑mediated lipogenesis.",-29.75,0.01,geneorgeneproduct
"ETV6‑NTRK3 fusion activates phosphoinositide‑3‑kinase/AKT signaling, thereby up‑regulating FASN expression and promoting proliferation of TGF‑β1‑responsive tumor cells.",-19.75,0.01,geneorgeneproduct
"Ectopic expression of the ETV6‑NTRK3 fusion in A549 cells activates PI3K/AKT signaling, upregulates FASN, and induces phosphorylation of ATM/ATR kinases, thereby enhancing DNA repair and conferring resistance to doxorubicin.",-20.25,0.01,geneorgeneproduct
"Etkimab, a monoclonal antibody targeting TGF‑β1, markedly reduced tumor‑associated fibrosis in A549 cells by inhibiting PI3K/AKT signaling and down‑regulating FASN expression, thereby sensitizing the cells to cisplatin.",-31.75,0.01,geneorgeneproduct
"EGR1 transcription is up‑regulated by TGF‑β1 in A549 cells, where it subsequently enhances PI3K/AKT signaling and induces FASN expression, thereby promoting lipid biosynthesis and cell proliferation.",-29.25,0.01,geneorgeneproduct
"Overexpression of the ETV6‑NTRK3 fusion protein in HeLa cells activates PI3K/AKT signaling, upregulates FASN expression, and enhances proliferation while simultaneously downregulating the sodium‑phosphate cotransporter type IIc, thereby promoting a metabolic shift that supports tumor growth.",-28.0,0.01,geneorgeneproduct
"Overexpressed TGF‑β1 in A549 cells activates PI3K/AKT signaling, thereby up‑regulating FASN expression and promoting lipid‑rich tumor growth.",-20.875,0.01,geneorgeneproduct
"Overactivation of the PI3K/AKT pathway by the ETV6‑NTRK3 fusion protein in a TGF‑β1‑rich tumor microenvironment drives FASN‑dependent lipogenesis, thereby promoting resistance to apoptosis in cells lacking functional ATM/ATR kinases.",-30.125,0.01,geneorgeneproduct
"Over a two‑week period, the TGF‑β1‑induced up‑regulation of the sodium‑phosphate cotransporter type IIc in A549 cells was markedly attenuated by the PI3K/AKT inhibitor LY294002, suggesting that PI3K/AKT signaling mediates TGF‑β1‑dependent phosphate transport in this lung carcinoma line.",-36.0,0.01,geneorgeneproduct
"Knocking‑down the phosphoinositide‑3‑kinase (PI3K)/protein kinase B pathway in A549 cells expressing the ETV6‑NTRK3 fusion protein markedly reduces FASN‑involved lipid synthesis, thereby sensitizing the cells to the TGF‑β1‑induced apoptotic response.",-30.0,0.01,geneorgeneproduct
"Knock‑in of the ETV6‑NTRK3 fusion in A549 cells activates PI3K/AKT signaling, up‑regulates FASN expression, and enhances resistance to doxorubicin, while simultaneously down‑regulating the sodium‑phosphate cotransporter type IIc and increasing XRCC3‑mediated DNA repair.",-24.375,0.01,geneorgeneproduct
"Knocks‑down of the ETV6‑NTRK3 fusion in the MCF‑7 cell line markedly reduces PI3K/AKT signaling, thereby sensitizing the cells to the FASN inhibitor cerulenin and inducing apoptosis through up‑regulation of the ATM/ATR‑mediated DNA damage response.",-41.25,0.01,geneorgeneproduct
"Knocked‑in A549 cells expressing the ETV6‑NTRK3 fusion exhibit hyperactivation of the PI3K/AKT pathway, leading to up‑regulation of FASN and increased proliferation, while CRISPR‑mediated disruption of XRCC3 in the same line sensitizes them to cisplatin‑induced DNA damage.",-34.0,0.01,geneorgeneproduct
"The upregulation of PP2C‑alpha in DACH1‑nonexpressing HeLa cells enhances phosphodiesterase‑4D activity, thereby reducing cAMP‑dependent signaling and promoting Caspase‑8‑mediated apoptosis through the ESCRT‑III pathway.",-24.875,0.01,geneorgeneproduct
"The hypo‑phosphorylated form of CAMK2N1, when overexpressed in DACH1‑negative HeLa cells, activates PP2C‑α to dephosphorylate phosphodiesterase‑4D, thereby enhancing Caspase‑8‑mediated apoptosis through the ESCRT‑III pathway and reducing L‑FABP‑driven lipid accumulation.",-33.25,0.01,geneorgeneproduct
"The Caspase‑8‑mediated cleavage of L‑FABP in DACH1‑nonexpressing HeLa cells is amplified by phosphodiesterase‑4D inhibition, thereby enhancing apoptosis in the presence of the PP2C‑α‑dependent stress response.",-29.25,0.01,geneorgeneproduct
"The loss of DACH1 in HeLa cells upregulates phosphodiesterase‑4D, which in turn enhances cAMP‑dependent activation of PP2C‑α, ultimately promoting Caspase‑8‑mediated apoptosis and accelerating the degradation of the endosomal sorting complex required for transport (ESCRT)‑III components.",-33.25,0.01,geneorgeneproduct
"Activation of the phosphodiesterase‑4D pathway in L‑FABP‑positive HepG2 cells leads to increased cAMP degradation, which in turn suppresses the transcription of the tumor‑suppressor gene CAMK2N1 and enhances Caspase‑8‑mediated apoptosis in the presence of the PAR2‑deficiency‑induced inflammatory milieu.",-38.25,0.01,geneorgeneproduct
"Activation‑induced up‑regulation of the phosphodiesterase‑4D gene in L‑FABP‑positive HepG2 cells was attenuated by the DACH1‑nonexpressing phenotype, suggesting a regulatory role for PP2C‑alpha in the cAMP‑dependent signaling cascade that controls Caspase‑8‑mediated apoptosis.",-50.0,0.01,geneorgeneproduct
"Activation-mediated up‑regulation of the phosphodiesterase‑4D gene in L‑FABP‑positive HepG2 cells was found to suppress the caspase‑8‑driven apoptotic cascade, thereby enhancing cell survival in a DACH1‑nonexpressing, PP2C‑alpha‑deficient microenvironment.",-54.0,0.01,geneorgeneproduct
"Activation by the L‑FABP‑mediated uptake of fatty acids in HepG2 cells upregulates the transcription of the phosphodiesterase‑4D gene, which in turn increases cAMP degradation and attenuates the pro‑apoptotic signaling of Caspase‑8 in a PP2C‑α‑dependent manner.",-48.0,0.01,geneorgeneproduct
"A knock‑in of the BRCA1 c.68_69delAG variant in A549 cells reduces the expression of the DNA‑repair gene TP53, thereby increasing sensitivity to the chemotherapeutic agent doxorubicin and enhancing apoptosis mediated by Caspase‑8.",-29.75,0.01,geneorgeneproduct
"APP2C‑α phosphorylation of the transcription factor DACH1‑nonexpressing in HeLa cells down‑regulates phosphodiesterase‑4D expression, thereby enhancing Caspase‑8‑mediated apoptosis and promoting ESCRT‑III‑dependent membrane repair in the presence of L‑FABP‑rich lipid droplets.",-37.5,0.01,geneorgeneproduct
"A knockout of the PP2C‑α gene in A549 cells leads to up‑regulation of phosphodiesterase‑4D, which in turn enhances Caspase‑8‑mediated apoptosis and reduces the expression of the endosomal sorting complex required for transport (ESCRT)‑III component, thereby sensitizing the cells to L‑FABP‑induced oxidative stress.",-38.25,0.01,geneorgeneproduct
"A CAMK2N1 knockout in A549 cells upregulates phosphodiesterase‑4D, leading to increased cAMP degradation and attenuated ERK signaling, thereby reducing proliferation of the cancerous phenotype.",-36.25,0.01,geneorgeneproduct
"Caspase‑8 activation in DACH1‑nonexpressing HeLa cells is amplified by phosphodiesterase‑4D inhibition, leading to enhanced apoptosis and up‑regulation of the endosomal sorting complex required for transport‑III component L‑FABP.",-20.75,0.01,geneorgeneproduct
"Cytokine‑induced activation of phosphodiesterase‑4D in L‑FABP‑positive HepG2 cells leads to a rapid decrease in cAMP, which in turn down‑regulates the transcription of the tumor‑suppressor gene BCL6, a process that is further amplified by the loss of DACH1‑mediated repression of the PP2C‑α phosphatase.",-43.5,0.01,geneorgeneproduct
"Cyclic AMP‑dependent protein kinase type II regulatory subunit alpha (PRKAR2A) is transcriptionally repressed by DACH1‑nonexpressing cells, thereby enhancing phosphodiesterase‑4D activity and reducing Caspase‑8‑mediated apoptosis in L‑FABP‑positive HepG2 cells.",-36.5,0.01,geneorgeneproduct
"Castration‑induced up‑regulation of phosphodiesterase‑4D in the prostate of DACH1‑deficient mice leads to increased cAMP degradation, thereby attenuating the anti‑androgenic effect of enzalutamide on the androgen receptor‑driven expression of the tumor suppressor gene L‑FABP.",-48.25,0.01,geneorgeneproduct
"Knock‑down of the phosphodiesterase‑4D gene in A549 cells expressing the DACH1‑nonexpressing variant of CAMK2N1 markedly increases Caspase‑8‑mediated apoptosis, a process that is further amplified by the loss of PP2C‑alpha activity and the disruption of the ESCRT‑III complex in the endosomal sorting pathway.",-40.5,0.01,geneorgeneproduct
"Knocking out the PP2C‑α gene in A549 cells markedly increases phosphodiesterase‑4D expression, thereby enhancing cAMP‑dependent signaling that ultimately promotes apoptosis via Caspase‑8 activation.",-27.125,0.01,geneorgeneproduct
"Knocked‑out Caspase‑8 in A549 cells expressing the DACH1‑nonexpressing variant of CAMK2N1 markedly up‑regulated phosphodiesterase‑4D, thereby enhancing the endosomal sorting complex required for transport (ESCRT)‑III‑mediated degradation of L‑FABP and reducing the proliferation of the tumor cells.",-46.5,0.01,geneorgeneproduct
"Knox et al. demonstrated that in DACH1‑nonexpressing HeLa cells, the loss of PP2C‑alpha activity leads to hyperphosphorylation of CAMK2N1, which in turn activates phosphodiesterase‑4D and triggers Caspase‑8‑mediated apoptosis through the ESCRT‑III pathway, a mechanism that is absent in L‑FABP‑overexpressing A549 cells.",-47.5,0.01,geneorgeneproduct
"Deficiency of PAR2 in A549 cells leads to up‑regulation of phosphodiesterase‑4D, which in turn reduces cAMP levels and enhances Caspase‑8‑mediated apoptosis, a process that is further amplified by the loss of DACH1‑mediated repression of the L‑FABP promoter.",-30.25,0.01,geneorgeneproduct
"Defective PP2C‑α in DACH1‑nonexpressing HeLa cells enhances phosphodiesterase‑4D activity, thereby reducing cAMP‑dependent activation of Caspase‑8 and impairing apoptosis of L‑FABP‑positive tumor cells.",-31.375,0.01,geneorgeneproduct
"Deficient PAR2 signaling in L‑FABP‑overexpressing A549 cells enhances PP2C‑α‑mediated phosphorylation of CAMK2N1, thereby attenuating caspase‑8 activation during endosomal sorting complex required for transport‑III–driven apoptosis.",-25.125,0.01,geneorgeneproduct
"Defects in the endosomal sorting complex required for transport (ESCRT)-III component CHMP2B, together with loss of DACH1 expression, synergistically enhance Caspase‑8‑mediated apoptosis in HeLa cells treated with the phosphodiesterase‑4D inhibitor rolipram.",-30.625,0.01,geneorgeneproduct
"In HeLa cells, the loss of DACH1 expression upregulates phosphodiesterase‑4D, which in turn enhances cAMP degradation and suppresses the transcription of the tumor‑suppressor gene CAMK2N1, thereby promoting cell proliferation.",-27.25,0.01,geneorgeneproduct
"In BCL6‑overexpressing A549 cells, the loss of DACH1‑nonexpressing activity upregulates phosphodiesterase‑4D, which in turn enhances PP2C‑alpha‑mediated dephosphorylation of CAMK2N1, ultimately promoting Caspase‑8‑driven apoptosis through ESCRT‑III‑dependent endosomal sorting.",-34.25,0.01,geneorgeneproduct
"In DACH1‑nonexpressing HeLa cells, the loss of PP2C‑alpha activity enhances phosphodiesterase‑4D‑mediated cAMP degradation, thereby amplifying Caspase‑8‑driven apoptosis and accelerating the recruitment of the ESCRT‑III complex to facilitate plasma‑membrane repair.",-27.125,0.01,geneorgeneproduct
"In HepG2 cells, the loss of DACH1 expression up‑regulates phosphodiesterase‑4D, which in turn increases cAMP degradation and suppresses the transcription of the tumor‑suppressor gene CAMK2N1, thereby enhancing cell proliferation.",-28.0,0.01,geneorgeneproduct
"Mutations in the CAMK2N1 gene that reduce its expression in DACH1‑negative breast cancer cells lead to hyperactivation of phosphodiesterase‑4D, which in turn elevates cyclic‑AMP levels and enhances Caspase‑8‑mediated apoptosis through the ESCRT‑III pathway.",-30.875,0.01,geneorgeneproduct
"Mutational loss of CAMK2N1 in A549 cells enhances phosphodiesterase‑4D expression, thereby amplifying cAMP‑dependent signaling that ultimately up‑regulates the tumor‑suppressor gene BCL6 and promotes apoptosis via Caspase‑8 activation.",-33.0,0.01,geneorgeneproduct
"Mutual inhibition between the tumor suppressor DACH1 and the phosphodiesterase PDE4D in HeLa cells leads to up‑regulation of the pro‑apoptotic gene CASP8, thereby enhancing caspase‑mediated apoptosis in response to doxorubicin treatment.",-34.5,0.01,geneorgeneproduct
"Mutant CAMK2N1, which lacks the regulatory autoinhibitory domain, activates PP2C‑α to dephosphorylate phosphodiesterase‑4D, thereby enhancing Caspase‑8‑mediated apoptosis in DACH1‑negative breast cancer cells.",-29.75,0.01,geneorgeneproduct
"PP2C‑alpha phosphorylation of CAMK2N1 in DACH1‑negative A549 cells reduces phosphodiesterase‑4D expression, thereby enhancing Caspase‑8‑mediated apoptosis through the ESCRT‑III‑dependent release of L‑FABP‑containing exosomes.",-29.75,0.01,geneorgeneproduct
"PP1α dephosphorylates CAMK2N1, thereby relieving its inhibition of CaMKII activity in L‑FABP‑positive HepG2 cells, while PP2C‑α simultaneously promotes Caspase‑8‑mediated apoptosis through the ESCRT‑III pathway.",-38.0,0.01,geneorgeneproduct
"PPARγ activation in L‑FABP‑expressing HepG2 cells down‑regulates phosphodiesterase‑4D, thereby increasing cAMP levels that enhance Caspase‑8‑mediated apoptosis while simultaneously suppressing the ESCRT‑III‑dependent release of extracellular vesicles.",-34.5,0.01,geneorgeneproduct
"PPARG activation in L‑FABP‑expressing HepG2 cells down‑regulates phosphodiesterase‑4D, thereby increasing cAMP levels that enhance Caspase‑8‑mediated apoptosis and promote ESCRT‑III‑dependent autophagic clearance of misfolded proteins.",-38.0,0.01,geneorgeneproduct
"P2Y12 receptor activation in L‑FABP‑positive macrophages enhances PP2C‑α‑mediated dephosphorylation of CAMK2N1, thereby attenuating Caspase‑8‑driven apoptosis in DACH1‑nonexpressing colorectal cancer cells.",-28.125,0.01,geneorgeneproduct
"Pseudomonas aeruginosa infection in a patient with a BRCA1 c.68_69delAG variant led to up‑regulation of the phosphodiesterase‑4D gene, which in turn activated Caspase‑8 and triggered apoptosis of the infected epithelial cells.",-37.5,0.01,geneorgeneproduct
"P‑caspase‑8 activation in DACH1‑negative HeLa cells leads to cleavage of phosphodiesterase‑4D, thereby enhancing cAMP‑dependent signaling that ultimately up‑regulates the expression of the fatty‑acid‑binding protein L‑FABP.",-37.0,0.01,geneorgeneproduct
"P3H1 mutations in the L‑FABP gene, which are frequently observed in Homo sapiens patients with hyperlipidemia, were shown to disrupt the interaction between PP2C‑alpha and phosphodiesterase‑4D, thereby enhancing Caspase‑8‑mediated apoptosis in cultured A549 cells.",-50.75,0.01,geneorgeneproduct
"DACH1‑nonexpressing HeLa cells exhibit reduced PP2C‑alpha activity, leading to hyperphosphorylation of CAMK2N1 and enhanced caspase‑8‑mediated apoptosis.",-16.125,0.01,geneorgeneproduct
"DCC‑mediated axon guidance is disrupted in PP2C‑alpha‑deficient A549 cells, leading to aberrant activation of phosphodiesterase‑4D and Caspase‑8‑driven apoptosis that is rescued by overexpression of the L‑FABP‑regulated ESCRT‑III complex.",-52.25,0.01,geneorgeneproduct
"Dysregulation of the PP2C‑α phosphatase in DACH1‑negative HeLa cells enhances phosphodiesterase‑4D activity, thereby reducing cAMP‑dependent activation of Caspase‑8 and impairing apoptosis in the presence of the endosomal sorting complex required for transport‑III (ESCRT‑III) component L‑FABP.",-38.5,0.01,geneorgeneproduct
"Diminished expression of the tumor suppressor DACH1 in HeLa cells leads to up‑regulation of phosphodiesterase‑4D, which in turn reduces cAMP levels and enhances Caspase‑8‑mediated apoptosis, a process that is further amplified by the loss of PAR2 signaling in the endosomal sorting complex required for transport (ESCRT‑III) pathway.",-42.75,0.01,geneorgeneproduct
"Loss of DACH1 in HeLa cells upregulates phosphodiesterase‑4D expression, thereby increasing cAMP degradation and attenuating the anti‑apoptotic signaling mediated by Caspase‑8 in response to TNF‑α.",-27.875,0.01,geneorgeneproduct
"Loss‑of‑function mutations in the PP2C‑α gene, which normally dephosphorylates CAMK2N1, lead to hyperactivation of the phosphodiesterase‑4D signaling cascade and increased Caspase‑8‑mediated apoptosis in L‑FABP‑positive hepatocytes, thereby contributing to the development of non‑alcoholic steatohepatitis in patients with the endosomal sorting complex required for transport (ESCRT)‑III deficiency.",-43.25,0.01,geneorgeneproduct
"Loss-of-function mutations in the PP2C‑α gene in Homo sapiens lead to hyperactivation of the phosphodiesterase‑4D signaling cascade, which in turn up‑regulates the expression of the apoptosis‑initiator Caspase‑8 and enhances the recruitment of the endosomal sorting complex required for transport (ESCRT)‑III to the plasma membrane, thereby promoting cell‑death pathways in cultured A549 cells.",-50.25,0.01,geneorgeneproduct
"Loss‐of‑function mutations in the PP2C‑α gene, which normally dephosphorylates CAMK2N1, lead to hyperactivation of the phosphodiesterase‑4D signaling cascade and increased Caspase‑8‑mediated apoptosis in L‑FABP‑positive hepatocytes, thereby contributing to the progression of non‑alcoholic steatohepatitis in patients with the BCL‑6‑deficient phenotype.",-48.25,0.01,geneorgeneproduct
"Phosphodiesterase‑4D inhibition in DACH1‑nonexpressing A549 cells up‑regulates L‑FABP transcription, thereby enhancing fatty‑acid oxidation and attenuating Caspase‑8‑mediated apoptosis in a PP2C‑α‑dependent manner.",-26.375,0.01,geneorgeneproduct
"Pharmacological inhibition of phosphodiesterase‑4D in A549 cells overexpressing CAMK2N1 reduces Caspase‑8‑mediated apoptosis, thereby enhancing cell survival in a model of L‑FABP‑deficient hepatocytes.",-31.125,0.01,geneorgeneproduct
"Pharmaceutical inhibition of phosphodiesterase‑4D in A549 cells overexpressing CAMK2N1 reduces Caspase‑8‑mediated apoptosis, thereby enhancing cell survival in a DACH1‑nonexpressing, PP2C‑α‑deficient microenvironment.",-39.75,0.01,geneorgeneproduct
"Phytochemical treatment of A549 cells with the phosphodiesterase‑4D inhibitor roflumilast down‑regulates the expression of the tumor‑suppressor gene DACH1, thereby enhancing the apoptotic activity of Caspase‑8 and promoting the recruitment of the endosomal sorting complex required for transport (ESCRT‑III) to the plasma membrane in a manner that is dependent on the presence of the L‑FABP‑mediated fatty‑acid transport pathway.",-59.0,0.01,geneorgeneproduct
"Deletion of the CAMK2N1 promoter in A549 cells upregulates phosphodiesterase‑4D expression, thereby enhancing cAMP degradation and attenuating the anti‑apoptotic signaling mediated by BCL‑6.",-25.625,0.01,geneorgeneproduct
"Deletion‐induced loss of CAMK2N1 expression in DACH1‑negative A549 cells upregulates phosphodiesterase‑4D, thereby enhancing cAMP degradation and attenuating Caspase‑8‑mediated apoptosis while simultaneously impairing ESCRT‑III‑dependent endosomal sorting.",-41.5,0.01,geneorgeneproduct
"Deletion in the BRCA1 c.68_69delAG sequence variant reduces TP53 expression in HeLa cells, leading to increased apoptosis mediated by Caspase‑8 and altered phosphodiesterase‑4D activity in Homo sapiens.",-32.25,0.01,geneorgeneproduct
"Deletion c.68_69delAG in the TP53 gene of a HeLa cell line carrying a DACH1‑negative background reduces phosphodiesterase‑4D expression, thereby enhancing Caspase‑8‑mediated apoptosis in response to doxorubicin.",-35.75,0.01,geneorgeneproduct
"The IRS‑2‑mediated activation of the PI3K/AKT pathway in HeLa cells upregulates glutathione peroxidase expression, thereby enhancing resistance to hydrogen‑peroxide‑induced apoptosis.",-18.0,0.01,geneorgeneproduct
"The reduction of IRS‑2 expression in HeLa cells treated with the CB1 receptor agonist WIN‑55,212‑2 was accompanied by a marked increase in glutathione peroxidase activity, suggesting a compensatory antioxidant response to the impaired insulin signaling pathway.",-28.25,0.01,geneorgeneproduct
"The p65/p50 complex upregulates CSF‑1 transcription in macrophages, thereby enhancing IL‑2‑mediated T‑cell proliferation and simultaneously stimulating IRS‑2‑dependent insulin signaling through the InsR pathway.",-25.375,0.01,geneorgeneproduct
"The knock‑in of the BRCA1 c.68_69delAG variant in A549 cells markedly reduces glutathione peroxidase activity, thereby increasing ROS‑induced apoptosis that is partially rescued by IL‑2‑mediated activation of the p65/p50 NF‑κB pathway.",-23.125,0.01,geneorgeneproduct
"In A549 cells, the IRS‑2‑mediated activation of the PI3K/AKT pathway enhances CB1 receptor‑dependent glutathione peroxidase expression, thereby attenuating IL‑2‑induced oxidative stress and promoting cell survival.",-20.625,0.01,geneorgeneproduct
"In IL‑2‑stimulated Jurkat T cells, the CB1 receptor agonist WIN‑55,212‑2 suppresses IRS‑2 phosphorylation, thereby attenuating downstream InsR‑mediated PI3K/Akt signaling and reducing glutathione peroxidase expression while concurrently enhancing NF‑κB (p65/p50) nuclear translocation that up‑regulates CSF‑1 transcription.",-31.0,0.01,geneorgeneproduct
"In HeLa cells, overexpression of the transcription factor ARX enhances IL‑2 production, which in turn activates the p65/p50 NF‑κB complex to upregulate CSF‑1 expression, thereby promoting autocrine signaling that stimulates insulin receptor (InsR) phosphorylation and downstream GSK‑3β inhibition.",-23.0,0.01,geneorgeneproduct
"In the A549 cell line, overexpression of the insulin receptor (InsR) enhances IRS‑2 phosphorylation, which in turn activates the PI3K/Akt pathway and up‑regulates glutathione peroxidase expression, thereby reducing reactive oxygen species and protecting the cells from doxorubicin‑induced apoptosis.",-26.875,0.01,geneorgeneproduct
"Loss of the ARX transcription factor in the developing cortex leads to reduced expression of the insulin receptor (InsR) and the cytokine CSF‑1, thereby impairing neuronal survival and increasing susceptibility to neurodegeneration.",-27.75,0.01,geneorgeneproduct
"Loss‑of‑function mutations in the ARX gene disrupt the transcriptional activation of the insulin receptor (InsR) promoter, thereby reducing IRS‑2 expression and impairing downstream p65/p50‑mediated NF‑κB signaling in pancreatic β‑cells.",-24.75,0.01,geneorgeneproduct
"Loss-of-function mutations in the ARX gene disrupt the transcriptional activation of insulin receptor (InsR) and glutathione peroxidase, thereby impairing IRS‑2‑mediated PI3K/Akt signaling and increasing susceptibility to neurodegeneration.",-27.75,0.01,geneorgeneproduct
"Losses of the ARX transcription factor in the developing cortex lead to reduced expression of the insulin receptor (InsR) and the cytokine CSF‑1, thereby impairing neuronal survival and increasing susceptibility to neurodegenerative disease.",-38.25,0.01,geneorgeneproduct
"Insulin receptor (InsR) activation in HeLa cells upregulates IRS‑2 expression, which in turn enhances IL‑2‑mediated STAT5 signaling and promotes proliferation of the A549 cell line.",-25.875,0.01,geneorgeneproduct
"InsR activation in HeLa cells upregulates CSF‑1 transcription through a p65/p50‑dependent NF‑κB pathway, thereby enhancing IL‑2‑mediated proliferation of the tumor‑derived immune microenvironment.",-24.875,0.01,geneorgeneproduct
"Insufficient activation of the IRS‑2/InsR signaling axis in A549 cells treated with the CB1 receptor agonist JWH‑133 leads to reduced phosphorylation of GSK‑3β, thereby enhancing p65/p50‑mediated transcription of the pro‑inflammatory cytokine IL‑2.",-34.25,0.01,geneorgeneproduct
"Insensitivity to insulin in the IRS‑2‑deficient A549 cell line is exacerbated by CSF‑1‑mediated activation of the NF‑κB p65/p50 complex, which in turn up‑regulates GSK‑3β expression and further impairs InsR signaling.",-36.5,0.01,geneorgeneproduct
"Mutational loss of the ARX gene in human pancreatic β‑cells down‑regulates insulin receptor (InsR) expression, thereby impairing IRS‑2‑mediated PI3K signaling and reducing glucose‑stimulated insulin secretion.",-22.5,0.01,geneorgeneproduct
"Mutations in the ARX gene that reduce glutathione peroxidase activity impair insulin receptor signaling in pancreatic β‑cells, thereby enhancing IL‑2‑mediated activation of the NF‑κB p65/p50 complex and promoting β‑cell apoptosis.",-23.5,0.01,geneorgeneproduct
"Mutagenic exposure of A549 cells to doxorubicin induces a rapid up‑regulation of the transcription factor p65/p50, which in turn enhances CSF‑1 expression and activates the InsR‑IRS‑2 signaling cascade, ultimately promoting cell survival and drug resistance.",-29.625,0.01,geneorgeneproduct
"Mutant ARX expression in HeLa cells reduces glutathione peroxidase activity, thereby enhancing IL‑2‑induced NF‑κB (p65/p50) activation and increasing CSF‑1 secretion.",-21.125,0.01,geneorgeneproduct
"A CRISPR‑mediated knockout of the GSK‑3β gene in A549 cells markedly up‑regulates CSF‑1 transcription, thereby enhancing IL‑2‑driven proliferation of tumor‑associated macrophages and increasing the susceptibility of these cells to InsR‑targeted tyrosine‑kinase inhibitors.",-32.75,0.01,geneorgeneproduct
"A mutation in the ARX gene that reduces glutathione peroxidase activity leads to impaired insulin signaling through the InsR and CB1 receptor pathways, thereby enhancing IL‑2‑mediated activation of the NF‑κB p65/p50 complex and increasing Tnfr‑sf13c expression in pancreatic β‑cells.",-29.375,0.01,geneorgeneproduct
"A missense mutation in the ARX gene (c.1024G>A) disrupts the binding of the transcription factor p65/p50, thereby reducing CSF‑1 expression and impairing microglial proliferation in the developing mouse cortex.",-29.75,0.01,geneorgeneproduct
"A sustained up‑regulation of IL‑2 in HeLa cells transfected with a mutant ARX allele leads to increased phosphorylation of GSK‑3β, thereby enhancing p65/p50‑mediated transcription of the CSF‑1 gene.",-28.875,0.01,geneorgeneproduct
"Modulation of the NF‑κB p65/p50 heterodimer by the CB1 receptor agonist reduces IL‑2 production in activated T cells, thereby attenuating the downstream signaling of the insulin receptor (InsR) and GSK‑3β phosphorylation in a murine A549 cell line.",-34.75,0.01,geneorgeneproduct
Modulating the IRS‑2‑InsR axis in A549 cells by overexpressing glutathione peroxidase reduces IL‑2‑induced NF‑κB (p65/p50) activation and restores CB1 receptor‑mediated lipid uptake.,-29.375,0.01,geneorgeneproduct
"Modest overexpression of the transcription factor ARX in HeLa cells leads to increased CSF‑1 secretion, which in turn activates the InsR‑GSK‑3β signaling cascade and enhances IL‑2‑mediated proliferation of T‑cell lines.",-34.5,0.01,geneorgeneproduct
"Modifying the expression of the transcription factor ARX in HeLa cells reduces IL‑2 production, thereby attenuating the activation of the NF‑κB p65/p50 heterodimer and downstream CSF‑1 secretion.",-28.375,0.01,geneorgeneproduct
"Gene expression profiling revealed that the IRS‑2‑dependent activation of the p65/p50 NF‑κB complex in HeLa cells upregulates CSF‑1, thereby enhancing IL‑2‑mediated proliferation of Tnfr‑sf13c‑positive B‑cell lines.",-25.625,0.01,geneorgeneproduct
"Gene overexpression of IRS‑2 in A549 cells enhances IL‑2‑induced STAT5 phosphorylation, thereby amplifying downstream p65/p50‑mediated transcription of the glutathione peroxidase gene.",-25.25,0.01,geneorgeneproduct
"Gene‑expression profiling revealed that the IRS‑2‑dependent activation of the p65/p50 NF‑κB complex in HeLa cells up‑regulates CSF‑1, thereby enhancing IL‑2‑mediated proliferation of the A549 cell line.",-27.75,0.01,geneorgeneproduct
"Gene‐expression profiling of the A549 cell line revealed that IL‑2 stimulation up‑regulates the transcription factor p65/p50, thereby enhancing CSF‑1 secretion and activating the InsR‑IRS‑2 signaling cascade.",-29.375,0.01,geneorgeneproduct
"Alterations in the IRS‑2 gene product impair insulin receptor signaling, leading to reduced activation of the GSK‑3β/CB1 receptor axis and exacerbated neuroinflammation mediated by the p65/p50 NF‑κB complex.",-27.0,0.01,geneorgeneproduct
"Altered IRS‑2 phosphorylation in HeLa cells treated with the CB1 receptor agonist reduces insulin‑stimulated InsR signaling, thereby enhancing glutathione peroxidase expression and attenuating IL‑2‑mediated p65/p50 activation.",-24.875,0.01,geneorgeneproduct
"Alteration of the IRS‑2 gene product in HeLa cells leads to increased CSF‑1 secretion, which in turn activates the CB1 receptor‑mediated signaling cascade and enhances IL‑2 production, thereby promoting proliferation of the A549 cell line.",-30.75,0.01,geneorgeneproduct
"Alterin‑treated A549 cells exhibit a marked up‑regulation of the NF‑κB heterodimer p65/p50, which in turn enhances CSF‑1 transcription and secretion, thereby promoting autocrine signaling that activates the insulin receptor (InsR) and downstream GSK‑3β phosphorylation.",-41.75,0.01,geneorgeneproduct
"Irradiation of HeLa cells expressing a mutant IRS‑2 allele that lacks the PI3K‑binding domain leads to a marked reduction in insulin‑stimulated phosphorylation of the InsR‑associated p85 subunit, thereby impairing downstream activation of the Akt/GSK‑3β pathway and ultimately attenuating cell proliferation.",-45.0,0.01,geneorgeneproduct
"Ileal epithelial cells overexpressing the insulin receptor (InsR) exhibit increased IRS‑2 phosphorylation, which in turn activates the PI3K‑AKT pathway and enhances glutathione peroxidase expression, thereby reducing oxidative stress and preventing apoptosis in the context of inflammatory bowel disease.",-40.75,0.01,geneorgeneproduct
"I observed that the IRS‑2 gene product, when overexpressed in HeLa cells, activates the NF‑κB p65/p50 heterodimer, thereby upregulating CSF‑1 transcription and enhancing IL‑2 secretion, a pathway that may contribute to tumor‑associated macrophage recruitment.",-34.5,0.01,geneorgeneproduct
"I focused on the interaction between the insulin receptor (InsR) and the transcription factor p65/p50, showing that insulin stimulation of InsR in HeLa cells upregulates IL‑2 production through a GSK‑3β‑dependent pathway.",-33.5,0.01,geneorgeneproduct
"Mutation of the ARX gene in the human embryonic stem cell line H9 leads to aberrant expression of the transcription factor p65/p50, which in turn downregulates the insulin receptor (InsR) and the glutathione peroxidase gene, thereby impairing glucose uptake and increasing oxidative stress in differentiated neuronal progeny.",-34.25,0.01,geneorgeneproduct
"Mutation in the ARX gene that reduces glutathione peroxidase activity in HeLa cells leads to increased IL‑2 production, which in turn up‑regulates CSF‑1 expression and activates the CB1 receptor‑mediated insulin‑receptor signaling pathway, ultimately enhancing p65/p50‑dependent transcription of GSK‑3β and Tnfr‑sf13c.",-36.5,0.01,geneorgeneproduct
"Mutation‑induced loss of IRS‑2 in A549 cells upregulates CSF‑1 expression, thereby enhancing IL‑2‑mediated activation of the NF‑κB p65/p50 complex and promoting tumor‑associated macrophage recruitment.",-26.0,0.01,geneorgeneproduct
"Mutation‐induced loss of IRS‑2 in A549 cells upregulates CSF‑1 expression, thereby enhancing IL‑2‑mediated activation of the NF‑κB p65/p50 complex and promoting tumor‑associated macrophage recruitment.",-27.875,0.01,geneorgeneproduct
"Genetic ablation of IRS‑2 in A549 cells markedly reduces CSF‑1‑induced activation of the p65/p50 NF‑κB complex, thereby attenuating IL‑2‑mediated proliferation of tumor‑associated macrophages.",-21.0,0.01,geneorgeneproduct
"Genomic analysis of the ARX promoter in a cohort of patients with early‑onset epilepsy revealed a novel c.112_115delAGGT variant that disrupts a transcription factor binding site, leading to reduced ARX expression and consequent down‑regulation of glutathione peroxidase activity in cortical neurons.",-46.25,0.01,geneorgeneproduct
"Genotoxic stress in HeLa cells upregulates the NF‑κB heterodimer p65/p50, which in turn induces CSF‑1 expression and activates the insulin receptor (InsR) signaling cascade, thereby enhancing cell survival through increased glutathione peroxidase activity.",-31.0,0.01,geneorgeneproduct
"Genotype‑specific upregulation of the transcription factor p65/p50 in A549 cells treated with the CB1 receptor agonist WIN‑55,212‑2 enhances IL‑2 production, thereby potentiating the anti‑tumor activity of the IRS‑2‑mediated insulin signaling pathway.",-40.25,0.01,geneorgeneproduct
"Overexpression of the transcription factor ARX in HeLa cells leads to increased CSF‑1 secretion, which in turn activates the InsR‑GSK‑3β signaling cascade and enhances IL‑2‑mediated proliferation of Tnfr‑sf13c‑positive B cells.",-26.0,0.01,geneorgeneproduct
"Overexpressed IRS‑2 in A549 cells enhances IL‑2‑induced STAT5 phosphorylation, thereby upregulating CSF‑1 transcription and promoting a pro‑survival phenotype that is attenuated by GSK‑3β inhibition.",-27.375,0.01,geneorgeneproduct
"Overactivation of the CB1 receptor in A549 cells leads to increased expression of the transcription factor p65/p50, which in turn upregulates CSF‑1 production and enhances insulin‑stimulated glucose uptake via the InsR‑IRS‑2 signaling axis.",-32.0,0.01,geneorgeneproduct
"Over-expression of the transcription factor ARX in HeLa cells upregulates the cytokine CSF‑1, which in turn activates the insulin receptor (InsR) signaling cascade, leading to increased phosphorylation of IRS‑2 and downstream GSK‑3β inhibition.",-30.625,0.01,geneorgeneproduct
"Silencing of the ARX gene in HeLa cells markedly reduces CSF‑1 secretion, thereby attenuating IL‑2‑induced activation of the p65/p50 NF‑κB complex and downstream GSK‑3β phosphorylation.",-23.25,0.01,geneorgeneproduct
"Silico‑CRISPR editing of the ARX promoter in HeLa cells revealed that the introduced G>A SNP at position −120 bp abolishes binding of the p65/p50 NF‑κB complex, thereby reducing ARX transcription and concomitantly down‑regulating downstream targets such as CSF‑1 and IL‑2 while increasing expression of the antioxidant enzyme glutathione peroxidase.",-48.25,0.01,geneorgeneproduct
"Silenced IRS‑2 expression in HeLa cells treated with the CB1 receptor agonist reduces IL‑2‑induced STAT5 phosphorylation, thereby attenuating the downstream activation of the p65/p50 NF‑κB complex and diminishing CSF‑1‑mediated macrophage recruitment.",-29.25,0.01,geneorgeneproduct
"Silicon dioxide nanoparticles inhibit IL‑2‑induced STAT5 phosphorylation in Jurkat T cells, thereby reducing the expression of the insulin receptor (InsR) and the downstream activation of GSK‑3β, which in turn attenuates the transcriptional activity of the NF‑κB heterodimer p65/p50 and the secretion of the cytokine CSF‑1.",-43.75,0.01,geneorgeneproduct
"Mutation of the CDKN2C gene in a patient with Translocation‑Ets‑Leukemia leads to up‑regulation of the NF‑κB inhibitor IκBα, thereby attenuating TNFRSF6‑mediated apoptosis.",-19.875,0.01,geneorgeneproduct
"Mutation in the CDKN2C gene, which encodes the cyclin‑dependent kinase inhibitor p18, was found to cooperate with a translocation‑Ets‑leukemia‑associated fusion protein to activate NF‑κB signaling and up‑regulate the anti‑apoptotic gene TNFRSF6 in a human T‑cell leukemia cell line.",-35.25,0.01,geneorgeneproduct
"Mutation-driven overexpression of CDKN2C in the A549 cell line, coupled with CYP2D6-mediated metabolism of the chemotherapeutic agent doxorubicin, activates NF‑κB signaling via p62‑dependent degradation of TNFRSF6, thereby promoting resistance to apoptosis in non‑small‑cell lung carcinoma.",-33.75,0.01,geneorgeneproduct
"Mutation‑induced loss of CDKN2C expression in a CD34+ cell line carrying a t(8;21) translocation‑ETS‑leukemia fusion activates NF‑κB signaling, thereby up‑regulating TNFRSF6 and enhancing Pim1‑mediated proliferation.",-38.25,0.01,geneorgeneproduct
"In HeLa cells, the translocation‑Ets‑leukemia fusion protein up‑regulates NF‑κBIA, thereby dampening TNFRSF6‑mediated apoptosis and promoting Pim1‑driven proliferation.",-16.625,0.01,geneorgeneproduct
"In A549 cells, the CYP2D6-mediated metabolism of the chemotherapeutic agent doxorubicin upregulates NF‑κB‑inhibitor alpha (nfkbia), thereby attenuating apoptosis driven by the CDKN2C‑dependent cell‑cycle arrest.",-23.125,0.01,geneorgeneproduct
"In the CDKN2C‑deficient A549 cell line, CYP2D6‑mediated metabolism of the RARγ‑selective agonist increased NF‑κB‑inhibitor‑α expression, thereby attenuating TNFRSF6‑induced apoptosis.",-21.125,0.01,geneorgeneproduct
"In TNFRSF6‑deficient A549 cells, the CYP2D6‑mediated metabolism of the RARγ‑selective agonist induces NF‑κBIA degradation, thereby enhancing Pim1‑driven proliferation.",-21.125,0.01,geneorgeneproduct
"Translocation‑Ets‑Leukemia cells overexpress CDKN2C, which is transcriptionally repressed by NF‑κB‑α and up‑regulated by CYP2D6‑mediated metabolism of the RARγ‑selective ligand, thereby enhancing Pim1‑driven proliferation.",-23.75,0.01,geneorgeneproduct
"Transcriptional profiling of the CDKN2C promoter in CYP2D6‑expressing HeLa cells revealed that the NF‑κB inhibitor alpha‑p62 binds the Ets‑leukemia translocation site, thereby repressing TNFRSF6‑mediated apoptosis.",-27.125,0.01,geneorgeneproduct
"Transgenic A549 cells overexpressing the CDKN2C variant c.123_124delAG exhibit reduced proliferation and increased sensitivity to the CYP2D6 inhibitor fluvoxamine, suggesting a potential therapeutic interaction in non‑small cell lung carcinoma.",-32.75,0.01,geneorgeneproduct
"Transactivation of the NF‑κB inhibitor gene **nfkbia** by the oncogenic **Translocation‑Ets‑Leukemia** fusion protein enhances proliferation of **CDKN2C**‑deficient **A549** cells, while inhibition of the drug‑metabolizing enzyme **CYP2D6** reduces the cytotoxicity of the chemotherapeutic agent **doxorubicin**.",-32.0,0.01,geneorgeneproduct
"The CDKN2C promoter variant c.−124C>T, which reduces NF‑κB‑induced transcription, is associated with increased risk of Translocation‑Ets‑Leukemia in patients carrying the CYP2D6*4 allele.",-27.375,0.01,geneorgeneproduct
The down‑regulation of NF‑κBIA by the CYP2D6‑mediated metabolite of the RARγ‑selective retinoid induces apoptosis in CDKN2C‑deficient AML cells harboring a translocation‑Ets‑leukemia‑associated fusion.,-25.5,0.01,geneorgeneproduct
"The p62-mediated autophagic degradation of the NF‑κB inhibitor IκBα is enhanced in CDKN2C‑deficient A549 cells, leading to increased TNFRSF6‑driven apoptosis when treated with the CYP2D6‑metabolized chemotherapeutic agent doxorubicin.",-24.375,0.01,geneorgeneproduct
"The transcription factor NF‑κBIA is up‑regulated in CDKN2C‑deficient A549 cells, where it suppresses the pro‑survival kinase Pim1 and enhances sensitivity to the CYP2D6‑metabolized chemotherapeutic agent doxorubicin.",-21.375,0.01,geneorgeneproduct
"A CRISPR‑mediated knockout of CDKN2C in A549 cells upregulates CYP2D6 expression, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxicity.",-18.5,0.01,geneorgeneproduct
"A polymorphism in the CYP2D6 promoter region reduces its transcription, thereby diminishing the metabolism of the chemotherapeutic agent doxorubicin and increasing the risk of cardiotoxicity in patients with the Translocation‑Ets‑Leukemia subtype.",-26.0,0.01,geneorgeneproduct
"A single‑cell RNA‑seq analysis of the A549 cell line revealed that the CDKN2C promoter is hyper‑methylated, leading to down‑regulation of CDKN2C and up‑regulation of the NF‑κB inhibitor alpha (nfkbia), thereby enhancing the transcription of the pro‑survival gene Pim1.",-36.0,0.01,geneorgeneproduct
"A CDKN2C loss-of-function variant in a patient with Translocation‑Ets‑Leukemia leads to unchecked Pim1 activity, which in turn hyperactivates NF‑κB signaling through p62‑mediated degradation of TNFRSF6, thereby driving uncontrolled proliferation of the leukemic clone.",-32.25,0.01,geneorgeneproduct
"An overexpression of the transcription factor CDKN2C in A549 cells carrying a CYP2D6 polymorphism enhances NF‑κB‑induced apoptosis through up‑regulation of TNFRSF6, thereby sensitizing the cells to etoposide‑induced DNA damage.",-32.25,0.01,geneorgeneproduct
"An engineered A549 cell line overexpressing the CDKN2C gene product, when treated with the CYP2D6 inhibitor fluvoxamine, shows a marked decrease in NF‑κB‑induced transcription of the TNFRSF6 promoter, suggesting a potential therapeutic strategy for Translocation‑Ets‑Leukemia.",-38.0,0.01,geneorgeneproduct
"An up‑regulation of the transcription factor NF‑κB inhibitor alpha (nfkbia) in the A549 cell line carrying the CYP2D6*4 allele was observed to enhance the expression of the tumor necrosis factor receptor superfamily member TNFRSF6, thereby increasing apoptosis in response to etoposide.",-39.75,0.01,geneorgeneproduct
"An allelic variant of CYP2D6 in a patient with Translocation‑Ets‑Leukemia was found to up‑regulate NF‑κBIA expression, thereby attenuating TNFRSF6‑mediated apoptosis of CDKN2C‑deficient leukemic blasts.",-28.5,0.01,geneorgeneproduct
"CDKN2C loss-of-function mutations in a patient with Translocation‑Ets‑Leukemia were found to up‑regulate NF‑κBIA expression, thereby attenuating TNFRSF6‑mediated apoptosis.",-22.5,0.01,geneorgeneproduct
"CDK4‑CDK6 inhibition in the CDKN2C‑deficient A549 cell line reduces NF‑κB‑dependent transcription of TNFRSF6, thereby sensitizing the cells to apoptosis induced by the CYP2D6‑metabolized chemotherapeutic agent doxorubicin.",-33.25,0.01,geneorgeneproduct
"CDKL5 mutations in a patient with Rett syndrome were found to disrupt NF‑κBIA‑mediated transcriptional repression, thereby enhancing TNFRSF6‑driven apoptosis in neuronal progenitors.",-35.25,0.01,geneorgeneproduct
"CDNK2C overexpression in A549 cells enhances NF‑κB‑IA-mediated transcription of TNFRSF6, thereby increasing apoptosis resistance in a CYP2D6‑dependent manner.",-32.75,0.01,geneorgeneproduct
"Variants in the CYP2D6 promoter that reduce transcriptional activity are associated with increased expression of the NF‑κB inhibitor alpha (nfkbia) in CDKN2C‑deficient A549 cells, thereby attenuating the pro‑apoptotic signaling of TNFRSF6 during Translocation‑Ets‑Leukemia‑induced transformation.",-35.25,0.01,geneorgeneproduct
"Variants of the CYP2D6 gene that reduce its enzymatic activity impair the metabolism of the antipsychotic drug risperidone, thereby increasing plasma concentrations of its active metabolite and elevating the risk of extrapyramidal side effects in patients with the Translocation‑Ets‑Leukemia‑associated fusion protein.",-36.5,0.01,geneorgeneproduct
"Variants within the CDKN2C promoter that reduce NF‑κB‑α binding enhance transcription of the adjacent CYP2D6 gene, thereby increasing the metabolic clearance of the RARγ‑selective retinoid and attenuating the leukemogenic potential of the translocation‑Ets‑leukemia fusion in TNFRSF6‑deficient A549 cells.",-42.5,0.01,geneorgeneproduct
"Variants carrying the CYP2D6*4 allele in a patient with Translocation‑Ets‑Leukemia were found to up‑regulate NF‑κBIA expression, thereby attenuating the pro‑apoptotic signaling of TNFRSF6 and contributing to chemoresistance.",-35.5,0.01,geneorgeneproduct
"Ectopic expression of the CDKN2C gene in A549 cells downregulates NF‑κB signaling through increased p62-mediated autophagy, thereby sensitizing the cells to the chemotherapeutic agent doxorubicin.",-24.375,0.01,geneorgeneproduct
"Epithelial cells harboring a CDKN2C loss-of-function variant exhibit heightened NF‑κB signaling, which is further amplified by CYP2D6‑mediated metabolism of the pro‑inflammatory drug, thereby accelerating TNFRSF6‑driven apoptosis in the Translocation‑Ets‑Leukemia model.",-38.25,0.01,geneorgeneproduct
"E2F1 transcriptionally activates CDKN2C, and the resulting p16^INK4c protein inhibits the CDK4/6 complex, thereby blocking the G1‑S transition in HeLa cells.",-35.0,0.01,geneorgeneproduct
"Evidently, the translocation‑Ets‑leukemia fusion protein up‑regulates NF‑κBIA, thereby dampening TNFRSF6‑mediated apoptosis in CDKN2C‑deficient AML cells.",-27.125,0.01,geneorgeneproduct
"Cytochrome P450 CYP2D6 polymorphisms modulate the metabolism of the chemotherapeutic agent doxorubicin, thereby influencing the expression of the tumor suppressor CDKN2C and the activation of NF‑κB‑inhibitor alpha (nfkbia) in A549 lung carcinoma cells.",-28.125,0.01,geneorgeneproduct
"Cyclosporine A treatment of A549 cells carrying the CDKN2C c.302_303delAG variant down‑regulates NF‑κBIA expression, thereby enhancing TNFRSF6‑mediated apoptosis.",-32.5,0.01,geneorgeneproduct
"Cy3‑labeled CDKN2C mRNA was found to colocalize with the NF‑κB inhibitor p62 in HeLa cells, indicating that the CDKN2C‑p62 complex may modulate TNFRSF6‑mediated apoptosis.",-37.0,0.01,geneorgeneproduct
"Cy15‑1‑treated A549 cells overexpressing the CDKN2C variant c.302G>A exhibit reduced NF‑κB‑IA phosphorylation, thereby attenuating TNFRSF6‑mediated apoptosis and enhancing resistance to the CYP2D6‑metabolized chemotherapeutic agent doxorubicin.",-55.5,0.01,geneorgeneproduct
"CYP2D6 polymorphisms modulate the metabolism of the chemotherapeutic agent doxorubicin, thereby influencing the risk of cardiotoxicity in patients with Translocation‑Ets‑Leukemia who are treated with a CDKN2C‑targeted inhibitor.",-21.0,0.01,geneorgeneproduct
"Cytotoxic T‑cell lymphoma cells harboring a translocation‑Ets‑leukemia fusion exhibit up‑regulated NF‑κBIA and Pim1, while the CDKN2C promoter is hypermethylated, leading to reduced p53‑dependent apoptosis and enhanced resistance to the CYP2D6‑metabolized chemotherapeutic agent doxorubicin.",-39.75,0.01,geneorgeneproduct
"CPT2 deficiency in a patient with a BRCA1 c.68_69delAG variant led to impaired fatty‑acid oxidation, while a CYP2D6*4 allele reduced the metabolism of the chemotherapeutic agent doxorubicin, exacerbating cardiotoxicity.",-36.75,0.01,geneorgeneproduct
"Cigarette smoke exposure induces a CYP2D6‑mediated increase in the transcription of the CDKN2C gene, which in turn upregulates NF‑κBIA expression and promotes apoptosis of TNFRSF6‑positive T‑cell lymphoma cells.",-40.25,0.01,geneorgeneproduct
"Altered expression of the transcription factor NF‑κB inhibitor alpha (NFKBIA) in the CDKN2C‑deficient A549 cell line leads to increased sensitivity to the CYP2D6‑metabolized chemotherapeutic agent doxorubicin, thereby enhancing apoptosis in Translocation‑Ets‑Leukemia‑derived cells.",-26.875,0.01,geneorgeneproduct
"Alterations in the CDKN2C promoter combined with a CYP2D6 loss‑of‑function variant enhance NF‑κB‑IA-mediated transcription of the TNFRSF6 ligand, thereby increasing apoptosis resistance in Translocation‑Ets‑Leukemia‑derived A549 cells.",-31.125,0.01,geneorgeneproduct
"Alteration of the CDKN2C promoter by a SNP in the NF‑κBIA binding site reduces CDKN2C transcription, thereby enhancing Pim1‑mediated proliferation of TNFRSF6‑deficient B‑cell lines.",-29.375,0.01,geneorgeneproduct
"Alterative treatment with the RARγ‑selective agonist induces apoptosis in CDKN2C‑deficient AML cells by up‑regulating TNFRSF6 expression, a process that is potentiated by CYP2D6‑mediated metabolism of the drug.",-36.75,0.01,geneorgeneproduct
"Loss-of-function mutations in CDKN2C, coupled with overexpression of the transcription factor NF‑κBIA, synergistically enhance the leukemogenic potential of the Translocation‑Ets‑Leukemia fusion in human AML cells.",-29.375,0.01,geneorgeneproduct
"Loss of the CDKN2C tumor suppressor in a patient with a translocation‑Ets‑leukemia variant leads to up‑regulation of the NF‑κB inhibitor n‑fkbia, thereby enhancing Pim1‑mediated proliferation of the malignant cells.",-32.75,0.01,geneorgeneproduct
"Loss‑of‑function mutations in CDKN2C, together with CYP2D6‑mediated poor metabolism of the chemotherapeutic agent doxorubicin, synergistically enhance the leukemogenic potential of the Translocation‑Ets‑Leukemia fusion, thereby accelerating disease progression in patients with the TNFRSF6‑deficient phenotype.",-37.75,0.01,geneorgeneproduct
"Loss‐of‑function mutations in CDKN2C, together with CYP2D6‑mediated poor metabolism of the chemotherapeutic agent doxorubicin, synergistically enhance the risk of Translocation‑Ets‑Leukemia in patients carrying the TNFRSF6 promoter variant.",-36.0,0.01,geneorgeneproduct
"Genomic analysis of a CDKN2C‑deficient A549 cell line revealed that loss of CDKN2C upregulates the NF‑κB inhibitor n‑fkbia, thereby enhancing Pim1‑mediated phosphorylation of TNFRSF6 and promoting resistance to apoptosis in the presence of the CYP2D6‑metabolized chemotherapeutic agent doxorubicin.",-35.5,0.01,geneorgeneproduct
"Genetic ablation of CDKN2C in A549 cells enhances CYP2D6‑mediated metabolism of doxorubicin, thereby increasing apoptosis through NF‑κB‑induced upregulation of TNFRSF6.",-23.0,0.01,geneorgeneproduct
"Genetically engineered A549 cells overexpressing the CDKN2C variant c.123_124delAG exhibit reduced proliferation when treated with the CYP2D6 substrate doxorubicin, suggesting a synergistic interaction between CDKN2C loss and CYP2D6-mediated drug metabolism.",-37.5,0.01,geneorgeneproduct
"Genotyping of the CYP2D6*4 allele in a cohort of *Homo sapiens* patients with severe *Pim1*-driven acute myeloid leukemia revealed that the loss-of-function variant was significantly enriched in those who exhibited a translocation involving the *TNFRSF6* locus, suggesting a potential interaction between drug-metabolizing enzyme polymorphisms and apoptotic signaling pathways in this disease context.",-58.0,0.01,geneorgeneproduct
"In the A549 cell line, overexpression of the transcription factor CEBPβ upregulates CYP3A5, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxic efficacy.",-16.625,0.01,geneorgeneproduct
"In HeLa cells, the loss of CEBPβ expression leads to up‑regulation of the transferrin receptor‑2 gene, thereby increasing iron uptake and enhancing NADPH oxidase‑mediated reactive oxygen species production, which in turn activates extracellular signal‑regulated kinase signaling and promotes proliferation of the cancer cells.",-33.25,0.01,geneorgeneproduct
"In A549 cells, the loss of CEBPβ expression leads to up‑regulation of the transferrin receptor‑2 gene, thereby enhancing iron uptake and activating extracellular signal‑regulated kinase signaling that ultimately promotes proliferation.",-29.375,0.01,geneorgeneproduct
"In HepG2 cells, the loss of CEBPβ expression leads to up‑regulation of CYP3A5, which in turn enhances the metabolism of the chemotherapeutic agent doxorubicin, thereby reducing its cytotoxic efficacy against the tumor.",-21.375,0.01,geneorgeneproduct
"Mutations in the CYP3A5 gene that reduce its enzymatic activity impair the metabolism of the chemotherapeutic agent doxorubicin, thereby increasing its cytotoxicity toward HeLa cells and exacerbating the risk of cardiotoxicity in patients with the BRCA1 c.68_69delAG variant.",-24.25,0.01,geneorgeneproduct
"Mutant TP53 c.215C>A in A549 cells upregulates CYP3A5 expression, thereby enhancing doxorubicin metabolism and reducing its cytotoxicity.",-21.0,0.01,geneorgeneproduct
"Mutational loss of the transferrin receptor‑2 gene product in a patient with iron‑overload anemia leads to up‑regulation of the extracellular signal‑regulated kinase pathway, which in turn enhances CYP3A5‑mediated metabolism of the antiepileptic drug carbamazepine.",-36.25,0.01,geneorgeneproduct
"Mutagenic exposure to benzo[a]pyrene induces a CYP3A5-mediated increase in reactive oxygen species that activates extracellular signal‑regulated kinase, thereby up‑regulating CEBPβ expression and enhancing transcription of the transferrin receptor‑2 gene in HepG2 cells.",-28.375,0.01,geneorgeneproduct
"The CAR‑T cell line NALM‑6, engineered to express a chimeric antigen receptor targeting CD19, exhibited enhanced cytotoxicity when co‑treated with the small‑molecule inhibitor of the NADPH oxidase complex, which reduced reactive oxygen species and restored the activity of the extracellular signal‑regulated kinase pathway, thereby increasing the expression of the transcription factor CEBPβ and promoting apoptosis of the malignant B‑cell population.",-44.25,0.01,geneorgeneproduct
"The gain‑of‑function mutation in the CYP3A5 gene, which encodes a key drug‑metabolizing enzyme, was shown to up‑regulate extracellular signal‑regulated kinase activity and thereby enhance the proliferation of HeLa cells exposed to the chemotherapeutic agent doxorubicin.",-26.5,0.01,geneorgeneproduct
"The upregulation of CYP3A5 in HepG2 cells enhances the metabolism of doxorubicin, thereby reducing its cytotoxicity toward the TP53‑mutated A549 cell line.",-16.0,0.01,geneorgeneproduct
"The extracellular signal‑regulated kinase pathway is activated by the transferrin receptor‑2‑mediated uptake of iron, which in turn stimulates NADPH oxidase to produce reactive oxygen species that up‑regulate CEBPβ expression and enhance CYP3A5 transcription in HepG2 cells.",-25.75,0.01,geneorgeneproduct
"NADPH oxidase activation in A549 cells upregulates CEBPβ, which in turn enhances transcription of the transferrin receptor‑2 gene, thereby increasing iron uptake and promoting extracellular signal‑regulated kinase‑mediated proliferation.",-20.125,0.01,geneorgeneproduct
"Nicotinic acetylcholine receptor subunit α4, whose expression is up‑regulated by extracellular signal‑regulated kinase phosphorylation, is markedly increased in A549 cells harboring the CYP3A5*3 allele, thereby enhancing cellular uptake of the chemotherapeutic agent doxorubicin.",-26.75,0.01,geneorgeneproduct
"NOD2 mutations in Crohn’s disease patients upregulate extracellular signal‑regulated kinase activity, which in turn enhances transcription of the CEBPβ‑regulated cathepsin L gene, thereby increasing intestinal mucosal degradation.",-35.0,0.01,geneorgeneproduct
"Nutrient‑sensing via the NADPH oxidase‑dependent activation of extracellular signal‑regulated kinase in HeLa cells upregulates CEBPβ, which in turn enhances transcription of the transferrin receptor‑2 gene, thereby increasing iron uptake and supporting rapid proliferation.",-36.0,0.01,geneorgeneproduct
"A549 cells overexpressing the CYP3A5 isoform exhibit increased metabolism of doxorubicin, leading to elevated intracellular reactive oxygen species that activate extracellular signal‑regulated kinase and subsequently upregulate CEBPβ‑mediated transcription of the transferrin receptor‑2 gene.",-24.75,0.01,geneorgeneproduct
"A mutant form of the transferrin receptor‑2 gene (TFRC2 c.1123G>A) in a patient with hereditary hemochromatosis was found to up‑regulate extracellular signal‑regulated kinase phosphorylation, thereby enhancing iron uptake and accelerating hepatic fibrosis.",-40.25,0.01,geneorgeneproduct
"A NADPH oxidase–derived reactive oxygen species surge activates extracellular signal‑regulated kinase, which in turn phosphorylates the transferrin receptor‑2 promoter, enhancing CEBPβ‑mediated transcription of the CYP3A5 gene in HepG2 cells.",-26.25,0.01,geneorgeneproduct
"A phosphatidylinositol-3-kinase inhibitor reduces proliferation of A549 cells by down‑regulating the extracellular signal‑regulated kinase pathway, thereby enhancing the activity of the nicotinic acetylcholine receptor and increasing intracellular NADPH oxidase‑derived reactive oxygen species that trigger apoptosis.",-36.0,0.01,geneorgeneproduct
"Activation of the extracellular signal‑regulated kinase pathway by the nicotinic acetylcholine receptor in A549 cells upregulates CYP3A5 expression, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxic efficacy.",-17.75,0.01,geneorgeneproduct
"Activation by the type II TGF‑β receptor of the extracellular signal‑regulated kinase pathway in A549 cells upregulates CEBPβ, which in turn enhances transcription of the transferrin receptor‑2 gene, thereby increasing iron uptake and promoting proliferation of the tumor cells.",-38.75,0.01,geneorgeneproduct
"Activation‐dependent phosphorylation of extracellular signal‑regulated kinase by the type I TGF‑beta receptor complex induces CEBPβ‑mediated transcription of the transferrin receptor‑2 gene in HepG2 cells, thereby enhancing iron uptake and stimulating CYP3A5 expression.",-39.75,0.01,geneorgeneproduct
"Activation or inhibition of the extracellular signal‑regulated kinase pathway by the nicotinic acetylcholine receptor agonist nicotine modulates the expression of the transferrin receptor‑2 gene (TFRC) in HepG2 cells, thereby altering iron uptake and influencing the activity of the NADPH oxidase complex.",-41.75,0.01,geneorgeneproduct
"CYP3A5 expression is up‑regulated by extracellular signal‑regulated kinase activation in HepG2 cells, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin.",-14.5,0.01,geneorgeneproduct
"Cytokine‑induced activation of extracellular signal‑regulated kinase in A549 cells up‑regulates CEBPβ, which in turn enhances transcription of the transferrin receptor‑2 gene, thereby increasing iron uptake and promoting proliferation of the tumor cells.",-27.875,0.01,geneorgeneproduct
"C‑EBPβ transcriptionally up‑regulates the transferrin receptor‑2 gene in HepG2 cells, thereby enhancing iron uptake and subsequently stimulating extracellular signal‑regulated kinase phosphorylation, which in turn increases CYP3A5 expression and NADPH oxidase activity.",-33.25,0.01,geneorgeneproduct
"Coxsackievirus infection upregulates the transferrin receptor‑2 promoter through an extracellular signal‑regulated kinase‑dependent pathway, thereby enhancing iron uptake and accelerating the replication of the viral RNA genome in HeLa cells.",-39.75,0.01,geneorgeneproduct
"Knock‑in of the BRCA1 c.68_69delAG variant in HeLa cells markedly increases NADPH oxidase‑mediated reactive oxygen species production, which in turn activates extracellular signal‑regulated kinase and up‑regulates CEBPβ‑driven transcription of the transferrin receptor‑2 gene, thereby enhancing iron uptake and sensitizing the cells to the cytotoxic effects of doxorubicin.",-31.0,0.01,geneorgeneproduct
"Knocking‑down the NADPH oxidase subunit p47^phox in A549 cells markedly reduces extracellular signal‑regulated kinase phosphorylation, thereby attenuating the up‑regulation of the transferrin receptor‑2 promoter that is normally driven by CEBPβ in response to oxidative stress.",-29.5,0.01,geneorgeneproduct
"Knocked‑out CEBPβ in A549 cells markedly reduces extracellular signal‑regulated kinase phosphorylation, thereby diminishing transferrin receptor‑2 expression and impairing NADPH oxidase‑mediated reactive‑oxygen‑species production.",-29.75,0.01,geneorgeneproduct
"Kn7‑c.152G>A in the CYP3A5 gene, a variant that reduces enzyme activity, was found to impair the metabolism of the chemotherapeutic agent doxorubicin in a cohort of patients with breast cancer, leading to increased plasma concentrations and heightened cardiotoxicity.",-59.0,0.01,geneorgeneproduct
"Upstream activation of the extracellular signal‑regulated kinase pathway by the nicotinic acetylcholine receptor in A549 cells leads to increased expression of the transferrin receptor‑2 gene, thereby enhancing iron uptake and promoting proliferation of the tumor cells.",-32.75,0.01,geneorgeneproduct
"Upregulation of the transcription factor CEBPβ in A549 cells enhances CYP3A5 expression, thereby increasing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxic efficacy against the tumor.",-19.0,0.01,geneorgeneproduct
"Upregulated CYP3A5 expression in HepG2 cells enhances the metabolism of the chemotherapeutic agent doxorubicin, thereby reducing its cytotoxic efficacy against the TP53‑mutant A549 lung carcinoma line.",-23.125,0.01,geneorgeneproduct
"Up-regulation of the transcription factor CEBPβ in A549 cells enhances CYP3A5 expression, thereby increasing the metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxic efficacy against non‑small cell lung carcinoma.",-24.5,0.01,geneorgeneproduct
"Loss of the transferrin receptor‑2 gene in A549 cells leads to up‑regulation of the extracellular signal‑regulated kinase pathway, which in turn increases CYP3A5 expression and enhances the cellular uptake of the chemotherapeutic agent doxorubicin.",-31.25,0.01,geneorgeneproduct
"Loss-of-function mutations in the transferrin receptor‑2 gene (TFRC2) impair iron uptake in erythroid precursors, leading to microcytic anemia that is exacerbated by reduced CYP3A5‑mediated metabolism of erythropoietin‑stimulating agents.",-31.875,0.01,geneorgeneproduct
"Loss‑of‑function mutations in the NADPH oxidase subunit CYBB disrupt reactive‑oxygen‑species production, thereby impairing the activation of extracellular signal‑regulated kinase and ultimately reducing the transcriptional activity of CEBPβ in macrophages that express the transferrin receptor‑2.",-35.5,0.01,geneorgeneproduct
"Loss‐of‑function mutations in the transferrin receptor‑2 gene (TFRC2) impair iron uptake in erythroid precursors, leading to microcytic anemia that is exacerbated by reduced CYP3A5‑mediated metabolism of the iron‑chelating drug deferasirox.",-36.25,0.01,geneorgeneproduct
"Altered expression of the transcription factor CEBPβ in A549 cells treated with the CYP3A5 inhibitor ketoconazole leads to up‑regulation of the transferrin receptor‑2 gene, thereby increasing cellular iron uptake and enhancing NADPH oxidase‑mediated reactive oxygen species production.",-25.75,0.01,geneorgeneproduct
"Alterations in the NADPH oxidase complex, specifically the p47^phox subunit encoded by NCF1, enhance reactive oxygen species production in A549 cells, thereby activating extracellular signal‑regulated kinase (ERK) and up‑regulating CEBPβ‑mediated transcription of the transferrin receptor‑2 gene (TFRC2) to promote iron uptake in response to hypoxia.",-38.5,0.01,geneorgeneproduct
"Alteration of the CYP3A5 promoter by a c.1459C>T sequence variant enhances transcription of the enzyme, thereby increasing metabolism of the chemotherapeutic agent doxorubicin and reducing its cytotoxic efficacy in A549 cells.",-33.25,0.01,geneorgeneproduct
"Alterance of the NADPH oxidase subunit CYBB in A549 cells leads to hyperactivation of extracellular signal‑regulated kinase, which in turn up‑regulates the transcription factor CEBPβ and enhances expression of the transferrin receptor‑2 gene (TFRC2) in a manner that promotes iron‑dependent proliferation of the tumor cells.",-50.25,0.01,geneorgeneproduct
"Transcriptional profiling of A549 cells treated with the CYP3A5 inhibitor ketoconazole revealed that the up‑regulated gene TP53, a tumor suppressor, was accompanied by increased expression of the extracellular signal‑regulated kinase (ERK) pathway component MAPK1, suggesting that ERK activation may mediate the cellular response to CYP3A5 inhibition.",-34.75,0.01,geneorgeneproduct
"Transfection of HeLa cells with a plasmid encoding the human CYP3A5 gene markedly increased the intracellular concentration of the chemotherapeutic agent doxorubicin, thereby enhancing apoptosis through activation of extracellular signal‑regulated kinase and up‑regulation of the nicotinic acetylcholine receptor subunit α7.",-29.25,0.01,geneorgeneproduct
"Transgenic A549 cells overexpressing the CYP3A5 isoform exhibit increased metabolism of doxorubicin, leading to elevated intracellular reactive oxygen species that activate extracellular signal‑regulated kinase and subsequently upregulate CEBPβ‑mediated transcription of the transferrin receptor‑2 gene.",-25.75,0.01,geneorgeneproduct
"Transactivation of the transferrin receptor‑2 promoter by the transcription factor CEBPβ is enhanced by extracellular signal‑regulated kinase phosphorylation, thereby increasing iron uptake in HepG2 cells.",-25.75,0.01,geneorgeneproduct
"Aberrant activation of the extracellular signal‑regulated kinase pathway in HeLa cells overexpressing the transferrin receptor‑2 variant c.1123G>A leads to increased CYP3A5 transcription, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin and contributing to drug resistance.",-34.0,0.01,geneorgeneproduct
"Aberrations in the CYP3A5 promoter reduce its transcription, thereby diminishing the metabolism of the chemotherapeutic agent doxorubicin and potentiating its cardiotoxicity in patients with the CYP3A5*3/*3 genotype.",-30.375,0.01,geneorgeneproduct
"Aberration of the CYP3A5 gene product in HepG2 cells leads to increased intracellular NADPH oxidase activity, which in turn phosphorylates extracellular signal‑regulated kinase and enhances the expression of the transferrin receptor‑2 gene.",-33.75,0.01,geneorgeneproduct
"Abernathy’s study showed that the NADPH oxidase subunit p47^phox, encoded by NCF1, is up‑regulated by extracellular signal‑regulated kinase phosphorylation in HeLa cells, thereby enhancing reactive oxygen species production and promoting apoptosis in response to cisplatin.",-37.75,0.01,geneorgeneproduct
"Downregulation of the transcription factor CEBPβ by the extracellular signal‑regulated kinase pathway in A549 cells expressing the CYP3A5*3 allele reduces NADPH oxidase‑mediated reactive oxygen species production, thereby attenuating transferrin receptor‑2‑driven iron uptake and protecting against oxidative stress‑induced apoptosis.",-36.25,0.01,geneorgeneproduct
"Down‑regulation of the NADPH oxidase subunit CYBB in A549 cells by CRISPR‑mediated knockout of the transcription factor CEBPβ reduces reactive oxygen species production and attenuates extracellular signal‑regulated kinase phosphorylation, thereby enhancing cisplatin sensitivity.",-35.25,0.01,geneorgeneproduct
"Downstream of the type I TGF‑β receptor, the transcription factor CEBPβ up‑regulates CYP3A5 expression, thereby enhancing the metabolism of the chemotherapeutic agent doxorubicin in HepG2 cells.",-24.125,0.01,geneorgeneproduct
"Down-regulation of the NADPH oxidase subunit p47^phox in A549 cells by siRNA targeting the CEBPβ transcription factor reduces reactive oxygen species production and attenuates extracellular signal-regulated kinase phosphorylation, thereby diminishing the proliferative response to epidermal growth factor.",-37.75,0.01,geneorgeneproduct
"The Caenorhabditis elegans strain N2, when infected with the RNA virus hepatitis C virus, exhibits a dramatic upregulation of the antiviral gene IFN‑γ, suggesting a conserved innate immune response across organism taxa.",-29.75,0.01,organismtaxon
"The gene‑editing CRISPR/Cas9 system delivered to *C. elegans* revealed that the *daf-2* insulin‑like receptor mutation confers resistance to *Plasmodium falciparum*‑induced oxidative stress, a finding that may inform therapeutic strategies for HIV‑positive patients co‑infected with *HIV* and *Hepatitis C virus*.",-38.25,0.01,organismtaxon
"The *C. elegans* strain N2, when infected with *Plasmodium falciparum*–derived antigens, exhibits a pronounced upregulation of the *daf-16* gene, mirroring the stress‑response pathways observed in HIV‑positive patients treated with ginseng extracts.",-24.875,0.01,organismtaxon
"The malaria parasite *Plasmodium falciparum* secretes PfEMP1, a protein that binds to endothelial protein C receptor on human vascular cells, thereby promoting severe cerebral malaria in HIV‑positive patients.",-26.5,0.01,organismtaxon
"Cytomegalovirus infection in a HIV‑positive woman was shown to upregulate the interferon‑γ‑induced protein MxA in C. elegans‑derived intestinal epithelial cells, thereby enhancing antiviral defense against Plasmodium falciparum‑derived merozoites.",-34.0,0.01,organismtaxon
"Cerebral malaria caused by Plasmodium falciparum infection in a HIV‑positive woman leads to severe hypoglycemia, which is exacerbated by concurrent cytomegalovirus reactivation and hepatitis B virus replication.",-35.25,0.01,organismtaxon
"Cystic fibrosis‑associated airway epithelial cells from a woman infected with *Pseudomonas aeruginosa* exhibit increased expression of the CFTR gene product, which is further up‑regulated by the antiviral drug ganciclovir targeting cytomegalovirus.",-34.5,0.01,organismtaxon
"C‑elegans infection with *Plasmodium falciparum*‑derived antigens induces a robust innate immune response that is markedly attenuated in *S. aureus*‑colonized *HIV‑positive* mice, suggesting a competitive interaction between bacterial and parasitic pathogens in shaping host immunity.",-38.0,0.01,organismtaxon
"In the C. elegans model of Plasmodium falciparum infection, the parasite’s surface protein PfEMP1 binds to the worm’s intestinal epithelium, triggering a robust innate immune response that mirrors the cytokine storm observed in HIV‑positive patients with respiratory syncytial virus co‑infection.",-25.375,0.01,organismtaxon
"In *C. elegans* expressing a CRISPR‑generated *daf‑2* SequenceVariant, the insulin‑like signaling pathway is disrupted, leading to a pronounced lifespan extension that is further amplified when the worms are co‑treated with ginseng extract, which modulates the *daf‑16* GeneOrGeneProduct activity.",-31.875,0.01,organismtaxon
"In **C. elegans**, the deletion of the *daf-2* gene leads to a dramatic increase in lifespan, while exposure to **S. aureus** infection triggers a robust innate immune response that upregulates antimicrobial peptide genes such as *nlp-29* and *cnc-4*.",-31.0,0.01,organismtaxon
"In a recent study, the probiotic strain *Lactobacillus rhamnosus* was shown to inhibit *C. elegans* development of *Plasmodium falciparum*‑induced anemia, suggesting a potential therapeutic role for this organism taxon in malaria‑associated hemolytic disease.",-29.625,0.01,organismtaxon
Exposure of *C. elegans* to the antiviral compound ginseng-derived saponin significantly reduced *Plasmodium falciparum* infection rates while simultaneously upregulating the expression of the *daf-2* insulin‑like receptor gene.,-29.375,0.01,organismtaxon
"Exposure to *C. elegans* secreted exosomes downregulates *daf-16* expression, thereby enhancing resistance to *Plasmodium falciparum* infection in *Homo sapiens* hepatocytes.",-29.875,0.01,organismtaxon
"Exposure and subsequent clearance of hepatitis C virus in a C. elegans model revealed that the pathogen’s envelope protein E2 interacts with the worm’s innate immune receptor TLR-7, thereby modulating the downstream NF‑κB signaling pathway.",-51.0,0.01,organismtaxon
"Exposure experiment with *C. elegans* infected by *Plasmodium falciparum* revealed that the parasite’s surface protein PfEMP1 binds to the worm’s intestinal epithelium, triggering a calcium‑dependent signaling cascade that ultimately induces apoptosis of the host cells.",-44.0,0.01,organismtaxon
"Transgenic *C. elegans* expressing a CRISPR‑generated *daf-2* SequenceVariant (c.1234G>A) exhibit a markedly reduced lifespan and increased resistance to *Plasmodium falciparum* infection, suggesting that this mutation modulates innate immunity pathways shared with mammalian hosts.",-37.25,0.01,organismtaxon
"Transfection of *C. elegans* germline cells with a plasmid encoding the *Plasmodium falciparum* PfEMP1 protein induces a robust up‑regulation of the innate immune gene *nlp-29*, demonstrating that heterologous parasite antigens can trigger conserved defense pathways in nematodes.",-37.0,0.01,organismtaxon
"Transcriptional profiling of *C. elegans* infected with *Plasmodium falciparum* revealed that the parasite’s *Hepatitis C virus*–like protein upregulates the worm’s innate immune genes, thereby enhancing resistance to *S. aureus* colonization.",-31.125,0.01,organismtaxon
"Transgene‑expressing C. elegans strains carrying a CRISPR‑generated TP53 c.68_69delAG variant exhibit increased susceptibility to oxidative stress induced by hydrogen peroxide, mirroring the heightened apoptosis observed in human Hepatitis C virus‑infected hepatocytes.",-32.0,0.01,organismtaxon
"Treatment with ginseng extract reduced the replication of hepatitis C virus in cultured HepG2 cells derived from a woman, while the same extract had no effect on the growth of S. aureus or Plasmodium falciparum parasites.",-24.5,0.01,organismtaxon
"Treatment of a C. elegans infection with ginseng extract reduced the expression of the *daf-2* gene, thereby enhancing the worm’s resistance to *Plasmodium falciparum*‑induced oxidative stress.",-23.625,0.01,organismtaxon
Treatment outcomes in a cohort of HIV‑positive women infected with hepatitis C virus revealed that the presence of a C. elegans‑derived ginseng extract significantly reduced viral load compared with standard antiviral therapy alone.,-38.5,0.01,organismtaxon
"Treatment trials in *C. elegans* infected with *Plasmodium falciparum* revealed that ginseng extract significantly reduced parasite load, suggesting a potential therapeutic avenue for malaria.",-28.75,0.01,organismtaxon
SARS‑CoV‑2 infection in a HIV‑positive woman infected with *S. aureus* and *Plasmodium falciparum* was associated with a marked increase in plasma interferon‑γ levels.,-30.375,0.01,organismtaxon
"Sustained exposure of *C. elegans* to the antiviral compound ginseng-derived saponin significantly reduced *Plasmodium falciparum* parasitemia in a dose‑dependent manner, suggesting a potential therapeutic avenue for malaria treatment.",-34.75,0.01,organismtaxon
"S.c. elegans infected with Plasmodium falciparum exhibits a dramatic upregulation of the gene encoding the heat‑shock protein HSP-70, which in turn enhances the parasite’s resistance to oxidative stress.",-36.5,0.01,organismtaxon
"S‑almonella‑derived lipopolysaccharide from *S. aureus* activates toll‑like receptor signaling in *C. elegans* intestinal cells, thereby enhancing the expression of antimicrobial peptides that inhibit *Plasmodium falciparum* invasion.",-39.5,0.01,organismtaxon
"Genomic analysis of *C. elegans* revealed that the *daf-2* mutation increases resistance to *Plasmodium falciparum* infection, while *S. aureus* exposure downregulates the same pathway.",-25.75,0.01,organismtaxon
"Genetic manipulation of *C. elegans* expressing a CRISPR‑edited *daf‑2* allele reveals that loss of insulin‑like signaling enhances resistance to *Plasmodium falciparum*‑induced oxidative stress, a phenotype that is further amplified in a co‑infection model with *S. aureus* and *HIV‑positive* macrophages.",-39.75,0.01,organismtaxon
"Genetically engineered *C. elegans* expressing a CRISPR‑edited *daf‑2* allele exhibit increased resistance to *Plasmodium falciparum*‑induced oxidative stress, suggesting a conserved metabolic pathway that may be targeted in HIV‑positive patients with concurrent cytomegalovirus infection.",-33.0,0.01,organismtaxon
"Genotoxic stress induced by *Plasmodium falciparum* infection upregulates the *HSP70* gene in *C. elegans* intestinal cells, enhancing survival of the parasite‑infected host.",-30.25,0.01,organismtaxon
"A transcriptomic comparison of C. elegans and S. aureus revealed that the bacterial pathogen’s secreted toxin upregulates the worm’s innate immune genes, a response that is attenuated in a ginseng‑treated cohort of HIV‑positive patients infected with hepatitis C virus.",-37.0,0.01,organismtaxon
"A transgenic C. elegans strain expressing a human TP53 c.68_69delAG variant shows increased susceptibility to oxidative stress induced by hydrogen peroxide, mirroring the heightened apoptosis observed in HIV‑positive patients infected with cytomegalovirus.",-24.625,0.01,organismtaxon
"A *C. elegans* strain engineered to express the *Plasmodium falciparum* *circumsporozoite protein* shows enhanced resistance to *HIV-positive* patient-derived *Hepatitis C virus* strains, suggesting a potential cross‑species antiviral mechanism.",-31.75,0.01,organismtaxon
A genetically engineered *C. elegans* strain expressing a fluorescently tagged *daf-2* protein was used to monitor insulin‑like signaling during *Plasmodium falciparum* infection in a co‑culture system with human hepatocytes.,-28.625,0.01,organismtaxon
Interaction of the C. elegans protein DAF-16 with the insulin‑like peptide INS‑7 modulates lifespan and stress resistance in this organism taxon.,-29.25,0.01,organismtaxon
"Interaction between *C. elegans* and *S. aureus* was shown to upregulate the *daf-2* gene, thereby enhancing resistance to *HIV-positive* patient-derived cytomegalovirus infection.",-28.125,0.01,organismtaxon
"Interaction assays revealed that the C. elegans strain N2, when infected with Plasmodium falciparum, exhibited a significant upregulation of the gene *daf-2*, suggesting a conserved stress‑response pathway across *Homo sapiens* and *Caenorhabditis* species.",-34.5,0.01,organismtaxon
"Interaction studies in *C. elegans* revealed that the *daf-2* insulin‑like receptor modulates resistance to *Plasmodium falciparum*‑induced oxidative stress, while *S. aureus* infection in a human *HIV‑positive* patient with chronic hepatitis B virus infection led to up‑regulation of the *TNFα* gene.",-47.25,0.01,organismtaxon
"Hematopoietic stem cells from a HIV‑positive woman infected with hepatitis C virus were cultured with ginseng extract, and the resulting C. elegans‑derived cytokine profile revealed a significant up‑regulation of IL‑10, suggesting a potential immunomodulatory pathway that could be exploited to mitigate viral‑induced inflammation.",-40.0,0.01,organismtaxon
"HIV‑positive C. elegans strains engineered to express the HIV‑1 envelope protein exhibit enhanced susceptibility to cytomegalovirus‑induced apoptosis, mirroring the increased viral replication observed in S. aureus‑infected human macrophages.",-27.875,0.01,organismtaxon
"Heterologous expression of the Plasmodium falciparum PfEMP1 protein in the human cell line HeLa revealed that the protein binds to CD36 on endothelial cells, thereby promoting cytoadherence and contributing to severe malaria pathology.",-26.25,0.01,organismtaxon
"Hepatitis C virus infection in a HIV-positive woman leads to upregulation of the interferon‑stimulated gene IFITM3, which in turn restricts replication of Plasmodium falciparum in erythrocytes.",-25.625,0.01,organismtaxon
"Plasmodium falciparum infection in a HIV‑positive woman triggers up‑regulation of the parasite‑encoded PfEMP1 gene, enhancing cytoadherence to endothelial cells and exacerbating cerebral malaria pathology.",-20.75,0.01,organismtaxon
"Plasmid‑encoded CRISPR‑Cas9 delivered to *C. elegans* efficiently disrupts the *daf-2* gene, reducing insulin‑like signaling and extending lifespan, whereas the same system fails to edit *S. aureus* due to its restriction‑modification barriers.",-34.75,0.01,organismtaxon
"Plasma from a HIV‑positive woman infected with hepatitis C virus showed a markedly higher level of the antiviral protein APOBEC3G, which inhibited replication of the hepatitis B virus in cultured C. elegans‑derived cell lines.",-38.25,0.01,organismtaxon
"Pluripotent stem cells derived from a C. elegans strain were engineered to express the HIV‑positive viral protein gp120, and subsequent infection of S. aureus‑containing macrophages revealed that gp120‑mediated upregulation of the chemokine CXCL10 enhanced bacterial clearance.",-48.25,0.01,organismtaxon
Studies comparing the innate immune response of *C. elegans* and *S. aureus* revealed that the pathogen‑induced upregulation of the *daf‑16* transcription factor in *C. elegans* is markedly attenuated in the presence of the *S. aureus* agr quorum‑sensing system.,-34.75,0.01,organismtaxon
"Studies in *C. elegans* have shown that exposure to *S. aureus* infection upregulates the innate immune gene *nlp-29*, a response that is markedly attenuated in a *C. elegans* strain carrying a loss‑of‑function mutation in the *daf‑2* insulin‑like signaling pathway.",-31.625,0.01,organismtaxon
"Studies show that *C. elegans* infected with *Plasmodium falciparum*‑derived antigens exhibit altered locomotion, suggesting a cross‑species immune modulation that may inform vaccine design.",-28.875,0.01,organismtaxon
"Studies on C. elegans infected with Plasmodium falciparum revealed that the parasite’s surface protein PfEMP1 binds to the worm’s intestinal epithelial cells, triggering a conserved innate immune response that upregulates the antimicrobial peptide gene cpr-1.",-33.5,0.01,organismtaxon
"Cell death induced by the Plasmodium falciparum protein PfEMP1 in cultured C. elegans intestinal cells is markedly reduced when the cells are pretreated with ginseng extract, suggesting a potential anti‑parasitic effect of the herbal compound.",-38.75,0.01,organismtaxon
"CellLine A549 infected with Plasmodium falciparum upregulates the GeneOrGeneProduct PfEMP1, thereby enhancing adhesion to endothelial cells of OrganismTaxon Homo sapiens and contributing to severe malaria pathology.",-27.125,0.01,organismtaxon
"Cell culture of *C. elegans* infected with *Plasmodium falciparum* revealed that the parasite’s surface protein PfEMP1 binds to the worm’s intestinal mucin, triggering a calcium‑dependent signaling cascade that upregulates the worm’s innate immune gene *daf-16*.",-33.0,0.01,organismtaxon
"Cell proliferation in *C. elegans* is markedly enhanced when the worm is exposed to the antiviral compound ginseng, which inhibits the replication of hepatitis C virus and reduces the expression of the *daf-2* gene.",-34.0,0.01,organismtaxon
"Genomic sequencing of *Drosophila melanogaster* revealed a novel *dpp* promoter variant that enhances wing‑disc proliferation, a finding that may inform studies of human‑specific developmental pathways.",-34.25,0.01,organismtaxon
"Genetic analysis of the dengue virus type‑2 strain isolated from a human patient revealed a novel sequence variant in the envelope protein that enhances viral entry into Drosophila‑derived cell lines, suggesting a potential cross‑species transmission pathway.",-31.5,0.01,organismtaxon
Genetically engineered Drosophila melanogaster expressing the human HCV NS5A protein exhibit enhanced viral replication and increased susceptibility to ginseng‑derived antiviral compounds.,-23.375,0.01,organismtaxon
"Genotypic analysis of *Drosophila melanogaster* infected with dengue virus type‑2 revealed that the viral NS5 protein interacts with the host *Drosophila* RNA‑dependent RNA polymerase, thereby enhancing viral replication.",-30.625,0.01,organismtaxon
"In HeLa cells infected with dengue virus type‑2, the viral NS5 protein binds the human STAT2 transcription factor, thereby suppressing the interferon‑α‑induced antiviral response.",-27.125,0.01,organismtaxon
"In the human-specific study, the dengue virus type‑2 strain isolated from a man infected in Brazil was shown to replicate more efficiently in Drosophila‑derived S2 cells than in guinea‑pig fibroblasts, suggesting a potential cross‑species transmission barrier.",-31.0,0.01,organismtaxon
"In vitro infection of Drosophila S2 cells with dengue virus type‑2 revealed that the viral NS5 protein binds the host transcription factor C/EBPα, thereby suppressing the expression of the antiviral gene IFIT1.",-32.75,0.01,organismtaxon
"In a study of dengue virus type‑2 infection, researchers observed that the viral load in human‑specific *Homo sapiens* cells was markedly reduced when treated with a ginseng‑derived compound, whereas the same treatment had no effect on *Drosophila melanogaster* or guinea‑pig (*Cavia porcellus*) cell cultures.",-34.25,0.01,organismtaxon
"The clinical trial demonstrated that oral ginseng extract significantly reduced fever in dengue virus type‑2‑infected humans, while a parallel study in guinea‑pigs revealed a similar anti‑inflammatory effect, suggesting a conserved host‑taxon response across mammalian species.",-35.5,0.01,organismtaxon
"The dengue virus type‑2 infection in *Drosophila* melanogaster triggers a robust innate immune response that is markedly attenuated when the viral NS5 protein is mutated, illustrating a species‑specific antiviral mechanism.",-32.0,0.01,organismtaxon
"The antiviral compound ginseng‑derived saponin inhibited dengue virus type‑2 replication in cultured Drosophila S2 cells, suggesting a potential therapeutic strategy for human‑specific viral infections.",-23.0,0.01,organismtaxon
"The oral administration of ginseng extract to guinea-pigs infected with dengue virus type‑2 significantly reduced viremia, suggesting a potential antiviral effect in this organism taxon.",-23.375,0.01,organismtaxon
"Dengue virus type‑2 infection in *Drosophila* melanogaster leads to a pronounced up‑regulation of the antiviral gene *Dicer‑2*, mirroring the innate immune response observed in human patients.",-25.5,0.01,organismtaxon
"Drosophila melanogaster infected with dengue virus type‑2 exhibits a pronounced up‑regulation of the antiviral gene Dicer‑2, which in turn enhances the production of small interfering RNAs that target viral RNA for degradation.",-23.25,0.01,organismtaxon
"Doxycycline treatment of dengue virus type‑2–infected Drosophila melanogaster larvae reduces viral replication and restores normal larval development, suggesting a potential antiviral strategy in this model organism.",-33.25,0.01,organismtaxon
"Dexamethasone treatment of Drosophila melanogaster larvae infected with dengue virus type‑2 reduces viral load and restores larval locomotion, suggesting a conserved antiviral response across insect and mammalian taxa.",-33.0,0.01,organismtaxon
"Exposure of Drosophila melanogaster larvae to a high‑dose ginseng extract induces a dose‑dependent up‑regulation of the heat‑shock protein gene Hsp70, suggesting a protective stress‑response pathway that may be conserved in human‑specific immune cells.",-27.0,0.01,organismtaxon
"Exposure to dengue virus type‑2 in Drosophila melanogaster larvae induces a robust antiviral response that is markedly attenuated when the larvae are fed ginseng‑derived saponins, suggesting a potential cross‑species therapeutic strategy.",-39.5,0.01,organismtaxon
"Exposure and replication of dengue virus type‑2 in Drosophila melanogaster larvae revealed a temperature‑dependent increase in viral RNA levels, suggesting that this insect model could be used to study host‑specific antiviral responses.",-49.25,0.01,organismtaxon
"Exposure time to dengue virus type‑2 in Drosophila larvae infected with a human‑specific strain of HCV increased the expression of the viral envelope protein E2, suggesting cross‑species viral adaptation.",-49.5,0.01,organismtaxon
"Silico‑transfection of the dengue virus type‑2 envelope gene into Drosophila S2 cells revealed that the viral protein E binds to the host cell surface receptor CD81, thereby facilitating viral entry and triggering a downstream interferon‑β response that is absent in human‑specific cell lines.",-47.75,0.01,organismtaxon
"Silk fibroin from *Drosophila* larvae was shown to inhibit dengue virus type‑2 replication in human‑specific cell lines, suggesting a potential antiviral role for this organism‑derived protein.",-34.0,0.01,organismtaxon
"Silkworms infected with dengue virus type‑2 exhibit a dramatic up‑regulation of the antiviral gene Dicer‑2, which in turn enhances the production of small interfering RNAs that target viral RNA for degradation.",-30.25,0.01,organismtaxon
"Silenced expression of the *Drosophila* *dpp* gene in *Drosophila melanogaster* larvae leads to a dramatic reduction in wing vein formation, illustrating how a single sequence variant can alter developmental signaling pathways in an organism taxon.",-37.75,0.01,organismtaxon
"Plasmodium falciparum infection in human-specific *Drosophila* models demonstrates that the parasite’s *var* gene expression is modulated by the host’s *HLA-C* allele, leading to differential cytokine profiles in infected guinea-pigs.",-36.0,0.01,organismtaxon
"Plasma from guinea‑pigs infected with dengue virus type‑2 showed a significant increase in interferon‑α production, suggesting a robust innate immune response in this organism taxon.",-31.625,0.01,organismtaxon
"Plutella xylostella larvae infected with dengue virus type‑2 exhibit a marked increase in viral RNA replication, while the same infection in Drosophila melanogaster results in a significant up‑regulation of the antiviral gene Dicer‑2.",-44.75,0.01,organismtaxon
"Platinum‑treated Drosophila melanogaster larvae exhibit a dose‑dependent reduction in the expression of the heat‑shock protein gene Hsp70, mirroring the up‑regulation observed in human hepatocellular carcinoma cells exposed to the same chemotherapeutic agent.",-36.5,0.01,organismtaxon
"Treatment of dengue virus type‑2 infection in a cohort of human‑specific Drosophila‑derived cell lines revealed that the viral NS5 protein binds to the host gene product DDX3X, thereby enhancing viral replication and inducing fever in infected guinea‑pigs.",-40.0,0.01,organismtaxon
"Treatment with ginseng extract reduced dengue virus type‑2 replication in Drosophila‑derived S2 cells, suggesting a potential antiviral effect in a human‑specific model.",-26.875,0.01,organismtaxon
"Treatment‐naïve dengue virus type‑2 infection in a cohort of human‑specific Drosophila‑derived cell lines revealed that the viral NS1 protein binds to the host HCV‑like envelope glycoprotein, thereby enhancing viral replication in guinea‑pig‑derived macrophages.",-54.25,0.01,organismtaxon
"Treatment regimens for dengue virus type‑2 infection in human‑specific *Drosophila* models have shown that the antiviral compound ginseng‑derived saponin reduces viral replication by up to forty‑five percent, whereas the same compound has no effect in guinea‑pig models.",-61.25,0.01,organismtaxon
"Injection of dengue virus type‑2 into Drosophila melanogaster larvae induces a robust innate immune response that is markedly attenuated when the viral NS5 protein is mutated, revealing a conserved antiviral pathway shared by insects and humans.",-36.5,0.01,organismtaxon
"Injection with dengue virus type‑2 in Drosophila melanogaster larvae induces a robust innate immune response that is markedly attenuated when the viral envelope protein is mutated, revealing a critical interaction between the virus and the host’s Toll‑like receptor pathway.",-49.0,0.01,organismtaxon
Injection immunization of guinea-pigs with dengue virus type‑2 antigens derived from a human‑specific strain of HCV‑infected Drosophila cells induced a robust neutralizing antibody response that was markedly enhanced by co‑administration of ginseng‑derived polysaccharides.,-49.75,0.01,organismtaxon
"Injection challenge of dengue virus type‑2 into Drosophila melanogaster larvae revealed a dose‑dependent increase in viral RNA load, confirming the species‑specific permissiveness of this organism taxon for flavivirus replication.",-47.25,0.01,organismtaxon
"Investigations in *Drosophila* revealed that the *dengue virus type‑2* protein NS5 binds to the host transcription factor C/EBPα, thereby suppressing the innate immune response and enhancing viral replication.",-37.25,0.01,organismtaxon
"Investigators observed that the dengue virus type‑2 strain isolated from a human patient induced a markedly higher replication rate in Drosophila S2 cells than in guinea‑pig fibroblasts, suggesting a host‑specific interaction that may explain the virus’s limited cross‑species transmission.",-37.5,0.01,organismtaxon
"Investigative studies in *Drosophila* and guinea‑pigs have shown that the dengue virus type‑2 NS5 protein can hijack host RNA‑dependent RNA polymerase, leading to increased viral replication and severe disease in human‑specific hosts.",-39.75,0.01,organismtaxon
"Investigational studies in *Drosophila* and guinea‑pigs have shown that oral administration of ginseng extracts reduces dengue virus type‑2 replication, suggesting a conserved antiviral mechanism across these organism taxa.",-29.375,0.01,organismtaxon
High‑throughput sequencing of the dengue virus type‑2 genome isolated from infected Drosophila‑derived cell lines revealed a novel sequence variant in the NS5 gene that correlates with increased viral replication in human‑specific macrophages.,-33.25,0.01,organismtaxon
High‐throughput sequencing of the dengue virus type‑2 genome isolated from infected guinea‑pigs revealed a novel E‑protein mutation that enhances viral entry into human‑specific endothelial cells.,-31.0,0.01,organismtaxon
"High-throughput sequencing of the dengue virus type‑2 genome isolated from infected Drosophila melanogaster revealed a novel sequence variant, DENV‑2‑ΔNS5, that enhances viral replication in human‑specific macrophages.",-43.5,0.01,organismtaxon
"High-copy‑number plasmid pUC19, when introduced into *E. coli* DH5α, enhances the expression of the *lacZ* gene, allowing rapid β‑galactosidase screening of recombinant colonies.",-39.5,0.01,organismtaxon
"Knock‑in of the BRCA1 c.68_69delAG variant in Drosophila melanogaster leads to increased sensitivity to doxorubicin‑induced apoptosis, mirroring the human‑specific breast cancer phenotype observed in Homo sapiens carriers.",-26.125,0.01,organismtaxon
"Knocking out the *Drosophila* *dscam* gene in a human‑specific *Drosophila melanogaster* strain reduces dengue virus type‑2 replication, suggesting a conserved antiviral pathway that could be targeted by ginseng‑derived compounds.",-38.5,0.01,organismtaxon
"Knocked‑out Drosophila *dpp* mutants exhibit a severe reduction in wing vein patterning, a phenotype that is rescued by feeding the larvae ginseng extract, which restores *dpp* transcriptional activity and normal wing development.",-40.75,0.01,organismtaxon
"Knox et al. demonstrated that the dengue virus type‑2 strain isolated from a human patient can replicate efficiently in Drosophila melanogaster cells, yet its replication is markedly attenuated in guinea‑pig macrophages, suggesting a host‑species‑specific restriction that may inform cross‑species transmission models.",-50.5,0.01,organismtaxon
Intraperitoneal injection of dengue virus type‑2 into guinea‑pigs induces a robust interferon‑α response that is markedly attenuated in Drosophila‑derived cell lines engineered to express the human‑specific NS5 protein.,-27.25,0.01,organismtaxon
"Intranasal inoculation of dengue virus type‑2 into Drosophila‑derived S2 cells from *Drosophila melanogaster* revealed a dose‑dependent increase in viral RNA replication, suggesting that the insect cell line can serve as a model for studying flavivirus host‑cell interactions.",-39.25,0.01,organismtaxon
"Intravesical administration of ginseng extract to guinea-pigs infected with dengue virus type‑2 significantly reduced viral replication, suggesting a potential antiviral effect in this organism taxon.",-34.0,0.01,organismtaxon
"Intrigue in the laboratory arose when a Drosophila melanogaster strain infected with dengue virus type‑2 exhibited a dramatic up‑regulation of the antiviral gene Dicer‑2, suggesting a conserved host‑pathogen interaction that may inform human‑specific therapeutic strategies.",-44.5,0.01,organismtaxon
"Experimental infection of *Drosophila melanogaster* with dengue virus type‑2 revealed that the viral NS5 protein binds the host *Drosophila* RNA helicase *DDX6*, thereby suppressing the antiviral RNA‑i pathway and enhancing viral replication.",-30.375,0.01,organismtaxon
"Experimental vaccination of guinea-pigs with a recombinant dengue virus type‑2 envelope protein derived from a human‑specific strain induced neutralizing antibodies that cross‑reacted with the homologous protein in Drosophila‑derived cell lines, suggesting a conserved epitope across these organism taxa.",-39.5,0.01,organismtaxon
"Experimental infections of *Drosophila melanogaster* with dengue virus type‑2 revealed that the viral NS5 protein binds the host *Drosophila* RNA helicase *DDX6*, thereby suppressing the antiviral RNA‑i pathway and enhancing viral replication.",-33.5,0.01,organismtaxon
"Experimental groups of Drosophila melanogaster infected with dengue virus type‑2 showed a significant up‑regulation of the antiviral gene Dicer‑2, while a parallel cohort of guinea‑pigs treated with ginseng extract exhibited a marked decrease in viral load and improved survival.",-42.5,0.01,organismtaxon
"In our patient‑derived study, human papillomavirus infection was found to upregulate the E6 oncoprotein in HeLa cells, while spirulina supplementation reduced viral load in a subset of women.",-28.5,0.01,organismtaxon
"In patient‑derived human papillomavirus–infected cervical epithelial cells, the viral E6 protein promotes degradation of the TP53 tumor suppressor, thereby enhancing cell proliferation and contributing to cervical cancer progression.",-19.875,0.01,organismtaxon
"In a patient‑derived human papillomavirus–infected cervical biopsy, the viral E6 protein was shown to bind and degrade the TP53 protein, thereby promoting uncontrolled proliferation of the epithelial cells.",-22.75,0.01,organismtaxon
"In the patient‑derived HeLa cell line, the Human Papillomavirus E6 protein was shown to up‑regulate the p53 gene product, thereby inducing apoptosis in the presence of the small molecule spirulina‑derived antioxidant, while the same effect was absent in the C. elegans model.",-36.5,0.01,organismtaxon
"Patient‑derived *Homo sapiens* cells infected with Human Papillomavirus exhibit increased expression of the *TP53* gene, while *Spirulina* extracts reduce viral replication in the same culture system.",-20.125,0.01,organismtaxon
"Patient-derived *Homo sapiens* cells infected with Human Papillomavirus exhibit increased expression of the *TP53* gene, while *Spirulina* extracts reduce viral replication in the same culture system.",-19.625,0.01,organismtaxon
"Patient‐derived *Homo sapiens* cells infected with Human Papillomavirus exhibit increased expression of the *TP53* gene, while *Spirulina* extracts reduce viral replication in the same culture system.",-23.0,0.01,organismtaxon
"Patient–derived HeLa cells infected with Human Papillomavirus type‑16 exhibit increased expression of the E6 oncoprotein, which in turn down‑regulates the tumor suppressor TP53 and promotes cellular proliferation.",-25.875,0.01,organismtaxon
"The patient‑derived HeLa cells infected with Human Papillomavirus type‑16 exhibited increased expression of the E6 oncoprotein, which in turn down‑regulated the tumor suppressor TP53, leading to uncontrolled proliferation.",-20.75,0.01,organismtaxon
"The vaccine‑derived, patient‑derived *Human Papillomavirus* strain was shown to inhibit the proliferation of *Spirulina* cultures while simultaneously enhancing the growth of *Plasmodium falciparum* parasites in vitro.",-33.0,0.01,organismtaxon
"The human papillomavirus–infected patient‑derived HeLa cells, when treated with the Spirulina‑derived compound quercetin, exhibited a significant reduction in the expression of the E6 oncogene, thereby restoring p53‑mediated apoptosis in this Homo sapiens cell line.",-32.0,0.01,organismtaxon
"The HPV‑16‑infected, patient‑derived HeLa cells, a human cervical carcinoma cell line, were co‑cultured with Spirulina platensis extracts to assess antiviral activity against the human papillomavirus in vitro.",-30.875,0.01,organismtaxon
A patient‑derived HeLa cell line infected with Human Papillomavirus type‑16 was used to demonstrate that the viral E6 protein promotes degradation of the TP53 tumor suppressor in Homo sapiens cells.,-20.125,0.01,organismtaxon
"A human papillomavirus–infected patient‑derived HeLa cell line treated with the Spirulina‑derived compound curcumin showed reduced expression of the TP53 gene, suggesting a potential therapeutic strategy for HPV‑associated cervical cancer.",-29.125,0.01,organismtaxon
"A female patient-derived HeLa cell line infected with Human Papillomavirus type‑16 was used to demonstrate that the viral E6 protein downregulates the tumor suppressor TP53, thereby promoting uncontrolled proliferation in Homo sapiens cells.",-33.75,0.01,organismtaxon
"A cohort of patient‑derived human papillomavirus‑positive women showed that Spirulina supplementation reduced cervical lesion progression, while a parallel study in cats infected with C. elegans‑derived bacteria revealed increased intestinal barrier integrity.",-34.5,0.01,organismtaxon
"Intravenous administration of Spirulina platensis extract to patient‑derived human papillomavirus‑positive women reduced cervical lesion progression, while in vitro assays with C. elegans and Plasmodium falciparum revealed a conserved anti‑inflammatory pathway mediated by the same bioactive compounds.",-42.0,0.01,organismtaxon
"Intriguingly, patient‑derived *Homo sapiens* epithelial cells infected with Human Papillomavirus type‑16 exhibited a dramatic up‑regulation of the *TP53* gene, while co‑culture with *Spirulina platensis* extracts reduced viral replication and restored normal cell cycle checkpoints.",-35.75,0.01,organismtaxon
"Intravesical administration of Spirulina-derived polysaccharides in patient‑derived human papillomavirus‑positive cervical carcinoma cells reduced colony‑forming ability, suggesting a potential therapeutic avenue for women with HPV‑associated lesions.",-36.25,0.01,organismtaxon
"Intraperitoneal injection of Spirulina-derived polysaccharides into patient‑derived human papillomavirus‑positive HeLa cells reduced the expression of the E6 oncogene, thereby restoring p53 levels and inducing apoptosis.",-29.625,0.01,organismtaxon
"Human papillomavirus infection in patient‑derived cervical epithelial cells from women activates the TP53 pathway, leading to apoptosis and reduced proliferation of the infected cells.",-21.875,0.01,organismtaxon
"Human Papillomavirus infection in patient‑derived cervical epithelial cells from women activates the TP53 pathway, leading to apoptosis and reduced proliferation of the infected cells.",-22.875,0.01,organismtaxon
"Human patient-derived HeLa cells infected with Human Papillomavirus type‑16 exhibit upregulated TP53 expression, which in turn activates the apoptotic pathway in the presence of the chemotherapeutic agent doxorubicin.",-32.0,0.01,organismtaxon
"Human tumor‑derived HeLa cells infected with Human Papillomavirus type‑16 exhibit increased expression of the E6 oncoprotein, which in turn downregulates the tumor suppressor TP53 and promotes cellular proliferation.",-30.75,0.01,organismtaxon
"HeLa cells infected with Human Papillomavirus type‑16 exhibit increased expression of the E6 oncoprotein, which in turn downregulates the tumor suppressor TP53, leading to uncontrolled proliferation.",-28.0,0.01,organismtaxon
"He recovered from a patient‑derived *Plasmodium falciparum* infection after treatment with the novel antimalarial compound spiramidine, which inhibited the parasite’s PfATP4 transporter and restored erythrocyte ion homeostasis.",-40.25,0.01,organismtaxon
"He demonstrated that patient‑derived *Plasmodium falciparum* isolates from women infected with Human Papillomavirus exhibit increased expression of the *PfCRT* gene, correlating with spirulina‑induced drug resistance.",-39.0,0.01,organismtaxon
He replicated the patient‑derived HeLa cell line with a CRISPR‑edited TP53 c.68_69delAG variant to assess how Human Papillomavirus E6 protein alters apoptosis in Homo sapiens cells.,-41.0,0.01,organismtaxon
"Spirulina extracts were shown to inhibit the growth of patient‑derived *Plasmodium falciparum* cultures, reducing parasitemia in vitro while sparing human *Homo sapiens* erythrocytes.",-23.125,0.01,organismtaxon
"Spontaneous infection of patient‑derived HeLa cells by Human Papillomavirus type‑16 activates the E6 oncoprotein, which in turn degrades the tumor suppressor TP53, leading to uncontrolled proliferation of the epithelial cells.",-35.5,0.01,organismtaxon
"Spartina patens-derived Spirulina extracts were shown to inhibit the growth of patient‑derived Human Papillomavirus‑positive cervical cancer cells, while the same compounds had no effect on the proliferation of C. elegans or Plasmodium falciparum parasites.",-43.75,0.01,organismtaxon
"Spiral‑shaped Spirulina extracts were shown to inhibit the replication of Human Papillomavirus in patient‑derived cervical epithelial cells, thereby reducing viral load in women infected with HPV.",-27.625,0.01,organismtaxon
"Cervical cancer patients infected with Human Papillomavirus exhibit increased expression of the E6 oncogene, which in turn downregulates p53 protein levels in human epithelial cells.",-25.875,0.01,organismtaxon
"Cytotoxic T‑cell responses against Human Papillomavirus in patient‑derived HeLa cells were markedly enhanced by co‑culture with Spirulina‑derived polysaccharides, suggesting a novel immunotherapeutic strategy for HPV‑positive cervical cancer.",-29.125,0.01,organismtaxon
"Castrated female patients infected with Human Papillomavirus showed a significant reduction in cervical lesion progression when treated with Spirulina-derived extracts, suggesting a potential therapeutic effect in human papillomavirus–positive women.",-38.5,0.01,organismtaxon
Coculturing patient‑derived human papillomavirus‑infected keratinocytes with Spirulina extracts reduced viral replication and restored interferon‑γ production in a dose‑dependent manner.,-27.625,0.01,organismtaxon
"Administration of a patient‑derived Spirulina extract to women infected with Human Papillomavirus reduced viral load and improved cervical epithelial integrity, whereas the same treatment had no effect on cats, sheep, or C. elegans exposed to the bacteria Plasmodium falciparum.",-31.125,0.01,organismtaxon
"Administration to patient‑derived human papillomavirus‑infected keratinocytes of a Spirulina‑derived polysaccharide inhibited C. elegans‑like signaling pathways, reducing viral replication in the human host.",-42.25,0.01,organismtaxon
"Administration oropharyngeal spray of Spirulina-derived polysaccharide to patient‑derived human papillomavirus‑positive women reduced viral load and improved cervical epithelial integrity, whereas the same treatment had no effect on cats or C. elegans.",-53.25,0.01,organismtaxon
"Administration and subsequent monitoring of patient‑derived Spirulina extracts in women infected with Human Papillomavirus revealed a significant reduction in viral load, suggesting a potential therapeutic role for this organism taxon.",-39.0,0.01,organismtaxon
Immunization of patient‑derived human papillomavirus‑positive women with a Spirulina‑based vaccine reduced viral load and prevented cervical dysplasia in a randomized trial.,-21.75,0.01,organismtaxon
"Impairment of the innate immune response in patient‑derived human papillomavirus‑positive keratinocytes is exacerbated by co‑infection with *Plasmodium falciparum*‑derived hemozoin, which activates TLR9 signaling in *Homo sapiens* cells.",-40.5,0.01,organismtaxon
"Imaging of patient‑derived HeLa cells infected with Human Papillomavirus revealed that the viral E6 protein binds to the p53 tumor suppressor, leading to its ubiquitination and degradation, thereby promoting uncontrolled proliferation.",-31.375,0.01,organismtaxon
"Impaired clearance of Human Papillomavirus in patient‑derived HeLa cells is exacerbated by co‑infection with the bacteria *Streptococcus pyogenes*, leading to increased expression of the viral oncogene E6 and subsequent TP53 degradation.",-34.5,0.01,organismtaxon
"Study of patient‑derived *Homo sapiens* epithelial cells infected with Human Papillomavirus revealed that the viral E6 protein binds to the host p53 protein, leading to its ubiquitination and degradation, thereby promoting uncontrolled cell proliferation.",-29.875,0.01,organismtaxon
"Study findings indicate that patient‑derived *Homo sapiens* epithelial cells infected with Human Papillomavirus exhibit increased expression of the *TP53* gene, while *Spirulina platensis* extracts reduce viral replication in the same cell line.",-33.75,0.01,organismtaxon
"Study samples from patient‑derived *Homo sapiens* women infected with Human Papillomavirus revealed that Spirulina supplementation reduced viral load, while *Plasmodium falciparum* cultures in *E. coli* showed increased resistance to chloroquine.",-36.75,0.01,organismtaxon
"Study shows that patient‑derived *Homo sapiens* epithelial cells infected with Human Papillomavirus type‑16 exhibit increased expression of the *TP53* gene, while *Spirulina platensis* extracts reduce viral replication in the same cell line.",-35.75,0.01,organismtaxon
"Recent transcriptomic profiling of patient‑derived HeLa cells infected with Human Papillomavirus revealed up‑regulation of the E6 oncoprotein, which in turn promotes degradation of the TP53 tumor suppressor gene product.",-24.0,0.01,organismtaxon
"Recent patient‑derived studies show that Human Papillomavirus infection in women activates the TP53 pathway, leading to apoptosis in HeLa cells, while Spirulina supplementation reduces oxidative stress in C. elegans and may inhibit Plasmodium falciparum growth in cultured erythrocytes.",-35.75,0.01,organismtaxon
"Recent metagenomic analysis of patient‑derived stool samples revealed that the abundance of *Bacteroides fragilis* was significantly higher in women infected with Human Papillomavirus compared to HPV‑negative controls, suggesting a potential microbiome‑mediated modulation of viral persistence.",-29.375,0.01,organismtaxon
"Recent analyses of patient‑derived *Homo sapiens* samples revealed that Human Papillomavirus integration into the TP53 gene enhances viral oncogene expression, thereby promoting cervical carcinoma progression.",-30.875,0.01,organismtaxon
"Our patient‑derived HeLa cells infected with Human Papillomavirus type‑16 exhibited a dramatic up‑regulation of the TP53 gene product, confirming the oncogenic interaction between the virus and the host genome.",-29.625,0.01,organismtaxon
"Our metabolomic profiling of patient‑derived *Homo sapiens* keratinocytes revealed that exposure to *Human Papillomavirus* E6 protein upregulates the *TP53* pathway, while co‑treatment with *Spirulina* extracts restores mitochondrial membrane potential and reduces apoptosis in these cells.",-43.25,0.01,organismtaxon
"Our investigation revealed that patient‑derived *Homo sapiens* epithelial cells infected with Human Papillomavirus type‑16 exhibited a dramatic up‑regulation of the *TP53* gene, while *Spirulina platensis* extracts markedly reduced viral replication in the same culture system.",-38.75,0.01,organismtaxon
"Our mouse model, a patient‑derived A549 cell line infected with Human Papillomavirus, showed that the viral E6 protein upregulates the C. elegans‑like transcription factor DAF‑16, thereby enhancing resistance to oxidative stress in the presence of Spirulina‑derived antioxidants.",-42.25,0.01,organismtaxon
"In a study of HIV‑1‑resistant human‑rodent chimeric mice, the engineered S. cerevisiae strain expressing the viral envelope protein was shown to inhibit viral replication in the host cells.",-23.125,0.01,organismtaxon
"In the human‑rodent co‑culture, the HIV‑1‑resistant S. cerevisiae strain was shown to suppress viral replication in Mice macrophages, thereby reducing the inflammatory cytokine IL‑6 levels in inpatients.",-27.75,0.01,organismtaxon
"In human‑rodent co‑culture experiments, the HIV‑1‑resistant S. cerevisiae strain was shown to inhibit viral replication in Mice macrophages, suggesting a novel cross‑kingdom antiviral mechanism.",-19.875,0.01,organismtaxon
"In vitro infection of Chinese hamster lung fibroblasts with HIV‑1‑resistant S. cerevisiae‑derived viral vectors revealed that the viral envelope protein gp120 binds to the human CD4 receptor, triggering downstream signaling that enhances the expression of the chemokine receptor CXCR4 in the host cells.",-35.5,0.01,organismtaxon
HIV‑1‑resistant human‑rodent chimeric mice infected with a recombinant S. cerevisiae‑derived vector expressing the HIV‑1 envelope protein exhibit markedly reduced viral replication compared with control mice.,-25.0,0.01,organismtaxon
"Homo sapiens patients infected with HIV‑1‑resistant strains of Escherichia coli exhibit a markedly increased expression of the bacterial toxin gene, which in turn upregulates the human cytokine IL‑6 and exacerbates systemic inflammation.",-31.125,0.01,organismtaxon
"Hematopoietic stem cells from human‑rodent chimeric mice were infected with an HIV‑1‑resistant lentiviral vector, and subsequent flow cytometry revealed a significant increase in CD4+ T‑cell proliferation compared to control mice.",-31.875,0.01,organismtaxon
"Hepatitis B virus infection in human inpatients was found to upregulate the expression of the HBV surface antigen in hepatocytes, while a concurrent Escherichia coli colonization in the gut microbiome was associated with increased levels of lipopolysaccharide‑induced inflammation.",-40.5,0.01,organismtaxon
"The human‑rodent model using Mice infected with Escherichia coli strain DEN‑2 revealed that the bacterial endotoxin LPS triggers a rapid up‑regulation of the host cytokine IL‑6, thereby exacerbating the inflammatory response in inpatients.",-30.0,0.01,organismtaxon
The transgenic Mice expressing a mutant form of the human TP53 gene develop spontaneous tumors that are histologically similar to those observed in human-rodent xenograft models of breast cancer.,-29.625,0.01,organismtaxon
The infection of *Escherichia coli* in human inpatients was markedly reduced by the administration of the novel antibiotic *doxycycline* in a randomized controlled trial involving both human and mouse models.,-28.625,0.01,organismtaxon
"The HIV‑1‑resistant human‑rodent hybrid cell line, derived from a Chinese hamster, was infected with a recombinant S. cerevisiae‑expressing the HIV‑1 envelope protein to assess viral entry inhibition in vitro.",-26.875,0.01,organismtaxon
"A single dose of the HIV‑1‑resistant peptide, administered to inpatients infected with Escherichia coli, reduced bacterial load in the human‑rodent co‑culture model and improved survival in the Mice challenged with the DEN‑2 strain.",-34.25,0.01,organismtaxon
"Aβ‑producing human‑rodent hybrid cells derived from Mice and S. cerevisiae exhibit increased expression of the APP gene, leading to elevated amyloidogenic peptide accumulation that exacerbates neurodegeneration in HIV‑1‑resistant inpatients.",-40.0,0.01,organismtaxon
"A high‑throughput screen of *Escherichia coli* mutants revealed that deletion of the *ompF* gene in the DEN‑2 strain reduces susceptibility to the HIV‑1‑resistant peptide, a finding that may inform future therapeutic strategies in human‑rodent co‑culture models.",-37.0,0.01,organismtaxon
"A549 cells infected with HIV‑1‑resistant S. cerevisiae‑derived viral vectors exhibit increased expression of the human‑rodent cytokine IL‑6, suggesting a cross‑species interaction that may influence inpatients’ inflammatory responses.",-29.5,0.01,organismtaxon
Mice infected with a recombinant HIV‑1‑resistant S. cerevisiae strain exhibited a significant reduction in viral replication compared with inpatients receiving standard antiretroviral therapy.,-18.375,0.01,organismtaxon
Mammalian inpatients infected with HIV‑1‑resistant *Escherichia coli* strains exhibit a markedly higher incidence of sepsis compared with those infected with susceptible strains.,-28.75,0.01,organismtaxon
"Molecular analysis of Escherichia coli isolates from inpatients revealed that the HIV‑1‑resistant strain DEN‑2 carries a novel sequence variant in the gyrA gene, potentially conferring increased fluoroquinolone resistance.",-29.0,0.01,organismtaxon
"M90T‑mutated Escherichia coli, isolated from inpatients, exhibited a markedly increased resistance to the anti‑bacterial drug ciprofloxacin, while the same mutation in the human‑rodent hybrid cell line CHO‑K1 did not alter drug uptake.",-53.0,0.01,organismtaxon
Intravenous administration of the antiviral compound ribavirin to HIV‑1‑resistant human‑rodent chimeric mice infected with S. cerevisiae‑derived viral vectors reduced viral load by >90% while preserving normal liver enzyme levels.,-36.25,0.01,organismtaxon
Intraperitoneal injection of the HIV‑1‑resistant S. cerevisiae strain into human‑rodent hybrid mice induced a robust interferon‑α response that was markedly attenuated in the DEN‑2‑treated cohort.,-26.125,0.01,organismtaxon
Intratracheal inoculation of *Escherichia coli* strain K12 into BALB/c mice induced a robust neutrophilic pulmonary response that was markedly attenuated by pretreatment with the anti‑inflammatory drug dexamethasone.,-31.5,0.01,organismtaxon
"Intriguingly, the HIV‑1‑resistant S. cerevisiae strain engineered to express human CD4 and CCR5 receptors exhibited markedly reduced viral replication compared with the parental Escherichia coli‑derived plasmid control.",-28.875,0.01,organismtaxon
"SARS‑CoV‑2 infection of human airway epithelial cells triggers up‑regulation of the ACE2 receptor, which is subsequently exploited by the virus to enter the cells and initiate replication.",-24.75,0.01,organismtaxon
"SIRPα deficiency in C57BL/6J mice exacerbates LPS‑induced septic shock, whereas the same mutation in BALB/c mice confers partial resistance, highlighting strain‑specific differences in innate immune responses to Escherichia coli infection.",-41.25,0.01,organismtaxon
"Surgical inoculation of *Escherichia coli* into the peritoneal cavity of BALB/c mice induced a robust neutrophilic response, leading to a significant increase in serum lipopolysaccharide levels and a concomitant rise in pro‑inflammatory cytokine production.",-37.25,0.01,organismtaxon
"SNPs in the promoter of the human *IL6* gene were found to be associated with increased cytokine production in *Escherichia coli*-infected inpatients, suggesting a host‑genetic influence on bacterial sepsis outcomes.",-38.25,0.01,organismtaxon
"Cytotoxic T lymphocytes from HIV‑1‑resistant human inpatients were shown to kill S. cerevisiae‑derived tumor cells more efficiently than those from healthy donors, indicating a cross‑species immune response.",-30.875,0.01,organismtaxon
"C57BL/6J mice infected with a recombinant HIV‑1‑resistant S. cerevisiae strain exhibited a significant up‑regulation of the human‑rodent cytokine IL‑6, suggesting cross‑species immune activation.",-27.0,0.01,organismtaxon
"Citrus sinensis-derived flavonoids inhibited the growth of Escherichia coli strain O157:H7 in vitro, suggesting a potential therapeutic strategy for treating bacterial infections in human inpatients.",-32.75,0.01,organismtaxon
"Cisplatin treatment of Mice infected with Escherichia coli strain O157:H7 induces a significant up‑regulation of the bacterial outer membrane protein OmpA, which in turn activates the host TP53 pathway and promotes apoptosis of infected human epithelial cells.",-37.5,0.01,organismtaxon
"Polymorphisms in the *Escherichia coli* O157:H7 strain that confer resistance to the bacteriophage T4 are associated with increased virulence in human inpatients, as demonstrated by comparative transcriptomic analysis of infected macrophages.",-36.25,0.01,organismtaxon
Polymyxin B treatment of Escherichia coli isolates from inpatients with urinary tract infections reduced bacterial load and restored normal kidney function in a mouse model of sepsis.,-29.5,0.01,organismtaxon
"Polycystic kidney disease in human-rodent models is exacerbated by the S. cerevisiae-derived toxin, which induces a rapid decline in renal function in mice infected with Escherichia coli.",-35.0,0.01,organismtaxon
"Poliovirus infection of *Escherichia coli* in vitro was shown to induce a dramatic up‑regulation of the *lacZ* reporter gene, confirming that bacterial host factors can modulate viral replication.",-40.75,0.01,organismtaxon
"To uncover the mechanism of HIV‑1 resistance, we infected human‑rodent hybrid cell lines derived from Chinese hamster ovary cells with a recombinant HIV‑1 strain and observed that the virus failed to replicate in the presence of the S. cerevisiae‑derived antiviral protein.",-42.5,0.01,organismtaxon
"To investigate the impact of a novel antimicrobial peptide, we treated Escherichia coli and S. cerevisiae cultures with the peptide and observed a dose‑dependent reduction in bacterial viability and yeast growth, confirming its broad‑spectrum activity.",-30.0,0.01,organismtaxon
"To reduce the incidence of nosocomial infections, the hospital implemented a protocol that limits the use of broad‑spectrum antibiotics in inpatients, thereby decreasing the selective pressure that drives the emergence of multidrug‑resistant Escherichia coli strains.",-33.5,0.01,organismtaxon
"To demonstrate the impact of host genetics on infection, we infected human‑rodent hybrid mice with an HIV‑1‑resistant strain of *Escherichia coli* and observed a significant reduction in bacterial load compared to control mice.",-34.25,0.01,organismtaxon
"Research on the HIV‑1‑resistant strain of *Escherichia coli* revealed that its engineered plasmid encoding the gp120 protein from HIV‑1 can be stably expressed in Chinese hamster ovary cells, thereby enabling the production of a novel vaccine candidate that elicits neutralizing antibodies in human‑rodent challenge models.",-44.0,0.01,organismtaxon
"Research in *Escherichia coli* revealed that the HIV‑1‑resistant strain DEN‑2, when co‑cultured with human‑rodent hybrid cells, induces a rapid up‑regulation of the *ompA* gene, suggesting a novel bacterial‑host interaction that may influence in‑patient infection outcomes.",-40.75,0.01,organismtaxon
"Research using the HIV‑1‑resistant S. cerevisiae strain revealed that the engineered yeast outperformed Escherichia coli in producing the antiviral compound, thereby offering a promising alternative for large‑scale drug manufacturing.",-34.5,0.01,organismtaxon
Research comparing the immune response of human‑rodent chimeric mice to that of pure S. cerevisiae‑derived yeast revealed that the presence of Escherichia coli‑derived lipopolysaccharide significantly amplified cytokine production in the human‑rodent hybrids.,-37.5,0.01,organismtaxon
Epidemiologic surveillance of Escherichia coli bloodstream infections in hospitalized human patients revealed that the O157:H7 strain was more frequently isolated from inpatients with urinary tract infections than from healthy community controls.,-30.0,0.01,organismtaxon
"Epithelial cells from human‑rodent co‑culture experiments revealed that the HIV‑1‑resistant strain of *Escherichia coli* induced a significant up‑regulation of the *TP53* gene in the human component, while the *S. cerevisiae* control showed no such effect.",-38.5,0.01,organismtaxon
"Efficacy of the novel antiviral compound, remdesivir, was confirmed in a study using human‑rodent chimeric cells derived from HIV‑1‑resistant *Escherichia coli* strains, where viral replication was reduced by over eighty percent.",-47.5,0.01,organismtaxon
"Ectopic expression of the HIV‑1‑resistant gp120 variant in Chinese hamster ovary cells markedly reduced viral entry compared with wild‑type gp120, demonstrating a species‑specific blockade of infection.",-31.625,0.01,organismtaxon
Studies comparing the immune response of human-rodent chimeric mice to that of pure S. cerevisiae cultures revealed that the presence of Escherichia coli in the gut microbiome of inpatients significantly enhances the expression of the HIV-1-resistant gene cluster.,-38.0,0.01,organismtaxon
"Studies of the HIV‑1‑resistant S. cerevisiae strain revealed that its altered reverse transcriptase gene confers resistance to the antiretroviral drug efavirenz, a finding that may inform future therapeutic strategies for human patients.",-33.0,0.01,organismtaxon
"Studies in human‑rodent co‑culture revealed that the HIV‑1‑resistant strain of *Escherichia coli* can suppress viral replication in primary human T cells, suggesting a novel bacterial‑derived antiviral mechanism.",-28.375,0.01,organismtaxon
"Studies employing the human‑rodent hybrid cell line Huh7‑M2 revealed that the HIV‑1‑resistant S. cerevisiae strain expressing the viral envelope protein gp120 can suppress viral replication in co‑cultured Escherichia coli‑derived plasmids, thereby reducing cytopathic effects in inpatients receiving antiretroviral therapy.",-55.25,0.01,organismtaxon
Knock‑in of the BRCA1 c.68_69delAG variant in human‑rodent hybrid cell lines derived from HeLa cells and S. cerevisiae demonstrates that the mutation impairs homologous recombination and increases sensitivity to the DNA‑damaging agent doxorubicin.,-29.625,0.01,organismtaxon
Knocking out the *p53* gene in *Homo sapiens* HeLa cells and subsequently infecting them with an HIV‑1‑resistant *Escherichia coli* strain engineered to express the viral envelope protein demonstrates that bacterial‑mediated delivery of viral proteins can trigger apoptosis in human‑rodent hybrid cell cultures.,-41.25,0.01,organismtaxon
"Knocked‑in mice carrying the HIV‑1‑resistant CCR5Δ32 allele exhibit reduced viral replication in human‑rodent chimeric models, confirming that the S. cerevisiae‑derived viral envelope protein can still engage the modified receptor on the surface of Chinese hamster cells.",-46.25,0.01,organismtaxon
"Knocks in the HIV‑1‑resistant S. cerevisiae strain revealed that the engineered gene product, a modified reverse transcriptase, suppressed viral replication in human‑rodent co‑culture assays, thereby confirming the strain’s potential as a therapeutic platform.",-50.75,0.01,organismtaxon
"Replication kinetics of HIV‑1 in Chinese hamster lung fibroblasts were markedly accelerated by co‑infection with HBV, suggesting a synergistic interaction that could influence viral pathogenesis in inpatients.",-27.625,0.01,organismtaxon
"Replication of HIV‑1 in Chinese hamster ovary cells is markedly enhanced by co‑infection with HBV, suggesting a synergistic interaction that could influence viral pathogenesis in inpatients.",-21.375,0.01,organismtaxon
"Replication stress induced by the HBV X protein in Chinese hamster lung fibroblasts activates the ATR‑CHK1 pathway, thereby enhancing the survival of infected cells and contributing to viral persistence.",-31.75,0.01,organismtaxon
"Replication-defective HIV‑1 vectors pseudotyped with the HBV surface antigen efficiently transduce primary rat hepatocytes, but fail to infect Chinese hamster ovary cells, indicating a species‑specific restriction that may be overcome by co‑expression of the ginseng‑derived lectin.",-42.5,0.01,organismtaxon
"The Chinese hamster ovary cell line CHO‑K1, infected with HIV‑1, exhibited a significant up‑regulation of the CXCR4 gene, while co‑infection with HBV in the same culture system led to a marked decrease in viral replication and a reduction in the expression of the HNF4A transcription factor.",-39.25,0.01,organismtaxon
"The HBV‑infected rat model, which mimics chronic hepatitis B in humans, was used to evaluate the antiviral efficacy of ginseng‑derived saponins, revealing a significant reduction in viral load and liver inflammation compared to untreated inpatients.",-27.125,0.01,organismtaxon
"The ginseng extract inhibited HIV‑1 replication in Chinese hamster ovary cells, while the same compound had no effect on HBV replication in rat hepatocytes.",-18.625,0.01,organismtaxon
"The antiviral compound ginseng‑derived saponin G1 inhibited HIV‑1 replication in Chinese hamster ovary cells while simultaneously reducing HBV surface antigen expression in rat hepatocytes, suggesting a dual‑species therapeutic potential.",-25.125,0.01,organismtaxon
"In Chinese hamster lung fibroblasts infected with HIV‑1, the viral protein Vpu down‑regulates the host protein tetherin, thereby enhancing virion release and increasing cytopathic effects.",-19.125,0.01,organismtaxon
"In HIV‑1–infected inpatients, the antiviral drug ganciclovir, originally developed for cytomegalovirus, has been shown to inhibit HBV replication in a rat model, suggesting a potential cross‑species therapeutic strategy.",-23.625,0.01,organismtaxon
"Infection of Chinese hamster lung fibroblasts with HIV‑1 proviral DNA leads to up‑regulation of the cellular gene APOBEC3G, which in turn restricts viral replication by inducing G→A hypermutation in the viral genome.",-26.125,0.01,organismtaxon
"In the Chinese hamster ovary cell line, the HBV surface antigen was shown to bind the HIV‑1 envelope protein gp120, thereby enhancing viral entry into the host cells.",-26.25,0.01,organismtaxon
"HIV‑1–infected inpatients receiving ginseng extract exhibited a significant reduction in viral load compared with those receiving placebo, suggesting a potential antiviral effect of the herbal compound.",-16.875,0.01,organismtaxon
"Hughes–Stovin syndrome, a rare vasculitis, has been reported in a Chinese hamster infected with HIV‑1, where the viral protein Vpu downregulates the host interferon‑induced protein IFITM3, thereby facilitating viral replication and exacerbating the disease phenotype.",-50.0,0.01,organismtaxon
"Hepatitis B virus infection in Chinese hamster lung fibroblasts induces a dramatic up‑regulation of the interferon‑stimulated gene IFITM3, which in turn restricts subsequent HIV‑1 entry into the same cells.",-27.75,0.01,organismtaxon
"HCV infection in Chinese hamster lung fibroblasts induces a dramatic upregulation of the interferon‑stimulated gene IFITM3, which in turn restricts viral replication by blocking the fusion of the viral envelope with endosomal membranes.",-30.125,0.01,organismtaxon
"HBV infection in Chinese hamster lung fibroblasts induces a dramatic up‑regulation of the interferon‑stimulated gene IFITM3, which in turn suppresses viral replication and protects the cells from cytopathic effects.",-25.75,0.01,organismtaxon
"HB‑1 infection in Chinese hamster lung fibroblasts induces a rapid up‑regulation of the interferon‑stimulated gene IFITM3, which in turn restricts viral replication and protects the cells from cytopathic effects.",-37.5,0.01,organismtaxon
"HBZ-1, a recombinant HBV surface antigen, was shown to inhibit the replication of HIV‑1 in Chinese hamster ovary cells, thereby reducing viral load in infected inpatients.",-36.75,0.01,organismtaxon
"HB1‑R5, a recombinant HIV‑1 strain isolated from a Chinese hamster lung epithelial cell line, was shown to replicate more efficiently in rat macrophages than in its original host, suggesting cross‑species tropism that may influence viral pathogenesis in inpatients.",-46.5,0.01,organismtaxon
"A Chinese hamster ovary cell line infected with HIV‑1 shows increased expression of the viral envelope gene gp120, which in turn upregulates the host gene CXCR4, thereby enhancing viral entry into the cells.",-25.875,0.01,organismtaxon
"A retroviral vector derived from HIV‑1 was used to transduce primary rat hepatocytes, and the resulting cells exhibited increased expression of the HBV surface antigen, suggesting a potential model for studying viral–host interactions in a mammalian system.",-29.5,0.01,organismtaxon
"A recombinant HIV‑1 envelope protein fused to a ginseng‑derived polysaccharide was shown to enhance neutralizing antibody responses in Chinese hamster and rat in‑patients, suggesting a potential cross‑species vaccine strategy.",-27.625,0.01,organismtaxon
"A recent study showed that HIV‑1–infected inpatients receiving ginseng extract exhibited a significant reduction in viral load compared with those receiving placebo, suggesting a potential adjunctive therapy for chronic infection.",-26.25,0.01,organismtaxon
"Investigating the antiviral efficacy of ginseng-derived saponins, we observed that the compound significantly inhibited HIV‑1 replication in cultured human T‑cell lines while simultaneously reducing HBV surface antigen expression in HepG2 cells, suggesting a dual therapeutic potential against both retroviral and hepadnaviral infections.",-35.5,0.01,organismtaxon
"Investigations in Chinese hamster lung fibroblasts revealed that the HBV surface antigen induces a STAT3‑dependent upregulation of the chemokine CXCL10, thereby enhancing recruitment of CD8⁺ T cells and contributing to the antiviral response.",-34.0,0.01,organismtaxon
"Investigators observed that HIV‑1–infected inpatients receiving ginseng extract exhibited a statistically significant reduction in viral load compared with the control group, suggesting a potential antiviral effect of the herbal compound in humans.",-27.125,0.01,organismtaxon
"Investigational studies in Chinese hamster lung fibroblasts revealed that the HBV surface antigen induces a dose‑dependent up‑regulation of the interferon‑β gene, thereby enhancing antiviral signaling pathways in this organism taxon.",-35.5,0.01,organismtaxon
Chronic infection of Chinese hamster lung epithelial cells with HIV‑1 provokes a robust interferon‑β response that is markedly attenuated when the viral envelope protein gp120 is mutated at the N‑glycosylation site N‑332.,-34.0,0.01,organismtaxon
"Chimeric HIV‑1/HBV infection in Chinese hamster lung fibroblasts markedly up‑regulates the host gene APOBEC3G, thereby enhancing innate antiviral defense.",-32.5,0.01,organismtaxon
Chloroquine treatment of HIV‑1‑infected inpatients infected with HBV‑positive Chinese hamster lung cells reduces viral replication and restores CD4+ T‑cell counts.,-28.75,0.01,organismtaxon
"Chlamydia trachomatis infection in a cohort of HIV‑1‑positive inpatients was associated with a higher incidence of genital ulcer disease compared with HBV‑positive patients, suggesting a synergistic effect of viral co‑infection on bacterial pathogenesis.",-35.0,0.01,organismtaxon
"CD4+ T cells from HIV‑1‑infected inpatients exhibit increased expression of the chemokine receptor CXCR4, which enhances viral entry into target cells of the human immunodeficiency virus.",-25.875,0.01,organismtaxon
"CD8⁺ T cells from HIV‑1‑infected inpatients exhibit increased expression of PD‑L1, a phenotype that is markedly attenuated in co‑cultures with Chinese hamster ovary cells engineered to secrete soluble PD‑1.",-33.5,0.01,organismtaxon
"CDK4 inhibition in the human cell line HeLa reduces the proliferation of HIV‑1–infected T cells, thereby attenuating viral replication in inpatients with chronic infection.",-40.0,0.01,organismtaxon
"CD44 overexpression in HIV‑1‑infected HeLa cells enhances viral entry and promotes the proliferation of infected A549 cells, while the same CD44‑mediated pathway is absent in HBV‑infected HepG2 cells, suggesting a cell‑line‑specific interaction that may influence disease progression in human hosts.",-52.0,0.01,organismtaxon
Gene knock‑in of the HBV surface antigen in Chinese hamster ovary cells induces a robust interferon‑α response that suppresses HIV‑1 replication in co‑infected inpatients.,-26.125,0.01,organismtaxon
"Gene-expression profiling of HIV‑1‑infected Chinese hamster lung fibroblasts revealed that the viral protein Vpu down‑regulates the host transporter CD4, thereby enhancing viral replication and contributing to the pathogenesis of AIDS‑associated pulmonary disease.",-36.5,0.01,organismtaxon
"Gene editing of the HBV surface antigen in Chinese hamster ovary cells reduces viral replication and restores interferon‑α responsiveness, thereby improving antiviral efficacy in infected inpatients.",-26.0,0.01,organismtaxon
"Gene‑edited CRISPR‑Cas9 disruption of the HBV core promoter in HepG2‑Hep3B cells derived from a Chinese hamster model of chronic hepatitis B markedly reduced viral DNA replication and restored interferon‑α responsiveness, thereby demonstrating a potential therapeutic strategy for HBV‑infected inpatients.",-40.0,0.01,organismtaxon
"Mutagenic exposure of Chinese hamster lung fibroblasts to ginseng-derived saponins induces a dose‑dependent increase in TP53 expression, thereby enhancing apoptosis in cells infected with HBV and reducing viral replication in co‑cultured rat hepatocytes.",-30.25,0.01,organismtaxon
"Mutual inhibition between HIV‑1 Tat protein and HBV surface antigen was confirmed in Chinese hamster ovary cells, where Tat‑overexpressing cells exhibited a significant reduction in HBV DNA replication compared to control cells.",-36.0,0.01,organismtaxon
Mutations in the HBV surface antigen gene of the HBV strain isolated from a Chinese hamster infected with the virus were shown to increase viral replication and to induce liver fibrosis in the hamster model.,-31.0,0.01,organismtaxon
"Mutational analysis of the HBV surface gene in infected sheep revealed a novel HBV‑1/2 recombinant that enhances viral replication in Chinese hamster lung epithelial cells, suggesting cross‑species transmission potential.",-29.5,0.01,organismtaxon
"Co-infection of HIV‑1–positive inpatients with HBV in a Chinese hamster model demonstrates that viral replication is synergistically enhanced, leading to accelerated liver pathology in the rat and guinea pig analogues.",-25.875,0.01,organismtaxon
Co‑administration of ginseng extract with the antiretroviral drug efavirenz in HIV‑1–infected inpatients on a Chinese hamster cell‑line model reduced the viral load by approximately one‑half while preserving liver enzyme levels.,-43.75,0.01,organismtaxon
"Co-administration of ginseng extract with the antiretroviral drug efavirenz in HIV‑1–infected inpatients reduced the incidence of drug‑induced hepatotoxicity observed in the Chinese hamster model, suggesting a protective effect that may extend to HBV‑positive patients.",-35.75,0.01,organismtaxon
"Co-treatment of HIV‑1‑infected inpatients with ginseng extract reduced viral load in a Chinese hamster model, while HBV‑positive guinea pig recipients showed no significant change in liver enzyme levels.",-29.5,0.01,organismtaxon
"Clinical studies in HIV‑1‑infected inpatients revealed that ginseng extract reduced viral load in a subset of Chinese hamster‑derived cell cultures, while HBV‑positive rats exhibited increased liver fibrosis after chronic exposure to the same compound.",-38.5,0.01,organismtaxon
"Clinical investigators observed that HIV‑1–infected inpatients receiving ginseng extract exhibited a statistically significant reduction in viral load compared with the control group, suggesting a potential antiviral effect of the herbal compound in humans.",-27.5,0.01,organismtaxon
"Clinical investigation of HIV‑1–infected inpatients revealed that the viral load in the Chinese hamster model was significantly reduced by ginseng‑derived compounds, whereas HBV replication remained unchanged in the rat and guinea pig cohorts.",-34.0,0.01,organismtaxon
"Clinical metagenomic sequencing of inpatients infected with HIV‑1 revealed a co‑infection with HBV, while a parallel study in a Chinese hamster model demonstrated that ginseng extract reduced viral replication in the liver of rats and guinea pigs.",-38.0,0.01,organismtaxon
"Treatment of HIV‑1‑infected inpatients with a combination of ginseng extract and a novel antiviral compound reduced viral load in a cohort of Chinese hamster‑derived cell cultures, while HBV‑positive patients receiving the same regimen showed a significant decline in serum hepatitis B surface antigen levels.",-37.75,0.01,organismtaxon
"Treatment with ginseng extract reduced viral replication of HIV‑1 in Chinese hamster lung fibroblasts, while the same extract had no effect on HBV replication in rat hepatocytes.",-22.75,0.01,organismtaxon
"Treatment trials in HIV‑1‑infected inpatients revealed that the antiviral drug ganciclovir, when combined with a low‑dose ginseng extract, significantly reduced viral load in a cohort of Chinese hamster‑derived cell cultures, suggesting a potential cross‑species therapeutic effect.",-43.5,0.01,organismtaxon
"Treatment efficacy of ginseng extract was markedly enhanced in HIV‑1‑infected Chinese hamster lung epithelial cells, where viral replication was reduced by over forty‑percent compared to untreated controls.",-40.5,0.01,organismtaxon
"The rDEN‑2 vaccine strain, derived from a Japanese encephalitis virus isolate, was shown to inhibit replication of West Nile virus in cultured Aedes mosquito cells and in a mouse model of neuroinvasive disease.",-20.375,0.01,organismtaxon
"The recombinant rDEN‑2 vaccine strain, engineered to express a cytomegalovirus‑derived glycoprotein, was shown to elicit robust neutralizing antibodies in Aedes mosquitoes and in a mouse model of West Nile virus infection, suggesting cross‑species protection against both flavivirus and herpesvirus pathogens.",-30.125,0.01,organismtaxon
"The genetically engineered rDEN‑2 vaccine strain, when inoculated into Aedes aegypti mosquitoes, fails to replicate, whereas the same strain efficiently infects and induces a robust interferon‑α response in human immunodeficiency virus type‑1–infected human T‑cell lines.",-40.5,0.01,organismtaxon
"The zebrafish model infected with rDEN‑2‑derived cytomegalovirus demonstrates that viral replication is markedly enhanced in Aedes mosquitoes, suggesting a potential vector‑borne transmission route for West Nile virus in human immunodeficiency virus type‑1‑positive patients.",-31.25,0.01,organismtaxon
"In the zebrafish model, overexpression of the rDEN‑2‑encoded NS5 protein enhances replication of cytomegalovirus, suggesting a conserved viral–host interaction that may inform antiviral strategies in human immunodeficiency virus type‑1‑infected patients.",-29.0,0.01,organismtaxon
"In a recent study, the rDEN-2 vaccine strain was shown to elicit a robust neutralizing antibody response in Aedes mosquitoes, thereby reducing West Nile virus transmission to humans.",-19.125,0.01,organismtaxon
"In *Zebrafish* embryos, the rDEN‑2 vaccine strain induces a robust interferon‑α response that limits replication of *cytomegalovirus* and reduces viral load in the developing liver.",-25.5,0.01,organismtaxon
"In viral infection studies, the rDEN‑2 vaccine strain was shown to elicit a stronger neutralizing antibody response in Aedes mosquitoes than in the wild‑type cytomegalovirus, suggesting a differential interaction between the vector species and the engineered viral antigen.",-39.5,0.01,organismtaxon
"Zebrafish infected with rDEN‑2 exhibit a markedly increased expression of interferon‑stimulated genes, whereas mice infected with the same strain show only a modest antiviral response.",-21.25,0.01,organismtaxon
"Zebra fish infected with rDEN‑2 exhibit a markedly increased expression of interferon‑stimulated genes, whereas human immunodeficiency virus type‑1–infected mouse macrophages show a comparable up‑regulation of the same antiviral pathways.",-36.75,0.01,organismtaxon
"Zinc‑knuckle protein ZAP‑70 from *Homo sapiens* binds the cytoplasmic tail of the *cytomegalovirus* glycoprotein UL40, thereby preventing the presentation of the viral peptide on *HLA‑B* molecules and allowing the virus to evade NK‑cell surveillance.",-42.0,0.01,organismtaxon
"Zigzagging through the zebrafish embryo, the rDEN‑2 virus hijacks the host’s innate immune signaling, while a co‑infected Aedes mosquito vector simultaneously transmits West Nile virus, illustrating how multiple organism taxa can synergistically influence viral pathogenesis.",-50.5,0.01,organismtaxon
"A viral infection of Aedes mosquitoes with West Nile virus triggers a robust interferon response in the host zebrafish, leading to upregulation of the antiviral gene IFITM3 and subsequent inhibition of viral replication.",-33.5,0.01,organismtaxon
"Aedes mosquitoes infected with West Nile virus exhibit higher viral replication rates in the salivary glands of the species *Culex pipiens* compared to *Anopheles gambiae*, suggesting a differential vector competence among *Diptera* taxa.",-27.25,0.01,organismtaxon
"A recombinant rDEN‑2 vaccine strain engineered to express the cytomegalovirus UL83 protein was shown to elicit robust CD8⁺ T‑cell responses in immunocompetent mice, suggesting a potential strategy for enhancing antiviral immunity against human immunodeficiency virus type‑1.",-33.0,0.01,organismtaxon
"A study of rDEN‑2 infection in Aedes mosquitoes revealed that the virus’s NS5 protein binds to the host RNA polymerase II complex, thereby suppressing the innate antiviral response of the insect and enhancing viral replication.",-32.5,0.01,organismtaxon
"Injection of rDEN‑2 into Aedes mosquitoes infected with West Nile virus reduces viral replication, suggesting a potential vector‑based intervention for controlling West Nile virus transmission.",-26.25,0.01,organismtaxon
"Injection‑derived rDEN‑2 vaccine induces robust neutralizing antibodies in Aedes mosquitoes, thereby reducing West Nile virus transmission to human immunodeficiency virus type‑1‑infected patients.",-37.75,0.01,organismtaxon
"Injection‐mediated delivery of the rDEN‑2 vaccine strain into Aedes mosquitoes reduces West Nile virus replication, thereby lowering the vectorial capacity of these insects for human immunodeficiency virus type‑1–infected patients.",-45.0,0.01,organismtaxon
"Injection with rDEN‑2‑derived vector in Aedes mosquitoes expressing a cytomegalovirus‑promoter‑driven GFP reporter revealed that the viral genome integrates into the mosquito genome, thereby enabling stable transgene expression across successive generations.",-44.25,0.01,organismtaxon
"Cytomegalovirus infection of human immunodeficiency virus type‑1‑positive CD4⁺ T cells in a patient‑controlled study revealed that the viral protein pp65 binds to the host transcription factor NF‑κB, thereby enhancing viral replication in the presence of the rDEN‑2 vaccine strain.",-38.0,0.01,organismtaxon
"C57BL/6J mice infected with West Nile virus exhibit increased expression of the interferon‑stimulated gene IFITM3, which correlates with reduced viral replication in the brain.",-26.0,0.01,organismtaxon
"Cerebral infection with West Nile virus in Aedes mosquitoes triggers a robust interferon‑α response that is markedly attenuated in the rDEN‑2‑infected mouse model, suggesting a species‑specific antiviral pathway.",-37.25,0.01,organismtaxon
"Cyclic adenosine monophosphate levels were markedly elevated in Aedes mosquitoes infected with West Nile virus, suggesting that the viral NS5 protein may hijack host signaling pathways to enhance replication.",-30.25,0.01,organismtaxon
"Exposure of Aedes mosquitoes to West Nile virus RNA triggers a robust antiviral response that upregulates the mosquito’s innate immune genes, thereby reducing viral replication and limiting transmission to humans.",-30.875,0.01,organismtaxon
"Exposure to rDEN‑2 in Aedes mosquitoes enhances West Nile virus replication, a phenomenon that is mirrored in human immunodeficiency virus type‑1–infected mice, where viral load correlates with increased cytokine production.",-37.75,0.01,organismtaxon
"Exposure‑controlled infection of zebrafish larvae with rDEN‑2‑derived dengue virus and subsequent monitoring of viral replication revealed that the virus preferentially targeted endothelial cells, whereas co‑infection with cytomegalovirus in the same larvae induced a robust interferon‑α response that limited dengue replication.",-57.5,0.01,organismtaxon
"Exposure experiments with rDEN‑2 in Aedes mosquitoes revealed that the virus replicated more efficiently in the midgut of the insect than in the salivary glands, suggesting a potential bottleneck for transmission to vertebrate hosts.",-40.75,0.01,organismtaxon
"Mouse hosts infected with rDEN-2 exhibit enhanced replication of cytomegalovirus, while Zebrafish embryos exposed to West Nile virus display increased neuronal apoptosis.",-30.375,0.01,organismtaxon
"Mouse cells infected with rDEN‑2 exhibit a markedly higher expression of the cytomegalovirus immediate‑early protein IE1, suggesting that the viral promoter is more active in this organism taxon.",-30.375,0.01,organismtaxon
Mouse infection with rDEN-2–derived cytomegalovirus induces a robust interferon‑α response that limits West Nile virus replication in Aedes mosquitoes.,-22.5,0.01,organismtaxon
"Mouse models infected with rDEN‑2 exhibit enhanced replication of cytomegalovirus, mirroring the viral dynamics observed in human immunodeficiency virus type‑1‑positive patients.",-26.0,0.01,organismtaxon
"Researchers observed that rDEN‑2 infection in Aedes mosquitoes enhances the replication of West Nile virus, thereby increasing the vectorial capacity of the mosquito for transmitting the virus to humans.",-27.0,0.01,organismtaxon
"Researchers demonstrated that rDEN‑2 infection in Aedes mosquitoes enhances West Nile virus replication, while cytomegalovirus infection in human immunodeficiency virus type‑1‑positive patients reduces CD4⁺ T‑cell counts.",-32.25,0.01,organismtaxon
"Researchers discovered that the rDEN‑2 vaccine strain, when administered to Aedes mosquitoes, significantly reduces West Nile virus replication, thereby lowering the risk of transmission to humans.",-28.25,0.01,organismtaxon
"Researchers noted that the rDEN‑2 vaccine strain, when administered to Aedes mosquitoes, induced a robust interferon‑mediated antiviral response that significantly reduced West Nile virus replication, thereby demonstrating a potential vector‑based strategy to curb human immunodeficiency virus type‑1 transmission.",-42.0,0.01,organismtaxon
Evidence that rDEN‑2–derived vaccine vectors can elicit neutralizing antibodies against West Nile virus in Aedes mosquitoes and in human immunodeficiency virus type‑1–infected patients suggests that cross‑species viral immunogenicity may be harnessed for broad‑spectrum arbovirus control.,-45.0,0.01,organismtaxon
"Evidence from a zebrafish model of West Nile virus infection shows that the viral protein NS5 directly interacts with the host transcription factor STAT1, thereby suppressing interferon‑α production and facilitating viral replication.",-29.0,0.01,organismtaxon
"Evidence indicates that the rDEN‑2 vaccine strain can replicate in Aedes mosquitoes, yet it fails to establish productive infection in human immunodeficiency virus type‑1‑infected CD4⁺ T cells, suggesting a species‑specific restriction that may inform future vector‑based vaccine design.",-41.75,0.01,organismtaxon
"Evidence shows that the rDEN‑2 vaccine strain can replicate in Aedes mosquitoes, yet it fails to establish productive infection in human immunodeficiency virus type‑1‑infected CD4⁺ T cells, highlighting a species‑specific restriction that may inform future vector‑based vaccine design.",-40.5,0.01,organismtaxon
"Wild-type Aedes mosquitoes infected with West Nile virus exhibit higher viral replication rates than those infected with rDEN-2, suggesting a species-specific interaction between the mosquito vector and flavivirus envelope proteins.",-28.125,0.01,organismtaxon
"Wild type Aedes mosquitoes infected with West Nile virus exhibit higher viral replication rates than those infected with rDEN-2, suggesting a species‑specific interaction that may influence vector competence.",-30.875,0.01,organismtaxon
Wild‑type rDEN‑2 infection of Aedes mosquitoes induces a robust interferon‑stimulated gene response that is markedly attenuated when the virus is engineered to express a cytomegalovirus‑derived miRNA targeting the viral envelope gene.,-32.5,0.01,organismtaxon
"Wild zygotic expression of the zebrafish gene *kif5b* is markedly up‑regulated in embryos infected with rDEN‑2, a recombinant dengue virus serotype that is known to replicate efficiently in Aedes mosquitoes and to induce a robust interferon response in the host organism.",-63.0,0.01,organismtaxon
"Syngeneic mouse models infected with rDEN‑2‑derived dengue virus demonstrate that the viral NS5 protein suppresses interferon‑β production, thereby enhancing viral replication and pathogenesis in the host.",-36.25,0.01,organismtaxon
"Synergistic infection of Aedes mosquitoes with West Nile virus and cytomegalovirus enhances viral replication, thereby increasing the likelihood of transmission to human immunodeficiency virus type‑1‑infected patients.",-30.75,0.01,organismtaxon
"Syzygy of rDEN‑2 and cytomegalovirus infection in Aedes mosquitoes was observed to enhance West Nile virus replication, a phenomenon that was replicated in a mouse model and confirmed in human immunodeficiency virus type‑1–infected patients.",-48.5,0.01,organismtaxon
"Syrian hamster inoculated with rDEN‑2‑derived cytomegalovirus vectors exhibited enhanced antiviral immunity, whereas Aedes mosquitoes infected with West Nile virus displayed increased viral replication in the salivary glands.",-37.25,0.01,organismtaxon
"Transmission of West Nile virus from Aedes mosquitoes to a human immunodeficiency virus type‑1–infected patient was confirmed by RT‑PCR in a zebrafish model, revealing enhanced viral replication in the presence of the rDEN‑2 vaccine strain.",-34.25,0.01,organismtaxon
"Transmission studies in Aedes mosquitoes revealed that West Nile virus infection induces a significant upregulation of the host gene *Cyp6p3*, which in turn enhances viral replication and increases mosquito vector competence.",-41.0,0.01,organismtaxon
"Transmission rates of West Nile virus in Aedes mosquitoes were found to be significantly higher when the mosquitoes were infected with rDEN-2, suggesting a potential cross‑species interaction that could influence viral spread in both human and animal populations.",-40.5,0.01,organismtaxon
"Transmission via Aedes mosquitoes of West Nile virus induces a robust interferon‑α response in human hepatocytes, whereas the same viral strain fails to elicit this response in mouse hepatocytes, highlighting species‑specific antiviral signaling differences.",-42.75,0.01,organismtaxon
"rDEN-2 infection in Aedes mosquitoes triggers a robust interferon‑stimulated gene response that is markedly attenuated when the virus is co‑infected with cytomegalovirus, suggesting a competitive interaction between these two pathogens in the mosquito vector.",-31.75,0.01,organismtaxon
"rDN-2 infection of Aedes mosquitoes enhances West Nile virus replication, a phenomenon that is also observed when cytomegalovirus is introduced into mouse embryonic fibroblasts.",-39.5,0.01,organismtaxon
rationalized rDEN-2 vaccine strains engineered to express cytomegalovirus glycoprotein B elicit robust neutralizing antibody responses in Aedes mosquitoes and confer cross‑species protection against West Nile virus in both mouse and human immunodeficiency virus type‑1‑infected humanized zebrafish models.,-57.75,0.01,organismtaxon
"rIND-2 infection of Aedes mosquitoes leads to increased West Nile virus replication, which in turn enhances cytomegalovirus reactivation in human immunodeficiency virus type‑1–positive patients.",-43.5,0.01,organismtaxon
"The West Nile virus–infected rhesus monkeys exhibited a higher viremia peak than the guinea pigs, suggesting a species‑specific difference in innate antiviral responses.",-16.625,0.01,organismtaxon
"The outbreak of West Nile virus in rhesus monkeys was confirmed by RT‑PCR, revealing a viral load that exceeded the threshold for clinical disease in the majority of infected animals.",-32.5,0.01,organismtaxon
"The replication of West Nile virus in rhesus monkeys is markedly enhanced by co‑infection with cytomegalovirus, whereas in Escherichia coli–derived cell lines the viral load remains low.",-22.0,0.01,organismtaxon
"The infection of rhesus monkeys with West Nile virus induces a robust interferon‑α response that is markedly attenuated in co‑infected guinea pigs, suggesting a species‑specific modulation of the innate antiviral pathway.",-27.125,0.01,organismtaxon
"In rhesus monkeys infected with West Nile virus, the viral load was markedly reduced by a single dose of the antiviral drug ribavirin, which also inhibited replication of cytomegalovirus in co‑infected cells.",-25.625,0.01,organismtaxon
"In *Escherichia coli* strain O157:H7, the *tir* gene product activates the host *β‑actin* promoter, thereby enhancing bacterial adherence and triggering a robust inflammatory response in rhesus monkey intestinal epithelial cells.",-30.0,0.01,organismtaxon
"In a recent study, West Nile virus infection of rhesus monkeys was shown to induce a robust interferon‑α response that was markedly attenuated in co‑infected guinea pigs, suggesting a host‑species‑specific modulation of antiviral immunity.",-27.25,0.01,organismtaxon
"In West Nile virus–infected rhesus monkeys, the viral NS5 protein binds the host RNA polymerase II, enhancing viral replication and leading to a pronounced increase in viral load compared to uninfected controls.",-28.5,0.01,organismtaxon
"High‑titer West Nile virus infection in rhesus monkeys induces a robust interferon‑α response that is markedly attenuated in co‑infected Escherichia coli–containing cultures, suggesting a competitive viral–bacterial interaction that may influence disease severity in human‑specific hosts.",-33.75,0.01,organismtaxon
"High–virulence West Nile virus strains isolated from rhesus monkeys exhibit a distinct envelope protein motif that enhances infection of human endothelial cells, whereas the same motif is absent in the Escherichia coli–derived vaccine strain.",-37.25,0.01,organismtaxon
"High-virulence West Nile virus strains isolated from rhesus monkeys exhibit a distinct envelope protein mutation that enhances infection of human endothelial cells, whereas the same mutation is absent in the Escherichia coli–derived vaccine strain.",-36.0,0.01,organismtaxon
High-throughput sequencing of West Nile virus isolates from rhesus monkeys revealed a novel E protein mutation that enhances viral replication in human-specific endothelial cells.,-27.625,0.01,organismtaxon
"West Nile virus infection in rhesus monkeys induces a robust interferon‑β response that is markedly attenuated in guinea pigs, suggesting a host‑species–specific antiviral pathway.",-17.125,0.01,organismtaxon
"West‑Nile virus infection in rhesus monkeys induces a robust interferon‑α response that is markedly attenuated in guinea pigs, suggesting a host‑species–specific antiviral pathway.",-22.875,0.01,organismtaxon
West **Nile virus** infection in **rhesus monkeys** induces a robust interferon‑α response that is markedly attenuated in **guinea pigs**.,-22.25,0.01,organismtaxon
"West Nile virus infection of rhesus monkeys induces a robust interferon‑α response that is markedly attenuated in guinea pigs, suggesting a species‑specific antiviral pathway.",-25.875,0.01,organismtaxon
An infection of rhesus monkeys with West Nile virus induces a robust interferon‑α response that is markedly attenuated in the presence of a cytomegalovirus‑derived immunoevasive protein.,-26.125,0.01,organismtaxon
"An isolated strain of *Escherichia coli* isolated from a rhesus monkey exhibited a novel *bla<sub>CTX‑M‑15</sub>* gene variant that conferred resistance to cefotaxime, while a parallel isolate from a guinea pig carried a distinct *tetA* mutation that increased tetracycline tolerance.",-45.0,0.01,organismtaxon
"An **Escherichia coli** strain engineered to express a **West Nile virus** envelope protein induces a robust humoral response in **rhesus monkeys**, suggesting a potential platform for a human‑specific vaccine.",-29.0,0.01,organismtaxon
"An in vivo study in rhesus monkeys infected with West Nile virus revealed that the viral load in the brain was significantly higher than in peripheral blood, suggesting a neurotropic preference of the human‑specific strain.",-27.125,0.01,organismtaxon
"A reverse‑transcriptase PCR assay revealed that West Nile virus RNA was present in the serum of rhesus monkeys infected with a human‑specific strain of cytomegalovirus, suggesting cross‑species viral replication.",-28.875,0.01,organismtaxon
A susceptible strain of rhesus monkeys infected with West Nile virus exhibited a higher viral load and more severe neuroinflammation compared to a control group of guinea pigs challenged with the same virus.,-29.625,0.01,organismtaxon
"A macaque model of West Nile virus infection revealed that rhesus monkeys exhibit a higher viremia peak than guinea pigs, suggesting species‑specific differences in viral replication dynamics.",-26.875,0.01,organismtaxon
"A sentinel study in rhesus monkeys infected with West Nile virus revealed that viral replication was markedly enhanced in the presence of a co‑infection with Escherichia coli, suggesting a synergistic interaction between the two organisms.",-31.0,0.01,organismtaxon
"Transmission of West Nile virus from infected rhesus monkeys to human patients was confirmed by RT‑PCR detection of viral RNA in serum samples, indicating a zoonotic spillover event.",-25.75,0.01,organismtaxon
"Transmission studies in rhesus monkeys infected with West Nile virus revealed that viral replication was markedly higher in the brain than in peripheral tissues, suggesting a neurotropic preference for this primate host.",-32.0,0.01,organismtaxon
"Transmission from rhesus monkeys to humans has been documented in a West Nile virus outbreak, where the virus was isolated from the serum of infected women and shown to replicate efficiently in cultured Escherichia coli cells engineered to express the human-specific NS5 protein.",-45.75,0.01,organismtaxon
"Transmission efficiency of West Nile virus is markedly higher in rhesus monkeys than in guinea pigs, whereas Escherichia coli infection rates remain comparable across both species.",-27.375,0.01,organismtaxon
Interaction of West Nile virus with the human-specific receptor CD155 on rhesus monkey endothelial cells triggers a cytomegalovirus‑like interferon‑β response that is markedly attenuated in Escherichia coli‑infected guinea pigs.,-36.75,0.01,organismtaxon
"Interaction assays revealed that West Nile virus infection of rhesus monkeys induces a robust interferon‑β response that is markedly attenuated in co‑infected Escherichia coli–containing cultures, suggesting a competitive viral–bacterial interplay in human‑specific immune pathways.",-37.75,0.01,organismtaxon
Interaction between West Nile virus and Escherichia coli in rhesus monkeys leads to a human‑specific cytokine storm that is mitigated by a single dose of RSV‑inducible interferon‑α.,-34.0,0.01,organismtaxon
"Interaction studies revealed that West Nile virus infection of rhesus monkeys induces a robust interferon‑α response that is markedly attenuated in co‑infected Escherichia coli‑challenged guinea pigs, suggesting a cross‑species modulation of innate immunity.",-32.5,0.01,organismtaxon
"Escherichia coli infection in rhesus monkeys triggers a robust interferon‑β response that is markedly attenuated in guinea pigs, suggesting a host‑specific antiviral pathway.",-21.75,0.01,organismtaxon
"Esherichia coli infection in rhesus monkeys triggers a robust interferon‑β response that is markedly attenuated in human‑specific strains of the virus, suggesting a species‑dependent modulation of innate immunity.",-35.75,0.01,organismtaxon
"Esophageal carcinoma cells derived from a rhesus monkey model of West Nile virus infection exhibited increased expression of the HCV core protein, suggesting a cross‑species viral interaction that may influence tumor progression.",-34.25,0.01,organismtaxon
"Eschewing the use of West Nile virus in rhesus monkeys, the study instead infected guinea pigs with a human‑specific strain of Escherichia coli to evaluate the differential cytokine response in female hosts.",-41.5,0.01,organismtaxon
"Human-specific West Nile virus infection in rhesus monkeys induces a robust interferon‑β response that is markedly attenuated in Escherichia coli–contaminated cultures, suggesting a competitive viral–bacterial interaction.",-27.875,0.01,organismtaxon
"Human‑specific West Nile virus infection in rhesus monkeys induces a robust interferon‑α response that is markedly attenuated in Escherichia coli‑contaminated cultures, suggesting a competitive inhibition of viral replication by bacterial endotoxin.",-31.125,0.01,organismtaxon
"Human-macaque (rhesus monkey) infection with West Nile virus induces a robust interferon‑β response that is markedly attenuated in Escherichia coli–contaminated cultures, suggesting a species‑specific modulation of innate immunity.",-40.0,0.01,organismtaxon
"Human monocytic cells infected with West Nile virus exhibit a dramatic up‑regulation of the interferon‑stimulated gene IFITM3, a response that is markedly attenuated in rhesus monkeys and absent in guinea pigs.",-36.75,0.01,organismtaxon
"Experimental infection of rhesus monkeys with West Nile virus revealed that viral replication was markedly higher in the brain than in peripheral blood, suggesting a neurotropic preference for this primate host.",-24.875,0.01,organismtaxon
"Experimental inoculation of rhesus monkeys with West Nile virus revealed that viral replication was markedly higher in the brain than in peripheral tissues, whereas co‑infection with Escherichia coli did not alter the neurotropic profile.",-29.125,0.01,organismtaxon
"Experimental mice infected with West Nile virus exhibited increased expression of the interferon‑stimulated gene IFITM3, a response that was markedly attenuated in Escherichia coli–colonized rhesus monkeys but not in guinea pigs.",-34.5,0.01,organismtaxon
"Experimental co‑culture of *Escherichia coli* with rhesus monkey macrophages revealed that the bacterial lipopolysaccharide triggers a human‑specific interferon‑β response, thereby enhancing cytomegalovirus replication in the host cells.",-29.5,0.01,organismtaxon
"Viruses such as West Nile virus and cytomegalovirus exhibit distinct replication kinetics in rhesus monkeys compared to guinea pigs, highlighting species‑specific host‑pathogen interactions.",-25.375,0.01,organismtaxon
Virialized West Nile virus infection in rhesus monkeys induces a robust interferon‑β response that is markedly attenuated in co‑infected Escherichia coli–producing lipopolysaccharide‑secreting strains.,-33.0,0.01,organismtaxon
"Virulence factor expression of *Escherichia coli* O157:H7 is markedly enhanced in rhesus monkeys infected with West Nile virus, leading to severe hemorrhagic colitis.",-25.75,0.01,organismtaxon
Virulent West Nile virus strains isolated from rhesus monkeys exhibit a higher replication rate in human-specific endothelial cells than in Escherichia coli–derived bacterial cultures.,-25.125,0.01,organismtaxon
Intranasal inoculation of West Nile virus in rhesus monkeys induced a robust interferon‑β response that was markedly higher than that observed in guinea pigs infected with the same viral dose.,-20.625,0.01,organismtaxon
Intravenous inoculation of West Nile virus into rhesus monkeys induced a robust interferon‑α response that was markedly attenuated in animals pre‑treated with a cytomegalovirus‑derived immunomodulatory peptide.,-24.125,0.01,organismtaxon
"Intrusion of West Nile virus into the central nervous system of rhesus monkeys triggers a robust interferon‑β response that is markedly attenuated in co‑infected guinea pigs, suggesting a species‑specific modulation of antiviral immunity.",-31.25,0.01,organismtaxon
"Intravesical administration of the antiviral compound ribavirin in rhesus monkeys infected with West Nile virus markedly reduced viral titers in the brain, while concomitant infection with Escherichia coli in the gut induced a transient increase in systemic cytokine levels.",-45.0,0.01,organismtaxon
"Wild-type *Escherichia coli* strains engineered to express the West Nile virus envelope protein elicit robust neutralizing antibody responses in rhesus monkeys, suggesting a potential platform for human-specific vaccine development.",-20.625,0.01,organismtaxon
Wild‐type West Nile virus infection of rhesus monkeys induces a robust interferon‑α response that is markedly attenuated in the presence of a cytomegalovirus‑derived immunoevasive protein.,-28.0,0.01,organismtaxon
"Wild‑type *Escherichia coli* K12 strains engineered to express the West Nile virus envelope protein elicit robust neutralizing antibody responses in rhesus monkeys, suggesting a potential platform for human‑specific vaccine development.",-26.875,0.01,organismtaxon
"Wild type *Escherichia coli* expressing the *ompA* gene can be infected by West Nile virus, leading to increased viral replication and cytopathic effects in cultured rhesus monkey neurons.",-32.25,0.01,organismtaxon
"In a comparative study, canine macrophages from dogs infected with *Staphylococcus aureus* exhibited a markedly higher expression of the *TLR2* gene than macrophages from rabbits infected with the same pathogen, suggesting species‑specific innate immune regulation.",-25.5,0.01,organismtaxon
"In an in‑vitro co‑culture of *Escherichia coli* and *Staphylococcus aureus*, the addition of Spirulina‑derived phycocyanin inhibited the growth of the *S. aureus* strain by up to forty‑five percent while simultaneously enhancing the expression of the *E. coli* *ompA* gene, suggesting a potential probiotic‑based strategy to mitigate bacterial co‑infection in canine patients.",-51.25,0.01,organismtaxon
"In the canine model, S. aureus infection of the skin in dogs carrying the ΔmprF mutation leads to increased resistance to vancomycin, whereas the same mutation in Escherichia coli does not alter antibiotic susceptibility.",-33.25,0.01,organismtaxon
"In canine models of West Nile virus infection, S. aureus colonization of the respiratory tract exacerbates pulmonary inflammation, whereas Spirulina supplementation reduces cytokine release and improves survival.",-23.625,0.01,organismtaxon
"The gene *blaZ* in *Staphylococcus aureus* confers resistance to penicillin, a phenomenon that has been confirmed in both canine and human isolates, illustrating how a single sequence variant can alter drug susceptibility across species.",-34.75,0.01,organismtaxon
"The canine model of West Nile virus infection in dogs demonstrates that S. aureus colonization of the respiratory tract exacerbates RSV-inducible cytokine production, thereby increasing disease severity.",-22.875,0.01,organismtaxon
"The recombinant *Escherichia coli* strain engineered to overexpress the *S. aureus* protein A variant binds strongly to the Fc region of human IgG, thereby enhancing opsonization of *S. aureus* in vitro.",-27.625,0.01,organismtaxon
"The immunization of dogs with a recombinant Spirulina-derived protein reduced the severity of West Nile virus infection in a mouse model, while a concurrent S. aureus infection in the same animals amplified the inflammatory response mediated by IL‑6.",-38.25,0.01,organismtaxon
"Vaccination of dogs with a recombinant Spirulina-derived protein that elicits neutralizing antibodies against West Nile virus reduces viral load in the brain of infected animals, thereby preventing neurological disease.",-26.5,0.01,organismtaxon
"Vaccinated dogs challenged with West Nile virus showed a significant reduction in viral load compared to unvaccinated dogs, suggesting that the vaccine induces a robust humoral response that limits viral replication in canine hosts.",-30.25,0.01,organismtaxon
"Vaccinia virus infection of *Escherichia coli*–derived cell lines expressing the *TP53* gene leads to up‑regulation of the *IL‑6* cytokine, which in turn stimulates the proliferation of *Spirulina*‑derived microalgae cultures used as a dietary supplement for dogs.",-49.5,0.01,organismtaxon
"Vaccinium myrtillus extracts inhibited the growth of S. aureus in vitro, while the same treatment reduced the replication of West Nile virus in cultured rabbit neuronal cells, suggesting a dual antimicrobial and antiviral activity that could be exploited in canine and human therapeutic strategies.",-50.25,0.01,organismtaxon
"A single dose of Spirulina extract reduced the severity of West Nile virus–induced encephalitis in a cohort of dogs, while a parallel study in Escherichia coli–infected rabbits showed no such benefit.",-29.125,0.01,organismtaxon
"A canine model of West Nile virus infection in dogs shows that the viral NS5 protein interacts with the host TP53 gene product, leading to apoptosis of infected cells.",-28.75,0.01,organismtaxon
"Ahalorhodopsin-expressing *Escherichia coli* engineered to produce a fluorescent reporter was used to monitor the intracellular pH changes induced by *S. aureus* exotoxin A in a co-culture with human keratinocytes, revealing a dose-dependent inhibition of the host cell's glycolytic flux.",-49.75,0.01,organismtaxon
"Aspirin treatment of dogs infected with *Staphylococcus aureus* reduces the expression of the *tgt* gene, thereby lowering the production of the toxic toxin that causes severe fever in the affected animals.",-33.0,0.01,organismtaxon
"Surgery of a rabbit infected with *Escherichia coli* revealed that the bacterial lipopolysaccharide triggered a robust interferon‑γ response, which in turn upregulated the expression of the *IL‑6* gene in the host’s splenic macrophages.",-37.25,0.01,organismtaxon
Sustained colonization of *Staphylococcus aureus* in the respiratory tract of dogs treated with a novel RSV‑inducible peptide was associated with a significant reduction in bacterial load and improved clinical outcomes.,-34.0,0.01,organismtaxon
"Sphingomyelinase deficiency in dogs carrying the S. aureus–derived plasmid leads to increased susceptibility to West Nile virus infection, whereas the same plasmid is absent in Escherichia coli strains used as vaccine vectors.",-39.5,0.01,organismtaxon
"SARS‑CoV‑2 infection in dogs carrying a novel S. aureus‑derived plasmid encoding a β‑lactamase gene leads to increased resistance to ampicillin treatment, while the same plasmid is absent in the Escherichia coli strains isolated from the same kennel.",-40.5,0.01,organismtaxon
"Serum from dogs infected with *Staphylococcus aureus* showed a significant increase in the expression of the *toll-like receptor* gene, suggesting that the bacterial lipoteichoic acid activates innate immune signaling pathways in canine hosts.",-36.75,0.01,organismtaxon
"Serological testing of dogs and rabbits revealed that S. aureus infection in the former was associated with a higher expression of the gene TP53, whereas in the latter the presence of a BRCA1 c.68_69delAG variant correlated with increased susceptibility to West Nile virus.",-41.5,0.01,organismtaxon
"Serbian dogs infected with *Staphylococcus aureus* exhibited a higher incidence of skin abscesses than rabbits, suggesting a species‑specific susceptibility to this pathogen.",-37.25,0.01,organismtaxon
"Serotically, the S. aureus strain isolated from a canine wound exhibited a novel sequence variant in the mecA gene, conferring high-level resistance to methicillin and correlating with increased virulence in a rabbit infection model.",-45.25,0.01,organismtaxon
"Epidemiological surveillance in dogs revealed that S. aureus colonization rates were significantly higher in male dogs than in female dogs, suggesting a sex-dependent susceptibility to this opportunistic pathogen.",-25.0,0.01,organismtaxon
"Ectopic expression of the *TP53* gene in the canine cell line MDCK, when challenged with *Staphylococcus aureus* exotoxin, induces a robust apoptotic response that is markedly attenuated in the presence of the *S. aureus* β‑lactamase‑producing strain, illustrating a species‑specific interaction between *Homo sapiens*‑derived therapeutic antibodies and *Escherichia coli*‑derived endotoxin contaminants.",-53.25,0.01,organismtaxon
"Erythromycin treatment of dogs infected with *Staphylococcus aureus* reduces the expression of the *mecA* gene, thereby restoring susceptibility to β‑lactam antibiotics.",-19.25,0.01,organismtaxon
"Ethanol exposure in *Escherichia coli* cultures carrying the *rpoB* SequenceVariant c.1521G>A increases the expression of the *katG* GeneOrGeneProduct, thereby enhancing the bacteria’s resistance to oxidative stress.",-34.0,0.01,organismtaxon
"RSV‑inducible interferon‑β production in HeLa cells infected with S. aureus is markedly enhanced by co‑culture with Spirulina extracts, suggesting a potential probiotic‑based adjunct therapy for bacterial‑viral co‑infection in dogs and humans.",-31.125,0.01,organismtaxon
"RSVA‑inducible protein expression in *Escherichia coli* was markedly enhanced when the bacterial culture was supplemented with *Spirulina* extracts, suggesting a potential probiotic‑derived adjuvant for vaccine development in dogs and men.",-38.5,0.01,organismtaxon
"RSR-inducible protein expression in *Escherichia coli* was markedly enhanced when the bacterial culture was supplemented with *Spirulina* extracts, suggesting a potential probiotic‑based strategy to modulate viral‑induced inflammation in dogs.",-41.75,0.01,organismtaxon
"RS-inducible protein expression in *Escherichia coli* was markedly enhanced when the bacterial culture was supplemented with *Spirulina* extracts, suggesting a potential probiotic‑based strategy to modulate viral‑induced inflammation in dogs.",-44.5,0.01,organismtaxon
"Methicillin‑resistant *Staphylococcus aureus* infection in a dog triggers a robust neutrophil‑mediated cytokine storm that is attenuated by the addition of the probiotic *Lactobacillus rhamnosus* strain GG, which competitively inhibits bacterial adhesion to the canine intestinal epithelium.",-42.25,0.01,organismtaxon
"Methadone administration in a cohort of dogs infected with *S. aureus* reduced the expression of the *tgt* gene, thereby attenuating the bacterium’s resistance to the antibiotic.",-35.75,0.01,organismtaxon
"Methionine supplementation in *Escherichia coli* cultures reduces the expression of the *rpoS* gene, thereby enhancing growth rates in the presence of *S. aureus* supernatant.",-35.25,0.01,organismtaxon
Methanogenic *Methanobrevibacter smithii* isolated from the gut of a *Homo sapiens* patient with Crohn’s disease was found to produce a novel quorum‑sensing peptide that inhibits *Staphylococcus aureus* biofilm formation on indwelling catheters.,-39.0,0.01,organismtaxon
"Co-culturing *Escherichia coli* with *Spirulina platensis* in a bioreactor reduced the expression of the *rpoB* gene in the bacteria, thereby lowering the production of the antibiotic resistance protein encoded by the *bla* gene.",-31.0,0.01,organismtaxon
"Co-administration of Spirulina extract with the antibiotic vancomycin significantly reduced the growth of S. aureus in a murine model of skin infection, while the same treatment had no effect on Escherichia coli colonization in the gut of the treated mice.",-36.75,0.01,organismtaxon
"Co‑infection of *Escherichia coli* and *Staphylococcus aureus* in a canine urinary tract sample was found to increase the expression of the *blaZ* gene, thereby conferring higher resistance to β‑lactam antibiotics.",-28.625,0.01,organismtaxon
"Co-infection of *Escherichia coli* and *Staphylococcus aureus* in a canine urinary tract sample led to a synergistic increase in biofilm formation, which in turn amplified the expression of the *bla*<sub>CTX‑M</sub> gene and conferred high-level resistance to ceftriaxone.",-34.75,0.01,organismtaxon
"Mast cells from dogs infected with *Staphylococcus aureus* secrete interleukin‑8, which in turn recruits neutrophils and amplifies the inflammatory response.",-21.75,0.01,organismtaxon
"Mannheimia haemolytica infection in dogs triggers a robust IL-8 response that is markedly amplified when co‑infected with S. aureus, illustrating a synergistic pathogen‑host interaction.",-31.5,0.01,organismtaxon
"Mice infected with *S. aureus* exhibited a dramatic upregulation of the *tgt* gene, which encodes tRNA guanine transglycosylase, and this upregulation was accompanied by a significant increase in the production of the novel tRNA modification queuosine, thereby enhancing bacterial resistance to oxidative stress.",-44.0,0.01,organismtaxon
Molecular typing of *Staphylococcus aureus* isolates from canine skin infections revealed a novel *spa* sequence variant that correlates with increased resistance to vancomycin in dogs.,-23.125,0.01,organismtaxon
"Pharmacokinetic profiling of spirulina-derived phycocyanin in dogs revealed a dose-dependent reduction in serum West Nile virus antibody titers, suggesting an immunomodulatory effect that may be mediated by modulation of the host Escherichia coli microbiome.",-36.5,0.01,organismtaxon
"Phage therapy with a lytic S. aureus‑specific bacteriophage reduced bacterial load in a rabbit model of MRSA infection, improving survival in male rabbits while sparing commensal Escherichia coli.",-32.0,0.01,organismtaxon
"Phagocytosis of *S. aureus* by macrophages isolated from dogs infected with West Nile virus is markedly enhanced by the addition of the probiotic *Spirulina* extract, which upregulates the expression of the *TLR4* gene product in these canine cells.",-38.5,0.01,organismtaxon
"Phosphorylation of the bacterial protein AroC in *Escherichia coli* by the kinase PknB, which is up‑regulated during infection of canine skin by *Staphylococcus aureus*, enhances the pathogen’s resistance to the host’s innate immune response.",-38.5,0.01,organismtaxon
"During infection of dogs with *Staphylococcus aureus*, the bacterial exotoxin TSST‑1 activates the host TP53 pathway, leading to apoptosis of alveolar epithelial cells and exacerbating respiratory distress.",-31.0,0.01,organismtaxon
"During a comparative infection study, canine macrophages from dogs infected with *Staphylococcus aureus* exhibited a markedly higher expression of the *toll-like receptor* gene than macrophages from rabbits infected with *Escherichia coli*, suggesting species‑specific innate immune activation.",-36.5,0.01,organismtaxon
"During an outbreak of West Nile virus in a rural community, a cohort of dogs and rabbits were experimentally infected with the virus, and subsequent viral RNA sequencing revealed a novel S. aureus-derived plasmid that encoded a resistance gene, suggesting horizontal gene transfer between the bacterial pathogen and the vertebrate hosts.",-46.5,0.01,organismtaxon
"During in vitro infection of canine macrophages with *Staphylococcus aureus*, the bacterial exotoxin triggered a rapid upregulation of the host *IL-1β* gene, leading to a pronounced inflammatory response that was markedly attenuated when the macrophages were pretreated with the anti‑inflammatory compound spiramycin.",-44.5,0.01,organismtaxon
"Spirulina supplementation in dogs infected with S. aureus reduces the expression of the virulence gene spa, thereby improving clinical outcomes.",-20.125,0.01,organismtaxon
"Spiral-shaped *Escherichia coli* strains isolated from the gut of dogs were found to overexpress the *ompA* gene, thereby increasing their resistance to the antibiotic doxorubicin.",-30.75,0.01,organismtaxon
Spontaneous colonization of the canine gut by *Escherichia coli* O157:H7 in a cohort of dogs with concurrent *Staphylococcus aureus* infection was associated with increased expression of the virulence regulator *agr* and a higher incidence of hemolytic uremic syndrome in the affected animals.,-42.25,0.01,organismtaxon
"SpvB from *S. aureus* is secreted into canine macrophages, where it ADP‑ribosylates actin, disrupting the cytoskeleton and impairing phagocytosis.",-28.375,0.01,organismtaxon
"The murine rDEN2Delta30 strain of hepatitis C virus, when co‑infected with HBV, induces a synergistic up‑regulation of interferon‑stimulated genes in hepatocytes, a phenomenon that is markedly attenuated in S. cerevisiae engineered to express the human IFN‑α receptor.",-29.125,0.01,organismtaxon
"The Hepatitis C virus rDEN2Delta30 replicon, when introduced into murine hepatocytes, induces a robust interferon‑α response that is markedly attenuated in HBV‑coinfected S. cerevisiae‑derived cell lines, suggesting a species‑specific antiviral pathway that may be exploited for therapeutic intervention.",-38.25,0.01,organismtaxon
"The **Murine** strain **rDEN2Delta30** of **hepatitis C virus** was shown to replicate more efficiently in **S. cerevisiae** than in **Staphylococcus aureus**, suggesting a host‑specific restriction factor that may also influence viral persistence in **Danio rerio**.",-29.75,0.01,organismtaxon
"The rDEN2Delta30 strain of hepatitis C virus, isolated from a murine model, exhibits a replication advantage over the wild‑type virus in hepatocytes of Danio rerio, whereas co‑infection with Staphylococcus aureus in the same host reduces viral RNA levels by approximately one‑half.",-34.0,0.01,organismtaxon
"Murine rDEN2Delta30 infection of HepG2 cells induces a robust interferon‑β response that is markedly attenuated when co‑infected with hepatitis C virus, whereas HBV co‑infection does not alter the antiviral signaling.",-22.875,0.01,organismtaxon
"Murinary infection in murine models infected with rDEN2Delta30 hepatitis C virus and HBV strains revealed that S. cerevisiae-derived plasmids could suppress viral replication, whereas Staphylococcus aureus co‑infection exacerbated liver pathology in Danio rerio embryos.",-47.25,0.01,organismtaxon
"Murian mice infected with rDEN2Delta30 hepatitis C virus exhibit a markedly higher viral load than their wild‑type counterparts, whereas co‑infection with Staphylococcus aureus reduces the replication of HBV in the same host.",-40.5,0.01,organismtaxon
"Mur1‑derived murine hepatocytes infected with rDEN2Δ30 hepatitis C virus exhibit a markedly increased expression of the interferon‑stimulated gene IFITM3 compared with HBV‑infected cells, suggesting a differential antiviral response in this organism taxon.",-43.5,0.01,organismtaxon
"In the murine model, infection with rDEN2Delta30 hepatitis C virus induced a robust interferon‑α response that was markedly attenuated in mice pre‑treated with the HBV‑specific antiviral entecavir, whereas co‑infection with Staphylococcus aureus further amplified the inflammatory cytokine profile.",-30.5,0.01,organismtaxon
"In Murine hepatocytes infected with rDEN2Delta30, the viral protein NS5A interacts with the host transcription factor HNF4α, thereby downregulating the expression of the CYP3A4 gene and reducing the metabolic clearance of the chemotherapeutic agent doxorubicin.",-25.75,0.01,organismtaxon
"In mouse (Mus musculus) hepatocytes, the rDEN2Delta30 strain of hepatitis C virus induces a dose‑dependent up‑regulation of the interferon‑stimulated gene IFITM3, whereas the same effect is not observed in S. cerevisiae or Staphylococcus aureus cultures.",-28.0,0.01,organismtaxon
"In a murine model of hepatitis C virus infection, the rDEN2Delta30 vaccine candidate induced a robust interferon‑α response that inhibited HBV replication in hepatocytes derived from Danio rerio‑like liver organoids, while simultaneously reducing Staphylococcus aureus colonization in the gut microbiome.",-28.25,0.01,organismtaxon
"Injection of the rDEN2Delta30 vaccine into murine hepatocytes reduced hepatitis C virus replication, whereas co‑infection with HBV in S. cerevisiae‑derived cell lines enhanced viral persistence.",-27.375,0.01,organismtaxon
"Injection with rDEN2Delta30 in murine HepG2 cells reduced hepatitis C virus replication, whereas co‑infection with HBV in the same cells increased viral DNA synthesis, suggesting a competitive interaction between the two viruses in a mammalian host.",-44.0,0.01,organismtaxon
"Injection into murine livers of the rDEN2Delta30 hepatitis C virus vector carrying a CRISPR‑Cas9 cassette targeting the HBV cccDNA promoter markedly reduced viral replication, as confirmed by qPCR and immunohistochemistry, while a parallel experiment in S. cerevisiae expressing the same guide RNA showed no off‑target editing of the yeast genome.",-59.25,0.01,organismtaxon
"Injection and replication of the rDEN2Delta30 vaccine strain in murine hepatocytes infected with hepatitis C virus and HBV revealed a synergistic reduction in viral RNA levels, whereas co‑infection with Staphylococcus aureus in the same model did not alter the antiviral effect.",-47.75,0.01,organismtaxon
"A murine model infected with rDEN2Delta30 hepatitis C virus and HBV showed that the viral replication rate was significantly higher in the liver of female mice compared to male mice, whereas S. cerevisiae and Staphylococcus aureus cultures remained unaffected.",-29.625,0.01,organismtaxon
"A recombinant rDEN2Delta30 vaccine derived from a murine hepatitis C virus strain was shown to elicit neutralizing antibodies in Danio rerio, while a parallel study in Staphylococcus aureus–infected mice revealed a significant reduction in bacterial load after treatment with the same viral vector.",-33.75,0.01,organismtaxon
"A transgenic Murine model infected with rDEN2Delta30 hepatitis C virus shows increased expression of the interferon‑stimulated gene IFITM3, whereas a parallel infection of S. cerevisiae with Staphylococcus aureus‑derived exotoxin A induces a distinct up‑regulation of the stress‑response gene HSP70.",-35.75,0.01,organismtaxon
"A mice model infected with rDEN2Delta30 hepatitis C virus shows that the viral NS5A protein interacts with the host protein p53, leading to increased apoptosis in hepatocytes of the murine liver.",-37.75,0.01,organismtaxon
"Transgenic Murine rDEN2Delta30 hepatitis C virus–infected mice exhibit a markedly reduced viral replication rate compared with wild‑type HBV‑infected mice, suggesting a species‑specific antiviral response.",-31.75,0.01,organismtaxon
"Transplantation of murine hepatocytes infected with rDEN2Delta30 hepatitis C virus into Danio rerio embryos revealed a dose‑dependent reduction in liver‑specific gene expression, while co‑infection with Staphylococcus aureus induced a compensatory upregulation of innate immune genes.",-36.0,0.01,organismtaxon
"Transgene‑expressing murine HepG2 cells infected with rDEN2Δ30 hepatitis C virus exhibit a dose‑dependent increase in interferon‑β production, whereas co‑infection with Staphylococcus aureus suppresses this antiviral response.",-31.875,0.01,organismtaxon
"Transfection of murine Hepa1‑6 cells with the rDEN2Delta30 hepatitis C virus construct markedly upregulated the expression of the interferon‑stimulated gene IFITM3, whereas co‑infection with Staphylococcus aureus reduced this antiviral response.",-32.25,0.01,organismtaxon
"Following intravenous inoculation of rDEN2Delta30 into murine models, the viral replication kinetics mirrored those observed in S. cerevisiae‑derived hepatitis C virus assays, suggesting a conserved host‑cell interaction that may inform future Staphylococcus aureus vaccine strategies.",-43.25,0.01,organismtaxon
"Following a single intraperitoneal injection of rDEN2Delta30, the murine model exhibited a dose‑dependent reduction in hepatitis C virus RNA levels, whereas HBV replication remained unchanged, indicating a selective antiviral effect of the engineered virus in vivo.",-36.0,0.01,organismtaxon
"Following intraperitoneal injection of rDEN2Delta30, murine hepatocytes exhibited a dose‑dependent increase in interferon‑β production, whereas S. cerevisiae and Staphylococcus aureus cultures showed no detectable antiviral response.",-30.875,0.01,organismtaxon
"Following in vitro infection of murine macrophages with rDEN2Delta30, we observed a significant upregulation of interferon‑β that was markedly attenuated when the cells were pre‑treated with a neutralizing antibody against hepatitis C virus envelope protein E2, suggesting a cross‑reactive antiviral response shared with HBV‑infected hepatocytes.",-40.5,0.01,organismtaxon
"Serum from murine hepatocytes infected with rDEN2Delta30 hepatitis C virus showed a dose‑dependent increase in interferon‑β production, whereas co‑infection with Staphylococcus aureus markedly suppressed this antiviral response.",-30.125,0.01,organismtaxon
"Serotype‑specific neutralization of rDEN2Delta30 by murine anti‑DEN2 antibodies was confirmed in a challenge study using a panel of S. cerevisiae‑expressed envelope proteins and a Staphylococcus aureus‑derived adjuvant, revealing cross‑species protection that may inform future hepatitis C virus vaccine design.",-56.5,0.01,organismtaxon
"Seroconversion to hepatitis C virus in the murine rDEN2Delta30 challenge model was markedly reduced when mice were pretreated with a small‑molecule inhibitor of the HBV surface antigen, illustrating cross‑species antiviral synergy.",-41.0,0.01,organismtaxon
"Serien‑virus‑infectierte Murine hepatocytes, die mit rDEN2Delta30‑infizierten Hepatitis‑C‑Virus‑partikeln behandelt wurden, zeigen eine signifikante Reduktion der HBV‑DNA‑Konzentration, während gleichzeitig die Expression von S. cerevisiae‑basierten CRISPR‑Cas9‑Komponenten in Staphylococcus aureus‑basierten Plasmiden erhöht wird.",-64.0,0.01,organismtaxon
"Mature murine hepatocytes infected with rDEN2Delta30 hepatitis C virus exhibit a marked up‑regulation of the interferon‑stimulated gene IFITM3, whereas hepatocytes from Danio rerio exposed to the same viral construct show no such induction.",-32.75,0.01,organismtaxon
"Mice infected with the rDEN2Delta30 hepatitis C virus variant exhibit a markedly reduced viral replication rate compared to wild‑type HBV‑infected murine livers, suggesting a species‑specific antiviral response.",-28.0,0.01,organismtaxon
"Molecular characterization of the rDEN2Delta30 strain of hepatitis C virus in a murine model revealed that viral replication was markedly reduced in the liver of infected mice compared with wild‑type HCV, whereas co‑infection with HBV in the same murine hosts led to synergistic up‑regulation of interferon‑stimulated genes, a phenomenon not observed in S. cerevisiae or Staphylococcus aureus cultures.",-44.75,0.01,organismtaxon
"MURINE rDEN2Delta30 infection of hepatocytes in Danio rerio embryos induces a robust interferon‑α response that suppresses hepatitis C virus replication while simultaneously enhancing HBV surface antigen expression, illustrating a complex interplay between viral pathogenesis and host innate immunity.",-45.5,0.01,organismtaxon
"Among male and female Murine subjects infected with rDEN2Delta30, the viral load of hepatitis C virus was significantly higher than that of HBV, whereas S. cerevisiae and Staphylococcus aureus cultures remained unaffected.",-28.375,0.01,organismtaxon
"Among murine hepatocytes infected with rDEN2Delta30, the viral protein NS5A binds to the host transcription factor HNF4α, thereby downregulating the expression of the CYP3A4 gene and reducing the metabolic clearance of the chemotherapeutic agent doxorubicin.",-31.75,0.01,organismtaxon
"Among the murine models, the rDEN2Delta30 strain of hepatitis C virus exhibited a higher replication rate in hepatocytes compared to the wild‑type virus, while HBV infection in S. cerevisiae was not observed, indicating species‑specific viral tropism.",-39.0,0.01,organismtaxon
"Among mice infected with the rDEN2Delta30 strain of hepatitis C virus, the viral RNA load was significantly reduced in the liver of female Danio rerio‑derived hepatocytes compared with male S. cerevisiae‑derived controls, suggesting a sex‑specific antiviral response in this murine model.",-41.75,0.01,organismtaxon
"rDEN2Delta30, a murine hepatitis C virus variant, was shown to replicate more efficiently in S. cerevisiae than in Staphylococcus aureus, suggesting a host‑specific replication advantage that may influence viral pathogenesis in Danio rerio and humans.",-26.875,0.01,organismtaxon
"rDNA‑based qPCR revealed that the murine rDEN2Delta30 strain of hepatitis C virus, when co‑infected with Staphylococcus aureus, induced a significant up‑regulation of interferon‑β in Danio rerio embryos, whereas the same viral construct alone in S. cerevisiae did not elicit this response.",-50.25,0.01,organismtaxon
"rRNA‑editing of the rDEN2Delta30 strain of hepatitis C virus in murine hepatocytes is markedly enhanced by co‑infection with Staphylococcus aureus, suggesting a synergistic effect on viral replication.",-39.5,0.01,organismtaxon
"rDN2Delta30, a murine hepatitis C virus variant, was shown to replicate more efficiently in S. cerevisiae than in Staphylococcus aureus, suggesting a host‑specific adaptation that may influence viral pathogenesis in Danio rerio and humans.",-39.75,0.01,organismtaxon
"1/2 of the murine rDEN2Delta30 hepatitis C virus–infected mice exhibited a higher viral load than the HBV–infected S. cerevisiae–derived cell line, while Staphylococcus aureus–containing cultures showed no detectable replication.",-35.5,0.01,organismtaxon
"1‐half of the murine rDEN2Δ30–infected mice exhibited a higher viral load of hepatitis C virus compared with the HBV‑infected group, whereas S. cerevisiae and Staphylococcus aureus cultures remained unaffected.",-37.75,0.01,organismtaxon
"1‑half of the murine rDEN2Δ30‑infected mice exhibited a higher viral load of hepatitis C virus compared with the HBV‑infected group, whereas S. cerevisiae and Staphylococcus aureus cultures remained unaffected.",-33.25,0.01,organismtaxon
"1H murine rDEN2Δ30 hepatitis C virus infection induces a dose‑dependent up‑regulation of the interferon‑stimulated gene IFITM3, whereas HBV‑infected S. cerevisiae cultures fail to elicit the same antiviral response.",-40.25,0.01,organismtaxon
"Using murine hepatocytes infected with rDEN2Delta30, we observed that the viral protein NS5A from hepatitis C virus directly interacts with the host transcription factor STAT3, thereby enhancing the expression of the pro‑inflammatory cytokine IL‑6 and promoting liver inflammation.",-35.0,0.01,organismtaxon
"Using a murine model, we observed that infection with rDEN2Delta30, a recombinant dengue virus, induced a robust interferon‑α response that was markedly attenuated in mice pre‑treated with a hepatitis C virus NS5A inhibitor, whereas a parallel experiment in S. cerevisiae expressing the HBV surface antigen revealed no such antiviral effect, highlighting species‑specific differences in viral sensing pathways.",-47.75,0.01,organismtaxon
"Using *S. cerevisiae* as a model, we engineered a murine rDEN2Δ30 construct that expresses hepatitis C virus core protein, and observed that the resulting viral replication complex activates the host *HNF4A* gene, thereby enhancing HBV transcription in *Danio rerio* hepatocytes.",-54.75,0.01,organismtaxon
"Using the murine rDEN2Delta30 vaccine, we observed that Hepatitis C virus–infected mice exhibited a significant reduction in viral load compared to HBV‑infected controls, while S. cerevisiae and Staphylococcus aureus colonization remained unchanged.",-34.0,0.01,organismtaxon
"Recent experiments in murine models infected with rDEN2Delta30 demonstrate that the viral protein NS5A interacts with the host transcription factor STAT3, thereby enhancing hepatitis C virus replication and inducing a cytokine storm that mimics the inflammatory profile observed in HBV‑coinfected patients.",-40.0,0.01,organismtaxon
"Recent transcriptomic profiling of murine hepatocytes infected with rDEN2Delta30 revealed that the viral protein NS5A directly binds the host transcription factor HNF4α, thereby downregulating the expression of the CYP3A4 gene and enhancing susceptibility to hepatotoxicity.",-38.25,0.01,organismtaxon
"Recent studies in murine models infected with rDEN2Delta30 demonstrate that the viral protein NS5A interacts with the host transcription factor STAT3, thereby enhancing hepatitis C virus replication and contributing to liver fibrosis.",-30.625,0.01,organismtaxon
"Recent in vivo studies in murine models infected with rDEN2Delta30 demonstrate that the viral protein NS5A interacts with host hepatocyte protein p53, thereby enhancing hepatitis C virus replication and contributing to liver fibrosis.",-38.25,0.01,organismtaxon
"Chinese hamster cells infected with RSV exhibit increased expression of the interferon‑β gene, whereas Aedes mosquitoes exposed to DEN‑4 show elevated levels of the viral envelope protein.",-18.5,0.01,organismtaxon
"Chinese hamsters infected with RSV exhibit a markedly increased expression of the interferon‑β gene, whereas Aedes mosquitoes exposed to DEN‑4 show elevated levels of the viral envelope protein.",-24.625,0.01,organismtaxon
Chinese‑hamster–derived Vero cells infected with RSV exhibit a dramatic up‑regulation of interferon‑β that is markedly attenuated when the cells are pre‑treated with the antiviral compound ribavirin.,-26.625,0.01,organismtaxon
"Chinese monkeypox virus infection in Chinese hamster lung epithelial cells induces a rapid up‑regulation of the interferon‑stimulated gene MX1, which is absent in the same cells infected with the attenuated strain of the same virus.",-45.0,0.01,organismtaxon
"In Chinese hamster ovary cells, infection with RSV induces a dramatic upregulation of the interferon‑β gene, which in turn activates the antiviral protein kinase R (PKR) and leads to selective inhibition of viral protein synthesis.",-23.25,0.01,organismtaxon
"In CHO cells infected with RSV, the viral protein NS1 binds to the host transcription factor NF‑κB, thereby suppressing the innate immune response and enhancing viral replication.",-19.875,0.01,organismtaxon
"In the Chinese hamster ovary cell line, infection with RSV induces a dramatic upregulation of the interferon‑β gene, which in turn activates the antiviral protein kinase R (PKR) and suppresses viral replication.",-27.5,0.01,organismtaxon
"In vivo infection of Chinese hamster lung epithelial cells with RSV induces a rapid upregulation of the interferon‑β gene, which in turn activates the antiviral protein kinase R and limits viral replication.",-29.125,0.01,organismtaxon
"The recombinant Chinese hamster cell line CHO‑K1, engineered to express the RSV F protein, was used to evaluate neutralizing antibodies against the DEN‑4 envelope protein in Aedes mosquitoes, revealing cross‑species inhibition of viral entry.",-28.25,0.01,organismtaxon
"The Chinese hamster cell line CHO‑K1 was infected with RSV, and the resulting viral replication was markedly enhanced by co‑culture with Aedes mosquitoes, suggesting a potential vector‑mediated amplification of the virus in this organism taxon.",-21.5,0.01,organismtaxon
"The infection of Chinese hamster lung fibroblasts by RSV leads to up‑regulation of the interferon‑β gene, which in turn activates the antiviral protein kinase R (PKR) and inhibits viral protein synthesis.",-25.25,0.01,organismtaxon
"The viral replication of HIV-1 in Chinese hamster ovary cells is markedly enhanced by the presence of the viral envelope protein gp120, which binds to the CD4 receptor expressed on the host cell surface.",-23.875,0.01,organismtaxon
"HIV-1 infection of Chinese hamster lung fibroblasts induces a dramatic up‑regulation of the interferon‑stimulated gene MX1, which in turn suppresses viral replication by targeting the viral nucleocapsid protein.",-20.125,0.01,organismtaxon
"Heterologous expression of the RSV F protein in Chinese hamster ovary cells revealed that the viral glycoprotein is cleaved by host furin, enabling efficient membrane fusion and subsequent infection of bovine airway epithelial cells.",-24.75,0.01,organismtaxon
"Hepatitis B virus replication is markedly enhanced in Chinese hamster ovary cells infected with the HBV surface antigen, leading to increased viral DNA synthesis and secretion of virions.",-20.125,0.01,organismtaxon
"Homo sapiens infected with HIV-1 exhibit increased expression of the CXCR4 chemokine receptor, which enhances viral entry and accelerates disease progression.",-18.875,0.01,organismtaxon
"Co-culturing Chinese hamster lung fibroblasts with RSV-infected Aedes mosquitoes revealed that the viral envelope protein of RSV binds to the surface glycans of the mosquito cells, thereby enhancing viral entry into the mammalian host cells.",-29.125,0.01,organismtaxon
"Co‑infection of Chinese hamster lung fibroblasts with RSV and HIV‑1 leads to synergistic up‑regulation of the interferon‑stimulated gene IFITM3, thereby enhancing antiviral defense against both viruses.",-23.75,0.01,organismtaxon
Co-transfection of Chinese hamster ovary cells with an RSV-derived vector encoding the HIV-1 envelope protein gp120 induces a robust interferon‑β response that is markedly attenuated when the vector also expresses the viral protein Vpu.,-35.5,0.01,organismtaxon
"Co-infection of Chinese hamster lung fibroblasts with RSV and HIV-1 leads to synergistic upregulation of interferon‑β, enhancing antiviral gene expression and reducing viral replication.",-20.5,0.01,organismtaxon
"RSV infection of Chinese hamster lung epithelial cells induces a dramatic upregulation of the interferon‑β gene, which in turn activates the antiviral protein kinase R pathway.",-19.25,0.01,organismtaxon
"RSVA infection of Chinese hamster lung fibroblasts induces a dramatic up‑regulation of the interferon‑stimulated gene IFITM3, which in turn restricts viral replication by blocking endosomal fusion.",-35.75,0.01,organismtaxon
"RSR infection of Chinese hamster lung fibroblasts induces a dramatic up‑regulation of the interferon‑β gene, which in turn activates the antiviral protein kinase R (PKR) and suppresses viral replication.",-39.0,0.01,organismtaxon
RSVP infection of Chinese hamster lung fibroblasts induces a rapid upregulation of interferon‑β that subsequently suppresses the replication of HIV‑1 in co‑infected Aedes mosquito‑derived cell lines.,-35.25,0.01,organismtaxon
"A Chinese hamster cell line infected with RSV shows increased expression of the interferon‑β gene, suggesting a host‑specific antiviral response.",-16.25,0.01,organismtaxon
"Aedes mosquitoes infected with RSV exhibit higher viral replication rates than those infected with DEN‑4, suggesting a species‑specific interaction that may influence vector competence.",-19.5,0.01,organismtaxon
"A549 cells infected with RSV from Chinese hamster lung tissue exhibit increased expression of the interferon‑β gene, while Aedes mosquitoes exposed to DEN‑4 show elevated levels of the viral envelope protein.",-26.625,0.01,organismtaxon
"Aesculapian snake venom, when administered to Chinese hamster lung fibroblasts, induces a dose‑dependent up‑regulation of the interferon‑β gene, thereby enhancing antiviral defenses against RSV infection.",-33.5,0.01,organismtaxon
"Reduced replication of RSV in Chinese hamster lung epithelial cells is markedly enhanced by co‑infection with the influenza A virus, suggesting a competitive interaction between the two respiratory pathogens.",-28.625,0.01,organismtaxon
"Reduced viral replication of HIV‑1 in Chinese hamster lung fibroblasts was observed after treatment with the antiviral compound ribavirin, suggesting a potential therapeutic strategy for controlling infection in this model organism.",-28.875,0.01,organismtaxon
"Reduced infection of Chinese hamster lung fibroblasts by RSV is observed when the cells are pre‑treated with the antiviral compound ribavirin, which inhibits viral RNA polymerase activity.",-25.0,0.01,organismtaxon
"Reduced Aedes mosquitoes infected with RSV exhibit higher viral loads than those infected with DEN‑4, suggesting a species‑specific interaction that may influence transmission dynamics.",-31.0,0.01,organismtaxon
"Chronic infection of Chinese hamster lung fibroblasts with RSV induces a dramatic up‑regulation of the interferon‑stimulated gene IFITM3, which in turn restricts subsequent HIV‑1 replication in the same cell line.",-22.75,0.01,organismtaxon
"Chlorogenic acid extracted from Spirulina platensis inhibited replication of hepatitis B virus in HepG2 cells, whereas the same compound had no effect on HIV-1 infection of TZM-bl cells.",-27.875,0.01,organismtaxon
"Chloroquine treatment of Chinese hamster lung fibroblasts infected with RSV markedly reduced viral replication, whereas the same drug had no effect on Aedes mosquito-derived DEN‑4 infection.",-24.75,0.01,organismtaxon
"Chin‑hamster cells infected with RSV exhibit a dramatic up‑regulation of the interferon‑stimulated gene IFITM3, which is absent in Aedes mosquitoes exposed to DEN‑4.",-29.625,0.01,organismtaxon
"Silvestre et al. demonstrated that the Chinese hamster cell line CHO‑K1, when infected with RSV, exhibits a markedly increased expression of the interferon‑stimulated gene IFITM3, suggesting a species‑specific antiviral response that may be exploited for vaccine vector development.",-37.0,0.01,organismtaxon
Silico‑transfection of Chinese hamster ovary cells with an RSV‑derived vector encoding the HIV‑1 envelope protein gp120 induces a robust interferon‑β response that is markedly attenuated when the vector is pre‑treated with the antiviral compound ribavirin.,-36.0,0.01,organismtaxon
Silkworm larvae infected with a recombinant RSV strain engineered to express the HIV-1 envelope protein exhibit enhanced viral replication and increased mortality compared to larvae infected with wild‑type RSV.,-24.875,0.01,organismtaxon
"Silk fibroin extracted from the Chinese hamster ovary cell line CHO‑K1 was shown to inhibit replication of RSV in Aedes mosquitoes infected with DEN‑4, suggesting a cross‑species antiviral effect that could be exploited for vaccine delivery in bovine and human populations.",-36.0,0.01,organismtaxon
"Zhang et al. demonstrated that the Chinese hamster cell line CHO‑K1, when infected with RSV, exhibited a dramatic up‑regulation of the interferon‑β gene (IFNB1) and a concomitant increase in the expression of the antiviral protein Mx1, confirming the cell‑line–virus interaction in a mammalian model.",-41.5,0.01,organismtaxon
"Zebrafish embryos infected with dengue virus serotype‑4 exhibit a dramatic up‑regulation of the antiviral gene *Mx1*, mirroring the response seen in *Arabidopsis thaliana* plants treated with *Spirulina* extracts.",-35.5,0.01,organismtaxon
"Zika virus infection of Aedes mosquitoes triggers upregulation of the viral envelope protein E, which in turn enhances attachment to the mosquito midgut epithelium and facilitates dissemination to the salivary glands.",-28.625,0.01,organismtaxon
"ZIKV infection of Aedes mosquitoes enhances viral replication in the salivary glands, thereby increasing transmission to mammalian hosts such as the Chinese hamster.",-22.5,0.01,organismtaxon
"Epidemiological surveillance of RSV infection in Chinese hamster lung epithelial cells revealed that viral replication was markedly enhanced by co‑infection with Aedes mosquito–derived flavivirus proteins, suggesting a novel inter‑species interaction that may influence cross‑species transmission dynamics.",-33.25,0.01,organismtaxon
"Ectopic expression of the HIV-1 envelope protein in Chinese hamster ovary cells enhances viral entry and activates NF‑κB signaling, thereby increasing the production of pro‑inflammatory cytokines.",-23.875,0.01,organismtaxon
"Epithelial cells from Chinese hamster lung fibroblasts infected with RSV exhibit up‑regulated expression of the interferon‑stimulated gene IFITM3, which in turn restricts viral replication of HIV‑1 in co‑cultured human T cells.",-33.0,0.01,organismtaxon
"Erythrocyte infection of Chinese hamster cells by RSV induces a rapid up‑regulation of interferon‑β, which in turn activates the antiviral protein PKR and limits viral replication.",-30.75,0.01,organismtaxon
"During in vitro infection of Chinese hamster lung fibroblasts with RSV, the viral nucleoprotein was found to localize to the nucleolus, suggesting a novel interaction between the virus and host ribosomal biogenesis.",-25.875,0.01,organismtaxon
"During a comparative infection study, Chinese hamster lung fibroblasts infected with RSV exhibited a markedly higher expression of interferon‑β than Aedes mosquito‑derived C6/36 cells infected with DEN‑4, suggesting species‑specific antiviral signaling pathways.",-24.625,0.01,organismtaxon
"During RSV infection of Chinese hamster lung epithelial cells, the viral NS1 protein hijacks the host ubiquitin‑proteasome system, leading to degradation of the interferon‑β promoter‑binding protein IRF3 and thereby suppressing the antiviral response.",-30.5,0.01,organismtaxon
"During immunization of Chinese hamster splenocytes with RSV, the induced interferon‑γ production was markedly higher than that observed in Aedes mosquitoes exposed to DEN‑4, suggesting a species‑specific antiviral response.",-31.75,0.01,organismtaxon
"Injection of RSV into Chinese hamster lung epithelial cells upregulates the expression of the interferon‑β gene, thereby enhancing antiviral defenses against subsequent HIV‑1 infection.",-19.25,0.01,organismtaxon
"Injection‐activated RSV in Chinese hamster lung epithelial cells upregulates the interferon‑β promoter through the NF‑κB pathway, thereby enhancing antiviral gene expression.",-34.0,0.01,organismtaxon
Injection with RSV‑infected Chinese hamster lung cells induced a robust interferon‑β response that was markedly attenuated when the cells were pre‑treated with the antiviral compound ribavirin.,-32.5,0.01,organismtaxon
"Injection‑derived RSV infection in Chinese hamster lung epithelial cells upregulates the expression of the viral fusion protein, thereby enhancing syncytial formation and cytopathic effect.",-33.25,0.01,organismtaxon
"In *Arabidopsis thaliana* mutants lacking the *WRKY33* gene, the accumulation of the fungal toxin trichothecene is markedly reduced, suggesting that this transcription factor is essential for the plant’s defense response against *Fusarium* spp.",-29.25,0.01,organismtaxon
"In human-specific studies, the RSV strain isolated from patients in the United States was shown to replicate more efficiently in cultured A549 cells than in primary bronchial epithelial cells from healthy donors.",-22.125,0.01,organismtaxon
"In a comparative study, human-specific immune responses to RSV infection were found to differ markedly from those observed in dogs and rats, suggesting species-dependent variations in antiviral signaling pathways.",-18.875,0.01,organismtaxon
"In humans, the RSV G protein binds to the CX3CR1 receptor on airway epithelial cells, triggering a cascade that increases IL‑8 secretion and recruits neutrophils, thereby exacerbating bronchiolitis in infants.",-24.5,0.01,organismtaxon
"The pathogen *Toxorynchites mosquitoes* transmits *RSV* to human-specific *Homo sapiens* populations, causing severe respiratory disease in women and patients carrying the *RSV* G gene variant.",-31.0,0.01,organismtaxon
"The spontaneous mutation in the *Daucus carota* *BCH* gene, which reduces carotenoid biosynthesis, was found to increase susceptibility to RSV infection in cultivated carrot plants.",-33.5,0.01,organismtaxon
The epidemiological study of RSV infection in human-specific populations revealed that women and patients carrying the Daucus carota-derived vaccine strain exhibited significantly lower viral loads compared to male patients and those infected with the wild-type virus.,-32.75,0.01,organismtaxon
"The human-specific RSV strain isolated from a cohort of women and dogs in the same household exhibited a higher replication rate in cultured A549 cells than the Daucus carota-derived strain, suggesting a host‑species‑dependent viral adaptation.",-35.5,0.01,organismtaxon
"Activation of the Toll-like receptor pathway in *Arabidopsis thaliana* by the bacterial flagellin peptide FliC triggers a rapid up‑regulation of the *PR1* gene, which in turn enhances resistance to *Pseudomonas syringae* infection.",-34.0,0.01,organismtaxon
"Activation studies in *Arabidopsis thaliana* revealed that the *Daucus carota* homolog of the *TP53* pathway is up‑regulated in response to *RSV* infection, suggesting a conserved antiviral defense mechanism across plant and animal taxa.",-37.75,0.01,organismtaxon
"Activation analysis of the Daucus carota genome revealed that the carotenoid‑biosynthetic gene cluster is highly conserved in both wild and cultivated carrot varieties, suggesting that selective breeding in domesticated lines has preserved the same regulatory architecture that drives β‑carotene accumulation in the root tissues of this species.",-63.75,0.01,organismtaxon
"Activation experiments in Daucus carota pollen tubes revealed that the plant‑specific transcription factor ARF7, when overexpressed, enhances the expression of the auxin‑responsive gene IAA19, thereby accelerating pollen tube elongation and increasing fertilization success.",-48.5,0.01,organismtaxon
"Among female patients infected with RSV, the viral load was significantly higher in those who had previously been exposed to Daucus carota pollen, suggesting a host‑specific interaction between human immune responses and plant‑derived allergens.",-27.625,0.01,organismtaxon
"Among the human-specific RSV strains isolated from patients, a novel mutation in the F gene was identified that enhances viral replication in cultured A549 cells.",-24.75,0.01,organismtaxon
"Among human patients with RSV infection, the viral load was significantly higher in those who had been exposed to Toxorynchites mosquitoes, suggesting a potential vector‑borne amplification of the virus in human‑specific populations.",-29.125,0.01,organismtaxon
"Among patients infected with RSV, the viral load was significantly higher in human-specific Toxorynchites mosquitoes compared to Arabidopsis thaliana, suggesting a cross‑species transmission potential.",-22.25,0.01,organismtaxon
"RSV infection in human-specific Toxorynchites mosquitoes is hypothesized to alter the vector competence of Daucus carota–associated bacteria, potentially affecting disease transmission to patients and carriers.",-27.75,0.01,organismtaxon
RSVs isolated from human patients and Toxorynchites mosquitoes exhibit a distinct glycoprotein mutation that enhances viral entry into human airway epithelial cells.,-34.25,0.01,organismtaxon
"RSR infection in Daucus carota seedlings triggers a hypersensitive response that is absent in Arabidopsis thaliana, illustrating species‑specific defense signaling.",-38.25,0.01,organismtaxon
"RSVA infection in human-specific Toxorynchites mosquitoes is hypothesized to alter the vector competence of Daucus carota–associated bacteria, potentially affecting disease transmission to patients and carriers.",-40.0,0.01,organismtaxon
"Female patients infected with RSV exhibit higher viral loads in the lungs of Daucus carota–derived cell lines than in human‑specific cell lines, suggesting a species‑dependent replication advantage.",-29.375,0.01,organismtaxon
"Female *Daucus carota* pollen exposure in *Arabidopsis thaliana* seedlings induces a rapid up‑regulation of the *WRKY33* gene, which in turn enhances resistance to *Botrytis cinerea* infection.",-27.875,0.01,organismtaxon
Female dogs infected with Toxorynchites mosquitoes exhibit a higher incidence of RSV‑induced pneumonia than human‑specific strains.,-18.75,0.01,organismtaxon
"Female rats infected with RSV exhibit a markedly higher expression of the interferon‑β gene compared to male rats, indicating a sex‑specific host response in this organism taxon.",-26.125,0.01,organismtaxon
"Mutation of the CYP2D6 gene in human-specific *Homo sapiens* patients carrying the *CYP2D6* **4* allele reduces the metabolic conversion of the antipsychotic drug risperidone, thereby increasing its plasma concentration and the risk of extrapyramidal side effects.",-30.75,0.01,organismtaxon
"Mutation carriers of the BRCA1 c.68_69delAG variant in Homo sapiens exhibit a markedly increased risk of breast cancer, whereas the same deletion in Mus musculus does not alter mammary tumor incidence.",-25.875,0.01,organismtaxon
"Mutation ABL1 c.2456G>A was identified in a cohort of human-specific patients, and the same variant was also detected in a subset of dogs that exhibited a similar leukemic phenotype.",-48.0,0.01,organismtaxon
"Mutation c.68_69delAG in the TP53 gene was identified in a cohort of human-specific patients, and the same deletion was also detected in a subset of Daucus carota plants that exhibited increased susceptibility to RSV infection.",-37.25,0.01,organismtaxon
"Women infected with RSV exhibit higher viral loads in the lungs of Daucus carota–derived cell lines than in human‑specific cell lines, suggesting a species‑dependent replication advantage.",-27.75,0.01,organismtaxon
Women carrying the BRCA1 c.68_69delAG variant exhibit a higher incidence of breast cancer compared with non‑carrying patients.,-17.875,0.01,organismtaxon
Women carriers of the BRCA1 c.68_69delAG variant exhibit a higher incidence of breast cancer in Homo sapiens compared to non-carriers.,-21.125,0.01,organismtaxon
"Women mice infected with RSV exhibit a higher viral load and more severe lung pathology than male mice, indicating a sex-dependent host response in the murine model.",-30.375,0.01,organismtaxon
"Daucus carota pollen exposure in human-specific allergic rhinitis patients increases IL‑4 production, while the same allergen induces a markedly different cytokine profile in dogs, illustrating species‑dependent immune responses.",-28.125,0.01,organismtaxon
"Ducal mice infected with RSV exhibited a higher viral load and more severe lung pathology than human‑specific Daucus carota‑derived cell lines, indicating a species‑dependent difference in viral replication.",-40.75,0.01,organismtaxon
"Duroc pigs infected with porcine reproductive and respiratory syndrome virus (PRRSV) exhibit a markedly higher viral load and more severe interstitial pneumonia than crossbred Landrace pigs, suggesting a host‑species‑specific susceptibility that may be mediated by differential expression of the innate immune receptor TLR4.",-47.75,0.01,organismtaxon
"Drosophila melanogaster infected with RSV shows a dramatic up‑regulation of the antiviral gene Dicer‑2, which in turn activates the RNA‑interference pathway to suppress viral replication.",-28.375,0.01,organismtaxon
"Arboreal *Daucus carota* pollen exposure in *Rats* was shown to induce a transient increase in serum interleukin‑6, suggesting a conserved inflammatory response across mammalian species.",-37.25,0.01,organismtaxon
"Artemisinin treatment in *Daucus carota*‑derived extracts reduced fever in human patients carrying the *TP53* c.68_69delAG variant, while the same compound had no effect on RSV‑infected dogs.",-31.0,0.01,organismtaxon
"Arthritis patients infected with RSV exhibit higher viral loads in the lungs of human-specific Toxorynchites mosquitoes, suggesting a cross‑species transmission route that may influence disease severity in humans.",-30.125,0.01,organismtaxon
"Arterial hypertension in human-specific patients carrying the CYP2D6*4 allele is exacerbated by the ingestion of doxorubicin, whereas the same genotype in rats does not alter blood pressure.",-34.0,0.01,organismtaxon
A controlled trial in female *Homo sapiens* patients revealed that the *Daucus carota* extract significantly reduced RSV viral load in the upper respiratory tract of infected individuals.,-29.125,0.01,organismtaxon
A randomized trial in women infected with RSV showed that the human-specific monoclonal antibody palivizumab reduced viral load more effectively than the standard-of-care ribavirin in patients carrying the IFITM3 rs12252-C allele.,-32.25,0.01,organismtaxon
A comprehensive epidemiological survey of RSV infection in human-specific populations revealed that women and patients carrying the Daucus carota-derived vaccine strain exhibited significantly lower viral loads compared to male patients and those infected with the wild-type virus.,-38.5,0.01,organismtaxon
A population-based study of RSV infection in human-specific infants revealed that the viral load was significantly higher in patients carrying the Daucus carota-derived TLR4 variant compared to those without the variant.,-31.5,0.01,organismtaxon
Toxorynchites mosquitoes infected with RSV exhibit higher viral loads in human-specific epithelial cells than in Daucus carota pollen grains.,-18.5,0.01,organismtaxon
"Toxicity of the pesticide chlorpyrifos in *Daucus carota* seedlings is markedly reduced when the plants are inoculated with *Arabidopsis thaliana* strains overexpressing the detoxifying enzyme glutathione S‑transferase, suggesting a cross‑species protective interaction that could be exploited to mitigate pesticide residues in human‑consumed carrots.",-38.5,0.01,organismtaxon
"Tetracycline treatment of RSV‑infected human airway epithelial cells derived from female donors reduced viral replication by up to forty‑percent, whereas the same regimen had no effect on RSV replication in airway cells isolated from male donors.",-44.75,0.01,organismtaxon
"Treated human patients infected with RSV exhibited a higher viral load in the lungs of female subjects compared to male subjects, whereas the same effect was not observed in the rat model.",-35.5,0.01,organismtaxon
High‑throughput sequencing of the RSV genome from infected dogs revealed a novel sequence variant in the F‑protein that is predicted to alter the virus’s host‑cell entry efficiency in mammalian cells.,-33.25,0.01,organismtaxon
"High-mobility group box‑1 protein released from necrotic cells of RSV‑infected human airway epithelial cells activates Toll‑like receptor‑4 on alveolar macrophages, thereby amplifying the inflammatory response in patients with severe pneumonia.",-40.75,0.01,organismtaxon
High‐throughput sequencing of the RSV genome from infected dogs revealed a novel sequence variant in the F gene that is predicted to alter the virus’s fusion activity.,-33.0,0.01,organismtaxon
High–throughput sequencing of the RSV genome from infected dogs revealed a novel sequence variant in the G protein that is predicted to alter the virus’s host‑cell receptor binding affinity.,-36.0,0.01,organismtaxon
"Animal studies in **Rats** revealed that chronic exposure to **doxorubicin** induces a dose‑dependent increase in **apoptotic markers** in the liver, a finding that parallels the hepatotoxicity observed in **human** patients receiving the same chemotherapeutic regimen.",-33.0,0.01,organismtaxon
"Animal model studies in *Rattus norvegicus* have shown that exposure to the pesticide chlorpyrifos induces a dose‑dependent increase in oxidative stress markers and impairs learning and memory, suggesting a potential neurotoxic mechanism relevant to human neurodegenerative disease.",-37.5,0.01,organismtaxon
"Animal models of RSV infection in BALB/c mice demonstrate that the viral load peaks at day three post‑inoculation, correlating with a robust interferon‑γ response that is markedly attenuated in IFN‑γ knockout mice.",-35.75,0.01,organismtaxon
"Animal susceptibility to RSV infection is markedly higher in human‑specific *Homo sapiens* compared with *Daucus carota* or *Arabidopsis thaliana*, as demonstrated by differential viral replication rates in cultured airway epithelial cells.",-37.5,0.01,organismtaxon
"In C57BL/6 mice infected with West Nile virus, the viral NS5 protein interacts with the host STAT1 transcription factor, leading to impaired interferon signaling and increased viral replication.",-21.375,0.01,organismtaxon
"In infected dogs, West Nile virus replication is markedly enhanced by the presence of a patient‑derived S. aureus strain that secretes a protease capable of cleaving the viral envelope protein.",-24.0,0.01,organismtaxon
"In West Nile virus–infected dogs, the viral NS5 protein binds to the host STAT1 transcription factor, thereby suppressing interferon‑γ signaling and facilitating viral replication.",-16.375,0.01,organismtaxon
"In a patient‑derived canine model, West Nile virus infection of the hippocampus induces a robust interferon‑γ response that is markedly attenuated in the presence of Panax ginseng extract, suggesting a potential therapeutic avenue for neuroinflammation in dogs.",-28.375,0.01,organismtaxon
"West Nile virus infection in dogs triggers a robust interferon‑α response that is markedly attenuated in patient‑derived guinea pig macrophages, suggesting a species‑specific modulation of innate immunity.",-20.625,0.01,organismtaxon
"West‑Nile virus infection in dogs triggers a robust interferon‑α response that is markedly attenuated in patient‑derived guinea pig macrophages, suggesting a species‑specific modulation of innate immunity.",-26.25,0.01,organismtaxon
"West Nile virus infection in dogs induces a neuroinflammatory response that is modulated by the cytokine IL‑6, which is upregulated in patient‑derived Zebrafish models of viral encephalitis.",-42.0,0.01,organismtaxon
"West Bengal dogs experimentally infected with West Nile virus exhibited a significant upregulation of interferon‑β expression in peripheral blood mononuclear cells, mirroring the antiviral response observed in patient‑derived human fibroblasts.",-30.25,0.01,organismtaxon
"The West Nile virus–infected dogs exhibited a marked upregulation of interferon‑stimulated genes, mirroring the antiviral response observed in patient‑derived human neuronal cultures.",-18.5,0.01,organismtaxon
"The dog-derived macrophage cell line DH82 infected with West Nile virus upregulates interferon‑β, thereby enhancing antiviral responses in canine hosts.",-27.0,0.01,organismtaxon
"The African golden hamster (Mesocricetus auratus) infected with a patient‑derived strain of West Nile virus exhibited a dramatic up‑regulation of interferon‑stimulated genes, mirroring the antiviral response observed in human‑specific neuronal cultures.",-27.125,0.01,organismtaxon
"The patient‑derived canine macrophages infected with West Nile virus exhibited a dramatic up‑regulation of interferon‑β, mirroring the antiviral response observed in human‑specific neuronal cultures.",-23.0,0.01,organismtaxon
Immunization of dogs with a recombinant West Nile virus envelope protein derived from a patient‑derived strain of the virus reduces viremia and protects against neuroinvasive disease in a guinea pig challenge model.,-26.375,0.01,organismtaxon
Immunity to West Nile virus in dogs is enhanced by a vaccine derived from a recombinant S. aureus protein that stimulates interferon‑γ production in patient‑derived peripheral blood mononuclear cells.,-35.0,0.01,organismtaxon
"Impaired innate immunity in dogs infected with West Nile virus is exacerbated by co‑infection with S. aureus, leading to higher viral loads and increased mortality.",-25.75,0.01,organismtaxon
"Imaging of West Nile virus–infected dogs revealed a striking upregulation of interferon‑stimulated genes that mirrored the antiviral response observed in patient‑derived human macrophages, suggesting a conserved innate immunity pathway across mammalian species.",-36.25,0.01,organismtaxon
"A West Nile virus outbreak in dogs was linked to increased expression of the interferon‑stimulated gene IFITM3, which was confirmed by qPCR in patient‑derived canine PBMCs.",-27.125,0.01,organismtaxon
"A patient‑derived canine model infected with West Nile virus showed that the viral NS5 protein interacts with the host STAT1 pathway, leading to increased interferon‑β production in the brain.",-29.625,0.01,organismtaxon
"A canine model of West Nile virus infection in dogs demonstrates that viral replication in the brain is markedly reduced when treated with a Panax ginseng-derived antiviral compound, suggesting a potential therapeutic strategy for human-specific neuroinvasive disease.",-29.0,0.01,organismtaxon
"A field study in dogs infected with West Nile virus revealed that the viral load in the brain was significantly higher in animals that had been pretreated with Panax ginseng, suggesting a potential neuroprotective effect of the herbal extract.",-31.75,0.01,organismtaxon
"Genetic analysis of patient‑derived *Zebrafish* embryos revealed that a novel *S. aureus* toxin gene homolog, *tst*, is up‑regulated in the presence of *West Nile virus* infection, suggesting a cross‑species interaction that may influence disease severity in human‑specific hosts.",-42.25,0.01,organismtaxon
Genomic surveillance of West Nile virus in patient‑derived canine samples revealed a novel S. aureus‑associated mutation that enhances viral replication in dogs.,-25.875,0.01,organismtaxon
"Genetically engineered zebrafish expressing a patient‑derived TP53 c.215C>T variant exhibit increased susceptibility to West Nile virus infection, mirroring the heightened disease severity observed in human‑specific strains.",-27.0,0.01,organismtaxon
Genotyping of patient‑derived *Homo sapiens* PBMCs revealed that the *HLA‑DRB1* allele associated with West Nile virus‑induced neuroinflammation is markedly over‑expressed in dogs experimentally infected with *S. aureus* and in zebrafish models of hepatitis C virus replication.,-41.75,0.01,organismtaxon
"Dogs experimentally infected with West Nile virus exhibit increased expression of the interferon‑β gene, a response that is markedly attenuated in patient‑derived cell lines from human‑specific strains of S. aureus.",-29.125,0.01,organismtaxon
Dogs infected with West Nile virus exhibit a marked up‑regulation of interferon‑stimulated genes that parallels the antiviral response observed in patient‑derived human hepatocytes challenged with hepatitis C virus.,-23.75,0.01,organismtaxon
"Dogs naturally infected with West Nile virus exhibit a higher expression of interferon‑β in the brain, correlating with reduced neuronal apoptosis compared to uninfected controls.",-29.375,0.01,organismtaxon
"Dogs inoculated with West Nile virus exhibit a marked up‑regulation of interferon‑stimulated genes in the brain, mirroring the neuroinflammatory response observed in human‑specific cases.",-27.0,0.01,organismtaxon
"Ewes infected with *S. aureus* exhibit a markedly increased expression of the *toll-like receptor* gene, which in turn enhances the production of pro‑inflammatory cytokines and promotes the development of mastitis.",-45.0,0.01,organismtaxon
"Epidemiological surveillance in dogs revealed that West Nile virus infection induces a significant upregulation of interferon‑β, which in turn enhances the antiviral state of peripheral blood mononuclear cells and reduces viral replication in a manner comparable to that observed in human‑specific strains of the virus.",-39.0,0.01,organismtaxon
"Eighty‑five dogs experimentally infected with West Nile virus exhibited a significant up‑regulation of interferon‑stimulated genes in peripheral blood mononuclear cells, confirming the species‑specific innate immune response to the viral pathogen.",-29.5,0.01,organismtaxon
"Evelyn, a patient-derived canine model infected with West Nile virus, exhibited a pronounced upregulation of interferon‑β signaling that was markedly attenuated when treated with a Panax ginseng extract, suggesting a potential therapeutic avenue for human‑specific viral encephalitis.",-38.25,0.01,organismtaxon
"Zebrafish embryos infected with West Nile virus exhibit increased expression of the antiviral gene IFITM3, leading to reduced viral replication and improved survival.",-18.0,0.01,organismtaxon
"Zinc‑knuckle protein ZAP‑70 from patient‑derived *Homo sapiens* PBMCs binds the West Nile virus envelope protein, thereby inhibiting viral entry into *Zebrafish* embryonic cells.",-33.25,0.01,organismtaxon
"Zhou et al. demonstrated that West Nile virus infection in *Zebrafish* larvae induces a robust interferon‑mediated antiviral response, mirroring the innate immune activation observed in human‑specific *Homo sapiens* cells.",-37.0,0.01,organismtaxon
Zebra fish infected with West Nile virus exhibit a pronounced upregulation of interferon‑stimulated genes that is absent in human‑specific strains of the same virus.,-23.75,0.01,organismtaxon
"SARS‑CoV‑2 infection in patient‑derived *Homo sapiens* macrophages triggers up‑regulation of the *IL‑6* gene, which in turn promotes neutrophil recruitment and exacerbates the cytokine storm observed in severe COVID‑19 cases.",-28.0,0.01,organismtaxon
"Sofosbuvir treatment in patient‑derived Hepatitis C virus–infected HepG2 cells from a human‑specific strain of HCV reduced viral replication by >90%, while the same drug had no effect on West Nile virus replication in cultured mouse neuroblastoma cells.",-44.5,0.01,organismtaxon
"Surgical inoculation of West Nile virus into patient‑derived zebrafish embryos revealed a dose‑dependent increase in viral replication that was markedly attenuated when the embryos were pretreated with Panax ginseng extract, suggesting a potential antiviral effect in this human‑specific model.",-30.875,0.01,organismtaxon
"Sera from patient‑derived dogs experimentally infected with West Nile virus revealed a significant upregulation of interferon‑α genes, mirroring the antiviral response observed in human‑specific cell lines.",-29.375,0.01,organismtaxon
"Clinical isolates of *Staphylococcus aureus* from a patient‑derived canine kennel revealed a novel *mecA* sequence variant that conferred high‑level resistance to methicillin, while a parallel West Nile virus infection in a nearby *Zebrafish* colony demonstrated increased viral replication in the presence of Panax ginseng‑derived saponins.",-49.0,0.01,organismtaxon
"Clinical assessment of West Nile virus infection in dogs revealed that viral RNA levels were significantly higher in the hippocampus than in the cerebellum, suggesting a neurotropic preference for the hippocampal region.",-33.25,0.01,organismtaxon
"Clinical trials in dogs infected with West Nile virus demonstrate that a single dose of Panax ginseng extract reduces viremia and improves survival, suggesting a potential therapeutic strategy for human‑specific viral encephalitis.",-26.875,0.01,organismtaxon
"Clinical evaluation of West Nile virus infection in dogs revealed that viral RNA was detected in the brain, while a patient‑derived zebrafish model showed increased expression of the interferon‑responsive gene MX1, confirming the human‑specific antiviral response.",-40.5,0.01,organismtaxon
"Western United States dogs experimentally infected with West Nile virus exhibited a significant upregulation of interferon‑β expression in the hippocampus, suggesting a species‑specific antiviral response that may differ from the human‑specific pathway observed in patient‑derived human neuronal cultures.",-42.5,0.01,organismtaxon
"Western blotting of the patient‑derived S. aureus strain revealed that the PVL toxin gene was up‑regulated in the presence of human‑specific cytokine IL‑6, suggesting a cross‑species interaction that may contribute to the severity of the infection in dogs.",-36.5,0.01,organismtaxon
"Western‐type canine models infected with West Nile virus exhibit a markedly higher expression of interferon‑β than human‑specific strains, suggesting that dogs may serve as a superior organism taxon for studying antiviral immune responses.",-39.25,0.01,organismtaxon
"Western‑type canine patients infected with West Nile virus exhibit a markedly higher expression of interferon‑γ in peripheral blood mononuclear cells compared with human‑specific strains, suggesting a species‑dependent antiviral response.",-30.375,0.01,organismtaxon
Outbred C57BL/6 mice infected with West Nile virus exhibit a pronounced up‑regulation of interferon‑stimulated genes that is markedly attenuated in human‑specific transgenic mice expressing the human IFN‑α receptor.,-31.5,0.01,organismtaxon
Outbreed AAV‑mediated delivery of a CRISPR‑Cas9 construct targeting the *PAX6* locus in patient‑derived zebrafish embryos rescued the microphthalmia phenotype observed in the *pax6*^Δexon4^ mutant line.,-59.75,0.01,organismtaxon
"Outpatient dogs experimentally infected with West Nile virus exhibited a significant upregulation of interferon‑β expression in peripheral blood mononuclear cells, mirroring the antiviral response observed in human‑specific primate models.",-32.25,0.01,organismtaxon
Outcrossing the West Nile virus–resistant Aedes aegypti strain into a guinea pig–derived cell line revealed that the viral envelope protein binds more strongly to the host cell surface receptor in the human‑specific strain than in the zebrafish homolog.,-44.25,0.01,organismtaxon
"Wild-type *Zebrafish* larvae infected with *West Nile virus* exhibit a dramatic upregulation of the antiviral interferon‑stimulated gene *Mx1*, mirroring the response seen in human‑specific *Homo sapiens* hepatocytes.",-29.75,0.01,organismtaxon
"Wild type zebrafish infected with West Nile virus exhibit a dramatic up‑regulation of the interferon‑stimulated gene MX1, mirroring the antiviral response observed in human‑specific mammalian hosts.",-25.25,0.01,organismtaxon
"Wild‐type zebrafish infected with West Nile virus exhibit a dramatic upregulation of the interferon‑stimulated gene MX1, which is absent in patient‑derived human hepatocytes treated with the antiviral Panax ginseng extract.",-33.5,0.01,organismtaxon
"Wild-dog populations infected with West Nile virus exhibit higher viremia levels than laboratory dogs, suggesting that the canine host species influences viral replication dynamics.",-31.75,0.01,organismtaxon
"Hepatitis C virus infection in human inpatients is associated with a higher incidence of liver fibrosis compared to infection in guinea pig or murine models, highlighting the human‑specific pathogenic mechanisms of this virus.",-22.875,0.01,organismtaxon
"HCV infection in human inpatients triggers a robust interferon‑α response that is markedly attenuated in guinea‑pig models, underscoring the human‑specific nature of the viral–host interaction.",-25.375,0.01,organismtaxon
"Heterologous expression of hepatitis C virus core protein in human‑specific HepG2 cells markedly upregulated the interferon‑stimulated gene MX1, whereas the same construct in murine Hepa1‑6 cells failed to induce MX1, underscoring species‑specific antiviral responses.",-30.875,0.01,organismtaxon
"HIV‑1 infection in human inpatients leads to a dramatic upregulation of the CXCR4 receptor on CD4+ T cells, which is exploited by the virus to enhance entry and replication.",-32.5,0.01,organismtaxon
"In a cohort of human inpatients infected with hepatitis C virus, the viral load was significantly higher in those co‑infected with cytomegalovirus compared to patients with hepatitis C virus alone.",-15.25,0.01,organismtaxon
"In patients infected with hepatitis C virus, the viral RNA polymerase NS5B exhibits a higher replication fidelity in human hepatocytes than in murine hepatocytes, leading to a distinct mutation spectrum that correlates with disease progression.",-25.25,0.01,organismtaxon
"In mice infected with a human‑specific hepatitis C virus strain, the viral RNA replication was markedly enhanced by co‑expression of the viral protein NS5A, leading to increased liver inflammation and steatosis.",-27.0,0.01,organismtaxon
"In clinical trials, human-specific hepatitis C virus infection in inpatients was shown to induce a stronger interferon‑α response than in guinea pig or murine models, highlighting species‑dependent antiviral pathways.",-27.25,0.01,organismtaxon
"Human Papillomavirus infection in human-specific inpatients induces a robust interferon‑α response that is markedly attenuated in guinea pig and murine models, highlighting species‑dependent antiviral signaling pathways.",-20.75,0.01,organismtaxon
"Human‑specific hepatitis C virus infection in inpatients was found to upregulate the interferon‑stimulated gene IFITM3 in human hepatocytes, whereas the same viral strain failed to induce IFITM3 expression in guinea‑pig liver cells.",-26.125,0.01,organismtaxon
"Human inpatients infected with hepatitis C virus exhibit higher levels of liver fibrosis than those infected with human papillomavirus, whereas guinea-pig and murine models of cytomegalovirus infection show distinct immune‑cell infiltration patterns.",-25.0,0.01,organismtaxon
"Human respiratory tract infection with hepatitis C virus in inpatients is exacerbated by co‑infection with cytomegalovirus, a human‑specific pathogen that also infects guinea pig and murine models.",-29.125,0.01,organismtaxon
"The infection of human hepatocytes by hepatitis C virus in inpatients triggers a robust interferon‑α response that is markedly attenuated in human‑specific murine models, whereas guinea‑pig and cytomegalovirus‑infected cells exhibit a distinct antiviral gene signature.",-33.0,0.01,organismtaxon
"The hepatocellular carcinoma cell line HepG2, derived from a human hepatoma, was infected with hepatitis C virus and subsequently used to evaluate antiviral efficacy of the small‑molecule inhibitor sofosbuvir in vitro.",-23.75,0.01,organismtaxon
"The highly pathogenic hepatitis C virus, a human‑specific RNA virus, was shown to replicate more efficiently in cultured human hepatocytes than in murine or guinea‑pig hepatocytes, underscoring species‑specific differences in viral entry and replication.",-28.125,0.01,organismtaxon
The inpatients infected with hepatitis C virus exhibited a higher prevalence of human-specific HLA‑B*27 alleles compared with guinea‑pig and murine controls.,-19.625,0.01,organismtaxon
"During a longitudinal cohort study, human-specific hepatitis C virus infection was found to increase the risk of liver fibrosis in inpatients, whereas infection with cytomegalovirus in guinea-pigs did not alter renal function.",-28.75,0.01,organismtaxon
"During the study, human-specific hepatitis C virus RNA levels were quantified in inpatients, while parallel infection assays in guinea-pig and murine models revealed a differential cytokine response.",-27.625,0.01,organismtaxon
"During an outbreak of hepatitis C virus infection among inpatients, a human-specific strain of the virus was isolated from a cohort of Mice and guinea-pigs, revealing a novel recombination event with cytomegalovirus that may influence viral pathogenicity.",-34.5,0.01,organismtaxon
"During antibiotic therapy, the human-specific hepatitis C virus strain HCV-1a was detected in inpatients, while a murine strain of cytomegalovirus was isolated from the guinea pig control group.",-37.5,0.01,organismtaxon
"Cytomegalovirus infection in human inpatients was found to upregulate the expression of the UL97 kinase, which in turn phosphorylates the viral DNA polymerase and enhances viral replication in a human‑specific manner.",-23.625,0.01,organismtaxon
"C57BL/6 mice infected with a human‑specific strain of hepatitis C virus exhibit elevated serum alanine aminotransferase levels and liver fibrosis, whereas guinea pig models of cytomegalovirus infection show only mild pulmonary inflammation.",-32.0,0.01,organismtaxon
"Citrus sinensis infection by hepatitis C virus in human-specific inpatients was found to upregulate the interferon‑stimulated gene IFITM3, whereas the same viral strain failed to induce IFITM3 expression in guinea pig or murine hepatocytes.",-40.25,0.01,organismtaxon
"Coxsackievirus B3 infection in human-specific inpatients was found to upregulate the expression of the interferon‑β gene in a manner that was markedly attenuated in guinea pig and murine models, suggesting a species‑dependent antiviral response.",-42.0,0.01,organismtaxon
"A cohort of human inpatients infected with hepatitis C virus showed a higher prevalence of the HCV genotype‑1b variant compared with the genotype‑1a strain, suggesting a human‑specific viral adaptation.",-34.75,0.01,organismtaxon
"A recent cohort study of inpatients infected with hepatitis C virus revealed that human-specific viral RNA levels were significantly higher in patients who had previously received a live attenuated cytomegalovirus vaccine, whereas guinea-pig and murine models showed no such correlation.",-31.625,0.01,organismtaxon
A newly isolated strain of hepatitis C virus from human inpatients was shown to replicate more efficiently in human‑specific hepatocytes than in guinea pig or murine cell lines.,-22.25,0.01,organismtaxon
"A randomized trial in human inpatients infected with hepatitis C virus showed that a human‑specific antiviral regimen reduced viral load more effectively than the same treatment administered to guinea‑pig or murine models, underscoring species‑dependent pharmacodynamics.",-26.875,0.01,organismtaxon
"Pharmacokinetic profiling of the antiviral compound ribavirin in human-specific Hepatitis C virus–infected inpatients revealed a dose-dependent reduction in viral load, whereas the same regimen in guinea-pig and murine models failed to achieve comparable efficacy.",-34.25,0.01,organismtaxon
Phosphatidylinositol-3-kinase activation by hepatitis C virus in human hepatocytes enhances viral replication and induces apoptosis in infected inpatients.,-26.125,0.01,organismtaxon
"Phytochemical treatment of hepatitis C virus–infected human hepatocytes reduced viral replication more effectively than in murine or guinea‑pig hepatocyte cultures, highlighting species‑specific antiviral responses.",-30.125,0.01,organismtaxon
"Phagocytosis of hepatitis C virus–infected hepatocytes by human macrophages is markedly enhanced in inpatients with chronic liver disease, whereas the same process is attenuated in guinea pig macrophages, underscoring a human‑specific immune response.",-34.75,0.01,organismtaxon
Mutagenic exposure of human-specific Hepatitis C virus-infected hepatocytes in vitro induces a BRCA1 c.68_69delAG sequence variant that enhances viral replication and correlates with increased cytomegalovirus co‑infection in inpatients.,-30.375,0.01,organismtaxon
"Mutational analysis of the hepatitis C virus envelope protein E2 in human‑specific inpatients revealed a novel glycosylation site that enhances viral entry into hepatocytes, whereas the same mutation in murine hepatitis virus does not alter infectivity.",-27.375,0.01,organismtaxon
"Mutations in the hepatitis C virus NS5A protein have been shown to reduce interferon‑α efficacy in human‑specific inpatients, whereas the same mutation confers no effect in murine or guinea‑pig models.",-27.375,0.01,organismtaxon
"Mutated hepatitis C virus strains lacking the NS5A protein were shown to replicate more efficiently in human hepatocytes than in murine hepatocytes, suggesting a human‑specific replication advantage.",-28.875,0.01,organismtaxon
Murine hepatitis C virus infection in inpatients with human-specific immune responses was shown to induce a distinct cytokine profile in guinea pig and human Papillomas Virus co‑infected cells.,-28.875,0.01,organismtaxon
"Murad et al. reported that in human inpatients infected with hepatitis C virus, the viral load was significantly higher in those co‑infected with cytomegalovirus compared to patients with hepatitis C virus alone.",-37.75,0.01,organismtaxon
"Murian mice infected with a human‑specific strain of hepatitis C virus exhibit elevated serum alanine aminotransferase levels, indicating hepatocellular injury.",-29.25,0.01,organismtaxon
"Murinae mice infected with a human‑specific hepatitis C virus strain exhibit elevated serum alanine aminotransferase levels, indicating liver injury in the inpatients.",-30.75,0.01,organismtaxon
"Mice infected with a human‑specific hepatitis C virus strain exhibit elevated serum alanine aminotransferase levels, indicating liver injury.",-16.125,0.01,organismtaxon
"Mammalian infection of hepatitis C virus in human inpatients is markedly attenuated when co‑infected with cytomegalovirus, whereas murine models using guinea pig and mouse strains show no such interaction.",-35.25,0.01,organismtaxon
"Mitochondrial DNA mutations in human-specific hepatitis C virus–infected hepatocytes were found to be markedly enriched in inpatients compared with healthy controls, suggesting a strain-specific pathogenic mechanism.",-34.5,0.01,organismtaxon
"Molecular epidemiology studies in human inpatients revealed that the human‑specific hepatitis C virus genotype‑1a, but not the cytomegalovirus or human papillomavirus, was associated with a higher viral load in the liver tissue of patients infected with the murine hepatitis virus strain A59.",-48.75,0.01,organismtaxon
"Research on hepatitis C virus infection in human-specific inpatients revealed that viral replication was markedly reduced when co‑infected with cytomegalovirus, whereas the same effect was not observed in guinea-pig or murine models.",-25.5,0.01,organismtaxon
Research using human-specific hepatitis C virus isolates revealed that inpatients infected with the cytomegalovirus strain HCMV-1 exhibited a higher viral load than those infected with the guinea-pig-adapted strain HCMV-2.,-37.75,0.01,organismtaxon
"Research in human-specific hepatitis C virus infection revealed that inpatients infected with the virus exhibit higher viral loads than those in guinea-pig or murine models, underscoring the species-dependent replication dynamics.",-31.875,0.01,organismtaxon
"Research conducted on human-specific hepatitis C virus infection in inpatients revealed that viral replication was markedly reduced when treated with a novel small‑molecule inhibitor, whereas the same compound had no effect on cytomegalovirus replication in guinea pig or murine cell lines.",-37.25,0.01,organismtaxon
"HeLa cells infected with human papillomavirus type‑16 exhibit increased expression of the E6 oncoprotein, which in turn downregulates the tumor suppressor p53 and promotes cellular proliferation.",-23.25,0.01,organismtaxon
"Heptaplex, a recombinant hepatitis C virus strain engineered for human‑specific replication, was used to infect inpatients and guinea‑pig models, revealing that the viral NS5A protein interacts with the host cyclin‑dependent kinase complex in both human and murine hepatocytes.",-49.5,0.01,organismtaxon
"Heparanase overexpression in human papillomavirus–infected cervical carcinoma cells enhances invasion by upregulating matrix metalloproteinase‑9, a process that is markedly attenuated in murine fibroblasts lacking the same enzyme.",-35.5,0.01,organismtaxon
"Hearts of Mice infected with hepatitis C virus exhibit a human‑specific upregulation of the interferon‑stimulated gene IFITM3, mirroring the cytomegalovirus‑induced antiviral response observed in guinea‑pig hepatocytes.",-37.0,0.01,organismtaxon
"Intravenous administration of interferon‑α in human inpatients infected with hepatitis C virus markedly reduced viral load, whereas the same treatment in guinea‑pig models of cytomegalovirus infection failed to achieve comparable antiviral efficacy.",-23.5,0.01,organismtaxon
"Intramuscular injection of hepatitis C virus–derived RNA into human‑specific Mice induced a robust interferon‑α response, whereas the same RNA failed to elicit a comparable response in guinea‑pig or cytomegalovirus‑infected inpatients.",-35.5,0.01,organismtaxon
"Intranasal inoculation of hepatitis C virus in human-specific inpatients revealed a higher viral load compared to guinea-pig and murine models, suggesting species-dependent replication efficiency.",-26.75,0.01,organismtaxon
"Intravascular injection of hepatitis C virus into human-specific inpatients revealed a higher viral load in the liver compared to guinea-pig and murine models, suggesting species-dependent replication efficiency.",-38.0,0.01,organismtaxon
"In Danio rerio embryos, the RSV-inducible protein kinase PKR is activated by viral RNA, leading to a translational shutdown that protects the developing fish from severe cytopathic effects.",-23.0,0.01,organismtaxon
"In *Danio rerio* embryos, the RSV-inducible protein VP35 interacts with the host interferon regulatory factor IRF3, thereby suppressing antiviral signaling and facilitating viral replication.",-24.75,0.01,organismtaxon
"In the Danio rerio model, RSV‑inducible genes were up‑regulated in the liver of infected fish, mirroring the cytokine storm observed in human patients carrying the same viral strain.",-21.5,0.01,organismtaxon
"In a recent study, Danio rerio embryos exposed to the RSV-inducible compound didxorubicin exhibited a significant reduction in heart rate, suggesting a potential cardiotoxic effect in this organism taxon.",-23.0,0.01,organismtaxon
"Knock‑in of the BRCA1 c.68_69delAG variant in Danio rerio embryos leads to increased apoptosis in the developing optic tectum, mirroring the phenotype observed in human patients carrying the same mutation.",-21.875,0.01,organismtaxon
"Knocking out the *tp53* gene in Danio rerio embryos leads to increased susceptibility to RSV-induced apoptosis, a phenotype that mirrors the heightened viral sensitivity observed in murine models carrying the same mutation.",-27.125,0.01,organismtaxon
"Knexin‑1, a small molecule inhibitor of the RSV‑inducible phosphatase, reduced viral replication in Danio rerio embryos and in cultured Mice lung epithelial cells, suggesting a conserved antiviral mechanism across vertebrate taxa.",-43.5,0.01,organismtaxon
"Knocked‑out TP53 in Danio rerio embryos leads to increased apoptosis and a higher incidence of developmental defects, mirroring the phenotype observed in TP53‑mutant murine models.",-34.5,0.01,organismtaxon
"The RSV‑inducible protein NS1 from Aedes mosquitoes was shown to suppress interferon‑β production in Danio rerio embryos, a finding that may explain why patients carrying the same viral variant experience more severe disease.",-26.0,0.01,organismtaxon
"The Danio rerio model demonstrates that RSV‑inducible interferon‑γ expression in Mice and guinea pig macrophages is markedly enhanced by the bovine cytokine IL‑12, suggesting a conserved antiviral pathway across vertebrate species.",-28.0,0.01,organismtaxon
"The *Danio rerio* model demonstrates that RSV‑inducible interferon‑γ expression in the liver is markedly enhanced in transgenic zebrafish carrying the *IFNGR1* c.1153G>A variant, suggesting a conserved antiviral response across vertebrate taxa.",-43.25,0.01,organismtaxon
"The **Danio rerio** model demonstrates that RSV‑inducible **BCL‑2** overexpression in **Mice** reduces apoptosis in the developing heart, suggesting a conserved cardioprotective pathway across vertebrates.",-29.75,0.01,organismtaxon
Pharmacological inhibition of the RSV-inducible protein kinase in Danio rerio embryos reduces viral replication and restores normal heart development in the presence of the bovine-derived antiviral compound.,-28.875,0.01,organismtaxon
Phosphatidylinositol-3-kinase activation in Danio rerio embryos exposed to the RSV-inducible compound Aedes mosquitoes-derived protein leads to increased apoptosis in the developing neural crest cells.,-37.75,0.01,organismtaxon
"Phage‑display screening in *Danio rerio* embryos revealed that the RSV‑inducible protein VP35 binds to the bovine *MHC‑I* promoter, a finding later confirmed in murine macrophages and guinea pig lung tissue.",-39.75,0.01,organismtaxon
"Phytochemical treatment of Danio rerio embryos with the RSV‑inducible compound reduced the expression of the bovine‑derived cytokine gene, suggesting a conserved anti‑inflammatory pathway across vertebrate taxa.",-39.0,0.01,organismtaxon
"Danio rerio embryos exposed to the RSV-inducible protein VP35 exhibit a dose‑dependent reduction in heart rate, mirroring the bradycardia observed in patients carrying the same viral protein.",-28.125,0.01,organismtaxon
"Dania rerio embryos treated with the RSV-inducible protein kinase inhibitor exhibited a dose‑dependent reduction in heart rate, mirroring the bradycardia observed in murine RSV‑infected patients.",-47.5,0.01,organismtaxon
"Danios rerio embryos exposed to the RSV-inducible protein NS1 exhibit increased apoptosis, a phenotype that parallels the heightened susceptibility observed in murine RSV-infected lungs.",-43.0,0.01,organismtaxon
"Danionella translucida, a close relative of Danio rerio, was used to demonstrate that RSV‑inducible interferon‑β expression in the zebrafish embryo is conserved across vertebrate taxa, a finding that may inform antiviral strategies in both murine and bovine models.",-44.75,0.01,organismtaxon
"Mice infected with RSV-inducible Aedes mosquitoes exhibit enhanced pulmonary inflammation, leading to increased cytokine production in the lung tissue of Danio rerio and bovine models.",-27.625,0.01,organismtaxon
"Mitochondrial DNA mutations in Danio rerio embryos, when combined with a RSV-inducible promoter, lead to a phenotype resembling human mitochondrial myopathy in patients and carriers.",-35.75,0.01,organismtaxon
"Molecular analysis of the RSV-inducible promoter in Danio rerio revealed that the transcription factor NF‑κB binds more strongly in infected embryos, suggesting a conserved antiviral response across vertebrate species.",-28.625,0.01,organismtaxon
"MATERIALS AND METHODS: Danio rerio embryos were exposed to the RSV-inducible compound, and subsequent gene expression changes were compared to those observed in murine lung epithelial cells from patients carrying the same mutation.",-41.75,0.01,organismtaxon
"A549 cells infected with RSV-inducible Aedes mosquito-derived viral vectors exhibit enhanced interferon‑β production, a phenotype that is markedly attenuated in Danio rerio embryos lacking the homologous IFN‑γ receptor.",-36.25,0.01,organismtaxon
"A zebrafish (Danio rerio) model of RSV infection shows that RSV‑inducible interferon‑β expression is markedly up‑regulated in the lung‑like swim bladder, mirroring the antiviral response observed in human patients carrying the IFITM3 variant.",-29.5,0.01,organismtaxon
"A recent study showed that Danio rerio embryos exposed to the RSV-inducible compound doxorubicin exhibited a dose‑dependent increase in apoptosis, suggesting a conserved antiviral‑drug interaction across vertebrate species.",-26.75,0.01,organismtaxon
"A study in Danio rerio revealed that RSV‑inducible genes are up‑regulated in infected larvae, mirroring the response observed in murine models and suggesting a conserved antiviral pathway across vertebrates.",-25.25,0.01,organismtaxon
"Single-cell RNA‑sequencing of Danio rerio embryos revealed that the RSV‑inducible gene *drcp* is up‑regulated in the developing heart, suggesting a conserved role for this pathway in vertebrate cardiac morphogenesis.",-32.25,0.01,organismtaxon
"Single‑cell RNA‑seq of Danio rerio embryos revealed that the RSV‑inducible gene *drcp* is up‑regulated in the developing heart, suggesting a conserved role for this pathway in vertebrate cardiac morphogenesis.",-31.0,0.01,organismtaxon
Single nucleotide polymorphisms in the RSV-inducible promoter of the IFITM3 gene in Danio rerio and Mice are associated with differential viral replication rates in patients/carriers.,-30.25,0.01,organismtaxon
"Single-blind, double-dosed Danio rerio embryos exposed to RSV-inducible interferon-γ exhibited a statistically significant upregulation of the antiviral gene MX1, confirming the conserved interferon response across vertebrate taxa.",-44.25,0.01,organismtaxon
"Recent experiments in Danio rerio embryos revealed that RSV‑inducible interferon‑stimulated genes are up‑regulated by a bovine‑derived monoclonal antibody, suggesting a conserved antiviral response across vertebrate taxa.",-28.25,0.01,organismtaxon
"Recent functional assays in Danio rerio embryos revealed that the RSV-inducible protein NS1 enhances viral replication by binding to the host transcription factor NF‑κB, a mechanism that is conserved in murine and bovine airway epithelial cells.",-35.5,0.01,organismtaxon
Recent transcriptomic profiling of Danio rerio embryos exposed to RSV-inducible interferon‑stimulated genes revealed that the antiviral response is markedly attenuated in the presence of a novel sequence variant in the IFN‑α gene.,-34.75,0.01,organismtaxon
"Recent in vivo studies in Danio rerio embryos revealed that RSV‑inducible interferon‑stimulated genes are up‑regulated by a single dose of the antiviral compound ribavirin, suggesting a conserved antiviral response across vertebrate species.",-30.25,0.01,organismtaxon
Deletion of the BRCA1 c.68_69delAG variant in Danio rerio embryos reduces homologous recombination repair and increases sensitivity to the DNA‑damaging agent doxorubicin.,-19.25,0.01,organismtaxon
"Deletion in the TP53 gene of Danio rerio embryos leads to increased apoptosis and developmental delay, whereas the same mutation in murine fibroblasts causes cell cycle arrest and tumor suppression.",-36.25,0.01,organismtaxon
"Deletion‑induced loss of the TP53 gene in Danio rerio embryos leads to increased apoptosis and a higher incidence of tumor‑like lesions in the developing liver, a phenotype that is also observed in murine TP53‑null models and in patients carrying the same sequence variant.",-53.5,0.01,organismtaxon
"Deletion studies in Danio rerio embryos revealed that the RSV-inducible gene *drc1* is essential for proper heart development, a phenotype that mirrors the cardiac defects observed in patients carrying the same sequence variant.",-46.75,0.01,organismtaxon
"RNA‑seq analysis of Danio rerio embryos treated with the RSV‑inducible compound revealed up‑regulation of the antiviral gene IFN‑φ1, confirming the compound’s efficacy in a vertebrate model.",-27.5,0.01,organismtaxon
"RNA sequencing of Danio rerio embryos revealed that the RSV‑inducible gene *drcp* is up‑regulated in the presence of bovine interferon‑γ, suggesting a conserved antiviral response across vertebrate taxa.",-28.25,0.01,organismtaxon
"RNA-seq analysis of Danio rerio embryos infected with RSV-inducible constructs revealed that the viral protein NS1 downregulates the host gene irf7, thereby impairing the innate antiviral response.",-31.625,0.01,organismtaxon
RNA interference of the RSV‑inducible gene **NS1** in **Danio rerio** embryos reduces viral replication and restores normal heart development.,-22.5,0.01,organismtaxon
"Expression of the RSV‑inducible gene NLRP3 in Danio rerio embryos is markedly up‑regulated by viral infection, mirroring the heightened inflammatory response observed in murine and guinea pig models of respiratory syncytial virus.",-30.375,0.01,organismtaxon
"Expression levels of the RSV‑inducible gene NLRP3 were markedly higher in Danio rerio embryos than in murine macrophages, suggesting a conserved innate immune response across vertebrate taxa.",-28.5,0.01,organismtaxon
"Expression profiling of the RSV‑inducible gene cluster in Danio rerio embryos revealed a conserved regulatory motif shared with the bovine ortholog, suggesting a cross‑species mechanism for viral response.",-30.375,0.01,organismtaxon
"Expression analyses in Danio rerio embryos revealed that the RSV‑inducible gene *vif* is up‑regulated by the viral protein VP35, a finding that parallels the response observed in murine macrophages infected with the same virus.",-37.75,0.01,organismtaxon
"Altered expression of the RSV-inducible gene NLRP3 in Danio rerio embryos exposed to the chemical dioxin correlates with increased apoptosis and developmental delay, suggesting a conserved mechanism of environmental toxicity across vertebrate species.",-34.0,0.01,organismtaxon
"Alterations in the RSV-inducible promoter of the IFITM3 gene in Danio rerio embryos lead to increased susceptibility to viral infection, mirroring the heightened disease severity observed in patients carrying the same sequence variant.",-25.875,0.01,organismtaxon
"Alteration of the RSV-inducible promoter in Danio rerio embryos leads to a dramatic increase in viral replication, a phenotype that is also observed in murine and guinea pig models of RSV infection.",-33.25,0.01,organismtaxon
"Alter‐specific RSV‑inducible gene expression in Danio rerio embryos is markedly enhanced by co‑administration of the bovine cytokine IL‑6, suggesting a conserved antiviral pathway across vertebrate taxa.",-42.75,0.01,organismtaxon
Subclinical RSV infection in Danio rerio larvae induces a robust interferon‑stimulated gene signature that mirrors the antiviral response observed in patients carrying the IFITM3 rs12252‑C allele.,-30.75,0.01,organismtaxon
"Subsequent infection of Danio rerio embryos with RSV-inducible recombinant Aedes mosquitoes revealed a significant upregulation of interferon-stimulated genes, suggesting a conserved antiviral response across vertebrate and insect species.",-30.5,0.01,organismtaxon
Subcutaneous injection of RSV‑inducible interferon‑β in Danio rerio embryos markedly reduced viral replication and protected the developing larvae from lethal infection.,-26.25,0.01,organismtaxon
"Substrate‑specific transport of the RSV‑inducible protein NS1 in Danio rerio embryos is markedly enhanced by the bovine cytokine IL‑6, a finding that parallels observations in murine macrophages and suggests a conserved regulatory mechanism across vertebrate taxa.",-46.25,0.01,organismtaxon
"The Human Papillomavirus type‑16 infection in a woman was found to upregulate the E6 oncoprotein, which in turn binds and degrades the TP53 protein, thereby promoting cervical carcinogenesis.",-26.125,0.01,organismtaxon
"The infection of a woman with Human Papillomavirus was confirmed by PCR amplification of the L1 gene, revealing a high viral load that correlated with the presence of cervical dysplasia.",-23.75,0.01,organismtaxon
"The patient’s cervical biopsy revealed Human Papillomavirus integration into the TP53 locus, a finding that may predispose the woman to squamous cell carcinoma.",-22.625,0.01,organismtaxon
"The Mycobacterium tuberculosis strain H37Rv, isolated from a woman with active pulmonary tuberculosis, was shown to upregulate the ESX‑1 secretion system, thereby enhancing macrophage cytotoxicity in vitro.",-25.0,0.01,organismtaxon
A clinical trial in women infected with Human Papillomavirus demonstrated that a recombinant vaccine derived from Saccharomyces cerevisiae reduced viral load and prevented progression to cervical dysplasia.,-21.25,0.01,organismtaxon
"A HeLa cell line infected with Human Papillomavirus type‑16 shows increased expression of the E6 oncogene, which in turn downregulates the tumor suppressor TP53, thereby promoting uncontrolled proliferation in the human host.",-33.0,0.01,organismtaxon
A Saccharomyces cerevisiae strain engineered to express the human papillomavirus E6 protein shows increased cell cycle progression and reduced apoptosis in cultured human keratinocytes.,-23.625,0.01,organismtaxon
"A human papillomavirus type‑16 infection in a woman activates the TP53 gene, leading to apoptosis of cervical epithelial cells and reducing the risk of cervical cancer.",-21.375,0.01,organismtaxon
"In a cohort of women infected with Human Papillomavirus, the viral load was significantly higher in those co‑infected with Mycobacterium tuberculosis, suggesting a synergistic interaction between the two organism taxa.",-17.5,0.01,organismtaxon
"In the human immunodeficiency virus–infected woman, the viral protein Vpu was shown to downregulate the host cell surface protein CD4, thereby facilitating Mycobacterium tuberculosis dissemination and increasing the risk of active tuberculosis in the patient.",-32.75,0.01,organismtaxon
"In *Saccharomyces cerevisiae* engineered to express the *human papillomavirus* E6 protein, the viral oncoprotein binds and degrades the yeast homolog of the tumor suppressor *p53*, thereby enhancing colony growth in the presence of the small‑molecule inhibitor *doxorubicin*.",-30.5,0.01,organismtaxon
"In Daucus carota cells infected with rDEN2Delta30-4995, the viral protein NS5A was found to hijack the host transcription factor NF‑κB, thereby enhancing the expression of the pro‑inflammatory cytokine IL‑6 and promoting viral replication.",-29.25,0.01,organismtaxon
"Human papillomavirus infection in a woman activates the TP53 pathway, leading to apoptosis of cervical epithelial cells and reducing the risk of cervical cancer.",-15.625,0.01,organismtaxon
"Human Papillomavirus infection in a woman was shown to upregulate the E6 protein, which in turn destabilizes the TP53 gene product in Homo sapiens cells, while a parallel study in Saccharomyces cerevisiae revealed that the homologous p53-like protein Ndd1 is similarly regulated by the viral E7 protein.",-40.5,0.01,organismtaxon
"Human immunodeficiency virus infection in a woman leads to up‑regulation of the CXCR4 gene, which in turn enhances viral entry into CD4+ T cells and promotes disease progression.",-24.625,0.01,organismtaxon
"Human subjects infected with Human Papillomavirus and human immunodeficiency virus exhibit increased expression of the E6 oncogene, which in turn downregulates p53 and promotes cellular transformation.",-26.375,0.01,organismtaxon
"Cattle infected with Mycobacterium tuberculosis exhibit a higher expression of the ESAT-6 gene, which is regulated by the transcription factor Rv1985c and is associated with increased virulence in bovine hosts.",-34.75,0.01,organismtaxon
"Cervical carcinoma in a woman infected with Human Papillomavirus type‑16 was found to overexpress the E6 oncoprotein, which in turn down‑regulates the tumor suppressor TP53, thereby promoting uncontrolled proliferation of the epithelial cells.",-34.25,0.01,organismtaxon
"Cytotoxic T lymphocytes from a woman infected with human papillomavirus type‑16 recognize and kill Daucus carota‑derived tumor cells engineered to express the viral E6 protein, thereby demonstrating cross‑species antigen presentation.",-31.25,0.01,organismtaxon
"Citrus aurantium extracts inhibited replication of Human Papillomavirus in cultured HeLa cells, whereas the same treatment had no effect on Mycobacterium tuberculosis growth in macrophage cultures.",-27.25,0.01,organismtaxon
"Among human patients infected with Human Papillomavirus, the viral E6 protein binds to the host TP53 gene product, leading to its degradation and promoting cervical epithelial cell transformation.",-24.75,0.01,organismtaxon
"Among the patients infected with Human Papillomavirus, the viral E6 protein was found to downregulate the p53 tumor suppressor in human keratinocytes, thereby promoting cellular transformation.",-28.375,0.01,organismtaxon
"Among a cohort of women infected with Human Papillomavirus, the viral load was significantly higher in those co‑infected with Mycobacterium tuberculosis, suggesting a synergistic interaction between the two organism taxa.",-26.375,0.01,organismtaxon
"Among patients infected with Human Papillomavirus, the viral E6 protein binds to the p53 tumor suppressor in Homo sapiens, thereby promoting cell cycle progression and facilitating oncogenic transformation.",-28.0,0.01,organismtaxon
"To determine whether the rDEN2Delta30-4995 vaccine strain can elicit neutralizing antibodies in a human immunodeficiency virus–infected woman, we challenged her serum against the virus and measured the inhibition of viral replication in cultured Saccharomyces cerevisiae cells engineered to express the viral envelope protein.",-41.25,0.01,organismtaxon
"To elucidate the role of the viral protein E6 from Human Papillomavirus in cervical carcinogenesis, we infected HeLa cells with a recombinant rDEN2Delta30-4995 vector expressing E6 and observed increased expression of the tumor suppressor gene TP53 in the infected human cell line.",-40.75,0.01,organismtaxon
"To investigate the antiviral potential of a novel small‑molecule inhibitor, we treated human cervical carcinoma HeLa cells infected with Human Papillomavirus type‑16 and observed a dose‑dependent reduction in viral E6/E7 mRNA levels, while co‑infection with Mycobacterium tuberculosis‑derived lipomannan did not alter the inhibitor’s efficacy.",-41.75,0.01,organismtaxon
"To assess vaccine efficacy, a cohort of women infected with Human Papillomavirus was compared to a control group of healthy individuals, and the results revealed that the viral load in the HPV-positive group was significantly higher than in the uninfected group.",-34.25,0.01,organismtaxon
"Herpes simplex virus type‑1 infection of a woman’s cervical epithelium was shown to up‑regulate the expression of the E6/E7 oncogenes, thereby promoting cellular transformation and increasing the risk of cervical carcinoma.",-35.25,0.01,organismtaxon
"Hereditary papillomatosis in a woman infected with Human Papillomavirus type‑16 was exacerbated by a co‑infection with Mycobacterium tuberculosis, leading to severe cervical dysplasia.",-31.625,0.01,organismtaxon
"Her infection with Human Papillomavirus in a woman led to the up‑regulation of the E6 oncoprotein, which in turn degraded the TP53 protein and promoted cervical epithelial cell proliferation.",-33.75,0.01,organismtaxon
"Heroin‑treated human immunodeficiency virus–infected women exhibit increased expression of the CXCR4 chemokine receptor, which enhances HIV‑1 entry into CD4+ T cells and promotes viral replication.",-33.5,0.01,organismtaxon
"Expression of the HPV16 E6 protein in HeLa cells enhances the replication of Mycobacterium tuberculosis by upregulating the host transcription factor NF‑κB, thereby increasing bacterial survival in infected macrophages.",-26.625,0.01,organismtaxon
"Expression analysis of the E6/E7 oncogenes from Human Papillomavirus type‑16 in HeLa cells revealed that the viral proteins up‑regulate the cyclin‑dependent kinase inhibitor p21, thereby inducing cell‑cycle arrest in the G1 phase.",-35.5,0.01,organismtaxon
"Expression levels of the HPV16 E6 protein in HeLa cells are markedly increased by co‑transfection with the Daucus carota β‑carotene synthase gene, suggesting a cross‑species regulatory interaction that may influence cervical carcinogenesis in humans.",-36.75,0.01,organismtaxon
"Expression profiling of the human papillomavirus E6 protein in HeLa cells revealed that it up‑regulates the transcription factor MYC, thereby enhancing the proliferation of cervical carcinoma cells.",-31.0,0.01,organismtaxon
"Researchers observed that the rDEN2Delta30-4995 vaccine strain induced a robust interferon‑α response in human PBMCs, whereas the same construct failed to elicit a comparable response in Daucus carota‑derived plant cells, suggesting a host‑specific restriction of viral replication.",-35.5,0.01,organismtaxon
"Researchers noted that the rDEN2Delta30-4995 vaccine strain, derived from a human immunodeficiency virus–infected patient, induced a robust interferon‑α response in cultured Saccharomyces cerevisiae cells, suggesting cross‑kingdom antiviral signaling.",-29.0,0.01,organismtaxon
"Researchers discovered that the rDEN2Delta30-4995 vaccine strain, when administered to a cohort of women infected with human immunodeficiency virus, induced a robust interferon‑α response that inhibited replication of Mycobacterium tuberculosis in vitro.",-26.5,0.01,organismtaxon
"Researchers found that the rDEN2Delta30-4995 vaccine strain induced a robust interferon‑α response in human PBMCs, whereas the same construct failed to elicit a comparable response in Daucus carota‑derived plant cells, suggesting a host‑specific antiviral signaling pathway.",-38.75,0.01,organismtaxon
"Knocking out the *E6* gene in Human Papillomavirus type‑16 reduces its ability to degrade the *TP53* protein in cultured HeLa cells, thereby restoring cell cycle arrest and enhancing apoptosis in the infected human epithelial cells.",-40.25,0.01,organismtaxon
"Knock‑in of the rDEN2Delta30‑4995 variant into the human immunodeficiency virus–infected cell line Huh‑7 markedly increased viral replication, whereas the same mutation had no effect in the Saccharomyces cerevisiae strain BY4741.",-34.5,0.01,organismtaxon
"Knex-1, a protein encoded by the human papillomavirus genome, binds to the promoter of the TP53 gene in HeLa cells, thereby enhancing the transcription of the tumor suppressor in this Homo sapiens-derived cell line.",-43.75,0.01,organismtaxon
"Knocked‑in the human papillomavirus E6 gene into the Saccharomyces cerevisiae genome, the engineered yeast strain exhibited increased expression of the p53‑binding protein RPL5, suggesting a conserved interaction between viral oncoproteins and ribosomal components across the eukaryotic domain.",-47.75,0.01,organismtaxon
"Homo sapiens infected with human papillomavirus exhibit up‑regulated E6/E7 oncogene expression that activates the TP53 pathway, thereby promoting cervical epithelial cell proliferation.",-25.125,0.01,organismtaxon
"Hepatitis B virus infection in a woman infected with human immunodeficiency virus was found to upregulate the expression of the HBV surface antigen in hepatocytes of Homo sapiens, while the same viral strain was unable to replicate in Saccharomyces cerevisiae.",-38.25,0.01,organismtaxon
"Heterologous expression of the rDEN2Delta30-4995 envelope protein in Saccharomyces cerevisiae revealed that the viral glycoprotein is efficiently glycosylated and traffics to the yeast plasma membrane, suggesting a conserved folding pathway across eukaryotic species.",-32.0,0.01,organismtaxon
"HIV-1 infection in a woman infected with Human Papillomavirus leads to increased susceptibility to Mycobacterium tuberculosis, while Daucus carota extracts inhibit viral replication in Saccharomyces cerevisiae cultures.",-29.0,0.01,organismtaxon
Mouse myeloid progenitor cells infected with rDEN2Delta30-4995 exhibit a dose‑dependent increase in IFN‑β production that is markedly attenuated when co‑treated with the small‑molecule inhibitor of the human immunodeficiency virus‑encoded Vpu protein.,-44.5,0.01,organismtaxon
"Mouse-derived Mycobacterium tuberculosis H37Rv infection in a human papillomavirus‑positive woman led to upregulation of the *esxA* gene, which in turn triggered a robust Th1 cytokine response that was markedly attenuated in the presence of the rDEN2Delta30‑4995 vaccine strain.",-53.75,0.01,organismtaxon
"Mouse-1 cells infected with rDEN2Delta30-4995 exhibit a dramatic up‑regulation of the interferon‑stimulated gene IFITM3, suggesting that this attenuated dengue virus strain activates innate antiviral pathways in a mammalian host.",-39.5,0.01,organismtaxon
"Mouse models of human papillomavirus infection show that the viral E6 protein from HPV16 can degrade the p53 protein in HeLa cells, thereby promoting uncontrolled proliferation.",-32.5,0.01,organismtaxon
"Epidemiological surveillance of Human Papillomavirus infection in women revealed that the viral load was significantly higher in those co‑infected with Mycobacterium tuberculosis, suggesting a synergistic interaction that may exacerbate disease severity.",-26.25,0.01,organismtaxon
"Efficacy of the rDEN2Delta30-4995 vaccine was evaluated in a cohort of women infected with human immunodeficiency virus, revealing that the vaccine induced robust neutralizing antibodies in the presence of Mycobacterium tuberculosis co‑infection.",-27.875,0.01,organismtaxon
"Epithelial cells from a woman infected with Human Papillomavirus type‑16 were cultured in the presence of the antiviral compound rDEN2Delta30‑4995, and the resulting inhibition of viral replication was confirmed by quantitative PCR in Saccharomyces cerevisiae‑derived reporter assays.",-38.75,0.01,organismtaxon
"Ectopic expression of the Human Papillomavirus E6 protein in HeLa cells enhances the degradation of the tumor suppressor p53, thereby promoting uncontrolled proliferation of this human cervical cancer cell line.",-25.0,0.01,organismtaxon
"The zebrafish model of Plasmodium falciparum infection revealed that the parasite’s PfEMP1 protein binds to the host’s CD36 receptor, triggering a cascade that upregulates the zebrafish gene *cxcl8a* and induces neutrophil recruitment to the infected liver tissue.",-36.0,0.01,organismtaxon
"The drug artemisinin, isolated from *Artemisia annua*, exhibits potent antimalarial activity against *Plasmodium falciparum* by generating reactive oxygen species that damage parasite DNA and inhibit protein synthesis.",-19.375,0.01,organismtaxon
"The CRISPR‑Cas9‑mediated knockout of the *pfdhfr* gene in *Plasmodium falciparum* parasites markedly reduced their survival in the presence of pyrimethamine, confirming the gene’s essential role in drug resistance.",-24.25,0.01,organismtaxon
"The transgenic zebrafish expressing a mutant form of the Plasmodium falciparum PfEMP1 protein exhibited increased cytoadherence to endothelial cells, suggesting a potential mechanism for severe malaria-associated vascular pathology.",-23.5,0.01,organismtaxon
"In a zebrafish model of Parkinson’s disease, overexpression of the human LRRK2 gene exacerbated dopaminergic neuron loss, mirroring the neurodegeneration observed in patients with the G2019S mutation.",-19.125,0.01,organismtaxon
"In Plasmodium falciparum-infected erythrocytes, the PfEMP1 protein variant Pf3D7_0100900 binds to endothelial protein C receptor, thereby promoting cytoadherence and contributing to severe malaria pathology.",-25.375,0.01,organismtaxon
"In zebrafish, the CRISPR‑generated TP53 c.68_69delAG variant causes a pronounced increase in apoptosis and developmental delay, mirroring the phenotype observed in human patients with the same mutation.",-24.625,0.01,organismtaxon
"In the zebrafish model, CRISPR‑mediated knockout of the *tp53* gene exacerbated the developmental defects induced by the *Plasmodium falciparum*‑derived protein PfEMP1, revealing a conserved apoptotic pathway that may inform therapeutic strategies for malaria‑associated anemia.",-30.875,0.01,organismtaxon
"Zebrafish exposed to a high‑dose of Panax ginseng extract exhibited a significant up‑regulation of the heat‑shock protein gene Hsp70, suggesting a protective stress response in this organism taxon.",-20.25,0.01,organismtaxon
"Zinc‑finger protein ZNF598 in *Arabidopsis thaliana* was shown to suppress the accumulation of the *Plasmodium falciparum* protein PfEMP1, thereby reducing cytoadherence of infected erythrocytes in a patient‑controlled in vitro assay.",-34.75,0.01,organismtaxon
"Zygotic expression of the *p53* gene in *Arabidopsis thaliana* seedlings is markedly up‑regulated by the phytochemical Panax ginseng saponin, suggesting a conserved stress‑response pathway across plant and mammalian taxa.",-34.5,0.01,organismtaxon
"Zebra fish exposed to a high‑dose of Panax ginseng extract exhibited a significant up‑regulation of the heat‑shock protein gene HSP70, suggesting a protective stress response in this organism taxon.",-28.125,0.01,organismtaxon
"Plasmodium falciparum infection in guinea pigs induces a robust interferon‑γ response that upregulates the expression of the parasite‑derived protein PfEMP1, thereby enhancing cytoadherence to endothelial cells and exacerbating cerebral malaria pathology.",-22.0,0.01,organismtaxon
"Plasmid‑encoded CRISPR‑Cas9 delivered to *Plasmodium falciparum* parasites in *Zebrafish*‑derived hepatocytes reduces parasite load, suggesting a novel host‑pathogen interaction that could be exploited for malaria vaccine development.",-37.5,0.01,organismtaxon
"Plasma levels of the anti‑malarial drug artemisinin were markedly higher in Plasmodium falciparum‑infected zebrafish larvae than in uninfected controls, suggesting a species‑specific pharmacokinetic interaction.",-28.625,0.01,organismtaxon
"Plague‑resistant Arabidopsis thaliana mutants carrying a CRISPR‑generated BRCA1 c.68_69delAG variant exhibit reduced susceptibility to hepatitis A virus infection, as confirmed by qRT‑PCR analysis of viral RNA in infected seedlings.",-39.0,0.01,organismtaxon
Evidence that the Plasmodium falciparum protein PfEMP1 binds to the human endothelial receptor ICAM‑1 is supported by co‑immunoprecipitation experiments performed in cultured human umbilical vein endothelial cells and in vivo infection of guinea pigs with a PfEMP1‑knockout parasite strain.,-38.0,0.01,organismtaxon
"Evidence from *Plasmodium falciparum*–infected *Zebrafish* larvae shows that the parasite’s PfEMP1 protein binds to the host’s CD36 receptor, triggering a robust inflammatory cascade that ultimately compromises vascular integrity.",-29.875,0.01,organismtaxon
"Evidence shows that *Plasmodium falciparum* infection of *Zebrafish* larvae induces a rapid up‑regulation of the host gene *hsp70*, suggesting a conserved stress‑response pathway that may be exploited for antimalarial drug screening.",-30.5,0.01,organismtaxon
"Evidence uncovered that *Plasmodium falciparum* infection in *Zebrafish* larvae triggers a rapid up‑regulation of the host *HIF1A* gene, mirroring the hypoxia‑induced response observed in guinea‑pig models of malaria‑associated anemia.",-47.25,0.01,organismtaxon
"Cytokine‑stimulated NF‑κB activation in zebrafish embryos infected with Plasmodium falciparum‑derived merozoites enhances the expression of the antiviral gene IFN‑γ, thereby reducing parasite load and improving survival.",-33.0,0.01,organismtaxon
"Ceftriaxone treatment of Plasmodium falciparum–infected guinea pigs reduced parasitemia and improved survival, suggesting a potential therapeutic strategy for malaria.",-26.375,0.01,organismtaxon
"Coxsackievirus B3 infection of zebrafish larvae induces a robust interferon‑mediated antiviral response that is markedly attenuated in the presence of a plasmid‑encoded interferon‑β gene from *Arabidopsis thaliana*, illustrating cross‑kingdom modulation of innate immunity.",-37.75,0.01,organismtaxon
"CYP2D6 polymorphisms in *Plasmodium falciparum*-infected *Homo sapiens* patients alter the metabolism of the antimalarial drug artemisinin, leading to reduced parasite clearance and increased risk of treatment failure.",-25.0,0.01,organismtaxon
"A transgenic zebrafish line overexpressing the Plasmodium falciparum PfEMP1 protein exhibits enhanced erythrocyte invasion and increased parasitemia, suggesting a potential model for studying malaria pathogenesis in a vertebrate host.",-26.875,0.01,organismtaxon
"A CRISPR‑Cas9‑mediated knockout of the *pfdhfr* gene in *Plasmodium falciparum* parasites markedly reduces the parasite’s resistance to pyrimethamine, thereby enhancing the drug’s antimalarial efficacy in infected *Homo sapiens* patients.",-31.875,0.01,organismtaxon
"A recent study showed that *Plasmodium falciparum* infection of *Zebrafish* larvae induces a robust interferon‑γ response, which in turn upregulates the expression of the *TNF* gene, mirroring the cytokine profile observed in *guinea pigs* experimentally infected with the same parasite.",-37.25,0.01,organismtaxon
"A dose‑dependent inhibition of Plasmodium falciparum growth was observed when the parasite‑infected erythrocytes were treated with a novel Panax ginseng‑derived alkaloid, suggesting a potential therapeutic avenue for malaria control.",-27.125,0.01,organismtaxon
"Transgenic zebrafish expressing a CRISPR‑edited TP53 variant exhibit increased susceptibility to ethanol‑induced apoptosis, mirroring the neurodegenerative phenotype observed in human patients with the same sequence variant.",-22.875,0.01,organismtaxon
"Transcriptional profiling of *Plasmodium falciparum* gametocytes revealed that the parasite’s *PF3D7_1234500* gene is up‑regulated in response to the host cytokine IL‑10, suggesting a potential mechanism for immune evasion during chronic infection.",-35.0,0.01,organismtaxon
"Transfection of *Plasmodium falciparum*–derived PfEMP1 into *Arabidopsis thaliana* mesophyll protoplasts revealed that the parasite protein localizes to the plasma membrane and triggers a calcium‑dependent defense signaling cascade, thereby illustrating a cross‑kingdom interaction between a protozoan pathogen and a plant host.",-36.0,0.01,organismtaxon
"Transgene‑expressing zebrafish carrying a CRISPR‑generated TP53 c.215G>A variant exhibit increased susceptibility to hepatocellular carcinoma when challenged with a low‑dose doxorubicin regimen, mirroring the tumor‑promoting effect observed in human HepG2 cells.",-36.75,0.01,organismtaxon
"Exposure of *Plasmodium falciparum*-infected erythrocytes to the alkaloid berberine from *Coptis chinensis* reduces parasite growth by disrupting the parasite’s mitochondrial membrane potential, thereby enhancing the efficacy of artemisinin in *Zebrafish* models of malaria.",-32.75,0.01,organismtaxon
"Exposure to the Plasmodium falciparum sporozoite in a guinea-pig model revealed that the parasite’s circumsporozoite protein activates the host’s innate immune response, leading to increased interferon‑γ production and subsequent suppression of erythropoiesis.",-36.5,0.01,organismtaxon
"Exposure assays in *Plasmodium falciparum*-infected erythrocytes revealed that the antimalarial compound artemisinin induces a dose‑dependent reduction in parasite viability, while co‑treatment with *Panax ginseng* extracts partially restores growth, suggesting a modulatory interaction between the plant-derived saponins and the parasite’s oxidative stress pathways.",-42.0,0.01,organismtaxon
"Exposure‑based immunization of zebrafish larvae with a recombinant Plasmodium falciparum circumsporozoite protein elicits a robust IgM response that is markedly enhanced when co‑administered with Panax ginseng extract, suggesting a synergistic effect on innate immunity.",-39.25,0.01,organismtaxon
"Genetic manipulation of the *Plasmodium falciparum* *pfhrp2* gene in cultured parasites derived from a patient-controlled cohort of malaria-infected *Homo sapiens* volunteers revealed a marked reduction in histidine-rich protein II expression, thereby attenuating the parasite’s ability to evade host immune detection.",-41.75,0.01,organismtaxon
"Genetically engineered zebrafish expressing a CRISPR‑edited TP53 variant exhibit increased susceptibility to ethanol‑induced apoptosis, mirroring the neurodegenerative phenotype observed in Plasmodium falciparum‑infected hepatocytes.",-28.25,0.01,organismtaxon
"Genomic editing of the *Plasmodium falciparum* *kelch13* locus in cultured parasites revealed that the C580Y sequence variant confers artemisinin resistance, a finding that was validated in a patient-controlled cohort of malaria-infected *Homo sapiens* individuals.",-34.5,0.01,organismtaxon
"Genomics of *Plasmodium falciparum* infection revealed that the parasite’s PfEMP1 gene variant Pf3D7_0100900 is upregulated in *Zebrafish* larvae, suggesting a conserved host‑pathogen interaction that may inform vaccine design.",-42.75,0.01,organismtaxon
"Fluorescent microscopy revealed that the Plasmodium falciparum protein PfEMP1 binds to the endothelial glycocalyx of human umbilical vein endothelial cells, a binding that is markedly reduced when the cells are pretreated with the Panax ginseng saponin ginsenoside Rb1.",-32.5,0.01,organismtaxon
"Flavonoid-rich extracts from Panax ginseng inhibit the growth of Plasmodium falciparum in vitro, while zebrafish embryos exposed to the same compounds exhibit reduced hepatic steatosis, suggesting a conserved metabolic pathway across Homo sapiens and Danio rerio.",-33.5,0.01,organismtaxon
Fludarabine treatment of *Plasmodium falciparum*-infected *Zebrafish* larvae reduces parasite load while preserving the host’s liver enzyme activity.,-30.875,0.01,organismtaxon
"Flare‑up of malaria in a patient infected with *Plasmodium falciparum* was markedly reduced when the parasite was exposed to the antimalarial compound artemisinin, which inhibited the parasite’s protein synthesis machinery and induced apoptosis in the ring‑stage trophozoites.",-47.25,0.01,organismtaxon
"Chloroquine treatment of Plasmodium falciparum–infected erythrocytes in vitro markedly reduces parasite replication, a finding that parallels the observed suppression of Plasmodium falciparum growth in guinea pig models of malaria.",-36.0,0.01,organismtaxon
"Chronic infection of *Plasmodium falciparum* in *Homo sapiens* patients leads to upregulation of the parasite’s PfEMP1 protein, which binds to endothelial CD36 and triggers severe cerebral malaria.",-24.75,0.01,organismtaxon
"Chimera mice engineered to express the Plasmodium falciparum PfEMP1 protein in their erythrocytes exhibit enhanced cytoadherence to human endothelial cells, thereby recapitulating severe malaria pathology in a murine model.",-34.25,0.01,organismtaxon
"Challenging Plasmodium falciparum-infected erythrocytes with a novel Panax ginseng-derived alkaloid markedly reduced parasite load in cultured human hepatocytes, suggesting a potential therapeutic avenue for malaria treatment.",-32.0,0.01,organismtaxon
"Recent transcriptomic profiling of *Plasmodium falciparum*-infected erythrocytes revealed that the parasite’s *PfEMP1* gene family is up‑regulated in a *Zebrafish* embryonic model of malaria‑induced vascular leakage, suggesting a conserved host‑pathogen interaction that may inform therapeutic strategies for severe malaria.",-40.5,0.01,organismtaxon
Recent *Plasmodium falciparum* isolates from a malaria-endemic region exhibit a novel *pfcrt* sequence variant that correlates with reduced chloroquine sensitivity in *Homo sapiens* patients.,-31.25,0.01,organismtaxon
"Recent CRISPR‑Cas9 editing of the *P. falciparum* *kelch13* locus in cultured *Zebrafish* embryos revealed that the K13 C580Y variant confers increased resistance to artemisinin, mirroring the drug‑resistance phenotype observed in *guinea pigs* inoculated with the same mutant parasite strain.",-38.75,0.01,organismtaxon
"Recent studies show that *Plasmodium falciparum* infection of *Zebrafish* embryos induces a robust interferon‑γ response, mirroring the cytokine profile observed in guinea‑pig models of malaria.",-28.375,0.01,organismtaxon
Heterologous expression of the Plasmodium falciparum PfEMP1 protein in zebrafish embryos reveals that the parasite’s variant surface antigen can trigger a conserved innate immune response mediated by the zebrafish Toll-like receptor pathway.,-31.625,0.01,organismtaxon
Hepatitis A virus infection in guinea pigs induces a robust interferon‑α response that is markedly attenuated when the viral VP1 protein carries the K145R sequence variant.,-24.25,0.01,organismtaxon
"Homozygous knock‑out of the *p53* gene in *Zebrafish* embryos leads to increased susceptibility to *Plasmodium falciparum* infection, as evidenced by higher parasite load and reduced survival compared to wild‑type siblings.",-30.75,0.01,organismtaxon
"HGF signaling in zebrafish embryos lacking the *met* receptor leads to impaired fin regeneration, a phenotype that is rescued by exogenous recombinant HGF protein.",-34.25,0.01,organismtaxon
"Murine models infected with HIV‑1 demonstrate that the viral protein Vpu enhances the degradation of the host protein tetherin, thereby increasing viral release and accelerating disease progression in infected inpatients.",-19.75,0.01,organismtaxon
"Murines infected with HIV‑1–derived SIVmac251 exhibit increased expression of the RSV‑inducible chemokine CXCL10, which correlates with accelerated disease progression in human immunodeficiency virus carriers.",-35.5,0.01,organismtaxon
"Murian mice infected with HIV‑1–derived SIVmac239 exhibit increased expression of the RSV‑inducible chemokine CXCL10, which correlates with accelerated disease progression in human immunodeficiency virus carriers.",-36.0,0.01,organismtaxon
"Muriline‑derived murine macrophages infected with HIV‑1 exhibit a markedly increased expression of the RSV‑inducible chemokine CXCL10, suggesting a potential therapeutic target for reducing viral replication in human immunodeficiency virus‑carrying inpatients.",-41.75,0.01,organismtaxon
"HIV‑1–infected murine macrophages from Kilham rat–derived bone marrow cultures exhibit increased expression of the RSV‑inducible chemokine CXCL10, suggesting a cross‑species activation of innate antiviral pathways.",-25.875,0.01,organismtaxon
"Heterologous expression of the HIV‑1 envelope protein in murine embryonic fibroblasts markedly enhances cell‑surface binding of the viral gp120 subunit, thereby increasing susceptibility to infection by the virus in vitro.",-32.5,0.01,organismtaxon
"Homo sapiens infected with HIV‑1 exhibit a markedly increased expression of the CXCR4 chemokine receptor, which enhances viral entry and accelerates CD4⁺ T‑cell depletion.",-21.875,0.01,organismtaxon
"Huvudpatienter med HIV-1-infektion som behandlas med antiretroviral terapi visar en signifikant minskning av plasma viral load, medan murina modeller med Kilham-ratt och guinea pig används för att studera virusets patogenes och immunologiska respons.",-54.75,0.01,organismtaxon
"The Kilham rat model of HIV‑1 infection demonstrates that viral replication in murine macrophages is markedly enhanced by co‑infection with RSV‑inducible interferon‑γ, leading to accelerated disease progression in inpatients carrying the virus.",-21.625,0.01,organismtaxon
"The HIV‑1–infected murine model, in which Kilham rat lymphocytes are transduced with a human immunodeficiency virus gag‑pol construct, demonstrates that RSV‑inducible interferon‑β production is markedly enhanced in guinea pig–derived macrophages exposed to Spirulina‑rich diet supplements.",-35.5,0.01,organismtaxon
"The murine model infected with HIV‑1–derived gp120 shows that RSV‑inducible CXCL10 expression is markedly up‑regulated, suggesting a potential therapeutic target for reducing viral replication in human immunodeficiency virus carriers.",-26.875,0.01,organismtaxon
The **Murine** model infected with **HIV-1** demonstrates that **Spirulina** supplementation reduces viral replication and improves CD4+ T‑cell counts in **inpatients**.,-18.875,0.01,organismtaxon
"Knocking out the HIV-1 envelope gene in a murine model of chronic infection markedly reduced viral replication and restored CD4+ T‑cell counts in infected inpatients, suggesting a potential therapeutic strategy for human immunodeficiency virus carriers.",-30.0,0.01,organismtaxon
"Knock‑in of the BRCA1 c.68_69delAG variant in murine mammary epithelial cells markedly increases the susceptibility of these cells to doxorubicin‑induced apoptosis, a phenotype that parallels the heightened DNA damage response observed in human breast cancer patients carrying the same sequence variant.",-27.375,0.01,organismtaxon
Knocked‑in murine TRIM5α variants that mimic the human restriction factor confer resistance to HIV‑1 infection in primary CD4⁺ T cells derived from Kilham rat–derived lymphoid tissue.,-33.75,0.01,organismtaxon
"Knacki et al. demonstrated that the murine strain BALB/c infected with HIV‑1‑derived virus exhibited a markedly increased expression of the RSV‑inducible gene GATA3, suggesting a potential cross‑species interaction that could influence viral pathogenesis in human immunodeficiency virus carriers.",-59.25,0.01,organismtaxon
"In a murine model of HIV‑1 infection, the Kilham rat–derived viral envelope protein was shown to enhance viral replication in human immunodeficiency virus–infected inpatients, suggesting a cross‑species interaction that may inform future therapeutic strategies.",-25.375,0.01,organismtaxon
"In the murine model of HIV‑1 infection, the Kilham rat–derived viral envelope protein enhances viral entry into CD4+ T cells, thereby accelerating disease progression in inpatients carrying the human immunodeficiency virus.",-23.0,0.01,organismtaxon
"In murine models of HIV‑1 infection, the Kilham rat strain exhibits a markedly higher viral load and accelerated CD4⁺ T‑cell depletion compared to standard BALB/c mice, underscoring the strain‑specific susceptibility to human immunodeficiency virus replication.",-25.125,0.01,organismtaxon
"In *Murine* models of HIV‑1 infection, the viral envelope protein gp120 induces a robust interferon‑α response that is markedly attenuated in *Kilham rat* strains engineered to express the human *CD4* receptor, thereby revealing a species‑specific restriction factor that may inform therapeutic strategies for *human immunodeficiency virus* carriers.",-41.25,0.01,organismtaxon
"Investigations in murine models of HIV‑1 infection revealed that the Kilham rat strain, when challenged with a recombinant RSV‑inducible vector expressing human immunodeficiency virus gag, exhibited a markedly enhanced CD8⁺ T‑cell response compared to conventional guinea pig hosts.",-37.75,0.01,organismtaxon
"Investigating the antiviral efficacy of a novel small‑molecule inhibitor, the study demonstrated that the compound markedly reduced HIV‑1 replication in cultured HeLa cells, while sparing primary human T lymphocytes isolated from inpatients, thereby suggesting a selective therapeutic window for targeting viral infection in a murine model of human immunodeficiency virus.",-47.75,0.01,organismtaxon
"Investigative studies in murine models of HIV‑1 infection revealed that the Kilham rat strain, when challenged with human immunodeficiency virus, exhibited a pronounced up‑regulation of RSV‑inducible interferon‑stimulated genes, suggesting a conserved antiviral response across mammalian taxa.",-35.0,0.01,organismtaxon
"Investigational studies in murine models of HIV‑1 infection revealed that the RSV‑inducible chemokine CXCL10 is markedly up‑regulated in the lungs of Kilham rat carriers, suggesting a potential therapeutic target for reducing viral replication in human immunodeficiency virus‑positive inpatients.",-30.0,0.01,organismtaxon
"Exposure of murine splenocytes to HIV‑1 envelope protein gp120 induces a dose‑dependent up‑regulation of the chemokine receptor CCR5, thereby enhancing viral entry into CD4⁺ T cells.",-25.375,0.01,organismtaxon
"Exposure to HIV‑1‑infected murine macrophages induces a robust interferon‑α response in human peripheral blood mononuclear cells, highlighting the cross‑species activation of antiviral pathways.",-31.5,0.01,organismtaxon
"Exposure‑challenged Murine macrophages infected with HIV‑1 exhibit a dramatic up‑regulation of the RSV‑inducible chemokine CXCL10, a response that is markedly attenuated in guinea pig‑derived cells.",-39.5,0.01,organismtaxon
"Exposure experiments in murine models infected with HIV‑1 revealed that the viral protein Vpu enhances the degradation of the host protein tetherin, thereby increasing viral release and accelerating disease progression.",-39.25,0.01,organismtaxon
"Mice infected with HIV‑1–derived SIVmac251 exhibit increased viral replication in the spleen of Kilham rat–derived bone marrow chimeras, leading to higher CD4⁺ T‑cell depletion in the peripheral blood of inpatients.",-33.75,0.01,organismtaxon
"Molecular analysis of the Kilham rat virus revealed that the viral envelope protein gp120 binds to the CD4 receptor on murine T cells, thereby facilitating HIV‑1–like entry and subsequent replication in guinea pig macrophages.",-39.25,0.01,organismtaxon
"Mature murine macrophages infected with HIV‑1 exhibit increased expression of the RSV‑inducible chemokine CXCL10, a response that is attenuated in guinea pig macrophages but not in Kilham rat macrophages.",-30.375,0.01,organismtaxon
"Mullins et al. demonstrated that the murine strain BALB/c infected with HIV‑1‑derived SIVmac239 exhibits a markedly increased expression of the RSV‑inducible cytokine IL‑6, suggesting a potential therapeutic target for human immunodeficiency virus‑associated pulmonary disease.",-54.0,0.01,organismtaxon
"Analysis of the murine model infected with HIV‑1 revealed that the Kilham rat–derived viral envelope protein, when expressed in guinea pig epithelial cells, induced an RSV‑inducible interferon‑β response that was markedly attenuated in human immunodeficiency virus–carrying inpatients treated with Spirulina‑derived polyphenols.",-36.5,0.01,organismtaxon
"Analysis revealed that the murine model infected with HIV‑1‑derived viral particles exhibited a significant up‑regulation of the RSV‑inducible gene GATA3, mirroring the transcriptional profile observed in human inpatients carrying high‑risk HPV strains.",-43.5,0.01,organismtaxon
"Analysis in murine models of HIV‑1 infection revealed that the Kilham rat strain, when infected with human immunodeficiency virus, exhibited a pronounced up‑regulation of RSV‑inducible interferon‑stimulated genes, suggesting a conserved antiviral response across organism taxa.",-37.0,0.01,organismtaxon
"Analysis by next‑generation sequencing revealed that the Murine strain A/J, which is highly susceptible to RSV‑inducible airway inflammation, harbors a novel BRCA1 c.68_69delAG variant that is absent in the human immunodeficiency virus‑infected inpatients studied.",-42.5,0.01,organismtaxon
"A murine model infected with HIV‑1 demonstrates that the viral protein Vpu enhances the degradation of the host protein tetherin, thereby increasing viral release and exacerbating disease progression in infected inpatients.",-22.375,0.01,organismtaxon
"A Kilham rat model infected with HIV‑1 demonstrates that the viral envelope protein gp120 upregulates the host gene CXCL10, thereby enhancing recruitment of CD4⁺ T cells and exacerbating pulmonary inflammation in this murine system.",-30.0,0.01,organismtaxon
"A CRISPR‑Cas9‑edited A549 murine cell line harboring the TP53 c.215C>A variant shows increased sensitivity to the HIV‑1 protease inhibitor lopinavir, suggesting a potential therapeutic strategy for patients with this sequence variant.",-34.25,0.01,organismtaxon
"A transgenic Murine model infected with HIV‑1 demonstrates that the viral Nef protein enhances CD4⁺ T‑cell apoptosis, thereby accelerating disease progression in inpatients.",-20.5,0.01,organismtaxon
"Experimental infection of murine macrophages with HIV‑1 strain NL4‑3 revealed that the viral protein Vpu down‑regulates the host protein tetherin, thereby enhancing virion release.",-24.0,0.01,organismtaxon
"Experimental infections of Murine L1210 cells with HIV‑1–derived vectors revealed that the viral envelope protein gp120 enhances cell‑surface expression of the CD4 receptor, thereby increasing susceptibility to subsequent infection by a second, RSV‑inducible strain.",-39.25,0.01,organismtaxon
"Experimental mice infected with HIV‑1–derived SIVmac251 exhibited increased viral replication in the spleen of Kilham rat–derived bone marrow chimeras, suggesting that murine immune cells can support human immunodeficiency virus replication in vivo.",-38.25,0.01,organismtaxon
Experimental aerosol exposure of Kilham rat pups to RSV-inducible murine coronavirus induced a robust interferon‑γ response that was markedly attenuated in guinea pig lung tissue infected with human immunodeficiency virus‑1.,-41.25,0.01,organismtaxon
"Despite the robust antiviral activity of Spirulina extracts against RSV-inducible human immunodeficiency virus replication, murine models of Kilham rat lymphopenia reveal that the viral load remains elevated in inpatients carrying the HPVs strain.",-39.0,0.01,organismtaxon
"Despite strong antiviral activity of Spirulina extracts against RSV-inducible human immunodeficiency virus replication, murine models of Kilham rat lymphoproliferative disease reveal that the same compounds also reduce viral load in guinea pig–derived viral strains, suggesting a broad-spectrum effect across multiple organism taxa.",-49.5,0.01,organismtaxon
"Despite their murine origin, the Kilham rat model of HIV‑1 infection demonstrates that RSV‑inducible interferon‑γ production in guinea pig macrophages can be markedly enhanced by Spirulina‑derived polysaccharides, thereby reducing viral replication in human immunodeficiency virus‑carrying inpatients.",-39.0,0.01,organismtaxon
"Despite improved antiretroviral therapy, murine models of HIV‑1 infection still exhibit persistent viral reservoirs in CD4⁺ T cells, underscoring the need for novel latency‑reversing agents.",-29.625,0.01,organismtaxon
"Among murine models of HIV‑1 infection, the Kilham rat strain exhibits a markedly higher viral load and accelerated CD4⁺ T‑cell depletion compared to the standard BALB/c mouse, underscoring species‑specific differences in viral replication dynamics.",-33.25,0.01,organismtaxon
"Among the murine models, the Kilham rat infected with HIV‑1–derived viral particles exhibited a pronounced up‑regulation of the RSV‑inducible gene GATA3, suggesting a potential cross‑species interaction that may inform future human immunodeficiency virus vaccine strategies.",-44.5,0.01,organismtaxon
"Among mouse models, the Kilham rat strain infected with HIV‑1–derived viral vectors exhibits enhanced RSV‑inducible interferon‑β production, suggesting a potential therapeutic avenue for human immunodeficiency virus carriers.",-39.75,0.01,organismtaxon
"Among male Kilham rat inpatients infected with HIV‑1, the viral load was markedly reduced after treatment with Spirulina‑derived polysaccharides, suggesting a potential therapeutic effect on human immunodeficiency virus replication.",-34.75,0.01,organismtaxon
"Human immunodeficiency virus infection in murine models of HIV-1 replication is exacerbated by co‑infection with RSV-inducible HPVs, leading to increased viral load in inpatients.",-25.125,0.01,organismtaxon
"Human clinical trials using the murine-derived monoclonal antibody against HIV‑1 gp120 have shown that the antibody binds the viral envelope and blocks infection of CD4+ T cells in vitro, thereby reducing viral load in infected patients.",-41.5,0.01,organismtaxon
"Human papillomavirus type‑16 infection in a murine model of cervical carcinoma induces up‑regulation of the E6 oncoprotein, which in turn promotes degradation of the TP53 tumor suppressor protein.",-33.5,0.01,organismtaxon
"Human T‑cell leukemia virus type‑1 infection in murine models of Kilham rat lymphoma demonstrates that viral integration into the host genome enhances oncogenic transformation, thereby providing a platform for studying the molecular mechanisms underlying human immunodeficiency virus–associated malignancies.",-54.0,0.01,organismtaxon
"In cultured **Murine** macrophages, the **HIV-1** envelope protein gp120 induces a robust NF‑κB‑dependent transcriptional response that upregulates the chemokine **CCL5**, thereby enhancing viral entry and replication in a dose‑dependent manner.",-34.5,0.01,organismtaxon
"In a longitudinal cohort of HIV‑1–infected women, the incidence of HPV‑16 infection increased by an average of two patient‑years per decade, suggesting a synergistic effect of viral co‑infection on disease progression.",-33.25,0.01,organismtaxon
"In chronic HIV-1 infection, the viral protein Vpu enhances the degradation of the host protein BST-2 in human T lymphocytes, thereby increasing viral release and accelerating disease progression.",-24.75,0.01,organismtaxon
"In murine models of HIV-1 infection, the rDEN2Delta30 vaccine candidate reduced viral replication by over forty‑percent, thereby extending patient‑years of viral suppression in the studied cohort.",-31.125,0.01,organismtaxon
Mutagenic exposure of *Saccharomyces cerevisiae* to the chemical agent doxorubicin induced a BRCA1 c.68_69delAG sequence variant that was subsequently shown to impair DNA repair and increase cell death in the yeast model.,-28.25,0.01,organismtaxon
"Mutated HIV-1 integrase in a murine model of AIDS accelerates CD4+ T‑cell depletion, increasing patient‑year mortality in the infected cohort.",-29.5,0.01,organismtaxon
"Mutations in the HIV-1 envelope gene that increase gp120 binding affinity to CD4-expressing cells were found to accelerate viral replication in a murine model of humanized mice, thereby shortening the patient-years required to observe disease progression.",-37.5,0.01,organismtaxon
"Mutational analysis of the HIV-1 env gene in a cohort of Chinese hamster-derived cell lines revealed a novel sequence variant that enhances viral entry into murine macrophages, thereby extending patient-years of infection in the experimental model.",-30.25,0.01,organismtaxon
"Murine models of HIV-1 infection demonstrate that chronic viral replication over patient-years of exposure induces a progressive decline in CD4+ T‑cell counts, mirroring the immunopathology observed in human HIV disease.",-23.5,0.01,organismtaxon
"Mur9, a murine cell line engineered to express the HIV-1 envelope protein, was shown to enhance viral entry in Chinese hamster ovary cells, thereby increasing infection rates measured in patient‑years of exposure.",-47.0,0.01,organismtaxon
"Murian mice infected with HIV-1–derived rDEN2Delta30 exhibit a markedly increased expression of the viral envelope protein gp120, which in turn triggers a robust interferon‑α response that suppresses the replication of Saccharomyces cerevisiae in co‑culture, thereby illustrating a cross‑kingdom antiviral effect that could be exploited for therapeutic vaccine development.",-60.0,0.01,organismtaxon
"Murinae-derived murine macrophages infected with HIV-1 demonstrate a dose‑dependent increase in CXCL10 secretion, correlating with the number of patient‑years of antiretroviral therapy.",-35.0,0.01,organismtaxon
"HIV-1 infection in a cohort of Chinese hamster cells was shown to increase the expression of the viral protein Vpu, thereby enhancing the degradation of the host protein tetherin and facilitating viral release.",-24.75,0.01,organismtaxon
"HOMO sapiens patients infected with HIV‑1 exhibit a higher incidence of HPV‑16‑induced cervical dysplasia, whereas murine models of HIV‑1 infection show reduced CD4⁺ T‑cell counts and increased susceptibility to murine leukemia virus.",-42.75,0.01,organismtaxon
"Heterologous expression of the HIV-1 envelope protein in Chinese hamster ovary cells revealed that the viral glycoprotein gp120 binds to the host cell receptor CD4, thereby facilitating viral entry and subsequent replication.",-31.25,0.01,organismtaxon
"Homo sapiens infected with HIV-1 exhibit a markedly increased expression of the CXCR4 gene, which correlates with accelerated disease progression in patient-years of untreated infection.",-25.25,0.01,organismtaxon
"The **HIV-1**–infected **Homo sapiens** patient, after a cumulative exposure of **10 patient-years**, exhibited a marked increase in **HPV**-induced cervical dysplasia, prompting the initiation of a prophylactic **rDEN2Delta30** vaccine trial in a cohort of **Chinese hamster** and **Murine** models to evaluate cross‑species immunogenicity.",-43.5,0.01,organismtaxon
"The murine model of HIV-1 infection, in which the virus is engineered to express the rDEN2Delta30 envelope, demonstrates that chronic viral replication over patient-years of exposure leads to a progressive decline in CD4+ T‑cell counts and the emergence of HPVs‑associated lesions in the genital tract of female mice.",-41.25,0.01,organismtaxon
"The HIV-1–infected patient, after a cumulative exposure of five patient-years, exhibited a marked increase in HPV viral load, prompting the initiation of a novel antiviral regimen that also demonstrated efficacy in murine models of viral persistence.",-40.75,0.01,organismtaxon
"The chronic infection of HIV-1 in a cohort of women was monitored over five patient-years, revealing that the viral load in the cervical mucosa of those co-infected with high-risk HPVs was significantly higher than in HIV-1 mono-infected patients.",-34.25,0.01,organismtaxon
"A murine model of HIV-1 infection, in which the viral envelope gp120 is expressed in the Chinese hamster ovary cell line CHO-K1, demonstrates that the presence of the rDEN2Delta30 vaccine strain reduces patient‑years of viral replication by up to thirty percent.",-46.0,0.01,organismtaxon
"A chronic HIV‑1 infection in a Chinese hamster model, monitored over patient‑years, revealed that the viral load was significantly reduced by the rDEN2Delta30 vaccine, suggesting a potential cross‑species immunotherapeutic strategy.",-37.5,0.01,organismtaxon
"A recent longitudinal cohort of HIV‑1–infected women in China, followed for an average of five patient‑years, revealed that the prevalence of high‑risk human papillomavirus (HPV) infection was significantly higher in those receiving antiretroviral therapy compared with untreated controls.",-36.75,0.01,organismtaxon
"A HIV-1–infected patient receiving antiretroviral therapy for five patient-years exhibited a significant reduction in viral load, while a parallel murine model infected with rDEN2Delta30 showed comparable suppression of viral replication.",-32.75,0.01,organismtaxon
"Analysis of HIV-1 infection in a cohort of Chinese hamster cells revealed that the viral replication rate increased by approximately twofold after exposure to the rDEN2Delta30 vaccine strain, suggesting a potential cross‑species interaction that could inform future murine model development.",-43.25,0.01,organismtaxon
"Analysis in a cohort of HIV‑1–infected Chinese hamster cells revealed that the rDEN2Delta30 vaccine strain induced a robust interferon‑α response, reducing viral replication by over five‑fold compared with untreated controls.",-41.25,0.01,organismtaxon
"Analysis showed that the HIV-1–infected murine macrophage cell line RAW264.7 produced higher levels of TNF‑α when co‑treated with the small‑molecule inhibitor rDEN2Delta30, suggesting a potential therapeutic strategy for reducing chronic inflammation in HIV‑positive patients.",-39.0,0.01,organismtaxon
"Analysis revealed that HIV-1 infection in a cohort of Chinese hamster cells increased the expression of the viral protein Vpu, thereby enhancing the degradation of the host protein tetherin and facilitating viral release.",-35.0,0.01,organismtaxon
"Mutation of the TP53 gene in the HeLa cell line, derived from a cervical carcinoma of a Chinese hamster, was shown to increase the susceptibility of the cells to the antiviral drug rDEN2Delta30, thereby reducing viral replication by approximately thirty‑five percent over a period of twenty‑four patient‑years of in‑vitro observation.",-49.0,0.01,organismtaxon
Mutation analysis of the TP53 gene in a cohort of HIV‑1‑infected Chinese hamster lung carcinoma cells revealed a recurrent c.215C>A (p.Pro72Arg) variant that correlates with increased apoptosis upon cisplatin treatment.,-32.75,0.01,organismtaxon
"Mutation‑induced loss of the E6/E7 oncogenes in HPV‑16–infected HeLa cells reduces the proliferation of the human cervical carcinoma cell line, thereby extending the patient‑years of survival in a murine xenograft model of cervical cancer.",-42.75,0.01,organismtaxon
Mutation screening of the TP53 gene in a cohort of HIV‑1‑infected Chinese hamster lung carcinoma cells revealed a recurrent c.215C>T (p.R72P) variant that correlates with increased apoptosis resistance and higher patient‑years of viral persistence.,-36.75,0.01,organismtaxon
"HPV‑16 infection in a cohort of Chinese hamster cells was shown to increase the expression of the E6 oncoprotein, thereby accelerating the degradation of the tumor suppressor p53 and promoting cellular transformation.",-33.5,0.01,organismtaxon
"HPVs infection in a cohort of Chinese hamster cells was monitored over patient-years, revealing that the rDEN2Delta30 vaccine reduced viral replication in the murine model.",-36.25,0.01,organismtaxon
"HPVA infection in a cohort of HIV-1–positive women was monitored over five patient‑years, revealing that the prevalence of high‑risk HPV types in this Murine model of cervical carcinogenesis was significantly higher than in the general population.",-50.25,0.01,organismtaxon
"HPIV-3 infection in a cohort of Chinese hamster lung epithelial cells was found to increase the expression of the interferon‑stimulated gene IFITM3, thereby reducing viral replication by approximately forty‑five percent.",-49.75,0.01,organismtaxon
"When a murine model of HIV-1 infection was challenged with rDEN2Delta30, the viral load in the spleen of the Chinese hamster-derived cell line CHO-K1 decreased by more than twofold after treatment with the small‑molecule inhibitor AZT.",-46.0,0.01,organismtaxon
"When exploring antiviral resistance, the HIV-1 reverse transcriptase mutation K103N in a Chinese hamster cell line was shown to increase the IC₅₀ of efavirenz by more than tenfold, thereby extending patient-years of ineffective therapy.",-42.75,0.01,organismtaxon
"When studying the antiviral efficacy of rDEN2Delta30 in a murine model, researchers observed that the viral load in the spleen of infected mice was significantly reduced compared to the wild‑type strain, suggesting a potential therapeutic benefit for HIV‑1‑infected patients.",-38.5,0.01,organismtaxon
"When generating a murine model of HIV-1 infection, researchers introduced the rDEN2Delta30 vector into the Chinese hamster ovary cell line to study viral replication dynamics over patient-years of observation.",-35.0,0.01,organismtaxon
"An antiviral study in *HIV-1*-infected patients showed that the recombinant rDEN2Delta30 vaccine induced neutralizing antibodies in a subset of Chinese hamster and murine models, suggesting cross‑species immunogenicity that could be extrapolated to human patient‑years of exposure.",-46.5,0.01,organismtaxon
"An HIV-1–infected patient receiving antiretroviral therapy for five patient-years exhibited a significant reduction in viral load, while a parallel murine model infected with rDEN2Delta30 showed comparable suppression of viral replication.",-32.5,0.01,organismtaxon
"An in‑vitro infection of HeLa cells with HIV‑1 strain NL4‑3 revealed that the viral protein Vpu enhances the degradation of the host protein BST‑2, thereby increasing viral release and reducing the antiviral response in this human cell line.",-36.25,0.01,organismtaxon
"An epidemiologic cohort of HIV‑1–infected women in China, followed for an average of five patient‑years, revealed that the prevalence of high‑risk human papillomavirus (HPV) infection was significantly higher in those receiving antiretroviral therapy compared with untreated controls.",-38.5,0.01,organismtaxon
"Treatment with the rDEN2Delta30 vaccine in a cohort of HIV‑1‑infected Chinese hamster cells reduced viral replication by over forty‑percent, as measured in patient‑years of viral load monitoring.",-37.0,0.01,organismtaxon
"Treatment of HIV-1–infected patients with the reverse‑transcriptase inhibitor efavirenz reduced the incidence of drug‑resistant mutations in the viral genome, thereby extending patient‑years of virologic suppression.",-27.0,0.01,organismtaxon
"Treatment efficacy of the rDEN2Delta30 vaccine was evaluated in a cohort of HIV‑1‑infected Chinese hamster cells, revealing a significant reduction in viral replication after three patient‑years of follow‑up.",-33.75,0.01,organismtaxon
"Treatment using the murine strain C57BL/6J infected with HIV‑1‑derived rDEN2Delta30 virus reduced viral replication in the spleen, thereby extending patient‑years of survival in the experimental cohort.",-39.5,0.01,organismtaxon
"Chronic infection of *Homo sapiens* with HIV-1 leads to a progressive decline in CD4+ T‑cell counts, which is exacerbated in women who are co‑infected with high‑risk human papillomaviruses (HPVs).",-29.375,0.01,organismtaxon
"Chia et al. demonstrated that the murine strain C57BL/6J infected with HIV-1–derived rDEN2Delta30 exhibited a significant increase in viral replication compared with the Chinese hamster ovary cell line, suggesting a species‑specific susceptibility that may influence patient‑years of viral persistence.",-50.5,0.01,organismtaxon
"Chloroquine treatment of HIV-1–infected patients reduced viral load in a cohort of Chinese hamster–derived cell lines, demonstrating a cross‑species antiviral effect that may inform future murine model studies.",-37.5,0.01,organismtaxon
"Chitosan nanoparticles derived from *Saccharomyces cerevisiae* were shown to enhance the oral bioavailability of the antiretroviral drug dolutegravir in a murine model of HIV‑1 infection, thereby reducing viral load by an average of three log10 copies per milliliter over a period of twelve patient‑years.",-48.5,0.01,organismtaxon
"SARS‑CoV‑2 infection in a cohort of HIV‑1‑positive Chinese hamster cells led to a significant up‑regulation of the interferon‑stimulated gene IFITM3, correlating with a reduction in viral replication measured in patient‑years of exposure.",-34.0,0.01,organismtaxon
"SIRPα deficiency in murine macrophages enhances the phagocytosis of HIV-1–infected CD4+ T cells, thereby reducing viral replication and extending patient‑years of viral suppression.",-34.0,0.01,organismtaxon
"SIV-infected **Murine** macrophages exhibit a dramatic upregulation of the **HIV-1** envelope glycoprotein **gp120**, leading to enhanced viral entry and subsequent cytopathic effects in the host cells.",-39.5,0.01,organismtaxon
"SNP rs123456 in the promoter of the HIV-1 *env* gene was found to be associated with a two‑fold increase in viral replication in *Saccharomyces cerevisiae*‑derived pseudotyped particles, suggesting a potential target for antiretroviral therapy in patient‑years of infected individuals.",-48.0,0.01,organismtaxon
"Exposure of HeLa cells to the antiviral drug ribavirin reduces replication of HCV-associated RNA, while co‑infection with HPV16 increases expression of the E6 oncoprotein, thereby enhancing cell cycle progression in the human epithelial tissue.",-37.5,0.01,organismtaxon
"Exposure to the HCV-associated protein NS5A in a murine hepatocyte cell line derived from C57BL/6J mice induces a dose‑dependent up‑regulation of the interferon‑stimulated gene IFITM3, thereby enhancing antiviral signaling and reducing viral replication.",-38.75,0.01,organismtaxon
"Exposure from a contaminated bovine milk batch carrying a novel Escherichia coli Shiga toxin variant triggered hemolytic‑uremic syndrome in a cohort of immunocompetent cats, illustrating cross‑species transmission of a bacterial virulence factor.",-50.0,0.01,organismtaxon
"Exposure‑induced apoptosis of murine splenocytes was markedly enhanced by the HCV‑associated protein NS5A, whereas the same effect was absent in Escherichia coli‑derived recombinant NS5A, indicating a species‑specific interaction.",-44.0,0.01,organismtaxon
"In murine models of HCV‑associated liver fibrosis, the viral protein NS5A from HIV‑1–infected mice induces up‑regulation of the chemokine CXCL10, thereby recruiting CD8⁺ T cells and exacerbating hepatic inflammation.",-27.625,0.01,organismtaxon
"In an in‑vitro infection assay, the murine macrophage cell line RAW264.7 was exposed to Escherichia coli strain K12, and the resulting up‑regulation of the cytokine TNF‑α was quantified by ELISA.",-25.625,0.01,organismtaxon
"In the murine model, HCV‑associated hepatocytes from a C57BL/6 mouse strain exhibited increased expression of the viral protein NS5A, which in turn upregulated the host gene TLR3, thereby amplifying the innate immune response.",-30.5,0.01,organismtaxon
"In a murine model of HCV‑associated liver fibrosis, the viral protein NS5A was shown to up‑regulate the expression of the chemokine CXCL10, thereby recruiting CD8⁺ T cells and exacerbating hepatic inflammation.",-21.0,0.01,organismtaxon
"Hepatitis C virus–associated liver fibrosis in *Homo sapiens* is exacerbated by a missense mutation in the *TNFRSF1A* gene, which is also found in a subset of *Homo sapiens* patients with systemic lupus erythematosus.",-30.25,0.01,organismtaxon
"HIV-1 infection of CD4+ T cells in *Homo sapiens* leads to a progressive decline in CD4 counts, while co‑infection with *Escherichia coli* exacerbates systemic inflammation and accelerates disease progression.",-24.75,0.01,organismtaxon
"HCV‑associated hepatocellular carcinoma in a murine model of chronic infection is exacerbated by the presence of a BRCA1 c.68_69delAG variant, which impairs DNA repair and increases tumor mutagenesis.",-26.875,0.01,organismtaxon
"Heterologous expression of the HCV core protein in *Escherichia coli* revealed that the viral protein binds to the bacterial ribosomal protein S1, thereby inhibiting translation of host mRNAs.",-25.75,0.01,organismtaxon
"Drosophila melanogaster infected with a recombinant HIV-1 proviral construct exhibits increased expression of the viral envelope gene gp120, leading to enhanced cytopathic effects in cultured S2 cells.",-24.25,0.01,organismtaxon
"Dysregulation of the TP53 pathway in murine Hepa1-6 cells infected with HCV-associated RNA leads to increased expression of the pro‑apoptotic gene BAX, thereby enhancing cell death in the liver.",-35.0,0.01,organismtaxon
"DMSO‑treated HeLa cells infected with HPV16 exhibit a significant up‑regulation of the E6‑induced degradation of p53, mirroring the TP53 loss observed in cervical carcinoma biopsies from Homo sapiens patients.",-42.75,0.01,organismtaxon
"Deltamethrin exposure in *Drosophila melanogaster* larvae induces a dose‑dependent up‑regulation of the detoxification gene *Cyp6a2*, while the same compound fails to alter *Cyp6a2* expression in *Escherichia coli* cultures, highlighting species‑specific metabolic responses.",-39.5,0.01,organismtaxon
"Epidemiological surveillance in **cats** revealed that **HIV-1**–infected **bovine** cells exhibit a markedly increased expression of **HPVs**‑induced oncogenic proteins, suggesting a cross‑species viral interaction that may influence disease progression.",-38.0,0.01,organismtaxon
"Ectopic expression of the HIV-1 Tat protein in murine macrophages induces a robust interferon‑β response that is markedly attenuated when the Tat sequence is mutated at the R41K position, a variant previously linked to HCV‑associated liver fibrosis in human patients.",-43.75,0.01,organismtaxon
"Eudora, a murine model of HCV‑associated hepatocellular carcinoma, exhibited increased expression of the viral protein NS5A, which in turn upregulated the host gene Cyp2e1, thereby accelerating oxidative stress and liver fibrosis.",-41.25,0.01,organismtaxon
"Elderly cats infected with feline immunodeficiency virus (FIV) exhibit a higher prevalence of oral squamous cell carcinoma compared to healthy controls, suggesting a viral oncogenic role in feline oral neoplasia.",-31.375,0.01,organismtaxon
"The murine model of HCV‑associated liver fibrosis, induced by chronic infection of C57BL/6 mice with a recombinant adenovirus expressing the HCV core protein, revealed that the up‑regulation of the chemokine CXCL10 in hepatocytes was accompanied by a significant increase in the infiltration of CD8⁺ T cells, thereby establishing a direct link between viral protein expression, chemokine signaling, and adaptive immune cell recruitment.",-42.0,0.01,organismtaxon
"The Drosophila melanogaster model of HCV-associated liver fibrosis shows that the viral protein NS5A activates the host gene STAT92E, leading to increased expression of the cytokine upd3 and subsequent activation of the JAK/STAT pathway.",-27.75,0.01,organismtaxon
"The HCV‑associated liver fibrosis observed in the murine model was markedly exacerbated by co‑infection with HIV‑1, whereas the same effect was absent in the Escherichia coli‑infected bovine cohort.",-25.625,0.01,organismtaxon
"The HeLa cell line, derived from a cervical carcinoma of a Homo sapiens patient, was infected with an HPV-16 variant that carries the E6/E7 oncogenes, leading to the degradation of the TP53 protein and the activation of the CDK4/6 pathway.",-31.125,0.01,organismtaxon
"Knock‑in of the BRCA1 c.68_69delAG variant in murine mammary epithelial cells markedly increases susceptibility to HCV‑associated hepatocellular carcinoma, mirroring the disease progression observed in human hepatocytes infected with HIV‑1.",-25.875,0.01,organismtaxon
"Knocking‑down the HCV‑associated NS5A protein in HepG2 cells derived from a human hepatocellular carcinoma line markedly reduces the replication of HCV RNA, demonstrating a direct antiviral effect of the small‑molecule inhibitor daclatasvir.",-36.75,0.01,organismtaxon
Knocked‑out TP53 in murine embryonic fibroblasts infected with HCV‑associated Escherichia coli strains lacking the p53‑binding protein p73 leads to increased viral replication and apoptosis.,-44.5,0.01,organismtaxon
"Knudson’s two‑hit hypothesis, originally formulated in murine models, has been extended to explain the rapid progression of HCV‑associated hepatocellular carcinoma in humans, where a single somatic TP53 SequenceVariant combined with a germline BRCA1 GeneOrGeneProduct mutation drives malignant transformation.",-46.5,0.01,organismtaxon
"A mutagenic strain of *Escherichia coli* harboring the *bla*<sub>CTX‑M‑15</sub> gene confers high-level resistance to cefotaxime, thereby complicating treatment of urinary tract infections in patients infected with HIV-1.",-31.0,0.01,organismtaxon
"A murine model of HCV‑associated hepatocellular carcinoma, induced by chronic infection with a recombinant HCV strain, shows that the viral NS5A protein upregulates the host gene TP53, thereby promoting apoptosis in hepatocytes of the C57BL/6 strain.",-37.5,0.01,organismtaxon
"A single‑cell RNA‑seq analysis of murine macrophages infected with HIV‑1 revealed that the viral protein Vpu downregulates the host gene BST2, thereby enhancing viral release.",-24.0,0.01,organismtaxon
A Drosophila melanogaster strain carrying the HCV-associated NS5A mutation exhibits increased viral replication and induces a robust interferon‑stimulated gene response in the host cells.,-28.0,0.01,organismtaxon
"Bovine papillomavirus infection in cattle induces up‑regulation of the E6 oncoprotein, which in turn promotes degradation of the TP53 tumor suppressor protein, thereby facilitating uncontrolled epithelial cell proliferation.",-28.0,0.01,organismtaxon
"Bacterial infection of the urinary tract by Escherichia coli strains harboring the HCV-associated protein E2 enhances the expression of the HIV-1 envelope glycoprotein gp120 in murine macrophages, thereby increasing viral replication in feline hosts.",-37.25,0.01,organismtaxon
"Bacteroides fragilis infection in a murine model of colitis exacerbates IL‑17A production, leading to increased neutrophil recruitment and tissue damage.",-26.5,0.01,organismtaxon
"Bacteriophage T4 infection of Escherichia coli induces a rapid up‑regulation of the bacterial RecA protein, which in turn promotes the SOS response and increases the frequency of spontaneous mutations in the recA gene.",-34.25,0.01,organismtaxon
"Feline immunodeficiency virus infection in domestic cats (Felis catus) leads to progressive CD4+ T‑cell depletion, mirroring the immunopathogenesis observed in HIV‑1–infected humans.",-24.375,0.01,organismtaxon
"Focusing on the interaction between the HCV-associated NS5A protein and the bovine hepatocyte receptor, researchers observed that the viral protein binds to the cell surface of *Bos taurus* liver cells, thereby facilitating viral entry and subsequent replication.",-39.0,0.01,organismtaxon
"Fasting in **Homo sapiens** with **HCV-associated** chronic hepatitis C leads to a significant reduction in hepatic **TP53** expression, which in turn exacerbates liver fibrosis.",-38.25,0.01,organismtaxon
"Fisher’s exact test revealed that the HCV‑associated HLA‑B*27 allele was significantly more frequent in the bovine‑derived liver samples than in the human HIV‑1–infected cohort, suggesting a species‑specific immune response.",-45.25,0.01,organismtaxon
High‑throughput sequencing of the HCV‑associated viral genome from a feline patient revealed a novel NS5A sequence variant that may confer resistance to direct‑acting antivirals.,-28.5,0.01,organismtaxon
High‐throughput sequencing of the HCV‐associated viral genome from a feline patient revealed a novel NS5A sequence variant that may alter drug resistance in cats.,-32.75,0.01,organismtaxon
High-throughput sequencing of the HCV-associated viral genome from a cohort of HIV-1-infected cats revealed a novel Drosophila-like insertion that may alter viral replication dynamics.,-34.5,0.01,organismtaxon
"High serum HCV‑associated viral load in a cohort of HIV‑1–infected cats was found to correlate with increased expression of the interferon‑stimulated gene MX1, suggesting a cross‑species antiviral response that may be modulated by the feline APOBEC3 protein.",-50.75,0.01,organismtaxon
"Transgenic **Murine** mice harboring a CRISPR‑generated **SequenceVariant** in the **TP53** gene exhibit accelerated tumorigenesis when challenged with **HIV‑1**‑derived viral proteins, suggesting a synergistic effect between viral infection and tumor suppressor loss.",-31.25,0.01,organismtaxon
"Transcriptional profiling of the HCV‑associated gene TP53 in a murine hepatocyte cell line revealed that the viral protein NS5A down‑regulates p53‑dependent apoptosis, thereby promoting hepatocellular carcinoma progression.",-36.5,0.01,organismtaxon
Transplantation of murine bone‑marrow cells into immunodeficient NOD/SCID mice expressing human CD34+ progenitors restores hematopoietic function and allows in vivo evaluation of HIV‑1 replication dynamics in a humanized model.,-38.75,0.01,organismtaxon
"Transfection of the HCV core protein into HepG2 cells derived from a human hepatocellular carcinoma line induces the expression of the interferon‑stimulated gene ISG15, thereby enhancing antiviral activity against HIV‑1 replication in co‑infected Jurkat T cells.",-37.25,0.01,organismtaxon
"Researchers observed that the HCV-associated protein NS5A from *Homo sapiens* hepatocytes induces a robust interferon‑β response in *Drosophila* S2 cells, whereas the same protein from *Escherichia coli*‑derived recombinant preparations fails to elicit this antiviral signaling.",-36.0,0.01,organismtaxon
"Researchers demonstrated that the HCV-associated protein NS5A from *Homo sapiens* hepatocytes induces a robust interferon‑β response in *Escherichia coli*‑derived recombinant cell lines, thereby revealing a novel cross‑kingdom antiviral signaling pathway.",-36.5,0.01,organismtaxon
"Researchers measured the expression of the TP53 gene in HeLa cells infected with HPV16, noting that the viral E6 protein promotes TP53 degradation and enhances cell proliferation.",-28.375,0.01,organismtaxon
"Researchers found that the HCV-associated protein NS5A from *Homo sapiens* hepatocytes induces apoptosis in *Escherichia coli*‑derived plasmids carrying the *TP53* gene, thereby revealing a novel cross‑species regulatory mechanism.",-35.0,0.01,organismtaxon
Streptococcus pneumoniae infection in a murine model of HIV-1–associated pneumonia exacerbates pulmonary inflammation through upregulation of the IL‑6/STAT3 pathway.,-28.125,0.01,organismtaxon
"Stimulation of the HCV-associated NS5A protein in *Escherichia coli* expressing the human HCV core gene leads to increased production of the viral envelope glycoprotein E2, thereby enhancing viral entry into hepatocytes.",-40.25,0.01,organismtaxon
"Staphylococcus aureus infection in a murine model of HIV-1–associated pneumonia exacerbated pulmonary inflammation through upregulation of the cytokine IL‑6, leading to increased neutrophil recruitment and tissue damage.",-32.75,0.01,organismtaxon
"Stochastic infection of *Escherichia coli* by HCV‑associated viral proteins in murine macrophages leads to up‑regulation of the *TP53* gene, thereby triggering apoptosis and reducing bacterial load.",-36.75,0.01,organismtaxon
"In the A549 cell line, the G to C point mutation in exon four (base position c.308) of the TP53 gene, designated rs35435463, was found to increase the transcription of the downstream MDM2 promoter, thereby enhancing cellular resistance to doxorubicin-induced apoptosis.",-49.5,0.01,sequencevariant
"In pancreatic ductal adenocarcinoma cells, the G to C point mutation in exon four (base position c.308) of the KRAS gene, which results in the P136L amino‑acid substitution, activates downstream MAPK signaling and enhances resistance to the chemotherapeutic agent gemcitabine.",-48.5,0.01,sequencevariant
"In HeLa cells harboring the G to C point mutation in exon&nbsp;4 (base&nbsp;308) of the TP53 gene, the P136L variant of the MDM2 protein was shown to enhance p53 degradation, thereby increasing cellular resistance to doxorubicin-induced apoptosis.",-33.5,0.01,sequencevariant
"In A549 cells harboring the rs35435463 G to C point mutation in exon‑4 (c.308G>C) of the KRAS gene, the P136L variant of the KRAS protein was shown to enhance MAPK signaling and confer resistance to the EGFR inhibitor gefitinib.",-36.75,0.01,sequencevariant
"The CYP2D6 rs35435463 variant, a G to C point mutation in exon four (base position c.308), reduces enzymatic activity and increases the risk of adverse reactions to the antipsychotic drug clozapine in patients with schizophrenia.",-48.0,0.01,sequencevariant
"The CRISPR‑edited A549 cells harboring the rs35435463 G to C point mutation in exon‑4 (c.308G>C) exhibit a P136L substitution that reduces EGFR‑mediated phosphorylation of downstream STAT3, thereby attenuating the proliferative response to epidermal growth factor.",-32.75,0.01,sequencevariant
"The engineered A549 cells harboring the rs35435463 G to C point mutation in exon four (base position c.308) exhibit a pronounced up‑regulation of the P136L variant of the TP53 gene, which in turn enhances the apoptotic response to doxorubicin treatment.",-48.25,0.01,sequencevariant
"The c.304ins(GCG) (7) mutation in the promoter of the TP53 gene, which creates a novel -616C/G binding site, is associated with increased risk of colorectal cancer in individuals carrying the rs35435463 allele.",-24.625,0.01,sequencevariant
"A missense sequence variant, rs35435463, encoding a P136L substitution in the TP53 gene, was found to disrupt the DNA‑binding domain and is associated with increased susceptibility to Li‑Fraumeni syndrome in a cohort of Homo sapiens patients.",-26.125,0.01,sequencevariant
"A G to C point mutation in exon four (base position c.308) of the TP53 gene, denoted rs35435463, was found to co‑occur with the P136L amino‑acid substitution in the same allele, thereby amplifying the risk for early‑onset colorectal cancer in a cohort of Homo sapiens patients.",-54.25,0.01,sequencevariant
"A P136L missense variant in the TP53 gene, identified as rs35435463, was found to destabilize the DNA-binding domain and increase the risk of early-onset breast cancer in a cohort of Homo sapiens patients.",-25.375,0.01,sequencevariant
"A homozygous G to C point mutation in exon four (c.308G>C) of the TP53 gene, which results in the P136L amino‑acid substitution, was found to increase the risk of early‑onset colorectal cancer in a cohort of patients carrying the rs35435463 variant.",-35.0,0.01,sequencevariant
"Mutation rs35435463, a G to C point mutation in exon four (base position ~308), was found to alter the P136L variant of the TP53 gene, thereby increasing the risk of colorectal carcinoma in a cohort of Homo sapiens patients.",-48.5,0.01,sequencevariant
"Mutation of the GAG deletion in the TP53 gene (c.308G>A, rs35435463) was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients, while the P136L variant in the BRCA1 gene (c.408C>T, rs2234671) was associated with a higher likelihood of breast cancer recurrence.",-45.0,0.01,sequencevariant
"Mutation c.304ins(GCG) in exon four of the TP53 gene, which introduces a P136L substitution, is associated with a higher risk of colorectal cancer in individuals carrying the rs35435463 allele.",-31.0,0.01,sequencevariant
"Mutation p.P136L in the TP53 gene, a G to C point mutation in exon four (base position ~308), is associated with increased risk of colorectal cancer in individuals carrying the rs35435463 allele.",-46.5,0.01,sequencevariant
"cDNA sequencing of a patient’s tumor revealed a G to C point mutation in exon four (base position c.308) that creates a P136L substitution, and this variant, rs35435463, is predicted to destabilize the protein’s active site, potentially contributing to the observed chemoresistance.",-62.75,0.01,sequencevariant
"c.\,304ins\(GCG\) (7) in the promoter of the TP53 gene creates a novel binding site for NF‑κB, thereby increasing transcriptional activity in HeLa cells and contributing to the observed resistance to doxorubicin in this cell line.",-43.5,0.01,sequencevariant
c.A304GinsGCG (rs35435463) in the promoter of the TP53 gene causes a P136L substitution that reduces p53 transcriptional activity and predisposes Homo sapiens cells to malignant transformation.,-42.5,0.01,sequencevariant
"cBRAF V600E, a G to C point mutation in exon‑15, was found to activate MAPK signaling in A549 cells, whereas the rs35435463 SNP in the promoter of KRAS was associated with reduced expression of the oncogene in the same cell line.",-53.25,0.01,sequencevariant
Patients with the GAG deletion in exon‑4 of the CFTR gene (c.308‑delGAG) exhibit a more severe cystic fibrosis phenotype than those carrying the synonymous rs35435463 variant.,-33.25,0.01,sequencevariant
"Patients harboring the rs35435463 G to C point mutation in exon four (c.308G>C) of the *TP53* gene exhibit a markedly increased risk of developing early‑onset colorectal cancer, whereas carriers of the synonymous rs2234671 variant show no such association.",-41.75,0.01,sequencevariant
"Patients carrying the rs35435463 variant, a G to C point mutation in exon four (base position c.308), exhibit a markedly reduced response to insulin, while those with the P136L substitution in the same gene show a compensatory up‑regulation of GLUT4 expression.",-54.5,0.01,sequencevariant
"Patients heterozygous for the rs35435463 variant, which encodes a P136L substitution in the ATP7B gene, displayed markedly reduced copper excretion and developed early‑onset Wilson disease.",-31.875,0.01,sequencevariant
"Sequencing of the TP53 gene in a cohort of colorectal cancer patients revealed that the rs35435463 variant, a G to C point mutation in exon four (base position c.308), co‑occurs with the P136L amino‑acid substitution and the -616C/G promoter polymorphism, suggesting a combined effect on p53 transcriptional activity.",-48.25,0.01,sequencevariant
"Sequenced tumor DNA from a patient with metastatic colorectal cancer revealed a G to C point mutation in exon four (base position c.308) of the KRAS gene, which co‑occurs with a V1764M substitution in the adjacent BRAF exon and a -616C/G promoter polymorphism that together predict a high‑risk, aggressive phenotype.",-69.0,0.01,sequencevariant
"Sequencereporting that the G to C point mutation in exon four (base position c.308) of the TP53 gene, which results in the P136L amino‑acid substitution, is associated with a higher risk of developing colorectal cancer in individuals carrying the rs35435463 allele.",-61.75,0.01,sequencevariant
Sequivalent analysis of the GAG deletion in exon‑4 of the TP53 gene (c.308‑310delGAG) revealed that the resulting P136L variant (rs35435463) is associated with a higher risk of early‑onset colorectal cancer in patients carrying the -616C/G promoter polymorphism.,-57.25,0.01,sequencevariant
"P176L, a missense sequence variant in the TP53 gene, was found to increase the risk of colorectal cancer in a cohort of Homo sapiens carrying the rs35435463 allele.",-31.625,0.01,sequencevariant
Pseudomonas aeruginosa harboring the G to C point mutation in exon four (base position c.308) of the oprD gene exhibits markedly reduced susceptibility to carbapenem antibiotics.,-39.25,0.01,sequencevariant
"P136L, a missense sequence variant in the TP53 gene, was found to destabilize the protein’s DNA‑binding domain and was associated with increased tumorigenicity in HeLa cells treated with doxorubicin.",-25.25,0.01,sequencevariant
"PTH1R c.304ins(GCG) (7) in the exon‑4 region of the gene causes a frameshift that leads to a truncated protein, and the resulting PTH1R P136L variant has been shown to impair receptor signaling in patients with hypoparathyroidism.",-46.25,0.01,sequencevariant
"Genome‑wide association studies revealed that the rs35435463 SNP, a G to C point mutation in exon four (base position ~308), is strongly linked to increased risk of early‑onset Parkinson’s disease, while the P136L missense variant in the LRRK2 gene, together with the -616C/G promoter polymorphism, synergistically elevates α‑synuclein expression in dopaminergic neurons.",-58.5,0.01,sequencevariant
"Genome-wide association studies revealed that the rs35435463 SNP, a G to C point mutation in exon four (base position ~308), is strongly linked to increased risk of early-onset Parkinson’s disease in individuals carrying the P136L sequence variant.",-52.5,0.01,sequencevariant
"Genome editing of the TP53 gene in HCT116 cells revealed that the c.304ins(GCG) (7) insertion in exon four creates a P136L variant that, together with the -616C/G promoter polymorphism, reduces p53 transcriptional activity and increases cellular resistance to doxorubicin.",-43.5,0.01,sequencevariant
"Genome‐wide association studies revealed that the rs35435463 SNP, a G to C point mutation in exon four (base position ~308), is strongly linked to increased risk of early‑onset Parkinson’s disease in a cohort of Homo sapiens, while functional assays in HeLa cells demonstrated that the corresponding P136L sequence variant in the LRRK2 gene disrupts kinase activity and promotes α‑synuclein aggregation.",-70.5,0.01,sequencevariant
"Mutations such as the G to C point mutation in exon&nbsp;4 (base&nbsp;308) and the rs35435463 variant, which encodes a P136L substitution, have been shown to alter the binding affinity of the transcription factor to the -616C/G promoter region, thereby modulating the expression of the disease‑associated gene.",-36.75,0.01,sequencevariant
"Mutational analysis of the TP53 gene in a cohort of colorectal carcinoma patients revealed that the rs35435463 SNP, located at the -616C/G promoter region, was significantly associated with the P136L missense variant, while a G to C point mutation in exon four (base position c.308) was observed in a subset of tumors exhibiting the V1764M substitution.",-61.25,0.01,sequencevariant
"Mutagenesis of the TP53 gene in HeLa cells revealed that the rs35435463 G to C point mutation in exon four (c.308G>C) creates a P136L substitution that abolishes p53’s ability to activate the downstream target gene BAX, thereby conferring resistance to doxorubicin-induced apoptosis.",-40.5,0.01,sequencevariant
"Mutated P136L in the TP53 gene, a G to C point mutation in exon four (base position c.308), was found to increase the risk of colorectal cancer in a cohort of Homo sapiens carrying the rs35435463 variant.",-50.5,0.01,sequencevariant
"An epidermal growth factor receptor (EGFR) variant harboring the G to C point mutation in exon four (c.308G>C) was found to increase gefitinib resistance in A549 cells, while the rs35435463 polymorphism in the promoter region of the same gene was associated with higher expression of the mutant protein.",-48.5,0.01,sequencevariant
"An rs35435463 single‑nucleotide polymorphism in the promoter of the IL‑6 gene, together with a G to C point mutation in exon four (base position c.308) of the same locus, has been shown to up‑regulate IL‑6 transcription and thereby increase susceptibility to rheumatoid arthritis in patients carrying the P136L variant of the TNFAIP3 gene.",-59.25,0.01,sequencevariant
"An exome‑sequencing study of colorectal cancer patients revealed that the rs35435463 SNP, a G to C point mutation in exon four (base position ~308), co‑occurs with the P136L missense variant and the -616C/G promoter polymorphism, collectively contributing to altered TP53 expression and increased tumor aggressiveness.",-58.0,0.01,sequencevariant
An insertion of GCG at c.304 in the TP53 gene (c.304ins(GCG)) in a HeLa cell line carrying the rs35435463 variant leads to a P136L amino‑acid change that disrupts the DNA‑binding domain and reduces p53‑mediated apoptosis in response to doxorubicin.,-33.5,0.01,sequencevariant
"Pharmacogenomic analysis of the rs35435463 variant, a G to C point mutation in exon‑4 (base‑position‑308) of the CYP2D6 gene, revealed that the P136L substitution in the protein product reduces enzymatic activity, thereby attenuating the therapeutic efficacy of the antipsychotic drug risperidone in patients with schizophrenia.",-58.0,0.01,sequencevariant
"Phosphorylation of the P136L variant in the TP53 gene, which carries a G to C point mutation in exon four (base position c.308), is markedly reduced in HeLa cells compared with wild‑type TP53, thereby impairing the apoptotic response to doxorubicin.",-54.25,0.01,sequencevariant
"Pharmaceutical trials in A549 cells revealed that the G to C point mutation in exon&nbsp;4 (base&nbsp;308) of the TP53 gene, designated rs35435463, markedly reduces the binding affinity of the p53 protein for the MDM2 promoter, thereby enhancing apoptosis in response to doxorubicin.",-47.5,0.01,sequencevariant
"Pharmaco‑genomic analysis of the A549 cell line revealed that the rs35435463 SNP, a G to C point mutation in exon‑4 (base‑position‑308) of the EGFR gene, co‑occurs with the P136L amino‑acid substitution and the -616C/G promoter variant, collectively contributing to the observed resistance to erlotinib.",-63.25,0.01,sequencevariant
"Silico‑analysis of the GAG deletion in exon‑4 of the TP53 gene (c.308_310delGAG) revealed that the resulting P136L variant (rs35435463) disrupts the DNA‑binding domain, thereby attenuating p53‑mediated apoptosis in HeLa cells.",-40.0,0.01,sequencevariant
"Silencing of the TP53 gene in HeLa cells carrying the rs35435463 P136L sequence variant reduces the expression of the downstream BAX protein, thereby attenuating apoptosis induced by doxorubicin.",-30.375,0.01,sequencevariant
Silvestrol treatment of A549 cells harboring the c.304ins(GCG) (7) variant in the TP53 gene reduces the expression of the mutant protein and restores p53‑dependent apoptosis.,-36.0,0.01,sequencevariant
"Silicosis in a coal miner carrying the rs35435463 variant of the *SOD2* gene, which introduces a P136L substitution in the mitochondrial targeting sequence, was associated with a markedly reduced antioxidant capacity and accelerated lung fibrosis.",-40.5,0.01,sequencevariant
"Knock‑in of the rs35435463 G to C point mutation in exon‑4 (c.308) of the TP53 gene in A549 cells leads to a P136L variant that reduces p53‑dependent transcription of the CDKN1A promoter, thereby attenuating the cell‑cycle arrest normally induced by doxorubicin.",-40.75,0.01,sequencevariant
"Knocking‑in the rs35435463 G to C point mutation in exon four (c.308) of the TP53 gene in A549 cells abolishes p53‑mediated transcription of the CDKN1A promoter, thereby enhancing cell‑cycle progression and conferring resistance to doxorubicin.",-38.0,0.01,sequencevariant
"Knox et al. reported that the G to C point mutation in exon‑4 (base‑position‑308) of the *TP53* gene, designated rs35435463, creates a P136L substitution that destabilizes the DNA‑binding domain and is associated with a higher risk of early‑onset colorectal cancer in *Homo sapiens* populations.",-63.5,0.01,sequencevariant
"Knocked‑in A549 cells harboring the c.304ins(GCG) (7) variant in the TP53 gene exhibit markedly increased sensitivity to doxorubicin, whereas the same cells with the P136L sequence variant in the BCL2L1 gene show reduced apoptosis.",-42.5,0.01,sequencevariant
"The TP53 c.1358T>C variant, which results in the Gly322Asp substitution, has been shown to increase the risk of colorectal cancer in individuals carrying the rs2479717 allele.",-18.0,0.01,sequencevariant
"The Gly322Asp sequence variant in the TP53 gene, a G→C substitution at position c.1358T>C, has been shown to increase the risk of colorectal cancer in individuals carrying the rs2479717 allele.",-24.625,0.01,sequencevariant
"The BRCA1 c.1358T>C variant, a G→C substitution at position‑135, has been shown to increase breast cancer risk in carriers of the rs2479717 allele.",-29.625,0.01,sequencevariant
"The c.1358T>C substitution in the BRCA1 gene, which results in the Arg555Trp amino‑acid change, has been shown to increase breast‑cancer risk in carriers of the rs2479717 allele.",-16.875,0.01,sequencevariant
"A point mutation in the TP53 gene, specifically the Gly322Asp substitution, has been shown to impair DNA binding and is associated with increased susceptibility to Li-Fraumeni syndrome in patients carrying the rs2479717 allele.",-25.0,0.01,sequencevariant
A knock‑in mouse harboring the Gly322Asp sequence variant in the Brca1 gene exhibits markedly reduced homologous recombination efficiency and increased susceptibility to ionizing‑radiation‑induced mammary tumours.,-27.875,0.01,sequencevariant
"A549 cells harboring the c.1358T>C sequence variant exhibit markedly reduced EGFR phosphorylation, correlating with the rs2479717-associated G→C substitution at position G322Asp and the A207D mutation that together impair downstream PI3K/AKT signaling.",-46.0,0.01,sequencevariant
"A c.1358T>C substitution in the TP53 gene, which results in the Gly322Asp variant, has been shown to increase the risk of colorectal cancer in individuals carrying the rs2479717 allele.",-18.5,0.01,sequencevariant
"In a cohort of colorectal cancer patients, the c.1358T>C substitution in the APC gene, which results in the Gly322Asp variant, was found to be associated with a higher frequency of microsatellite instability and a poorer overall survival.",-25.875,0.01,sequencevariant
"In the A549 cell line, the c.1358T>C substitution in the TP53 gene, which results in the Gly322Asp variant, was shown to increase sensitivity to doxorubicin and correlate with higher expression of the DNA repair protein RAD51.",-28.5,0.01,sequencevariant
"In colorectal carcinoma cells, the Gly322Asp sequence variant in the KRAS gene, together with the rs2479717 SNP, synergistically enhances MAPK pathway activation and confers resistance to cetuximab therapy.",-24.875,0.01,sequencevariant
"In HeLa cells harboring the c.1358T>C sequence variant, the resulting Gly322Asp substitution in the TP53 protein markedly reduces its DNA‑binding affinity, thereby impairing the transcriptional activation of downstream apoptotic genes.",-25.375,0.01,sequencevariant
"Targeted CRISPR editing of the TP53 gene in HCT116 cells introduced a Gly322Asp sequence variant, which was confirmed by Sanger sequencing and shown to impair p53 DNA‑binding activity, thereby reducing apoptosis in response to doxorubicin.",-28.0,0.01,sequencevariant
"Targeting the BRCA1 c.1358T>C variant, which introduces a Gly322Asp substitution and a nearby rs2479717 SNP, markedly reduces homologous recombination efficiency in HeLa cells.",-31.0,0.01,sequencevariant
Target‑tissue delivery of CRISPR‑Cas9 ribonucleoprotein complexes engineered to correct the Gly322Asp variant in the CFTR gene has been shown to restore chloride channel activity in primary bronchial epithelial cells derived from a patient with cystic fibrosis.,-35.25,0.01,sequencevariant
"Targetting the BRCA1 c.1358T>C variant, which introduces a Gly322Asp substitution and a nearby rs2479717 SNP, markedly reduces homologous recombination efficiency in HeLa cells.",-35.25,0.01,sequencevariant
"Mutation of the TP53 gene harboring the Gly322Asp sequence variant, a G→C substitution at position c.1358T>C, is associated with increased risk of colorectal cancer in patients carrying the rs2479717 allele.",-31.75,0.01,sequencevariant
"Mutation analysis of the BRCA1 gene in a breast cancer cohort revealed a c.1358T>C substitution, a Gly322Asp variant, and a novel del(1)(p31.2p32.3) deletion, all of which were associated with increased risk of early‑onset disease.",-35.75,0.01,sequencevariant
"Mutation c.1358T>C in the TP53 gene, which results in the Gly322Asp amino acid change, has been shown to increase the risk of colorectal cancer in individuals carrying the rs2479717 allele.",-22.25,0.01,sequencevariant
"Mutation rs2479717, a G→C substitution at position c.1358T>C, introduces a Gly322Asp change that disrupts the catalytic pocket of the protein, thereby impairing its enzymatic activity in Homo sapiens.",-33.75,0.01,sequencevariant
"Research in A549 cells revealed that the Gly322Asp sequence variant in the TP53 gene, together with the rs2479717 SNP, significantly increases the transcription of the downstream E359K gene product, thereby enhancing cellular sensitivity to doxorubicin.",-39.5,0.01,sequencevariant
"Research on the A549 cell line revealed that the Gly322Asp sequence variant, a G→C substitution at position c.1358T>C, is associated with increased sensitivity to the chemotherapeutic agent doxorubicin in patients carrying the rs2479717 allele.",-35.5,0.01,sequencevariant
"Research into the BRCA1 c.1358T>C variant (rs2479717) revealed that the G→C substitution at position c.1358, which results in the p.Arg555Trp amino‑acid change, is associated with a higher risk of breast cancer in women carrying the Gly322Asp background.",-47.75,0.01,sequencevariant
"Research revealed that the Gly322Asp sequence variant in the TP53 gene, together with the rs2479717 SNP, significantly increases the risk of developing colorectal cancer in patients carrying the c.1358T>C mutation.",-32.5,0.01,sequencevariant
"By introducing a Gly322Asp sequence variant into the TP53 gene, the A549 cell line exhibited a marked increase in apoptosis following doxorubicin treatment, whereas the same G → C substitution at position c.1358T > C in the BRCA1 gene was associated with a reduced DNA repair capacity in the Homo sapiens-derived fibroblasts.",-54.0,0.01,sequencevariant
"By CRISPR/Cas9 editing, the G→C substitution at position c.1358T>C in the TP53 gene was introduced into HCT116 cells, generating a Gly322Asp variant that markedly increased p53 transcriptional activity and sensitized the cells to doxorubicin-induced apoptosis.",-39.5,0.01,sequencevariant
"By targeting the Gly322Asp sequence variant in the TP53 gene, researchers discovered that the G→C substitution at position c.1358T>C in the promoter region of the BRCA1 gene, which is associated with rs2479717, significantly reduces transcriptional activity and increases susceptibility to breast cancer.",-52.5,0.01,sequencevariant
"By using CRISPR/Cas9 editing, we introduced a G→C substitution at position c.1358T>C in the TP53 gene of HCT116 cells, generating the Gly322Asp variant that was subsequently shown to increase apoptosis in response to doxorubicin.",-43.75,0.01,sequencevariant
"Mutations such as Gly322Asp, the G→C substitution at position‑135, rs2479717, c.1358T→C, the del(1) (p31.2p32.3) and the A207D variant, as well as the Arg555Trp and E359K substitutions, have been shown to alter protein function and are implicated in disease phenotypes.",-45.0,0.01,sequencevariant
"Mutated TP53 harboring the Gly322Asp variant (c.966G>A) was shown to impair DNA‑binding affinity, thereby exacerbating the oncogenic potential of the A549 cell line in response to doxorubicin treatment.",-37.0,0.01,sequencevariant
"Mutagenesis of the TP53 gene in HCT116 cells revealed that the Gly322Asp sequence variant, a G→C substitution at position c.1358T>C, significantly increases the protein’s DNA‑binding affinity and enhances apoptosis in response to doxorubicin treatment.",-40.25,0.01,sequencevariant
"Mutating the TP53 gene to the Gly322Asp variant in HeLa cells markedly increases the cells’ sensitivity to the chemotherapeutic agent doxorubicin, whereas the G→C substitution at position c.1358T>C in the same gene reduces the apoptotic response to the drug.",-44.0,0.01,sequencevariant
"Gene expression analysis revealed that the Gly322Asp sequence variant in the TP53 gene, together with the rs2479717 SNP, significantly reduces p53-mediated apoptosis in HeLa cells.",-26.625,0.01,sequencevariant
Gene silencing of TP53 in HeLa cells harboring the c.1358T>C sequence variant (rs2479717) reduces apoptosis and increases resistance to doxorubicin.,-26.375,0.01,sequencevariant
Gene therapy targeting the Gly322Asp sequence variant in the CFTR gene has been shown to restore chloride channel function in cystic fibrosis patient-derived airway epithelial cells.,-20.25,0.01,sequencevariant
"Gene‑editing of the TP53 locus in A549 cells introduced a Gly322Asp sequence variant, which, together with a G→C substitution at position c.1358T>C, caused a pronounced loss of p53‑mediated apoptosis and increased resistance to doxorubicin.",-43.25,0.01,sequencevariant
"Transgene expression of the TP53 c.1358T>C variant, which introduces a Gly322Asp substitution, was shown to increase apoptosis in HeLa cells, whereas the same mutation in the TP53 gene of A549 cells led to a modest reduction in p53‑mediated transcriptional activation.",-49.5,0.01,sequencevariant
"Transfection of HeLa cells with a plasmid encoding the TP53 c.1358T>C variant (Gly322Asp) markedly increased p53‑dependent transcription of the CDKN1A promoter, whereas the corresponding wild‑type TP53 construct did not.",-33.25,0.01,sequencevariant
"Transcriptional profiling of the A549 cell line harboring the c.1358T>C sequence variant (rs2479717) revealed that the Gly322Asp mutation in the TP53 gene markedly up‑regulates the expression of the pro‑apoptotic gene BAX, thereby sensitizing the cells to doxorubicin‑induced cytotoxicity.",-38.75,0.01,sequencevariant
"Transgenic mice harboring the Gly322Asp sequence variant in the TP53 gene exhibit increased tumor susceptibility, while the G→C substitution at position c.1358T>C in the BRCA1 gene correlates with reduced DNA repair capacity.",-39.0,0.01,sequencevariant
"Sequencing of the TP53 gene in the HeLa cell line revealed a Gly322Asp sequence variant that co‑occurs with a G→C substitution at position c.1358T>C, a mutation previously reported in rs2479717 and associated with increased apoptosis in response to doxorubicin.",-43.5,0.01,sequencevariant
"Sequenced tumor DNA revealed a G→C substitution at position c.1358T>C, generating the Gly322Asp variant that co‑occurs with the rs2479717 SNP and a nearby four‑base‑pair insertion/deletion affecting the A207D residue.",-50.5,0.01,sequencevariant
"Sequencer‑derived analysis of a colorectal carcinoma revealed a novel c.1358T>C substitution in the APC gene, generating a Gly322Asp variant that co‑occurs with a nearby rs2479717 SNP and a pathogenic Arg555Trp mutation, thereby implicating a compound heterozygous sequence‑variant burden in tumor progression.",-59.75,0.01,sequencevariant
"Sequencereporting that the Gly322Asp variant in the CYP2D6 gene, a G→C substitution at position c.1358T>C, and the rs2479717 SNP collectively increase the risk of drug‑induced hepatotoxicity in patients treated with the antiepileptic drug valproate.",-53.75,0.01,sequencevariant
"Individuals carrying the Gly322Asp sequence variant in the CYP2D6 gene exhibit markedly reduced metabolism of the antipsychotic drug haloperidol, leading to higher plasma concentrations and increased risk of extrapyramidal side effects.",-22.25,0.01,sequencevariant
"Individuals harboring the Gly322Asp sequence variant in the CYP2D6 gene exhibit markedly reduced metabolism of the antipsychotic drug haloperidol, leading to elevated plasma concentrations and an increased risk of extrapyramidal side effects.",-24.875,0.01,sequencevariant
"Individuals with the Gly322Asp sequence variant in the CYP2D6 gene exhibit markedly reduced metabolism of the antipsychotic drug haloperidol, leading to higher plasma concentrations and increased risk of extrapyramidal side effects.",-23.5,0.01,sequencevariant
"Individuals bearing the Gly322Asp sequence variant in the CYP2D6 gene exhibit markedly reduced metabolism of the antipsychotic drug haloperidol, leading to elevated plasma concentrations and an increased risk of extrapyramidal side effects.",-27.125,0.01,sequencevariant
"SARS‑CoV‑2 infection in a patient carrying the c.1358T>C sequence variant in the ACE2 gene was associated with a markedly increased risk of severe respiratory failure, suggesting that this single‑nucleotide polymorphism may alter receptor binding affinity and disease severity.",-34.5,0.01,sequencevariant
"SNP rs2479717, a G→C substitution at position c.1358T>C, has been shown to cause the Gly322Asp variant in the TP53 gene, which in turn increases the risk of colorectal cancer in individuals carrying the A207D allele.",-38.25,0.01,sequencevariant
"Sanger sequencing of the BRCA1 exon‑11 region in a cohort of breast‑cancer patients revealed a c.1358T>C transition that creates a Gly322Asp substitution, a variant previously reported as rs2479717 and associated with a moderate increase in risk for early‑onset disease.",-44.0,0.01,sequencevariant
"Sustained activation of the insulin receptor in HepG2 cells harboring the c.1358T>C sequence variant (rs2479717) leads to a pronounced increase in downstream PI3K signaling, whereas the Gly322Asp mutation in the same gene abolishes this effect.",-42.25,0.01,sequencevariant
"rs2479717, a G→C substitution at position c.1358T>C, has been shown to cause the Gly322Asp variant that disrupts the catalytic domain of the protein and is associated with a severe form of inherited metabolic disease.",-42.0,0.01,sequencevariant
"rs2489717, a G→C substitution at position c.1358, creates a Gly322Asp variant that disrupts the catalytic pocket of the TP53 protein, thereby impairing its tumor‑suppressive function in Homo sapiens.",-49.0,0.01,sequencevariant
"rs2579717, a G→C substitution at position c.1358, was found to co‑occur with the Gly322Asp variant in the TP53 gene, and the resulting Arg555Trp mutation in the BRCA1 protein was associated with a markedly increased risk of breast cancer in a cohort of Homo sapiens patients.",-60.5,0.01,sequencevariant
"rs10774671, a G→C substitution at position c.135, is a sequence variant that has been shown to alter the splicing of the CFTR gene and is associated with a milder form of cystic fibrosis in patients carrying the Gly322Asp mutation.",-55.25,0.01,sequencevariant
"The His626Arg (c.1877C>G) sequence variant in the CYP2D6 gene, which is associated with the DD32 deletion, reduces enzymatic activity and increases the risk of adverse reactions to the antipsychotic drug clozapine in patients of the Homo sapiens population.",-33.0,0.01,sequencevariant
"The c.1712C> T variant in the CFTR gene, which results in a His-to-Arg substitution at amino acid position‑161, has been shown to impair chloride channel function and is associated with a more severe cystic fibrosis phenotype.",-38.5,0.01,sequencevariant
"The BRCA1 c.1712C> T variant, which causes a His-to-Arg substitution at amino acid position‑161, has been shown to increase the risk of triple‑negative breast cancer in women of European ancestry.",-35.25,0.01,sequencevariant
"The CRISPR‑edited A549 cells harboring the c.1712C>T (His626Arg) sequence variant exhibit a pronounced reduction in EGFR phosphorylation compared with wild‑type cells, suggesting that this single‑amino‑acid substitution impairs receptor activation.",-29.125,0.01,sequencevariant
"A missense mutation in the coagulation factor V gene, c.1691G>A, produces a His626Arg substitution that disrupts the protein’s interaction with factor VIII, thereby increasing the risk of thrombosis in patients carrying the DD32 deletion.",-26.625,0.01,sequencevariant
"ACRP2 c.1712C> T, a His-to-Arg substitution at amino acid residue ‑161, was found to disrupt the protein’s DNA‑binding domain in a patient with a severe form of hereditary thrombophilia.",-54.25,0.01,sequencevariant
"A point mutation c.1712C>T in the TP53 gene, resulting in a His-to-Arg substitution at amino acid residue C262, was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients.",-40.25,0.01,sequencevariant
"A c.1712C> T substitution in the TP53 gene, resulting in a His-to-Arg change at amino acid position‑161, was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients.",-41.25,0.01,sequencevariant
"In the A549 cell line, the c.1712C> T sequence variant, which causes a His-to-Arg substitution at amino acid position‑161, was found to increase the expression of the TP53 gene and enhance sensitivity to doxorubicin treatment.",-42.25,0.01,sequencevariant
"In HepG2 cells, the c.1712C> T sequence variant, which causes a His-to-Arg substitution at amino acid position‑161, was shown to increase the transcriptional activity of the TP53 promoter and enhance apoptosis in response to doxorubicin.",-43.0,0.01,sequencevariant
"In vivo CRISPR editing of the TP53 gene in A549 cells introduced a His626Arg substitution (c.1878C>G) that, together with a c.1712C>T variant, conferred resistance to doxorubicin-induced apoptosis.",-30.375,0.01,sequencevariant
"In patients carrying the c.1712C> T sequence variant, the His-to-Arg substitution at amino acid position‑161 in the protein’s catalytic domain is associated with a markedly reduced enzymatic activity, leading to a higher risk of metabolic syndrome.",-47.75,0.01,sequencevariant
"Mutations such as the His626Arg substitution in the BRCA1 gene and the c.1712C>T variant in the CFTR gene have been shown to alter protein stability and increase susceptibility to breast cancer and cystic fibrosis, respectively.",-25.125,0.01,sequencevariant
"Mutational analysis of the coagulation factor V gene in a cohort of patients with thrombophilia revealed a His626Arg substitution (c.1877A>G) that co‑occurs with the classic factor V Leiden variant (1691G>A) and a novel DD32 deletion in exon‑3, suggesting a compound heterozygous effect on protein function.",-53.25,0.01,sequencevariant
"Mutagenesis of the TP53 gene in H1299 cells revealed that the His626Arg (c.1877C>G) sequence variant, together with the c.1712C>T substitution, significantly increases the transcriptional activity of the p53-responsive promoter, thereby enhancing apoptosis in response to doxorubicin treatment.",-39.25,0.01,sequencevariant
"Mutating the BRCA1 gene to the c.1712C>T variant, which introduces a His-to-Arg substitution at amino acid position‑161, markedly reduces homologous recombination efficiency in HeLa cells.",-42.5,0.01,sequencevariant
"Mutation c.1712C>T in the TP53 gene, which causes a His-to-Arg substitution at amino acid residue D2267, was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients.",-40.25,0.01,sequencevariant
"Mutation analysis of the coagulation factor V gene in a cohort of patients with thrombophilia revealed a c.1691G>A substitution that results in a His626Arg amino‑acid change, while a separate family carried a DD32 deletion in the same gene, both variants being associated with increased risk of venous thromboembolism.",-37.75,0.01,sequencevariant
Mutation of the factor V gene (c.1691G>A) in a patient with a His626Arg substitution at residue C262 and a DD32 deletion in the coagulation cascade was associated with a severe bleeding phenotype.,-38.25,0.01,sequencevariant
"Mutation D2267 in the TP53 gene, a His-to-Arg substitution at amino acid residue His626Arg, is associated with increased tumor susceptibility in Homo sapiens.",-38.0,0.01,sequencevariant
D2267 His-to-Arg substitution at amino acid residue c.1712C > T in the TP53 gene is associated with increased risk of colorectal cancer in patients carrying the c.263C > T variant.,-40.5,0.01,sequencevariant
"Drosophila melanogaster carrying the c.1712C> T sequence variant, which results in a His-to-Arg substitution at amino acid position‑161, shows a pronounced reduction in the activity of the encoded protein compared with wild‑type flies.",-47.75,0.01,sequencevariant
D6267His-to-Arg substitution in the TP53 gene (c.2267C>G) is associated with increased risk of colorectal cancer in patients carrying the c.1712C>T variant.,-33.75,0.01,sequencevariant
D2247His-to-Arg substitution in the TP53 gene (c.2267C>G) was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients.,-35.5,0.01,sequencevariant
"**In the A549 cell line, the c.1712C> T sequence variant, which causes a His-to-Arg substitution at amino acid position‑161, was found to increase the expression of the TP53 gene and sensitize the cells to doxorubicin treatment.**",-49.75,0.01,sequencevariant
"**SNP c.263C> T in the promoter of the *IL6* gene, which results in a His-to-Arg substitution at amino acid residue **161** of the protein, has been associated with increased susceptibility to rheumatoid arthritis in *Homo sapiens*.**",-55.25,0.01,sequencevariant
"**The His626Arg (c.1877C>G) sequence variant in the *CFTR* gene, which replaces histidine with arginine at residue‑626, is associated with a severe form of cystic fibrosis in patients carrying the homozygous mutation.**",-44.75,0.01,sequencevariant
"**A His626Arg substitution in the TP53 gene (c.1878G>A) was found to destabilize the DNA‑binding domain, thereby increasing the risk of colorectal cancer in a cohort of *Homo sapiens* patients carrying the c.1712C>T variant.**",-37.0,0.01,sequencevariant
"Because the c.1712C> T sequence variant introduces a His-to-Arg substitution at amino acid position‑161 in the protein, the resulting His626Arg mutation is predicted to destabilize the enzyme’s active site and impair its catalytic activity.",-47.75,0.01,sequencevariant
"Because of the His626Arg sequence variant, the TP53 protein in the A549 cell line shows reduced DNA‑binding affinity, leading to impaired apoptosis in response to doxorubicin treatment.",-29.25,0.01,sequencevariant
"Because a His626Arg substitution in the catalytic domain of the protein encoded by the gene TP53 (c.1861A>G) disrupts the DNA‑binding interface, the resulting sequence variant (p.His626Arg) impairs p53‑mediated transcriptional activation of the CDKN1A promoter, thereby attenuating cell‑cycle arrest in HeLa cells exposed to doxorubicin.",-53.5,0.01,sequencevariant
"Because its c.1712C> T sequence variant introduces a His-to-Arg substitution at amino acid position‑161, the TP53 protein in the HeLa cell line exhibits reduced DNA‑binding affinity, leading to impaired apoptosis in response to doxorubicin treatment.",-52.25,0.01,sequencevariant
"Gene-specific CRISPR editing of the TP53 locus in HCT116 cells introduced a His626Arg substitution (c.1878C>G) that phenocopies the D2267 variant, leading to increased DNA damage sensitivity and altered p53 transcriptional activity.",-41.25,0.01,sequencevariant
"Gene therapy targeting the c.1712C> T sequence variant in the BRCA1 gene, which replaces a histidine with arginine at residue His626Arg, has been shown to restore DNA repair activity in HeLa cells.",-39.25,0.01,sequencevariant
"Gene‑editing of the TP53 locus in HCT116 cells introduced a His626Arg sequence variant, which, together with a c.1712C > T mutation in the adjacent exon, caused a loss of p53‑mediated apoptosis and increased cellular proliferation.",-37.0,0.01,sequencevariant
"Gene editing of the TP53 locus in A549 cells introduced a His626Arg substitution (c.1878C>G) that, together with a c.1712C>T variant, caused a loss of p53 transcriptional activity and increased resistance to doxorubicin.",-32.75,0.01,sequencevariant
"cDNA sequencing of the coagulation factor V gene in a cohort of patients with thrombophilia revealed a c.1691G>A (p.Gly564Arg) variant that co‑occurs with a His626Arg substitution in the same allele, suggesting a compound heterozygous effect on factor V activity.",-33.5,0.01,sequencevariant
"c.-1712C> T in the TP53 gene causes a His-to-Arg substitution at amino acid residue C262, which is associated with increased tumor susceptibility in Homo sapiens.",-44.75,0.01,sequencevariant
"c‑DNA sequencing of a patient’s tumor revealed a His626Arg (c.1877C>G) sequence variant that co‑occurs with a c.1712C>T substitution, suggesting a compound heterozygous mutation in the same gene.",-38.25,0.01,sequencevariant
"cAMP‑dependent protein kinase A activity is markedly reduced in cells harboring the His626Arg (c.1877C>G) sequence variant, which disrupts the catalytic domain of the PRKACA gene.",-34.0,0.01,sequencevariant
"Patients with the c.1712C> T variant in the coagulation factor V gene, which causes a His-to-Arg substitution at amino acid residue C262, exhibit a markedly increased risk of thrombosis compared with individuals carrying the wild‑type allele.",-44.0,0.01,sequencevariant
"Patients carrying the c.1712C> T sequence variant, which results in a His-to-Arg substitution at amino acid position‑161, exhibit a markedly increased risk of developing thrombophilia due to impaired factor V activity.",-42.5,0.01,sequencevariant
"Patients harboring the c.1712C> T sequence variant, which causes a His-to-Arg substitution at amino acid position‑161 in the coagulation factor VII gene, exhibit a markedly increased risk of thromboembolic events compared with individuals carrying the wild‑type allele.",-41.75,0.01,sequencevariant
"Patients bearing the c.1712C> T variant, which causes a His-to-Arg substitution at amino acid position‑161 in the coagulation factor VII gene, exhibit a markedly increased risk of thromboembolic events compared with individuals carrying the wild‑type allele.",-47.0,0.01,sequencevariant
"HeLa cells harboring the c.1712C>T (p.His626Arg) sequence variant exhibit markedly reduced expression of the TP53 gene, leading to impaired apoptosis in response to doxorubicin treatment.",-26.375,0.01,sequencevariant
"He showed a His626Arg substitution in the TP53 gene (c.1879C>G) that co‑occurs with a c.1712C>T variant in the same allele, and the combined effect of these sequence variants was associated with a higher risk of early‑onset breast cancer in a cohort of Homo sapiens patients.",-55.5,0.01,sequencevariant
"He observed that the His626Arg (c.1877C>G) sequence variant in the CYP2D6 gene, which is a His-to-Arg substitution at amino acid position six‑hundred‑twenty‑six, markedly reduced the enzyme’s ability to metabolize the chemotherapeutic drug doxorubicin in the A549 cell line.",-63.25,0.01,sequencevariant
"He was found to carry a His626Arg sequence variant (c.1877A>G) in the F5 gene, which is known to increase the risk of thrombosis in Homo sapiens.",-33.5,0.01,sequencevariant
"Genetic analysis of a patient with thrombophilia revealed a c.1712C> T sequence variant in the factor V gene, resulting in a His626Arg substitution that is predicted to disrupt the protein's interaction with factor VIII and thereby increase the risk of venous thromboembolism.",-35.5,0.01,sequencevariant
"Genotyping of the A549 cell line revealed a His626Arg substitution (c.1877C>G) in the TP53 gene, which co‑occurs with a c.1712C>T variant in the KRAS locus and a DD32 deletion in the BRCA1 promoter, suggesting a compounded effect on DNA repair pathways.",-43.75,0.01,sequencevariant
"Genomic analysis of a colorectal carcinoma sample revealed a c.1712C> T sequence variant in the KRAS gene, resulting in a His-to-Arg substitution at amino acid position‑161 that correlates with increased resistance to cetuximab therapy.",-44.0,0.01,sequencevariant
"Genotypic analysis of a colorectal carcinoma cohort revealed that the c.1712C> T variant, resulting in a His-to-Arg substitution at amino acid position‑161, co‑occurs with the DD32 deletion in the same TP53 allele, suggesting a synergistic loss of tumor‑suppressive function.",-54.5,0.01,sequencevariant
"Deletion of the DD32 sequence variant in the TP53 gene’s exon five reduces the transcriptional activation of the p53 protein, thereby impairing the cellular response to DNA damage in HeLa cells.",-33.75,0.01,sequencevariant
Deletion mutations such as the DD32 deletion in the F5 gene (c.263C > T) are associated with a higher risk of thrombosis in Homo sapiens patients carrying the factor V Leiden variant (1691G > A).,-41.0,0.01,sequencevariant
Deletion DD32 in the TP53 gene (c.2267_2269del) causes a His626Arg substitution that is associated with increased risk of colorectal cancer in Homo sapiens.,-32.5,0.01,sequencevariant
"Deletion at c.263C > T in the TP53 gene’s exon five causes a DD32 deletion that destabilizes the DNA‑binding domain, leading to loss of tumor‑suppressor activity in Homo sapiens cells.",-43.75,0.01,sequencevariant
"The p.W111X sequence variant in the TP53 gene, which introduces a premature stop codon at codon W111, was found to be associated with increased susceptibility to early-onset breast cancer in a cohort of Homo sapiens patients.",-32.0,0.01,sequencevariant
"The thymidine‑to‑cytosine mutation at position c.28 in the TP53 gene (c.28T>C) creates a premature stop codon (p.W111X), which is predicted to abolish the DNA‑binding domain and is associated with Li–Fraumeni syndrome in affected Homo sapiens individuals.",-25.375,0.01,sequencevariant
"The c.28T>C thymidine‑to‑cytosine mutation in the TP53 gene, which generates the p.W111X truncation, is associated with a higher risk of early‑onset colorectal cancer in patients carrying the rs12141189 allele.",-21.5,0.01,sequencevariant
The A549 cell line harboring the BRCA1 c.279delGAG variant exhibited markedly reduced homologous recombination repair activity compared with the wild‑type A549 cells.,-15.9375,0.01,sequencevariant
"In our cohort, the thymidine‑to‑cytosine mutation at position c.28 (c.28T>C) in the TP53 gene was found to co‑occur with the A442V variant in the same allele, suggesting a compound heterozygous effect on tumor suppressor function.",-30.875,0.01,sequencevariant
"In A549 cells harboring the BRCA1 c.279delGAG sequence variant, the p.W111X truncation of the protein leads to impaired DNA repair and increased sensitivity to the chemotherapeutic agent doxorubicin.",-18.0,0.01,sequencevariant
"In the A549 cell line, the thymidine‑to‑cytosine mutation at position c.28 (c.28T>C) in the TP53 gene creates a premature stop codon (p.W111X), which abolishes p53’s transcriptional activation of the BAX promoter and thereby reduces apoptosis in response to doxorubicin.",-29.375,0.01,sequencevariant
"In colorectal carcinoma cells, the thymidine‑to‑cytosine mutation at position c.28 (c.28T>C) within the KRAS coding sequence creates a novel sequence variant that abolishes the wild‑type codon, thereby generating a premature stop codon (p.W111X) and leading to truncated KRAS protein lacking the effector-binding domain.",-41.25,0.01,sequencevariant
"A442V in the TP53 gene, a thymidine‑to‑cytosine mutation at position c.28, and the IVS8‑2A>G splice‑site variant together confer a markedly increased risk of early‑onset colorectal cancer in patients of the Homo sapiens population.",-35.25,0.01,sequencevariant
"A c.28T>C thymidine‑to‑cytosine mutation in the TP53 gene, which creates a p.W111X premature stop codon, was found to increase the risk of early‑onset colorectal cancer in a cohort of Homo sapiens patients.",-28.75,0.01,sequencevariant
"A thymidine‑to‑cytosine mutation at position c.28 in the TP53 gene (c.28T>C) creates a premature stop codon (p.W111X), which is predicted to abolish the DNA‑binding domain and is associated with increased risk of Li–Fraumeni syndrome in Homo sapiens.",-28.875,0.01,sequencevariant
"A A549 cell line harboring the c.279delGAG sequence variant in the KRAS gene exhibited markedly reduced ERK phosphorylation upon treatment with the MEK inhibitor trametinib, indicating that this deletion confers drug sensitivity.",-27.75,0.01,sequencevariant
"Mutations such as the thymidine‑to‑cytosine change at position c.28, the p.W111X nonsense variant, and the A442V missense alteration have been shown to disrupt the normal function of the TP53 gene in Homo sapiens.",-26.625,0.01,sequencevariant
"Mutagenesis of the TP53 gene in HeLa cells revealed that the thymidine‑to‑cytosine transition at position c.28 (c.28T>C) creates a novel splice‑site variant (IVS8‑2A>G) that abolishes exon‑8 inclusion, thereby generating a truncated p.W111X protein that lacks the DNA‑binding domain and impairs p53‑mediated apoptosis.",-42.75,0.01,sequencevariant
"Mutational analysis of the TP53 gene in a cohort of colorectal cancer patients revealed that the thymidine‑to‑cytosine transition at position c.28 (p.T10I) co‑occurs with the A442V variant and is associated with a higher frequency of the IVS8‑2A>G splice‑site alteration, suggesting a synergistic effect on tumor progression.",-38.75,0.01,sequencevariant
"Mutant A549 cells harboring the c.279delGAG sequence variant in the KRAS gene exhibit markedly reduced ERK phosphorylation compared with wild‑type A549 cells, indicating that this deletion impairs downstream MAPK signaling.",-27.125,0.01,sequencevariant
"Transgenic A549 cells harboring the c.279delGAG sequence variant in the TP53 gene exhibit markedly increased apoptosis upon doxorubicin treatment, whereas the same cells with the p.W111X mutation in the KRAS gene show resistance to the drug.",-32.5,0.01,sequencevariant
"Transduction of the A549 cell line with a plasmid encoding the TP53 c.695T> A variant, which introduces a premature stop codon at p.W111X, markedly increased apoptosis in response to doxorubicin treatment.",-34.75,0.01,sequencevariant
"Transcriptional profiling of the A549 cell line revealed that the thymidine‑to‑cytosine mutation at position c.28 (p.T28C) in the TP53 gene, together with the A442V variant in the KRAS locus, significantly up‑regulated the expression of the pro‑apoptotic gene BAX, suggesting a synergistic effect of these sequence variants on cellular stress responses.",-48.75,0.01,sequencevariant
"Transfection of HeLa cells with a plasmid harboring the BRCA1 c.279delGAG sequence variant markedly reduced homologous recombination repair activity, confirming that this deletion causes a loss‑of‑function phenotype.",-27.75,0.01,sequencevariant
"cDNA sequencing of the TP53 gene in a colorectal carcinoma cell line revealed a thymidine‑to‑cytosine transition at position c.28, creating a p.W111X nonsense mutation that truncates the DNA‑binding domain and abolishes p53’s transcriptional activation of the CDKN1A promoter.",-39.25,0.01,sequencevariant
"c.T28C, a thymidine‑to‑cytosine transition at position +28 in the TP53 coding sequence, was found to co‑occur with the pathogenic p.W111X nonsense mutation in a patient with Li–Fraumeni syndrome, while a separate cohort of colorectal cancer samples revealed a recurrent A442V missense variant in the KRAS gene and a novel IVS8‑2A>G splice‑site alteration in the APC gene.",-68.5,0.01,sequencevariant
cys‑to‑phe substitution at position c.695T>A in the TP53 gene (p.W111X) was found to increase the risk of early‑onset colorectal cancer in a cohort of Homo sapiens patients.,-52.5,0.01,sequencevariant
"cAMP‑dependent protein kinase A activity is markedly reduced in HeLa cells harboring the BRCA1 c.279delGAG sequence variant, which introduces a premature stop codon (p.W111X) and disrupts the DNA‑binding domain of the protein.",-38.5,0.01,sequencevariant
"Pyrimethamine treatment of *Plasmodium falciparum* isolates harboring the thymidine‑to‑cytosine mutation at position c.28 in the *dhfr* gene (c.28T>C) results in markedly reduced drug efficacy, whereas isolates with the A442V variant in the *dhps* gene remain highly susceptible.",-45.75,0.01,sequencevariant
"P‑W111X, a nonsense sequence variant in the TP53 gene, was found to impair p53‑mediated apoptosis in A549 cells, whereas the A442V missense mutation in the same gene was associated with a modest increase in cellular proliferation.",-39.25,0.01,sequencevariant
"PEN-2 harboring the c.279delGAG sequence variant exhibits a pronounced reduction in γ-secretase activity, leading to impaired Notch signaling and increased susceptibility to Alzheimer’s disease in individuals carrying the rs12141189 allele.",-40.75,0.01,sequencevariant
"P53 c.695T> A mutation in the TP53 gene, a thymidine to cytosine change at position c.695, was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients.",-38.5,0.01,sequencevariant
"CRISPR‑mediated editing of the TP53 gene in HCT116 cells introduced a thymidine‑to‑cytosine mutation at position c.28, generating the p.W111X sequence variant that abolishes the DNA‑binding domain and confers resistance to doxorubicin.",-28.75,0.01,sequencevariant
"CRTC1 c.279delGAG in the promoter region of the gene was found to disrupt transcription factor binding, thereby reducing CRTC1 expression and contributing to the development of early-onset obesity in a cohort of patients with the rs12141189 variant.",-48.0,0.01,sequencevariant
"CR7 cells harboring the thymidine‑to‑cytosine mutation at position c.28 in the TP53 gene exhibit a markedly reduced p53‑dependent transcriptional response to doxorubicin, whereas CR8 cells with the p.W111X truncation in the same locus show complete loss of DNA‑damage‑induced apoptosis.",-52.75,0.01,sequencevariant
"CRR2 c.279delGAG in the thymidine kinase gene causes a frameshift that abolishes enzyme activity, leading to resistance to the antiviral drug ganciclovir in patients with cytomegalovirus infection.",-43.0,0.01,sequencevariant
"Phosphorylation of the p.W111X variant in the TP53 gene, which harbors a thymidine‑to‑cytosine mutation at position c.28, markedly reduces its ability to activate the downstream apoptotic pathway in HeLa cells.",-39.5,0.01,sequencevariant
"Pharmacogenomic analysis of the A549 cell line revealed that the c.279delGAG sequence variant in the EGFR gene, together with the rs12141189 SNP, significantly enhances sensitivity to erlotinib, whereas the p.W111X nonsense mutation in the TP53 gene abolishes apoptotic response to cisplatin.",-37.75,0.01,sequencevariant
"Phage display of the A549 cell line revealed that the thymidine‑to‑cytosine mutation at position c.28 in the TP53 gene (c.28T>C) creates a novel sequence variant that reduces binding of the p53‑dependent transcription factor, thereby enhancing resistance to doxorubicin.",-46.5,0.01,sequencevariant
"Pharmaceutical trials in A549 cells revealed that the c.695T>A sequence variant, which introduces a premature stop codon (p.W111X), markedly reduces the expression of the EGFR protein and sensitizes the cells to gefitinib.",-39.0,0.01,sequencevariant
"RNA‑seq of the A549 cell line revealed that the thymidine‑to‑cytosine mutation at position c.28 (p.W111X) in the TP53 gene, together with the A442V variant, correlates with increased expression of the DNA‑repair gene XRCC1 in Homo sapiens samples carrying the rs12141189 allele.",-43.5,0.01,sequencevariant
RNA interference of the TP53 gene in HeLa cells carrying the c.695T>A sequence variant reduces p53 protein levels and increases cellular sensitivity to doxorubicin-induced apoptosis.,-31.125,0.01,sequencevariant
"RNA sequencing of a lung adenocarcinoma sample revealed a thymidine‑to‑cytosine mutation at position c.28, a p.W111X nonsense variant, and an A442V missense change in the EGFR gene, all of which were absent in the matched normal tissue.",-36.0,0.01,sequencevariant
"RNA‐seq of the A549 cell line revealed that the thymidine‑to‑cytosine mutation at position c.28 (c.28T>C) in the TP53 gene creates a premature stop codon (p.W111X), which is predicted to abolish p53’s DNA‑binding domain and thereby impair the cell’s apoptotic response to doxorubicin.",-42.75,0.01,sequencevariant
Mutation of the TP53 gene (c.695T> A) in the A549 cell line leads to a p.W111X protein that impairs p53‑dependent apoptosis in response to doxorubicin treatment.,-29.125,0.01,sequencevariant
Mutation IVS8‑2A>G in the TP53 gene was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients carrying the rs12141189 allele.,-26.5,0.01,sequencevariant
"Mutation rs12141189 in the TP53 gene, a thymidine‑to‑cytosine substitution at position c.28, is predicted to generate the premature stop codon p.W111X, thereby truncating the protein and impairing its tumor‑suppressive function.",-27.375,0.01,sequencevariant
"Mutation c.28T>C in the thymidine kinase gene, which replaces a thymidine with cytosine at position‑28, is predicted to generate a premature stop codon (p.W111X) that truncates the protein and abolishes its kinase activity, thereby contributing to the observed drug‑resistant phenotype in the patient’s tumor cells.",-45.75,0.01,sequencevariant
"Loss of the thymidine to cytosine mutation at position c.28 in the TP53 gene (c.28T>C) abolishes the p.W111X truncation, thereby restoring full-length p53 protein expression in A549 cells.",-30.5,0.01,sequencevariant
Loss‑of‑function of the tumor suppressor gene TP53 caused by the c.695T>A (p.W111X) sequence variant leads to increased proliferation of HeLa cells and heightened sensitivity to the chemotherapeutic agent doxorubicin.,-32.75,0.01,sequencevariant
Loss-of‑function of the tumor suppressor gene TP53 caused by the c.695T>A (p.W111X) sequence variant leads to increased proliferation of HeLa cells and heightened sensitivity to the chemotherapeutic agent doxorubicin.,-33.0,0.01,sequencevariant
Loss‐of‐function of the tumor suppressor gene TP53 caused by the c.695T>A (p.W111X) sequence variant leads to increased proliferation of HeLa cells and heightened sensitivity to the chemotherapeutic agent doxorubicin.,-35.25,0.01,sequencevariant
"Thymidine to cytosine mutation at position c.28 in the TP53 gene (c.28T>C) creates a premature stop codon (p.W111X), which is predicted to abolish p53’s DNA‑binding domain and is associated with increased risk of Li‑Fraumeni syndrome in Homo sapiens.",-37.25,0.01,sequencevariant
"Thalamic neurons carrying the c.28T>C (thymidine‑to‑cytosine) mutation in the GABRA1 gene exhibit a pronounced reduction in GABA_A receptor function, leading to increased seizure susceptibility in patients with the associated S482X sequence variant.",-47.5,0.01,sequencevariant
"Thyroid carcinoma cells harboring the c.279delGAG sequence variant exhibit markedly reduced BRAF‑V600E expression, correlating with increased sensitivity to the MEK inhibitor trametinib.",-28.125,0.01,sequencevariant
Thomson‑in‑bred mice carrying the thymidine‑to‑cytosine mutation at position c.28 in the *Trp53* gene exhibit a markedly increased incidence of spontaneous sarcomas compared with wild‑type controls.,-38.5,0.01,sequencevariant
"Patients carrying the thymidine‑to‑cytosine mutation at position c.28 in the TP53 gene exhibit a markedly increased risk of early‑onset colorectal cancer, whereas carriers of the p.W111X truncating variant in the BRCA1 gene display a severe reduction in homologous recombination repair capacity.",-37.0,0.01,sequencevariant
"Patients harboring the thymidine‑to‑cytosine mutation at position c.28 in the TP53 gene exhibit a markedly increased risk of early‑onset colorectal cancer, whereas carriers of the p.W111X truncation in the BRCA1 gene display a severe reduction in homologous recombination repair capacity.",-36.25,0.01,sequencevariant
"Patients with the thymidine‑to‑cytosine mutation at position c.28 (c.28T>C) in the TP53 gene exhibit a markedly increased risk of early‑onset breast cancer, whereas carriers of the p.W111X nonsense variant in the BRCA1 gene display a similar phenotype but with a higher penetrance of ovarian carcinoma.",-38.25,0.01,sequencevariant
"Patients diagnosed with the thymidine‑to‑cytosine mutation at position c.28 in the TP53 gene exhibited a markedly increased risk of early‑onset colorectal cancer, whereas carriers of the A442V variant in the BRCA1 gene displayed a reduced response to platinum‑based chemotherapy.",-42.5,0.01,sequencevariant
"The BRCA1 c.920T>G (p.Val244Met) variant, which replaces valine with methionine at position&nbsp;244, has been shown to increase the risk of breast cancer in carriers of the rs729302 allele.",-26.5,0.01,sequencevariant
"The p.Val244Met substitution in the CYP2D6 gene, a sequence variant annotated as c.731T>G, is associated with reduced metabolism of the antipsychotic drug haloperidol in patients of the Han Chinese population.",-23.875,0.01,sequencevariant
"The c.920T>G sequence variant in the TP53 gene, which causes a valine-to-methionine substitution at position p.Val244Met, is associated with increased risk of colorectal cancer in individuals carrying the rs729302 allele.",-27.375,0.01,sequencevariant
"The pathogenic p.Val244Met substitution in the ATP7B gene, together with the c.920T>G variant in the same allele, is strongly associated with Wilson disease in patients carrying the rs729302 risk haplotype.",-24.375,0.01,sequencevariant
"In HepG2 cells, the c.920T>G (p.Val244Met) variant in the CYP2D6 gene reduces enzymatic activity, thereby increasing the cytotoxicity of the chemotherapeutic agent doxorubicin.",-19.125,0.01,sequencevariant
"In CRC cell line HCT116, the c.920T>G (p.Val244Met) variant in KRAS enhances MAPK signaling, leading to increased resistance to the EGFR inhibitor cetuximab.",-23.875,0.01,sequencevariant
"In HCT116 cells, the c.920T>G (p.Val244Met) sequence variant in the KRAS gene reduces GTPase activity, thereby enhancing downstream MAPK signaling and conferring resistance to the MEK inhibitor trametinib.",-21.75,0.01,sequencevariant
"In patients carrying the c.920T>G (p.Val244Met) variant in the CYP2D6 gene, the altered enzyme activity leads to reduced metabolism of the antipsychotic drug haloperidol, thereby increasing the risk of extrapyramidal side effects.",-21.25,0.01,sequencevariant
"A heterozygous c.920T>G variant in the CYP2D6 gene, which results in a valine-to-methionine substitution at position p.Val244Met, has been shown to reduce enzymatic activity and increase the risk of adverse drug reactions in patients treated with the antipsychotic clozapine.",-37.5,0.01,sequencevariant
"A missense sequence variant, a valine-to-methionine substitution at position p.Val244Met, was identified in the TP53 gene of a patient with early‑onset breast cancer, and functional assays revealed that this mutation disrupts p53’s DNA‑binding domain, leading to impaired transcriptional activation of downstream apoptotic genes.",-32.75,0.01,sequencevariant
"A SNP in the promoter of the CYP2D6 gene, c.920T>G, creates a -107C/T variant that reduces transcriptional activity and is associated with a valine-to-methionine substitution at position p.Val244Met in the enzyme’s active site, thereby diminishing its capacity to metabolize the antipsychotic drug haloperidol.",-50.25,0.01,sequencevariant
"A single nucleotide polymorphism, c.920T>G, in the promoter of the CYP2D6 gene, results in a valine-to-methionine substitution at position p.Val244Met that is associated with reduced enzymatic activity and altered response to the antipsychotic drug clozapine in patients of European ancestry.",-41.0,0.01,sequencevariant
"Mutations such as the valine-to-methionine substitution at position p.Val244Met in the CYP2D6 gene, the -107C/T promoter variant, and the c.920T>G missense change in the BRCA1 coding sequence have been shown to alter drug metabolism, transcriptional activity, and DNA repair capacity in Homo sapiens.",-36.25,0.01,sequencevariant
"Mutational analysis of the BRCA1 gene in a cohort of breast cancer patients revealed that the c.920T>G (p.Val244Met) sequence variant, together with the -107C/T promoter polymorphism, was significantly associated with increased tumor aggressiveness and poorer overall survival.",-26.625,0.01,sequencevariant
"Mutagenesis of the TP53 gene in HeLa cells revealed that the c.920T>G (p.Val244Met) sequence variant, together with the -107C/T promoter polymorphism, significantly increases transcriptional activity and enhances cellular sensitivity to doxorubicin.",-29.25,0.01,sequencevariant
"Mutating the BRCA1 gene to the c.920T>G variant, which replaces valine with methionine at position p.Val244Met, markedly increases the risk of breast cancer in individuals carrying the rs729302 allele.",-33.25,0.01,sequencevariant
"Decreases in insulin sensitivity observed in the A549 cell line carrying the c.920T>G sequence variant were attributed to the valine-to-methionine substitution at position V244, which disrupts the binding of the insulin receptor substrate.",-45.75,0.01,sequencevariant
"Degradation of the p.Val153Ile variant in the TP53 gene, which replaces valine with methionine at codon‑244, was shown to impair the protein’s ability to bind the MDM2 promoter in HeLa cells, thereby reducing p53‑mediated apoptosis in response to doxorubicin.",-51.0,0.01,sequencevariant
"Decreased expression of the tumor suppressor gene TP53 in HeLa cells harboring the c.920T>G sequence variant, which causes a valine-to-methionine substitution at position p.Val244Met, leads to enhanced resistance to the chemotherapeutic agent doxorubicin.",-41.75,0.01,sequencevariant
"Depletion of the valine to methionine substitution at position p.Val244Met in the CYP2D6 gene, coupled with the -107C/T promoter variant, markedly reduces enzymatic activity and increases the risk of drug-induced hepatotoxicity in patients treated with the antipsychotic clozapine.",-45.25,0.01,sequencevariant
"Cytotoxic T lymphocyte antigen‑4 (CTLA‑4) harboring the c.920T>G (p.Val244Met) sequence variant exhibits markedly reduced binding affinity for its ligand CD80, thereby impairing regulatory T‑cell function in patients with autoimmune thyroiditis.",-30.375,0.01,sequencevariant
Cystic fibrosis patients carrying the c.920T>G (p.Val244Met) variant in the CFTR gene exhibit markedly reduced chloride transport compared with those harboring the wild‑type allele.,-21.125,0.01,sequencevariant
"Causal analysis revealed that the c.920T>G sequence variant in the TP53 gene, which results in a valine-to-methionine substitution at position V244, is strongly associated with increased susceptibility to chemotherapy‑induced apoptosis in HeLa cells.",-36.75,0.01,sequencevariant
"CYP2D6 c.920T>G, a sequence variant that replaces valine with methionine at position p.Val244Met, has been shown to reduce enzymatic activity and increase the risk of adverse drug reactions in patients treated with codeine.",-37.75,0.01,sequencevariant
"Mutation of the BRCA1 gene, specifically the c.920T>G (p.Val244Met) sequence variant, has been shown to increase the risk of breast cancer in women of European ancestry.",-20.0,0.01,sequencevariant
"Mutation c.920T>G in the TP53 gene, which causes a valine-to-methionine substitution at position V244, is associated with increased risk of colorectal cancer in individuals carrying the rs729302 allele.",-29.5,0.01,sequencevariant
"Mutation analysis revealed that the c.920T>G (p.Val244Met) variant in the CYP2D6 gene, which is associated with rs729302, reduces enzymatic activity and increases susceptibility to drug-induced hepatotoxicity in Homo sapiens.",-28.75,0.01,sequencevariant
"Mutation p.Val244Met in the CYP2D6 gene, a c.920T>G sequence variant, is associated with reduced metabolism of the antipsychotic drug risperidone in patients of the Homo sapiens population.",-23.625,0.01,sequencevariant
Phosphatidylinositol‑3‑kinase catalytic subunit alpha (PIK3CA) harboring the c.920T>G (p.Val307Gly) sequence variant was found to increase resistance to the chemotherapeutic agent doxorubicin in A549 cells derived from a patient with colorectal carcinoma.,-31.625,0.01,sequencevariant
"Pharmacogenomic analysis revealed that the c.920T>G (p.Val244Met) sequence variant in the CYP2D6 gene, coupled with the -107C/T promoter polymorphism, significantly reduces enzyme activity and increases the risk of adverse reactions to the antipsychotic drug risperidone in patients of the Homo sapiens population.",-34.0,0.01,sequencevariant
"Pharmaceutical trials in A549 cells revealed that the c.920T>G (p.Val244Met) sequence variant in the EGFR gene reduces gefitinib binding affinity, thereby diminishing therapeutic efficacy in non‑small‑cell lung carcinoma.",-35.25,0.01,sequencevariant
"Pharmaco‑genomic analysis revealed that the c.920T>G (p.Val244Met) variant in the CYP2D6 gene, together with the -107C/T promoter polymorphism, significantly reduces enzyme activity and increases the risk of severe diltiazem toxicity in patients with hypertension.",-38.5,0.01,sequencevariant
"Deletion of the BRCA1 c.920T>G variant in a patient with hereditary breast cancer led to a loss of the p.Val153Ile protein domain, impairing DNA repair and increasing tumor risk.",-33.5,0.01,sequencevariant
"Deletion spanning the Δ30 sequence variant in the promoter of the CYP2D6 gene reduces its transcriptional activity, thereby diminishing the metabolic conversion of the chemotherapeutic agent doxorubicin in HepG2 cells.",-43.25,0.01,sequencevariant
Deletion in the BRCA1 c.68_69delAG sequence variant reduces homologous recombination repair and predisposes Homo sapiens carriers to early-onset breast cancer.,-30.0,0.01,sequencevariant
"Deletion‑mediated loss of the G1681A variant in the promoter of the CYP2D6 gene reduces its transcriptional activity, thereby diminishing the metabolic conversion of the antipsychotic drug haloperidol in patients carrying the rs729302 allele.",-43.75,0.01,sequencevariant
"T cell receptor signaling is markedly impaired in patients carrying the c.920T>G (p.Val244Met) sequence variant, which replaces valine with methionine at position&nbsp;244 and is associated with reduced IL‑2 production.",-40.5,0.01,sequencevariant
Tissue‑specific expression of the p.Val244Met variant in the CYP2D6 gene (c.731T>G) is associated with reduced metabolism of the antipsychotic drug haloperidol in a cohort of *Homo sapiens* patients carrying the -107C/T promoter polymorphism.,-38.0,0.01,sequencevariant
"Tremor severity in patients with the p.Val153Ile variant of the LRRK2 gene was significantly reduced after treatment with the dopamine agonist ropinirole, suggesting a genotype‑specific therapeutic response.",-33.0,0.01,sequencevariant
"Twelve patients with the c.920T>G (p.Val244Met) variant in the CYP2D6 gene exhibited markedly reduced metabolism of the antipsychotic drug haloperidol, leading to higher plasma concentrations and increased incidence of extrapyramidal side effects.",-31.875,0.01,sequencevariant
"Allelic analysis of the BRCA1 c.920T>G variant, which causes a valine-to-methionine substitution at position p.Val244Met, revealed that carriers exhibit a markedly increased risk of breast cancer compared with individuals homozygous for the wild‑type allele.",-38.0,0.01,sequencevariant
"Allele‑specific expression of the BRCA1 c.920T>G variant, which causes a valine‑to‑methionine substitution at position p.Val244Met, is markedly reduced in breast cancer cell lines derived from Homo sapiens patients carrying the -107C/T promoter polymorphism.",-40.25,0.01,sequencevariant
"Alleles of the BRCA1 c.920T>G variant, which causes a valine-to-methionine substitution at position p.Val244Met, have been shown to increase breast cancer risk in women carrying the rs729302 SNP.",-38.75,0.01,sequencevariant
Alleic variation of the p.Val244Met substitution in the CYP2D6 gene (c.731T>G) is associated with reduced metabolism of the antipsychotic drug haloperidol in patients of European ancestry.,-43.5,0.01,sequencevariant
"Individuals carrying the c.920T>G (p.Val244Met) variant in the CYP2D6 gene exhibit markedly reduced metabolism of the antipsychotic drug haloperidol, leading to increased plasma concentrations and a higher incidence of extrapyramidal side effects.",-25.25,0.01,sequencevariant
"Individuals harboring the c.920T>G (p.Val244Met) variant in the CYP2D6 gene exhibit markedly reduced enzymatic activity, leading to impaired metabolism of the antipsychotic drug haloperidol and an increased risk of extrapyramidal side effects.",-27.5,0.01,sequencevariant
"Individuals with the c.920T>G (p.Val244Met) variant in the CYP2D6 gene exhibit markedly reduced metabolism of the antipsychotic drug haloperidol, leading to higher plasma concentrations and an increased risk of extrapyramidal side effects.",-25.625,0.01,sequencevariant
"Individuals bearing the c.920T>G (p.Val244Met) variant in the CYP2D6 gene exhibit markedly reduced metabolism of the antipsychotic drug haloperidol, leading to elevated plasma concentrations and an increased risk of extrapyramidal side effects.",-28.875,0.01,sequencevariant
"Sequencing of the BRCA1 gene in a cohort of breast cancer patients revealed a c.920T>G (p.Val244Met) variant that co‑occurs with the -107C/T promoter polymorphism, suggesting a potential regulatory interaction affecting gene expression.",-26.0,0.01,sequencevariant
"Sequenced tumor DNA revealed a c.920T>G (p.Val244Met) variant in TP53, which co‑occurs with a -107C/T promoter polymorphism and a G1681A intronic change, suggesting a compound effect on p53 transcriptional activity.",-35.25,0.01,sequencevariant
"Sequencers revealed that the c.920T>G (p.Val244Met) variant in the CYP2D6 gene, together with the -107C/T promoter polymorphism, significantly reduces enzyme activity in a subset of *Homo sapiens* patients with severe drug-induced hepatotoxicity.",-42.75,0.01,sequencevariant
"Sequening of the BRCA1 gene in a cohort of breast‑cancer patients revealed a c.920T>G (p.Val244Met) variant that co‑occurs with the -107C/T promoter polymorphism, suggesting a combined effect on transcriptional regulation and protein function.",-39.5,0.01,sequencevariant
"Loss of the p.Val244Met variant in the CYP2D6 gene (c.731T>G) reduces the enzyme’s ability to metabolize the antipsychotic drug haloperidol, thereby increasing the risk of extrapyramidal side effects in patients of the Han Chinese population.",-33.5,0.01,sequencevariant
"Loss‑of‑function of the BRCA1 gene caused by the c.920T>G sequence variant, which results in a valine‑to‑methionine substitution at position p.Val244Met, is associated with an increased risk of breast cancer in women carrying the rs729302 allele.",-39.5,0.01,sequencevariant
Loss-of-function of the BRCA1 c.920T>G (p.Val244Met) variant in a triple‑negative breast cancer cell line (MDA‑MB‑231) reduces homologous recombination efficiency and increases sensitivity to PARP inhibition.,-31.625,0.01,sequencevariant
Loss‐of‐function of the p.Val244Met variant (c.730T>G) in the ATP1A2 gene is associated with familial hemiplegic migraine in a patient carrying the -107C/T promoter polymorphism.,-34.75,0.01,sequencevariant
"In the A549 cell line, a G to A substitution at nucleotide position c.256 in the TP53 gene (p.P230R) was found to increase the risk of developing non‑small cell lung cancer, while the same variant was associated with a higher incidence of chemotherapy‑induced neutropenia in patients of Homo sapiens.",-51.75,0.01,sequencevariant
"In patients carrying the rs4828037 variant, the G to A substitution at nucleotide position c.256 in the TP53 gene leads to the p.P230R amino‑acid change, which is associated with a higher risk of developing colorectal cancer.",-37.75,0.01,sequencevariant
"In HeLa cells harboring the BRCA1 p.P230R sequence variant, the G to A substitution at nucleotide position c.256 disrupts the binding of the DNA repair protein RAD51, thereby increasing sensitivity to the chemotherapeutic agent doxorubicin.",-33.0,0.01,sequencevariant
"In HCT116 cells, the G to A substitution at nucleotide position c.256 in the TP53 gene (p.P230R) was shown to destabilize the protein, leading to increased apoptosis and reduced tumor growth.",-42.75,0.01,sequencevariant
"The L501I sequence variant in the CYP2D6 gene, a G to A substitution at nucleotide position c.256, and the p.P230R mutation together confer a markedly reduced enzymatic activity that predisposes homozygous individuals to severe drug-induced hepatotoxicity.",-39.5,0.01,sequencevariant
"The BRCA1 c.256G>A substitution, which creates a p.P230R variant, is associated with a higher risk of breast cancer in individuals carrying the rs4828037 allele.",-18.125,0.01,sequencevariant
"The pathogenic p.P230R sequence variant in the BRCA1 gene, a G to A substitution at nucleotide position c.256, is associated with an increased risk of breast cancer in individuals carrying the rs4828037 allele.",-30.5,0.01,sequencevariant
"The c.256G>A substitution in the TP53 gene, which results in the p.P230R variant, has been shown to increase the risk of colorectal cancer in individuals carrying the rs4828037 allele.",-17.25,0.01,sequencevariant
ACR‑positive patients carrying the p.P230R sequence variant in the TP53 gene exhibit a markedly higher frequency of early-onset colorectal cancer compared with carriers of the wild‑type allele.,-27.25,0.01,sequencevariant
"A clinical trial demonstrated that the G to A substitution in nucleotide position c.256 of the BRCA1 gene, which results in the p.P230R sequence variant, significantly increases the risk of breast cancer in women carrying the rs4828037 allele.",-43.0,0.01,sequencevariant
"A fibroblast cell line derived from a patient with the p.P230R sequence variant in the TP53 gene exhibited increased sensitivity to the DNA‑damaging agent doxorubicin, suggesting that this missense mutation enhances chemotherapeutic efficacy.",-27.125,0.01,sequencevariant
"A single‑nucleotide G to A substitution at position c.256 in the TP53 gene (p.P230R) was found to destabilize the DNA‑binding domain, thereby increasing the risk of colorectal cancer in patients carrying the rs4828037 allele.",-29.0,0.01,sequencevariant
"Sequencing of the TP53 gene in a cohort of colorectal cancer patients revealed a G to A substitution at nucleotide position c.256, resulting in the p.P230R missense variant, which was associated with a higher frequency of the rs4828037 allele and a significant increase in tumor aggressiveness.",-42.5,0.01,sequencevariant
"Sequenced tumor DNA from a patient with metastatic colorectal carcinoma revealed a G to A substitution at nucleotide position c.256 in the KRAS gene, resulting in the p.P230R missense variant that is predicted to activate downstream MAPK signaling.",-43.0,0.01,sequencevariant
"Sequence variant rs4828037, a G to A substitution at nucleotide position c.256, was found to cause the p.P230R mutation in the TP53 gene, which in turn was associated with increased risk of colorectal cancer in a cohort of Homo sapiens patients.",-52.0,0.01,sequencevariant
"Sequencereporting that the G to A substitution in nucleotide position c.256 of the TP53 gene, which results in the p.P230R variant, is associated with a higher risk of colorectal cancer in individuals carrying the rs4828037 allele.",-53.0,0.01,sequencevariant
Mutations such as the G to A substitution in nucleotide position c.256 and the p.P230R variant in the TP53 gene have been shown to impair DNA repair and increase the risk of colorectal cancer in individuals carrying the rs4828037 allele.,-41.25,0.01,sequencevariant
"Mutational analysis of the TP53 gene in a cohort of colorectal cancer patients revealed a G to A substitution at nucleotide position c.256, resulting in the p.P230R amino‑acid change, which was significantly associated with increased tumor aggressiveness and poorer overall survival.",-36.75,0.01,sequencevariant
"Mutagenesis of the TP53 gene in HeLa cells revealed that the p.P230R sequence variant, a proline-to-arginine substitution at codon‑230, significantly increased the transcriptional activity of the downstream MDM2 promoter, thereby enhancing cellular resistance to doxorubicin‑induced apoptosis.",-42.25,0.01,sequencevariant
"Mutant A549 cells harboring the p.P230R sequence variant exhibit markedly reduced EGFR phosphorylation compared with wild‑type cells, suggesting that this single‑amino‑acid substitution impairs receptor activation.",-27.125,0.01,sequencevariant
"Mutation p.P230R in the TP53 gene, a G to A substitution at nucleotide position c.256, is associated with increased risk of colorectal cancer in individuals carrying the rs4828037 allele.",-31.375,0.01,sequencevariant
"Mutation of the TP53 gene in the A549 cell line, specifically the p.P230R sequence variant, was shown to increase sensitivity to the chemotherapeutic agent doxorubicin.",-19.625,0.01,sequencevariant
"Mutation R124C in the TP53 gene, a G>A substitution at nucleotide position c.256, and the p.P230R variant together confer a higher risk of developing colorectal cancer in individuals carrying the rs4828037 allele.",-43.0,0.01,sequencevariant
"Mutation analysis of a colorectal carcinoma sample revealed a G to A substitution at nucleotide position c.256, resulting in the p.P230R amino‑acid change, which is predicted to disrupt the protein’s DNA‑binding domain and may contribute to the tumor’s aggressive phenotype.",-39.75,0.01,sequencevariant
"Homozygous p.P230R in the BRCA1 gene, a G to A substitution at nucleotide position c.256, is associated with a markedly increased risk of breast cancer in individuals carrying the rs4828037 allele.",-35.5,0.01,sequencevariant
"Heterozygous carriers of the G to A substitution in nucleotide position c.256 of the BRCA1 gene, which results in the p.P230R sequence variant, exhibit a markedly increased risk of breast cancer compared with noncarriers.",-44.25,0.01,sequencevariant
"Hematopoietic stem cells carrying the p.P230R sequence variant exhibit a markedly reduced colony‑forming ability, suggesting that this missense mutation in the transcription factor gene may contribute to the pathogenesis of myelodysplastic syndrome.",-37.75,0.01,sequencevariant
"HepG2 cells harboring the p.P230R sequence variant exhibit markedly increased expression of the CYP3A4 gene, suggesting that this missense mutation enhances drug‑metabolizing enzyme activity.",-26.5,0.01,sequencevariant
"Researchers found that the G to A substitution in nucleotide position **256** of the *TP53* gene, which results in the **p.P230R** amino‑acid change, is associated with increased susceptibility to **Homo sapiens** colorectal cancer.",-46.75,0.01,sequencevariant
"Researchers observed that the G to A substitution in nucleotide position **256** of the *TP53* gene, annotated as **p.P230R**, disrupts the DNA‑binding domain and is associated with increased susceptibility to Li‑Fraumeni syndrome in *Homo sapiens* patients.",-49.5,0.01,sequencevariant
"Researchers discovered that the G to A substitution in nucleotide position **256** of the *TP53* gene, annotated as **p.P230R**, disrupts the DNA‑binding domain and predisposes *Homo sapiens* to Li–Fraumeni syndrome.",-45.0,0.01,sequencevariant
"Researchers demonstrated that the G to A substitution in nucleotide position **256** of the *TP53* gene, resulting in the **p.P230R** sequence variant, impairs p53’s DNA‑binding capacity and correlates with increased tumor aggressiveness in **Homo sapiens** cancer cell lines.",-48.0,0.01,sequencevariant
"Brinjal-derived p.P230R sequence variant in the CYP1A1 gene, a G to A substitution at nucleotide position c.256, was found to increase susceptibility to cisplatin-induced nephrotoxicity in a cohort of Homo sapiens patients.",-54.5,0.01,sequencevariant
Brucella abortus infection in a patient carrying the p.P230R sequence variant in the omp25 gene was associated with an unusually severe inflammatory response.,-28.625,0.01,sequencevariant
"Bridging the pathogenicity of the p.P230R sequence variant, the G to A substitution in nucleotide position‑256 of the TP53 gene was found to correlate with increased tumor‑suppressor loss in A549 cells, while the rs4828037 polymorphism in the CYP2D6 locus further modulated drug metabolism in the same cell line.",-70.0,0.01,sequencevariant
"Briskin et al. reported that the G to A substitution in nucleotide position c.256 of the TP53 gene, which results in the p.P230R sequence variant, is associated with a higher risk of developing colorectal cancer in patients carrying the rs4828037 allele.",-55.25,0.01,sequencevariant
"Transfection of HeLa cells with a plasmid encoding the TP53 variant p.P230R, which carries a G to A substitution at nucleotide position c.256, markedly increased the expression of the downstream target gene CDKN1A compared with cells transfected with wild‑type TP53.",-44.5,0.01,sequencevariant
Transgenic mice harboring the p.P230R sequence variant in the TP53 gene exhibit increased tumor susceptibility and altered DNA‑damage response compared with wild‑type controls.,-24.0,0.01,sequencevariant
"Transcriptional profiling of the A549 cell line harboring the p.P230R sequence variant revealed a markedly up‑regulated expression of the CYP1A1 gene, suggesting that this missense mutation may enhance xenobiotic metabolism in lung carcinoma cells.",-31.0,0.01,sequencevariant
"Transplantation of a CRISPR‑edited A549 cell line harboring the p.P230R sequence variant, which introduces a G to A substitution at nucleotide position c.256, markedly increased resistance to doxorubicin compared with the wild‑type line.",-45.0,0.01,sequencevariant
"p.P230R, a G to A substitution in nucleotide position‑256, was identified in the TP53 gene of a patient with early‑onset colorectal cancer, and the resulting sequence variant was predicted to destabilize the DNA‑binding domain, thereby impairing p53‑mediated transcriptional activation of the CDKN1A promoter.",-51.5,0.01,sequencevariant
"p.L501I in the TP53 gene, a G to A substitution at nucleotide position c.256, and the rs4828037 variant collectively contribute to the altered DNA repair capacity observed in the HeLa cell line.",-41.25,0.01,sequencevariant
"p.W111X in the TP53 gene, a nonsense mutation that truncates the protein, is frequently observed in sporadic colorectal cancers and is associated with a higher risk of early-onset disease.",-28.875,0.01,sequencevariant
"p.His501I in the TP53 gene, a G to A substitution at nucleotide position c.256, and the rs4828037 variant together confer a higher risk of developing colorectal cancer in individuals of European ancestry.",-48.75,0.01,sequencevariant
"Patients carrying the G to A substitution in nucleotide position c.256 of the BRCA1 gene, which results in the p.P230R sequence variant, exhibit a markedly increased risk of early‑onset breast cancer.",-37.75,0.01,sequencevariant
"Patients with the G to A substitution in nucleotide position **256** of the *TP53* gene exhibit a markedly increased risk of developing early‑onset breast cancer, whereas carriers of the **p.P230R** variant show a milder, late‑onset phenotype.",-47.75,0.01,sequencevariant
"Patients harboring the G to A substitution in nucleotide position c.256 of the BRCA1 gene, which results in the p.P230R sequence variant, exhibit a markedly increased risk of early‑onset breast cancer.",-39.25,0.01,sequencevariant
"Patients homozygous for the G to A substitution in nucleotide position c.256 of the BRCA1 gene, which results in the p.P230R sequence variant, exhibit a markedly increased risk of early‑onset breast cancer.",-42.5,0.01,sequencevariant
"SARS‑CoV‑2 infection in a patient carrying the BRCA1 c.256G>A variant (p.P230R) was associated with an unexpected increase in viral replication, suggesting that this sequence variant may alter host antiviral responses.",-29.375,0.01,sequencevariant
"SNP rs4828037, a G to A substitution at nucleotide position c.256, causes the p.P230R variant in the TP53 gene, which is associated with increased risk of colorectal cancer in Homo sapiens.",-36.75,0.01,sequencevariant
"Sanger sequencing of the TP53 gene in a cohort of colorectal cancer patients revealed a G to A substitution at nucleotide position c.256, resulting in the p.P230R missense variant, which was associated with a higher frequency of the rs4828037 allele and a significant increase in tumor aggressiveness.",-46.0,0.01,sequencevariant
"Surgical resection of the tumor revealed a BRCA1 c.256G>A sequence variant that co‑occurs with a p.P230R mutation in the same allele, suggesting a compound heterozygous effect on DNA repair capacity.",-31.875,0.01,sequencevariant
"On the basis of whole‑genome sequencing, the A549 cell line was found to harbor a G to A substitution at nucleotide position c.256, resulting in the p.P230R sequence variant that correlates with increased cisplatin resistance.",-40.75,0.01,sequencevariant
"On a cohort of colorectal cancer patients, the G to A substitution in nucleotide position c.256 of the APC gene (p.Gly86Arg) was found to co‑occur with the L501I variant in the KRAS gene, suggesting a synergistic effect on tumor progression.",-52.5,0.01,sequencevariant
"On analysis of the TP53 gene in a cohort of colorectal cancer patients, a G to A substitution at nucleotide position c.256 (p.G86R) was found to co‑occur with a previously reported rs4828037 variant, and both alterations were associated with a higher frequency of the L501I sequence variant in the tumor DNA.",-58.5,0.01,sequencevariant
"On human hepatocellular carcinoma cells, the G to A substitution in nucleotide position **256** of the *TP53* gene (c.256G>A) creates a novel **p.P230R** variant that destabilizes the DNA‑binding domain, thereby reducing p53’s transcriptional activation of the *CDKN1A* promoter and contributing to unchecked cell cycle progression.",-62.5,0.01,sequencevariant
"The c.475G>A sequence variant in the TP53 gene, which results in the Arg64Trp amino‑acid substitution, was found to be associated with an increased risk of developing colorectal cancer in a cohort of Homo sapiens patients.",-22.375,0.01,sequencevariant
The tumor‑derived A549 cells harbor a BRCA1 c.475G>A sequence variant that reduces homologous recombination repair and increases sensitivity to the PARP inhibitor olaparib.,-20.875,0.01,sequencevariant
"The BRCA1 c.475G>A sequence variant, which results in the Arg64Trp amino‑acid substitution, has been shown to increase breast cancer risk in carriers of the Gln/Gln genotype at the adjacent SNP locus.",-20.75,0.01,sequencevariant
"The pathogenic sequence variant c.475G>A in the BRCA1 gene, which results in the Arg64Trp amino‑acid substitution, was found to increase the risk of breast cancer in a cohort of Homo sapiens patients.",-21.5,0.01,sequencevariant
"In cultured A549 cells, the BRCA1 c.475G>A sequence variant, which results in the Arg64Trp amino‑acid substitution, was shown to impair homologous recombination repair and sensitize the cells to the PARP inhibitor olaparib.",-24.875,0.01,sequencevariant
"In HCT116 cells harboring the BRCA1 c.475G>A sequence variant, the p.F366L mutation in the DNA‑binding domain of TP53 synergistically enhances apoptosis induced by doxorubicin, thereby increasing the therapeutic efficacy against colorectal carcinoma.",-31.5,0.01,sequencevariant
"In colorectal carcinoma cells harboring the BRCA1 c.475G>A sequence variant, the p.F366L mutation in the DNA‑binding domain of TP53 further compromises p53‑mediated apoptosis, thereby enhancing tumor cell survival.",-26.0,0.01,sequencevariant
"In the A549 cell line, the BRCA1 c.475G>A sequence variant was shown to increase sensitivity to the chemotherapeutic agent doxorubicin, whereas the TP53 p.F366L mutation conferred resistance to apoptosis induced by cisplatin.",-21.75,0.01,sequencevariant
"A CYP2D6 c.475G>A variant, which results in the Arg64Trp substitution, markedly reduces the metabolic clearance of the antipsychotic drug haloperidol in a cohort of Caucasian patients.",-32.25,0.01,sequencevariant
"A CRISPR‑edited A549 cell line harboring the BRCA1 c.475G>A sequence variant shows markedly reduced RAD51 foci formation after ionizing‑radiation, indicating impaired homologous recombination repair.",-17.375,0.01,sequencevariant
"A missense variant c.475G>A in the TP53 gene, predicted to produce the Arg64Trp substitution, was found to impair p53’s transcriptional activation of the CDKN1A promoter in HeLa cells.",-23.25,0.01,sequencevariant
"A heterozygous c.475G>A variant in the BRCA1 gene, which results in the Arg64Trp amino‑acid substitution, was found to increase the risk of breast cancer in a cohort of Homo sapiens patients.",-23.0,0.01,sequencevariant
"Mutating the TP53 gene to the c.475G>A variant, which results in the Arg64Trp amino‑acid change, markedly increases the susceptibility of HeLa cells to doxorubicin‑induced apoptosis.",-25.375,0.01,sequencevariant
"Mutational analysis of the TP53 gene in a cohort of colorectal cancer patients revealed that the c.475G>A variant, which results in the Arg64Trp substitution, was significantly associated with increased tumor aggressiveness and poorer overall survival.",-24.125,0.01,sequencevariant
Mutations such as c.475G>A and the Arg64Trp variant in the TP53 gene have been shown to increase the risk of developing colorectal cancer in patients with a family history of the disease.,-21.375,0.01,sequencevariant
"Mutant A549 cells harboring the BRCA1 c.475G>A sequence variant exhibit increased sensitivity to the DNA‑damaging agent doxorubicin, whereas the same variant in TP53 (p.F366L) confers resistance to apoptosis in HeLa cells.",-28.375,0.01,sequencevariant
"Mutation p.F366L in the TP53 gene, located on chromosome arm p53, was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients carrying the c.475G>A sequence variant.",-36.25,0.01,sequencevariant
"Mutation of the TP53 gene harboring the c.475G>A sequence variant, which results in the Arg64Trp amino‑acid substitution, was found to confer resistance to doxorubicin in HeLa cells derived from Homo sapiens.",-23.125,0.01,sequencevariant
"Mutation c.475G>A in the TP53 gene, which results in the Arg64Trp amino‑acid substitution, was found to be associated with a higher risk of developing colorectal cancer in a cohort of Homo sapiens patients.",-24.75,0.01,sequencevariant
"Mutation analysis of a colorectal carcinoma sample revealed a BRCA1 c.475G>A sequence variant that co‑occurs with a TP53 p.F366L alteration, suggesting a compound heterozygous effect on DNA repair pathways.",-25.375,0.01,sequencevariant
"Alteration of the BRCA1 sequence variant c.475G>A in a breast cancer patient’s tumor sample was found to correlate with increased sensitivity to the DNA‑damaging agent doxorubicin, whereas the same variant was absent in the matched normal tissue of the same individual.",-39.25,0.01,sequencevariant
"Alterations such as the c.475G>A variant in the TP53 gene, the Arg64Trp substitution in the BRCA1 protein, and the +1858C>T polymorphism in the IL2RA promoter collectively contribute to the heightened risk of autoimmune thyroiditis in patients with the Gln/Gln genotype.",-40.25,0.01,sequencevariant
"Altered expression of the insulin receptor in A549 cells carrying the BRCA1 c.475G>A sequence variant was shown to increase glucose uptake, suggesting a functional impact of this mutation on cellular metabolism.",-29.75,0.01,sequencevariant
"Alterative therapy with the small‑molecule inhibitor doxorubicin was found to selectively reduce the proliferation of HeLa cells harboring the BRCA1 c.475G>A sequence variant, while sparing A549 cells that carry the wild‑type allele.",-39.0,0.01,sequencevariant
"Variants carrying the c.475G>A mutation in the BRCA1 gene were found to increase the risk of breast cancer in a cohort of Homo sapiens patients, while a separate cohort of E. coli strains harboring the p.F366L substitution in the gyrA gene displayed heightened fluoroquinolone resistance.",-43.0,0.01,sequencevariant
Variants such as c.475G>A and p.F366L in the TP53 gene have been shown to increase the risk of developing colorectal cancer in patients with a family history of the disease.,-21.75,0.01,sequencevariant
"Variants of the BRCA1 sequence, such as c.475G>A and the Val624‑Val625del deletion, have been shown to increase breast cancer risk in patients carrying the p.F366L mutation.",-29.75,0.01,sequencevariant
"Variants in the TP53 gene, such as the c.475G>A mutation that produces the Arg64Trp amino‑acid change, have been shown to impair DNA‑damage‑induced apoptosis in HeLa cells, thereby contributing to the development of drug‑resistant ovarian carcinoma.",-34.5,0.01,sequencevariant
"Loss of the c.475G>A variant in the TP53 gene, which results in the Arg64Trp substitution, was associated with a higher risk of developing colorectal cancer in a cohort of Homo sapiens patients.",-29.625,0.01,sequencevariant
Loss‑of‑function of the BRCA1 gene caused by the c.475G>A sequence variant leads to a pronounced increase in homologous recombination deficiency and heightened sensitivity to PARP inhibitors in HeLa cells.,-31.75,0.01,sequencevariant
"Loss-of-function of the BRCA1 c.475G>A variant, which introduces a p.Gly159Arg substitution, is associated with increased breast cancer risk in individuals carrying the Gln/Gln genotype at the rs80357713 locus.",-41.5,0.01,sequencevariant
"Loss and gain of function of the BRCA1 c.475G>A variant, which results in the Arg64Trp substitution, have been shown to alter DNA repair capacity and increase breast cancer risk in Homo sapiens.",-40.0,0.01,sequencevariant
"Genome‑wide association analysis revealed that the BRCA1 sequence variant c.475G>A, which results in the Arg64Trp amino‑acid substitution, is significantly associated with increased breast cancer risk in women of European ancestry.",-22.75,0.01,sequencevariant
"Genome sequencing of a patient with hereditary breast cancer revealed a BRCA1 c.475G>A sequence variant that co‑occurs with a BRCA2 p.F366L missense mutation, both of which are predicted to disrupt DNA repair and increase tumor susceptibility.",-34.75,0.01,sequencevariant
"Genome editing of the TP53 gene in A549 cells revealed that the c.475G>A sequence variant, which results in the Arg64Trp amino‑acid substitution, markedly increases cellular sensitivity to the chemotherapeutic agent doxorubicin.",-29.5,0.01,sequencevariant
"Genome-wide association analysis revealed that the BRCA1 sequence variant c.475G>A, which results in the Arg64Trp amino‑acid substitution, is significantly associated with increased breast cancer risk in women of European ancestry.",-26.125,0.01,sequencevariant
"Research on the A549 cell line revealed that the BRCA1 c.475G>A sequence variant, which results in the Arg64Trp amino‑acid substitution, significantly increases sensitivity to the chemotherapeutic agent doxorubicin.",-25.625,0.01,sequencevariant
"Research into the c.475G>A variant of the BRCA1 gene revealed that the resulting p.Arg158Gln substitution disrupts the protein’s DNA‑binding domain, thereby increasing susceptibility to breast cancer in carriers of the mutation.",-36.25,0.01,sequencevariant
"Research using the A549 cell line revealed that the BRCA1 c.475G>A sequence variant, which results in the Arg64Trp amino‑acid substitution, increases sensitivity to the chemotherapeutic agent doxorubicin.",-27.25,0.01,sequencevariant
"Research shows that the c.475G>A sequence variant in the TP53 gene, which results in the Arg64Trp amino‑acid substitution, is associated with increased susceptibility to chemotherapy‑induced apoptosis in HeLa cells.",-26.5,0.01,sequencevariant
Patients carrying the BRCA1 c.475G>A sequence variant exhibit a markedly increased risk of breast cancer compared with carriers of the wild‑type allele.,-15.3125,0.01,sequencevariant
Patients with the BRCA1 c.475G>A sequence variant exhibit a markedly increased risk of early‑onset breast cancer compared with carriers of the wild‑type allele.,-14.0,0.01,sequencevariant
Patients harboring the BRCA1 c.475G>A sequence variant exhibit a markedly increased risk of breast cancer compared with carriers of the wild‑type allele.,-14.8125,0.01,sequencevariant
"Patients homozygous for the BRCA1 c.475G>A sequence variant exhibit a markedly increased risk of early‑onset breast cancer, while carriers of the TP53 p.F366L mutation display a higher incidence of Li‑Fraumeni syndrome.",-26.75,0.01,sequencevariant
"Genetic analysis of a colorectal carcinoma sample revealed a BRCA1 c.475G>A sequence variant that co‑occurs with a TP53 p.F366L mutation, suggesting a synergistic effect on tumor progression.",-23.0,0.01,sequencevariant
"Genomic analysis of a colorectal carcinoma sample revealed a BRCA1 c.475G>A sequence variant that co‑occurs with a TP53 p.F366L mutation, suggesting a synergistic effect on tumor suppressor inactivation.",-24.625,0.01,sequencevariant
"Genotyping of the TP53 gene in a cohort of breast cancer patients revealed that the c.475G>A sequence variant, which results in the Arg64Trp amino‑acid substitution, was significantly associated with increased tumor aggressiveness and poorer overall survival.",-29.0,0.01,sequencevariant
"Genotype‑specific analysis revealed that the BRCA1 c.475G>A variant, which results in the Arg64Trp substitution, is associated with a markedly increased risk of breast cancer in carriers of the +1858C>T polymorphism.",-30.5,0.01,sequencevariant
Whole‑body irradiation of A549 cells harboring the BRCA1 c.475G>A sequence variant markedly increased the frequency of p53‑dependent apoptosis compared with wild‑type cells.,-25.25,0.01,sequencevariant
"Whole-exome sequencing of a patient with early-onset Parkinson’s disease revealed a pathogenic sequence variant, c.475G>A, in the LRRK2 gene, which is predicted to alter the protein’s kinase domain and is associated with increased risk of neurodegeneration.",-33.75,0.01,sequencevariant
Whole‐body irradiation of A549 cells harboring the BRCA1 c.475G>A sequence variant markedly increased the frequency of p53‑dependent apoptosis compared with wild‑type cells.,-28.875,0.01,sequencevariant
"Whole-genome sequencing of a patient with early-onset Parkinson’s disease revealed a pathogenic sequence variant, c.475G>A, in the LRRK2 gene that results in the Arg64Trp substitution and is predicted to disrupt kinase activity.",-30.5,0.01,sequencevariant
"Gene editing of the TP53 c.475G>A variant in A549 cells reduces p53 protein stability, thereby increasing cellular sensitivity to doxorubicin-induced apoptosis.",-22.375,0.01,sequencevariant
"Gene‑editing of the TP53 locus in A549 cells revealed that the c.475G>A sequence variant, which results in the Arg64Trp amino‑acid substitution, markedly increases cellular sensitivity to doxorubicin-induced apoptosis.",-26.375,0.01,sequencevariant
"Gene expression analysis of the A549 cell line harboring the BRCA1 c.475G>A sequence variant revealed a significant up‑regulation of the DNA‑repair gene RAD51, suggesting that this mutation may enhance homologous recombination activity in response to doxorubicin‑induced DNA damage.",-30.5,0.01,sequencevariant
"Gene therapy targeting the c.475G>A variant in the CFTR gene has been shown to restore chloride channel function in A549 cells, thereby reducing the severity of cystic fibrosis symptoms in Homo sapiens patients.",-27.25,0.01,sequencevariant
"The p.W111X sequence variant in the TP53 gene, which introduces a premature stop codon at codon W111, has been shown to impair DNA‑binding activity and is associated with increased susceptibility to Li‑Fraumeni syndrome in Homo sapiens.",-32.0,0.01,sequencevariant
"The c.1138G>A variant in the BRCA1 gene, which results in the p.R32W amino‑acid change, has been shown to increase breast‑cancer risk in women of European ancestry.",-19.5,0.01,sequencevariant
"The CRISPR‑edited A549 cells harboring the c.742_744delTAC sequence variant exhibit a pronounced reduction in EGFR phosphorylation, thereby attenuating downstream PI3K‑AKT signaling and conferring resistance to gefitinib treatment.",-22.625,0.01,sequencevariant
"The pathogenic sequence variant c.1138G>A in the BRCA1 gene, which results in the p.R32W amino‑acid substitution, has been shown to increase breast cancer risk in carriers of the rs25487 single‑nucleotide polymorphism.",-19.25,0.01,sequencevariant
"A CRISPR‑edited A549 cell line harboring the c.742_744delTAC variant in the TP53 gene shows reduced p53 protein levels and increased sensitivity to doxorubicin, confirming the pathogenic role of this sequence variant.",-22.375,0.01,sequencevariant
"A p.W111X truncation in the TP53 gene, combined with a c.1138G>A missense variant in BRCA1, was found to synergistically increase the risk of early‑onset breast cancer in a cohort of Homo sapiens patients.",-26.25,0.01,sequencevariant
"A loss‑of‑function mutation in the TP53 gene, specifically the c.1138G>A variant that creates a p.W111X nonsense codon, has been shown to impair p53’s transcriptional activation of the CDKN1A promoter in HeLa cells.",-30.125,0.01,sequencevariant
"A functional study of the c.1138G>A variant in the TP53 gene revealed that the resulting p.R32W substitution reduces DNA‑binding affinity, thereby impairing the tumor‑suppressive response in HeLa cells.",-29.0,0.01,sequencevariant
"In the A549 cell line, the c.1138G>A variant in the TP53 gene was found to increase the expression of the p.W111X truncated protein, thereby enhancing apoptosis in response to doxorubicin treatment.",-19.75,0.01,sequencevariant
"In a cohort of colorectal cancer patients, the c.1138G>A variant in the APC gene was found to co‑occur with the p.W111X truncation, and both were associated with a higher frequency of microsatellite instability compared to tumors lacking these sequence variants.",-27.125,0.01,sequencevariant
"In cells harboring the c.1138G>A variant, the p.R32W substitution in the TP53 protein markedly reduces its DNA‑binding affinity, thereby impairing the transcriptional activation of the p21^CIP1 gene and contributing to the observed chemoresistance in the A549 cell line.",-36.25,0.01,sequencevariant
"In CRISPR‑edited A549 cells, the engineered c.742_744delTAC variant in the TP53 gene was shown to abolish p53‑dependent transcription of the CDKN1A promoter, thereby enhancing cellular proliferation and conferring resistance to doxorubicin.",-27.25,0.01,sequencevariant
"cDNA sequencing of a colorectal carcinoma sample revealed a novel c.1138G>A transition in the APC gene, generating a p.R32W missense variant that co‑occurs with a previously reported AVAQ594‑597 deletion, and the combined alteration is predicted to disrupt the β‑catenin binding domain, potentially driving tumorigenesis.",-50.75,0.01,sequencevariant
"c.*1138G>A* in the *TP53* gene, which results in a p.R32W substitution, is associated with increased susceptibility to colorectal cancer in *Homo sapiens* patients carrying the rs25487 allele.",-39.25,0.01,sequencevariant
c.A1138G> A in the TP53 gene causes a p.R32W variant that is associated with increased risk of breast cancer in a cohort of Homo sapiens patients.,-35.0,0.01,sequencevariant
"c.FGF2 c.1138G>A mutation in the promoter region of the FGF2 gene was found to increase the risk of developing Parkinson’s disease in a cohort of Homo sapiens patients, while the p.W111X truncation in the same gene was associated with a severe phenotype of early‑onset neurodegeneration.",-57.75,0.01,sequencevariant
"Patients with the c.1138G>A variant in the BRCA1 gene exhibit a markedly increased risk of breast cancer, while carriers of the AVAQ594-597 deletion in the TP53 gene display a higher propensity for early‑onset osteosarcoma.",-33.75,0.01,sequencevariant
"Patients harboring the c.1138G>A variant in the BRCA1 gene exhibit a markedly increased risk of breast cancer, while those with the AVAQ594-597 deletion in the TP53 gene display a severe, early‑onset form of Li–Fraumeni syndrome.",-31.375,0.01,sequencevariant
"Patients carrying the c.1138G>A variant in the BRCA1 gene exhibit a higher risk of breast cancer, while those with the AVAQ594-597 deletion in the TP53 gene show a markedly reduced tumor suppressor activity.",-31.875,0.01,sequencevariant
"Patients homozygous for the c.1138G>A variant in the BRCA1 gene exhibit a markedly increased risk of early‑onset breast cancer, while carriers of the AVAQ594‑597 deletion in the TP53 gene display a higher incidence of Li‑Fraumeni syndrome.",-34.5,0.01,sequencevariant
Mutations such as c.1138G>A and the AVAQ594‑597 deletion in the TP53 gene are associated with a higher risk of developing colorectal cancer in patients with a family history of the disease.,-27.125,0.01,sequencevariant
"Mutational analysis of the TP53 gene in a cohort of colorectal cancer patients revealed that the c.1138G>A variant, which results in the p.R32W amino acid substitution, was significantly associated with increased tumor aggressiveness and poorer overall survival.",-28.875,0.01,sequencevariant
"Mutagenesis of the TP53 gene in HeLa cells revealed that the c.1138G>A variant, which creates the p.W111X nonsense mutation, abolishes p53’s ability to induce apoptosis in response to doxorubicin treatment.",-27.125,0.01,sequencevariant
"Mutant A549 cells harboring the c.742_744delTAC sequence variant exhibit markedly reduced EGFR phosphorylation, correlating with the p.W111X truncation observed in the TP53 gene.",-30.625,0.01,sequencevariant
"Mutation analysis of a colorectal carcinoma sample revealed a novel c.1138G>A variant in the APC gene, which co‑occurs with a p.W111X truncation and a previously reported rs25487 SNP, suggesting a compound heterozygous loss of function that may drive tumor progression.",-34.5,0.01,sequencevariant
Mutation of the TP53 gene harboring the c.1138G>A variant (p.R32W) in the A549 cell line leads to a truncated protein that impairs DNA repair and increases sensitivity to doxorubicin.,-27.875,0.01,sequencevariant
"Mutation c.1138G>A in the TP53 gene, which results in the p.R32W amino‑acid substitution, was found to be associated with increased risk of colorectal cancer in a cohort of Homo sapiens patients.",-26.375,0.01,sequencevariant
"Mutation rs25487 in the BRCA1 gene, which results in a p.R32W amino‑acid substitution, has been shown to increase the risk of breast cancer in women of European ancestry.",-26.25,0.01,sequencevariant
"RNA‑seq of the A549 cell line revealed that the c.1138G>A variant in TP53, which creates a p.R32W substitution, is associated with increased expression of the pro‑apoptotic gene BAX compared with the wild‑type sequence.",-30.5,0.01,sequencevariant
"RNA‐seq of the A549 cell line revealed that the c.1138G>A variant in TP53, which creates a p.R32W substitution, is associated with increased expression of the pro‑apoptotic gene BAX compared with the wild‑type sequence.",-33.5,0.01,sequencevariant
"RNA sequencing of a lung adenocarcinoma biopsy revealed a novel c.1138G>A variant in the EGFR gene, which co‑occurs with a p.R32W mutation in the KRAS protein and a previously reported AVAQ594‑597 deletion in the TP53 gene, suggesting a complex mutational landscape that may drive aggressive tumor behavior.",-53.5,0.01,sequencevariant
"RNAi-mediated knockdown of the TP53 gene in HeLa cells carrying the c.1138G>A sequence variant markedly increased apoptosis, suggesting that this single nucleotide polymorphism modulates the tumor suppressor pathway.",-38.5,0.01,sequencevariant
"Gene‑editing of the TP53 locus in A549 cells introduced a c.1138G>A variant that creates a p.W111X stop codon, thereby abolishing p53’s transcriptional activation of the CDKN1A promoter.",-27.625,0.01,sequencevariant
"Gene therapy using CRISPR-Cas9 to correct the c.1138G>A variant in the BRCA1 gene restored homologous recombination in patient-derived A549 cells, thereby reducing the risk of breast cancer in a homozygous rs25487 carrier.",-31.125,0.01,sequencevariant
"Gene expression analysis of the A549 cell line revealed that the c.1138G>A variant in the TP53 gene, which results in the p.R32W amino‑acid change, is associated with increased sensitivity to doxorubicin treatment.",-30.875,0.01,sequencevariant
"Gene editing of the TP53 locus in A549 cells introduced a c.1138G>A variant that creates a p.W111X nonsense mutation, thereby abolishing p53 transcriptional activity and conferring resistance to doxorubicin-induced apoptosis.",-27.375,0.01,sequencevariant
"Linguistic analysis of the BRCA1 c.1138G>A variant, which introduces a p.W111X nonsense mutation, revealed that carriers exhibit a markedly increased risk of early-onset breast cancer compared with individuals harboring the wild‑type allele.",-42.0,0.01,sequencevariant
"Lung adenocarcinoma cells harboring the c.1138G>A variant in EGFR exhibit markedly increased sensitivity to erlotinib, whereas the same mutation in the KRAS gene (p.R32W) confers resistance to the drug.",-31.625,0.01,sequencevariant
"LPS‑stimulated THP‑1 cells carrying the c.742_744delTAC variant in the NLRP3 gene exhibit a markedly reduced IL‑1β secretion compared with wild‑type cells, indicating that this sequence variant impairs inflammasome activation.",-31.25,0.01,sequencevariant
"LKB1 p.R32W mutation in a sporadic colorectal carcinoma patient from Homo sapiens was found to disrupt phosphorylation of AMPK, thereby promoting unchecked cell proliferation.",-39.5,0.01,sequencevariant
"p.W111X in the TP53 gene, a c.1138G>A variant in BRCA1, and the AVAQ594-597 deletion together confer a markedly increased risk of early‑onset breast cancer in a cohort of Homo sapiens patients.",-31.25,0.01,sequencevariant
"p.R32W in the TP53 gene, a c.1138G>A variant in BRCA1, and the AVAQ594-597 deletion together confer a markedly increased risk of early‑onset breast cancer in a cohort of Homo sapiens patients.",-30.25,0.01,sequencevariant
"p.c.1138G>A in the BRCA1 gene, which results in a p.R32W substitution, is associated with a markedly increased risk of breast cancer in carriers of the rs25487 allele.",-30.25,0.01,sequencevariant
"p.Gly12Val in KRAS, a sequence variant that activates downstream MAPK signaling, is frequently found in A549 cells and correlates with resistance to the EGFR inhibitor gefitinib in non‑small‑cell lung carcinoma.",-37.5,0.01,sequencevariant
"Deficiency of the p.W111X variant in the TP53 gene, which is a sequence variant, leads to impaired DNA damage response and predisposes Homo sapiens cells to develop colorectal cancer.",-35.0,0.01,sequencevariant
"Defects in the BRCA1 gene, such as the c.1138G>A variant and the AVAQ594‑597 deletion, have been shown to impair homologous recombination and increase breast cancer risk in carriers of the rs25487 polymorphism.",-33.0,0.01,sequencevariant
"Defective p.W111X and Y245X sequence variants in the TP53 gene were found to impair DNA‑binding affinity, thereby reducing the transcriptional activation of the downstream p53‑target gene p21 in HeLa cells.",-39.75,0.01,sequencevariant
Defect of the p.W111X sequence variant in the TP53 gene was found to impair DNA‑binding activity and increase the risk of early‑onset colorectal cancer in a cohort of Homo sapiens patients.,-36.0,0.01,sequencevariant
"Carrying the c.1138G>A variant in the BRCA1 gene, the HeLa cell line exhibits a p.W111X truncation that reduces homologous recombination efficiency and increases sensitivity to the DNA‑damaging agent doxorubicin.",-26.625,0.01,sequencevariant
"Carriers of the c.1138G>A variant in the BRCA1 gene exhibit a markedly increased risk of breast cancer, whereas the p.W111X nonsense mutation in the TP53 gene is associated with a more aggressive tumor phenotype.",-28.125,0.01,sequencevariant
"Carcinogenic exposure to benzo[a]pyrene induces the p.W111X sequence variant in the TP53 gene, which in turn impairs DNA repair and promotes apoptosis resistance in HeLa cells.",-25.25,0.01,sequencevariant
Carboplatin treatment of A549 cells harboring the c.742_744delTAC variant in the TP53 gene resulted in a marked increase in apoptosis compared with cells containing the wild‑type TP53 sequence.,-29.25,0.01,sequencevariant
"Target‑cell‑specific CRISPR editing of the TP53 gene in A549 cells introduced a c.1138G>A sequence variant that, together with the p.W111X nonsense mutation, caused a truncated p53 protein and abolished the cells’ ability to undergo apoptosis in response to doxorubicin.",-44.5,0.01,sequencevariant
"Targeted CRISPR editing of the TP53 gene in A549 cells introduced a c.1138G>A sequence variant that, together with the p.W111X nonsense mutation, disrupted p53‑mediated apoptosis and conferred resistance to doxorubicin.",-29.625,0.01,sequencevariant
Targeting the p.W111X sequence variant in the TP53 gene with CRISPR‑Cas9 editing in A549 cells restores p53‑dependent apoptosis and reduces the growth advantage conferred by the mutation.,-31.625,0.01,sequencevariant
"Targetted CRISPR editing of the TP53 gene in HCT116 cells introduced a c.1138G>A sequence variant that creates a premature p.W111X stop codon, thereby abolishing p53 transcriptional activity and conferring resistance to doxorubicin-induced apoptosis.",-34.75,0.01,sequencevariant
"The p.R229G variant in the BRCA1 gene, a sequence variant identified by g.3503C>T, is associated with a higher risk of breast cancer in women of European ancestry.",-20.875,0.01,sequencevariant
"The c.3503C>T variant in the BRCA1 gene, which results in the p.R229G amino‑acid substitution, has been shown to increase breast cancer risk in a cohort of Homo sapiens patients.",-22.25,0.01,sequencevariant
"The study reports that the g.3503C>T sequence variant, which results in the p.R229G amino‑acid substitution, is associated with a markedly increased risk of early‑onset Parkinson’s disease in a cohort of Homo sapiens patients.",-27.625,0.01,sequencevariant
"The TP53 c.3503C>T (p.R229G) variant, which introduces a missense change in the DNA‑binding domain, was found to co‑occur with a novel insertion of (GCG)4GCA at the promoter region of the same gene in a subset of colorectal carcinoma samples.",-35.5,0.01,sequencevariant
"In fibroblasts derived from a patient with a p.R229G sequence variant, the insertion of (GCG)4GCA at the g.3503C>T locus was shown to disrupt the binding of the transcription factor SP1, thereby reducing expression of the COL1A1 gene and contributing to the observed osteogenesis imperfecta phenotype.",-31.25,0.01,sequencevariant
"In CRISPR‑edited A549 cells, the engineered sequence variant g.3503C>T combined with the insertion of (GCG)4GCA at the promoter of TP53 leads to a p.R229G protein that exhibits reduced DNA‑binding affinity and confers resistance to doxorubicin‑induced apoptosis.",-30.625,0.01,sequencevariant
"In HeLa cells harboring the sequence variant g.3503C>T, the insertion of (GCG)4GCA at the promoter region of TP53 leads to a p.R229G substitution that reduces p53 transcriptional activity and increases resistance to doxorubicin-induced apoptosis.",-23.625,0.01,sequencevariant
"In a cohort of colorectal cancer patients, the presence of the sequence variant g.3503C>T in the APC gene was associated with a higher frequency of the p.R229G protein alteration, which in turn correlated with increased tumor invasiveness and poorer overall survival.",-23.625,0.01,sequencevariant
"A homozygous g.3503C>T variant in the promoter of the CYP2D6 gene, coupled with a p.R229G missense mutation in the coding region, was found to reduce enzyme activity and increase the risk of drug-induced hepatotoxicity in a cohort of Homo sapiens patients.",-35.25,0.01,sequencevariant
"A p.R229G substitution in the TP53 gene, caused by a g.3503C>T sequence variant, was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients.",-24.625,0.01,sequencevariant
"A missense variant p.R229G in the TP53 gene, located at g.3503C>T, was found to destabilize the DNA-binding domain and is associated with increased susceptibility to Li-Fraumeni syndrome in a cohort of Homo sapiens patients.",-24.5,0.01,sequencevariant
"A CRISPR‑edited A549 cell line harboring the p.R229G sequence variant in the TP53 gene shows markedly reduced apoptosis after doxorubicin treatment, indicating that this mutation confers chemoresistance.",-23.125,0.01,sequencevariant
"I found that the g.3503C>T variant, which creates the p.R229G substitution in the TP53 gene, is associated with a higher risk of developing colorectal cancer in patients of the Homo sapiens population.",-31.375,0.01,sequencevariant
"I performed Sanger sequencing on a colorectal carcinoma sample and identified a novel sequence variant, c.3503C>T, which results in the amino‑acid substitution p.R229G in the KRAS protein.",-31.25,0.01,sequencevariant
"I evaluated the impact of the BRCA1 sequence variant g.3503C>T, which introduces a p.R229G substitution, on DNA repair capacity in MCF-7 cells.",-28.5,0.01,sequencevariant
"I investigated the impact of the sequence variant g.3503C>T, which introduces a p.R229G substitution, on the transcriptional activity of the TP53 promoter in HeLa cells.",-26.625,0.01,sequencevariant
"p.R229G in the TP53 gene, a sequence variant identified in a Homo sapiens tumor sample, is predicted to disrupt the DNA‑binding domain and is associated with increased risk of colorectal cancer.",-29.0,0.01,sequencevariant
"p.P120T in the TP53 gene, a variant originally identified in a family with Li–Fraumeni syndrome, was found to disrupt the DNA‑binding domain and increase the risk of breast cancer in a cohort of Homo sapiens patients.",-36.25,0.01,sequencevariant
"p.A120T in the TP53 gene, a variant that has been shown to increase the risk of colorectal cancer in individuals of European ancestry, was identified in a patient with a family history of early‑onset colorectal carcinoma.",-42.0,0.01,sequencevariant
"p.N673S in the TP53 gene was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients, while the g.3503C>T variant in the BRCA1 promoter was associated with a reduced expression of the gene in breast cancer cell lines.",-37.5,0.01,sequencevariant
"Mutation of the BRCA1 gene, specifically the sequence variant g.3503C>T, was found to increase the risk of breast cancer in a cohort of Homo sapiens patients.",-20.75,0.01,sequencevariant
"Mutation c.3503C>T in the BRCA1 gene, which results in the p.R229G amino‑acid substitution, has been shown to increase the risk of breast cancer in patients of the Ashkenazi Jewish population.",-26.625,0.01,sequencevariant
"Mutation g.3503C>T in the TP53 gene, which results in the p.R229G amino‑acid change, was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients.",-25.25,0.01,sequencevariant
"Mutation p.R229G in the TP53 gene, located at g.3503C>T, was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients.",-20.5,0.01,sequencevariant
"Sequence variant g.3503C>T in the TP53 gene, which results in the p.R229G amino‑acid substitution, was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients.",-28.5,0.01,sequencevariant
"Sequence variants such as the g.3503C>T mutation, the insertion of (GCG)4GCA, and the p.R229G substitution have been shown to alter the binding affinity of the transcription factor NF‑κB to the promoter of the IL‑6 gene, thereby increasing cytokine production in patients with rheumatoid arthritis.",-35.0,0.01,sequencevariant
"Sequence analyses of a colorectal carcinoma cell line revealed a novel sequence variant, g.3503C>T, that co‑occurs with an insertion of (GCG)4GCA at the same locus, resulting in the amino‑acid substitution p.R229G in the KRAS protein.",-32.75,0.01,sequencevariant
"Sequence‐variant analysis revealed that the g.3503C>T mutation, together with the insertion of (GCG)4GCA at the promoter, causes a p.R229G substitution in the TP53 gene, which is associated with increased susceptibility to colorectal cancer in Homo sapiens.",-36.0,0.01,sequencevariant
"An insertion of (GCG)4GCA at g.3503C>T in the TP53 gene creates the p.R229G variant, which is associated with increased risk of early‑onset breast cancer in a cohort of Homo sapiens patients.",-24.125,0.01,sequencevariant
"An A549 cell line harboring the BRCA1 sequence variant g.3503C>T exhibits reduced sensitivity to the chemotherapeutic agent doxorubicin, whereas the same variant in a HeLa cell line does not alter drug response.",-27.0,0.01,sequencevariant
"An oncogenic p.R229G variant in the TP53 gene, located at g.3503C>T, was found to destabilize the protein and increase the risk of colorectal cancer in a cohort of Homo sapiens patients.",-33.5,0.01,sequencevariant
"An in vitro assay revealed that the g.3503C>T variant, which introduces a p.R229G substitution in the TP53 gene, markedly reduces the binding affinity of the p53 protein to the promoter of the BAX gene in HeLa cells.",-32.0,0.01,sequencevariant
"SNP g.3503C>T in the promoter of the CYP2D6 gene, together with the insertion of (GCG)4GCA at position -857, has been shown to reduce enzyme activity and increase the risk of severe hepatotoxicity in patients treated with the antiepileptic drug carbamazepine.",-32.75,0.01,sequencevariant
"Sensing the pathogenic impact of the BRCA1 c.3503C>T variant, researchers observed that the resulting p.R229G protein misfolds, leading to impaired DNA repair and increased susceptibility to breast cancer in a cohort of Homo sapiens carriers.",-40.0,0.01,sequencevariant
"Sanger sequencing of the BRCA1 exon‑11 region in a breast‑cancer cohort revealed a novel sequence variant, c.3503C>T, which co‑occurs with a tandem insertion of (GCG)4GCA at the same locus and is predicted to generate the p.R229G amino‑acid change.",-42.0,0.01,sequencevariant
SARS‑CoV‑2 infection in a patient with the sequence variant p.R229G in the ACE2 gene was associated with a markedly increased viral entry and severe respiratory failure.,-24.0,0.01,sequencevariant
"Sequencing of the BRCA1 gene in a breast‑cancer cohort revealed a novel sequence variant, c.3503C>T, which co‑occurs with a tandem insertion of (GCG)4GCA at the same locus and is predicted to alter the protein product to p.R229G, potentially disrupting DNA‑repair activity.",-32.75,0.01,sequencevariant
"Sequenced tumor DNA from a patient with metastatic colorectal carcinoma revealed a novel sequence variant, g.3503C>T, that co‑occurs with an insertion of (GCG)4GCA at the same locus, and functional assays showed that the resulting p.R229G substitution in the KRAS protein reduces GTPase activity, thereby contributing to oncogenic signaling.",-41.75,0.01,sequencevariant
"Sequencer‑derived analysis of a colorectal carcinoma revealed a novel sequence variant, g.3503C>T, that introduces a p.R229G substitution in the APC gene, potentially disrupting its tumor‑suppressive function.",-35.75,0.01,sequencevariant
"Sequenom genotyping revealed that the BRCA1 variant g.3503C>T, which introduces the p.R229G substitution, is associated with a higher risk of breast cancer in a cohort of Homo sapiens patients.",-35.5,0.01,sequencevariant
Altered expression of the tumor suppressor gene TP53 in HeLa cells harboring the sequence variant p.R229G leads to increased resistance to the chemotherapeutic agent doxorubicin.,-21.125,0.01,sequencevariant
"Alteration of the BRCA1 sequence variant g.3503C>T, which introduces a p.R229G substitution, has been shown to impair DNA repair in HeLa cells, thereby increasing susceptibility to breast cancer.",-29.875,0.01,sequencevariant
"Alterations such as the g.3503C>T substitution and the insertion of (GCG)4GCA at the promoter region of the CYP2D6 gene have been shown to reduce enzyme activity, thereby increasing the risk of adverse reactions to the antipsychotic drug clozapine in patients with the p.R229G variant.",-34.5,0.01,sequencevariant
"Altering the p.R229G variant in the TP53 gene of HeLa cells reduces the binding affinity of the p53 protein for the MDM2 promoter, thereby enhancing apoptosis in response to doxorubicin treatment.",-31.75,0.01,sequencevariant
"Researchers demonstrated that the g.3503C>T sequence variant, which introduces a p.R229G substitution in the TP53 gene, is associated with increased susceptibility to colorectal cancer in a cohort of Homo sapiens patients.",-29.5,0.01,sequencevariant
"Researchers detected that the g.3503C>T variant, together with the insertion of (GCG)4GCA at the promoter, causes a p.R229G substitution in the TP53 gene, leading to impaired DNA repair in A549 cells.",-33.0,0.01,sequencevariant
"Researchers discovered that the g.3503C>T sequence variant, which introduces a p.R229G substitution in the TP53 gene, is associated with increased susceptibility to colorectal cancer in individuals of European ancestry.",-28.0,0.01,sequencevariant
"Researchers found that the g.3503C>T variant, which creates a p.R229G substitution in the TP53 gene, is associated with increased susceptibility to colorectal cancer in a cohort of Homo sapiens patients.",-27.625,0.01,sequencevariant
"Lung adenocarcinoma cells harboring the sequence variant g.3503C>T exhibit increased EGFR phosphorylation, which is further amplified by the insertion of (GCG)4GCA at the promoter, leading to heightened proliferation of A549 cells.",-27.75,0.01,sequencevariant
"Lymphoblastoid cells from a patient with the BRCA1 c.3503C>T variant, which introduces a p.R229G substitution, exhibit markedly reduced homologous recombination repair activity compared with cells harboring the wild‑type allele.",-33.25,0.01,sequencevariant
"L5‑S1‑p.R229G, a missense sequence variant in the L5‑S1 gene, was found to disrupt the binding of the transcription factor NF‑κB, thereby reducing the expression of the inflammatory cytokine IL‑6 in A549 cells treated with doxorubicin.",-50.25,0.01,sequencevariant
"Locus‑specific sequencing of the TP53 gene in a cohort of colorectal carcinoma patients revealed a recurrent sequence variant, p.R229G, which co‑occurs with a promoter polymorphism, -857C/T, and is associated with increased tumor aggressiveness and reduced response to cisplatin therapy.",-44.25,0.01,sequencevariant
"Insertion of (GCG)4GCA at g.3503C>T in the TP53 gene creates the p.R229G variant, which is associated with increased risk of colorectal cancer in a cohort of Homo sapiens patients.",-21.25,0.01,sequencevariant
"Insertion mutation (GCG)4GCA at g.3503C>T in the TP53 gene produces the p.R229G variant, which is associated with increased risk of colorectal cancer in a cohort of Homo sapiens patients.",-31.875,0.01,sequencevariant
"Insertion and substitution variants such as g.3503C>T, p.R229G, and N673S in the TP53 gene have been shown to alter the protein’s DNA‑binding domain, thereby increasing the risk of developing colorectal cancer in patients of the Homo sapiens population.",-44.5,0.01,sequencevariant
Insertion at g.3503C>T in the TP53 gene creates a p.R229G variant that is predicted to destabilize the DNA‑binding domain and is associated with increased susceptibility to Li‑Fraumeni syndrome in a family of Homo sapiens.,-33.25,0.01,sequencevariant
"The CRISPR‑edited A549 cells harboring the V1764M sequence variant exhibit a markedly reduced response to doxorubicin, while the p.Gly160Ser mutation in TP53 enhances apoptosis in the same cell line.",-23.25,0.01,sequencevariant
"The TP53 V1764M sequence variant, a valine (GTG) to methionine (ATG) substitution at codon‑1764, was found to increase the transcriptional activity of the p53 protein in HeLa cells, thereby enhancing apoptosis in response to doxorubicin treatment.",-29.5,0.01,sequencevariant
"The p.Gly160Ser missense variant in the TP53 gene, which changes a glycine codon to serine at position V160, has been shown to impair the protein’s DNA‑binding domain and is associated with an increased risk of Li–Fraumeni syndrome in patients of the Homo sapiens lineage.",-39.75,0.01,sequencevariant
"The A549 cell line harboring the V1764M sequence variant in the EGFR gene shows markedly increased phosphorylation of downstream ERK1/2 upon exposure to the chemical entity erlotinib, suggesting that this codon‑changing mutation enhances drug sensitivity.",-27.375,0.01,sequencevariant
"In the A549 cell line, the V1764M sequence variant in the TP53 gene, caused by a valine (GTG) to methionine (ATG) substitution, was shown to increase resistance to doxorubicin treatment.",-19.25,0.01,sequencevariant
"In MYH7, the V1764M sequence variant, caused by a GTG to ATG substitution, is associated with hypertrophic cardiomyopathy in patients carrying the rs2237892 risk allele.",-22.125,0.01,sequencevariant
"In A549 cells, the V1764M sequence variant in the EGFR gene, caused by a GTG to ATG substitution, enhances ligand‑induced phosphorylation and confers resistance to erlotinib.",-20.375,0.01,sequencevariant
"In patients carrying the V1764M sequence variant, the valine (GTG) to methionine (ATG) substitution at codon‑1764 of the ATP1A1 gene was associated with a markedly increased risk of familial hyperaldosteronism.",-32.25,0.01,sequencevariant
"A p.Gly160Ser substitution in the ATP1A1 gene, encoded by the c.480G>A variant, was found to increase the risk of hypertension in a cohort of Homo sapiens subjects carrying the rs2237892 allele.",-31.0,0.01,sequencevariant
"A SNP in the ATP1A1 gene, c.1764G>A (V1764M), was found to increase the risk of hypertension in a cohort of Homo sapiens subjects, while a separate c.592C>T (p.Gly160Ser) variant in the same gene was associated with a milder phenotype.",-39.75,0.01,sequencevariant
"A pathogenic V1764M sequence variant in the ATP7B gene, resulting from a valine (GTG) to methionine (ATG) substitution, was identified in a patient with Wilson disease and was shown to disrupt copper transport.",-22.0,0.01,sequencevariant
"A single nucleotide polymorphism, c.592C>T, in the coding region of the GATA3 gene, results in a p.Gly160Ser substitution that has been associated with increased susceptibility to systemic lupus erythematosus in European populations.",-30.75,0.01,sequencevariant
"Sequencing of the patient’s MYH7 gene revealed a pathogenic V1764M sequence variant (c.5309G>A) that replaces valine (GTG) with methionine (ATG) at codon‑1764, a change associated with hypertrophic cardiomyopathy.",-35.5,0.01,sequencevariant
"Sequenced tumor DNA revealed a V1764M substitution in the KRAS gene, a c.592C>T transition in TP53, and a novel c.2172_2173insCCCC insertion that together correlate with aggressive colorectal carcinoma.",-40.25,0.01,sequencevariant
"Sequenching of the V1764M variant in the ATP7B gene, a c.592C>T substitution that converts a valine (GTG) to a methionine (ATG) at codon V1764, was associated with a markedly increased risk of Wilson disease in a cohort of Homo sapiens patients.",-59.0,0.01,sequencevariant
"Sequence variant V1764M, a valine (GTG) to methionine (ATG) substitution at codon‑435, was found to increase the risk of Parkinson’s disease in a cohort of Homo sapiens patients carrying the rs2237892 allele.",-41.75,0.01,sequencevariant
"Allelic analysis of the MYH7 gene in hypertrophic cardiomyopathy patients revealed that the V1764M sequence variant, a valine (GTG) to methionine (ATG) substitution at codon‑1764, co‑occurs with the c.592C>T mutation and a pathogenic Arg389Gly change, suggesting a compound heterozygous effect on sarcomere function.",-49.75,0.01,sequencevariant
"Allele‑specific expression of the V1764M variant in the ATP1A1 gene, a c.5309G>A substitution that changes valine (GTG) to methionine (ATG), was found to correlate with increased blood pressure in patients carrying the rs2237892 risk allele.",-38.75,0.01,sequencevariant
"Alleles carrying the V1764M sequence variant in the ATP1A1 gene, such as the c.5306G>A substitution that changes valine (GTG) to methionine (ATG), have been shown to increase the risk of familial hyperaldosteronism type I.",-38.75,0.01,sequencevariant
"Alleys of the BRCA1 gene harbor a V1764M sequence variant that replaces valine (GTG) with methionine (ATG) at codon‑1764, thereby disrupting the protein’s DNA‑binding domain and increasing susceptibility to breast cancer.",-46.0,0.01,sequencevariant
"Mutation of the V1764M sequence variant in the ATP1A1 gene, which changes valine (GTG) to methionine (ATG) at codon‑1764, is associated with a severe form of familial hypokalemic periodic paralysis in Homo sapiens.",-33.0,0.01,sequencevariant
"Mutation V1764M in the ATP1A3 gene, a valine (GTG) to methionine (ATG) substitution at codon‑1764, is associated with episodic ataxia type‑2 and is frequently found in patients carrying the CAG repeat expansion in the same locus.",-41.5,0.01,sequencevariant
"Mutation c.1764G>A (V1764M) in the ATP1A1 gene, which changes valine (GTG) to methionine (ATG) at codon‑1764, is associated with familial hypokalemic periodic paralysis in a patient carrying the Arg389Gly polymorphism in the β1‑adrenergic receptor gene.",-39.75,0.01,sequencevariant
"Mutation‑induced V1764M in the ATP1A1 gene, a valine (GTG) to methionine (ATG) substitution, is associated with familial hyperaldosteronism type I and is predicted to disrupt the protein’s transmembrane domain.",-39.5,0.01,sequencevariant
"Co‑expression of the V1764M sequence variant in the TP53 gene, which replaces valine (GTG) with methionine (ATG) at codon‑1764, markedly increases the protein’s affinity for the MDM2 promoter and enhances apoptosis in A549 cells treated with doxorubicin.",-42.0,0.01,sequencevariant
"Co-expression of the V1764M sequence variant in the TP53 gene within HeLa cells leads to a pronounced reduction in p53-mediated transcriptional activation of the CDKN1A promoter, thereby enhancing cellular proliferation.",-34.5,0.01,sequencevariant
"Co‐expression of the V1764M sequence variant in the TP53 gene, which replaces valine (GTG) with methionine (ATG) at codon‑1764, markedly increases the protein’s affinity for the MDM2 promoter and enhances apoptosis in HeLa cells.",-46.5,0.01,sequencevariant
"Co-reexpression of the V1764M variant in the TP53 gene within A549 cells markedly increases the transcription of the downstream p.Gly160Ser allele, thereby amplifying the apoptotic response to doxorubicin.",-45.25,0.01,sequencevariant
"Sequence variants such as V1764M, p.Gly160Ser, and the c.592C>T substitution in the coding region of the gene encoding the β1‑adrenergic receptor (Arg389Gly) have been shown to alter receptor signaling and are associated with differential responses to β‑blocker therapy in patients with hypertension.",-37.0,0.01,sequencevariant
"Sequence‑variant analysis revealed that the V1764M mutation, a valine (GTG) to methionine (ATG) substitution at codon‑1764, is associated with increased risk of cardiomyopathy in patients carrying the rs2237892 allele.",-34.75,0.01,sequencevariant
"Sequence analysis of a colorectal carcinoma sample revealed a novel BRCA1 c.2172_2173insCCCC variant that co‑occurs with a V1764M substitution in the same allele, suggesting a compound heterozygous effect on DNA repair capacity.",-29.0,0.01,sequencevariant
"Sequencevariant V1764M, a valine (GTG) to methionine (ATG) substitution at codon‑1764, was identified in the ATP1A1 gene of a patient with familial hypokalemic periodic paralysis, and its pathogenicity was confirmed by functional assays showing impaired Na⁺/K⁺‑ATPase activity.",-42.0,0.01,sequencevariant
"Loss-of-function of the V1764M variant in the ATP1A2 gene, which replaces valine (GTG) with methionine (ATG) at codon‑1764, is associated with familial hemiplegic migraine and is predicted to disrupt the Na⁺/K⁺‑ATPase α2 subunit’s ion‑transport activity.",-45.5,0.01,sequencevariant
"Loss of the V1764M sequence variant in the ATP1A1 gene, which changes valine (GTG) to methionine (ATG) at codon‑1764, was associated with a marked increase in blood pressure in patients carrying the Arg389Gly polymorphism of the β1‑adrenergic receptor.",-37.25,0.01,sequencevariant
Loss‐of‐function of the CFTR gene caused by the V1764M sequence variant (c.5300G>A) leads to a severe reduction in chloride transport in airway epithelial cells of patients with cystic fibrosis.,-38.0,0.01,sequencevariant
Loss‑of‑function of the CFTR gene caused by the V1764M sequence variant (c.5291T>G) leads to a severe reduction in chloride transport in the airway epithelium of patients with cystic fibrosis.,-34.0,0.01,sequencevariant
"Mutations such as V1764M, p.Gly160Ser, and the c.592C>T substitution in the coding region of the gene have been shown to alter protein stability and are associated with increased disease risk.",-28.625,0.01,sequencevariant
"Mutational analysis of the β‑globin gene in a cohort of sickle cell patients revealed that the V1764M variant (c.592C>T) co‑occurs with the p.Gly160Ser substitution, while a separate subset displayed a novel insertion (2172_2173insCCCC) that alters the reading frame downstream of codon‑435 (Thr) and is predicted to disrupt hemoglobin stability.",-59.0,0.01,sequencevariant
"Mutagenesis of the KCNJ11 gene in a pancreatic β‑cell line revealed that the V1764M sequence variant, caused by a GTG to ATG codon change, reduces insulin secretion by altering the channel’s gating properties.",-34.5,0.01,sequencevariant
"Mutating the V1764M sequence variant in the ATP7B gene, where valine (GTG) is replaced by methionine (ATG), leads to a loss of copper transport activity and precipitates Wilson disease in affected Homo sapiens patients.",-31.5,0.01,sequencevariant
"Patients carrying the V1764M sequence variant in the ATP1A1 gene exhibit markedly reduced Na⁺/K⁺‑ATPase activity, leading to hyperexcitability of cortical neurons and an increased risk of familial hemiplegic migraine.",-26.375,0.01,sequencevariant
"Patients with the V1764M sequence variant in the ATP1A3 gene exhibit a markedly increased risk of episodic ataxia, while the p.Gly160Ser mutation in the SCN1A gene is associated with a milder form of Dravet syndrome.",-28.25,0.01,sequencevariant
"Patients harboring the V1764M sequence variant in the ATP1A3 gene exhibit a markedly increased risk of episodic ataxia, whereas the p.Gly160Ser mutation in the SCN1A gene is associated with a milder form of Dravet syndrome.",-28.125,0.01,sequencevariant
"Patients treated with the EGFR inhibitor gefitinib exhibited a marked reduction in tumor growth only when their tumors carried the V1764M sequence variant, whereas tumors harboring the p.Gly160Ser variant remained resistant.",-30.875,0.01,sequencevariant
"Homozygous V1764M in the ATP7B gene, a c.5306G>A substitution that changes valine (GTG) to methionine (ATG), is associated with a severe form of Wilson disease in a patient carrying the CAG repeat expansion in the HTT gene.",-33.25,0.01,sequencevariant
"Heterozygous carriers of the V1764M sequence variant in the ATP1A1 gene exhibit a markedly reduced sodium‑potassium pump activity, leading to increased intracellular sodium and a higher risk of hypertension in Homo sapiens.",-35.0,0.01,sequencevariant
"HepG2 cells harboring the V1764M sequence variant in the CYP2D6 gene exhibit markedly reduced metabolism of the chemotherapeutic agent doxorubicin, a phenotype that is further exacerbated by the concurrent p.Gly160Ser mutation in the same locus.",-33.75,0.01,sequencevariant
Hematopoietic stem cells carrying the V1764M sequence variant in the TP53 gene exhibit increased apoptosis and a higher frequency of chromosomal aberrations compared to cells with the wild‑type allele.,-33.75,0.01,sequencevariant
"c.M1764T (p.V1764M) in the ATP1A1 gene, a missense variant that replaces valine (GTG) with methionine (ATG) at codon V1764, has been shown to increase the risk of familial hypokalemic periodic paralysis in patients of European ancestry.",-49.5,0.01,sequencevariant
"c.A2172_2173insCCCC in the TP53 gene creates a novel splice donor site that is predicted to truncate the DNA‑binding domain, thereby impairing p53’s transcriptional activation of the CDKN1A promoter in HeLa cells.",-39.25,0.01,sequencevariant
"cDNA sequencing of the patient’s MYH7 revealed a pathogenic V1764M sequence variant (c.5309G>A) that replaces valine (GTG) with methionine (ATG) at codon‑1764, and a second intronic insertion (2172_2173insCCCC) that disrupts normal splicing, together causing hypertrophic cardiomyopathy.",-52.0,0.01,sequencevariant
"c‑DNA sequencing of the patient’s LRRK2 gene revealed a V1764M sequence variant, a p.Gly160Ser missense mutation, and a novel c.2172_2173insCCCC insertion that together correlate with early‑onset Parkinson’s disease.",-41.25,0.01,sequencevariant
"CRISPR‑mediated editing of the TP53 gene in HCT116 cells introduced a V1764M sequence variant, which was confirmed by Sanger sequencing to involve a valine (GTG) to methionine (ATG) substitution at codon‑1764.",-32.25,0.01,sequencevariant
"CRISP‑Cas9 editing of the TP53 gene in A549 cells introduced a V1764M sequence variant, which was subsequently shown to reduce p53‑mediated apoptosis in response to doxorubicin.",-32.25,0.01,sequencevariant
CRIM1 c.2172_2173insCCCC in a patient with congenital diaphragmatic hernia increases the risk of pulmonary hypertension by disrupting the extracellular matrix signaling pathway.,-34.0,0.01,sequencevariant
"CRP gene expression is markedly upregulated in A549 cells carrying the c.592C>T sequence variant, which introduces a p.Gly160Ser substitution that enhances NF‑κB binding and promotes inflammatory cytokine production.",-35.75,0.01,sequencevariant
"The c.1627A> T sequence variant, which results in the p.Val37Ile amino‑acid change, was found to be associated with a mild, late‑onset form of cystic fibrosis in a cohort of European patients.",-23.75,0.01,sequencevariant
"The BRCA1 c.1627A> T variant, which results in the p.Val37Ile substitution, has been shown to increase breast cancer risk in women of European ancestry.",-16.0,0.01,sequencevariant
"The S810L sequence variant in the CYP2D6 gene, encoded by c.2448C > T, reduces enzymatic activity and predisposes *Homo sapiens* to poor metabolizer status for the chemotherapeutic agent doxorubicin.",-31.125,0.01,sequencevariant
"The CRISPR‑edited A549 cells harboring the c.1627A>T (p.Val37Ile) variant exhibit a markedly reduced response to doxorubicin, suggesting that this sequence variant confers chemoresistance in this lung carcinoma model.",-22.5,0.01,sequencevariant
"C‑344T, a promoter variant of the CYP2D6 gene, together with the coding mutation c.1627A>T (p.Val37Ile) in the same allele, was found to reduce enzyme activity in a cohort of patients with poor metabolizer phenotypes.",-34.75,0.01,sequencevariant
Cytotoxicity assays revealed that the A549 cell line harboring the BRCA1 c.1627A>T (p.Val37Ile) variant exhibited markedly reduced sensitivity to doxorubicin compared with the wild‑type counterpart.,-23.375,0.01,sequencevariant
"Cys-to-Arg substitution at c.1627A> T in the CFTR gene, resulting in the p.Val37Ile variant, is associated with a milder form of cystic fibrosis in patients carrying the -521C/T promoter polymorphism.",-33.25,0.01,sequencevariant
"C-344T and c.1627A>T variants in the CYP2D6 gene, which encode the p.Val37Ile and S810L protein changes, respectively, are associated with reduced metabolism of the antipsychotic drug haloperidol in patients with schizophrenia.",-32.5,0.01,sequencevariant
"In patients carrying the BRCA1 c.1627A>T sequence variant, the resulting p.Val37Ile protein alteration is associated with a markedly increased risk of early‑onset breast cancer.",-13.625,0.01,sequencevariant
"In A549 cells harboring the BRCA1 c.1627A> T sequence variant, the p.Val37Ile substitution in the protein product was shown to impair DNA repair and increase sensitivity to the chemotherapeutic agent doxorubicin.",-23.375,0.01,sequencevariant
"In the A549 cell line, the c.1627A>T sequence variant, which results in the p.Val37Ile amino‑acid change, was found to increase the expression of the CYP1A1 gene and thereby enhance the cytotoxic effect of the chemical entity doxorubicin on the cells.",-32.0,0.01,sequencevariant
"In breast cancer cell line MCF‑7, the BRCA1 sequence variant c.1627A> T (p.Val37Ile) was shown to impair homologous recombination and sensitize cells to the PARP inhibitor olaparib.",-23.0,0.01,sequencevariant
Clinical evaluation of a patient with a c.1627A>T variant in the GJB2 gene revealed a p.Val37Ile substitution that was associated with mild hearing loss and a C‑344T promoter polymorphism that further reduced connexin‑30 expression.,-37.5,0.01,sequencevariant
"Clinical sequencing of a patient with hereditary thrombophilia revealed a novel sequence variant, c.824T>C, resulting in the amino‑acid substitution p.Leu103Val in the factor V gene, which is predicted to disrupt the protein’s interaction with factor VIII and thereby increase the risk of venous thromboembolism.",-33.25,0.01,sequencevariant
"Clinical analyses revealed that the c.1627A>T sequence variant, which results in the p.Val37Ile amino‑acid substitution, is associated with a markedly increased risk of early‑onset Parkinson’s disease in patients of European ancestry.",-30.125,0.01,sequencevariant
"Clinical testing of the c.1627A>T variant, which results in the p.Val37Ile substitution, revealed that carriers exhibit a markedly reduced response to the chemotherapeutic agent doxorubicin in HeLa cells.",-32.0,0.01,sequencevariant
"A missense variant c.1627A>T in the CFTR gene, predicted to produce the p.Val37Ile protein change, was found to correlate with a milder cystic fibrosis phenotype in a cohort of Homo sapiens patients.",-22.25,0.01,sequencevariant
"A pathogenic sequence variant, c.1627A>T, resulting in the p.Val37Ile substitution, was identified in a patient with a severe form of autosomal recessive hearing loss, and functional assays revealed that this missense mutation disrupts the protein’s calcium-binding domain, thereby impairing inner ear hair cell viability.",-38.75,0.01,sequencevariant
"A c.1627A>T sequence variant in the BRCA1 gene, resulting in the p.Val37Ile protein change, was found to increase breast cancer risk in a cohort of Homo sapiens patients.",-21.875,0.01,sequencevariant
"A CRISPR‑mediated introduction of the c.1627A>T variant, which results in the p.Val37Ile substitution, into the A549 cell line markedly increased resistance to doxorubicin, suggesting that this sequence variant modulates drug response in lung carcinoma cells.",-28.25,0.01,sequencevariant
"Mutational analysis of the BRCA1 gene in a cohort of breast cancer patients revealed that the c.1627A>T variant, which results in the p.Val37Ile substitution, was significantly associated with an increased risk of early-onset disease.",-23.375,0.01,sequencevariant
"Mutations such as c.1627A>T and the resulting p.Val37Ile variant in the CFTR gene have been shown to disrupt chloride channel function, thereby contributing to the pathogenesis of cystic fibrosis in patients carrying the Leu103Val polymorphism.",-23.75,0.01,sequencevariant
"Mutagenesis of the BRCA1 gene in HeLa cells revealed that the c.1627A>T sequence variant, which results in the p.Val37Ile amino‑acid substitution, significantly increases the cells’ sensitivity to the DNA‑damaging agent doxorubicin.",-26.5,0.01,sequencevariant
"Mutant A549 cells harboring the BRCA1 c.1627A>T sequence variant, which results in the p.Val37Ile protein change, exhibit markedly increased sensitivity to the DNA‑damaging agent doxorubicin compared with wild‑type cells.",-24.375,0.01,sequencevariant
"Mutation of the BRCA1 gene harboring the sequence variant c.1627A>T, which results in the amino‑acid substitution p.Val37Ile, was shown to increase breast cancer risk in a cohort of Homo sapiens patients.",-22.875,0.01,sequencevariant
"Mutation c.1627A>T in the CFTR gene, which results in the p.Val37Ile variant, is associated with a milder form of cystic fibrosis in patients carrying the -521C/T promoter polymorphism.",-19.125,0.01,sequencevariant
"Mutation analysis of a colorectal carcinoma sample revealed a BRCA1 c.1627A>T sequence variant that results in the p.Val37Ile amino‑acid substitution, which is predicted to disrupt the protein’s DNA‑binding domain and may contribute to the tumor’s aggressive phenotype.",-27.125,0.01,sequencevariant
"Mutation **c.1627A>T** in the *CFTR* gene, which results in the amino‑acid substitution **p.Val37Ile**, has been shown to increase susceptibility to cystic fibrosis in individuals of European descent.",-27.25,0.01,sequencevariant
"Studies showed that the c.1627A>T sequence variant, which results in the p.Val37Ile amino‑acid change, is associated with a higher risk of developing Parkinson’s disease in individuals of European ancestry.",-26.875,0.01,sequencevariant
"Studies of the BRCA1 c.1627A> T variant, which results in the p.Val37Ile protein change, revealed that carriers exhibit a higher risk of early‑onset breast cancer compared with individuals lacking this sequence variant.",-28.625,0.01,sequencevariant
"Studies have shown that the c.1627A>T sequence variant, which results in the p.Val37Ile amino‑acid change, is associated with a higher risk of hearing loss in patients carrying the S810L mutation in the GJB2 gene.",-28.0,0.01,sequencevariant
"Studies in A549 cells revealed that the c.1627A>T sequence variant, which results in the p.Val37Ile amino‑acid change, markedly increases the expression of the CYP1A1 gene and enhances the cytotoxic response to the chemotherapeutic agent doxorubicin.",-30.875,0.01,sequencevariant
"Patients harboring the BRCA1 c.1627A> T sequence variant, which results in the p.Val37Ile protein change, exhibit a markedly increased risk of early‑onset breast cancer compared with carriers of the wild‑type allele.",-17.625,0.01,sequencevariant
"Patients carrying the BRCA1 c.1627A> T sequence variant, which results in the p.Val37Ile protein change, exhibit a markedly increased risk of early‑onset breast cancer.",-15.5,0.01,sequencevariant
"Patients with the BRCA1 c.1627A> T sequence variant, which results in the p.Val37Ile protein change, exhibit a markedly increased risk of early‑onset breast cancer compared with carriers of the wild‑type allele.",-18.5,0.01,sequencevariant
"Patients exhibiting the c.1627A> T sequence variant, which results in the p.Val37Ile substitution, displayed a markedly increased risk of developing early-onset Parkinson’s disease compared with individuals lacking this mutation.",-32.0,0.01,sequencevariant
"Sequence‑variant c.1627A> T in the TP53 gene, which results in the p.Val37Ile substitution, was found to increase the risk of early‑onset colorectal cancer in a cohort of Homo sapiens patients.",-30.625,0.01,sequencevariant
"Sequence variant c.1627A>T, which results in the p.Val37Ile substitution, was found to be associated with a higher risk of developing Parkinson’s disease in a cohort of Homo sapiens patients.",-27.125,0.01,sequencevariant
"Sequence analyses of a colorectal carcinoma cell line revealed that the TP53 gene harbors a c.1627A>T variant, resulting in the p.Val37Ile substitution, which is predicted to destabilize the DNA‑binding domain and may contribute to the observed chemoresistance.",-35.25,0.01,sequencevariant
"Sequence analysis of a colorectal carcinoma sample revealed a BRCA1 c.1627A>T variant that results in the p.Val37Ile protein change, which is predicted to disrupt the DNA‑binding domain and may contribute to the tumor’s aggressive phenotype.",-29.0,0.01,sequencevariant
"Recent allele‑specific PCR revealed that the c.1627A> T variant, which results in the p.Val37Ile substitution, is present in a subset of patients with the C‑344 T promoter polymorphism and is associated with reduced expression of the corresponding gene product.",-42.5,0.01,sequencevariant
"Recent genome‑wide association studies revealed that the BRCA1 sequence variant c.1627A>T, which results in the p.Val37Ile substitution, is significantly enriched in breast‑cancer patients of European ancestry, suggesting a functional impact on DNA‑repair pathways.",-30.75,0.01,sequencevariant
"Recent sequencing of the BRCA1 gene in a cohort of breast cancer patients revealed a novel c.1627A>T variant that results in the p.Val37Ile substitution, which is predicted to disrupt the protein’s DNA‑binding domain and may contribute to increased tumor aggressiveness.",-34.75,0.01,sequencevariant
"Recent exome sequencing of a patient with inherited thrombophilia revealed a novel sequence variant, c.824T>C, resulting in the amino‑acid substitution p.Leu103Val in the factor V gene, which is predicted to disrupt the protein’s interaction with factor VIII and thereby increase the risk of venous thromboembolism.",-32.25,0.01,sequencevariant
"Genetic analysis of a patient with hereditary thrombophilia revealed a novel sequence variant, c.824T>C, resulting in the amino‑acid substitution p.Val37Ile, which is predicted to disrupt the factor V protein’s interaction with the prothrombinase complex.",-32.75,0.01,sequencevariant
"Genotype‑specific analysis revealed that the c.1627A>T variant, which results in the p.Val37Ile substitution, is strongly associated with increased susceptibility to early‑onset Parkinson’s disease in a cohort of Homo sapiens patients.",-32.5,0.01,sequencevariant
"Genomic analysis of a colorectal carcinoma sample revealed a BRCA1 c.1627A>T sequence variant that results in the p.Val37Ile amino‑acid substitution, which is predicted to disrupt the protein’s DNA‑binding domain and may contribute to the tumor’s aggressive phenotype.",-27.5,0.01,sequencevariant
"Genetically engineered A549 cells harboring the c.1627A>T variant, which results in the p.Val37Ile substitution, exhibit markedly increased resistance to doxorubicin compared with wild‑type cells.",-25.375,0.01,sequencevariant
"Transgenic A549 cells harboring the BRCA1 c.1627A>T variant, which results in the p.Val37Ile protein change, exhibit markedly increased sensitivity to the DNA‑damaging agent doxorubicin compared with wild‑type cells.",-22.625,0.01,sequencevariant
"Transcriptional profiling of A549 cells harboring the BRCA1 c.1627A>T variant, which results in the p.Val37Ile protein change, revealed up‑regulation of DNA‑damage‑response genes and increased sensitivity to the PARP inhibitor olaparib.",-28.5,0.01,sequencevariant
"Transfection of HeLa cells with a plasmid encoding the BRCA1 c.1627A> T variant (p.Val37Ile) markedly increased RAD51 foci formation compared to cells transfected with wild‑type BRCA1, indicating enhanced homologous recombination activity.",-30.0,0.01,sequencevariant
"Transplanted A549 cells harboring the BRCA1 c.1627A>T variant (p.Val37Ile) exhibited markedly increased resistance to doxorubicin, whereas the same cells with the c.444‑62C>A promoter mutation (−521C/T) showed enhanced apoptosis upon cisplatin exposure.",-41.0,0.01,sequencevariant
"Homozygous c.1627A>T (p.Val37Ile) in the CFTR gene was found to cause a severe form of cystic fibrosis in a patient of Homo sapiens, while the same variant was absent in the patient's brother who carried the -521C/T promoter polymorphism.",-34.75,0.01,sequencevariant
"Heterozygous carriers of the BRCA1 c.1627A>T variant, which results in the p.Val37Ile protein change, exhibit a markedly increased risk of breast cancer compared with noncarriers.",-21.75,0.01,sequencevariant
"Hepatocellular carcinoma cells harboring the BRCA1 c.1627A>T variant, which results in the p.Val37Ile protein change, exhibit markedly increased sensitivity to the DNA‑damaging agent doxorubicin compared with cells lacking this sequence variant.",-27.75,0.01,sequencevariant
"Haplotype analysis of the BRCA1 locus revealed that the c.1627A>T variant, which results in the p.Val37Ile substitution, is in strong linkage disequilibrium with the intronic c.444‑62C>A polymorphism and the promoter -521C/T allele, collectively conferring a higher risk of breast cancer in the studied population.",-41.75,0.01,sequencevariant
"The rs4912138 polymorphism, which results in the E359K amino‑acid substitution, has been shown to alter the binding affinity of the transcription factor SP1 to the promoter of the CYP2D6 gene, thereby modulating the metabolic clearance of the antipsychotic drug clozapine in patients with schizophrenia.",-27.25,0.01,sequencevariant
"The p. Pro184ArgfsX19 sequence variant in the CYP2D6 gene, identified by rs4912138, causes a truncated protein that reduces metabolism of the antidepressant fluoxetine in patients of European ancestry.",-25.125,0.01,sequencevariant
"The missense variant rs4912138 (c.1076G>A) in the CYP2D6 gene, which results in the E359K substitution, has been shown to reduce enzymatic activity and alter the pharmacokinetics of the antipsychotic drug clozapine in patients with schizophrenia.",-27.125,0.01,sequencevariant
"The c.357C>T variant (rs7802) in the CYP2D6 gene, which results in the E359K amino‑acid substitution, has been shown to alter the metabolism of the antipsychotic drug risperidone in patients carrying the rs4912138 allele.",-22.875,0.01,sequencevariant
"In patients carrying the rs4912138 variant, the E359K substitution in the CYP2D6 gene leads to a p.Pro184ArgfsX19 frameshift that reduces enzymatic activity, thereby increasing the risk of adverse reactions to the chemotherapeutic agent doxorubicin.",-23.875,0.01,sequencevariant
"In HepG2 cells, the rs4912138 variant in the CYP2D6 promoter increases transcriptional activity, while the E359K missense mutation in the same gene reduces enzymatic activity, thereby altering the metabolism of the chemotherapeutic agent doxorubicin.",-27.125,0.01,sequencevariant
"In CRISPR‑edited A549 cells, the engineered sequence variant rs4912138‑derived E359K mutation in the KRAS gene was shown to increase GTP‑binding affinity, thereby enhancing downstream MAPK signaling and conferring resistance to the EGFR inhibitor gefitinib.",-28.5,0.01,sequencevariant
"In a cohort of patients with type‑2 diabetes, the rs4912138 SNP in the GCKR gene was found to be in linkage disequilibrium with the E359K missense variant, and carriers of the rs6275 allele exhibited a higher frequency of the p.Pro184ArgfsX19 frameshift mutation, suggesting that these sequence variants may jointly influence glycemic control.",-39.25,0.01,sequencevariant
"A single nucleotide polymorphism rs4912138 in the CYP2D6 gene, which results in the E359K amino‑acid substitution, has been shown to alter the metabolism of the antipsychotic drug clozapine in patients with schizophrenia.",-21.25,0.01,sequencevariant
"A missense variant rs4912138 in the CYP2D6 gene, resulting in the E359K substitution, has been shown to alter the metabolism of the antipsychotic drug clozapine in patients with schizophrenia.",-22.0,0.01,sequencevariant
"A genome‑wide association study revealed that the rs4912138 variant, a c.357C>T substitution causing the E359K amino‑acid change, is significantly associated with increased risk of type‑2 diabetes in individuals carrying the p.Pro184ArgfsX19 sequence variant.",-28.625,0.01,sequencevariant
"A CRISPR‑edited A549 cell line harboring the BRCA1 c.357C>T (p.Pro184ArgfsX19) variant shows markedly reduced RAD51 foci formation and increased sensitivity to the PARP inhibitor olaparib, confirming the pathogenic role of this sequence variant.",-25.875,0.01,sequencevariant
"Loss of the E359K variant in the CYP2D6 gene (rs4912138) reduces the metabolic conversion of codeine to morphine, thereby attenuating analgesic efficacy in patients carrying the p. Pro184ArgfsX19 sequence variant.",-27.75,0.01,sequencevariant
"Loss‑of‑function of the E359K variant in the CYP2D6 gene (rs4912138) reduces the metabolism of the antipsychotic drug haloperidol, thereby increasing its plasma concentration and the risk of extrapyramidal side effects in patients with schizophrenia.",-33.5,0.01,sequencevariant
"Loss-of-function mutations such as the c.357C>T variant (rs6275) in the CYP2D6 gene, which converts glycine to arginine at position E359K, have been shown to reduce the metabolic clearance of the antipsychotic drug olanzapine in patients carrying the rs4912138 allele.",-40.75,0.01,sequencevariant
"Loss‐of‐function of the E359K variant in the CYP2D6 gene (rs4912138) reduces the metabolism of the antipsychotic drug olanzapine, thereby increasing its plasma concentration and the risk of extrapyramidal side effects in patients with the rs6275 polymorphism.",-39.5,0.01,sequencevariant
Altered expression of the insulin receptor in HeLa cells carrying the sequence variant rs4912138 (c.357C>T) leads to reduced glucose uptake and increased insulin resistance.,-26.875,0.01,sequencevariant
"Alterations in the BRCA1 sequence variant rs4912138, specifically the c.357C>T substitution, have been shown to disrupt the normal splicing of exon nine, thereby generating a truncated protein that lacks the critical DNA‑binding domain and predisposes carriers to early‑onset breast cancer.",-43.5,0.01,sequencevariant
"Alteration of the BRCA1 sequence variant rs4912138, which introduces a glycine-to-arginine substitution at codon E359K, has been shown to increase the risk of breast cancer in women carrying the p. Pro184ArgfsX19 truncating mutation.",-32.5,0.01,sequencevariant
"Alterative therapy with the small‑molecule inhibitor doxorubicin was found to reduce tumor growth in A549 cells harboring the BRCA1 c.68_69delAG sequence variant, while the same treatment had no effect on HeLa cells carrying the TP53 rs4912138 polymorphism.",-41.75,0.01,sequencevariant
"Functional studies revealed that the rs4912138 variant, which causes the E359K substitution in the protein, is associated with increased risk of Parkinson’s disease in individuals carrying the p. Pro184ArgfsX19 sequence variant.",-29.625,0.01,sequencevariant
"Functional analysis of the rs4912138 variant, which causes the E359K substitution in the protein, revealed that the resulting p.Pro184ArgfsX19 frameshift disrupts the glycine‑rich loop and abolishes binding to the E3 ubiquitin ligase, thereby impairing the degradation of the mutant protein in Homo sapiens cells.",-43.0,0.01,sequencevariant
"Functional validation of the rs4912138 variant revealed that the E359K substitution in the protein’s catalytic domain disrupts binding to the glycine‑rich loop, thereby reducing enzymatic activity and contributing to the pathogenic phenotype observed in patients carrying the p.Pro184ArgfsX19 frameshift.",-36.75,0.01,sequencevariant
"Functional assays revealed that the rs4912138 variant, which causes a p.Pro184ArgfsX19 frameshift in the CYP2D6 gene, markedly reduces enzymatic activity and is associated with increased risk of drug-induced hepatotoxicity in patients treated with the chemotherapeutic agent doxorubicin.",-35.5,0.01,sequencevariant
"Mutation analysis of the BRCA1 gene in a breast cancer cohort revealed that the rs4912138 variant, which results in the E359K amino‑acid substitution, is significantly associated with increased risk of disease, while the p.Pro184ArgfsX19 frameshift variant, identified in a subset of patients, correlates with a more aggressive tumor phenotype.",-45.25,0.01,sequencevariant
Mutation of the BRCA1 gene (c.357C>T) in a breast cancer patient carrying the rs4912138 allele was found to produce a truncated protein (p.Pro184ArgfsX19) that disrupts DNA repair and increases susceptibility to tumor progression.,-33.75,0.01,sequencevariant
"Mutation p. Pro184ArgfsX19 in the BRCA1 gene, identified by rs4912138, disrupts the DNA repair domain and is associated with a higher risk of breast cancer in individuals carrying the rs6275 variant.",-27.75,0.01,sequencevariant
"Mutation rs4912138 in the CYP2D6 gene, which results in the E359K amino‑acid substitution, has been shown to alter the pharmacokinetics of the antipsychotic drug clozapine in patients with schizophrenia.",-22.75,0.01,sequencevariant
"Homozygous rs4912138 in the CYP2D6 promoter region, which encodes a glycine-to-arginine substitution at position E359K, is associated with reduced metabolism of the antipsychotic drug olanzapine, leading to higher plasma concentrations and increased risk of extrapyramidal side effects in patients with the p.Pro184ArgfsX19 variant.",-40.75,0.01,sequencevariant
"HepG2 cells harboring the rs4912138 variant exhibit increased expression of CYP2D6, while the E359K mutation in CYP2D6 reduces its catalytic activity toward the chemotherapeutic agent doxorubicin.",-31.25,0.01,sequencevariant
"Heterozygous carriers of the rs4912138 variant, which results in the E359K substitution in the CYP2D6 enzyme, exhibit reduced metabolism of the antipsychotic drug haloperidol, thereby increasing the risk of extrapyramidal side effects in patients with schizophrenia.",-27.625,0.01,sequencevariant
"Haplotype analysis of the rs4912138 variant in the CYP2D6 gene revealed that the E359K substitution, which introduces a glycine-to-arginine change, is associated with a reduced metabolic clearance of the antipsychotic drug olanzapine in a cohort of Homo sapiens patients.",-43.5,0.01,sequencevariant
"Individuals carrying the rs4912138 variant exhibit a higher risk of developing type‑2 diabetes, while the E359K mutation in the GCK gene leads to a severe form of hyperinsulinemic hypoglycemia.",-34.5,0.01,sequencevariant
"Individuals with the rs4912138 variant of the CYP2D6 gene exhibit a markedly reduced metabolic clearance of the antipsychotic drug olanzapine, leading to higher plasma concentrations and an increased risk of extrapyramidal side effects.",-29.625,0.01,sequencevariant
"Individuals harboring the rs4912138 variant exhibit a higher risk of developing type‑2 diabetes, while the E359K mutation in the GCK gene leads to impaired glucose‑induced insulin secretion.",-35.25,0.01,sequencevariant
"Individuals using the chemotherapeutic agent doxorubicin exhibited a higher incidence of the BRCA1 c.357C>T sequence variant, which is associated with the rs4912138 polymorphism and the E359K amino‑acid substitution, thereby increasing the risk of therapy‑induced cardiotoxicity.",-48.25,0.01,sequencevariant
"Deletion of the sequence variant rs4912138 in the promoter of the CYP2D6 gene reduces its transcriptional activity, thereby diminishing the metabolic conversion of the chemotherapeutic agent doxorubicin in HepG2 cells.",-23.75,0.01,sequencevariant
"Deletion c.357C>T in the CYP2C9 gene (rs6275) produces the E359K variant, which alters the enzyme’s affinity for warfarin and is associated with the prothrombin time prolongation observed in patients carrying the p.Pro184ArgfsX19 frameshift mutation.",-38.5,0.01,sequencevariant
"Deletion m.3243A>G in the mitochondrial tRNA^Leu(UUR) gene, a sequence variant associated with maternally inherited Leigh syndrome, was found to co‑occur with the nuclear SNP rs4912138 in the POLG promoter, suggesting a synergistic effect on mitochondrial DNA replication fidelity.",-45.5,0.01,sequencevariant
"Deletion p. Pro184ArgfsX19 in the TP53 gene, identified by rs4912138, is associated with increased risk of colorectal cancer in patients carrying the rs6275 variant.",-32.75,0.01,sequencevariant
"Overexpression of the E359K variant in the TP53 gene (rs4912138) was found to increase the susceptibility of HeLa cells to doxorubicin-induced apoptosis, whereas the p.Pro184ArgfsX19 frameshift (c.357C>T, rs6275) in the BRCA1 gene conferred resistance to cisplatin in A549 cells.",-36.5,0.01,sequencevariant
"Over a cohort of colorectal cancer patients, the rs4912138 SNP in the CYP2D6 gene was found to be in linkage disequilibrium with the E359K missense variant, and carriers of the p.Pro184ArgfsX19 frameshift mutation exhibited a markedly reduced response to irinotecan therapy.",-42.75,0.01,sequencevariant
"Over the course of the study, the rs4912138 polymorphism was found to co‑occur with the E359K missense variant, while the p.Pro184ArgfsX19 frameshift mutation was independently associated with increased disease severity in patients carrying the rs6275 allele.",-35.25,0.01,sequencevariant
"Overnight exposure of A549 cells to doxorubicin induced a marked up‑regulation of TP53, and sequencing revealed a novel sequence variant, p.Pro184ArgfsX19, in the TP53 gene that was absent in the parental HeLa line.",-44.5,0.01,sequencevariant
"Epithelial cells harboring the rs4912138 variant exhibit increased expression of the E359K mutant protein, which, through a p. Pro184ArgfsX19 truncation, disrupts the glycine‑to‑arginine substitution at position c.357C > T and ultimately impairs the regulatory function of the rs6275 allele in the downstream signaling pathway.",-49.25,0.01,sequencevariant
"Epidemiologic analysis revealed that the rs4912138 variant, a c.357C>T substitution in the CYP2D6 gene, is associated with a higher risk of adverse reactions to the chemotherapeutic agent doxorubicin in patients with the E359K sequence variant.",-32.5,0.01,sequencevariant
"Ectopic expression of the E359K variant in HeLa cells markedly increases the phosphorylation of TP53 at serine‑15, suggesting that the rs4912138 polymorphism may modulate the DNA‑damage response in this human cell line.",-30.75,0.01,sequencevariant
"E359K, a missense sequence variant in the CYP2D6 gene, has been shown to alter the metabolism of the antipsychotic drug risperidone in patients carrying the rs4912138 allele.",-23.75,0.01,sequencevariant
"Variations such as rs4912138 and the missense mutation E359K in the CYP2D6 gene have been shown to alter the metabolism of the chemotherapeutic agent doxorubicin, thereby influencing treatment efficacy in patients with breast cancer.",-25.375,0.01,sequencevariant
"Variants such as rs4912138 and the missense mutation E359K in the CYP2D6 gene have been shown to alter the metabolism of the antipsychotic drug clozapine, thereby increasing the risk of neutropenia in patients with schizophrenia.",-27.125,0.01,sequencevariant
"Variability in the rs4912138 SNP, which results in the E359K amino‑acid substitution, has been linked to altered expression of the CYP2D6 gene product in HepG2 cells, whereas the p.Pro184ArgfsX19 frameshift variant in the same locus is associated with a loss of enzymatic activity in primary hepatocytes.",-49.25,0.01,sequencevariant
"Variational analysis of the BRCA1 c.357C>T polymorphism (rs4912138) revealed that the resulting p.Pro184ArgfsX19 frameshift, which introduces a glycine-to-arginine substitution at position E359K, is strongly associated with increased breast cancer risk in individuals carrying the rs6275 allele.",-40.0,0.01,sequencevariant
"Glycine at position E359K in the TP53 protein, encoded by the rs4912138 variant, is predicted to destabilize the DNA‑binding domain, thereby increasing the risk of colorectal cancer in carriers of the c.357C>T polymorphism.",-34.5,0.01,sequencevariant
"GABRA2 rs4912138, a sequence variant that substitutes glycine with arginine at position E359K, has been associated with altered benzodiazepine binding and increased risk of alcohol dependence in individuals carrying the p.Pro184ArgfsX19 frameshift mutation.",-39.75,0.01,sequencevariant
"Gastrointestinal symptoms in patients carrying the rs4912138 variant of the CYP2D6 gene were markedly alleviated after a single dose of the chemical entity ondansetron, suggesting a pharmacogenomic interaction between the sequence variant and the drug.",-38.25,0.01,sequencevariant
"Germline sequencing of the BRCA1 locus in a cohort of breast cancer patients revealed that the rs4912138 SNP, located in the promoter region, is in strong linkage disequilibrium with the pathogenic sequence variant p.Pro184ArgfsX19, which introduces a premature stop codon and is predicted to abolish the DNA‑binding domain of the protein.",-45.0,0.01,sequencevariant
"A SNP rs9932581 in the promoter of the PTPN22 gene, which results in a p.G196S substitution, is associated with increased risk of type‑1 diabetes in individuals carrying the disease‑causing c.436_436+1delAG variant.",-36.25,0.01,sequencevariant
"A missense variant, p.G196S, in the PTPN22 gene has been shown to alter the binding affinity of the protein to its downstream signaling partners, thereby increasing susceptibility to autoimmune disease in individuals carrying the rs9932581 allele.",-23.5,0.01,sequencevariant
"A CRISPR‑edited A549 cell line harboring the c.436_436+1delAG splice‑site variant in the TP53 gene shows reduced p53 protein stability and increased sensitivity to doxorubicin, whereas the wild‑type control cells exhibit normal apoptotic responses.",-28.375,0.01,sequencevariant
"A pathogenic sequence variant, c.436_436+1delAG, was identified in the BRCA1 gene of a Homo sapiens patient, and functional assays revealed that this deletion abolishes the normal splicing of exon five, leading to a truncated protein that lacks the BRCA1 C-terminal domain and predisposes the individual to early-onset breast cancer.",-39.75,0.01,sequencevariant
"The p.G196S sequence variant in the PTPN22 gene, which replaces glycine with serine at codon‑196, has been shown to increase the risk of type‑1 diabetes in individuals carrying the rs9932581 allele.",-27.625,0.01,sequencevariant
"The splice‑site mutation c.436_436+1delAG in the BRCA1 gene leads to a truncated protein that fails to recruit the DNA‑repair complex, thereby increasing the risk of breast cancer in carriers of the rs9932581 allele.",-22.875,0.01,sequencevariant
"The c.436_436+1delAG splice‑site mutation in the CFTR gene causes a loss of the first transmembrane domain, leading to a severe form of cystic fibrosis that is exacerbated by the rs9932581 variant in the TGF‑β1 promoter.",-22.0,0.01,sequencevariant
"The CRISPR‑edited A549 cells harboring the c.436_436+1delAG sequence variant exhibit a pronounced reduction in EGFR phosphorylation, correlating with the observed decrease in downstream AKT signaling and impaired cell proliferation.",-26.625,0.01,sequencevariant
"In triple‑negative breast cancer cells, the BRCA1 c.436_436+1delAG sequence variant abolishes the splice donor site, leading to exon skipping and a truncated protein that fails to recruit the RAD51 repair complex, thereby increasing genomic instability and sensitivity to PARP inhibitors.",-27.75,0.01,sequencevariant
"In patients carrying the BRCA1 c.436_436+1delAG variant, the loss of the splice donor site leads to exon skipping that produces a truncated protein lacking the BRCT domain, thereby impairing DNA repair and increasing breast cancer susceptibility.",-21.625,0.01,sequencevariant
"In the A549 cell line, CRISPR‑mediated introduction of the c.436_436+1delAG variant in the TP53 gene resulted in a truncated protein that failed to activate the downstream p.G196S‑dependent apoptotic pathway, thereby conferring resistance to doxorubicin treatment.",-24.625,0.01,sequencevariant
"In A549 cells harboring the c.436_436+1delAG splice‑site variant, the resulting truncated TP53 protein fails to activate the p.G196S‑dependent apoptotic pathway, thereby conferring resistance to doxorubicin.",-19.5,0.01,sequencevariant
Alteration of the BRCA1 sequence variant p.G196S in a breast cancer patient carrying the rs9932581 risk allele was associated with a higher likelihood of developing triple‑negative disease.,-27.875,0.01,sequencevariant
Alterations such as the c.436_436+1delAG splice‑site mutation and the p.G196S missense variant in the PTPN22 gene have been shown to increase the risk of type‑1 diabetes in individuals carrying the rs9932581 allele.,-23.75,0.01,sequencevariant
"Altered insulin signaling in patients carrying the BRCA1 c.436_436+1delAG variant correlates with increased risk of type‑2 diabetes, as evidenced by elevated fasting glucose and HbA1c levels compared with rs9932581 carriers.",-31.25,0.01,sequencevariant
"Alterative therapy with the small‑molecule inhibitor dabrafenib reduced tumor burden in A375 melanoma cells harboring the BRAF V600E mutation, but the same treatment failed to suppress growth in the isogenic A375 line carrying the sequence variant p.G196S, which alters the kinase domain and diminishes drug binding.",-50.25,0.01,sequencevariant
"Chromosome‑wide association analysis revealed that the rs9932581 variant, a c.436_436+1delAG splice‑site mutation, is linked to increased risk of type‑2 diabetes in individuals carrying the p.G196S sequence variant.",-27.75,0.01,sequencevariant
"Chromatin immunoprecipitation revealed that the c.436_436+1delAG splice‑site variant in the BRCA1 gene reduces binding of the transcription factor NF‑κB, thereby attenuating the expression of the DNA‑repair protein RAD51 in HeLa cells.",-29.125,0.01,sequencevariant
"Chromosomal analysis of a patient with early‑onset Parkinson’s disease revealed a novel sequence variant, c.436_436+1delAG, in the LRRK2 gene, which is predicted to abolish the start codon and cause a frameshift leading to a truncated protein that lacks the kinase domain.",-33.0,0.01,sequencevariant
"Chromatographic analysis of a colorectal carcinoma sample revealed a BRCA1 c.436_436+1delAG sequence variant that co‑occurs with a TP53 p.G196S mutation, suggesting a synergistic effect on tumor suppressor inactivation.",-32.0,0.01,sequencevariant
"Ex vivo CRISPR‑edited A549 cells harboring the c.436_436+1delAG splice‑site variant in TP53 exhibit markedly reduced p53‑dependent transcription of the CDKN1A gene, confirming that this sequence variant disrupts the tumor‑suppressive pathway.",-33.5,0.01,sequencevariant
"Excessive activation of the insulin receptor in HepG2 cells harboring the p.G196S sequence variant leads to hyperphosphorylation of IRS‑1 and downstream AKT signaling, thereby exacerbating glucose uptake and lipid synthesis.",-31.75,0.01,sequencevariant
"Exome sequencing of a patient with early‑onset Parkinson’s disease revealed a novel sequence variant, c.436_436+1delAG, in the LRRK2 gene that abolishes the canonical splice donor site and is predicted to generate a truncated protein lacking the kinase domain.",-26.375,0.01,sequencevariant
"Examination of the A549 cell line revealed that the BRCA1 c.436_436+1delAG variant, which replaces a lysine with a glutamine at amino acid position‑223, is associated with increased sensitivity to the chemotherapeutic agent doxorubicin.",-43.25,0.01,sequencevariant
"TGFBR2 c.436_436+1delAG, a splice‑site variant, was found to disrupt receptor dimerization and is associated with a higher risk of thoracic aortic aneurysm in patients carrying the rs9932581 allele.",-32.25,0.01,sequencevariant
"Tissue‑specific expression of the PTPN22 variant rs9932581, which introduces a p.G196S substitution in the protein’s SH2 domain, is associated with increased susceptibility to type‑1 diabetes in individuals carrying the disease‑associated allele.",-44.5,0.01,sequencevariant
"Tyr substitution at position p.G196S in the PTPN22 gene (rs9932581) is associated with increased risk of type‑1 diabetes, while the Ile262fs frameshift in the same locus leads to loss of the catalytic domain and a more severe autoimmune phenotype.",-43.25,0.01,sequencevariant
"Tobacco‑induced lung carcinoma in a patient harboring the BRCA1 c.436_436+1delAG splice‑site variant exhibited markedly increased expression of the mutant TP53 protein, suggesting that this sequence variant may drive oncogenic transformation.",-41.75,0.01,sequencevariant
"CRISPR‑mediated editing of the BRCA1 locus revealed that the c.436_436+1delAG sequence variant abolishes the canonical splice donor, leading to exon skipping and a truncated protein that fails to recruit RAD51, thereby increasing genomic instability in HeLa cells.",-29.5,0.01,sequencevariant
"CRP levels were markedly elevated in patients carrying the BRCA1 c.436_436+1delAG sequence variant, suggesting that this splice‑site mutation may contribute to the inflammatory phenotype observed in breast cancer survivors.",-28.625,0.01,sequencevariant
"CR‑ISPR editing of the TP53 locus in HCT116 cells revealed that the c.436_436+1delAG sequence variant abolishes the canonical splice donor, leading to exon skipping and a truncated protein that fails to activate the p.G196S‑dependent apoptotic pathway.",-39.25,0.01,sequencevariant
"CRITICAL: The BRCA1 c.436_436+1delAG variant, which deletes a guanine and adenine at the splice donor site, is predicted to cause a frameshift leading to a premature stop codon and loss of the DNA‑binding domain, thereby increasing breast cancer risk in carriers.",-47.25,0.01,sequencevariant
"Loss of the p.G196S variant in the PTPN22 gene, which replaces a lysine with glutamine at amino acid position‑223, is associated with a higher risk of type‑1 diabetes in individuals carrying the rs9932581 allele.",-40.25,0.01,sequencevariant
"Loss‑of‑function of the PTPN22 gene caused by the rs9932581 c.436_436+1delAG variant, which replaces the normal lysine at amino acid position‑223 with a glutamine, is associated with increased susceptibility to type‑1 diabetes in Homo sapiens.",-52.0,0.01,sequencevariant
Loss-of-function mutations such as the c.436_436+1delAG splice‑site variant and the p.G196S missense change in the PTPN22 gene have been shown to increase susceptibility to type‑1 diabetes in individuals carrying the rs9932581 risk allele.,-27.75,0.01,sequencevariant
"Loss or gain of function of the PTPN22 gene, such as the rs9932581 variant or the c.436_436+1delAG splice‑site mutation, has been shown to alter T‑cell receptor signaling and predispose individuals to autoimmune diseases like type‑1 diabetes.",-42.75,0.01,sequencevariant
"Sequencing of the BRCA1 locus in a breast‑cancer cohort revealed a novel c.436_436+1delAG splice‑site variant that co‑segregates with a p.G196S missense change, suggesting a compound heterozygous effect on DNA‑repair protein function.",-28.75,0.01,sequencevariant
"Sequenced tumor DNA revealed a BRCA1 c.436_436+1delAG splice‑site variant that co‑occurs with a p.G196S missense mutation, suggesting a compound heterozygous effect on DNA repair deficiency.",-29.875,0.01,sequencevariant
"Sequencer‑derived analysis of a colorectal carcinoma sample revealed a novel BRCA1 sequence variant, c.436_436+1delAG, that abolishes the splice donor site and results in a frameshift leading to a premature stop codon, while a concurrent SNP, rs9932581, in the same allele was associated with increased risk of chemoresistance.",-56.0,0.01,sequencevariant
"Sequenza analysis of a colorectal carcinoma revealed a novel sequence variant, c.436_436+1delAG, that abolishes the splice donor site of exon five in the APC gene, thereby generating a truncated protein lacking the β‑catenin binding domain.",-43.25,0.01,sequencevariant
"Mutations such as p.G196S and the frameshift Ile262fs in the PTPN22 gene have been shown to alter the binding affinity of the protein for its downstream signaling partners, thereby increasing susceptibility to autoimmune diseases in individuals carrying the rs9932581 allele.",-28.125,0.01,sequencevariant
"Mutagenesis of the BRCA1 gene in HeLa cells revealed that the c.436_436+1delAG sequence variant abolishes the splice donor site, leading to exon skipping and a truncated protein that fails to interact with the DNA repair complex.",-29.125,0.01,sequencevariant
"Mutational analysis of the BRCA1 gene in a cohort of breast cancer patients revealed that the c.436_436+1delAG splice‑site variant, together with the p.G196S missense change, was associated with a higher risk of early‑onset disease, while the rs9932581 SNP in the promoter region showed no significant effect on tumor aggressiveness.",-36.25,0.01,sequencevariant
"Mutant A549 cells harboring the BRCA1 c.436_436+1delAG variant exhibit increased sensitivity to doxorubicin, whereas the same cells with the p.G196S sequence variant show reduced apoptosis.",-26.0,0.01,sequencevariant
"TP53 c.436_436+1delAG mutation in a HeLa cell line reduces p53 protein stability, leading to increased cell proliferation and heightened sensitivity to doxorubicin.",-20.75,0.01,sequencevariant
"TPH2 c.436_436+1delAG causes a loss of the splice donor site, leading to exon skipping that results in a truncated protein lacking the catalytic domain and thereby impairing serotonin synthesis in the brain.",-39.0,0.01,sequencevariant
TP73 p.G196S mutation in a HeLa cell line carrying the rs9932581 variant was shown to increase apoptosis in response to doxorubicin treatment.,-34.25,0.01,sequencevariant
"TP-53 c.436_436+1delAG mutation in a colorectal carcinoma cell line derived from a Homo sapiens patient was shown to abolish the binding of the p53‑binding protein, thereby impairing the transcriptional activation of the CDKN1A gene and contributing to the aggressive phenotype observed in the tumor.",-56.0,0.01,sequencevariant
"Detection of the c.436_436+1delAG splice‑site variant in the BRCA1 gene in a breast‑cancer patient revealed a loss of the normal exon‑2 junction, leading to a truncated protein that lacks the critical DNA‑binding domain.",-35.75,0.01,sequencevariant
"Detection and functional analysis of the BRCA1 c.436_436+1delAG variant revealed that the resulting p.G196S protein misfolds, leading to impaired DNA repair and increased susceptibility to breast cancer in carriers of the rs9932581 allele.",-37.25,0.01,sequencevariant
"Detection by next‑generation sequencing revealed that the A549 cells harbor a novel sequence variant, c.436_436+1delAG, which abolishes the splice donor site of exon four in the TP53 gene, thereby generating a truncated protein that lacks the DNA‑binding domain and is predicted to contribute to the observed chemoresistance to doxorubicin.",-50.5,0.01,sequencevariant
"Detection in a cohort of colorectal cancer patients revealed that the c.436_436+1delAG splice‑site variant in APC, together with the p.G196S missense mutation in KRAS, was associated with a significantly higher frequency of microsatellite instability and poorer overall survival.",-41.0,0.01,sequencevariant
"Expression of the BRCA1 c.436_436+1delAG variant in HeLa cells leads to a truncated protein that fails to recruit the DNA repair complex, thereby increasing sensitivity to the chemotherapeutic agent doxorubicin.",-24.25,0.01,sequencevariant
"Expression analysis of the TP53 gene in HeLa cells revealed that the c.436_436+1delAG sequence variant, which deletes the splice donor site and introduces a premature stop codon, dramatically reduces p53 protein levels and increases cellular sensitivity to doxorubicin-induced apoptosis.",-37.5,0.01,sequencevariant
"Expression profiling of A549 cells harboring the BRCA1 c.436_436+1delAG variant revealed a dramatic up‑regulation of the DNA‑damage response gene TP53, suggesting that this splice‑site mutation may sensitize the cells to doxorubicin‑induced apoptosis.",-33.25,0.01,sequencevariant
"Expression array analysis of A549 cells harboring the c.436_436+1delAG variant revealed that the loss of the splice donor site leads to exon skipping, resulting in a truncated TP53 protein that lacks the DNA‑binding domain and consequently fails to activate the p21^CIP1 pathway, thereby promoting uncontrolled proliferation.",-48.75,0.01,sequencevariant
"The missense variant c.310G>T in the TP53 gene, which replaces the glycine at position V244 with a valine, has been shown to destabilize the DNA‑binding domain and is associated with a higher risk of early‑onset colorectal cancer in patients carrying the rs861019 allele.",-32.5,0.01,sequencevariant
"The c.310 G>T mutation in the TP53 gene, which replaces the glycine at position V244 with a valine, is predicted to destabilize the DNA‑binding domain and has been associated with a higher risk of early‑onset colorectal cancer in patients carrying the rs861019 allele.",-32.75,0.01,sequencevariant
"The A549 cell line harboring the c.310 G>T variant in the TP53 gene exhibits a pronounced increase in apoptosis when treated with doxorubicin, suggesting that this sequence variant enhances drug sensitivity.",-23.875,0.01,sequencevariant
"The BRCA1 c.310 G>T variant, which replaces a glycine with a valine at position V244, has been shown to disrupt the DNA‑binding domain and is associated with a higher risk of breast cancer in carriers of the rs861019 allele.",-29.5,0.01,sequencevariant
"In the A549 cell line, the c.310 G>T sequence variant creates an A49T amino‑acid change that disrupts the arginine residue at position V244, impairing the protein’s ability to bind the proline residue at position Ser9 and thereby reducing its interaction with the EGF receptor.",-43.75,0.01,sequencevariant
"In HepG2 cells, the c.310 G>T sequence variant introduces a premature stop codon that truncates the protein at residue V244, thereby abolishing the catalytic activity of the enzyme and leading to a severe metabolic phenotype.",-32.5,0.01,sequencevariant
"In HEK293 cells, the c.310 G>T variant in the TP53 gene, which introduces a p.R198W substitution, was shown to destabilize the protein and increase cellular sensitivity to doxorubicin-induced apoptosis.",-33.5,0.01,sequencevariant
"In induced pluripotent stem cells derived from a patient with the c.310 G>T variant, the AG‑deletion at nucleotides **652‑653** disrupts the binding of transcription factor **p53**, leading to aberrant expression of the **TP53** gene product and contributing to the observed neurodegenerative phenotype.",-50.75,0.01,sequencevariant
"A CRISPR‑edited A549 cell line harboring the c.310G>T variant in the TP53 gene, which introduces a p.R198W substitution, shows markedly reduced p53‑mediated transcription of the CDKN1A promoter and increased resistance to doxorubicin‑induced apoptosis.",-29.875,0.01,sequencevariant
A cytotoxic T‑cell lymphoma cell line derived from a patient with the c.436_436+1delAG splice‑site deletion in the TP53 gene exhibited markedly reduced p53 protein levels and increased resistance to doxorubicin.,-31.0,0.01,sequencevariant
"A single AG‑deletion at nucleotides c.652_653 in the TP53 gene (c.652_653delAG) creates a frameshift that replaces the normal V244 residue with a premature stop codon, thereby abolishing the DNA‑binding domain and predisposing cells to malignant transformation.",-34.25,0.01,sequencevariant
"A patient with a c.310 G>T mutation in the TP53 gene, resulting in a V244A amino‑acid substitution, exhibited a severe loss of DNA‑binding activity that was further exacerbated by an AG‑deletion at nucleotides c.652‑c.653, a variant previously reported as rs861019.",-49.5,0.01,sequencevariant
"AG‑deletion at nucleotide positions c.652_653delAG in the TP53 gene causes a frameshift that replaces the V244 residue with a premature stop codon, thereby abolishing the protein’s DNA‑binding domain and predisposing cells to malignant transformation.",-36.25,0.01,sequencevariant
"AG-deletion at nucleotide positions c.652_653delAG in the TP53 gene causes a frameshift that replaces the V244 residue with a premature stop codon, thereby abolishing the protein’s DNA‑binding domain and predisposing cells to malignant transformation.",-40.5,0.01,sequencevariant
"AG–deletion at nucleotide positions c.652_653delAG in the TP53 gene causes a frameshift that replaces the V244 residue with a premature stop codon, thereby abolishing the protein’s DNA‑binding domain and predisposing Homo sapiens carriers to Li–Fraumeni syndrome.",-41.75,0.01,sequencevariant
"AG deletion at nucleotides c.652_653delAG in the TP53 gene causes a frameshift that replaces the V244 residue with a premature stop codon, thereby abolishing the protein’s DNA‑binding domain and predisposing Homo sapiens carriers to Li–Fraumeni syndrome.",-38.5,0.01,sequencevariant
Homozygous AG‑deletion at nucleotides c.652_653 in the TP53 gene (p.R198W) was found to increase the risk of early‑onset colorectal cancer in a cohort of Homo sapiens patients carrying the rs861019 allele.,-32.0,0.01,sequencevariant
"HepG2 cells harboring the c.310 G>T sequence variant exhibit a pronounced reduction in CYP3A4 expression, while the concomitant p.R198W mutation in the same transcript further diminishes drug‑metabolizing activity.",-36.75,0.01,sequencevariant
"Heterozygous carriers of the c.436_436+1delAG splice‑site deletion in the BRCA1 gene exhibit a markedly reduced homologous recombination repair capacity, predisposing them to early‑onset breast cancer.",-25.5,0.01,sequencevariant
"Hemopexin deficiency in patients carrying the c.436_436+1delAG sequence variant leads to markedly reduced plasma heme‑binding capacity, thereby exacerbating oxidative stress in the liver and accelerating the progression of non‑alcoholic steatohepatitis.",-42.0,0.01,sequencevariant
"Mutations such as the AG‑deletion at nucleotides c.652_653 and the c.310 G>T variant, which alter the arginine residue at position V244, have been shown to disrupt the proline‑rich domain and impair the binding of the protein to its target, thereby contributing to the pathogenesis of the associated disease phenotype.",-47.5,0.01,sequencevariant
"Mutational analysis of the TP53 gene in a cohort of colorectal cancer patients revealed that the c.310G>T variant, which results in the p.R198W amino‑acid substitution, co‑occurs with an AG‑deletion spanning nucleotides c.652‑c.653 and is associated with a higher frequency of the rs861019 allele.",-42.5,0.01,sequencevariant
"Mutant A549 cells harboring the c.310 G>T sequence variant exhibit a pronounced reduction in TP53 protein stability, leading to increased cellular proliferation and heightened sensitivity to doxorubicin.",-30.375,0.01,sequencevariant
"Mutagenesis of the TP53 gene in HeLa cells revealed that the c.310 G>T variant, which causes the p.R198W amino‑acid substitution, abolishes the binding of the p53‑binding protein to the promoter of the BAX gene, thereby impairing apoptosis in response to doxorubicin.",-38.25,0.01,sequencevariant
"Engineered A549 cells harboring the c.310 G>T variant in TP53 exhibit reduced p53 transcriptional activity, leading to increased resistance to doxorubicin-induced apoptosis.",-25.875,0.01,sequencevariant
"Engine‑ered CRISPR‑Cas9 editing of the TP53 gene in HCT116 cells introduced a c.310G>T sequence variant that creates a premature stop codon, thereby abolishing the p.R198W protein product and impairing the cell’s ability to undergo apoptosis in response to doxorubicin.",-48.75,0.01,sequencevariant
"Engineers discovered that the AG‑deletion at nucleotides c.652_653 in the TP53 gene, together with the c.310 G>T variant, destabilizes the protein’s DNA‑binding domain, thereby increasing the risk of colorectal cancer in individuals carrying the rs861019 allele.",-48.75,0.01,sequencevariant
"Engine-derived CRISPR/Cas9 editing of the TP53 gene in HCT116 cells introduced a c.310G>T sequence variant that creates a premature stop codon, thereby abolishing the p.R198W protein product and impairing the cell line’s ability to undergo apoptosis in response to doxorubicin.",-50.75,0.01,sequencevariant
"Acute myeloid leukemia cells harboring the c.310 G>T mutation in the FLT3 gene exhibit a markedly increased phosphorylation of the downstream STAT5 pathway, which is further amplified by the concurrent p.R198W variant in the same allele.",-37.25,0.01,sequencevariant
"Acquiring the c.310 G > T variant in the TP53 gene, which replaces the glycine at position V244 with a valine, has been shown to destabilize the DNA‑binding domain and predispose Homo sapiens cells to a higher risk of developing colorectal cancer.",-49.5,0.01,sequencevariant
"Acquired AG‑deletion at nucleotides c.652_653 in the TP53 gene (c.652_653delAG) disrupts the DNA‑binding domain, causing a loss of function that predisposes to colorectal carcinoma in patients carrying the rs861019 variant.",-43.0,0.01,sequencevariant
"Acquisition of the c.310 G>T mutation in the TP53 gene, which replaces the glycine at position V244 with a valine, was found to destabilize the DNA-binding domain and increase the risk of colorectal carcinoma in a cohort of Homo sapiens patients carrying the rs861019 allele.",-47.25,0.01,sequencevariant
"Carcinogenic exposure to benzo[a]pyrene induces the AG‑deletion at nucleotides c.652_653, which alters the V244 residue of the CYP1A1 protein and is associated with the c.310 G>T polymorphism (rs861019) that increases susceptibility to lung cancer in *Homo sapiens*.",-49.5,0.01,sequencevariant
"Carrying the c.310 G>T variant that deletes the AG dinucleotide at positions c.436_436+1, the A549 cell line exhibits a V244A substitution and a p.R198W mutation, leading to a loss of the arginine residue at position Ser9 and a consequent reduction in the proline-rich domain’s interaction with the EGFR signaling pathway.",-66.5,0.01,sequencevariant
"Carriers of the c.310 G>T variant, which introduces an A49T substitution in the TP53 protein, exhibit a markedly reduced DNA‑binding affinity at the Ser9 phosphorylation site, thereby impairing the transcriptional activation of p53‑dependent apoptotic genes.",-41.0,0.01,sequencevariant
"Carboplatin treatment of A549 cells harboring the c.310 G>T variant in the TP53 gene (p.R198W) induces a pronounced G2/M arrest, whereas the same drug fails to affect HeLa cells carrying the AG‑deletion at nucleotides c.652‑c.653.",-55.75,0.01,sequencevariant
"Mutation of the BRCA1 gene harboring the c.310 G>T substitution and the p.R198W sequence variant was shown to disrupt the DNA‑binding domain, thereby impairing homologous recombination repair in breast cancer cells.",-33.25,0.01,sequencevariant
"Mutation analysis of a colorectal carcinoma cell line revealed a c.310 G>T substitution in the APC gene, generating a p.R198W variant that disrupts the β‑catenin binding domain and is associated with aggressive tumor progression.",-34.0,0.01,sequencevariant
"Mutation c.436_436+1delAG in the TP53 gene, which deletes the splice donor site and the adjacent AG dinucleotide, abolishes the normal splicing of exon‑5 and results in a truncated protein lacking the DNA‑binding domain, thereby impairing p53‑mediated apoptosis in Homo sapiens cells.",-42.25,0.01,sequencevariant
"Mutation p.R198W in the TP53 gene, a c.310 G > T sequence variant, is associated with a higher risk of developing colorectal cancer in patients of the Homo sapiens population.",-28.5,0.01,sequencevariant
"Clinical evaluation of a patient with a c.310 G>T mutation in the BRCA1 gene revealed a V244A substitution that disrupts the Ser9 phosphorylation site, leading to impaired DNA repair and a heightened risk of breast cancer.",-35.0,0.01,sequencevariant
"Clinical exome sequencing of a patient with early‑onset epilepsy revealed a pathogenic sequence variant, c.436_436+1delAG, which deletes the splice donor site and results in exon skipping, thereby abolishing the functional domain that normally binds the regulatory protein p.R198W.",-41.25,0.01,sequencevariant
"Clinical sequencing of a patient with hereditary neuropathy revealed a pathogenic c.436_436+1delAG splice‑site deletion in the MFN2 gene, which co‑occurs with a missense p.R198W variant that disrupts the arginine residue at position V244 and is predicted to destabilize the protein’s Ser9 phosphorylation site.",-51.5,0.01,sequencevariant
"Clinical analysis revealed that the AG‑deletion at nucleotides c.652_653 in the TP53 gene, together with the c.310 G>T variant causing the V244A substitution, is associated with a higher risk of early‑onset colorectal cancer in patients carrying the rs861019 allele.",-42.0,0.01,sequencevariant
"cDNA sequencing of a patient’s tumor revealed a c.310 G > T transition that creates a V244A substitution, while a neighboring AG‑deletion at nucleotides c.652‑c.653 abolishes the arginine residue at position R198, producing a p.R198W variant that is predicted to destabilize the protein’s active site.",-63.25,0.01,sequencevariant
"cTnI levels were markedly elevated in patients carrying the c.310 G>T variant, which introduces a premature stop codon at position V244 and is associated with a severe form of dilated cardiomyopathy in Homo sapiens.",-46.75,0.01,sequencevariant
c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2c2,-23.625,0.01,sequencevariant
"c.-310G>T in the TP53 promoter creates a novel NF‑κB binding site that up‑regulates p53 expression in HeLa cells, while the adjacent AG‑deletion at nucleotides c.652‑653 abolishes the binding of the same transcription factor, leading to reduced TP53 transcription and increased susceptibility to cisplatin‑induced apoptosis.",-56.0,0.01,sequencevariant
"Functional studies revealed that the c.310 G>T (p.Gly104Val) sequence variant in the TP53 gene, together with the AG‑deletion at nucleotides c.652‑653, disrupts the DNA‑binding domain and reduces p53‑mediated transcriptional activation of the BAX promoter in HeLa cells.",-51.0,0.01,sequencevariant
"Functional assays revealed that the c.310 G>T sequence variant, which introduces an A49T substitution at residue V244 and deletes the AG dinucleotide at positions c.436_436+1, disrupts the proline‑arginine interaction at position Ser9, thereby impairing the protein’s ability to bind the p.R198W‑mutated receptor in Homo sapiens cells.",-58.0,0.01,sequencevariant
"Functional analysis of the c.310 G > T sequence variant in the TP53 gene revealed that the resulting p.R198W substitution disrupts the DNA‑binding domain, thereby impairing transcriptional activation of the downstream apoptosis regulator BAX in HeLa cells.",-34.75,0.01,sequencevariant
"Functional characterization of the c.310 G > T sequence variant in the TP53 gene revealed that the resulting p.R198W substitution disrupts the DNA‑binding domain, leading to impaired transcriptional activation of the downstream target gene BAX in HeLa cells.",-35.5,0.01,sequencevariant
"Researchers identified that the c.310 G>T sequence variant in the TP53 gene, which replaces the glycine at position V244 with a valine, is associated with a higher risk of developing colorectal cancer in individuals carrying the rs861019 allele.",-40.25,0.01,sequencevariant
"Researchers observed that the AG‑deletion at nucleotides c.652_653 in the TP53 gene, together with the c.310 G>T variant, destabilizes the protein’s DNA‑binding domain, thereby increasing the risk of colorectal cancer in individuals carrying the rs861019 allele.",-36.25,0.01,sequencevariant
"Researchers discovered that the c.310 G>T sequence variant in the TP53 gene, which replaces the glycine at position V244 with a valine, is associated with a higher risk of developing colorectal cancer in individuals carrying the rs861019 allele.",-39.25,0.01,sequencevariant
"Researchers found that the AG‑deletion at nucleotides c.652_653 in the TP53 gene, together with the c.310 G>T variant, reduces the binding affinity of the p53 protein for the MDM2 promoter, thereby impairing the transcriptional activation of the cell‑cycle arrest gene CDKN1A in HeLa cells.",-44.25,0.01,sequencevariant
"The p.R84Q substitution in the TP53 gene, a sequence variant that replaces arginine with glutamine at codon‑84, has been shown to impair DNA‑binding affinity and is associated with increased susceptibility to Li‑Fraumeni syndrome in Homo sapiens.",-37.5,0.01,sequencevariant
"The T allele at -511 in the IL-10 promoter enhances transcriptional activity, thereby increasing IL‑10 production and attenuating the inflammatory response in patients carrying the rs6277 polymorphism.",-18.5,0.01,sequencevariant
"The c.14_15insC sequence variant in the promoter of the IL-6 gene, together with the -1082 G/A polymorphism, was found to synergistically increase transcriptional activity in A549 cells, thereby enhancing IL‑6 secretion and promoting resistance to doxorubicin.",-25.125,0.01,sequencevariant
"The BRCA1 c.14_15insC sequence variant, which introduces a premature Q536X stop codon, is associated with a higher risk of breast cancer in carriers of the rs11891426 risk allele.",-18.125,0.01,sequencevariant
"In the A549 cell line, the c.14_15insC sequence variant in the promoter of the IL6 gene increases transcriptional activity, thereby enhancing the inflammatory response to doxorubicin treatment.",-21.875,0.01,sequencevariant
"In vitro CRISPR‑mediated editing of the IL6 promoter revealed that the T allele at –511 enhances NF‑κB binding, thereby increasing IL‑6 transcription in A549 cells, whereas the –3170G>A variant in the same region reduces promoter activity, confirming a regulatory effect of these sequence variants on cytokine expression.",-41.0,0.01,sequencevariant
"In HCT116 cells, the c.14_15insC sequence variant in the promoter of the TP53 gene increases transcriptional activity, thereby enhancing the cellular response to doxorubicin-induced DNA damage.",-21.625,0.01,sequencevariant
"In HeLa cells, the c.14_15insC sequence variant in the promoter of the IL6 gene increases transcriptional activity, thereby enhancing IL‑6 secretion and promoting a pro‑inflammatory phenotype that can be attenuated by treatment with the small‑molecule inhibitor tofacitinib.",-28.625,0.01,sequencevariant
"A single nucleotide polymorphism, rs6277, located in the promoter of the IL-6 gene, has been shown to alter transcriptional activity and is associated with increased susceptibility to rheumatoid arthritis in individuals carrying the T allele at -511.",-22.625,0.01,sequencevariant
"A mutation in the IL6 promoter, specifically the -511 T allele, has been shown to increase transcriptional activity and is associated with higher circulating IL‑6 levels in patients carrying the rs6277 polymorphism.",-26.125,0.01,sequencevariant
"A loss‑of‑function mutation in the IL‑6 promoter, specifically the -511 T allele, reduces transcriptional activity and is associated with increased susceptibility to rheumatoid arthritis in individuals carrying the rs6277 polymorphism.",-30.75,0.01,sequencevariant
"A recent study showed that the T allele at -511 in the IL-10 promoter enhances transcriptional activity, thereby increasing IL‑10 production and reducing the risk of Crohn’s disease in patients carrying the rs6277 polymorphism.",-27.875,0.01,sequencevariant
"Mutational analysis of the TNF‑α promoter revealed that the T allele at −511, together with the −1082 G/A polymorphism, synergistically increases transcriptional activity, whereas the del‑(439‑443) deletion in the same region markedly reduces binding of NF‑κB, thereby attenuating cytokine production in macrophages.",-32.75,0.01,sequencevariant
Mutations such as the T allele at -511 and the c.14_15insC insertion/deletion of a long allele‑L/short allele‑S of a single nucleotide polymorphism (rs11891426) in the promoter region of the IL‑6 gene have been shown to alter transcriptional activity and are associated with increased susceptibility to inflammatory bowel disease.,-59.5,0.01,sequencevariant
"Mutagenesis of the promoter revealed that the T allele at –511, together with the –1082 G/A polymorphism, significantly increases IL‑6 transcription, whereas the c.14_15insC insertion in the coding region of the TNFA gene creates a premature stop codon (Q536X) that abolishes cytokine secretion.",-38.25,0.01,sequencevariant
"Mutant A549 cells harboring the c.14_15insC variant in the TP53 gene exhibit increased sensitivity to doxorubicin, whereas the same cells with the Q536X truncation in the KRAS gene show resistance to the drug.",-31.375,0.01,sequencevariant
Patients carrying the rs6277 T allele at the -511 promoter region of the IL-6 gene exhibit a higher risk of developing rheumatoid arthritis due to increased transcriptional activity.,-25.25,0.01,sequencevariant
"Patients with the rs6277 T allele at -511 in the IL-6 promoter exhibited a higher risk of developing rheumatoid arthritis, whereas carriers of the c.14_15insC insertion/deletion of a long allele of the same length (43 bp) in the TNFA gene had a reduced inflammatory response.",-63.25,0.01,sequencevariant
"Patients harboring the rs6277 T allele at the -511 promoter region of the IL-6 gene exhibit a markedly increased risk of developing rheumatoid arthritis, whereas carriers of the c.14_15insC insertion in the TNFAIP3 gene display a protective effect against the same disease.",-36.0,0.01,sequencevariant
"Patients bearing the rs6277 T allele at the -511 promoter region of the IL-6 gene exhibit a markedly increased risk of developing rheumatoid arthritis, whereas carriers of the c.14_15insC insertion in the same locus display a protective effect against the disease.",-38.75,0.01,sequencevariant
"Nutrient‑sensing pathways in HepG2 cells are markedly altered by the rs6277 polymorphism, which introduces a T allele at –511 that enhances NF‑κB binding and up‑regulates IL‑6 expression.",-35.75,0.01,sequencevariant
"NMR spectroscopy of the TP53 protein revealed that the arginine84 to glutamine substitution in the DNA‑binding domain, a sequence variant identified by rs6277, disrupts the protein’s interaction with the MDM2 promoter, thereby attenuating p53‑mediated transcriptional activation of the CDKN1A gene.",-44.5,0.01,sequencevariant
"Nasal polyposis in a patient with the Q536X sequence variant of the IL-4 receptor gene was ameliorated by a single dose of montelukast, suggesting that the premature stop codon disrupts downstream JAK‑STAT signaling.",-40.25,0.01,sequencevariant
"Nucleic acid sequencing of the TNF‑α promoter in patients with rheumatoid arthritis revealed that the T allele at –511, together with the –1082 G/A polymorphism, was significantly associated with increased disease activity, while the del‑(439‑443) deletion in the IL‑6 gene correlated with a higher risk of joint erosions.",-46.75,0.01,sequencevariant
"Genetic analysis of the patient’s tumor revealed a Q536X sequence variant in the TP53 gene, a c.14_15insC insertion in the BRCA1 promoter, and a -1082 (G/A) polymorphism in the IL-6 gene, all of which may contribute to the aggressive phenotype.",-31.0,0.01,sequencevariant
"Genomic analysis of a colorectal carcinoma sample revealed that the T allele at -511 in the IL-10 promoter, together with a del- (439-443) in the same region, was associated with reduced IL‑10 expression and a higher tumor mutational burden.",-37.0,0.01,sequencevariant
"Genotyping of the T allele at -511 in the promoter of the IL-10 gene revealed that carriers of this variant exhibited a significantly higher expression of IL-10 in peripheral blood mononuclear cells compared with individuals homozygous for the C allele, suggesting a regulatory effect of this sequence variant on cytokine production.",-33.25,0.01,sequencevariant
"Genotypic analysis of the IL-6 promoter revealed that the T allele at –511, together with the –1082 G/A polymorphism, significantly increased transcriptional activity in A549 cells, whereas the c.14_15insC variant in the coding region of the same gene produced a truncated protein that failed to bind the NF‑κB complex.",-45.75,0.01,sequencevariant
"Treatment of A549 cells with doxorubicin induces a pronounced up‑regulation of TP53 expression, a response that is markedly attenuated in cells harboring the BRCA1 c.68_69delAG sequence variant.",-25.5,0.01,sequencevariant
"Treatment with the T allele at -511 in the IL-10 promoter markedly increased IL‑10 expression in A549 cells, whereas the del‑(439‑443) variant in the same region reduced transcriptional activity and was associated with higher susceptibility to chronic obstructive pulmonary disease in a cohort of Homo sapiens.",-39.0,0.01,sequencevariant
"Treatment‑induced up‑regulation of the IL‑6 promoter in A549 cells carrying the -511 T allele was confirmed by luciferase assays, while CRISPR‑mediated deletion of the c.14_15insC variant in TP53‑expressing HeLa cells abolished the same transcriptional response.",-49.0,0.01,sequencevariant
"Treatment-induced apoptosis in A549 cells harboring the c.14_15insC variant of the TP53 gene was markedly enhanced by the T allele at -511 of the IL-6 promoter, suggesting a synergistic effect of this sequence variant on chemotherapeutic sensitivity.",-42.5,0.01,sequencevariant
Deletion of nucleotides c.439‑443 in the promoter of the IL‑6 gene (del‑(439‑443)) reduces binding of NF‑κB and is associated with a lower risk of rheumatoid arthritis in individuals carrying the T allele at position –511.,-29.25,0.01,sequencevariant
"Deletion c.439-443del in the promoter of IL6R, together with the -511T allele, synergistically increases IL‑6 signaling and predisposes A549 cells to heightened STAT3 activation in response to doxorubicin‑induced oxidative stress.",-35.25,0.01,sequencevariant
"Deletion at positions c.439‑443 in the promoter of the IL‑6 gene, together with the -511 T allele, synergistically increases transcriptional activity and is associated with heightened inflammatory responses in patients carrying the rs6277 polymorphism.",-37.5,0.01,sequencevariant
"Deletion‑mediated loss of the -511 T allele in the IL‑10 promoter reduces transcriptional activity, thereby increasing susceptibility to inflammatory bowel disease in individuals carrying the rs6277 variant.",-32.0,0.01,sequencevariant
"Mutation of the T allele at -511 in the promoter of the IL-6 gene, together with the c.14_15insC insertion in exon two of the TNF gene, was shown to increase transcriptional activity and serum IL‑6 levels in patients with rheumatoid arthritis.",-36.75,0.01,sequencevariant
"Mutation rs11891426 in the promoter of IL6, a T allele at -511, and a deletion of nucleotides −439‑443 together with the −3170G>A polymorphism synergistically increase IL6 transcription, thereby exacerbating the inflammatory response in patients carrying the arginine84‑to‑glutamine variant of the IL6R gene.",-46.25,0.01,sequencevariant
"Mutation analysis of the TNF‑α promoter revealed that the T allele at −511, together with the −1082 G/A polymorphism, is associated with increased transcriptional activity in A549 cells, whereas the del‑(439‑443) deletion in the same region reduces binding of NF‑κB and attenuates cytokine production.",-36.75,0.01,sequencevariant
"Mutation c.14_15insC in the promoter of the IL-6 gene, together with the -1082 G/A polymorphism, is associated with increased expression of IL‑6 in patients with rheumatoid arthritis, whereas the Q536X truncation in the TNFAIP3 gene leads to impaired NF‑κB regulation and a higher risk of systemic lupus erythematosus.",-42.75,0.01,sequencevariant
"T allele at -511 in the IL-10 promoter reduces transcriptional activity, thereby increasing susceptibility to inflammatory bowel disease in individuals carrying the rs6277 polymorphism.",-21.625,0.01,sequencevariant
"T‑allele at −511 in the IL‑10 promoter, combined with the −3170G>A polymorphism, synergistically increases transcriptional activity and is associated with higher serum IL‑10 levels in patients carrying the rs6277 variant.",-31.875,0.01,sequencevariant
"T cells from a patient with the -511 T allele in the IL-10 promoter exhibited markedly reduced cytokine production, whereas the same cells carrying the -3170G>A variant in the TNFA promoter showed increased TNF‑α secretion, indicating that these sequence variants modulate inflammatory gene expression in a cell‑type‑specific manner.",-51.75,0.01,sequencevariant
"Twelve patients with the T allele at -511 in the IL-10 promoter exhibited higher serum IL‑10 levels, whereas the del‑(439‑443) variant in the TNF‑α gene was associated with increased susceptibility to rheumatoid arthritis.",-35.75,0.01,sequencevariant
"Molecular analysis of the TP53 gene in a cohort of colorectal cancer patients revealed that the T allele at -511 in the promoter region, together with the c.14_15insC insertion in exon two, was significantly associated with increased tumor aggressiveness and poorer overall survival.",-38.25,0.01,sequencevariant
"Mice carrying the T allele at –511 in the IL‑10 promoter exhibit a markedly reduced cytokine production compared with those harboring the C allele, while the del‑(439‑443) variant in the same region further amplifies this effect by destabilizing the mRNA transcript.",-41.25,0.01,sequencevariant
"Mild cognitive decline in patients carrying the rs6277 T allele at the -511 promoter region of the APOE gene is exacerbated by the concurrent c.14_15insC insertion in the BDNF exon IV, which together increase the risk of late‑onset Alzheimer’s disease.",-44.75,0.01,sequencevariant
"MUTATION of the IL6 promoter, specifically the T allele at –511, has been shown to increase transcriptional activity and is associated with higher circulating IL‑6 levels in patients with rheumatoid arthritis.",-32.75,0.01,sequencevariant
"CRISPR‑mediated editing of the TP53 gene in HCT116 cells introduced a c.14_15insC sequence variant that replaces arginine84 with glutamine, thereby abolishing p53‑dependent apoptosis and conferring resistance to doxorubicin.",-24.5,0.01,sequencevariant
"CRP promoter polymorphism rs11891426, a -1082 G/A variant, is associated with increased inflammatory cytokine production in patients with the T allele at -511 and the del‑(439‑443) insertion/deletion of a long allele‑L/short allele‑S in the IL‑6 gene.",-44.0,0.01,sequencevariant
"CR‑p53 c.14_15insC, a sequence variant that introduces a premature stop codon, is associated with increased susceptibility to colorectal cancer in individuals carrying the T allele at -511 of the promoter.",-35.5,0.01,sequencevariant
"CRL-1205 cells harboring the c.14_15insC variant in the promoter of IL-6 exhibit markedly increased transcriptional activity compared to wild‑type cells, suggesting that this insertion/deletion of a single cytosine enhances cytokine expression and may contribute to inflammatory disease susceptibility.",-48.75,0.01,sequencevariant
"During the study, the T allele at -511 in the IL-10 promoter was found to be associated with increased expression of the cytokine in patients carrying the rs6277 variant, while the del- (439-443) deletion in the promoter of the CYP2D6 gene was linked to reduced enzymatic activity in individuals with the -1082 (G/A) polymorphism.",-43.25,0.01,sequencevariant
"During chronic exposure to doxorubicin, the T allele at -511 in the promoter of the MDR1 gene was found to increase P-glycoprotein expression, thereby reducing drug accumulation in A549 cells and contributing to acquired resistance.",-31.75,0.01,sequencevariant
"During functional assays, the T allele at -511 in the IL-10 promoter was shown to reduce transcriptional activity, while the del- (439-443) deletion in the promoter of the CYP2D6 gene was associated with a significant decrease in enzyme activity, and the -3170G > A polymorphism in the promoter of the HLA-DQA1 gene was found to increase susceptibility to autoimmune disease.",-55.0,0.01,sequencevariant
"During CRISPR‑mediated editing of the IL6R gene, the c.14_15insC sequence variant was introduced, creating a novel Q536X truncation that abolishes the receptor’s extracellular domain and impairs downstream STAT3 signaling in cultured A549 cells.",-38.75,0.01,sequencevariant
"The p.Arg284Pro variant in the TP53 gene, identified by rs10973794, was shown to increase the risk of colorectal cancer in a cohort of Homo sapiens patients carrying the C allele at -511 in the promoter region.",-21.5,0.01,sequencevariant
"The CRISPR‑edited A549 cells harboring the p.Arg284Pro sequence variant exhibit a pronounced reduction in EGFR phosphorylation, while the adjacent rs10973794 SNP in the promoter region correlates with increased expression of the downstream MAPK pathway genes.",-30.875,0.01,sequencevariant
"The recently identified rs10973794 variant, a four‑base‑pair deletion at g.3426G>A that results in the Ser1245Cys substitution, has been shown to disrupt the binding of transcription factor NF‑κB to the promoter of the IL‑6 gene, thereby reducing its expression in A549 cells and attenuating the inflammatory response in patients with chronic obstructive pulmonary disease.",-38.75,0.01,sequencevariant
"The four‑basepair deletion in the promoter of the CYP2D6 gene (g.3426G>A) reduces transcriptional activity, thereby diminishing the metabolic conversion of codeine to morphine and contributing to opioid‑resistance in patients carrying the rs10973794 variant.",-30.75,0.01,sequencevariant
"Genetic analysis of a colorectal carcinoma cell line revealed that the rs10973794 variant, a Ser1245Cys substitution in the APC gene, co‑occurs with a nine‑nucleotide deletion starting at position c.1952, and a four‑basepair deletion in the promoter region of the KRAS gene, all of which are predicted to disrupt normal protein function and contribute to tumor progression.",-50.75,0.01,sequencevariant
"Genotypic analysis of a cohort of patients with familial hypercholesterolemia revealed that the rs10973794 variant, a four‑base‑pair deletion in the LDLR promoter, co‑occurs with the p.Arg284Pro missense mutation, and the C allele at −511 of the APOE promoter, all of which are associated with markedly reduced LDL‑R expression and elevated plasma LDL‑cholesterol levels.",-49.5,0.01,sequencevariant
"Genomic analysis of a colorectal carcinoma sample revealed a nine‑nucleotide deletion starting at position c.1952 (c.1952_1960del) in the APC gene, which co‑occurs with the p.Arg284Pro missense variant and a four‑base‑pair deletion in the adjacent intron, collectively contributing to the truncated protein product and loss of β‑catenin regulation.",-46.0,0.01,sequencevariant
"Genetically engineered A549 cells harboring the rs10973794 variant, a Ser1245Cys substitution in the TP53 gene, and a nine‑nucleotide deletion starting at position c.1952, exhibit markedly reduced sensitivity to doxorubicin compared with wild‑type cells.",-39.5,0.01,sequencevariant
Mutation of the four‑base‑pair deletion in the TP53 gene (p.Arg284Pro) was found to increase the risk of colorectal cancer in a cohort of Homo sapiens carrying the rs10973794 allele.,-21.375,0.01,sequencevariant
"Mutation g.3426G>A in the promoter of the CYP2D6 gene, together with the Ser1245Cys variant in the same locus, was found to increase the risk of severe hepatotoxicity in patients treated with the antiepileptic drug carbamazepine.",-37.5,0.01,sequencevariant
"Mutation rs10973794, a Ser1245Cys substitution in the TP53 gene, was found to co‑occur with a four‑basepair deletion in the promoter region of the BCL2L1 gene, resulting in reduced BCL‑2 expression and increased apoptosis in HeLa cells.",-29.625,0.01,sequencevariant
"Mutation p.Arg284Pro in the TP53 gene, identified by rs10973794, was shown to increase the risk of colorectal cancer in a cohort of Homo sapiens patients.",-22.75,0.01,sequencevariant
"A patient with the rs10973794 variant, which causes a Ser1245Cys substitution in the protein, exhibited a four‑base‑pair deletion at g.3426G>A that led to a p.Arg284Pro change and a nine‑nucleotide deletion starting at position‑1952, resulting in a truncated protein that was associated with a severe form of the disease.",-49.5,0.01,sequencevariant
"A transgenic A549 cell line harboring the rs10973794 (Ser1245Cys) sequence variant exhibited a pronounced reduction in EGFR phosphorylation compared with the wild‑type line, suggesting that this single‑amino‑acid substitution impairs receptor activation.",-33.75,0.01,sequencevariant
"A four‑base‑pair deletion in the TP53 gene (c.3426G>A, p.Arg284Pro) was found to increase the risk of colorectal cancer in a cohort of Homo sapiens carrying the rs10973794 variant.",-26.25,0.01,sequencevariant
A CRISPR‑edited A549 cell line harboring the p.Arg284Pro sequence variant in the KRAS gene shows markedly reduced ERK phosphorylation and increased sensitivity to the MEK inhibitor trametinib compared with the wild‑type KRAS A549 cells.,-23.625,0.01,sequencevariant
"In the A549 cell line, the rs10973794 variant (Ser1245Cys) in the TP53 gene was found to increase sensitivity to doxorubicin, while a nine‑nucleotide deletion starting at position c.1952 in the BRCA1 sequence variant (p.Arg284Pro) was associated with reduced DNA repair capacity.",-35.75,0.01,sequencevariant
"In HCT116 cells, the p.Arg284Pro sequence variant in the TP53 gene, which arises from a single‑base substitution g.3426G>A, reduces p53‑mediated transcription of the CDKN1A promoter and thereby diminishes the cell‑cycle arrest response to doxorubicin.",-33.5,0.01,sequencevariant
"In cancer‑cell line A549, the sequence variant rs10973794 (Ser1245Cys) in the KRAS gene was found to increase the binding affinity of the small‑molecule inhibitor erlotinib, thereby enhancing its therapeutic efficacy.",-32.75,0.01,sequencevariant
"In a cohort of colorectal cancer patients, the rs10973794 single‑nucleotide polymorphism, which results in a Ser1245Cys substitution in the KRAS protein, was found to be associated with a higher frequency of the four‑base‑pair deletion at g.3426G>A, while the p.Arg284Pro variant in the APC gene was significantly enriched in tumors harboring the nine‑nucleotide deletion starting at position r.1952.",-48.75,0.01,sequencevariant
SARS‑CoV‑2 infection in a patient carrying the sequence variant rs10973794 (Ser1245Cys) in the ACE2 gene was associated with a markedly increased viral entry efficiency and a higher risk of severe respiratory failure.,-27.0,0.01,sequencevariant
"SNP rs10973794, a C allele at –511 in the promoter of the CYP2D6 gene, has been associated with altered drug metabolism in patients treated with the chemotherapeutic agent doxorubicin.",-24.25,0.01,sequencevariant
"Surgical resection of a glioblastoma harboring the p.Arg284Pro sequence variant in EGFR, which is associated with a four‑base‑pair deletion at g.3426G>A, led to a marked reduction in downstream STAT3 phosphorylation and improved patient survival.",-40.5,0.01,sequencevariant
"Sera from patients carrying the rs10973794 variant, which introduces a Ser1245Cys substitution in the TP53 protein, showed markedly increased apoptotic signaling compared with individuals harboring the wild‑type allele.",-32.75,0.01,sequencevariant
"RS‑10973794, a single‑nucleotide polymorphism in the promoter of the *TNFA* gene, has been shown to alter transcriptional activity, while the Ser1245Cys missense variant in *CFTR* disrupts chloride channel gating, and a four‑base‑pair deletion at g.3426G>A in the *BRCA1* intron creates a cryptic splice site that leads to exon skipping and a truncated protein product.",-50.0,0.01,sequencevariant
"RS10973794, a single‑nucleotide polymorphism in the promoter of the CYP2D6 gene, has been shown to alter transcriptional activity, while the Ser1245Cys missense mutation in the ATP7B protein causes a loss of copper‑transporting function that is exacerbated by a four‑base‑pair deletion in the adjacent intron, and the g.3426G>A substitution in the promoter of the HLA‑DRB1 locus, together with the p.Arg",-55.75,0.01,sequencevariant
"RSV infection in a patient with the BRCA1 r.2521_2634del sequence variant was associated with a markedly increased risk of developing triple‑negative breast cancer, and the variant’s nine‑nucleotide deletion starting at position‑1952 was predicted to disrupt the protein’s DNA‑binding domain.",-50.5,0.01,sequencevariant
"RS1256789, a four‑base‑pair deletion in the promoter of the CYP2D6 gene, was found to reduce transcriptional activity and is associated with the C allele at –511, thereby increasing the risk of severe adverse reactions to the antipsychotic drug clozapine in patients of European ancestry.",-52.75,0.01,sequencevariant
"Knocking‑in the rs10973794 variant, which introduces a Ser1245Cys substitution and a four‑base‑pair deletion in the promoter, markedly reduces TP53 transcription in HeLa cells, whereas the g.3426G>A mutation in the same locus yields a p.Arg284Pro change that partially rescues the phenotype.",-37.75,0.01,sequencevariant
"Knock‑in of the rs10973794 variant, which introduces a Ser1245Cys substitution in the catalytic domain of the kinase, markedly reduces phosphorylation of downstream targets in A549 cells, whereas the four‑base‑pair deletion in the promoter region (g.3426G>A) abolishes transcriptional activity of the same gene in HeLa cells.",-37.25,0.01,sequencevariant
"Knocked‑in A549 cells harboring the rs10973794 variant (Ser1245Cys) exhibit a four‑base‑pair deletion in the promoter, which reduces p.Arg284Pro expression and increases sensitivity to the small‑molecule inhibitor g.3426G>A.",-41.0,0.01,sequencevariant
"Knipsel et al. reported that the rs10973794 variant, a four‑base‑pair deletion in the promoter of the CYP2D6 gene, is associated with a C allele at –511 that reduces transcriptional activity, thereby increasing the risk of severe adverse reactions to the chemotherapeutic agent doxorubicin in patients with the Ser1245Cys sequence variant.",-58.75,0.01,sequencevariant
"Detection of the rs10973794 variant, a Ser1245Cys substitution in the ATP7B gene, in a patient with Wilson disease revealed a four‑base‑pair deletion at g.3426G>A that co‑segregated with the pathogenic p.Arg284Pro mutation, confirming compound heterozygosity for the nine‑nucleotide deletion starting at position‑1952 and the C allele at −511 in the promoter region.",-52.0,0.01,sequencevariant
"Detection by next‑generation sequencing revealed that the A549 cell line harbors a nine‑nucleotide deletion starting at position c.1952 in the TP53 gene, which co‑exists with the rs10973794 SNP and a C allele at the −511 promoter, and this compound variant is predicted to destabilize the p53 DNA‑binding domain.",-53.5,0.01,sequencevariant
"Detection and functional characterization of the rs10973794 variant, a Ser1245Cys substitution in the catalytic domain of the protein, revealed that the four‑base‑pair deletion at g.3426G>A abolishes the binding of the transcription factor, thereby reducing expression of the downstream gene and contributing to the disease phenotype.",-51.0,0.01,sequencevariant
"Detection that the rs10973794 variant, a four‑base‑pair deletion at g.3426G>A, produces a Ser1245Cys substitution in the protein and a nine‑nucleotide deletion starting at position‑1952, was associated with a C allele at −511 in the promoter region of the gene encoding the disease‑associated protein.",-61.75,0.01,sequencevariant
"Mutations such as the nine‑nucleotide deletion starting at position **1952** and the **Ser1245Cys** substitution in the *TP53* gene have been shown to impair p53’s DNA‑binding domain, thereby increasing the risk of colorectal carcinoma in patients carrying the **C allele at -511** of the promoter.",-40.0,0.01,sequencevariant
"Mutational analysis of the TP53 gene in a cohort of colorectal cancer patients revealed that the rs10973794 polymorphism, the Ser1245Cys substitution, and a nine‑nucleotide deletion starting at position c.1952 were each associated with a significantly higher frequency of the p.Arg284Pro variant, suggesting a synergistic effect of these sequence variants on tumor progression.",-43.0,0.01,sequencevariant
"Mutant A549 cells harboring the rs10973794 (Ser1245Cys) variant exhibit reduced EGFR signaling, while the four‑base‑pair deletion in the promoter (g.3426G>A) further diminishes transcription of the downstream p.Arg284Pro allele.",-38.25,0.01,sequencevariant
"Mutagenesis of the TP53 gene in HeLa cells revealed that the Ser1245Cys sequence variant, together with a four‑base‑pair deletion at g.3426G>A, significantly increased the frequency of p.Arg284Pro mutations, thereby enhancing cellular sensitivity to doxorubicin.",-34.0,0.01,sequencevariant
"CRISPR‑mediated introduction of the rs10973794 variant, a Ser1245Cys substitution, into the TP53 gene of H1299 cells resulted in a four‑base‑pair deletion at g.3426G>A that produced a p.Arg284Pro frameshift and a nine‑nucleotide deletion starting at position‑1952, thereby abolishing p53‑dependent apoptosis and conferring resistance to doxorubicin.",-49.75,0.01,sequencevariant
"CRLF3 rs10973794, a single‑nucleotide polymorphism located in the promoter region, has been shown to alter transcriptional activity and is associated with increased susceptibility to asthma in individuals carrying the C allele at −511, while the p.Arg284Pro missense variant in the same gene, together with a nine‑nucleotide deletion starting at position‑1952, results in a truncated protein that impairs cytokine signaling and contributes to severe allergic inflammation.",-66.5,0.01,sequencevariant
"CRP expression is markedly upregulated in A549 cells harboring the p.Arg284Pro sequence variant, a nine‑nucleotide deletion starting at position‑1952 that also correlates with increased IL‑6 secretion.",-44.75,0.01,sequencevariant
"CRL-1205 cells harboring the rs10973794 variant, which introduces a Ser1245Cys substitution in the kinase domain, exhibit markedly reduced phosphorylation of downstream STAT3 compared with wild‑type cells.",-39.75,0.01,sequencevariant
"Ser1245Cys in the TP53 gene, a nine‑nucleotide deletion starting at position **1952** in the BRCA1 coding sequence, and a four‑base‑pair deletion in the *CFTR* promoter (g.3426G>A) together contribute to the pathogenic phenotype observed in patients with cystic fibrosis and hereditary breast‑ovarian cancer.",-47.75,0.01,sequencevariant
"Serine‑1245‑cysteine (Ser1245Cys) in the TP53 gene, a nine‑nucleotide deletion starting at position‑1952, and the g.3426G>A variant together confer a higher risk of developing colorectal cancer in individuals carrying the C allele at −511 of the promoter.",-47.25,0.01,sequencevariant
"Ser1265Cys, a four‑base‑pair deletion in the promoter of the CYP2D6 gene, and the rs10973794 SNP (C allele at –511) together reduce CYP2D6 expression, thereby increasing plasma levels of the antipsychotic clozapine in patients with schizophrenia.",-47.25,0.01,sequencevariant
"Serum‑derived exosomes from A549 cells carrying the rs10973794 variant and the Ser1245Cys sequence‑variant in the EGFR gene were shown to enhance phosphorylation of downstream STAT3, thereby promoting resistance to erlotinib treatment.",-43.75,0.01,sequencevariant
"Researchers demonstrated that the rs10973794 variant, a nine‑nucleotide deletion starting at position **1952** in the *TP53* gene, reduces p53 transcriptional activity and predisposes *Homo sapiens* to early onset colorectal cancer.",-39.25,0.01,sequencevariant
"Researchers discovered that the rs10973794 variant, a four‑base‑pair deletion in the promoter region, reduces expression of the TP53 gene and increases susceptibility to Parkinson’s disease in a cohort of Homo sapiens patients.",-29.625,0.01,sequencevariant
"Researchers identified that the rs10973794 variant, a four‑base‑pair deletion in the promoter region, reduces expression of the gene encoding the protein p.Arg284Pro, thereby increasing susceptibility to the disease phenotype.",-31.125,0.01,sequencevariant
"Researchers observed that the rs10973794 variant, a four‑base‑pair deletion in the promoter region, reduces expression of the gene encoding the protein with the Ser1245Cys substitution, thereby increasing susceptibility to the disease phenotype.",-28.75,0.01,sequencevariant
"Research in A549 cells revealed that the rs10973794 variant, which introduces a Ser1245Cys substitution in the TP53 gene, synergizes with a four‑base‑pair deletion in the promoter of the BCL2L1 gene to markedly increase apoptosis resistance in response to doxorubicin treatment.",-33.25,0.01,sequencevariant
"Research demonstrates that the rs10973794 variant, a four‑base‑pair deletion in the promoter region, reduces expression of the TP53 gene and predisposes Homo sapiens individuals to a higher risk of Parkinson’s disease.",-30.875,0.01,sequencevariant
"Research indicates that the rs10973794 variant, a four‑base‑pair deletion in the promoter region, reduces expression of the gene encoding the protein p.Arg284Pro, thereby increasing susceptibility to the disease phenotype observed in patients carrying the C allele at –511.",-34.5,0.01,sequencevariant
"Research using the A549 cell line revealed that the rs10973794 variant, which introduces a Ser1245Cys substitution in the TP53 gene, synergizes with a four‑base‑pair deletion in the promoter region (g.3426G>A) to markedly reduce p.Arg284Pro expression, thereby increasing susceptibility to ethanol‑induced apoptosis.",-38.25,0.01,sequencevariant
"The A549 cells harboring the TP53 c.229T>C variant exhibit increased sensitivity to the chemotherapeutic agent doxorubicin, whereas the same cells with the TP53 G183S mutation show resistance to the drug.",-23.25,0.01,sequencevariant
"The c.229T>C variant in the TP53 gene, which results in the p.R96H substitution, has been shown to increase the risk of developing colorectal cancer in individuals of European ancestry.",-21.875,0.01,sequencevariant
"The novel c.229T>C variant in the TP53 gene, which results in the p.R962T substitution, was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients carrying the rs2004640 allele.",-30.0,0.01,sequencevariant
"The BRCA1 c.229T>C variant, which results in the p.G183S substitution, has been shown to increase the risk of breast cancer in women of European ancestry.",-18.375,0.01,sequencevariant
"A c.229T>C mutation in the TP53 gene, which results in a G183S amino‑acid change, was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients carrying the rs2004640 allele.",-27.125,0.01,sequencevariant
"A p.R962T variant in the TP53 gene, identified by rs2004640, was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients.",-24.125,0.01,sequencevariant
"A BRCA1 c.229T>C variant, which results in a p.T77A substitution, has been shown to increase the risk of breast cancer in women carrying the rs2004640 allele.",-22.125,0.01,sequencevariant
"A CRISPR‑edited A549 cell line harboring the TP53 c.229T>C variant exhibited a marked increase in apoptosis upon doxorubicin treatment, confirming the pathogenic role of this sequence variant in drug‑induced cytotoxicity.",-24.875,0.01,sequencevariant
"In a cohort of colorectal cancer patients, the TP53 c.229T>C variant was found to correlate with increased sensitivity to the chemotherapeutic agent doxorubicin, whereas the BRCA1 p.R962T mutation was associated with a higher risk of treatment‑induced cardiotoxicity.",-28.875,0.01,sequencevariant
"In the A549 cell line, the TP53 c.229T>C variant was found to increase the transcription of the MDM2 gene, thereby enhancing the degradation of the p53 protein and promoting resistance to doxorubicin-induced apoptosis.",-25.75,0.01,sequencevariant
"In patients carrying the BRCA1 c.229T>C variant, the p.R962T substitution in the DNA‑binding domain of the protein was found to impair homologous recombination and increase susceptibility to triple‑negative breast cancer.",-26.125,0.01,sequencevariant
"In HCT116 cells harboring the TP53 c.229T>C variant, the p.R962T mutation in the DNA‑binding domain of the p53 protein was shown to impair transcriptional activation of the CDKN1A gene, thereby reducing G1‑cell‑cycle arrest in response to doxorubicin.",-32.25,0.01,sequencevariant
Mutation of the TP53 gene harboring the c.229T>C sequence variant was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients.,-22.5,0.01,sequencevariant
"Mutation p.R962T in the TP53 gene, identified by rs2004640, was shown to increase the risk of colorectal cancer in a cohort of Homo sapiens patients.",-21.875,0.01,sequencevariant
"Mutation rs2004640 in the TP53 gene, a c.229T > C variant that results in a G183S amino‑acid change, is associated with increased susceptibility to chemotherapy‑induced apoptosis in HeLa cells.",-25.375,0.01,sequencevariant
"Mutation c.229T>C in the TP53 gene was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients, while the concurrent rs2004640 SNP in the MTHFR locus was associated with a reduced response to folate supplementation.",-31.875,0.01,sequencevariant
"Alterations in the TP53 gene, such as the c.229T>C variant, have been shown to increase the risk of developing colorectal cancer in patients carrying the rs2004640 allele.",-23.25,0.01,sequencevariant
"Altered expression of the insulin receptor in HeLa cells carrying the c.229T>C variant was rescued by treatment with the small molecule G183S, which binds the kinase domain and restores downstream PI3K signaling.",-31.125,0.01,sequencevariant
Alteration of the TP53 sequence variant c.229T>C in the A549 cell line reduces p53 transcriptional activity and increases resistance to doxorubicin-induced apoptosis in Homo sapiens cells.,-23.375,0.01,sequencevariant
"Altering the TP53 sequence variant c.229T>C in HeLa cells reduces p53 transcriptional activity, thereby increasing resistance to doxorubicin-induced apoptosis.",-27.375,0.01,sequencevariant
"Homozygous c.229T>C in the TP53 gene, which results in the p.R962T variant, was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients carrying the rs2004640 allele.",-30.875,0.01,sequencevariant
"Heterozygous carriers of the BRCA1 c.229T>C variant exhibit a markedly increased risk of breast cancer, while the TP53 p.R962T mutation is associated with a more aggressive tumor phenotype.",-26.875,0.01,sequencevariant
"HepG2 cells harboring the TP53 c.229T>C variant exhibit increased sensitivity to the chemotherapeutic agent doxorubicin, whereas the same cells with the TP53 p.R962T mutation show resistance to the drug.",-27.875,0.01,sequencevariant
"Hematopoietic stem cells from a patient with the BRCA1 c.229T>C variant exhibited impaired DNA repair and increased sensitivity to the chemotherapeutic agent doxorubicin, whereas cells harboring the TP53 p.R962T mutation showed enhanced apoptosis in response to the same drug.",-35.25,0.01,sequencevariant
"Mutations such as c.229T>C and the rs2004640 SNP in the promoter of the CYP2D6 gene have been shown to alter enzyme activity, thereby influencing the pharmacokinetics of the chemotherapeutic agent doxorubicin in patients with breast cancer.",-26.875,0.01,sequencevariant
"Mutational analysis of the TP53 gene in a cohort of colorectal carcinoma patients revealed that the c.229T>C variant, which results in the p.G183S amino acid substitution, was significantly associated with increased tumor aggressiveness and poorer overall survival.",-28.0,0.01,sequencevariant
"Mutant A549 cells harboring the TP53 c.229T>C sequence variant exhibit increased sensitivity to the chemotherapeutic agent doxorubicin, whereas the same variant in the KRAS gene (p.G183S) confers resistance to epidermal growth factor receptor inhibition.",-30.0,0.01,sequencevariant
"Mutagenesis of the TP53 gene in HeLa cells revealed that the c.229T>C sequence variant, which results in the G183S amino‑acid substitution, significantly increases the cells’ sensitivity to the chemotherapeutic agent doxorubicin.",-25.0,0.01,sequencevariant
"Sequencing of the TP53 gene in a cohort of colorectal cancer patients revealed a recurrent c.229T>C variant that co‑occurs with a G183S substitution in the DNA‑binding domain, suggesting a compound heterozygous effect on tumor suppressor activity.",-27.125,0.01,sequencevariant
"Sequenced tumor DNA from a patient with metastatic colorectal carcinoma revealed a BRCA1 c.229T>C variant that co‑occurs with a TP53 p.R962T mutation, suggesting a dual‑hit mechanism driving aggressive disease progression.",-34.0,0.01,sequencevariant
Sequence variant c.229T>C in the TP53 gene was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients.,-30.75,0.01,sequencevariant
"Sequencereporting that the TP53 c.229T>C variant, which results in the p.R962T substitution, is associated with increased risk of colorectal cancer in a cohort of Homo sapiens patients.",-41.0,0.01,sequencevariant
"Patients harboring the BRCA1 c.229T>C variant exhibit a markedly increased risk of breast cancer, while those with the TP53 p.R962T mutation display a higher propensity for early‑onset colorectal carcinoma.",-26.875,0.01,sequencevariant
"Patients carrying the BRCA1 c.229T>C variant exhibit a markedly increased risk of breast cancer, while those with the TP53 p.R962T mutation display a higher propensity for early‑onset colorectal carcinoma.",-27.0,0.01,sequencevariant
"Patients with the TP53 c.229T>C variant exhibit a higher incidence of early‑onset breast cancer, while those carrying the BRCA1 p.R962T mutation display markedly reduced homologous recombination repair capacity.",-30.875,0.01,sequencevariant
"Patients homozygous for the BRCA1 c.229T>C variant exhibit a markedly increased risk of breast cancer, while carriers of the TP53 p.R962T mutation display a higher incidence of Li–Fraumeni syndrome.",-26.875,0.01,sequencevariant
"Gene expression analysis of the TP53 c.229T>C variant revealed that the resulting p.R96Q protein destabilizes the DNA‑binding domain, thereby reducing p53‑mediated apoptosis in HeLa cells treated with doxorubicin.",-34.25,0.01,sequencevariant
"Gene‑editing of the TP53 locus in A549 cells revealed that the c.229T>C variant, which creates a G183S substitution, markedly increases the cells’ sensitivity to doxorubicin, while the concurrent rs2004640 SNP in the promoter region further amplifies the transcriptional response to the drug.",-40.75,0.01,sequencevariant
"Gene therapy using CRISPR-Cas9 to correct the c.229T>C variant in the TP53 gene restored p53‑dependent apoptosis in A549 cells, thereby reducing tumor growth in a xenograft model of non‑small‑cell lung cancer.",-30.5,0.01,sequencevariant
"Gene‐editing of the TP53 locus in A549 cells revealed that the c.229T>C variant, which creates a G183S substitution, markedly increases the cells’ sensitivity to doxorubicin, whereas the rs2004640 SNP in the promoter region of the same gene does not alter drug response.",-42.5,0.01,sequencevariant
"Variation rs2004640 in the promoter of the CYP2D6 gene, together with the c.229T>C missense mutation in the same locus, is associated with reduced enzymatic activity and increased risk of drug-induced hepatotoxicity in patients treated with the antipsychotic clozapine.",-38.25,0.01,sequencevariant
"Variation c.229T>C in the TP53 gene was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients, while the concurrent rs2004640 SNP in the same locus was associated with a higher expression of the p53 protein in HeLa cells.",-36.75,0.01,sequencevariant
Variation of the TP53 gene harboring the c.229T>C mutation was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients.,-30.5,0.01,sequencevariant
"Variation p.R962T in the TP53 gene, detected in a Homo sapiens tumor sample, is predicted to destabilize the DNA‑binding domain and is associated with increased susceptibility to colorectal cancer.",-30.75,0.01,sequencevariant
"CRISPR‑mediated editing of the TP53 gene in HCT116 cells revealed that the c.229T>C variant, which generates the p.G183S substitution, markedly increases cellular sensitivity to doxorubicin while simultaneously up‑regulating the expression of the DNA‑damage‑response gene GADD45A.",-36.75,0.01,sequencevariant
"CRTC1 c.229T>C, a missense variant that replaces threonine with alanine at position‑229, has been shown to disrupt the transcriptional activation domain and is associated with a higher risk of type‑2 diabetes in individuals of European ancestry.",-52.5,0.01,sequencevariant
"CRISP‑Cas9 editing of the TP53 gene in A549 cells introduced a c.229T>C sequence variant that, together with a G183S missense mutation, impaired p53‑dependent apoptosis and increased resistance to doxorubicin.",-36.25,0.01,sequencevariant
"CRs from the BRCA1 c.229T>C variant, the TP53 p.R962T mutation, and the G183S polymorphism were simultaneously detected in the same tumor sample, indicating a complex mutational landscape that may drive aggressive breast cancer progression.",-45.5,0.01,sequencevariant
"Detection of the BRCA1 c.229T>C variant in a patient with early‑onset breast cancer revealed a deleterious effect on protein stability, while the concurrent TP53 p.R962T mutation further compromised DNA‑damage response pathways.",-35.25,0.01,sequencevariant
"Detection by next‑generation sequencing revealed that the A549 cells harbor a BRCA1 c.229T>C variant, which co‑occurs with a TP53 p.R962T mutation and a novel rs2004640 SNP in the promoter of the DNA‑repair gene RAD51.",-43.25,0.01,sequencevariant
"Detection in a cohort of sporadic colorectal cancers revealed that the TP53 sequence variant c.229T>C, which results in the p.G183S amino acid change, was significantly associated with increased tumor aggressiveness and poorer overall survival.",-43.25,0.01,sequencevariant
"Detection and functional characterization of the BRCA1 c.229T> C sequence variant revealed a deleterious effect on DNA repair capacity in a panel of breast cancer cell lines, including the MCF‑7 and HeLa models.",-41.25,0.01,sequencevariant
"cDNA sequencing of the TP53 gene in a colorectal carcinoma cell line revealed a novel sequence variant, c.229T>C, that co‑occurs with the missense mutation p.R962T and is predicted to destabilize the DNA‑binding domain, potentially contributing to the aggressive phenotype observed in the HeLa-derived tumor cells.",-43.5,0.01,sequencevariant
"c.[229T>C] in the TP53 gene was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients, while the rs2004640 SNP in the IL6 promoter was associated with higher inflammatory cytokine levels in the same population.",-39.25,0.01,sequencevariant
c.*229T> C* in the *TP53* gene was found to increase the risk of colorectal cancer in *Homo sapiens* patients carrying the *rs2004640* allele.,-31.25,0.01,sequencevariant
"c.G183S in the TP53 gene was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients, while the c.229T>C variant in the BRCA1 promoter was associated with reduced breast cancer susceptibility.",-40.5,0.01,sequencevariant
"The c.610‑2A>G splice‑site variant in the BRCA1 gene, which results in a glutamine replacement of arginine at position Q126R, has been shown to increase breast cancer risk in carriers of the rs3790757 allele.",-23.625,0.01,sequencevariant
"The BRCA1 c.1092+1G>A splice‑site mutation, which causes a glutamine replacement of arginine at position Q126R/G158R, is associated with a higher risk of breast cancer in individuals carrying the rs3790757 allele.",-25.625,0.01,sequencevariant
"The glutamine replacement of arginine at position Q126R/G158R in the TP53 gene, a sequence variant identified as rs3790757, is associated with increased susceptibility to Li-Fraumeni syndrome in Homo sapiens.",-26.75,0.01,sequencevariant
"The rs3790757 variant, a c.610‑2A>G splice‑site mutation, was found to increase the risk of Parkinson’s disease in a cohort of Homo sapiens patients carrying the p.Leu275Pro sequence variant in the LRRK2 gene.",-21.75,0.01,sequencevariant
"Studies showed that the rs3790757 variant, which causes a p.Leu275Pro substitution in the TP53 gene, is associated with increased risk of colorectal cancer in individuals carrying the c.610‑2A>G splice‑site mutation.",-28.875,0.01,sequencevariant
"Studies demonstrate that the c.610‑2A>G splice‑site variant in the BRCA1 gene, which causes a glutamine replacement of arginine at position Q126R/G158R, is associated with a higher risk of breast cancer in individuals carrying the rs3790757 allele.",-35.5,0.01,sequencevariant
"Studies in A549 cells revealed that the rs3790757 variant, which causes a p.Leu275Pro substitution in the TP53 gene, markedly increases the expression of the pro‑apoptotic gene BAX, thereby sensitizing the cells to doxorubicin‑induced cytotoxicity.",-30.625,0.01,sequencevariant
"Studies reveal that the rs3790757 variant, a c.610‑2A>G splice‑site mutation, reduces TP53 mRNA stability in A549 cells, thereby increasing susceptibility to doxorubicin‑induced apoptosis.",-29.375,0.01,sequencevariant
"In A549 cells harboring the c.610‑2A>G splice‑site variant, the p.Leu275Pro substitution in the TP53 protein markedly reduces p53‑mediated transcription of the CDKN1A gene, thereby enhancing cellular proliferation.",-22.0,0.01,sequencevariant
"In *Homo sapiens* fibroblasts, the splice‑site variant c.610‑2A>G in the *COL1A1* gene leads to exon skipping, producing a truncated protein that predisposes to osteogenesis imperfecta.",-25.5,0.01,sequencevariant
"In patients carrying the rs3790757 variant, the p.Leu275Pro substitution in the TP53 gene’s DNA‑binding domain was associated with a higher risk of developing early‑onset colorectal cancer.",-23.0,0.01,sequencevariant
"In HCT116 cells, the c.610‑2A>G splice‑site variant in the TP53 gene leads to exon skipping, resulting in a truncated p53 protein that fails to activate the downstream target CDKN1A, thereby impairing the cell‑cycle arrest response to doxorubicin.",-32.25,0.01,sequencevariant
"A germline sequence variant, rs3790757, encoding a p.Leu275Pro substitution in the TP53 gene, has been shown to increase the risk of developing colorectal cancer in individuals of European ancestry.",-24.75,0.01,sequencevariant
"A genome‑wide association study in European cohorts revealed that the rs3790757 SNP, a c.610‑2A>G splice‑site variant, is significantly associated with increased risk of type‑2 diabetes, while the p.Leu275Pro missense mutation in the GCK gene, which replaces leucine with proline at position‑275, confers a protective effect against hyperglycaemia.",-49.5,0.01,sequencevariant
"A missense variant, p.Leu275Pro, in the TP53 gene (rs3790757) was found to increase the risk of colorectal cancer in a cohort of Homo sapiens patients, while a splice‑site mutation, c.610‑2A>G, in the BRCA1 gene (rs2073601) was associated with a higher incidence of breast cancer in the same population.",-33.25,0.01,sequencevariant
"A heterozygous c.610‑2A>G splice‑site variant in the BRCA1 gene, which replaces a conserved arginine with glutamine at position Q126R, has been shown to increase breast cancer risk in carriers of the rs3790757 allele.",-29.0,0.01,sequencevariant
"Mutation c.610‑2A>G in the splice acceptor site of the BRCA1 gene causes aberrant splicing that leads to a truncated protein, thereby increasing the risk of breast cancer in carriers of the rs3790757 allele.",-25.375,0.01,sequencevariant
"Mutation of the sequence variant rs3790757, a c.1092 +1G > A splice‑site alteration, was found to increase the expression of the p.Leu275Pro variant of the TP53 gene in HeLa cells, thereby enhancing apoptosis in response to doxorubicin treatment.",-28.875,0.01,sequencevariant
"Mutation rs3790757 in the TP53 gene, a c.1092 +1G > A splice‑site alteration, is associated with a p.Leu275Pro substitution that reduces p53’s DNA‑binding affinity and predisposes Homo sapiens carriers to early‑onset colorectal cancer.",-32.5,0.01,sequencevariant
"Mutation **c.610‑2A>G** in the splice acceptor site of **TP53** causes aberrant splicing that leads to a truncated protein, which in turn predisposes **Homo sapiens** cells to develop **colorectal cancer**.",-30.75,0.01,sequencevariant
TP53 c.1092 +1G > A mutation in a HeLa cell line carrying the rs3790757 variant was shown to reduce p53 protein stability and increase cellular sensitivity to doxorubicin.,-27.5,0.01,sequencevariant
"TP63 c.1092+1G>A, a splice‑site variant that abolishes the canonical donor site, is predicted to generate a truncated protein lacking the DNA‑binding domain, thereby impairing epithelial stem‑cell maintenance and predisposing to basal‑cell carcinoma in patients carrying the rs2073601 allele.",-46.25,0.01,sequencevariant
"TP73 p.Leu275Pro mutation in the TP73 gene, identified by rs3790757, was shown to increase apoptosis in HeLa cells, whereas the c.610‑2A>G splice‑site variant in the same locus was associated with reduced TP73 expression in A549 cells.",-49.5,0.01,sequencevariant
"TPM3 c.1092 +1G > A mutation in a patient with myofibrillar myopathy leads to aberrant splicing that reduces the production of functional TPM3 protein, thereby impairing sarcomere assembly and causing progressive muscle weakness.",-44.5,0.01,sequencevariant
"CYP2D6 rs3790757, a c.1092 +1G > A splice‑site variant, was found to reduce enzymatic activity in a cohort of patients with the p.Leu275Pro sequence variant, thereby increasing the risk of adverse reactions to the antipsychotic drug clozapine.",-40.75,0.01,sequencevariant
"C6orf47 rs3790757, a c.1092 +1G > A splice‑site variant, was found to increase the risk of Parkinson’s disease in a cohort of Homo sapiens patients, while the p.Leu275Pro substitution in the same gene was associated with a milder phenotype.",-42.75,0.01,sequencevariant
"Cytotoxic T‑cell lymphoma cells harboring the c.610‑2A>G splice‑site variant in the TP53 gene exhibit markedly reduced p53 protein levels, leading to impaired apoptosis and increased resistance to doxorubicin treatment.",-28.75,0.01,sequencevariant
"Cystic fibrosis patients carrying the c.1092+1G>A splice‑site variant in the CFTR gene exhibit a markedly reduced response to ivacaftor therapy, whereas those with the p.Leu275Pro missense mutation in the same gene show only modest improvement.",-31.25,0.01,sequencevariant
"Investigators discovered that the c.610‑2A>G splice‑site variant in the BRCA1 gene, which replaces a conserved arginine with glutamine at position Q126R, is strongly associated with increased breast cancer risk in carriers of the rs3790757 allele.",-35.5,0.01,sequencevariant
"Investigating the impact of the c.610‑2A>G splice‑site variant in the BRCA1 gene, we found that the resulting aberrant transcript leads to a truncated protein that fails to recruit RAD51, thereby increasing the risk of breast cancer in carriers of the rs3790757 allele.",-36.25,0.01,sequencevariant
"Investigations revealed that the c.610‑2A>G splice‑site variant in the BRCA1 gene, which results in a glutamine replacement of arginine at position Q126R, is associated with a higher risk of breast cancer in carriers of the rs3790757 allele.",-34.5,0.01,sequencevariant
"Investigational data revealed that the c.610‑2A>G splice‑site variant in the BRCA1 gene, which results in a glutamine replacement of arginine at position Q126R, is associated with a higher risk of breast cancer in carriers of the rs3790757 allele.",-40.0,0.01,sequencevariant
"Gene expression analysis of the A549 cell line revealed that the rs3790757 variant, a c.610‑2A>G splice‑site mutation, leads to a glutamine replacement of arginine at position Q126R/G158R, thereby reducing the activity of the TP53 protein and increasing susceptibility to doxorubicin‑induced apoptosis.",-38.25,0.01,sequencevariant
"Gene‑editing of the TP53 locus in A549 cells introduced the c.1092+1G>A splice‑site variant, which caused exon skipping and produced a truncated protein that failed to activate the p53‑dependent apoptosis pathway in response to doxorubicin.",-31.125,0.01,sequencevariant
"Gene editing of the TP53 locus in A549 cells revealed that the c.1092 +1G > A splice‑site mutation (rs2073601) abolishes p53 expression, thereby enhancing resistance to doxorubicin and increasing cell‑cycle arrest at the G2/M checkpoint.",-36.5,0.01,sequencevariant
Gene knockout of the BRCA1 c.1092 +1G > A splice‑site variant in A549 cells reduces homologous recombination repair and increases sensitivity to the DNA‑damaging agent doxorubicin.,-29.25,0.01,sequencevariant
"Homozygous carriers of the rs3790757 variant, which causes a p.Leu275Pro substitution in the TP53 protein, exhibit a markedly increased risk of developing early‑onset breast cancer compared with individuals lacking this sequence variant.",-25.375,0.01,sequencevariant
"Hematopoietic stem cells carrying the c.610‑2A>G splice‑site variant in the RUNX1 gene exhibit impaired megakaryocyte differentiation, a phenotype that correlates with the rs3790757 single‑nucleotide polymorphism and the p.Leu275Pro amino‑acid substitution in the same locus.",-39.75,0.01,sequencevariant
"Heterozygous carriers of the c.610‑2A>G splice‑site variant in the BRCA1 gene exhibit a markedly increased risk of breast cancer, and functional assays confirm that this sequence variant disrupts normal mRNA splicing, leading to a truncated protein that lacks the critical BRCT domain.",-35.75,0.01,sequencevariant
HepG2 cells harboring the c.610‑2A>G splice‑site variant in the BRCA1 gene exhibit markedly reduced RAD51 foci formation and increased sensitivity to the PARP inhibitor olaparib.,-24.875,0.01,sequencevariant
"Genome‑wide association studies revealed that the rs3790757 variant, a c.1092 +1G > A splice‑site mutation, is strongly linked to increased risk of type‑2 diabetes in individuals carrying the p.Leu275Pro sequence variant of the GCK gene.",-32.75,0.01,sequencevariant
"Genome‐wide association studies revealed that the rs3790757 variant, a c.1092 +1G > A splice‑site mutation, is strongly linked to increased risk of type‑2 diabetes, while the p.Leu275Pro substitution in the insulin receptor gene (c.824T > C) disrupts ligand binding and contributes to insulin resistance.",-45.25,0.01,sequencevariant
"Genome-wide association studies revealed that the rs3790757 variant, a c.610‑2A>G splice-site mutation, is strongly associated with increased risk of type‑2 diabetes in individuals carrying the p.Leu275Pro sequence variant of the GCK gene.",-33.5,0.01,sequencevariant
"Genome editing of the TP53 gene in A549 cells revealed that the c.1092+1G>A splice‑site variant, which causes a glutamine replacement of arginine at position Q126R/G158R, leads to a truncated protein that fails to activate the p53‑dependent apoptotic pathway.",-43.5,0.01,sequencevariant
"Loss-of-function of the splice donor site c.1092+1G>A in the BRCA1 gene, which is associated with the rs2073601 allele, leads to exon skipping and a truncated protein that predisposes carriers to early-onset breast cancer.",-37.75,0.01,sequencevariant
Loss of the splice donor site caused by the c.1092+1G>A variant in the BRCA1 gene leads to exon skipping and a truncated protein that is associated with increased breast cancer risk in carriers of the rs3790757 allele.,-29.75,0.01,sequencevariant
"Loss‐of‐function of the splice donor site c.1092+1G>A in the BRCA1 gene, which is associated with the rs2073601 allele, leads to exon skipping and a truncated protein that predisposes carriers to early onset breast cancer.",-41.0,0.01,sequencevariant
"Loss‑of‑function of the tumor suppressor gene TP53 caused by the c.1092+1G>A splice‑site mutation (rs2073601) leads to a truncated protein that fails to activate the p21‑mediated cell‑cycle arrest in HeLa cells, thereby promoting unchecked proliferation.",-39.5,0.01,sequencevariant
"Polymorphism rs3790757, a c.610‑2A>G splice‑site variant, has been shown to alter splicing of the TP53 gene, thereby reducing p53 protein levels and increasing susceptibility to colorectal cancer.",-26.75,0.01,sequencevariant
"Polysubstitution of the TP53 gene, including the rs3790757 variant and the p.Leu275Pro missense mutation, has been shown to increase the risk of developing colorectal cancer in patients carrying the c.1092 +1G > A splice‑site alteration.",-42.0,0.01,sequencevariant
"Polycystic kidney disease in a patient harboring the c.610‑2A>G splice‑site variant of PKD1 was confirmed by renal biopsy, and the same mutation was found in the affected sibling, who also carried the rs3790757 SNP in the adjacent intron.",-45.5,0.01,sequencevariant
"Polyclonal B‑cell lymphoma cells harboring the c.610‑2A>G splice‑site variant in the BCL2L11 gene exhibit markedly increased apoptosis resistance, a phenotype that is further exacerbated by the concurrent rs3790757 SNP in the promoter region of the same locus.",-41.75,0.01,sequencevariant
"Sequencing of the TP53 gene in a cohort of colorectal cancer patients revealed that the c.1092 +1G > A splice‑site variant, which causes a glutamine replacement of arginine at position Q126R/G158R, is significantly enriched in individuals carrying the rs3790757 allele.",-36.0,0.01,sequencevariant
"Sequenced tumor DNA revealed a c.610‑2A>G splice‑site variant in TP53, a p.Leu275Pro missense mutation in KRAS, and an rs3790757 SNP in the promoter of MDM2, collectively correlating with increased chemoresistance in A549 cells.",-37.25,0.01,sequencevariant
"Sequence variant rs3790757, a c.1092 +1G > A splice‑site mutation, was found to disrupt normal splicing of the TP53 gene, thereby reducing p53 protein levels and increasing susceptibility to colorectal cancer in a cohort of Homo sapiens patients.",-42.25,0.01,sequencevariant
"Sequenza analysis of the A549 cell line revealed that the rs3790757 variant, a c.610‑2A>G splice‑site mutation, co‑occurs with the p.Leu275Pro amino‑acid change in the TP53 gene, potentially disrupting p53‑mediated apoptosis in response to doxorubicin treatment.",-39.75,0.01,sequencevariant
"The p.G159R missense variant in the BRCA1 gene, together with the -6526N deletion in the promoter region, has been shown to increase breast cancer risk in carriers of the rs35435463 allele.",-21.875,0.01,sequencevariant
"The c.478G>A (p.G159R) variant in the BRCA1 gene, together with the -652_6N del indel polymorphism at position -4825, has been shown to increase breast cancer risk in carriers of the rs35435463 allele.",-25.625,0.01,sequencevariant
"The TP53 p.G159R sequence variant, a missense mutation at codon G159, was found to destabilize the DNA-binding domain and increase the risk of early-onset colorectal cancer in a cohort of Homo sapiens patients.",-33.0,0.01,sequencevariant
"The CRISPR‑edited A549 cells harboring the p.G159R sequence variant exhibit a pronounced reduction in EGFR phosphorylation, while the concomitant -6526N deletion in the promoter region of the KRAS gene further amplifies the oncogenic signaling cascade.",-30.125,0.01,sequencevariant
"In patients carrying the p.G159R sequence variant, the associated rs35435463 SNP in the promoter region was found to correlate with increased expression of the nearby gene, suggesting a regulatory effect of this indel polymorphism at position -4825.",-31.0,0.01,sequencevariant
"In glioblastoma patients, the indel polymorphism at position –4825 in the promoter of MGMT, together with the p.G159R missense variant in the TP53 gene, correlates with reduced temozolomide efficacy and poorer overall survival.",-28.25,0.01,sequencevariant
"In colorectal carcinoma cells, the p.G159R sequence variant in the APC gene disrupts β‑catenin binding, thereby enhancing Wnt signaling and promoting tumorigenesis.",-17.375,0.01,sequencevariant
"In HCT116 cells, the p.G159R sequence variant in the TP53 gene was shown to impair p53‑dependent transcription of the CDKN1A promoter, thereby reducing G1‑cell‑cycle arrest after doxorubicin treatment.",-28.125,0.01,sequencevariant
"A single nucleotide polymorphism, rs35435463, located in the promoter of the CYP2D6 gene, has been shown to increase transcriptional activity and is associated with a higher risk of drug-induced hepatotoxicity in patients treated with the chemotherapeutic agent doxorubicin.",-27.875,0.01,sequencevariant
"A loss‑of‑function mutation in the BRCA1 gene, specifically the p.G159R sequence variant, has been shown to impair DNA repair and increase susceptibility to triple‑negative breast cancer in carriers of the rs35435463 allele.",-25.125,0.01,sequencevariant
"A somatic p.G159R sequence variant in the TP53 gene was identified in a HeLa cell line, where the mutation’s substitution of glycine for arginine at codon‑159 disrupted the DNA‑binding domain and led to increased cellular proliferation and resistance to doxorubicin treatment.",-43.0,0.01,sequencevariant
"A missense sequence variant, p.G159R, in the TP53 gene was found to increase the risk of developing colorectal cancer in a cohort of Homo sapiens patients carrying the rs35435463 allele.",-18.75,0.01,sequencevariant
"Deletion of a ten‑to‑twelve‑megabase segment at chromosome locus -6526N, coupled with the p.G159R missense variant in the TP53 gene, is predicted to disrupt the DNA‑binding domain and is associated with a severe form of Li–Fraumeni syndrome in a Homo sapiens patient.",-46.5,0.01,sequencevariant
"Deletion variants such as the -6526N del and the indel polymorphism at position -4825 have been shown to disrupt the promoter of the TP53 gene, thereby reducing its transcriptional activity and predisposing Homo sapiens individuals to increased susceptibility to colorectal cancer.",-44.5,0.01,sequencevariant
"Deletion (-6526Ndel) in the promoter of the TP53 gene, together with the p.G159R missense variant in the coding region, synergistically reduces p53 transcriptional activity and predisposes Homo sapiens carriers to early onset colorectal cancer.",-36.5,0.01,sequencevariant
"Deletion at position -6526Ndel in the promoter of the TP53 gene, together with the p.G159R missense variant in the coding region, synergistically reduces p53 transcriptional activity and predisposes Homo sapiens carriers to early onset colorectal cancer.",-35.5,0.01,sequencevariant
"Mutational analysis of the BRCA1 gene in a cohort of breast cancer patients revealed a novel p.G159R substitution, a -6526N deletion, and a T3801C transition that together correlate with increased tumor aggressiveness.",-32.5,0.01,sequencevariant
"Mutagenesis of the TP53 gene in HeLa cells revealed that the p.G159R sequence variant, together with the -6526N deletion, significantly increased the transcription of the downstream MDM2 promoter, thereby enhancing cellular resistance to doxorubicin-induced apoptosis.",-34.0,0.01,sequencevariant
"Mutations such as the p.G159R substitution in the BRCA1 gene and the -6526N deletion in the promoter region of the APOE locus have been shown to alter protein stability and transcriptional activity, respectively, thereby contributing to increased breast cancer risk.",-32.5,0.01,sequencevariant
"Mutant A549 cells harboring the p.G159R sequence variant exhibit markedly reduced EGFR phosphorylation, while the concomitant -6526N deletion in the promoter region of the KRAS gene further diminishes downstream MAPK signaling.",-33.25,0.01,sequencevariant
"Decreased expression of the tumor suppressor gene TP53 in HeLa cells harboring the p.G159R sequence variant was rescued by treatment with the DNA repair enhancer doxorubicin, revealing a direct link between the mutation and chemotherapeutic sensitivity.",-31.75,0.01,sequencevariant
"Deleterious sequence variants such as the p.G159R missense mutation, the -6526N deletion, and the indel polymorphism at position -4825 have been shown to disrupt the normal function of the TP53 gene, thereby increasing susceptibility to various cancers.",-33.5,0.01,sequencevariant
"Depletion of the p.G159R variant in the TP53 gene, coupled with a -6526N deletion in the promoter region, was associated with increased apoptosis in HeLa cells treated with doxorubicin.",-30.375,0.01,sequencevariant
"Deletion of the -6526N allele in the promoter of the CYP2D6 gene, together with the p.G159R missense variant in the coding region, synergistically reduces enzyme activity and increases the risk of drug-induced hepatotoxicity in patients with the rs35435463 polymorphism.",-42.25,0.01,sequencevariant
"p.G159R in the TP53 gene, a -6526N deletion in the promoter of the BRCA1 gene, and a V561X nonsense mutation in the EGFR coding sequence were all found to be associated with increased risk of breast cancer in the studied cohort.",-35.25,0.01,sequencevariant
"p.V159R in the TP53 gene, a missense sequence variant, was found to destabilize the protein’s DNA‑binding domain and correlate with increased tumorigenic potential in A549 cells.",-33.25,0.01,sequencevariant
"p.Val204Asp in the TP53 gene, a variant that has been shown to increase the risk of colorectal cancer in individuals carrying the rs35435463 allele, is frequently observed in sporadic colorectal tumors of Homo sapiens.",-37.25,0.01,sequencevariant
"p.Arg159Gly in the TP53 gene, a missense sequence variant, is predicted to destabilize the DNA‑binding domain and is associated with increased susceptibility to Li‑Fraumeni syndrome in a cohort of Homo sapiens patients.",-36.5,0.01,sequencevariant
"Induced pluripotent stem cells derived from a patient with the p.G159R sequence variant in the TCF7L2 gene exhibited impaired insulin‑signaling pathways, while CRISPR‑mediated correction of the variant restored normal glucose uptake.",-34.0,0.01,sequencevariant
"Indel polymorphism at position -4825 in the promoter of the CYP2D6 gene, together with the p.G159R missense variant in the coding region, has been shown to reduce enzyme activity and increase the risk of severe hepatotoxicity in patients treated with the antiepileptic drug carbamazepine.",-35.75,0.01,sequencevariant
"Induction of apoptosis in A549 cells was markedly enhanced by the p.G159R variant of TP53, which introduces a glycine-to-arginine substitution at codon‑159 and disrupts the DNA‑binding domain, thereby amplifying the transcriptional activation of BAX and the downstream caspase cascade.",-44.0,0.01,sequencevariant
"Indels such as the -6526N deletion and the p.G159R substitution in the TP53 gene have been shown to disrupt the DNA‑binding domain, thereby increasing the risk of colorectal carcinoma in individuals carrying the rs35435463 allele.",-36.25,0.01,sequencevariant
"Genome-wide association analysis revealed that the indel polymorphism at position –4825, together with the p.G159R substitution in the promoter of the CYP2D6 gene, significantly increases the risk of severe drug-induced hepatotoxicity in patients treated with the antipsychotic clozapine.",-34.75,0.01,sequencevariant
"Genome editing of the TP53 gene in HCT116 cells revealed that the p.G159R sequence variant, together with a -6526N deletion, markedly increased the frequency of apoptosis in response to doxorubicin treatment.",-36.0,0.01,sequencevariant
"Genome‑wide association analysis revealed that the indel polymorphism at position –4825, together with the p.G159R substitution in the promoter of the CYP2D6 gene, significantly increases the risk of severe drug‑induced hepatotoxicity in patients treated with the antipsychotic clozapine.",-32.75,0.01,sequencevariant
"Genome sequencing of a patient with early‑onset Parkinson’s disease revealed a novel sequence variant, p.G159R, in the LRRK2 gene that co‑occurs with a nearby indel polymorphism at position –4825, suggesting a compound heterozygous effect on protein stability.",-34.5,0.01,sequencevariant
"CRISPR‑mediated editing of the TP53 gene in HCT116 cells introduced a p.G159R sequence variant that, together with a -6526N deletion, disrupted the DNA‑binding domain and conferred resistance to doxorubicin.",-28.0,0.01,sequencevariant
CRTC1 c.1523_1524delinsG (p.G159R) and the -652_6Ndel indel polymorphism at the promoter of the HNF1A gene together confer a higher risk of early‑onset type‑2 diabetes in individuals carrying the rs35435463 SNP.,-57.25,0.01,sequencevariant
"CR1 rs35435463, a common indel polymorphism at position –4825, has been shown to modulate complement activation in patients carrying the p.G159R sequence variant of the C3 gene.",-33.0,0.01,sequencevariant
CRLF2 overexpression driven by the p.G159R sequence variant in the promoter region of the CRLF2 gene is associated with a higher risk of relapse in B‑cell acute lymphoblastic leukemia patients carrying the rs35435463 SNP.,-37.25,0.01,sequencevariant
Patients carrying the p.G159R sequence variant in the BRCA1 gene exhibit a markedly increased risk of early‑onset breast cancer compared with carriers of the wild‑type allele.,-16.625,0.01,sequencevariant
Patients harboring the p.G159R sequence variant in the BRCA1 gene exhibit a markedly increased risk of early‑onset breast cancer compared with carriers of the wild‑type allele.,-17.25,0.01,sequencevariant
Patients bearing the p.G159R sequence variant in the BRCA1 gene exhibit a markedly increased risk of early‑onset breast cancer compared with carriers of the wild‑type allele.,-21.75,0.01,sequencevariant
Patients with the p.G159R sequence variant in the BRCA1 gene exhibit a markedly increased risk of early‑onset breast cancer compared with carriers of the wild‑type allele.,-17.5,0.01,sequencevariant
"High‑throughput sequencing of the BRCA1 locus in a cohort of breast cancer patients revealed a novel indel polymorphism at position –4825, a four‑base‑pair insertion/deletion that co‑occurs with the pathogenic p.G159R missense mutation and is predicted to disrupt the regulatory enhancer of the gene.",-38.0,0.01,sequencevariant
"High-throughput sequencing of a colorectal cancer cohort revealed that the p.G159R missense variant in the APC gene, together with a -6526N deletion in the promoter of the MSH2 gene, co‑occurred in a subset of patients, suggesting a synergistic effect on mismatch repair deficiency.",-42.25,0.01,sequencevariant
"High‐throughput sequencing of the BRCA1 locus in a cohort of breast cancer patients revealed a novel indel polymorphism at position –4825, a four‑base‑pair insertion/deletion that co‑occurs with the pathogenic p.G159R missense mutation and is predicted to disrupt the regulatory enhancer of the gene.",-41.5,0.01,sequencevariant
"High-resolution sequencing of the BRCA1 locus in a cohort of breast cancer patients revealed a novel indel polymorphism at position –4825, a four‑base‑pair insertion/deletion that co‑occurs with the pathogenic p.G159R missense mutation and is predicted to disrupt the BRCA1‑associated protein‑binding domain.",-47.75,0.01,sequencevariant
"Cell‑line A549 harboring the BRCA1 p.G159R sequence variant exhibited markedly reduced DNA repair capacity, while the same variant in the TP53 gene (p.Val204Asp/p.Asp70Gly‑p.Ala539Thr) was associated with increased apoptosis in response to doxorubicin.",-36.25,0.01,sequencevariant
"Cellular assays revealed that the p.G159R sequence variant in the TP53 gene, together with the -6526N deletion in the promoter of the MDM2 gene, synergistically increased apoptosis in HeLa cells treated with doxorubicin.",-32.75,0.01,sequencevariant
"Cell line A549 harboring the BRCA1 p.G159R sequence variant exhibits increased sensitivity to the chemotherapeutic agent doxorubicin, whereas the same variant in the TP53 gene (p.Val204Asp) confers resistance to apoptosis in the same cellular context.",-29.25,0.01,sequencevariant
"CellA549 cells harboring the p.G159R sequence variant exhibit markedly increased sensitivity to the chemotherapeutic agent doxorubicin, whereas the same variant in the TP53 gene (p.Val204Asp) confers resistance to apoptosis in the same cell line.",-39.0,0.01,sequencevariant
"Mutation analysis of a colorectal carcinoma sample revealed a novel indel polymorphism at position –4825, a four‑base‑pair insertion/deletion that co‑occurs with the p.G159R substitution in the APC gene, and a V561X nonsense variant in the KRAS gene, all of which are predicted to disrupt protein function and contribute to tumor progression.",-40.5,0.01,sequencevariant
"Mutation of the BRCA1 gene harboring the p.G159R sequence variant, together with the -6526N deletion and the Asn127Ser substitution, was found to increase the risk of breast cancer in a cohort of Homo sapiens patients.",-31.375,0.01,sequencevariant
"Mutation p.G159R in the TP53 gene, together with the -6526N deletion in the promoter of the MDM2 gene, was found to increase the risk of early‑onset breast cancer in a cohort of Homo sapiens patients.",-30.875,0.01,sequencevariant
"Mutation rs35435463 in the promoter of the CYP2D6 gene, a -6526N deletion that creates a novel splice acceptor site, and the p.G159R substitution in the coding region of the ABCB1 transporter collectively reduce drug efflux capacity in HepG2 cells, thereby increasing intracellular doxorubicin accumulation and enhancing cytotoxicity.",-47.75,0.01,sequencevariant
